<SEC-DOCUMENT>0001193125-20-157787.txt : 20200602
<SEC-HEADER>0001193125-20-157787.hdr.sgml : 20200602
<ACCEPTANCE-DATETIME>20200602060820
ACCESSION NUMBER:		0001193125-20-157787
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		53
FILED AS OF DATE:		20200602
DATE AS OF CHANGE:		20200602

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PLIANT THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001746473
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				474272481
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-238146
		FILM NUMBER:		20935546

	BUSINESS ADDRESS:	
		STREET 1:		260 LITTLEFIELD AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-481-6770

	MAIL ADDRESS:	
		STREET 1:		260 LITTLEFIELD AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>d729258ds1a.htm
<DESCRIPTION>S-1/A
<TEXT>
<HTML><HEAD>
<TITLE>S-1/A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on June&nbsp;2, 2020 </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-238146</FONT> </B></P>
<P STYLE="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Amendment
No.&nbsp;2 to </B></P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">S-1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>PLIANT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of Registrant as specified in its charter) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>2834</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">47-4272481</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Primary Standard Industrial</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Classification Code Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>260 Littlefield Avenue </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>South San Francisco, CA 94080 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(650) <FONT STYLE="white-space:nowrap">481-6770</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address, including zip code and telephone number, including area code, of Registrant&#146;s principal executive offices) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Bernard Coulie, M.D., Ph.D. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>President and Chief Executive Officer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>260 Littlefield Avenue </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>South San Francisco, CA 94080 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(650) <FONT STYLE="white-space:nowrap">481-6770</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address, including zip code, and telephone number, including area code, of agent for service) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to: </I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Sam Zucker</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Deepa M. Rich</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>James
Xu</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Goodwin Procter LLP</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>601 Marshall Street</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Redwood
City, CA 94063</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(650) <FONT STYLE="white-space:nowrap">752-3100</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Keith Cummings, M.D.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Chief Financial Officer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>260 Littlefield Avenue</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>South San Francisco, CA 94080</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(650) <FONT STYLE="white-space:nowrap">481-6770</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Kristin VanderPas</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Sean Clayton</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>David
Peinsipp</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Charles S. Kim</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Cooley LLP</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>101 California
Street 5th Floor</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>San Francisco, CA 94111</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(415) <FONT STYLE="white-space:nowrap">693-2000</FONT></B></P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale to the public:</B> As soon as practicable after the effective date of this registration
statement. </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415
under the Securities Act of 1933 check the following box.&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If this Form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744;</P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering.&nbsp;&nbsp;&#9744;</P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT
STYLE="white-space:nowrap">non-accelerated</FONT> filer, a smaller reporting company, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company,&#148;
and &#147;emerging growth company&#148; in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated&nbsp;filer</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
</TABLE> <center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9744;</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF
REGISTRATION FEE </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of Each Class of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Securities to be Registered</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount&nbsp;to&nbsp;be<BR>Registered&nbsp;(1)</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed<BR>Maximum</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Offering Price<BR>Per&nbsp;Share(2)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed<BR>Maximum</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Aggregate<BR>Offering&nbsp;Price(3)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Registration&nbsp;Fee(4)</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Common Stock, par value $0.0001 per share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">10,350,000</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$16.00</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$165,600,000.00</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$21,494.88</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Includes 1,350,000 shares that the underwriters have the option to purchase. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Estimated solely for the purpose of computing the registration fee in accordance with Rule&nbsp;457(a) under the Securities Act of 1933, as amended. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(3)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Includes the aggregate offering price of 1,350,000 shares that the underwriters have the option to purchase. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(4)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Calculated pursuant to Rule 457(a) under the Securities Act of 1933 as amended. $14,329.92 of this registration fee was previously paid by the Registrant in connection with the filing of its Registration Statement on
Form&nbsp;S-1 on May&nbsp;26, 2020. </TD></TR></TABLE>  <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman"><B>The Registrant
hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become
effective in accordance with Section&nbsp;8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&nbsp;8(a),
may determine. </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><FONT COLOR="#de1a1e"><B>The information in this preliminary prospectus is not complete and may be changed. We may not
sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting offers to buy these securities in
any state or other jurisdiction where the offer or sale is not permitted. </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#de1a1e"><B>SUBJECT TO COMPLETION, DATED JUNE&nbsp;2, 2020 </B></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PRELIMINARY PROSPECTUS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g20r95.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>9,000,000 Shares </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:30pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">This is the initial public offering of our common stock. We are selling 9,000,000 shares of common stock. Prior to this offering there has been
no public market for our shares. We currently expect the initial public offering price to be between $14.00 and $16.00 per share of common stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">We have granted the underwriters an option to purchase up to 1,350,000 additional shares of common stock. The underwriters can exercise this
option at any time within 30&nbsp;days after the date of this prospectus. </P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">We have applied to list our common stock on The Nasdaq
Global Market under the symbol &#147;PLRX.&#148; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Investing in our
common stock involves risks. See &#147;<A HREF="#toc729258_3">Risk Factors</A>&#148; beginning on page&nbsp;13. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">We are an
&#147;emerging growth company&#148; as defined in the Jumpstart Our Business Startups Act of 2012 and, as such, we have elected to comply with certain reduced reporting requirements for this prospectus and may elect to do so in future filings. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the
accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Public Offering Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Underwriting Discounts and
Commissions<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Proceeds to Pliant Therapeutics, Inc. (before expenses)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See &#147;Underwriting&#148; for additional information regarding total underwriter compensation. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">Novartis Institutes for Biomedical Research, Inc., or Novartis, our strategic partner and one of our existing stockholders has agreed to
purchase $10.0&nbsp;million in shares of our common stock at the initial public offering price per share, in a private placement transaction that would close concurrently with, and be contingent and conditioned upon consummation of, this offering.
The sale of such shares to Novartis will not be registered under the Securities Act of 1933, as amended, and these shares will be subject to certain restrictions on transfer pursuant to applicable securities laws and these shares are subject to a
180-day lock-up agreement with the underwriters in this offering. The closing of this offering is not conditioned upon the closing of the proposed concurrent private placement. The underwriters will not receive any fees in connection with the sale
of shares to Novartis in the proposed concurrent private placement. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">The underwriters expect to deliver the shares of common stock to
purchasers on or about&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 through book-entry facilities of The Depository Trust Company. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><I>Joint Book-Running Managers </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:16pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:16pt">
<TD VALIGN="top"><B>Citigroup</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Cowen&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>Piper Sandler</B></TD></TR>
</TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><I>Lead Manager </I></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Needham&nbsp;&amp; Company </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P></center>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_1">Prospectus Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_2">The Offering</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_3">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_4">Cautionary Note Regarding Forward-looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_999">Market and Industry Data and Forecasts </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_5">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_6">Dividend Policy</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_7">Capitalization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_8">Dilution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_9">Selected Financial Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_10">Management&#146;s Discussion and Analysis of Financial Condition and Results
 of Operations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_11">Business</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_12">Management</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_13">Executive Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_13a">Director Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_14">Certain Relationships and Related Party Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_15">Principal Stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_16">Description of Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_17">Shares Eligible for Future Sale</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">201</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_18">Material U.S. Federal Income Tax Considerations to <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> holders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">203</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_19">Underwriting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">207</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_20">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_21">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_22">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc729258_23">Index to Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and the underwriters have not authorized anyone to provide any information other than that contained in
this prospectus or in any free writing prospectus prepared by or on behalf of us or to which we have referred you. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you.
We and the underwriters are not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus is accurate only as of the date on the front
cover of this prospectus. Our business, financial condition, results of operations and prospects may have changed since that date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For
investors outside of the United States: We have not, and the underwriters have not, done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other
than the United States. Persons outside of the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of common stock and the distribution of this
prospectus outside of the United States. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_1"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights information contained elsewhere in this prospectus and does not contain all of the information that you should
consider in making your investment decision. Before investing in our common stock, you should carefully read this entire prospectus, including our financial statements and the related notes included elsewhere in this prospectus. You should also
consider, among other things, the matters described in the sections entitled &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations.&#148; Unless otherwise stated, all references
to &#147;us,&#148; &#147;our,&#148; &#147;Pliant,&#148; &#147;we,&#148; the &#147;Company&#148; and similar designations refer to Pliant Therapeutics, Inc. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Overview </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a
clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Our initial focus is on treating fibrosis by inhibiting integrin-mediated activation of
<FONT STYLE="white-space:nowrap">TGF-&szlig;.</FONT> We have applied our deep understanding of fibrosis biology, along with our medicinal chemistry and translational medicine expertise to develop a set of proprietary tools designed to discover and <FONT
STYLE="white-space:nowrap">de-risk</FONT> product candidates quickly and efficiently. Our wholly-owned lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> is an oral small-molecule dual selective inhibitor of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrins that we are developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis, or
PSC. We have completed a Phase&nbsp;1a SAD/MAD trial and a Phase&nbsp;1b proof-of-mechanism trial of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in IPF and are recruiting two Phase&nbsp;2a trials in IPF. We submitted an investigational new
drug application, or IND, for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> for the treatment of PSC in March of 2020, and plan to initiate a Phase&nbsp;2a PSC trial in the second half of 2020, when it is feasible to do so in light of the
COVID-19 pandemic. Our second product candidate, <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> is a small-molecule selective inhibitor of
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> for the treatment of liver fibrosis associated with NASH, which we have partnered
with Novartis. <FONT STYLE="white-space:nowrap">PLN-1474</FONT> is currently undergoing a Phase&nbsp;1 trial with top-line data expected by the end of 2020, subject to the impact of the COVID-19 pandemic. In addition to our clinical programs, we
currently have preclinical integrin-based programs targeting oncology and muscular dystrophies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Fibrosis Background </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fibrosis refers to excessive scarring, often resulting from aberrant tissue repair processes. Fibrosis occurs when normal tissue repair
pathways become dysregulated, causing excessive collagen deposition in the affected organs and ultimately impairing their physiological function. Fibrosis occurs in many organ systems throughout the body including the lungs, liver, kidneys,
gastrointestinal tract, skin and muscles. While the exact pathologies for diseases in these organs vary, the development of fibrosis involves many common cell types and biochemical pathways including the transforming growth factor beta, or <FONT
STYLE="white-space:nowrap">TGF-&szlig;,</FONT> signaling pathway. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> and Integrins in Fibrosis
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling is the central pathway by which fibrosis occurs. <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> is a signaling molecule that is secreted by cells as an inactive complex and stored in the extra-cellular matrix. In healthy tissue, <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> is transiently
activated in response to tissue injury, resulting in collagen production and, ultimately, healing of the tissue. In fibrosis, however, <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> becomes continuously activated, leading to excess collagen
production, sometimes even in the absence of the initial tissue injury, which leads to thickening and stiffening of tissues. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There have
been a number of prior approaches to treating fibrosis through <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> inhibition, including through antibodies to <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> and its receptor. However, systemic
blockade of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling has shown significant toxicity due to effects on <FONT STYLE="white-space:nowrap">TGF-&szlig;&#146;s</FONT> normal physiologic functions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> can be activated by a class of cell surface proteins known as integrins. In certain
fibrotic diseases such as IPF and PSC, the integrins <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>, which are normally expressed at very low levels, have been
</P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shown to be upregulated and to cause the continuous activation of <FONT STYLE="white-space:nowrap">TGF-&szlig;.</FONT> We believe that, by inhibiting fibrosis-specific <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> activators such as <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>, it may be possible to block abnormal
<FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in fibrotic tissues without affecting <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling in healthy tissues. Historically, integrin drug development has been hampered by the
difficulty of developing integrin inhibitors that are both selective for specific integrins and bioavailable. We believe our pipeline of bioavailable, highly selective integrin inhibitors has the potential to address these challenges. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Our Pipeline </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g03k41.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">PLN-74809</FONT> in IPF and PSC </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our lead wholly-owned product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> is an oral small-molecule, dual-selective inhibitor
of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> that we are advancing in IPF and PSC. IPF is the most common and severe form of progressive pulmonary fibrosis, affecting
approximately 140,000 patients in the United States. The average life expectancy for patients with confirmed IPF is between three and five years. There are currently two U.S. Food and Drug Administration, or FDA, approved therapies for IPF. Both
have shown modest slowing of disease progression. However, both therapies have raised significant safety and tolerability concerns. PSC is a progressive liver disorder affecting approximately 30,000 to 45,000 patients in the United States. Patients
have a median survival of 10 to 12&nbsp;years without intervention and carry high lifetime risk of developing gastrointestinal malignancies. There are currently no <FONT STYLE="white-space:nowrap">FDA-approved</FONT> therapies for PSC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While expressed at very low levels in normal tissues, <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> are upregulated in the pulmonary tissues of IPF patients, and in the liver tissues of PSC patients. They both serve as activators of <FONT STYLE="white-space:nowrap">TGF-&szlig;,</FONT> leading to
increased collagen production and fibrosis in these tissues. By blocking <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation by both
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>, we believe <FONT STYLE="white-space:nowrap">PLN-74809</FONT> may slow and potentially halt the progression of fibrosis in these
patient populations. <FONT STYLE="white-space:nowrap">PLN-74809</FONT> has been granted orphan drug designation by the FDA for both IPF and PSC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have completed a Phase 1a single ascending dose, or SAD, multiple ascending dose, or MAD, and food effect clinical trial involving 85
healthy volunteers in which <FONT STYLE="white-space:nowrap">PLN-74809</FONT> was shown to be orally bioavailable and generally well tolerated with a half-life that may support once-daily dosing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have also completed a Phase 1b proof-of-mechanism trial in healthy volunteers evaluating PLN-74809&#146;s ability to inhibit TGF-&szlig;
activation as measured through pSMAD2/3 activation levels. pSMADs act as signaling </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
molecules directly downstream from the TGF-&szlig; receptor, and therefore pSMAD2/3 activation is used as a reliable biomarker for TGF-&szlig; activation. In the Phase 1b trial, PLN-74809 was
shown to inhibit TGF-&szlig; activation by up to 70% in alveolar macrophages collected from healthy volunteers, in a dose- and exposure-dependent manner. Additionally, PLN-74809 was well tolerated with only mild adverse events and no drug-related
adverse events. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are recruiting two Phase 2a trials of PLN-74809 in IPF. In the first of these trials, we plan to enroll IPF patients
and utilize a positron emission tomography, or PET, ligand to measure av&szlig;6 target engagement by PLN-74809 in the lungs post-treatment. The second trial is a 12-week double blind placebo-controlled trial recruiting IPF patients across up to
four cohorts consisting of up to three doses of PLN-74809 and one placebo and will evaluate safety, tolerability and pharmacokinetics, or PK. We also plan to employ exploratory efficacy endpoints including Quantitative Lung Fibrosis imaging
analysis, biomarkers and pulmonary function. We submitted an IND for PLN-74809 in PSC in March 2020 and plan to initiate a Phase&nbsp;2a trial in the second half of 2020, when it is feasible to do so in light of the impact of the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic. This trial will be a 12-week double blind placebo-controlled trial recruiting PSC patients across up to four cohorts consisting of up to three doses of PLN-74809 and one placebo and will evaluate
safety, tolerability and PK. We also plan to employ exploratory efficacy endpoints including biomarkers and evaluation of liver-stiffness. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>PLN-1474
in F3/F4 Liver Fibrosis Associated with NASH </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our second clinical-stage product candidate, PLN-1474, is a small-molecule, selective
inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> in development for treatment of stage F3/F4 liver fibrosis
associated with nonalcoholic steatohepatitis, or NASH. NASH is a more severe form of non-alcoholic fatty liver disease, or NAFLD. In October 2019, we entered into a license and collaboration agreement with Novartis Institutes for Biomedical
Research, Inc., or Novartis, in which Novartis licensed global rights to PLN-1474. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NASH is highly prevalent, affecting approximately
16.5&nbsp;million adults in the United States, including approximately 3.3&nbsp;million with stage F3/F4 fibrosis. The stage of fibrosis is the strongest predictor of liver-related morbidity and all-cause mortality in NASH. Patients with F3 and F4
fibrosis carry liver-related mortality risk that is 17 times and 42 times greater, respectively, than NASH patients without fibrosis. Therefore, we believe that treating F3/F4 liver fibrosis will have an impact on liver-related morbidity and
all-cause mortality in NASH. There are currently no approved therapies for NASH and the candidates in development to date have shown only modest antifibrotic effects in published clinical trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our collaboration with Novartis, Novartis will reimburse us for all development activities associated with the PLN-1474 Phase 1
trials and will be responsible for all development and commercialization activities following Phase 1 trials. In addition to PLN-1474, during the research term, Novartis will also collaborate with us on up to three separate integrin research
programs. Novartis will also pay us tiered royalties, on a product-by-product basis based on annual net sales of products, at percentages ranging from high-single digits to low teens of the applicable licensed products and mid-single digits to
high-single digits for any products resulting from the research programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> serves as an activator of TGF-&szlig; and its expression has been shown to be upregulated in activated hepatic stellate cells and
correlated with severity of liver fibrosis. By inhibiting <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>, we believe PLN-1474
could have a potent direct antifibrotic effect in advanced liver fibrosis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have shown through our assays of live human fibrotic liver
tissue that PLN-1474 is able to decrease the expression of pro-fibrotic genes such as <I>COL1A1</I>, the gene associated with the production of the most abundant type of collagen produced in fibrosis. We have also shown in multiple animal models of
NASH that PLN-1474 has a potent anti-fibrotic effect. Despite delays resulting from the COVID-19 pandemic, we are currently conducting a Phase 1 trial of PLN-1474 in healthy volunteers with data expected by the end of 2020. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to our clinical programs, we are developing two additional preclinical
integrin-based programs. The first of these is our oncology program. As TGF-&szlig; biology has been elucidated, it has become increasingly understood in the scientific literature that TGF-&szlig; plays an important anti-inflammatory role in the
tumor micro-environment, preventing T-cell infiltration and inhibiting release of various cytokines. This mechanism is becoming increasingly recognized as a potential cause of the resistance to checkpoint inhibitors such as <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-PD-1</FONT></FONT> therapies seen in many tumors. We are targeting the TGF-&szlig; activating integrin <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">8</SUB>, which is upregulated in certain tumors with the goal of sensitizing tumors to checkpoint inhibitors. This program has generated
positive data in preclinical tumor models and our candidate is currently undergoing IND-enabling studies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our second preclinical program
is an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor being developed for treatment of muscular dystrophies, including Duchenne Muscular Dystrophy. The target integrin is upregulated on muscle cells across multiple
muscular dystrophy indications, acting as a substitute for dystrophin and helping to anchor muscle cells to the extracellular matrix. The program utilizes an allosteric agonistic antibody to activate the target in order to augment the naturally
occurring compensatory mechanism. Because the antibody is not mutation specific, it could potentially be effective as a single therapy or in combination with other treatment modalities across multiple muscular dystrophy indications. This program is
currently in the candidate selection phase of development. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Our Approach and Capabilities </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our approach to drug development in fibrosis combines our deep knowledge of the biology of fibrosis with various cellular, tissue, and <I>in
vivo</I> assays developed in house to uncover pathways and potential targets. We have developed and utilized a quantitative fibrosis target expression atlas to identify and validate novel fibrosis targets. We have built a library of over 7,000
integrin inhibitors that we test against these identified targets to select potential candidates. In addition to our integrin library, we have a non-integrin based library of over 70,000 compounds that we also screen against non-integrin targets. We
evaluate potential candidates in a series of integrin selectivity assays, cell-based assays, precision cut tissue slices and animal models prior to advancing our product candidates into development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A key component of our de-risking strategy is our live fibrotic human tissue program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We obtain live fibrotic human tissue post-transplant through partnerships with research hospitals and organ tissue networks and utilize
proprietary protocols to maintain viability of these tissues for multiple days. We test our product candidates in this live tissue and measure multiple markers of antifibrotic activity, effectively bridging the gap between animal models and clinical
proof-of-concept. We believe data from these live fibrotic human tissue experiments will increase our confidence that the tested product candidates will show anti-fibrotic effects in patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once in the clinic, we seek to further <FONT STYLE="white-space:nowrap">de-risk</FONT> our programs by designing clinical trials that allow us
to show proof-of-mechanism in advance of clinical efficacy data. We utilize pharmacodynamic biomarkers and advanced imaging techniques, including positron emission tomography, or PET, to evaluate target engagement of our product candidates over
relatively short time periods and observe whether the product candidate is having its anticipated effect. We believe these collective capabilities uniquely allow us to (i)&nbsp;efficiently identify targets, (ii)&nbsp;optimize the potency and
selectivity of candidates and <FONT STYLE="white-space:nowrap">(iii)&nbsp;de-risk</FONT> product candidates in advance of clinical proof-of-concept. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pliant was founded in 2015 by world-renowned researchers Dean Sheppard, Rik Derynck, Bill DeGrado and Hal Chapman from the University of
California, San Francisco who bring broad experience in fibrosis biology </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and small-molecule chemistry among other related disciplines. In addition, we have built an executive team with highly relevant experience in drug discovery and clinical development. To date,
Pliant has raised over $220&nbsp;million from investors including, Third Rock Ventures, Cowen Healthcare Investments, Eventide Asset Management, Novartis, Redmile Group, Farallon Capital Management, Cormorant Asset Management, Surveyor Capital (a
Citadel company), Logos Capital, Schroder Adveq Management, Menlo Ventures, <FONT STYLE="white-space:nowrap">S-Cubed</FONT> Capital and Agent Capital. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Our Strategy </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our goal is
to become a world-leading fibrosis company, developing and commercializing disease-modifying therapies across a spectrum of fibrotic diseases. To achieve this, we are focused on the following key strategies: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Rapidly advance <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in IPF and PSC through clinical development and
commercialization. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Rapidly advance our second product candidate, <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> through Phase 1
for subsequent trials in NASH associated liver fibrosis. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Selectively evaluate additional partnerships in indications and geographies where we believe partners can add
commercial and/or development capabilities. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Explore opportunities for our pipeline assets in additional fibrotic indications. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Leverage our industry leading tools and capabilities to advance our mission of becoming a leading fibrosis
company. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Impact of the COVID-19 Pandemic on Our Operations </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The COVID-19 pandemic is causing significant industry-wide delays in clinical trials. There are multiple causes of these delays, including
reluctance of patients to enroll or continue in trials for fear of exposure to COVID-19, local and regional shelter-in-place orders and regulations that discourage, hamper, or prohibit patient visits, healthcare providers and health systems shifting
away from clinical trials toward the acute care of COVID-19 patients and the FDA and other regulators making product candidates for the treatment of COVID-19 a priority over product candidates unrelated to the pandemic. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are working closely with our contract research organizations, or CROs, manufacturers, investigators and clinical trial sites to assess the
full impact of the COVID-19 pandemic on timelines and expected costs for each of our programs. Our CROs are largely decentralized organizations and, to date, have not experienced significant impacts to their ability to support our trials. Our
manufacturers have experienced impacts to their operations, however, these operational challenges have had minimal impact on their ability to produce and deliver materials to us in a timely manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of the COVID-19 pandemic and shelter-in-place restrictions, commencement of enrollment of our clinical trials of PLN-74809 in IPF
and PSC has been delayed. We anticipate delays in site start-up activities of one to two quarters for both the PLN-74809 IPF and PSC Phase 2a trials, and we could experience slower than expected enrollment. In addition, after enrollment in these
trials, if patients contract COVID-19 during participation in our trials or are subject to isolation or shelter in place restrictions, this may cause them to drop out of our trials, miss scheduled doses or follow-up visits or otherwise fail to
follow trial protocols. If patients are unable to follow the trial protocols or if our trial results are otherwise disputed due to the effects of the COVID-19 pandemic or actions taken to mitigate its spread, the integrity of data from our trials
may be compromised or not accepted by the FDA or other regulatory authorities, which would represent a significant setback for the applicable program. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently focusing our efforts on completing site-readiness and conducting an
awareness campaign to generate interest in our trials. We are not aware of any of our directors or employees being infected with coronavirus, but the virus can remain asymptomatic for a significant period of time and methods and availability of
testing are continuing to evolve. Notwithstanding the current shelter-in-place orders, our directors or employees or their family members could become infected. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We note the high level of difficulty in projecting the effects of COVID-19 on our programs and our company, given the rapid and dramatic
evolution in the course and impact of the pandemic and the societal and governmental response to it. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For additional information, see the
section titled &#147;Business&#151;Impact of the COVID-19 Pandemic.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Risks Associated with Our Business </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business is subject to numerous risks that you should be aware of before making an investment decision. These risks are described more
fully in the section entitled &#147;Risk Factors.&#148; These risks include, among others: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We have a limited operating history, which may make it difficult to evaluate our prospects and likelihood of
success. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our business is highly dependent on the success of our lead product candidate,
<FONT STYLE="white-space:nowrap">PLN-74809,</FONT> as well as any other product candidates that we advance into the clinic. All of our product candidates will require significant additional preclinical and clinical development before we may be able
to seek regulatory approval for and launch a product commercially. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Clinical development involves a lengthy, complex and expensive process, with an uncertain outcome.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may incur additional costs or experience delays in completing, or ultimately be unable to complete, the
development and commercialization of PLN-74809 or any other product candidates. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could
be delayed or otherwise adversely affected. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We face substantial competition, which may result in others discovering, developing or commercializing products
before or more successfully than us. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We have entered into a collaboration agreement with Novartis for the development of PLN-1474, and may in the
future seek to enter into collaborations with third parties for the development and commercialization of other product candidates. If we fail to enter into such collaborations, or our collaborations are not successful, we may be unable to continue
development of such product candidates, we would not receive any contemplated milestone payments or royalties, and we could fail to capitalize on the market potential of such product candidates. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The outbreak of the novel coronavirus disease, COVID-19, could adversely impact our business, including our
preclinical studies and clinical trials. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If we lose key management personnel, or if we fail to recruit additional highly skilled personnel, our ability to
develop current product candidates or identify and develop new product candidates will be impaired, could result in loss of markets or market share and could make us less competitive. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our success depends in part on our ability to protect our intellectual property. It is difficult and costly to
protect our proprietary rights and technology, and we may not be able to ensure their protection. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Concurrent Private Placement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Novartis, our strategic partner and one of our existing stockholders, has agreed to purchase $10.0 million in shares of our common stock at
the initial public offering price per share, in a private placement transaction that would close concurrently with, and be contingent and conditioned upon consummation of, this offering, or the Concurrent Private Placement. The sale of such shares
to Novartis will not be registered under the Securities Act of 1933, as amended, and these shares will be subject to certain restrictions on transfer pursuant to applicable securities laws and these shares are subject to a 180-day lock-up agreement
with the underwriters in this offering. The closing of this offering is not conditioned upon the closing of the Concurrent Private Placement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Corporate History and Information </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were incorporated under the laws of the State of Delaware in June 2015. Our principal executive office is located at 260 Littlefield
Avenue, South San Francisco, California 94080, and our telephone number is <FONT STYLE="white-space:nowrap">(650)&nbsp;481-6770.</FONT> Our website address is https://pliantrx.com. We do not incorporate the information on or accessible through our
website into this prospectus, and you should not consider any information on, or that can be accessed through, our website as part of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We use various trademarks and trade names in our business, including without limitation our corporate name and logo. All other trademarks or
trade names referred to in this prospectus are the property of their respective owners. Solely for convenience, the trademarks and trade names in this prospectus may be referred to without the
<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and <I><SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP></I> symbols, but such references should not be construed as any indicator that their respective owners will not assert, to
the fullest extent under applicable law, their rights thereto. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Implications of Being an Emerging Growth Company and a Smaller Reporting
Company </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We qualify as an &#147;emerging growth company,&#148; or EGC, as defined in the Jumpstart Our Business Startups Act of 2012,
as amended, or the JOBS Act. As an EGC, we may take advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. These provisions include, but are not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">being permitted to present only two years of audited financial statements in this prospectus and only two years
of related &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; in our periodic reports and registration statements, including this prospectus; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not being required to comply with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley
Act of 2002, as amended; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements, and
registration statements, including in this prospectus; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder
approval of any golden parachute payments not previously approved. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may take advantage of these exemptions for up to
five years from the date of effectiveness of this registration statement or such earlier time that we are no longer an EGC. We will cease to be an EGC on the date that is the earliest of (i)&nbsp;the last day of the fiscal year in which we have
total annual gross revenues of $1.07&nbsp;billion or more; (ii)&nbsp;the last day of our fiscal year following the fifth anniversary of the date of the completion of this offering; (iii)&nbsp;the date on which we have issued more than
$1.0&nbsp;billion in nonconvertible debt during the previous three years; or (iv)&nbsp;the last day of the fiscal year in which we are deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission, or SEC, which
means the market value of our common stock that is held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $700&nbsp;million as of the prior June 30th. We may </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
choose to take advantage of some but not all of these exemptions. We have taken advantage of reduced reporting requirements in this prospectus. Accordingly, the information contained herein may
be different from the information you receive from other public companies in which you hold stock. In addition, the JOBS Act provides that an EGC can take advantage of an extended transition period for complying with new or revised accounting
standards. This provision allows an EGC to delay the adoption of some accounting standards until those standards would otherwise apply to private companies. We have elected to use this extended transition period for complying with new or revised
accounting standards that have different effective dates for public and private companies until the earlier of the date we (i) are no longer an EGC or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS
Act. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are also a &#147;smaller reporting company&#148; as defined in the Exchange Act. We may continue to be a smaller reporting company even
after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies until the fiscal year following the determination that our voting and <FONT
STYLE="white-space:nowrap">non-voting</FONT> common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is more than $250&nbsp;million measured on the last business day of our second fiscal quarter, or our annual revenues are less
than $100&nbsp;million during the most recently completed fiscal year and our voting and <FONT STYLE="white-space:nowrap">non-voting</FONT> common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is more than $700&nbsp;million
measured on the last business day of our second fiscal quarter. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_2"></A>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B></B>Common stock offered by us </P></TD>
<TD>9,000,000 shares. </TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Option to purchase additional shares </P></TD>
<TD>We have granted the underwriters an option to purchase up to 1,350,000 additional shares of common stock from us. The underwriters can exercise this option at any time within 30&nbsp;days from the date of this prospectus. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock to be outstanding immediately after this offering and the Concurrent Private Placement
</P></TD>
<TD><BR>34,243,012 shares (or 35,593,012 shares if the underwriters exercise their option to purchase additional shares in full). </TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>We estimate that we will receive net proceeds from the sale of our common stock in this offering of approximately $120.6&nbsp;million, or $139.4&nbsp;million if the underwriters exercise in full their option to purchase additional shares,
assuming an initial public offering price of $15.00 per share, the midpoint of the price range set forth on the cover page of this prospectus, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us.
In addition, we expect to receive net proceeds of $10.0 million from the sale of shares of our common stock to Novartis in the Concurrent Private Placement. We intend to use the net proceeds from this offering and the Concurrent Private Placement to
fund the clinical development of our lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> the preclinical development of our programs in oncology and muscular dystrophy, and the remainder, if any, for additional early-stage
research and development activities, for business development activities, working capital and other general corporate purposes. See the section entitled &#147;Use of Proceeds&#148; for additional information. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Concurrent Private Placement </P></TD>
<TD>Novartis, our strategic partner and one of our existing stockholders, has agreed to purchase $10.0 million in shares of our common stock (or 666,666 shares assuming an initial public offering price of $15.00, the midpoint of the price range set
forth on the cover page of this prospectus) at the initial public offering price per share, in the Concurrent Private Placement that would close concurrently with, and be contingent and conditioned upon consummation of, this offering. The sale of
such shares to Novartis will not be registered under the Securities Act of 1933, as amended, and these shares will be subject to certain restrictions on transfer pursuant to applicable securities laws and these shares are subject to a 180-day
lock-up agreement with the underwriters in this offering. The closing of this offering is not conditioned upon the closing of the Concurrent Private Placement. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </P></TD>
<TD>You should read carefully the section entitled &#147;Risk Factors&#148; and other information included in this prospectus for a discussion of factors that you should consider before deciding to invest in our common stock. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Proposed Nasdaq Global Market symbol </P></TD>
<TD>&#147;PLRX&#148; </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of our common stock to be outstanding after this offering and the
Concurrent Private Placement is based on 24,576,346 shares of common stock (including our redeemable convertible preferred stock on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis) outstanding as of March 31, 2020, and excludes: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">2,607,939 shares of our common stock issuable upon the exercise of options outstanding as of March 31, 2020,
under the 2015 Equity Incentive Plan, or the 2015 Plan, at a weighted-average exercise price of $4.69 per share, or pursuant to rights to purchase restricted stock at a weighted-average purchase price of $0.08 per share; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,047,247 shares of our common stock reserved for future issuance under the 2015 Plan as of March 31, 2020, which
shares will no longer be reserved upon the effectiveness of our 2020 Stock Option and Incentive Plan as described below; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4,200,000 shares of our common stock reserved for future issuance under our 2020 Stock Option and Incentive Plan,
or the 2020 Plan, which will become available for issuance upon the effectiveness of the registration statement of which this prospectus is a part; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">700,000 shares of our common stock reserved for future issuance under our 2020 Employee Stock Purchase Plan, or
the 2020 ESPP, which will become available for issuance upon the effectiveness of the registration statement of which this prospectus is a part. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our 2020 Plan and 2020 ESPP each provide for annual automatic increases in the number of shares of our common stock reserved thereunder and our
2020 Plan also provides for increases to the number of shares of common stock that may be granted thereunder based on shares underlying any awards under our 2020 Plan and 2015 Plan that expire, are forfeited or are otherwise terminated, as more
fully described in the section titled &#147;Executive Compensation&#151;Employee Benefits and Equity Compensation Plans.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless
otherwise indicated, this prospectus reflects and assumes the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-7.15</FONT></FONT> reverse stock split
of our common stock that was effected on May&nbsp;22, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the automatic conversion of all outstanding shares of our redeemable convertible preferred stock into an
aggregate of 22,432,029 shares of our common stock immediately prior to the completion of this offering; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuance of 666,666 shares of our common stock (assuming an initial public offering price of $15.00, the
midpoint of the price range set forth on the cover page of this prospectus) in the Concurrent Private Placement, which is to be completed concurrently with, and be contingent and conditioned upon consummation of, the closing of this offering;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise of the outstanding options or purchase rights described above; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise by the underwriters of their option to purchase up to 1,350,000 additional shares of our common stock
in this offering; and </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the filing and effectiveness of our amended and restated certificate of incorporation and the adoption of our
amended and restated bylaws, which will occur immediately prior to the completion of this offering. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise
indicated, the number of shares of common stock outstanding includes 237,997 unvested restricted shares of common stock subject to repurchase as of March 31, 2020. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Summary Financial Data </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables present summary financial data for our business. We have derived the summary statements of operations data for the years
ended December&nbsp;31, 2018 and 2019 from our audited financial statements included elsewhere in this prospectus. We have derived the summary statements of operations data for the three months ended March&nbsp;31, 2019 and 2020, and the summary
balance sheet data as of March&nbsp;31, 2020, from our unaudited condensed financial statements included elsewhere in this prospectus. We have prepared the unaudited condensed financial statements on the same basis as the audited financial
statements. We have included all adjustments consisting only of normal recurring adjustments that we consider necessary for a fair presentation of the financial information set forth in those unaudited condensed financial statements. Our historical
results are not necessarily indicative of the results that may be expected in the future and our operating results for the three months ended March&nbsp;31, 2020 are not necessarily indicative of the actual or expected results for the full year
ending December&nbsp;31, 2020 or any other interim periods or any future period. You should read this data together with our financial statements and related notes appearing elsewhere in this prospectus and the information in the sections entitled
&#147;Selected Financial Data&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(In thousands, except share and per share amounts)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years Ended</B><br><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months&nbsp;Ended</B><br><B>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Statements of Operations Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue&#151;related party</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,415</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,353</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,749</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,919</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,601</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,011</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,350</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Loss) income from operations</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,231</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,350</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (expense) income, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,023</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,876</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,344</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Undistributed earnings to preferred shareholders</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,029</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) income attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,856</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(15,367</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) income per share attributable to common stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10.90</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10.90</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used in computing net (loss) income per share attributable to common
stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,165,454 </TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,623,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,409,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,897,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR></TD>
<TD VALIGN="bottom" ALIGN="right">1,165,454<BR></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,623,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,409,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,897,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000; MARGIN-LEFT:0px; MARGIN-RIGHT:0px; max-width:100%">
<div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>(In thousands, except share and per share amounts)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended</B><br><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three<BR>Months&nbsp;Ended</B><br><B>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net (loss) income per share attributable to common stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares outstanding used in computing pro forma net income per share attributable
to common stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,510,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,829,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,510,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,861,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See Notes 2 and 16 to our audited financial statements and our condensed financial statements included elsewhere in this prospectus for an explanation of the calculations of our basic and diluted net (loss) income per
share, pro forma net (loss) income per share and the weighted-average number of shares used in the computation of the per share amounts. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(In thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of March&nbsp;31, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma<BR>As&nbsp;Adjusted<SUP STYLE="font-size:85%; vertical-align:top">(2)(4)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance Sheet Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">141,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">169,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">302,470</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">297,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">184,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">184,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313,877</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">238,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65,266</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65,266</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(67,807</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; (deficit) equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(64,751</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">173,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The pro forma column in the balance sheet data table above gives effect to (i)&nbsp;the automatic conversion of all outstanding shares of our redeemable convertible preferred stock as of March&nbsp;31, 2020 into an
aggregate of 22,432,029 shares of our common stock immediately prior to the completion of this offering as if such conversion had occurred as of March&nbsp;31, 2020; (ii)&nbsp;the filing and effectiveness of our amended and restated certificate of
incorporation, which will occur immediately prior to the completion of this offering; and (iii)&nbsp;the receipt of $27.8&nbsp;million in payments under the Novartis Agreement in the second quarter of 2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The pro forma as adjusted column in the balance sheet data table above gives effect to (i)&nbsp;the pro forma adjustments set forth in footnote (1)&nbsp;above; (ii)&nbsp;the issuance and sale of 9,000,000 shares of
common stock in this offering at an assumed initial public offering price of $15.00 per share, the midpoint of the price range set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and commissions and
estimated offering expenses payable by us and (iii) our sale of $10.0 million of our common stock in a Concurrent Private Placement to Novartis at the assumed offering price of $15.00 per share; and (iv)&nbsp;the payment of the milestone payment of
$2.4&nbsp;million in the second quarter of 2020 to the UC Regents, calculated using a price per share of $15.00, the midpoint of the price range set forth on the cover of this prospectus, multiplied by 162,738, an amount determined by calculating
2.0% of the Company&#146;s fully diluted outstanding shares as of a date defined in the license agreement with UCSF. See Note 7 to our condensed financial statements included elsewhere in this prospectus for additional information.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(3)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We define working capital as current assets less current liabilities. See our condensed financial statements and related notes appearing elsewhere in this prospectus for details regarding our current assets and current
liabilities. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(4)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Each $1.00 increase or decrease in the assumed initial public offering price of $15.00&nbsp;per share, the midpoint of the price range set forth on the cover page of this prospectus, would increase or decrease, as
applicable, the amount of each of cash and cash equivalents, working capital, total assets and total stockholders&#146; (deficit) equity by approximately $8.4&nbsp;million, assuming (i) the number of shares offered by us, as set forth on the cover
page of this prospectus, remains the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. We may also increase or decrease the number of shares we are offering. Each increase or decrease of
1.0&nbsp;million shares in the number of shares we are offering would increase or decrease, as applicable, the amount of each of cash and cash equivalents, working capital, total assets and total stockholders&#146; (deficit) equity by approximately
$14.0&nbsp;million, based on the assumed initial public offering price of $15.00 per share, the midpoint of the price range as set forth on the cover page of this prospectus, remains the same. The pro forma as adjusted information is illustrative
only, and we will adjust this information based on the actual initial public offering price and other terms of this offering determined at pricing. </TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_3"></A>RISK FACTORS</B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Investing in our common stock involves a high degree of risk. You should carefully consider the risks described below, as well as the other
information in this prospectus, including our financial statements and related notes appearing elsewhere in this prospectus and in the section entitled &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of
Operations,&#148; before deciding whether to invest in our common stock. The occurrence of any of the events or developments described below could harm our business, financial condition, results of operations and growth prospects. In such an event,
the market price of our common stock could decline and you may lose all or part of your investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Financial Position and Need for Additional Capital </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We have incurred significant net losses since inception and we expect to continue to incur significant net losses for the foreseeable
future. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have incurred significant net losses since our inception and have financed our operations principally through equity
financing.&nbsp;We continue to incur significant research and development and other expenses related to our ongoing operations. For the years ended December&nbsp;31, 2018 and 2019, we reported a net loss of $30.3 million and $0.6&nbsp;million,
respectively, and for the three months ended March 31, 2019 and 2020, we reported a net loss of $14.0 million and net income of $11.0 million, respectively. As of December&nbsp;31, 2019 and March 31, 2020, we had an accumulated deficit of
$76.3&nbsp;million and $65.3 million, respectively. We have devoted substantially all of our resources and efforts to research and development and we expect that it will be several years, if ever, before we generate revenue from product sales. Even
if we receive marketing approval for and commercialize one or more of our product candidates, we expect that we will continue to incur substantial research and development and other expenses in order to develop and market additional potential
product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to continue to incur significant losses for the foreseeable future, and we anticipate that our expenses
will increase substantially if, and as, we: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance the development of our lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> and our
second product candidate, PLN 1474, and our other product candidates through clinical development, and, if successful, later-stage clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">discover and develop new product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance our preclinical development programs into clinical development; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">experience delays or interruptions to preclinical studies, clinical trials, our receipt of services from our
third-party service providers on whom we rely, or our supply chain due to the COVID-19 pandemic; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">seek regulatory approvals for any product candidates that successfully complete clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">commercialize <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> our other product candidates and any future
product candidates, if approved; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increase the amount of research and development activities to identify and develop product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">hire additional clinical development, quality control, scientific and management personnel;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expand our operational, financial and management systems and increase personnel, including personnel to support
our clinical development and manufacturing efforts and our operations as a public company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish a sales, marketing, medical affairs and distribution infrastructure to commercialize any products for
which we may obtain marketing approval and intend to commercialize on our own or jointly with third parties; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">maintain, expand and protect our intellectual property portfolio; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">invest in or <FONT STYLE="white-space:nowrap">in-license</FONT> other technologies or product candidates.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To become and remain profitable, we must develop and eventually commercialize products with
significant market potential. This will require us to be successful in a range of challenging activities, including completing preclinical studies and clinical trials, obtaining marketing approval for product candidates, manufacturing, marketing and
selling products for which we may obtain marketing approval and satisfying any post-marketing requirements. We may never succeed in any or all of these activities and, even if we do, we may never generate revenue that is significant enough to
achieve profitability. If we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable would decrease the value of our company and could impair our
ability to raise capital, maintain our research and development efforts, expand our business or continue our operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Even if
this offering and the Concurrent Private Placement are successful, we will require substantial additional capital to finance our operations. If we are unable to raise such capital when needed, or on acceptable terms, we may be forced to delay,
reduce and/or eliminate one or more of our research and drug development programs, future commercialization efforts or other operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Developing biopharmaceutical products, including conducting preclinical studies and clinical trials, is a very time-consuming, expensive and
uncertain process that takes years to complete. Our operations have consumed substantial amounts of cash since inception. We expect our expenses to increase in connection with our ongoing activities, particularly as we conduct our planned clinical
trials of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and <FONT STYLE="white-space:nowrap">PLN-1474</FONT> and any future product candidates that we may develop, seek regulatory approvals for our product candidates and to launch and
commercialize any products for which we receive regulatory approval. Following this offering, we also expect to incur additional costs associated with operating as a public company. Accordingly, we will need to obtain substantial additional funding
in order to maintain our continuing operations. If we are unable to raise capital when needed or on acceptable terms, we may be forced to delay, reduce or eliminate one or more of our research and drug development programs or future
commercialization efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March 31, 2020, we had approximately $141.4&nbsp;million in cash, cash equivalents and short-term
investments. Based on our current operating plan, we believe that the net proceeds from this offering and the Concurrent Private Placement, together with existing cash, cash equivalents and short-term investments, will be sufficient to fund our
operating expenses and capital expenditure requirements into 2023. However, our future capital requirements and the period for which our existing resources will support our operations may vary significantly from what we expect, and we will in any
event require additional capital in order to complete clinical development of any of our current programs. Our monthly spending levels will vary based on new and ongoing development and corporate activities. Because the length of time and activities
associated with development of our product candidates is highly uncertain, we are unable to estimate the actual funds we will require for development, marketing and commercialization activities. Our future funding requirements, both near and
long-term, will depend on many factors, including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the initiation, progress, timing, costs and results of preclinical studies and clinical trials for our product
candidates;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the clinical development plans we establish for these product candidates;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timelines of our clinical trials and the overall costs to finish the clinical trials due to the COVID-19
pandemic; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number and characteristics of product candidates that we develop;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outcome, timing and cost of meeting regulatory requirements established by the U.S. Food and Drug
Administration, or FDA, and other comparable foreign regulatory authorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we are able to maintain our existing collaboration with Novartis and enter into additional collaboration
agreements and the terms of any such agreements;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of filing, prosecuting, defending and enforcing our patent claims and other intellectual property
rights;</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of defending intellectual property disputes, including patent infringement actions brought by third
parties against us or our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect of competing technological and market developments;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost and timing of completion of commercial-scale outsourced manufacturing activities;
and</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of establishing sales, marketing and distribution capabilities for any product candidates for which we
may receive regulatory approval in regions where we choose to commercialize our products on our own. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not have any
committed external source of funds or other support for our development efforts and we cannot be certain that additional funding will be available on acceptable terms, or at all. Until we can generate sufficient revenue to finance our cash
requirements, which we may never do, we expect to finance our future cash needs through a combination of public or private equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements and other marketing or
distribution arrangements. If we raise additional funds through public or private equity offerings, the terms of these securities may include liquidation or other preferences that adversely the rights of our common stockholders. Further, to the
extent that we raise additional capital through the sale of common stock or securities convertible or exchangeable into common stock, your ownership interest will be diluted. In addition, any debt financing may subject us to fixed payment
obligations and covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise additional capital through marketing and distribution
arrangements or other collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish certain valuable intellectual property or other rights to our product candidates, technologies, future revenue streams
or research programs or grant licenses on terms that may not be favorable to us. We also may be required to seek collaborators for any of our product candidates at an earlier stage than otherwise would be desirable or relinquish our rights to
product candidates or technologies that we otherwise would seek to develop or commercialize ourselves. Market volatility resulting from the COVID-19 pandemic or other factors could also adversely impact our ability to access capital as and when
needed. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly delay, scale back or discontinue the development or commercialization of one or more of our product candidates or
one or more of our other research and development initiatives. Any of the above events could significantly harm our business, prospects, financial condition and results of operations and cause the price of our common stock to decline. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The amount of our future losses is uncertain and our quarterly operating results may fluctuate significantly or may fall below the
expectations of investors or securities analysts, each of which may cause our stock price to fluctuate or decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our quarterly
and annual operating results may fluctuate significantly in the future due to a variety of factors, many of which are outside of our control and may be difficult to predict, including the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and success or failure of clinical trials for our product candidates or competing product candidates,
or any other change in the competitive landscape of our industry, including consolidation among our competitors or partners; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to successfully recruit and retain subjects for clinical trials, and any delays caused by
difficulties in such efforts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain marketing approval for our product candidates, and the timing and scope of any such
approvals we may receive; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and cost of, and level of investment in, research and development activities relating to our product
candidates, which may change from time to time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of manufacturing our product candidates, which may vary depending on the quantity of production and the
terms of our agreements with manufacturers; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract, hire and retain qualified personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expenditures that we will or may incur to develop additional product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the level of demand for our product candidates should they receive approval, which may vary significantly;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk/benefit profile, cost and reimbursement policies with respect to our product candidates, if approved,
and existing and potential future therapeutics that compete with our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">general market conditions or extraordinary external events, such as recessions or the COVID-19 pandemic;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the changing and volatile U.S. and global economic environments; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">future accounting pronouncements or changes in our accounting policies. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The cumulative effects of these factors could result in large fluctuations and unpredictability in our quarterly and annual operating results.
As a result, comparing our operating results on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">a&nbsp;period-to-period&nbsp;basis</FONT></FONT> may not be meaningful. This variability and unpredictability could also result in our
failing to meet the expectations of industry or financial analysts or investors for any period. If our revenue or operating results fall below the expectations of analysts or investors or below any forecasts we may provide to the market, or if the
forecasts we provide to the market are below the expectations of analysts or investors, the price of our common stock could decline substantially. Such a stock price decline could occur even when we have met any previously publicly stated guidance
we may provide. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Research and Development and the Biopharmaceutical Industry </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We have a limited operating history, which may make it difficult to evaluate our prospects and likelihood of success. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a clinical-stage biopharmaceutical company with a limited operating history. We were incorporated in 2015, have no products approved for
commercial sale and have not generated any revenue. Our operations to date have been limited to organizing and staffing our company, business planning, raising capital, establishing our intellectual property portfolio and performing research and
development of our product candidates and our technology related to transforming growth factor beta, or <FONT STYLE="white-space:nowrap">TGF-&szlig;,</FONT> signaling and integrin biology, medicinal chemistry, translational screening technologies,
and clinical insights to discover and develop novel therapies for the treatment of fibrosis. Our approach to the discovery and development of product candidates is unproven, and we do not know whether we will be able to develop any products of
commercial value.&nbsp;In addition, our lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> is in early clinical development for the treatment of IPF and preclinical development for the treatment of PSC, and our second product
candidate, <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> is in early clinical development. Both programs will require substantial additional development and clinical research time and resources before we would be able to apply for or receive
regulatory approvals and begin generating revenue from product sales. We have not yet demonstrated the ability to progress any product candidate through clinical trials. We are still in preclinical and early clinical development and may be unable to
obtain regulatory approval, manufacture a commercial scale product, or arrange for a third party to do so on our behalf, or conduct sales and marketing activities necessary for successful product commercialization. Investment in biopharmaceutical
product development is highly speculative because it entails substantial upfront capital expenditures and significant risk that any potential product candidate will fail to demonstrate adequate efficacy or an acceptable safety profile, gain
regulatory approval and become commercially viable. In addition, as a business with a limited operating history, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors and risks frequently
experienced by early-stage biopharmaceutical companies in rapidly evolving fields. Consequently, we have no meaningful history of operations upon which to evaluate our business, and predictions about our future success or viability may not be as
accurate as they could be if we had a longer operating history or a history of successfully developing and commercializing drug products. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our business is highly dependent on the success of our lead product candidate, <FONT
STYLE="white-space:nowrap">PLN-74809,</FONT> as well as <FONT STYLE="white-space:nowrap">PLN-1474</FONT> and any other product candidates that we advance into the clinic. All of our product candidates will require significant additional preclinical
and clinical development before we may be able to seek regulatory approval for and launch a product commercially. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently
have no products that are approved for commercial sale and may never be able to develop marketable products. We are very early in our development efforts and have only one product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> in
early clinical development. Because <FONT STYLE="white-space:nowrap">PLN-74809</FONT> is our lead product candidate, if <FONT STYLE="white-space:nowrap">PLN-74809</FONT> encounters safety or efficacy problems, development delays, regulatory issues
or other problems, our development plans and business would be significantly harmed. We have completed a Phase 1a SAD/MAD trial and a Phase 1b proof-of-mechanism trial of PLN-74809 in IPF and are recruiting two Phase 2a trials in IPF. We submitted
an IND for PLN-74809 for the treatment of primary sclerosing cholangitis, or PSC, in March 2020, and plan to initiate a Phase 2a PSC trial in the second half of 2020, when it is feasible to do so in light of the impact of the COVID-19 pandemic. We
are also collaborating with Novartis to develop <FONT STYLE="white-space:nowrap">PLN-1474</FONT> for liver fibrosis associated with nonalcoholic steatohepatitis, or NASH, and are currently evaluating PLN-1474 in Phase 1a SAD/MAD testing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before we can generate any revenue from sales of our lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> or any of our
other product candidates, we must undergo additional preclinical and clinical development, regulatory review and approval in one or more jurisdictions. In addition, if one or more of our product candidates are approved, we must ensure access to
sufficient commercial manufacturing capacity and conduct significant marketing efforts in connection with any commercial launch. These efforts will require substantial investment, and we may not have the financial resources to continue development
of our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may experience setbacks that could delay or prevent regulatory approval of, or our ability to
commercialize, our product candidates, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">negative or inconclusive results from our preclinical studies or clinical trials or the clinical trials of others
for product candidates similar to ours, leading to a decision or requirement to conduct additional preclinical testing or clinical trials or abandon a program; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product-related side effects experienced by subjects in our clinical trials or by individuals using drugs or
therapeutics similar to our product candidates;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in submitting INDs or comparable foreign applications or delays or failure in obtaining the necessary
approvals from regulators to commence a clinical trial, or a suspension or termination of a clinical trial once commenced; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">conditions imposed by the FDA or comparable foreign authorities regarding the scope or design of our clinical
trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in enrolling subjects in clinical trials, including due to the COVID-19 pandemic;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">high <FONT STYLE="white-space:nowrap">drop-out</FONT> rates of subjects from clinical trials;&nbsp;inadequate
supply or quality of product candidates or other materials necessary for the conduct of our clinical trials;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">greater than anticipated clinical trial costs;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">inability to compete with other therapies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">poor efficacy of our product candidates during clinical trials;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unfavorable FDA or other regulatory agency inspection and review of a clinical trial site;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure of our third-party contractors or investigators to comply with regulatory requirements or otherwise meet
their contractual obligations in a timely manner, or at all;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays related to the impact of the spread of the COVID-19 pandemic, including the impact of COVID-19 on the
FDA&#146;s ability to continue its normal operations; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays and changes in regulatory requirements, policy and guidelines, including the imposition of additional
regulatory oversight around clinical testing generally or with respect to our technology in particular; or</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">varying interpretations of data by the FDA and similar foreign regulatory agencies. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not have complete control over many of these factors, including certain aspects of clinical development and the regulatory submission
process, potential threats to our intellectual property rights and our manufacturing, marketing, distribution and sales efforts or that of any future collaborator. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our approach to drug discovery and development in the area of fibrotic diseases, with an initial focus on tissue-specific integrin
modulation and <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling inhibition, is unproven and may not result in marketable products. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our approach is designed to discover and develop targeted treatments for fibrosis with an initial focus on the antagonism of tissue-specific <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling through the inhibition of integrins known to mediate the release of activated <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> in fibrotic tissue. However, although multiple studies are
currently underway, to date, this mechanism has not been definitively proven to successfully treat fibrosis. Targeting integrins to treat fibrosis is a novel approach in a rapidly developing field, and there can be no assurance that we will not
experience currently unknown problems or delays in developing our product candidates, that such problems or delays will not result in unanticipated costs, or that any such development problems can be solved. We have only tested our lead product
candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> in healthy volunteers. Therefore, we may ultimately discover that our approach and any product candidates resulting therefrom do not possess properties required for therapeutic
effectiveness. As a result, we may never succeed in developing a marketable product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, while we have developed an extensive
panel of cell assays and precision cut tissue assays and have utilized animal models to uncover biological pathways, understood gene expression changes and optimized the potency and selectivity of our potential product candidates, there can be no
assurance that our technology will yield their intended benefits. While we believe our assays represent a differentiator in our approach to drug development, our approach has not yet been clinically proven to yield results. Our practice of
evaluating our product candidates in live human fibrotic tissue samples before advancing them into the clinic is intended to serve as a bridge between animal models and clinical proof-of-concept. However, there can be no assurance that positive
results observed from preclinical animal testing and human fibrotic tissue models will be replicated when a program is advanced into clinical development. In addition, our practice of utilizing live human fibrotic tissue as part of our development
efforts may become more widespread in the future, and this approach may be adopted and replicated by others, including our competitors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Studies involving human tissue samples may also be subject to institutional and government human subject privacy policies that may vary by
territory. We or our partners who provide us with human tissue samples, or conduct tissue and/or animal studies on our behalf, may be found to be in violation of one or more of these regulations or policies and may be subject to closure, censure or
other penalties. In some cases, these penalties could materially impact the performance, availability, or validity of studies conducted by us on our behalf. Even in the absence of violations resulting in penalties, regulatory and other authorities
may refuse to authorize the conduct or to accept the results of studies for regulatory or ethical reasons. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Clinical development
involves a lengthy, complex and expensive process, with an uncertain outcome. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To obtain the requisite regulatory approvals to
commercialize any product candidates, we must demonstrate through extensive preclinical studies and clinical trials that our product candidates are safe and effective in humans. Clinical testing is expensive and can take many years to complete, and
its outcome is inherently uncertain. In particular, the general approach for FDA approval of a new drug is dispositive data from two well-controlled, Phase&nbsp;3 clinical trials of the relevant drug in the relevant patient population. Phase&nbsp;3
clinical trials </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
typically involve hundreds of patients, have significant costs and take years to complete. A product candidate can fail at any stage of testing, even after observing promising signals of activity
in earlier preclinical studies or clinical trials. The results of preclinical studies and early clinical trials of our product candidates may not be predictive of the results of later-stage clinical trials. In addition, initial success in clinical
trials may not be indicative of results obtained when such trials are completed. There is typically an extremely high rate of attrition from the failure of product candidates proceeding through clinical trials. Product candidates in later stages of
clinical trials may fail to show the desired safety and efficacy profile despite having progressed through preclinical studies and initial clinical trials. A number of companies in the biopharmaceutical industry have suffered significant setbacks in
advanced clinical trials due to lack of efficacy or unacceptable safety issues, notwithstanding promising results in earlier trials. Most product candidates that commence clinical trials are never approved as products and there can be no assurance
that any of our future clinical trials will ultimately be successful or support further clinical development of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any of our other product candidates. Product candidates that appear promising in the
early phases of development may fail to reach the market for several reasons, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preclinical studies or clinical trials may show the product candidates to be less effective than expected
(e.g.,&nbsp;a clinical trial could fail to meet its primary endpoint(s)) or to have unacceptable side effects or toxicities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to establish clinical endpoints that applicable regulatory authorities would consider clinically
meaningful; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to receive the necessary regulatory approvals;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">manufacturing costs, formulation issues, pricing or reimbursement issues, or other factors that make a product
candidate uneconomical; and</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the proprietary rights of others and their competing products and technologies that may prevent one of our
product candidates from being commercialized. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, differences in trial design between early-stage clinical
trials and later-stage clinical trials make it difficult to extrapolate the results of earlier clinical trials to later clinical trials. Moreover, clinical data are often susceptible to varying interpretations and analyses, and many companies that
have believed their product candidates performed satisfactorily in clinical trials have nonetheless failed to obtain marketing approval of their products. Additionally, some of our trials may be open-label studies, where both the patient and
investigator know whether the patient is receiving the investigational product candidate or either an existing approved drug or placebo. Most typically, open-label clinical trials test only the investigational product candidate and sometimes do so
at different dose levels. Open-label clinical trials are subject to various limitations that may exaggerate any therapeutic effect as patients in open-label clinical trials are aware when they are receiving treatment. In addition, open-label
clinical trials may be subject to an &#147;investigator bias&#148; where those assessing and reviewing the physiological outcomes of the clinical trials are aware of which patients have received treatment and may interpret the information of the
treated group more favorably given this knowledge. Therefore, it is possible that positive results observed in open-label trials will not be replicated in later placebo-controlled trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the standards that the FDA and comparable foreign regulatory authorities use when regulating us require judgment and can change,
which makes it difficult to predict with certainty how they will be applied. Although we are initially focusing our efforts on development of small molecule drug products, we may in the future pursue development of biological products, including a
potential candidate for muscular dystrophies, which could make us subject to additional regulatory requirements. Any analysis we perform of data from preclinical and clinical activities is subject to confirmation and interpretation by regulatory
authorities, which could delay, limit or prevent regulatory approval. We may also encounter unexpected delays or increased costs due to new government regulations. Examples of such regulations include future legislation or administrative action, or
changes in FDA policy during the period of product development and FDA regulatory review. It is impossible to predict whether legislative changes will be enacted, or whether FDA or foreign regulations,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
guidance or interpretations will be changed, or what the impact of such changes, if any, may be. The FDA may also require a panel of experts, referred to as an Advisory Committee, to deliberate
on the adequacy of the safety and efficacy data to support approval. The opinion of the Advisory Committee, although not binding, may have a significant impact on our ability to obtain approval of any product candidates that we develop. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we seek to conduct clinical trials in foreign countries or pursue marketing approvals in foreign jurisdictions, we must comply with
numerous foreign regulatory requirements governing, among other things, the conduct of clinical trials, manufacturing and marketing authorization, pricing and third-party reimbursement. The foreign regulatory approval process varies among countries
and may include all of the risks associated with FDA approval described above as well as risks attributable to the satisfaction of local regulations in foreign jurisdictions. Moreover, the time required to obtain approval may differ from that
required to obtain FDA approval. Approval by the FDA does not ensure approval by regulatory authorities outside the United States and vice versa. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Successful completion of clinical trials is a prerequisite to submitting a marketing application to the FDA and similar marketing applications
to comparable foreign regulatory authorities, for each product candidate and, consequently, the ultimate approval and commercial marketing of any product candidates. We may experience negative or inconclusive results, which may result in our
deciding, or our being required by regulators, to conduct additional clinical studies or trials or abandon some or all of our product development programs, which could have a material adverse effect on our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development and
commercialization of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any other product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may experience delays
in initiating or completing clinical trials. We also may experience numerous unforeseen events during, or as a result of, any future clinical trials that could delay or prevent our ability to receive marketing approval or commercialize <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> or any other product candidates, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulators or institutional review boards, or IRBs, or ethics committees may not authorize us or our
investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA or other comparable regulatory authorities may disagree with our clinical trial design, including with
respect to dosing levels administered in our planned clinical trials, which may delay or prevent us from initiating our clinical trials with our originally intended trial design;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may experience delays in reaching, or fail to reach, agreement on acceptable terms with prospective trial
sites and prospective contract research organizations, or CROs, which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of subjects required for clinical trials of any product candidates may be larger than we anticipate or
subjects may drop out of these clinical trials or fail to return for post-treatment <FONT STYLE="white-space:nowrap">follow-up</FONT> at a higher rate than we anticipate;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations
to us in a timely manner, or at all, or may deviate from the clinical trial protocol or drop out of the trial, which may require that we add new clinical trial sites or investigators;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">due to the impact of the COVID-19 pandemic, we have experienced, and may continue to experience, delays and
interruptions to our preclinical studies and clinical trials, we may experience delays or interruptions to our manufacturing supply chain, or we could suffer delays in reaching, or we may fail to reach, agreement on acceptable terms with third-party
service providers on whom we rely; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additional delays and interruptions to our clinical trials could extend the duration of the trials and increase
the overall costs to finish the trials as our fixed costs are not substantially reduced during delays; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may elect to, or regulators, IRBs, Data Safety Monitoring Boards, or DSMBs, or ethics committees may require
that we or our investigators, suspend or terminate clinical research or trials for various </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may not have the financial resources available to begin and complete the planned trials, or the cost of
clinical trials of any product candidates may be greater than we anticipate;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the supply or quality of our product candidates or other materials necessary to conduct clinical trials of our
product candidates may be insufficient or inadequate to initiate or complete a given clinical trial; and</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA or other comparable foreign regulatory authorities may require us to submit additional data such as
long-term toxicology studies, or impose other requirements before permitting us to initiate a clinical trial. </P></TD></TR></TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
product development costs will increase if we experience additional delays in clinical testing or in obtaining marketing approvals. We do not know whether any of our clinical trials will begin as planned, will need to be restructured or will be
completed on schedule, or at all. If we do not achieve our product development goals in the time frames we announce and expect, the approval and commercialization of our product candidates may be delayed or prevented entirely. Significant clinical
trial delays also could shorten any periods during which we may have the exclusive right to commercialize our product candidates and may allow our competitors to bring products to market before we do, potentially impairing our ability to
successfully commercialize our product candidates and harming our business and results of operations. Any delays in our clinical development programs may harm our business, financial condition and results of operations significantly. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our ongoing and future clinical trials may reveal significant adverse events or unexpected drug-drug interactions not seen in our
preclinical studies and may result in a safety profile that could delay or prevent regulatory approval or market acceptance of any of our product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We completed our Phase 1a clinical trial of our lead product candidate <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in healthy volunteers,
and, with the exception of a number of reported minor adverse events, the product candidate was observed to be generally well-tolerated across all doses in 71 trial participants. However, if significant adverse events or other side effects are
observed in any of our ongoing or future clinical trials, we may have difficulty recruiting patients to our clinical trials, patients may drop out of our trials, or we may be required to abandon the trials or our development efforts altogether. In
addition, in our planned Phase 2a clinical trials, we expect to evaluate <FONT STYLE="white-space:nowrap">PLN-74809</FONT> administered with approved IPF agents. As a result, we may encounter unexpected drug-drug interactions in our planned trials,
and may be required to further test these candidates, including in drug-drug interaction studies, which may be expensive, time-consuming and result in delays to our programs. Some potential therapeutics developed in the biopharmaceutical industry
that initially showed therapeutic promise in early-stage trials have later been found to cause side effects that prevented their further development. Even if the side effects do not preclude the product candidate from obtaining or maintaining
marketing approval, undesirable side effects may inhibit market acceptance of the approved product due to its tolerability versus other therapies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or
otherwise adversely affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may experience difficulties in patient enrollment in our clinical trials for a variety of
reasons. The timely completion of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of patients who remain in the trial until its conclusion. The enrollment of patients
depends on many factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patient eligibility and exclusion criteria defined in the protocol;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size of the patient population required for analysis of the trial&#146;s primary endpoints and the process
for identifying patients;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the willingness or availability (including legality under applicable COVID-19 shelter-in-place regulations) of
patients to participate in our trials (including due to fears of contracting COVID-19); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the proximity of patients to trial sites;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the design of the trial;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to recruit clinical trial investigators with the appropriate competencies and
experience;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">clinicians&#146; and patients&#146; perceptions as to the potential advantages and risks of the product candidate
being studied in relation to other available therapies, including any new products that may be approved for the indications we are investigating;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of competing commercially available therapies and other competing product candidates&#146;
clinical trials;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain and maintain patient informed consents; and</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that patients enrolled in clinical trials will drop out of the trials before completion.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For example, we are initially developing <FONT STYLE="white-space:nowrap">PLN-74809</FONT> for the treatment of IPF and
PSC, each of which is an orphan indication. In the United States, IPF is estimated to affect approximately 140,000 patients, while PSC is estimated to affect approximately 30,000 to 45,000 patients. As a result, we may encounter difficulties
enrolling subjects in our clinical trials of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> due, in part, to the small size of these patient populations. In addition, our clinical trials will compete with other clinical trials for product
candidates that are in the same therapeutic areas as our product candidates, and this competition will reduce the number and types of patients available to us, because some patients who might have opted to enroll in our trials may instead opt to
enroll in a trial being conducted by one of our competitors. Since the number of qualified clinical investigators is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which
will reduce the number of patients who are available for our clinical trials in such clinical trial site. Certain of our planned clinical trials may also involve invasive procedures such as bronchoscopy and broncho-alveolar lavage, or BAL,
procedure, which may lead some patients to drop out of trials to avoid these follow-up procedures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, timely enrollment in clinical
trials is reliant on clinical trial sites which may be adversely affected by global health matters, including, among other things, pandemics. For example, our clinical trial sites have been affected by the COVID-19 pandemic. Commencement of
enrollment of our clinical trials of PLN-74809 in IPF and PSC has been delayed. We anticipate delays in site start-up activities of one to two quarters for both the PLN-74809 IPF and PSC Phase&nbsp;2a trials, and we could experience slower than
expected enrollment. In addition, after enrollment in these trials, if patients contract COVID-19 during participation in our trials or are subject to isolation or shelter-in-place restrictions, this may cause them to drop out of our trials, miss
scheduled doses or follow-up visits or otherwise fail to follow trial protocols. If patients are unable to follow the trial protocols or if our trial results are otherwise disputed due to the effects of the COVID-19 pandemic or actions taken to
mitigate its spread, the integrity of data from our trials may be compromised or not accepted by the FDA or other regulatory authorities, which would represent a significant setback for the applicable program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some factors from the COVID-19 pandemic that we believe may adversely affect enrollment in our trials include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the diversion of healthcare resources away from the conduct of clinical trial matters to focus on pandemic
concerns, including the attention of infectious disease physicians serving as our clinical trial investigators, hospitals serving as our clinical trial sites and hospital staff supporting the conduct of our clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">given that our clinical trials target respiratory indications, patients who would otherwise be candidates for
enrollment in our clinical trials, may become infected with coronavirus, which may kill some patients and render others too ill to participate, limiting the available pool of participants for our trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inability of patients to come to hospitals and universities to participate in our trial, which may force us
to conduct our trials in patients&#146; homes, rendering the trials more difficult and costly to conduct; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limitations on travel that interrupt key trial activities, such as clinical trial site initiations and
monitoring; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruption in global shipping affecting the transport of clinical trial materials, such as investigational drug
product and comparator drugs used in our trials; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">employee furlough days that delay necessary interactions with local regulators, ethics committees and other
important agencies and contractors. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These and other factors arising from the COVID-19 pandemic could worsen in
countries that are already afflicted with the virus or could continue to spread to additional countries, each of which may further adversely impact our clinical trials. The global outbreak of the COVID-19 pandemic continues to evolve and the conduct
of our trials may continue to be adversely affected, despite efforts to mitigate this impact. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The design or execution of our
ongoing and future clinical trials may not support marketing approval. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The design or execution of a clinical trial can determine
whether its results will support marketing approval, and flaws in the design or execution of a clinical trial may not become apparent until the clinical trial is well advanced. We are currently recruiting two Phase 2a trials of PLN-74809 in IPF,
subject to the impact of the COVID-19 pandemic. In the first of these trials, we plan to enroll IPF patients and utilize a positron emission tomography, or PET, ligand to measure av&szlig;6 target engagement by PLN-74809 in the lungs post-treatment.
The second trial is a 12-week double blind placebo-controlled trial recruiting IPF patients across up to four cohorts consisting of up to three doses of PLN-74809 and one placebo and will evaluate safety, tolerability and pharmacokinetics, or PK. It
is possible that we may need to amend our clinical trial, which would require us to resubmit our clinical trial protocols to IRBs for reexamination, and may impact the costs, timing or successful completion of such clinical trial. In addition, we
may desire to test <FONT STYLE="white-space:nowrap">PLN-74809</FONT> at doses exceeding those evaluated in the Phase&nbsp;1a trial, and may not be able to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, in some instances, there can be significant variability in safety or efficacy results between different trials with the same
product candidate due to numerous factors, including differences in trial protocols, size and type of the patient populations, variable adherence to the dosing regimen or other protocol requirements and the rate of dropout among clinical trial
participants. We do not know whether any clinical trials we conduct will demonstrate consistent or adequate efficacy and safety to obtain marketing approval to market our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, the FDA and comparable foreign regulatory authorities have substantial discretion in the approval process and in determining when or
whether marketing approval will be obtained for any of our product candidates. Our product candidates may not be approved even if they achieve their primary endpoints in future Phase&nbsp;3 clinical trials or registrational trials. The FDA or
comparable foreign regulatory authorities may disagree with our trial designs and our interpretation of data from preclinical studies or clinical trials. In addition, any of these regulatory authorities may change requirements for the approval of a
product candidate even after reviewing and providing comments or advice on a protocol for a pivotal Phase&nbsp;3 or registrational clinical trial. In addition, any of these regulatory authorities may also approve a product candidate for fewer or
more limited indications than we request or may grant approval contingent on the performance of costly post-marketing clinical trials. The FDA or comparable foreign regulatory authorities may not approve the labeling claims that we believe would be
necessary or desirable for the successful commercialization of our product candidates, if approved. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delays in patient enrollment may
result in increased costs or may affect the timing or outcome of our future clinical trials, which could prevent completion of these trials and adversely affect our ability to advance the development of our product candidates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Although we have received U.S. orphan drug designation for <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> for IPF and PSC indications, we may be unable to obtain and maintain orphan drug designation for our other product candidates and, even if we obtain such designation, we may not be able to realize the
benefits of such designation, including potential marketing exclusivity of our product candidates, if approved. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Regulatory
authorities in some jurisdictions, including the United States and other major markets, may designate drugs intended to treat conditions or diseases affecting relatively small patient populations as orphan drugs. Under the Orphan Drug Act of 1983,
the FDA may designate a product candidate as an orphan drug if it is intended to treat a rare disease or condition, which is generally defined as having a patient population of fewer than 200,000 individuals in the United States, or a patient
population greater than 200,000 in the United States where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we have received U.S. orphan drug designation for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> for IPF and PSC indications, the
designation of any of our product candidates as an orphan drug does not mean that any regulatory agency will accelerate regulatory review of, or ultimately approve, that product candidate, nor does it limit the ability of any regulatory agency to
grant orphan drug designation to product candidates of other companies that treat the same indications as our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, if a product candidate with an orphan drug designation receives the first marketing approval for the indication for which it has
such designation, the product is entitled to a period of marketing exclusivity, which precludes the FDA or foreign regulatory authorities from approving another marketing application for a product that constitutes the same drug treating the same
indication for that marketing exclusivity period, except in limited circumstances. The applicable period is seven years in the United States. Orphan drug exclusivity may be revoked if any regulatory agency determines that the request for designation
was materially defective or if the manufacturer is unable to assure sufficient quantity of the product to meet the needs of patients with the rare disease or condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if we obtain orphan drug exclusivity for a product candidate, that exclusivity may not effectively protect the product candidate from
competition because different drugs can be approved for the same condition in the United States. Even after an orphan drug is approved, the FDA may subsequently approve another drug for the same condition if the FDA concludes that the latter drug is
not the same drug or is clinically superior in that it is shown to be safer, more effective or makes a major contribution to patient care. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Changes in methods of product candidate manufacturing or formulation may result in additional costs or delay. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As product candidates progress through preclinical to late stage clinical trials to marketing approval and commercialization, it is common that
various aspects of the development program, such as manufacturing methods and formulation, are altered along the way in an effort to optimize yield, manufacturing batch size, minimize costs and achieve consistent quality and results. Such changes
carry the risk that they will not achieve these intended objectives. Any of these changes could cause our product candidates to perform differently and affect the results of planned clinical trials or other future clinical trials conducted with the
altered materials. This could delay completion of clinical trials, require the conduct of bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay approval of our product candidates and
jeopardize our ability to commercialize our product candidates and generate revenue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, there are risks associated with large
scale manufacturing for clinical trials or commercial scale including, among others, cost overruns, potential problems with <FONT STYLE="white-space:nowrap">process&nbsp;scale-up,&nbsp;process</FONT> reproducibility, stability issues, compliance
with good manufacturing practices, lot consistency and timely availability of raw materials. Even if we obtain marketing approval for any of our product candidates, there is no assurance that our manufacturers will be able to manufacture the
approved product to specifications acceptable to the FDA or other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
comparable foreign regulatory authorities, to produce it in sufficient quantities to meet the requirements for the potential commercial launch of the product or to meet potential future demand.
Additionally, if we advance a biological candidate into IND-enabling studies, the manufacturing processes for biological products is more complex and expensive than with small molecule products and additional manufacturing suppliers may be needed to
manufacture clinical supplies for these programs. If our manufacturers are unable to produce sufficient quantities for clinical trials or for commercialization, our development and commercialization efforts would be impaired, which would have an
adverse effect on our business, financial condition, results of operations and growth prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may not be successful in our
efforts to identify or discover additional product candidates in the future. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our research programs may initially show promise in
identifying potential product candidates, yet fail to yield product candidates for clinical development for a number of reasons, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inability to design such product candidates with the pharmacological properties that we desire or attractive
pharmacokinetics; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potential product candidates may, on further study, be shown to have harmful side effects or other
characteristics that indicate that they are unlikely to be medicines that will receive marketing approval and achieve market acceptance. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research programs to identify new product candidates require substantial technical, financial and human resources. If we are unable to
identify suitable compounds for preclinical and clinical development, we will not be able to obtain product revenue in future periods, which likely would result in significant harm to our financial position and adversely impact our stock price. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Due to our limited resources and access to capital, we must make decisions on the allocation of resources to certain programs and
product candidates; these decisions may prove to be wrong and may adversely affect our business. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have limited financial and
human resources and intend to initially focus on research programs and product candidates for a limited set of indications. As a result, we may forgo or delay pursuit of opportunities with other product candidates or for other indications that later
prove to have greater commercial potential or a greater likelihood of success. In addition, we seek to accelerate our development timelines, including by initiating certain clinical trials of our product candidates before earlier-stage studies have
been completed. This approach may cause us to commit significant resources to prepare for and conduct later-stage trials for one or more product candidates that subsequently fail earlier-stage clinical testing. Therefore, our resource allocation
decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities, or expend resources on product candidates that are not viable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There can be no assurance that we will ever be able to identify additional therapeutic opportunities for our product candidates or to develop
suitable potential product candidates through internal research programs, which could materially adversely affect our future growth and prospects. We may focus our efforts and resources on potential product candidates or other potential programs
that ultimately prove to be unsuccessful. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If product liability lawsuits are brought against us, we may incur substantial financial
or other liabilities and may be required to limit commercialization of our product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We face an inherent risk of product
liability as a result of testing <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and any of our other product candidates in clinical trials, and will face an even greater risk if we commercialize any products. For example, we may be sued if our
product candidates cause or are perceived to cause injury or are found to be otherwise unsuitable during clinical trials, manufacturing, marketing or sale. Any such product liability claims may include
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability or a breach of warranties. Claims could also be
asserted under state consumer protection acts. If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit commercialization of our product candidates. Even successful
defense would require significant financial and management resources. Regardless of the merits or eventual outcome, liability claims may result in: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">inability to bring a product candidate to the market;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">decreased demand for our products;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injury to our reputation;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">withdrawal of clinical trial participants and inability to continue clinical trials;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">initiation of investigations by regulators; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fines, injunctions or criminal penalties; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs to defend the related litigation;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">diversion of management&#146;s time and our resources;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">substantial monetary awards to trial participants;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product recalls, withdrawals or labeling, marketing or promotional restrictions;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">loss of revenue;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exhaustion of any available insurance and our capital resources;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inability to commercialize any product candidate, if approved; and</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">decline in our share price. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our inability to obtain sufficient product liability insurance at an acceptable cost to protect against potential product liability claims
could prevent or inhibit the commercialization of products we develop. We will need to obtain additional insurance for clinical trials as <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and PLN-1474 continue clinical development and as additional
product candidates enter the clinic. However, we may be unable to obtain, or may obtain on unfavorable terms, clinical trial insurance in amounts adequate to cover any liabilities from any of our clinical trials. Our insurance policies may also have
various exclusions, and we may be subject to a product liability claim for which we have no coverage. We may have to pay any amounts awarded by a court or negotiated in a settlement that exceed our coverage limitations or that are not covered by our
insurance, and we may not have, or be able to obtain, sufficient capital to pay such amounts. Even if our agreements with any future corporate collaborators entitle us to indemnification against losses, such indemnification may not be available or
adequate should any claim arise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We face substantial competition, which may result in others discovering, developing or
commercializing products before or more successfully than us. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The development and commercialization of new drug products is highly
competitive. We may face competition with respect to any product candidates that we seek to develop or commercialize in the future from major biopharmaceutical companies, specialty biopharmaceutical companies, and biotechnology companies worldwide.
Potential competitors also include academic institutions, government agencies, and other public and private research organizations that conduct research, seek patent protection, and establish collaborative arrangements for research, development,
manufacturing, and commercialization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are a number of large biopharmaceutical and biotechnology companies that are currently
pursuing the development of products for the treatment of fibrosis. Companies that we are aware of that are targeting the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
treatment of various fibrosis indications through inhibiting various parts of the TGF-&szlig; pathway include large companies with significant financial resources such as Biogen, Inc., AbbVie
Inc., Gilead Sciences, Inc., Indalo Therapeutics, Inc., FibroGen, Inc., Galapagos NV, Bristol Myers Squibb Co., and Novartis AG. However, we know of no other companies currently in clinical development with an orally bioavailable small-molecule,
selective integrin inhibitor. For additional information regarding our competition, see &#147;Business&#151;Competition.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many of
our current or potential competitors, either alone or with their strategic partners, have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining
regulatory approvals, and marketing approved products than we do. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mergers and acquisitions in the biopharmaceutical and biotechnology
industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and
established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring
technologies complementary to, or necessary for, our programs. Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, more convenient, or less expensive than
any products that we may develop. Furthermore, products currently approved for other indications could be discovered to be effective treatments of fibrosis as well, which could give such products significant regulatory and market timing advantages
over <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or other product candidates that we may identify. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours and may
do, which could result in our competitors establishing a strong market position before we are able to enter the market. Additionally, products or technologies developed by our competitors may render our potential product candidates uneconomical or
obsolete and we may not be successful in marketing any product candidates we may develop against competitors. The availability of competitive products could limit the demand, and the price we are able to charge, for any products that we may develop
and commercialize. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Marketing, Reimbursement, Healthcare Regulations and Ongoing Regulatory Compliance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Even if a product candidate we develop receives marketing approval, it may fail to achieve the degree of market acceptance by physicians,
patients, third-party payors and others in the medical community necessary for commercial success. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> or any other product candidate we develop receives marketing approval, it may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payors, such as Medicare and
Medicaid programs and managed care organizations, and others in the medical community. In addition, the availability of coverage by third-party payors may be affected by existing and future health care reform measures designed to reduce the cost of
health care. If the product candidates we develop do not achieve an adequate level of acceptance, we may not generate significant product revenues and we may not become profitable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The degree of market acceptance of any product candidate, if approved for commercial sale, will depend on a number of factors, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">efficacy and potential advantages compared to alternative treatments;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to offer our products, if approved, for sale at competitive prices;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">convenience and ease of administration compared to alternative treatments;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the willingness of the target patient population to try new therapies and of physicians to prescribe these
therapies;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the recommendations with respect to our product candidates in guidelines published by various scientific
organizations applicable to us and our product candidates; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the strength of marketing and distribution support;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to obtain sufficient third-party coverage and adequate reimbursement; and</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the prevalence and severity of any side effects. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If government and other third-party payors do not provide coverage and adequate reimbursement levels for any products we commercialize, market
acceptance and commercial success would be reduced. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Coverage and reimbursement may be limited or unavailable in certain market
segments for our product candidates, if approved, which could make it difficult for us to sell any product candidates profitably. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Significant uncertainty exists as to the coverage and reimbursement status of any products for which we may obtain regulatory approval. In the
U.S., sales of any products for which we may receive regulatory marketing approval will depend, in part, on the availability of coverage and reimbursement from third-party payors. Third-party payors include government authorities such as Medicare,
Medicaid, TRICARE, and the Veterans Administration, managed care providers, private health insurers, and other organizations. Patients who are provided medical treatment for their conditions generally rely on third-party payors to reimburse all or
part of the costs associated with their treatment. Coverage and adequate reimbursement from governmental healthcare programs, such as Medicare and Medicaid, and commercial payors is critical to new product acceptance. Patients are unlikely to use
our product candidates unless coverage is provided and reimbursement is adequate to cover a significant portion of the cost. We cannot be sure that coverage and reimbursement will be available for, or accurately estimate the potential revenue from,
our product candidates or assure that coverage and reimbursement will be available for any product that we may develop. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Government
authorities and other third-party payors decide which drugs and treatments they will cover and the amount of reimbursement. Coverage and reimbursement by a third-party payor may depend upon a number of factors, including the third-party payor&#146;s
determination that use of a product is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a covered benefit under its health plan;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">safe, effective and medically necessary;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appropriate for the specific patient;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cost-effective; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">neither experimental nor investigational. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, no uniform policy of coverage and reimbursement for products exists among third-party payors. As a result, obtaining
coverage and reimbursement approval of a product from a government or other third-party payor is a time-consuming and costly process that could require us to provide to each payor supporting scientific, clinical and cost-effectiveness data for the
use of our products on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">payor-by-payor</FONT></FONT> basis, with no assurance that coverage and adequate reimbursement will be obtained. Even if we obtain coverage for a given
product, the resulting reimbursement payment rates might not be adequate for us to achieve or sustain profitability or may require <FONT STYLE="white-space:nowrap">co-payments</FONT> that patients find unacceptably high. Additionally, third-party
payors may not cover, or provide adequate reimbursement for, long-term <FONT STYLE="white-space:nowrap">follow-up</FONT> evaluations required following the use of product candidates, once approved. It is difficult to predict at this time what
third-party payors will decide with respect to the coverage and reimbursement for our product candidates, if approved. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Medicare
Prescription Drug, Improvement, and Modernization Act of 2003, also called the Medicare Modernization Act, or the MMA, established the Medicare Part D program to provide a voluntary prescription drug and biologic benefit to Medicare beneficiaries.
Under Part D, Medicare beneficiaries may enroll in prescription drug plans offered by private entities that provide coverage of outpatient prescription drugs and biologics. Unlike Medicare Parts A and B, Part D coverage is not standardized. Part D
prescription drug plan </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sponsors are not required to pay for all covered Part D drugs and biologics, and each drug plan can develop its own formulary that identifies which drugs and biologics it will cover, and at what
tier or level. However, Part D prescription drug formularies must include products within each therapeutic category and class of covered Part D drugs, though not necessarily all the drugs and biologics in each category or class. Any formulary used
by a Part D prescription drug plan must be developed and reviewed by a pharmacy and therapeutic committee. Government payment for some of the costs of prescription drugs and biologics may increase demand for products for which we obtain marketing
approval. Any negotiated prices for any of our products covered by a Part D prescription drug plan will likely be lower than the prices we might otherwise obtain. Moreover, while the MMA applies only to drug benefits for Medicare beneficiaries,
private payors often follow Medicare coverage policy and payment limitations in setting their own payment rates. Any reduction in payment that results from the MMA may result in a similar reduction in payments from
<FONT STYLE="white-space:nowrap">non-governmental</FONT> payors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a drug or biologic product to receive federal reimbursement under
the Medicaid or Medicare Part B programs or to be sold directly to U.S. government agencies, the manufacturer must extend discounts to entities eligible to participate in the 340B drug pricing program. The required 340B discount on a given product
is calculated based on the average manufacturer price, or AMP, and Medicaid rebate amounts reported by the manufacturer. As of 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of
2010, or collectively the ACA, expanded the types of entities eligible to receive discounted 340B pricing, although under the current state of the law these newly eligible entities (with the exception of children&#146;s hospitals) will not be
eligible to receive discounted 340B pricing on orphan drugs. As 340B drug pricing is determined based on AMP and Medicaid rebate data, the revisions to the Medicaid rebate formula and AMP definition described above could cause the required 340B
discount to increase. Further, on December&nbsp;27, 2018, the District Court for the District of Columbia invalidated a reimbursement formula change instituted by the Centers for Medicare &amp; Medicaid Services, or CMS, under the 340B program. For
the 2019 and 2018 fiscal years, CMS altered the reimbursement formula. The court ruled this change was not an &#147;adjustment&#148; that was within the Secretary&#146;s discretion to make but was instead a fundamental change in the reimbursement
calculation, and such a dramatic change was beyond the scope of the Secretary&#146;s authority. On May 6, 2019, the district court reiterated that the rate reduction exceeded the Secretary&#146;s authority and declared that the rate reduction for
2019 also exceeded the Secretary&#146;s authority and remanded the issue to HHS to devise an appropriate remedy. On July 10, 2019, the district court entered its final judgment and CMS has filed an appeal and a decision by the Court of Appeals for
the D.C. Circuit is pending. However, subsequently, hospitals have filed a complaint in the U.S. District Court for D.C. to enjoin the reimbursement cuts for 2020. It is unclear how such litigation could affect covered hospitals who might purchase
our products in the future, and affect the rates we may charge such facilities for our approved products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Changes to these current laws
and state and federal healthcare reform measures that may be adopted in the future may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices we may obtain for any product candidates for which we may
obtain regulatory approval or the frequency with which any such product candidate is prescribed or used. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Even if we obtain FDA
approval of any of our product candidates, we may never obtain approval or commercialize such products outside of the United States, which would limit our ability to realize their full market potential. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to market any products outside of the United States, we must establish and comply with numerous and varying regulatory requirements of
other countries regarding safety and efficacy. Clinical trials conducted in one country may not be accepted by regulatory authorities in other countries, and regulatory approval in one country does not mean that regulatory approval will be obtained
in any other country. Approval procedures vary among countries and can involve additional product testing and validation and additional administrative review periods. Seeking foreign regulatory approvals could result in significant delays,
difficulties and costs for us and may require additional preclinical studies or clinical trials which would be costly and time consuming. Regulatory requirements can vary widely from country to country and could delay or prevent the introduction of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
our products in those countries. Satisfying these and other regulatory requirements is costly, time consuming, uncertain and subject to unanticipated delays. In addition, our failure to obtain
regulatory approval in any country may delay or have negative effects on the process for regulatory approval in other countries. We do not have any product candidates approved for sale in any jurisdiction, including international markets, and we do
not have experience in obtaining regulatory approval in international markets. If we fail to comply with regulatory requirements in international markets or to obtain and maintain required approvals, our ability to realize the full market potential
of our products will be harmed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We currently have no marketing and sales organization and have no experience as a company in
commercializing products, and we may have to invest significant resources to develop these capabilities. If we are unable to establish marketing and sales capabilities or enter into agreements with third parties to market and sell our products, we
may not be able to generate product revenue. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have no internal sales, marketing or distribution capabilities, nor have we
commercialized a product. If any of our product candidates ultimately receives regulatory approval, we expect to establish a marketing and sales organization with technical expertise and supporting distribution capabilities to commercialize each
such product in major markets, which will be expensive and time consuming. We have no prior experience as a company in the marketing, sale and distribution of pharmaceutical products and there are significant risks involved in building and managing
a sales organization, including our ability to hire, retain and incentivize qualified individuals, generate sufficient sales leads, provide adequate training to sales and marketing personnel and effectively manage a geographically dispersed sales
and marketing team. Any failure or delay in the development of our internal sales, marketing and distribution capabilities would adversely impact the commercialization of these products. We may also choose to collaborate with third parties that have
direct sales forces and established distribution systems, either to augment our own sales force and distribution systems or in lieu of our own sales force and distribution systems. We may not be able to enter into collaborations or hire consultants
or external service providers to assist us in sales, marketing and distribution functions on acceptable financial terms, or at all. In addition, our product revenues and our profitability, if any, may be lower if we rely on third parties for these
functions than if we were to market, sell and distribute any products that we develop ourselves. We likely will have little control over such third parties, and any of them may fail to devote the necessary resources and attention to sell and market
our products effectively. If we are not successful in commercializing our products, either on our own or through arrangements with one or more third parties, we may not be able to generate any future product revenue and we would incur significant
additional losses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our relationships with healthcare providers and physicians and third-party payors will be subject to applicable
anti-kickback, fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished profits and future earnings. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Healthcare providers, physicians and third-party payors in the United States and elsewhere play a primary role in the recommendation and
prescription of biopharmaceutical products. Arrangements with third-party payors and customers can expose biopharmaceutical manufacturers to broadly applicable fraud and abuse and other healthcare laws and regulations, including, without limitation,
the federal Anti-Kickback Statute and the federal False Claims Act, or FCA, which may constrain the business or financial arrangements and relationships through which such companies sell, market and distribute biopharmaceutical products. In
particular, the research of our product candidates, as well as the promotion, sales and marketing of healthcare items and services, as well as certain business arrangements in the healthcare industry, are subject to extensive laws designed to
prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, structuring and commission(s), certain customer incentive programs
and other business arrangements generally. Activities subject to these laws also involve the improper use of information obtained in the course of patient recruitment for clinical trials. The applicable
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
federal, state and foreign healthcare laws and regulations laws that may affect our ability to operate include, but are not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Anti-Kickback Statute, which prohibits, among other things, knowingly and willfully soliciting,
receiving, offering or paying any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual, or the purchase,
lease, order or recommendation of any good, facility, item or service for which payment may be made, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. A person or entity can be found guilty of
violating the statute without actual knowledge of the statute or specific intent to violate it. In addition, a claim submitted for payment to any federal health care program that includes items or services that were made as a result of a violation
of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the FCA. The Anti-Kickback Statute has been interpreted to apply to arrangements between biopharmaceutical manufacturers on the one hand and prescribers,
purchasers, and formulary managers, among others, on the other. There are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal civil and criminal false claims laws, including the FCA, and civil monetary penalty laws which
prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, false, fictitious or fraudulent claims for payment to, or approval by Medicare, Medicaid, or other federal healthcare programs; knowingly
making, using or causing to be made or used a false record or statement material to a false or fraudulent claim or an obligation to pay or transmit money or property to the federal government; or knowingly concealing or knowingly and improperly
avoiding or decreasing or concealing an obligation to pay money to the federal government. A claim that includes items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim under the FCA.
Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#147;cause&#148; the submission of false or fraudulent claims. The FCA also permits a private individual acting
as a &#147;whistleblower&#148; to bring <I>qui tam</I> actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created additional
federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the
money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g.,&nbsp;public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a
material fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity can
be found guilty of violating HIPAA without actual knowledge of the statute or specific intent to violate it;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH,
and their respective implementing regulations, which impose, among other things, requirements relating to the privacy, security and transmission of individually identifiable health information on certain covered healthcare providers, health plans,
and healthcare clearinghouses, known as covered entities, as well as their respective &#147;business associates,&#148; those independent contractors or agents of covered entities that perform services for covered entities that involve the creation,
use, receipt, maintenance or disclosure of individually identifiable health information. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and
gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#146; fees and costs associated with pursuing federal civil actions;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Physician Payments Sunshine Act, created under the ACA, and its implementing regulations, which
require some manufacturers of drugs, devices, biologics and medical supplies for which payment is </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
available under Medicare, Medicaid or the Children&#146;s Health Insurance Program (with certain exceptions) to report annually to CMS information related to payments or other transfers of value
made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Effective January 1,
2022, these reporting obligations will extend to include transfers of value made in the previous year to certain non-physician providers such as physician assistants and nurse practitioners;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and
activities that potentially harm consumers; and</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">analogous state and foreign laws and regulations, such as state anti-kickback and false claims laws, which may
apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by third-party payors, including private insurers, and may be broader in scope than their federal equivalents; state and foreign laws that require
biopharmaceutical companies to comply with the biopharmaceutical industry&#146;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare
providers and other potential referral sources; state and foreign laws that require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers, marketing expenditures or
drug pricing; state and local laws that require the registration of biopharmaceutical sales representatives; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each
other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The distribution
of biopharmaceutical products is subject to additional requirements and regulations, including extensive record-keeping, licensing, storage and security requirements intended to prevent the unauthorized sale of biopharmaceutical products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform,
especially in light of the lack of applicable precedent and regulations. Ensuring business arrangements comply with applicable healthcare laws, as well as responding to possible investigations by government authorities, can be time- and
resource-consuming and can divert a company&#146;s attention from the business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is possible that governmental and enforcement
authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law interpreting applicable fraud and abuse or other healthcare laws and regulations. If any such actions are instituted
against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant civil, criminal and administrative penalties, damages,
fines, disgorgement, imprisonment, reputational harm, possible exclusion from participation in federal and state funded healthcare programs, contractual damages and the curtailment or restricting of our operations, as well as additional reporting
obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these laws. Further, if any of the physicians or other
healthcare providers or entities with whom we expect to do business is found to be not in compliance with applicable laws, they may be subject to significant criminal, civil or administrative sanctions, including exclusions from government funded
healthcare programs. Any action for violation of these laws, even if successfully defended, could cause a biopharmaceutical manufacturer to incur significant legal expenses and divert management&#146;s attention from the operation of the business.
Prohibitions or restrictions on sales or withdrawal of future marketed products could materially affect business in an adverse way. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Even if we receive regulatory approval of any product candidates, we will be subject
to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our
product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any of our product candidates are approved, they will be subject to ongoing regulatory requirements for
manufacturing, labeling, packaging, storage, advertising, promotion, sampling, record-keeping, conduct of post-marketing studies and submission of safety, efficacy and other post-market information, including both federal and state requirements in
the United States and requirements of comparable foreign regulatory authorities. In addition, we will be subject to continued compliance with cGMP and GCP requirements for any clinical trials that we conduct post-approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Manufacturers and their facilities are required to comply with extensive FDA and comparable foreign regulatory authority requirements,
including ensuring that quality control and manufacturing procedures conform to cGMP regulations. As such, we and our contract manufacturers will be subject to continual review and inspections to assess compliance with cGMP and adherence to
commitments made in any marketing application, and previous responses to inspection observations. Accordingly, we and others with whom we work must continue to expend time, money, and effort in all areas of regulatory compliance, including
manufacturing, production and quality control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any regulatory approvals that we receive for our product candidates may be subject to
limitations on the approved indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing testing, including Phase&nbsp;4 clinical trials and surveillance to
monitor the safety and efficacy of the product candidate. The FDA may also require a risk evaluation and mitigation strategies, or REMS, program as a condition of approval of our product candidates, which could entail requirements for long-term
patient <FONT STYLE="white-space:nowrap">follow-up,</FONT> a medication guide, physician communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. In
addition, if the FDA or a comparable foreign regulatory authority approves our product candidates, we will have to comply with requirements including submissions of safety and other post-marketing information and reports and registration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA may impose consent decrees or withdraw approval if compliance with regulatory requirements and standards is not maintained or if
problems occur after the product reaches the market. Later discovery of previously unknown problems with our product candidates, including adverse events of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing
processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of
distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrictions on the marketing or manufacturing of our products, withdrawal of the product from the market or
voluntary or mandatory product recalls;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fines, warning letters or holds on clinical trials;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusal by the FDA to approve pending applications or supplements to approved applications filed by us or
suspension or revocation of license approvals;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product seizure or detention or refusal to permit the import or export of our product candidates;
and</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injunctions or the imposition of civil or criminal penalties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA strictly regulates marketing, labeling, advertising, and promotion of products that are placed on the market. Products may be promoted
only for the approved indications and in accordance with the provisions of the approved label. However companies may share truthful and not misleading information that is not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
inconsistent with the labeling. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of <FONT STYLE="white-space:nowrap">off-label</FONT> uses and a
company that is found to have improperly promoted <FONT STYLE="white-space:nowrap">off-label</FONT> uses may be subject to significant liability. The policies of the FDA and of other regulatory authorities may change and additional government
regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action,
either in the United States or abroad. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval
that we may have obtained and we may not achieve or sustain profitability. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Ongoing healthcare legislative and regulatory reform
measures may have a material adverse effect on our business and results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Changes in regulations, statutes or the
interpretation of existing regulations could impact our business in the future by requiring, for example: (i)&nbsp;changes to our manufacturing arrangements; (ii)&nbsp;additions or modifications to product labeling; (iii)&nbsp;the recall or
discontinuation of our products; or (iv)&nbsp;additional record-keeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, there have been and continue to be a number of legislative initiatives to contain healthcare costs. For example, in
March 2010, the ACA was passed, which substantially changed the way health care is financed by both governmental and private insurers, and significantly impacted the U.S. biopharmaceutical industry. The ACA, among other things, addressed a new
methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, increased the minimum Medicaid rebates owed by manufacturers under the
Medicaid Drug Rebate Program and extended the rebate program to individuals enrolled in Medicaid managed care organizations, established annual fees and taxes on manufacturers of certain branded prescription drugs, and created a new Medicare
Part&nbsp;D coverage gap discount program, in which manufacturers must agree to offer 70% (increased pursuant to the Bipartisan Budget Act of 2018, effective as of 2019)
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-of-sale</FONT></FONT> discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the
manufacturer&#146;s outpatient drugs to be covered under Medicare Part&nbsp;D. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since its enactment, there have been numerous judicial,
administrative, executive, and legislative challenges to certain aspects of the ACA, and we expect there will be additional challenges and amendments to the ACA in the future. On December&nbsp;14, 2018, a Texas U.S. District Court Judge ruled that
the ACA is unconstitutional in its entirety because the &#147;individual mandate&#148; was repealed by Congress as part of the Tax Act. Additionally, on December&nbsp;18, 2019, the U.S. Court of Appeals for the 5th Circuit upheld the District Court
ruling that the individual mandate was unconstitutional and remanded the case back to the District Court to determine whether the remaining provisions of the ACA are invalid as well. On March&nbsp;2, 2020, the United States Supreme Court granted the
petitions for writs of certiorari to review this case, and has allotted one hour for oral arguments, which are expected to occur in the fall. It is unclear how such litigation and other efforts to repeal and replace the ACA will impact the ACA and
our business. In addition, the Trump Administration has issued various Executive Orders which eliminated cost sharing subsidies and various provisions that would impose a fiscal burden on states or a cost, fee, tax, penalty or regulatory burden on
individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices. Additionally, Congress has introduced several pieces of legislation aimed at significantly revising or repealing the ACA. It is unclear
whether the ACA will be overturned, repealed, replaced, or further amended. We cannot predict what affect further changes to the ACA would have on our business. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other legislative changes have been proposed and adopted in the United States since the ACA was enacted. The Budget Control Act of 2011, among
other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach
required goals, thereby triggering the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
legislation&#146;s automatic reduction to several government programs, including aggregate reductions of Medicare payments to providers of 2% per fiscal year. These reductions went into effect on
April&nbsp;1, 2013 and, due to subsequent legislative amendments to the statute, including the Bipartisan Budget Act of 2018, or BBA, will remain in effect through 2030, unless additional congressional action is taken. However, these Medicare
sequester reductions will be suspended from May&nbsp;1, 2020 through December&nbsp;31, 2020 due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. The BBA also amended the ACA, effective January 1, 2019, by increasing the
point-of-sale discount that is owed by pharmaceutical manufacturers who participate in Medicare Part D and closing the coverage gap in most Medicare drug plans, commonly referred to as the &#147;donut hole&#148;. On January&nbsp;2, 2013, the
American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several types of providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of
limitations period for the government to recover overpayments to providers from three to five years. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moreover, increasing efforts by
governmental and third-party payors in the United States and abroad to cap or reduce healthcare costs may cause such organizations to limit both coverage and the level of reimbursement for newly approved products and, as a result, they may not cover
or provide adequate payment for our product candidates. There has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S.
Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing
and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the federal level, the Trump
administration&#146;s budget for fiscal year 2021 includes a $135&nbsp;billion allowance to support legislative proposals seeking to reduce drug prices, increase competition, lower out-of-pocket drug costs for patients, and increase patient access
to lower-cost generic and biosimilar drugs. On March&nbsp;10, 2020, the Trump administration sent &#147;principles&#148; for drug pricing to Congress, calling for legislation that would, among other things, cap Medicare Part&nbsp;D beneficiary
out-of-pocket pharmacy expenses, provide an option to cap Medicare Part&nbsp;D beneficiary monthly out-of-pocket expenses, and place limits on pharmaceutical price increases. The Trump administration previously released a &#147;Blueprint&#148; to
lower drug prices and reduce out of pocket costs of drugs that contained proposals to increase manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of
their products and reduce the out of pocket costs of drug products paid by consumers. The U.S. Department of Health and Human Services, or HHS, has solicited feedback on some of these measures and has implemented others under its existing authority.
For example, in May 2019, CMS issued a final rule that would allow Medicare Advantage Plans the option of using step therapy, a type of prior authorization, for Part B drugs beginning January&nbsp;1, 2020. This final rule codified CMS&#146;s policy
change that was effective January&nbsp;1, 2019. Although a number of these and other measures may require additional authorization to become effective, Congress and the Trump administration have each indicated that it will continue to seek new
legislative and/or administrative measures to control drug costs. Any reduction in reimbursement from Medicare and other government programs may result in a similar reduction in payments from private payers. In addition, individual states in the
United States have also increasingly passed legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and
marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the state level, legislatures are increasingly passing legislation and implementing regulations designed to control biopharmaceutical and
biologic product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from
other countries and bulk purchasing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These laws, and future state and federal healthcare reform measures may be adopted in the future,
any of which may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices we may </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obtain for any of our product candidates for which we may obtain regulatory approval or the frequency with which any such product candidate is prescribed or used. Additionally, we expect to
experience pricing pressures in connection with the sale of any future approved product candidates due to the trend toward managed healthcare, the increasing influence of health maintenance organizations, cost containment initiatives and additional
legislative changes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Inadequate funding for the FDA, the SEC and other government agencies could hinder their ability to hire and
retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our
business may rely, which could negatively impact our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ability of the FDA to review and approve new products can be
affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have
fluctuated in recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities, is subject to the political process,
which is inherently fluid and unpredictable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Disruptions at the FDA and other agencies may also slow the time necessary for new drugs to
be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA and
the SEC, have had to furlough critical employees and stop critical activities. Separately, in response to the COVID-19 pandemic, on March 10, 2020 the FDA announced its intention to temporarily postpone most inspections of foreign manufacturing
facilities and products. On March&nbsp;18, 2020, the FDA announced its intention to temporarily postpone routine surveillance inspections of domestic manufacturing facilities and provided guidance regarding the conduct of clinical trials, which has
since been further updated. In April 2020, the FDA stated that its New Drug Program was continuing to meet program user fee performance goals, but due to many agency staff working on COVID-19 activities, it was possible that the FDA would not be
able to sustain that level of performance indefinitely. Regulatory authorities outside the United States may adopt similar restrictions or other policy measures in response to the COVID-19 pandemic. If a prolonged government shutdown occurs, or if
global health concerns continue to prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA to timely review and process
our regulatory submissions, which could have a material adverse effect on our business. Further, upon completion of this offering and in our operations as a public company, future government shutdowns could impact our ability to access the public
markets and obtain necessary capital in order to properly capitalize and continue our operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>EU drug marketing and
reimbursement regulations may materially affect our ability to market and receive coverage for our products in the European member states. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to seek approval to market our product candidates in both the United States and in selected foreign jurisdictions. If we obtain
approval in one or more foreign jurisdictions for our product candidates, we will be subject to rules and regulations in those jurisdictions. In some foreign countries, particularly those in the EU, the pricing of drugs is subject to governmental
control and other market regulations which could put pressure on the pricing and usage of our product candidates. In these countries, pricing negotiations with governmental authorities can take considerable time after obtaining marketing approval of
a product candidate. In addition, market acceptance and sales of our product candidates will depend significantly on the availability of adequate coverage and reimbursement from third-party payors for our product candidates and may be affected by
existing and future health care reform measures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Much like the federal Anti-Kickback Statute prohibition in the United States, the
provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal products is also prohibited in the EU. The provision of benefits or advantages to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
physicians is governed by the national anti-bribery laws of EU Member States, and in respect of the U.K. (which is longer a member of the EU), the U.K. Bribery Act 2010. Infringement of these
laws could result in substantial fines and imprisonment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments made to physicians in certain EU Member States must be publicly
disclosed. Moreover, agreements with physicians often must be the subject of prior notification and approval by the physician&#146;s employer, his or her competent professional organization and/or the regulatory authorities of the individual EU
Member States. These requirements are provided in the national laws, industry codes or professional codes of conduct, applicable in the EU Member States. Failure to comply with these requirements could result in reputational risk, public reprimands,
administrative penalties, fines or imprisonment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in most foreign countries, including the European Economic Area, or EEA,
the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing and reimbursement vary widely from country to country. For example, the EU provides options for its member states to
restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. Reference pricing used by various EU member states and parallel
distribution, or arbitrage between <FONT STYLE="white-space:nowrap">low-priced</FONT> and high-priced member states, can further reduce prices. A member state may approve a specific price for the medicinal product or it may instead adopt a system of
direct or indirect controls on the profitability of the company placing the medicinal product on the market. In some countries, we may be required to conduct a clinical study or other studies that compare the cost-effectiveness of any of our product
candidates to other available therapies in order to obtain or maintain reimbursement or pricing approval. There can be no assurance that any country that has price controls or reimbursement limitations for biopharmaceutical products will allow
favorable reimbursement and pricing arrangements for any of our products. Historically, products launched in the EU do not follow price structures of the United States and generally prices tend to be significantly lower. Publication of discounts by
third-party payors or authorities may lead to further pressure on the prices or reimbursement levels within the country of publication and other countries. If pricing is set at unsatisfactory levels or if reimbursement of our products is unavailable
or limited in scope or amount, our revenues from sales and the potential profitability of any of our product candidates in those countries would be negatively affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may incur substantial costs in our efforts to comply with evolving global data protection laws and regulations, and any failure or
perceived failure by us to comply with such laws and regulations may harm our business and operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The global data protection
landscape is rapidly evolving, and we may be or become subject to or affected by numerous federal, state and foreign laws and regulations, as well as regulatory guidance, governing the collection, use, disclosure, transfer, security and processing
of personal data, such as information that we collect about participants and healthcare providers in connection with clinical trials. Implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future, which
may create uncertainty in our business, affect our or our service providers&#146; ability to operate in certain jurisdictions or to collect, store, transfer use and share personal data, result in liability or impose additional compliance or other
costs on us. Any failure or perceived failure by us to comply with federal, state, or foreign laws or self-regulatory standards could result in negative publicity, diversion of management time and effort and proceedings against us by governmental
entities or others. Recently, California passed the California Data Privacy Protection Act of 2018, or the CCPA, which went into effect in January 2020 and provides new data privacy rights for consumers and new operational requirements for
companies, which may increase our compliance costs and potential liability. The CCPA gives California residents expanded rights to access and delete their personal information, opt out of certain personal information sharing, and receive detailed
information about how their personal information is used. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. While there is currently an
exception for protected health information that is subject to HIPAA and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
clinical trial regulations, as currently written, the CCPA may impact certain of our business activities. The new California law may lead to similar laws in other U.S. states or at a national
level, which could increase our potential liability and adversely affect our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to our operations in the United
States, which may be subject to healthcare and other laws relating to the privacy and security of health information and other personal information, may seek to conduct clinical trials in EEA and may become subject to additional European data
privacy laws, regulations and guidelines. The General Data Protection Regulation, (EU) 2016/679, or GDPR, became effective on May&nbsp;25, 2018, and deals with the collection, use, storage, disclosure, transfer, or other processing of personal data,
including personal health data, regarding individuals in the EEA. The GDPR imposes a broad range of strict requirements on companies subject to the GDPR, including requirements relating to having legal bases for processing personal information
relating to identifiable individuals and transferring such information outside the EEA, including to the United States, providing details to those individuals regarding the processing of their personal health and other sensitive data, obtaining
consent of the individuals to whom the personal data relates, keeping personal information secure, having data processing agreements with third parties who process personal information, responding to individuals&#146; requests to exercise their
rights in respect of their personal information, reporting security breaches involving personal data to the competent national data protection authority and affected individuals, appointing data protection officers, conducting data protection impact
assessments, and record-keeping. The GDPR increases substantially the penalties to which we could be subject in the event of any <FONT STYLE="white-space:nowrap">non-compliance,</FONT> including fines of up to 10,000,000 Euros or up to 2% of our
total worldwide annual turnover for certain comparatively minor offenses, or up to 20,000,000 Euros or up to 4% of our total worldwide annual turnover, whichever is greater, for more serious offenses. The GDPR also confers a private right of action
on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR. In addition, the GDPR includes restrictions on
cross-border data transfers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, national laws of member states of the EU are in the process of being adapted to the requirements
under the GDPR, thereby implementing national laws which may partially deviate from the GDPR and impose different obligations from country to country, so that we do not expect to operate in a uniform legal landscape in the EEA. Also, as it relates
to processing and transfer of genetic data, the GDPR specifically allows national laws to impose additional and more specific requirements or restrictions, and European laws have historically differed quite substantially in this field, leading to
additional uncertainty. The United Kingdom&#146;s decision to leave the EU, often referred to as Brexit, has created uncertainty with regard to data protection regulation in the United Kingdom. In particular, it is unclear how data transfers to and
from the United Kingdom will be regulated now that the United Kingdom has left the EU. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event we commence clinical trials in the
EEA, the GDPR may increase our responsibility and liability in relation to personal data that we process where such processing is subject to the GDPR, and we may be required to put in place additional mechanisms and safeguards to ensure compliance
with the GDPR, including as implemented by individual countries. Compliance with the GDPR will be a rigorous and time-intensive process that may increase our cost of doing business or require us to change our business practices, and despite those
efforts, there is a risk that we may be subject to fines and penalties, litigation, and reputational harm in connection with our European activities. We expect that we will continue to face uncertainty as to whether our efforts to comply with any
obligations under European privacy laws will be sufficient. If we are investigated by a European data protection authority, we may face fines and other penalties. Any such investigation or charges by European data protection authorities could have a
negative effect on our existing business and on our ability to attract and retain new clients or biopharmaceutical partners. We may also experience hesitancy, reluctance, or refusal by European or multi-national clients or biopharmaceutical partners
to continue to use our products and solutions due to the potential risk exposure as a result of the current (and, in particular, future) data protection obligations imposed on them by certain data protection authorities in interpretation of current
law, including the GDPR. Such clients or biopharmaceutical partners may also view any alternative approaches to compliance as being too costly, too burdensome, too legally uncertain, or otherwise objectionable and therefore decide not to do
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
business with us. Any of the forgoing could materially harm our business, prospects, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Legal, political and economic uncertainty surrounding the exit of the U.K. from the EU may be a source of instability in international
markets, create significant currency fluctuations, adversely affect our operations in the U.K. and pose additional risks to our business, revenue, financial condition, and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June 23, 2016, the U.K. held a referendum in which a majority of the eligible members of the electorate voted to leave the EU, commonly
referred to as Brexit. Pursuant to Article 50 of the Treaty on EU, the U.K. ceased being a Member State of the EU on January 31, 2020. However, the terms of the withdrawal have yet to be fully negotiated. The implementation period began February 1,
2020 and will continue until December 31, 2020. During this 11-month period, the U.K. will continue to follow all of the EU&#146;s rules, the EU&#146;s pharmaceutical law remains applicable to the U.K. and the U.K.&#146;s trading relationship will
remain the same. However, regulations (including financial laws and regulations, tax and free trade agreements, intellectual property rights, data protection laws, supply chain logistics, environmental, health and safety laws and regulations
medicine licensing and regulations, immigration laws and employment laws), have yet to be addressed. This lack of clarity on future U.K. laws and regulations and their interaction with the EU laws and regulations may negatively impact foreign direct
investment in the U.K., increase costs, depress economic activity and restrict access to capital. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The uncertainty concerning the
U.K.&#146;s legal, political and economic relationship with the EU after Brexit may be a source of instability in the international markets, create significant currency fluctuations, and/or otherwise adversely affect trading agreements or similar
cross-border co-operation arrangements (whether economic, tax, fiscal, legal, regulatory or otherwise) beyond the date of Brexit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These
developments, or the perception that any of them could occur, may have a significant adverse effect on global economic conditions and the stability of global financial markets, and could significantly reduce global market liquidity and limit the
ability of key market participants to operate in certain financial markets. In particular, it could also lead to a period of considerable uncertainty in relation to the U.K. financial and banking markets, as well as on the regulatory process in
Europe. Asset valuations, currency exchange rates and credit ratings may also be subject to increased market volatility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the U.K. and
the EU are unable to negotiate acceptable agreements or if other EU member states pursue withdrawal, barrier-free access between the U.K. and other EU member states or among the European Economic Area overall could be diminished or eliminated. The
long-term effects of Brexit will depend on any agreements (or lack thereof) between the U.K. and the EU and, in particular, any arrangements for the U.K. to retain access to EU markets either during a transitional period from January&nbsp;1, 2021 or
more permanently. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such a withdrawal from the EU is unprecedented, and it is unclear how the U.K.&#146;s access to the European single
market for goods, capital, services and labor within the EU, or single market, and the wider commercial, legal and regulatory environment, will impact our current and future operations (including business activities conducted by third parties and
contract manufacturers on our behalf) and clinical activities in the U.K. In addition to the foregoing, our U.K. operations support our current and future operations and clinical activities in the EU and European Economic Area, or EEA, and these
operations and clinical activities could be disrupted by Brexit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also face new regulatory costs and challenges that could have an
adverse effect on our operations. Depending on the terms of the U.K.&#146;s withdrawal from the EU, the U.K. could lose the benefits of global trade agreements negotiated by the EU on behalf of its members, which may result in increased trade
barriers that could make our doing business in the EU and the EEA more difficult. Since the regulatory framework in the U.K. covering quality, safety and efficacy of pharmaceutical products, clinical trials, marketing authorization,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
commercial sales and distribution of pharmaceutical products is derived from EU directives and regulations, Brexit could materially impact the future regulatory regime with respect to the
approval of our product candidates in the U.K. For instance, in November 2017, EU member states voted to move the EMA, the EU&#146;s regulatory body, from London to Amsterdam. Operations in Amsterdam commenced in March 2019, and the move itself may
cause significant disruption to the regulatory approval process in Europe. It remains to be seen how, if at all, Brexit will impact regulatory requirements for product candidates and products in the U.K. Any delay in obtaining, or an inability to
obtain, any regulatory approvals, as a result of Brexit or otherwise, would prevent us from commercializing our product candidates in the U.K. and/or the EU and restrict our ability to generate revenue and achieve and sustain profitability. If any
of these outcomes occur, we may be forced to restrict or delay efforts to seek regulatory approval in the U.K. and/or EU for our product candidates, which could significantly and materially harm our business. Even prior to any change to the
U.K.&#146;s relationship with the EU, the announcement of Brexit has created economic uncertainty surrounding the terms of Brexit and its consequences could adversely impact customer confidence resulting in customers reducing their spending budgets
on our product candidates, if approved, which could adversely affect our business, financial condition, results of operations and could adversely affect the market price of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Additional laws and regulations governing international operations could negatively impact or restrict our operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we expand our operations outside of the United States, we must dedicate additional resources to comply with numerous laws and regulations in
each jurisdiction in which we plan to operate. The U.S. Foreign Corrupt Practices Act, or the FCPA, prohibits any U.S. individual or business entity from paying, offering, authorizing payment or offering of anything of value, directly or indirectly,
to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose
securities are listed in the United States to comply with certain accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries,
and to devise and maintain an adequate system of internal accounting controls for international operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compliance with the FCPA is
expensive and difficult, particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents particular challenges in the biopharmaceutical industry, because, in many countries, hospitals are operated by the
government, and doctors and other hospital employees are considered foreign officials. Certain payments to hospitals and healthcare providers in connection with clinical trials and other work have been deemed to be improper payments to government
officials and have led to FCPA enforcement actions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Various laws, regulations and executive orders also restrict the use and
dissemination outside of the United States, or the sharing with certain <FONT STYLE="white-space:nowrap">non-U.S.</FONT> nationals, of information products classified for national security purposes, as well as certain products, technology and
technical data relating to those products. If we expand our presence outside of the United States, it will require us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing, or
selling certain products and product candidates outside of the United States, which could limit our growth potential and increase our development costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The failure to comply with laws governing international business practices may result in substantial civil and criminal penalties and
suspension or debarment from government contracting. The Securities and Exchange Commission, or SEC, also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#146;s accounting provisions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We are subject to certain U.S. and foreign anti-corruption, anti-money laundering,
export control, sanctions, and other trade laws and regulations. We can face serious consequences for violations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Among other
matters, U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions, and other trade laws and regulations, which are collectively referred to as Trade Laws, prohibit companies and their employees, agents, clinical research
organizations, legal counsel, accountants, consultants, contractors, and other partners from authorizing, promising, offering, providing, soliciting, or receiving directly or indirectly, corrupt or improper payments or anything else of value to or
from recipients in the public or private sector. Violations of Trade Laws can result in substantial criminal fines and civil penalties, imprisonment, the loss of trade privileges, debarment, tax reassessments, breach of contract and fraud
litigation, reputational harm, and other consequences. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities, and other organizations. We also expect our <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> activities to increase in time. We plan to engage third parties for clinical trials and/or to obtain necessary permits, licenses, patent registrations, and other regulatory approvals and we can be held
liable for the corrupt or other illegal activities of our personnel, agents, or partners, even if we do not explicitly authorize or have prior knowledge of such activities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Intellectual Property </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our success depends in part on our ability to protect our intellectual property. It is difficult and costly to protect our proprietary
rights and technology, and we may not be able to ensure their protection. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business will depend in large part on obtaining and
maintaining patent, trademark and trade secret protection of our proprietary technologies and our product candidates, their respective components, synthetic intermediates, formulations, combination therapies, methods used to manufacture them and
methods of treatment, as well as successfully defending these patents against third-party challenges. Our ability to stop unauthorized third parties from making, using, selling, offering to sell or importing our product candidates is dependent upon
the extent to which we have rights under valid and enforceable patents that cover these activities and whether a court would issue an injunctive remedy. If we are unable to secure and maintain patent protection for any product or technology we
develop, or if the scope of the patent protection secured is not sufficiently broad, our competitors could develop and commercialize products and technology similar or identical to ours, and our ability to commercialize any product candidates we may
develop may be adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The patenting process is expensive and time-consuming, and we may not be able to file and prosecute
all necessary or desirable patent applications at a reasonable cost or in a timely manner. In addition, we may not pursue, obtain, or maintain patent protection in all relevant markets. It is also possible that we will fail to identify patentable
aspects of our research and development output before it is too late to obtain patent protection. Moreover, in some circumstances, we may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain
the patents, covering technology that we license from or license to third parties and are reliant on our licensors or licensees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
strength of patents in the biotechnology and biopharmaceutical field involves complex legal and scientific questions and can be uncertain. The patent applications that we own or <FONT STYLE="white-space:nowrap">in-license</FONT> may fail to result
in issued patents with claims that cover our product candidates or uses thereof in the United States or in other foreign countries. Even if the patents do successfully issue, third parties may challenge the validity, enforceability or scope thereof,
which may result in such patents being narrowed, invalidated or held unenforceable. Furthermore, even if they are unchallenged, our patents and patent applications may not adequately protect our technology, including our product candidates, or
prevent others from designing around our claims. If the breadth or strength of protection provided by the patent applications we hold with respect to our product candidates is threatened, it could dissuade companies from collaborating with us to
develop, and threaten our ability to commercialize, our product candidates. Further, if we encounter delays in our clinical trials, the period of time during which we could market our product candidates under patent protection would be reduced. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot be certain that we were the first to file any patent application related to our
technology, including our product candidates, and, if we were not, we may be precluded from obtaining patent protection for our technology, including our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot be certain that we are the first to invent the inventions covered by pending patent applications and, if we are not, we may be
subject to priority disputes. Furthermore, for United States applications in which all claims are entitled to a priority date before March&nbsp;16, 2013, an interference proceeding can be provoked by a third-party or instituted by the United States
Patent and Trademark Office, or USPTO, to determine who was the first to invent any of the subject matter covered by the patent claims of our applications. Similarly, for United States applications in which at least one claim is not entitled to a
priority date before March&nbsp;16, 2013, derivation proceedings can be instituted to determine whether the subject matter of a patent claim was derived from a prior inventor&#146;s disclosure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may be required to disclaim part or all of the term of certain patents or all of the term of certain patent applications. There may be
prior art of which we are not aware that may affect the validity or enforceability of a patent or patent application claim. There also may be prior art of which we are aware, but which we do not believe affects the validity or enforceability of a
claim, which may, nonetheless, ultimately be found to affect the validity or enforceability of a claim. No assurance can be given that if challenged, our patents would be declared by a court to be valid or enforceable or that even if found valid and
enforceable, would adequately protect our product candidates, or would be found by a court to be infringed by a competitor&#146;s technology or product. We may analyze patents or patent applications of our competitors that we believe are relevant to
our activities, and consider that we are free to operate in relation to our product candidates, but our competitors may achieve issued claims, including in patents we consider to be unrelated, which block our efforts or may potentially result in our
product candidates or our activities infringing such claims. The possibility exists that others will develop products which have the same effect as our products on an independent basis which do not infringe our patents or other intellectual property
rights, or will design around the claims of patents that may issue that cover our products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Recent or future patent reform legislation
could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents. Under the enacted Leahy-Smith America Invents Act, or America Invents Act, enacted in 2013, the
United States moved from a &#147;first to invent&#148; to a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;first-to-file&#148;</FONT></FONT> system. Under a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;first-to-file&#148;</FONT></FONT> system, assuming the other requirements for patentability are met, the first inventor to file&nbsp;a patent application generally will be
entitled to a patent on the invention regardless of whether another inventor had made the invention earlier. The America Invents Act includes a number of other significant changes to U.S. patent law, including provisions that affect the way patent
applications are prosecuted, redefine prior art and establish a new post-grant review system. The effects of these changes are currently unclear as the USPTO only recently developed new regulations and procedures in connection with the America
Invents Act and many of the substantive changes to patent law, including the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;first-to-file&#148;</FONT></FONT> provisions, only became effective in March 2013. In addition, the
courts have yet to address many of these provisions and the applicability of the act and new regulations on specific patents discussed herein have not been determined and would need to be reviewed. However, the America Invents Act and its
implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business and financial
condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The degree of future protection for our proprietary rights is uncertain because legal means afford only limited protection and
may not adequately protect our rights or permit us to gain or keep our competitive advantage. For example: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may be able to make or use compounds that are similar to the compositions of our product candidates but
that are not covered by the claims of our patents or those of our licensors; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or our licensors, as the case may be, may fail to meet our obligations to the U.S. government in regards to
any <FONT STYLE="white-space:nowrap">in-licensed</FONT> patents and patent applications funded by U.S. government grants, leading to the loss of patent rights;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or our licensors, as the case may be, might not have been the first to file patent applications for these
inventions;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may independently develop similar or alternative technologies or duplicate any of our
technologies;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that our pending patent applications will not result in issued patents;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that there are prior public disclosures that could invalidate our or our licensors&#146; patents,
as the case may be, or parts of our or their patents;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that others may circumvent our owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT>
patents;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that there are unpublished applications or patent applications maintained in secrecy that may
later issue with claims covering our products or technology similar to ours;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the laws of foreign countries may not protect our or our licensors&#146;, as the case may be, proprietary rights
to the same extent as the laws of the United States;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the claims of our owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT> issued patents or patent
applications, if and when issued, may not cover our product candidates;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT> issued patents may not provide us with any
competitive advantages, may be narrowed in scope, or be held invalid or unenforceable as a result of legal challenges by third parties;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inventors of our owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT> patents or patent applications
may become involved with competitors, develop products or processes which design around our patents, or become hostile to us or the patents or patent applications on which they are named as inventors;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that our owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT> patents or patent
applications omit individual(s) that should be listed as inventor(s) or include individual(s) that should not be listed as inventor(s), which may cause these patents or patents issuing from these patent applications to be held invalid or
unenforceable;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we have engaged in scientific collaborations in the past, and will continue to do so in the future. Such
collaborators may develop adjacent or competing products to ours that are outside the scope of our patents;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may not develop additional proprietary technologies for which we can obtain patent
protection;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that product candidates or diagnostic tests we develop may be covered by third parties&#146;
patents or other exclusive rights; or</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patents of others may have an adverse effect on our business. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may enter into license or other collaboration agreements in the future that may impose certain obligations on us. If we fail to
comply with our obligations under such future agreements with third parties, we could lose license rights that may be important to our future business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with our efforts to expand our pipeline of product candidates, we may enter into certain licenses or other collaboration
agreements in the future pertaining to the in-license of rights to additional candidates. Such agreements may impose various diligence, milestone payment, royalty, insurance or other obligations on us. If we fail to comply with these obligations,
our licensor or collaboration partners may have the right to terminate the relevant agreement, in which event we would not be able to develop or market the products covered by such licensed intellectual property. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, disputes may arise regarding intellectual property subject to a licensing agreement, including:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope of rights granted under the license agreement and other interpretation-related issues;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which our product candidates, technology and processes infringe on intellectual property of the
licensor that is not subject to the licensing agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sublicensing of patent and other rights under our collaborative development relationships;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our diligence obligations under the license agreement and what activities satisfy those diligence obligations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of
intellectual property by our licensors and us and our partners; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the priority of invention of patented technology. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the agreements under which we currently license intellectual property or technology from third parties are complex, and certain
provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property
or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations, and prospects.
Moreover, if disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize the
affected product candidates, which could have a material adverse effect on our business, financial conditions, results of operations, and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we may have limited control over the maintenance and prosecution of these in-licensed patents and patent applications, or any
other intellectual property that may be related to our in-licensed intellectual property. For example, we cannot be certain that such activities by any future licensors have been or will be conducted in compliance with applicable laws and
regulations or will result in valid and enforceable patents and other intellectual property rights. We have limited control over the manner in which our licensors initiate an infringement proceeding against a third-party infringer of the
intellectual property rights, or defend certain of the intellectual property that is licensed to us. It is possible that the licensors&#146; infringement proceeding or defense activities may be less vigorous than had we conducted them ourselves.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to patent protection, we rely heavily upon <FONT STYLE="white-space:nowrap">know-how</FONT> and trade secret
protection, as well as <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements and invention assignment agreements with our employees, consultants and third-parties, to protect our confidential and proprietary information, especially where
we do not believe patent protection is appropriate or obtainable. In addition to contractual measures, we try to protect the confidential nature of our proprietary information using physical and technological security measures. Such measures may
not, for example, in the case of misappropriation of a trade secret by an employee or third-party with authorized access, provide adequate protection for our proprietary information. Our security measures may not prevent an employee or consultant
from misappropriating our trade secrets and providing them to a competitor, and recourse we take against such misconduct may not provide an adequate remedy to protect our interests fully. Enforcing a claim that a party illegally disclosed or
misappropriated a trade secret can be difficult, expensive, and time-consuming, and the outcome is unpredictable. In addition, trade secrets may be independently developed by others in a manner that could prevent legal recourse by us. For example,
our clinical development strategy includes the testing of live tissue samples, and our techniques for preserving and testing these samples are proprietary and confidential. If one or more third parties obtain or are otherwise able to replicate these
techniques, an important feature and differentiator of our clinical development strategy will become available to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
potential competitors. If any of our confidential or proprietary information, such as our trade secrets, were to be disclosed or misappropriated, or if any such information was independently
developed by a competitor, our competitive position could be harmed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, courts outside the United States are sometimes less
willing to protect trade secrets. If we choose to go to court to stop a third-party from using any of our trade secrets, we may incur substantial costs. These lawsuits may consume our time and other resources even if we are successful. Although we
take steps to protect our proprietary information and trade secrets, including through contractual means with our employees and consultants, third parties may independently develop substantially equivalent proprietary information and techniques or
otherwise gain access to our trade secrets or disclose our technology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Thus, we may not be able to meaningfully protect our trade
secrets. It is our policy to require our employees, consultants, outside scientific collaborators, sponsored researchers and other advisors to execute confidentiality agreements upon the commencement of employment or consulting relationships with
us. These agreements provide that all confidential information concerning our business or financial affairs developed or made known to the individual or entity during the course of the party&#146;s relationship with us is to be kept confidential and
not disclosed to third parties except in specific circumstances. In the case of employees, the agreements provide that all inventions conceived by the individual, and which are related to our current or planned business or research and development
or made during normal working hours, on our premises or using our equipment or proprietary information, are our exclusive property. In addition, we take other appropriate precautions, such as physical and technological security measures, to guard
against misappropriation of our proprietary technology by third parties. We have also adopted policies and conduct training that provides guidance on our expectations, and our advice for best practices, in protecting our trade secrets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Third-party claims of intellectual property infringement may prevent or delay our product discovery and development efforts.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our commercial success depends in part on our ability to develop, manufacture, market and sell our product candidates and use our
proprietary technologies without infringing the proprietary rights of third parties. There is a substantial amount of litigation involving patents and other intellectual property rights in the biotechnology and biopharmaceutical industries, as well
as administrative proceedings for challenging patents, including interference, derivation,<I>&nbsp;inter partes</I>&nbsp;review, post grant review, and reexamination proceedings before the USPTO or oppositions and other comparable proceedings in
foreign jurisdictions. We may be exposed to, or threatened with, future litigation by third parties having patent or other intellectual property rights alleging that our product candidates and/or proprietary technologies infringe their intellectual
property rights. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing our product candidates. As the biotechnology and biopharmaceutical industries
expand and more patents are issued, the risk increases that our product candidates may give rise to claims of infringement of the patent rights of others. Moreover, it is not always clear to industry participants, including us, which patents cover
various types of drugs, products or their methods of use or manufacture. Thus, because of the large number of patents issued and patent applications filed in our fields, there may be a risk that third parties may allege they have patent rights
encompassing our product candidates, technologies or methods. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a third-party claims that we infringe its intellectual property rights,
we may face a number of issues, including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">infringement and other intellectual property claims which, regardless of merit, may be expensive and
time-consuming to litigate and may divert our management&#146;s attention from our core business;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">substantial damages for infringement, which we may have to pay if a court decides that the product candidate or
technology at issue infringes on or violates the third-party&#146;s rights, and, if the court finds that the infringement was willful, we could be ordered to pay treble damages and the patent owner&#146;s attorneys&#146; fees; </P></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a court prohibiting us from developing, manufacturing, marketing or selling our product candidates, or from using
our proprietary technologies, unless the third-party licenses its product rights to us, which it is not required to do;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if a license is available from a third-party, we may have to pay substantial royalties, upfront fees and other
amounts, and/or grant cross-licenses to intellectual property rights for our products and any license that is available may be non-exclusive, which could result in our competitors gaining access to the same intellectual property;
and</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">redesigning our product candidates or processes so they do not infringe, which may not be possible or may require
substantial monetary expenditures and time. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some of our competitors may be able to sustain the costs of complex patent
litigation more effectively than we can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise
the funds necessary to continue our operations or could otherwise have a material adverse effect on our business, results of operations, financial condition and prospects. Furthermore, because of the substantial amount of discovery required in
connection with intellectual property litigation or administrative proceedings, there is a risk that some of our confidential information could be compromised by disclosure. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our collaborators may assert ownership or commercial rights to inventions they develop from research we support or that we develop from
our use of the tissue samples or other biological materials, which they provide to us, or otherwise arising from the collaboration. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We collaborate with several institutions, universities, medical centers, physicians and researchers in scientific matters and expect to
continue to enter into additional collaboration agreements. In certain cases, we do not have written agreements with these collaborators, or the written agreements we have do not cover intellectual property rights. Also, we rely on numerous third
parties to provide us with tissue samples and biological materials that we use to conduct our research activities and develop our product candidates. If we cannot successfully negotiate sufficient ownership and commercial rights to any inventions
that result from our use of a third-party collaborator&#146;s materials, or if disputes arise with respect to the intellectual property developed with the use of a collaborator&#146;s samples, or data developed in a collaborator&#146;s study, we may
be limited in our ability to capitalize on the market potential of these inventions or developments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Third parties may assert that
we are employing their proprietary technology without authorization. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There may be third-party patents of which we are currently
unaware with claims to compositions of matter, materials, formulations, methods of manufacture or methods for treatment that encompass the composition, use or manufacture of our product candidates. There may be currently pending patent applications
of which we are currently unaware which may later result in issued patents that our product candidates or their use or manufacture may infringe. In addition, third parties may obtain patents in the future and claim that use of our technologies
infringes upon these patents. If any third-party patent were held by a court of competent jurisdiction to cover our product candidates, intermediates used in the manufacture of our product candidates or our materials generally, aspects of our
formulations or methods of use, the holders of any such patent may be able to block our ability to develop and commercialize the product candidate unless we obtained a license or until such patent expires or is finally determined to be held invalid
or unenforceable. In either case, such a license may not be available on commercially reasonable terms or at all. If we are unable to obtain a necessary license to a third-party patent on commercially reasonable terms, or at all, our ability to
commercialize our product candidates may be impaired or delayed, which could in turn significantly harm our business. Even if we obtain a license, it may be <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> thereby giving our competitors access
to the same technologies licensed to us. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize
current or future product candidates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Parties making claims against us may seek and obtain injunctive or other equitable relief,
which could effectively block our ability to further develop and commercialize our product candidates. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of employee
resources from our business. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys&#146; fees for willful infringement, obtain one or more licenses from third
parties, pay royalties or redesign our infringing products, which may be impossible or require substantial time and monetary expenditure. We cannot predict whether any such license would be available at all or whether it would be available on
commercially reasonable terms. Furthermore, even in the absence of litigation, we may need to obtain licenses from third parties to advance our research or allow commercialization of our product candidates. We may fail to obtain any of these
licenses at a reasonable cost or on reasonable terms, if at all. In that event, we would be unable to further develop and commercialize our product candidates, which could harm our business significantly. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Third parties may assert that our employees or consultants have wrongfully used or disclosed confidential information or misappropriated
trade secrets. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As is common in the biotechnology and biopharmaceutical industries, we employ individuals who were previously
employed at universities or other biotechnology or biopharmaceutical companies, including our competitors or potential competitors. Although no claims against us are currently pending, and although we try to ensure that our employees and consultants
do not use the proprietary information or <FONT STYLE="white-space:nowrap">know-how</FONT> of others in their work for us, we may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise
used or disclosed intellectual property, including trade secrets or other proprietary information, of a former employer or other third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in
addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation or other legal proceedings relating to intellectual property claims may cause
us to incur significant expenses, and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or
developments, and, if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. This type of litigation or proceeding could substantially increase our
operating losses and reduce our resources available for development activities. We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors may be able to sustain the costs of
such litigation or proceedings more effectively than we can because of their substantially greater financial resources. Uncertainties resulting from the initiation and continuation of patent litigation or other intellectual property related
proceedings could adversely affect our ability to compete in the marketplace. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may not be successful in obtaining or maintaining
necessary rights to develop any future product candidates on acceptable terms. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because our programs may involve additional product
candidates that may require the use of proprietary rights held by third parties, the growth of our business may depend in part on our ability to acquire, <FONT STYLE="white-space:nowrap">in-license</FONT> or use these proprietary rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our product candidates may also require specific formulations to work effectively and efficiently and these rights may be held by others. We
may develop products containing our compounds and <FONT STYLE="white-space:nowrap">pre-existing</FONT> biopharmaceutical compounds. We may be unable to acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> any compositions, methods of use,
processes or other third-party intellectual property rights from third parties that we identify as necessary or important to our business operations. We may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, if at all,
which would harm our business. We may need to cease use of the compositions or methods covered by such third-party intellectual property rights, and may need to seek to develop alternative approaches that do not infringe on such intellectual
property rights which may entail additional costs and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
development delays, even if we were able to develop such alternatives, which may not be feasible. Even if we are able to obtain a license, it may be
<FONT STYLE="white-space:nowrap">non-exclusive,</FONT> thereby giving our competitors access to the same technologies licensed to us. In that event, we may be required to expend significant time and resources to develop or license replacement
technology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, we sometimes collaborate with academic institutions to accelerate our preclinical research or development under
written agreements with these institutions. In certain cases, these institutions provide us with an option to negotiate a license to any of the institution&#146;s rights in technology resulting from the collaboration. Regardless of such option, we
may be unable to negotiate a license within the specified timeframe or under terms that are acceptable to us. If we are unable to do so, the institution may offer the intellectual property rights to others, potentially blocking our ability to pursue
our program. If we are unable to successfully obtain rights to required third-party intellectual property or to maintain the existing intellectual property rights we have, we may have to abandon development of such program and our business and
financial condition could suffer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The licensing and acquisition of third-party intellectual property rights is a competitive area, and
companies, which may be more established, or have greater resources than we do, may also be pursuing strategies to license or acquire third-party intellectual property rights that we may consider necessary or attractive in order to commercialize our
product candidates. More established companies may have a competitive advantage over us due to their size, cash resources and greater clinical development and commercialization capabilities. There can be no assurance that we will be able to
successfully complete such negotiations and ultimately acquire the rights to the intellectual property surrounding the additional product candidates that we may seek to acquire. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may be involved in lawsuits to protect or enforce our patents or the patents of our licensors, which could be expensive,
time-consuming and unsuccessful. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Competitors may infringe our patents or the patents of our current or future licensors. To
counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. In addition, in an infringement proceeding, a court may decide that one or more of our patents is not valid or is
unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question or for other reasons. An adverse result in any litigation or defense proceedings could
put one or more of our patents at risk of being invalidated, held unenforceable, or interpreted narrowly and could put our patent applications at risk of not issuing. Defense of these claims, regardless of their merit, would involve substantial
litigation expense and would be a substantial diversion of employee resources from our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may choose to challenge the
patentability of claims in a third-party&#146;s U.S. patent by requesting that the USPTO review the patent claims in
an<I><FONT STYLE="white-space:nowrap">&nbsp;ex-parte</FONT></I><FONT STYLE="white-space:nowrap">&nbsp;re-examination,</FONT><I>&nbsp;inter partes</I>&nbsp;review or post-grant review proceedings. These proceedings are expensive and may consume our
time or other resources. We may choose to challenge a third-party&#146;s patent in patent opposition proceedings in the European Patent Office, or EPO, or other foreign patent office. The costs of these opposition proceedings could be substantial,
and may consume our time or other resources. If we fail to obtain a favorable result at the USPTO, EPO or other patent office then we may be exposed to litigation by a third-party alleging that the patent may be infringed by our product candidates
or proprietary technologies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, because some patent applications in the United States may be maintained in secrecy until the
patents are issued, patent applications in the United States and many foreign jurisdictions are typically not published until 18&nbsp;months after filing, and publications in the scientific literature often lag behind actual discoveries, we cannot
be certain that others have not filed patent applications for technology covered by our owned and <FONT STYLE="white-space:nowrap">in-licensed</FONT> issued patents or our pending applications, or that we or, if applicable, a licensor were the first
to invent the technology. Our competitors may have filed, and may in the future file, patent applications covering our products or technology similar to ours. Any such patent application may have priority over our owned and <FONT
STYLE="white-space:nowrap">in-licensed</FONT> patent applications or patents, which could require us to obtain rights to issued patents </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
covering such technologies. If another party has filed a U.S. patent application on inventions similar to those owned by or <FONT STYLE="white-space:nowrap">in-licensed</FONT> to us, we or, in
the case of <FONT STYLE="white-space:nowrap">in-licensed</FONT> technology, the licensor may have to participate in an interference or derivation proceeding declared by the USPTO to determine priority of invention in the United States. If we or one
of our licensors is a party to an interference or derivation proceeding involving a U.S. patent application on inventions owned by or <FONT STYLE="white-space:nowrap">in-licensed</FONT> to us, we may incur substantial costs, divert management&#146;s
time and expend other resources, even if we are successful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interference or derivation proceedings provoked by third parties or brought
by us or declared by the USPTO may be necessary to determine the priority of inventions with respect to our patents or patent applications or those of our licensors. An unfavorable outcome could result in a loss of our current patent rights and
could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms or at all, or
if a non-exclusive license is offered and our competitors gain access to the same technology. Litigation or interference proceedings may result in a decision adverse to our interests and, even if we are successful, may result in substantial costs
and distract our management and other employees. We may not be able to prevent, alone or with our licensors, misappropriation of our trade secrets or confidential information, particularly in countries where the laws may not protect those rights as
fully as in the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, because of the substantial amount of discovery required in connection with intellectual
property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, there could be public announcements of the results of hearings, motions or other interim
proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and
other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these requirements. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Periodic maintenance fees on any issued patent are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime
of the patent. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other provisions during the patent application process and following the issuance of a patent.
While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent
application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Noncompliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to
official actions within prescribed time limits, <FONT STYLE="white-space:nowrap">non-payment</FONT> of fees and failure to properly legalize and submit formal documents. In certain circumstances, even inadvertent noncompliance events may permanently
and irrevocably jeopardize patent rights. In such an event, our competitors might be able to enter the market, which would have a material adverse effect on our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Any patents, if issued patents covering our product candidates could be found invalid or unenforceable if challenged in court or the
USPTO. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we or one of our licensors initiate legal proceedings against a third-party to enforce a patent covering one of our
product candidates, the defendant could counterclaim that the patent covering our product candidate, as applicable, is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or
unenforceability are commonplace, and there are numerous grounds upon which a third-party can assert invalidity or unenforceability of a patent. Third parties may also raise similar claims before administrative bodies in the United States or abroad,
even outside the context of litigation. Such mechanisms include <FONT STYLE="white-space:nowrap">re-examination,</FONT> inter partes review, post grant review, and equivalent proceedings in foreign jurisdictions (e.g.,&nbsp;opposition proceedings).
Such proceedings could result in revocation or amendment to our patents in such a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
way that they no longer cover our product candidates. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for
example, we cannot be certain that there is no invalidating prior art, of which we, our patent counsel and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity and/or
unenforceability, or if we are otherwise unable to adequately protect our rights, we would lose at least part, and perhaps all, of the patent protection on our product candidates. Such a loss of patent protection could have a material adverse impact
on our business and our ability to commercialize or license our technology and product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Likewise, our current licensed patents
covering our companion technologies, licensed from UCSF are expected to expire in 2036, without taking into account any possible patent term adjustments or extensions. Our earliest patents may expire before, or soon after, our first product achieves
marketing approval in the United States or foreign jurisdictions. Upon the expiration of our current patents, we may lose the right to exclude others from practicing these inventions. The expiration of these patents could also have a similar
material adverse effect on our business, results of operations, financial condition and prospects. We own pending patent applications covering our proprietary technologies or our product candidates that if issued as patents are expected to expire
from 2037 through 2040, without taking into account any possible patent term adjustments or extensions. However, we cannot be assured that the USPTO or relevant foreign patent offices will grant any of these patent applications. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Changes in patent law in the U.S. and in foreign jurisdictions could diminish the value of patents in general, thereby impairing our
ability to protect our products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Changes in either the patent laws or interpretation of the patent laws in the United States could
increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. Assuming that other requirements for patentability are met, prior to March&nbsp;16, 2013, in the
United&nbsp;States, the first to invent the claimed invention was entitled to the patent, while outside the United States, the first to file a patent application was entitled to the patent. On March&nbsp;16, 2013, under the Leahy-Smith America
Invents Act, or the America Invents Act, enacted in September 2011, the United States transitioned to a first inventor to file system in which, assuming that other requirements for patentability are met, the first inventor to file a patent
application will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. A third party that files a patent application in the USPTO on or after March&nbsp;16, 2013, but before us
could therefore be awarded a patent covering an invention of ours even if we had made the invention before it was made by such third party. This will require us to be cognizant of the time from invention to filing of a patent application. Since
patent applications in the United States and most other countries are confidential for a period of time after filing or until issuance, we cannot be certain that we or our licensors were the first to either (i)&nbsp;file any patent application
related to our product candidates or (ii)&nbsp;invent any of the inventions claimed in our or our licensor&#146;s patents or patent applications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The America Invents Act also includes a number of significant changes that affect the way patent applications will be prosecuted and also may
affect patent litigation. These include allowing third party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent by USPTO administered post-grant proceedings, including
post-grant review, inter-partes review, and derivation proceedings. Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standard in United States federal courts necessary to invalidate a patent claim, a third
party could potentially provide evidence in a USPTO proceeding sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action. Accordingly, a
third party may attempt to use the USPTO procedures to invalidate our patent claims that would not have been invalidated if first challenged by the third party as a defendant in a district court action. Therefore, the America Invents Act and its
implementation could increase the uncertainties and costs surrounding the prosecution of our owned or <FONT STYLE="white-space:nowrap">in-licensed</FONT> patent applications and the enforcement or defense of our owned or <FONT
STYLE="white-space:nowrap">in-licensed</FONT> issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations, and prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the patent positions of companies in the development and commercialization of
biopharmaceuticals are particularly uncertain. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. This combination of
events has created uncertainty with respect to the validity and enforceability of patents, once obtained. Depending on future actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in
unpredictable ways that could have a material adverse effect on our existing patent portfolio and our ability to protect and enforce our intellectual property in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We have limited foreign intellectual property rights and may not be able to protect our intellectual property rights throughout the
world. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have limited intellectual property rights outside the United States. Filing, prosecuting and defending patents on
product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws
of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries
outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to
develop their own products and, further, may export otherwise infringing products to territories where we have patent protection but where enforcement is not as strong as that in the United States. These products may compete with our products in
jurisdictions where we do not have any issued patents and our patent claims or other intellectual property rights may not be effective or sufficient to prevent them from competing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The
legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of, and may require a compulsory license to, patents, trade secrets and other intellectual property protection, particularly those relating
to biopharmaceutical products, which could make it difficult for us to stop the infringement of our patents or marketing of competing products against third parties in violation of our proprietary rights generally. The initiation of proceedings by
third parties to challenge the scope or validity of our patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business. Proceedings to enforce our patent rights in
foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not
issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our
intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Patent terms may be inadequate to protect our competitive position on our product candidates for an adequate amount of time.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent
is generally 20&nbsp;years from its earliest U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> filing date. Various extensions such as patent term adjustments and/or extensions, may be available, but the life of a patent, and the
protection it affords, is limited. Even if patents covering our product candidates are obtained, once the patent life has expired, we may be open to competition from competitive products. Given the amount of time required for the development,
testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with
sufficient rights to exclude others from commercializing products similar or identical to ours. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we do not obtain patent term extension and data exclusivity for any product
candidates we may develop, our business may be materially harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depending upon the timing, duration and specifics of any FDA
marketing approval of any product candidates we may develop, one or more of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Action of 1984 Hatch-Waxman Amendments. The
Hatch-Waxman Amendments permit a patent extension term of up to five years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of
14&nbsp;years from the date of product approval, only one patent may be extended and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. However, we may not be granted an extension
because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents, or otherwise failing to satisfy
applicable requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension or the term of any such extension is less than we request, our
competitors may obtain approval of competing products following our patent expiration, and our business, financial condition, results of operations, and prospects could be materially harmed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of
interest and our business may be adversely affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our trademarks or trade names may be challenged, infringed, circumvented or
declared generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names or may be forced to stop using these names, which we need for name recognition by potential partners or
customers in our markets of interest. If we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our business may be adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Reliance on Third Parties </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We have entered into a collaboration agreement with Novartis for the development of PLN-1474, and may in the future seek to enter into
collaborations with third parties for the development and commercialization of other product candidates. If we fail to enter into such collaborations, or our collaborations are not successful, we may be unable to continue development of such product
candidates, we would not receive any contemplated milestone payments or royalties, and we could fail to capitalize on the market potential of such product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2019, we entered into a license and collaboration agreement with Novartis for the development and commercialization of our then
preclinical product candidate, <FONT STYLE="white-space:nowrap">PLN-1474</FONT> and up to three integrin research targets. In December 2019, we received an upfront license payment of $50.0&nbsp;million for the worldwide exclusive license to <FONT
STYLE="white-space:nowrap">PLN-1474.</FONT> Pursuant to the Novartis Agreement, we expect to receive research and development funding totaling $19.6&nbsp;million for <FONT STYLE="white-space:nowrap">PLN-1474</FONT> development services and funding
of up to $13.4&nbsp;million for option research and development services on the integrin research targets. Additionally, we are eligible to receive developmental, regulatory and commercial milestone payments of up to $416.0&nbsp;million if defined
development, regulatory and commercialization milestones are achieved and tiered royalties, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-product</FONT></FONT> basis based on annual nets sales of products, at
percentages ranging from high-single digits to low teens of the applicable licensed products and <FONT STYLE="white-space:nowrap">mid-single</FONT> digits to high-single digits for any products resulting from the research programs. If we are unable
to successfully advance the development of our product candidates or achieve milestones, revenue and cash resources from milestone payments under our collaboration agreements will be substantially less than expected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, to the extent that any of our existing or future collaborators were to terminate a collaboration agreement, we may be forced to
independently develop these product candidates, including funding preclinical or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
clinical trials, assuming marketing and distribution costs and defending intellectual property rights, or, in certain instances, abandon product candidates altogether, any of which could result
in a change to our business plan and a material and adverse effect on our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We rely on third parties to conduct certain aspects of our preclinical studies and clinical trials. If these third parties do not
successfully carry out their contractual duties, meet expected deadlines or comply with regulatory requirements, we may not be able to obtain regulatory approval of or commercialize any potential product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We depend upon third parties to conduct certain aspects of our preclinical studies and clinical trials, under agreements with universities,
medical institutions, CROs, strategic collaborators and others. We expect to have to negotiate budgets and contracts with such third parties, which may result in delays to our development timelines and increased costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will rely especially heavily on third parties over the course of our clinical trials, and, as a result, will have limited control over the
clinical investigators and limited visibility into their <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> activities, including with respect to their compliance with the approved clinical protocol.
Nevertheless, we are responsible for ensuring that each of our trials is conducted in accordance with the applicable protocol, legal and regulatory requirements and scientific standards, and our reliance on third parties does not relieve us of our
regulatory responsibilities. We and these third parties are required to comply with GCP requirements, which are regulations and guidelines enforced by the FDA and comparable foreign regulatory authorities for product candidates in clinical
development. Regulatory authorities enforce these GCP requirements through periodic inspections of trial sponsors, clinical investigators and trial sites. If we or any of these third parties fail to comply with applicable GCP requirements, the
clinical data generated in our clinical trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to suspend or terminate these trials or perform additional preclinical studies or clinical trials before
approving our marketing applications. We cannot be certain that, upon inspection, such regulatory authorities will determine that any of our clinical trials comply with the GCP requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our failure or any failure by these third parties to comply with these regulations or to recruit a sufficient number of patients may require
us to repeat clinical trials, which would delay the regulatory approval process. Moreover, our business may be implicated if any of these third parties violates federal or state fraud and abuse or false claims laws and regulations or healthcare
privacy and security laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any third parties conducting aspects of our preclinical studies or clinical trials will not be our employees
and, except for remedies that may be available to us under our agreements with such third parties, we cannot control whether or not they devote sufficient time and resources to our preclinical studies and clinical programs. These third parties may
also have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical trials or other product development activities, which could affect their performance on our behalf. If these third
parties do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the preclinical or clinical data they obtain is compromised due to the failure to
adhere to our protocols or regulatory requirements or for other reasons or if due to federal or state orders or absenteeism due to the COVID-19 pandemic they are unable to meet their contractual and regulatory obligations, our development timelines,
including clinical development timelines, may be extended, delayed or terminated and we may not be able to complete development of, obtain regulatory approval of or successfully commercialize our product candidates. As a result, our financial
results and the commercial prospects for our product candidates would be harmed, our costs could increase and our ability to generate revenue could be delayed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any of our relationships with these third-party CROs or others terminate, we may not be able to enter into arrangements with alternative
CROs or other third parties or to do so on commercially reasonable terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Switching or adding additional CROs involves additional cost and requires management time
and focus. In addition, there is a natural transition period when a new CRO begins work. As a result, delays may occur, which can materially impact our ability to meet our desired development timelines. Though we carefully manage our relationships
with our CROs, there can be no assurance that we will not encounter similar challenges or delays in the future or that these delays or challenges will not have a material adverse impact on our business, financial condition and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We rely on third parties for tissue samples and other materials required for our research and development activities, and if we are
unable to reach agreements with these third parties our research and development activities would be delayed.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We rely on third parties, primarily hospitals, health clinics and academic institutions, for the provision of tissue samples and other
materials required in our research and development activities. Obtaining these materials requires various approvals as well as reaching a commercial agreement on acceptable terms with the hospital or other provider of the materials. While we
currently have agreements in place with the institutions from which we receive our tissue samples, we do not have any exclusive arrangements with such sources and there is no guarantee that we will be able to maintain or renew such agreements on
commercially reasonable terms, if at all. If we were unable to maintain or renew such agreements we would be forced to seek new arrangements with new hospitals, clinics or health institutions. If so, we may not be able to reach agreements with
alternative partners or do so on terms acceptable to us. If we are unable to enter into such agreements, our research and development activities will be delayed and our ability to implement a key part of our development strategy will be compromised.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Because we rely on third-party manufacturing and supply vendors, our supply of research and development, preclinical and clinical
development materials may become limited or interrupted or may not be of satisfactory quantity or quality. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We rely on third-party
contract manufacturers to manufacture our product candidates for preclinical studies and clinical trials. We do not own manufacturing facilities for producing any clinical trial product supplies. There can be no assurance that our preclinical and
clinical development product supplies will not be limited, interrupted, or of satisfactory quality or continue to be available at acceptable prices. For example, the extent to which the COVID-19 pandemic impacts our ability to procure sufficient
supplies for the development of our product candidates will depend on the severity and duration of the spread of the virus, and the actions undertaken to contain COVID-19 or treat its effects. In particular, any replacement of our manufacturer could
require significant effort and expertise because there may be a limited number of qualified replacements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The manufacturing process for a
product candidate is subject to FDA and foreign regulatory authority review. Suppliers and manufacturers must meet applicable manufacturing requirements and undergo rigorous facility and process validation tests required by regulatory authorities in
order to comply with regulatory standards, such as cGMPs. In the event that any of our manufacturers fails to comply with such requirements or to perform its obligations to us in relation to quality, timing or otherwise, or if our supply of
components or other materials becomes limited or interrupted for other reasons, we may be forced to manufacture the materials ourselves, for which we currently do not have the capabilities or resources, or enter into an agreement with another
third-party, which we may not be able to do on reasonable terms, if at all. In some cases, the technical skills or technology required to manufacture our product candidates may be unique or proprietary to the original manufacturer and we may have
difficulty transferring such skills or technology to another third-party and a feasible alternative may not exist. These factors would increase our reliance on such manufacturer or require us to obtain a license from such manufacturer in order to
have another third-party manufacture our product candidates. If we are required to change manufacturers for any reason, we will be required to verify that the new manufacturer maintains facilities and procedures that comply with quality standards
and with all applicable regulations and guidelines. The delays associated with the verification of a new manufacturer could negatively affect our ability to develop product candidates in a timely manner or within budget. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to continue to rely on third-party manufacturers if we receive regulatory approval
for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any other product candidate. To the extent that we have existing, or enter into future, manufacturing arrangements with third parties, we will depend on these third parties to perform their
obligations in a timely manner consistent with contractual and regulatory requirements, including those related to quality control and assurance. If we are unable to obtain or maintain third-party manufacturing for product candidates, or to do so on
commercially reasonable terms, we may not be able to develop and commercialize our product candidates successfully. Our or a third-party&#146;s failure to execute on our manufacturing requirements and comply with cGMP could adversely affect our
business in a number of ways, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an inability to initiate or continue clinical trials of product candidates under
development;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delay in submitting regulatory applications, or receiving regulatory approvals, for product
candidates;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">loss of the cooperation of an existing or future collaborator;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subjecting third-party manufacturing facilities or our manufacturing facilities to additional inspections by
regulatory authorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">requirements to cease distribution or to recall batches of our product candidates; and</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the event of approval to market and commercialize a product candidate, an inability to meet commercial demands
for our products. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We rely on a sole supplier for the manufacture of PLN-74809. If this sole supplier is unable to
supply to us in the quantities we require, or at all, or otherwise defaults on its supply obligations to us, we may not be able to obtain alternative supplies from other suppliers on acceptable terms, in a timely manner, or at all. We also do not
have long-term supply agreements with any of our suppliers. Our current contracts with certain suppliers may be canceled or not extended by such suppliers and, therefore, do not afford us with protection against a reduction or interruption in
supplies. Moreover, in the event any of these suppliers breach their contracts with us, our legal remedies associated with such a breach may be insufficient to compensate us for any damages we may suffer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we contract with fill and finishing providers with the appropriate expertise, facilities and scale to meet our needs. Failure to
maintain cGMP can result in a contractor receiving FDA sanctions, which can impact our ability to operate or lead to delays in any clinical development programs. We believe that our current fill and finish contractor is operating in accordance with
cGMP, but we can give no assurance that FDA or other regulatory agencies will not conclude that a lack of compliance exists. In addition, any delay in contracting for fill and finish services, or failure of the contract manufacturer to perform the
services as needed, may delay any clinical trials, registration and launches, which could negatively affect our business. In the future, if we advance a biological product candidate into IND-enabling studies, we will need to identify and contract
with suppliers who are able to produce biological product candidates and adhere to additional cGMP compliance obligations required for biologicals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our existing collaborations and future collaborations are and will be important to our business. If we are unable to enter into new
collaborations, or if these collaborations are not successful, our business could be adversely affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A part of our strategy is
to selectively evaluate partnerships in indications and geographies where we believe partners can add significant commercial and/or development capabilities. Further, we have limited capabilities for product development and do not yet have any
capability for commercialization. Accordingly, we have and may in the future enter into collaborations with other companies to provide us with important technologies and funding for our programs and technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our existing collaborations and any future collaborations we enter into may pose a number of risks, including the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators have significant discretion in determining the efforts and resources that they will
apply;</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may not perform their obligations as expected;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may not pursue development and commercialization of any product candidates that achieve regulatory
approval or may elect not to continue or renew development or commercialization programs or license arrangements based on clinical trial results, changes in the collaborators&#146; strategic focus or available funding, or external factors, such as a
strategic transaction that may divert resources or create competing priorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a
clinical trial or abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators could independently develop, or develop with third parties, products that compete directly or
indirectly with our products and product candidates if the collaborators believe that the competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than
ours;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product candidates discovered in collaboration with us may be viewed by our collaborators as competitive with
their own product candidates or products, which may cause collaborators to cease to devote resources to the commercialization of our product candidates;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may fail to comply with applicable regulatory requirements regarding the development, manufacture,
distribution or marketing of a product candidate or product;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators with marketing and distribution rights to one or more of our product candidates that achieve
regulatory approval may not commit sufficient resources to the marketing and distribution of such product or products;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may not provide us with timely and accurate information regarding development progress and activity
under any future license agreement, which could adversely impact our ability to report progress to our investors and otherwise plan development of our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disagreements with collaborators, including disagreements over proprietary rights, contract interpretation or the
preferred course of development, might cause delays or terminations of the research, development or commercialization of product candidates, might lead to additional responsibilities for us with respect to product candidates, or might result in
litigation or arbitration, any of which would be time-consuming and expensive;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may not properly maintain or defend our intellectual property rights or may use our proprietary
information in such a way as to invite litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential litigation;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may infringe the intellectual property rights of third parties, which may expose us to litigation
and potential liability;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if a collaborator of ours is involved in a business combination, the collaborator might deemphasize or terminate
the development or commercialization of any product candidate licensed to it by us; and</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborations may be terminated by the collaborator, and, if terminated, we could be required to raise
additional capital to pursue further development or commercialization of the applicable product candidates. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our
existing collaborations and any future collaborations we enter into do not result in the successful discovery, development and commercialization of product candidates or if one of our collaborators terminates its agreement with us, we may not
receive any future research funding or milestone or royalty payments under such collaboration. All of the risks relating to product development, regulatory approval and commercialization described in this prospectus also apply to the activities of
our therapeutic collaborators. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, if one of our existing or future collaborators terminates its agreement with
us, we may find it more difficult to attract new collaborators and our perception in the business and financial communities could be adversely affected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We face significant competition in seeking appropriate collaborators for our product candidates, and the negotiation process is time-consuming
and complex. In order for us to successfully establish a collaboration for one or more of our product candidates, potential collaborators must view these product candidates as economically valuable in markets they determine to be attractive in light
of the terms that we are seeking and other available products for licensing by other companies. Collaborations are complex and time-consuming to negotiate and document. In addition, there have been a significant number of recent business
combinations among large biopharmaceutical companies that have resulted in a reduced number of potential future collaborators. Our ability to reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of
the collaborator&#146;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#146;s evaluation of a number of factors. If we are unable to reach agreements with suitable collaborators on a
timely basis, on acceptable terms, or at all, we may have to curtail the development of a product candidate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce
the scope of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities
on our own, we may need to obtain additional expertise and additional capital, which may not be available to us on acceptable terms, or at all. If we fail to enter into future collaborations or do not have sufficient funds or expertise to undertake
the necessary development and commercialization activities, we may not be able to further develop our product candidates, bring them to market and generate revenue from sales of drugs or continue to develop our technology, and our business may be
materially and adversely affected. Even if we are successful in our efforts to establish new strategic collaborations, the terms that we agree upon may not be favorable to us, and we may not be able to maintain such strategic collaborations if, for
example, development or approval of a product candidate is delayed or sales of an approved product are disappointing. Any delay in entering into new strategic collaboration agreements related to our product candidates could delay the development and
commercialization of our product candidates and reduce their competitiveness even if they reach the market. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Managing Our Business and
Operations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The outbreak of the novel coronavirus disease, COVID-19, could adversely impact our business, including our
preclinical studies and clinical trials. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, a novel strain of the coronavirus disease, COVID-19, was identified in
Wuhan, China. This virus continues to spread globally and, as of May 2020, has spread to a number countries globally, including the United States. The outbreak and government measures taken in response have also had a significant impact, both direct
and indirect, on businesses and commerce, as worker shortages have occurred; supply chains have been disrupted; facilities and production have been suspended; and demand for certain goods and services, such as medical services and supplies, has
spiked, while demand for other goods and services, such as travel, has fallen. In response to the spread of COVID-19, we have closed our executive offices with our administrative employees continuing their work outside of our offices and limited the
number of staff in any given research and development laboratory. As a result of the COVID-19 pandemic, we have experienced disruptions and may continue to experience disruptions that could severely impact our business, preclinical studies and
clinical trials, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays or difficulties in commencing enrollment of patients in our clinical trials, including our Phase 2a
clinical trials of PLN-74809 in IPF and PSC and our Phase 1 clinical trial of PLN-1474; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact from potential delays, including potential difficulties in clinical site initiation, including
difficulties in recruiting clinical site investigators and clinical site staff; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">diversion of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals
serving as our clinical trial sites and hospital staff supporting the conduct of our clinical trials; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruption of key clinical trial activities, such as clinical trial site data monitoring, due to limitations on
travel imposed or recommended by federal or state governments, employers and others or interruption of clinical trial subject visits and study procedures that are deemed non-essential, which may impact the integrity of subject data and clinical
study endpoints; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruption or delays in the operations of the FDA or other regulatory authorities, which may impact review and
approval timelines; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruption of, or delays in receiving, supplies of our product candidates from our contract manufacturing
organizations due to staffing shortages, production slowdowns or stoppages and disruptions in delivery systems; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruptions in preclinical studies due to restricted or limited operations at our laboratory facility;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limitations on employee resources that would otherwise be focused on the conduct of our preclinical studies and
clinical trials, including because of sickness of employees or their families or the desire of employees to avoid contact with large groups of people; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruption or delays to our sourced discovery and clinical activities. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The COVID-19 pandemic continues to rapidly evolve. The extent to which the outbreak impacts our business, preclinical studies and clinical
trials will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, the duration of the pandemic, travel restrictions and social distancing in the
United States and other countries, business closures or business disruptions and the effectiveness of actions taken in the United States and other countries to contain and treat the disease. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We may encounter difficulties in managing our growth, which could adversely affect our operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, we had 62 full-time employees. As our clinical development and commercialization plans and strategies develop,
and as we transition into operating as a public company, we will need to expand our managerial, clinical, regulatory, sales, marketing, financial, development, manufacturing and legal capabilities or contract with third parties to provide these
capabilities for us. As our operations expand, we expect that we will need to manage additional relationships with various strategic collaborators, suppliers and other third parties. Our future growth would impose significant added responsibilities
on members of management, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying, recruiting, integrating, maintaining and motivating additional employees; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">managing our development and commercialization efforts effectively, including the clinical and FDA review process
for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and any other product candidates, while complying with our contractual obligations to contractors and other third parties; and</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">improving our operational, financial and management controls, reporting systems and procedures.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ability to continue to develop and, if approved, commercialize our product candidates will depend, in part, on our
ability to effectively manage any future growth. Our management may also have to divert a disproportionate amount of its attention away from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> activities in
order to devote a substantial amount of time to managing these growth activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently rely, and for the foreseeable future will
continue to rely, in substantial part on certain independent organizations, advisors and consultants to provide certain services, including contract manufacturers and companies focused on research and development and discovery activities. There can
be no assurance that the services of independent organizations, advisors and consultants will continue to be available to us on a timely basis when needed, or that we can find qualified replacements. In addition, if we are unable to effectively
manage our outsourced activities or if the quality, accuracy or quantity of the services provided is compromised for any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reason, our clinical trials may be extended, delayed or terminated, and we may not be able to obtain, or may be substantially delayed in obtaining, regulatory approval of our product candidates
or otherwise advance our business. There can be no assurance that we will be able to manage our existing consultants or find other competent outside contractors and consultants on economically reasonable terms, or at all. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we are not able to effectively expand our organization by hiring new employees and expanding our groups of consultants and contractors, we
may not be able to successfully implement the tasks necessary to further develop and commercialize <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any other product candidates and, accordingly, may not achieve our research, development and
commercialization goals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may acquire additional technology and complementary businesses in the future. Acquisitions involve many
risks, any of which could materially harm our business, including the diversion of management&#146;s attention from core business concerns, failure to effectively exploit acquired technologies, failure to successfully integrate the acquired business
or realize expected synergies or the loss of key employees from either our business or the acquired businesses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we lose key
management personnel, or if we fail to recruit additional highly skilled personnel, our ability to develop current product candidates or identify and develop new product candidates will be impaired, could result in loss of markets or market share
and could make us less competitive. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ability to compete in the highly competitive biotechnology and biopharmaceutical
industries depends upon our ability to attract and retain highly qualified managerial, scientific and medical personnel. We are highly dependent on our management, scientific and medical personnel, including Bernard Coulie, M.D., Ph.D., our Chief
Executive Officer and President, Keith Cummings, M.D., our Chief Financial Officer, Barbara Howes, our Chief Human Resources Officer, Johannes (Hans) Hull, J.D., our Chief Business Officer and &Eacute;ric Lefebvre, M.D., our Chief Medical Officer.
The loss of the services of any of our executive officers, other key employees, and other scientific and medical advisors, and our inability to find suitable replacements could result in delays in product development and harm our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We conduct our operations at our facility in South San Francisco, California. This region is headquarters to many other biopharmaceutical
companies, biotechnology companies and research institutions. Competition for skilled personnel in our market is intense and may limit our ability to hire and retain highly qualified personnel on acceptable terms or at all. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To induce valuable employees to remain at our company, in addition to salary and cash incentives, we have provided restricted stock awards and
stock options that vest over time. The value to employees of restricted stock awards and stock options that vest over time may be significantly affected by movements in our stock price that are beyond our control, and may at any time be insufficient
to counteract more lucrative offers from other companies. Despite our efforts to retain valuable employees, members of our management, scientific and development teams may terminate their employment with us on short notice. Our key employees are <FONT
STYLE="white-space:nowrap">at-will</FONT> employees, which means that any of our employees could leave our employment at any time, with or without notice. We do not maintain &#147;key person&#148; insurance policies on the lives of these individuals
or the lives of any of our other employees. Our success also depends on our ability to continue to attract, retain and motivate highly skilled junior, <FONT STYLE="white-space:nowrap">mid-level</FONT> and senior scientific and medical personnel.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our internal computer systems, or those of our collaborators or other contractors or consultants, may fail or suffer security
breaches, which could result in a material disruption of our product development programs. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our internal computer systems and those
of our current and any future collaborators and other contractors or consultants are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. While we have not
experienced any such material system </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
failure, accident or security breach to date, if such an event were to occur and cause interruptions in our operations, it could result in a disruption of our development programs and our
business operations, whether due to a loss of our trade secrets or other proprietary information or other similar disruptions. For example, the loss of clinical trial data from future clinical trials could result in delays in our regulatory approval
efforts and significantly increase our costs to recover or reproduce the data. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or
proprietary information, we could incur liability, our competitive position could be harmed and the further development and commercialization of our product candidates could be delayed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We could be subject to risks caused by misappropriation, misuse, leakage, falsification or intentional or accidental release or loss of
information maintained in the information systems and networks of our company and our vendors, including personal information of our employees and study subjects, and company and vendor confidential data. In addition, outside parties may attempt to
penetrate our systems or those of our vendors or fraudulently induce our personnel or the personnel of our vendors to disclose sensitive information in order to gain access to our data and/or systems. We may experience threats to our data and
systems, including malicious codes and viruses, phishing and other cyberattack. The number and complexity of these threats continue to increase over time. If a material breach of, or accidental or intentional loss of data from, our information
technology systems or those of our vendors occurs, the market perception of the effectiveness of our security measures could be harmed and our reputation and credibility could be damaged. We could be required to expend significant amounts of money
and other resources to repair or replace information systems or networks. In addition, we could be subject to regulatory actions and/or claims made by individuals and groups in private litigation involving privacy issues related to data collection
and use practices and other data privacy laws and regulations, including claims for misuse or inappropriate disclosure of data, as well as unfair or deceptive practices. Although we develop and maintain systems and controls designed to prevent these
events from occurring, and we have a process to identify and mitigate threats, the development and maintenance of these systems, controls and processes is costly and requires ongoing monitoring and updating as technologies change and efforts to
overcome security measures become increasingly sophisticated. Moreover, despite our efforts, the possibility of these events occurring cannot be eliminated entirely. As we outsource more of our information systems to vendors, engage in more
electronic transactions with payors and patients, and rely more on cloud-based information systems, the related security risks will increase and we will need to expend additional resources to protect our technology and information systems. In
addition, there can be no assurance that our internal information technology systems or those of our third-party contractors, or our consultants&#146; efforts to implement adequate security and control measures, will be sufficient to protect us
against breakdowns, service disruption, data deterioration or loss in the event of a system malfunction, or prevent data from being stolen or corrupted in the event of a cyberattack, security breach, industrial espionage attacks or insider threat
attacks which could result in financial, legal, business or reputational harm. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our current operations are concentrated in one
location, and we or the third parties upon whom we depend may be adversely affected by earthquakes or other natural disasters, as well as occurrences of civil unrest, and our business continuity and disaster recovery plans may not adequately protect
us from a serious disaster, including earthquakes, outbreak of disease or other natural disasters and civil unrest. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our current
operations are located in our facilities in South San Francisco, California. Any unplanned event, such as flood, fire, explosion, earthquake, extreme weather condition, medical epidemics, power shortage, telecommunication failure or other natural or
manmade accidents or incidents, including events of civil unrest, that result in us being unable to fully utilize our facilities, or the manufacturing facilities of our third-party contract manufacturers, may have a material and adverse effect on
our ability to operate our business, particularly on a daily basis, and have significant negative consequences on our financial and operating conditions. Loss of access to these facilities may result in increased costs, delays in the development of
our product candidates or interruption of our business operations. Earthquakes or other natural disasters could further disrupt our operations, and have a material and adverse effect on our business, financial condition, results of operations and
prospects. If a natural disaster, power outage or other event occurred that prevented us from using all or a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
significant portion of our headquarters, that damaged critical infrastructure, such as our research facilities or the manufacturing facilities of our third-party contract manufacturers, or that
otherwise disrupted operations, it may be difficult or, in certain cases, impossible, for us to continue our business for a substantial period of time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The disaster recovery and business continuity plans we have in place may prove inadequate in the event of a serious disaster or similar event.
We may incur substantial expenses as a result of the limited nature of our disaster recovery and business continuity plans, which, could have a material adverse effect on our business. As part of our risk management policy, we maintain insurance
coverage at levels that we believe are appropriate for our business. However, in the event of an accident or incident at these facilities, we cannot assure you that the amounts of insurance will be sufficient to satisfy any damages and losses. If
our facilities, or the manufacturing facilities of our third-party contract manufacturers, are unable to operate because of an accident or incident or for any other reason, even for a short period of time, any or all of our research and development
programs may be harmed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Unfavorable global economic conditions could adversely affect our business, financial condition or results
of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our results of operations could be adversely affected by general conditions in the global economy and in the global
financial markets. Portions of our future clinical trials may be conducted outside of the United States and unfavorable economic conditions resulting in the weakening of the U.S. dollar would make those clinical trials more costly to operate.
Furthermore, the most recent global financial crisis caused extreme volatility and disruptions in the capital and credit markets. A severe or prolonged economic downturn, including due to the impact of the COVID-19 pandemic, could result in a
variety of risks to our business, including a reduced ability to raise additional capital when needed on acceptable terms, if at all. A weak or declining economy or international trade disputes could also strain our suppliers, some of which are
located outside of the United States, possibly resulting in supply disruption. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could
adversely impact our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The increasing use of social media platforms presents new risks and challenges. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Social media is increasingly being used to communicate about our clinical development programs and the diseases our therapeutics are being
developed to treat, and we intend to utilize appropriate social media in connection with our commercialization efforts following approval of our product candidates, if any. Social media practices in the biopharmaceutical industry continue to evolve
and regulations and regulatory guidance relating to such use are evolving and not always clear. This evolution creates uncertainty and risk of noncompliance with regulations applicable to our business, resulting in potential regulatory actions
against us, along with the potential for litigation related to off-label marketing or other prohibited activities. For example, patients may use social media channels to comment on their experience in an ongoing blinded clinical trial or to report
an alleged adverse event. When such disclosures occur, there is a risk that trial enrollment may be adversely impacted, we fail to monitor and comply with applicable adverse event reporting obligations or that we may not be able to defend our
business or the public&#146;s legitimate interests in the face of the political and market pressures generated by social media due to restrictions on what we may say about our product candidates. There is also a risk of inappropriate disclosure of
sensitive information or negative or inaccurate posts or comments about us on any social networking website. If any of these events were to occur or we otherwise fail to comply with applicable regulations, we could incur liability, face regulatory
actions or incur other harm to our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The estimates of market opportunity and forecasts of market growth included in this
prospectus may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, our business may not grow at similar rates, or at all. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Market opportunity estimates and growth forecasts included in this prospectus are subject to significant uncertainty and are based on
assumptions and estimates which may not prove to be accurate. The estimates and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
forecasts included in this prospectus relating to size and expected growth of our target market may prove to be inaccurate. Even if the markets in which we compete meet the size estimates and
growth forecasts included in this prospectus, our business may not grow at similar rates, or at all. Our growth is subject to many factors, including our success in implementing our business strategy, which is subject to many risks and
uncertainties. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our employees, independent contractors, consultants, commercial partners, collaborators and vendors may engage in
misconduct or other improper activities, including noncompliance with regulatory standards and requirements. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are exposed to the
risk of employee fraud or other illegal activity by our employees, independent contractors, consultants, commercial partners, collaborators and vendors. Misconduct by these parties could include intentional, reckless and/or negligent conduct that
fails to comply with the laws of the FDA and other similar foreign regulatory bodies, provide true, complete and accurate information to the FDA and other similar foreign regulatory bodies, comply with manufacturing standards we have established,
comply with healthcare fraud and abuse laws in the United States and similar foreign fraudulent misconduct laws, or report financial information or data accurately or to disclose unauthorized activities to us. If we obtain FDA approval of any of our
product candidates and begin commercializing those products in the United States, our potential exposure under such laws will increase significantly, and our costs associated with compliance with such laws will also increase. These laws may impact,
among other things, our current activities with principal investigators and research patients, as well as proposed and future sales, marketing and education programs. In connection with this offering, we will adopt a code of business conduct and
ethics, but it is not always possible to identify and deter misconduct by our employees, independent contractors, consultants, commercial partners and vendors, and the precautions we take to detect and prevent this activity may not be effective in
controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any actions are instituted against us and we are
not successful in defending ourselves or asserting our rights, those actions could result in the imposition of civil, criminal and administrative penalties, damages, monetary fines, imprisonment, disgorgement, possible exclusion from participation
in government healthcare programs, additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these
laws, contractual damages, reputational harm, diminished profits and future earnings and the curtailment of our operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We use
and generate materials that may expose us to material liability. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our research programs involve the use of hazardous materials and
chemicals, which are currently only handled by third parties. We are subject to foreign, federal, state and local environmental and health and safety laws and regulations governing, among other matters, the use, manufacture, handling, storage and
disposal of hazardous materials and waste products such as human tissue samples that may have the potential to transmit diseases. We may incur significant costs to comply with these current or future environmental and health and safety laws and
regulations. In addition, we cannot completely eliminate the risk of contamination or injury from hazardous materials and may incur material liability as a result of such contamination or injury. In the event of an accident, an injured party may
seek to hold us liable for any damages that result. Any liability could exceed the limits or fall outside the coverage of our workers&#146; compensation, property and business interruption insurance and we may not be able to maintain insurance on
acceptable terms, if at all. We currently carry no insurance specifically covering environmental claims. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to comply with
environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures
and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our research and development activities involve the use of biological and hazardous materials and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these
materials, which could cause an interruption of our commercialization efforts, research and development efforts and business operations, environmental damage resulting in costly <FONT STYLE="white-space:nowrap">clean-up</FONT> and liabilities under
applicable laws and regulations governing the use, storage, handling and disposal of these materials and specified waste products. Although we believe that the safety procedures utilized by our third-party manufacturers for handling and disposing of
these materials generally comply with the standards prescribed by these laws and regulations, we cannot guarantee that this is the case or eliminate the risk of accidental contamination or injury from these materials. In such an event, we may be
held liable for any resulting damages and such liability could exceed our resources and state or federal or other applicable authorities may curtail our use of certain materials and/or interrupt our business operations. Furthermore, environmental
laws and regulations are complex, change frequently and have tended to become more stringent. We cannot predict the impact of such changes and cannot be certain of our future compliance. In addition, we may incur substantial costs in order to comply
with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our research, development or production efforts. Failure to comply with these laws and regulations also may result
in substantial fines, penalties or other sanctions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we maintain workers&#146; compensation insurance to cover us for costs and
expenses we may incur due to injuries to our employees resulting from the use of hazardous materials or other work-related injuries, this insurance may not provide adequate coverage against potential liabilities. We do not carry specific biological
waste or hazardous waste insurance coverage, workers compensation or property and casualty and general liability insurance policies that include coverage for damages and fines arising from biological or hazardous waste exposure or contamination.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Compliance with governmental regulations regarding the treatment of animals used in research could increase our operating costs,
which would adversely affect the commercialization of our products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Animal Welfare Act, or AWA, is the federal law that covers
the treatment of certain animals used in research. Currently, the AWA imposes a wide variety of specific regulations that govern the humane handling, care, treatment and transportation of certain animals by producers and users of research animals,
most notably relating to personnel, facilities, sanitation, cage size, and feeding, watering and shipping conditions. Third parties with whom we contract are subject to registration, inspections and reporting requirements under the AWA. Furthermore,
some states have their own regulations, including general anti-cruelty legislation, which establish certain standards in handling animals. Comparable rules, regulations, and or obligations exist in many foreign jurisdictions. If we or our
contractors fail to comply with regulations concerning the treatment of animals used in research, we may be subject to fines and penalties and adverse publicity, and our operations could be adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Changes in U.S. tax law could adversely affect our financial condition and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rules dealing with U.S. federal, state, and local income taxation are constantly under review by persons involved in the legislative
process and by the Internal Revenue Service and the U.S. Treasury Department. Changes to tax laws (which changes may have retroactive application) could adversely affect us or holders of our common stock. In recent years, many such changes have been
made and changes are likely to continue to occur in the future. Future changes in U.S. tax laws could have a material adverse effect on our business, cash flow, financial condition or results of operations. We urge investors to consult with their
legal and tax advisors regarding the implications of potential changes in U.S. tax laws on an investment in our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our
ability to use our net operating loss carryforwards and certain tax credit carryforwards may be subject to limitation. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of
December 31, 2019, we had net operating loss carryforwards for U.S. federal and state income tax purposes of $58.7 million and $60.7 million, respectively, some of which will begin to expire in 2035. As of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
December 31, 2019, we also had available tax credit carryforwards for U.S. federal income tax purposes of $4.7&nbsp;million, which begin to expire in 2036, and state income tax purposes of $2.1
million. Under Section&nbsp;382 of the Internal Revenue Code of 1986, as amended, or the Code, changes in our ownership may limit the amount of our net operating loss carryforwards and tax credit carryforwards that could be utilized annually to
offset our future taxable income, if any. This limitation would generally apply in the event of a cumulative change in ownership of our company of more than 50 percentage points within a three-year period. Any such limitation may significantly
reduce our ability to utilize our net operating loss carryforwards and tax credit carryforwards before they expire. Private placements and other transactions that have occurred since our inception, as well as this offering and the Concurrent Private
Placement, may trigger such an ownership change pursuant to Section&nbsp;382. Any such limitation, whether as the result of this offering, the Concurrent Private Placement, prior private placements, sales of our common stock by our existing
stockholders or additional sales of our common stock by us, could have a material adverse effect on our results of operations in future years. Our ability to utilize those net operating loss carryforwards could be limited by an &#147;ownership
change&#148; as described above, which could result in increased tax liability to us. Net operating losses generated after December&nbsp;31, 2017 are not subject to expiration, but may not be carried back to prior taxable years, except that net
operating losses generated in 2018, 2019 and 2020 may be carried back five taxable years. Additionally, the deductibility of such U.S. federal net operating losses is limited to 80% of our taxable income in any taxable year beginning after December
31, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Common Stock and this Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>There has been no prior public market for our common stock, the stock price of our common stock may be volatile or may decline regardless
of our operating performance and you may not be able to resell your shares at or above the initial public offering price. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to
this offering there has been no public market for shares of our common stock. You may not be able to sell your shares quickly or at the market price if trading in shares of our common stock is not active. The initial public offering price for our
common stock will be determined through negotiations with the underwriters, and the negotiated price may not be indicative of the market price of the common stock after the offering. An active or liquid market in our common stock may not develop
upon the completion of this offering or, if it does develop, it may not be sustainable. As a result of these and other factors, you may be unable to resell your shares of our common stock at or above the initial public offering price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, an inactive market may also impair our ability to raise capital by selling shares of our common stock and may impair our ability to
enter into strategic collaborations or acquire companies or products by using our shares of common stock as consideration. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The
price of our stock may be volatile, and you could lose all or part of your investment. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading price of our common stock
following this offering is likely to be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control, including limited trading volume. In addition to the factors discussed in this
&#147;Risk Factors&#148; section and elsewhere in this prospectus, these factors include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the commencement, enrollment or results of our current Phase&nbsp;2a clinical trials of <FONT
STYLE="white-space:nowrap">PLN-74809;</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any delay in identifying and advancing a clinical candidate for our other development
programs;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any delay in our regulatory filings for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or our other product
candidates and any adverse development or perceived adverse development with respect to the applicable regulatory authority&#146;s review of such filings, including without limitation the FDA&#146;s issuance of a &#147;refusal to file&#148; letter
or a request for additional information; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adverse results or delays in future clinical trials;</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our decision to initiate a clinical trial, not to initiate a clinical trial or to terminate an existing clinical
trial;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adverse regulatory decisions, including failure to receive regulatory approval of
<FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any other product candidate;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in laws or regulations applicable to <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any other
product candidate, including but not limited to clinical trial requirements for approvals;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adverse developments concerning our manufacturers;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inability to obtain adequate product supply for any approved product or inability to do so at acceptable
prices;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inability to establish collaborations, if needed;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure to commercialize our product candidates, if approved;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additions or departures of key scientific or management personnel;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unanticipated serious safety concerns related to the use of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or
any other product candidate;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">introduction of new products or services offered by us or our competitors;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">announcements of significant acquisitions, strategic partnerships, joint ventures or capital commitments by us or
our competitors;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to effectively manage our growth;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">actual or anticipated variations in quarterly operating results;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our cash position;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure to meet the estimates and projections of the investment community or that we may otherwise provide to
the public;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">publication of research reports about us or our industry, or product candidates in particular, or positive or
negative recommendations or withdrawal of research coverage by securities analysts;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the market valuations of similar companies;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the structure of the healthcare payment systems; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overall performance of the equity markets;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales of our common stock by us or our stockholders in the future;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">trading volume of our common stock;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in accounting practices;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ineffectiveness of our internal controls;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disputes or other developments relating to proprietary rights, including patents, litigation matters and our
ability to obtain patent protection for our technologies;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">significant lawsuits, including patent or stockholder litigation;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">general political and economic conditions; and</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other events or factors, many of which are beyond our control. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the stock market in general, and the market for biopharmaceutical companies in particular, have experienced extreme price and
volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies, including as a result of the COVID-19 pandemic. Broad market and industry factors may negatively affect the market price of our
common stock, regardless of our actual operating </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
performance. If the market price of our common stock after this offering does not exceed the initial public offering price, you may not realize any return on your investment in us and may lose
some or all of your investment. In the past, securities class action litigation has often been instituted against companies following periods of volatility in the market price of a company&#146;s securities. This type of litigation, if instituted,
could result in substantial costs and a diversion of management&#146;s attention and resources. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We do not intend to pay dividends
on our common stock so any returns will be limited to the value of our stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently anticipate that we will retain future
earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. Furthermore, future debt or other financing arrangements may contain terms prohibiting or
limiting the amount of dividends that may be declared or paid on our common stock. Any return to stockholders will therefore be limited to the appreciation of their stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our executive officers, directors and their affiliates and our principal stockholders own a significant percentage of our stock and will
be able to exert significant control over matters subject to stockholder approval. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on shares outstanding as of May 15,
2020 and immediately following the completion of this offering and the Concurrent Private Placement, our executive officers, directors and their affiliates and our principal stockholders will beneficially hold, in the aggregate, approximately 51.1%
of our outstanding voting stock, excluding any shares purchased in this offering. These stockholders, acting together, would be able to significantly influence all matters requiring stockholder approval. For example, these stockholders would be able
to significantly influence elections of directors, amendments of our organizational documents, or approval of any merger, sale of assets, or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or
offers for our common stock that you may feel are in your best interest as one of our stockholders. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>The Concurrent Private
Placement and the potential purchases of shares in this offering by our principal stockholders may reduce the number of freely tradeable shares of our common stock. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Novartis has agreed to purchase $10.0 million of shares of our common stock at a price per share equal to the initial public offering price (or
666,666 shares based on the assumed initial public offering price of $15.00 per share, the midpoint of the price range set forth on the cover page of this prospectus) in a private placement transaction that would close concurrently with, and be
contingent and conditioned upon consummation of, this offering. The sale of these shares to Novartis will not be registered in this offering, and these shares are subject to a 180-day lock-up agreement with the underwriters in this offering. Certain
of our principal stockholders including stockholders affiliated with certain of our directors, have indicated an interest in purchasing a substantial amount of the shares of our common stock offered in this offering at the initial public offering
price and on the same terms and conditions as the other purchasers in this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Concurrent Private Placement and the potential
purchases of shares in this offering by certain of our principal stockholders may reduce the number of shares of our common stock that are freely tradeable because Novartis will be restricted from selling the shares pursuant to restrictions under
applicable securities laws, and our existing stockholders, to the extent they are affiliated with us, may be restricted from selling any shares purchased by them pursuant to lock-up agreements they have entered into with the underwriters in this
offering. As a result, the sale of common stock in the Concurrent Private Placement and to our existing stockholders may reduce the liquidity of our common stock relative to what it would have been had these shares been sold in this offering and
been purchased by investors that were not affiliated with us. Following this offering and the Concurrent Private Placement, the number of shares beneficially owned by Novartis and our other principal stockholders after this offering will be as set
forth in the beneficial ownership table in &#147;Principal Stockholders&#148; elsewhere in this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If you purchase our common stock in this offering, you will incur immediate and
substantial dilution in the book value of your shares. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The initial public offering price will be substantially higher than the
pro forma as adjusted net tangible book value per share of our common stock after this offering. Investors purchasing common stock in this offering and the Concurrent Private Placement will pay a price per share that substantially exceeds the pro
forma as adjusted net tangible book value per share after this offering. As a result, investors purchasing common stock in this offering will incur immediate dilution of $6.20 per share, based on an assumed initial public offering price of $15.00
per share, the midpoint of the price range set forth on the cover page of this prospectus and the sale of shares of common stock in the Concurrent Private Placement, representing the difference between our pro forma as adjusted net tangible book
value per share after giving effect to this offering and the assumed initial public offering price. Further, investors purchasing common stock in this offering will contribute approximately 39.2% of the total amount invested by stockholders since
our inception, but will own only approximately 28.2% of the shares of common stock outstanding after this offering and the Concurrent Private Placement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This dilution is due to our investors who purchased shares prior to this offering having paid substantially less when they purchased their
shares than the price offered to the public in this offering. To the extent outstanding options are exercised, there will be further dilution to new investors. As a result of the dilution to investors purchasing shares in this offering, investors
may receive significantly less than the purchase price paid in this offering, if anything, in the event of our liquidation. For a further description of the dilution that you will experience immediately after this offering, see the section entitled
&#147;Dilution.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We are an emerging growth company, and we cannot be certain if the reduced reporting requirements applicable
to emerging growth companies will make our common stock less attractive to investors. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an emerging growth company, or EGC,
as defined in the Jumpstart Our Business Startups Act, or the JOBS Act, enacted in April 2012. For as long as we continue to be an EGC, we may take advantage of exemptions from various reporting requirements that are applicable to other public
companies that are not EGCs, including not being required to comply with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act of 2002, as amended, or the Sarbanes-Oxley Act, reduced disclosure obligations regarding
executive compensation in this prospectus and our periodic reports and proxy statements and exemptions from the requirements of holding nonbinding advisory votes on executive compensation and stockholder approval of any golden parachute payments not
previously approved. We could be an EGC for up to five years following the year in which we complete this offering, although circumstances could cause us to lose that status earlier. We will remain an EGC until the earlier of (i)&nbsp;the last day
of the fiscal year (a)&nbsp;following the fifth anniversary of the completion of this offering, (b)&nbsp;in which we have total annual gross revenue of at least $1.07&nbsp;billion or (c)&nbsp;in which we are deemed to be a large accelerated filer,
which requires the market value of our common stock that is held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> to exceed $700.0&nbsp;million as of the prior June&nbsp;30th, and (ii)&nbsp;the date on which we have issued more than
$1.0&nbsp;billion in <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt during the prior three-year period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may choose to
take advantage of some, but not all, of the available exemptions. We have taken advantage of reduced reporting burdens in this prospectus. In particular, we have not included all of the executive compensation information that would be required if we
were not an EGC. We cannot predict whether investors will find our common stock less attractive if we rely on certain or all of these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading
market for our common stock and our stock price may be more volatile. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the JOBS Act, EGCs can also delay adopting new or revised
accounting standards until such time as those standards apply to private companies, which may make our financial statements less comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We will incur significant increased costs as a result of operating as a public
company, and our management will be required to devote substantial time to new compliance initiatives. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a public company, we
will incur significant legal, accounting and other expenses that we did not incur as a private company. We will be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, which will require, among other things, that
we file with the SEC annual, quarterly and current reports with respect to our business and financial condition. In addition, the Sarbanes-Oxley Act, as well as rules subsequently adopted by the SEC and the Nasdaq Global Market to implement
provisions of the Sarbanes-Oxley Act, impose significant requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial reporting controls and changes in corporate governance practices.
Further, in July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, was enacted. There are significant corporate governance and executive compensation related provisions in the Dodd-Frank Act that require the
SEC to adopt additional rules and regulations in these areas such as &#147;say on pay&#148; and proxy access. Recent legislation permits EGCs to implement many of these requirements over a longer period and up to five years from the pricing of this
offering. Stockholder activism, the current political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance
costs and impact the manner in which we operate our business in ways we cannot currently anticipate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect the rules and regulations
applicable to public companies to substantially increase our legal and financial compliance costs and to make some activities more time-consuming and costly. If these requirements divert the attention of our management and personnel from other
business concerns, they could have an adverse effect on our business. The increased costs will decrease our net income or increase our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products
or services. For example, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to incur substantial costs to maintain the same or similar
coverage. We cannot predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to
serve on our board of directors, our board committees or as executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to maintain an effective system of
internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, stockholders could lose confidence in our financial and other public reporting, which would harm our business and
the trading price of our common stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective internal controls over financial reporting are necessary for us to provide
reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us
to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section&nbsp;404, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls
over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Inferior internal controls could also
cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will be required to disclose changes made in our internal controls and procedures on a quarterly basis and our management will be required
to assess the effectiveness of these controls annually. However, for as long as we are an EGC, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting
pursuant to Section&nbsp;404. We could be an EGC for up to five years. An independent assessment of the effectiveness of our internal controls over financial reporting could detect problems that our management&#146;s assessment might not. Undetected
material weaknesses in our internal controls over financial reporting could lead to restatements of our financial statements and require us to incur the expense of remediation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our disclosure controls and procedures may not prevent or detect all errors or acts of
fraud. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon completion of this offering, we will become subject to certain reporting requirements of the Exchange Act. Our
disclosure controls and procedures are designed to reasonably assure that information required to be disclosed by us in reports we file or submit under the Exchange Act is accumulated and communicated to management, recorded, processed, summarized
and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well conceived and operated, can provide only reasonable, not
absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally,
controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements or
insufficient disclosures due to error or fraud may occur and not be detected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Substantial amounts of our outstanding shares may be
sold into the market <FONT STYLE="white-space:nowrap">when&nbsp;lock-up&nbsp;or</FONT> market standoff periods end. If there are substantial sales of shares of our common stock, the price of our common stock could decline. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public market after the <FONT
STYLE="white-space:nowrap">lock-up</FONT> and other legal restrictions on resale discussed in this prospectus lapse, the trading price of our common stock could decline. Based on shares of common stock outstanding as of March&nbsp;31, 2020, upon the
completion of this offering and the Concurrent Private Placement we will have outstanding a total of 34,243,012 shares of common stock. Of these shares, only the shares of common stock sold in this offering by us, plus any shares sold upon exercise
of the underwriters&#146; option to purchase additional shares, will be freely tradable without restriction in the public market immediately following this offering and the Concurrent Private Placement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements pertaining to this offering will expire 180&nbsp;days from the date of this
prospectus, subject to earlier release of all or a portion of the shares subject to such agreements by the representatives of the underwriters in this offering in their sole discretion. After the <FONT STYLE="white-space:nowrap">lock-up</FONT>
agreements expire, based upon the number of shares of common stock, on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, outstanding as of March&nbsp;31, 2020, up to an additional 24,576,346 shares of common stock will be eligible for
sale in the public market. Approximately 37.3% of these additional shares are beneficially held by directors, executive officers and their affiliates and will be subject to certain limitations of Rule&nbsp;144 under the Securities Act of 1933, as
amended, or the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, shares of common stock that are either subject to outstanding options or reserved for future
issuance under our existing equity compensation plans will become eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules, the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements and
Rule&nbsp;144 and Rule&nbsp;701 under the Securities Act. If these additional shares of common stock are sold, or if it is perceived that they will be sold, in the public market, the trading price of our common stock could decline. Additionally, the
number of shares of our common stock reserved for issuance under our 2020 Stock Option and Incentive Plan will automatically increase on January&nbsp;1 of each year, beginning on January&nbsp;1, 2021, by 5% of the total number of shares of our
capital stock outstanding on December&nbsp;31 of the preceding calendar year, or a lesser number of shares determined by our board of directors or compensation committee. Moreover, the number of shares of our common stock reserved for issuance under
our 2020 Employee Stock Purchase Plan will automatically increase on January&nbsp;1 of each year, beginning on January&nbsp;1, 2021, by the lesser of 700,000 shares of common stock, 1% of the total number of shares of our capital stock outstanding
on December&nbsp;31 of the preceding calendar year, or a lesser number of shares determined by our board of directors or compensation committee. Unless our board of directors elects not to increase the number of shares available for future grant
each year, our stockholders may experience additional dilution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After this offering, the holders of 23,098,695 shares of our common stock
will be entitled to rights with respect to the registration of their shares under the Securities Act as provided under the terms of an investors&#146; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
rights agreement between us and the holders of our redeemable convertible preferred stock, subject to the <FONT STYLE="white-space:nowrap">180-day</FONT>
<FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described above. See &#147;Description of Capital Stock&#151;Registration Rights.&#148; Registration of these shares under the Securities Act would result in the shares becoming freely
tradable without restriction under the Securities Act, except for shares held by affiliates, as defined in Rule&nbsp;144 under the Securities Act. Any sales of securities by these stockholders could have a material adverse effect on the trading
price of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>We have broad discretion in the use of our existing cash, cash equivalents and short-term investments
and the net proceeds from this offering and the Concurrent Private Placement and may not use them effectively. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management will
have broad discretion in the application of our existing cash, cash equivalents and short-term investments and the net proceeds from this offering and the Concurrent Private Placement, other than the payment required to be made to UCSF pursuant to
our license agreement with them upon the closing of this offering, including for any of the purposes described in the section entitled &#147;Use of Proceeds,&#148; and you will not have the opportunity as part of your investment decision to assess
whether such proceeds are being used appropriately. Because of the number and variability of factors that will determine our use of our existing cash, cash equivalents and short-term investments and the net proceeds from this offering, their
ultimate use may vary substantially from their currently intended use. Our management might not apply our existing cash, cash equivalents and short-term investments and the net proceeds from this offering in ways that ultimately increase the value
of your investment. The failure by our management to apply these funds effectively could harm our business. Pending their use, we may invest the net proceeds from this offering and the Concurrent Private Placement in short-term, investment-grade,
interest-bearing securities. These investments may not yield a favorable return to our stockholders. If we do not invest or apply the net proceeds from this offering and the Concurrent Private Placement in ways that enhance stockholder value, we may
fail to achieve expected financial results, which could cause our stock price to decline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Anti-takeover provisions under our
charter documents and Delaware law could delay or prevent a change of control which could limit the market price of our common stock and may prevent or frustrate attempts by our stockholders to replace or remove our current management. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and amended and restated bylaws, which are to become effective upon the completion of
this offering, contain provisions that could delay or prevent a change of control of our company or changes in our board of directors that our stockholders might consider favorable. Some of these provisions include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a board of directors divided into three classes serving staggered three-year terms, such that not all members of
the board will be elected at one time;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a prohibition on stockholder action through written consent, which requires that all stockholder actions be taken
at a meeting of our stockholders;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement that special meetings of stockholders be called only by the board of directors acting pursuant to a
resolution approved by the affirmative vote of a majority of the directors then in office;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance notice requirements for stockholder proposals and nominations for election to our board of
directors;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement that no member of our board of directors may be removed from office by our stockholders except for
cause and, in addition to any other vote required by law, upon the approval of not less than <FONT STYLE="white-space:nowrap">two-thirds</FONT> of all outstanding shares of our voting stock then entitled to vote in the election of
directors;</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement of approval of not less than <FONT STYLE="white-space:nowrap">two-thirds</FONT> of all outstanding
shares of our voting stock to amend any bylaws by stockholder action or to amend specific provisions of our certificate of incorporation; and</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the authority of the board of directors to issue convertible preferred stock on terms determined by the board of
directors without stockholder approval and which convertible preferred stock may include rights superior to the rights of the holders of common stock. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, because we are incorporated in Delaware, we are governed by the provisions of Section&nbsp;203 of the General Corporation Law of
the State of Delaware, which may prohibit certain business combinations with stockholders owning 15% or more of our outstanding voting stock. These anti-takeover provisions and other provisions in our amended and restated certificate of
incorporation and amended and restated bylaws could make it more difficult for stockholders or potential acquirers to obtain control of our board of directors or initiate actions that are opposed by the then-current board of directors and could also
delay or impede a merger, tender offer or proxy contest involving our company. These provisions could also discourage proxy contests and make it more difficult for you and other stockholders to elect directors of your choosing or cause us to take
other corporate actions you desire. Any delay or prevention of a change of control transaction or changes in our board of directors could cause the market price of our common stock to decline. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock
price and trading volume could decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading market for our common stock will depend in part on the research and reports
that securities or industry analysts publish about us or our business. Securities and industry analysts do not currently, and may never, publish research on our company. If no securities or industry analysts commence coverage of our company, the
trading price for our stock would likely be negatively impacted. In the event securities or industry analysts initiate coverage, if one or more of the analysts who covers us downgrades our stock or publishes inaccurate or unfavorable research about
our business, our stock price may decline. If one or more of these analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which might cause our stock price and trading volume to
decline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> will designate certain courts as the exclusive
forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders&#146; ability to litigate disputes with us in a different judicial forum. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our amended and restated <FONT STYLE="white-space:nowrap">by-laws,</FONT> as will be in effect upon the completion of this
offering, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for any state law claims for: (i)&nbsp;any derivative action or proceeding brought
on our behalf; (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty or other wrongdoing by any of our directors, officers, employees or agents to us or our stockholders; (iii)&nbsp;any action asserting a claim against us arising
pursuant to any provision of the General Corporation Law of the State of Delaware, our amended and restated certificate of incorporation or our amended and restated <FONT STYLE="white-space:nowrap">by-laws;</FONT> (iv)&nbsp;any action to interpret,
apply, enforce or determine the validity of our certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws;</FONT> or (v)&nbsp;any action asserting a claim governed by the internal affairs doctrine, in each case subject to the Court of
Chancery having personal jurisdiction over the indispensable parties named as defendants therein, or the Delaware forum provision. This exclusive forum provision will not apply to any causes of action arising under the Securities Act or the Exchange
Act or any other claim for which the federal courts have exclusive jurisdiction. Unless we consent in writing to the selection of an alternate forum, the United States District Court for the Northern District of California shall be the sole and
exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, or the federal forum provision, as our principal office is located in South San Francisco, California. In addition, our amended and restated
bylaws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our common stock is deemed to have notice of and consented to the Delaware forum provision and the Federal forum provision; provided, however, that
stockholders cannot and will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Delaware forum provision and the federal forum provision may impose additional
litigation costs on stockholders who assert the provision is not enforceable and may impose more general additional litigation costs in pursuing any such claims, particularly if the stockholders do not reside in or near the State of Delaware or the
State of California. In addition, these forum selection clauses in our bylaws may limit our stockholders&#146; ability to bring a claim in a judicial forum that they find favorable for disputes with us or our directors, officers or employees, which
may discourage such lawsuits against us and our directors, officers and employees even though an action, if successful, might benefit our stockholders. In addition, while the Delaware Supreme Court ruled in March 2020 that federal forum selection
provisions purporting to require claims under the Securities Act be brought in federal court were &#147;facially valid&#148; under Delaware law, there is uncertainty as to whether other courts will enforce our Federal forum provision. If the Federal
forum provision is found to be unenforceable, we may incur additional costs associated with resolving such matters. The federal forum provision may also impose additional litigation costs on stockholders who assert the provision is not enforceable
or invalid. The Court of Chancery of the State of Delaware and the United States District Court for the Northern District of California may also reach different judgments or results than would other courts, including courts where a stockholder
considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our issuance of additional capital stock in connection with financings, acquisitions, investments, our stock incentive plans or
otherwise will dilute all other stockholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to issue additional capital stock in the future that will result in
dilution to all other stockholders. We expect to grant equity awards to employees, directors, and consultants under our stock incentive plans. We may also raise capital through equity financings in the future. As part of our business strategy, we
may acquire or make investments in complementary companies, products, or technologies and issue equity securities to pay for any such acquisition or investment. Any such issuances of additional capital stock may cause stockholders to experience
significant dilution of their ownership interests and the per share value of our common stock to decline. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_4"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, including the sections entitled &#147;Prospectus Summary,&#148; &#147;Risk Factors,&#148; &#147;Management&#146;s Discussion
and Analysis of Financial Condition and Results of Operations&#148; and &#147;Business,&#148; contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, concerning our business, operations and
financial performance and condition, as well as our plans, objectives and expectations for our business operations and financial performance and condition that are based on our management&#146;s belief and assumptions and on information currently
available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to our strategy, future operations, future financial position, future revenue, projected
costs, prospects, plans, objectives of management and expected market growth, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially
different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements in this prospectus include, but are not limited to, statements about: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success, cost and timing of our product development activities and clinical trials of our lead product
candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> as well as PLN-1474 and our other product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outbreak of the novel coronavirus disease, COVID-19, pandemic which has had an adverse impact on our
business, including our preclinical studies and clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ours or our current or future collaborators plans to initiate, recruit and enroll patients in, and conduct our
clinical trials at the pace that we project; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans and strategy to obtain and maintain regulatory approvals of our product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans and strategy to obtain funding for our operations, including funding necessary to complete further
development and, upon successful development, if approved, commercialize any of our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential benefit of orphan drug designations for <FONT STYLE="white-space:nowrap">PLN-74809;</FONT>
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to compete with companies currently marketing or engaged in the development of treatments for
fibrosis; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans and strategy regarding obtaining and maintaining intellectual property protection for our product
candidates and the duration of such protection; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans and strategy regarding the manufacture of our product candidates for clinical trials and for commercial
use, if approved; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our dependence on current and future collaborators for developing, obtaining regulatory approval for and
commercializing product candidates in the collaboration; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our receipt and timing of any milestone payments or royalties under any current of future research collaboration
or license agreements or arrangements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans and strategy regarding the commercialization of any products that are approved for marketing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size and growth potential of the markets for our product candidates, and our ability to serve those markets,
either alone or in combination with others; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract and retain qualified employees and key personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding government and third-party payor coverage and reimbursement; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expected use of the proceeds from this offering and the Concurrent Private Placement. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In some cases, you can identify forward-looking statements by terminology such as
&#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;expects,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;predicts,&#148; &#147;potential,&#148;
&#147;continue&#148; or the negative of these terms or other comparable terminology. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties
and other factors, which are, in some cases, beyond our control and which could materially affect results. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed in the section
entitled &#147;Risk factors&#148; and elsewhere in this prospectus. If one or more of these risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or
projected by the forward-looking statements. No forward-looking statement is a guarantee of future performance. You should read this prospectus and the documents that we reference in this prospectus and have filed with the SEC as exhibits to the
registration statement, of which this prospectus is a part, completely and with the understanding that our actual future results may be materially different from any future results expressed or implied by these forward-looking statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The forward-looking statements in this prospectus represent our views as of the date of this prospectus. We anticipate that subsequent events
and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we assume no obligation to update or revise any forward-looking statements except to the extent
required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, statements that &#147;we believe&#148; and similar statements reflect our beliefs and opinions on the relevant subject. These
statements are based upon information available to us as of the date of this prospectus, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not
be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and you are cautioned not to rely unduly upon these statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_999"></A>MARKET AND INDUSTRY DATA AND FORECASTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We obtained the industry, market and competitive position data used throughout this prospectus from our own internal estimates and research,
as well as from independent market research, industry and general publications and surveys, governmental agencies and publicly available information in addition to research, surveys and studies conducted by third parties. Internal estimates are
derived from publicly available information released by industry analysts and third-party sources, our internal research and our industry experience, and are based on assumptions made by us based on such data and our knowledge of our industry and
market, which we believe to be reasonable. In some cases, we do not expressly refer to the sources from which this data is derived. In that regard, when we refer to one or more sources of this type of data in any paragraph, you should assume that
other data of this type appearing in the same paragraph is derived from the same sources, unless otherwise expressly stated or the context otherwise requires. In addition, while we believe the industry, market and competitive position data included
in this prospectus is reliable and based on reasonable assumptions, such data involve risks and uncertainties and are subject to change based on various factors, including those discussed in the section entitled &#147;Risk Factors.&#148; These and
other factors could cause results to differ materially from those expressed in the estimates made by the independent parties or by us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate that the net proceeds from our issuance and sale of 9,000,000 shares of our common stock in this offering will be approximately
$120.6&nbsp;million, or approximately $139.4&nbsp;million if the underwriters exercise in full their option to purchase 1,350,000 additional shares, assuming an initial public offering price of $15.00 per share, the midpoint of the price range set
forth on the cover page of this prospectus, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. We also expect to receive net proceeds of $10.0 million from the sale of shares of our common stock
to Novartis, in the Concurrent Private Placement, based on the assumed initial public offering price of $15.00 per share, for aggregate net proceeds to be raised by us in this offering and the Concurrent Private Placement of $130.6&nbsp;million.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each $1.00 increase or decrease in the assumed initial public offering price of $15.00 per share, the midpoint of the price range set
forth on the cover page of this prospectus, would increase or decrease, as applicable, the net proceeds to us from this offering by approximately $8.4 million, assuming the number of shares offered by us, as set forth on the cover page of this
prospectus, remains the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us and assuming completion of the Concurrent Private Placement. We may also increase or decrease the number of shares
we are offering. Each increase or decrease of 1.0&nbsp;million shares in the number of shares we are offering would increase or decrease, as applicable, the net proceeds to us from this offering by approximately $14.0 million, assuming the assumed
initial public offering price to the public remains the same, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. We do not expect that a change in the initial price to the public or the number
of shares by these amounts would have a material effect on the uses of the proceeds from this offering, although it may accelerate the time at which we will need to seek additional capital. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The principal purposes of this offering are to increase our financial flexibility, create a public market for our common stock and facilitate
our future access to capital markets. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently intend to use the net proceeds from this offering and the Concurrent Private Placement,
together with our existing cash, cash equivalents and short-term investments as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately $90.0&nbsp;million to fund the clinical development of our lead product candidate, PLN-74809,
including for conducting our Phase&nbsp;2a clinical trials in IPF and PSC; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately $20.0 million to fund the preclinical development of our early-stage programs in oncology and
muscular dystrophy; and </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the remainder, if any, for additional early-stage research and development activities, business development
activities, working capital and other general corporate purposes. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, under our license agreement with
UCSF, we are required to pay a sum of $2.4 million, based on the assumed sale of 9,000,000 shares of common stock in this offering and an assumed offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover of
this prospectus. We plan to make this payment shortly following the completion of this offering from our existing cash resources. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on our current plans, we believe our existing cash, cash equivalents and short-term investments, together with the net proceeds from
this offering and the Concurrent Private Placement, will be sufficient to fund our operating expenses and capital expenditure requirements into 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also use a portion of the net proceeds to <FONT STYLE="white-space:nowrap">in-license,</FONT> acquire or invest in new businesses,
technology or assets. Although we have no current agreements, commitments or understandings with respect to any such <FONT STYLE="white-space:nowrap">in-license</FONT> or acquisition, we evaluate such opportunities and engage in related discussions
with third parties from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The expected use of net proceeds from this offering and the Concurrent Private Placement represents
our intentions based upon our present plans and business conditions. We cannot specify with certainty all of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
particular uses for the net proceeds to be received upon the closing of this offering. Due to uncertainties inherent in the product development process, it is difficult to estimate the exact
amounts of the net proceeds that will be used for any particular purpose. We may use our existing cash, cash equivalents and short-term investments and the future payments, if any, generated from any future collaboration agreements to fund our
operations, either of which may alter the amount of net proceeds used for a particular purpose. In addition, the amount, allocation and timing of our actual expenditures will depend upon numerous factors, including the results of our research and
development efforts, the timing and success of clinical trials and the timing of regulatory submissions. Accordingly, we will have broad discretion in using these proceeds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pending the uses described above, we plan to invest the net proceeds of this offering and the Concurrent Private Placement in short- and
immediate- term, interest-bearing obligations, investment-grade instruments, certificates of deposit or direct or guaranteed obligations of the U.S. government. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_6"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never declared or paid any cash dividends on our capital stock. We do not anticipate paying any dividends on our capital stock in the
foreseeable future. We currently intend to retain all available funds and any future earnings to fund the development and growth of our business. Any future determination to declare dividends will be subject to the discretion of our board of
directors and will depend on various factors, including applicable laws, our results of operations, financial condition, future prospects and any other factors deemed relevant by our board of directors. Investors should not purchase our common stock
with the expectation of receiving cash dividends. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_7"></A>CAPITALIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth our cash, cash equivalents and short term investments and our capitalization as of March 31, 2020: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on an actual basis; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma basis to give effect to (i) the automatic conversion of all outstanding shares of our redeemable
convertible preferred stock into an aggregate of 22,432,029 shares of our common stock as if such conversion had occurred as of March&nbsp;31, 2020, (ii) the filing and effectiveness of our amended and restated certificate of incorporation
immediately prior to the completion of this offering; and (iii)&nbsp;the receipt of $27.8&nbsp;million in payments under the Novartis Agreement in the second quarter of 2020; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma as adjusted basis to give effect to (i)&nbsp;the pro forma adjustments described above, and
(ii)&nbsp;the issuance and sale of 9,000,000 shares of our common stock in this offering at an assumed initial public offering price of $15.00&nbsp;per share, the midpoint of the price range set forth on the cover page of this prospectus, after
deducting underwriting discounts and commissions and estimated offering expenses payable by us; (iii) our sale of $10.0&nbsp;million of shares of common stock in the Concurrent Private Placement to Novartis (or 666,666 shares at the assumed initial
public offering price of $15.00 per share); and (iv)&nbsp;the payment of the milestone payment of $2.4&nbsp;million in the second quarter of 2020 to the UC Regents, calculated using a price per share of $15.00, the midpoint of the price range set
forth on the cover of this prospectus, multiplied by 162,738, an amount determined by calculating 2.0% of the Company&#146;s fully diluted outstanding shares as of a date defined in the license agreement with UCSF. See Note&nbsp;7 to our condensed
financial statements included elsewhere in this prospectus for additional information. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read this
information together with our financial statements and related notes appearing elsewhere in this prospectus and the information set forth in the sections entitled &#147;Selected Financial Data&#148; and &#147;Management&#146;s Discussion and
Analysis of Financial Condition and Results of Operations.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of March 31, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro<BR>Forma As<BR>Adjusted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands, except share and per<BR>share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">141,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">169,254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">302,470</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock, par value $0.0001 per share; 160,501,221 shares
authorized, 160,389,279 issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">238,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; (deficit) equity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, par value $0.0001 per share; 210,000,000 shares authorized, 1,906,349 shares issued
and outstanding, actual; 300,000,000 shares authorized, 24,576,346 shares issued and outstanding, pro forma; 300,000,000 shares authorized, 34,243,012 shares issued and outstanding, pro forma as
adjusted<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, $0.0001 par value per share; no shares authorized, issued or outstanding, actual;
10,000,000 shares authorized, no shares issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">238,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">369,378</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65,266</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65,266</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(67,807</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive gain</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; (deficit) equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(64,751</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">173,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">173,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">173,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">301,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Each $1.00 increase or decrease in the assumed initial public offering price of $15.00 per share, the midpoint of the price range set forth on the cover page of this prospectus and the Concurrent Private Placement,
would increase or decrease, as applicable, each of pro forma as adjusted cash and cash equivalents, additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital, total stockholders&#146; (deficit) equity, and total capitalization by
approximately $8.4&nbsp;million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same. We may also increase or decrease the number of shares we are offering. Each increase or decrease
of 1.0&nbsp;million shares in the number of shares we are offering would increase or decrease, as applicable, each of pro forma as adjusted cash and cash equivalents, additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital, total
stockholders&#146; (deficit) equity, and total capitalization by approximately $14.0 million, assuming the assumed initial public offering price per share, as set forth on the cover page of this prospectus, remains the same. The pro forma as
adjusted information is illustrative only, and we will adjust this information based on the actual initial public offering price and other terms of this offering determined at pricing. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Shares issued and outstanding, pro forma and pro forma as adjusted includes 237,997&nbsp;unvested restricted shares subject to repurchase. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of common stock issued and outstanding pro forma and pro forma as adjusted in the table above is based on 24,576,346
shares of common stock (including our redeemable convertible preferred stock on an as-converted basis) outstanding as of March&nbsp;31, 2020, and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">2,607,939 shares of common stock issuable upon exercise of outstanding options issued as of
March&nbsp;31,&nbsp;2020 under our 2015 Plan, at a weighted-average exercise price of $4.69 per share, or pursuant to rights to purchase restricted stock at a weighted average purchase price of $0.08 per share; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,047,247 shares of common stock reserved for future issuance under our 2015 Plan as of March&nbsp;31, 2020,
which shares will no longer be reserved upon the effectiveness of our 2020 Plan as described below; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4,200,000 shares of our common stock reserved for future issuance under our 2020 Plan, which will become
available for issuance upon the effectiveness of the registration statement of which this prospectus is a part; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">700,000 shares of our common stock reserved for future issuance under our 2020 ESPP, which will become available
for issuance upon the effectiveness of the registration statement of which this prospectus is a part. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our 2020 Plan and
2020 ESPP each provide for annual automatic increases in the number of shares of our common stock reserved thereunder and our 2020 Plan also provides for increases to the number of shares of common stock that may be granted thereunder based on
shares underlying any awards under our 2020 Plan and 2015 Plan that expire, are forfeited or are otherwise terminated, as more fully described in the section titled &#147;Executive Compensation&#151;Employee Benefits and Equity Compensation
Plans.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_8"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you invest in our common stock in this offering, your ownership interest will be diluted to the extent of the difference between the
initial public offering price per share of our common stock and the pro forma as adjusted net tangible book (deficit) value per share of our common stock immediately after this offering and the Concurrent Private Placement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our historical net tangible book value (deficit) per share as of March&nbsp;31, 2020 is determined by dividing our total tangible assets less
our total liabilities and redeemable convertible preferred stock, which are not included within stockholders&#146; deficit, by the number of shares of common stock outstanding as of such date. Our historical net tangible book value (deficit) was
$(64.8)&nbsp;million, or $(33.97) per share as of March&nbsp;31, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our pro forma net tangible book value (deficit) as of
March&nbsp;31, 2020 was $173.6&nbsp;million, or $7.06 per share. Our pro forma net tangible book value (deficit) per share represents the amount of our total tangible assets reduced by the amount of our total liabilities and divided by the total
number of shares of our common stock outstanding as of March 31, 2020, assuming the automatic conversion of all outstanding shares of our redeemable convertible preferred stock, unvested outstanding restricted shares and outstanding shares of common
stock as of March 31, 2020 into an aggregate of 24,576,346 shares of common stock, which conversion will occur immediately prior to the completion of this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our pro forma as adjusted net tangible book value (deficit) represents our pro forma net tangible book (deficit) value, plus the effect of (i)
the sale of shares of common stock in this offering at an assumed initial public offering price of $15.00 per share, the midpoint of the price range set forth on the cover page of this prospectus, after deducting underwriting discounts and
commissions and estimated offering expenses payable by us; (ii)&nbsp;the sale of shares of common stock in the Concurrent Private Placement to Novartis at an assumed initial public offering price of $15.00 per share and (iii)&nbsp;the payment of the
milestone payment of $2.4&nbsp;million in the second quarter of 2020 to the UC Regents, calculated using a price per share of $15.00, the midpoint of the price range set forth on the cover of this prospectus, multiplied by 162,738, an amount
determined by calculating 2.0% of the Company&#146;s fully diluted outstanding shares as of a date defined in the license agreement with UCSF. Net tangible book value dilution per share to new investors represents the difference between the amount
per share paid by purchasers of shares of common stock in this offering and the pro forma as adjusted net tangible book value per share of common stock immediately after completion of this offering. After giving effect to our sale of shares of
common stock in this offering at an assumed initial public offering price of $15.00 per share, the midpoint of the price range set forth on the cover page of this prospectus, and after deducting underwriting discounts and commissions and estimated
offering expenses payable by us, our pro forma as adjusted net tangible book value as of March&nbsp;31, 2020 would have been $301.6&nbsp;million, or $8.80 per share. This represents an immediate increase in net tangible book value of $1.74 per share
to existing stockholders and an immediate dilution in net tangible book value of $6.20 per share to purchasers of common stock in this offering, as illustrated in the following table: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed initial public offering price per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Historical net tangible book value (deficit) per share as of March 31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(33.97</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma increase in net tangible book value (deficit) per share as of March&nbsp;31,
2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net tangible book value (deficit) per share as of March 31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in pro forma net tangible book value per share attributable to new investors
participating in this offering and to Novartis in the Concurrent Private Placement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma as adjusted net tangible book value (deficit) per share after this offering and the
Concurrent Private Placement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution per share to new investors participating in this offering and to Novartis in the
Concurrent Private Placement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the underwriters&#146; option to purchase additional shares from us is exercised in
full, the pro forma as adjusted net tangible book value per share after this offering and the Concurrent Private Placement would be $9.00 per share, the increase in pro forma as adjusted net tangible book value per share to existing stockholders
would be $0.20 per share and the dilution to new investors purchasing shares in this offering would be $6.00 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each $1.00
increase or decrease in the assumed public offering price of $15.00 per share, the midpoint of the price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, our pro forma as adjusted net tangible book
value by $8.4&nbsp;million, or $0.25 per share, and dilution per share to investors in this offering and the Concurrent Private Placement by $0.75 per share, assuming that the number of shares offered by us, as set forth on the cover of this
prospectus, remains the same assuming the number of shares sold in our Concurrent Private Placement are increased or decreased accordingly, and after deducting underwriting discounts and commissions, and estimated offering expenses payable by us. We
may also increase or decrease the number of shares we are offering. Each increase or decrease of 1.0&nbsp;million shares in the number of shares we are offering would increase or decrease, as applicable, our pro forma as adjusted net tangible book
value by approximately $14.0&nbsp;million, or approximately $0.15 per share and would increase or decrease, as applicable, dilution per share to investors in this offering and the Concurrent Private Placement by approximately $0.15 per share,
assuming the assumed initial public offering price per share remains the same and after deducting underwriting discounts and commissions, and estimated offering expenses payable by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the underwriters&#146; option to purchase additional shares from us is exercised in full, the pro forma as adjusted net tangible book value
per share after this offering and the Concurrent Private Placement would be decreased or increased, as applicable, accordingly by $0.20 per share, the increase in pro forma as adjusted net tangible book value per share to existing stockholders would
be $0.20 per share and the dilution to new investors purchasing shares in this offering and the Concurrent Private Placement would be $0.20 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows, as of March 31, 2020, on a pro forma as adjusted basis described above (but before deducting underwriting discounts
and commissions and estimated offering expenses payable by us), the differences between the existing stockholders and the purchasers of shares in this offering and the Concurrent Private Placement with respect to the number of shares purchased from
us, the total consideration paid, which includes net proceeds received from the issuance of common and redeemable convertible preferred stock, cash received from the exercise of stock options, and the value of any stock issued for services and the
average price paid per share (in thousands, except per share amounts and percentages): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average&nbsp;Price<BR>Per Share</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Existing stockholders before this offering and the Concurrent Private Placement<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,576,346</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">225,001,453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New investors participating in this offering and the Concurrent Private Placement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,666,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,999,990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,243,012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">370,001,443</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10.81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Certain of our principal stockholders, including stockholders affiliated with certain of our directors, have indicated an interest in purchasing a substantial amount of the shares of our common stock offered in this
offering at the initial public offering price and on the same terms and conditions as the other purchasers in this offering. However, because indications of interest are not binding agreements or commitments to purchase, the underwriters could sell
more, fewer or no shares to any of these potential purchasers, and any of these potential purchasers could determine to purchase more, fewer or no shares in this offering. The underwriters will receive the same underwriting discounts and commissions
on any shares purchased by these parties as they will on any other shares sold to the public in this offering. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing tables and calculations (other than the historical net tangible book value (deficit)
calculations) are based on 24,576,346 shares of common stock (including our redeemable convertible preferred stock on an as converted basis) outstanding as of March&nbsp;31, 2020 and excludes: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">2,607,939 shares of common stock issuable upon exercise of outstanding options issued as of
March&nbsp;31,&nbsp;2020 under our 2015 Plan, at a weighted-average exercise price of $4.69 per share, or pursuant to rights to purchase restricted stock at a weighted average purchase price of $0.08 per share; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,047,247 shares of common stock reserved for future issuance under our 2015 Plan as of March&nbsp;31, 2020,
which shares will no longer be reserved upon the effectiveness of our 2020 Plan as described below; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">4,200,000 shares of our common stock reserved for future issuance under our 2020 Plan, which will become
available for issuance upon the effectiveness of the registration statement of which this prospectus is a part; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">700,000 shares of our common stock reserved for future issuance under our 2020 ESPP, which will become available
for issuance upon the effectiveness of the registration statement of which this prospectus is a part. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our 2020 Plan and
2020 ESPP each provide for annual automatic increases in the number of shares of our common stock reserved thereunder and our 2020 Plan also provides for increases to the number of shares of common stock that may be granted thereunder based on
shares underlying any awards under our 2020 Plan and 2015 Plan that expire, are forfeited or are otherwise terminated, as more fully described in the section titled &#147;Executive Compensation&#151;Employee Benefits and Equity Compensation
Plans.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that any outstanding options are exercised, new options are issued under our stock-based compensation plans or
we issue additional shares of common stock or convertible debt in the future, there will be further dilution to investors participating in this offering and the Concurrent Private Placement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_9"></A>SELECTED FINANCIAL DATA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables present selected financial data for our business. We have derived the summary statements of operations and balance sheets
data for the years ended December&nbsp;31, 2018 and 2019 from our audited financial statements included elsewhere in this prospectus. We have derived the summary statements of operations data for the three months ended March&nbsp;31, 2019 and 2020,
and the summary balance sheet data as of March 31, 2020 from our unaudited condensed financial statements included elsewhere in this prospectus. We have prepared the unaudited condensed financial statements on the same basis as our audited financial
statements. Our historical results are not necessarily indicative of the results that may be expected in the future and our operating results for the three months ended March&nbsp;31, 2020 are not necessarily indicative of the actual or expected
results for the full year ending December&nbsp;31, 2020 or any other interim periods or any future period. You should read this data together with our financial statements and related notes appearing elsewhere in this prospectus and the information
in the section entitled &#147;Management Discussion and Analysis of Financial Condition and Results of Operations.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(In thousands, except share and per share amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Statements of Operations Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue&#151;related party</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,415</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,353</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,749</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,919</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,601</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,011</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,350</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Loss) profit from operations</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,231</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,350</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,023</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible
preferred</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,876</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,344</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Undistributed earnings to preferred shareholders</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,029</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) income attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,856</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(15,367</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) income per share attributable to common stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10.90</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10.90</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used in computing net (loss) income per share attributable to common
stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,165,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,623,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,409,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,897,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,165,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,623,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,409,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,897,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net (loss) income per share attributable to common stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(In thousands, except share and per share amounts)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,</B><br><B>2019</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended<BR>March&nbsp;31,</B><br><B>2020</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares outstanding used in computing pro forma net (loss) income per share
attributable to common stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,510,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,829,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,510,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,861,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See Notes 2 and 16 to our audited financial statements and to our condensed financial statements included elsewhere in the prospectus for an explanation of the calculations of our basic and diluted net (loss) income per
share, pro forma net income per share and the weighted-average number of shares used in the computation of the per share amounts. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(In thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31, </B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance Sheets Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 60,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">102,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">141,431</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,649</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,529</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">119,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">184,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">132,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">186,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">238,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,470</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65,266</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,469</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(64,751</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We define working capital as current assets less current liabilities. See our financial statements and related notes appearing elsewhere in this prospectus for details regarding our current assets and current
liabilities. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_10"></A>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>You should read the following discussion and analysis of our financial condition and results of
operations together with the section entitled &#147;Selected Financial Data&#148; and our financial statements and related notes appearing elsewhere in this prospectus. This discussion and other parts of this prospectus contain <FONT
STYLE="white-space:nowrap">forward-looking</FONT> statements that involve risks and uncertainties, such as our plans, objectives, expectations, intentions and beliefs. Our actual results could differ materially from those discussed in these
forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the section entitled &#147;Risk Factors.&#148; </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a clinical stage
biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Our initial focus is on treating fibrosis by inhibiting integrin-mediated activation of
<FONT STYLE="white-space:nowrap">TGF-&szlig;.</FONT> We have applied our deep understanding of fibrosis biology, along with our medicinal chemistry and translational medicine expertise to develop a set of proprietary tools designed to discover and <FONT
STYLE="white-space:nowrap">de-risk</FONT> product candidates quickly and efficiently. Our wholly-owned lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> is an oral small-molecule dual selective inhibitor of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrins that we are developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis, or
PSC. We have completed a Phase&nbsp;1a SAD/MAD trial and a Phase 1b <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-mechanism</FONT></FONT> trial of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in IPF. We are
recruiting two Phase&nbsp;2a trials of PLN-74809 in IPF. We submitted an IND for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> for the treatment of PSC in March 2020, and plan to initiate a Phase&nbsp;2a PSC trial in the second half of 2020,
subject to the impact of the COVID-19 pandemic. Our second product candidate, <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> is a small-molecule selective inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> for the treatment of liver fibrosis associated with NASH, which we have partnered with Novartis.
<FONT STYLE="white-space:nowrap">PLN-1474</FONT> is currently undergoing a Phase&nbsp;1 trial with top-line data expected by the end of 2020, when it is feasible to do so in light of the impact of the COVID-19 pandemic. In addition to our clinical
programs, we currently have preclinical integrin-based programs targeting oncology and muscular dystrophies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2019, we entered
into a Collaboration and License Agreement with Novartis, or the Novartis Agreement, for the development and commercialization of our then preclinical product candidate, PLN-1474 and up to three integrin research targets. PLN-1474 is an internally
discovered small molecule selective inhibitor of integrin <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>, currently being
developed for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis, or NASH. In December 2019, we received an upfront license payment of $50.0&nbsp;million for the worldwide exclusive license to PLN-1474. During the second
quarter of 2020, we received $27.8&nbsp;million in payments from Novartis. Pursuant to the Novartis Agreement, we expect to receive research and development funding totaling $19.6&nbsp;million for PLN-1474 development services and funding of up to
$13.4&nbsp;million for option research and development services on the integrin research targets. Additionally, we are eligible to receive developmental, regulatory and commercial milestone payments of up to $416.0&nbsp;million in total, if defined
development, regulatory and commercialization milestones are achieved and tiered royalties, on a product-by-product basis based on annual nets sales of products, at percentages ranging from high-single digits to low teens of the applicable licensed
products and mid-single digits to high-single digits for any products resulting from the research programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;19, 2019, we
issued 26.4&nbsp;million shares of Series&nbsp;C redeemable convertible preferred stock, or the Series C Funding, for aggregate cash proceeds of $48.2&nbsp;million. Novartis purchased 10.9&nbsp;million shares of the December&nbsp;19, 2019
Series&nbsp;C redeemable convertible preferred stock offering at $1.83 per share, which as at fair value as the Company sold Series C redeemable convertible preferred stock investor which is at arms-length transaction as $1.83 per share was the
purchase price paid for shares by other unrelated investors who participated in the funding round. In February 2020, we issued an additional 28.5&nbsp;million shares of Series&nbsp;C redeemable convertible preferred stock for aggregate cash proceeds
of $52.2&nbsp;million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since our inception in 2015, our operations have included organizing and hiring personnel
for our company, business planning, raising capital, establishing our intellectual property portfolio and performing research and development of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling and integrin biology, medicinal chemistry,
translational screening technologies, and clinical insights to create tissue-specific inhibitors of fibrotic diseases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have incurred
net losses since inception and expect to incur losses in the future as we continue our research and development activities. To date, we have funded our operations primarily through private placements of our redeemable convertible preferred stock and
from revenue generated from the Novartis Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, all our revenue has solely been generated from the Novartis Agreement. We
expect revenue will continue to fluctuate from period to period and there can be no assurance that we will generate other revenue, that we will enter into new collaborations, or that new or existing collaborations will continue beyond their initial
terms or that we will be able to meet the milestones specified in these agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since our inception, we have incurred significant
operating losses. Our net loss was $30.3&nbsp;million and $0.6&nbsp;million for the years ended December&nbsp;31, 2018 and December 31, 2019 and our net income was $11.0&nbsp;million for the three months ended March 31, 2020. As of
December&nbsp;31,&nbsp;2018, December&nbsp;31, 2019 and March&nbsp;31,&nbsp;2020, we had an accumulated deficit of $71.5&nbsp;million, $76.3 million and $65.3 million, respectively. We expect to continue to incur significant expenses and operating
losses for the foreseeable future. In addition, we anticipate that our expenses will increase significantly in connection with our ongoing activities, as we: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance the development of our lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> through
clinical development, and, if approved by the FDA, commercialization; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance our other preclinical development programs into clinical development; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">seek regulatory approvals for any product candidates that successfully complete clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increase the amount of research and development activities to identify and develop product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">hire additional clinical, quality control and scientific personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expand our operational, financial and management systems and increase personnel, including personnel to support
our clinical development, manufacturing and commercialization efforts and our operations as a public company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">maintain, expand and protect our intellectual property portfolio; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish a sales, marketing, medical affairs and distribution infrastructure to commercialize any products for
which we may obtain marketing approval and intend to commercialize on our own or jointly with third parties; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">invest in or <FONT STYLE="white-space:nowrap">in-license</FONT> other technologies or product candidates.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not generate revenue from product sales unless and until we successfully complete clinical development and
obtain regulatory approval for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any of our other product candidates. In addition, if we obtain regulatory approval for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or any of our other product
candidates and do not enter into one or more collaborations with third-parties for commercialization, we expect to incur significant expenses related to developing our commercialization capability to support product sales, marketing and distribution
activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result, we will need substantial additional funding to support our continuing operations and pursue our growth strategy.
Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through a combination of public or private equity offerings and debt financings, government funding arrangements, collaborations,
strategic alliances and marketing, distribution or licensing arrangements. We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter
into such agreements as, and when, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
needed, we may have to significantly delay, scale back or discontinue the development and commercialization of one or more of our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because of the numerous risks and uncertainties associated with pharmaceutical product development and the economic and developmental
uncertainty arising from the COVID-19 pandemic, we may be unable to accurately predict the timing or magnitude of all expenses. Even if we can generate product sales, we may not become profitable. If we fail to become profitable or are unable to
sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March 31, 2020, we had cash, cash equivalents and short-term investments of $141.4 million. We expect to continue to incur losses for
the foreseeable future and will require additional financial resources to continue to advance our products and intellectual property. We believe that the net proceeds from this offering and the Concurrent Private Placement, together with our
existing cash, cash equivalents and short term investments, will enable us to fund our operating expenses and capital expenditure requirements into 2023. As a result, we will need substantial additional funding to support our continuing operations
and pursue our growth strategy. Until such time, if ever, as we can generate substantial product revenue, we expect to finance our operations through a combination of equity offerings, debt financings, collaborations, strategic alliances and
marketing, distribution or licensing arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of these securities may include
liquidation or other preferences that adversely affect your rights as a common stockholder. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take
specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends. If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements
with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or drug candidates, or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds
through equity or debt financings or other arrangements when needed, we may be required to delay, limit, reduce or terminate our research, product development or future commercialization efforts, or grant rights to develop and market product
candidates that we would otherwise prefer to develop and market ourselves </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>COVID-19 Pandemic </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2020, the World Health Organization declared the outbreak of a novel coronavirus, or COVID-19, as a pandemic, which continues to
spread throughout the United States and worldwide. We could be materially and adversely affected by the risks, or the public perception of the risks, related to an epidemic, pandemic, outbreak, or other public health crisis, such as the recent
outbreak of COVID-19. Among other things, our clinical trials have been and may continue to be delayed, extending the timelines and increasing the overall costs to finish the clinical trials, as our fixed costs are not substantially reduced while
the clinical trials are delayed. The ultimate extent of the impact of any epidemic, pandemic, outbreak, or other public health crisis on our business, financial condition and results of operations will depend on future developments, which are highly
uncertain and cannot be predicted, including new information that may emerge concerning the severity of such epidemic, pandemic, outbreak, or other public health crisis and actions taken to contain or prevent the further spread, among others.
Accordingly, we cannot predict the extent to which our business, financial condition and results of operations will be affected. We remain focused on maintaining a strong balance sheet, liquidity and financial flexibility and continue to monitor
developments as we deal with the disruptions and uncertainties from a business and financial perspective relating to COVID-19. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Operations
Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Revenue&#151;Related Party </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2019, we entered into the Novartis Agreement for the development and commercialization of our then preclinical product candidate,
PLN-1474 and up to three additional integrin research targets. Under the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
terms of the Novartis Agreement, in December 2019, Novartis paid Pliant an upfront license fee payment of $50.0 million for the worldwide exclusive license to PLN-1474. Novartis will fund our
research and development activities for PLN-1474 through Phase 1 after which Novartis will assume responsibility for all future development, manufacturing and commercialization of PLN-1474. Novartis will also fund the research and development
activities associated with the integrin research targets as outlined in the Novartis Agreement. We are scheduled to receive up to $19.6 million in funding for PLN -1474 development services through Phase 1, and are expected to receive up to $13.4
million in funding for optional development and research services on the integrin research targets. The research and development funding payments are expected to be paid periodically throughout 2020, 2021 and 2022. We are eligible for milestone
payments of up to $416.0 million in total, if defined developmental, regulatory and commercialization milestones are achieved, and tiered royalties on a product-by-product basis based on annual nets sales of products, at percentages ranging from <FONT
STYLE="white-space:nowrap">high-single</FONT> digits to low teens of the applicable licensed products and mid-single digits to high-single digits for any products resulting from the research programs. Novartis became a related party to us following
its purchase of 10.9 million shares of our Series C redeemable convertible preferred stock on December&nbsp;19, 2019, representing aggregate holdings of 7.4% and 5.4% of our outstanding shares on a fully diluted basis as of December&nbsp;31, 2019
and March 31, 2020, respectively. See Notes 6, 9 and 14 to our financial statements included elsewhere in the prospectus for more information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Operating Expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Research
and Development </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our research and development expenses consist of expenses incurred in connection with the development of our product
candidates. Research and development expenses include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">employee-related expenses, which include salaries, benefits and stock-based compensation for our research and
development personnel; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expenses incurred under agreements with third-party contract organizations for pre-clinical studies,
investigative clinical trial sites and consultants that conduct research and development activities on our behalf; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs associated with clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">depreciation of laboratory equipment and costs of equipment and supplies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs associated with technology and intellectual property licenses; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">facilities and other allocated expenses, which include expenses for rent and other facility related costs and
other supplies. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our research and development expenses for the years ended December 31,
2018 and 2019 and the three months ended March 31, 2019 and 2020: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years&nbsp;Ended<BR>December&nbsp;31, </B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended</B><br><B>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee related expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,171</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,227</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,251</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outside and consulting services for preclinical studies and research and development activities by
third party contract organizations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,849</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,043</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clinical trials expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation of lab equipment and costs of equipment and supplies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,829</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Technology and intellectual property licenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">288</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Facilities and other allocated expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">802</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">47,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,749</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,919</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expense all research and development costs in the periods in which they are incurred. We
do not allocate our costs by product candidates or by preclinical programs as these are in early stages of clinical trials or development, and our internal expenses are not allocated between product candidates and programs. Although external
third-party costs are allocable between product candidates and programs, we do not perform this allocation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During 2018, we were eligible
for a research and development tax credit. The tax incentive was available to us based on research and development activity within the United States and California during those years. These research and development tax incentives are recognized as a
contra to FICA payroll tax expense when the right to receive has been attained and funds are collectible and is capped at $250,000 per year. In 2019, we longer qualified for the research and development tax credit as we generated revenue in the
fourth quarter of 2019. For additional information, see Note 2 to our audited financial statements included elsewhere in this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect our research and development expenses to increase substantially for the foreseeable future as we continue to invest in research and
development activities related to developing our product candidates and our preclinical programs and as they advance into later stages of development. The process of conducting the necessary clinical research to obtain regulatory approval is costly
and time-consuming, and the successful development of our product candidates is highly uncertain. As a result, we are unable to determine the duration and completion costs of our research and development projects or when and to what extent we will
generate revenue from the commercialization and sale of any of our product candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>General and Administrative </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our general and administrative expenses consist primarily of personnel costs, allocated facilities costs and other expenses for outside
professional services, including legal, marketing, investor relations, human resource and accounting services. Personnel costs consist of salaries, benefits and stock-based compensation for our general and administrative personnel. We expect to
incur additional expenses as a result of operating as a public company, including expenses related to compliance with the rules and regulations of the SEC, The Nasdaq Global Market, additional insurance expenses, investor relations activities and
other administrative and professional services. We also expect to increase the size of our administrative function to support the growth of our business. In addition, if we obtain regulatory approval for any of our product candidates and do not
enter into a third-party commercialization collaboration, we expect to incur significant expenses related to building a sales and marketing team to support product sales, marketing and distribution activities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Income </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our interest
income consists of interest income earned on cash and cash equivalents, money market funds and short-term investments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Results of Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described above in &#147;&#151;COVID 19 Pandemic&#148;, the ultimate extent of the impact of any epidemic, pandemic, outbreak or other
public health crisis on our results of operations will depend on future developments, which are highly uncertain, including new information that may emerge concerning the severity of the COVID-19 pandemic or other public health crisis and actions
taken to contain or prevent the further spread, among others. Accordingly, we cannot fully predict the extent to which our business and results of operations will be affected; however we expect the COVID-19 pandemic to impact our operations in
several ways. Many clinical trial sites have been impacted by the pandemic, forcing them to delay enrollment in research trials, including ours. This will likely impact the speed of enrollment in our current trials. Additionally, the pandemic has
limited our ability to perform basic science R&amp;D in our facilities due to government shelter-in-place orders, ultimately slowing, but not stopping, progress of several early stage projects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Years Ended December&nbsp;31, 2018 and 2019 </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(In thousands, except percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$ Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%&nbsp;Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue&#151;related party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 57,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,415</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,353</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,938</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,430</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,368</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,231</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(96.0</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other expense, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(167</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">29,645</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(97.9</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">NM:</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Results not meaningful </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Revenue - Related Party </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Revenue-related party consists primarily of revenue generated from the Novartis Agreement. The increase of $57.1 million in revenue-related
party for the year ended December 31, 2019 compared to year ended December 31, 2018 was due to the recognition of $50.0 million in upfront license fee revenue and $7.1 million in research and development services revenue. We anticipate revenue over
the next several years will be derived primarily from the Novartis Agreement as we continue to recognize revenue-related party from research and development services and from the potential achievement of the Novartis Agreement&#146;s developmental,
regulatory and commercial milestones. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development expenses increased by $22.9&nbsp;million, or 94.0%, for the year ended December&nbsp;31, 2019, compared to the year
ended December&nbsp;31, 2018. The increase was primarily due to $18.1&nbsp;million of increased consulting and outside services costs, $3.7&nbsp;million of increased compensation costs, $0.5 million of increased rent expense, $0.5 million in
increased stock-based compensation costs, $0.4 million of increased depreciation expense, $0.3&nbsp;million of increased sponsored research expenses and $0.2 million of increased miscellaneous and other expenses partially offset by a decrease in
equipment and supplies expense of $0.8&nbsp;million. Consulting and outside services costs increased due to increased <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and <FONT STYLE="white-space:nowrap">PLN-1474</FONT> development activities.
Compensation costs and stock-based compensation costs increased as a result of increased headcount. Rent expense increased due to the move to new office space in South San Francisco in <FONT STYLE="white-space:nowrap">mid-2018.</FONT> Depreciation
expense increased due to increased leasehold improvements installed at the South San Francisco office. Sponsored research expenses increased due to increased research sponsorship activities with universities in 2019. The reduction in equipment and
supplies expense was due to a decrease in purchases of laboratory equipment during the year ended December 31, 2019 when compared to in the year ended December&nbsp;31, 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses increased by $4.4&nbsp;million, or 68.2%, for the year ended December&nbsp;31, 2019, compared to the year
ended December&nbsp;31, 2018. The increase was primarily due to $1.9 million of increased compensation costs, $1.1 million of increased stock-based compensation costs, $0.8&nbsp;million of increased professional and consulting costs,
$0.2&nbsp;million of increased miscellaneous and other expenses, $0.2&nbsp;million of increased rent expense, $0.2 million in increased travel expense and $0.1&nbsp;million of increased equipment and supplies expense. Compensation costs and
stock-based compensation costs increased as a result of increased headcount. Professional and consulting costs increased primarily as a result of increased legal, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
marketing, investor relations and accounting fees. Travel expenses increased primarily due to increased executive travel associated with equity financing initiatives. Equipment and supplies
expense increased primarily due to increased purchases of office supplies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Interest Income </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest income increased by $0.1&nbsp;million for the year ended December&nbsp;31, 2019, compared to the year ended December&nbsp;31, 2018.
The increase was attributable to interest income earned on higher cash and cash equivalents balances resulting from preferred stock issuances in the second half of 2019. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Three Months Ended March&nbsp;31, 2019 and 2020 </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(In thousands, except percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months<BR>Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$&nbsp;Change</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%&nbsp;Change</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue&#151;related party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;28,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,749</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,919</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,601</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,011</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,350</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,350</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(104</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(33.2</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other expense/(income), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(202</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss)/income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,023</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">NM</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">NM: Results not meaningful </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Revenue&#151;Related Party </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Revenue-related party consists primarily of revenue generated from the Novartis Agreement. The increase of $28.9&nbsp;million in
revenue-related party for the three months ended March&nbsp;31, 2020 compared to three months ended March&nbsp;31, 2019 was due to us recognizing revenue&#151;related party of $25.0&nbsp;million as we achieved the first patient dosing milestone of
the Novartis agreement. In addition, we also recognized revenue&#151;related party of $3.9&nbsp;million in funding generated from research and development services performed during the three months ended March&nbsp;31, 2020. Over the next several
years, we expect our revenue will be derived primarily from the Novartis Agreement as we continue to recognize revenue-related party from research and development services funding and from the potential achievement of the Novartis Agreement&#146;s
developmental, regulatory and commercial milestones. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development expenses increased by $2.2&nbsp;million, or 18.5%, for the three months ended March&nbsp;31, 2020, compared to the
three months ended March&nbsp;31, 2019. The increase was primarily due to $1.0&nbsp;million of increased consulting and outside services costs, $1.0&nbsp;million of increased compensation costs, $0.1&nbsp;million in increased equipment and supplies
costs, $0.1&nbsp;million in increased stock-based compensation costs, $0.1&nbsp;million of increased depreciation expense, offset by a $0.1&nbsp;million in decreased research studies and license fee expenses. Consulting and outside services costs
increased due to increased <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and <FONT STYLE="white-space:nowrap">PLN-1474</FONT> development activities with external vendors. Compensation costs and stock-based compensation costs increased as a
result of increased headcount. Depreciation expense increased due to increased leasehold improvements installed at the South San Francisco office. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General and administrative expenses increased by $1.4&nbsp;million, or 54.2%, for the three months ended March&nbsp;31, 2020, compared to the
three months ended March&nbsp;31, 2019. The increase was primarily due to $0.8&nbsp;million of increased consulting and outside services costs, $0.3&nbsp;million of increased compensation costs and $0.3&nbsp;million of increased charitable
contributions, offset by $0.1&nbsp;million of decreased miscellaneous and other expenses. Compensation costs and stock-based compensation costs increased as a result of increased headcount. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Interest Income </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest
income decreased by $0.1&nbsp;million for the three months ended March&nbsp;31, 2020, compared to the three months ended March&nbsp;31, 2019. The decrease was primarily attributable lower interest rates in the three months ended March&nbsp;31, 2020
when compared to the corresponding period in 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Capital Resources </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Overview </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of
March 31, 2020, we had cash, cash equivalents and short-term investments of $141.4&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Due to the COVID-19 pandemic, our
clinical trials with universities were temporarily delayed and our ability to identify and enroll patients in future clinical trials may become more difficult and costly. Our liquidity and financial condition evaluation includes an estimate of the
financial impact of the delay in clinical trials and increased patient enrollment costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on our current cash balance and our
ability to control discretionary spending, such as research and development expenditures with outside service providers, we have evaluated and concluded our financial condition is sufficient to fund our planned operations, commitments and
contractual obligations for a period of at least one year following the date that these financial statements are issued. Further, our cash position is expected to improve in 2020, as we raised an additional $52.2&nbsp;million from the issuance of an
additional 28.5&nbsp;million shares of our Series&nbsp;C redeemable convertible preferred stock in February of 2020, and have achieved the first patient dosing milestone of the Novartis Agreement triggering the receipt of a $25.0 million payment
which was received from Novartis in the second quarter of 2020 along with an additional $2.8&nbsp;million representing amounts recorded to revenue for prior periods. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Funding Requirements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our primary use of cash is to fund operating expenses, primarily research and development expenditures. Cash used to fund operating expenses is
impacted by the timing of when we pay these expenses, as reflected in the change in our outstanding accounts payable, accrued expenses and prepaid expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our future funding requirements will depend on many factors, including the following:</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the initiation, progress, timing, costs and results of preclinical studies and clinical trials for our product
candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the clinical development plans we establish for these product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timelines of our clinical trials and the overall costs to finish the clinical trials due to the COVID-19
pandemic; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number and characteristics of product candidates that we develop; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the outcome, timing and cost of meeting regulatory requirements established by the U.S. Food and Drug
Administration, or FDA, and other comparable foreign regulatory authorities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we enter into any collaboration agreements and the terms of any such agreements; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of filing, prosecuting, defending and enforcing our patent claims and other intellectual property
rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of defending intellectual property disputes, including patent infringement actions brought by third
parties against us or our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect of competing technological and market developments; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost and timing of completion of commercial-scale outsourced manufacturing activities; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of establishing sales, marketing and distribution capabilities for any product candidates for which we
may receive regulatory approval in regions where we choose to commercialize our products on our own. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, our
operating plan may change, and we may need additional funds to meet operational needs and capital requirements for clinical trials and other research and development expenditures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we need to raise additional capital to fund our operations, funding may not be available to us on acceptable terms, or at all. If we are
unable to obtain adequate financing when needed, we may have to delay, reduce the scope of or suspend one or more of our preclinical studies, clinical trials, research and development programs or commercialization efforts. We may seek to raise any
necessary additional capital through a combination of public or private equity offerings, debt financings, collaborations and other licensing arrangements. If we raise additional capital through debt financing, we may be subject to covenants
limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise additional capital through marketing and distribution arrangements or other
collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish certain valuable rights to our product candidates, technologies, future revenue streams or research programs or grant licenses on terms that
may not be favorable to us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash Flows </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Years Ended December 31, 2018 and 2019 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summarizes our cash flows for the periods indicated (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years&nbsp;Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(28,328</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2,750</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,323</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,931</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,349</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 56,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 24,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Cash Used in Operating Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities was $2.8&nbsp;million for the year ended December&nbsp;31, 2019 and $28.3&nbsp;million for the year ended
December&nbsp;31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cash used in operating activities in the year ended December&nbsp;31, 2019 was primarily due to our net loss for
the period of $0.6&nbsp;million adjusted by non-cash charges of $2.9&nbsp;million and net change of $5.1&nbsp;million in our net operating assets and liabilities. The non-cash charges consisted of $1.1&nbsp;million of depreciation expense and
$1.8&nbsp;million of stock-based compensation expense. The changes in our net operating assets and liabilities were primarily due to an increase of $7.1&nbsp;million in accounts receivable, an increase of $1.5&nbsp;million in prepaid expense and
other current assets, a decrease of $1.3&nbsp;million in accounts payable, partially offset by an increase of $4.3&nbsp;million in accrued expenses, a decrease of $0.2&nbsp;million in other non-current assets and a decrease of $0.2&nbsp;million in
tax credit receivable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cash used in operating activities in the year ended December&nbsp;31, 2018, was primarily
due to our net loss for the year of $30.3&nbsp;million adjusted by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $0.9&nbsp;million and a net change of $1.1&nbsp;million in our net operating assets and liabilities. The <FONT
STYLE="white-space:nowrap">non-cash</FONT> charges consisted of $0.7&nbsp;million of depreciation expense and $0.2&nbsp;million of stock-based compensation expense. The changes in our net operating assets and liabilities were primarily due to an
increase of $1.5&nbsp;million in accounts payable and accrued expenses and $0.4&nbsp;million increase in deferred rent and other long-term liabilities, partially offset by a decrease of $0.8 million in other
<FONT STYLE="white-space:nowrap">non-current</FONT> assets, prepayments and tax credit receivable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Cash Used in Investing
Activities </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the years ended December&nbsp;31, 2019 and 2018, cash used in investing activities was $17.9&nbsp;million and
$2.3&nbsp;million, respectively. Cash used in investing activities for the year ended December 31,&nbsp;2019 was primarily due to the purchase of short-term investments of $51.7 million, purchases of property, plant and equipment of
$1.0&nbsp;million and $0.3&nbsp;million of accretion of short-term investments, partially offset by $35.0&nbsp;million in maturities of short term investments . Cash used in investing activities for the year ended December 31,&nbsp;2018 was
primarily resulting from the purchase of laboratory equipment and leasehold improvements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Cash Provided by Financing Activities
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31,&nbsp;2019, cash provided by financing activities was $45.5&nbsp;million. Cash provided by
financing activities for the year ended December 31,&nbsp;2019 was primarily due to net proceeds from the issuance of our Series C redeemable convertible preferred stock financing of $47.9&nbsp;million and proceeds from the exercise of stock options
of $0.2&nbsp;million, partially offset by the payment of deferred offering costs of $2.6&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended
December&nbsp;31, 2018, cash provided by financing activities was $87.3&nbsp;million of net proceeds from the issuance of shares of Series A and Series B redeemable convertible preferred stock. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Three Months Ended March&nbsp;31, 2019 and 2020 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following summarizes our cash flows for the periods indicated (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months&nbsp;Ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10,847</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(12,766</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,417</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,373</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash provided by (used in) financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(127</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase (decrease) in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(38,391</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Cash Used in Operating Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities was $12.8&nbsp;million for the three months ended March&nbsp;31, 2020 and $10.8&nbsp;million for the
three months ended March&nbsp;31, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cash used in operating activities in the three months ended March&nbsp;31, 2020 was primarily due
to our net income for the period of $11.0&nbsp;million adjusted by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $0.7&nbsp;million and net change of $24.5&nbsp;million in our net operating assets and liabilities. The <FONT
STYLE="white-space:nowrap">non-cash</FONT> charges consisted of $0.3&nbsp;million of depreciation expense and $0.4&nbsp;million of stock-based compensation expense. The changes in our net operating assets and liabilities were primarily due to an
increase of $24.7&nbsp;million in accounts receivable, an increase of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
$0.9&nbsp;million in prepaid expenses and other current assets, a decrease of $0.4&nbsp;million in accrued expenses, partially offset by an increase of $1.2&nbsp;million in accounts payable and a
$0.2&nbsp;million decrease in other <FONT STYLE="white-space:nowrap">non-current</FONT> assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cash used in operating activities in the
three months ended March&nbsp;31, 2019 was primarily due to our net loss for the period of $14.0&nbsp;million adjusted by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $0.6&nbsp;million and net change of $2.6&nbsp;million in our net
operating assets and liabilities. The <FONT STYLE="white-space:nowrap">non-cash</FONT> charges consisted of $0.3&nbsp;million of depreciation expense and $0.3&nbsp;million of stock-based compensation expense. The changes in our net operating assets
and liabilities were primarily due to an increase of $2.9&nbsp;million in accounts payable and accrued expenses, partially offset by an increase of $0.3&nbsp;million in other <FONT STYLE="white-space:nowrap">non-current</FONT> assets, prepayments
and a tax credit receivable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Cash Used in Investing Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2020 and 2019, cash used in investing activities was $11.4&nbsp;million and $27.4&nbsp;million,
respectively. Cash used in investing activities for the three months ended March&nbsp;31, 2020 was primarily due to the purchase of short-term investments of $11.0&nbsp;million and purchases of property and equipment of $0.3&nbsp;million. Cash used
in investing activities for the three months ended March&nbsp;31, 2019 was primarily due to the purchase of short-term investments of $27.2&nbsp;million and purchases of property and equipment of $0.3&nbsp;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Cash Provided by (Used in) Financing Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2020, cash provided by financing activities was $51.7&nbsp;million. Cash provided by financing
activities for the three months ended March&nbsp;31, 2020 was primarily due to net proceeds from the issuance of our Series C redeemable convertible preferred stock financing of $52.0&nbsp;million, partially offset by the payment of deferred
offering costs of $0.4&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2019, cash used in financing activities was
$0.1&nbsp;million for payment of deferred offering costs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contractual Obligations and Other Commitments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our contractual obligations and other commitments as of December&nbsp;31,&nbsp;2019 (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payments Due by Period</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Less&nbsp;than<BR>1 Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>1 to 3<BR>Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>3 to 5<BR>Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>More&nbsp;Than<BR>5 Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,645</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total obligations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,645</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We enter into contracts in the normal course of business with third-party contract organizations for clinical
trials, <FONT STYLE="white-space:nowrap">non-clinical</FONT> studies and testing, manufacturing and other services and products. These contracts generally provide for termination following a certain period after notice and therefore we believe that
our cancelable obligations under these agreements are not material and they are not included in the table above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have not included
milestone or royalty payments or other contractual payment obligations in the table above if the timing and amount of such obligations are unknown or uncertain. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Off-Balance&nbsp;Sheet</FONT> Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the periods presented, we did not have, nor do we currently have,
<FONT STYLE="white-space:nowrap">any&nbsp;off-balance&nbsp;sheet</FONT> arrangements or holdings in any variable interest entities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Quantitative and Qualitative Disclosures about Market Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The primary objectives of our investment activities are to ensure liquidity and to preserve capital. We are exposed to market risks in the
ordinary course of our business. These risks primarily include interest rate sensitivities. We had cash, cash equivalents and short-term investments of $141.4 million as of March 31, 2020 which consisted of bank deposits and highly liquid money
market funds. Historical fluctuations in interest rates have not been significant for us. We had no outstanding debt as of March 31, 2020. Due to the short-term maturities of our cash equivalents, an immediate 100 basis point change in interest
rates would not have a material effect on the fair market value of our cash equivalents. To minimize the risk in the future, we intend to maintain our portfolio of cash equivalents in institutional market funds that are composed of U.S. Treasury and
U.S. Treasury-backed repurchase agreements or short-term U.S. Treasury securities. We do not believe that inflation, interest rate changes, or exchange rate fluctuations had a significant impact on our results of operations for any periods presented
herein. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Critical Accounting Polices and Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management&#146;s discussion and analysis of our financial condition and results of operations is based on our financial statements, which
have been prepared in accordance with United States generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and
the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors
that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from
these estimates under different assumptions or conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While our significant accounting policies are described in more detail in Note
2 to our financial statements appearing elsewhere in this prospectus, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Revenue Recognition </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March 31, 2020, all of our revenue to date has been generated from the Novartis Agreement. Effective January 1, 2018, we adopted the
provisions of ASC Topic 606, Revenue from Contracts with Customers (&#147;Topic 606&#148;) using the full retrospective transition method. We did not have any prior collaboration agreements and did not recognize revenue during the year ended
December 31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Topic 606, we recognize revenue when our customer obtains control of promised goods or services, in an amount
that reflects the consideration which we expect to receive in exchange for those goods or services. To determine the appropriate amount of revenue to be recognized for arrangements determined to be within the scope of Topic 606, we perform the
following five steps: (i)&nbsp;identification of the contract(s) with the customer, (ii)&nbsp;identification of the promised goods or services in the contract and determination of whether the promised goods or services are performance obligations,
(iii)&nbsp;measurement of the transaction price, (iv)&nbsp;allocation of the transaction price to the performance obligations, and (v)&nbsp;recognition of revenue when (or as) we satisfy each performance obligation. We only apply the five-step model
to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services we transfer to our customer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I></I></B><I>Identification of the Contracts with the Customers</I><B><I> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We evaluate every contract to determine whether it in its entirety or in part represent a contract with a customer, or a collaboration
agreement and, based on this determination, apply appropriate accounting guidance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We account for a contract with a customer that is
within the scope of Topic 606 when all of the following criteria are met: (i)&nbsp;the arrangement has been approved by the parties and the parties are committed to perform </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
their respective obligations, (ii)&nbsp;each party&#146;s rights regarding the goods or services to be transferred can be identified, (iii)&nbsp;the payment terms for the goods or services to be
transferred can be identified, (iv)&nbsp;the arrangement has commercial substance and (v)&nbsp;collection of substantially all of the consideration to which we will be entitled in exchange for the goods or services that will be transferred to the
customer is probable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I></I></B><I>Identification of the Performance Obligations</I><B><I> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The promised goods or services in our collaboration and option arrangements consist of research and development services. The arrangements also
have options for additional items (i.e.,&nbsp;license rights). Options are considered to be marketing offers and are to be accounted for as separate contracts when the customer elects such options, unless we determine the option provides a material
right which would not be provided without entering into the contract. The determination as to whether such options are material rights requires significant management judgment, and management considers factors such as other similar arrangements,
market data and the terms of the contractual arrangement to make such conclusion. Performance obligations are promised goods or services in a contract to transfer a distinct good or service to the customer. Promised goods or services are considered
distinct when:&nbsp;(i)&nbsp;the customer can benefit from the good or service on its own or together with other readily available resources and (ii)&nbsp;the promised good or service is separately identifiable from other promises in the contract.
In assessing whether promised goods or services are distinct, we consider factors such as the stage of development of the underlying intellectual property, the capabilities of our customer to develop the intellectual property on their own and
whether the required expertise is readily available. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I></I></B><I>Determination of the Transaction Price</I><B><I> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate the transaction price based on the amount of consideration we expect to receive for transferring the promised goods or services in
the contract. The consideration may include both fixed consideration and variable consideration. At the inception of each arrangement that includes variable consideration, we evaluate the amount of the potential payments and the likelihood that the
payments will be received. We utilize either the most likely amount method or expected value method to estimate the transaction price based on which method better predicts the amount of consideration expected to be received. If it is probable that a
significant revenue reversal would not occur, the variable consideration is included in the transaction price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All contingent future
payments, which include research, development, regulatory, and sales-based royalty payments, have not been considered in the initial analysis, as they are contingent upon option(s) being exercised or are subject to significant risk of achievement.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Allocation of Transaction Price </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We allocate the transaction price based on the estimated standalone selling price. We must develop assumptions that require judgment to
determine the standalone selling price for each performance obligation identified in the contract. We utilize key assumptions to determine the standalone selling price, which may include other comparable transactions, pricing considered in
negotiating the transaction, and the estimated costs. Certain variable consideration is allocated specifically to one or more performance obligations in a contract when the terms of the variable consideration relate to the satisfaction of the
performance obligation and the resulting amounts allocated to each performance obligation are consistent with the amounts we would expect to receive for satisfying each performance obligation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Recognition of Revenue </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We considered the license to PLN-1474 as functional intellectual property, as when control of the license was transferred to Novartis at the
inception of the Novartis Agreement, Novartis had the right to access its technology and it was functional. The license was distinct from the research and development services as the services are not transformative in nature. As such, under Topic
606, the Company determined the $50.0 million was standalone selling price PLN-1474 license and was recorded to revenue at the inception of the Novartis Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We recognize revenue as we perform the research and development services based on an input
method, as such costs have direct relationship between our effort and the progress made towards satisfying its performance obligations to Novartis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Accrued Research and Development Costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We record accrued expenses for estimated costs of our research and development activities conducted by third-party service providers, which
include the conduct of clinical studies and preclinical studies. We record the estimated costs of research and development activities based upon the estimated amount of services provided but not yet invoiced and include these costs in accrued
liabilities in the balance sheets and within research and development expense in the statements of operations and comprehensive (loss) income. These costs are a significant component of our research and development expenses. We record accrued
expenses for these costs based on factors such as estimates of the work completed and in accordance with agreements established with these third-party service providers. Any payments made in advance of services provided are recorded as prepaid
assets, which are expensed as the contracted services are performed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate the amount of work completed through discussions with
internal personnel and external service providers as to the progress or stage of completion of the services and the agreed-upon fee to be paid for such services. We make significant judgments and estimates in determining the accrued balance in each
reporting period. As actual costs become known, we adjust our accrued estimates. Our accrued expenses are dependent, in part, upon the receipt of timely and accurate reporting from clinical research organizations and other third-party service
providers. If we under estimate or over estimate the level of services performed or the costs of these services, our accrued expenses could differ from our estimates. For the periods presented, we have experienced no material differences between our
accrued expenses and actual expenses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Stock-Based Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We recognize compensation costs related to stock awards and stock options granted to employees, nonemployees and directors based on the
estimated fair value of the awards on the date of grant. We estimate the grant date fair value and the resulting stock-based compensation expense, using the Black-Scholes option-pricing model. The grant date fair value of the stock-based awards is
recognized on a straight-line basis over the requisite service periods, which are generally the vesting period of the respective awards. Forfeitures are accounted for as they occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Black-Scholes option-pricing model requires the use of subjective assumptions which determine the fair value of stock-based awards,
including the expected term and the price volatility of the underlying stock. These assumptions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Fair value of common stock</I>&#151;See &#147;Determination of the Fair Value of Our Common Stock&#148; below.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected term</I>&#151;The expected term represents the period that the stock-based awards are expected to be
outstanding. The expected term for our stock options was calculated based on the weighted-average vesting term of the awards and the contract period, or simplified method, as allowed by the SEC. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected volatility</I>&#151;Since we are not yet a public company and do not have any trading history for our
common stock, the expected volatility was estimated based on the average historical volatilities of common stock of comparable publicly traded entities over a period equal to the expected term of the stock option grants. The comparable companies
were chosen based on their size, stage in the life cycle or area of specialty. We will continue to apply this process until enough historical information regarding the volatility of our own stock price becomes available. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Risk-free interest rate</I>&#151;The risk-free interest rate is based on the U.S. Treasury yield in effect at
the time of grant <FONT STYLE="white-space:nowrap">for&nbsp;zero-coupon&nbsp;U.S.</FONT> Treasury notes with maturities approximately equal to the expected term of the awards. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected dividend</I>&#151;We have never paid dividends on our common stock and have no plans to pay dividends
on our common stock. Therefore, we used an expected dividend yield of zero. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Determination of the Fair Value of
Our Common Stock </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As there has been no public market for our common stock to date, the estimated fair value of our common stock has
been determined by our board of directors as of the date of each option grant, with input from management, considering our most recently available third-party valuations of common stock and our board of directors&#146; assessment of additional
objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent valuation through the date of the grant. These third-party valuations were performed in accordance with the guidance outlined
in the American Institute of Certified Public Accountants&#146; Accounting and Valuation Guide, <I>Valuation of Privately-Held-Company Equity Securities Issued as Compensation</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For stock awards and options granted in 2018 and 2019, we considered the use of the Income and Market approaches. Under the income approach,
the cash generating ability of the company is valued. This approach focuses on determining a forecast benefit stream that is reflective of the subject company&#146;s most likely future performance. The forecast benefit stream is then discounted to
present value based on the appropriate risk-adjusted discount rate or capitalization rate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Market approach, we referenced
actual transactions involving our company or similar assets and/or enterprises. The Market approach generally consists of two primary methodologies: The Guideline Comparables Method, or GCM and the Guideline Transaction Method, or GTM. The GCM
involves identifying and selecting publicly traded companies or guideline public companies, or Guideline Public Companies, with financial and operating characteristics like the subject being valued, and subsequently deriving multiples and other
metrics from such Guideline Public Companies to apply to the subject being valued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Taking the stage of our development into consideration
and expected liquidity events into account, we elected not to rely upon a pure application of the Income or Market valuation approaches. We determined that the PWERM was more appropriate to value our equity classes as the approach is based upon an
analysis of future values for the entire enterprise assuming various future outcomes. We did consider elements of the Income and Market approaches for gauging the appropriateness of certain PWERM inputs and assumptions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to considering the results of these third-party valuations, our board of directors considered various objective and subjective
factors to determine the fair value of our common stock as of each grant date, which may be as a date later than the most recent third-party valuation date, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the prices at which we sold shares of preferred stock and the superior rights and preferences of the preferred
stock relative to our common stock at the time of each grant; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the progress of our research and development programs, including the status of
<FONT STYLE="white-space:nowrap">pre-clinical</FONT> and planned clinical trials for our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our stage of development and commercialization and our business strategy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">external market conditions affecting the biotechnology industry, and trends within the biotechnology industry;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our financial position, including cash on hand, and our historical and forecasted performance and operating
results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the lack of an active public market for our common stock and our preferred stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the likelihood of achieving a liquidity event, such as an initial public offering, or IPO, or a sale of our
company considering prevailing market conditions; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the analysis of IPOs and the market performance of similar companies in the biopharmaceutical industry.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For financial reporting purposes, we considered the amount of time between the valuation
date and the grant date of our stock awards and options to determine whether to use the latest common stock valuation or an interpolated fair value between the two valuation dates. This determination included an evaluation of whether the subsequent
valuation indicated that any significant change in valuation had occurred between the previous valuation and the grant date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
assumptions underlying these valuations represent management&#146;s best estimates, which involve inherent uncertainties and the application of management judgment. As a result, if factors or expected outcomes change and we use significantly
different assumptions or estimates, our stock-based compensation expense could be materially different. Following the closing of this offering, the fair value of our common stock will be determined based on the quoted market price of our common
stock. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, there was $0.4&nbsp;million of unrecognized compensation costs that is expected to be recognized over
the weighted-average periods of 2.2&nbsp;years related to restricted stock awards. As of December&nbsp;31, 2019, there was $4.4&nbsp;million of unrecognized compensation costs that is expected to be recognized over the weighted-average periods of
3.0&nbsp;years related to stock options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2020, there was $0.4&nbsp;million of unrecognized compensation costs that
is expected to be recognized over the weighted-average periods of 1.9 years related to restricted stock awards. As of March&nbsp;31, 2020, there was $8.9&nbsp;million of unrecognized compensation costs that is expected to be recognized over the
weighted-average periods of 3.3&nbsp;years related to stock options. Based upon the assumed initial public offering price of $15.00, the midpoint of the price range set forth on the cover page of this prospectus, the aggregate intrinsic value of
options outstanding as of March&nbsp;31, 2020 was $26.9 million, $22.4 million of which related to unvested options. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Accounting Pronouncements
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See Note&nbsp;2 to our condensed financial statements appearing elsewhere in this prospectus for more information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Emerging Growth Company Status and JOBS Act Accounting Election </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company,&#148; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. Under the JOBS
Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. We have elected to avail ourselves of this
exemption and adopt ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-02</FONT> <I>(Topic 842</I>), Leases when the standard is effective for private companies which is for fiscal years beginning after December&nbsp;15, 2020. As a result, our
financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we intend to rely on the other exemptions and reduced reporting requirements provided by the JOBS Act. Subject to certain
conditions set forth in the JOBS Act, if as an &#147;emerging growth company&#148; we intend to rely on such exemptions, we are not required to, among other things, (i)&nbsp;provide an auditor&#146;s attestation report on our system of internal
controls over financial reporting pursuant to Section&nbsp;404(b) of the Sarbanes-Oxley Act of 2002, (ii) provide all of the compensation disclosure that may be required <FONT STYLE="white-space:nowrap">of&nbsp;non-emerging&nbsp;growth</FONT> public
companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii)&nbsp;comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the
auditor&#146;s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv)&nbsp;disclose certain executive compensation-related items such as the correlation between executive
compensation and performance and comparisons of the Chief Executive Officer&#146;s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of this offering or until we no longer
meet the requirements of being an emerging growth company, whichever is earlier. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_11"></A>Business </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a clinical stage
biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Our initial focus is on treating fibrosis by inhibiting integrin-mediated activation of
<FONT STYLE="white-space:nowrap">TGF-&szlig;.</FONT> We have applied our deep understanding of fibrosis biology, along with our medicinal chemistry and translational medicine expertise to develop a set of proprietary tools designed to discover and <FONT
STYLE="white-space:nowrap">de-risk</FONT> product candidates quickly and efficiently. Our wholly-owned lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> is an oral small-molecule dual selective inhibitor of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrins that we are developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis, or
PSC. We have completed a Phase&nbsp;1a SAD/MAD trial and a Phase 1b <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-mechanism</FONT></FONT> trial of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in IPF and are
recruiting two Phase&nbsp;2a trials in IPF. We submitted an IND for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> for the treatment of PSC in March 2020, and plan to initiate a Phase&nbsp;2a PSC trial in the second half of 2020, when it is
feasible to do so in light of the impact of the COVID-19 pandemic. Our second product candidate, <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> is a small-molecule selective inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> for the treatment of stage liver fibrosis associated with NASH, which we have partnered with Novartis. <FONT
STYLE="white-space:nowrap">PLN-1474</FONT> is currently undergoing a Phase 1 trial testing with top-line data expected by the end of 2020, subject to the impact of the COVID-19 pandemic. In addition to our clinical programs, we currently have
preclinical integrin-based programs targeting oncology and muscular dystrophies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fibrosis refers to the abnormal thickening and scarring
of connective tissue due to the production and deposition of excess collagen in the extra-cellular matrix. Fibrosis can occur in many different tissues including lung, liver, kidney, muscle, skin and the gastrointestinal tract, and often causes
severe and debilitating disease potentially leading to organ failure and death. Fibrosis has historically proven difficult to treat, which we believe is due to the complexity of the disease biology and the challenge of targeting fibrotic tissues
selectively without affecting healthy tissues. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that tissue-specific inhibition of TGF-&szlig; may hold the key to successfully
treating fibrosis. In normal tissues <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> is activated in response to tissue injury which initiates a cascade that results in collagen production and, ultimately, scar formation to heal the tissue. In
fibrosis, however, <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling becomes dysregulated, with <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> being continuously activated, leading to excess collagen deposition, even in the absence
of acute tissue injury. <FONT STYLE="white-space:nowrap">TGF-&szlig;,</FONT> while implicated in fibrosis pathophysiology, is expressed and intermittently activated across all tissue types and plays important, context-specific roles in tissue
homeostasis. Therefore, <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> cannot be blocked systemically without disrupting these homeostatic functions and causing significant toxicities. To more precisely treat fibrosis in specific tissues, we
believe it is crucial to discover and treat the underlying mechanism causing excess <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our scientific founders are pioneers in elucidating the role of specific extracellular receptors known as integrins as a key element in the
activation of <FONT STYLE="white-space:nowrap">TGF-&szlig;.</FONT> While the role of integrins in <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation has been well-characterized over the past 10 years, integrins have historically been
difficult to target therapeutically using small-molecules due to the difficulty of engineering molecules with high receptor selectivity and bioavailability. We believe that we have addressed these challenges with our platform. We have built a
library of compounds that includes bioavailable, selective and potent inhibitors of multiple integrins that may be used to target a range of fibrotic diseases across different tissues. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Pipeline </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g03k41.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our lead wholly-owned product
candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> is an oral small-molecule, dual-selective inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> that we are advancing in
IPF and PSC. While expressed at very low levels in normal tissues, <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> are upregulated in the pulmonary tissues of IPF patients, and in the liver tissues of
PSC patients. They both serve as activators of <FONT STYLE="white-space:nowrap">TGF-&szlig;,</FONT> leading to increased collagen production and fibrosis in these tissues. By blocking <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation by
both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>, we believe <FONT STYLE="white-space:nowrap">PLN-74809</FONT> may slow and potentially halt the progression of fibrosis in these
patient populations. <FONT STYLE="white-space:nowrap">PLN-74809</FONT> has been granted orphan drug designation by the U.S. Food and Drug Administration, or FDA, for both IPF and PSC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IPF is the most common and severe form of progressive pulmonary fibrosis, affecting approximately 140,000 patients in the United States. While
the underlying cause of IPF is unknown, the course of the disease is well documented, with progressive scarring that destroys the structure and function of the lungs over time. The average life expectancy for patients with confirmed IPF is between
three and five years. There are currently two <FONT STYLE="white-space:nowrap">FDA-approved</FONT> therapies for IPF. Both have shown modest slowing of disease progression. However, both therapies have raised significant safety and tolerability
concerns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PSC is a progressive liver disorder affecting approximately 30,000 to 45,000 patients in the United States. The disease is
characterized by fibrosis originating in the bile ducts that ultimately results in bile flow obstruction, or cholestasis, causing liver damage and progressive fibrosis of the liver. Patients have a median survival of 10 to 12&nbsp;years without
intervention and carry high lifetime risk of developing gastrointestinal malignancies. There are currently no <FONT STYLE="white-space:nowrap">FDA-approved</FONT> therapies for PSC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In our live human tissue assay, <FONT STYLE="white-space:nowrap">PLN-74809</FONT> showed a greater than 50&nbsp;percent decrease in the
expression of <FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> genes, such as collagen type I alpha1 chain, or <I>COL1A1,</I> and collagen type 3 alpha1 chain, or<I> COL3A1, </I>that are responsible for collagen production in human IPF and PSC
tissues. Additionally, we have completed a study in <FONT STYLE="white-space:nowrap">non-human</FONT> primates in which we showed that inhibition of
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> reduced <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation by greater than 75% in cells isolated from the lungs after
seven days of treatment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have completed a Phase 1a single ascending dose, or SAD, multiple ascending dose, or MAD, and food effect
clinical trial in which <FONT STYLE="white-space:nowrap">PLN-74809</FONT> was shown to be orally bioavailable and generally well tolerated with a half-life that may support once-daily dosing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have also completed a Phase 1b proof-of-mechanism trial in healthy volunteers evaluating PLN-74809&#146;s ability to inhibit TGF-&szlig;
activation as measured through pSMAD2/3 activation levels. pSMADs act as signaling </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
molecules directly downstream from the TGF-&szlig; receptor, and therefore pSMAD2/3 activation is used as a reliable biomarker for TGF-&szlig; activation. In the Phase 1b trial, PLN-74809 was
shown to inhibit TGF-&szlig; activation by up to 70% in alveolar macrophages collected from healthy volunteers, in a dose- and exposure-dependent manner. Additionally, PLN-74809 was well tolerated with only mild adverse events and no drug-related
adverse events. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are recruiting two Phase 2a trials of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in IPF. In the first of these
trials, we plan to enroll IPF patients and utilize a positron emission tomography, or PET, ligand to measure av&szlig;6 target engagement by <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in the lungs post-treatment. The second trial is a <FONT
STYLE="white-space:nowrap">12-week</FONT> double blind placebo-controlled trial involving IPF patients across four cohorts consisting of three doses of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and one placebo and will evaluate safety,
tolerability and pharmacokinetics, or PK. We also plan to employ exploratory efficacy endpoints including Quantitative Lung Fibrosis imaging analysis, biomarkers and pulmonary function. We submitted an IND for PLN-74809 in PSC in March of 2020 and
plan to initiate a Phase&nbsp;2a trial in the second half of 2020, when it is feasible to do so in light of the impact of the COVID-19 pandemic. This trial will be a <FONT STYLE="white-space:nowrap">12-week</FONT> double blind placebo-controlled
trial involving PSC patients across four cohorts consisting of three doses of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and one placebo and will evaluate safety, tolerability and PK. We also plan to employ exploratory efficacy endpoints
including biomarkers and evaluation of liver-stiffness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our second clinical stage product candidate,
<FONT STYLE="white-space:nowrap">PLN-1474,</FONT> is a small-molecule, selective inhibitor of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation by the integrin <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>, in development for treatment of stage F3/F4 NASH. <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> serves as an activator of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> and its expression has been shown to be upregulated in
hepatic stellate cells in stage F3 and F4 NASH-associated liver fibrosis. In October 2019, we entered into a collaboration and license agreement with Novartis in which Novartis licensed global rights to PLN-1474. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NASH is a severe form of <FONT STYLE="white-space:nowrap">non-alcoholic</FONT> fatty liver disease, or NAFLD, that is associated with the
development of liver fibrosis and potentially life-threatening liver dysfunction. NASH is highly prevalent, affecting approximately 16.5&nbsp;million adults in the United States, including approximately 3.3&nbsp;million with stage F3/F4 fibrosis.
Over time, NASH-related liver fibrosis may progress to cirrhosis, resulting in impaired liver function and increased risk of liver-related complications and mortality. There are currently no FDA approved therapies for NASH, and to date
investigational NASH therapies have only shown modest anti-fibrotic benefits in clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have shown through our assays of live
human fibrotic liver tissue that <FONT STYLE="white-space:nowrap">PLN-1474</FONT> is able to decrease the expression of <FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> genes such as <I>COL1A1</I>, the gene associated with the production of the
most abundant type of collagen produced in fibrosis. We have also shown in multiple animal models of NASH that <FONT STYLE="white-space:nowrap">PLN-1474</FONT> has a potent anti-fibrotic effect. Despite delays resulting from the COVID-19 pandemic,
we are currently conducting a Phase 1 trial of <FONT STYLE="white-space:nowrap">PLN-1474</FONT> in healthy volunteers with data expected by the end of 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our collaboration with Novartis, Novartis will reimburse us for all development activities associated with the PLN-1474 Phase 1
trials, and will be responsible for all development and commercialization activities following Phase 1 trials. In addition to PLN-1474, during the research term, Novartis will also collaborate with us on up to three separate integrin research
programs. We will be eligible to receive up to $416.0 million in total from various developmental regulatory and commercial milestones as well as tiered royalties, on a product-by-product basis based on annual nets sales of products, at percentages
ranging from high-single digits to low teens of the applicable licensed products and mid-single digits to high-single digits for any products resulting from the research programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to our clinical programs, we are developing two additional preclinical integrin-based programs. The first of these is our oncology
program. As TGF-&szlig; biology has been elucidated, it has become increasingly understood in the scientific literature that TGF-&szlig; plays an important anti-inflammatory role in the tumor micro-environment, preventing T-cell infiltration and
inhibiting release of various cytokines. This mechanism is becoming increasingly recognized as a potential cause of the resistance to checkpoint inhibitors such as anti-PD-</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
1 therapies seen in many tumors. We are targeting the TGF-&szlig; activating integrin
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><FONT STYLE="font-family:Times New Roman; font-size:6.5pt">v</FONT><FONT STYLE="font-family:Times New Roman; font-size:10pt">&szlig;</FONT><FONT STYLE="font-family:Times New Roman; font-size:6.5pt">8</FONT>
<FONT STYLE="font-family:Times New Roman; font-size:10pt">, which is upregulated in certain tumors with the goal of sensitizing tumors to checkpoint inhibitors. This program has generated positive data in preclinical tumor models and our candidate
is currently undergoing IND-enabling studies. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our second preclinical program is an allosteric agonistic monoclonal antibody
against an undisclosed integrin receptor being developed for treatment of muscular dystrophies, including Duchenne Muscular Dystrophy. The target integrin is upregulated on muscle cells across multiple muscular dystrophy indications, acting as a
substitute for dystrophin and helping to anchor muscle cells to the extracellular matrix. The program utilizes an allosteric agonistic antibody to activate the target in order to augment the naturally occurring compensatory mechanism. Because the
antibody is not mutation specific, it could potentially be effective as a single therapy or in combination with other treatment modalities across multiple muscular dystrophy indications. This program is currently in the candidate selection phase of
development. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pliant was formed to build upon our scientific founders&#146; pioneering work elucidating the biology of fibrosis and its
underlying causes. Our mission is to advance the understanding of fibrosis by building a biology-, chemistry- and screening-based engine to drive drug development across the spectrum of fibrotic diseases. We have established what we believe is a
leading capability to both identify relevant fibrosis targets across different tissue types and address those targets with product candidates that have been optimized for potency and selectivity. We have established collaborations with medical
research institutions and tissue networks that provide us access to human fibrotic tissue from patients undergoing transplant to use in evaluation of our product candidates and share insights with thought leaders to further engage them in our
mission. By refining the development of biology-driven product candidates in our laboratories through testing in freshly obtained human fibrotic tissue, we believe that we may be able to increase the efficiency of our development process and
maximize the probability of success. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have assembled an executive team with highly relevant experience in fibrosis, small-molecule drug
discovery and clinical development. Bernard Coulie, M.D., Ph.D., our CEO, has 20 years of experience in drug development, previously serving as CEO and CMO of ActoGeniX, as well as holding senior roles at Johnson&nbsp;&amp; Johnson. &Eacute;ric
Lefebvre, M.D., our Chief Medical Officer, brings deep experience in clinical development in liver disease. He previously served as head of clinical research and development for NASH at Allergan. Prior to Allergan, Dr.&nbsp;Lefebvre led HIV and HCV
development at Janssen and later served as CMO at Tobira. We were founded by world-renowned researchers Dean Sheppard, Rik Derynck, Bill DeGrado and Hal Chapman from the University of California, San Francisco, who bring broad experience in fibrosis
biology and small-molecule chemistry among other related disciplines. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, we have raised over $220&nbsp;million from investors
including Third Rock Ventures, Cowen Healthcare Investments, Eventide Asset Management, Novartis, Redmile Group, Farallon Capital Management, Cormorant Asset Management, Surveyor Capital (a Citadel Company), Logos Capital, Schroder Adveq Management,
Menlo Ventures, SCubed Capital and Agent Capital<B>. </B> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Strategy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our goal is to become a world-leading fibrosis company, developing and commercializing disease-modifying therapies across a spectrum of
fibrotic diseases. To achieve this, we are focused on the following key strategies: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Rapidly advance <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in IPF and PSC through clinical development
and commercialization</B>.&nbsp;&nbsp;&nbsp;&nbsp;We are developing our lead oral small-molecule inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> as a novel therapy for
both IPF and PSC, each areas of high unmet medical need. Both IPF and PSC are orphan indications that we believe we can commercialize on our own in key geographies using targeted sales forces. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Rapidly advance our second product candidate, <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> through Phase
1 for subsequent trials in NASH</B> associated liver <FONT STYLE="white-space:nowrap">fibrosis.&nbsp;&nbsp;&nbsp;&nbsp;PLN-1474</FONT> is a small-molecule selective inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> in development for the treatment of stage F3/F4 liver fibrosis associated with NASH, an area of high unmet medical need with no
currently FDA-approved treatments. In October 2019, we entered into a license and collaboration agreement with Novartis, or the Novartis Agreement, under which Novartis licensed global rights to PLN-1474. We are currently executing a Phase 1 SAD/MAD
trial of PLN-1474. Novartis will reimburse us for all development activities associated with the Phase 1 trials, and will be responsible for all development and commercialization activities following Phase 1. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Selectively evaluate additional partnerships in indications and geographies where we believe partners can add
significant commercial and/or development capabilities.&nbsp;&nbsp;&nbsp;&nbsp;</B>Fibrotic diseases represent a broad set of disease indications to pursue. Our focus is to commercialize our assets in orphan fibrosis indications and to selectively
work with partners in larger indications and in geographies outside of North America. Given the size and competitive dynamics of the NASH indication, we believe that our collaboration with Novartis gives PLN-1474 the best chance for success.
Furthermore, we will evaluate and potentially choose to partner our unpartnered product candidates in indications outside of fibrosis. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Explore opportunities for our pipeline assets in additional fibrotic
indications.&nbsp;&nbsp;&nbsp;&nbsp;</B>We are evaluating the potential benefit of our product candidates outside of their lead indications. Our product candidates have shown anti-fibrotic activity in multiple animal models as well as human tissue
in indications outside of IPF, PSC and NASH. We will continue to evaluate additional indications to maximize the potential of our pipeline. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Leverage our industry leading tools and capabilities to advance our mission of becoming a leading fibrosis
company.&nbsp;&nbsp;&nbsp;&nbsp;</B>Since our founding we have endeavored to advance the understanding of fibrosis biology, uncover new targets and advance novel product candidates. Currently, our proprietary capabilities include a target expression
atlas, an expansive library of over 7,000 integrin inhibitor molecules, integrin screening assay platform, live fibrotic human tissue program, <FONT STYLE="white-space:nowrap">PET-ligand</FONT> imaging program, and biomarker assays. We continue to
expand our integrin inhibitor library and develop tools such as additional <FONT STYLE="white-space:nowrap">PET-ligands</FONT> as well as novel disease biomarkers. In addition, we have a library of over 70,000 compounds for <FONT
STYLE="white-space:nowrap">non-integrin</FONT> targets. We intend to leverage these tools and capabilities in a target- and modality-agnostic manner to expand our pipeline with a mission to become a world-leading fibrosis company.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Impact of the COVID-19 Pandemic </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The COVID-19 pandemic is causing significant industry-wide delays in clinical trials. There are multiple causes of these delays, including
reluctance of patients to enroll or continue in trials for fear of exposure to coronavirus, local and regional shelter-in-place orders and regulations that discourage, hamper, or prohibit patient visits, healthcare providers and health systems
shifting away from clinical trials toward the acute care of COVID-19 patients and the FDA and other regulators making product candidates for the treatment of COVID-19 a priority over product candidates unrelated to the pandemic.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are working closely with our contract research organizations, or CROs, manufacturers, investigators and clinical trial sites to assess the
full impact of the COVID-19 pandemic on timelines and expected costs for each of our programs. Our CRO&#146;s are largely decentralized organizations and, to date, have not experienced significant impacts to their ability to support our trials. Our
manufacturers, particularly in China, have, to varying degrees, experienced impacts to their operations as a result of the COVID-19 pandemic. To date, however, these operational challenges have had minimal impact on their ability to produce and
deliver materials to us in a timely manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are surveying each of our more than 60 global clinical trial sites per program (i.e., IPF
and PSC) to assess the local and regional impacts of the COVID-19 pandemic and will adjust the conduct of our clinical trials accordingly. Our sites have informed us that while they can review new study applications, they currently
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
anticipate delays in site start-up activities of one to two quarters for both the PLN-74809 IPF and PSC Phase 2a trials and could experience slower than expected enrollment, but cannot yet
quantify any effects on enrollment and retention of patients in our trials. At this time, approximately 58% of our global IPF sites expect to begin enrolling within one to six months. Approximately 77% of our global PSC sites expect to begin
enrolling within three months. We are focusing our efforts on completing site-readiness and conducting an awareness campaign to generate interest in our trials. The campaign includes clinical research site calls with our founders and KOLs,
engagement with scientific and patient communities and foundations, and active social media channels.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">People living with IPF are
considered at higher risk for developing serious illness if they become infected by the coronavirus. These patients may be instructed to avoid non-essential visits to medical centers, and to instead self-isolate at home.&nbsp;We are actively
evaluating potential home care solutions for both our IPF and PSC clinical trials in order to mitigate COVID-19 infection risk in these vulnerable populations. We do not yet know the feasibility of home care or other potential solutions for our IPF
and PSC programs or their impact on our projected timelines. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our pipeline and early-stage programs are being impacted by the COVID-19
pandemic due to local California shelter-in-place orders in effect since March&nbsp;16, 2020. These impacts may be mitigated by our ability to outsource work to third parties, such as CMC. Additionally, we are subject to certain exceptions to the
shelter-in-place order through the nature of our early stage research and continue to conduct essential lab work utilizing social distancing measures such as alternating shifts and reduced staff. In response to the spread of COVID-19, we have closed
our executive offices with our administrative employees continuing their work outside of our offices and limited the number of staff in any given research and development laboratory. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are not aware of any of our directors employees being infected with coronavirus, but the virus can remain asymptomatic for a significant
period of time and methods and availability of testing continue to evolve. Notwithstanding the current shelter-in-place orders, our employees or their family members could become infected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We note the high level of difficulty in projecting the effects of the COVID-19 pandemic on our programs and our company, given the rapid and
dramatic evolution in the course and impact of the pandemic and the societal and governmental response to it. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fibrosis: A Condition of Uncontrolled
Scarring </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fibrosis refers to excessive scarring often resulting from aberrant tissue repair processes. In normal tissues, fibrotic
pathways represent a repair mechanism by which the tissues heal themselves in response to injury or disease. These pathways are normally deactivated upon completion of tissue repair. However, when they become dysregulated and remain activated,
excess collagen deposition can cause tissues to thicken and become stiff, ultimately impairing their physiological function. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fibrosis is
a disease of connective tissue. Normal connective tissue forms a supportive network between cells, lending structure and integrity to tissues built up of many cell types. Connective tissue is composed of collagenous and elastic fibers, as well as a
number of supporting cells such as fibroblasts and white blood cells. These supporting cells are embedded in a <FONT STYLE="white-space:nowrap">gel-like</FONT> matrix made up of proteins known as the extra-cellular matrix. The most important protein
in this matrix is collagen, which takes the form of elongated, fine fibers, providing flexible support to the surrounding cells. In fibrotic tissues, initial insults such as tissue damage or inflammation spur the deposition of excess collagen.
Normally such responses are balanced in finely controlled feedback loops, but in fibrotic disease these feedback loops are dysregulated,&nbsp;resulting in progressive scarring, thickening, and loss of function. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fibrosis occurs in many organ systems throughout the body including the lungs, liver, kidneys, gastrointestinal tract, skin and muscles. While
the exact pathologies of diseases in these organs vary, the development of fibrosis involves many common cell types and biochemical pathways, including the TGF-&szlig;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
signaling pathway. The ultimate result is similar across many tissues: secretion and extracellular activation of growth factors that stimulate fibroblasts to secrete excess collagen, leading to
runaway growth of scar tissue. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g22z44.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Role of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> Signaling in Fibrosis </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that selectively inhibiting TGF-&szlig; activation holds the key to successfully treating fibrosis across multiple tissues and
organs. <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> is secreted by nearly all cells and organs in mammals and stored in large amounts outside of cells, in the extra-cellular matrix, as part of an inactive complex. In healthy tissues, <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> is transiently activated in response to tissue injury which initiates a cascade that results in collagen production and, ultimately, healing of the tissue. In fibrosis, however <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling becomes dysregulated and perpetuated, with <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> being continuously activated, leading to excess collagen deposition in the absence of acute tissue
injury. Moreover, induced activation of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> alone in animal models has been shown to be sufficient to induce fibrosis, and inhibition of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation
has been shown to prevent or attenuate fibrosis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> can be activated in multiple ways in
response to specific tissue injury. One important class of cell-surface proteins that activate <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> in fibrosis are integrins. Integrins have a variety of functions, including signaling inside the
cells, providing tissue structure and stability through adhesion between cells. Integrins are heterodimeric proteins, meaning they are composed of two different protein subunits paired together. These subunits are known as <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT> and &szlig; subunits. In humans, there are eighteen distinct <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT> subunits and eight distinct &szlig; subunits, which combine to form 24 known and functional integrin
pairs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain integrins bind the inactive <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> complex. In response to tissue injury, the
cells expressing these integrins are induced to contract, exerting physical force on the bound <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> complex. This mechanical force changes the shape of the complex, releasing active <FONT
STYLE="white-space:nowrap">TGF-&szlig;.</FONT> This activation triggers a biological cascade which results in collagen production, and when dysregulated leads to fibrosis. As depicted in the figure below, this cascade involves (i)&nbsp;binding of
active <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> to its receptor, the <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> type I receptor kinase also known as ALK5; (ii) phosphorylation of immediate downstream signaling proteins known as
SMAD2 and SMAD3; (iii)&nbsp;formation of a transcription initiation complex by pSMAD2, pSMAD3 and SMAD4; and (iv)&nbsp;subsequent transcription of target genes that encode fibrotic proteins such as collagen. Importantly, whereas certain <FONT
STYLE="white-space:nowrap">TGF-&szlig;-activating</FONT> integrins are expressed at very low levels in healthy tissues, the <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> cascade can lead to the upregulation of these integrins resulting in a <FONT
STYLE="white-space:nowrap">TGF-&szlig;-driven</FONT> positive feed-forward loop which further increases <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation. Furthermore, as fibrosis progresses and the fibrotic organ gets stiffer, it
becomes progressively easier for contracting cells to activate integrin-bound <FONT STYLE="white-space:nowrap">TGF-&szlig;.</FONT> It is because of this continued, tissue-specific </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
upregulation of integrins and their key roles in continued <FONT STYLE="white-space:nowrap">TGF-&szlig;-activation</FONT> that we believe that integrins provide an avenue to selectively inhibit <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in fibrotic tissue without affecting <FONT STYLE="white-space:nowrap">TGF-&szlig;&#146;s</FONT> important physiological roles in healthy tissues. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB> Integrins promote
fibrosis through activation of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g14g69.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Model of integrin regulation of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Historical Challenges to Drug Development in Fibrosis </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fibrosis has historically been a difficult therapeutic area to target pharmaceutically. The biology and underlying causes of fibrosis are
complex and, in many diseases, poorly understood. In the past, many patients with fibrotic disease were treated with anti-inflammatory agents such as steroids. While steroids may have a mild anti-fibrotic effect in some forms of fibrosis, they can
exacerbate others, such as IPF. Additionally, the negative effects of chronic steroid exposure make it difficult to treat patients with these agents for long-term periods. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">More recently, it has become well understood that regardless of the underlying cause, TGF-&szlig; activation is at the heart of several key
processes that drive fibrosis, including collagen formation, deposition of extracellular matrix proteins and activation and proliferation of fibroblast cells. As such, much of the historic drug development efforts to treat fibrosis have been aimed
at systemically inhibiting or disrupting the TGF-&szlig; signaling pathway by either (i)&nbsp;blocking TGF-&szlig; binding to the TGF-&szlig; receptors with an antibody or (ii)&nbsp;preventing the type I TGF-&szlig; receptor, also known as ALK5,
from activating the SMADs using a small-molecule kinase inhibitor. However, because of TGF-&szlig;&#146;s role in normal physiology, these approaches cause substantial toxicity and dysregulation of normal functions. In fact, documented toxicities
that arise from systemic inhibition of TGF-&szlig; signaling include cardiac toxicity, inflammation, and focal epithelial hyperplasia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A
potentially safer approach to fibrosis therapy is to inhibit specific <FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> signaling molecules, such as connective tissue growth factor and autotaxin, which operate downstream of TGF-&szlig;
activation, thereby mitigating the tolerability issues associated with systemic TGF-&szlig; inhibition. While tolerability has been shown to improve with this approach, the efficacy shown to date has been modest, likely because TGF-&szlig; activates
multiple <FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> signaling pathways in addition to those targeted by these approaches. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Another recent approach is to prevent TGF-&szlig; activation by stabilizing TGF-&szlig; in its inactive form. However, it is not known whether
latent TGF-&szlig; stabilization can be accomplished in a tissue specific manner. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">109 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the historical difficulty in targeting
<FONT STYLE="white-space:nowrap">TGF-&szlig;,</FONT> clinical development for the treatment of fibrosis has also been limited by the lack of tools to understand this complex multicellular process. Only certain parts of this process can be modeled
using cellular assays. More complete representations of fibrosis can be generated in animal models, but these models tend to be acute in nature and do not accurately represent disease pathology in humans which, in most cases, develops over decades.
While fibrosis has historically been a difficult area of development, there has been significant interest in the space from large-cap pharma companies due to the relative scarcity of companies developing antifibrotic candidates. This is evidenced by
several recent notable acquisitions in the space including Roche&#146;s acquisitions of InterMune and Promedior, Allergan&#146;s acquisition of Tobira, and Gilead&#146;s strategic investment in Galapagos. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Integrin Inhibitors as a Potential Treatment for Fibrosis </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An ideal approach to fibrosis treatment would be one that inhibits TGF-&szlig; activation in only those tissues where fibrosis is occurring.
One potential way to accomplish this is to inhibit the integrin proteins that are known to be overexpressed in specific fibrotic tissue and cause the abnormal activation of TGF-&szlig;. In several forms of fibrosis, namely IPF and PSC, TGF-&szlig;
activating integrins such as <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> are over-expressed. These integrins are normally expressed at low levels in healthy tissue. Therefore, we would not expect <FONT
STYLE="white-space:nowrap">off-target</FONT> toxicity effects by selectively inhibiting
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>. By inhibiting fibrosis-specific TGF-&szlig; activators such as these specific integrins, it is possible to block abnormal
TGF-&szlig; activation in the specific tissues where fibrosis occurs, without affecting TGF-&szlig; signaling in healthy tissues. However, integrin drug development has historically been challenging due to the difficulty of developing small molecule
integrin inhibitors that are both selective for specific integrins and bioavailable. Notably, a recent approach targeting integrins selectively with a monoclonal antibody was terminated due to safety concerns, which we believe may be related to
antibody-mediated immune activation. We believe our pipeline of bioavailable highly selective small molecule integrin inhibitors has the potential to address these challenges. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Recently, large biopharmaceutical companies have begun to recognize the potential of anti-integrin approaches to treat fibrosis and made large
investments in the space. AbbVie recently <FONT STYLE="white-space:nowrap">in-licensed</FONT> a set of preclinical integrin inhibitors for the treatment of fibrosis including an <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> inhibitor targeting IPF.<B> </B>The AbbVie product candidate is a single selective inhibitor of
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB>; however, it has been shown that the expression of both <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> is upregulated in IPF. We believe that our dual-selective <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB>/<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> inhibitor approach has the potential to provide a more potent anti-fibrotic effect than a single selective <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> inhibitor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
believe that recent developments in the field of integrin inhibitors validate our initial focus on integrin inhibitors as a treatment for fibrosis. Utilizing our proprietary discovery and development capabilities, we believe that we have overcome
key historical challenges to the development of integrin inhibitors, including potency, selectivity and bioavailability. We have identified two bioavailable and highly potent and selective integrin inhibitors. Our lead product candidate, <FONT
STYLE="white-space:nowrap">PLN-74809,</FONT> has completed Phase 1a trials and has demonstrated potential for a once daily oral dosing profile. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our
Capability and Approach to Fibrosis Drug Discovery and Development </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our approach to drug development in fibrosis combines our deep
knowledge of the biology of fibrosis with various cellular, tissue, and <I>in vivo</I> assays developed in house to interrogate the biology of fibrosis and uncover pathways and potential targets. We developed an extensive panel of cell assays,
precision cut tissue assays and animal models covering various types of fibrotic diseases. These assays allow us to evaluate target expression in fibrotic tissues as well as the anti-fibrotic activity of our candidates after treatment and begin to
establish proof-of-biological-mechanism in both animal models and human tissue prior to initiating clinical trials. We believe these collective capabilities uniquely allow us to (i)&nbsp;efficiently identify targets, (ii)&nbsp;optimize the potency
and selectivity of candidates and <FONT STYLE="white-space:nowrap">(iii)&nbsp;de-risk</FONT> product candidates in advance of human proof-of-concept. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The first tool we use in our discovery process is our target expression atlas. Utilizing samples from normal and fibrotic human tissue, we
developed a quantitative atlas of gene and protein expression across multiple </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">110 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
fibrotic diseases. This database represents a wealth of data that we use to quantify expression of tissue specific targets for potential therapeutics. The atlas is continuously expanding through
acquisition of additional samples as well as additional analyses. To date, we have advanced multiple potential targets to our early discovery pipeline. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The second important tool in our discovery process is our compound library that we screen for activity against targets identified through our
target atlas. While we are agnostic to treatment modality, our initial targeted chemistry effort has been focused on integrin inhibitors, and our medicinal chemistry team has developed a proprietary library of over 7,000 potential integrin
inhibitors. The goal of the library is to maximize structural diversity while targeting optimal absorption, distribution, metabolism and excretion, or ADME, properties. We expect that the library will continue to grow as we investigate new
structures. We have designed the library based on in silico known <FONT STYLE="white-space:nowrap">X-ray</FONT> structures/homology models, structure-activity relationships of structural motifs of known integrin inhibitors, and de novo molecular
design. In addition to our proprietary integrin inhibitor library, we have a <FONT STYLE="white-space:nowrap">non-integrin</FONT> compound library of over 70,000 compounds that we screen against <FONT STYLE="white-space:nowrap">non-integrin</FONT>
targets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once we have identified a potential target through our target expression atlas, we screen our library of compounds against the
target. We have developed screening assays for 20 of the 24 known integrins and use these assays to evaluate the potency and selectivity of binding for our potential drug candidates prior to preclinical studies. Given the selectivity and potency
challenges that have hampered integrin drug development, we believe our integrin assay panel represents a major step forward in integrin-based drug development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe a key advantage of our development strategy is our ability to test our product candidates in live human fibrotic tissue, which
helps us to bridge the gap between animal models and clinical proof-of-concept. We have developed proprietary protocols that extend the viability of live human explant tissue samples which allow us to reproducibly perform multiday experiments. We
also maintain an <FONT STYLE="white-space:nowrap">on-call,</FONT> around the clock team that obtains tissue samples following transplant procedures and transports those tissues to our lab within hours of explant, in a highly coordinated process. Our
access to these live tissue samples allows us to evaluate the effects of our product candidates on multiple markers of anti-fibrotic activity. The data from these experiments increase our confidence that the tested product candidates will show
anti-fibrotic effects in patients. In this way, our human tissue program serves to further <FONT STYLE="white-space:nowrap">de-risk</FONT> product candidates and increase their likelihood of success in the clinic. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once in clinical development, we seek to further <FONT STYLE="white-space:nowrap">de-risk</FONT> our programs by designing clinical trials
that allow us to show proof-of-mechanism in advance of clinical efficacy data. Because fibrosis is a chronic disease, proof-of-efficacy in human trials is expensive and takes years to complete. We utilize pharmacodynamic biomarkers and advanced
imaging techniques, including PET, to evaluate target engagement by our product candidates over relatively short time periods and observe whether the product candidate is having the anticipated effect. We believe obtaining these clinical data points
in an efficient manner will allow us to optimize our clinical development strategy and resource allocation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and our partners also
proactively conduct observational, natural history trials in target diseases to better understand disease pathophysiology and progression and develop new molecular biomarkers. Through these trials, we have gone on to develop patient registries and
establish relationships with clinicians at leading medical research institutions dedicated to bringing novel fibrosis therapies to their patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are developing an extensive biomarker discovery and validation program. We are seeking to develop biomarkers to (i)&nbsp;identify patients
at high risk of rapid disease progression, (ii)&nbsp;identify patients more likely to respond to treatment and (iii)&nbsp;monitor early treatment responses. We are conducting clinical studies and other research with leading academic centers to track
disease progression and collect biological samples such as blood, urine, and tissue biopsies which we can use to discover and validate novel biomarkers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g55f69.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our systematic approach to identifying and targeting integrins in fibrosis </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Selective inhibition of TGF-&szlig; activation in fibrotic tissues could potentially be the safest and most effective approach to treating
fibrosis. One way to accomplish this is to inhibit the integrin receptors that drive excessive activation of TGF-&szlig;. Given the importance of integrins in regulating the initial steps in fibrosis, we have focused our initial drug discovery
efforts on a dual approach. This approach includes both biological profiling to identify which integrins are important in various diseased tissues and chemical profiling of libraries containing proprietary integrin inhibitors to help determine their
selectivity and potency for individual integrins. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Utilizing our extensive <FONT STYLE="white-space:nowrap">in-house</FONT> medicinal
chemistry expertise, we have created a library of over 7,000 integrin-inhibitors. We screen this library against the integrin targets that we identify through our expression atlas and or biological profiling process. To our knowledge, this type of
industrial-scale, systematic biological and chemical profiling, seeking selective inhibitors of one or more integrins, has not previously been carried out. We believe this combination makes our approach distinctive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Central to our integrin inhibitor discovery process are our integrin assay panels. A key challenge in integrin inhibition, historically, has
been selectivity for specific integrins. To address this challenge, we have developed assays against the 20 most relevant known integrins. We use these screening assays to measure potency and selectivity of potential candidates against these
integrins. This allows us to quickly optimize the integrin binding profiles of potential development candidates in an iterative process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Integrins can undergo conformational change. This results in different binding affinities. We believe an ideal integrin inhibitor should
potently bind across the spectrum of conformations. Through the use of specific assays, we can measure the potency of our product candidates against multiple integrin conformations and seek to optimize for candidates that are able to potently bind
to all conformations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to our deep understanding of integrin biology, we have gained significant insight in structure-activity
relationships that determine integrin selectivity and optimal PK profiles. Utilizing this knowledge, we are now able to precisely engineer bioavailable integrin inhibitors with high potency and desired selectivity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our integrin inhibitor profiling capability has enabled us to quickly identify inhibitors that target individual integrins such as <FONT
STYLE="white-space:nowrap">PLN-1474,</FONT> which selectively inhibits <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>, as well
as dual inhibitors such <FONT STYLE="white-space:nowrap">PLN-74809</FONT> which selectively targets both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>. Combining the data from
our biological profiling and chemical profiling sets has enabled us to identify compounds that we believe have the highest potential for therapeutic activity in specific fibrotic diseases. Our iterative drug discovery effort focuses on drug-like
properties of compounds early in the testing process. Compounds are screened for <I>in vitro</I> potency/selectivity and ADME/PK properties. This enables us to move from compound optimization to <I>in vivo</I> testing in a matter of months. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">112 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to PLN-1474 and PLN-74809, we continue to evaluate our broad proprietary library
of integrin inhibitors to identify additional product candidates to treat fibrotic diseases. Furthermore, our approach allows us to use our discovery and development capabilities to develop <FONT STYLE="white-space:nowrap">non-integrin</FONT>
therapeutic modalities to treat fibrotic diseases. Our rich library also provides a deep series of potential backup molecules with structurally unique chemotypes that we believe can enhance the probability of clinical success. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As with all of our development efforts, a key approach to preclinically <FONT STYLE="white-space:nowrap">de-risking</FONT> our integrin
inhibitor candidates is evaluation of candidates in live human fibrotic tissue obtained following transplant procedures. The ability to observe effects of our product candidates on gene expression in human tissues prior to entering the clinic
provides a bridge from animal models to clinical proof-of-concept and helps give us additional confidence as we move toward human trials. Similarly, if our <I>ex vivo </I>live human tissue studies show little or no effect on the target genes, we can
quickly reallocate resources, saving time and money, and minimizing unnecessary patient exposure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A second important <FONT
STYLE="white-space:nowrap">de-risking</FONT> strategy involves biomarker measurement in both preclinical and early stage clinical studies. By utilizing specific biomarkers such as pSMAD2/3 that operate immediately downstream from <FONT
STYLE="white-space:nowrap">TGF-&szlig;,</FONT> we are able to measure the effects of our drugs on <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation. We believe understanding the ability of our drug candidates to reduce TGF-&szlig;
activation is crucial to gaining confidence in the anti-fibrotic activity of our product candidates as we move forward in the clinic. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
our Phase 2 clinical trials, we will use an advanced imaging technique to generate mechanistic data and <FONT STYLE="white-space:nowrap">de-risk</FONT> the development of our candidates. Fibrosis is a chronic process and it can take 6 months to a
year to see a clinical benefit with a product candidate. We will utilize PET imaging to evaluate target engagement in patients and to determine if PLN-74809 is having an effect in the tissues. We have an ongoing collaboration with Stanford pursuant
to which we are evaluating Stanford&#146;s <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> PET ligand in IPF patients. We are
using this ligand to evaluate the level of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> expression in the lungs of IPF
patients, as well as to measure our product candidate&#146;s ability to bind <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB>. In
addition to the <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> PET ligand, we are internally developing PET ligands to other
integrins that we will use to evaluate subsequent product candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our product candidates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">PLN-74809</FONT> for the treatment of IPF and PSC </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our lead product candidate, <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> is an oral small-molecule, dual-selective inhibitor of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrins which we are developing for the treatment of IPF and PSC. We have received orphan drug designation for <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> in both IPF and PSC. We completed a Phase 1a trial of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in healthy volunteers and a Phase 1b trial in which we assessed target engagement and
proof-of-mechanism in healthy volunteers by examining the inhibition of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in alveolar macrophages. We are recruiting two Phase&nbsp;2a trials of PLN-74809 in IPF patients. We submitted an
IND for PLN-74809 in PSC in March 2020 and plan to initiate a Phase&nbsp;2a trial in the second half of 2020, when it is feasible to do so in light of the impact of the COVID-19 pandemic. We plan to utilize a similar approach to the previously
described IPF study for which we plan to enroll PSC patients, evaluating up to three doses of PLN-74809 or placebo. We intend to first enroll a 40 mg cohort, then amend the protocol to add 80 mg and 160 mg cohorts, subject to our ongoing phase 1
dose escalation trial. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Idiopathic pulmonary fibrosis background </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IPF is a debilitating, <FONT STYLE="white-space:nowrap">age-related</FONT> lung disease of unknown causes that has few treatment options. It is
a form of progressive pulmonary fibrosis that leads to thickening and stiffening of the lung tissue resulting in the loss of lung function. As tissue scarring progresses, the lungs&#146; ability to transfer oxygen into the bloodstream becomes
increasingly impaired. Average life expectancy at the time of confirmatory diagnosis of IPF is estimated to be between three and four years. Approximately 60 to 80&nbsp;percent of patients die within five years of diagnosis. These survival rates are
worse than those of many late stage cancers, such as stage 3 breast cancer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patients with IPF experience debilitating symptoms, including
shortness of breath and difficulty performing routine functions, such as walking and talking. Other symptoms include a chronic, dry, hacking cough; fatigue; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">113 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
weakness; discomfort in the chest; loss of appetite; and weight loss. IPF is a rare disease that affects approximately 140,000 people in the United States. There are an estimated 30,000 to 40,000
new cases diagnosed each year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currently, there is no pharmacological cure for IPF and only a small proportion of late-stage IPF patients
may be eligible for a lung transplant. The current <FONT STYLE="white-space:nowrap">non-transplant</FONT> standard of care aims to slow the disease progression and improve the quality of life. Two therapies to treat IPF have recently been approved
by the FDA: Esbriet<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (pirfenidone), marketed by Genentech, and OFEV<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (nintedanib), marketed by Boehringer Ingelheim. After decades
during which the FDA approved no new treatments for IPF, the approvals of pirfenidone and nintedanib represented a major breakthrough for IPF patients. However, while these therapies may help slow the decline of lung function, neither drug has been
shown to stop the progression of IPF. We believe that, despite the approval of pirfenidone and nintedanib by FDA, there remains an unmet need for IPF patients that we plan to address through our product candidate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Despite its mechanism of action being unknown, pirfenidone has been shown in registrational trials to have a modest effect on slowing the
progression of IPF as measured by forced vital capacity, or FVC, in approximately fifteen percent of patients. Recent studies suggest that pirfenidone may have an impact on survival compared to placebo, but these results have not been confirmed. In
March 2020, the FDA granted breakthrough therapy designation for pirfenidone for treatment of unclassifiable lung fibrosis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nintedanib is
an inhibitor of multiple tyrosine kinases that are receptors for growth factors such as platelet-derived growth factor, or PDGF, fibroblast growth factor, or FGF, and vascular endothelial growth factor or VEGF. Nintedanib reduced the rate of decline
of pulmonary function in multiple trials by approximately half and led to significant delays in the time to acute disease exacerbation. While treatment was associated with a trend towards increased survival in<B> </B>registration trials, it has not
been shown conclusively to have a survival benefit. Recent exploratory analyses from pooled data from six clinical trials of nintedanib suggest that nintedanib may extend life expectancy in patients with IPF. The FDA approved nintedanib for the
treatment of lung fibrosis associated with systemic sclerosis in September 2019, and for the treatment of chronic fibrosing interstitial lung disease, or ILD with a progressive phenotype in March 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Elevated liver enzymes have been observed with both of these drugs, requiring monitoring of liver tests and potentially temporary dose
reduction and discontinuation. Cases of drug-induced liver injury, including one fatal outcome, have been reported in patients treated with nintedanib. Pirfenidone&#146;s prescribing information also carries a similar warning about elevated liver
enzymes. Despite the remaining unmet need, combined sales of pirfenidone and nintedanib in 2019 were over $2.7&nbsp;billion. IPF remains a major cause of morbidity and mortality and an area of high unmet medical need for which a commercial
opportunity remains. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Primary sclerosing cholangitis background </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PSC is a progressive liver disorder characterized by inflammation and fibrosis of the bile ducts which transport bile from the liver to the
intestines. This type of fibrosis often results in obstruction or interruption of bile flow from the liver, a condition known as cholestasis, leading to liver fibrosis. Cirrhosis eventually develops and many individuals ultimately require a liver
transplant. PSC patients are also at a higher risk of developing hepatobiliary cancers, including a 5 to 20&nbsp;percent lifetime chance of developing cholangiocarcinoma, a typically rare form of cancer with an especially poor prognosis. The exact
cause of PSC is unknown. PSC is normally diagnosed at middle age, with a median age at diagnosis of approximately 40 years old. The prevalence of PSC in the United States is estimated to be between 30,000 and 45,000 patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the absence of liver transplant, median survival of PSC patients is 10 to 12 years following diagnosis without intervention. There are
currently no approved pharmacological treatments for PSC. A number of immunosuppressive and anti-inflammatory agents have been studied in patients with PSC, but none has been conclusively proven to slow progression. Liver transplantation is the only
available treatment for PSC patients; however, disease has been shown to recur in up to 20&nbsp;percent of patients following transplantation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our solution, <FONT STYLE="white-space:nowrap">PLN-74809</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">PLN-74809</FONT> is a small-molecule that selectively inhibits both
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrins that we are developing as a potential therapy for IPF and PSC. We have determined that
<FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in fibrosis associated with IPF and PSC involves both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrins. It has been
shown that expression of both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> on epithelial cells and <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> on fibroblasts can lead to excessive activation of
<FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> in fibrosis. Epithelial tissue includes any tissue that lines the surfaces of the body such as alveoli, bile ducts, urinary tract, skin, and gastrointestinal tract. Each of these tissues contains
multiple cell types including epithelial cells and fibroblasts. An important secondary effect of the <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> cascade is that it promotes upregulation of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> on epithelial cells. The increased expression of these integrins on the cell surface contributes in turn to further <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in a <FONT STYLE="white-space:nowrap">TGF-&szlig;-driven</FONT> positive feed-forward loop. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="80%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="37%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g729258g91e38.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Activation of TGF-&szlig; by
</B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> leads to:</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Activation of TGF-&szlig; signaling pathways</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Expression of pro-fibrotic
genes including <I>COL1A1</I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Subsequent collagen production and deposition</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Additional upregulation of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Epithelial tissue fibrosis is driven by two types of integrins</B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Data from our lab, as well as scientific literature, have shown that <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> proteins are overexpressed in at least two different fibrosis indications: IPF and PSC. In lung tissue from IPF patients we and others have shown that alveolar epithelial cells have elevated <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> expression, and that the level of over-expression correlates with disease severity. We
have also shown that in these patients, <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> expression is upregulated. In liver
tissue from PSC patients, we have shown that <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> is upregulated in cholangiocytes,
the epithelial cells that line the bile ducts, and that <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> is upregulated in whole
fibrotic liver tissue. <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> are normally expressed at very low levels in healthy tissue making them ideal targets for selectively inhibiting <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in IPF and PSC. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g51g23.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> is upregulated in the lung tissue of IPF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>patients and the liver tissue of PSC patients </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">115 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g78q60.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">= p &lt; 0.05<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP> </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">A p-value is the probability that the reported result was achieved purely by chance, such that a p-value of less than or equal to 0.05 or 0.01 means that there is a 5.0% or 1.0% or less probability, respectively, that
the difference between the control group and the treatment group is purely due to chance. A p-value of 0.05 or less typically represents a statistically significant result. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> expression is upregulated in lung and liver fibrosis </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have conducted a <FONT
STYLE="white-space:nowrap">non-interventional</FONT> clinical trial in IPF patients to assess the expression of integrin <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">6</SUB> using a PET ligand. This trial confirmed that patients with IPF have high levels of integrin
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> expression, which tend to be <FONT STYLE="white-space:nowrap">co-localized</FONT>
with fibrotic regions of the lungs. This trial was published in Nature Communications in 2019. The specificity of this PET ligand can be seen in images from an IPF patient who received a unilateral lung transplant. The PET ligand is only taken up in
the diseased lung but not in the transplanted healthy lung. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g08k75.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pulmonary </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> PET ligand uptake in an IPF patient with a unilateral lung transplantation is confined to the IPF lung </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">116 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have shown that inhibition of both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrins is required to maximally inhibit the expression of <I>COL1A1</I>, a key gene that encodes type&nbsp;I collagen, in models of lung and biliary fibrosis as well as in human IPF tissue.
<I>COL1A1</I> is a <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> regulated gene that is expressed in fibrotic tissue. The expression level of <I>COL1A1</I> correlates with the amount of collagen deposited as measured by the standard
biochemical method of quantification of hydroxyproline, an amino acid that is a major component of collagen. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Clinical development
of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Completed trials </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We completed a Phase 1a SAD/MAD and food effect clinical trial of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in healthy volunteers. In
the SAD portion of the trial, single doses of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> were administered to 32 volunteers across four cohorts at doses of 15, 30, 50 and 75&nbsp;mg. Eight additional volunteers in the SAD portion of the trial
received placebo. In the MAD portion of the trial, <FONT STYLE="white-space:nowrap">PLN-74809</FONT> was administered orally to 27 volunteers, once-daily over 14&nbsp;days at 10, 20 and 40&nbsp;mg. Six additional volunteers in the MAD portion of the
trial received placebo. In the food effect part of the trial, <FONT STYLE="white-space:nowrap">PLN-74809</FONT> was administered to 12 volunteers, administered as a single dose with and without food. <FONT STYLE="white-space:nowrap">PLN-74809</FONT>
was shown to be well tolerated with no dose-related adverse events. All but two adverse events reported in the entire trial were mild except for a moderate adverse event of dental abscess (SAD, 30&nbsp;mg dose cohort) and a moderate adverse event of
viral syndrome (MAD, 40&nbsp;mg dose cohort). All adverse events resolved or recovered and no dose relationship for adverse events was observed. No notable findings were observed for laboratory abnormalities, vital signs or ECG/telemetry. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Adverse Events Reported by Participants Receiving PLN-74809 in Phase 1a Trials </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g99j21.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, <FONT STYLE="white-space:nowrap">PLN-74809</FONT> was well absorbed, and displayed a
half-life of over 40 hours. <FONT STYLE="white-space:nowrap">PLN-74809</FONT> reached steady state plasma concentrations after seven days of dosing. <FONT STYLE="white-space:nowrap">Co-administration</FONT> of
<FONT STYLE="white-space:nowrap">PLN-74809</FONT> with food decreased drug concentrations relative to the fasted state, with AUC decreasing by approximately 40&nbsp;percent and C<SUB STYLE="font-size:85%; vertical-align:bottom">max</SUB> by
approximately 50&nbsp;percent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">117 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">


<IMG SRC="g729258g08e28.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have also completed a Phase 1b proof-of-mechanism trial in healthy volunteers that was similar in design to
our previously completed non-human primate mechanistic trial. The purpose of this randomized, double-blind, ascending-dose, placebo-controlled trial was to evaluate PLN-74809&#146;s ability to inhibit
TGF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#098;</FONT> activation in the lung as measured by pSMAD2 levels in pulmonary alveolar macrophages collected from BAL fluid and to further characterize the PK/PD relationship in humans. Additionally, this trial
will serve to inform dosing in our planned Phase 2a trials. We conducted this trial in healthy volunteers due to the safety risks associated with performing multiple BAL procedures in IPF patients. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We enrolled 18 volunteers across four dose cohorts (each cohort randomized 3:1 active to placebo). Two cohorts were dosed at 20&nbsp;mg once
daily and two cohorts were dosed at 40&nbsp;mg once daily. Volunteers underwent an initial BAL procedure prior to treatment to measure baseline pSMAD levels. They were then treated with <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or placebo
for seven days, after which they underwent two additional BAL procedures to measure the amount of pSMAD reduction post-treatment at multiple time points. By utilizing two cohorts each for the 20 mg and 40&nbsp;mg doses, we were able to measure pSMAD
and drug levels at 4 different time points post treatment for each dose (3, 6, 12 and 24&nbsp;hours post-dose on day&nbsp;7), allowing assessment of PK/PD relationship over a <FONT STYLE="white-space:nowrap">24-hour</FONT> period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the Phase 1b trial, 16 participants completed pre- and post-treatment BAL procedures. Four out of six participants (66%) receiving the high
dose of PLN-74809 experienced <FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>49% reductions in pSMAD2 levels at six hours post-dose relative to baseline levels. Notably, all four of the volunteers in the high dose cohort with reductions in pSMAD2
levels also achieved plasma concentrations of PLN-74809 corresponding to the predicted plasma protein adjusted IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB> of 700 ng/ml. The two volunteers in the high dose cohort who did not achieve
these concentrations did not experience reductions in pSMAD2 levels. In the low dose cohort, no volunteers achieved plasma protein adjusted IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB>, and only one volunteer experienced significant
reduction in pSMAD2 levels post treatment, relative to baseline levels. These results demonstrate PLN-74809&#146;s effect on reducing TGF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#098;</FONT> activation in the lungs in a dose- and exposure-dependent
manner, supporting a PK/PD relationship in humans. These data support the biological activity of PLN-74809 and will guide dose selection and trial design as we move into Phase 2a trials. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">118 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g65l95.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Treatment with PLN-74809 was well tolerated with no drug-related adverse events. None of the adverse events
reported were observed in more than one participant. In the 40-mg dose cohort, two trial participants discontinued treatment prematurely (one participant receiving PLN-74809 and one receiving placebo) and did not undergo post-treatment BAL
procedures; these participants were subsequently replaced. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Adverse Events Reported by Participants Receiving PLN-74809 in Phase 1b
Trial </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g78b78.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Current and planned clinical trials for IPF and PSC </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently recruiting two Phase&nbsp;2a trials of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in patients with IPF, subject to the
impact of the COVID-19 pandemic. The first of these is an open label trial utilizing a PET ligand to <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">6</SUB> that allows imaging of target engagement by <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in the lungs of IPF patients during treatment. Patients will receive a single dose of PLN-74809 across
a dose range starting at 60 mg. We will obtain a PET scan at baseline to evaluate <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB>
expression levels in the patients&#146; lungs and then initiate treatment with open-label <FONT STYLE="white-space:nowrap">PLN-74809.</FONT> A post-treatment PET scan will be performed at approximately three hours after administration of the dose,
which will enable us to evaluate <FONT STYLE="white-space:nowrap">PLN-74809&#146;s</FONT> target engagement in patients&#146; lungs at maximum drug concentration. When <FONT STYLE="white-space:nowrap">PLN-74809</FONT> binds to the <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> receptor, we would expect to see decreased PET ligand uptake in the lungs
post-treatment when compared to <FONT STYLE="white-space:nowrap">pre-treatment</FONT> levels. The relationship between dose and target engagement is important to guide dose selection in future studies. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our second Phase 2a trial is a randomized, double-blind, placebo-controlled IPF trial evaluating up to three doses of PLN-74809 in IPF
patients. We plan to explore doses up to 160mg per day at the highest dose. This trial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">119 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
is a 12-week trial evaluating safety and tolerability, as well as PK in IPF patients. We plan to evaluate exploratory endpoints including pulmonary function tests, biomarkers, and imaging,
including Quantitative Lung Fibrosis HRCT imaging, or QLF. This is a multinational trial with over 40 sites in U.S., Canada, Australia, New Zealand and multiple countries in Europe. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>12 Week Safety, PK, Biomarker Trial in IPF Patients </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g69t17.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Design of 12 week Phase 2a IPF trial </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In our 12-week Phase 2a IPF trial, we will utilize QLF as a biomarker for early detection of changes in lung fibrosis. QLF is a fibrosis
biomarker assessed using high resolution CT imaging, and utilizes quantitative image analysis to measure the density of lung tissue and quantify the volume of fibrosis present in the lung. QLF technology was developed by MedQIA, and has been
evaluated in over 5,000 ILD patients, showing an ability to predict FVC decline in patients with IPF. While we will measure both endpoints, we believe QLF may allow us to detect changes in lung fibrosis in a more specific way than FVC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">120 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">QLF has been utilized in recent clinical trials to evaluate early treatment effects in the
amount of lung fibrosis present. In Biogen&#146;s Phase 2a trial of BG00011, a mAb targeting <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">6</SUB>, dose-dependent trends in QLF were seen at 8 weeks, with the 1mg/kg cohort actually showing a decrease in the amount of fibrosis present with a r=-0.49 correlation to FVC. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g04r02.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Biogen&#146;s Phase 2a 8-week QLF Results </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, Fibrogen utilized FVC in their Phase 2 trial of pamrevlumab, their anti-CTGF mAb, in IPF. Fibrogen showed 71% and 50% reductions
in progression of fibrosis versus placebo at 24 and 48 weeks, respectively, as measured by QLF. </P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g03g67.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the two Phase 2a trials, we recently completed dosing an extended Phase&nbsp;1 dose
escalation trial in healthy volunteers with data expected in the third quarter of 2020. Based on preclinical findings and the results of our Phase 1b healthy volunteer BAL trial, we believe the human effective dose range for PLN-74809 may be between
40&nbsp;mg and 160&nbsp;mg administered once daily. To efficiently evaluate safety and PK at these higher doses, we are conducting a single center, randomized, blinded, placebo-controlled, sequential SAD/MAD trial. In the SAD cohorts, volunteers
received a single dose of PLN-74809, starting at 120&nbsp;mg in cohort&nbsp;1 and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">121 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
increasing to a max of 320 mg in cohort 4. There were no new safety concerns revealed in the SAD portion of the trial. Most AEs were mild with the most common being dry throat/mouth and headache.
One SAE of severe catheter (IV) site infection was reported in the 120 mg SAD, and deemed not related by the study investigator. In the MAD cohorts, volunteers received once-daily doses of PLN-74809 for seven days, starting at 80 mg per day and
increasing to a max of 160 mg per day. One SAE of moderate breathlessness and cough-related chest pain was reported in the 80 mg MAD cohort and was deemed related to study drug by the study investigator; as the events occurred 14 days after the last
dose of PLN-74809, Pliant could not establish or exclude the possibility of a cause and effect relationship and further follow-up is ongoing. The selection of doses in the SAD cohorts was chosen to provide daily plasma concentrations (area under the
curve or AUC) of PLN-74809 similar to steady state concentrations expected to be achieved in the corresponding MAD cohorts. The results of the continued SAD/MAD trial will guide dose selection in the 12-week Phase 2a IPF and PSC trials. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g21k52.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Design of Extended SAD/MAD Dose Escalation Trial </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We submitted an IND for <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in PSC in March 2020 and plan to initiate Part 1 of our third
Phase&nbsp;2a randomized, double-blind, placebo-controlled trial in PSC patients in the second half of 2020, when it is feasible to do so in light of the impact of the COVID-19 pandemic. We plan to utilize a similar approach to the previously
described IPF study for which we plan to enroll PSC patients, evaluating up to three doses of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or placebo. We plan to first enroll a 40 mg cohort, then submit a protocol amendment for FDA review to
add higher dose cohorts, subject to the results of Part 1 of the trial. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">122 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>12 Week Safety, PK, Biomarker Trial in PSC Patients </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g32m38.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">subject to FDA review </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Design of 12 week Phase 2a PSC trial </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The primary endpoints for our Phase&nbsp;2a PSC trial will be safety and tolerability, as well as PK. We will also employ exploratory
endpoints including fibrosis biomarkers including PRO-C3 and ELF, which are predictive of transplant-free survival in PSC patients, change in alkaline phosphatase, and liver imaging. Regulators have suggested that composite endpoints including
biomarkers such as a alkaline phosphatase, PRO-C3 and ELF coupled with liver histology may support approval in PSC. Gilead and Dr. Falk&#146;s are both including liver histology as a primary endpoint in their respective Phase&nbsp;3 PSC trials. NGM
Biopharmaceuticals, Inc., or NGM, showed dose-dependent changes in PRO-C3 and ELF at 12 weeks in its Phase&nbsp;2a PSC trial, with levels returning to baseline after treatment was removed. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g88s66.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NGM ELF and Pro-C3 Data Over 12 Weeks of Treatment in PSC </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">123 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Other Potential Development Plans for PLN-74809 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently exploring the potential effects of PLN-74809 in fibrotic diseases outside of IPF and PSC and may choose to explore the
development of PLN-74809 in additional indications in the future. For example, we believe PLN-74809 could provide anti-fibrotic benefits in several pulmonary and hepatic fibrosis diseases where there is over-expression of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB>, including pulmonary fibrosis associated with systemic sclerosis, pulmonary fibrosis
associated with rheumatoid arthritis, pulmonary fibrosis associated with other forms of interstitial lung disease, primary biliary cholangitis, or PBC, biliary atresia and progressive familial intrahepatic cholestasis, or PFIC. Additionally, we
believe that PLN-74809 could provide anti-fibrotic benefits in the setting of end stage renal disease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to pulmonary and liver
fibrosis, there is research supporting the potential activity of </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PLN-74809 in acute respiratory distress syndrome, or ARDS, a major cause of mortality
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">associated with COVID-19. Research has shown that <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB><FONT
STYLE="FONT-FAMILY:SYMBOL">&#098;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> expression is elevated in the lungs of COVID-19 patients leading to increased TGF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#098;</FONT> levels. Increased TGF-<FONT
STYLE="FONT-FAMILY:SYMBOL">&#098;</FONT> levels in ARDS lead to epithelial cell death, alveolar and vascular leak, increased immune cell infiltration, inhibition of sodium channel transport of fluid out of alveoli and fibroproliferation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By inhibiting <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB><FONT
STYLE="FONT-FAMILY:SYMBOL">&#098;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB>-mediated activation of TGF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#098;</FONT>, we believe that PLN-74809 may be able to reduce the likelihood of
progression from pneumonia to ARDS in the setting of COVID-19. We are currently evaluating the feasibility of initiating a clinical program testing PLN-74809 in COVID-19 patients. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">124 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Preclinical data in IPF </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="65%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-TOP:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8; padding-left:8pt" BGCOLOR="#4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #ffffff; padding-left:8pt; padding-right:2pt" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Summary Preclinical
Data in IPF</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt" BGCOLOR="#4b61a8">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #ffffff; BORDER-RIGHT:1px solid #4b61a8" BGCOLOR="#4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Preclinical Findings</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#4b61a8" STYLE=" BORDER-LEFT:1px solid #ffffff; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Observations</B></FONT></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-74809</FONT> reduced collagen gene expression in live human ILD lung tissue</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Greater than 50% decrease in expression of <I>COL1A1</I> <I></I>relative to DMSO vehicle control
seen in lung tissue from five IPF patients and one systemic sclerosis patient</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;An antibody to <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> did not significantly decrease expression</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt">pSMAD3 was correlated with extractable collagen levels in patients suspected of having IPF</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;pSMAD3 and extractable, or newly formed, collagen 1 were measured in biopsy samples from 18
patients and 5 controls.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;pSMAD3 and extractable collagen 1 were correlated with an r value of
0.7807 (p&lt;0.0001)</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> expression is elevated
in mouse bleomycin IPF models</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;In both acute and chronic bleomycin IPF mouse models, expression of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrins was higher in bleomycin exposed animals compared to healthy controls</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt">Dual <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> inhibition decreased
collagen more than <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> or <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> single inhibition in live human IPF lung tissue</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Dual inhibition of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> at 10x IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB> significantly decreased expression of <I>COL1A1</I> and other profibrotic genes relative to DMSO vehicle control</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Single inhibition of either <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> at 10x IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB> did not show significant decrease in<I> COL1A1</I> expression</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-74809</FONT> showed a dose dependent reduction in collagen fiber density in a mouse bleomycin IPF
model</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Three weeks of treatment with PLN-74809 utilizing second-harmonic generation resulted in a dose
dependent decrease in collagen fiber density</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Fibrous composite score was significantly reduced
in a dose dependent manner vs. vehicle control</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-74809</FONT> decreased <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in chronic bleomycin
mouse model</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;After two weeks of treatment with <FONT STYLE="white-space:nowrap">PLN-74809</FONT> levels of
pSMAD3 were significantly reduced compared to PBS vehicle control</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Post-treatment pSMAD3 levels
were similar to those of healthy controls</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt">Inhibition of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> blocked <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in the pulmonary cells of <FONT STYLE="white-space:nowrap">non-human</FONT> primates</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;After seven days of treatment with dual <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> inhibitor pSMAD2 levels were reduced by greater than 75% in pulmonary cells of <FONT STYLE="white-space:nowrap">non-human</FONT> primates</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;An <FONT STYLE="white-space:nowrap">anti-</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> antibody showed approximately 50% decrease</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Dual inhibition showed a clear PK/PD relationship with maximal pSMAD2 suppression was achieved and
maintained while drug concentrations were in the effective dose range (i.e., above the plasma protein adjusted IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB>, or p.a.
IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB>)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-74809</FONT> binds to all conformations of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> in biochemical assays</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">&#149;&#8195;&#8202;PLN-74809</FONT> binds both bent-closed and extended-open conformations of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-74809</FONT> reduced collagen gene expression in live human ILD lung
tissue </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In an assay using live lung tissue from five patients with IPF, application of
<FONT STYLE="white-space:nowrap">PLN-74809</FONT> for seven days led to significant decrease of &gt;50% in expression of <I>COL1A1</I>, a key gene responsible for collagen production. The degree of inhibition observed with <FONT
STYLE="white-space:nowrap">PLN-74809</FONT> approaching that of a complete blockade of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">125 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
using a direct inhibitor of its <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> type I receptor kinase, also known as ALK5. In contrast, an <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB><FONT STYLE="white-space:nowrap">-specific</FONT> monoclonal antibody, or mAb, that we synthesized based on publicly available
information regarding Biogen&#146;s antibody, 3G9, was unable to significantly inhibit <I>COL1A1</I> <I></I>expression. In the same assay, using live lung tissue from a patient with systemic sclerosis-associated pulmonary fibrosis, application of
PLN-74809 for seven days also led to a decrease of &gt;50% in expression of <I>COL1A1</I>. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g19w26.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Combined inhibition of </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> provided increased anti-fibrotic activity in live human fibrotic tissue as compared to DMSO vehicle control. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>pSMAD3 was correlated with extractable collagen levels in patients suspected of having IPF </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Open lung biopsies for histologic confirmation of IPF diagnosis were performed in 18 patients with interstitial lung disease, or ILD, who were
suspected of having IPF. As part of this analysis, five controls <FONT STYLE="white-space:nowrap">(non-transplanted</FONT> donor lungs) were also included. Multiple biopsies were taken from different lobes of each lung. Total pSMAD3 and extractable
collagen 1 were measured by western blot. Extractable collagen 1 is thought to be collagen that has been recently formed and has not been cross-linked to the extracellular matrix. Total pSMAD3 and extractable collagen were significantly correlated.
Higher pSMAD3 levels corresponded to higher levels of recently produced collagen. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g69b59.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>pSMAD3 levels are correlated with extractable collagen in lung biopsies from patients </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>suspected of having IPF </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">126 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I></I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and </I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> expression is elevated in mouse bleomycin IPF model </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We used the increased
expression of both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrins in human disease samples to select animal models with similar characteristics which we then employed for higher-throughput
and more extensive testing than would be feasible with primary human tissue. The bleomycin model is the most extensively used model of IPF due to its ability to reproduce many aspects of the disease. The pattern of expression of integrins suggests
that the bleomycin model can serve as a valid preclinical surrogate for evaluating the effects of integrin inhibition in IPF.<B> </B>We confirmed that both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrins are upregulated in a mouse model of pulmonary fibrosis induced by exposure to bleomycin. In both acute and chronic versions of this model, expression of
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrins were higher in bleomycin-exposed animals compared to healthy controls. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g90l67.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> expression in murine bleomycin model </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Dual
</I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and </I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> inhibition decreased collagen more than </I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> or </I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> single inhibition in live human IPF lung tissue </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To further understand the
anti-fibrotic effect of single vs. dual integrin inhibition, we performed assays on live human lung tissue explanted from IPF patients during transplant. We incubated the samples for seven days with either a single selective <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> small molecule inhibitor, a single selective
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> inhibitor (<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> mAb), or a dual selective
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB>/<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> inhibitor. Dual selective inhibition was accomplished with either <FONT STYLE="white-space:nowrap">PLN-74809</FONT> or a combination
of the small molecule <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> inhibitor and the
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> mAb. In this assay, we also compared against an inhibitor of the <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> receptor kinase ALK5, as a positive control. We measured effects on <FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> gene expression through the mRNA counts for <I>COL1A1</I>. The small molecule
inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> and the <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> mAb, each dosed at 10x their IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB>, failed to show a significant reduction in
<I>Col1a1</I> expression when administered individually. When the small molecule inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> and the <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> mAb were incubated
as a combination therapy, <I>COL1A1</I> expression was significantly reduced. PLN-74809 also showed a significant reduction in <I>COL1A1</I> expression. We also evaluated gene expression across a broad panel of additional pro-fibrotic genes. Similar
to <I></I><I>COL1A1</I>, dual inhibition resulted in a greater reduction in gene expression across the panel versus single inhibition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">127 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g29q85.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dual </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB>/</B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> inhibition blocked profibrotic gene</B><B><I> </I></B><B>expression more than single inhibition (</B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> or </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB>) in live human IPF lung tissue </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>PLN-74809 showed a dose-dependent reduction in
collagen fiber density in a mouse bleomycin IPF model </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We evaluated three doses of PLN-74809 in a mouse bleomycin IPF model utilizing
second-harmonic generation to evaluate the amount of new collagen formation ongoing post-treatment with PLN-74809. We evaluated a range of doses against vehicle control and saw a dose dependent reduction in collagen fiber density and fibrosis
composite score. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g78r97.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PLN-74809 resulted in a dose-dependent decrease in collagen fiber density in a mouse bleomycin IPF model
as measured through second-harmonic generation </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-74809</FONT> decreased <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in chronic bleomycin mouse model </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We confirmed through biochemical analyses
that anti-fibrotic efficacy of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> in the bleomycin model was due to blockade of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation. A key biochemical marker of
<FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation is the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">128 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
phosphorylation of SMAD2/3. In the bleomycin model, two weeks of treatment with <FONT STYLE="white-space:nowrap">PLN-74809</FONT> reduced pSMAD3 levels in a dose-dependent manner to those seen in
control mice that had not been exposed to bleomycin in the acute IPF model. In addition, levels of newly formed collagen, or <FONT STYLE="white-space:nowrap">neo-collagen,</FONT> and total lung collagen as measured by hydroxyproline content were
significantly reduced in a dose-dependent manner in the treatment group. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g03d54.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-74809</FONT> blocked
<FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in a chronic bleomycin model </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ability to measure <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation through SMAD phosphorylation also provided us with the opportunity to develop SMAD2/3 phosphorylation as a biomarker that correlates with <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrin inhibition. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Inhibition of
</I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and </I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> blocked <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation in the pulmonary cells of
<FONT STYLE="white-space:nowrap">non-human</FONT> primates </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We conducted a <FONT STYLE="white-space:nowrap">non-human</FONT> primate
study to validate pSMAD as a biomarker for <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation for future clinical studies. Given that this study will not be part of our regulatory package for our lead compound, <FONT
STYLE="white-space:nowrap">PLN-74809,</FONT> we used <FONT STYLE="white-space:nowrap">PLN-75068,</FONT> a close analog to <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> with a similar binding and PK profile for this particular study. In the
first stage of this study, we treated <FONT STYLE="white-space:nowrap">non-human</FONT> primates with <FONT STYLE="white-space:nowrap">PLN-75068</FONT> twice daily, or with the <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> mAb at 1&nbsp;mg/kg every other day for seven days. We performed BAL procedures on the monkeys
<FONT STYLE="white-space:nowrap">pre-</FONT> and post- treatment and measured pSMAD2 levels in the pulmonary macrophages. BAL fluid collected three hours after dosing showed a significant reduction of pSMAD2 levels when compared to <FONT
STYLE="white-space:nowrap">pre-treatment</FONT> levels. The <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> mAb showed pSMAD2
level reduction as well, but the effect was less pronounced than for <FONT STYLE="white-space:nowrap">PLN-75068.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">129 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g06j64.jpg" ALT="LOGO">
<B></B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BID Dosing of <FONT STYLE="white-space:nowrap">PLN-75068</FONT> reduced pSMAD2 levels in <FONT
STYLE="white-space:nowrap">non-human</FONT> primate alveolar fluid </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A second stage of this study was designed to evaluate the PK/PD
relationship between <FONT STYLE="white-space:nowrap">PLN-75068</FONT> and the inhibition of <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation. In this stage, we dosed monkeys at either a low or high dose once a day for seven days. We
designed the study to obtain multiple BAL measurements after the last treatment in order to understand how changes in the pSMAD2 levels relate to serum levels of <FONT STYLE="white-space:nowrap">PLN-75068.</FONT> Dosing of <FONT
STYLE="white-space:nowrap">PLN-75068</FONT> in <FONT STYLE="white-space:nowrap">non-human</FONT> primates showed a decrease in the pSMAD2 levels at both doses. Soon after dosing, when drug concentrations were at their peak, the levels of pSMAD2
levels showed a reduction of more than 75&nbsp;percent. As the drug concentration decreased, pSMAD2 levels gradually returned to baseline levels. Importantly, both dosing groups resulted in similar levels of pSMAD2 level reduction; however, the
higher dose stayed in the effective dose range longer, and therefore maintained pSMAD2 level reduction for a longer period. </P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g56w36.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QD dosing of <FONT STYLE="white-space:nowrap">PLN-75068</FONT> reduced pSMAD2 levels </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">130 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-74809</FONT> binds to all conformations of </I><FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and </I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> in biochemical assays </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Integrins are cellular adhesion proteins having a high degree of structural flexibility with two predominant forms: an extended form with high
affinity for binding to ligands, and a bent or closed form in which the ligand binding domain has low affinity for binding to ligands. The conformation of the integrin can also dramatically alter the binding of potential therapeutics such as
antibodies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Biochemical profiling of <FONT STYLE="white-space:nowrap">PLN-74809</FONT> confirms that it can inhibit both <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrins in both the high-affinity, extended open conformation as well as in the lower-affinity, bent closed conformation and thus
has the potential to block integrin interactions regardless of the initial state of the receptor. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g16d60.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-74809</FONT> binds to both high-affinity and low-affinity
conformations of </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> and
</B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Preclinical data in PSC </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="67%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3" BGCOLOR="#4b61a8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Summary Preclinical Data in PSC</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#4b61a8"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #ffffff" BGCOLOR="#4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Preclinical Findings</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#4b61a8" STYLE=" BORDER-LEFT:1px solid #ffffff">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Observations</B></FONT></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> are overexpressed in
human PSC liver tissue as well as a mouse model of PSC</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;We confirmed that the widely used <I>Mdr2</I> knockout PSC mouse model shows upregulation of
both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>, similar to our observations in diseased tissue from PSC patients</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-74809</FONT> showed a dose dependent reduction in fibrosis in a mouse PSC model</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Six weeks of treatment with <FONT STYLE="white-space:nowrap">PLN-74809</FONT> resulted in a
significant dose-dependent reduction in fibrosis compared to vehicle treated mice</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;pSMAD3
levels were also significantly reduced in a dose-dependent manner</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-74809</FONT> reduced cholestasis markers in PSC model</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;After six weeks of treatment with <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> at the
highest dose tested, we observed a significant reduction of alkaline phosphatase and total bilirubin</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt">PLN-74809 decreased <I>COL1A1</I> expression in live human PSC and PBC liver tissue samples more than OCA</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;After two days incubation with PLN-74809 we observed dose-dependent reductions in <I>COL1A1</I>
gene expression in live liver samples from a PSC patient and a PBC patient after transplant</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Incubation with OCA did not achieve the same level of reduction of <I>COL1A1</I> expression as
PLN-74809</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">131 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I></I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and </I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> are overexpressed in human PSC liver tissue as well as a mouse model of PSC </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similar to our approach in diseased tissue from an IPF patient, we examined the expression patterns of integrins in live, diseased tissue
obtained from a patient with PSC. We found that both <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrins are overexpressed in these tissues. We then went to the standard animal model
for PSC based on a deletion of the <I>Mdr2</I> gene in mice<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>and confirmed that in this model both
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> are overexpressed compared to normal control mice. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g729258g39k78.jpg" ALT="LOGO">
</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Both </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">6</SUB> and </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> are overexpressed in a </B><B><I>Mdr2</I></B><B> knockout model of PSC </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT
STYLE="white-space:nowrap">PLN-74809</FONT> showed a dose dependent reduction in fibrosis in a mouse PSC model </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
<I>Mdr2</I>-deficient mice that have developed biliary fibrosis resembling PSC, dosing with <FONT STYLE="white-space:nowrap">PLN-74809</FONT> for six weeks resulted in a significant, dose-dependent reduction in fibrosis compared to vehicle treated
mice. Similar results were observed whether the analyses were based on collagen levels as measured by hydroxyproline, pSMAD3 levels or histological staining. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">132 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g69y11.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-74809</FONT> showed reduction of fibrosis in the
</B><B><I>Mdr2</I></B><B> deficient PSC model </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="80%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g729258g37k41.jpg" ALT="LOGO">
</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-74809</FONT> showed improved histology score in the
</B><B><I>Mdr2</I></B><B> deficient PSC model </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-74809</FONT> reduced cholestasis liver
biomarkers in PSC model </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Treatment of <I>Mdr2</I>-deficient mice with <FONT STYLE="white-space:nowrap">PLN-74809</FONT> also reduced in
a dose-dependent manner serum levels of alkaline phosphatase and total bilirubin compared to vehicle controls. Both are markers of cholestasis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">133 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g87v56.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-74809</FONT> reduced cholestasis markers in PSC model </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>PLN-74809 decreased COL1A1 expression in live human PSC and PBC liver tissue samples more than OCA </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We assessed the anti-fibrotic activity of our integrin inhibitors using liver samples obtained from a PSC patient and a PBC patient. We used <FONT
STYLE="white-space:nowrap">precision-cut</FONT> tissue slices to establish <I>ex vivo</I> tissue culture samples that mimic the multicellular characteristics of organs. The use of these <FONT STYLE="white-space:nowrap">precision-cut</FONT> tissue
culture assays not only provides the opportunity to assess the effects of our compounds directly on diseased human tissue, but also allows this to be done in a three-dimensional, multicellular context that better represents the complexity of the
diseased tissue environment. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g50q98.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Assessing anti-fibrotic activity of compounds in live human liver fibrosis tissue </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">134 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Live tissue samples from a PSC patient and a PBC patient were incubated for two days with
varying concentrations of PLN-74809 and obeticholic acid, or OCA, a drug approved for the treatment of PBC. Incubation with PLN-74809 led to a significant dose-dependent decrease of <I>COL1A1 </I>expression, while incubation with OCA did not. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g79j79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-74809</FONT> blocked fibrosis in live human PSC and PBC liver tissue
</B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">PLN-1474</FONT> and NASH </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> is a selective inhibitor of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrin that we are developing for the treatment of stage F3/F4 liver fibrosis in patients with NASH. <FONT
STYLE="white-space:nowrap">PLN-1474</FONT> is a bioavailable inhibitor that has shown anti-fibrotic activity in multiple animal models of liver fibrosis as well as in live human NASH fibrotic liver tissue. In October 2019, we entered into a license
and collaboration agreement with Novartis under which Novartis received global rights to develop and commercialize PLN-1474 for NASH associated liver fibrosis. Despite delays resulting from the COVID-19 pandemic, we are currently conducting a Phase
1 trial of PLN-1474 in healthy volunteers and expect data by the end of 2020. Novartis will reimburse us for all development activities associated with the Phase 1 trials, and will be responsible for all development and commercialization following
Phase 1. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Background on liver fibrosis and NASH </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NASH is a severe form of NAFLD that is associated with the development of liver fibrosis and potentially life-threatening liver dysfunction.
NAFLD is characterized by increased amounts of fat in the liver, or steatosis. NAFLD is believed to occur due to a combination of factors including high caloric diet, obesity and metabolic syndrome, type 2 diabetes mellitus and genetics. Early
stages of the disease often have no symptoms other than slightly elevated or fluctuating levels of liver enzymes in some patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As
excess fat builds up in the liver, it can eventually cause lipotoxicity, resulting in inflammation in the liver and leading to injury of hepatocytes, known as ballooning. It is this combination of steatosis, inflammation and hepatocellular
ballooning that defines NASH. Over time, NASH can lead to fibrosis of the liver. Fibrosis can progress to cirrhosis, resulting in impaired liver function and increased risk of liver-related complications and mortality. In fact, liver fibrosis is an
independent predictor of liver-related morbidity and <FONT STYLE="white-space:nowrap">all-cause</FONT> mortality in NASH. There are currently no FDA approved therapies for NASH, and to date investigational NASH therapies have only shown modest
anti-fibrotic benefits in published clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is estimated that 30 to 40&nbsp;percent of adults in the United States have NAFLD
and approximately 30&nbsp;percent of these patients, or up to 12&nbsp;percent of adults, will develop NASH. NASH is already highly prevalent, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">135 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
affecting approximately 16.5&nbsp;million adults in the United States with approximately 3.3&nbsp;million at stage F3/F4 liver fibrosis. NASH is a growing problem with U.S. cases expected to top
27&nbsp;million by 2030, with approximately eight million at stage F3/F4 liver fibrosis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While NASH is becoming more common in the
general population, identifying patients with increased risk of liver-related morbidity and mortality is important for clinical management. While steatosis, inflammation and hepatocellular ballooning are the measures used to diagnose NASH, to date,
the presence and severity of liver fibrosis is the only proven independent predictor of poor clinical outcomes in NASH. Cirrhosis associated with NASH is the fastest growing indication for liver transplantation in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approximately 10 to 15&nbsp;percent of NASH patients will ultimately progress to cirrhosis over time. On average, these patients advance one
fibrosis stage every seven years. NASH patients, regardless of stage of fibrosis, have an estimated annual mortality rate of 1.5 to 3.5&nbsp;percent per year, mostly due to cardiovascular complications. However, when patients progress to stage F2
fibrosis or greater, liver-related complications become the highest risk for mortality. Each progressive stage of fibrosis correlates to a dramatic increase in liver-related mortality risk. Moreover, patients with F3 and F4 fibrosis carry
liver-related mortality risk that is 17 times and 42 times greater, respectively, than NASH patients without fibrosis. We believe treatments with a potent anti-fibrotic effect would be more likely to have a meaningful impact on clinical outcomes for
NASH patients with F3 to F4 fibrosis. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g38a86.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Stages of liver fibrosis </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are currently no FDA approved therapies for the treatment of NAFLD or NASH. Lifestyle changes and exercise to reduce body weight and
treatment of concomitant diabetes and dyslipidemia comprise the cornerstone of treatment but are not sustainable in the majority of patients. For patients with cirrhosis, liver transplantation is the only potential treatment option, but transplant
livers are not widely available, and only a minority of these patients will be eligible for a transplant due to the risks, costs and complexities associated with the procedure. NASH is the second leading indication for liver transplantation in the
United States, but is also the most rapidly growing indication and is expected to eventually overtake alcoholic liver disease as the largest driver of liver transplant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">136 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are many candidates in development for the treatment of NASH that target various
aspects of the disease. A number of these candidates are directed at reducing the underlying causes of the disease such as obesity and diabetes or addressing fat accumulation in the liver by altering lipid metabolism. Other candidates are focused on
suppressing the inflammatory stage of NASH with the intent of preventing the progression of fibrosis. To date, only modest improvements in liver fibrosis stage or severity have been reported with investigational compounds evaluated in patients with
NASH. Our approach is to directly target the fibrosis pathway with the goal of preventing progression or reversing advanced fibrosis (F3/F4). Given <FONT STYLE="white-space:nowrap">TGF-</FONT> &szlig;&#146;s central role to fibrosis pathophysiology,
we believe that directly targeting the <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation pathway via <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> integrin inhibition holds the potential to provide a more clinically meaningful anti-fibrotic effect than current investigational therapies, and ultimately prevent disease progression to cirrhosis
and liver related complications. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our solution, <FONT STYLE="white-space:nowrap">PLN-1474</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> is a bioavailable, small-molecule, selective inhibitor of
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> mediated <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation. We are
developing <FONT STYLE="white-space:nowrap">PLN-1474</FONT> as an anti-fibrotic therapy for patients with F3/F4 stage liver fibrosis associated with NASH. We have shown that in human fibrotic liver tissue from patients with NASH that the levels of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> are significantly elevated in tissue from patients with stage 4 fibrotic disease.
Overexpression of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> is correlated with
<FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation as measured by pSMAD3 levels. Therefore, we believe a single-selective inhibitor of
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> is a promising and differentiated approach to treating NASH associated liver
fibrosis. In October of 2019, we entered into a license and collaboration agreement with Novartis through which Novartis obtained a global license to PLN-1474. Despite delays resulting from the COVID-19 pandemic, we are currently conducting a Phase
1 trial with PLN-1474 in healthy volunteers and expect data by the end of 2020. Novartis will reimburse us for all development activities associated with the Phase 1 trials, and will be responsible for all development and commercialization following
Phase&nbsp;1. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">137 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Preclinical data </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="67%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3" BGCOLOR="#4b61a8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #ffffff" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Summary of Preclinical Data in NASH</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#4b61a8"></TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #ffffff" BGCOLOR="#4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Preclinical Findings</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#4b61a8" STYLE=" BORDER-LEFT:1px solid #ffffff">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" BGCOLOR="#4b61a8"><FONT COLOR="#FFFFFF"><B>Observations</B></FONT></TD></TR>


<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> and <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation are upregulated in human F4 NASH liver biopsies</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Levels of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> and pSMAD3 levels are both significantly elevated in tissues from patients with stage F4 liver fibrosis</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Levels of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> and pSMAD3 levels are highly correlated in NASH liver biopsies</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> is associated with anti-fibrotic activity in live human fibrotic NASH liver tissue</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;After two days incubation with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> we observed a
significant reduction in <I>COL1A1</I> gene expression in live liver samples from three NASH patients after transplant</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Gene expression of <I>TIMP1</I>, a strong predictor of mortality in patients with fibrosis, was
also reduced after incubation</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> resulted in a broad decrease in expression of
<FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> genes in an abbreviated mouse model of NASH</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;In an abbreviated <FONT STYLE="white-space:nowrap">CDA-HFD</FONT> mouse NASH model, after 3
weeks of treatment, mice treated with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> showed decreased expression of a broad set of profibrotic genes relative to vehicle controls</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> showed dose-dependent reduction of fibrosis in NASH and liver fibrosis mouse models</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Six weeks of treatment with <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> resulted in a
significant dose-dependent decrease in expression of <I>Col1a1</I> and <I>Col1a2</I> as well as hydroxyproline in a <FONT STYLE="white-space:nowrap">CDA-HFD</FONT> NASH mouse model</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;After one week of treatment with <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> we observed
significant dose-dependent reductions in <I>Col1a1</I>, <I>Col1a2</I> and <I>Col3a1</I> in a CCL<SUB STYLE="font-size:85%; vertical-align:bottom">4</SUB> liver fibrosis mouse model</P></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#dbdfed">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR BGCOLOR="#dbdfed" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> decreased collagen fiber density and characteristics via 2nd harmonic generation analysis in a
NASH fibrosis model</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Six weeks of treatment with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> utilizing 2<SUP
STYLE="font-size:85%; vertical-align:top">nd</SUP> harmonic generation, resulted in a dose-dependent decrease in collagen fiber density and fibrosis composite score in a <FONT STYLE="white-space:nowrap">CDA-HFD</FONT> NASH mouse model</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" STYLE="BORDER-LEFT:1px solid #4b61a8; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-RIGHT:1px solid #4b61a8">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-left:8pt"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> potently binds to all conformations of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #4b61a8; BORDER-BOTTOM:1px solid #4b61a8; padding-right:2pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">&#149;&#8195;&#8202;PLN-1474</FONT> binds both bent-closed and extended-open conformations of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB></P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> and TGF-</I>&szlig;<I> activation are upregulated in human F4 NASH liver biopsies</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We measured <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> protein expression and pSMAD3 levels in a group of late-stage liver fibrosis biopsies. In F4 biopsies, <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> was significantly overexpressed relative to F0/F1 biopsies. Similarly, the pSMAD3 levels were also significantly elevated in F4
biopsies compared to F0/F1. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">138 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g01c33.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> and pSMAD3 levels are both upregulated in F4 liver fibrosis </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-1474</FONT> is associated with anti-fibrotic activity in live human fibrotic NASH liver tissue
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We assessed the anti-fibrotic activity of <FONT STYLE="white-space:nowrap">PLN-1474</FONT> in live human NASH liver tissue. Precision
cut tissue slices from multiple F4 NASH livers treated with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> exhibited a mean 50&nbsp;percent reduction in the levels of <I>COL1A1</I> expression compared to vehicle treated controls. In the <FONT
STYLE="white-space:nowrap">PLN-1474</FONT> treated tissue slices, we also saw a significant reduction in the gene expression of <I>TIMP1</I>, which encodes the tissue inhibitor of metallopeptidase, or TIMP-1. In a recent study, <FONT
STYLE="white-space:nowrap">TIMP-1</FONT> was shown to be a strong predictor of <FONT STYLE="white-space:nowrap">all-cause</FONT> mortality in patients with fibrosis. <FONT STYLE="white-space:nowrap">TIMP-1</FONT> is one of the three components of
the Enhanced Liver Fibrosis, or ELF, score, a <FONT STYLE="white-space:nowrap">non-invasive</FONT> clinical diagnostic test to assess the likelihood of having clinically significant fibrosis. These results suggest that selective inhibition of <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> could have clinically meaningful anti-fibrotic activity in NASH patients with advanced
fibrosis. </P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g02m36.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-1474</FONT> significantly reduced </B><B><I>COL1A1</I></B><B> and
</B><B><I>TIMP1</I></B><B> gene expression in human NASH liver tissue </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-1474</FONT> resulted in
a decrease in expression levels of a broad panel of <FONT STYLE="white-space:nowrap">pro-fibrotic</FONT> genes in an abbreviated mouse model of NASH </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mice were treated prophylactically with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> for 3 weeks in an abbreviated <FONT
STYLE="white-space:nowrap">CDA-HFD</FONT> mouse NASH fibrosis model. A broad panel of profibrotic genes showed decreased expression in mice treated with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> relative to mice that were treated with a
vehicle control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">139 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Profibrotic Gene Expression After Treatment with PLN-1474 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g03w96.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Treatment with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> resulted in decreased expression of a
broad set of profibrotic genes in a <FONT STYLE="white-space:nowrap">CDA-HFD</FONT> mouse NASH liver fibrosis model </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT
STYLE="white-space:nowrap">PLN-1474</FONT> showed dose-dependent reduction of fibrosis in NASH and liver fibrosis mouse models </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
tested the ability of <FONT STYLE="white-space:nowrap">PLN-1474</FONT> to inhibit fibrosis in a mouse model of NASH induced by a choline-deficient high fat diet. Treatment of these mice for six weeks, beginning at week five of the high fat diet,
resulted in a dose-dependent reduction in collagen production as measured by hydroxyproline levels compared to vehicle-treated controls. Similar dose-dependent decreases in the expression of <I>Col1a1</I> genes and picrosirius red staining, a
histologic marker for fibrosis, were observed after treatment with <FONT STYLE="white-space:nowrap">PLN-1474.</FONT> Treatment with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> also led to decreases in pSMAD3 levels indicating that <FONT
STYLE="white-space:nowrap">PLN-1474</FONT> was able to block <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> activation. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g43h10.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">140 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-1474</FONT> inhibits fibrosis in NASH fibrosis model
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">PLN-1474</FONT> also inhibited fibrosis in an acute CCl<SUB
STYLE="font-size:85%; vertical-align:bottom">4</SUB> model of liver fibrosis. In this model, liver fibrosis in mice is induced by two weeks of exposure to CCl<SUB STYLE="font-size:85%; vertical-align:bottom">4.</SUB> Treatment with <FONT
STYLE="white-space:nowrap">PLN-1474</FONT> for one week reduced the expression of <I>Col1a1</I>, C<I>ol1a2</I> and <I>Col3a1</I> compared to vehicle-treated controls. Treatment with <FONT STYLE="white-space:nowrap">PLN-1474</FONT> also reduced <FONT
STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling to baseline levels as measured by pSMAD3 levels. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the chronic version of the
CCL<SUB STYLE="font-size:85%; vertical-align:bottom">4</SUB> model, fibrosis is induced by 21 days of exposure to CCl<SUB STYLE="font-size:85%; vertical-align:bottom">4</SUB>. Treatment of these mice with
<FONT STYLE="white-space:nowrap">PLN-1474</FONT> resulted in significant reductions in the expression of collagen genes beginning as soon as two hours after dosing. These results suggest that <FONT STYLE="white-space:nowrap">PLN-1474</FONT> has the
potential to lead to significant and rapid changes in fibrosis even in livers containing extensive and established fibrotic lesions. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g38b11.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-1474</FONT> inhibited collagen expression in a chronic CCl<SUB
STYLE="font-size:85%; vertical-align:bottom">4</SUB> liver fibrosis model </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">141 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-1474</FONT> decreased collagen fiber density and
characteristics via second-harmonic generation analysis in a NASH fibrosis model </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We evaluated three doses of <FONT
STYLE="white-space:nowrap">PLN-1474</FONT> in a NASH fibrosis mouse model utilizing second-harmonic generation to evaluate the amount of new collagen formation ongoing post-treatment with <FONT STYLE="white-space:nowrap">PLN-1474.</FONT> We
evaluated a range of doses against placebo in a NASH fibrosis model and saw a dose-dependent reduction in collagen fiber density and fibrosis composite score. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g95m24.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">PLN-1474</FONT> resulted in a dose-dependent decrease in collagen fiber
density in a NASH fibrosis model as measured through second-harmonic generation </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">PLN-1474</FONT>
potently binds to all conformations of </I><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><I></I><I><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similar to our observations with <FONT STYLE="white-space:nowrap">PLN-74809,</FONT> we have shown that
<FONT STYLE="white-space:nowrap">PLN-1474</FONT> binds to both the higher-affinity, extended open conformation of integrin <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB> as well as the lower-affinity, bent closed conformation and thus has the potential to block integrin interactions regardless of the state of the receptor. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Planned clinical development of <FONT STYLE="white-space:nowrap">PLN-1474</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are planning to enroll a Phase 1 trial of PLN-1474 in healthy volunteers and expect data by the end of 2020, subject to the impact of the
COVID-19 pandemic. This trial will evaluate safety and tolerability as well as PK of PLN-1474. Once the Phase 1 trial is complete, Novartis will take over the program and be responsible for further development of PLN-1474 in NASH associated liver
fibrosis. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Applying our fibrosis expertise in developing additional products </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are pursuing potential uses of our existing product candidates, <FONT STYLE="white-space:nowrap">PLN-74809</FONT> and <FONT
STYLE="white-space:nowrap">PLN-1474,</FONT> in additional fibrotic indications. We use our precision cut human fibrotic tissue assays in addition to our animal model data to inform our clinical development programs and potentially select additional
indications where we think our pipeline candidates could have an effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our mission is to advance the understanding of fibrosis by
building a biology-, chemistry- and screening-based engine to drive drug development across the spectrum of fibrotic diseases. While our initial focus is on small-molecule integrin inhibitors in lung and liver fibrosis, we are actively pursuing
additional treatment modalities across fibrosis indications in multiple different organs. We have identified other potential <FONT STYLE="white-space:nowrap">non-integrin</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">142 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
targets related to <FONT STYLE="white-space:nowrap">TGF-&szlig;</FONT> signaling as well as other pathways across multiple fibrosis indications, such as regulators of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">epithelial-to-mesenchymal</FONT></FONT> transition, a critical process in fibrosis. In addition, while our initial focus is on small-molecule drug candidates, we are agnostic to treatment
modalities in the development of our pipeline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Our oncology program-TGF-&szlig; signaling in the tumor microenvironment
</I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Over the past several years, the checkpoint inhibitor class of immuno-oncology drugs has changed the way many cancers are treated.
Checkpoint inhibitors work to block signals that prevent the body&#146;s immune system from recognizing tumor cells. By blocking checkpoint signals such as PD-1, these drugs have the ability to sensitize T-cells, allowing them to recognize and kill
tumor cells. While checkpoint inhibitors have led to dramatic improvements in survival rates for certain cancer indications, there are still a significant proportion of patients who do not respond to the drugs. Much effort is being devoted to
understanding the root causes of checkpoint inhibitor resistance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As TGF-&szlig; biology has been elucidated, it has become increasingly
understood in the scientific literature that TGF-&szlig; plays an important anti-inflammatory role in the tumor microenvironment. One of TGF-&szlig;&#146;s core physiologic roles is an anti-inflammatory effect that it provides in the wound healing
process. In the tumor microenvironment, however, certain integrins, such as <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">8</SUB>, can
be overexpressed on multiple different cell types, resulting in increased activation and signaling of TGF-&szlig;. This over activation of TGF-&szlig; can lead to a strong anti-inflammatory effect in the tumor microenvironment, resulting in
decreased T-cell infiltration and decreased release of pro-inflammatory cytokines such as granzyme B and interferon <FONT STYLE="FONT-FAMILY:SYMBOL">&#103;</FONT>. This mechanism is becoming increasingly recognized as a potential cause of the
resistance to checkpoint inhibitors such as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-PD-1</FONT></FONT> therapies seen in many tumors. We are targeting TGF-&szlig; activating integrins such as <FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">8</SUB> that are upregulated in certain tumors with the goal of removing the anti-inflammatory
effect and, ultimately, sensitizing tumors to checkpoint inhibitors. This program has generated positive data in preclinical tumor models and our candidate is currently undergoing IND-enabling studies. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g74z56.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Integrin Upregulation in the Tumor Microenvironment </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are developing small molecule inhibitors against <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">8</SUB> as well as other TGF-&szlig;-activating integrins that have been shown to be upregulated in the tumor microenvironment. We have
shown in an EMT6 anti-PD-1 resistant tumor mouse model that our small molecule inhibitors of <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB
STYLE="font-size:85%; vertical-align:bottom">8</SUB>-mediated TGF-&szlig; activation are able to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">143 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sensitize tumors to anti-PD-1 therapy and extend survival. Additionally, our molecules perform similarly to monoclonal antibodies against the <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">8</SUB> integrin receptor. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g16k85.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Small Molecule </B><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><B></B><B><SUB
STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">8</SUB> Inhibitors Enhanced PD-1 Activity in an EMT6 Anti-PD-1 Resistant Mouse Tumor Model </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently in lead-optimization stage of our oncology program developing small molecule inhibitors of
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">8</SUB> targeting multiple potential PD-1 resistant tumor types. We have identified
multiple potent and selective molecules and plan to nominate a developmental candidate in 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I></I><B><I>Our</I></B><I></I><B><I>
Muscular Dystrophy Program</I></B><I> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Muscular Dystrophy comprises a group of inherited diseases, all characterized by inborn errors
in dystrophin, a protein that anchors muscle cells to the extracellular matrix, or ECM, and facilitates contraction of skeletal muscles. Mutations in the gene that codes for dystrophin can cause the dystrophin protein to be misshapen and ineffective
in anchoring the muscle cell to the extracellular matrix. The lack of dystrophin anchoring results in damage to skeletal muscle cells upon contraction. Over time, muscle cells are unable to regenerate, and are eventually replaced by fat and
fibrosis, resulting in loss of muscle function. Severe forms of muscular dystrophy cause progressive weakening of the heart and diaphragm, leading to death. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The most common form of muscular dystrophy is Duchenne muscular dystrophy, or DMD, which affects 1 in 3,500 boys worldwide. Disease
progression varies, usually presenting with muscle weakness around age four. Most DMD patients need a wheelchair by age 12, with most dying in their 20&#146;s. DMD is caused by mutations to the DMD gene, which codes for dystrophin. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Treatment for DMD is mostly focused on mitigating the symptoms. Aggressive management of dilated cardiomyopathy with anti-congestive
medications is used, including cardiac transplantation in severe cases. Assistive devices for respiratory complications may be needed, especially at night. The steroid prednisone is given to improve the strength and function of individuals with DMD.
Prednisone has been shown to prolong the ability to walk by 2 to 5 years. While a new treatment, etiplirsen, was recently approved in a subset of patients, this remains an area of tremendous unmet medical need. There are a number of novel modalities
such as gene therapy and CRISPR being explored as potential treatments for DMD, but they remain years from approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have identified a
target integrin receptor that acts as a natural compensatory mechanism that anchors the muscle cell to the ECM in DMD, as well as other types of muscular dystrophy. It is expressed on the surface of skeletal muscle cells and has been shown to be
upregulated in patients with muscular dystrophy. The target integrin is able to bind to laminin in the ECM and serve as a substitute for the dystrophin complex that normally holds muscle cells to the ECM. This compensatory mechanism serves to
stabilize the muscle cell membrane, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">144 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
which decreases muscle damage upon contraction. Moreover, mutations in this integrin, or in the laminin protein that it binds to, have been reported, and result in congenital myopathies with
phenotypes similar to those of muscular dystrophy. Like other integrins, our integrin target can exist in various conformations, some of which are active, and others that are not. The natural compensatory ability of the target is limited by the
number of integrin receptors in the active conformation at any given time. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g10f17.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our muscular dystrophy program utilizes an allosteric, agonistic, monoclonal antibody which binds to the
alpha subunit of the target integrin and stabilizes it in its active conformation. By maximizing the number of target integrins that are active, the mAb is designed to increase the overall binding of the muscle cell membrane to the ECM and to
stabilize the membrane. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g21y89.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Allosteric agonistic monoclonal antibody binds to the inactive integrin inducing conformational change
increasing laminin binding </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have developed a humanized antibody that is highly potent and selective for the alpha subunit of the
target integrin. Our mAb candidate has been tested in an mdx /DBA2 DMD mouse model where it showed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">145 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
significantly decreased muscle damage as measured through clinical biomarkers including serum creatinine kinase and troponin. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g95c69.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Treatment with mAb resulted in decreased muscle damage in a mdx/DBA2 mouse model </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to protecting against muscle damage, the antibody showed an increase in diaphragm contractility in the mice tested. The antibody
was able to return diaphragm contractility to near the same level as the wild type controls. This is crucial, given that the primary cause of death in patients with muscular dystrophy is cardiopulmonary failure resulting from progressive wasting of
cardiac and respiratory muscles. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g65k14.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Agonistic mAb restored diaphragm force back to the same level as wild type control </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The antibody protected the gastrocnemius muscle from eccentric injury in which the muscle loses contractile force over a series of
contractions. Interestingly, mice treated with an antibody that blocks the integrin receptor showed an increase in eccentric injury. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">146 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g45l24.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Integrin Agonistic Antibody Protected Gastrocnemius Muscle from Eccentric Injury While Antagonistic
Antibody Increased Injury </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Lastly, our mAb showed a reduction in hydroxyproline levels in the gastrocnemius muscles of the test mice,
suggesting less fibrosis in the muscles, possibly as a result of decreased muscle damage. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g61n50.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Agonistic mAb significantly reduced collagen content in gastrocnemius muscles of treated mice </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have nominated a development candidate and are currently conducting CMC scale-up activities. We plan to initiate IND enabling studies in
2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The biotechnology
and biopharmaceutical industries are characterized by rapidly advancing technologies, strong competition and an emphasis on proprietary products. While we believe that our technology, knowledge, experience and scientific personnel provide us with
competitive advantages, we face substantial competition from many different sources, including larger pharmaceutical companies with greater resources. Smaller specialty biotechnology and biopharmaceutical companies, academic research institutions,
governmental agencies, as well as public and private institutions are also potential sources of competitive products and technologies, including through collaborative arrangements with large and established biopharmaceutical
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">147 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
companies. We also face competition in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and enrolling patients for clinical trials, and
acquiring technologies complementary to, or necessary for, our programs. We believe that the key competitive factors affecting the success of any of our product candidates will include efficacy, safety profile, convenience, method of administration,
cost, level of promotional activity and intellectual property protection. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are a number of large biopharmaceutical and biotechnology
companies that are currently pursuing the development of products for the treatment of fibrosis. Companies that we are aware of that are targeting the treatment of various fibrosis indications through inhibiting various parts of the TGF-&szlig;
pathway include large companies with significant financial resources such as Biogen, Inc., AbbVie Inc., Gilead Sciences, Inc., Indalo Therapeutics, Inc., FibroGen, Inc., Galapagos NV, Bristol Myers Squibb Co., and Novartis AG. However, we know of no
other companies currently in clinical development with an orally bioavailable small-molecule, selective integrin inhibitor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although our
novel approach is unique from most other existing or investigational therapies across the disease areas where we are focusing our development, we will need to compete with currently approved therapies, and potentially those in currently in
development if they are approved. We are aware of several marketed and investigational products in our leading disease areas, including but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>IPF:&nbsp;</I>There are currently two approved products for the treatment of IPF; Esbriet, marketed by Roche
Holding AG, and Ofev, marketed by Boehringer Ingelheim GmbH.&nbsp;Companies currently developing product candidates in IPF include AbbVie, Galapagos, Indalo, Kadmon Holdings, Inc., Galecto Biotech, Inc., Roche Holding AG and Liminal BioSciences.
Inc. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>PSC</I>:<I>&nbsp;</I>There are currently no approved therapies for the treatment of PSC.&nbsp;Companies
currently developing product candidates in PSC include Gilead, Allergan plc, Dr. Falk Pharma and Intercept Pharmaceuticals, Inc.. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>NASH:&nbsp;</I>There are currently no FDA approved therapies for the treatment of NASH.&nbsp;There are a
number of companies developing product candidates for the treatment of NASH including Intercept, Pfizer Inc., Gilead, Allergan, Novartis, AstraZeneca plc, Eli Lilly &amp; Company, GlaxoSmithKline plc, Amgen, Inc., BMS, Johnson &amp; Johnson, Merck
&amp; Co., Inc., Roche, Sanofi S.A., Takeda Pharmaceuticals, Novo Nordisk, Genfit SA, Madrigal Pharmaceuticals, Inc., Viking Therapeutics, Inc., Cirius Therapeutics, Inc., NGM Biopharmaceuticals, Akero Therapeutics, Inc. and Metacrine,
Inc..&nbsp;Most of the drugs currently in development for NASH are focused on decreasing liver fat or improving liver inflammation as opposed to direct liver anti-fibrotic approaches. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The availability of reimbursement from government and other third-party payors will also significantly affect the pricing and competitiveness
of our product candidates, if approved for marketing. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we do, which could result in our competitors establishing a strong market position before we
are able to enter the market. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Overview </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We strive
to protect and enhance the proprietary technology, inventions, and improvements that are commercially important to the development of our business, including seeking, maintaining, and defending patent rights, whether developed internally or licensed
from third parties. We also rely on trade secrets relating to our proprietary technology platform and on <FONT STYLE="white-space:nowrap">know-how,</FONT> continuing technological innovation and <FONT STYLE="white-space:nowrap">in-licensing</FONT>
opportunities to develop, strengthen, and maintain our proprietary position in the field of fibrosis that may be important for the development of our business. We additionally may rely on regulatory protection afforded through data exclusivity,
market exclusivity, and patent term extensions, where available. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">148 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our commercial success may depend in part on our ability to: obtain and maintain patent and
other proprietary protection for commercially important technology, inventions and <FONT STYLE="white-space:nowrap">know-how</FONT> related to our business; defend and enforce our patents; preserve the confidentiality of our trade secrets; and
operate without infringing the valid enforceable patents and proprietary rights of third parties. Our ability to stop third parties from making, using, selling, offering to sell, or importing our products may depend on the extent to which we have
rights under valid and enforceable licenses, patents, or trade secrets that cover these activities. In some cases, enforcement of these rights may depend on third party licensors. With respect to both licensed and company-owned intellectual
property, we cannot be sure that patents will be granted with respect to any of our pending patent applications or with respect to any patent applications filed by us in the future, nor can we be sure that any of our existing patents or any patents
that may be granted to us in the future will be commercially useful in protecting our commercial products and methods of manufacturing the same. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of May 1, 2020, we own or license over 30 pending patent applications, worldwide, including in the United States and corresponding foreign
patent applications. At least four pending patent applications have been filed in the United States or corresponding foreign jurisdictions by or on behalf of the Regents of the University of California, which have granted us exclusive license rights
to the technology. To date, two patents have issued to us or to our licensors. Our policy is to file patent applications to protect technology, inventions and improvements to inventions that are commercially important to the development of our
business. We seek United States and foreign patent protection for a variety of technologies, including: research compounds and methods, candidate compounds and antibodies for modulating the activity of integrins, methods for treating diseases of
interest, and methods for manufacturing our products. We also intend to seek patent protection or rely upon trade secret rights to protect other technologies that may be used to discover and validate targets and that may be used to identify and
develop novel products. We seek protection, in part, through confidentiality and proprietary information agreements. We are a party to various other license agreements that give us rights to use specific technologies in our research and development.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Company Owned IP </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We own multiple families of patent applications that are directed to small-molecule compositions capable of modulating integrins and methods
for treating or preventing diseases associated with integrins. Certain applications in these families relate to our <FONT STYLE="white-space:nowrap">PLN-1474</FONT> and <FONT STYLE="white-space:nowrap">PLN-74809</FONT> small-molecule product
candidates, backup compounds and structural analogs, various unit dosages, dosing regimens, and routes of administration. We are also pursuing innovative ways to modulate integrin function using antibodies, and have one pending patent application to
that technology in the United States. Patents that may issue from these company owned applications are generally expected to expire between the years 2037 to 2040, subject to possible patent term adjustment and/or extension. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Licensed IP </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
have obtained an exclusive license from the Regents of the University of California to two patent families, which are expected to expire in 2034 and 2036, respectively. Included in these families are two issued U.S. patents with claims directed to
small-molecule integrin inhibitors and methods of using such inhibitors for treating fibrotic and other diseases, as well as related patent applications that are pending in Canada and Europe. The molecules currently being developed by us as product
candidates are not within the scope of the agreement with the Regents of the University of California. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Trademark Protection
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have two registered U.S. trademarks for use in connection with our products. We may pursue additional registrations for future
products in markets of interest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">149 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Trade Secret Protection </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Finally, we may rely, in some circumstances, on trade secrets to protect our technology. We seek to protect our proprietary technology and
processes, in part, by entering into confidentiality agreements with our employees, consultants, scientific advisors, and contractors. We also seek to preserve the integrity and confidentiality of our data and trade secrets by maintaining physical
security of our premises and physical and electronic security of our information technology systems. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the above, we have
established expertise and development capabilities focused in the areas of preclinical research and development, manufacturing and manufacturing process development, quality control, quality assurance, regulatory affairs, and clinical trial design
and implementation. We believe that our focus and expertise will help us develop products based on our proprietary intellectual property. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>License
Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Novartis Collaboration and License Agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2019, we entered into a collaboration and license agreement, or the Novartis Agreement, with Novartis Institutes for Biomedical
Research, Inc., or Novartis, for the research, development and commercialization of PLN-1474, and up to three additional integrin targets, or the Research Targets. Under the terms of the Novartis Agreement, we will be responsible for the clinical
development and manufacture of PLN-1474 through the first-in-human study and Novartis will then be responsible for all future development, manufacturing and commercialization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the research term, which shall initially be three years and extendable, we will collaborate, through a joint steering committee, with
Novartis on up to three separate research programs, to biologically validate certain potential Research Targets and identify and synthesize potential research compounds for each Research Target in accordance with the applicable research plan. We
will be responsible for advancing product candidates targeting selected Research Targets to development candidate stage and Novartis will then be responsible for all future development, manufacturing and commercialization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have also granted to Novartis an (i) exclusive (even as to us), transferable, sublicensable license to certain of our technology to
commercialize licensed products in the field and (ii) co-exclusive (with us), transferable, sublicensable license to research, develop and manufacture certain licensed compounds and licensed products for disease treatment worldwide. Upon the
completion of the first Phase 1 study, such co-exclusive license shall become exclusive for Novartis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, pursuant to the
Novartis Agreement, we have granted to Novartis and its affiliates an (i)&nbsp;exclusive (even as to us), transferable, sublicensable license to certain of our technology to commercialize certain research products in the field and (ii) a coexclusive
(with us), transferable, sublicensable license to develop, manufacture, and commercialize certain selected research compounds and research products for disease treatment worldwide. Upon the selection of relevant candidate small molecule compound
selective modulator, such co-exclusive license shall become exclusive for Novartis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Novartis paid us a nonrefundable, non-creditable
one-time payment of $50.0 million as an initial license fee in October 2019. Novartis will also pay us a $4.0 million target validation fee for each candidate target that achieves target validation and is deemed a research target, for up to three
candidate targets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Novartis shall also pay us certain development and commercialization milestone payments, in total up to
$416.0&nbsp;million under the agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Novartis shall also pay us tiered royalties, on a product-by-product basis based on annual nets
sales of products at percentages ranging from high-single digits to low teens of the applicable licensed products and mid-single digits to high-single digits for any products resulting from the research programs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">150 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless earlier terminated, the Novartis Agreement will expire upon the expiration of all
royalty obligations. The royalty period will expire on a product-by-product and country-by-country basis upon the later of (i) ten years from the first commercial sale, (ii) the expiration of all regulatory or data exclusivity and (iii) the
expiration of the last-to-expire valid patent claim. Novartis has the right to terminate the Novartis Agreement for convenience on a target-by-target basis upon sixty (60) days&#146; prior written notice, so long as such right is exercised prior to
the first commercial sale of any licensed product or research product with respect to the applicable target. After the first commercial sale, Novartis has the right to terminate the Novartis Agreement for convenience on a target-by-target basis upon
six (6) months&#146; prior written notice. We may not terminate the agreement for convenience. Either we or Novartis may terminate the Novartis Agreement if the other party is in material breach and such breach is not cured within the specified cure
period. In addition, either we or Novartis may terminate the Novartis Agreement in the event of specified insolvency events involving the other party. If we terminate the agreement as a result of Novartis&#146; uncured material breach or Novartis
terminates at will, we retain a royalty-bearing, non-exclusive license to certain Novartis technology in order to develop, manufacture and commercialize certain compounds and products as set forth in the Novartis Agreement, subject to certain
conditions. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Adimab Collaboration Agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2018, we entered into a collaboration agreement, or the Adimab Agreement, with Adimab, LLC, or Adimab, for the discovery and
optimization of proprietary antibodies as potential therapeutic product candidates. Under the Adimab Agreement, we have initially agreed with Adimab to collaborate on an initial research program. In addition, we may select up to three additional
biological targets against which Adimab will use its technology to research and develop antibodies pursuant to a mutually agreed upon research plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the ongoing research period and for a specified evaluation period thereafter, or the Evaluation Term, Adimab will grant us a worldwide,
<FONT STYLE="white-space:nowrap">non-exclusive</FONT> license to Adimab&#146;s technology to perform our responsibilities under the specified research plan and to evaluate the program antibodies to determine, at our election, how to proceed with any
antibodies discovered as a result of such research program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On a research program by research program basis, Adimab has granted to us an
exclusive option to acquire the rights to up to a certain specified number of discovered antibodies for development and commercialization as biopharmaceutical products. We have also granted Adimab a
<FONT STYLE="white-space:nowrap">non-exclusive,</FONT> non-sublicensable license under our technology during each research program, and during the relevant Evaluation Term solely to perform Adimab&#146;s responsibilities under such research plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon execution of the Adimab Agreement we paid to Adimab a <FONT STYLE="white-space:nowrap">one-time,</FONT> <FONT
STYLE="white-space:nowrap">non-creditable</FONT> <FONT STYLE="white-space:nowrap">non-refundable</FONT> technology access fee in the low-five figures. For each agreed upon research program that is commenced, we are required to pay Adimab an agreed
upon rate for its full-time employees during a given research program, a specified discovery delivery fee, and an optimization completion fee in the low-six figures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we choose to exercise our option with respect to a specific research program, we are required to pay Adimab a <FONT
STYLE="white-space:nowrap">non-creditable,</FONT> <FONT STYLE="white-space:nowrap">non-refundable</FONT> high <FONT STYLE="white-space:nowrap">six-figure</FONT> option exercise fee, payable in installments. If we exercise our option with respect to
more than the specified number of antibodies resulting from such research program, we are obligated to make an additional specified payment for each additional optioned antibody. To date, we have not exercised any options under the Adimab Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are required to make certain milestone payments to Adimab upon the achievement of certain clinical and regulatory milestone events in
the development of therapeutic products and diagnostic products which use the antibodies we have obtained pursuant to our exclusive option. The milestone payments total approximately $12&nbsp;million for each therapeutic product. For any product
that is commercialized pursuant to the Adimab Agreement, we are required to pay Adimab low single digit percentage tiered royalty payments based on annual aggregate worldwide net sales thresholds for such products, subject to reduction as specified
in the Adimab </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">151 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement. Royalty terms with respect to each product will expire on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis upon the later of
(a)&nbsp;ten years after the first commercial sale of such product in such country and (b)&nbsp;the expiration of the last patent related to any antibody acquired by us pursuant to our option from a specified research program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Adimab Agreement, we are required to use commercially reasonable efforts to conduct certain research to discover and optimize
antibodies directed against the targets that we select. The Adimab Agreement will expire unless earlier terminated (a)&nbsp;in the event that we do not exercise any option pursuant to a research program, upon the conclusion of the last to expire
Evaluation Term, or (b)&nbsp;if we do exercise an option, on the expiration of the last royalty term for a product in a particular country. We have the right to terminate the Adimab Agreement at any time upon advance written notice to Adimab. In
addition, subject to certain conditions, either we or Adimab may terminate the Adimab Agreement if the other party commits a material breach of the agreement and fails to cure such breach within a specified cure period after written notice is
provided. Upon expiration or termination of the Adimab Agreement, all licenses granted to us on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-product</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis will continue on a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> fully-paid, worldwide, royalty-free, irrevocable basis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Manufacturing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our product candidates,
PLN-74809 and PLN-1474, are small molecule inhibitors amenable to standard formulation technologies. We have validated the synthetic process and manufactured large kilogram quantities similar to the campaigns that will be required to provide drug
product for our anticipated Phase 2a clinical trials. The manufacturing process of the drug substance for such product candidates is robust and accessed from readily available starting materials. The synthetic route is amenable to large-scale
production and does not require unusual equipment or handling during the manufacturing process. We have obtained an adequate supply chain of the drug substance for PLN-74809 and PLN-1474 from our first North American contract manufacturing
organization, or CMO, to satisfy both our clinical and preclinical requirements in 2020. We rely on a sole supplier for the manufacture of PLN-74809. We are engaging secondary raw material suppliers in addition to North American and European CMOs to
mitigate global supply chain risk and ensure continuity of supply of drug substance. To maximize flexibility, we have established relationships with non-overlapping vendors for manufacturing of not only raw materials but also drug substance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently rely on third-party manufacturers for the GMP production of larger quantities of our drug product candidates for our clinical
trials. Our internal personnel have extensive cGMP manufacturing experience in order to ensure seamless technology transfer and to manage the manufacturing and development processes conducted by third-party manufacturers. Our agreements with
third-party manufacturers include confidentiality and intellectual property provisions as well as routine quality audits. In some instances, we have reserved resources from third-party manufacturers for the development and manufacture of our product
candidates for near-term clinical programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not own or operate facilities for clinical drug manufacturing, storage, distribution or
quality testing. Currently, all of our clinical manufacturing is outsourced to third-party manufacturers. As our development programs expand and we build new process efficiencies, we expect to continually evaluate this strategy with the objective of
satisfying demand for our clinical trials and, if approved, the manufacture, sale and distribution of commercial products. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Government Regulation
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA and comparable regulatory authorities in state and local jurisdictions and in other countries impose substantial and
burdensome requirements upon companies involved in the clinical development, manufacture, marketing and distribution of drugs, such as those we are developing. These agencies and other federal, state and local entities regulate, among other things,
the research and development, testing, manufacture, quality control, safety, effectiveness, labeling, storage, record keeping, approval, advertising and promotion, distribution, post-approval monitoring and reporting, sampling and export and import
of our product candidates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">152 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>U.S. government regulation of drug products </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act, or FDCA, and its implementing regulations. The
FDA also regulates biological products under the FDCA and the Public Health Service Act, or PHSA. If we advance clinical development of a biologic candidate in the future, these development activities will be subject to additional regulatory
requirements specific to biologics. The process of obtaining regulatory approvals and the subsequent compliance with applicable federal, state, local and foreign statutes and regulations requires the expenditure of substantial time and financial
resources. Failure to comply with the applicable U.S. requirements at any time during the product development process, approval process or after approval, may subject an applicant to a variety of administrative or judicial sanctions, such as the
FDA&#146;s refusal to approve pending New Drug Applications, or NDAs, withdrawal of an approval, imposition of a clinical hold, issuance of warning letters, product recalls, product seizures, total or partial suspension of production or
distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement or civil or criminal penalties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The process
required by the FDA before a drug may be marketed in the United States generally involves the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Completion of preclinical laboratory tests, animal studies and formulation studies in compliance with the
FDA&#146;s good laboratory practice, or GLP, regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Submission to the FDA of an investigational new drug application, or IND, which must become effective before
human clinical trials may begin; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Approval by an independent institutional review board, or IRB, at each clinical site before each trial may be
initiated; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Performance of adequate and well-controlled human clinical trials in accordance with good clinical practice, or
GCP, requirements to establish the safety and efficacy of the proposed drug product for each indication; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Submission to the FDA of an NDA; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Satisfactory completion of an FDA advisory committee review, if applicable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Satisfactory completion of an FDA inspection of the manufacturing facility or facilities at which the product is
produced to assess compliance with current good manufacturing practice, or cGMP, requirements and to assure that the facilities, methods and controls are adequate to preserve the drug&#146;s identity, strength, quality and purity;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Satisfactory completion of FDA audits of clinical trial sites to assure compliance with GCPs and the integrity of
the clinical data; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Payment of user fees and securing FDA approval of the NDA; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Compliance with any post-approval requirements, including the potential requirement to implement a Risk
Evaluation and Mitigation Strategy, or REMS, and the potential requirement to conduct post-approval studies. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Preclinical studies </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preclinical studies include laboratory evaluation of product chemistry, toxicity and formulation, as well as animal studies to assess potential
safety and efficacy. An IND sponsor must submit the results of the preclinical tests, together with manufacturing information, analytical data and any available clinical data or literature, among other things, to the FDA as part of an IND. Some
preclinical testing may continue even after the IND is submitted. An IND automatically becomes effective 30 days after receipt by the FDA, unless before that time the FDA raises concerns or questions related to one or more proposed clinical trials
and places the clinical trial on a clinical hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. As a result, submission of an IND may not result in the FDA allowing clinical
trials to initiate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">153 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Clinical trials </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Clinical trials involve the administration of the investigational new drug to human subjects under the supervision of qualified investigators
in accordance with GCP requirements, which include the requirement that all research subjects provide their informed consent in writing for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among
other things, the objectives of the trial, the parameters to be used in monitoring safety, and the effectiveness criteria to be evaluated. A protocol for each clinical trial and any subsequent protocol amendments must be submitted to the FDA as part
of the IND. In addition, an IRB at each institution participating in the clinical trial must review and approve the plan for any clinical trial before it initiates at that institution. Information about certain clinical trials must be submitted
within specific timeframes to the National Institutes of Health, or NIH, for public dissemination on their www.clinicaltrials.gov website. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Human clinical trials are typically conducted in three sequential phases, which may overlap or be combined: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Phase 1: The drug is initially introduced into healthy human subjects or patients with the target disease or
condition and tested for safety, dosage tolerance, absorption, metabolism, distribution, excretion and, if possible, to gain an early indication of its effectiveness. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Phase 2: The drug is administered to a limited patient population to identify possible adverse effects and safety
risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to determine dosage tolerance and optimal dosage. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Phase 3: The drug is administered to an expanded patient population, generally at geographically dispersed
clinical trial sites, in well-controlled clinical trials to generate enough data to statistically evaluate the efficacy and safety of the product for approval, to establish the overall risk-benefit profile of the product, and to provide adequate
information for the labeling of the product. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Progress reports detailing the results of the clinical trials must be
submitted at least annually to the FDA and more frequently if serious adverse events occur. Phase 1, Phase 2 and Phase 3 trials may not be completed successfully within any specified period, or at all. Furthermore, the FDA or the sponsor may suspend
or terminate a clinical trial at any time on various grounds, including a finding that the research subjects are being exposed to an unacceptable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution
if the clinical trial is not being conducted in accordance with the IRB&#146;s requirements or if the drug has been associated with unexpected serious harm to patients. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Marketing approval </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assuming successful completion of the required clinical testing, the results of the preclinical and clinical studies, together with detailed
information relating to the product&#146;s chemistry, manufacture, controls and proposed labeling, among other things, are submitted to the FDA as part of an NDA requesting approval to market the product for one or more indications. In most cases,
the submission of an NDA is subject to a substantial application user fee. Under the Prescription Drug User Fee Act, or PDUFA, guidelines that are currently in effect, the FDA has a goal of ten months from the date of &#147;filing&#148; of a
standard NDA, for a new molecular entity to review and act on the submission. This review typically takes twelve months from the date the NDA is submitted to FDA because the FDA has approximately two months to make a &#147;filing&#148; decision.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, under the Pediatric Research Equity Act of 2003, or PREA, as amended and reauthorized, certain NDAs or supplements to an NDA
must contain data that are adequate to assess the safety and effectiveness of the drug for the claimed indications in all relevant pediatric subpopulations, and to support dosing and administration for each pediatric subpopulation for which the
product is safe and effective. The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until after approval of the product for use in adults, or full or partial waivers from
the pediatric data requirements. An Agreed Initial Pediatric Study Plan requesting a waiver from the requirement to conduct clinical studies has been submitted to the FDA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">154 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA also may require submission of a risk evaluation and mitigation strategy, or REMS,
plan to ensure that the benefits of the drug outweigh its risks. The REMS plan could include medication guides, physician communication plans, assessment plans, and/or elements to assure safe use, such as restricted distribution methods, patient
registries, or other risk minimization tools. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA conducts a preliminary review of all NDAs within the first 60 days after
submission, before accepting them for filing, to determine whether they are sufficiently complete to permit substantive review. The FDA may request additional information rather than accept an NDA for filing. In this event, the application must be
resubmitted with the additional information. The resubmitted application is also subject to review before the FDA accepts it for filing. Once the submission is accepted for filing, the FDA begins an <FONT STYLE="white-space:nowrap">in-depth</FONT>
substantive review. The FDA reviews an NDA to determine, among other things, whether the drug is safe and effective and whether the facility in which it is manufactured, processed, packaged or held meets standards designed to assure the
product&#146;s continued safety, quality and purity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA may refer an application for a novel drug to an advisory committee. An
advisory committee is a panel of independent experts, including clinicians and other scientific experts, which reviews, evaluates and provides a recommendation as to whether the application should be approved and under what conditions. The FDA is
not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before
approving an NDA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP
requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving an NDA, the FDA may inspect one or more clinical trial sites to assure compliance with GCP requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After evaluating the NDA and all related information, including the advisory committee recommendation, if any, and inspection reports
regarding the manufacturing facilities and clinical trial sites, the FDA may issue an approval letter, or, in some cases, a complete response letter. A complete response letter generally contains a statement of specific conditions that must be met
in order to secure final approval of the NDA and may require additional clinical or preclinical testing in order for FDA to reconsider the application. Even with submission of this additional information, the FDA ultimately may decide that the
application does not satisfy the regulatory criteria for approval. If and when those conditions have been met to the FDA&#146;s satisfaction, the FDA will typically issue an approval letter. An approval letter authorizes commercial marketing of the
drug with specific prescribing information for specific indications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if the FDA approves a product, it may limit the approved
indications for use of the product, require that contraindications, warnings or precautions be included in the product labeling, require that post-approval studies, including Phase 4 clinical trials, be conducted to further assess a drug&#146;s
safety after approval, require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution and use restrictions or other risk management mechanisms under a REMS, which can
materially affect the potential market and profitability of the product. The FDA may prevent or limit further marketing of a product based on the results of post-marketing studies or surveillance programs. After approval, some types of changes to
the approved product, such as adding new indications, manufacturing changes, and additional labeling claims, are subject to further testing requirements and FDA review and approval. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Orphan drug designation and exclusivity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Orphan Drug Act, the FDA may designate a drug product as an &#147;orphan drug&#148; if it is intended to treat a rare disease or
condition (generally meaning that it affects fewer than 200,000 individuals in the United States, or more in cases in which there is no reasonable expectation that the cost of developing and making a drug product available in the United States for
treatment of the disease or condition will be recovered from sales of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">155 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
product). A company must request orphan product designation before submitting an NDA. If the request is granted, the FDA will disclose the identity of the therapeutic agent and its potential use.
Orphan product designation does not convey any advantage in or shorten the duration of the regulatory review and approval process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a
product with orphan status receives the first FDA approval for the disease or condition for which it has such designation or for a select indication or use within the rare disease or condition for which it was designated, the product generally will
be receiving orphan product exclusivity. Orphan product exclusivity means that the FDA may not approve any other applications for the same product for the same indication for seven years, except in certain limited circumstances. If a drug or drug
product designated as an orphan product ultimately receives marketing approval for an indication broader than what was designated in its orphan product application, it may not be entitled to exclusivity. Orphan exclusivity will not bar approval of
another product under certain circumstances, including if a subsequent product with the same active ingredient for the same indication is shown to be clinically superior to the approved product on the basis of greater efficacy or safety, or
providing a major contribution to patient care, or if the company with orphan drug exclusivity is not able to meet market demand. Further, the FDA may approve more than one product for the same orphan indication or disease as long as the products
contain different active ingredients. Moreover, competitors may receive approval of different products for the indication for which the orphan product has exclusivity or obtain approval for the same product but for a different indication for which
the orphan product has exclusivity. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>U.S. marketing exclusivity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Market exclusivity provisions under the FDCA also can delay the submission or the approval of certain applications. The FDCA provides a
five-year period <FONT STYLE="white-space:nowrap">of&nbsp;non-patent&nbsp;marketing</FONT> exclusivity within the United States to the first applicant to gain approval of an NDA for a new chemical entity. A drug is a new chemical entity if the FDA
has not previously approved any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not accept for review an Abbreviated New Drug
Application, or ANDA, or a 505(b)(2) NDA submitted by another company for another version of such drug where the applicant does not own or have a legal right of reference to all the data required for approval. However, an application may be
submitted after four years if it contains a certification of patent invalidity <FONT STYLE="white-space:nowrap">or&nbsp;non-infringement.&nbsp;The</FONT> FDCA also provides three years of marketing exclusivity for a NDA, 505(b)(2) NDA or supplement
to an existing NDA if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the FDA to be essential to the approval of the application, for example, new indications, dosages
or strengths of an existing drug. This three-year exclusivity covers only the conditions of use associated with the new clinical investigations and does not prohibit the FDA from approving ANDAs for the original
<FONT STYLE="white-space:nowrap">non-modified</FONT> version of the drug. Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct or
obtain a right of reference to all of the preclinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pediatric exclusivity is another type of regulatory market exclusivity in the United States. Pediatric exclusivity, if granted, adds six
months to existing regulatory exclusivity periods. <FONT STYLE="white-space:nowrap">This&nbsp;six-month&nbsp;exclusivity</FONT> may be granted based on the voluntary completion of a pediatric trial in accordance with
<FONT STYLE="white-space:nowrap">an&nbsp;FDA-issued&nbsp;&#147;Written</FONT> Request&#148; for such a trial. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Post-approval
requirements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the
FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, advertising and promotion and reporting of adverse experiences with the product. After approval, most changes to the
approved product, such as adding new indications or other labeling claims are subject to prior FDA review and approval. There are continuing, annual user fee requirements for any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">156 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
marketed products and the establishments where such products are manufactured, as well as new application fees for supplemental applications with clinical data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA may impose a number of post-approval requirements as a condition of approval of an NDA. For example, the FDA may require
post-marketing testing, including Phase 4 clinical trials, and surveillance to further assess and monitor the product&#146;s safety and effectiveness after commercialization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, drug manufacturers and other entities involved in the manufacture and distribution of approved drugs are required to register
their establishments with the FDA and state agencies, and are subject to periodic unannounced inspections by the FDA and these state agencies for compliance with cGMP requirements. Changes to the manufacturing process are strictly regulated and
often require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP requirements and impose reporting and documentation requirements upon the sponsor and any third-party
manufacturers that the sponsor may decide to use. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control to maintain cGMP compliance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once an approval of a drug is granted, the FDA may withdraw the approval if compliance with regulatory requirements and standards is not
maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to
comply with regulatory requirements, may result in mandatory revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution or other
restrictions under a REMS program. Other potential consequences include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market
or product recalls; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Fines, warning letters or holds on post-approval clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Refusal of the FDA to approve pending NDAs or supplements to approved NDAs, or suspension or revocation of
product approvals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Product seizure or detention, or refusal to permit the import or export of products; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Injunctions or the imposition of civil or criminal penalties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Drugs may be promoted by
a manufacturer and any third parties acting on behalf of a manufacturer only for the approved indications and in a manner consistent with the approved label for the product. The FDA and other agencies actively enforce the laws and regulations
prohibiting the promotion of <FONT STYLE="white-space:nowrap">off-label</FONT> uses, and a company that is found to have improperly promoted <FONT STYLE="white-space:nowrap">off-label</FONT> uses may be subject to significant liability. On
May&nbsp;10, 2019, the Centers for Medicare and Medicaid Services announced a new pricing transparency rule, which was set to take effect on July 9, 2019. The rule would have required direct-to-consumer television advertisements for prescription
drugs and biological products for which reimbursement is available, directly or indirectly, through or under Medicare or Medicaid to include the list price of that product, except for a prescription drug or biological product that has a list price
of less than $35 per month for a 30-day supply or typical course of treatment. The final rule was vacated by the D.C. District Court prior to taking effect. Several states have adopted price transparency requirements and those as well as any future
federal price transparency requirements that may be implemented in the future could have a negative effect on our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Other
healthcare laws </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Healthcare providers, physicians, and third party payors play a primary role in the recommendation and
prescription of drug products for which we obtain marketing approval. Arrangements with third party payors, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">157 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
healthcare providers and physicians, in connection with the clinical research, sales, marketing and promotion of products, once approved, and related activities, may expose a pharmaceutical
manufacturer to broadly applicable fraud and abuse and other healthcare laws and regulations. In the United States, these laws include, without limitation, state and federal&nbsp;anti- kickback,&nbsp;false claims, physician transparency, and patient
data privacy and security laws and regulations, including but not limited to those described below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Anti-Kickback Statute, or AKS, which makes it illegal for any person, including a prescription drug
manufacturer (or a party acting on its behalf) to knowingly and willfully solicit, receive, offer or pay any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, that is intended
to induce or reward, referrals including the purchase recommendation, order or prescription of a particular drug for which payment may be made under a federal healthcare program, such as the Medicare and Medicaid programs. A person or entity does
not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. In addition, the government may assert that a claim including items or services resulting from a violation of the federal
Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal False Claims Act, or FCA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal civil and criminal false claims laws, including the FCA, which can be enforced through &#147;qui
tam&#148; or &#147;whistleblower&#148; actions, and civil monetary penalty laws, which impose criminal and civil penalties against individuals or entities for, among other things, knowingly presenting, or causing to be presented, claims for payment
or approval from Medicare, Medicaid, or other federal health care programs that are false or fraudulent; knowingly making or causing a false statement material to a false or fraudulent claim or an obligation to pay or transmit money or property to
the federal government; or knowingly concealing or knowingly and improperly avoiding or decreasing such an obligation. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of these statutes or
specific intent to violate them in order to have committed a violation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created additional
federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the
money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material
fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH,
and their respective implementing regulations, which impose requirements on certain covered healthcare providers, health plans, and healthcare clearinghouses as well as their respective business associates that perform services for them that involve
the creation, use, receipt, maintenance or disclosure of individually identifiable health information, relating to the privacy, security and transmission of individually identifiable health information; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Physician Payments Sunshine Act, created under Patient Protection and Affordable Care Act, as amended
by the Health Care and Education Reconciliation Act of 2010, or collectively, the ACA, and its implementing regulations, which require manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare,
Medicaid or the Children&#146;s Health Insurance Program to report annually to the Centers for Medicare and Medicaid Services, or CMS, under the Open Payments Program, information related to payments or other transfers of value made to physicians
(defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Effective January&nbsp;1, 2022, these
reporting obligations will extend to include transfers of value made during the previous year to certain non-physician providers such as physician assistants and nurse practitioners; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">158 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">analogous state and foreign laws and regulations, such as state and foreign anti-kickback, false claims, consumer
protection and unfair competition laws which may apply to pharmaceutical business practices, including but not limited to, research, distribution, sales and marketing arrangements as well as submitting claims involving healthcare items or services
reimbursed by any third-party payor, including commercial insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#146;s voluntary compliance guidelines and the relevant compliance guidance promulgated
by the federal government that otherwise restricts payments that may be made to healthcare providers and other potential referral sources; state laws that require drug manufacturers to file reports with states regarding pricing and marketing
information, such as the tracking and reporting of gifts, compensations and other remuneration and items of value provided to healthcare professionals and entities; state and local laws requiring the registration of pharmaceutical sales
representatives; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance
efforts. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because of the breadth of these laws and the narrowness of the statutory exceptions and regulatory safe
harbors available, it is possible that some of a pharmaceutical manufacturer&#146;s business activities could be subject to challenge under one or more of such laws. Efforts to ensure that business arrangements comply with applicable healthcare laws
involve substantial costs. It is possible that governmental and enforcement authorities will conclude that a pharmaceutical manufacturer&#146;s business practices do not comply with current or future statutes, regulations or case law interpreting
applicable fraud and abuse or other healthcare laws and regulations. If any such actions are instituted against a pharmaceutical manufacturer, and it is not successful in defending itself or asserting its rights, those actions could have a
significant impact on its business, including the imposition of significant civil, criminal and administrative penalties, damages, disgorgement, imprisonment, monetary fines, possible exclusion from participation in Medicare, Medicaid and other
federal healthcare programs, reporting obligations and oversight if we become subject to integrity and oversight agreements to resolve allegations of <FONT STYLE="white-space:nowrap">non-compliance,</FONT> contractual damages, reputational harm,
diminished profits and future earnings, and curtailment of operations, any of which could adversely affect a pharmaceutical manufacturer&#146;s ability to operate its business and the results of operations. In addition, commercialization of any drug
product outside the United States will also likely be subject to foreign equivalents of the healthcare laws mentioned above, among other foreign laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the U.S., numerous federal and state laws and regulations, including state data breach notification laws, state health information privacy
laws, and federal and state consumer protection laws, govern the collection, use, disclosure, and protection of health-related and other personal information. For example, in June 2018, the State of California enacted the California Consumer Privacy
Act of 2018, or the CCPA, which came into effect on January 1, 2020 and provides new data privacy rights for consumers and new operational requirements for companies, which may increase our compliance costs and potential liability. The CCPA gives
California residents expanded rights to access and delete their personal information, opt out of certain personal information sharing, and receive detailed information about how their personal information is used. The CCPA provides for civil
penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. While there is currently an exception for protected health information that is subject to HIPAA and clinical trial
regulations, as currently written, the CCPA may impact certain of our business activities. The CCPA could mark the beginning of a trend toward more stringent state privacy legislation in the U.S., which could increase our potential liability and
adversely affect our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event we decide to conduct clinical trials or continue to enroll subjects in our ongoing or future
clinical trials, we may be subject to additional privacy restrictions. The collection, use, storage, disclosure, transfer, or other processing of personal data regarding individuals in the European Economic Area, or EEA, including personal health
data, is subject to the EU General Data Protection Regulation, or GDPR, which became effective on May 25, 2018. The GDPR is wide-ranging in scope and imposes numerous requirements on companies that process personal data, including requirements
relating to processing health and other sensitive data, obtaining consent of the individuals to whom the personal data relates, providing information to individuals regarding data processing activities, implementing safeguards to protect the
security and confidentiality of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">159 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
personal data, providing notification of data breaches, and taking certain measures when engaging third-party processors. The GDPR also imposes strict rules on the transfer of personal data to
countries outside the EEA, including the United States, and permits data protection authorities to impose large penalties for violations of the GDPR, including potential fines of up to &#128;20 million or 4% of annual global revenues, whichever is
greater. The GDPR also confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR.
In addition, the GDPR includes restrictions on cross-border data transfers. The GDPR may increase our responsibility and liability in relation to personal data that we process where such processing is subject to the GDPR, and we may be required to
put in place additional mechanisms to ensure compliance with the GDPR, including as implemented by individual countries. Compliance with the GDPR will be a rigorous and time-intensive process that may increase our cost of doing business or require
us to change our business practices, and despite those efforts, there is a risk that we may be subject to fines and penalties, litigation, and reputational harm in connection with our European activities. Further, the United Kingdom&#146;s decision
to leave the EU, often referred to as Brexit, has created uncertainty with regard to data protection regulation in the United Kingdom. In particular, it is unclear how data transfers to and from the United Kingdom will be regulated now that the
United Kingdom has left the EU. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Current and future healthcare reform legislation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In both the United States and certain foreign jurisdictions, there have been a number of legislative and regulatory changes to the health care
system. In particular, in 2010 the ACA was enacted, which, among other things, increased the minimum Medicaid rebates owed by most manufacturers under the Medicaid Drug Rebate Program, extended the Medicaid Drug Rebate Program to utilization of
prescriptions of individuals&nbsp;enrolled in Medicaid managed care organizations, subjected manufacturers to new annual fees and taxes for certain branded prescription drugs, and provided incentives to programs that increase the federal
government&#146;s comparative effectiveness research. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There remain judicial, administrative, executive, and legislative challenges to
certain aspects of the ACA, and we expect there will be additional challenges and amendments to the ACA in the future. On December&nbsp;14, 2018, a Texas U.S. District Court Judge ruled that the ACA is unconstitutional in its entirety because the
&#147;individual mandate&#148; was repealed by Congress as part of the Tax Act. Additionally, on December&nbsp;18, 2019, the U.S. Court of Appeals for the 5th Circuit upheld the District Court ruling that the individual mandate was unconstitutional
and remanded the case back to the District Court to determine whether the remaining provisions of the ACA are invalid as well. On March&nbsp;2, 2020, the United States Supreme Court granted the petitions for writs of certiorari to review this case,
and has allotted one hour for oral arguments, which are expected to occur in the fall. In addition, the Trump Administration has issued various Executive Orders which eliminated cost sharing subsidies and various provisions that would impose a
fiscal burden on states or a cost, fee, tax, penalty or regulatory burden on individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices. Additionally, Congress has introduced several pieces of
legislation aimed at significantly revising or repealing the ACA. It is unclear whether the ACA will be overturned, repealed, replaced, or further amended. We cannot predict what affect further changes to the ACA would have on our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, other legislative changes have been proposed and adopted in the United States since the ACA was enacted. In August&nbsp;2011, the
Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013
through 2021, was unable to reach required goals, thereby triggering the legislation&#146;s automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to providers of 2%&nbsp;per fiscal year, which
went into effect in&nbsp;2013, and, due to subsequent legislative amendments, will remain in effect through 2030 unless additional Congressional action is taken. However, the Medicare sequester reductions under the Budget Control Act of 2011 will be
suspended from May&nbsp;1, 2020 through December 31, 2020 due to the COVID-19 pandemic. The American Taxpayer Relief Act of 2012 further reduced Medicare payments to several providers, including hospitals and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">160 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. The Bipartisan Budget Act of 2018, also
amended the ACA, effective January 1, 2019, by increasing the point-of-sale discount that is owed by pharmaceutical manufacturers who participate in Medicare Part D and closing the coverage gap in most Medicare drug plans, commonly referred to as
the &#147;donut hole&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, there has been heightened governmental scrutiny in the United States of pharmaceutical pricing
practices in light of the rising cost of prescription drugs and biologics. At the federal level, the U.S. Presidential administration&#146;s budget proposal for the fiscal year 2021 includes a $135&nbsp;billion allowance to support legislative
proposals seeking to reduce drug prices, increase competition, lower out-of-pocket drug costs for patients, and increase patient access to lower-cost generic and biosimilar drugs. On March 10, 2020, the Trump administration sent
&#147;principles&#148; for drug pricing to Congress, calling for legislation that would, among other things, cap Medicare Part D beneficiary out-of-pocket pharmacy expenses, provide an option to cap Medicare Part D beneficiary monthly out-of-pocket
expenses, and place limits on pharmaceutical price increases. Moreover, the U.S. Presidential administration previously released a &#147;Blueprint&#148; to lower drug prices and reduce out of pocket costs of drugs that contained proposals to
increase manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out of pocket costs of drug products paid by consumers.
Although a number of these and other measures may require additional authorization to become effective, Congress and the U.S. Presidential administration have each indicated that it will continue to seek new legislative and/or administrative
measures to control drug costs. Any reduction in reimbursement from Medicare and other government programs may result in a similar reduction in payments from private payers. In addition, individual states in the United States have also increasingly
passed legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency
measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Legislative and regulatory
proposals, and enactment of laws, at the foreign, federal and state levels, directed at containing or lowering the cost of healthcare, will continue into the future. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Rest of World Regulation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For other countries outside of the European Union and the United States, such as countries in Eastern Europe, Latin America or Asia, the
requirements governing product development, the conduct of clinical trials, manufacturing, distribution, marketing approval, product licensing, pricing and reimbursement vary from country to country. Additionally, clinical trials must be conducted
in accordance with GCP requirements and the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we fail to comply with applicable foreign regulatory requirements, we may be subject to, among other things, fines, suspension or
withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally,
to the extent that any of our product candidates, once approved, are sold in a foreign country, we may be subject to applicable post-marketing requirements, including safety surveillance, anti-fraud and abuse laws and implementation of corporate
compliance programs and reporting of payments or other transfers of value to healthcare professionals. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Coverage and reimbursement
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Successful commercialization of new drug products depends in part on the extent to which reimbursement for those drug products
will be available from government health administration authorities, private health insurers, and other organizations. Government authorities and third-party payors, such as private health insurers </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">161 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and health maintenance organizations, decide which drug products they will pay for and establish reimbursement levels. The availability and extent of reimbursement by governmental and private
payors is essential for most patients to be able to afford a drug product. Sales of drug products depend substantially, both domestically and abroad, on the extent to which the costs of drugs products are paid for by health maintenance, managed
care, pharmacy benefit and similar healthcare management organizations, or reimbursed by government health administration authorities, private health coverage insurers and other third-party payors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A primary trend in the U.S. healthcare industry and elsewhere is cost containment. Government authorities and third-party payors have
attempted to control costs by limiting coverage and the amount of reimbursement for particular drug products. In many countries, the prices of drug products are subject to varying price control mechanisms as part of national health systems. In
general, the prices of drug products under such systems are substantially lower than in the United States. Other countries allow companies to fix their own prices for drug products, but monitor and control company profits. Accordingly, in markets
outside the United States, the reimbursement for drug products may be reduced compared with the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, the
principal decisions about reimbursement for new drug products are typically made by CMS, an agency within the HHS. CMS decides whether and to what extent a new drug product will be covered and reimbursed under Medicare, and private payors tend to
follow CMS to a substantial degree. However, no uniform policy of coverage and reimbursement for drug products exists among third-party payors and coverage and reimbursement levels for drug products can differ significantly from payor to payor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Medicare Prescription Drug, Improvement, and Modernization Act of 2003, or the MMA, established the Medicare Part D program to provide a
voluntary prescription drug benefit to Medicare beneficiaries. Under Part&nbsp;D, Medicare beneficiaries may enroll in prescription drug plans offered by private entities that provide coverage of outpatient prescription drugs. While all Medicare
drug plans must give at least a standard level of coverage set by Medicare, Part D prescription drug plan sponsors are not required to pay for all covered Part D drugs, and each Part D prescription drug plan can develop its own drug formulary that
identifies which drugs it will cover and at what tier or level. However, Part D prescription drug formularies must include drugs within each therapeutic category and class of covered Part D drugs, though not necessarily all the drugs in each
category or class. Any formulary used by a Part D prescription drug plan must be developed and reviewed by a pharmacy and therapeutic committee. Government payment for some of the costs of prescription drugs may increase demand for drugs for which
we obtain marketing approval. Any negotiated prices for any of our products covered by a Part D prescription drug plan will likely be lower than the prices we might otherwise obtain. Moreover, while the MMA applies only to drug benefits for Medicare
beneficiaries, private payors often follow Medicare coverage policy and payment limitations in setting their own payment rates. Any reduction in payment that results from the MMA may result in a similar reduction in payments from <FONT
STYLE="white-space:nowrap">non-governmental</FONT> payors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a drug product to receive federal reimbursement under the Medicaid or
Medicare Part B programs or to be sold directly to U.S. government agencies, the manufacturer must extend discounts to entities eligible to participate in the 340B drug pricing program. The required 340B discount on a given product is calculated
based on the average manufacturer price, or AMP, and Medicaid rebate amounts reported by the manufacturer. As of 2010, the ACA expanded the types of entities eligible to receive discounted 340B pricing, although under the current state of the law
these newly eligible entities (with the exception of children&#146;s hospitals) will not be eligible to receive discounted 340B pricing on orphan drugs. As 340B drug pricing is determined based on average manufacturer price, or AMP, and Medicaid
rebate data, the revisions to the Medicaid rebate formula and AMP definition described above could cause the required 340B discount to increase. The American Recovery and Reinvestment Act of 2009 provides funding for the federal government to
compare the effectiveness of different treatments for the same illness. The plan for the research was published in 2012 by the Department of Health and Human Services, the Agency for Healthcare Research and Quality and the National Institutes for
Health, and periodic reports on the status of the research and related expenditures are made to Congress. Although the results of the comparative effectiveness studies are not intended to mandate coverage policies for public or private payors, it is
not clear what effect, if any, the research will have on the sales of our product </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">162 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
candidates, if any such drug or the condition that they are intended to treat are the subject of a trial. It is also possible that comparative effectiveness research demonstrating benefits in a
competitor&#146;s drug could adversely affect the sales of our product candidate. If third-party payors do not consider our drugs to be cost-effective compared to other available therapies, they may not cover our drugs after approval as a benefit
under their plans or, if they do, the level of payment may not be sufficient to allow us to sell our drugs on a profitable basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These
laws, and future state and federal healthcare reform measures may be adopted in the future, any of which may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices we may obtain for any product
candidates for which we may obtain regulatory approval or the frequency with which any such product candidate is prescribed or used. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Outside of the United States, the pricing of pharmaceutical products and medical devices is subject to governmental control in many countries.
For example, in the European Union, pricing and reimbursement schemes vary widely from country to country. Some countries provide that products may be marketed only after a reimbursement price has been agreed. Some countries may require the
completion of additional studies that compare the cost effectiveness of a particular therapy to currently available therapies or <FONT STYLE="white-space:nowrap">so-called</FONT> health technology assessments, in order to obtain reimbursement or
pricing approval. Other countries may allow companies to fix their own prices for products, but monitor and control product volumes and issue guidance to physicians to limit prescriptions. Efforts to control prices and utilization of pharmaceutical
products and medical devices will likely continue as countries attempt to manage healthcare expenditures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, we had 62 <FONT STYLE="white-space:nowrap">full-time</FONT> employees, including 21&nbsp;with Ph.D. or M.D.
degrees and 37 are engaged in research and development activities. None of our employees are represented by labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Facilities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We lease a facility
containing 32,974 square feet of laboratory and office space, which is located at 260 Littlefield Avenue, South San Francisco, California 94080. The lease expires on February&nbsp;28, 2025. We believe that our current facilities are sufficient to
meet our current and <FONT STYLE="white-space:nowrap">near-term</FONT> needs and that, should it be needed, suitable additional space will be available. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal Proceedings </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this
prospectus, we are not party to any material legal matters or claims. We may become party to legal matters and claims arising in the ordinary course of business. We cannot predict the outcome of any such legal matters or claims, and despite the
potential outcomes, the existence thereof may have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">163 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_12"></A>MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers and Directors </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following table sets forth certain information about our executive officers and directors, including their ages, as of June&nbsp;2 , 2020. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="61%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;Age&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position(s)</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Executive Officers:</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard Coulie, M.D., Ph.D., MBA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">54</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President, Chief Executive Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Keith Cummings, M.D., MBA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">43</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barbara Howes, MBA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">56</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Human Resource Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hans Hull, J.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">45</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Business Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&Eacute;ric Lefebvre, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">56</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Medical Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Non-Employee Directors:</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hoyoung Huh, M.D., Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">51</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lead Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Suzanne Bruhn, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">56</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gayle Crowell<SUP STYLE="font-size:85%; vertical-align:top">(1)(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">69</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Curnutte, M.D., Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP><SUP
STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">68</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Neil Exter, MBA<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">61</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles Homcy, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP><SUP
STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">71</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Smital Shah, MBA<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">44</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Member of the Audit Committee. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Member of the Compensation Committee. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Member of the Nominating and Corporate Governance Committee. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Member of the Research and Development Committee </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Executive Officers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Bernard Coulie, M.D., Ph.D., MBA,</I></B> has served as our Chief Executive Officer and as a Director since February 2016. Prior to
joining us, Dr.&nbsp;Coulie cofounded ActoGeniX N.V., a biopharmaceutical company, and held roles of increasing responsibility there, including as Vice President R&amp;D, Chief Medical Officer and Chief Executive Officer, from September 2006 until
February 2015, when it was acquired by Intrexon Corporation. Prior to cofounding ActoGeniX, Dr.&nbsp;Coulie held various positions with increasing responsibilities in drug discovery and clinical development at&nbsp;Johnson&nbsp;&amp; Johnson
Pharmaceutical Research and Development Europe. Dr.&nbsp;Coulie previously served as a director of ActoGeniX from April 2010 until February 2015, Biogazelle N.V. from July 2015 until November 2018, Myoscience from June 2016 until March 2019.
Dr.&nbsp;Coulie is currently serving as a director and Chairman of Calypso BV. Dr.&nbsp;Coulie holds an M.D. and Ph.D. from the University of Leuven, Belgium and an MBA from the Vlerick Management School, Leuven, Belgium. We believe that
Dr.&nbsp;Coulie is qualified to serve on our board of directors based on our review of his experience and expertise in operations management and executive leadership at various biopharmaceutical companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Keith Cummings, M.D., MBA,</I></B> has served as our Chief Financial Officer since December 2018. Prior to joining us, Dr.&nbsp;Cummings
served as a Director in the Investment Banking Healthcare Group at Citigroup Global Markets from September 2014 until December 2018. Prior to joining Citigroup, Dr.&nbsp;Cummings worked at Lehman Brothers and, subsequently, at Barclays Investment
Bank from August 2009 to September 2014, where he served as a vice president of investment banking. He holds a B.S. in Biochemistry from North Carolina State University, an MBA from Duke University&#146;s Fuqua School of Business and an M.D. from
Duke University School of Medicine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Barbara Howes</I></B><B><I>, MBA, </I></B>has served as our served as our Chief Human Resource
Officer since May 2019. Prior to joining us, Ms.&nbsp;Howes worked full time in consulting full-time in October 2014 where she served as the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">164 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
interim Head of Human Resources for several biotechnology companies, including Pliant prior to joining us full time. Ms.&nbsp;Howes has over 20 years&#146; experience designing and delivering
creative and impactful human resources, leadership development and change management solutions with a focus on optimizing organizational performance in the areas of innovation, collaboration, culture and strategy. Prior to founding her consulting
practice in October 2014, Ms.&nbsp;Howes led the executive and organization development, career&nbsp;&amp; learning, diversity, and workforce research teams at Genentech from June 2008 through October 2014.&nbsp;Prior to joining Genentech,
Ms.&nbsp;Howes spent 12 years at The Walt Disney Company, where she held various development positions at The Disney Stores, Walt Disney Imagineering, and Corporate. She holds a B.A. in Liberal Arts from Mount Saint Mary&#146;s College and an MBA
with an emphasis in Organizational Behavior from California Lutheran University. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Hans Hull, J.D.,</I></B> has served as our Chief
Business Officer since March 2016. Prior to joining us, Mr.&nbsp;Hull held roles of increasing responsibility at Avalanche Biotechnologies, Inc., a biopharmaceutical company, from March 2011 until December 2015, including Vice President, Legal and
Corporate Development, then Senior Vice President, Business Operations and interim President, and then Chief Executive Officer. Prior to Avalanche, from May 2008 to December 2011, he served as a legal and business development consultant for life
sciences companies, including Second Genome, a biotechnology company, and Aprecia Pharmaceuticals, a pharmaceutical company. Mr.&nbsp;Hull was also the Vice President and then Chief Executive Officer of Orthobond Corporation, a medical device
startup from March 2005 to April 2008. Mr.&nbsp;Hull also had an earlier career as an intellectual property attorney at Heller Ehrman LLP and life science consultant at ZS Associates. He holds an A.B. in Chemistry from Princeton University and a
J.D. from the University of California, Berkeley. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>&Eacute;ric Lefebvre, M.D.,</I></B> has served as our Chief Medical Officer since
May 2018. Prior to joining us, Dr.&nbsp;Lefebvre served as the Vice President of Allergan plc, a global pharmaceutical company, from November 2016 until April 2018. Prior to Allergan, Dr.&nbsp;Lefebvre served as Chief Medical Officer of Tobira
Therapeutics, Inc., a clinical-stage biopharmaceutical company, from January 2012 until November 2016. Dr.&nbsp;Lefebvre also led global clinical development and global medical affairs at Janssen Pharmaceuticals for 10 years prior to starting his
pharmaceutical career at GlaxoSmithKline Canada. This was preceded by 15 years of providing primary care at Clinique Medicale L&#146;Actuel in Montreal, Canada. He holds a B.S. in Health Sciences from Edouard-Montpetit College and an M.D. from the
University of Montreal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Non-Employee Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Hoyoung Huh,</I></B> <B><I>M.D., Ph.D.,</I></B> has served as Lead Director of our board of directors since December 2017. He is the
founder of pH Pharma and Healthcare&nbsp;&amp; Humanity Foundation. Dr.&nbsp;Huh was a Managing Director of Konus Advisory Group, Inc. from January 2012 to September 2014. Prior to founding Konus Advisory Group, Inc., Dr.&nbsp;Huh was Chief
Executive Officer and Chairman of the board of directors of BiPar Sciences, Inc. from February 2008 until December 2010. In addition, Dr.&nbsp;Huh has been involved in the formation, management and board positions of multiple biotechnology and
innovation-based companies. He previously served as the Chairman of the board of directors of Geron Corporation from September 2011 to December 2018, and CytomX Therapeutics, Inc. from February 2012 to December 2018, a member of the board of
directors of Rezolute, Inc. (f/k/a AntriaBio, Inc.) from 2013 to January 2019, the Chairman of the board of directors of Epizyme, Inc. from October 2009 to February 2012, and as a member of the board of directors of Facet Biotech Corporation, Nektar
Therapeutics, Inc., Addex Therapeutics Ltd. and EOS, S.p.A (Milano, Italy). Earlier in his career, Dr.&nbsp;Huh was a partner at McKinsey&nbsp;&amp; Company. He holds A.B. in Biochemistry from Dartmouth College, an M.D. from Cornell University
Medical College and a Ph.D. in Cell Biology and Genetics from Cornell University Sloan Kettering Institute. We believe Dr.&nbsp;Huh is qualified to serve on our board of directors based on his significant leadership experience in and familiarity
with the biopharmaceutical industry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Suzanne Bruhn, Ph.D.,</I></B> has served as a member of our board of directors since July
2016. Dr.&nbsp;Bruhn currently serves as President and Chief Executive Officer of Tiaki Therapeutics, a preclinical biotechnology company, since May 2019. Prior to that, Dr.&nbsp;Bruhn served as President and Chief Executive Officer of Proclara
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">165 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Biosciences, Inc, a clinical-stage biotechnology company, from April 2017 until September 2018. Prior to Proclara, Dr.&nbsp;Bruhn served as President and Chief Executive Officer of Promedior,
Inc., a private clinical-stage biotech company developing targeted therapies to treat diseases involving fibrosis, from May 2012 until November 2015. She currently also serves on the board of directors of Aeglea BioTherapeutics, Inc, a publicly
traded biotherapeutics company, from February 2017, Retrophin, Inc., a publicly traded pharmaceutical company, from April 2020, and Cerecor Inc., a publicly traded pharmaceutical company, from April 2020. She previously served as a member of the
board of directors of Novelion Therapeutics, Inc, a publicly traded pharmaceutical company, from October 2017 through January 2020, and Raptor Pharmaceuticals Corp., a publicly traded pharmaceutical company, from April 2011 until it was acquired by
Horizon Pharma plc in October 2016. She holds a B.S. in Chemistry from Iowa State University and a Ph.D. in Chemistry from Massachusetts Institute of Technology and completed her postdoctoral fellowship in the department of human genetics at Harvard
Medical School. We believe Dr.&nbsp;Bruhn is qualified to serve on our board of directors based on her extensive expertise and experience in the biopharmaceutical industry, including her expertise in the development of treatments for rare diseases
and diseases involving fibrosis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Gayle Crowell</I></B><B><I>,</I></B> has served as a member of our board of directors since
December 2019. Ms.&nbsp;Crowell serves as a member of the board of directors of Envestnet, Inc., a role she has held since March 2016. Prior to that she served as lead independent director of Yodlee, Inc. from March 2014 and as a member of the
Yodlee, Inc. board of directors from July 2002 until November 19, 2015, when Yodlee, Inc. was acquired by Envestnet. Ms.&nbsp;Crowell served as an operational business consultant for Warburg Pincus LLC, a private equity firm, from June 2001 to
January 2019. From January 2000 to June 2001, Ms.&nbsp;Crowell served as president of Epiphany, Inc., a developer of customer relationship management software which was acquired by SSA Global Technologies, Inc. in September 2005. Ms.&nbsp;Crowell
also currently serves on the board of directors of Dude Solutions Inc., a provider of facilities maintenance software, and of Hercules Capital, a specialty finance company, effective February&nbsp;4, 2019. Ms.&nbsp;Crowell received an undergraduate
degree in education from the University of Nevada at Reno. We believe Ms.&nbsp;Crowell is qualified to serve on our board of directors based on her extensive leadership experience as a board member and senior executive of other private and public
companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>John Curnutte, M.D., Ph.D.,</I></B> has served as a member of our board of directors since August 2017. From February
2011 through his retirement in May 2019, Dr.&nbsp;Curnutte served as Executive Vice President of Research and Development at Portola Pharmaceuticals, Inc., a biopharmaceutical company developing product candidates for thrombosis and other
hematologic diseases. He remains as a consultant to Portola. Prior to that, Dr.&nbsp;Curnutte served as the Chief Executive Officer of <FONT STYLE="white-space:nowrap">3-V</FONT> Biosciences, Inc., a biotechnology company. Earlier in his career, he
served as a President of Schering-Plough Biopharma and previously held several senior management positions at Genentech, Inc., a biotechnology company. Prior to Genentech, Dr.&nbsp;Curnutte was a tenured faculty member at The Scripps Research
Institute, pursuing basic and clinical research in inflammation biochemistry and the molecular genetics of congenital immune deficiencies. He was an adjunct clinical professor of pediatrics at Stanford University School of Medicine and a member of
the medical staff from 1993 to 2013. From May 2015 to June 2016, Dr. Curnutte served as a member of the board of directors of Diadexus, Inc., a cardiovascular diagnostics company. Since August 2019, he serves as a member of the board of directors of
Orchard Therapeutics, a company focused on ex vivo autologous bone marrow gene therapy. Dr.&nbsp;Curnutte holds a B.S. in Biochemistry and Molecular Biology from Harvard University and an M.D. and a Ph.D. in Biological Chemistry from Harvard Medical
School. We believe Dr.&nbsp;Curnutte is qualified to serve on our board of directors based on his extensive experience in the biopharmaceutical industry, including his operational experience in drug discovery and development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Neil Exter, MBA, </I></B>has served as a member of our board of directors since June 2015. He has been a partner at Third Rock Ventures
since November 2007. Mr. Exter has more than 30 years of business development, strategy and operating management experience, across the spectrum of emerging and established biotech and technology companies. Mr. Exter is currently the interim chief
business officer and a director of Cedilla Therapeutics. Prior to joining Third Rock Ventures, Mr. Exter was CBO of Alantos Pharmaceuticals and led the sale of that company to Amgen. Previously, he served as Vice President of Business Development
for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">166 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Millennium Pharmaceuticals. Mr.&nbsp;Exter presently is a board member of Element Science, Goldfinch Bio, Pliant Therapeutics, Revolution Medicines, Celsius Therapeutics, Decibel Therapeutics,
Motus Therapeutics, and NEVCA; he previously served as a director of Rhythm Pharmaceuticals and Cibiem. He is a member of the Research Committee of Children&#146;s Hospital Boston, the investment committee of the Innovation Research Fund at Partners
Healthcare, and the board of directors of the New England Venture Capital Association. He holds an MBA as a Baker Scholar from Harvard Business School, an M.S. from Stanford University, and a B.S. from Cornell University. We believe that Mr.
Exter&#146;s extensive experience in the life sciences industry as a venture capitalist and senior executive, as well as his service on the boards of directors of numerous biotechnology companies provide him with the qualifications to serve as a
director of our company. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Charles Homcy, M.D.,</I></B> has served as a member of our board of directors since July 2015.
Dr.&nbsp;Homcy is a cofounder of BridgeBio Pharma, Inc., and has served as a director since November 2018, Chairman of Pharmaceuticals since February 2019, and lead director since February 2020. Dr.&nbsp;Homcy joined Third Rock Ventures, a venture
capital firm in 2010, where he was a partner until October 2019 and now serves in an advisory capacity. In 2003, he co-founded Portola Pharmaceuticals, a clinical biotechnology company, and he served as president and chief executive officer until
2010. Prior to that, Dr. Homcy served as the president of research and development at Millennium Pharmaceuticals, Inc. a biopharmaceutical company, following its acquisition of COR Therapeutics, Inc. in 2002. He joined COR Therapeutics, Inc., a
biopharmaceutical company, in 1995 as executive vice president of research and development, and he served as a director of the company from 1998 to 2002. He was previously president of the medical research division of American Cyanamid-Lederle
Laboratories. Dr. Homcy was a clinical professor of medicine at the University of California, San Francisco Medical School, and attending physician at the San Francisco Veterans Affairs Hospital from 1997 to 2008. He was previously a member of the
Cardiac Unit of the Massachusetts General Hospital and an Associate Professor of Medicine at Harvard Medical School. Dr.&nbsp;Homcy holds a B.A. and an M.D. from Johns Hopkins University and currently serves on its board of trustees. Dr.&nbsp;Homcy
is a cofounder of multiple biotechnology companies including GBT, MyoKardia, Relay, Goldfinch, Pliant, Ambys and Maze. We believe Dr.&nbsp;Homcy is qualified to serve on our board of directors based on his significant experience building and leading
successful biotechnology companies and his scientific expertise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Smital Shah, MBA,</I></B> has served as a member of our board of
directors since March 2019. Since October 2014, Ms.&nbsp;Shah has served in roles of increasing responsibility at ProQR Therapeutics NV, a rare disease company, including as Chief Financial Officer and most recently as Chief Business and Financial
Officer. Previously, Ms.&nbsp;Shah managed the multi-billion-dollar debt, cash and investment portfolios of Gilead Sciences, Inc. Prior to Gilead, she was an investment banker at Leerink Partners and JP Morgan focused on capital raising and
strategic transactions in the biotechnology space. Previously, Ms.&nbsp;Shah held various research and development roles at Johnson&nbsp;&amp; Johnson Company. She holds a B.S. in Chemical Engineering from the University of Mumbai, a M.S. in
Chemical Engineering from Virginia Tech and an MBA from the University of California, Berkeley Haas School of Business. We believe Ms.&nbsp;Shah is qualified to serve on our board of directors due to her extensive experience in the life sciences
industry and her leadership experience as a senior financial executive. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Family Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no family relationships among any of our executive officers or directors.<B> </B> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Composition of Our Board of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The authorized number of our board of directors is set at nine and currently contains 8&nbsp;members with one vacancy. Each of the members of
our board of directors serves pursuant to the board composition provisions of our certificate of incorporation and agreements with our stockholders. These board composition provisions will terminate upon the completion of this offering and the
vacancy will terminate upon the effectiveness of the registration statement. Upon the termination of these provisions, there will be no further contractual obligations </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">167 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
regarding the election of our directors. Our nominating and corporate governance committee and our board of directors may consider a broad range of factors relating to the qualifications and
background of nominees. Our nominating and corporate governance committee&#146;s and our board of directors&#146; priority in selecting board members is to identify persons who will further the interests of our stockholders through his or her
established record of professional accomplishments, the ability to contribute positively to the collaborative culture among board members, knowledge of our business, understanding of the competitive landscape, diversity of background and perspective
and professional and personal experiences and expertise relevant to our growth strategy. Our directors hold office until their successors have been elected and qualified or until the earlier of their resignation or removal. Our amended and restated
certificate of incorporation and amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> that will become effective immediately prior to the closing of this offering also provide that our directors may be removed only for cause by the
affirmative vote of the holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the votes that all our stockholders would be entitled to cast in an annual election of directors, and that any vacancy on our board of directors,
including a vacancy resulting from an enlargement of our board of directors, may be filled only by vote of a majority of our directors then in office. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Director Independence </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have applied to list our common stock on the Nasdaq Global Market. Applicable Nasdaq rules require a majority of a listed company&#146;s
board of directors to be comprised of independent directors within one year of listing. In addition, the Nasdaq rules require that (i)&nbsp;on the date of the initial listing, at least one member of each of a listed company&#146;s audit,
compensation and nominating and corporate governance committees be independent, (ii)&nbsp;within 90 days of the date of the initial listing, a majority of the members of such committees be independent and (iii)&nbsp;within one year of the date of
the initial listing, all the members of such committees be independent. Audit committee members must also satisfy the independence criteria set forth in Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Exchange Act. Under applicable
Nasdaq rules, a director will only qualify as an &#147;independent director&#148; if, in the opinion of the listed company&#146;s board of directors, that person does not have a relationship that would interfere with the exercise of independent
judgment in carrying out the responsibilities of a director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to be considered independent for purposes of Rule <FONT
STYLE="white-space:nowrap">10A-3,</FONT> a member of an audit committee of a listed company may not, other than in his or her capacity as a member of the audit committee, the board of directors, or any other board committee, accept, directly or
indirectly, any consulting, advisory or other compensatory fee from the listed company or any of its subsidiaries or otherwise be an affiliated person of the listed company or any of its subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has determined that all members of the board of directors, except Dr.&nbsp;Coulie, are independent directors, including
for purposes of the rules of Nasdaq and the SEC. In making such independence determination, our board of directors considered the relationships that each <FONT STYLE="white-space:nowrap">non-employee</FONT> director has with us and all other facts
and circumstances that our board of directors deemed relevant in determining his or her independence, including the beneficial ownership of our capital stock by each <FONT STYLE="white-space:nowrap">non-employee</FONT> director. In considering the
independence of the directors listed above, our board of directors considered the association of our directors with the holders of more than 5% of our common stock. Upon the completion of this offering, we expect that the composition and functioning
of our board of directors and each of our committees will comply with all applicable requirements of Nasdaq and the rules and regulations of the SEC. Dr.&nbsp;Coulie is not an independent director under these rules because he is currently employed
as the chief executive officer of our company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Staggered Board </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the terms of our amended and restated certificate of incorporation and amended and restated by-laws that will become
effective immediately prior to the closing of this offering, our board of directors will be divided into three staggered classes of directors and each will be assigned to one of the three classes. At each annual meeting of the stockholders, a class
of directors will be elected for a three-year term to succeed the directors of the same class whose terms are then expiring. The terms of the directors will expire upon </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">168 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the election and qualification of successor directors at the annual meeting of stockholders to be held during the years 2021 for Class&nbsp;I directors, 2022 for Class&nbsp;II directors and 2023
for Class&nbsp;III directors. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Class&nbsp;I directors will be Hoyoung Huh, M.D., Ph.D. and Neil Exter. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Class&nbsp;II directors will be John Curnutte, M.D., Ph.D., Smital Shah and Charles Homcy, M.D.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Class&nbsp;III directors will be Bernard Coulie, M.D., Ph.D., Gayle Crowell and Suzanne Bruhn, Ph.D.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and amended and restated
<FONT STYLE="white-space:nowrap">by-laws</FONT> that will become effective immediately prior to the closing of this offering will provide that the number of directors shall be fixed from time to time by a resolution of the majority of our board of
directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The division of our board of directors into three classes with staggered three-year terms may delay or prevent stockholder
efforts to effect a change of our board of directors or a change in control. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Leadership Structure and Board&#146;s Role in Risk Oversight
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Hoyoung Huh, M.D., Ph.D. is our current Lead Director and Bernard Coulie, M.D., Ph.D. is our current chief executive officer, hence
the roles of lead director or chairman and the chief executive officer and president are separated. We plan to keep these roles separated following the completion of this offering. We believe that separating these positions allows our chief
executive officer to focus on setting the overall strategic direction of the company, expanding the organization to deliver on our strategy and overseeing our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT>
business, while allowing a lead director of the board to lead the board of directors in its fundamental role of providing strategic advice. Our board of directors recognizes the time, effort and energy that the chief executive officer is required to
devote to his position in the current business environment, as well as the commitment required to serve as our lead director, particularly as the board of directors&#146; oversight responsibilities continue to grow. While our amended and restated <FONT
STYLE="white-space:nowrap">by-laws</FONT> and corporate governance guidelines do not require that our lead director and chief executive officer positions be separate, our board of directors believes that having separate positions is the appropriate
leadership structure for us at this time and demonstrates our commitment to good corporate governance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Risk is inherent with every
business, and how well a business manages risk can ultimately determine its success. We face a number of risks, including risks relating to our financial condition, development and commercialization activities, operations, strategic direction and
intellectual property as more fully discussed in the section entitled &#147;Risk Factors&#148; appearing elsewhere in this prospectus. Management is responsible for the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> management of risks we face, while our board of directors, as a whole and through its committees, has responsibility for the oversight of risk management. In
its risk oversight role, our board of directors has the responsibility to satisfy itself that the risk management processes designed and implemented by management are adequate and functioning as designed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The role of the board of directors in overseeing the management of our risks is conducted primarily through committees of the board of
directors, as disclosed in the descriptions of each of the committees below and in the charters of each of the committees. The full board of directors (or the appropriate board committee in the case of risks that are under the purview of a
particular committee) discusses with management our major risk exposures, their potential impact on us, and the steps we take to manage them. When a board committee is responsible for evaluating and overseeing the management of a particular risk or
risks, the chairperson of the relevant committee reports on the discussion to the full board of directors during the committee reports portion of the next board meeting. This enables the board of directors and its committees to coordinate the risk
oversight role, particularly with respect to risk interrelationships. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Committees of Our Board of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has established an audit committee, a compensation committee, a nominating and corporate governance committee and a
research and development committee, each of which will operate pursuant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">169 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to a charter adopted by our board of directors and will be effective upon the effectiveness of the registration statement of which this prospectus is a part. Upon the effectiveness of the
registration statement of which this prospectus is a part, the composition and functioning of all of our committees will comply with all applicable requirements of the Sarbanes-Oxley Act of 2002, and with Nasdaq and SEC rules and regulations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective upon the effectiveness of the registration statement of which this prospectus is a part, Smital Shah, Suzanne Bruhn, Ph.D. and Gayle
Crowell will serve on the audit committee, which will be chaired by Smital Shah. Our board of directors has determined that&nbsp;each of Ms. Shah, Dr. Bruhn and Ms. Crowell are &#147;independent&#148; for audit committee purposes as that term is
defined in the rules of the SEC and the applicable Nasdaq rules, and each has sufficient knowledge in financial and auditing matters to serve on the audit committee. Our board of directors has designated Ms. Shah as an &#147;audit committee
financial expert,&#148; as defined under the applicable Nasdaq rules. The audit committee&#146;s responsibilities include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appointing, approving the compensation of, and assessing the independence of our independent<B> </B>registered
public accounting firm; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">pre-approving</FONT> auditing and permissible
<FONT STYLE="white-space:nowrap">non-audit</FONT> services, and the terms of such services, to be provided by our independent registered public accounting firm; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and discussing with management and our independent registered public accounting firm our annual and
quarterly financial statements and related disclosures as well as critical accounting policies and practices used by us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">coordinating the oversight and reviewing the adequacy of our internal control over financial reporting;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing policies and procedures for the receipt and retention of accounting-related complaints and concerns;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recommending based upon the audit committee&#146;s review and discussions with management and our independent
registered public accounting firm whether our audited financial statements shall be included in our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K;</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as
they relate to our financial statements and accounting matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing the audit committee report required by SEC rules to be included in our annual proxy statement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing material related person transactions for potential conflict of interest situations and approving such
transactions; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at least annually, review and reassess the adequacy of the audit committee charter and recommend to the board of
directors any amendments or modifications to the charter that the audit committee deems appropriate. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Compensation
Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective upon the effectiveness of the registration statement of which this prospectus is a part, Suzanne Bruhn, Ph.D.,
John Curnutte, M.D., Ph.D., and Neil Exter will serve on the compensation committee, which will be chaired by Suzanne Bruhn, Ph.D. Our board of directors has determined that Drs. Bruhn and Curnutte are &#147;independent&#148; as defined in the
applicable Nasdaq rules. Mr.&nbsp;Exter has not been deemed &#147;independent&#148; for compensation committee purposes and we may rely on the phase-in schedules set forth in Nasdaq listing rule&nbsp;5615(b)(1) with respect to Mr.&nbsp;Exter&#146;s
service on the compensation committee. Pursuant to the phase-in schedules, we must have all members of the compensation committee be independent within one year of listing. The compensation committee&#146;s responsibilities include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing on a periodic basis the operation of our executive compensation programs to determine whether they
remain supportive of our business objectives; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">170 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the performance of our Chief Executive Officer and approving the compensation of our Chief Executive
Officer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the performance of our other executive officers, and approving or recommending to the board of
directors the compensation of our other executive officers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing and administering our compensation and similar plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving structures and guidelines for various incentive compensation and benefit plans;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and recommending to the board of directors the compensation of our outside directors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing the compensation committee report required by SEC rules, if and when required, to be included in our
annual proxy statement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the retention, termination or compensation of any consulting firm or outside advisor to
assist in the evaluation of compensation matters; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at least annually, review and reassess the adequacy of the compensation committee charter and recommend to the
board of directors any amendments or modifications to the charter that the compensation committee deems appropriate. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective upon the effectiveness of the registration statement of which this prospectus is a part, Hoyoung Huh, M.D., Ph.D., Gayle Crowell and
Charles Homcy, M.D.,&nbsp;will serve on the nominating and corporate governance committee, which will be chaired by Hoyoung Huh, M.D., Ph.D. Our board of directors has determined that each member of the nominating and corporate governance committee
is &#147;independent&#148; as defined in the applicable Nasdaq rules. The nominating and corporate governance committee&#146;s responsibilities include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing and recommending to the board of directors criteria for board and committee membership;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing procedures for identifying and evaluating board of director candidates, including nominees
recommended by stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the composition of the board of directors to ensure that it is composed of members containing the
appropriate skills and expertise to advise us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying individuals qualified to become members of the board of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recommending to the board of directors the persons to be nominated for election as directors and to each of the
board&#146;s committees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing and recommending to the board of directors a code of business conduct and ethics and a set of
corporate governance guidelines; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing the evaluation of our board of directors; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at least annually, review and reassess the adequacy of the nominating and corporate governance committee charter
and recommend to the board of directors any amendments or modifications to the charter that the nominating and corporate governance committee deems appropriate. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective upon the effectiveness of the registration statement of which this prospectus is a part, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">John Curnutte, M.D., Ph.D. and Charles Homcy, M.D. will serve on the research and development committee, which will be chaired by John Curnutte, M.D., Ph.D.
The purpose of the research and development committee is to assist us in evaluating research and development issues and decisions and to provide to the Board a detailed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">171 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
perspective on research and development efforts. The research and development committee&#146;s responsibilities include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at least annually, providing feedback and analysis to our management and personnel and assist our board of
directors regarding its oversight of, pre-clinical and clinical decision-making through a series of periodic pipeline reviews and in-depth assessments of select project strategies and plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing, evaluating and advising the board or directors regarding our progress in achieving our short-term and
long-term strategic research and development goals and objectives; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing, evaluating and advising the board or directors regarding the quality, direction and competitiveness of
our research and development programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">providing recommendations regarding key discovery and development strategies to align with our business needs;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">providing assistance to the compensation committee and the board of directors in assessing the capabilities of
and evaluating the performance of our key scientific and technical personnel, and the depth and breadth of the our scientific resources; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at least annually, review and reassess the adequacy of the research and development committee charter and
recommend to the board of directors any amendments or modifications to the charter that the research and development committee deems appropriate. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:6%; font-size:10pt; font-family:Times New Roman">Our board of directors may from time to time establish other committees. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the members of our compensation committee has at any time during the prior three years been one of our officers or employees. None of
our executive officers currently serves, or in the past fiscal year has served, as a member of the board of directors or compensation committee of any entity that has one or more executive officers serving on our board of directors or compensation
committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Governance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
have adopted a written code of business conduct and ethics, effective upon the effectiveness of the registration statement of which this prospectus is a part, that applies to our directors, officers and employees, including our principal executive
officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. Following the effectiveness of the registration statement of which this prospectus is a part, a current copy of the code will
be posted on the investor relations section of our website, which is located at https://pliantrx.com. The inclusion of our website address in this prospectus does not incorporate by reference the information on or accessible through our website into
this prospectus. If we make any substantive amendments to, or grant any waivers from, the code of business conduct and ethics for any officer or director, we will disclose the nature of such amendment or waiver on our website or in a current report
on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitation on Liability and Indemnification Matters </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation, which will become effective immediately prior to the completion of this offering, will
contain provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by Delaware law. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any
breach of fiduciary duties as directors, except liability for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any breach of the director&#146;s duty of loyalty to us or our stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">172 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section&nbsp;174 of
the Delaware General Corporation Law; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any transaction from which the director derived an improper personal benefit. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated bylaws, which will become effective immediately prior to the completion of this offering, will provide that we are
required to indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law. Our amended and restated bylaws will also obligate us to advance expenses incurred by a director or officer in advance of the final
disposition of any action or proceeding, and permit us to secure insurance on behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in that capacity regardless of whether we would otherwise be
permitted to indemnify him or her under Delaware law. We have entered and expect to continue to enter into agreements to indemnify our directors, executive officers and other officers as determined by our board of directors or our compensation
committee. With specified exceptions, these agreements provide for indemnification for related expenses including, among other things, attorneys&#146; fees, judgments, fines and settlement amounts incurred by any of these individuals in certain
actions or proceedings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that these certificate of incorporation and bylaw provisions and indemnification agreements are
necessary to attract and retain qualified persons as directors and officers. We also maintain directors&#146; and officers&#146; liability insurance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated
bylaws may discourage stockholders from bringing a lawsuit against our directors and officers for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against our directors and officers, even though an action,
if successful, might benefit us and our stockholders. Further, a stockholder&#146;s investment may be adversely affected to the extent that we pay the costs of settlement and damage. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">173 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_13"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following discussion
contains forward-looking statements that are based on our current plans and expectations regarding our future compensation programs. The actual amount and form of compensation that we pay and the compensation policies and practices that we adopt in
the future may differ materially from the currently-planned programs that are summarized in this discussion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The compensation provided to
our named executive officers for the fiscal year ended December&nbsp;31, 2019 is detailed in the 2019 Summary Compensation Table and accompanying footnotes and narrative that follow. Our named executive officers for the fiscal year ended
December&nbsp;31, 2019, which consists of our Chief Executive Officer and our two most highly-compensated individuals (other than our Chief Executive Officer) who were serving as executive officers on December&nbsp;31, 2019, are: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Bernard J. Coulie, M.D., Ph.D., our Chief Executive Officer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Keith L. Cummings, M.D., MBA, our Chief Financial Officer; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Hans Hull, J.D., our Chief Business Officer. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2019 Summary Compensation Table </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following table provides information regarding the total compensation awarded to, earned by, and paid to our named executive officers for services rendered to us in all capacities for the fiscal year ended December&nbsp;31, 2019. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name&nbsp;and&nbsp;Principal&nbsp;Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Awards<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-equity</FONT><BR>Incentive Plan<BR>Compensation<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard J. Coulie, M.D., Ph.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">428,108</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,000</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,673,280</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">219,193</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">49,905</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,372,486</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Keith L. Cummings, M.D., MBA</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;<I>Chief Financial Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">340,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">252,000</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">964,285</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">122,403</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11,200</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,689,888</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hans Hull, J.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>&nbsp;&nbsp;&nbsp;&nbsp;Chief Business Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">355,137</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">268,560</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">136,369</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">11,200</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">846,266</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP><B></B></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B></B><B></B>The amounts reported represent the aggregate grant date fair value of the restricted stock awards granted to our named executive officers during the 2019 fiscal year, calculated in accordance with
Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 718. Such grant date fair values do not take into account any estimated forfeitures. The assumptions used in calculating the grant date fair value of the
restricted stock awards reported in this column are set forth in note&nbsp;11 of our financial statements included elsewhere in this prospectus. The amounts reported in this column reflect the accounting cost for these restricted stock awards and do
not correspond to the actual economic value that may be received by our named executive officers upon the vesting of the restricted stock awards or any sale of the underlying shares of common stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amounts reported represent the aggregate grant date fair value of the stock option awards granted to our named executive officers during the 2019 fiscal year, calculated in accordance with FASB ASC Topic 718. Such
grant date fair values do not take into account any estimated forfeitures. The assumptions used in calculating the grant date fair value of the stock option awards reported in this column are set forth in note 11 of our financial statements included
elsewhere in this prospectus. The amounts reported in this column reflect the accounting cost for these stock option awards and do not correspond to the actual economic value that may be received by our named executive officers upon the exercise of
the stock option awards or any sale of the underlying shares of common stock. For Mr. Hull, the grant date fair value of his performance-based stock option award is reported based on the probable outcome of the applicable performance metrics and the
grant date fair value of the such performance-based stock option award, based on maximum level of achievement of the applicable performance metrics, is $178,920. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents amounts earned by our named executive officers under our short-term incentive program, based on the Company&#146;s achievement of certain corporate performance goals and the named executive officers&#146;
individual performance during the 2019 fiscal year. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">174 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents a one-time discretionary performance bonus that Dr. Coulie received in connection with the execution of the Novartis Agreement in October 2019. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amounts reported represents $11,200 for matching contributions made by the Company under its 401(k) plan, $20,000 for travel reimbursements, and $18,705 for tax <FONT STYLE="white-space:nowrap">gross-ups</FONT> paid
by the Company for such travel reimbursements. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents a one-time discretionary performance bonus equal to $250,000 that Dr. Cummings received in connection with the Company&#146;s issuance of Series C Redeemable Convertible Preferred stock in December 2019 and a
one-time discretionary performance bonus equal to $2,000 that Dr. Cummings received in connection with the execution of the Novartis Agreement in October 2019. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amount reported represents $11,200 for matching contributions made by the Company under its 401(k) plan. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents a <FONT STYLE="white-space:nowrap">one-time</FONT> discretionary performance bonus that Mr. Hull received in connection with the execution of the Novartis Agreement in October 2019. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Narrative to Summary Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Base Salaries </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From
January&nbsp;1, 2019 through February 14, 2019, the annual base salaries for Dr.&nbsp;Coulie and Mr.&nbsp;Hull were $413,631 and $344,793, respectively. Effective as of February 15, 2019, the annual base salaries for Dr.&nbsp;Coulie and
Mr.&nbsp;Hull were increased to $428,108 and $355,137, respectively. Dr. Cummings&#146; annual base salary for the fiscal year ended December 31, 2019 was $340,000. Effective upon our initial public offering, the annual base salaries for Drs. Coulie
and Cummings and Mr. Hull will be increased to $540,000, $364,200 and $374,500, respectively. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Annual Bonuses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the fiscal year ended December&nbsp;31, 2019, our named executive officers were eligible to participate in the Company&#146;s short-term
incentive program, pursuant to which each was eligible to earn an annual bonus based on the achievement of certain Company performance objectives and individual performance. For the fiscal year ended December 31, 2019, the target annual bonuses for
Drs.&nbsp;Coulie and Cummings and Mr.&nbsp;Hull were 40.0%, 30.0% and 30.0%, respectively, of the applicable named executive officer&#146;s annual base salary. Effective upon our initial public offering, the target annual bonuses for Drs. Coulie and
Cummings and Mr. Hull will be increased to 50%, 35% and 35%, respectively, of their annual base salary. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Discretionary Bonuses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the fiscal year ended December 31, 2019, we also provided our named executive officers with certain one-time discretionary performance
bonuses for their contributions to the successful execution of the Novartis Agreement and/or the Company&#146;s issuance of Series C Redeemable Convertible Preferred stock, each as described further in our &#147;Executive Compensation&#151;2019
Summary Compensation Table&#148; above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Equity Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the fiscal year ended December&nbsp;31, 2019, we granted stock option awards to each of our named executive officers, as described in
more detail in the &#147;Outstanding equity awards at fiscal 2019 <FONT STYLE="white-space:nowrap">year-end&#148;</FONT> table. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>401(k) Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
maintain a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> 401(k) plan that provides eligible U.S. employees with an opportunity to save for retirement on a <FONT STYLE="white-space:nowrap">tax-advantaged</FONT> basis. Plan participants are
able to defer eligible compensation subject to applicable annual Internal Revenue Code limits. We provide a safe harbor matching contribution equal to 100% on the first 3% of participant contributions and an additional 50% on the next 2% of
participant contributions, which is 100% vested when contributed. We may also decide to make nonelective contributions, although we are not required to do so pursuant to the terms of the 401(k) plan. The 401(k) plan is intended to be qualified under
Section&nbsp;401(a) of the Internal Revenue Code with the 401(k) plan&#146;s related trust intended to be tax exempt under Section&nbsp;501(a) of the Internal Revenue Code. As a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plan,
contributions to the 401(k) plan and earnings on those contributions are not taxable to the employees until distributed from the 401(k) plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">175 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Perquisites </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We generally do not provide perquisites to our employees, other than travel reimbursements and related tax gross ups to Dr.&nbsp;Coulie. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Executive Employment Arrangements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We initially entered into an offer letter with each of the named executive officers in connection with his employment with us, which set forth
the terms and conditions of his employment. Each named executive officer also entered into our standard confidentiality and inventions assignment agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Offer Letters in Place During the Fiscal Year Ended December&nbsp;31, 2019 for Our Named Executive Officers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Bernard Coulie, M.D., Ph.D. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;12, 2015, we entered into an offer letter with Dr.&nbsp;Coulie, who currently serves as our Chief Executive Officer. The offer
letter provides for Dr.&nbsp;Coulie&#146;s <FONT STYLE="white-space:nowrap">at-will</FONT> employment and set forth his initial annual base salary, initial target annual bonus opportunity, a $250,000 <FONT STYLE="white-space:nowrap">sign-on</FONT>
bonus, annual travel reimbursements of up to $20,000 and an initial restricted stock grant for 385,983&nbsp;shares of our common stock, as well as his eligibility to participate in our employee benefit plans generally. Dr. Coulie&#146;s offer letter
also provides that, in the event of a termination of his employment by the Company without &#147;cause&#148; (as defined in Dr.&nbsp;Coulie&#146;s offer letter) and other than for death or disability, subject to Dr.&nbsp;Coulie&#146;s execution of
an effective release of claims in favor of the Company and his continued compliance with all legal and contractual obligations to the Company, Dr.&nbsp;Coulie will be entitled to a severance benefit in the form of a lump sum payment equal to six
months of his then-base salary. Dr. Coulie is subject to our standard confidential information and inventions assignment agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Keith Cummings, M.D., MBA </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;31, 2018, we entered into an offer letter with Dr.&nbsp;Cummings, who currently serves as our Chief Financial Officer. The
offer letter provides for Dr.&nbsp;Cummings&#146; <FONT STYLE="white-space:nowrap">at-will</FONT> employment and set forth his initial annual base salary, initial target bonus opportunity, a $100,000 <FONT STYLE="white-space:nowrap">sign-on</FONT>
bonus, a performance-based bonus of $250,000 based on the consummation of a collaboration agreement in which the Company receives certain significant payments, a stock option award for 225,489&nbsp;shares of our common stock, as well as his
eligibility to participate in our employee benefit plans generally. Dr. Cummings&#146; offer letter also provides that, in the event of a termination of his employment by the Company without &#147;cause&#148; (as defined in Dr.&nbsp;Cummings&#146;
offer letter), subject to Dr.&nbsp;Cummings&#146; execution of an effective release of claims in favor of the Company, Dr. Cummings will be entitled to a severance benefit of 12 months&#146; base salary continuation, payable in accordance with the
Company&#146;s normal payroll schedule. Dr. Cummings is subject to our standard confidential information and inventions assignment agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Hans Hull, J.D. </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
February&nbsp;10, 2016, we entered into an offer letter with Mr.&nbsp;Hull, who currently serves as our Chief Business Officer. The offer letter provides for Mr.&nbsp;Hull&#146;s <FONT STYLE="white-space:nowrap">at-will</FONT> employment and set
forth his initial annual base salary, initial target annual bonus opportunity, and an initial restricted stock grant for 129,650&nbsp;shares of our common stock, as well as his eligibility to participate in our employee benefit plans generally.
Mr.&nbsp;Hull&#146;s offer letter also provides that, in the event of a termination of his employment by the Company without &#147;cause&#148; (as defined in Mr.&nbsp;Hull&#146;s offer letter) and other than for death or disability, subject to
Mr.&nbsp;Hull&#146;s execution of an effective release of claims in favor of the Company and his continued compliance with all legal and contractual obligations to the Company, Mr.&nbsp;Hull will be entitled to a severance benefit in the form of a
lump sum payment equal to six months of his then-base salary. Mr. Hull is subject to our standard confidential information and inventions assignment agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">176 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Severance Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has adopted an Executive Severance Plan, or the Severance Plan, subject to the effectiveness of this offering, in which
our named executive officers, and certain other executives, will participate. The benefits provided in the Severance Plan will replace any severance for which our named executive officers may be eligible under their existing offer letters or other
agreements or arrangements, except to the extent such offer letters or other agreements or arrangements provide for greater benefits; provided, that, the defined terms in the Severance Plan will supersede the corresponding defined terms or other
similar terms in such offer letter or other agreements or arrangements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Severance Plan will provide that upon a termination by us for
any reason other than for &#147;cause,&#148; as defined in the Severance Plan, death or &#147;disability,&#148; as defined in the Severance Plan, outside of the change in control period (i.e., the period of one&nbsp;year after a &#147;change in
control,&#148; as defined in the Severance Plan), an eligible participant will be entitled to receive, subject to the execution and delivery of an effective release of claims in favor of the Company and continued compliance with all applicable
restrictive covenants, (i) 12 months of &#147;base salary&#148; (i.e., the higher of the annual base salary in effect immediately prior to the date of termination or the annual base salary in effect for the year immediately prior to the year in
which the date of termination occurs) for our Chief Executive Officer and nine months of base salary for the other named executive officers, (ii) an amount equal to the named executive officer&#146;s target annual bonus in effect immediately prior
to the date of termination, pro-rated for the number of days employed during the year of termination, and (iii) an amount equal to the monthly employer contribution, based on the premiums as of the date of termination, that we would have made to
provide health insurance for the named executive officer if he had remained employed by us for up to 12 months for our Chief Executive Officer and nine months for our other named executive officers. The payments under (i), (ii) and (iii) will be
paid in substantially equal installments in accordance with our payroll practice over 12&nbsp;months for our Chief Executive Officer and nine months for our other named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Severance Plan will also provide that upon a (A) termination by us other than for cause, death or disability or (B) resignation for
&#147;good reason,&#148; as defined in the Severance Plan, in each case within the change in control period, an eligible participant will be entitled to receive, in lieu of the payments and benefits above and subject to the execution and delivery of
an effective release of claims in favor of the Company and continued compliance with all applicable restrictive covenants, (I) a lump sum amount equal to 150% of the base salary and 150% of the target annual bonus in effect immediately prior to the
date of termination (or immediately prior to the change in control, if higher) for our Chief Executive Officer and 100% of the base salary and 100% of the target annual bonus in effect immediately prior to the date of termination (or immediately
prior to the change in control, if higher) for our other named executive officers (II)&nbsp;a lump sum amount equal to the monthly employer contribution, based on the premiums as of the date of termination, that we would have made to provide health
insurance for the participant if the applicable named executive officer had remained employed by us for 18 months for our Chief Executive Officer and 12 months for our other named executive officers and (III) for all outstanding and unvested equity
awards of the Company that are subject to time-based vesting held by the participant, full accelerated vesting of such awards; provided, that the performance conditions applicable to any outstanding and unvested equity awards subject to
performance-based vesting will be deemed satisfied at the target level specified in the terms of the applicable award agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
payments and benefits provided under the Severance Plan in connection with a change in control may not be eligible for a federal income tax deduction by us pursuant to Section&nbsp;280G of the Code. These payments and benefits may also subject an
eligible participant, including the named executive officers, to an excise tax under Section&nbsp;4999 of the Code. If the payments or benefits payable in connection with a change in control would be subject to the excise tax imposed under
Section&nbsp;4999 of the Code, then those payments or benefits will be reduced if such reduction would result in a higher net after-tax benefit to the participant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">177 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at Fiscal 2019 <FONT STYLE="white-space:nowrap">Year-End</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding outstanding equity awards held by our named executive officers as of December&nbsp;31,
2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option&nbsp;Awards<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock&nbsp;Awards<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vesting<BR>Commencement<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options&nbsp;(#)<BR>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>Incentive<BR>Plan<BR>Awards:<BR>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Unearned<BR>Options (#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares&nbsp;or<BR>Units of<BR>Stock that<BR>have Not<BR>Vested (#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value of<BR>Shares&nbsp;or<BR>Units&nbsp;of<BR>Stock that<BR>have
Not<BR>Vested&nbsp;($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Bernard Coulie, M.D.,&nbsp;Ph.D</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/8/18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/1/18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,402</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/24/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/24/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,864</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/23/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Keith Cummings, M.D.,&nbsp;MBA</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/24/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/31/18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169,116</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/23/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Hans&nbsp;Hull,&nbsp;J.D</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/7/16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/9/16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,103</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,359</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/8/18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/1/18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,900</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/24/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/24/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,171</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/23/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/24/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/24/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,958</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/23/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Each equity award is subject to the terms of our 2015 Plan and certain acceleration of vesting provisions under the Executive Severance Plan (as well as the acceleration of vesting provisions described below).
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Based on the fair market value of a share of our common stock on 12/31/19, which was $7.08. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">25% of the shares vest on the first anniversary of the vesting commencement date and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the named executive officer&#146;s continuous service
relationship with us through each applicable vesting date. Notwithstanding the foregoing, the shares are subject to certain acceleration of vesting provisions upon the occurrence of certain events or termination of the named executive officer&#146;s
service relationship, provided that the named executive officer is in &#147;good standing&#148; (as defined in the applicable restricted stock award agreement) at the time of such event and subject to the named executive officer&#146;s continued
service to the Company through such event or termination: (i) acceleration of vesting of 25% of the shares subject to the award upon the named executive officer&#146;s death; (ii) acceleration of vesting of 12.5% of the shares subject to the award
upon a termination of employment by the Company; and (iii) acceleration of vesting of 100% of the then unvested shares upon a termination in connection with or after a &#147;sale event&#148; (as defined in the applicable restricted stock award
agreement). </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the shares vest and become exercisable on each monthly anniversary while the named executive officer is providing continuous service to the Company through
each vesting date. Notwithstanding the foregoing, in the event of a &#147;change in control&#148; (as defined in our 2015 Plan) (i) pursuant to which the award is assumed or continued by the surviving or acquiring corporation in such change in
control, as determined by our board of directors, and (ii) we terminate the named executive officer&#146;s continuous service without &#147;cause&#148; (as defined in our 2015 Plan) or the named executive officer terminates his employment for
&#147;good reason&#148; (as defined in the applicable stock option award agreement), in either case within twelve (12) months following such change in control and subject to the named executive officer&#146;s execution and non-revocation of a
release of claims in the form prescribed by us within sixty (60) days after the date of such termination, the award shall be 100% vested upon the date of such termination of employment. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employee Benefits and Equity Compensation Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>2020 Stock Option and Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our 2020 Stock Option and Incentive Plan, or 2020 Plan, was approved by our board of directors and our stockholders on May&nbsp;14, 2020 and
May&nbsp;21, 2020, respectively, and will become effective on the date immediately prior to the date on which the registration statement of which this prospectus is part is declared effective by the SEC. The 2020 Plan will replace our 2015 Plan, as
our board of directors will not make additional awards under the 2015 Plan following the closing of this offering. The 2020 Plan will provide flexibility to our compensation committee to use various equity-based incentive awards as compensation
tools to motivate our workforce. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will initially reserve 4,200,000&nbsp;shares of our common stock, or the Initial Limit, for the
issuance of awards under the 2020 Plan. The 2020 Plan provides that the number of shares reserved and available for issuance under the plan will automatically increase each January&nbsp;1, beginning on January&nbsp;1, 2021, by 5% of the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">178 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
outstanding number of shares of our common stock on the immediately preceding December&nbsp;31, or such lesser number of shares as determined by our compensation committee. This is referred to
herein as the Annual Increase. This number will be subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares we issue under the 2020 Plan will be authorized but unissued shares or shares that we reacquire. The shares of common stock
underlying any awards that are forfeited, cancelled, held back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, reacquired by us prior to vesting, satisfied without any issuance of stock, expire or are
otherwise terminated (other than by exercise) under the 2020 Plan and the 2015 Plan will be added back to the shares of common stock available for issuance under the 2020 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The maximum aggregate number of shares of common stock that may be issued as incentive stock options may not exceed the Initial Limit
cumulatively increased on January&nbsp;1, 2021, and on each January&nbsp;1 thereafter by 5% of the number of shares of common stock issued and outstanding on the immediately preceding December&nbsp;31, or such lesser number of shares as approved by
the administrator of the 2020 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The grant date fair value of all awards made under our 2020 Plan and all other cash compensation paid
by us to any <FONT STYLE="white-space:nowrap">non-employee</FONT> director in any calendar year may not exceed $1,000,000 for the first year of service and $750,000 for each year of service thereafter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2020 Plan will be administered by our compensation committee. Our compensation committee will have full power to select, from among the
individuals eligible for awards, the individuals to whom awards will be granted, to make any combination of awards to participants, and to determine the specific terms and conditions of each award, subject to the provisions of the 2020 Plan. Persons
eligible to participate in the 2020 Plan will be those full or part-time employees, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and consultants of our company and our affiliates, as selected from time to time by our compensation
committee in its discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2020 Plan will permit the granting of both options to purchase common stock intended to qualify as
incentive stock options under Section&nbsp;422 of the Internal Revenue Code and options that do not so qualify. The option exercise price of each option will be determined by our compensation committee but may not be less than 100% of the fair
market value of our common stock on the date of grant. The term of each option will be fixed by our compensation committee and may not exceed ten years from the date of grant. Our compensation committee will determine at what time or times each
option may be exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation committee will be able to award stock appreciation rights subject to such conditions and
restrictions as it may determine. Stock appreciation rights will entitle the recipient to shares of common stock or cash, equal to the value of the appreciation in our stock price over the exercise price. The exercise price of each stock
appreciation right may not be less than 100% of the fair market value of the common stock on the date of grant. The term of each stock appreciation right will be fixed by our compensation committee and may not exceed ten years from the date of
grant. Our compensation committee will determine at what time or times each stock appreciation right may be exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation
committee will be able to award restricted shares of common stock and restricted stock units to participants subject to such conditions and restrictions as it may determine. These conditions and restrictions may include the achievement of certain
performance goals and/or continued employment or service relationship with us through a specified vesting period. Our compensation committee may also be permitted to grant shares of common stock that are free from any restrictions under the 2020
Plan. Unrestricted stock may be granted to participants in recognition of past services or other valid consideration and may be issued in lieu of cash compensation due to such participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation committee will be able to grant cash bonuses under the 2020 Plan to participants, subject to the achievement of certain
performance goals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">179 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2020 Plan will provide that upon the effectiveness of a &#147;sale event,&#148; as
defined in the 2020 Plan, an acquirer or successor entity may assume, continue or substitute outstanding awards under the 2020 Plan. To the extent that awards granted under our 2020 Plan are not assumed or continued or substituted by the successor
entity, except as may be otherwise provided in the relevant award certificate, all awards with time-based vesting, conditions or restrictions will become fully vested and nonforfeitable as of the effective time of the sale event, and all awards with
conditions and restrictions relating to the attainment of performance goals may become vested and nonforfeitable in connection with a sale event in the compensation committee&#146;s discretion or to the extent specified in the relevant award
certificate. Upon the effective time of the sale event, all outstanding awards granted under the 2020 Plan will terminate to the extent not assumed, continued or substituted for. In the event of such termination, individuals holding options and
stock appreciation rights will be permitted to exercise such options and stock appreciation rights (to the extent exercisable) within a specified period of time prior to the sale event. In addition, in connection with the termination of the 2020
Plan upon a sale event, we may make or provide for a payment, in cash or in kind, to participants holding vested and exercisable options and stock appreciation rights equal to the difference between the per share cash consideration payable to
stockholders in the sale event and the exercise price of the options or stock appreciation rights and we may make or provide for a payment, in cash or in kind, to participants holding other vested awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors will be able to amend or discontinue the 2020 Plan and our compensation committee will be permitted, at any time, to
amend or cancel outstanding awards for purposes of satisfying changes in law or any other lawful purpose but no such action may adversely affect rights under an award without the holder&#146;s consent. The compensation committee is specifically
authorized to exercise its discretion to reduce the exercise price of outstanding stock options or stock appreciation rights or effect the repricing of such awards through cancellation and <FONT STYLE="white-space:nowrap">re-grants.</FONT> Certain
amendments to the 2020 Plan will require the approval of our stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No awards will be granted under the 2020 Plan after the date
that is 10&nbsp;years from the date of stockholder approval. No awards under the 2020 Plan will be made prior to the date of this prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>2015 Equity Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors adopted, and our stockholders approved, our 2015 Plan, on August&nbsp;19, 2015. Our 2015 Plan was most recently amended
on March 17, 2020. The 2015 Plan allowed for the grant of incentive stock options to employees, including employees of any parent or subsidiary, and for the grant of nonstatutory stock options, stock appreciation rights, restricted stock awards,
restricted stock units and other stock awards to employees, directors, and consultants, including employees and consultants of our affiliates, subject in each case to compliance with applicable tax laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our 2020 Plan will become effective on the date immediately prior to the date on which the registration statement of which this prospectus is
part is declared effective by the SEC. As a result, we do not expect to grant any additional awards under the 2015 Plan following that date. Any awards granted under the 2015 Plan will remain subject to the terms of our 2015 Plan and applicable
award agreements. As of March&nbsp;31, 2020, options to purchase 2,607,939&nbsp;shares of common stock and unexercised rights to purchase 4,195 shares of restricted stock were outstanding under the 2015 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The maximum number of shares of our common stock that may have been issued under our 2015 Plan was 5,124,308. The maximum number of shares of
stock that may have been issued pursuant to the exercise of incentive stock options was three times such maximum number of shares. Shares subject to stock awards granted under our 2015 Plan that expire, are forfeited, are repurchased or otherwise
terminate without all the shares covered by such stock awards having been issued, or are settled in cash, do not reduce the number of shares available for issuance under our 2015 Plan. Additionally, shares used to pay the exercise price or purchase
price of a stock award or shares reacquired by the Company to satisfy the tax withholding obligations related to a stock award will return to the share reserve under the 2015 Plan. The shares issuable pursuant to stock awards granted under the 2015
Plan are authorized but unissued or reacquired shares, including shares repurchased by the Company on the open market or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">180 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s board of directors or a duly authorized committee of our board of
directors administers our 2015 Plan and the stock awards granted under it, and has the power to interpret and administer our 2015 Plan and any agreement thereunder and to determine the terms of awards, including the recipients, the number of shares
subject to each award, the exercise, purchase or strike price, if any, the vesting schedule applicable to the awards together with any vesting acceleration and the terms of the award agreement for use under our 2015 Plan. Under the 2015 Plan, the
board of directors also generally has the authority to effect, with the consent of any adversely affected participant, the reduction of the exercise price of any outstanding option or stock appreciation right, the cancellation of any outstanding
option or stock appreciation right and the grant in substitution therefore of other awards, cash, or other consideration, or any other action that is treated as a repricing under generally accepted accounting principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the 2015 Plan and subject to applicable law, the plan administrator may, in its discretion, delegate to one of more of our
officers, the power to designate <FONT STYLE="white-space:nowrap">non-officer</FONT> employees as recipients of options and/or stock appreciation rights and to determine the number of shares subject to such stock awards to be granted to such
employees; provided, however, the plan administrator must specify the total number of shares that may be subject to the stock awards granted by such officer and such officer may not grant options to himself or herself. The board of directors may not
delegate the authority to determine the fair market value of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our 2015 Plan provides that in the event of certain
specified significant corporate transactions, generally including: (i)&nbsp;a sale of all or substantially all of our assets, (ii)&nbsp;the sale or disposition of at least 90% of our outstanding securities, (iii)&nbsp;the consummation of a merger or
consolidation where we do not survive the transaction, and (iv)&nbsp;the consummation of a merger or consolidation where we do survive the transaction but the shares of common stock outstanding before such transaction are converted or exchanged into
other property by virtue of the transaction, unless otherwise provided in an award agreement or other written agreement between us and the award holder, the administrator may take one or more of the following actions with respect to such stock
awards: (A)&nbsp;arrange for the assumption, continuation or substitution of a stock award by a successor corporation, (B)&nbsp;arrange for the assignment of any reacquisition or repurchase rights held by us to a successor corporation,
(C)&nbsp;accelerate the vesting, in whole or in part, of the stock award and provide for its termination before the transaction, (D)&nbsp;arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by us,
(E)&nbsp;cancel or arrange for the cancellation of the stock award before the transaction in exchange for a cash payment, if any, determined by the board of directors, or (F)&nbsp;make a payment, in the form determined by the board of directors,
equal to the excess, if any, of the value of the property the participant would have received on exercise of the stock award before the transaction over any exercise price payable by the participant in connection with the exercise. The plan
administrator is not obligated to treat all stock awards, even those that are of the same type, or all participants, in the same manner. In the event of a change in control, awards granted under the 2015 Plan will not receive automatic acceleration
of vesting and exercisability, although the board of directors may provide for this treatment in an award agreement. Under the 2015 Plan, a change in control is defined to include (i)&nbsp;the acquisition by any person of more than 50% of the
combined voting power of our then outstanding stock, (ii)&nbsp;a merger, consolidation, or similar transaction in which our stockholders immediately before the transaction do not own, directly or indirectly, more than 50% of the combined voting
power of the surviving entity (or the parent of the surviving entity), or (iii)&nbsp;a sale, lease, exclusive license, or other disposition of all or substantially all of the assets to an entity that did not previously hold more than 50% of the
voting power of our stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our 2015 Plan, the board of directors may provide for limitations on the transferability of awards, in
its sole discretion. Option awards are generally not transferable other than by will or the laws of descent and distribution, except as otherwise provided under our 2015 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has the authority to amend, suspend, or terminate our 2015 Plan, although certain material amendments require the
approval of our stockholders, and amendments that would impair the rights of any participant require the written consent of that participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has determined not to make any further awards under the 2015 Plan following the completion of this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">181 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>2020 Employee Stock Purchase Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our 2020 Employee Stock Purchase plan, or the 2020 ESPP, was adopted by our board of directors and our stockholders on May 14, 2020 and
May&nbsp;21, 2020, respectively, and will become effective on the date immediately prior to the date on which the registration statement of which this prospectus is part is declared effective by the SEC. The 2020 ESPP will initially reserve and
authorize the issuance of up to a total of 700,000&nbsp;shares of common stock to participating employees. The 2020 ESPP will provide that the number of shares reserved and available for issuance will automatically increase each January&nbsp;1,
beginning on January&nbsp;1, 2021, by the lesser of (i)&nbsp;700,000 shares of our common stock, (ii)&nbsp;1% of the outstanding number of shares of our common stock on the immediately preceding December&nbsp;31, or (iii)&nbsp;such lesser number of
shares as determined by the administrator of the 2020 ESPP. This number will be subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All employees will be eligible to participate in the 2020 ESPP. Any employee who owns 5% or more of the total combined voting power or value
of all classes of stock will not be eligible to purchase shares under the 2020 ESPP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will make one or more offerings each year to our
employees to purchase shares under the 2020 ESPP. Other than the initial offering, offerings will usually begin every six months and will continue for <FONT STYLE="white-space:nowrap">six-month</FONT> periods, referred to as offering periods. Each
eligible employee may elect to participate in any offering by submitting an enrollment form at least 15&nbsp;business days before the relevant offering date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each employee who is a participant in the 2020 ESPP may purchase shares by authorizing contributions of between 1% and 15% of his or her
compensation during an offering period. Unless the participating employee has previously withdrawn from the offering, his or her accumulated contributions will be used to purchase shares on the last business day of the offering period at a price
equal to 85% of the fair market value of the shares on the first business day of the offering period or the last business day of the offering period, whichever is lower, provided that no more than 3,000 shares of common stock (or a lesser number as
established by the plan administrator in advance of the offering period) may be purchased by any one employee during each offering period. Under applicable tax rules, an employee may purchase no more than $25,000 worth of shares of common stock,
valued at the start of the offering period, under the 2020 ESPP for each calendar year in which a purchase right is outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
accumulated contributions of any employee who is not a participant on the last day of an offering period will be refunded. An employee&#146;s rights under the 2020 ESPP terminate upon voluntary withdrawal from the plan or when the employee ceases
employment with us for any reason. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2020 ESPP may be terminated or amended by our board of directors at any time, but will
automatically terminate on the <FONT STYLE="white-space:nowrap">10-year</FONT> anniversary of this offering. An amendment that increases the number of shares of common stock that are authorized under the 2020 ESPP and certain other amendments will
require the approval of our stockholders. The plan administrator may adopt subplans under the 2020 ESPP for employees of our <FONT STYLE="white-space:nowrap">non-U.S.</FONT> subsidiaries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Senior Executive Cash Incentive Bonus Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;6, 2020, our board of directors adopted the Senior Executive Cash Incentive Bonus Plan, or the Bonus Plan, which will become
effective on the date immediately prior to the date on which the registration statement of which this prospectus is part is declared effective by the SEC. The Bonus Plan will provide for cash bonus payments based upon the attainment of performance
targets established by our compensation committee. The payment targets will be related to financial and operational measures or objectives with respect to our company, or corporate performance goals, as well as individual performance objectives.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation committee may select corporate performance goals from among the following: research, pre-clinical, non-clinical
developmental, publication, clinical or regulatory milestones; cash flow (including, but </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">182 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not limited to, operating cash flow and free cash flow); revenue; corporate revenue; earnings before interest, taxes, depreciation and amortization; net income (loss) (either before or after
interest, taxes, depreciation and/or amortization); changes in the market price of our common stock; economic value-added; acquisitions, licenses, collaborations or strategic transactions; financing or other capital raising transactions; operating
income (loss); return on capital, assets, equity, or investment; stockholder returns; return on sales; total shareholder return; gross or net profit levels; productivity; expense efficiency; margins; operating efficiency; satisfaction of, or other
achievement metrics relating to, key third parties; working capital; earnings (loss) per share of the company&#146;s common stock; bookings, new bookings or renewals; sales or market shares; number of prescriptions or prescribing physicians;
coverage decisions; leadership development, employee retention and recruiting and other human resources matters; operating income and/or net annual recurring revenue, any of which may be measured in absolute terms, as compared to any incremental
increase, in terms of growth, as compared to results of a peer group, against the market as a whole, compared to applicable market indices and/or measured on a <FONT STYLE="white-space:nowrap">pre-tax</FONT> or
<FONT STYLE="white-space:nowrap">post-tax</FONT> basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each executive officer who is selected to participate in the Bonus Plan will have
a target bonus opportunity set for each performance period. The bonus formulas will be adopted in each performance period by the compensation committee and communicated to each executive. The corporate performance goals will be measured at the end
of each performance period after our financial reports have been published. If the corporate performance goals and individual performance objectives are met, payments will be made as soon as practicable following the end of each performance period.
Subject to the rights contained in any agreement between the executive officer and us, an executive officer must be employed by us on the bonus payment date to be eligible to receive a bonus payment. The Bonus Plan will also permit the compensation
committee to approve additional bonuses to executive officers in its sole discretion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">183 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_13a"></A>DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prior <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Program </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the fiscal year ended December&nbsp;31, 2019, we provided compensation to our <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors for their services on our board of directors, other than those associated with Third Rock Ventures or Cowen, pursuant to our <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation policies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation policy generally provides for an annual $25,000 cash retainer;
however, Mr.&nbsp;Raidy, a former member of our board of directors who is affiliated with Cowen, and Dr.&nbsp;Huh&#146;s did not receive any cash retainers. Certain members of our board of directors who are affiliated with Third Rock Ventures, one
of our principal stockholders, provided consulting services to the Company in 2019 for which the Company paid approximately $36,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
addition, upon initial election to our board of directors, Drs. Bruhn, Curnutte and Huh were granted a certain number of shares of our restricted common stock (approximately 25,174 shares for Drs. Bruhn and Curnutte and 93,466&nbsp;shares for
Dr.&nbsp;Huh) and Ms. Shah was granted an option to purchase 25,174&nbsp;shares of our common stock, together, the Initial <FONT STYLE="white-space:nowrap">Pre-IPO</FONT> Director Grants. Ms. Crowell did not did however receive an Initial Pre-IPO
Director Grant upon her appointment to the board of directors in December 2019. She received a grant for 25,174&nbsp;shares in March 2020. The Initial <FONT STYLE="white-space:nowrap">Pre-IPO</FONT> Director Grants vest on the last date of each
calendar quarter after the applicable <FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s commencement of his or her service to our company at a rate of approximately 1,573&nbsp;shares for Ms. Shah and Drs. Bruhn and Curnutte and
5,841 for Dr.&nbsp;Huh, subject to continued service to our company through each applicable vesting date. Upon a &#147;sale event&#148; (as defined in the applicable <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation policy),
the Initial <FONT STYLE="white-space:nowrap">Pre-IPO</FONT> Director Grants will vest in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On or following each anniversary of the
Initial <FONT STYLE="white-space:nowrap">Pre-IPO</FONT> Director Grant, continuing <FONT STYLE="white-space:nowrap">non-employee</FONT> directors are generally entitled to receive a grant of an option to purchase approximately 3,496&nbsp;shares of
our common stock, or an Annual Pre-IPO Director Grants. During the fiscal year ended December 31, 2019, Drs. Bruhn and Curnutte were each granted an option to purchase approximately 3,496&nbsp;shares of our common stock as their Annual <FONT
STYLE="white-space:nowrap">Pre-IPO</FONT> Director Grant; however Dr. Huh did not receive an Annual Pre-IPO Director Grant. The Annual <FONT STYLE="white-space:nowrap">Pre-IPO</FONT> Director Grants vest in equal quarterly installments over one year
from the date of grant, subject to the applicable director&#146;s continued service to our company through each applicable vesting date. Upon a sale event, such grants will vest in full. In addition to her Annual Pre-IPO Director Grant, in March
2019, Dr. Bruhn received an option to purchase 4,055&nbsp;shares of our common stock, which was fully vested as of the date of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
employee director received no additional compensation for their service as a director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We reimbursed all reasonable <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by directors for their attendance at meetings of our board of directors or any committee thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">184 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Non-Employee Director Compensation Policy </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this offering, our board of directors adopted a non-employee director compensation policy, to be effective the day
immediately prior to the date on which the registration statement of which this prospectus forms a part is declared effective by the SEC. The policy is designed to enable us to attract and retain, on a long-term basis, highly qualified non-employee
directors. Under the policy, our non-employee directors will be eligible to receive cash retainers (which will be prorated for partial years of service) and equity awards as set forth below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Annual Retainer for Board Membership</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service on the board of directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional retainer for annual service as non-executive chairperson or lead director of the board
of directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Additional Annual Retainer for Committee Membership</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as audit committee chairperson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as member of the audit committee (other than chair)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as compensation committee chairperson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as member of the compensation committee (other than chair)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as nominating and corporate governance committee chairperson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as member of the nominating and corporate governance committee (other than
chair)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as research and development committee chairperson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as member of the research and development committee (other than chair)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, our policy will provide that, upon initial election or appointment to our board of directors,
each new non-employee director will be granted a one-time grant of a non-statutory stock option to purchase 26,573 shares of our common stock on the date of such director&#146;s election or appointment to the board of directors, or the Director
Initial Grant. The Director Initial Grant will vest in substantially equal monthly installments over three years. On the date of each annual meeting of stockholders of our company following the completion of this offering, each non-employee director
who will continue as a non-employee director following such meeting will be granted an annual award of a non-statutory stock option to purchase 13,286 shares of common stock, or the Director Annual Grant. The Director Annual Grant will vest in equal
quarterly installments over one year and will vest in full on the earlier of the one-year anniversary of the grant date or on the date of our next annual meeting of stockholders. The Director Initial Grant and Director Annual Grant are subject to
full acceleration vesting upon the sale of our company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate amount of compensation, including both equity compensation and cash
compensation, paid to any non-employee director in a calendar year period will not exceed $1,000,000 in the first calendar year such individual becomes a non-employee director and $750,000 in any other calendar year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will reimburse all reasonable out-of-pocket expenses incurred by directors for their attendance at meetings of our board of directors or
any committee thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Employee directors will receive no additional compensation for their service as a director. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">185 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides information regarding the total compensation that was earned by or paid to each of our <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors during the fiscal year ended December&nbsp;31, 2019. Dr.&nbsp;Coulie, who is our Chief Executive Officer, did not receive any additional compensation for his service as a director. The
compensation received by Dr.&nbsp;Coulie, as a named executive officer of our company, is presented in &#147;Executive Compensation&#151;2019 Summary Compensation Table&#148; above. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees<BR>Earned&nbsp;or<BR>Paid<BR>in Cash<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Suzanne Bruhn, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">John Curnutte, M.D., Ph.D.,<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Neil Exter, MBA<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Charles Homcy, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,920</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,920</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hoyoung Huh, M.D., Ph.D.,<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kevin Raidy<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Smital Shah, MBA<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">132,498</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">153,074</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gayle Crowell<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Mr. Raidy served on our board of directors in 2019, and resigned as a director immediately prior to the public filing of the registration statement of which this prospectus is a part. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amounts reported represent the aggregate grant date fair value of the stock option awards granted to the <FONT STYLE="white-space:nowrap">non-employee</FONT> directors in the fiscal year ended December&nbsp;31,
2019, calculated in accordance with FASB ASC Topic&nbsp;718. Such grant date fair values do not take into account any estimated forfeitures. The assumptions used in calculating the grant date fair value of the stock option awards reported in this
column are set forth in note&nbsp;11 to our consolidated financial statements included elsewhere in this prospectus. The amounts reported in this column reflect the accounting cost for these stock option awards and do not correspond to the actual
economic value that may be received by the <FONT STYLE="white-space:nowrap">non-employee</FONT> directors upon the vesting of the stock option awards or any sale of the underlying shares of common stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of December&nbsp;31, 2019, Dr.&nbsp;Bruhn held 29,278&nbsp;shares of restricted stock and options to purchase 7,551 shares of our common stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of December&nbsp;31, 2019, Dr.&nbsp;Curnutte held 29,278&nbsp;shares of restricted stock and an option to purchase 3,496&nbsp;shares of our common stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of December&nbsp;31, 2019, Mr.&nbsp;Exter did not hold any outstanding equity awards. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of December 31, 2019, Dr. Homcy held 69,929&nbsp;shares of restricted stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of December&nbsp;31, 2019, pH Pharma Co. Ltd., or pH Pharma held 99,759&nbsp;shares of restricted stock. Dr. Huh has a majority ownership in pH Pharma and has voting power over the shares. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As of December&nbsp;31, 2019, Mr.&nbsp;Raidy did not hold any outstanding equity awards. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Ms. Shah has served as a member of the board of directors since March 2019 and her board fees were prorated accordingly. As of December&nbsp;31, 2019, Ms. Shah held an option to purchase 25,174&nbsp;shares of our common
stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Ms. Crowell has served as a member of the board of directors since December 2019 and her board fees were prorated accordingly. As of December 31, 2019, Ms. Crowell did not hold any outstanding equity awards.
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">186 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_14"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the compensation arrangements, including employment, termination of employment and change in control arrangements, with our
directors and executive officers, including those discussed in the sections entitled &#147;Management,&#148; &#147;Executive Compensation&#148; and &#147;Director Compensation,&#148; and the registration rights described in the section entitled
&#147;Description of Capital Stock&#151;Registration Rights,&#148; the following is a description of each transaction since January&nbsp;1, 2017 and each currently proposed transaction in which: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we have been or are to be a participant; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amounts involved exceeded or will exceed the lesser of $120,000 or 1% of the average of our total assets at
year end for the last two completed fiscal years; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the
immediate family of the foregoing persons, had or will have a direct or indirect material interest. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Private Placements of Securities
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series A redeemable convertible preferred stock financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From August 2015 through March 2018, we sold an aggregate of 56,000,000 shares of our Series A redeemable convertible preferred stock at a
purchase price of $1.00 per share, for an aggregate purchase price of $56.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All purchasers of our Series A redeemable
convertible preferred stock are entitled to specified registration rights. See the section entitled &#147;Description of Capital Stock&#151;Registration Rights&#148; for more information regarding these registration rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Series A redeemable convertible preferred stock purchased by members of our board of directors or their
affiliates and holders of more than 5% of our outstanding capital stock. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series A</B><br><B>redeemable<BR>convertible<BR>preferred<BR>stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>purchase</B><br><B>price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Third Rock
Ventures<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">pH Pharma Co., Ltd.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 39,750,000 shares held by Third Rock Ventures III, L.P., or TRV III, and 15,250,000 shares held by Third Rock Ventures IV, L.P., or TRV IV. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Hoyoung Huh, M.D., Ph.D., our lead director, has a majority ownership in pH Pharma, and has voting power over the shares. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series B redeemable convertible preferred stock financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From July 2018 through November 2018, we sold an aggregate of 49,501,221 shares of our Series B redeemable convertible preferred stock at a
purchase price of $1.3767 per share, for an aggregate purchase price of approximately $68.1&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All purchasers of our Series B
redeemable convertible preferred stock are entitled to specified registration rights. See the section entitled &#147;Description of Capital Stock&#151;Registration Rights&#148; for more information regarding these registration rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">187 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Series B redeemable convertible preferred stock purchased
by members of our board of directors or their affiliates and holders of more than 5% of our outstanding capital stock. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series B</B><br><B>redeemable<BR>convertible<BR>preferred<BR>stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>purchase<BR>price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Cowen Healthcare
Investments<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,895,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,999,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Eventide Asset Management LLC<SUP
STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,895,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,999,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bernard Coulie and Barbara Leyman, as Trustees of The Coulie/Leyman Family Trust<SUP
STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">181,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hans Hull</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,319</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 10,154,302 shares of Series B redeemable convertible preferred stock held by Cowen Healthcare Investments II LP, or Cowen II and (b) 741,317 shares of Series B redeemable convertible preferred stock held
by CHI EF II LP, or CHI EF II. Cowen Healthcare Investments II GP LLC is the sole general partner of Cowen II and CHI EF II. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 7,263,746 shares of Series B redeemable convertible preferred stock held by Eventide Gilead Fund and (b) 3,631,873 shares of Series B redeemable convertible preferred stock held by Eventide
Healthcare&nbsp;&amp; Life Sciences Fund. Eventide Gilead Fund and Eventide Healthcare&nbsp;&amp; Life Sciences Fund are registered investment companies for which Eventide Asset Management, LLC acts as investment advisor. Eventide Asset Management,
LLC has voting and investment power with respect to the shares. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 181,594 shares of Series B redeemable convertible preferred stock held by Bernard Coulie and Barbara Leyman, as Trustees of The Coulie/Leyman Family Trust, or Coulie/Leyman Family Trust, of which
Dr.&nbsp;Coulie and his spouse are the sole trustees. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series C redeemable convertible preferred stock financing
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From December 2019 through February 2020, we sold an aggregate of 54,888,058 shares of our Series&nbsp;C redeemable convertible
preferred stock at a purchase price of $1.83 per share, for an aggregate purchase price of approximately $100.4&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All
purchasers of our Series C redeemable convertible preferred stock are entitled to specified registration rights. See the section entitled &#147;Description of Capital Stock&#151;Registration Rights&#148; for more information regarding these
registration rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Series C redeemable convertible preferred stock purchased by our executive
officers, members of our board of directors or their affiliates and holders of more than 5% of our outstanding capital stock. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series C<BR>redeemable<BR>convertible<BR>preferred<BR>stock </B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>purchase<BR>price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Novartis Institutes for BioMedical Research,
Inc.<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,928,962</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Cowen Healthcare
Investments<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,732,240</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Eventide Asset Management LLC<SUP
STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,464,480</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redmile Biopharma Investments II,
L.P.<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,661,202</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Keith Cummings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Sloger Hull Family Trust<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barbara Howes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 10,928,962 shares of Series C redeemable convertible preferred stock held by Novartis. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 2,548,025 shares of Series C redeemable convertible preferred stock held by Cowen Healthcare Investments II LP, or Cowen II and (b) 184,215 shares of Series C redeemable convertible preferred stock held
by CHI EF II LP, or CHI EF II. Cowen Healthcare Investments II GP LLC is the sole general partner of Cowen II and CHI EF II. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 3,825,136 shares of Series C redeemable convertible preferred stock held by Mutual Fund Series Trust, on behalf of Eventide Gilead Fund, and (b) 1,639,344 shares of Series C redeemable convertible
preferred stock held by Mutual Fund Series Trust, on behalf of Eventide Healthcare &amp; Life Sciences Fund. Eventide Gilead Fund and Eventide Healthcare&nbsp;&amp; Life Sciences Fund are registered investment companies for which Eventide Asset
Management, LLC acts as investment advisor. Eventide Asset Management, LLC has voting and investment power with respect to the shares. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">188 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 13,661,202 shares of Series C redeemable convertible preferred stock held by Redmile Biopharma Investments II, L.P. Redmile Group, LLC is the investment manager of Redmile Biopharma Investments II, L.P. and
may be deemed to beneficially own the securities held by the Redmile Biopharma Investments II, L.P. Jeremy C. Green serves as the managing member of Redmile Group, LLC and as such shares voting and dispositive power over the shares held by Redmile
Biopharma Investments II, L.P. Redmile Group, LLC and Mr. Green each disclaim beneficial ownership of these shares, except to the extent of its or his pecuniary interest in such shares, if any. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" >&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 27,322 shares of Series C redeemable convertible preferred stock held by The Sloger Hull Family Trust, of which Hans Hull and his spouse are the trustees. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Novartis Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October 17, 2019,
we entered into the Novartis Agreement with Novartis covering the development and commercialization of our preclinical product candidate, PLN-1474 and up to three additional targets. Upon execution of the Novartis Agreement, we also entered into a
financing side letter with Novartis, whereby Novartis committed to provide up to $30.0 million in equity financing, of which $20.0 million was through the purchase of our Series C redeemable convertible preferred stock and the remaining $10.0
million will be provided for in the Concurrent Private Placement. See &#147;Business&#151;License Agreements&#151; Novartis Collaboration and License Agreements&#148; for additional details on the Novartis Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concurrent Private Placement with Novartis </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Novartis, our strategic partner and one of our existing stockholders has agreed to purchase $10.0 million in shares of our common stock at the
initial public offering price per share, in the Concurrent Private Placement that would close concurrently with, and be conditioned upon consummation of, this offering. The sale of such shares to Novartis will not be registered under the Securities
Act of 1933, as amended, and these shares will be subject to certain restrictions on transfer pursuant to applicable securities laws and these shares are subject to a 180-day lock-up agreement with the underwriters in this offering. The closing of
this offering is not conditioned upon the closing of the Concurrent Private Placement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participation in this Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our principal stockholders including stockholders affiliated with certain of our directors, have indicated an interest in purchasing
a substantial amount of the shares of our common stock offered in this offering at the initial public offering price and on the same terms and conditions as the other purchasers in this offering. However, because indications of interest are not
binding agreements or commitments to purchase, the underwriters could sell more, fewer or no shares to any of these potential purchasers, and any of these potential purchasers could determine to purchase more, fewer or no shares in this offering.
The underwriters will receive the same underwriting discounts and commissions on any shares purchased by these parties as they will on any other shares sold to the public in this offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Agreements with Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Investors&#146; rights agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, we entered into an Amended and Restated Investors&#146; Rights Agreement, which we refer to as our investors&#146; rights
agreement, with certain holders of our outstanding redeemable convertible preferred stock, including entities with which certain of our directors are affiliated. After the completion of this offering, the holders of shares of our common stock
issuable in connection with the automatic conversion of all outstanding shares of our redeemable convertible preferred stock into common stock, are entitled to rights with respect to the registration of their shares following this offering under the
Securities Act. See the section entitled &#147;Description of Capital Stock&#151;Registration Rights&#148; for more information regarding these registration rights. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Right of first refusal and <FONT STYLE="white-space:nowrap">co-sale</FONT> agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, we entered into an Amended and Restated Right of First Refusal and <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement,
which we refer to as our right of first refusal and <FONT STYLE="white-space:nowrap">co-sale</FONT> agreement, which imposes restrictions on certain holders with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">189 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respect to the transfer of our capital stock. Upon the completion of this offering, the right of first refusal and <FONT STYLE="white-space:nowrap">co-sale</FONT> agreement will terminate and the
restrictions on the transfer of our capital stock set forth in this agreement will no longer apply. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Voting agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, we entered into an Amended and Restated Voting Agreement we refer to as our voting agreement, under which certain holders of
our capital stock, including persons who hold more than 3% of our outstanding capital stock and entities with which certain of our directors are affiliated, have agreed to vote their shares on certain matters, including with respect to the election
of directors. Upon the completion of this offering, the voting agreement will terminate and none of our stockholders will have any special rights regarding the election or designation of members of our board of directors or the voting of our capital
stock of the company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Consulting or research agreements with related parties </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain employees of Third Rock Ventures, one of our stockholders, provide consulting services to us. Consulting service expenses of $54,000
and $36,000 were recorded for the years ended December&nbsp;31, 2018 and 2019, respectively. The consulting fees were paid in consideration for certain ordinary course business operations and management consulting services provided to us from time
to time by individuals related to Third Rock Ventures. There is no written agreement for the services provided to us by Third Rock Ventures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Charitable contributions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2018 and 2019, we made charitable contributions to the University of California, San Francisco Foundation, or the UCSF Foundation, which
were directed to support research performed in the laboratories of two of our scientific founders. Charitable contributions made to the UCSF Foundation were $0.5&nbsp;million and $0.3 million during the years ended December 31, 2018 and 2019,
respectively, which were directed to support research performed in the laboratories of two of our scientific founders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officer and Director
Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See the sections entitled &#147;Executive Compensation&#148; and &#147;Director Compensation&#148; for information
regarding compensation of our executive officers and directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than as described above, since January&nbsp;1, 2017, we have not entered into any transactions, nor are there any currently proposed
transactions, between us and a related party where the amount involved exceeds, or would exceed, the lesser of $120,000 or 1% of the average of our total assets at year end for the last two completed fiscal years and in which any related person had
or will have a direct or indirect material interest. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this offering, we intend to enter into new agreements to indemnify our directors, executive officers, and other officers as
determined from time to time by our board of directors or our compensation committee. These agreements and our amended and restated bylaws will, among other things, require us to indemnify these individuals for certain expenses (including
attorneys&#146; fees), judgments, fines and settlement amounts reasonably incurred by such person in certain actions or proceeding, including any action, on account of any services undertaken by such person on behalf of our company or that
person&#146;s status as a member of our board of directors to the maximum extent allowed under Delaware law. We are also required by these agreements to indemnify these individuals for certain expenses (including attorney&#146;s fees) in certain
action or proceeding by or in our right. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">190 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policies for Approval of Related Party Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to this offering, our board of directors adopted and approved a Related Person Transaction Policy, to be effective upon the effectiveness
of the registration statement of which this prospectus is a part. The policy sets forth our procedures for the identification, review, consideration and approval or ratification of related person transactions. For purposes of our policy only, a
related person transaction is any transaction in which the we are a participant and a related person has a direct or indirect material interest. Transactions involving compensation for services provided to us as an employee or director are not
covered by this policy. A related person is any executive officer, director, director nominee, or beneficial owner of more than 5% of any class of our voting securities, including any of their immediate family members. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the policy, we shall provide our audit committee with all material information regarding such related person transaction. Our audit
committee shall review the material facts of all related person transactions, taking into account, among other factors that it deems appropriate, whether the related person transaction is on terms no less favorable to us than terms generally
available in a transaction with an unaffiliated third-party under the same or similar circumstances and the extent of the related person&#146;s interest in the transaction. To facilitate identification of related person transactions, we will compile
a list of all related persons and related person affiliates, and updated the list at least annually, based on questionnaires completed by our directors and officers. Each of our directors, officers and director nominees shall also be responsible for
promptly notifying us of any change in the identity of relevant related party affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, under our Code of Conduct, which
we intend to adopt in connection with this offering, our employees and directors have an affirmative responsibility to disclose any transaction or relationship that reasonably could be expected to give rise to a conflict of interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In considering related person transactions, our audit committee, or other independent body of our board of directors, will take into account
the relevant available facts and circumstances including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks, costs, and benefits to us; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact on a director&#146;s independence in the event that the related person is a director, immediate family
member of a director, or an entity with which a director is affiliated; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of other sources for comparable services or products; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms available to or from, as the case may be, unrelated third parties or to or from employees generally.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The policy requires that, in determining whether to approve, ratify, or reject a related person transaction, our audit
committee, or other independent body of our board of directors, must consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, our best interests and those of our stockholders, as our audit committee, or
other independent body of our board of directors, determines in the good faith exercise of its discretion. All of the transactions described above were entered into prior to the adoption of the written policy, but all were approved by our board of
directors considering similar factors to those described above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">191 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_15"></A>PRINCIPAL STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents information concerning the beneficial ownership of the shares of our common stock as of May&nbsp;15, 2020 by:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person we know to be the beneficial owner of 5% or more of our outstanding shares of our capital stock;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our named executive officers; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of our current executive officers and directors as a group. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have determined beneficial ownership in accordance with SEC rules. The information does not necessarily indicate beneficial ownership for
any other purpose. Under these rules, a person is deemed to be a beneficial owner of our common stock if that person has a right to acquire ownership within 60 days by the exercise of options or the conversion of our redeemable convertible preferred
stock. A person is also deemed to be a beneficial owner of our common stock if that person has or shares voting power, which includes the power to vote or direct the voting of our common stock, or investment power, which includes the power to
dispose of or to direct the disposition of such capital stock. Except in cases where community property laws apply or as indicated in the footnotes to this table, we believe that each stockholder identified in the table possesses sole voting and
investment power over all shares of common stock shown as beneficially owned by the stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Percentage of beneficial ownership in
the table below is based on 24,649,540 shares of common stock deemed to be outstanding as of May&nbsp;15, 2020, assuming the automatic conversion of all outstanding shares of our redeemable convertible preferred stock into common stock, immediately
prior to the completion of this offering and the Concurrent Private Placement of $10.0 million of common stock to Novartis (or 666,666&nbsp;shares assuming such shares are sold to Novartis at $15.00&nbsp;per share, the midpoint of the price range on
the cover of this prospectus). The table below assumes that the underwriters do not exercise their option to purchase additional shares. Shares of common stock subject to options that are currently exercisable or exercisable within 60 days of
May&nbsp;15, 2020 are considered outstanding and beneficially owned by the person holding the options for the purpose of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage
ownership of any other person. Unless otherwise indicated below, the address of each individual listed below is c/o Pliant Therapeutics, Inc., 260 Littlefield Avenue, South San Francisco, California 94080. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our principal stockholders including stockholders affiliated with certain of our directors, have indicated an interest in
purchasing a substantial amount of the shares of our common stock offered in this offering at the initial public offering price and on the same terms and conditions as the other purchasers in this offering. However, because indications of interest
are not binding agreements or commitments to purchase, the underwriters could sell more, fewer or no shares to any of these potential purchasers, and any of these potential purchasers could determine to purchase more, fewer or no shares in this
offering. The underwriters will receive the same underwriting discounts and commissions on any shares purchased by these parties as they will on any other shares sold to the public in this offering. The following table does not reflect any such
potential purchases by these stockholders or their affiliated entities. If any shares are purchased by these stockholders, the number of shares of common stock beneficially owned after this offering and the percentage of common stock beneficially
owned after this offering would increase from that set forth in the table below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and address of beneficial owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>shares<BR>beneficially<BR>owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>of shares<BR>beneficially<BR>owned<BR>before<BR>offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>of<BR>shares<BR>beneficially<BR>owned<BR>after<BR>offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>5% or Greater Stockholders:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Entities affiliated with Third Rock
Ventures<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,972,027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Entities affiliated with Eventide Asset Management
LLC<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,288,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Redmile Biopharma Investments II,
L.P.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,910,657</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Entities affiliated with Cowen Healthcare
Investments<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,905,994</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Novartis Institutes for BioMedical Research,
Inc.<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,528,526</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">192 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and address of beneficial owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>shares<BR>beneficially<BR>owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>of shares<BR>beneficially<BR>owned<BR>before<BR>offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>of<BR>shares<BR>beneficially<BR>owned<BR>after<BR>offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="12"></TD>
<TD HEIGHT="12" COLSPAN="4"></TD>
<TD HEIGHT="12" COLSPAN="4"></TD>
<TD HEIGHT="12" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Named Executive Officers and Directors:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Bernard Coulie, M.D., Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">636,593</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Keith Cummings, M.D., MBA<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Hans Hull, J.D.<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">202,821</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Hoyoung Huh, M.D., Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Suzanne Bruhn, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,554</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Gayle Crowell<SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">4,720</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">John Curnutte, M.D., Ph.D.,<SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Neil Exter, MBA<SUP STYLE="font-size:85%; vertical-align:top">(13)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Charles Homcy, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(14)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,828</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Smital Shah, MBA<SUP STYLE="font-size:85%; vertical-align:top">(15)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">All executive officers and directors as a group (12 persons)<SUP
STYLE="font-size:85%; vertical-align:top">(16)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,587,324</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents beneficial ownership of less than one percent. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 279,720 shares of common stock held by TRV III, (b) 5,559,440 shares of common stock issuable upon conversion of shares of preferred stock held by TRV III and (c) 2,132,867 shares of common stock
issuable upon conversion of shares of convertible preferred stock held by TRV IV. The general partner of TRV III is Third Rock Ventures GP III, L.P., or TRV GP III LP. The general partner of TRV GP III LP is TRV GP III, LLC, or TRV GP&nbsp;III LLC.
Mark Levin, Kevin Starr and Robert Tepper, M.D. are the managing members of TRV GP III LLC who collectively make voting and investment decisions with respect to shares held by TRV III. The general partner of TRV&nbsp;IV is Third Rock Ventures GP IV,
L.P., or TRV GP IV LP. The general partner of TRV GP IV LP is TRV GP&nbsp;IV, LLC, or TRV GP IV LLC. Abbie Celniker, Ph.D., Dr.&nbsp;Tepper, Craig Muir and Cary Pfeffer, M.D. are the managing members of TRV GP IV LLC who collectively make voting and
investment decisions with respect to shares held by TRV IV. The address for TRV III and TRV IV is 29 Newbury Street, Suite 401, Boston, Massachusetts 02116. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a)&nbsp;1,550,892 shares of common stock issuable upon conversion of shares of convertible preferred stock held by Eventide Gilead Fund and (b)&nbsp;737,233 shares of common stock issuable upon conversion
of preferred stock held by Eventide Healthcare&nbsp;&amp; Life Sciences Fund. Eventide Gilead Fund and Eventide Healthcare&nbsp;&amp; Life Sciences Fund are registered investment companies for which Eventide Asset Management, LLC acts as investment
advisor. Eventide Asset Management, LLC has voting and investment power with respect to the shares. The principal business address of each of Eventide Gilead Fund and Eventide Healthcare&nbsp;&amp; Life Science Fund is One International Place,
Suite&nbsp;#3510, Boston, Massachusetts 02110. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 1,910,657 shares of common stock issuable upon conversion of shares of convertible preferred stock held by Redmile Biopharma Investments II, L.P. Redmile Group, LLC is the investment manager of Redmile
Biopharma Investments II, L.P. and may be deemed to beneficially own the securities held by the Redmile Biopharma Investments&nbsp;II, L.P. Jeremy&nbsp;C. Green serves as the managing member of Redmile Group, LLC and as such shares voting and
dispositive power over the shares held by Redmile Biopharma Investments&nbsp;II, L.P. Redmile Group, LLC and Mr.&nbsp;Green each disclaim beneficial ownership of these shares, except to the extent of its or his pecuniary interest in such shares, if
any. The address for Redmile Biopharma Investments II, L.P., Redmile Group LLC and Mr. Green is One Letterman Drive, Building&nbsp;D, Suite&nbsp;D3-300, San Francisco, California 94129. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a)&nbsp;1,776,549 shares of common stock issuable upon conversion of shares of convertible preferred stock held by Cowen&nbsp;II and (b)&nbsp;129,445 shares of common stock issuable upon conversion of
shares of preferred stock held by CHI EF&nbsp;II. Cowen Healthcare Investments&nbsp;II GP LLC is the sole general partner of Cowen&nbsp;II and CHI EF II. As managing partner of Cowen&nbsp;II and CHI EF II, Kevin&nbsp;J. Raidy exercises sole voting
and investment power of the securities held by Cowen&nbsp;II and CHI EF II. Mr.&nbsp;Raidy disclaims beneficial ownership of the shares held by Cowen&nbsp;II and CHI EF&nbsp;II, except to the extent of any actual pecuniary interest. The address for
Cowen&nbsp;II and CHI EF&nbsp;II is 599 Lexington Avenue, New York, New York 10022. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 1,528,526 shares of common stock issuable upon conversion of shares of convertible preferred stock held by Novartis. In addition, Novartis has agreed to purchase $10.0&nbsp;million of our common stock in a
Concurrent Private Placement at a price per share equal to the public offering price. The percentage of shares beneficially owned after offering for Novartis reflects the purchase of 666,666 shares in the Concurrent Private Placement at $15.00 per
share, the midpoint of the price range on the cover page of this prospectus. Novartis is an indirect wholly owned subsidiary of, and controlled by, Novartis AG. The address for Novartis is 250 Massachusetts Avenue, Cambridge, Massachusetts 02139.
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">193 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a)&nbsp;25,397&nbsp;shares of common stock issuable upon conversion of shares of convertible preferred stock held by Coulie/Leyman Family Trust, of which Dr.&nbsp;Coulie and his spouse are the sole
trustees, (b)&nbsp;448,920&nbsp;shares of common stock held by Coulie/Leyman Family Trust, of which 28,846 shares are subject to repurchase by us at the original purchase price as of May&nbsp;15, 2020, (c) 48,840 shares of common stock held by
Dr.&nbsp;Coulie and (d) 113,436 shares of common stock underlying options held by Dr.&nbsp;Coulie exercisable within 60 days of May&nbsp;15,&nbsp;2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 3,821 shares of common stock issuable upon conversion of shares of convertible preferred stock held by Dr. Cummings, (b) 19,300 shares of common stock held by Dr. Cummings and (c) 67,934 shares of common
stock underlying options held by Dr. Cummings exercisable within 60 days of May 15, 2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 5,079 shares of common stock issuable upon conversion of shares of convertible preferred stock held by Mr.&nbsp;Hull, (b) 3,821 shares of common stock issuable upon conversion of shares of convertible
preferred stock held by The Sloger Hull Family Trust, of which Mr. Hull and his spouse are the trustees, (c)&nbsp;112,167 shares of common stock held by Mr.&nbsp;Hull, of which 4,807 shares are subject to repurchase by us at the original purchase
price as of May&nbsp;15, 2020 (d)&nbsp;27,970 shares held in irrevocable trusts for the benefit of Mr.&nbsp;Hull&#146;s children for which Mr.&nbsp;Hull and his spouse serve as trustees and (e)&nbsp;53,784 shares of common stock underlying options
held by Mr.&nbsp;Hull exercisable within 60 days of May&nbsp;15, 2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a) 139,860 shares of common stock issuable upon conversion of shares of convertible preferred stock held by pH Pharma and (b) 99,759 shares of common stock held by pH Pharma, of which 35,050&nbsp;shares are
subject to repurchase by us at the original purchase price as of May&nbsp;15, 2020. Dr.&nbsp;Huh has a majority ownership in pH Pharma and also has voting power over the shares. Dr.&nbsp;Huh disclaims beneficial ownership of the shares held by pH
Pharma, except to the extent of his proportionate pecuniary interest therein. The address for pH Pharma is 9th Fl., <FONT STYLE="white-space:nowrap">The-K</FONT> Twin Towers, Tower A 50 Jongro <FONT STYLE="white-space:nowrap">1-gil,</FONT> <FONT
STYLE="white-space:nowrap">Jongno-gu,</FONT> Seoul 03142, Korea. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a)&nbsp;35,081&nbsp;shares of common stock held by Dr.&nbsp;Bruhn, of which 1,573&nbsp;shares are subject to repurchase by us at the original purchase price as of May 15, 2020 and (b)&nbsp;5,473 shares of
common stock underlying options held by Dr.&nbsp;Bruhn exercisable within 60 days of May 15, 2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 4,720 shares of common stock underlying options held by Ms. Crowell exercisable within 60 days of May&nbsp;15, 2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a)&nbsp;29,278&nbsp;shares of common stock held by Dr.&nbsp;Curnutte, of which 7,867&nbsp;shares are subject to repurchase by us at the original purchase price as of May 15, 2020 and (b)&nbsp;7,003 shares
of common stock underlying options held by Dr.&nbsp;Curnutte exercisable within 60 days of May 15, 2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(13)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 2,214 shares of common stock underlying options held by Mr. Exter, which commence vesting upon the effectiveness of an IPO by the Company (provided the IPO occurs no later than December 31, 2021),
exercisable within 60 days of May 15, 2020. Mr.&nbsp;Exter is a partner of Third Rock Ventures. Mr.&nbsp;Exter does not have voting or investment power over any of the shares directly held by TRV III and TRV IV referenced in footnote (1)&nbsp;above.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(14)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (a)&nbsp;73,378 shares of common stock held by Dr.&nbsp;Homcy and (b)&nbsp;3,450 shares of common stock underlying options held by Dr. Homcy exercisable within 60 days of May 15, 2020. Dr.&nbsp;Homcy was a
partner of Third Rock Ventures until October 2019 and now serves in an advisory capacity. Dr.&nbsp;Homcy does not have voting or investment power over any of the shares directly held by TRV III and TRV IV referenced in footnote (1)&nbsp;above.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(15)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 12,539 shares of common stock underlying options held by Ms.&nbsp;Shah exercisable within 60 days of May&nbsp;15,&nbsp;2020. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(16)</SUP>&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See footnotes 6 through 15 above; also includes &#201;ric Lefebvre and Barbara Howes, who are executive officers but not named executive officers. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">194 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_16"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the completion of this offering and the Concurrent Private Placement, our authorized capital stock will consist of 300,000,000 shares of
common stock, par value $0.0001 per share, and 10,000,000&nbsp;shares of preferred stock, par value $0.0001 per share, all of which will be undesignated, and there will be 34,243,012&nbsp;shares of common stock outstanding and no shares of preferred
stock outstanding. As of May 15, 2020, we had approximately 126 record holders of our capital stock. All of our outstanding shares of redeemable convertible preferred stock will convert into shares of our common stock immediately prior to the
completion of this offering and the Concurrent Private Placement. In addition, upon the completion of this offering and the Concurrent Private Placement, options to purchase 2,607,939&nbsp;shares of our common stock will be outstanding and
4,900,000&nbsp;shares of our common stock will be reserved for future grants under our equity incentive plans. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following
description of our capital stock and provisions of our amended and restated certificate of incorporation and bylaws are summaries of material terms and provisions and are qualified by reference to our amended and restated certificate of
incorporation and bylaws, copies of which have been filed with the SEC as exhibits to the registration statement of which this prospectus is a part. The descriptions of our common stock and preferred stock reflect amendments to our amended and
restated certificate of incorporation and bylaws that will become effective immediately prior to the completion of this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the completion of this offering, we will be authorized to issue one class of common stock. Holders of our common stock are
entitled to one vote for each share of common stock held of record for the election of directors and on all matters submitted to a vote of stockholders. Except as described under &#147;Anti-takeover Effects of Delaware Law and Provisions of our
Amended and Restated Certificate of Incorporation and Bylaws&#148; below, a majority vote of the holders of common stock is generally required to take action under our amended and restated certificate of incorporation and bylaws. Holders of our
common stock are entitled to receive dividends ratably, if any, as may be declared by our board of directors out of legally available funds, subject to any preferential dividend rights of any preferred stock then outstanding. Upon our dissolution,
liquidation or winding up, holders of our common stock are entitled to share ratably in our net assets legally available after the payment of all our debts and other liabilities, subject to the preferential rights of any preferred stock then
outstanding. Holders of our common stock have no preemptive, subscription, redemption or conversion rights and no sinking fund provisions are applicable to our common stock. The rights, preferences and privileges of holders of common stock are
subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that we may designate and issue in the future. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately prior to
completion of this offering, all outstanding shares of our redeemable convertible preferred stock will be converted into shares of our common stock. Upon the completion of this offering, our board of directors will be authorized, without action by
the stockholders, to designate and issue up to an aggregate of 10,000,000 shares of preferred stock in one or more series. Our board of directors can designate the rights, preferences and privileges of the shares of each series and any of its
qualifications, limitations or restrictions. Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of common stock. The
issuance of preferred stock, while providing flexibility in connection with possible future financings and acquisitions and other corporate purposes could, under certain circumstances, have the effect of restricting dividends on our common stock,
diluting the voting power of our common stock, impairing the liquidation rights of our common stock, or delaying, deferring or preventing a change in control of our company, which might harm the market price of our common stock. See also
&#147;&#151;Anti-takeover effects of Delaware Law and provisions of our amended and restated certificate of incorporation and bylaws&#151;Provisions of our amended and restated certificate of incorporation and bylaws&#151;Undesignated preferred
stock&#148; below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">195 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors will make any determination to issue such shares based on its
judgment as to our company&#146;s best interests and the best interests of our stockholders. Upon the completion of this offering, we will have no shares of preferred stock outstanding and we have no current plans to issue any shares of preferred
stock following completion of this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Options </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March 31, 2020, we had outstanding options to purchase 2,607,939&nbsp;shares of our common stock, with a per share weighted-average
exercise price of $4.69 under our 2015 Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the completion of this offering and the Concurrent Private Placement, the holders of 23,098,695 shares of our common stock, including
shares issuable upon the automatic conversion of our redeemable convertible preferred stock, or their permitted transferees, which we refer to as our registrable securities, are entitled to rights with respect to the registration of these securities
under the Securities Act. These rights are provided under the terms of the investor rights agreement. The investor rights agreement includes demand registration rights, short-form registration rights and piggyback registration rights. All fees,
costs and expenses incurred in connection with registrations under the investor rights agreement will be borne by us, and all selling expenses, including underwriting discounts and selling commissions, will be borne by the holders of the shares
being registered. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Demand registration rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beginning 180 days after the effective date of this registration statement, the holders of our registrable securities are entitled to demand
registration rights. Under the terms of our investor rights agreement, we will be required, upon the request of holders of at least a majority of our outstanding registrable securities, to file a registration statement and effect the registration of
these shares for public resale, unless our board of directors decides in good faith that such registration would be materially detrimental to us and our stockholders under the circumstances. We are required to effect up to two registrations pursuant
to this provision of the investor rights agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Short form registration rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the completion of this offering, the holders of our registrable securities are also entitled to short form registration rights. Pursuant
to our investor rights agreement, if we are eligible to file a registration statement on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> upon the request of holders of at least 20% of our outstanding registrable securities to sell registrable
securities with an anticipated aggregate offering amount of at least $5.0&nbsp;million net of certain expenses related to the offering, we will be required to effect a registration of such shares, unless our board of directors decides in good faith
that such registration would be materially detrimental to us and our stockholders under the circumstances. We are required to effect up to two registrations in any twelve-month period pursuant to this provision of the investor rights agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Piggyback registration rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of our registrable securities are entitled to piggyback registration rights. If we register any of our securities either for our
own account or for the account of other security holders, the holders of our outstanding registrable securities are entitled to include their shares in the registration. Subject to certain exceptions contained in the investor rights agreement, we
and the underwriters may limit the number of shares included in the underwritten offering if the underwriters determine that marketing factors require a limitation of the number of shares to be underwritten. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">196 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Indemnification </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our investor rights agreement contains customary cross-indemnification provisions, under which we are obligated to indemnify holders of
registrable securities in the event of material misstatements or omissions in the registration statement attributable to us, and they are obligated to indemnify us for material misstatements or omissions attributable to them. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Expenses of registration </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay the registration expenses, subject to certain limited exceptions contained in the investor rights agreement, of the holders of the
shares registered pursuant to the demand, short form and piggyback registration rights described above, including the expenses of one counsel for the selling holders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Expiration of registration rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registration rights granted under the investor rights agreement will terminate upon the earlier of (i)&nbsp;a deemed liquidation event, as
defined in our amended and restated certificate of incorporation (as in effect prior to the completion of this offering) or certain other events constituting a sale of the company, (ii)&nbsp;at such time after our initial public offering when all
registrable securities could be sold under Rule 144 of the Securities Act or a similar exemption without limitation during a three-month period without registration or (iii)&nbsp;the fifth anniversary of our initial public offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Effects of Delaware Law and Provisions of Our Amended and Restated Certificate of Incorporation and Bylaws </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain provisions of the Delaware General Corporation Law and of our amended and restated certificate of incorporation and bylaws that will
become effective immediately prior to the completion of this offering could have the effect of delaying, deferring or discouraging another party from acquiring control of us. These provisions, which are summarized below, are expected to discourage
certain types of coercive takeover practices and inadequate takeover bids and, as a consequence, they might also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover
attempts. These provisions are also designed in part to encourage anyone seeking to acquire control of us to first negotiate with our board of directors. These provisions might also have the effect of preventing changes in our board of directors or
management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders might otherwise deem to be in their best interests. However, we believe that the advantages gained by protecting our ability
to negotiate with any unsolicited and potentially unfriendly acquirer outweigh the disadvantages of discouraging such proposals, including those priced above the then-current market value of our common stock, because, among other reasons, the
negotiation of such proposals could improve their terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Delaware takeover statute </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon completion of this offering, we will be subject to the provisions of Section&nbsp;203 of the Delaware General Corporation Law. In general,
Section&nbsp;203 prohibits a publicly held Delaware corporation from engaging in a &#147;business combination&#148; with an &#147;interested stockholder&#148; for a three-year period following the time that this stockholder becomes an interested
stockholder, unless the business combination is approved in a prescribed manner. Under Section&nbsp;203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">before the stockholder became interested, our board of directors approved either the business combination or the
transaction which resulted in the stockholder becoming an interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the
interested stockholder owned at least 85% of the voting stock of the corporation </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">197 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and also officers, and employee
stock plans, in some instances, but not the outstanding voting stock owned by the interested stockholder; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at or after the time the stockholder became interested, the business combination was approved by our board of
directors and authorized at an annual or special meeting of the stockholders by the affirmative vote of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding voting stock which is not owned by the interested stockholder.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;203 defines a business combination to include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any merger or consolidation involving the corporation and the interested stockholder; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any sale, transfer, lease, pledge, exchange, mortgage or other disposition involving the interested stockholder
of 10% or more of the assets of the corporation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock
of the corporation to the interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to exceptions, any transaction involving the corporation that has the effect of increasing the
proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other
financial benefits provided by or through the corporation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, Section&nbsp;203 defines an interested
stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Provisions of our amended and restated certificate of incorporation and bylaws </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and bylaws to be in effect immediately prior to completion of this offering will include
a number of provisions that may have the effect of delaying, deferring or discouraging another party from acquiring control of us and encouraging persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with
our board of directors rather than pursue <FONT STYLE="white-space:nowrap">non-negotiated</FONT> takeover attempts. These provisions include the items described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Board composition and filling vacancies</I>. In accordance with our amended and restated certificate of incorporation, our board is divided
into three classes serving staggered three-year terms, with one class being elected each year. Our amended and restated certificate of incorporation also provides that directors may be removed only for cause and then only by the affirmative vote of
the holders of <FONT STYLE="white-space:nowrap">two-thirds</FONT> or more of the shares then entitled to vote at an election of directors. Furthermore, any vacancy on our board of directors, however occurring, including a vacancy resulting from an
increase in the size of our board, may only be filled by the affirmative vote of a majority of our directors then in office even if less than a quorum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>No written consent of stockholders</I>. Our amended and restated certificate of incorporation provides that all stockholder actions are
required to be taken by a vote of the stockholders at an annual or special meeting, and that stockholders may not take any action by written consent in lieu of a meeting. This limit may lengthen the amount of time required to take stockholder
actions and would prevent the amendment of our bylaws or removal of directors by our stockholder without holding a meeting of stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Meetings of stockholders</I>. Our amended and restated bylaws provide that only a majority of the members of our board of directors then in
office may call special meetings of stockholders and only those matters set forth in the notice of the special meeting may be considered or acted upon at a special meeting of stockholders. Our amended and restated bylaws limit the business that may
be conducted at an annual meeting of stockholders to those matters properly brought before the meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">198 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Advance notice requirements</I>. Our amended and restated bylaws establish advance notice
procedures with regard to stockholder proposals relating to the nomination of candidates for election as directors or new business to be brought before meetings of our stockholders. These procedures provide that notice of stockholder proposals must
be timely given in writing to our corporate secretary prior to the meeting at which the action is to be taken. Generally, to be timely, notice must be received at our principal executive offices not less than 90 days or more than 120 days prior to
the first anniversary date of the annual meeting for the preceding year. The notice must contain certain information specified in our amended and restated bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Amendment to certificate of incorporation and bylaws</I>. As required by the Delaware General Corporation Law, any amendment of our amended
and restated certificate of incorporation must first be approved by a majority of our board of directors, and if required by law or our amended and restated certificate of incorporation, must thereafter be approved by a majority of the outstanding
shares entitled to vote on the amendment, and a majority of the outstanding shares of each class entitled to vote thereon as a class, except that the amendment of the provisions relating to stockholder action, directors, limitation of liability and
the amendment of our amended and restated certificate of incorporation must be approved by not less than <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding shares entitled to vote on the amendment, and not less than <FONT
STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding shares of each class entitled to vote thereon as a class. Our bylaws may be amended by the affirmative vote of a majority vote of the directors then in office, subject to any
limitations set forth in the bylaws; and may also be amended by the affirmative vote of at least two thirds of the outstanding shares entitled to vote on the amendment, voting together as a single class. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Undesignated preferred stock</I>. Our amended and restated certificate of incorporation provides for authorized shares of preferred stock.
The existence of authorized but unissued shares of preferred stock may enable our board of directors to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. For
example, if in the due exercise of its fiduciary obligations, our board of directors were to determine that a takeover proposal is not in the best interests of us or our stockholders, our board of directors could cause shares of preferred stock to
be issued without stockholder approval in one or more private offerings or other transactions that might dilute the voting or other rights of the proposed acquirer or insurgent stockholder or stockholder group. In this regard, our amended and
restated certificate of incorporation grants our board of directors&#146; broad power to establish the rights and preferences of authorized and unissued shares of preferred stock. The issuance of shares of preferred stock could decrease the amount
of earnings and assets available for distribution to holders of shares of common stock. The issuance may also adversely affect the rights and powers, including voting rights, of these holders and may have the effect of delaying, deterring or
preventing a change in control of us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Exclusive forum</I>. Our amended and restated bylaws provide that the Court of Chancery of the
State of Delaware shall be the sole and exclusive forum for any state law claims for:&nbsp;(i)&nbsp;any derivative action or proceeding brought on behalf of our company, (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by
any of our directors or officers to the company or our stockholders, (iii)&nbsp;any action asserting a claim against our company arising pursuant to any provision of the Delaware General Corporation Law or our certificate of incorporation or bylaws,
(iv)&nbsp;any action to interpret, apply, enforce, or determine the validity of our certificate of incorporation or bylaws, or (v)&nbsp;any action asserting a claim against our company governed by the internal affairs doctrine. This exclusive forum
provision will not apply to any causes of action arising under the Securities Act or the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Unless we consent in writing to the selection of an alternate forum,
the United States District Court for the Northern District of California shall be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, as our principal executive office is located in
South San Francisco, California. Although our amended and restated bylaws contain the choice of forum provision described above, it is possible that a court could rule that such provisions are inapplicable for a particular claim or action or that
such provisions are unenforceable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">199 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for our common stock is Computershare Trust Company, N.A.. The transfer agent and registrar&#146;s address
is&nbsp;150 Royall Street, Canton, MA 02021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have applied to list our common stock on The Nasdaq Global Market under the symbol &#147;PLRX.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations of Liability and Indemnification Matters </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a discussion of liability and indemnification, see the section entitled &#147;Management&#151;Limitation on Liability and Indemnification
Matters.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">200 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_17"></A>SHARES ELIGIBLE FOR FUTURE SALE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to this offering, there has been no public market for our common stock. Future sales of our common stock in the public market, or the
availability of such shares for sale in the public market, could adversely affect market prices prevailing from time to time. As described below, since only a limited number of shares will be available for sale shortly after this offering due to
contractual and legal restrictions on resale, sales of substantial amounts of common stock in the public market after the restrictions lapse could adversely affect the prevailing market price for our common stock as well as our ability to raise
equity capital in the future. Nevertheless, sales of our common stock in the public market after such restrictions lapse, or the perception that those sales may occur, could adversely affect the prevailing market price at such time and our ability
to raise equity capital in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sale of Restricted Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the number of shares of common stock outstanding as of March&nbsp;31, 2020, upon completion of this offering and the Concurrent
Private Placement, 34,243,012&nbsp;shares of common stock will be outstanding, assuming no exercise by the underwriters of their option to purchase additional shares and no exercise of options. All of the shares sold in this offering will be freely
tradable. The remaining shares of common stock outstanding after this offering and the Concurrent Private Placement will be restricted as a result of securities laws or <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements as described below.
Following the expiration of the <FONT STYLE="white-space:nowrap">lock-up</FONT> period, all shares will be eligible for resale in compliance with Rule 144 or Rule 701 under the Securities Act. &#147;Restricted securities&#148; as defined under Rule
144 of the Securities Act were issued and sold by us in reliance on exemptions from the registration requirements of the Securities Act. These shares may be sold in the public market only if registered or qualified for an exemption from
registration, such as under Rule 144 or Rule 701 under the Securities Act. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule 144 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, a person who has beneficially owned restricted stock for at least six months would be entitled to sell their securities provided
that (i)&nbsp;such person is not deemed to have been one of our affiliates at the time of, or at any time during the 90 days preceding, a sale and (ii)&nbsp;we are subject to the Exchange Act periodic reporting requirements for at least 90 days
before the sale. Persons who have beneficially owned restricted shares for at least six months but who are our affiliates at the time of, or any time during the 90 days preceding, a sale, would be subject to additional restrictions, by which such
person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of either of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1% of the number of shares then outstanding, which will equal approximately 342,430&nbsp;shares immediately after
this offering and the Concurrent Private Placement assuming no exercise of the underwriters&#146; option to purchase additional shares, based on the number of shares outstanding as of March&nbsp;31, 2020; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the average weekly trading volume of our common stock on The Nasdaq Global Market during the four calendar weeks
preceding the filing of a notice on Form 144 with respect to the sale; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided, in each case, that we have been subject to the
Exchange Act periodic reporting requirements for at least 90 days before the sale. Such sales both by affiliates and by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> must also comply with the manner of sale, current public information and
notice provisions of Rule 144. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule 701 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Rule 701 under the Securities Act, or Rule 701, as in effect on the date of this prospectus, permits resales of shares in reliance upon Rule
144 but without compliance with certain restrictions of Rule 144, including the holding period requirement. Most of our employees, executive officers or directors who purchased shares under a written compensatory plan or contract may be entitled to
rely on the resale provisions of Rule 701, but all holders </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">201 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of Rule 701 shares are required to wait until 90 days after the date of this prospectus before selling their shares. However, substantially all Rule 701 shares are subject to <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements as described below and under &#147;Underwriting&#148; included elsewhere in this prospectus and will become eligible for sale upon the expiration of the restrictions set forth in those agreements.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this offering, we, each of our directors and executive officers, and holders of substantially all of our securities
(including shares issuable to Novartis in the Concurrent Private Placement) have agreed with the underwriters that for a period of 180 days following the date of this prospectus, subject to certain exceptions, we and they will not offer, sell,
assign, transfer, pledge, contract to sell or otherwise dispose of or hedge any shares of our common stock or any securities convertible into or exchangeable for shares of our common stock. The representatives of the underwriters may, in their sole
discretion, at any time, release all or any portion of the shares from the restrictions in this agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule
<FONT STYLE="white-space:nowrap">10b5-1</FONT> Trading Plans </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the completion of this offering, certain of our officers,
directors and significant stockholders may adopt written plans, known as Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> trading plans, in which they will contract with a broker to buy or sell shares of our common stock on a periodic basis to
diversify their assets and investments. Under these <FONT STYLE="white-space:nowrap">10b5-1</FONT> trading plans, a broker may execute trades pursuant to parameters established by the officer, director or stockholder when entering into the plan,
without further direction from such officer, director or stockholder. Such sales would not commence until the expiration of the applicable <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements entered into by such officer, director or
stockholder in connection with this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are party to an investor rights agreement which provides that holders holding 23,098,695&nbsp;shares of our common stock, including shares
issuable upon the automatic conversion of our redeemable convertible preferred stock, have the right to demand that we file a registration statement or request that their shares of our common stock be covered by a registration statement that we are
otherwise filing. See the section entitled &#147;Description of Capital Stock &#151; Registration Rights&#148; in this prospectus. Except for shares purchased by affiliates, registration of their shares under the Securities Act would result in these
shares becoming freely tradable without restriction under the Securities Act immediately upon effectiveness of the registration, subject to the expiration of the <FONT STYLE="white-space:nowrap">lock-up</FONT> period described above and in the
section entitled &#147;Underwriting&#148; in this prospectus, and to the extent such shares have been released from any repurchase option that we may hold. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Incentive Plans </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As soon as
practicable after the completion of this offering, we intend to file a Form <FONT STYLE="white-space:nowrap">S-8</FONT> registration statement under the Securities Act to register shares of our common stock subject to options and other equity awards
outstanding or reserved for issuance under our equity incentive plans. This registration statement will become effective immediately upon filing, and shares covered by this registration statement will thereupon be eligible for sale in the public
markets, subject to Rule 144 limitations applicable to affiliates and any <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements. For a more complete discussion of our equity incentive plans, see &#147;Executive Compensation &#151; Employee
Benefits and Equity Compensation Plans.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">202 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_18"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS TO <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following discussion is a summary of certain U.S. federal income tax
considerations applicable to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders (as defined below) with respect to their ownership and disposition of shares of our common stock issued pursuant to this offering. For purposes of this discussion,
a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder means a beneficial owner of our common stock that is for U.S. federal income tax purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a <FONT STYLE="white-space:nowrap">non-resident</FONT> alien individual; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a foreign corporation or any other foreign organization taxable as a corporation for U.S. federal income tax
purposes; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a foreign estate or trust, the income of which is not subject to U.S. federal income tax on a net income basis.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion does not address the tax treatment of partnerships or other entities that are <FONT
STYLE="white-space:nowrap">pass-through</FONT> entities for U.S. federal income tax purposes or persons that hold their common stock through partnerships or other <FONT STYLE="white-space:nowrap">pass-through</FONT> entities. A partner in a
partnership or other <FONT STYLE="white-space:nowrap">pass-through</FONT> entity that will hold our common stock should consult his, her or its tax advisor regarding the tax consequences of holding and disposing of our common stock through a
partnership or other <FONT STYLE="white-space:nowrap">pass-through</FONT> entity, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is based on current
provisions of the Code, existing and proposed U.S. Treasury Regulations promulgated thereunder, current administrative rulings and judicial decisions, all as in effect as of the date of this prospectus and, all of which are subject to change or to
differing interpretation, possibly with retroactive effect. Any such change or differing interpretation could alter the tax consequences to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders described in this prospectus. There can be no
assurance that the Internal Revenue Service, which we refer to as the IRS, will not challenge one or more of the tax consequences described herein. We assume in this discussion that a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder holds
shares of our common stock as a capital asset within the meaning of Section&nbsp;1221 of the Code, which is generally property held for investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion does not address all aspects of U.S. federal income taxation that may be relevant to a particular <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder in light of that <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s individual circumstances including the alternative minimum tax, or the Medicare tax on net investment income, the
timing of income accruals required under Section 451(b) of the Code, the rules regarding qualified small business stock within the meaning of Section&nbsp;1202 of the Code and any election to apply
<FONT STYLE="white-space:nowrap">Section&nbsp;1400Z-2</FONT> of the Code to gains recognized with respect to shares of our common stock. This discussion also does not address any U.S. state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
taxes or any other aspect of any U.S. federal tax other than the income tax. This discussion also does not consider any specific facts or circumstances that may apply to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder and does not address
the special tax rules applicable to particular <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders, such as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">insurance companies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-exempt</FONT> or governmental organizations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">financial institutions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">brokers or dealers in securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulated investment companies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pension plans; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;controlled foreign corporations,&#148; &#147;passive foreign investment companies,&#148; and corporations
that accumulate earnings to avoid U.S. federal income tax; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;qualified foreign pension funds,&#148; or entities wholly-owned by a &#147;qualified foreign pension
fund&#148;; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and
partners and investors therein); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">203 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons deemed to sell our common stock under the constructive sale provisions of the Code;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons that hold our common stock as part of a straddle, hedge, conversion transaction, synthetic security or
other integrated investment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who have elected to mark securities to market; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who have a functional currency other than the U.S. dollar; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise
as compensation; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain U.S. expatriates. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is for general information only and is not tax advice. Accordingly, all prospective
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders of our common stock should consult their tax advisors with respect to the U.S. federal, state, local and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax consequences of the purchase,
ownership and disposition of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions on our common stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Distributions, if any, on our common stock will constitute dividends for U.S. federal income tax purposes to the extent paid from our current
or accumulated earnings and profits, as determined under U.S. federal income tax principles. If a distribution exceeds our current and accumulated earnings and profits, the excess will be treated as a <FONT STYLE="white-space:nowrap">tax-free</FONT>
return of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s investment, up to such holder&#146;s tax basis in the common stock. Any remaining excess will be treated as capital gain, subject to the tax treatment described below in
&#147;Gain on sale or other taxable disposition of our common stock.&#148; Any such distributions will also be subject to the discussions below under the sections titled &#147;Backup withholding and information reporting&#148; and &#147;Withholding
and information reporting requirements&#151;FATCA.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion in the following two paragraphs in this section,
dividends paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will be subject to withholding of U.S. federal income tax at a 30% rate or such lower rate as may be specified by an applicable income tax treaty between the
United States and such holder&#146;s country of residence. If we or another withholding agent apply <FONT STYLE="white-space:nowrap">over-withholding</FONT> or if a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder does not timely provide us
with the required certification, the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder may be entitled to a refund or credit of any excess tax withheld by timely filing an appropriate claim with the IRS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends that are treated as effectively connected with a trade or business conducted by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holder within the United States and, if an applicable income tax treaty so provides, that are attributable to a permanent establishment or a fixed base maintained by the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder within the United
States, are generally exempt from the 30% withholding tax if the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder satisfies applicable certification and disclosure requirements. However, such U.S. effectively connected income, net of
specified deductions and credits, is taxed at the same graduated U.S. federal income tax rates applicable to United States persons (as defined in the Code). Any U.S. effectively connected income received by a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is a corporation may also, under certain circumstances, be subject to an additional &#147;branch profits tax&#148; at a 30% rate or such lower rate as may be specified by an applicable
income tax treaty between the United States and such holder&#146;s country of residence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of our common stock who claims the benefit of an applicable income tax treaty between the United States and such holder&#146;s country of residence generally will be required to provide a
properly executed IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (or successor form) to the applicable withholding agent and satisfy applicable
certification and other requirements. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders are urged to consult their tax advisors regarding their entitlement to benefits under a relevant income tax treaty. A
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is eligible for a reduced rate of U.S. withholding tax under an income tax treaty may obtain a refund or credit of any excess amounts withheld by timely filing a U.S. tax return with the
IRS. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">204 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gain on sale or other taxable disposition of our common stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussions below under &#147;Backup withholding and information reporting&#148; and &#147;Withholding and information reporting
requirements&#151;FATCA,&#148; a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will not be subject to any U.S. federal income tax on any gain realized upon such holder&#146;s sale or other taxable disposition of shares of our
common stock unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gain is effectively connected with the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s conduct
of a U.S. trade or business and, if an applicable income tax treaty so provides, is attributable to a permanent establishment or a <FONT STYLE="white-space:nowrap">fixed-base</FONT> maintained by such <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holder in the United States, in which case the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will be taxed on a net income basis at the graduated U.S. federal income tax rates applicable to United States persons (as defined in
the Code) and, if the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a foreign corporation, the branch profits tax described above in &#147;Distributions on our common stock&#148; also may apply; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a nonresident alien individual who is present in
the United States for a period or periods aggregating 183&nbsp;days or more in the taxable year of the disposition and certain other conditions are met, in which case the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be subject to a
30% tax (or such lower rate as may be specified by an applicable income tax treaty between the United States and such holder&#146;s country of residence) on the net gain derived from the disposition, which may be offset by certain U.S. source
capital losses of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder, if any (even though the individual is not considered a resident of the United States), provided that the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder has
timely filed U.S. federal income tax returns with respect to such losses; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are, or have been, at any time during the <FONT STYLE="white-space:nowrap">five-year</FONT> period preceding
such sale or other taxable disposition (or the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s holding period, if shorter) a &#147;U.S. real property holding corporation,&#148; unless our common stock is regularly traded on an
established securities market and the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder holds no more than 5% of our outstanding common stock, directly or indirectly, actually or constructively, during the shorter of the <FONT
STYLE="white-space:nowrap">5-year</FONT> period ending on the date of the disposition or the period that the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder held our common stock. Generally, a corporation is a U.S. real property holding
corporation only if the fair market value of its U.S. real property interests equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests plus its other assets used or held for use in a trade or business.
Although there can be no assurance, we do not believe that we are, or have been, a U.S. real property holding corporation, or that we are likely to become one in the future. No assurance can be provided that our common stock will be regularly traded
on an established securities market for purposes of the rules described above </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Backup withholding and information reporting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We must report annually to the IRS and to each <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder the gross amount of the distributions on
our common stock paid to such holder and the tax withheld, if any, with respect to such distributions. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders may have to comply with specific certification procedures to establish that the holder is
not a United&nbsp;States person (as defined in the Code) in order to avoid backup withholding at the applicable rate with respect to dividends on our common stock. Dividends paid to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders subject to
withholding of U.S. federal income tax, as described above in &#147;Distributions on our common stock,&#148; generally will be exempt from U.S. backup withholding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information reporting and backup withholding will generally apply to the proceeds of a disposition of our common stock by a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder effected by or through the U.S. office of any broker, U.S. or foreign, unless the holder certifies its status as a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder and satisfies certain other
requirements, or otherwise establishes an exemption. Generally, information reporting and backup withholding will not apply to a payment of disposition proceeds to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder where the transaction is
effected outside the United States through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a broker. However, for information reporting purposes, dispositions effected through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of
a broker with substantial U.S. ownership or operations generally will be treated in a manner similar to dispositions effected through a U.S. office of a broker. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax
advisors regarding the application of the information reporting and backup withholding rules to them. Copies of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">205 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
information returns may be made available to the tax authorities of the country in which the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder resides or is incorporated under the
provisions of a specific treaty or agreement. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules from a payment to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder can be refunded or
credited against the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s U.S. federal income tax liability, if any, provided that an appropriate claim is filed with the IRS in a timely manner. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Withholding and information reporting requirements&nbsp;&#151; FATCA </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provisions of the Code commonly referred to as the Foreign Account Tax Compliance Act, or FATCA, generally imposes a U.S. federal withholding
tax at a rate of 30% on payments of dividends on our common stock paid to a foreign entity unless (i)&nbsp;if the foreign entity is a &#147;foreign financial institution,&#148; such foreign entity undertakes certain due diligence, reporting,
withholding, and certification obligations, (ii)&nbsp;if the foreign entity is not a &#147;foreign financial institution,&#148; such foreign entity identifies certain of its U.S. investors, if any, or (iii)&nbsp;the foreign entity is otherwise
exempt under FATCA. Under applicable U.S. Treasury regulations, withholding under FATCA currently applies to payments of dividends on our common stock. Currently proposed U.S. Treasury Regulations provide that FATCA withholding does not apply to
gross proceeds from the disposition of property of a type that can produce U.S. source dividends or interest; however, prior versions of the rules would have made such gross proceeds subject to FATCA withholding. Taxpayers (including withholding
agents) can generally rely on the proposed Treasury Regulations until final Treasury Regulations are issued. Under certain circumstances, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder may be eligible for refunds or credits of this
withholding tax. An intergovernmental agreement between the United States and an applicable foreign country may modify the requirements described in this paragraph. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax
advisors regarding the possible implications of this legislation on their investment in our common stock and the entities through which they hold our common stock, including, without limitation, the process and deadlines for meeting the applicable
requirements to prevent the imposition of the 30% withholding tax under FATCA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">206 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_19"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc., Cowen and Company, LLC and Piper Sandler&nbsp;&amp; Co. are acting as joint book-running managers of this
offering and as representatives of the underwriters named below. Subject to the terms and conditions stated in the underwriting agreement dated the date of this prospectus, each underwriter named below has severally agreed to purchase, and we have
agreed to sell to that underwriter, the number of shares of common stock set forth opposite the underwriter&#146;s name in the following table. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cowen and Company, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Piper Sandler&nbsp;&amp; Co.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Needham&nbsp;&amp; Company, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriting agreement provides that the obligations of the underwriters to purchase the shares
included in this offering are subject to approval of legal matters by counsel and to other conditions. The underwriters are obligated to purchase all the shares (other than those covered by the underwriters&#146; option to purchase additional shares
described below) if they purchase any of the shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares sold by the underwriters to the public will initially be offered at the
initial public offering price set forth on the cover of this prospectus. Any shares sold by the underwriters to securities dealers may be sold at a discount from the initial public offering price not to exceed
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. If all the shares are not sold at the initial offering price, the underwriters may change the offering price and the other selling terms. The representatives have advised us that the
underwriters do not intend to make sales to discretionary accounts. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the underwriters sell more shares than the total number set
forth in the table above, we have granted to the underwriters an option, exercisable for 30 days from the date of this prospectus, to purchase up to 1,350,000 additional shares at the public offering price less the underwriting discount. To the
extent the option is exercised, each underwriter must purchase a number of additional shares approximately proportionate to that underwriter&#146;s initial purchase commitment. Any shares issued or sold under the option will be issued and sold on
the same terms and conditions as the other shares that are the subject of this offering. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our principal stockholders
including stockholders affiliated with certain of our directors, have indicated an interest in purchasing a substantial amount of the shares of our common stock offered in this offering at the initial public offering price and on the same terms and
conditions as the other purchasers in this offering. However, because indications of interest are not binding agreements or commitments to purchase, the underwriters could sell more, fewer or no shares to any of these potential purchasers, and any
of these potential purchasers could determine to purchase more, fewer or no shares in this offering. The underwriters will receive the same underwriting discounts and commissions on any shares purchased by these parties as they will on any other
shares sold to the public in this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, our officers, directors and holders of substantially all of our securities (including
shares issuable to Novartis in the Concurrent Private Placement) have agreed that, subject to specified limited exceptions, for a period of 180&nbsp;days from the date of this prospectus, we and they will not, without the prior written consent of
the representatives, dispose of or hedge any shares or any securities convertible into or exchangeable for shares of our common stock. The representatives, in their sole discretion, may release any of the securities subject to these <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements at any time, which, in the case of officers and directors, shall be with notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to this offering, there has been no public market for our shares. Consequently, the initial public offering price for the shares will be
determined by negotiations between us and the representatives. Among the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">207 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
factors considered in determining the initial public offering price will be our results of operations, our current financial condition, our future prospects, our markets, the economic conditions
in and future prospects for the industry in which we compete, our management and currently prevailing general conditions in the equity securities markets, including current market valuations of publicly traded companies considered comparable to our
company. We cannot ensure however, that the price at which the shares will sell in the public market after this offering will not be lower than the initial public offering price or that an active trading market in our shares will develop and
continue after this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have applied to have our shares listed on the Nasdaq Global Market under the symbol &#147;PLRX&#148;.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the underwriting discounts and commissions that we are to pay to the underwriters in connection with this
offering. These amounts are shown assuming both no exercise and full exercise of the underwriters&#146; option to purchase additional shares. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Paid&nbsp;by&nbsp;Pliant&nbsp;Therapeutics,&nbsp;Inc.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>No Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Full Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate that our portion of the total expenses of this offering will be approximately $4.9&nbsp;million.
We have also agreed to reimburse the underwriters for certain FINRA-related and other expenses incurred by them in connection with this offering in an amount up to $40,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the offering, the underwriters may purchase and sell shares in the open market. Purchases and sales in the open market may
include short sales, purchases to cover short positions, which may include purchases pursuant to the option to purchase additional shares, and stabilizing purchases. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Short sales involve secondary market sales by the underwriters of a greater number of shares than they are
required to purchase in the offering. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;Covered&#148; short sales are sales of shares in an amount up to the number of shares represented by the
underwriters&#146; option to purchase additional shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;Naked&#148; short sales are sales of shares in an amount in excess of the number of shares represented by
the underwriters&#146; option to purchase additional shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Covering transactions involve purchases of shares either pursuant to the underwriters&#146; option to purchase
additional shares or in the open market in order to cover short positions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To close a naked short position, the underwriters must purchase shares in the open market. A naked short position
is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the shares in the open market after pricing that could adversely affect investors who purchase in the offering. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To close a covered short position, the underwriters must purchase shares in the open market or must exercise the
option to purchase additional shares. In determining the source of shares to close the covered short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price
at which they may purchase shares through the option to purchase additional shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Stabilizing transactions involve bids to purchase shares so long as the stabilizing bids do not exceed a
specified maximum. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchases to cover short positions and stabilizing purchases, as well as other purchases by the
underwriters for their own accounts, may have the effect of preventing or retarding a decline in the market price of the shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">208 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
They may also cause the price of the shares to be higher than the price that would otherwise exist in the open market in the absence of these transactions. The underwriters may conduct these
transactions on the Nasdaq Global Market, in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or otherwise. If the underwriters commence any of these transactions, they may discontinue them
at any time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Relationships </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
underwriters are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment banking, financial advisory, investment management, principal investment, hedging, financing and
brokerage activities. The underwriters and their respective affiliates may, from time to time, engage in transactions with and perform services for us in the ordinary course of their business for which they may receive customary fees and
reimbursement of expenses. In the ordinary course of their various business activities, the underwriters and their respective affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related
derivative securities) and financial instruments (which may include bank loans and credit default swaps) for their own account and for the accounts of their customers and may at any time hold long and short positions in such securities and
instruments. Such investments and securities activities may involve securities and instruments of ours or our affiliates. The underwriters and their affiliates may also make investment recommendations and publish or express independent research
views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and short positions in such securities and instruments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Affiliates of Cowen and Company, LLC purchased 10,895,619&nbsp;shares of our Series&nbsp;B redeemable convertible preferred stock in our July
2018 Series&nbsp;B redeemable convertible preferred stock financing and 2,732,240 shares of our Series C redeemable convertible preferred stock in our December 2019 Series&nbsp;C redeemable convertible preferred stock financing. Those shares of
redeemable convertible preferred stock will automatically convert into 1,905,994&nbsp;shares of common stock immediately prior to and in connection with the completion of this offering. All such shares of Series C redeemable convertible preferred
stock (and the shares of common stock on an as-converted basis) are subject to the 180-day lock-up restrictions pursuant to FINRA Rule 5110(g) and all such shares of redeemable convertible preferred stock (and the shares of common stock on an
as-converted basis) are subject to a 180-day lock-up agreement with the underwriters in this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed to indemnify the
underwriters against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the underwriters may be required to make because of any of those liabilities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the European Economic Area and the United Kingdom </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In relation to each member state of the European Economic Area and the United Kingdom, or each, a &#147;Relevant State,&#148; no shares have
been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the publication of a prospectus in relation to the shares which has been approved by the competent authority in that Relevant State or, where
appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation), except that offers of shares may be made to the public in that Relevant State at any
time under the following exemptions under the Prospectus Regulation: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) to any legal entity which is a qualified investor as defined
under the Prospectus Regulation; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) to fewer than 150 natural or legal persons (other than qualified investors as defined under the
Prospectus Regulation), subject to obtaining the prior consent of the underwriters for any such offer; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) in any other
circumstances falling within Article 1(4) of the Prospectus Regulation, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that no such offer of shares shall require the Company or any
underwriter to publish a prospectus pursuant to Article&nbsp;3 of the Prospectus Regulation or supplement a prospectus pursuant to Article&nbsp;23 of the Prospectus Regulation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">209 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the expression an &#147;offer to the public&#148; in
relation to any shares in any Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares to be offered so as to enable an investor to decide to purchase or subscribe for any
shares, and the expression &#147;Prospectus Regulation&#148; means Regulation (EU) 2017/1129. References to the Prospectus Regulation includes, in relation to the United Kingdom, the Prospectus Regulation as it forms part of United Kingdom domestic
law by virtue of the European Union (Withdrawal) Act 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the United Kingdom </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document is for distribution only to persons who (i) have professional experience in matters relating to investments and who qualify as
investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 as amended the &#147;Financial Promotion Order&#148;, (ii)&nbsp;are persons falling within Article 49(2)(a)
to (d) (&#147;high net worth companies, unincorporated associations etc.&#148;) of the Financial Promotion Order, (iii) are outside the United Kingdom, or (iv) are persons to whom an invitation or inducement to engage in investment activity (within
the meaning of Section 21 of the Financial Services and Markets Act 2000, as amended, or FSMA) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together
being referred to as &#147;relevant persons&#148;) or otherwise in circumstances which have not resulted and will not result in an offer to the public of the shares in the United Kingdom within the meaning of the FSMA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any person in the United Kingdom that is not a relevant person should not act or rely on the information included in this document or use it
as basis for taking any action. In the United Kingdom, any investment or investment activity that this document relates to may be made or taken exclusively by relevant persons. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in France </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither this prospectus nor any other offering material relating to the shares described in this prospectus has been submitted to the clearance
procedures of the <I>Autorit&eacute; des March&eacute;s Financiers</I> or of the competent authority of another member state of the European Economic Area and notified to the <I>Autorit&eacute; des March&eacute;s Financiers.</I> The shares have not
been offered or sold and will not be offered or sold, directly or indirectly, to the public in France. Neither this prospectus nor any other offering material relating to the shares has been or will be: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">released, issued, distributed or caused to be released, issued or distributed to the public in France; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">used in connection with any offer for subscription or sale of the shares to the public in France.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such offers, sales and distributions will be made in France only: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to qualified investors (<I>investisseurs qualifi&eacute;s</I>) or to a restricted circle of investors (<I>cercle
restreint d&#146;investisseurs</I>), in each case investing for their own account, all as defined in, and in accordance with articles <FONT STYLE="white-space:nowrap">L.411-2,</FONT> <FONT STYLE="white-space:nowrap">D.411-1,</FONT> <FONT
STYLE="white-space:nowrap">D.411-2,</FONT> <FONT STYLE="white-space:nowrap">D.734-1,</FONT> <FONT STYLE="white-space:nowrap">D.744-1,</FONT> <FONT STYLE="white-space:nowrap">D.754-1</FONT> and <FONT STYLE="white-space:nowrap">D.764-1</FONT> of the
French <I>Code mon&eacute;taire et financier</I>; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to investment services providers authorized to engage in portfolio management on behalf of third parties; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in a transaction that, in accordance with article
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.411-2-II-1&deg;</FONT></FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">-or-2&deg;</FONT></FONT> <FONT
STYLE="white-space:nowrap">-or</FONT> 3&deg; of the French <I>Code mon&eacute;taire et financier</I> and article <FONT STYLE="white-space:nowrap">211-2</FONT> of the General Regulations (<I>R&egrave;glement G&eacute;n&eacute;ral</I>) of the
<I>Autorit&eacute; des March&eacute;s Financiers</I>, does not constitute a public offer (<I>appel public &agrave; l&#146;&eacute;pargne</I>). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares may be resold directly or indirectly, only in compliance with articles <FONT STYLE="white-space:nowrap">L.411-1,</FONT> <FONT
STYLE="white-space:nowrap">L.411-2,</FONT> <FONT STYLE="white-space:nowrap">L.412-1</FONT> and <FONT STYLE="white-space:nowrap">L.621-8</FONT> through <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.621-8-3</FONT></FONT> of the
French <I>Code mon&eacute;taire et financier</I>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Hong Kong </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No securities have been offered or sold, and no securities may be offered or sold, in Hong Kong, by means of any document, other than to
persons whose ordinary business is to buy or sell shares or debentures, whether as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">210 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
principal or agent; or to professional investors, as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong (&#147;SFO&#148;) and any rules made under that Ordinance; or in other
circumstances which do not result in the document being a prospectus, as defined in the Companies Ordinance (Cap. 32) of Hong Kong (&#147;CO&#148;) or which do not constitute an offer or invitation to the public for the purpose of the CO or the SFO.
No document, invitation or advertisement relating to the securities has been issued or may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the
contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted under the securities laws of Hong Kong) other than with respect to securities which are or are intended to be disposed of only to persons outside
Hong Kong or only to professional investors, as defined in the SFO and any rules made under that Ordinance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus has not been
registered with the Registrar of Companies in Hong Kong. Accordingly, this prospectus may not be issued, circulated or distributed in Hong Kong, and the securities may not be offered for subscription to members of the public in Hong Kong. Each
person acquiring the securities will be required, and is deemed by the acquisition of the securities, to confirm that he is aware of the restriction on offers of the securities described in this prospectus and the relevant offering documents and
that he is not acquiring, and has not been offered any securities in circumstances that contravene any such restrictions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to
Prospective Investors in Japan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offering has not been and will not be registered under the Financial Instruments and Exchange
Law of Japan (Law No.&nbsp;25 of 1948 of Japan, as amended), or FIEL, and the initial purchaser will not offer or sell any securities, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan (which term as used herein
means any person resident in Japan, including any corporation or other entity organized under the laws of Japan), or to others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in Japan or to, or for the
benefit of, any resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the FIEL and any other applicable laws, regulations and ministerial guidelines of Japan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Singapore </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this
prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares may not be circulated or distributed, nor may the shares be offered or sold, or be made the subject of an
invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i)&nbsp;to an institutional investor under Section&nbsp;274 of the Securities and Futures Act, Chapter 289 of Singapore (the
&#147;SFA&#148;), (ii) to a relevant person pursuant to Section&nbsp;275(1), or any person pursuant to Section&nbsp;275(1A), and in accordance with the conditions specified in Section&nbsp;275, of the SFA, or (iii)&nbsp;otherwise pursuant to, and in
accordance with the conditions of, any other applicable provision of the SFA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where the shares are subscribed or purchased under
Section&nbsp;275 of the SFA by a relevant person which is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole business
of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each
beneficiary of the trust is an individual who is an accredited investor, securities (as defined in Section&nbsp;239(1) of the SFA) of that corporation or the beneficiaries&#146; rights and interest (howsoever described) in that trust shall not be
transferred within six months after that corporation or that trust has acquired the shares pursuant to an offer made under Section&nbsp;275 of the SFA except: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to an institutional investor or to a relevant person defined in Section&nbsp;275(2) of the SFA, or to any person
arising from an offer referred to in Section&nbsp;275(1A) or Section&nbsp;276(4)(i)(B) of the SFA; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">211 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">where no consideration is or will be given for the transfer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">where the transfer is by operation of law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as specified in Section&nbsp;276(7) of the SFA; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (Shares and Debentures)
Regulations 2005 of Singapore. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Solely for the purposes of its obligations pursuant to Section&nbsp;309B of the SFA, we
have determined, and hereby notify all relevant persons (as defined in the CMP Regulations 2018), that the shares are &#147;prescribed capital markets products&#148; (as defined in the CMP Regulations 2018) and Excluded Investment Products (as
defined in MAS Notice SFA <FONT STYLE="white-space:nowrap">04-N12:</FONT> Notice on the Sale of Investment Products and MAS Notice <FONT STYLE="white-space:nowrap">FAA-N16:</FONT> Notice on Recommendations on Investment Products). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Australia </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is not a disclosure document for the purposes of Australia&#146;s Corporations Act 2001 (Cth) of Australia, or Corporations
Act, has not been lodged with the Australian Securities&nbsp;&amp; Investments Commission and is only directed to the categories of exempt persons set out below. Accordingly, if you receive this prospectus in Australia: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You confirm and warrant that you are either: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;sophisticated investor&#148; under section 708(8)(a) or (b)&nbsp;of the Corporations Act;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;sophisticated investor&#148; under section 708(8)(c) or (d)&nbsp;of the Corporations Act and that you
have provided an accountant&#146;s certificate to the Company which complies with the requirements of section 708(8)(c)(i) or (ii)&nbsp;of the Corporations Act and related regulations before the offer has been made; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a person associated with the Company under Section&nbsp;708(12) of the Corporations Act; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;professional investor&#148; within the meaning of section 708(11)(a) or (b)&nbsp;of the Corporations Act.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that you are unable to confirm or warrant that you are an exempt sophisticated investor, associated
person or professional investor under the Corporations Act any offer made to you under this prospectus is void and incapable of acceptance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You warrant and agree that you will not offer any of the securities issued to you pursuant to this prospectus for resale in Australia within
12 months of those securities being issued unless any such resale offer is exempt from the requirement to issue a disclosure document under section 708 of the Corporations Act. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Canada </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in
National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> <I>Prospectus Exemptions </I>or subsection 73.3(1) of the <I>Securities Act </I>(Ontario), and are permitted clients, as defined in National Instrument
<FONT STYLE="white-space:nowrap">31-103</FONT> <I>Registration</I> <I>Requirements, Exemptions and Ongoing Registrant Obligations</I>. Any resale of the shares must be made in accordance with an exemption from, or in a transaction not subject to,
the prospectus requirements of applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may
provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit
prescribed by the securities legislation of the purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these
rights or consult with a legal advisor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">212 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 (or, in the case of securities issued or guaranteed by the
government of a <FONT STYLE="white-space:nowrap">non-Canadian</FONT> jurisdiction, section 3A.4) of National Instrument <FONT STYLE="white-space:nowrap">33-105</FONT> <I>Underwriting Conflicts </I>(NI <FONT STYLE="white-space:nowrap">33-105),</FONT>
the underwriters are not required to comply with the disclosure requirements of NI <FONT STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of interest in connection with this offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Israel </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares offered by this prospectus have not been approved or disapproved by the Israel Securities Authority, or ISA, nor have such shares
been registered for sale in Israel. The shares may not be offered or sold, directly or indirectly, to the public in Israel, absent the publication of a prospectus that has been approved by the ISA. The ISA has not issued permits, approvals or
licenses in connection with this offering or publishing this prospectus, nor has it authenticated the details included herein, confirmed their reliability or completeness, or rendered an opinion as to the quality of the shares being offered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document does not constitute a prospectus under the Israeli Securities Law and has not been filed with or approved by the ISA. In the
State of Israel, this document may be distributed only to, and may be directed only at, and any offer of the shares may be directed only at investors listed in the first addendum to the Israeli Securities Law, or the Addendum, consisting primarily
of joint investment in trust funds, provident funds, insurance companies, banks, portfolio managers, investment advisors, members of the Tel Aviv Stock Exchange Ltd., underwriters, venture capital funds, entities with equity in excess of NIS 50
million and &#147;qualified individuals,&#148; each as defined in the Addendum (as it may be amended from time to time), collectively referred to as qualified investors (in each case purchasing for their own account or, where permitted under the
Addendum, for the accounts of their clients who are investors listed in the Addendum). Qualified investors will be required to submit written confirmation that they fall within the scope of the Addendum, are aware of the meaning of same and agree to
it. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">213 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_20"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the common stock offered hereby will be passed upon for us by Goodwin Procter LLP, Redwood City, California. Goodwin Procter
LLP and certain attorneys at Goodwin Procter LLP have a beneficial interest in an aggregate of less than 1% of our common stock. Certain legal matters in connection with our patents and intellectual property interests will be passed upon for us by
Morrison Foerster LLP, San Francisco, California. Legal matters in connection with the offering will be passed upon for the underwriters by Cooley LLP, San Francisco, California. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_21"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements as of and for the years ended December 31, 2019 and 2018, included in this prospectus have been audited by
Deloitte&nbsp;&amp; Touche LLP, an independent registered public accounting firm, as stated in their report appearing herein. Such financial statements have been so included in reliance upon the report of such firm given upon their authority as
experts in accounting and auditing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_22"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> under the Securities Act with
respect to the shares of common stock being offered by this prospectus, which constitutes a part of the registration statement. This prospectus does not contain all of the information in the registration statement and its exhibits. For further
information with respect to us and the common stock offered by this prospectus, we refer you to the registration statement and its exhibits. Statements contained in this prospectus as to the contents of any contract or any other document referred to
are not necessarily complete, and in each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is qualified in all respects by this reference. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You can read our SEC filings, including the registration statement, over the Internet at the SEC&#146;s website at www.sec.gov. Upon
completion of this offering, we will be subject to the information reporting requirements of the Exchange Act, and we will file reports, proxy statements and other information with the SEC. These reports, proxy statements and other information will
be available via the SEC&#146;s website at www.sec.gov. We also maintain a website at www.plianttrx.com, at which you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished
to, the SEC. However, the information contained in or accessible through our website is not part of this prospectus or the registration statement of which this prospectus forms a part, and investors should not rely on such information in making a
decision to purchase our common stock in this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">214 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc729258_23"></A>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="index"></A>Index to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page(s)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Audited Financial Statements as of and for the years ended December 31, 2018 and
2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_1">Report of Independent Registered Public Accounting Firm</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_2">Balance Sheets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_3">Statements of Operations and Comprehensive Loss</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_4">Statements of Redeemable Convertible Preferred Stock and Stockholders&#146; Deficit
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_5">Statements of Cash Flows</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_6">Notes to Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page(s)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Unaudited Condensed Financial Statements as of and for the three months ended March 31, 2019
and 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_8">Condensed Balance Sheets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_9">Condensed Statements of Operations and Comprehensive (Loss)
Income</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_10">Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders&#146;
 Deficit</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_11">Condensed Statements of Cash Flows</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin729258_12">Notes to Condensed Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_1"></A>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the stockholders and the Board of Directors of Pliant Therapeutics, Inc. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Opinion on the Financial Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
have audited the accompanying balance sheets of Pliant Therapeutics, Inc. (the &#147;Company&#148;) as of December&nbsp;31, 2019 and 2018 and the related statements of operations and comprehensive loss, redeemable convertible preferred stock and
stockholders&#146; deficit, and cash flows, for each of the two years for the period ended December&nbsp;31, 2019, and the related notes (collectively referred to as the &#147;financial statements&#148;). In our opinion, the financial statements
present fairly, in all material respects, the financial position of the Company as of December&nbsp;31, 2019 and 2018, and the results of its operations and its cash flows for each of the two years in the period ended December&nbsp;31, 2019, in
conformity with accounting principles generally accepted in the United States of America. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis for Opinion </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on the
Company&#146;s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in
accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#146;s internal control over financial
reporting. Accordingly, we express no such opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our audits included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable
basis for our opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">/s/ Deloitte&nbsp;and Touche LLP </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">San Francisco, CA </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">March&nbsp;13, 2020 (May&nbsp;26, 2020 as to the effects of the reverse stock split discussed in Note&nbsp;17) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have served as the Company&#146;s auditor since 2018. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_2"></A>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Balance Sheets </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>(In thousands, except share and per share amounts)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>December&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 60,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 85,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Tax credit receivable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other non-current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">536</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,085</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">66,529</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">119,064</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Liabilities, Redeemable Convertible Preferred Stock and Stockholders&#146; Deficit</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,576</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accrued liabilities (Note 5)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other long-term liabilities (Note 5)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,895</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Commitments and Contingencies (Note 13)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Series A redeemable convertible preferred stock, $0.0001 par value; 56,000,000 and 56,000,000 shares
authorized at December&nbsp;31, 2018 and 2019, respectively; 56,000,000 and 56,000,000 shares issued and outstanding, at December 31, 2018 and 2019, respectively; aggregate liquidation preference of $61,516 and $62,468 at December&nbsp;31, 2018 and
2019, respectively;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Series B redeemable convertible preferred stock, $0.0001 par value; 58,109,973 shares and 49,501,221
shares authorized at December 31, 2018 and 2019, respectively; 49,501,221 shares and 49,501,221 shares issued and outstanding at December 31, 2018 and 2019, respectively; aggregate liquidation preference of $70,587 and $75,860 at December&nbsp;31,
2018 and 2019, respectively;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,860 </TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Series C redeemable convertible preferred stock, $0.0001 par value; 0 shares and 44,000,000 shares
authorized at December 31, 2018 and 2019, respectively; 0 shares and 26,360,745 shares issued and outstanding at December 31, 2018 and 2019, respectively; aggregate liquidation preference of $0 and $47,947 at December 31, 2018 and 2019,
respectively;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Common stock, $0.0001 par value; 147,682,655 and 181,000,000 shares authorized at December 31, 2018
and 2019; and 1,363,000 and 1,846,024 shares issued and outstanding at December 31, 2018 and 2019, respectively;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Additional paid-in capital</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">(71,470</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">(76,295</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,469</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Total liabilities, redeemable convertible preferred stock and stockholders&#146;
deficit</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 66,529</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">119,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_3"></A>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Statements of Operations and Comprehensive Loss </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>(In thousands, except share and per share amounts)</B></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue &#151; related party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating expenses:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,415</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(47,353</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,915</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,231</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other expense, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,876</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,856</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, attributable to common stockholders, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares used in computing net loss per share attributable to common stockholders, basic and
diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,165,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,623,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share attributable to common stockholders, basic and diluted
(unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares used in computing pro forma net loss per share attributable to common stockholders, basic
and diluted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,510,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive Loss:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net unrealized loss on short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(632</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_4"></A>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Statements of Redeemable Convertible Preferred Stock and Stockholders&#146; Deficit </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands, except<BR>share amounts)</B></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="26" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redeemable Convertible Preferred Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR><FONT STYLE="white-space:nowrap">Paid-In</FONT><BR>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Other<BR>Comprehensive<BR>Loss</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Stockholders&#146;<BR>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series A</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series B</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series C</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,910</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,003,022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(36,566</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(36,565</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series A redeemable preferred stock, net of issuance costs of $16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,484</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series B redeemable preferred stock, net of issuance costs of $315</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vesting of founders&#146; common stock and restricted stock awards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">359,978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,754</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(248</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,628</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,876</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,363,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,470</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,469</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands, except<BR>share amounts)</B></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="26" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redeemable Convertible Preferred Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR><FONT STYLE="white-space:nowrap">Paid-In</FONT><BR>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Other<BR>Comprehensive<BR>Loss</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Stockholders&#146;<BR>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series A</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series B</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series C</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December 31, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,363,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,470</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,469</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series C redeemable preferred stock, net of issuance costs of $293</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,360,745</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vesting of founders&#146; common stock and restricted stock awards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">440,964</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Option exercises</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">952</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,031</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,194</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,829</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,829</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net unrealized loss on short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,360,745</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,846,024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_5"></A>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Statements of Cash Flows </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>(In thousands)</B></P> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,829</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credit receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(250</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">167</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,052</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,458</TD>
<TD NOWRAP VALIGN="bottom">) &nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">non-current</FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(505</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">232</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,255</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">776</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent and other long-term liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(28,328</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,750</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,713</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion of short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(254</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maturity of short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,323</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(964</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,323</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,931</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of Series A preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,484</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of Series B preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of Series C preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of restricted common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment of deferred offering costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,582</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,349</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents at beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,251</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents at end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 60,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">85,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Supplemental disclosures of noncash investing and financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of property and equipment in accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassification of restricted stock awards from liabilities to common stock upon vesting</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant improvement paid for by the landlord</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred offering costs in accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net unrealized loss on short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_6"></A>Notes to Financial Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Description of Business </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pliant
Therapeutics, Inc. (the &#147;Company&#148;) is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis with an initial focus on treating fibrosis by inhibiting integrin-mediated
activation of TGF-&szlig;. Fibrosis refers to the abnormal thickening and scarring of connective tissue due to the production and deposition of excess collagen in the extra-cellular matrix. Fibrosis can occur in many different tissues including
lung, liver, kidney, muscle, skin and the GI tract, and often causes severe and debilitating disease leading to organ failure. The Company is located in South San Francisco, California, and was incorporated in the state of Delaware in June 2015.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Summary of Significant Accounting Policies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Basis of Presentation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of
America (&#147;U.S. GAAP&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Use of Estimates </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets, liabilities, and expenses as well as the disclosure of contingent assets and liabilities as of and during the reporting period. The Company bases its estimates and assumptions on historical experience when available and
on various factors that it believes to be reasonable under the circumstances. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, useful lives assigned to property and equipment, the fair
values of common and redeemable convertible preferred stock, stock-based compensation expense, accruals for research and development costs, income taxes and uncertain tax positions. The Company assesses estimates on an ongoing basis; however, actual
results could materially differ from those estimates. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Revenue Recognition </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective January&nbsp;1, 2018 the Company adopted the provision of Accounting Standards Update or ASU, ASU
<FONT STYLE="white-space:nowrap">2014-09,</FONT> Topic 606 <I>Revenue from Contracts with Customers (</I><I>&#147;</I><I>Topic 606</I><I>&#148;</I><I>) </I>using the full retrospective transition method. ASU
<FONT STYLE="white-space:nowrap">2014-09</FONT> provides a single, comprehensive revenue recognition model for all contracts with customers. This standard contains principles for the determination of the measurement of revenue and the timing of when
such revenue is recognized. Revenue recognition will reflect the transfer of goods or services to customers at an amount that is expected to be earned in exchange for those goods or services. Subsequently, the FASB has issued the following guidance
to amend ASU <FONT STYLE="white-space:nowrap">2014-09:</FONT> ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2015-14,</FONT> Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date; ASU
<FONT STYLE="white-space:nowrap">No.&nbsp;2016-08,</FONT> Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net); ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-10,</FONT>
Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing; ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-12,</FONT> Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and
Practical Expedients; and ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-20,</FONT> Technical Corrections and Improvements to Topic 606, which clarifies narrow aspects of Topic 606 or corrects unintended application of the guidance. The Company
must adopt ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2015-14,</FONT> ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-08,</FONT> ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-10,</FONT> ASU
<FONT STYLE="white-space:nowrap">No.&nbsp;2016-12,</FONT> and ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-20</FONT> with ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2014-09,</FONT> which are referred to collectively as the &#147;Topic
606&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FASB issued ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2018-18,</FONT> &#147;Collaborative Arrangements (Topic
808)&#148; issued in November 2018. The Company assessed and concluded that they are not under ASC 808. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date all revenue has been generated from the Company&#146;s Collaboration and License
Agreement with Novartis (the &#147;Novartis Agreement&#148;). As a result, there was no impact of the adoption of Topic 606 to the Company&#146;s 2018 financial statements. See Note 6 for details of Topic 606 application to the Novartis Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s revenue&#151;related party is solely generated off of the Strategic Collaboration and License Agreement with Novartis.
The Company&#146;s licensing agreement includes upfront signing fees, cost reimbursements, research and development services, milestone payments and royalties on future licensee&#146;s product sales. The Company has both fixed and variable
consideration. <FONT STYLE="white-space:nowrap">Non-refundable</FONT> upfront fees are considered fixed, while funding of research and development activities and milestone payments are identified as variable consideration. A contract liability is an
obligation to transfer goods or services for which&nbsp;the Company&nbsp;has received consideration, or for which an amount of consideration is due from the customer. A contract asset is a right to consideration in exchange for goods or services
that&nbsp;the Company&nbsp;has transferred to a customer when that right is conditional on something other than the passage of time. A receivable will be recorded on the balance sheet when the Company has unconditional rights to consideration (i.e.,
only the passage of time is required before payment becomes due). Receivables cannot be netted against contract liabilities and are presented separately from contract assets. Contract assets and contract liabilities are netted at the contract level
and are then aggregated and presented separately each reporting period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In determining the appropriate amount of revenue to be recognized
as the Company fulfills its obligations under its agreements, the Company performs the following steps: (i)&nbsp;identification of the contract with a customer; (ii)&nbsp;identification of the performance obligations in the contract;
(iii)&nbsp;determination of the transaction price; (iv)&nbsp;allocation of the transaction price to the performance obligations in the contract; and (v)&nbsp;recognition of revenue when (or as) we satisfy each performance obligation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. The Company&#146;s performance
obligations include providing the worldwide license rights to compound <FONT STYLE="white-space:nowrap">PLN-1474,</FONT> provide research and development services for <FONT STYLE="white-space:nowrap">PLN-1474</FONT> through Phase 1 of its
development and provide research and development services on initial candidate targets, which services are combined with a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license to the initial candidate targets. The Company concluded that the
worldwide license was distinct because the customer can benefit from the license on its own or together with other resources that are readily available, and the research and development services are not transformative in nature. The Company
concluded the research and development services on initial candidate targets were not distinct from a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license for the initial candidate targets, primarily as a result of (i)&nbsp;Pliant being
unable to benefit on its own or together with other resources that are readily available as the license and (ii)&nbsp;the research and development services, including manufacturing in support of such services, were expected to significantly modify
the initial license. Therefore, the promised goods and services were considered a single performance obligation. Significant management judgment is required in the identification of performance obligations and to determine the level of effort
required under an arrangement and the period over which the Company expects to complete our performance obligations under the arrangement. If the Company cannot reasonably estimate when the performance obligations either are completed or become
inconsequential, then revenue recognition is deferred until the Company can reasonably make such estimates. The Company estimates the transaction price and records revenue in the amount for which it is probable that a significant reversal of
cumulative revenue recognized will not occur. At the end of each subsequent reporting period, we <FONT STYLE="white-space:nowrap">re-evaluate</FONT> the estimated variable consideration included in the transaction price and any related constraint,
and if necessary, adjusts its estimate of the overall transaction price. Revenue is then recognized over the remaining estimated period of performance using the cumulative <FONT STYLE="white-space:nowrap">catch-up</FONT> method. The estimated period
of performance and project costs are reviewed quarterly and adjusted, as needed, to reflect the Company&#146;s current assumptions regarding the timing of our deliverables. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone
selling price of each performance obligation identified in the contract. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company has never sold the performance obligations separately; therefore an observable stand-alone selling price does not exist. Accordingly, the Company estimates a stand-alone selling price
through maximizing the use of observable inputs such as market data, project cost estimates, and targeted margins. The Company determined that each of the performance obligations is priced and delivered at the stand-alone selling price. Therefore,
no reallocations are needed since there is no material right and the license and services are provided at the stand-alone selling price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2019, the entirety of the Company&#146;s revenue&#151;related party is related to the Collaboration
and License Agreement with Novartis. The Company did not have any prior collaboration agreements and did not recognize revenue during the year ended December&nbsp;31, 2018. Receivables from collaborations are typically unsecured and are concentrated
in the biopharmaceutical industry. Accordingly, the Company may be exposed to credit risk generally associated with biopharmaceutical companies or specific to the Novartis Agreement. An allowance on the receivables will be recorded if circumstances
indicate collection is doubtful for a particular receivables balance. To date, the Company has not experienced any losses related to these receivables. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Fair Value Measurements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market
in which to transact and the market-based risk. Fair value accounting is applied for all financial assets and liabilities and <FONT STYLE="white-space:nowrap">non-financial</FONT> assets and liabilities that are recognized or disclosed at fair value
in the financial statements on a recurring basis and at least annually. The carrying amount of the Company&#146;s financial instruments, including cash and cash equivalents, short-term investments, tax credit receivable, accounts receivable, prepaid
expenses and other current assets, accounts payable and accrued liabilities approximate fair value due to their short-term maturities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Concentration of Credit Risk and Other Risks and Uncertainties </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents, short-term
investments and accounts receivable. The Company invests in money market funds, treasury bill and notes and government notes. The Company limits its credit risk associated with its cash and cash equivalents by placing them with banks and
institutions it believes are highly credit worthy and in highly rated investments. The Company performs credit evaluations of its customer, and the risk with respect to accounts receivable is further mitigated by the short duration of customer
payment terms and the pedigree of the customer base. During the year ended December&nbsp;31, 2019, Novartis accounted for 100% of the Company&#146;s revenue&#151;related party and accounts receivable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s future results of operations involve several other risks and uncertainties. Factors that could affect the Company&#146;s
future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of results of clinical trials and reaching milestones, uncertainty of regulatory approval of the Company&#146;s
product candidates, uncertainty of market acceptance of the Company&#146;s product candidates, competition from substitute products, including those that may be developed or marketed by larger companies, securing and protecting intellectual
property, strategic relationships and dependence on key individuals and sole source suppliers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s product candidates
require approvals from the U.S. Food and Drug Administration (&#147;FDA&#148;) and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be no assurance that any product candidates will receive the necessary approvals. If the Company was denied approval, approval was delayed or the Company was unable to maintain approval for any
product candidate, it could have a materially adverse impact on the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Segments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company operates and manages its business as one reportable and operating segment, which is the business of developing and commercializing
novel therapies for fibrotic diseases. The Company&#146;s chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating and evaluating financial performance. All long-lived
assets are maintained in the United States of America. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Cash and Cash Equivalents </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be
cash equivalents. Cash equivalents consist primarily of amounts invested in Money Market Funds and United States (&#147;U.S.&#148;) government agency securities and are stated at fair value. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Short-Term Investments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s short-term investments consist of U.S. Treasury securities and U.S. government agency securities with remaining maturities
beyond three months at the date of purchase and one year or less from the balance sheet date. As of December 31, 2019, all of the Company&#146;s short-term investments were classified as <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">available-for-sale</FONT></FONT> and were carried at fair market value. The unrealized losses on the Company&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT>
securities are recorded in &#147;other comprehensive income and losses&#148; (&#147;OCI&#148;) in the statements of operations and comprehensive (loss) income. See Note&nbsp;3 for further details. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Short-term investments are considered impaired when a decline in fair value is judged to be other-than-temporary. The Company consults with
its investment managers and considers available quantitative and qualitative evidence in evaluating potential impairment of its short-term investments on a quarterly basis. If the cost of an individual investment exceeds its fair value, the Company
evaluates, among other factors, general market conditions, the duration and extent to which the fair value is less than cost and its intent and ability to hold the investment. Once a decline in fair value is determined to be other-than-temporary, an
impairment charge will be recorded to other expense, net, in the statements of operations and comprehensive (loss) income and a new cost basis in the short-term investment will be established. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Property and Equipment, Net </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Property and equipment are recorded at cost net of accumulated depreciation and amortization. Property and equipment are depreciated using the
straight-line method over the estimated useful lives of the assets. The useful lives of property and equipment are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment and software</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Shorter of remaining lease term or estimated useful life</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are
removed from the balance sheets and the resulting gain or loss is recorded to the statements of operations and comprehensive (loss) income. Repairs and maintenance are expensed as incurred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Impairment of Long-Lived Assets </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not
be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated
future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. There was no impairment of long-lived assets during the years ended December 31, 2018 and 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Redeemable Convertible Preferred Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company classifies redeemable convertible preferred stock outside of stockholders&#146; deficit because, upon the occurrence of certain
change in control events that are outside the Company&#146;s control, including liquidation, sale or transfer of the Company&#146;s assets, holders of the redeemable convertible preferred stock can cause redemption for cash. At any time on or after
December 19, 2024, the holders of a majority of the outstanding redeemable convertible preferred stock can also require the Company to redeem the redeemable convertible preferred stock by providing the Company a written notice requesting such
redemption. The Company recognizes changes in the redemption value immediately as they occur, for example changes in fair value of preferred stock, and adjusts the carrying amount of the redeemable convertible preferred stock to equal the redemption
value at the end of each reporting period. In the absence of retained earnings these accretion charges are recorded against additional paid in capital, if any, and then to accumulated deficit. The Company analyzed all embedded derivatives and
beneficial conversion features for its redeemable convertible preferred stock and concluded that none requires bifurcation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Expenses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development costs are expensed as incurred. Research and development expenses consist primarily of personnel costs for the
Company&#146;s research and product development employees. Also included are <FONT STYLE="white-space:nowrap">non-personnel</FONT> costs such as fees paid to consultants and third parties for preclinical and clinical studies, research and
development services, laboratory supplies and equipment maintenance costs, license costs, contract manufacturing costs and allocations of facility related costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company estimates preclinical and clinical studies and research expenses based on the services performed, pursuant to contracts with
research institutions that conduct and manage preclinical and clinical studies and research services on its behalf. The Company estimates these expenses based on discussions with internal management personnel and external service providers as to the
progress or stage of completion of services and the contracted fees to be paid for such services. If the actual timing of the performance of services or the level of effort varies from the original estimates, the Company will adjust the accrual
accordingly. Payments made to third parties under these arrangements in advance of the performance of the related services are recorded as prepaid expenses and are expensed over the time when services are rendered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments associated with licensing agreements to acquire exclusive licenses to develop, use, manufacture and commercialize products that have
not reached technological feasibility and do not have alternate commercial use are expensed as incurred. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Tax Credit Receivable
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is eligible for federal and California research and development credits for its research and development activities
performed within the United States and California, respectively. The credits are generally </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
available to offset federal and California income tax liabilities. The Company has applied $0.2 million of federal research and development credits to offset its federal payroll tax expenses for
the year ended December&nbsp;31, 2018 due to its small business status. Starting in the fourth quarter of 2019, the Company was no longer eligible for federal and California research development credits as it generated revenue during the year. As
such, all federal and California research and development credits generated and accrued during the first three quarters of 2019 were reversed. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Stock-Based Compensation</I></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s stock-based equity awards include restricted stock awards and stock options that are granted to employees and consultants
and accounted at fair value on the award grant date. Stock-based compensation expense is recognized over the awards&#146; vesting period on a straight-line basis and recorded as either research and development or general and administrative expenses
in the statements of operations and comprehensive (loss) income based on the function to which the related services are provided. Forfeitures are accounted for as they occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Black-Scholes option-pricing model, used to estimate fair value of stock-based awards, requires the use of the following assumptions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected term</I>&#151;The expected term represents the period that the stock-based awards are expected to be
outstanding. The expected term for the Company&#146;s stock options was calculated based on the weighted-average vesting term of the awards and the contract period, or simplified method. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected volatility</I>&#151;Since the Company is not yet a public company and does not have any trading
history for its common stock, the expected volatility was estimated based on the average historical volatilities of common stock of comparable publicly traded entities over a period equal to the expected term of the stock option grants. The
comparable companies were chosen based on their size, stage in the life cycle or area of specialty. The Company will continue to apply this process until enough historical information regarding the volatility of its stock price becomes available.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Risk-free interest rate</I>&#151;The risk-free interest rate is based on the U.S. Treasury yield in effect at
the time of grant <FONT STYLE="white-space:nowrap">for&nbsp;zero-coupon&nbsp;U.S.</FONT> Treasury notes with maturities approximately equal to the expected term of the awards. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected dividend</I>&#151;The Company has never paid dividends on the common stock and has no plans to pay
dividends on the common stock. Therefore, the Company used an expected dividend yield of zero. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fair value of the
common stock has been determined using independent third-party valuations based on relevant valuation methodologies as outlined in the American Institute of Certified Public Accountants (AICPA) Practice Aid, <I>&#147;Valuation of
Privately-Held-Company Equity Securities Issued as Compensation</I>&#148;. The Company also considered the amount of time between the independent third-party valuation dates and the grant dates and used interpolation of the fair value between the
two valuation dates to estimate common stock fair value at each grant date. This determination included an evaluation of whether the subsequent valuation indicated that any significant change in valuation had occurred between the previous valuation
and the grant date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Deferred Offering Costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Deferred offering costs, consisting of direct legal, accounting, filing and other fees directly related to the Company&#146;s proposed initial
public offering (&#147;IPO&#148;) are capitalized. The deferred offering costs will be reclassified to additional paid in capital upon completion of the IPO. The Company deferred $0.2&nbsp;million and $2.7&nbsp;million as of December&nbsp;31, 2018
and December&nbsp;31, 2019, respectively, which is recorded as other Non-current assets in the Balance Sheets. In the event the IPO is aborted, all capitalized deferred offering costs will be expensed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Leases and Rent Expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company records rent expense on a straight-line basis over the life of the lease. In cases where there is a free rent period or future
fixed rent escalations, the Company records a deferred rent liability. Additionally, the receipt of any lease incentives is recorded as a deferred rent liability which is amortized over the lease term as a reduction of rent expense. Building
improvements made with the lease incentives or tenant allowances are capitalized as leasehold improvements and included in property and equipment, net in the Balance Sheets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Income Taxes </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company provides for income taxes under the asset and liability method. Current income tax expense or benefit represents the amount of income taxes expected to be payable or refundable for the current year. Deferred income tax assets and liabilities
are determined based on differences between the financial statement reporting and tax basis of assets and liabilities and net operating loss and credit carryforwards and are measured using the enacted tax rates and laws that will be in effect when
such items are expected to reverse. Deferred income tax assets are reduced, as necessary, by a valuation allowance when management determines it is more likely than not that some or all the tax benefits will not be realized. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for uncertain tax positions in accordance with ASC <FONT STYLE="white-space:nowrap">No.&nbsp;740-10</FONT><I>, Accounting
for Uncertainty in Income Taxes</I>. The Company assesses all material positions taken in any income tax return, including all significant uncertain positions, in all tax years that are still subject to assessment or challenge by relevant taxing
authorities. Assessing an uncertain tax position begins with the initial determination of the position&#146;s sustainability and is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate
settlement. As of each balance sheet date, unresolved uncertain tax positions must be reassessed, and the Company will determine whether (i)&nbsp;the factors underlying the sustainability assertion have changed and (ii)&nbsp;the amount of the
recognized tax benefit is still appropriate. The recognition and measurement of tax benefits requires significant judgment. Judgments concerning the recognition and measurement of a tax benefit might change as new information becomes available. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company includes any penalties and interest expense related to income taxes as a component of income tax expense, as necessary.<B> </B>
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Comprehensive Loss </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Comprehensive loss includes net loss as well as other changes in stockholders&#146; deficit that result from transactions and economic events
other than those with stockholders. For the years ended December&nbsp;31, 2018 and 2019, the Company had no net unrealized losses on short-term investments and an $1,000 net unrealized loss on short-term investments, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Net Loss Per Share </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Basic net loss per share is computed by dividing net loss attributed to common stockholders by the weighted-average number of shares of common
stock outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares of common stock outstanding during the period and, if dilutive, the weighted-average number of potential shares of common stock.
Net loss per share attributable to common stockholders is calculated using <FONT STYLE="white-space:nowrap">the&nbsp;two-class&nbsp;method,</FONT> which is based on an earnings allocation formula that determines net loss per share for the
Company&#146;s common stockholders and holders of participating securities. The Company&#146;s redeemable convertible preferred stock contains participation rights in any dividend paid by the Company and is deemed to be a participating security. Net
loss attributable to common stockholders </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and participating preferred shares are allocated to each share on <FONT STYLE="white-space:nowrap">an&nbsp;as-converted&nbsp;basis</FONT> as if all the earnings for the period had been
distributed. The participating securities do not include a contractual obligation to share in losses of the Company and are not included in the calculation of net loss per share in the periods in which a net loss is recorded. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Diluted net loss per share is computed using the more dilutive of
<FONT STYLE="white-space:nowrap">(a)&nbsp;the&nbsp;two-class&nbsp;method</FONT> or (b)&nbsp;the <FONT STYLE="white-space:nowrap">as-converted</FONT> method. The Company allocates earnings first to redeemable convertible preferred shares stockholders
based on dividend rights and then to common and preferred stockholders based on ownership interests. The weighted-average number of shares of common stock included in the computation of diluted net loss gives effect to all potentially dilutive
common equivalent shares, including outstanding stock options and preferred stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Common stock equivalent shares are excluded from the
computation of diluted net loss per share if their effect is antidilutive. In periods in which the Company reports a net loss attributable to common stockholders, diluted net loss per share attributable to common stockholders is generally the same
as basic net loss per share attributable to common stockholders since dilutive common shares are not assumed to have been issued if their effect is antidilutive. The Company reported a net loss attributable to common stockholders for the years ended
December&nbsp;31, 2018 and 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Unaudited Pro Forma Information </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately prior to the completion of the Company&#146;s IPO resulting in net proceeds of at least $45.0&nbsp;million to the Company all
outstanding shares of redeemable convertible preferred stock will automatically convert into common stock. Unaudited pro forma balance sheet information as of December&nbsp;31, 2019, assumes the conversion of all outstanding redeemable convertible
preferred stock into shares of common stock. The shares of common stock issuable and the proceeds expected to be received in the IPO are excluded from such pro forma financial information. The unaudited pro forma net income per share for the year
ended December&nbsp;31, 2019, was computed using the weighted-average number of shares of common stock outstanding, including the pro forma effect of the conversion of all outstanding shares of redeemable convertible preferred stock, as if such
conversion had occurred at the beginning of the period, or their issuance dates, if later. The unaudited pro forma net income per share does not include the shares expected to be sold and related proceeds to be received from the IPO. Net income
attributable to common stockholders used in the unaudited pro forma net income per share calculation was adjusted for the accretion of redeemable convertible preferred stock, as all preferred stock is not considered outstanding prior to the closing
of the IPO. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Recently Issued Accounting Pronouncements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2016, the Financial Accounting Standards Board (&#147;FASB&#148;) issued Accounting Standard Update (&#147;ASU&#148;) <FONT
STYLE="white-space:nowrap">No.&nbsp;2016-02,</FONT> <I>Leases (&#147;Topic 842&#148;</I>), which requires an entity to recognize assets and liabilities arising from a lease for both financing and operating leases. For public entities, ASU <FONT
STYLE="white-space:nowrap">No.&nbsp;2016-02</FONT> is effective for fiscal years beginning after December&nbsp;15, 2018. The ASU will also require new qualitative and quantitative disclosures to help investors and other financial statement users
better understand the amount, timing, and uncertainty of cash flows arising from leases. As a result of the Company having elected the extended transition period for complying with new or revised accounting standards pursuant to Section&nbsp;107(b)
of the JOBS Act, ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-02</FONT> is effective for the Company in the fiscal years beginning after December&nbsp;15, 2020, with early adoption permitted. The Company is currently in the process of
evaluating the impact of the adoption of ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-02</FONT> on the Company&#146;s financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In November 2018, the FASB issued Accounting Standards Update 2018-18 (&#147;ASU
2018-18&#148;), Collaborative Arrangements (topic 808): Clarifying the Interaction between Topic 808 and Topic 606. ASU 2018-18 clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under ASC
606 when the counterparty is a customer. The guidance precludes an entity from presenting consideration from a transaction in a collaborative arrangement as revenue from contracts with customers if the counterparty is not a customer for that
transaction. The guidance amends ASC 808 to refer to the unit-of-account guidance in ASC 606 and requires it to be used only when assessing whether a transaction is in the scope of ASC 606. The guidance will be effective for the Company for fiscal
years beginning after December&nbsp;15, 2020 and interim periods within fiscal years beginning after December&nbsp;15, 2021 and has to be adopted using retrospective approach. The Company is currently evaluating the impact of ASU 2018-18 on its
financial statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Financial Instruments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s short-term investments in U.S. Treasury and U.S. government agency securities have been classified and accounted for as <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale.</FONT></FONT> The Company classifies its U.S. Treasury and U.S. government agency securities as short-term based on each instrument&#146;s underlying contractual
maturity date. Unrealized gains and losses on U.S. Treasury and U.S. government agency securities classified as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> are recognized in other comprehensive
loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assets and liabilities recorded at fair value on a recurring basis in the Balance Sheets and assets and liabilities measured at
fair value on a <FONT STYLE="white-space:nowrap">non-recurring</FONT> basis or disclosed at fair value, are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value
provides a framework for measuring fair value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability (an exit price) in
an orderly transaction between market participants at the measurement date. The accounting guidance also establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether
such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to
valuation techniques is briefly summarized as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B><B></B><I>Level 1</I>&#151;Inputs are unadjusted, quoted prices in active markets for identical assets or
liabilities at the measurement date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Level 2&#151;</I>Inputs are observable, unadjusted quoted prices in active markets for similar assets or
liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related
assets or liabilities; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Level 3&#151;</I>Unobservable inputs that are significant to the measurement of the fair value of the assets
or liabilities that are supported by little or no market data. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s cash equivalent Money Market Funds
are classified as Level&nbsp;1 because they are valued using quoted market prices. The fair value of the Company&#146;s short-term investments are classified as Level&nbsp;2 because they are valued using observable inputs to quoted market prices,
benchmark yields, reported trades, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency and include U.S. government agency securities and U.S. Treasury securities. These Level&nbsp;2 instruments require
more management judgment and subjectivity compared to Level&nbsp;1 instruments which include determining which instruments are most similar to the instrument being priced, determining whether the market is active and determining which model-derived
valuations are to be used when calculating fair value. The Company performs its analysis with the assistance of investment advisors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables show the Company&#146;s cash and cash equivalents, Money Market Funds
and short-term investments by significant investment category as of December&nbsp;31, 2018 and December&nbsp;31, 2019 (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adjusted<BR>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;1:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money Market Funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December 31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adjusted<BR>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;1:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money Market Funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;2:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Treasury securities included in short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. government agency securities included in cash and cash equivalents and short-term
investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,203</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,568</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,567</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may sell certain of its short-term securities prior to their stated maturities for reasons
including, but not limited to, managing liquidity, credit risk, duration and asset allocation.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There were no liabilities measured at fair
value on a recurring basis as of December&nbsp;31, 2018 and December&nbsp;31, 2019. There have been no transfers between fair value measurement levels during the year ended December&nbsp;31, 2018 and 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company records interest income and accretion income earned on Money Market Funds and U.S. Treasury and U.S. government agency securities
to interest income in its statements of operations and comprehensive (loss) income. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Property and Equipment, net </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Property and equipment, net consisted of the following (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment and software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">657</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Construction-in-progress</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total property and equipment, gross</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,267</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Accumulated depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,075</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depreciation expense for the years ended December 31, 2018 and 2019 was $0.7&nbsp;million and
$1.1&nbsp;million, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Accrued Liabilities and Other Long-Term Liabilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I></I><B><I>Accrued Liabilities</I></B><I> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accrued liabilities consisted of the following (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued compensation and benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,470</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">633</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accrued compensation and benefits consist primarily of accrued bonuses and accrued vacation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I></I><B><I>Other Long-Term Liabilities</I></B><I> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other long-term liabilities consisted of the following (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;As&nbsp;of&nbsp;December&nbsp;31,&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="border-bottom:1.00pt solid #000000" ALIGN="center"><FONT STYLE="font-size:8pt"><B>&nbsp;&nbsp;2018&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="border-bottom:1.00pt solid #000000" ALIGN="center"><FONT STYLE="font-size:8pt"><B>&nbsp;&nbsp;2019&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">261</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold incentive obligation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">444</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other liabilities &#151; deposits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other long-term liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Novartis Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2019, the Company entered into a Collaboration and License Agreement with Novartis (the &#147;Novartis Agreement&#148;), for the
development and commercialization of our preclinical product candidate, PLN-1474 and up to three additional integrin research targets. PLN-1474 is an internally discovered small molecule selective inhibitor of integrin
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>, currently being developed for the treatment of liver fibrosis associated with
nonalcoholic steatohepatitis (&#147;NASH&#148;). In accordance with the Novartis Agreement, on December 7, 2019, Novartis paid to Pliant an upfront non-refundable license fee of $50.0&nbsp;million for the worldwide exclusive license to PLN-1474.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Novartis will fund the Company&#146;s research and development services for PLN-1474 through Phase 1 after which Novartis will assume
responsibility for all future development, manufacturing and commercialization costs of PLN-1474. Novartis will also fund the research and development services associated with integrin research targets as outlined in the Novartis Agreement. The
Company is scheduled to receive up to $19.6 million in funding for PLN-1474 development services through Phase 1 of its development, which is expected to go through 2020. The Company is initially obligated to perform research and development
services for the integrin research targets for sixty days, and Novartis has the option to terminate the services with 60 days&#146; notice. Novartis has the option to continue the research and development services through 2022. If any of the targets
achieves target validation and are deemed a research target, Novartis holds the rights to exercise its license options to obtain an exclusive license for those deemed research targets on a research target-by-research target basis by paying an option
exercise fee for each target (up to three in total), including all license compounds that are the subject of the applicable research program. Upon exercise of an option, Novartis will be responsible for global clinical development and
commercialization of each licensed research target. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Novartis Agreement, the Company is eligible for developmental, regulatory and
commercial milestone payments related to PLN-1474 and the integrin research targets of up to $416.0 million if defined development and commercialization milestones are achieved and tiered royalties ranging from the mid-single digits to low teens on
product sales upon commercialization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon execution of the Novartis Agreement, Pliant also entered into a Financing Side Letter with
Novartis (the &#147;Financing Side Letter&#148;), whereby Novartis committed to provide up to $30.0 million in equity financing of which $20.0 million was provided for 10,928,962 shares of Series C Redeemable Convertible Preferred Stock on December
19, 2019 and the remaining $10.0 million will be provided for common shares in the event Pliant completes an Initial Public Offering.&nbsp;The Company determined that Novartis Agreement and the Financing Side Letter are separate agreements, they
were not entered into for single commercial objective, the consideration in each agreement are tied to separate and different types of performance obligations and they are not considered a single performance obligation. The Series C Redeemable
Preferred Stock was issued to Novartis at fair value of $1.83 per share in conjunction with its issuance to other investors at the same price. In addition, the contingent issuance of shares upon an Initial Public Offering would also be at fair
value. Further, Novartis became a related party to the Company following its purchase of 10.9 million shares of our Series C Redeemable Convertible Stock on December 19, 2019, representing holdings of 7.4% of our outstanding shares on a fully
diluted basis as of December 31, 2019. See Notes 9 and 14 to these financial statements for additional information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company evaluated
the Novartis Agreement under the revenue standard Topic 606 and concluded that Novartis is a customer. The Company identified the following performance obligations at the inception of the contract. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Provide Novartis worldwide license rights to PLN-1474. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Provide research and development services for PLN-1474 through Phase 1 of its development. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Provide non-exclusive license rights to integrin research targets and research and development services on
integrin research targets, together as a single performance obligation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company determined the transaction price at
inception of the Novartis Agreement is the $69.6 million consisting of the license fee of $50.0 million and research and development funding of $19.6 million payment to be allocated to the various performance obligations. The Novartis Agreement
includes variable consideration for the funding of research and development services and potential future milestones and royalties that were contingent on future success factors for development programs. The Company used the &#147;most likely&#148;
method to determine the variable consideration. None of the regulatory or development milestones were included in the transaction price. The Company will re-evaluate the transaction price in each reporting period as uncertain events are resolved or
other changes in circumstances occur. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company considered the license to PLN-1474 as functional intellectual property, as when control
of the license was transferred to Novartis at the inception of the Novartis Agreement, Novartis had the right to access its technology and it was functional. The Company determined the $50.0 million was standalone selling price PLN-1474 license and
was recognized as revenue when control of the license transferred to Novartis, which was at or near inception of the Novartis Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company estimated the standalone selling price of each research program based on internal and external costs to perform the research plus
a reasonable profit margin. The total estimated cost of the research and development services reflects the nature of the services to be performed and the Company&#146;s best estimate of the length of time required to perform the services. The
Company selected an input method of costs incurred to measure progress toward complete satisfaction of its performance obligation to provide research and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
development services as such method faithfully depicts the Company&#146;s performance in transferring control of the research and development service to Novartis. Changes in estimates of total
internal and external costs expected to be incurred are recognized in the period of change as a cumulative catch-up adjustment. There have been no changes to the Company&#146;s estimates to date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December 31, 2019, Company recognized revenue - related party of $50.0 million related to the license fee and revenue -
related party of $7.1 million generated from research and development services performed during 2019, the remaining $12.5 million is expected to be earned in 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2019, there is a receivable of $7.1 million related to the Novartis Agreement. There were no contract assets or contract
liabilities as of December 31, 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. License Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>UC Regents </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
August 2015, the Company entered into an exclusive, worldwide license agreement (the &#147;UC Agreement&#148;) with the Regents of the University of California (the &#147;UC Regents&#148;) relating to the use of certain patents and technology
relating to <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> compound in fibrosis indications. Pursuant to the UC Agreement, the
Company is obligated to (i)&nbsp;make a <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront license fee payment of $0.4&nbsp;million and annual license maintenance fee payments of $10,000 per year beginning on the first anniversary of the
UC Agreement escalating to $25,000 per year thereafter (ii)&nbsp;make royalty payments to the UC Regents of 3% of net sales of a therapeutic licensed product or 1% of net sales of a method of use licensed product, subject to an annual minimum of
$1.0&nbsp;million, (iii)&nbsp;make milestone payments up to an aggregate of $18.2&nbsp;million to the UC Regents upon the occurrence of certain events, (iv)&nbsp;make a milestone payment based on the number of outstanding shares and a price per
share as defined in the UC Agreement within 30 days of the closing of an IPO or change of control, and (v)&nbsp;reimburse the UC Regents for prosecution and maintenance expenses of the licensed patents without limitation. The Company will expense
any payments for milestones to research and development expenses prior to receiving FDA approval for any of its product candidates.&nbsp;These costs will be capitalized when FDA approval is obtained for any products being selected for
commercialization and amortized over the remaining life of the patent. If the Company sublicenses its rights under the UC Agreement, it is obligated to pay the UC Regents a percentage of the total gross proceeds received in consideration of the
grant of the sublicense, which total amount would be first reduced by the aggregate amount of certain research and development related expense incurred by the Company. The UC Regents have the right to purchase an amount equal to a low single-digit
percent of any securities offered by the Company to investors other than to Third Rock Ventures III, L.P. (&#147;TRV&#148;) or an affiliate of TRV. This participation right expires immediately before the completion of the IPO. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The UC Agreement can be terminated at any time upon the material breach of contract terms by either party to the agreement. The Company has
the right to terminate the agreement at any time upon providing written notice to the UC Regents. Unless terminated early, the UC Agreement will remain in effect from the effective date until the later of (i)&nbsp;the expiration or abandonment of
the patent rights licensed under the UC Agreement, or (ii)&nbsp;ten years from the date of the first commercial sale of the first licensed product under the agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Research Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Adimab
Development and Option Agreement </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2018, the Company and Adimab LLC (&#147;Adimab&#148;) entered into a development and
option agreement (the &#147;Adimab Agreement&#148;) for the discovery and optimization of proprietary antibodies as potential therapeutic product candidates. Under the Adimab Agreement, the Company will select biological targets against
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
which Adimab will use its proprietary platform technology to research and develop antibody proteins using a mutually agreed upon research plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the Company&#146;s selection of a target, the Company and Adimab will initiate a research plan and the discovery term begins. During the
discovery term, Adimab will grant the Company a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> <FONT STYLE="white-space:nowrap">non-sublicensable</FONT> license under its technology with respect to the target, to research, design and
preclinically develop and use antibodies that were modified or derived using Adimab technology, solely to evaluate such antibodies, perform the Company&#146;s responsibilities under the research plan and use such antibodies for certain diagnostic
purposes. The Company will also grant to Adimab a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> <FONT STYLE="white-space:nowrap">non-sublicensable</FONT> and <FONT STYLE="white-space:nowrap">non-transferable</FONT> license with respect to
the target under the Company&#146;s technology that covers or relates to such target, solely to perform its responsibilities under the research plan during the discovery period. The Company is required to pay Adimab at an agreed upon rate for its
full-time employees during the discovery period while Adimab performs research on each target under the applicable research plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Adimab
granted the Company an exclusive option to obtain a worldwide, royalty-bearing, sublicensable license under Adimab platform patents and other Adimab technology to research, develop and commercialize up to twenty four antibodies selected by the
Company (the &#147;Program Antibodies&#148;) against specific biological targets (the &#147;Commercialization Option&#148;). Upon the exercise of a Commercialization Option, and payment of the applicable option fee to Adimab, Adimab will assign the
patents that cover the Program Antibodies to Company. The Company will be required to use commercially reasonable efforts to develop, seek market approval of, and commercialize at least one antibody against the target covered by the
Commercialization Option in specified markets upon the exercise of a Commercialization Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Adimab Agreement, the
Company is obligated to (i)&nbsp;make a nonrefundable upfront license fee payment for access to Adimab&#146;s technology; (ii)&nbsp;pay Adimab at an agreed upon rate for each full-time employee (&#147;FTE&#148;) during the research period;
(iii)&nbsp;make additional payments upon the Company making other research related elections; (iv)&nbsp;pay up to a dollar amount in the low double digit millions for the achievement of certain research and development milestones for each research
target program which can vary by target type; (v)&nbsp;make royalty payments to Adimab on Company net sales of its products covered under the Adimab Agreement, subject to varying royalty payments on certain product types. Currently, no product types
have been selected by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December 31, 2018, the Company recognized research and development expense under
the Adimab Agreement of $0.1 million related to the technology access fees and FTE costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December 31, 2019, the
Company recognized research and development expense under the Adimab Agreement of $0.1 million related to antibody discovery fees and $0.2 million related to the FTE costs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Redeemable Convertible Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Company&#146;s Amended and Restated Certificate of Incorporation (&#147;Certificate of Incorporation&#148;), the Company is
authorized to issue two classes of shares: preferred and common stock. The preferred stock may </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be issued in series, and the Company&#146;s board of directors is authorized to determine the rights, preferences, and terms of each series. The following is a summary of the Company&#146;s
redeemable convertible preferred stock (in thousands except share amounts): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preferred stock consisted of the following as of December 31,
2018: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred<BR>Shares<BR>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares<BR>Issued&nbsp;and<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redemption<BR>Value/<BR>Liquidation<BR>Preference</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">61,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">61,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,109,973</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,109,973</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">132,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">132,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preferred stock consisted of the following as of December 31, 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred<BR>Shares<BR>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares<BR>Issued&nbsp;and<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redemption<BR>Value/<BR>Liquidation<BR>Preference</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,360,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">149,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,861,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">186,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">186,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series A Preferred </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In August 2015, the Company entered into a Series A Preferred Stock Purchase Agreement (the &#147;Series A Purchase Agreement&#148;) pursuant
to which it agreed to sell, and the purchasers agreed to purchase up to $45.0&nbsp;million of Series A Redeemable Convertible Preferred Stock (&#147;Series A Preferred&#148;) in three anticipated tranches based on the achievement of defined
performance milestones. The Series A Preferred stockholders may not assign the rights to purchase shares of Series A Preferred at any future milestone closing tranches separately without a transfer of already purchased shares. The Company determined
that these future tranche obligations did not meet the definition of a freestanding financial instrument because, while separately exercisable, they were not legally detachable. Further, the Company determined that the embedded future tranche
obligation did not require bifurcation for accounting purposes as it was clearly and closely related to the economic characteristics and risks of the Series A Preferred and would not meet the definition of a derivative on a standalone basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Series&nbsp;A Purchase Agreement, as part of the initial closing, the Company issued 6.5&nbsp;million shares of Series&nbsp;A
Preferred at $1.00 per share in exchange for cash proceeds of $6.4&nbsp;million and the conversion of convertible promissory notes in the amount of $0.1&nbsp;million representing outstanding principal and accrued interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In April 2016, the Company issued 5.0&nbsp;million shares of Series A Preferred at $1.00 per share in exchange for cash proceeds of
$5.0&nbsp;million in an additional closing of the first tranche. The final closing of the first tranche occurred in September of 2016, when the Company issued 5.0&nbsp;million additional shares of Series A Preferred at $1.00 per share in exchange
for cash proceeds of $5.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2017, the Company issued 8.0&nbsp;million shares of Series A Preferred at $1.00 per
share in exchange for cash proceeds of $8.0&nbsp;million in a closing of the second tranche. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2017, the Company issued 12.0&nbsp;million shares of Series A Preferred at $1.00 per
share in exchange for cash proceeds of $12.0&nbsp;million in an initial closing of the third tranche. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2018, the Company issued
8.5&nbsp;million shares of Series A Preferred at $1.00 per share in exchange for cash proceeds of $8.5&nbsp;million in an additional closing of the third tranche. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2018, based on the amendment to the Series&nbsp;A Purchase Agreement, the Company issued 11.0&nbsp;million additional shares of
Series A Preferred at $1.00 per share in exchange for cash proceeds of $11.0&nbsp;million in the final closing of the third tranche. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series B Preferred </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2018, the Company entered into a Series B Preferred Stock Purchase Agreement (the &#147;Series B Purchase Agreement&#148;) in which it
agreed to sell, and the purchasers agreed to purchase, up to $70.0&nbsp;million of Series B Redeemable Convertible Preferred Stock (&#147;Series B Preferred&#148;). Under the Series B Purchase Agreement, the Company initially issued
45.1&nbsp;million shares of Series B Preferred at $1.3767 per share in exchange for cash proceeds of approximately $62.1&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
November 2018, the Company issued 4.4&nbsp;million additional shares of Series B Preferred at $1.3767 per share in exchange for cash proceeds of approximately $6.0&nbsp;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series C Preferred </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, the Company entered into a Series C Preferred Stock Purchase Agreement (the &#147;Series C Purchase Agreement&#148;) in which
it agreed to sell, and the purchasers agreed to purchase, up to $80.5 million of Series C Redeemable Convertible Preferred Stock (&#147;Series C Preferred&#148;). Under the Series C Purchase Agreement, the Company initially issued 26.4 million
shares of Series C Preferred at $1.83 per share in exchange for aggregate cash proceeds of $48.2 million. Novartis purchased 10.9 million shares of this allotment of Series C Preferred at $1.83 per share for cash proceeds of $20.0 million. Novartis
became a related party following its purchase of 10.9 million shares of our Series C Preferred, representing aggregate holdings of 7.4% of our outstanding shares on a fully diluted basis as of December 31, 2019. See Note 14 for additional
information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series A Preferred, Series B Preferred and Series C Preferred (collectively, the &#147;Preferred Stock&#148;) have the
following rights and privileges: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Voting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each holder of shares of Preferred Stock is entitled to the number of votes equal to the number of shares of common stock into which such
shares could be converted and has voting rights and powers equal to the voting rights and powers of the common stock, and except as provided by law or by other provisions of the Company&#146;s Certificate of Incorporation, as amended, shall vote
together with the common stock as a single class on an as-converted basis on all matters as to which holders of common stock have the right to vote. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of Series A Preferred, voting separately as a single class, are entitled to elect two members of the Company&#146;s board of
directors. At any time when at least 12.5 million shares of Series B Preferred are outstanding, the holders of Series B Preferred are entitled to elect one member of the Company&#146;s board of directors. The holders of shares of common stock,
voting separately as a single class, are entitled to elect one member of the Company&#146;s board of directors. All remaining members of the Company&#146;s board of directors are elected by the holders of the common stock and Preferred Stock voting
together as a single class. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Conversion </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of the Preferred Stock are convertible at any time at the option of the holder into such number of shares as is determined by dividing
the original issuance price by the conversion price in effect at the time. The conversion price is the original issuance price for each series of Preferred Stock, as adjusted for the 1-for-7.15 reverse stock split of the Common Stock. Following such
adjustment, the per-share conversion price was $7.15 for Series A Preferred, $9.843405 for Series B Preferred and $13.0845 for Series C Preferred, subject to certain adjustments. As of December&nbsp;31, 2019, the Preferred Stock was convertible into
shares of the Company&#146;s common stock on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-7.15</FONT></FONT> basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All outstanding shares of Preferred Stock will automatically convert upon the completion of an IPO resulting in net proceeds to the Company of
at least $45.0&nbsp;million or the vote or written consent of a requisite majority of holders of the then outstanding shares of Preferred Stock on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to common stock basis. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Dividends </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
holders of Series A Preferred were originally entitled to receive cumulative dividends from their respective dates of issuance at the rate of 8.0% on their original issue price. In July 2018, in conjunction with the execution of the Series B
Purchase Agreement, the Series A Preferred accreted dividends were cancelled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Series B Purchase Agreement, the holders of both
shares of Series A and Series B Preferred are entitled to receive cumulative dividends commencing on July&nbsp;10, 2018, the issuance date of Series B Preferred, at an annual rate of 8.0% on their original issuance price. The Series A Preferred and
Series B Preferred dividends accrue from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day,</FONT></FONT> whether declared or not, and are payable only when and if declared by the Company&#146;s board of directors. As
such, the Company recorded accretion charges to adjust the carrying values of the Series A Preferred and Series B Preferred to their redemption values up until the date the Series C Purchase Agreement was executed. In December 2019, in conjunction
with the execution of the Series C Purchase Agreement, the Series A preferred and Series B preferred accreted dividends were cancelled. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Series C Purchase Agreement, the holders of Series A, Series B and Series C Preferred are entitled to receive non-cumulative
dividends commencing on December 19, 2019 at an annual rate of 8.0% on their original issuance price. The Series A, Series B and Series C Preferred dividends accrue from day-to-day, whether declared or not, and are payable only when and if declared
by the Company&#146;s board of directors. Since inception, the Company has never declared or paid any dividends. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Liquidation
Preferences </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon liquidation, dissolution, or winding up of the Company or a deemed liquidation event as defined in the
Company&#146;s Certificate of Incorporation, the holders of shares of Series C and Series B Preferred Stock will receive, on a pari passu basis, a per share amount equal to the Series C purchase price of $1.83 (plus any declared but unpaid
dividends) and equal to the original Series B purchase of $1.3767 (plus any declared but unpaid dividends), collectively (the &#147;Series C and Series B Liquidation Preference&#148;) or such amount per share as would have been payable had all
shares of Series C and Series B had been converted into common stock immediately prior to such liquidation event. The payment of Series C and Series B Liquidation Preference is to be made before any payment made to the holders of Series A Preferred
Stock and Common Stock. Thereafter, the Series A Preferred holders are entitled to receive their liquidation preference before any distributions are made to common stockholders, a per share amount equal to $1.00 (plus any declared but unpaid
dividends) (the &#147;Series A Liquidation Preference&#148;) or such amount per share as would have been payable had all shares of Series A had been converted into common stock immediately prior to such liquidation event. After payments of the full
liquidation preferences of the Series C and Series B Liquidation Preference and the Series A Liquidation Preference described above, any remaining assets of the Company shall be distributed to the holders of the common stock in proportion to the
number of shares of common stock that they hold. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Redemption </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series&nbsp;A Preferred were redeemable at any time on or after five years from August&nbsp;19, 2015, the original issuance date of the 6.5
million&nbsp;shares of Series A Preferred, upon receipt of a written notice from the holders of a majority of the shares of Series A Preferred. The initial redemption price was the greater of (i)&nbsp;the Series&nbsp;A Preferred original issuance
price per share, plus any accrued and unpaid dividends, whether or not declared by the board of directors, and (ii)&nbsp;the fair market value of Series&nbsp;A Preferred as mutually agreed upon by the Company and the holders of a majority of the
shares of Series&nbsp;A Preferred then outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2018, in conjunction with the execution of the Series B Preferred Purchase
Agreement, the Series&nbsp;A Preferred redemption provision was amended as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All outstanding shares of Preferred Stock shall be
redeemed by the Company at a price equal to the original issuance price per share, plus any accrued and unpaid dividends, whether or not declared, together with any other dividends declared but unpaid in three annual installments commencing not more
than sixty (60)&nbsp;days after receipt by the Company at any time on or after five years from the Series B Preferred original issuance date, July&nbsp;10, 2018, a written notice from the holders of a majority of the shares of Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounted for the changes in Series A Preferred redemption provision as a modification as there was no significant difference in
Series A Preferred fair value before and after the modification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, in conjunction with the execution of the Series C
Purchase Agreement, the Series A Preferred and Series B Preferred redemption provisions were modified as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All outstanding shares
of Preferred Stock shall be redeemed by the Company at a price equal to the original issuance price per share, plus any accrued and unpaid dividends, in three annual installments commencing not more than sixty (60) days after receipt by the Company
at any time on or after five years from the Series C Preferred original issuance date, December 19, 2019, a written notice from the holders of a majority of the shares of Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounted for the changes in Series A Preferred redemption and Series B Preferred redemption provisions as a modification as there
was no significant difference in Series A Preferred and Series B Preferred fair values before and after the modification. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The voting, dividend, and liquidation rights of the holders of the common stock are subject to and qualified by the rights, powers, and
preferences of the holders of the Preferred Stock. As of December&nbsp;31, 2018 and 2019, the Company had 147,682,655 and 181,000,000 authorized shares of common stock, respectively, at a par value of $0.0001 per share. The common stock has the
following rights and privileges: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Voting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of shares of common stock are entitled to one vote for each share of common stock held at any meeting of stockholders and at the
time of any written action in lieu of a meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Dividends </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of shares of common stock are entitled to receive dividends, when declared by the Company&#146;s board of directors. Cash dividends
may not be declared or paid to holders of shares of common stock until all unpaid dividends on the Preferred Stock have been paid in accordance with their terms. No dividends have been declared or paid by the Company since its inception.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Liquidation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After payment of the respective liquidation preferences to the holders of shares of Preferred Stock, the holders of shares of common stock are
entitled to share ratably in the Company&#146;s remaining assets available for distribution to its stockholders in the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company or upon occurrence of a deemed
liquidation event. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Shares reserved for future issuance </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B></B><B><I></I></B><B>As of December&nbsp;31, </B><B><I></I></B><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018 </B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019 </B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion of redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,755,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,442,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercises of outstanding stock option awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">113,174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,337,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares of common stock available for future grants under the 2015 Equity Incentive Plan, as
amended</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">983,177</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">567,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total shares reserved for future issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,581,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,346,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Founders&#146; Common Stock Awards </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During 2015, the Company&#146;s board of directors granted common stock awards to the Company&#146;s founders in exchange for services provided
to the Company. The purchase price of the common stock awards was the estimated fair value at the issuance date. The shares vest from one to four years and vesting could be accelerated upon a change in control. The vesting of certain
performance-based grants of restricted stock awards were contingent upon the filing of an Investigational New Drug Application by the Company with the FDA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the holder of founders&#146; common stock award terminates their relationship with the Company during the vesting period, the Company may
repurchase any unvested restricted common stock held by these individuals at their original purchase price. During the vesting term, holders of founders&#146; common stock awards are deemed to be common stockholders and have dividend and voting
rights. The Company issued 745,244&nbsp;shares of founders&#146; common stock during 2015. No founders&#146; common stock awards were granted in subsequent years. Total compensation expense was $25,000 for these founders&#146; common stock awards,
which are recorded to operating expenses in the statements of operations and comprehensive (loss) income over their respective vesting period. As of December 31, 2018, 46,675&nbsp;shares of founders&#146; common stock awards were expected to vest
and became fully vested in 2019. As of December&nbsp;31, 2019, all shares of founders&#146; common stock awards were fully vested. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. 2015 Equity
Incentive Plan and Stock-Based Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In August 2015, the board of directors adopted the 2015 Equity Incentive Plan, as amended
(the &#147;Plan&#148;), which provides for the grant of incentive stock options, nonqualified stock options or other awards including stock appreciation rights and restricted stock awards to the Company&#146;s employees, officers, directors,
advisors, and consultants for the purchase of up to 1.5&nbsp;million shares of the Company&#146;s common stock. In July 2018, the Plan was amended to increase the number of shares reserved thereunder by 1.0&nbsp;million shares. In January 2019, the
Company&#146;s board of directors and stockholders voted to increase the number of shares reserved for issuance under the 2015 Equity Incentive Plan by 0.4&nbsp;million shares. In December 2019, the Company&#146;s board of directors and stockholders
voted to increase the number of shares reserved for issuance under the 2015 Equity Incentive Plan by 0.4&nbsp;million shares. As of December 31, 2019, 0.6&nbsp;million shares remained available for issuance under the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Options under the Plan may be granted for periods of up to 10&nbsp;years and at prices no
less than 100.0% of the estimated fair value of the shares on the date of grant as determined by the board of directors, provided, however, that the exercise price of an incentive stock option granted to a 10.0% shareholder shall not be less than
110.0% of the estimated fair value of the shares on the date of grant and the option is not exercisable after the expiration of five&nbsp;years from the date of grant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Common Stock Awards </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company granted restricted stock awards under the Plan. The purchase price of the restricted common stock awards was the estimated fair
value as determined by the board of directors at the issuance date. The shares vest from one to four years and vesting could be accelerated upon a change in control. A holder of an award may pay a total purchase price or a part of the purchase price
for granted shares at any time during the vesting periods. Upon termination of employment, the Company has the right to repurchase any unvested restricted shares. The repurchase price for unvested shares of common stock will be the lower of
(i)&nbsp;the fair market value on the date of repurchase or (ii)&nbsp;their original purchase price. During the vesting term, holders of restricted stock awards are deemed to be a common stock shareholder and have dividends and voting rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounted for restricted stock awards as early exercised options and recognized a liability in other liabilities when cash was
received for the purchase of shares of restricted stock. As shares of restricted stock vested, the Company reclassified the liability to common stock and additional paid in capital. As of December&nbsp;31, 2018, and 2019, the Company recorded a
liability included in accrued expenses and other liabilities of $52,000 and $22,000, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company used Black-Scholes option
pricing model to estimate stock-based compensation expense related to restricted stock awards with the following assumptions for the year ended December&nbsp;31, 2018: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">69.60%&nbsp;-&nbsp;76.20%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">1.80%&nbsp;-&nbsp;2.48%</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">0.92&nbsp;-&nbsp;2.16</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underlying common stock fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$1.86&nbsp;-&nbsp;$2.36</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There were no grants of restricted stock awards for the year ended December 31, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes restricted stock activity during the years ended December&nbsp;31, 2018 and 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-Average</FONT><BR>Grant&nbsp;Date<BR>fair&nbsp;value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding and unvested, as of December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">643,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">339,615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(280,241</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding and unvested, as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">703,188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(394,289</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repurchases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,051</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding and unvested, as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">302,211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Restricted stock awards of 4,195 shares with a weighted-average grant date fair value of
$0.08 per share, were not purchased by the award holders as of December&nbsp;31, 2019. As these shares of the restricted common stock awards were not issued, they are not included in the table above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate fair value of restricted stock awards vested during the years ended December&nbsp;31, 2018 and 2019 was $0.1 million and $0.4
million, respectively. Total intrinsic value of outstanding unvested restricted stock awards was $3.6 million and $2.1&nbsp;million as of December&nbsp;31, 2018 and 2019, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Incentive Stock Options and Nonqualified Stock Options </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock options issued under the Plan generally vest over a four-year period and expire ten years from the date of grant. Certain options provide
for accelerated vesting if there is a change in control, as defined in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company used Black-Scholes option pricing model to
estimate stock-based compensation expense for stock option awards with the following assumptions for the years ended December&nbsp;31, 2018 and 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">81.80%&nbsp;-&nbsp;82.50%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">74.80%&nbsp;-&nbsp;82.53%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2.78% - 3.07%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">1.43%&nbsp;-&nbsp;2.59%</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.78 - 6.06</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.00&nbsp;-&nbsp;6.08</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underlying common stock fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$2.79 - $5.15</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$5.15&nbsp;-&nbsp;$7.08*</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Subsequent to the issuance of the Company&#146;s financial statements as of and for the period ended December&nbsp;31,&nbsp;2019, the Company&#146;s management determined that the disclosed range of underlying common
stock fair value incorrectly presented the range of the grant date fair value of options granted during the year ended 2019. The prior range disclosed as $0.59 - $0.74 has been updated as an immaterial correction to $0.72 - $0.99 (or $5.15 - $7.08,
respectively, on a post-reverse split basis). The disclosure correction did not result in a change to the stock-based compensation expense for the year ended December 31, 2019. Further, it did not modify any amounts presented in the financial
statements or require any other disclosure amendments. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company granted 113,174 stock options during the year ended
December 31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A summary of option activity under the Plan is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average&nbsp;Exercise<BR>Price per Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Remaining<BR>Contractual<BR>Term&nbsp;(in&nbsp;Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate<BR>Intrinsic<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">113,174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,303,041</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(42,059</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,655</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,337,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercisable as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">228,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested and expected to vest as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,337,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Aggregate intrinsic value represents the difference between the fair value of the underlying common stock and
the exercise price as of December 31, 2018 and 2019. The weighted-average grant date fair value of options granted during the years ended December 31, 2018 and 2019, was $3.44 per share and $4.37 per share, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock-Based Compensation Expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents the components and classification of stock-based compensation expense for the Company&#146;s stock-based awards
for the years ended December 31, 2018 and 2019 (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years Ended<BR>December 31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted stock awards and founders&#146; common stock awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">207</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">321</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,829</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">584</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2018, there was $0.7 million of unrecognized stock-based compensation expense that is
expected to be recognized over the weighted-average periods of 2.2 years related to restricted stock awards and stock options, respectively. As of December 31, 2018, there was $0.4 million of unrecognized stock-based compensation expense that is
expected to be recognized over the weighted-average periods of 3.7 years related to stock options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2019, there was
$0.4&nbsp;million of unrecognized compensation costs that is expected to be recognized over the weighted-average periods of 2.2&nbsp;years related to restricted stock awards. As of December&nbsp;31, 2019, there was $4.4&nbsp;million of unrecognized
compensation costs that is expected to be recognized over the weighted-average periods of 3.0&nbsp;years related to stock options. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Income Taxes
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No provision for income taxes was recorded for the years ended December 31, 2018 and December 31, 2019. The Company has incurred net
operating losses only in the United States since its inception. The Company has not reflected any benefit of such net operating loss carryforwards in the financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A reconciliation of the U.S. federal statutory income tax rate to the Company&#146;s effective income tax rate is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax computed at federal statutory rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State taxes, net of federal tax benefit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General business credit&#151;federal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">295.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.2</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(50.0</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other permanent differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.0</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2.4</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32.5</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(267.7</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effective income tax rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.5</TD>
<TD NOWRAP VALIGN="bottom">%)&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net deferred tax assets and liabilities consisted of the following (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Asset basis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">227</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,655</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development credits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Asset basis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(110</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(139</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(249</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,240</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(21,929</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net deferred taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net operating losses and tax credit carryforwards were as follows (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Expiration&nbsp;Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating losses, federal (starting from January 1, 2018)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">29,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Does&nbsp;not&nbsp;expire</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating losses, federal (before January&nbsp;1, 2018)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">29,457</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2035-2037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating losses, state</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">60,711</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2035-2039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credits, federal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,652</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2036-2039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credits, state</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Does not expire</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Utilization of the net operating loss carryforwards and research credit carryforwards may be subject to an
annual limitation due to the ownership percentage change limitations provided by the Internal Revenue Code (&#147;IRC&#148;) and similar state provisions. Annual limitations may result in the expiration of the net operating losses and tax credit
carryforwards before they are utilized. The Company performed a IRC Section 382 analysis through December 31, 2019 and does not expect any previous ownership changes to result in a limitation that will reduce the total amount of net operating loss
and tax credit carryforwards disclosed that can be utilized. Subsequent ownership changes may affect the limitation in future years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the years ended December 31, 2018 and 2019, the Company recorded a full valuation
allowance on federal and state deferred balances since management does not forecast the Company to be in a profitable position in the near future. Changes in the valuation allowance for deferred tax assets during the years ended December 31, 2018
and 2019 related primarily to the increases in net operating loss carryforwards and research and development tax credit carryforwards and were as follows (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance at the beginning of the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,240</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increases recorded to income tax provision</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,689</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance at the end of the year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,240</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,929</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s U.S. federal and state income tax returns are generally subject to tax examinations for the
tax years ended December 31, 2016 through December 31, 2019. There are currently no pending income tax examinations. To the extent the Company has tax attribute carryforwards, the tax years in which the attribute was generated may still be adjusted
upon examination by the Internal Revenue Service and state tax authorities to the extent utilized in a future period. The Company&#146;s policy is to record interest and penalties related to income taxes as part of its income tax provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The entire amount of the unrecognized tax benefits would not impact the Company&#146;s effective tax rate if recognized. The Company has
elected to include interest and penalties as a component of tax expense. During the years ended December 31, 2018 and 2019, the Company did not recognize accrued interest and penalties related to unrecognized tax benefits. The Company does not
anticipate that the amount of existing unrecognized tax benefits will significantly increase or decrease during the next 12 months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A
reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">January&nbsp;1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">855</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions based on tax positions related to current year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reductions for tax positions of prior year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(70</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December&nbsp;31</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Commitments and Contingencies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Purchase Commitments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has contractual arrangements with research and development organizations and suppliers; however, these contracts are generally
cancelable on 30 days&#146; notice and the obligations under these contracts are largely based on services performed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>License and
Collaboration Agreements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Potential payments related to the Company&#146;s license and research agreements, including milestone and
royalty payments, are detailed in Notes 6 and 7. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Leases </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2018, the Company leased approximately 18,000 square feet of corporate offices and research facilities in Redwood City, California. Rent
expense, including common area maintenance expense, was approximately $0.1&nbsp;million per month. This lease expired on June&nbsp;28, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2018, the Company entered into a <FONT STYLE="white-space:nowrap">non-cancelable</FONT> lease agreement (the &#147;Lease&#148;)
for premises consisting of approximately 32,974 square feet located in South San Francisco, California (the &#147;Premises&#148;). The Company moved into the Premises in July 2018. The Premises is being used for the Company&#146;s corporate
headquarters and principal operating facility. The term of the Lease is eighty-four months, which commenced on July&nbsp;1, 2018. Base rent was abated for the first two months of the lease term and thereafter is $0.2&nbsp;million per month during
the first year of the lease term, with specified annual increases thereafter. The Company paid a refundable security deposit of approximately $0.4&nbsp;million, which is included in Other non-current assets in the Balance Sheets at December&nbsp;31,
2018 and 2019. The Company has the right to extend the lease term by seven years upon written notice not more than twelve months nor less than nine months prior to the expiration of the original lease term, with monthly payments equal to the
&#147;fair rental value&#148; as defined in the Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the years ended December&nbsp;31, 2018 and 2019, rent expense, including
common area maintenance expense, was $1.8&nbsp;million and $2.5&nbsp;million, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Future minimum lease payments under the Lease
as of December&nbsp;31, 2019 were as follows (in thousands):<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Year ending December 31:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Operating&nbsp;Lease</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,098</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,171</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024 and beyond</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,390</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,645</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Legal Proceedings </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company, from time to time, may be party to litigation arising in the ordinary course of business. The Company was not subject to any
material legal proceedings during the years ended December&nbsp;31, 2018 and 2019, and, to the best of its knowledge, no material legal proceedings are currently pending or threatened. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Indemnification </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such
agreements, the Company may indemnify, hold harmless and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third party actions. In some cases, the
indemnification will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to
defend lawsuits or settle claims related to these indemnification provisions. The Company has also entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against
liabilities that may arise by reason of their status or service as directors or officers to the fullest extent permitted by Delaware corporate law. The Company currently has directors&#146; and officers&#146; insurance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Related Party Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain employees of Third Rock Ventures, a stockholder of the Company, provided consulting services to the Company. Consulting service
expenses of $0.1 million and $36,000 were recorded for the years ended December 31, 2018 and 2019, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2018 and 2019, the
Company made charitable contributions to the University of California, San Francisco Foundation (the &#147;UCSF Foundation&#148;), which were directed to support research performed in the laboratories of two of the Company&#146;s scientific
founders. The Company made a charitable contribution of $0.5 million and $0.3 million for the years ended December 31, 2018 and 2019, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2017, the Company entered into a consulting agreement with the founder of Healthcare&nbsp;&amp; Humanity Foundation (the
&#147;Director&#148;) pursuant to which the Director provided consulting services to the Company at a rate of $5,000 per month in 2018. In addition, the Company granted the Director 6,293 shares of restricted stock at a purchase price of $0.08 per
share with quarterly vesting over a one-year period contingent upon the Director providing consulting services during the vesting period. The Director became a director of the Company in December 2017. In February 2018, the agreement with the
Director terminated pursuant to its terms. General and administrative services provided while the Director was a director of the Company amounted to $5,000 and $0, respectively during the years ended December 31, 2018 and 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2018, the Company sold 1.0&nbsp;million shares of Series&nbsp;A Preferred to pH Pharma Co. Ltd. (&#147;pH Pharma&#148;), an entity in
which the Director has a majority ownership, for $1.0&nbsp;million. These shares of Series&nbsp;A Preferred represent 1.0% of the Company&#146;s outstanding equity on a fully diluted basis as of December&nbsp;31, 2019. In May 2018, the Company
entered into a research services agreement with pH Pharma. In the year ended December&nbsp;31, 2018, the Company was reimbursed $51,000 for services performed in connection with the research service agreement. As of December&nbsp;31, 2018, all
services were completed under this agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2019, the Company entered into the Novartis Agreement with Novartis covering the
development and commercialization of Pliant&#146;s preclinical product candidate, PLN-1474 and up to three additional targets. Upon execution of the Agreement, Pliant also entered into a financing side letter with Novartis, whereby Novartis
committed to provide up to $30.0 million in equity financing of which $20.0 million was provided for preferred shares as a part of a Series C equity offering and the remaining $10.0 million will be provided for common shares in the event Pliant
completes an Initial Public Offering. As of December 31, 2019, Novartis owns approximately 7.4% of the Company&#146;s outstanding shares on a fully diluted basis. See Notes 6 and Note 9 for additional information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. Defined Contribution Plan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company sponsors a defined contribution plan under Section&nbsp;401(k) of the IRC covering substantially all full-time U.S. employees. Employee contributions are voluntary and are determined on an individual basis subject to the maximum allowable
under federal tax regulations. The Company made contributions to the plan of $0.2&nbsp;million and $0.2&nbsp;million for the years ended December&nbsp;31, 2018 and 2019, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. Net Loss Per Share Attributable to Common Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share
attributable to common stockholders for the periods presented, because including them would have been antidilutive: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years Ended&nbsp;December 31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock (on an as-converted basis)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,755,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,442,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options to purchase common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">113,174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,337,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted stock awards granted and not purchased</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested restricted shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">703,188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">302,211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested shares of founders&#146; common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,623,011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,086,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A reconciliation of the numerator and denominator used in the calculation of the basic and diluted net loss per
share attributable to common stockholders is as follows (in thousands, except share and per share amounts): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years&nbsp;Ended&nbsp;December 31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss per share:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Numerator</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30,276</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Add: accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,876</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,225</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,856</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Denominator</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average common shares outstanding used to calculate net loss per share attributable to
common stockholders, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,165,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,623,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share attributable to common stockholders, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(30.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the Company&#146;s unaudited pro forma
basic and diluted net income per share attributable to common stockholders (in thousands, except share and per share data) assuming the automatic conversion of the redeemable convertible preferred stock based on the mid-point of the IPO price range
of $15.00 per share, upon consummation of an IPO as if such event had occurred as of the beginning of the respective period: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Unaudited Pro Forma Net Loss Per Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="top">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma adjustment to accretion to redemption value and cumulative dividends on redeemable
convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">(6,225</TD>
<TD NOWRAP VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:pt"><BR></P> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">)&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss attributable to common stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(631</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used to calculate net loss per share attributable to common
stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,623,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,623,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma adjustment to reflect assumed conversion of all redeemable convertible
preferred&nbsp;stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,886,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used to calculate pro forma net loss per share attributable to common
stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,510,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,510,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share attributable to common stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. Subsequent Events </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2020, the Company issued 28,527,313 shares of Series C Preferred at $1.83 per share in exchange for an aggregate purchase price of
$52.2 million in a closing of the second tranche. The sales of the Series C Preferred Shares are at a fair value of $1.83 per share, which was the price the remaining shares of Series C Redeemable Convertible Preferred Stock were sold to other
investors in a closing that occurred on December 19, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2020, the Company achieved the first patient dosing milestone of
the Novartis Agreement triggering the receipt of a $25.0 million payment expected in the second quarter of 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the
preparation of the financial statements, the Company has evaluated subsequent events for potential recognition and disclosure through March 13, 2020, the date these financial statements were issued, and has updated such evaluation for disclosure
purposes through May 26, 2020 with respect to the reverse </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stock split reflected in the amendment to the Company&#146;s amended and restated certificate of incorporation, filed on May 22, 2020, as discussed below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Reverse Stock Split </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May 22, 2020, the Company implemented a 1-for-7.15 reverse stock split of the Company&#146;s common stock. Stockholders entitled to
fractional shares as a result of the reverse stock split will receive a cash payment in lieu of receiving fractional shares. All share and per share data shown in the accompanying financial statements and related notes have been retroactively
revised to reflect the reverse stock split. Shares of common stock underlying outstanding stock options and other equity instruments were proportionately reduced and the respective exercise prices, if applicable, were proportionately increased in
accordance with the terms of the agreements governing such securities. Shares of common stock reserved for issuance upon the conversion of the Company&#146;s Preferred Stock were proportionately reduced and the respective conversion prices were
proportionately increased. As of December 31, 2018 and 2019, all outstanding shares of preferred stock were convertible into shares of common stock on a 1-for-7.15 basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_8"></A>Condensed Balance Sheets </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>(In thousands, except share and per share amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>March&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma<BR>as&nbsp;of<BR>March&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">85,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">113,368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">113,368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Tax credit receivable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">261</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">261</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">176,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">176,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,201</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,201</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other non-current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,085</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">119,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">184,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">184,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Liabilities, Redeemable Convertible Preferred Stock and Stockholders&#146; (Deficit)
Equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,532</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,532</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accrued liabilities (Note 5)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,564</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,564</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other long-term liabilities (Note 5)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">931</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">931</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Commitments and Contingencies (Note 13)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Series A redeemable convertible preferred stock, $0.0001 par value; 56,000,000 and 56,000,000
shares authorized at December&nbsp;31, 2019 and March&nbsp;31, 2020, respectively; 56,000,000 and 56,000,000 shares issued and outstanding, at December&nbsp;31, 2019 and March&nbsp;31, 2020, respectively; aggregate liquidation preference of $62,468
and $62,468 at December&nbsp;31, 2019 and March&nbsp;31, 2020, respectively; no shares authorized, issued and outstanding pro forma </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Series B redeemable convertible preferred stock, $0.0001 par value; 49,501,221 shares and
49,501,221 shares authorized at December&nbsp;31, 2019 and March&nbsp;31, 2020, respectively; 49,501,221 shares and 49,501,221 shares issued and outstanding at December&nbsp;31, 2019 and March&nbsp;31, 2020, respectively; aggregate liquidation
preference of $75,860 and $75,860 at December&nbsp;31, 2019 and March&nbsp;31, 2020, respectively; no shares authorized, issued and outstanding pro forma </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Series C redeemable convertible preferred stock, $0.0001 par value; 44,000,000 shares and
55,000,000 shares authorized at December&nbsp;31, 2019 and March&nbsp;31, 2020, respectively; 26,360,745 shares and 54,888,058 shares issued and outstanding at December&nbsp;31, 2019 and March&nbsp;31, 2020, respectively; aggregate liquidation
preference of $47,947 and $99,985 at December&nbsp;31, 2019 and March&nbsp;31, 2020, respectively; no shares authorized, issued and outstanding pro forma </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stockholders&#146; (deficit) equity</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Common stock, $0.0001 par value; 181,000,000 and 210,000,000 shares authorized at December&nbsp;31,
2019 and March&nbsp;31, 2020; and 1,846,024 and 1,906,349 shares issued and outstanding at December&nbsp;31, 2019 and March&nbsp;31, 2020, respectively; 24,576,346 shares issued and outstanding, pro forma </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Additional paid-in capital</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">238,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65,266</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(65,266</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accumulated other comprehensive (loss)/gain</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total stockholders&#146; (deficit) equity</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(64,751</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">173,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Total liabilities, redeemable convertible preferred stock and stockholders&#146; (deficit)
equity</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">119,064</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">184,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">184,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these condensed financial statements </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_9"></A>Condensed Statements of Operations and Comprehensive (Loss) Income </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2"><B>(In thousands, except share and per share amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months&nbsp;Ended</B><br><B>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue &#151; related party</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,749</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,919</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,601</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,011</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,350</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,930</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Loss) income from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,350</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,023</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,344</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Undistributed earnings to preferred shareholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,029</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) income attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(15,367</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) income per share, attributable to common stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10.90</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10.90</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares used in computing net (loss) income per share attributable to common stockholders:</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,409,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,897,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,409,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,897,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net income per share attributable to common stockholders (unaudited):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares used in computing pro forma net income per share attributable to common stockholders
(unaudited):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,829,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,861,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive (loss) income:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,023</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net unrealized gain on short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive (loss) income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,020</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,089</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these condensed financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_10"></A>Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders&#146; Deficit </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="3" ALIGN="center"><B>(In thousands,<BR>except share<BR>amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redeemable Convertible Preferred Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR>Paid-In<BR>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Other<BR>Comprehensive<BR>Gain </B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Stockholders&#146;<BR>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series A</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series B</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series C</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">61,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">70,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,363,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,470</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(71,469</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vesting of founders&#146; common stock and restricted stock awards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">126,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(320</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,024</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,344</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net unrealized gain on short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,023</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,023</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at March&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">61,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">71,931</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,489,057</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(86,517</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(86,513</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="3" ALIGN="center"><B>(In thousands,<BR>except share<BR>amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redeemable Convertible Preferred Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR>Paid-In<BR>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Other<BR>Comprehensive<BR>Gain (Loss)</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Stockholders&#146;<BR>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series A</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series B</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series C</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at December&nbsp;31, 2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,360,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,846,024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(76,295</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series C redeemable preferred stock, net of issuance costs of $167</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,527,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,038</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vesting of founders&#146; common stock and restricted stock awards</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Option exercises</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net unrealized gain on short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance at March&nbsp;31, 2020</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,888,058</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">99,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,906,349</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(65,266</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(64,751</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Common stock share amounts do not add up due to rounding. </TD></TR></TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an
integral part of these condensed financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_11"></A>Condensed Statements of Cash Flows </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2"><B>(In thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months&nbsp;Ended</B><br><B>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,023</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net (loss) income to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credit receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(63</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,710</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(237</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(883</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other non-current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,768</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(424</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent and other long-term liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,847</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,766</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,159</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,008</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion of short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(258</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(336</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,417</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,373</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of Series C preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,038</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment of deferred offering costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(127</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(364</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used)/provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(127</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (decrease)/increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(38,391</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents at beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,949</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents at end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,558</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">113,368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Supplemental disclosures of noncash investing and financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of property and equipment in accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassification of restricted stock awards from liabilities to common stock upon vesting</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accretion to redemption value and cumulative dividends on redeemable convertible preferred
stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred offering costs in accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">792</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net unrealized gain on short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these condensed financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin729258_12"></A>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Description of Business
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pliant Therapeutics, Inc. (the &#147;Company&#148;) is a clinical stage biopharmaceutical company focused on discovering and
developing novel therapies for the treatment of fibrosis with an initial focus on treating fibrosis by inhibiting integrin-mediated activation of TGF-&szlig;. Fibrosis refers to the abnormal thickening and scarring of connective tissue due to the
production and deposition of excess collagen in the extra-cellular matrix. Fibrosis can occur in many different tissues including lung, liver, kidney, muscle, skin and the GI tract, and often causes severe and debilitating disease leading to organ
failure. The Company is located in South San Francisco, California, and was incorporated in the state of Delaware in June 2015. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Summary of
Significant Accounting Policies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Basis of Presentation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of
America (&#147;U.S. GAAP&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The accompanying condensed balance sheet as of March&nbsp;31, 2020, condensed statements of operations
and comprehensive (loss) income, condensed statements of cash flows, and the condensed statements of convertible preferred shares and shareholders&#146; (deficit) equity for the three months ended March&nbsp;31, 2019 and 2020, are unaudited. The
balance sheet as of December&nbsp;31, 2019 was derived from audited financial statements as of and for the year ended December&nbsp;31, 2019. The unaudited interim condensed financial statements have been prepared on the same basis as the audited
annual financial statements as of and for the year ended December&nbsp;31, 2019, and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company&#146;s
financial position as of March&nbsp;31, 2020, and the results of its operations and its cash flows for the three months ended March&nbsp;31, 2019 and 2020. The financial data and other information disclosed in these notes related to the three months
ended March&nbsp;31, 2019 and 2020, are also unaudited. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Use of Estimates </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets, liabilities, and expenses as well as the disclosure of contingent assets and liabilities as of and during the reporting period. The Company bases its estimates and assumptions on historical experience when available and
on various factors that it believes to be reasonable under the circumstances. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, useful lives assigned to property and equipment, the fair
values of common and redeemable convertible preferred stock, stock-based compensation expense, accruals for research and development costs, income taxes and uncertain tax positions. The Company assesses estimates on an ongoing basis; however, actual
results could materially differ from those estimates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Revenue Recognition </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for its revenue under Accounting Standards Update or ASU, ASU 2014-09, Topic 606 <I>Revenue from Contracts with Customers
(&#147;Topic 606&#148;) </I>using the full retrospective transition method. ASU 2014-09 provides a single, comprehensive revenue recognition model for all contracts with customers. This standard contains principles for the determination of the
measurement of revenue and the timing of when such revenue is recognized. Revenue recognition will reflect the transfer of goods or services to customers at an amount that is expected to be earned in exchange for those goods or services.
Subsequently, the FASB has issued </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the following guidance to amend ASU 2014-09: ASU No.&nbsp;2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date; ASU No.&nbsp;2016-08, Revenue from Contracts
with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net); ASU No.&nbsp;2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing; ASU No.&nbsp;2016-12,
Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients; and ASU No.&nbsp;2016-20, Technical Corrections and Improvements to Topic 606, which clarifies narrow aspects of Topic 606 or corrects unintended
application of the guidance. The Company must adopt ASU No.&nbsp;2015-14, ASU No.&nbsp;2016-08, ASU No.&nbsp;2016-10, ASU No.&nbsp;2016-12, and ASU No.&nbsp;2016-20 with ASU No.&nbsp;2014-09, which are referred to collectively as the &#147;Topic
606&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FASB issued ASU No.&nbsp;2018-18, &#147;Collaborative Arrangements (Topic 808)&#148; issued in November 2018. The Company
assessed and concluded that they are not under Topic 808 and as the Novartis Agreement is not considered a collaboration under its provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date all revenue has been generated from the Company&#146;s Collaboration and License Agreement with Novartis (the &#147;Novartis
Agreement&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s revenue-related party is solely generated off of the Novartis Agreement. The Company&#146;s
licensing agreement includes upfront signing fees, cost reimbursements, research and development services, milestone payments and royalties on future licensee&#146;s product sales. The Company has both fixed and variable consideration.
Non-refundable upfront fees are considered fixed, while funding of research and development activities and milestone payments are identified as variable consideration. A contract liability is an obligation to transfer goods or services for
which&nbsp;the Company&nbsp;has received consideration, or for which an amount of consideration is due from the customer. A contract asset is a right to consideration in exchange for goods or services that&nbsp;the Company&nbsp;has transferred to a
customer when that right is conditional on something other than the passage of time. A receivable will be recorded on the balance sheet when the Company has unconditional rights to consideration (i.e., only the passage of time is required before
payment becomes due). Receivables cannot be netted against contract liabilities and are presented separately from contract assets. Contract assets and contract liabilities are netted at the contract level and are then aggregated and presented
separately each reporting period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In determining the appropriate amount of revenue to be recognized as the Company fulfills its
obligations under its agreements, the Company performs the following steps: (i)&nbsp;identification of the contract with a customer; (ii)&nbsp;identification of the performance obligations in the contract; (iii)&nbsp;determination of the transaction
price; (iv)&nbsp;allocation of the transaction price to the performance obligations in the contract; and (v)&nbsp;recognition of revenue when (or as) we satisfy each performance obligation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. The Company&#146;s performance
obligations include providing the worldwide license rights to compound PLN-1474, provide research and development services for PLN-1474 through Phase 1 of its development and provide research and development services on initial candidate targets,
which services are combined with a non-exclusive license to the initial candidate targets. The Company concluded that the worldwide license was distinct because the customer can benefit from the license on its own or together with other resources
that are readily available, and the research and development services are not transformative in nature. The Company concluded the research and development services on initial candidate targets were not distinct from a non-exclusive license for the
initial candidate targets, primarily as a result of (i)&nbsp;Pliant being unable to benefit on its own or together with other resources that are readily available as the license and (ii)&nbsp;the research and development services, including
manufacturing in support of such services, were expected to significantly modify the initial license. Therefore, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the promised goods and services were considered a single performance obligation. Significant management judgment is required in the identification of performance obligations and to determine the
level of effort required under an arrangement and the period over which the Company expects to complete our performance obligations under the arrangement. If the Company cannot reasonably estimate when the performance obligations either are
completed or become inconsequential, then revenue recognition is deferred until the Company can reasonably make such estimates. The Company estimates the transaction price and records revenue in the amount for which it is probable that a significant
reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, we re-evaluate the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its
estimate of the overall transaction price. Revenue is then recognized over the remaining estimated period of performance using the cumulative catch-up method. The estimated period of performance and project costs are reviewed quarterly and adjusted,
as needed, to reflect the Company&#146;s current assumptions regarding the timing of our deliverables. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of the accounting for
these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price of each performance obligation identified in the contract. The Company has never sold the performance obligations separately;
therefore an observable stand-alone selling price does not exist. Accordingly, the Company estimates a stand-alone selling price through maximizing the use of observable inputs such as market data, project cost estimates, and targeted margins. The
Company determined that each of the performance obligations is priced and delivered at the stand-alone selling price. Therefore, no reallocations are needed since there is no material right and the license and services are provided at the
stand-alone selling price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2020, the entirety of the Company&#146;s revenue&#151;related
party is related to the Collaboration and License Agreement with Novartis. The Company did not have any prior revenue agreements and did not recognize revenue during the three months ended March&nbsp;31, 2019. Receivables from collaborations are
typically unsecured and are concentrated in the biopharmaceutical industry. Accordingly, the Company may be exposed to credit risk generally associated with biopharmaceutical companies or specific to the Novartis Agreement. An allowance on the
receivables will be recorded if circumstances indicate collection is doubtful for a particular receivables balance. To date, the Company has not experienced any losses related to these receivables. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Fair Value Measurements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, the Company considers the principal or most advantageous market
in which to transact and the market-based risk. Fair value accounting is applied for all financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a
recurring basis. The carrying amount of the Company&#146;s financial instruments, including cash and cash equivalents, short-term investments, tax credit receivable, accounts receivable, prepaid expenses and other current assets, accounts payable
and accrued liabilities approximate fair value due to their short-term maturities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Concentration of Credit Risk and Other Risks and
Uncertainties </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and
cash equivalents, short-term investments and accounts receivable. The Company invests in money market funds, treasury bill and notes and government notes. The Company limits its credit risk associated with its cash
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and cash equivalents by placing them with banks and institutions it believes are highly credit worthy and in highly rated investments. The Company performs credit evaluations of its customer, and
the risk with respect to accounts receivable is further mitigated by the short duration of customer payment terms and the pedigree of the customer base. During the three months ended March&nbsp;31, 2020, Novartis accounted for 100% of the
Company&#146;s revenue&#151;related party and accounts receivable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s future results of operations involve several other
risks and uncertainties. Factors that could affect the Company&#146;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of results of clinical trials and reaching
milestones, uncertainty of regulatory approval of the Company&#146;s product candidates, uncertainty of market acceptance of the Company&#146;s product candidates, competition from substitute products, including those that may be developed or
marketed by larger companies, securing and protecting intellectual property, strategic relationships and dependence on key individuals and sole source suppliers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s product candidates require approvals from the U.S. Food and Drug Administration (&#147;FDA&#148;) and comparable foreign
regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company was denied approval, approval was delayed or the Company was
unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Segments
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company operates and manages its business as one reportable and operating segment, which is the business of developing and
commercializing novel therapies for fibrotic diseases. The Company&#146;s chief executive officer, who is the chief operating decision maker, reviews financial information on an aggregate basis for allocating and evaluating financial performance.
All long-lived assets are maintained in the United States of America. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Cash and Cash Equivalents </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be
cash equivalents. Cash equivalents consist primarily of amounts invested in Money Market Funds and United States (&#147;U.S.&#148;) government agency securities and are stated at fair value. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Short-Term Investments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s short-term investments consist of U.S. Treasury securities and U.S. government agency securities with remaining maturities
beyond three months at the date of purchase and one year or less from the balance sheet date. As of December&nbsp;31, 2019, all of the Company&#146;s short-term investments were classified as available-for-sale and were carried at fair market value.
The unrealized losses on the Company&#146;s available-for-sale securities are recorded in &#147;other comprehensive income and losses&#148; (&#147;OCI&#148;) in the statements of operations and comprehensive (loss) income. See Note 3 for further
details. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Short-term investments are considered impaired when a decline in fair value is judged to be other-than-temporary. The Company
consults with its investment managers and considers available quantitative and qualitative evidence in evaluating potential impairment of its short-term investments on a quarterly basis. If the cost of an individual investment exceeds its fair
value, the Company evaluates, among other factors, general market conditions, the duration and extent to which the fair value is less than cost and its intent and ability to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
hold the investment. Once a decline in fair value is determined to be other-than-temporary, an impairment charge will be recorded to other expense, net, in the statements of operations and
comprehensive (loss) income and a new cost basis in the short-term investment will be established. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Property and Equipment, Net
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Property and equipment are recorded at cost net of accumulated depreciation and amortization. Property and equipment are
depreciated using the straight-line method over the estimated useful lives of the assets. The useful lives of property and equipment are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment and software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3 years</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Shorter&nbsp;of&nbsp;remaining&nbsp;lease&nbsp;term&nbsp;or&nbsp;estimated&nbsp;useful&nbsp;life</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are
removed from the balance sheets and the resulting gain or loss is recorded to the statements of operations and comprehensive (loss) income. Repairs and maintenance are expensed as incurred. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Impairment of Long-Lived Assets </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not
be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated
future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. There was no impairment of long-lived assets during the three months ended March&nbsp;31, 2019 and
2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Redeemable Convertible Preferred Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company classifies redeemable convertible preferred stock outside of stockholders&#146; deficit because, upon the occurrence of certain
change in control events that are outside the Company&#146;s control, including liquidation, sale or transfer of the Company&#146;s assets, holders of the redeemable convertible preferred stock can cause redemption for cash. At any time on or after
December&nbsp;19, 2024, the holders of a majority of the outstanding redeemable convertible preferred stock can also require the Company to redeem the redeemable convertible preferred stock by providing the Company a written notice requesting such
redemption. The Company recognizes changes in the redemption value immediately as they occur, for example changes in fair value of preferred stock, and adjusts the carrying amount of the redeemable convertible preferred stock to equal the redemption
value at the end of each reporting period up through December 19, 2019, when the Company entered into the Series C Preferred Stock Purchase Agreement. See Note 9 for further details. In the absence of retained earnings these accretion charges are
recorded against additional paid in capital, if any, and then to accumulated deficit. The Company analyzed all embedded derivatives and beneficial conversion features for its redeemable convertible preferred stock and concluded that none requires
bifurcation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Expenses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development costs are expensed as incurred. Research and development expenses consist primarily of personnel costs for the
Company&#146;s research and product development employees. Also included are non-personnel costs such as fees paid to consultants and third parties for preclinical and clinical studies, research and development services, laboratory supplies and
equipment maintenance costs, license costs, contract manufacturing costs and allocations of facility related costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company estimates preclinical and clinical studies and research expenses based on the
services performed, pursuant to contracts with research institutions that conduct and manage preclinical and clinical studies and research services on its behalf. The Company estimates these expenses based on discussions with internal management
personnel and external service providers as to the progress or stage of completion of services and the contracted fees to be paid for such services. If the actual timing of the performance of services or the level of effort varies from the original
estimates, the Company will adjust the accrual accordingly. Payments made to third parties under these arrangements in advance of the performance of the related services are recorded as prepaid expenses and are expensed over the time when services
are rendered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payments associated with licensing agreements to acquire exclusive licenses to develop, use, manufacture and commercialize
products that have not reached technological feasibility and do not have alternate commercial use are expensed as incurred. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Tax
Credit Receivable </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to 2020, the Company was eligible for federal and California research and development credits for its
research and development activities performed within the United States and California, respectively. The credits are generally available to offset federal and California income tax liabilities. Starting in the fourth quarter of 2019, the Company was
no longer eligible for federal and California research development credits as it generated revenue during the year. As such, all federal and California research and development credits generated and accrued during the first three quarters of 2019
were reversed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Stock-Based Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s stock-based equity awards include restricted stock awards and stock options that are granted to employees and consultants
and accounted at fair value on the award grant date. Stock-based compensation expense is recognized over the awards&#146; vesting period on a straight-line basis and recorded as either research and development or general and administrative expenses
in the statements of operations and comprehensive (loss) income based on the function to which the related services are provided. Forfeitures are accounted for as they occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Black-Scholes option-pricing model, used to estimate fair value of stock-based awards, requires the use of the following assumptions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected term</I>&#151;The expected term represents the period that the stock-based awards are expected to be
outstanding. The expected term for the Company&#146;s stock options was calculated based on the weighted-average vesting term of the awards and the contract period, or simplified method. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected volatility</I>&#151;Since the Company is not yet a public company and does not have any trading
history for its common stock, the expected volatility was estimated based on the average historical volatilities of common stock of comparable publicly traded entities over a period equal to the expected term of the stock option grants. The
comparable companies were chosen based on their size, stage in the life cycle or area of specialty. The Company will continue to apply this process until enough historical information regarding the volatility of its stock price becomes available.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Risk-free interest rate</I>&#151;The risk-free interest rate is based on the U.S. Treasury yield in effect at
the time of grant for zero-coupon U.S. Treasury notes with maturities approximately equal to the expected term of the awards. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected dividend</I>&#151;The Company has never paid dividends on the common stock and has no plans to pay
dividends on the common stock. Therefore, the Company used an expected dividend yield of zero. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fair value of the common stock has been determined using independent third-party
valuations based on relevant valuation methodologies as outlined in the American Institute of Certified Public Accountants (AICPA) Practice Aid, <I>&#147;Valuation of Privately-Held-Company Equity Securities Issued as Compensation</I>&#148;. The
Company also considered the amount of time between the independent third-party valuation dates and the grant dates and used interpolation of the fair value between the two valuation dates to estimate common stock fair value at each grant date. This
determination included an evaluation of whether the subsequent valuation indicated that any significant change in valuation had occurred between the previous valuation and the grant date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Deferred Offering Costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Deferred offering costs, consisting of direct legal, accounting, filing and other fees directly related to the Company&#146;s proposed initial
public offering (&#147;IPO&#148;) are capitalized. The deferred offering costs will be reclassified to additional paid in capital upon completion of the IPO. The Company deferred $2.7&nbsp;million and $3.4&nbsp;million as of December&nbsp;31, 2019
and March&nbsp;31, 2020, respectively, which is recorded as other non-current assets in the Balance Sheets. In the event the IPO is aborted, all capitalized deferred offering costs will be expensed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Leases and Rent Expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company records rent expense on a straight-line basis over the life of the lease. In cases where there is a free rent period or future
fixed rent escalations, the Company records a deferred rent liability. Additionally, the receipt of any lease incentives is recorded as a deferred rent liability which is amortized over the lease term as a reduction of rent expense. Building
improvements made with the lease incentives or tenant allowances are capitalized as leasehold improvements and included in property and equipment, net in the Balance Sheets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Income Taxes </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company provides for income taxes under the asset and liability method. Current income tax expense or benefit represents the amount of income taxes expected to be payable or refundable for the current year. Deferred income tax assets and liabilities
are determined based on differences between the financial statement reporting and tax basis of assets and liabilities and net operating loss and credit carryforwards and are measured using the enacted tax rates and laws that will be in effect when
such items are expected to reverse. Deferred income tax assets are reduced, as necessary, by a valuation allowance when management determines it is more likely than not that some or all the tax benefits will not be realized. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounts for uncertain tax positions in accordance with ASC No.&nbsp;740-10<I>, Accounting for Uncertainty in Income Taxes</I>.
The Company assesses all material positions taken in any income tax return, including all significant uncertain positions, in all tax years that are still subject to assessment or challenge by relevant taxing authorities. Assessing an uncertain tax
position begins with the initial determination of the position&#146;s sustainability and is measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. As of each balance sheet
date, unresolved uncertain tax positions must be reassessed, and the Company will determine whether (i)&nbsp;the factors underlying the sustainability assertion have changed and (ii)&nbsp;the amount of the recognized tax benefit is still
appropriate. The recognition and measurement of tax benefits requires significant judgment. Judgments concerning the recognition and measurement of a tax benefit might change as new information becomes available. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company includes any penalties and interest expense related to income taxes as a component of income tax expense, as necessary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Comprehensive Gain </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Comprehensive gain includes net (loss) income as well as other changes in stockholders&#146; deficit that result from transactions and economic
events other than those with stockholders. For the three months ended March&nbsp;31, 2019 and 2020, the Company had a $3,000 and a $60,000 net unrealized gain on short-term investments, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Net (Loss) Income Per Share </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Basic net (loss) income per share is computed by dividing net (loss) income attributed to common stockholders by the weighted-average number of
shares of common stock outstanding during the period. Diluted net (loss) income per share is computed using the weighted-average number of shares of common stock outstanding during the period and, if dilutive, the weighted-average number of
potential shares of common stock. Net (loss) income per share attributable to common stockholders is calculated using the&nbsp;two-class&nbsp;method, which is based on an earnings allocation formula that determines net (loss) income per share for
the Company&#146;s common stockholders and holders of participating securities. The holders of preferred stock are entitled to receive dividends prior and in preference to any declaration or payment of any dividend on the common stock. For the three
months ended March&nbsp;31, 2020 the dividends the preferred shareholder would be entitled to, if a dividend was declared by the Board of Directors, exceeded net income for the period, resulting in the full amount of net income reflected as
<I>undistributed earnings to preferred shareholders</I> within our statements of operations and comprehensive (loss) income. Under this method, net (loss) income is increased or reduced by the amount of any dividends earned and accretion of
redeemable convertible preferred stock to its redemption value, if any, during the period. The undistributed earnings are allocated to common stock and each series of redeemable convertible preferred stock to the extent that each preferred security
may share in the earnings as if all of the earnings for the period had been distributed. Net (loss) income attributable to common stockholders and participating preferred shares are allocated to each share on an&nbsp;as-converted&nbsp;basis as if
all the earnings for the period had been distributed. The participating securities do not include a contractual obligation to share in losses of the Company and are not included in the calculation of net (loss) income per share in the periods in
which a net loss is recorded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Diluted net (loss) income per share is computed using the more dilutive of
(a)&nbsp;the&nbsp;two-class&nbsp;method or (b)&nbsp;the as-converted method. The Company allocates earnings first to redeemable convertible preferred shares stockholders based on dividend rights and then to common and preferred stockholders based on
ownership interests. The weighted-average number of shares of common stock included in the computation of diluted net (loss) income gives effect to all potentially dilutive common equivalent shares, including outstanding stock options and preferred
stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Common stock equivalent shares are excluded from the computation of diluted net loss income per share if their effect is
antidilutive. In periods in which the Company reports a net loss income attributable to common stockholders, diluted net loss income per share attributable to common stockholders is generally the same as basic net loss income per share attributable
to common stockholders since dilutive common shares are not assumed to have been issued if their effect is antidilutive. The Company reported a net loss attributable to common stockholders for the three months ended March&nbsp;31, 2019 and a net
income attributable to common stockholders for the three months ended March&nbsp;31, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Unaudited Pro Forma Information
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately prior to the completion of the Company&#146;s IPO resulting in net proceeds of at least $45.0&nbsp;million to the
Company all outstanding shares of redeemable convertible preferred stock will automatically </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
convert into common stock. Unaudited pro forma balance sheet information as of March&nbsp;31, 2020, assumes the conversion of all outstanding redeemable convertible preferred stock into shares of
common stock. The shares of common stock issuable and the proceeds expected to be received in the IPO are excluded from such pro forma financial information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma net income per share for the three months ended March&nbsp;31, 2020, was computed using the weighted-average number of
shares of common stock outstanding, including the pro forma effect of the conversion of all outstanding shares of redeemable convertible preferred stock, as if such conversion had occurred at the beginning of the period, or their issuance dates, if
later. The unaudited pro forma net income per share does not include the shares expected to be sold and related proceeds to be received from the IPO. Net income attributable to common stockholders used in the unaudited pro forma net income per share
calculation was adjusted for the accretion of redeemable convertible preferred stock, as all preferred stock is not considered outstanding prior to the closing of the IPO. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Recently Issued Accounting Pronouncements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2016, the Financial Accounting Standards Board (&#147;FASB&#148;) issued Accounting Standard Update (&#147;ASU&#148;)
No.&nbsp;2016-02, <I>Leases (&#147;Topic 842&#148;</I>), which requires an entity to recognize assets and liabilities arising from a lease for both financing and operating leases. For public entities, ASU No.&nbsp;2016-02 is effective for fiscal
years beginning after December&nbsp;15, 2018. The ASU will also require new qualitative and quantitative disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising
from leases. As a result of the Company having elected the extended transition period for complying with new or revised accounting standards pursuant to Section&nbsp;107(b) of the JOBS Act, ASU No.&nbsp;2016-02 is effective for the Company in the
fiscal years beginning after December&nbsp;15, 2020, with early adoption permitted. The Company is currently in the process of evaluating the impact of the adoption of ASU No.&nbsp;2016-02 on the Company&#146;s financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In November 2018, the FASB issued Accounting Standards Update 2018-18 (&#147;ASU 2018-18&#148;), Collaborative Arrangements (topic 808):
Clarifying the Interaction between Topic 808 and Topic 606. ASU 2018-18 clarifies that certain transactions between participants in a collaborative arrangement should be accounted for under ASC 606 when the counterparty is a customer. The guidance
precludes an entity from presenting consideration from a transaction in a collaborative arrangement as revenue from contracts with customers if the counterparty is not a customer for that transaction. The guidance amends ASC 808 to refer to the
unit-of-account guidance in ASC 606 and requires it to be used only when assessing whether a transaction is in the scope of ASC 606. The guidance will be effective for the Company for fiscal years beginning after December&nbsp;15, 2020 and interim
periods within fiscal years beginning after December&nbsp;15, 2021 and has to be adopted using retrospective approach. The Company is currently evaluating the impact of ASU 2018-18 on its financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December&nbsp;2019, the FASB issued Accounting Standards Update 2019-12 (&#147;ASU&nbsp;2019-12&#148;), Income Taxes (topic&nbsp;740):
Simplifying the Accounting for Income Taxes. The amendments in ASU 2019-12 simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic&nbsp;740. The amendments also improve consistent application of and
simplify GAAP for other areas of Topic&nbsp;740 by clarifying and amending existing guidance. ASU 2019-12 removes the exception for intraperiod tax allocations when there is a loss from continuing operations and income or a gain from other items
(other comprehensive income). ASU&nbsp;2019-12 is effective beginning on February&nbsp;1, 2021. Early adoption of the amendments is permitted. The Company has early adopted the new standard. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Financial Instruments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s short-term investments in U.S. Treasury and U.S. government agency securities have been classified and accounted for as
available-for-sale. The Company classifies its U.S. Treasury and U.S. government agency securities as short-term based on each instrument&#146;s underlying contractual maturity date. Unrealized gains and losses on U.S. Treasury and U.S. government
agency securities classified as available-for-sale are recognized in other comprehensive (loss) income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Assets and liabilities recorded
at fair value on a recurring basis in the Balance Sheets and assets and liabilities measured at fair value on a non-recurring basis or disclosed at fair value, are categorized based upon the level of judgment associated with inputs used to measure
their fair values. The accounting guidance for fair value provides a framework for measuring fair value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received upon the sale of
an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The accounting guidance also establishes a three-level valuation hierarchy that prioritizes the inputs to
valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the
reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Level 1</I>&#151;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at
the measurement date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Level 2&#151;</I>Inputs are observable, unadjusted quoted prices in active markets for similar assets or
liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related
assets or liabilities; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Level 3&#151;</I>Unobservable inputs that are significant to the measurement of the fair value of the assets
or liabilities that are supported by little or no market data. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s cash equivalent Money Market Funds
are classified as Level&nbsp;1 because they are valued using quoted market prices. The fair value of the Company&#146;s short-term investments are classified as Level&nbsp;2 because they are valued using observable inputs to quoted market prices,
benchmark yields, reported trades, broker/dealer quotes or alternative pricing sources with reasonable levels of price transparency and include U.S. government agency securities and U.S. Treasury securities. These Level&nbsp;2 instruments require
more management judgment and subjectivity compared to Level&nbsp;1 instruments which include determining which instruments are most similar to the instrument being priced, determining whether the market is active and determining which model-derived
valuations are to be used when calculating fair value. The Company performs its analysis with the assistance of investment advisors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables show the Company&#146;s cash and cash equivalents, Money Market Funds
and short-term investments by significant investment category as of December&nbsp;31, 2019 and March&nbsp;31, 2020 (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adjusted<BR>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;1:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money Market Funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;2:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Treasury securities included in short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. government agency securities included in cash and cash equivalents and short-term
investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,203</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,568</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,567</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of March&nbsp;31, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Adjusted<BR>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;1:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money Market Funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">95,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">95,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Level&nbsp;2:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Treasury securities included in short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,759</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,783</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. government agency securities included in short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">123,789</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">123,849</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may sell certain of its short-term securities prior to their stated maturities for reasons
including, but not limited to, managing liquidity, credit risk, duration and asset allocation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There were no liabilities measured at fair
value on a recurring basis as of December&nbsp;31, 2019 and March&nbsp;31, 2020. There have been no transfers between fair value measurement levels during the three months ended March&nbsp;31, 2019 and 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company records interest income and accretion income earned on Money Market Funds and U.S. Treasury and U.S. government agency securities
to interest income in its statement of operations and comprehensive (loss) income. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Property and Equipment, net </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Property and equipment, net consisted of the following (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of</B><br><B>March&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment and software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,978</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">657</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">701</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Construction-in-progress</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total property and equipment, gross</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,267</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,701</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Accumulated depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,201</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Depreciation expense for the three months ended March&nbsp;31, 2019 and 2020 was $0.3&nbsp;million and
$0.3&nbsp;million, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Accrued Liabilities and Other Long-Term Liabilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Accrued Liabilities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accrued liabilities consisted of the following (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of</B><br><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of</B><br><B>March&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued compensation and benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,051</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,639</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,922</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accrued compensation and benefits consist primarily of accrued bonuses and accrued vacation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Other Long-Term Liabilities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other long-term liabilities consisted of the following (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of</B><br><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of</B><br><B>March&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold incentive obligation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">444</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other liabilities &#151; deposits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other long-term liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">931</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Novartis Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2019, the Company entered into a Collaboration and License Agreement with Novartis (the &#147;Novartis Agreement&#148;), for the
development and commercialization of our preclinical product candidate, PLN-1474 and up to three additional integrin research targets. PLN-1474 is an internally discovered small molecule selective inhibitor of integrin
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>, currently being developed for the treatment of liver fibrosis associated with
nonalcoholic steatohepatitis (&#147;NASH&#148;). In accordance with the Novartis Agreement, on December&nbsp;7, 2019, Novartis paid to Pliant an upfront non-refundable license fee of $50.0&nbsp;million for the worldwide exclusive license to
PLN-1474. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Novartis will fund the Company&#146;s research and development services for PLN-1474 through Phase 1 after which Novartis will
assume responsibility for all future development, manufacturing and commercialization costs of PLN-1474. Novartis will also fund the research and development services associated with integrin research targets as outlined in the Novartis Agreement.
The Company is scheduled to receive up to $19.6 million in funding for PLN-1474 development services through Phase 1 of its development, which is expected to go through 2020. The Company is initially obligated to perform research and development
services on the integrin research targets for sixty days, and Novartis has the option to terminate the services with 60 days notification. Novartis has the option to continue the research and development services through 2022. If any of the targets
achieves target validation and are deemed a research target, Novartis holds the rights to exercise its license options to obtain an exclusive license for those deemed research targets on a research target-by-research target basis by paying an option
exercise fee for each target (up to three in total), including all license compounds that are the subject of the applicable research program. Novartis will also pay the Company a certain specified target validation fee of $4.0 million for each
candidate target that achieves target validation and is deemed a research target, for up to three candidate targets. Upon exercise of an option, Novartis will be responsible for global clinical development and commercialization of each licensed
research target. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Novartis Agreement, the Company is eligible for developmental, regulatory and commercial milestone payments
related to PLN-1474 and the integrin research targets of up to $416.0 million if defined development and commercialization milestones are achieved and tiered royalties ranging from the mid-single digits to low teens on product sales upon
commercialization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon execution of the Novartis Agreement, Pliant also entered into a Financing Side Letter with Novartis (the
&#147;Financing Side Letter&#148;), whereby Novartis committed to provide up to $30.0 million in equity financing of which $20.0 million was provided for 10,928,962 shares of Series C Redeemable Convertible Preferred Stock on December&nbsp;19, 2019
and the remaining $10.0 million will be provided for common shares in the event Pliant completes an Initial Public Offering.&nbsp;The Company determined that Novartis Agreement and the Financing Side Letter are separate agreements, they were not
entered into for single commercial objective, the consideration in each agreement are tied to separate and different types of performance obligations and they are not considered a single performance obligation. The Series C Redeemable Preferred
Stock was issued to Novartis at fair value of $1.83 per share in conjunction with its issuance to other investors at the same price. In addition, the contingent issuance of shares upon an Initial Public Offering would also be at fair value. Further,
Novartis became a related party to the Company following its purchase of 10.9&nbsp;million shares of our Series C Redeemable Convertible Stock on December&nbsp;19, 2019, representing holdings of 7.4% and 5.4% of our outstanding shares on a fully
diluted basis as of December&nbsp;31, 2019 and March&nbsp;31, 2020, respectively. See Notes 9 and 14 to these financial statements for additional information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company evaluated the Novartis Agreement under the revenue standard Topic 606 and
concluded that Novartis is a customer. The Company identified the following performance obligations at the inception of the contract. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Provide Novartis worldwide license rights to PLN-1474. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Provide research and development services for PLN-1474 through Phase 1 of its development. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Provide non-exclusive license rights to integrin research targets and research and development services on
integrin research targets, together as a single performance obligation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company determined the transaction price at
inception of the Novartis Agreement is the $69.6 million consisting of the license fee of $50.0 million and research and development funding of $19.6 million payment to be allocated to the various performance obligations. The Novartis Agreement
includes variable consideration for the funding of research and development services and potential future milestones and royalties that were contingent on future success factors for development programs. The Company used the &#147;most likely&#148;
method to determine the variable consideration. None of the regulatory or development milestones were included in the transaction price. The Company will re-evaluate the transaction price in each reporting period as uncertain events are resolved or
other changes in circumstances occur. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company considered the license to PLN-1474 as functional intellectual property, as when control
of the license was transferred to Novartis at the inception of the Novartis Agreement, Novartis had the right to access its technology and it was functional. The Company determined the $50.0 million was standalone selling price PLN-1474 license and
was recognized as revenue when control of the license transferred to Novartis, which was at or near inception of the Novartis Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company estimated the standalone selling price of each research program based on internal and external costs to perform the research plus
a reasonable profit margin. The total estimated cost of the research and development services reflects the nature of the services to be performed and the Company&#146;s best estimate of the length of time required to perform the services. The
Company selected an input method of costs incurred to measure progress toward complete satisfaction of its performance obligation to provide research and development services as such method faithfully depicts the Company&#146;s performance in
transferring control of the research and development service to Novartis. Changes in estimates of total internal and external costs expected to be incurred are recognized in the period of change as a cumulative catch-up adjustment. There have been
no changes to the Company&#146;s estimates to date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company recognized no revenue during the three months ended March&nbsp;31, 2019.
During the three months ended March&nbsp;31, 2020, the Company recognized revenue&#151;related party of $25.0 million as it achieved the first patient dosing milestone of the Novartis agreement. The Company also recognized revenue&#151;related party
of $3.9 million generated from research and development services performed during the three months ended March&nbsp;31, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of
December&nbsp;31, 2019 and March&nbsp;31, 2020, there is a receivable of $7.1 million and $31.8 million, respectively, related to the Novartis Agreement. There were no contract assets or contract liabilities as of December&nbsp;31, 2019 and
March&nbsp;31, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. License Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>UC Regents </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
August 2015, the Company entered into an exclusive, worldwide license agreement (the &#147;UC Agreement&#148;) with the Regents of the University of California (the &#147;UC Regents&#148;) relating to the use of certain
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
patents and technology relating to
<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT><SUB STYLE="font-size:85%; vertical-align:bottom">v</SUB>&szlig;<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> compound in fibrosis indications. Pursuant to the UC Agreement, the Company is
obligated to (i)&nbsp;make a non-refundable upfront license fee payment of $0.4&nbsp;million and annual license maintenance fee payments of $10,000 per year beginning on the first anniversary of the UC Agreement escalating to $25,000 per year
thereafter (ii)&nbsp;make royalty payments to the UC Regents of 3% of net sales of a therapeutic licensed product or 1% of net sales of a method of use licensed product, subject to an annual minimum of $1.0&nbsp;million, (iii)&nbsp;make milestone
payments up to an aggregate of $18.2&nbsp;million to the UC Regents upon the occurrence of certain events, (iv)&nbsp;make a milestone payment based on the number of outstanding shares and a price per share as defined in the UC Agreement within 30
days of the closing of an IPO or change of control, and (v)&nbsp;reimburse the UC Regents for prosecution and maintenance expenses of the licensed patents without limitation. The Company will expense any payments for milestones to research and
development expenses prior to receiving FDA approval for any of its product candidates.&nbsp;These costs will be capitalized when FDA approval is obtained for any products being selected for commercialization and amortized over the remaining life of
the patent. If the Company sublicenses its rights under the UC Agreement, it is obligated to pay the UC Regents a percentage of the total gross proceeds received in consideration of the grant of the sublicense, which total amount would be first
reduced by the aggregate amount of certain research and development related expense incurred by the Company. The UC Regents have the right to purchase an amount equal to a low single-digit percent of any securities offered by the Company to
investors other than to Third Rock Ventures III, L.P. (&#147;TRV&#148;) or an affiliate of TRV. This participation right expires immediately before the completion of the IPO. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The UC Agreement can be terminated at any time upon the material breach of contract terms by either party to the agreement. The Company has
the right to terminate the agreement at any time upon providing written notice to the UC Regents. Unless terminated early, the UC Agreement will remain in effect from the effective date until the later of (i)&nbsp;the expiration or abandonment of
the patent rights licensed under the UC Agreement, or (ii)&nbsp;ten years from the date of the first commercial sale of the first licensed product under the agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Research Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Adimab
Development and Option Agreement </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2018, the Company and Adimab LLC (&#147;Adimab&#148;) entered into a development and
option agreement (the &#147;Adimab Agreement&#148;) for the discovery and optimization of proprietary antibodies as potential therapeutic product candidates. Under the Adimab Agreement, the Company will select biological targets against which Adimab
will use its proprietary platform technology to research and develop antibody proteins using a mutually agreed upon research plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon
the Company&#146;s selection of a target, the Company and Adimab will initiate a research plan and the discovery term begins. During the discovery term, Adimab will grant the Company a non-exclusive, non-sublicensable license under its technology
with respect to the target, to research, design and preclinically develop and use antibodies that were modified or derived using Adimab technology, solely to evaluate such antibodies, perform the Company&#146;s responsibilities under the research
plan and use such antibodies for certain diagnostic purposes. The Company will also grant to Adimab a non-exclusive, non-sublicensable and non-transferable license with respect to the target under the Company&#146;s technology that covers or relates
to such target, solely to perform its responsibilities under the research plan during the discovery period. The Company is required to pay Adimab at an agreed upon rate for its full-time employees during the discovery period while Adimab performs
research on each target under the applicable research plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Adimab granted the Company an exclusive option to obtain a worldwide,
royalty-bearing, sublicensable license under Adimab platform patents and other Adimab technology to research, develop and commercialize up </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to twenty four antibodies selected by the Company (the &#147;Program Antibodies&#148;) against specific biological targets (the &#147;Commercialization Option&#148;). Upon the exercise of a
Commercialization Option, and payment of the applicable option fee to Adimab, Adimab will assign the patents that cover the Program Antibodies to Company. The Company will be required to use commercially reasonable efforts to develop, seek market
approval of, and commercialize at least one antibody against the target covered by the Commercialization Option in specified markets upon the exercise of a Commercialization Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Adimab Agreement, the Company is obligated to (i)&nbsp;make a nonrefundable upfront license fee payment for access to
Adimab&#146;s technology; (ii)&nbsp;pay Adimab at an agreed upon rate for each full-time employee (&#147;FTE&#148;) during the research period; (iii)&nbsp;make additional payments upon the Company making other research related elections;
(iv)&nbsp;pay up to a dollar amount in the low double digit millions for the achievement of certain research and development milestones for each research target program which can vary by target type; (v)&nbsp;make royalty payments to Adimab on
Company net sales of its products covered under the Adimab Agreement, subject to varying royalty payments on certain product types. Currently, no product types have been selected by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2019, the Company recognized research and development expense under the Adimab Agreement of $0.1
million related to the FTE costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2020, the Company did not recognize any research and
development expenses under the Adimab Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Redeemable Convertible Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Company&#146;s Amended and Restated Certificate of Incorporation (&#147;Certificate of Incorporation&#148;), the Company is
authorized to issue two classes of shares: preferred and common stock. The preferred stock may be issued in series, and the Company&#146;s board of directors is authorized to determine the rights, preferences, and terms of each series. The following
is a summary of the Company&#146;s redeemable convertible preferred stock (in thousands except share amounts): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preferred stock consisted
of the following as of December&nbsp;31, 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred<BR>Shares<BR>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares<BR>Issued&nbsp;and<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redemption<BR>Value/<BR>Liquidation<BR>Preference</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,360,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">149,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,861,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">186,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">186,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Preferred stock consisted of the following as of March&nbsp;31, 2020: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred<BR>Shares<BR>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares<BR>Issued&nbsp;and<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redemption<BR>Value/<BR>Liquidation<BR>Preference</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54,888,058</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,501,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,389,279</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">238,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">238,313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series A Preferred </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In August 2015, the Company entered into a Series A Preferred Stock Purchase Agreement (the &#147;Series A Purchase Agreement&#148;) pursuant
to which it agreed to sell, and the purchasers agreed to purchase up to $45.0&nbsp;million of Series A Redeemable Convertible Preferred Stock (&#147;Series A Preferred&#148;) in three anticipated tranches based on the achievement of defined
performance milestones. The Series A Preferred stockholders may not assign the rights to purchase shares of Series A Preferred at any future milestone closing tranches separately without a transfer of already purchased shares. The Company determined
that these future tranche obligations did not meet the definition of a freestanding financial instrument because, while separately exercisable, they were not legally detachable. Further, the Company determined that the embedded future tranche
obligation did not require bifurcation for accounting purposes as it was clearly and closely related to the economic characteristics and risks of the Series A Preferred and would not meet the definition of a derivative on a standalone basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Series&nbsp;A Purchase Agreement, as part of the initial closing, the Company issued 6.5&nbsp;million shares of Series&nbsp;A
Preferred at $1.00 per share in exchange for cash proceeds of $6.4&nbsp;million and the conversion of convertible promissory notes in the amount of $0.1&nbsp;million representing outstanding principal and accrued interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In April 2016, the Company issued 5.0&nbsp;million shares of Series A Preferred at $1.00 per share in exchange for cash proceeds of
$5.0&nbsp;million in an additional closing of the first tranche. The final closing of the first tranche occurred in September of 2016, when the Company issued 5.0&nbsp;million additional shares of Series A Preferred at $1.00 per share in exchange
for cash proceeds of $5.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2017, the Company issued 8.0&nbsp;million shares of Series A Preferred at $1.00 per
share in exchange for cash proceeds of $8.0&nbsp;million in a closing of the second tranche. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2017, the Company issued
12.0&nbsp;million shares of Series A Preferred at $1.00 per share in exchange for cash proceeds of $12.0&nbsp;million in an initial closing of the third tranche. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2018, the Company issued 8.5&nbsp;million shares of Series A Preferred at $1.00 per share in exchange for cash proceeds of
$8.5&nbsp;million in an additional closing of the third tranche. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2018, based on the amendment to the Series&nbsp;A Purchase
Agreement, the Company issued 11.0&nbsp;million additional shares of Series A Preferred at $1.00 per share in exchange for cash proceeds of $11.0&nbsp;million in the final closing of the third tranche. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series B Preferred </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2018, the Company entered into a Series B Preferred Stock Purchase Agreement (the &#147;Series B Purchase Agreement&#148;) in which it
agreed to sell, and the purchasers agreed to purchase, up to $70.0&nbsp;million of Series B Redeemable Convertible Preferred Stock (&#147;Series B Preferred&#148;). Under the Series B Purchase Agreement, the Company initially issued
45.1&nbsp;million shares of Series B Preferred at $1.3767 per share in exchange for cash proceeds of approximately $62.1&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
November 2018, the Company issued 4.4&nbsp;million additional shares of Series B Preferred at $1.3767 per share in exchange for cash proceeds of approximately $6.0&nbsp;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Series C Preferred </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, the Company entered into a Series C Preferred Stock Purchase Agreement (the &#147;Series C Purchase Agreement&#148;) in which
it agreed to sell, and the purchasers agreed to purchase, up to $80.5 million of Series C Redeemable Convertible Preferred Stock (&#147;Series C Preferred&#148;). Under the Series C Purchase Agreement, the Company initially issued 26.4&nbsp;million
shares of Series C Preferred at $1.83 per share in exchange for aggregate cash proceeds of $48.2 million. Novartis purchased 10.9&nbsp;million shares of this allotment of Series C Preferred at $1.83 per share for cash proceeds of $20.0 million.
Novartis became a related party following its purchase of 10.9&nbsp;million shares of our Series C Preferred, representing aggregate holdings of 7.4% and 5.4% of our outstanding shares on a fully diluted basis as of December&nbsp;31, 2019 and
March&nbsp;31, 2020, respectively. See Note 14 for additional information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2020, the Company issued an additional
28.5&nbsp;million additional shares of Series C Preferred at $1.83 per share in exchange for gross cash proceeds of $52.2&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series A Preferred, Series B Preferred and Series C Preferred (collectively, the &#147;Preferred Stock&#148;) have the following rights
and privileges: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Voting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each holder of shares of Preferred Stock is entitled to the number of votes equal to the number of shares of common stock into which such
shares could be converted and has voting rights and powers equal to the voting rights and powers of the common stock, and except as provided by law or by other provisions of the Company&#146;s Certificate of Incorporation, as amended, shall vote
together with the common stock as a single class on an as-converted basis on all matters as to which holders of common stock have the right to vote. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of Series A Preferred, voting separately as a single class, are entitled to elect two members of the Company&#146;s board of
directors. At any time when at least 12.5&nbsp;million shares of Series B Preferred are outstanding, the holders of Series B Preferred are entitled to elect one member of the Company&#146;s board of directors. The holders of shares of common stock,
voting separately as a single class, are entitled to elect one member of the Company&#146;s board of directors. All remaining members of the Company&#146;s board of directors are elected by the holders of the common stock and Preferred Stock voting
together as a single class. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Conversion </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of the Preferred Stock are convertible at any time at the option of the holder into such number of shares as is determined by dividing
the original issuance price by the conversion price in effect at the time. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conversion price is the original issuance price for each series of Preferred Stock, as adjusted for the 1-for-7.15 reverse stock split of the Common Stock. Following such adjustment, the
per-share conversion price was $7.15 for Series A Preferred, $9.843405 for Series B Preferred and $13.0845 for Series C Preferred, subject to certain adjustments. As of March&nbsp;31, 2020, the Preferred Stock was convertible into shares of the
Company&#146;s common stock on a one-for-7.15 basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All outstanding shares of Preferred Stock will automatically convert upon the
completion of an IPO resulting in net proceeds to the Company of at least $45.0&nbsp;million or the vote or written consent of a requisite majority of holders of the then outstanding shares of Preferred Stock on an as-converted to common stock
basis. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Dividends </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of Series A Preferred were originally entitled to receive cumulative dividends from their respective dates of issuance at the rate
of 8.0% on their original issue price. In July 2018, in conjunction with the execution of the Series B Purchase Agreement, the Series A Preferred accreted dividends were cancelled. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Series B Purchase Agreement, the holders of both shares of Series A and Series B Preferred are entitled to receive cumulative
dividends commencing on July&nbsp;10, 2018, the issuance date of Series B Preferred, at an annual rate of 8.0% on their original issuance price. The Series A Preferred and Series B Preferred dividends accrue from day-to-day, whether declared or not,
and are payable only when and if declared by the Company&#146;s board of directors. As such, the Company recorded accretion charges to adjust the carrying values of the Series A Preferred and Series B Preferred to their redemption values up until
the date the Series C Purchase Agreement was executed. In December 2019, in conjunction with the execution of the Series C Purchase agreement, the Series A preferred and Series B preferred accreted dividends were cancelled. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Series C Purchase Agreement, the holders of Series A, Series B and Series C Preferred are entitled to receive non-cumulative
dividends commencing on December&nbsp;19, 2019 at an annual rate of 8.0% on their original issuance price. The Series A, Series B and Series C Preferred dividends accrue from day-to-day, whether declared or not, and are payable only when and if
declared by the Company&#146;s board of directors. Since inception, the Company has never declared or paid any dividends. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Liquidation Preferences </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of all shares of preferred stock are entitled to receive dividends prior and in preference to any declaration or payment of any
dividend on the common stock. For the three months ended March 31, 2020 the dividends the preferred shareholder would be entitled to, if a dividend was declared by the Board of Directors, exceeded net income for the period, resulting in the full
amount of net income reflected as <I>undistributed earnings to preferred stockholders </I>within the Company&#146;s statements of operations and comprehensive (loss) income. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon liquidation, dissolution, or winding up of the Company or a deemed liquidation event as defined in the Company&#146;s Certificate of
Incorporation, the holders of shares of Series C and Series B Preferred Stock will receive, on a pari passu basis, a per share amount equal to the Series C purchase price of $1.83 (plus any declared but unpaid dividends) and equal to the original
Series B purchase of $1.3767 (plus any declared but unpaid dividends), collectively (the &#147;Series C and Series B Liquidation Preference&#148;) or such amount per share as would have been payable had all shares of Series C and Series B had been
converted into common stock immediately prior to such liquidation event. The payment of Series C and Series B Liquidation Preference is to be made before any payment made to the holders of Series A Preferred Stock and Common Stock. Thereafter, the
Series A Preferred holders are entitled to receive their liquidation preference before any distributions are made to common stockholders, a per share amount equal to $1.00 (plus any declared but unpaid dividends) (the &#147;Series A
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Liquidation Preference&#148;) or such amount per share as would have been payable had all shares of Series A had been converted into common stock immediately prior to such liquidation event.
After payments of the full liquidation preferences of the Series C and Series B Liquidation Preference and the Series A Liquidation Preference described above, any remaining assets of the Company shall be distributed to the holders of the common
stock in proportion to the number of shares of common stock that they hold. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Redemption </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Series&nbsp;A Preferred were redeemable at any time on or after five years from August&nbsp;19, 2015, the original issuance date of the 6.5
million&nbsp;shares of Series A Preferred, upon receipt of a written notice from the holders of a majority of the shares of Series A Preferred. The initial redemption price was the greater of (i)&nbsp;the Series&nbsp;A Preferred original issuance
price per share, plus any accrued and unpaid dividends, whether or not declared by the board of directors, and (ii)&nbsp;the fair market value of Series&nbsp;A Preferred as mutually agreed upon by the Company and the holders of a majority of the
shares of Series&nbsp;A Preferred then outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2018, in conjunction with the execution of the Series B Preferred Purchase
Agreement, the Series&nbsp;A Preferred redemption provision was amended as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All outstanding shares of Preferred Stock shall be
redeemed by the Company at a price equal to the original issuance price per share, plus any accrued and unpaid dividends, whether or not declared, together with any other dividends declared but unpaid in three annual installments commencing not more
than sixty (60)&nbsp;days after receipt by the Company at any time on or after five years from the Series B Preferred original issuance date, July&nbsp;10, 2018, a written notice from the holders of a majority of the shares of Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounted for the changes in Series A Preferred redemption provision as a modification as there was no significant difference in
Series A Preferred fair value before and after the modification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2019, in conjunction with the execution of the Series C
Preferred Purchase Agreement, the Series A Preferred and Series B Preferred redemption provisions were modified as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All
outstanding shares of Preferred Stock shall be redeemed by the Company at a price equal to the original issuance price per share, plus any dividends declared but unpaid, in three annual installments commencing not more than sixty (60)&nbsp;days
after receipt by the Company at any time on or after five years from the Series C Preferred original issuance date, December&nbsp;19, 2019, a written notice from the holders of a majority of the shares of Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounted for the changes in Series A Preferred redemption and Series B Preferred redemption provisions as a modification as there
was no significant difference in Series A Preferred and Series B Preferred fair values before and after the modification. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The voting, dividend, and liquidation rights of the holders of the common stock are subject to and qualified by the rights, powers, and
preferences of the holders of the Preferred Stock. As of December&nbsp;31, 2019 and March&nbsp;31, 2020, the Company had 181,000,000 and 210,000,000 authorized shares of common stock, respectively, at a par value of $0.0001 per share. The common
stock has the following rights and privileges: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Voting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of shares of common stock are entitled to one vote for each share of common stock held at any meeting of stockholders and at the
time of any written action in lieu of a meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Dividends </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of shares of common stock are entitled to receive dividends, when declared by the Company&#146;s board of directors. Cash dividends
may not be declared or paid to holders of shares of common stock until all unpaid dividends on the Preferred Stock have been paid in accordance with their terms. No dividends have been declared or paid by the Company since its inception. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Liquidation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After
payment of the respective liquidation preferences to the holders of shares of Preferred Stock, the holders of shares of common stock are entitled to share ratably in the Company&#146;s remaining assets available for distribution to its stockholders
in the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company or upon occurrence of a deemed liquidation event. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Shares reserved for future issuance </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of<BR>March&nbsp;31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion of redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,442,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,432,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercises of outstanding stock option awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,337,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,603,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares of common stock available for future grants under the 2015 Equity Incentive Plan, as
amended</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">567,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,047,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total shares reserved for future issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,346,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,083,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Founders&#146; Common Stock Awards </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During 2015, the Company&#146;s board of directors granted common stock awards to the Company&#146;s founders in exchange for services provided
to the Company. The purchase price of the common stock awards was the estimated fair value at the issuance date. The shares vest from one to four years and vesting could be accelerated upon a change in control. The vesting of certain
performance-based grants of restricted stock awards were contingent upon the filing of an Investigational New Drug Application by the Company with the FDA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the holder of founders&#146; common stock award terminates their relationship with the Company during the vesting period, the Company may
repurchase any unvested restricted common stock held by these individuals at their original purchase price. During the vesting term, holders of founders&#146; common stock awards are deemed to be common stockholders and have dividend and voting
rights. The Company issued 745,244 shares of founders&#146; common stock during 2015. No founders&#146; common stock awards were granted in subsequent years. Total compensation expense was $25,000 for these founders&#146; common stock awards, which
are recorded to operating expenses in the statements of operations over their respective vesting period. As of December&nbsp;31, 2019 and March&nbsp;31, 2020, all shares of founders&#146; common stock awards were fully vested. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. 2015 Equity Incentive Plan and Stock-Based Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In August 2015, the board of directors adopted the 2015 Equity Incentive Plan, as amended (the &#147;Plan&#148;), which provides for the grant
of incentive stock options, nonqualified stock options or other awards including stock appreciation rights and restricted stock awards to the Company&#146;s employees, officers, directors, advisors, and consultants for the purchase of up to 1.5
million shares of the Company&#146;s common stock. In July 2018, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Plan was amended to increase the number of shares reserved thereunder by 1.0&nbsp;million shares. In January 2019, the Company&#146;s board of directors and stockholders voted to increase the
number of shares reserved for issuance under the 2015 Equity Incentive Plan by 0.4&nbsp;million shares. In March 2020, the Company&#146;s board of directors and stockholders voted to increase the number of shares reserved for issuance under the 2015
Equity Incentive Plan by 1.4&nbsp;million shares. As of March&nbsp;31, 2020, 1.0&nbsp;million shares remained available for issuance under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Options under the Plan may be granted for periods of up to 10&nbsp;years and at prices no less than 100.0% of the estimated fair value of the
shares on the date of grant as determined by the board of directors, provided, however, that the exercise price of an incentive stock option granted to a 10.0% shareholder shall not be less than 110.0% of the estimated fair value of the shares on
the date of grant and the option is not exercisable after the expiration of five&nbsp;years from the date of grant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Restricted
Common Stock Awards </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company granted restricted stock awards under the Plan. The purchase price of the restricted common stock
awards was the estimated fair value as determined by the board of directors at the issuance date. The shares vest from one to four years and vesting could be accelerated upon a change in control. A holder of an award may pay a total purchase price
or a part of the purchase price for granted shares at any time during the vesting periods. Upon termination of employment, the Company has the right to repurchase any unvested restricted shares. The repurchase price for unvested shares of common
stock will be the lower of (i)&nbsp;the fair market value on the date of repurchase or (ii)&nbsp;their original purchase price. During the vesting term, holders of restricted stock awards are deemed to be a common stock shareholder and have
dividends and voting rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company accounted for restricted stock awards as early exercised options and recognized a liability in
other liabilities when cash was received for the purchase of shares of restricted stock. As shares of restricted stock vested, the Company reclassified the liability to common stock and additional paid in capital. As of December&nbsp;31, 2019 and
March&nbsp;31, 2020, the Company recorded a liability included in accrued expenses and other liabilities of $22,000 and $18,000, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There have been no grants of restricted stock awards for the three months ended March&nbsp;31, 2019 and 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes restricted stock activity during the three months ended March&nbsp;31, 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Grant&nbsp;Date<BR>fair&nbsp;value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding and unvested, as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">703,188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(106,122</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding and unvested, as of March&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">597,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes restricted stock activity during the three months ended
March&nbsp;31, 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Grant&nbsp;Date<BR>fair&nbsp;value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding and unvested, as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">302,211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(52,093</TD>
<TD NOWRAP VALIGN="bottom">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repurchases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,121</TD>
<TD NOWRAP VALIGN="bottom">)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding and unvested, as of March 31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Restricted stock awards of 4,195 shares with a weighted-average grant date fair value of $0.08 per share, were
not purchased by the award holders as of March&nbsp;31, 2020. As these shares of the restricted common stock awards were not issued, they are not included in the table above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate fair value of restricted stock awards vested during the three months ended March&nbsp;31, 2019 and 2020 was $96,000 and $58,000,
respectively. Total intrinsic value of outstanding unvested restricted stock awards was $1.5&nbsp;million as of March&nbsp;31, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Incentive Stock Options and Nonqualified Stock Options </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock options issued under the Plan generally vest over a four-year period and expire ten years from the date of grant. Certain options provide
for accelerated vesting if there is a change in control, as defined in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company used Black-Scholes option pricing model to
estimate stock-based compensation expense for stock option awards with the following assumptions for the three months ended March&nbsp;31, 2019 and 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">78.50%&nbsp;-82.55%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">72.10%&nbsp;-&nbsp;77.50%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">2.44%&nbsp;-&nbsp;2.59%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">0.52%&nbsp;-&nbsp;0.82%</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#151;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#151;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">5.00&nbsp;-&nbsp;6.05</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">5.38&nbsp;-&nbsp;6.75</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underlying common stock fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$5.15*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$6.22*</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Subsequent to the issuance of the Company&#146;s condensed financial statements as of and for the three months ended March 31, 2020, the Company&#146;s management determined that the disclosed range of underlying common
stock fair value incorrectly presented the grant date fair value of options granted during the three months ended March 31, 2019 and March 31, 2020 as ranges. The prior ranges disclosed as $0.72 - $0.87 and $0.87 - $1.09 have been updated as an
immaterial correction to grant date fair values of $0.72 and $0.87 for the three months ended March 31, 2019 and March 31, 2020, respectively (or $5.15 and $6.22, respectively, on a post-reverse split basis). The disclosure correction did not result
in a change to the stock-based compensation expense for the periods ended March 31, 2019 or 2020. Further, it did not modify any amounts presented in the financial statements or require any other disclosure amendments. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A summary of option activity under the Plan is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average&nbsp;Exercise<BR>Price per Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Remaining<BR>Contractual<BR>Term&nbsp;(in&nbsp;Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate<BR>Intrinsic<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">113,174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">939,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding as of March&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,052,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercisable as of March&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested and expected to vest as of March&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,052,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average&nbsp;Exercise<BR>Price per Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Remaining<BR>Contractual<BR>Term&nbsp;(in&nbsp;Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate<BR>Intrinsic<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,337,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,275,202</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,251</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(708</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding as of March&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,603,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,097</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercisable as of March&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">340,620</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,343</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested and expected to vest as of March&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,603,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,097</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Aggregate intrinsic value represents the difference between the fair value of the underlying common stock and
the exercise price as of December&nbsp;31, 2019 and March&nbsp;31, 2020. The weighted-average grant date fair value of options granted during the three months ended March&nbsp;31, 2019 and 2020, was $4.29 per share and $4.80 per share, respectively.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March, 2020 the Company granted 26,573 stock options with a grant date fair value of $0.1 million&nbsp;to a partner at Third Rock
Ventures, who is also serving as a non-employee director on the Company&#146;s Board of Directors. The common shares subject to these options vest 1/12th on the last day of each calendar quarter over a three year period and only commence vesting
upon the effectiveness of an IPO by the Company, provided that the IPO must occur no later than December&nbsp;31, 2021. Lastly, in order to vest at each calendar quarter end date, the shareholder must be providing continuous service to the Company
through such vesting date. On December&nbsp;31, 2021, this option will be cancelled if it has not commenced vesting. The stock-based compensation expense related to these options was immaterial during the three months ended March&nbsp;31,
2020.&nbsp;See Note 14 for additional information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Stock-Based Compensation Expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents the components and classification of stock-based compensation expense for the Company&#146;s stock-based awards
for the three months ended March&nbsp;31, 2019 and 2020 (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted stock awards and founders&#146; common stock awards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">236</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">261</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2019, there was $0.6&nbsp;million of unrecognized compensation costs that is expected to
be recognized over the weighted-average periods of 2.17&nbsp;years related to restricted stock awards. As of March&nbsp;31, 2019, there was $4.2&nbsp;million of unrecognized compensation costs that is expected to be recognized over the
weighted-average periods of 3.67&nbsp;years related to stock options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2020, there was $0.4&nbsp;million of
unrecognized compensation costs that is expected to be recognized over the weighted-average periods of 1.94&nbsp;years related to restricted stock awards. As of March&nbsp;31, 2020, there was $8.9&nbsp;million of unrecognized compensation costs that
is expected to be recognized over the weighted-average periods of 3.3&nbsp;years related to stock options. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Income Taxes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the three months ended March&nbsp;31, 2019 and 2020, the Company did not record an income tax provision. The Company will continue to
maintain a 100% valuation allowance on total deferred tax assets. The Company believes it is more likely than not that the related deferred tax asset will not be realized. As a result, the Company&#146;s effective tax rate will remain at 0.00%
because no items that are either estimated or discrete items would impact the tax provision for the period, which is comparable to the 0.05% effective tax rate disclosed in the audited financial statement for the year ended December 31, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (&#147;CARES&#148;) Act was enacted and </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">signed into law and GAAP requires recognition of the tax effects of new legislation during the reporting period </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">that includes the enactment date. The CARES Act, includes changes to the tax provisions that benefits business </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">entities, and makes certain technical corrections to the 2017 Tax Cuts and Jobs Act. The tax relief measures for </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">businesses include a five-year net operating loss carryback, suspension of annual deduction limitation of 80% of </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">taxable income from net operating losses generated in a tax year beginning after December 31, 2017, changes </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the deductibility of interest, acceleration of alternative minimum tax credit refunds, payroll tax relief, and a </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">technical correction to allow accelerated deductions for qualified improvement property. The CARES Act also providesother non-tax benefits to assist those
impacted by the pandemic. The Company evaluated the impact of the CARES Act and determined that its adoption did not have a material impact to the income tax provision for the three months ended March 31, 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Commitments and Contingencies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Purchase Commitments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has contractual arrangements with research and development organizations and suppliers; however, these contracts are generally
cancelable on 30 days&#146; notice and the obligations under these contracts are largely based on services performed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>License and
Collaboration Agreements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Potential payments related to the Company&#146;s license and research agreements, including milestone and
royalty payments, are detailed in Notes 6 and 7. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Leases </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2018, the Company leased approximately 18,000 square feet of corporate offices and research facilities in Redwood City, California. Rent
expense, including common area maintenance expense, was approximately $0.1&nbsp;million per month. This lease expired on June&nbsp;28, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2018, the Company entered into a non-cancelable lease agreement (the &#147;Lease&#148;) for premises consisting of approximately
32,974 square feet located in South San Francisco, California (the &#147;Premises&#148;). The Company moved into the Premises in July 2018. The Premises is being used for the Company&#146;s corporate headquarters and principal operating facility.
The term of the Lease is eighty-four months, which commenced on July&nbsp;1, 2018. Base rent was abated for the first two months of the lease term and thereafter is $0.2&nbsp;million per month during the first year of the lease term, with specified
annual increases thereafter. The Company paid a refundable security deposit of approximately $0.4&nbsp;million, which is included in Other non-current assets in the Balance Sheets at December&nbsp;31, 2018 and 2019. The Company has the right to
extend the lease term by seven years upon written notice not more than twelve months nor less than nine months prior to the expiration of the original lease term, with monthly payments equal to the &#147;fair rental value&#148; as defined in the
Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2019 and 2020, rent expense, including common area maintenance expense, was
$0.6&nbsp;million and $0.6&nbsp;million, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Future minimum lease payments under the Lease as of March&nbsp;31, 2020 were as
follows (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Year ending December&nbsp;31:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Operating&nbsp;Lease</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020 (remainder of the year)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,477</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,098</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,171</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024 and beyond</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,390</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Legal Proceedings </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company, from time to time, may be party to litigation arising in the ordinary course of business. The Company was not subject to any
material legal proceedings during the three months ended March&nbsp;31, 2019 and 2020, and, to the best of its knowledge, no material legal proceedings are currently pending or threatened. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Indemnification </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such
agreements, the Company may indemnify, hold harmless and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third party actions. In some cases, the
indemnification will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to
defend lawsuits or settle claims related to these indemnification provisions. The Company has also entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against
liabilities that may arise by reason of their status or service as directors or officers to the fullest extent permitted by Delaware corporate law. The Company currently has directors&#146; and officers&#146; insurance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Related Party Transactions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain
employees of Third Rock Ventures, a stockholder of the Company, provided consulting services to the Company. Consulting service expenses of $12,000 was recorded for the three months ended March&nbsp;31, 2019. In January 2020, Third Rock Ventures
ceased providing management consulting services to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2020, the Company granted 26,573 stock options with a grant date
fair value of $0.1 million&nbsp;to a partner at Third Rock Ventures, who is also serving as a non-employee director on the Company&#146;s Board of Directors. The common shares subject to these options vest 1/12th on the last day of each calendar
quarter over a three year period and only commence vesting upon the effectiveness of an IPO by the Company, provided that the IPO must occur no later than December&nbsp;31, 2021. Lastly, in order to vest at each calendar quarter end date, the
shareholder must be providing continuous service to the Company through such vesting date. See Note&nbsp;11 for additional information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2018 and 2019, the Company made charitable contributions to the University of California, San Francisco Foundation (the &#147;UCSF
Foundation&#148;), which were directed to support research performed in the laboratories of two of the Company&#146;s scientific founders. The Company made a charitable contribution of $0.4 million and $0.7 million for the three months ended
March&nbsp;31, 2019 and 2020, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2017, the Company entered into a consulting agreement with the founder of
Healthcare&nbsp;&amp; Humanity Foundation (the &#147;Director&#148;) pursuant to which the Director provided consulting services to the Company at a rate of $5,000 per month in 2018. In addition, the Company granted the Director 6,293 shares of
restricted stock at a purchase price of $0.08 per share with quarterly vesting over a one-year period contingent upon the Director providing consulting services during the vesting period. The Director became a director of the Company in December
2017. In February 2018, the agreement with the Director terminated pursuant to its terms. There were no general and administrative services provided while the Director was a director of the Company during the three months ended March&nbsp;31, 2019
and 2020, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2018, the Company sold 1.0&nbsp;million shares of Series&nbsp;A Preferred to pH Pharma Co. Ltd.
(&#147;pH Pharma&#148;), an entity in which the Director has a majority ownership, for $1.0&nbsp;million. These shares of Series&nbsp;A Preferred represent 1.0% and 0.8% of the Company&#146;s outstanding equity on a fully diluted basis as of
December&nbsp;31, 2019 and March&nbsp;31, 2020, respectively. In May 2018, the Company entered into a research services agreement with pH Pharma. As of December&nbsp;31, 2018, all services were completed under this agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2019, the Company entered into the Novartis Agreement with Novartis covering the
development and commercialization of Pliant&#146;s preclinical product candidate, PLN-1474 and up to three additional targets. Upon execution of the Agreement, Pliant also entered into a financing side letter with Novartis, whereby Novartis
committed to provide up to $30.0 million in equity financing of which $20.0 million was provided for preferred shares as a part of a Series C equity offering and the remaining $10.0 million will be provided for common shares in the event Pliant
completes an Initial Public Offering. As of March&nbsp;31, 2020, Novartis owns approximately 5.4% of the Company&#146;s outstanding shares on a fully diluted basis. See Notes 6 and Note 9 for additional information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. Defined Contribution Plan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company sponsors a defined contribution plan under Section&nbsp;401(k) of the Internal Revenue Code covering substantially all full-time U.S. employees. Employee contributions are voluntary and are determined on an individual basis subject to the
maximum allowable under federal tax regulations. The Company made contributions to the plan of $0.1&nbsp;million and $0.2&nbsp;million for the three months ended March&nbsp;31, 2019 and 2020, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. Net (Loss) Income Per Share Attributable to Common Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share
attributable to common stockholders for the periods presented, because including them would have been antidilutive: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended</B><br><B>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock (on an as-converted basis)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,755,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,432,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options to purchase common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,052,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,603,744</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted stock awards granted and not purchased</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested restricted shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">597,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237,997</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested shares of founders&#146; common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,741</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,436,639</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,277,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A reconciliation of the numerator and denominator used in the calculation of the basic and
diluted net loss per share attributable to common stockholders is as follows (in thousands, except share and per share amounts): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss per share:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Numerator</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,023</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Add: accretion to redemption value and cumulative dividends on redeemable convertible preferred
shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,344</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: undistributed earnings to preferred shareholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,029</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) income attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(15,367</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Denominator</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average common shares outstanding used to calculate net (loss) income per share
attributable to common stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,409,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,897,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,409,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,897,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net (loss) income per share attributable to common stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10.90</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10.90</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the Company&#146;s unaudited pro forma
basic and diluted net income per share attributable to common stockholders (in thousands, except share and per share data) assuming the automatic conversion of the redeemable convertible preferred stock based on the mid-point of the IPO price range
of $15.00, upon consummation of an IPO as if such event had occurred as of the beginning of the respective period: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months<BR>Ended<BR>March&nbsp;31,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Unaudited Pro Forma Net Income Per Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">11,029</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma adjustment to accretion to redemption value and cumulative dividends on redeemable
convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net income attributable to common stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used to calculate net income per share attributable to common
stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,897,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,897,699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma adjustment to reflect assumed conversion of all redeemable convertible
preferred&nbsp;stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">19,932,054</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used to calculate pro forma net income per share attributable to common
stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,829,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,861,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net income per share attributable to common stockholders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. Subsequent Events </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has evaluated subsequent events for financial statement purposes occurring through May 8, 2020, the date these financial statements
were issued, and has updated such evaluation for disclosure purposes through May 26, 2020 with respect to the reverse stock split reflected in the amendment to the Company&#146;s amended and restated certificate of incorporation, filed on May 22,
2020, as discussed below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>Reverse Stock Split </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May 22, 2020, the Company implemented a 1-for-7.15 reverse stock split of the Company&#146;s common stock. Stockholders entitled to
fractional shares as a result of the reverse stock split will receive a cash payment in lieu of receiving fractional shares. All share and per share data shown in the accompanying financial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Condensed Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statements and related notes have been retroactively revised to reflect the reverse stock split. Shares of common stock underlying outstanding stock options and other equity instruments were
proportionately reduced and the respective exercise prices, if applicable, were proportionately increased in accordance with the terms of the agreements governing such securities. Shares of common stock reserved for issuance upon the conversion of
the Company&#146;s Preferred Stock were proportionately reduced and the respective conversion prices were proportionately increased. As of March 31, 2019 and 2020, all outstanding shares of preferred stock were convertible into shares of common
stock on a 1-for-7.15 basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>  <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>9,000,000 Shares </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:30pt; font-family:Times New Roman" ALIGN="center"><B>Pliant Therapeutics, Inc. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g729258g83b31.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P></center>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRELIMINARY PROSPECTUS </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 </B></P>
<P STYLE="font-size:14pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P></center>
<P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><I>Joint Book-Running Managers </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Citigroup </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Cowen
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Piper Sandler </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P></center> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><I>Lead Manager
</I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Needham&nbsp;&amp; Company </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Through and including&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 (25 days after
the date of this prospectus), all dealers that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to a dealer&#146;s obligation to deliver a prospectus
when acting as an underwriter and with respect to an unsold allotment or subscription. </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Part II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Information Not Required in Prospectus </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;13. Other Expenses of Issuance and Distribution. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the fees and expenses, other than underwriting discounts and commissions, payable in connection with the
registration of the common stock hereunder. All amounts are estimates except the SEC registration fee, the FINRA filing fee and the Nasdaq Global Market listing fee. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount&nbsp;Paid<BR>or to<BR>Be Paid</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA filing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,340</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nasdaq Global Market listing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">223,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing and mailing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">579,404</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,032,986</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,874,827</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer agent and registrar fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">170,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,938,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;14. Indemnification of Directors and Officers. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145 of the Delaware General Corporation Law, or the DGCL, authorizes a corporation to indemnify its directors and officers against
liabilities arising out of actions, suits and proceedings to which they are made or threatened to be made a party by reason of the fact that they have served or are currently serving as a director or officer to a corporation. The indemnity may cover
expenses (including attorneys&#146; fees) judgments, fines and amounts paid in settlement actually and reasonably incurred by the director or officer in connection with any such action, suit or proceeding. Section&nbsp;145 permits corporations to
pay expenses (including attorneys&#146; fees) incurred by directors and officers in advance of the final disposition of such action, suit or proceeding. In addition, Section&nbsp;145 provides that a corporation has the power to purchase and maintain
insurance on behalf of its directors and officers against any liability asserted against them and incurred by them in their capacity as a director or officer, or arising out of their status as such, whether or not the corporation would have the
power to indemnify the director or officer against such liability under Section&nbsp;145. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted provisions in our amended and
restated certificate of incorporation and amended and restated bylaws to be in effect immediately prior to the completion of this offering that limit or eliminate the personal liability of our directors to the fullest extent permitted by the DGCL,
as it now exists or may in the future be amended. Consequently, a director will not be personally liable to us or our stockholders for monetary damages or breach of fiduciary duty as a director, except for liability for: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any breach of the director&#146;s duty of loyalty to us or our stockholders; any act or omission not in good
faith or that involves intentional misconduct or a knowing violation of law; any unlawful payments related to dividends or unlawful stock purchases, redemptions or other distributions; or any transaction from which the director derived an improper
personal benefit. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These limitations of liability do not alter director liability under the federal securities laws and
do not affect the availability of equitable remedies such as an injunction or rescission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, our bylaws provide that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will indemnify our directors, officers and, in the discretion of our board of directors, certain employees to
the fullest extent permitted by the DGCL, as it now exists or may in the future be amended; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will advance reasonable expenses, including attorneys&#146; fees, to our directors and, in the discretion of
our board of directors, to our officers and certain employees, in connection with legal proceedings relating to their service for or on behalf of us, subject to limited exceptions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to enter into indemnification agreements with each of our directors, executive officers, and other officers as determined from time
to time by our board of directors or our compensation committee. These agreements will provide that we will indemnify each of our directors, officers with whom we have entered into indemnification agreements, and, at times, their affiliates to the
fullest extent permitted by Delaware law. We will advance expenses, including attorneys&#146; fees (but excluding judgments, fines and settlement amounts), to each indemnified director, executive officer or affiliate in connection with any
proceeding in which indemnification is available and we will indemnify our directors and officers for certain actions or proceedings arising out of that person&#146;s services as a director or officer brought on behalf of us or in furtherance of our
rights. Additionally, certain of our directors or officers may have certain rights to indemnification, advancement of expenses or insurance provided by their affiliates or other third parties, which indemnification relates to and might apply to the
same proceedings arising out of such director&#146;s or officer&#146;s services as a director referenced herein. Nonetheless, we will agree in the indemnification agreements that our obligations to those same directors or officers are primary and
any obligation of such affiliates or other third parties to advance expenses or to provide indemnification for the expenses or liabilities incurred by those directors are secondary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will maintain general liability insurance which covers certain liabilities of our directors and officers arising out of claims based on
acts or omissions in their capacities as directors or officers, including liabilities under the Securities Act of 1933, as amended, or the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriting agreement filed as Exhibit&nbsp;1.1 to this registration statement provides for indemnification of us and our directors and
officers by the underwriters against certain liabilities under the Securities Act and the Securities Exchange Act of 1934. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;15. Recent Sales
of Unregistered Securities. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the three years preceding the filing of this registration statement, we have issued the following
securities that were not registered under the Securities Act. No underwriters were involved in the sales and the certificates representing the securities sold and issued contain legends restricting transfer of the securities without registration
under the Securities Act or an applicable exemption from registration. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>(a) Issuances of Capital Stock </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2017, we sold an aggregate of 8,000,000 shares of our Series A redeemable convertible preferred stock at a purchase price of $1.00
per share for an aggregate purchase price of approximately $8.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2017, we sold an aggregate of 12,000,000 shares of
our Series A redeemable convertible preferred stock at a purchase price of $1.00 per share for an aggregate purchase price of approximately $12.0&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2018, we sold an aggregate of 8,500,000 shares of our Series A redeemable convertible preferred stock at a purchase price of $1.00
per share for an aggregate purchase price of approximately $8.5&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2018, we sold an aggregate of 11,000,000 shares of
our Series A redeemable convertible preferred stock at a purchase price of $1.00 per share for an aggregate purchase price of approximately $11.0&nbsp;million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2018, we sold an aggregate of 45,142,960 shares of our Series B redeemable
convertible preferred stock at a purchase price of $1.3767 per share for an aggregate purchase price of approximately $62&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In November 2018, we sold an aggregate of 4,358,261 shares of our Series B redeemable convertible preferred stock at a purchase price of
$1.3767 per share for an aggregate purchase price of approximately $6&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From December 2019 through February 2020 we sold an
aggregate of 54,888,058 shares of our Series&nbsp;C redeemable convertible preferred stock at a purchase price of $1.83 per share for an aggregate purchase price of approximately $100.4 million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offers and sales of the securities described above were deemed to be exempt from registration pursuant to Section&nbsp;4(a)(2) of the
Securities Act, including Regulation&nbsp;D and Rule&nbsp;506 promulgated thereunder, as transactions by an issuer not involving a public offering. All of the purchasers in these transactions represented to us in connection with their purchase that
they were acquiring the securities for investment and not distribution, that they could bear the risks of the investment and could hold the securities for an indefinite period of time. Such purchasers received written disclosures that the securities
had not been registered under the Securities Act and that any resale must be made pursuant to a registration or an available exemption from such registration. All of the foregoing securities are deemed restricted securities for the purposes of the
Securities Act. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>(b) Grants and Exercises of Stock Options and Restricted Stock </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2017, we granted stock options to purchase 2,691,487&nbsp;shares of our common stock to our employees, directors and
consultants at a weighted average exercise price of $3.86 per share under the 2015 Plan. We also granted the right to purchase an aggregate of 567,151 shares of restricted stock to our employees, directors and consultants at a weighted average
purchase price of $0.08 per share under the 2015 Plan. We sold an aggregate of 815,278&nbsp;shares of common stock to employees, directors and consultants for cash consideration in the aggregate amount of $424,830&nbsp;pursuant to the exercise of
stock options and purchase of restricted stock under the 2015 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The issuances of the securities described above were deemed to be
exempt from registration pursuant to Section&nbsp;4(a)(2) of the Securities Act or Rule&nbsp;701 promulgated under the Securities Act as transactions pursuant to compensatory benefit plans and contracts relating to compensation as provided under
Rule 701. The recipients of such securities were the registrant&#146;s employees, consultants or directors and received the securities under the registrant&#146;s 2015 Equity Incentive Plan. The shares of common stock issued upon the exercise of
options are deemed to be restricted securities for purposes of the Securities Act. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;16. Exhibits and Financial Statement Schedules. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>(a) Exhibits. </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;1.1<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520150643/d729258dex11.htm">Form of Underwriting Agreement. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;3.1<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520137876/d729258dex31.htm">Amended and Restated Certificate of Incorporation, as amended, of the Registrant, as currently in effect. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;3.1.1<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520150643/d729258dex311.htm">Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;3.2<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520150643/d729258dex32.htm">Form of Amended and Restated Certificate of Incorporation of the Registrant, to be in effect immediately prior to completion of the offering.
 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;3.3<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520137876/d729258dex33.htm">Bylaws of the Registrant and the amendments thereto, as currently in
effect.</A></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="90%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;3.4<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520150643/d729258dex34.htm">Form of Amended and Restated Bylaws of the Registrant, to be in effect immediately prior to the completion of the offering.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;4.1<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520150643/d729258dex41.htm">Specimen Common Stock Certificate of the Registrant. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;4.2<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520137876/d729258dex42.htm">Amended and Restated Investors&#146; Rights Agreement by and among the Registrant and certain of its stockholders, dated December 19, 2019.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;5.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="d729258dex51.htm">Opinion of Goodwin Procter LLP. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.1+#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/1746473/000119312520137876/d729258dex101.htm">2015 Equity Incentive Plan and forms of award agreements thereunder. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.2<SUP STYLE="font-size:85%; vertical-align:top">+</SUP>#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520150643/d729258dex102.htm">2020 Stock Option and Incentive Plan and forms of award agreements thereunder. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.3<SUP STYLE="font-size:85%; vertical-align:top">+</SUP>#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520150643/d729258dex103.htm">2020 Employee Stock Purchase Plan. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.4<SUP STYLE="font-size:85%; vertical-align:top">+</SUP>#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520137876/d729258dex104.htm">Senior Executive Cash Incentive Bonus Plan.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.5<SUP STYLE="font-size:85%; vertical-align:top">+</SUP>#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520137876/d729258dex105.htm">Prior <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Policy. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.6<SUP STYLE="font-size:85%; vertical-align:top">+</SUP>#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520150643/d729258dex106.htm">Non-Employee Director Compensation Policy. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.7<SUP STYLE="font-size:85%; vertical-align:top">+</SUP>#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520137876/d729258dex107.htm">Executive Severance Plan.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.8<SUP STYLE="font-size:85%; vertical-align:top">+</SUP>#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520137876/d729258dex108.htm">Offer Letter, by and between the Registrant and Bernard Coulie, M.D., Ph.D., dated October 12, 2015. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.9<SUP STYLE="font-size:85%; vertical-align:top">+</SUP>#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520137876/d729258dex109.htm">Offer Letter, by and between the Registrant and Hans Hull, J.D., dated February&nbsp;10, 2016.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.10<SUP STYLE="font-size:85%; vertical-align:top">+</SUP>#<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520137876/d729258dex1010.htm">Offer Letter, by and between the Registrant and Keith Cummings, M.D., MBA, dated November 29, 2018. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.11<SUP STYLE="font-size:85%; vertical-align:top">+</SUP>#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520137876/d729258dex1011.htm">Offer Letter, by and between the Registrant and &#201;ric Lefebvre, M.D., dated February&nbsp;28, 2018.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.12<SUP STYLE="font-size:85%; vertical-align:top">+</SUP>#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520137876/d729258dex1012.htm">Offer Letter, by and between the Registrant and Barbara Howes, dated May&nbsp;1, 2019.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.13<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520137876/d729258dex1013.htm">Form of Indemnification Agreement, by and between the Registrant and each of its directors and certain officers. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.14<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520137876/d729258dex1014.htm">Office Lease, by and between the Registrant and 260 Littlefield Avenue South San Francisco, California 94080, dated February&nbsp;
6, 2018.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">10.15<SUP STYLE="font-size:85%; vertical-align:top">+<FONT STYLE="font-size:6.5pt">&#134;</FONT></SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="http://www.sec.gov/Archives/edgar/data/0001746473/000119312520137876/d729258dex1015.htm">Collaboration and License Agreement, by and between the Registrant and Novartis Institutes For Biomedical Research, Inc., dated October
 17, 2019.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="d729258dex231.htm">Consent of Deloitte&nbsp;&amp; Touche LLP, Independent Registered Public Accounting Firm.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">23.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><A HREF="d729258dex51.htm">Consent of Goodwin Procter LLP (included in Exhibit 5.1). </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">24.1<SUP STYLE="font-size:85%; vertical-align:top">+</SUP></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Power of Attorney (<A HREF="#sig">included on signature page</A>).</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">+</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Previously filed. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Certain confidential portions (indicated by brackets and asterisks) have been omitted from this exhibit. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">#</TD>
<TD WIDTH="1%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Represents management compensation plan, contract or arrangement. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><B><I>(b) Financial
statement schedules. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item 17. Undertakings. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful
defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby undertakes that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) The undersigned Registrant will provide to the underwriters at the closing specified in the underwriting agreement, certificates in such
denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) For purposes
of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant
to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus
shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>Signatures </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has duly caused this Registration Statement on Form <FONT
STYLE="white-space:nowrap">S-1</FONT> to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of South San Francisco, California, on the 2nd day of June, 2020. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PLIANT THERAPEUTICS, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bernard Coulie</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;Bernard Coulie, M.D., Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;President, Chief Executive Officer and Director</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has
been signed by the following persons in the capacities and on the dates indicated below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Bernard Coulie</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Bernard Coulie, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Chief Executive Officer and Director (Principal Executive Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;2, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Keith Cummings</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Keith Cummings, M.D., MBA</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Financial Officer (Principal Financial and Accounting Officer)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;2, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Hoyoung Huh, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lead Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;2, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Suzanne Bruhn, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;2, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Gayle Crowell</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;2, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">John Curnutte, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;2, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Neil Exter, MBA</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;2, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Charles Homcy, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;2, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Smital Shah, MBA</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June&nbsp;2, 2020</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">*By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bernard Coulie</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Bernard Coulie, M.D., Ph.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Attorney-in-fact</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-6 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d729258dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">June&nbsp;2, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pliant Therapeutics, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">260 Littlefield Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">South San Francisco, CA 94080 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Re:&nbsp;&nbsp;&nbsp;&nbsp;<U>Securities Registered under Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT></U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as counsel to you in connection with your filing of a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT>
(File <FONT STYLE="white-space:nowrap">No.&nbsp;333-238146)</FONT> (as amended or supplemented, the &#147;Registration Statement&#148;) pursuant to the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), relating to the registration
of the offering by Pliant Therapeutics, Inc., a Delaware corporation (the &#147;Company&#148;) of up to 10,350,000 shares (the &#147;Shares&#148;) of the Company&#146;s Common Stock, $0.0001 par value share, including 1,350,000 shares purchasable by
the underwriters upon their exercise of an over-allotment option granted to the underwriters by the Company. The Shares are being sold to the several underwriters named in, and pursuant to, an underwriting agreement among the Company and such
underwriters (the &#147;Underwriting Agreement&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have reviewed such documents and made such examination of law as we have deemed
appropriate to give the opinions set forth below. We have relied, without independent verification, on certificates of public officials and, as to matters of fact material to the opinions set forth below, on certificates of officers of the Company.<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinion set forth below is limited to the Delaware General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the foregoing, we are of the opinion that the Shares have been duly authorized and, upon issuance and delivery against payment
therefor in accordance with the terms of the Underwriting Agreement, the Shares will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the inclusion of this opinion as Exhibit 5.1 to the Registration Statement and to the references to our firm under the
caption &#147;Legal Matters&#148; in the Registration Statement. In giving our consent, we do not admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations
thereunder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Goodwin Procter LLP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">GOODWIN PROCTER LLP</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d729258dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><U>Exhibit 23.1 </U></B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the use in this Registration Statement <FONT STYLE="white-space:nowrap">No.&nbsp;333-238146</FONT> on
<FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> of our report dated March&nbsp;13, 2020 (May&nbsp;26, 2020, as to effects of the reverse stock split discussed in Note&nbsp;17), relating to the financial statements of Pliant Therapeutics, Inc.
We also consent to the reference to us under the heading &#147;Experts&#148; in such Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>/s/ Deloitte&nbsp;&amp; Touche LLP </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">San Francisco, California </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">June&nbsp;2, 2020 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g729258g01c33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g01c33.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2E"4&AO=&]S:&]P(#,N,  X0DE-! 0
M    *2:^$%-#A"24T$!       1QP!6@ #&R5'' (   (  1P"4  6071H=6
MMO<F%L86QA9V4@26YD=6YI;!P"-P (,C R,# S,3,< CP "S(S-3$U,2LP,#
M P #A"24T$)0      $%%DZ<YGSVV<;2%[1=4;.=TX0DE-!#H      .4
M 0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26
MYT965N=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;V
MP     "W!R:6YT97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7
M!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='
M5P     0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35
ME+ #A"24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;V
MYS    %P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L
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M1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M  $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F
M<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'
M1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $
M#.?"D  0 " ,Y\*0 !  (X0DE-!"8       X             /X   #A"24
MT$#0      !    !XX0DE-!!D       0    >.$))30/S       )
M     ! #A"24TG$       "@ !          (X0DE- _0      !( -0
M$ +0    8       $X0DE- _<      !P  /________________________
M____\#Z   .$))300(       0     0   D    )      #A"24T$'@
M  !      X0DE-!!H      S4    &              '*   %%@
M !                          $             !18   '*
M            $                         $     $       !N=6QL
M   @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;V
MYG          !,969T;&]N9P          0G1O;6QO;F<   '*     %)G:'
M1L;VYG   %%@    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V
M4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9
M    !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V
M)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&
MQO;F<          $)T;VUL;VYG   !R@    !29VAT;&]N9P  !18    #=7
M)L5$585     $       !N=6QL5$585     $       !-<V=E5$585
M$       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O;
M$    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15
M-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0
M]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6
MT    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;V
MYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&
M]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@       P
M "/_         X0DE-!!$       $! #A"24T$%       !     $X0DE-!
MP     #BT    !    H    #@   '@  !I    #A$ &  !_]C_[0 ,061O8F
M5?0TT  ?_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/#
MP/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,#
MP!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,#
MP,# P,# P,# P,# P,# P,# P,#/_  !$( #@ H ,!(@ "$0$#$0'_W0 $
MK_Q $_   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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MJGOL]XWM>P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MX2E$1TEE9VAUA[?5-3E(5%9BE)66TF1R='B$B)>BHZ2ELL7&U/_:  @! 0
M/P#W\:::::::H(\ (_ !'\-:P[O,[N]M&V3->X!K$M)];$M%F+F2&>NSL6<@
M6)(DHJ@N^3X%%L1$ZJBBP"4 !,?$(%\6M3W75(P*URLK6V-WH5LQC5MJT_N1
MR3D&D6^/N"M*6B+K5*NA6';"!6>D$7:5E4=E!PJDY*#,@ D<H+"38#+&^C;M
MA:0M,9D"[/8^3I3_ !-$3S&/KTW,OBR^;S31<91L='Q+%XZE'EC5@9-(J+--
M0S8Z)!6 I3@(8_Q;U-=J68[G7*/3;I9BSEH7L\,P1G,?7&!8HW"E,G,K::"[
MD9*)0;)WN+AV;F35@$3+J'9E(=%55=5- WZS=2?:]&PV1YBTVBU4M+%3.N3-
MH:7&@VR"FEZU<988.M6>"A7,9\HS,++2W@8-U6B O".%4DW3)L=5,ILK8JW6
MXQSQC?)5_P 7S;W^MDXLD/;HJX0,Q5I>K3\##C-BRLD%)-&TNU;.(]5G(I.$
M"',YCEP,B)5^2%UN8]4G;=5JQ0CY4NP(VRPT"CY#M*]&I]RG*55ZI>G8Q\)<
M)2:".7)#U5=X!43NI)?WQ QRBHW\)@$/TUGJ?80E[!N0AK)%7JD-MNF2V>+G
M$O(UN5D&F0[',G:LZ['T=-LR*K+3T[(.3)1M<:^\/%V9 DS+$9^)0O9+!U-]
MK-=HD?>7-IM#Y-U(7B.DJI#T2QR%ZJSO&+=HMD9"V59%E[[!%II';5686> 5
M,I7K<S4713#QUVZ]3+ ;5A<HFAVAX]OE=Q'5\RJA8:C;2TJN5"\0J%CJ$Q<[
M#'L/=XMK.Q3@JS..]X)*JG,FF1J!?&H3N$?U'=LQ<G06&96ZR"=_>V2K4*97
M9T^UGI,/D.XPS28K58>6]2.&';.+0BX.>OIN'0"N5,Q72B"G<T@91Y !^(<^
MOD/EY\"';T]/+5=------------4,(<#W]!_9K3+?1N5E]I^VNZ9QA8B#F9*
MMS="@6#2U2IX2LI+7:^UNDC*V"3(*8L(B'&?-)/5A4(7W=H8WM"^$NM;L']3
M:K3]%O,]F6,AF$M4\S'PK3I'"C]]E:GYZF3U6/MY9?#SN):G<S36-8/74=9"
MF579PLO#OVR\KX@3(;M4)U"JE9LR"RK*Z-EP6IMQC\TL+- U^QRUX?3CR]2E
M-6K1*PU;'D4'#5VQ*P<Q[B-1?,Y(RI7IFR20F'\,[U3\&-[=@:JURN9*M"N;
M,IVS$;X6]2F&$IB^WT^+6D))A=8-9DHZ3<%,#?Q-VYS%!@L:2(JNW;J!KN>-
M.H'AJ9J][D[[?JQ%2V-JUD')5E4@(Z?-"!C:C7FQTQ[*,5)1$KB0DHES" C8
M6#,5%FKY=K[) $'K43]SJ6_O;G=,E06+H"V3"LU9Y@]3@)IU6)QK3I6^(0HV
M)WCQI:7#-.-5NK.$(X?NXSQ^S1*U7:&<^_(*-2_ESOU -MVW*^OL;90M5CC;
M5#TZN9"LZ$+2K-8X^GT"QS$K L[I9Y*)C7;"(@T)*'D$GSAPL1T@FW,O[J=
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MN35O\M5\:7G=SA;;]3;!4*E&+/*MB.5Q)1C55Q'Q"BR_M).+4\9"MV?M"%:
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M\M/9$ >0* "/AY$  .?#Y<\!Y:H"28")@* &$..0Y >WE]7KH9%(_A\1"CX
MX+V#Z/V?#CT^_503('/T0[^?;[OWXT]F7GGCU'CGCMR/(@';R'U#5OL$NX>S
M+P(" @ < ("/(\@' #W[^78?+C5?8I\B8"@!A\S   8>/(!'CR#TU<!"E'D
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M\?J U:H*J?I<AMIW0XOW65FWVK$JT[)5>F7V?QP\LDG%%BH^7LE<!J,\A J
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M_MMWKM8Z@P?_ *J=J^S_ '1#UX_;Z:?G_MMO_!9Z@WW;4[4/[)'[?W'0.O\
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M1(",I;&!X)\5Y6X\I5$A,]FFXJ1S4H*$,*[E,"F*;@P>1_I5VW#%8ZAM,K&
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MH= I6S&R9:LT-ES?+;F.9;9'2"4O3<)0Q5F^W7%#Y/DS4T;5UBE-D.U1Q@\
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MO/TUUI*R0JTJ2(+/0RLF"ATS1B4HP.^ Z0")R"S!<CPJR8%$3\)<E IO$0
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MW8E\D6&6L&;,^SR!$K5G;*"S:9N+LJYA<*157;%22AJ#5DE1%1G6:@RC6"9
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M,V7'&3*.K$TL\CDVI6ZY47KX7A53.I%10%2#.@4A"AP!0 /L#]_Y-4!,@ (
M0H (<"   !Q\. [?;]??5/ 0H#X2@'F/(>?EY?9P'''EJ+GI2?V)-QO_ .?E
MN^_]:LC]G[ U*5IJQ0WA(8>.>"F'CD.1X 1X !$ $1^LP!]>L6U/*V.+S9++
M5:;D2G6BRTET1K<:Y V2)EYVLNE3'*5K.QK-TJZC5#"F8@I/4D3E4(8@<CR
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M.<J1  I1X  UP9NF!5@*)OX5F];@ \8".?YP0#CN B -C<\!]@?;Z>>'I2;
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M@?3?H;OJ/.9]SW8,;NM@$'%'Q!1(Z3H&S ]SFY,KTMIDURVRZ6*V5Z#]DR7
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ME<>Y> I2@N9/V0BH68O37R6 PIF H#XO";@0$ $!X$0X$P" #R   \#P;@1
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MDJAY(2>.<>WJI7IO$N4FDJ[J5AB[ V8.5B LDV>*Q#IVFU<&1."J2"YBJ'3
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M15:-WGL5W+=1,@D&'^L=2CJ-[5-B0YJW"*;(MTLOCJIO;18K11-P[)K>;K#
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MCU5UCDE5),JCI,YB$%2/;@<IC%)Q.,!2AQP4 X\N  ./L^&JZ::" #V$.0^
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M:DX>;02<&]FL9N#_ -U*Y;(NR) LFF8L)6^W^A^SYUS7MANVU_,LI@?&^,;
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M1]J@NF15%02>--0A3$,40YURA$4TRE*0A2E( %(4H 4I"E#@I2E* %*4 \@
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M'WB(_?SW^/;5/9D_VH=^PA\0Y >!^\ _R<ZNX#X!^ :IX2\\\!S^X:NU:<1
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M421C&MB6<&9,R(39E;I$*4A2$ I *!2@4H%*!?T2E  X I?[D \M?;35!$0
M1#SX_?[/M'L'F/;6',RY,<8DQ5D/*A*K;;V2A56<M25*I$:,M;[0:%8JO A8
M"-+W<OWHIBDDF B!B"*Q?$!!(;S'VFPWCJ0X,N6]K&4!<<O[E,$*XT+C"AXT
M&P0^+ZC8RWV-ND[1Z!.R;ABK8,J56O UJ&9)!]&J1J+ETY:,0.V;@ SA[*]K
M*F*:! SV7J3CY++[JQ7*Y0L/"Q[>P-, QF1Y(\[+8GQM;Y5F%@)68ITZ6,K[
MLX1:+R+J1]U+[B*!=2(Z:::M/SX1X'P]A^EY^'L/< ]>!XU#UNIZ:RF1]U>)
M]XF&'T$QN\5=*6KGW&EXD9]#%F=*G4?;H5><FF$.L95O?\9BN:3IS@[5S#OG
M BC*LQ\)5@EJ@JS7:RR+'UV"B()B"KER#*'CVD:U!R^<'=O7 (,T44O;.W2J
MCARJ!/&X7.=54QCF,8>=TTTTTTTTTU^9VI[%NJKX%5!334/X$0\2QO"F8?"D
M7CZ2I@ 2IEY#Q'$"@8!'7E)ROFG)O5=GK5C>E4%ZI9]MF3K-:W^U.>7N%!..
M.H1)2DK5G.N0(]W$EH>;;PZ/(W/":$>#R(A$XM!_,KJ KXR2C]++;#FW!6/[
MG9<[2EJ867)<TL(XVN<Q 6J::0U>DG<=2K==[% ^.)D,E/Z&$)!6UQ&E*VE%
M()I*OC*R[MX<LN@))@ !X0X#C@....!\7;CC@>>_/G]W;7TTU8ISX#"7S .?
M,0\N_IY_9Y:U8W=[AGFV7;GE//$7C^T91=X[K:\RE2JBU5>2KYT!R($5>D13
M45;P<7[49*POTB*J,8EHY<)I*&3 @^>&WP&3=W-(H74-P%4)_=-N _+=B_'[
MQI#N9JJX&DZ#&UV>KF0XG%;F4=E7E,)NYVQK0V0YV;C%'+]["2+Y!'PIHE)/
MAL\VNL, XOQVRN3&HV7+U=JYJR]OK*#:+2\%7'#]S*L\95ZV/V@6:0H=)!V6
M K RCQ1TXBH]HN]*+@Z@CNQIIIJA@Y*(<B'(#W#SU#I;^F@A!;^:)O!PVXKR
M]3LEHFIC</A.^R%@7I3^UR=8<037.V/V#)55@CE1JP*E77K*8:N(1]%O73I,
M&;U,BAY=(6OP=;CF4/7HB-@XF.;),V$9$L6T>P9-4>02;-6K1))%N@GR/@12
M(1,HF,(%Y.;GF------//7Q6( )J"403,)1X/QR &$/"!A*'8?0! ?,/4/,(
MWH3JC[1/;W&/R1D^(PW*57,]\PTVC;Z^1;.[/*8[?5Z(FK'#DCTW@)U@9.R1
MK,L@],W2;+K"#I1,HE'5U-ZJ^QNWI3BJN>:S6#0F8;+A A;5[Y#+35NK/N)7
MCJ+1.W4,K714DFR:,^L9&. 3%%PL@*R0'[?,]238Q6YNZ0<_NDQ7%2V/TY0U
MN;.9TX)1Q(-5)*7.1V1H=E(DC7#INV<'BG+L47"P-5 %P %UT]GU3=F":=I<
MW'-])H$1"6M_5(>4G9LICVT(Z*C99W-Q\<T;K2D5&M6TDBHZ"7:-U6I %5R"
M*7!AVIR'N!Q;C*'I$I89Y9^3)+Q-E0(^N,W%@E[B=Q%&FQ7KL;&@H[D636$*
M:6>.D %-HPX<*G IR"/'4S=+@"_UQ2U5W*=54KH.+6U:R<A*(13:03HX-/G6
M_BEI!1 9*/@S/4"24@U%1!H<3D5,04E/#I_F7?S+XYSW'XQK]=K4O54LBX H
M$A+2,K)(/)PN>8Q_,(V*&E&[=6 BHVK13)L8?EQVW2E7;Y-$BQ1,CXLAV7J-
M;=HF7RY4*W)V2^73#F4\684LE9A(APW7E<F9@=F0JU5K[^1(U9S#I!!)^ZDS
MMC&19)1RZ95ES\"/.1?4:V/2C&^2C#<]BIQ&XP8D?75RE-F*$(S).JUD5_$H
MU3-+%^<*)X$ B"OC_*10;&("YRD#B6W4>VIOY:A-ZYD^N62FW9M;"*Y.82:*
M51J\E6K!$U!K V)9V1N]8S<];IA*MQK,C3QA)METG E,)1#M5NZ@.S3'IV,?
M<MR6,X-_)3EFKS=-Y,*J&+,TV<1K5F8NP004%@>(L*Z4&X<2 M6ORF?W0BIU
MB&+K*>W[<#5-P<9=I"L,Y.)>XVR5;<4W&%F3(&?1]CJ;E$BJJ M5%6[N)EFC
MMK(Q,@02E=,UB')R)5 #882E$1$0 1$.!^S]_P";0"E#R  _</Y@U4# /D(?
M#[_AJNFJ%*4O/A*!>1$1X  Y$?,1X\Q'XZKIIIIIJ@\<=_+[1#R[^G?Z]:R7
M#;'B"V9\QUN96K[F-S5C6+FJ[%VROR2T([L51G6IVK^K71NU &]JK[194DE%
M-)<ISQ$DB5['K(\&3/LR"9.?%X0 P@ "(!P(\?$0\^-7Z::H/ \@/KR'KY<=
M_P#+_+JPZ9!()?"7@ $0#CL \" =OAZ<<<<=N-:S8@VQXAP9><N7[%$"ZJ+S
M.=BB+/?Z]'2*Z=+5M;!%PS<VB#K!N(R!FI\BOM+*M&)HI2[E!!RX1]Y*90^S
M7LR#W$H"/ !R/<> \@Y\^W\H_$=7B/'Q_ 1_9JG(?7^ _P VJZ::IX0XXX[<
M\\!V[\\^FJZ::::::::::L4_0-W$..!Y#S[" \??Y<^GGK61KMAQ$PW(+[IX
M.O.Z_F"4I2N/[7+0$BO&Q-ZKQW39U'?/B!2,6.L$S7CMSEK\ZX3&1CVSM9L#
MA5 023V;*0A0X*4"AY\ '  /U!Y%[]^ X[]_/5^FFFORNFS==!=)=NBX261.
MBLBJ0ITUT%"B11%4AP$JB2A#&*=,X"0Y1$# (=M:X[?]L^)=K[6YP.%H)_5:
MED&^RV19"GIR;EW5:U.SK9L27;4N(7,9M5X&0>HJ2:\%&>%BE*.7+ELD@DK[
M,-E@(4   *  7C@ #CCCL'''P#5VFJ<A_D^_^;C[>WGH \_'[P$-5U:!"AQP
M4 XYXX#X^?XZNTTTTTTTU\U1\*9S>?!1$0^H//CR[\>7U\:AVF>C_B">FLPS
M+K(=V]XS CGAM)I%CX8R<,3/,_3+)/#%BJDHH08M:FMFS$%3>)1%TY*MP/@\
M6';-T+<2V2>9S'Y:LAD:1=_M-E:0ZD3&+-6U:OI*FXN=-.1%XP%U\I2M0CY-
MA+/TW0,"*KM!8.4^%!UKJ'1.RK;,XSL#DRX1=/VKT5WD)3$-<K$ZG:YINVO5
M^AK\1!$TC%-GB*1I*,4/-)SIEO"#D[6,,HB1-;4A%UZ26(+AE+,>4G^0[BTD
M\U,\V,9-@C'PPLX4N::1$4B8^2U%4O:!\BL(A-[&E4 ?:.5#IJF,GP4=FKWM
M'8V:$VS!5[W.4JX;5&AXO'=P4AH^P%>Q<IC\N.IU.8@7AT6+A22ATT%TW!5T
MSQKU#VJ1#$5,4=6;MTEL97["N&L(S&4+:E!X,R4YM=9G8>&AXF;D*#8Y!*5R
M%BRQ+MC)H2L?D"03,XL4L)2/#I @BFU]FG_&<UD38]=,W9SW(M[19@H.W7(R
M^UQRVAX*&AG\Y>$\,1HOW;&,F#N"R-%;QTPPBX\RR4>NH\:BL* D P@/*YWV
M#R%LR1>,]XYM"2V0;!G+:?FR'I\RS:1=<CY#;<5]"F8GD$# Z=%LM?GI5\N+
MI,@-I!NW3(*H*G,$<[#HFY38[=Y%>7R:WN^XBHH308&KQWK6HT/&?OF<G^7!
M7;3L=&NY&U2*RB[;W8UB0/&)*@HQ7_I<Q72>8MO?1VLA=O>4(#<7EN02S;F&
MT2%T5M-2;QTDACN3-F9OFN+,@1=LWCYY[\ZFQ!G2 W;1CIJ<[)HH*1"*&PIN
M0Z->>GKN$AMOV3F\XTR/'W*&W 9*ODNSA9Z::W+-T5F>3;*5-M$.HL8-G,,W
M2[%6#<(3 K+MHYP4T<B*AIFMF.WFPX(:9LE[D^CWEKS3G"U9/<(PZAE6$97W
M#>/A*K&*+&^@L_;PT8F>363 I57BQA3+P0##N_KY+&$J1Q !,/  4I>.1,(@
M!0Y'L'(B "(]@#OZ:Q5?LKT#&BD$2]V^,J"EE?$B*^G-KK)(2$JHLU0!%$44
MU"F,1=\U2 ZYT6_M7"*1E"BJ00R0V=F4*!5#E,<!-],I?"!@3[&'CDQ0'Q"'
M8AC!SV*8P=]<@!RCQW\_+GD/(.>!Y\AX'G@>!U3QE]!]>/Y_K[<#SZ@(>6K]
M-----..?VZM\!0XX* "'D(!P/XZNTU:?] __ .*;]@_#O^&H<]\/4XLNUK<U
MC7;55*!C>8D[_C)YDD+5E?)[;&D"F#6V1]41@8I=RS<?*4PLN\]Z!IR0YR<@
M'8OBUTRT]8^FXIRS X\RS2A9QBV2,S8UMMDH+R4O;BK/L0T"IW9Z96$B8Y1Z
MY5=*655NX,FD+9FQ9%D#JBFMP&QLAU;-BL?+3,:.9BO4*[CZ!R?.ST;6[%(U
MN-J5JCDY.J*NIEJP4:%E;2@H5I7X,IADY.0$6B38%P\.N*?]7?8I%5*M7-]E
M:2:_.BX3=&:TU>ISS?(459*LT;/K%'6*ENFJ,Q$'BHY^RD5P5;"L=HY259@Y
M,<Q"<19NK'MPQE9<E0^6K,SJ[2KY,A\?41*!2DK/9[P9_2&UZ>O%ZRBT1>Q)
MXZ%< ]<-E!!T#0HBF@=Q_$F[GOPW[%VD;>,?YVIU'-D:'R=::; 0E@FW,G6*
M)28:YL1?LKMDN73CW4C7JTDC[NBJLI&@LB\=)(+@B(&#6 L5=8O&=FFMOE/R
M7CZ=I=AS/BG*&67L]495MDS'T!!8LDQBWKV,L-42?J3[.P&*#N,$B!';%%1)
MO)-$72I1UF%EU=]C,E1&>0V>4IMRW<7N0QF-41I=D<Y";VF+A!L\FB[IS9FK
M*M&+"M!\ONY%5+W5".Y554(LFHB3G:YU8-C=MMV'Z5 YP8.9;-L=6I:BJ'B9
M-"+4;71\^C:6TL,@Y;)HU^7N+R,?IUR,DC-W3P$/:&32 Z8'DK+P( (=@$.0
M^S5=-----------4$ $.![@.@  <    !Y<>FJZ:M/\ HF[B7Z(_2#S#MYAS
MVY#TY]=0HI=4R\3._7)NS>NXZQ41ABF[P52F9JUY<:UZ_6-N_I;6YR<Q4*,H
MQ.,NC'L7"@ BDY QCM54A*911,-==Q'UP,&6.^,:AF"+-C:#F,;8EO$-?X?Y
M7ME.]]RG:;15T&<],,F H5R&CGT)'(!.RIF[5P\E/8 (%1$^ME)/JY;)&#.W
MO$<D6*6)3L@+8K=-8/']LF7EAR T&9&3K%(:M8XREM>PK:O2DC-*0OO32,CD
MTG+IP0'*)3<["]5#9-:K]CC%U.R^E:[7E:N0=EJ:==@YB08HQ]F7?MZZ%A=H
MM## N)5W&2+,$7: "R69N$I 6:B8\X_Q?U;=M%C<XJJ5[M3>OY3RY,3C"#I]
M6:R=N:,(]KD:<QO 2\K(L6HBQ93DW"N&I%S(*$0<I."K^P11,KKK'46ZF4_L
M9O&*J%"8MA;4KDB%M=D5O.1KF;'>._;5=W$-RX_B+6O'NXP<AV!*3%:$82KA
MA' BU6%PY\7B O)5WK#;?#VO-U3O]:R'CYQ@>D88MEL=#77MN;R+_,466085
M^O+5EN^;2:\2=9LV5DTG(1<B119\R>"S:+*AV.>ZPNP>M0-,N+W,CI_7KM2
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M\%*'(B(B !R(B' B(^8CQVYYYX[:J!2@/(  #\> U77R6#E,P=^_A#SXYY,
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MLE&%DEDS'<$ A"RT@'  'P  [>6JZ:::::::::::::::::::::L4.4A1,81
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D'[V1EGWLP<R$E)2+EV_?.CII(H$4<.#@BV00;(E3013(7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g729258g02m36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g02m36.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2$,4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (/"^A#(X0DE-!"4      !                      .$))300Z
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M8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
M    3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K
M9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M  !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@            0G)D
M5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M4G-L=%5N=$8C4'AL0&G/A2         *=F5C=&]R1&%T86)O;VP!     %!G
M4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M      !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M         !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T
M;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C
M=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M     ! #O_XU  (  @.__C4  @ ".$))300F       .             #^
M   X0DE-! T       0    >.$))3009       $    'CA"24T#\P
M"0           0 X0DE-)Q        H  0         ".$))30/U      !(
M "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H
M   &       ! #4    ! "T    &       !.$))30/X      !P  #_____
M________________________ ^@     ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@  #A"24T$"       $     $   )    "0      X
M0DE-!!X       0     .$))300:      ,U    !@             "&P
M!18          0                         !              46   "
M&P                     !                         !     !
M    ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   "
M&P    !29VAT;&]N9P  !18    &<VQI8V5S5FQ,<P    %/8FIC     0
M    !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO
M;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'
M96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   AL     4F=H=&QO;F<
M  46     W5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G
M951%6%0    !       &86QT5&%G5$585     $       YC96QL5&5X=$ES
M2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE
M;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG
M;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO
M<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P
M3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O
M;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M       ,     C_P        .$))3001       ! 0 X0DE-!!0       0
M   '.$))300,     !;U     0   *    !"   !X   >\   !;9 !@  ?_8
M_^(,6$E#0U]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X
M @ )  8 ,0  86-S<$U31E0     245#('-21T(               $  /;6
M  $     TRU(4" @
M                   18W!R=    5     S9&5S8P   80   !L=W1P=
M ?     48FMP=    @0    4<EA96@   A@    49UA96@   BP    48EA9
M6@   D     49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&
M=FEE=P   ]0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#
M   ,<E120P  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=
M  !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD
M &1E<V,         $G-21T(@245#-C$Y-C8M,BXQ               2<U)'
M0B!)14,V,3DV-BTR+C$
M                         %A96B        #S40 !     1;,6%E:(
M                  !865H@        ;Z(  #CU   #D%A96B        !B
MF0  MX4  !C:6%E:(        "2@   /A   ML]D97-C         !9)14,@
M:'1T<#HO+W=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI
M96,N8V@
M        9&5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C
M;VQO=7(@<W!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$
M969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M         &1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO
M;B!I;B!)14,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN
M9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M          !V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %8
M65H@      !,"58 4    %<?YVUE87,          0
M      */     G-I9R      0U)4(&-U<G8        $      4 "@ / !0
M&0 > ", *  M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"&
M (L D "5 )H GP"D *D K@"R +< O #! ,8 RP#0 -4 VP#@ .4 ZP#P /8
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MQ1KL&Q0;.QMC&XH;LAO:' (<*AQ2''L<HQS,'/4='AU''7 =F1W#'>P>%AY
M'FH>E!Z^'ND?$Q\^'VD?E!^_'^H@%2!!(&P@F"#$(/ A'"%((74AH2'.(?LB
M)R)5(H(BKR+=(PHC."-F(Y0CPB/P)!\D321\)*LDVB4))3@E:"67)<<E]R8G
M)E<FAR:W)N@G&"=))WHGJR?<* TH/RAQ**(HU"D&*3@I:RF=*= J BHU*F@J
MFRK/*P(K-BMI*YTKT2P%+#DL;BRB+-<M#"U!+78MJRWA+A8N
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MM_ *)"<H-;'!)28T-SA(5='A0D968F6#A=/Q_\0 &@$! 0$! 0$!
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MX>0T<L@1^Q3+&,73A1BH<[9VL+E,X 29II^KSZ5[T2884P& P& P& P& P&
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MX K@4O>Z )]KY1A'/E:O.]\,Q<*8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MQCVB-62P#U !Z"'4.O0?4/W#TZAU_GA3 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MSQE</"F!&=5O[V[:G^A)1_\ >LO@28X# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# P!YV<M;QQB9Z@C-?06IWECV[=96K-;'N_9"6L-9UQ.
M%KK^R+C+V$6SQ<9&318&CXAF1$A'#U0I!5 XD3..Z_'&'9EVVYI^ NU^6U(M
M9Y-:3([5TE=S[%UX=-L^5;MAA[6+=L#Y4J2?1\F"75LY Z0^1>HR.>_/-,Z5
MRGOXPF/FW+(0"ATZ#^UY=!$0#J;Y]>@ 'F/G_'*1%(IO?+)7N@ B( '4?4>G
MK^7GA4<7'_\ O%.>W^8?%O\ V'?\F<SRCTK]I'SQ>\I'LJF P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P&! [VHL/8[ER-T[6]&M-[N>0D7
MI/8-K?N-2[[C./D4RTJSLL$G.IS$^_CWJECF)"R!&DB(EOW$&9DS/GJB*1"F
M%GY^,MT[I%<YC'3QG/YM5)?P>ND+L;BEI.Y5Z9V#/1DQ4TQ]Z[4FB6;8*[UA
M(OXZ40M%B2 $9I\RE&SQHG+-NK9ZV;HKI"*9RF$E)K:+3C,32]<:7K.'7.V%
MK- <HMS[,Y@\F] ;%UC$:ZJFHZKKRS:^4),)S=KLD3;GMC9C.3RS508J/1E!
M@A<QT2B4[EBW, .W)UE!(D6<,^V.^6>"QT'SGW>CSRM6CMEUR!UAH)M9+14M
M83=@UGL(;#N.1J=&):Y9:GWE.4"J*+MSE>"C%# JJRK=BX1C'"KH (:;CGNZ
M]\?3'>Y=4XP<A]9\CNU*W/;-7N[.ZA8CAU2H9X>TT6X4)Z1^GM%90Y4HVZ0T
M%)N6_<$.ZZ1:':F, ]Q4W7SIE6;==TS318# 8# 8# 8# 8# 8# 8# 8# 8#
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M?4OIK%OS2F%^S5*:S]XDL"87J^,0L$/!0HF939$3Q P8I']YPYC-A%I)R@)
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M@'JAR#"]"5@ $W=LH"9R;H #%%Z^3>_5)[]JUW-)OXO26I*6VV==F5>GU1%
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M..FR*Q?H!)'?E76,9!OX/0PORB]ZS7/*>>4<^5)[)%O;JM:)9I+0D,RJ2$+
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MDH>6!'75NG^5NVIZ?^Q)2!#^/]*JP"/\>@  C\N@8$F. Z!UZ]//TZ_GT^6
M]?7!BH  'H !Z!Y!T\@] _E^6 Z!TZ= Z>?ET\O/U\OW_G@5  #T  _AY8#
MH)2CZE ?(0\P ?(?4/X#^?SP4C3>YGRK@4Z!UZ] Z_/H'7\@]?X  ?R# XJ?
MD'<1!S$JPB'D^^C8Q^_9P4<HV2D)ETU;*KH1;)5XLW:)NWZI"M6ZCI=%N554
MIEE2)@8P!&Y+\\M_5^*DIZ=[.#DE#0<&P>2DM+2-XT2SCXV+8H*NG\B\<J["
M*D@T:MT3KKJ'$ (F0QA\@P;\[]F/_'+MFD^7$39IKCCPQWGM>.ILRI V8T!>
MM(>V1+\AC%2.Z8N;XBX]A>"FL9A(D3%F^33\5JLH3O"44]+WOO'EIR24<?\
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M)HE\G!_@?Q?Q_P L_P D1'_4XN*9_M%(BG%>.=8RFLS-IN^F_D_YA_M/YO\
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MGWCF'H CUQORFEL[VI>->4TMTC&KL>&C C.JW][=M3_0DI'^]9? DQP& P&
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M*8$</'_^\4Y[?YB<6O\ 8>P/W?\ C_C^4SF>4>E?MF/GB_\ KK\=XSD>RM&
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MH]Q<O[:8]/+#-)U]ZVPSCE6*:ZK4_$]VA(CY]F^8.H=.OQ,ZN'H'GZA[. B
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M<?'PQQ1''Q<$3-_Z\4Q:*3%=8C*L-Z'0   Z=.GET].GY=/W9O ]3 8# 8#
M8# 8# 8# 8# 8'EZ[5VF0&O.85>N]5CM]VN\;#U*[<W)K&<M);06OJE5G=XK
MU50=QCM1K(E29+2RK5Q8V#0$(:,;@2;>BDIWC&)$S2\4GMOYRP33]G2ZJTAP
MKT$I2*^%2K9J>^;M8(MO?7Y2,=M[!,MI)/\ &DBDDZM"II1)ZNI-G2*B^54,
MLU S4R1L&=/F\[QM-81F<6.+?*?0^]HZ\SFD7+N+X[UGDW%,I6&MU7*ZY&/]
M\;E;WBM+Q)E%DEV!X*!,HO,*6<I ;OV@-FQSBJ0 E-Q2,_JW:USEKCTI3?>5
MTJWQCWO%]H'*[1U_KB_:EK=WV!=[3O+9S_:<#:J'L*B3FN4J_56=0I:C'WQ5
M[Y$6%%FLDF*(MHKW<JX5>OFCWV8*5I%YKEE%9W6SG^,>H9C3/:F;EKTUN/:V
MZ5Y+AO29)*P[;E(25G&*8;/52-'LG$' 5]H5B!OVRI&;**%-_:4$>HB5-!@,
M!@,!@,!@,!@,!@,!@,!@,!@/0/X!Z!_X!@;)R^:-2=7;MLT*<1(0[E=- IU"
MAU,4@+'3[P  =?V3]>G7TZ".$[TGS2:=NOX>6W_E+7.?;G&V@<<-;ZG_  -)
M5[;5FF[9;UIF+6GWK>5TY8Z!;:86,<-)1LBQ:N)05"RJ*R*QWK4 01.@<3G,
M.^[T]^]$XG 3D19.1G#SC]N_9C^JM+SLC7D39;*T@RI1$6E)O 5!1)E'NW[I
M=FW3 A *FJX6-WC=>\ = P7KK'7";Q/ZURQEFLFJ18B:J*A%452E4(HF8JB:
MB9@ZD,F<@B!BG 0,4P")1+U_+!-:Z1WG.VG>\]*5K]<*8# 8# 8# 8# 8$)?
M:E3MLCGL))[!TYI%_I6O(R,16-G;#Y+*Z9EW$_L.N2-2L=81BDH5^=^*\:^5
M.T %%!*Y01>@1,&HG%OH1\TP\:[TFS,+LXZ>C2.*U3B"H,D'RT]<9&;79;9#
M=8O9M]9I)24>.]ABQCB2D@9YX@/&Y6#<8Y9,S(4A.D)C$_>E/;?)GD'7IY^O
MY]/3KA8PBN.9@1Q<?_[Q3GM_F'Q:_P!A[ R9]H^?PD?/%[RD=RJ8# 8# 8#
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M;S.]V>@,H"4I2F,)Q H )A  $P@  )A /(!,/F(!Y>?EA6K 8# 8# 8# 8#
M8# 8# \\O:'.]P5S<<7KZU[_ (&XM-OMIAI7=9L^&%6VRZH.JIR080+LURML
MA8$3MJY+606$0D=0J"DK*+-4B-SJ(@<"1O>B6OA#+UV=XH:1DJM.14] ?@YN
MU92D-2&VMX\WNU\\8.69*,T450K+B+>MG$6]C"JJ%2>-7)S"85!$1/?MV]>E
M,;7BK*_"J= ^0?/T_/YX$9]6 /\ *W;4'IY_!)2 Z_GT_I67\L"3' 8# 8#
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MY93GV_69\=/#3ZHM%_<JK?J6"L<_$_35\<W#82B<.4&C1* @ F_I)JW= 1]
M$WO'H C^0"/4<+O#>F+3\=/#3ZHM%_<JK?J6$KU\3];[2?'3PT^J+1?W*JWZ
ME@KU\3]'QT\-/JBT7]RJM^I8*]?$_1\=/#3ZHM%_<JK?J6"O7Q/T?'3PT^J+
M1?W*JWZEA>T^)Y\N4GQT\-/JBT7]RJM^I82O73"?KUP/CIX9_5%HO[E5;]2P
MO._B?K<M1N<_#8@@!N4&C"B( 8 -LFK (@8.H#YR/H(>8#^>$KU\3]-/QT\-
M/JBT7]RJM^I8*]?$_1\=/#3ZHM%_<JK?J6%QUORD^.GAI]46B_N55OU+"5Z^
M)^CXZ>&GU1:+^Y56_4L%>M^4Y=OV?'3PT^J+1?W*JWZE@K'/Q/T?'3PT^J+1
M?W*JWZE@KU\3EV_>347G/PV./=)R@T88WF/0-DU81Z '41\I'T  $1'\@ ?E
M@KU\2T_'3PS^J+1?W*JWZE@KUQIA.Z<\#XZ>&GU1:+^Y56_4L+C3&_*3XZ>&
MGU1:+^Y56_4L)7KXGZ/CIX:?5%HO[E5;]2PO:;\I^FHG.;ALH=--/D_HTZBJ
MB:229-DU<QU%53E323(4LB)C'44,4A2@ B)C  !UP9TOXGWP92(+IN4DET3D
M5162(LDLD<JB2J:A2G(=,X>1R&*8IB'+U*8I@, X2M<*?/XQA]L*8# 8# 8#
M 8$7]+[-Y/7FY+AMBE[WM,2)#;8D-.U]Q3:Y(,]/V3>=@BK/L^=(_<K%7NXR
MTE%&",831&R$(VD72:1UA\,2DK'BVE,,[:_3FM>]G14*/R(EMU/]B2]OIPS>
MSK=6M02M7@B0=?NFYH>)A=G2;N<*=20L47/MHQ0[.O/FI&D8K)/0(JNF*90)
M,V[8S6.76.6<Y5NRB^$OBT(  \<=&].HFZ?T5T@0 Q@ !'_L3U'IT$?SPTI\
M)'%CZ;]&?:JD?HF ^$CBQ]-^C/M51_T3 ?"1Q8^F_1GVJH_Z)@/A)XL!YAQP
MT8 ^O7^BJD>OS_[$P+$:)[.OC7IZ.V*PDM4:FO1KSMBY[&:+36K*:)JXSM1V
M)D*G' K%+]V*B"M#%: 0R:8 J?NI$ZB&"5]_A(XL!T#X;]&>7I_T54CR_+_X
M)\L!\)'%CZ;]&?+_ -55']/E_P!B8#X2.+'TWZ,^U5(_1,!\)'%CZ;]&?:JD
M?HF ^$CBQ]-^C/M52/T3 ?"1Q8^F_1GVJI'Z)@6,8]G9QM;\C)G>I]3:D4AY
M74,5K$FNC:LI@P+21C;:\LBEO1#W5X)I-XV<IQ2I_9BJ^S($**HD*!042O+/
M<[Z8V7S^$CBO]-^B_3I_ZJJ/Z?+_ +$],*I\(_%?Z;]%_:FC_P ?_@GS\\"O
MPD<6/IOT9]JJ1^B8#X2.+'TWZ,^U5(_1,!\)'%CZ;]&?:JC_ *)@/A(XL?3?
MHS[54C]$P+$[L[.KC=MA_IAW&:IU-22:JW+6]IR*$/JNF@G<HZ"B+!%K4^6!
M*,0 8J0/-I.E_%!9/Q6"!A0.)2B4E?GTWNL+[_"5Q:'UXXZ-^U=(_1,*I\)'
M%@?7CAHS[54C]$P'PD<6/IPT9]JJ1^B8#X2.+'TWZ,^U5'_1,#M]*T3I/6\N
MI/Z]U%K6C3BS11@M,5&D5NNRBK%4Y#JLU'T3&M')VJATTSG0,J*1C$(82B)0
M$ NM@,!@,!@,!@,!@,!@4, " @(=0$! 0^8"'00_F'E@11ZK[,U[I[84_L&H
M<A;$BYA8?9\+Q\C']&KCM/2;/<U\;[ OPJK'> I>EGLFDK'10RY6@14:X%),
M%E4R'PE<^G/VQZQ7T=GH_9P0-1Y.%WBZVG,3M$87_8VXZ[I1W5X9*)BMM;;J
M3>F7^SNK*"JDG)Q4C%(&585UPW(V9.G3@YE5DS@G@OZ1VIE2^$:8\K,N/A2X
MP=.GP[:0Z"83C_T6TG^V/41-_P!B?VA$1$1]1$1'"J?"AQ?^G72'VMI/Z)@/
MA0XO_3KI#[6TG]$P'PH<7_IUTA]K:3^B8#X4>+_TZZ0^UM)_1,#'JP]G5Q_G
M.2NM=[M]::DCZ]1-<W:C/]=)ZKJ 15@>6MXR=-; Y$D85O[7$E:&1;^(V44!
M-=0$U" <P&)YPB]-?/KAFR%^%#B_].ND/M;2?T3"GPH<7_IUTA]K:3^B8#X4
M.+_TZZ0^UM)_1,!\*'%_Z==(?:VD_HF ^%#B_P#3KI#[6TG]$P'PH<7_ *==
M(?:VD_HF ^%'B_\ 3KI#[6TG]$P+ \=.SOX]Z0IEFJT[JW45]<SVTMD[ ;2L
MGJVH"M'1UZM#N?8UM$'$8N<&5>;.21C,I3E2(W0(5)(B92D DS3?MS7^^%#B
M_P#3KI#[6TG]$PI\*'%_Z==(?:VD_HF ^%#B_P#3KI#[6TG]$P'PH<7_ *==
M(?:VD_HF ^%#B_\ 3KI#[6TG]$P \4.+_0?^KKI#^>K*3T_G_P"1,"P/)7L[
M^/F^-7+:^@=8:EUY(J6Z@V4++$:OIY'WLM.N,/:'L2!FT4W5*A.-XQ:(=AWQ
M*+5XJ50BA#&()(G*:UI&/ORYU7\+Q/XP 4H&X[:0,8  3&'5E)#O' H )^GN
M3H CT_+T],*U?"AQ?^G72'VMI/Z)@/A0XO\ TZZ0^UM)_1,!\*'%_P"G72'V
MMI/Z)@:B<5.,21R*I\>-))J)'(HFH35U**=-1,P'(<A@A0$IR' #%, @)3
M@(" 8%^4DDD$DT44R(HHID2223(4B:2290*1-,A0 I"$*4"E*4 *4H     &
M!],!@,!@,!@,!@! !\A#J'R' = ^7R_U>8?X#YA@,!@,!@1,\X><VP=)RVR=
M0TR#@HZPVO7Q8S0^V4;'$2<(TWJZ1462U7LEB8XIZYL=D8"FIK23LYV\/890
MP-3'*HF!#M[]!]NRRV3R?O5'O;;?D=M=S#1LHS>U>P;NA$X#8+&2E0<FG-=N
M3)I(I6EE3!:MC'N"**#)^ZEC,HXJK5F"F$GIE>V/+?-+ '3H'3TZ>7\,*8#
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M-OR]<WH2O47I;^/EKD85'7E-K]"%\UV?KNT,T4X[9%9V>1%464W4Y(LBZV+
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MQBX] K:/CF;9@Q;%$YB(,V:!&[9 IE#'4,5)%,B8"<YCB!0$QC&ZB(;S 8#
M8%##W0$WKT 1Z?/IY^N!YL+IO:!YSV60WMKVY[(@^37$.XJ6G4O".SNDJ^G+
M*ZKL4FQV3;X)FQ.W':87^G^T)0,BJ1RUKJY&L<1 CITH8P23:"X!\866RF?,
MB,J=O>[7O$Z^VC5)"^2$BWFM3,;]'HNYK7]=AA\ M?@C.W"SB7@E45$U985E
M5A$Q2]"3?"DTM,?/6-Y4DJPI@,!@8W\F^3FO.*E :7R_EDGA9VS0]*J-=A4
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MD<^UL-^E:),\Z?'/\X5\,\! !\A !#Y#Y^@]0_P'S_CE4P& P& P& P& P&
MP& P& P& P& P& P,..2?,.%T#9ZIK:NZNV7OG<-PA)2V1>J]21T:_L36E0#
MA%K-6^:=3,C&1D5"-W:Z$>S.LX.XDI-4C)J@8PF,4D5Z8_B+8QWB;<Y8$VCB
MQH?M+M;7W?W&C<.V=#7C;,=8=>;:C5S/74#(6"(04@9VC[JTG9';F#"<@W::
M2:R[$C)\V,@@]CGB@&34,_&^ZUR^-><1EIWG-)AQMT@_T[J74]6OTS![,VQ0
MM>0-$L&XC5AC%3]I0@VI&*9S.1!Q*H-C-4&J0-5GZY#@AXB@F4,(X2]=(KSF
M:7IEYT9&X4P& P*&,4I3&,(%*4!,8PCT "@'41$?R  #J(X$='-:Y<F;UQM'
M9W9UW_65ML]:GUY*<@9"(C+]#[/J4.JZCKC289P5U[,QLS<R+D$&YE"&<O6:
MD2L9NHN!RDBU(G]\\KS>:>J.'LTN/VZ;U=X#8]WB>/>Q^&*LW,;4UO4HE&\P
MUAX\<DH]96,L[:LZUN9'1JFFI+*RQ)NLN))S%UJ;24D:XBD5X!\8TPZ_6.*[
M]?C%Z-L!@,!@,#J=]MJ%"I%OO#J+EYQM3ZS.69Q#5]H#^=E4(.-<R2L?#LA.
MD#N2=IMC(,FXJ)@LX.F03E W4 \]EA[5>+V1>-5;_P".=XN41:PIC<;OP&W@
MW1HTMN[63Z077"]:&DG*KB"E=EQC@5VT.FVDSA9O9#UY9JV=)% 9N8GGSUC>
M,2<J=)T[;PQC!([Q,T_,7G;5MYP[*U(AH39.RX;\,0%%B)9ZTL<EJT!9NX!W
MON':&+7IC9"#Q)RZ8JH$7<5MD]/%"]<"!S94K%JX[ORT[T2184P& P& P& P
M& P& P& P& P&!L9!TW8LG<@\5!NT8MEW;I8X]4DFK0AG"ZR@ 4P]PB29C&$
MI!.  /=*(@ X9FN4:XS:>6%ZQXICC7S]\DN<6SM]62@7SA?:IB\\9H87S.8N
M.O+?1:)65=SPMK"+6IO(:W;!$DE0]8#"%%X0L+%KR-G%V5%F<BAD1&=+[]MW
M:B(Z;O;]7KK5U#A'Q5O7*O3EG83.VK!K+B=-[TMZM\XMU5O"WC7UFG*O;V\[
M,IZ6W1)-$+0EHRVV-([SV%!(%?'1E6K%VFU4Z#4GE>;TMO<TS>CMN@BV00;M
MR 1!!%)%$@>A$DB%33*'7SZ%(4I0Z^?0 PK[8# 8# 8'FM[1PO)P_,*EU#8-
MLLE+UIM*]ZXK'$_9U<N"]9T%1"@]37VQ6^15;4;+EN-ZN\65Q!U%C,+A7)9D
M\]@CP:OBJ^((W7'TMOJD2U3V9E,U3M]"P,MJ; D^/M2LYMB:;XO+2"B.N=6[
M(?F64EYV-526(_DX)JNL=W6*J_55AZXX<.3-4% $A2DY??//?K"3\ Z  ?(
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M1$96;:O.R%?0@ 8MT$WX*J%,XZFR4WT3=]^N'5)7E4P& P& P& P& P& P&
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ME;Q5XF8C4:E=YB)90SN;*YCA7FF2:#!C'-7;2&>@BW0D4VI <&752$YS-S=
MR#P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P&!H4225*!54TU2@(& JA"G*!@\P, & 0
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@4FFFB0J:29$DR^12)D*0A0Z]>A2E "AYB(^0>N!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g729258g03d54.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g03d54.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X<X':'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ
M-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O
M9&,O96QE;65N=',O,2XQ+R(^"B @(" @(" @(#QD8SIF;W)M870^87!P;&EC
M871I;VXO<&]S='-C<FEP=#PO9&,Z9F]R;6%T/@H@(" @(" @(" \9&,Z=&ET
M;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F
M.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/F<P,V0U-#PO<F1F.FQI/@H@(" @
M(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^"B @(" @
M(" @(#QD8SID97-C<FEP=&EO;CX*(" @(" @(" @(" @/')D9CI!;'0^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M<F5P86ER(CY&:6QE
M($YA;64Z(" @(" @(" @(" @(" @9S S9#4T+F%I)B-X03M5<V5R;F%M93H@
M(" @(" @(" @(" @(')R,CDV,S0W)B-X03M,;V-A;"!4:6UE.B @(" @(" @
M(" @(" P,BU-87DM,C R," Q,SHT-3HR-R8C>$$[15-4(%1I;64Z(" @(" @
M(" @(" @(" P,BU-87DM,C R," P-#HQ-3HR-R8C>$$[4V-R:7!T(%9E<G-I
M;VXZ(" @(" @(" @,BXV)B-X03M);&QU<W1R871O<B!697)S:6]N.B @(" Q
M-BXP+C F(WA!.T=R87!H:6,@='EP93H@(" @(" @(" @0F%R($-H87)T)B-X
M03LF(WA!.RHJ*E1H92!P<F5F;&EG:'0@8VAE8VL@:7,@8V]M<&QE=&4N(%!L
M96%S92!E;G-U<F4@;6%N=6%L(&-H96-K<R!A<F4@8V]M<&QE=&5D('!E<B!P
M<F]C97-S+BHJ*B8C>$$[)B-X03M4:&4@9F]L;&]W:6YG(&9O;G1S(&%R92!P
M<F5S96YT(&EN('1H92!D;V-U;65N=#HF(WA!.R @(" @(" @("!#86QI8G)I
M)B-X03L@(" @(" @(" @0V%L:6)R:2U";VQD)B-X03LF(WA!.U1H92!F;VQL
M;W=I;F<@8V]L;W)S(&%R92!P<F5S96YT(&EN('1H92!D;V-U;65N=#HF(WA!
M.R @(" @(" @("!";&%C:R8C>$$[(" @(" @(" @($--64LF(WA!.R8C>$$[
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM)B-X03L\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @
M(" @(" \+V1C.F1E<V-R:7!T:6]N/@H@(" @(" \+W)D9CI$97-C<FEP=&EO
M;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @
M(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M(@H@(" @(" @(" @("!X;6QN<SIX;7!'26UG/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O9R]I;6<O(CX*(" @(" @(" @/'AM<#I-971A9&%T841A
M=&4^,C R,"TP-2TP,E0Q-#HT-CHQ-2LP-3HS,#PO>&UP.DUE=&%D871A1&%T
M93X*(" @(" @(" @/'AM<#I-;V1I9GE$871E/C(P,C M,#4M,#)4,30Z-#8Z
M,34K,#4Z,S \+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \>&UP.D-R96%T
M941A=&4^,C R,"TP-2TP,E0Q-#HT-CHQ-"LP-3HS,#PO>&UP.D-R96%T941A
M=&4^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^061O8F4@26QL=7-T<F%T
M;W(@0U,V("A7:6YD;W=S*3PO>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \
M>&UP.E1H=6UB;F%I;',^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'AM<$=);6<Z=VED=&@^,C4V/"]X;7!'26UG.G=I
M9'1H/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIH96EG:'0^.#@\+WAM
M<$=);6<Z:&5I9VAT/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIF;W)M
M870^2E!%1SPO>&UP1TEM9SIF;W)M870^"B @(" @(" @(" @(" @(" @(#QX
M;7!'26UG.FEM86=E/B\Y:B\T04%14VM:2E)G04)!9T5!4T%"24%!1"\W44%S
M54=H=F1'.7IA1SEW241-=4U!0311:VQ.02LP04%!04%!0D%!4T%!04%!14$F
M(WA!.T%10DE!04%!05%!0B\K-$%$:T9K8C)*;$%'5$%!04%!068O8D%)44%"
M9U%%0D%514)G549"9VM'0E%92D-W9T="9V=,1$%O2T-W;TLF(WA!.T1"04U$
M07=-1$%W441!-%!%03A/1$)-5$9"451%>'=B1WAS8TAX.&9(>#AF2'@X9DAW
M14A"=V-.1$$P645"05E':%521E)O9DAX.&8F(WA!.TAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X
M9B\X04%%46=!5T%%04%W15(F(WA!.T%!25)!44U2068O14%A24%!04%(05%%
M0D%114%!04%!04%!04%!449!=TE'05%!2$-!:TM#=T5!06=)1$%114)!445!
M04%!04%!04$F(WA!.T%104-!=U%&0F=C24-1;TQ%04%#05%-1$%G44-"9V-$
M0D%)1T%N34)!9TU20D%!1DE227A15D5'13)%:6-9155-<$=H0GA7>%%I4$(F
M(WA!.U5T2&A->%II.$-2>6=V16Q1>E)4:W%+>5DS4$-.55%N:S9/>DYH9%5:
M2%1$,'5)24IO34I#:&=::$I21E)Q4S!6=$Y62T)R>30O4$4F(WA!.S%/5#!:
M6%=&;&%7,7AD6&PY5UHR:'!A;71S8E<U=EDS4C%D;F0T95AP-V9(,2MF,T]%
M:%EA2&E);4MI-'E.:F\K0VLU4U9L<&59;5HF(WA!.W%B;DHR96XU2VIP2U=M
M<#9I<'%Q=7-R839V;U)!04E#05%)1$)1545"45E%0T%-1&)114%!:$5$0D-%
M4TU514954DYH26=:>&=:17DF(WA!.V]B2'=&34A2-%-.0T962FEC=D5Z2D12
M1&=H85-5>5=I63=,0T(S4%-.94I%9WAD56MW9TI#:&=:2FI:1D=I9&MD1E4S
M.'%/>G=Y9W F(WA!.S K4'IH2E-K=$U453504FQD65=6<&)81C%E6#%2;%IM
M9&]A5W!R8D<Q=6(R4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E);4MI-'E.:F\F
M(WA!.RM$;$I75VPU:5IM<'5C;EHV9FMQ3VMP86%N<4MM<7$V>71R<2MV+V%!
M07=$05%!0T5135)!1#A!.54T<3=&5T=E8V9*4&U45W1D=&0F(WA!.U0P;GI*
M3F]Y,G-!:D5%871)<E-Q-T](6D,V>&M.54MW2S%)-SE-5EE8<FYL2%9V2SEP
M6EA/<RME8G<R+T]'3451,W,W<6)3,UE'4D8F(WA!.W1P5VQ*84M,;$E7<79,
M96TY34MP2D9R=&QC-F%K3G0K6D5I5VUL-F)B;VQY8F$V17)8,&PS3G=U851,
M1W-G2W1';U5-,TI62F]Q-S0F(WA!.W%I=%HQ1SAK,4\U,"MF.$%.93-T15-2
M-V4Y=')Q2#9Q=T%K=4994D9I9VPU1VE(:6%#;7@K>4U64F)A:%!$2F1O;C5P
M>$522E=W85HF(WA!.U5J9T)I86IC-7E84U=I>'5(03-R-$AF1D--,$1Y3C5T
M,65Z<SE5,'(X>$HW=E-O,&MI<U-K3$MN3TY"8G-Z05-+2$M44D]F:49.>FDF
M(WA!.VQN+VLO45!-5VM25')R5W5Y83(X=VI+3DI'22]46E,T9FI1='-W2S=E
M23DX0W-I>%8R2W5X5DMF3E=J,W5T841D85A:-FA*<&,Q,D8F(WA!.VIA*VAR
M-G%2.'=:4%1)6E-R36Q60G)T:7)%<%!),S5M=$ES;BM/1#EO;#!&;T95:&<T
M249*2VEN36-F.5%E3%9+<U8X=S)E=6%:<64F(WA!.VTK5SE6+TTQ<F4O=4QY
M,G9927!,3GI*3$@V<4I"0GI2*TY(;FED:GDX4#518U911G!.95%T<6-K9C5Q
M5'HS,$U5548T<5=6>F-34E F(WA!.S9,4G$T=&=8;U1,2GIO<61+;CEM;U94
M6F1F,&)73F5T=$U4.'=N=5 P5D9!,3-9>#(P>6QP;S=X5E-34UI!;S5C,U)'
M46UV8S1Q:VPF(WA!.VY/.6Y,9&EY+T],;D1A36M(,61O;'5736]T;TMC3U1S
M,'$K;D<U*T=V>%9R.&901E4V,4]#4'I$9FI2.40O36A6=CA!5UE"8GAH3V,F
M(WA!.S%W56ES>D9+<&I75EDT*U114U,Q-$LS2FXS,E=I<4]N+TQB.#-9-W!)
M3E X.4=(4WA!-DMX:5!Q=WEE;$=I8U5):T5I.&M9:W1)<$@F(WA!.TMO,WA6
M-D0U6C!J5TY-9W9).54Q5CE7964U864R:VM125E9;6I29E)&0V5116EU=U K
M5E1T9U9/359D:7)S5E-N>E)O8C8S<$0V96PF(WA!.S%*6G4P:TUG=4EM9$=!
M:6Q6,D@W=&]Z.%-Q5C8Y.%9955!Y,R]-3C=Q=V4U.#A45#(P37%3,SA"9TLK
M=4DS3'%O<$Q20CEN;TXK*T8F(WA!.U=)4S-/;4UT+V$R9C5P3F)H3TXY3D1C
M<35K:&MJ=5!7-7<X,E$K;DI#-G%%*TQF-&@T67%J-V952E1$6G!**V)T='IH
M9S148S%H:F0F(WA!.S5Y>GE+>G%:05(R0E$Y:%1&5D=$6#=F4G10=%HY62].
M94<O:&1::W5B:41H>F1*9C--1'=X4F5Q>$U5>'%Z02]:0G(T:%97='1,;C$F
M(WA!.T\Y:C!N5&9Z1FAL,4(P9#E+9W122E X058S4T]26%ES.#AR;7)Q6'!)
M,S=*<'1I<6$R;C5E+VY%-61B-WHT55)(6E5A0T5-,'-F0THF(WA!.U5:9U9J
M.4IU8V)S5E5T.7%L9D96-G!%<G)%:7E0-FMI<4$W,'!Y24<U;T]L8T-R<U99
M=6UJ-G1P3B]&9$YR.2]F4C-6,D5A,7528D<F(WA!.TI5:UIJ>%AH0W)$:4M!
M56)T.#9Q<V]X5DQD9# O44QQ,E-F5S!H83%S:3!O:W5'0WA*>FIA1FDU66AE
M2E-6:%)T=G!P:7%785@U5B\F(WA!.TQY-S!U5#E%-F9P,'5M,W-I4WEV6DQ%
M67!89VLY4D-8:3)B:2]V-V1-5E<S+W=#5U U9C,K<$IQ9#-O3G!*9DQ),'!L
M-&-E8G0K,4LF(WA!.W$P5U=H,UAM1%$W:6AX5F9C9FQR-4)U3$-3=V913$IB
M4U)(:6%/3T99<4Q)4WI"1VHT<VQ3>$Y624]+<'9O=6DV6F]U;5$V6G!K070F
M(WA!.S=',S5E;$-'6G%C,DQS4WIL;4I:;4I*2GA61S1Q-T9867$P>DMQ;&U)
M5E(Q2C)'2W52,611>45-<#-$03%">%9V1E5Q,4QY<#5B,4\F(WA!.RM7*S%(
M5%E,>3914DMK:S9#4VYO3S!K4D-T5F%O,&I&5%-U-7A6<3<X<"M73'A:,75T
M2W1:;'5I1W5!.$M(;5%624QB8B]91TMT2'DF(WA!.V@U5TUD,T@K:6)52F9Q
M:5AO15-$,59I4$M.6&].=VI';SA-5E%-4#5A9FPW03-+2'DS<#!48W56571O
M;"M,:7DQ,EAR>&-J1E93>B\F(WA!.T%#.3AL,E=U>&$Y6C941&)A<$-N<'A4
M=SAK54QX9&$K:W!%9DQJ2W<U8V$P4%A&5U$T<3=&6%EQ-&MG16=64%E9<7=B
M>2\U,3@X4VDF(WA!.V%4>DXU4T]I44Q06E<Y=DET-49C*V]B>6(P1V%I045"
M1UI.:G91-'%Z;D9867%W-C X;F533"LT;'1:9DQ#2W1G.&E&-VQ96D4U>7@F
M(WA!.W)5545S:DY72U%5-4Q11&)B<&A62'IF;'HU16UC>5-A1%IE;S-#<VEW
M<7)N,#9"9FE503=!52M7,U1!<6MN-5@O;#!T:F(R2CAU868F(WA!.TIA,FDX
M24DU645L-&<P<G4T66MM;35*<6-64G1L-4LX<%=/<'AA;EDV5&)7="]#:&IJ
M=4E)>$<S16=I:#0P0C)9.69%-'%N5TMU>%8F(WA!.VE(;E!7.6(P+W=!>2M5
M<E=Y:U=05#E3=EI93E)(<3(X8G-"2'EJ54I-:G9)3FUR-E1+=S(W67%N=70O
M.&5(+TU:1"](1E5Y>%9I9FXF(WA!.S,X>#E*.&QR64<O<S=Y.6)51VM71DQ*
M65-6.45+5TPK=$Q!4#)X4VA/6%EC17-H<4M$2VMN+TM,.'A.33AW869B-D)"
M63-L<&4V3G F(WA!.SEQ3&PW:U%E;2]&9E-0<&U+85EN-&M0,F=-3V)4>7@O
M56=30EI683-U:WDK86)U1T\S=48Q5T\R:5<T;61*4D-93V-N<&-39C-8>$TF
M(WA!.TAO4G5A93)536LV>%8R2W5X5C)+=7A63"]-1V=A6C5G,&DT,&I623)L
M<V)N:#9Y2DDX5$@P,U=285!'5F-F16<V2$95:#!4>3%P4&PF(WA!.W)8=$DP
M<E)O-4QE=UA43#%205I:6D8O9%0R;D$P9&U&4C9R8BLK2W-U>%8R2W5X5C)+
M<$XO:59V.%)F;U Y1C-F<F5N-B\Q<71T-D@F(WA!.V\X=4AQ9C,O04ML3U<Q
M3TA,,GA63V-69&ER<U9D:7%#=G1B,&UX=4QE,74W>4-#.'5Z>'1,85=616ML
M871!159I0V%S45!M44U664LF(WA!.W9M3'HQ<6QQ63EF.'-,;W1T2'%/:D<S
M=5!R851E;TAV;VUF-$%O25I'5E9).3EI44XQ6&\K2W!*-3$Q=3<P4'EZ939P
M84I'.7IB*VTF(WA!.TDQ;$)+5FML4U T9W!5;6Y0>'E-:E%T='=9>$]9:65R
M061,."LK84DY5VE75#9K.&5P-FAA<&-+<T5Q<T)-,$YQ,T%M9'%54F%I;T\F
M(WA!.RM9.$Y14U%+9'IQ3W@T-#A:;'A(65!1+TY-9'<R:GE08C-5,6Y,17E-
M2EE#;UDQ4$5Q95-U2V9&;54V1DUR845W=U)X1U(U:6EH5$PF(WA!.TE16&%N
M9&E!0E@V3591.%=S86).9GEA9DA/<EAS435345502E9*24)/,U%L5%0U67%J
M359D:7)X=&(S6#ED,3=Y<&-A-7 Y.#%Z<&TF(WA!.W8S.75P16%756%R2$-O
M4S1E37!C=$Q&=7EQ4DI(6&,W,')H5FY%;&PU<FEV8EHY5S%/,G4W43-Y1S-H
M9W1407=5<R]%37I34U9O=% F(WA!.W!X5FQ%;'IB4D]Q4U-O:G8Y:%=906YT
M<T1G5C1V+WIK;DMS8BM74W=99W1E+UI6;E R665Y9S5S97I4-GDQ-4]35B\X
M-#94<$PU=#$F(WA!.W9I2$9,0T0W4TUN*S=N+VU!>7IT23-3350R83 O=T-5
M>C%4+T%,6C)N9CA!2BLK>E9.<619<3=&6%EQ-T9867$X;SAQ5#8S3#5O+TTF
M(WA!.W1V3&)A9E!E0SET>&)03DQ-53ED26=K:V,S1EA#.%%R1#1F,G5O=W%Y
M8E%X-7(O>$1O<#AZ1WI/;VY3<C<Q4EEI45)I5#$W4&YV260F(WA!.W@P<'0T
M-$9::FER<U9F3D]G,F5U-GIO3VMA<F8R175O6'1Z6E<P>C,P,G18:7E333A3
M='I+9T5*5W1E23)'83)795%*.5@R3T5C:#<F(WA!.S-Q=C5F95ER,C O3'I5
M.5DQ;C$W:'1+;C%+4U-,,6ID5&5J85-/=VI35V-P>DE63TLX,DAZ1UIU2U9X
M<W5402MM,'4O-5="92]W0TLF(WA!.R]W0DPO=T-%.5DK<F954'%N1&YP6%!N
M-C-Q5G Y9G!X<#<U1#@Q1'99*U!&-DYO=7%1-G9O,6AQ<T5B>%%A:&)X6%55
M579%4TMK>4,F(WA!.U)69F=86&M!,CE'23DX>4%7-$9%<F-13DHV87E+,&YX
M9D%'0E!W541B93-)5BME2W(X5F1I<GDS.# U<G5F.$%-2#AV=$YI8C!O>F8F
M(WA!.U-8:G57;E9:0F)C1SE!:4932W-A379.9VQ2.%<R2V]Q4'I*-3<Q5S!+
M95E02W8V0W0T.5,P9C!*>F526$)K5C<K37-E0T0T4W!60G@F(WA!.U X,UAB
M1EAP1TMS4R].9&EV:TA61T-L>5!Q.49&2VXO045M4'A)1U%Y9E-82C!F.3=(
M,W9+.5!U-V@Y63!H5W-P;W=D4W-+=7AH;U F(WA!.SE-:38X6D=0-%IG-&@V
M9SE8<G!(=UIB2&PU9G):2"M9;FTW5F)B>EIF85 K;79Q3F=L=F)/;'13,497
M9FUZ3GEL:F0K<6IV;51L>5,F(WA!.VED;E,Y;F%01&QG5%!N-S!Y.'(K8F1:
M,41Y:C5R=35.5DXY4' Y=DDY<&-Q<T%-8D,R6GA4,%525%)H6&-:3$A-;4I*
M84YB<#AE4$PF(WA!.T=-4'!.351M,7)Z0F)V8S9J2'$Q,3EB34MO,&AC2&MS
M2$XT,4E+,&]':V(W.'AO-7!7-W).,EIG:D%K1&M#.6LX,&%R4'!0;"]53E$F
M(WA!.W0Q4C=I,F=K:V=75EI':35O:%IF53E*6&15,BM),#)Z4&534F5L,T9X
M8V%D8E182T-/-65.5&-)<7E);VMP.%E66E935&IY<E1K;TXF(WA!.TU694HK
M5S=45'AQ,FE15T5C;#9,3'IB<6HS=#%D=#8W<$Y):E599E579$DR25EF,SE.
M=S(S8D-R,E!7+RM01"]!2FI)9C0T1EEP-70F(WA!.S@R+VPP=FU(430W+T%&
M<E(Q=F10,4=28G1*-VTQ17-!5WEU4E-13S-+3VMP5')4-'%D.&U)4S=I<6-A
M-S54.&LK93='=W4W.58Q4WDF(WA!.VE$4S9F9%=L,TY':%=504UY4U=S<UED
M5T-J=5)H:&ML03=B1D)&<$(U1SAM*UAF3%AK<CE0-E)B>7=A=&9A3D9,9%A4
M,T9X8T9M14@F(WA!.W$Q0WI34W%V>'-4.$E'4VQL;$UJ:4YQ0E1W9E-V>DLX
M-&9P97EU=C W<6)83C%.6E<Y=UI)2$-V17,K>4Y7141J*RMF-S@R;51467@F
M(WA!.T5K1&1Q16IB-F,X-C9:0F8V9&)P4&)P8WAP8W=G23AS,$Y';6-7-&%S
M1$E45#%384A.2S-*<&%7='9P3VM*8C(X5"MH6G<P4T=-=DLF(WA!.S5#0W9&
M4S5:,DHW5DYC5E$K:&$K;7)I67)96#%J-E!(82MT,G1Y,TES4&<U9F%P>#,K
M:D95,'A6,DMV369+;#5O2&QV6%!Z13%A6G(F(WA!.VTS=&\W*T=E+VIE,6I6
M15EO4GIG*W)V33AW:W%',U97<69S,4IX5E!T1S@P85 U:SAX84YQ3VM03$Y:
M>F%69E-25%!"3D-J2SEX6F<F(WA!.V-7;%)!,4]*<GA*<#-X5FU'2W5X5C1D
M8F56+WI,.'5796TV1&(V9$1Q5G99,C!&=#EF9U4K;5)&1T5"26561W(X3RLR
M65(P9&TW8UDF(WA!.S1'84PU5S%J4V9Y=3AX-EA.=W9T574W9E9*,&ES,6-H
M-4QP6DA32TY7*TEM<F-2;51'2$1';312<4Y04&8X9E0O6&9Q2"M(=%0K=3$F
M(WA!.S0O5G9Q.&YQ5CA/4$=T8S$O=T-6:S1V:$8V5&)A.6,K5F9Y>3AV6$9X
M<#AS,39T<'!T:S)N<W=H:U=A5DDT=4QL>#A*4FHX5F,R2FPF(WA!.W=X<W55
M5%%E5V%:9&%P-54Q=E503VPY-5IS1U,R4RMV<#)S;6UI;DIN55-4=E=7.'5)
M<6M2.5!3*UA(2U)Q;VLP=SAC4&]N36QU9&DF(WA!.W)Z:CAY6F9Q=FYR>49C
M<D%L>DY,97I7<TU::&=E4E1)<48U1FUL26%-3$=R1G5.4V1Q8C!/2W5(;4QZ
M,W%D<5DO34AL:$Y&=&\Y4C F(WA!.UEW6$,S:7HX>$IF4DTO=VA%64UJ2W%K
M2'@R2D$S5EHU<5=Q,F5N4G!*9&5Q16MD63%-54TP,WA/=U)19E-2-E9:9T)8
M1E5,-6DP5T0F(WA!.WI$;T4K;7E3>5<X5C)Q2#%65VIR>&1:1BM&>#1R=4--
M16A9<'-X6D1#46M/:D1T2B],5E1Q<VMK;7%Y=75L6#EU-DE);WAZ.4993&\F
M(WA!.T)J,G%Z53(W6E1(04%B9&AL-U=Y6DEM2D%O;UAZ,S56.'=V-6IV=&)T
M<F5/87AL9W1O=V960T]':DQ+87%2+VQJ0FQX1U(R8F5Z=3 F(WA!.TE92453
M0E14>78U3#%I4%%034]M-FQW<S,Q:4YO26YJ8C%U0W9!66DU0SA/:&)P6$I9
M<UII2TQJ-C=74GDU0D]04FEK6#54,VQX<D8F(WA!.WIP:F%T3W-%8TUB3&1T
M6C,V>'E/-U-,2D=R=F,K;CA#;W!R56<X=F)):E0Q,6(U.7)M44DT968Y26\O
M.#-D5#@R;E94;S)L86@Y53 F(WA!.WDU,#A#.&<T=S%K.60U63,K2U-#9&@X
M0U4K16I$;7E'2EDY;39+3UE'*VEA+VQ0<F9M,U5,:E8T9DU/;V98>F)P879B
M2&I#=D0Q5$TF(WA!.T@O=5EB971F5%AQ1&AW>C1M=G1(4WAW>4%(5FHY+S59
M4&QZ>D@U46=V-49V-3E1.'E8=#=!8F%.3%-+1G)I1796;S%6:DE65E-+;&@F
M(WA!.U=T5'9L-W)78E-82&Y+4R]T;#%A>7-B87=7*U0P2F)A-&QM;%E";4-6
M4F]O,496;U-E6%AA;F-Q=FTO.'=5,3)X."LV,41,<# V9E@F(WA!.W13=5AS
M3V1T9&XQ,655.%=I2WA-<V=B='A*>F,V8E52:D%!:TY-;S)8,%HK5U-896PO
M;&AO4S,Y<&-1,U9V6DHV.6U9<$)/<E9.5CDF(WA!.TIG<FAV66EU87)-8FU7
M,$DS>3=A,U9X*U@Q;' W=WE7=#).3E-Z94LT5F\R5U990D5E44ER5&PS>7-'
M:6PT<' O=T-36&YG83%(<#<F(WA!.WIA64@P+S9J951U3&DT24UB5'9S;&)9
M5F(O4E<R3D(P,WIA-4\P27EJ5D9Q1U!D3V9Z9S@W*V-B1'IJ3G!7;F%T2EHV
M9D)(87IP06LF(WA!.TYQ+S<Q5SE535=L:6MF-U-$871-:&\Y2D1*0WES-6M&
M;G8U4&593EHX>&53=G)U=%A2=3=Z-C%C=TYC8U5I67!'-59D;U9J545$=4$F
M(WA!.TUX3E1J14IK0FY%,D=395A)949L37AK;&Q9,U8P;%IP6DII1FEU6DDP
M04UJ3E-I<4)T;4]Y5%A&6%EQ.'<O2W5A,G5V3U@U:GAR8FLF(WA!.U%J5F]U
M5%-33$](65)L5W%F5FUO43!D94\S1492445%0E9M;'=I<#5X,'!50592<'5O
M9TM"440Y+UDT<6LK<B]!2GEF;&QP1C=,6E@F(WA!.RMV=TID45-01%!&1W-S
M>%-32FEJ;R]P22]&;%E%14A">$)(144K.'9E82],;FU/,64V,%!526119VE)
M5U9O5W)W6FQ$0EA";U9.1# F(WA!.T])3G%$86$T575X5C)+<$@U,#!$4SEC
M.'9Z,G5P=&1*8E%&8G9L674V6$%A,U!Q3#9::G%X87$W061C16]G:6EG:3-J
M=&PU03!'+S@F(WA!.S!89FQU.6TX.7HR1&PW5U<V=DIL1VY33$EJ.5-I2DYW
M64M6<5)48V-Q5D9A+T%J,TU00VDY*WDQ<V1I<GI0.$%->4=6=GI%+TQQ4G F
M(WA!.S)%2S,Q>G=T1FA$2SAO:'%'33%156]T9F@W+U)I<2M,>DPU-S%E>DME
M65!+;C9"=#1T4S!G451.95(S0FM$6#AF36A554556D5&1"\F(WA!.T%$93)+
M;U!Z,RMB33)M-C=E-D)(<$U5=S V-',S3GI,9E)7-6-Q26)U9VID0U%0:316
M<FQ5<W9#86,O5#9!-5DX44E$3'9Y*S@V=#4F(WA!.W4P<39V;7-H671A,U17
M:E),3W1Y<E5I:FPU:5)&468W=7!4,GEC2E=,8V95641I;'=K,FTY:#5F,%A4
M-W57-W-R3T]#-6YQ2G!51D<F(WA!.V)K4518+V=2:VUH53%84TY0,5<R1G1F
M4FU704U(-$(S:BM)06=B;WEN=FEQ271R94LR9VIG:$)%55-H54)9<V%$>%II
M4V9P>%95>%8F(WA!.VAV-6PV9#518E),:E5.96Q7>EI95$-L*W%.2D]Q;74P
M4THX5$U#,5)11VU!>$(U=&M-,#1F4U-&+W=#5W0W-4HQ1%-P8C-Y<WEU:FPF
M(WA!.T5U-692:W0U1TE8,4DK56-O5G500U=Q;F]A-UEI24A*8VU752]Q3G%N
M;2]14$UU<&5:4$ML.7!D,G-/;F%695-Z-G9B3DLX4FQJ94PF(WA!.V=L06ET
M>C0Q8C1724)R.4E,5VY/="\X04AH+WI'42]X>%9-<U9D:7)S5E,R,S!+2T17
M-VY6>&181'I856%1>5%/>6U%2D=Z<V=646\F(WA!.U!W;59Q8CDX5EE(*UI0
M-4PV8C5Q,6-A,45(8E5:0D9&3W(S2S(X46EI4#=0*VDS8D9I<$DV9T1R-UIF
M:C%%;T-G>$UB45!N1'E:<5@F(WA!.VLO.$%+;&1'.&QN56ID0R]I;F,R8GEY
M6$Y*6F55=T17:5)/54AS;S(V-5!&35-Y6$]L23(R634K5$@O2W=0.$%'<U V
M52]42#9*.4LF(WA!.S<Y8C8W*VM0<3-R8W0V+U=F,UA0,4]8=E=U6D=R.$QH
M.5!$9FMX:&0W=F8X,7)9-T971"]!2F,S.2]D87HU=U,Y=E9U<$ED5V169VHF
M(WA!.VE+2D%G6&A';G)%3#9Z96UI:&I4-&%C86UM>7$O4U!+:T=J83=O;6YT
M<48O<4Q1-F1Q4DXU95A5<GI05S9T1TA)<7ER='IP<T]G1F4F(WA!.VU+;U!7
M+WE/.&QA<&509$I*9C9D2DY,2E!C0WIU;E9:2EIP1$Q)-T-54S=S-T5N:E1R
M:T1#2C9-94%-:3AV.$%K6'DW;T9K.7!P:V,F(WA!.SA3>D97=4I$8S-":VMD
M5D,X,F)N,6]/,4(W6DE2035*15%%,F94-$A*2F%98VA1.%HU;"LV:FEM1DQM
M,"M";41&<'%G8U)395E#;GDF(WA!.T0Y9F9&5R]Q14A*1S545E-T4#,X,4XO
M16,V3CE/2W1F;RM#<6YN3CA*<5 S.#-8,RM09C5(1EA(5#1#4U,X,C5Q851Z
M1#E4-'%Q>%<F(WA!.SAC5'4V;'E:2V-G-W4T,B]L1$5H9F]X5E5X5DMD43AT
M,F0O<F5N87102DE:9$U745<X1D5A3&Y*>')*4FQ:9S1#,$)5:EDT<7AN5TXF
M(WA!.V$X,C-..6,R1CEO071.2'1T53!S5VUR9E=58C$Q3V]X8FE%1&U0<W(Q
M<#%0:'5Q>6Y8-'(K83%I:G,W8U1S2C1*6'$T:D%70V1*5#$F(WA!.T)R54E2
M:7%:4FQM4E,V.$A)0EIA,6]E-')I<F5+=7A6,DMU>%94;'1R858P95=*2DAJ
M-65M>DM'2SAH>&%H4%-O,D]+<C!2155+:6@F(WA!.U9(44%52#19<3-I<D9"
M<69M8E8W;W=$>3E,<'DR1C!S:5A&+V-1<D9/:UI95FDK<FTU97 R4'A+3G4K
M2W!N8V%R<E9V3&)X5%=T:6HF(WA!.S-5:&EG5G(U;$Q/15HV2T=T=U=.14]Y
M,5 P5D]+<G)R561A=$QA5S5U<F%W9W1O5DUK,#!L-TEQ26EI<%IM3G11041&
M5S=E.3AX5#(F(WA!.SA5=S K,%53;W)H5&5/>$A)5G!63&1L4#!%:D96<T=P
M83-02DMK3G!9>4-"=E1L9$PQ;4-Y1#=56G!B:VAL1D-14C-'2W5U9%0Q=3,F
M(WA!.TU3>5=L:7)Z>4-+1D1F37)/>#-)6&QB<GE)549I0G912$964U-86#-J
M6DI,0WI-8D%H=V)U5VA"1D0O>#=9<6PR9U<X.7):*W!O*VPF(WA!.V%D1&$S
M2DUG84<Y9&MK,TY*07E7-TM1,U5B+VIH5FM52FU-4VU:5E-5:C0P4FDV9SEW
M1TE1;C=H9U9D:7%795E0,"MU;'DO-&97,R\F(WA!.T%%;50K-TXQ>451<C-)
M6&1U,C%2.#A64U133%!Z.# R;39J<E5/;5-A;&)7=#-B6%,R,#@X8U1'-&YI
M9$=13D1)4GAJ='=$53=K-'$F(WA!.VTY>F9E84EL:DUE;#)S>&5215E,95-$
M:7)':&,Q='5I.6-65G98.'@O=T1,1%HO.4IC=B]!1U19<6]Y,S-M:$HT23$P
M=3%K4U5S2DHF(WA!.U)E4T%29TM30S%B87!Q9'1S5E9V6#AX+SAS3FXO=T)*
M8W8X03)467%P9EA0378Q:C!V,&)A8T](3#%F<FML2S%P>' Y5W)I<7(V+VTF
M(WA!.U O;&AS+SA!<$QL+S=*<U9526(W>D\X.#AB85AA;VM*54I+8GE1:51K
M;UEK05<Q4E%M;2M+;S(Q;#%D<&%89'1B>%)5*S-&3SAR5C@F(WA!.T],47A$
M.&-64F5+=7A6:E!M565:-S8K6%1,1%196'-9+W%..$Y3=4QK>$E:8F4Y5U=3
M,S1*2$TY9E1H0D15<#A8=&EQ2G4Y5SAX,FDF(WA!.U).3EEA97)44WAW>'$R
M;W5N2C5';T%P93%8:V%B,$<U<'-#8U96+W)0;75N+TA/<TLY+SE/;2\W2DU6
M5U(S,VTQ,VM5-E9:2W%%0EHF(WA!.T1F>6-8<4MN:E,Q3&)D4&E!>%8P.3<U
M=6IH6C P;7IM9%)54DIF>4)M.6=8=%98-WII<3@S4&UU;3)N5T9F.$%M3VTO
M-TI-5E5).5<F(WA!.SAY>3-D>&%X-F193DIB2VAL23%">4$P9UEH0V]T4S9T
M>$%B-&Q!;U)1;F5I<G11,5AZ3EDR33DU3' Q:#9D=D<P:D$V9SA92556<'HF
M(WA!.VMT55)A.4MS=TAI8U96+W)8;6]G16%D645(=CEE;2\W2DU65&)&5D,O
M=5AT8D<T=5DT2DQP-$DR:U<R:$%-:VA513A%0DE(23E":7(F(WA!.T103&9L
M=3EU<C5F3UAN1UAN9D%'6%,Y3FU656DP=$I0:$E&82]V;51I2$I*-&UO53=M
M<7%":D9V*UHY-%1D5V$S4&M'>FM,,G-Z=E F(WA!.T)*95A+07!2;T-/371U
M=%,T66M64$=N4G-64E=V96%B:3=U8FYY4C5,=$$K;W=1>'A81CEX.4]W<TE(
M3%)':D%%4$I&=V]):SEX548F(WA!.U125E96=DHS-59E52]5;596;&U91UE7
M,%DK<S9H96Q0:4UC5F0S8FI52T1X565!>%94,')Y=&0V>C5I4&TO>F1A45$O
M5D(O=45S6$PF(WA!.T]B5DDS3'!C3U<T27-H2'AB<'E7<$)B64%&541F83-C
M9FU81DYP2&QX0VYL:4LU83,Q8E=P=6%,35E'4G94=%95;S!I<S%F:D1I:%@F
M(WA!.V-&5%)L6&]':S92<&UJ-F1"<'5L,C!D;EE7=TMW5S!1-&]G2DQ'9SEY
M4V-#;W9&6%EQ-T962S9U66)7,6UU<&E21$%J4WE%07-1<4$F(WA!.W-A2V]*
M3W<V1$970RM8-U!7=D]/<3)V;6I74V)844Q35#9Z-6$P;4YP235'96IX+U=B
M>C=.4U5.56I)*TAK469D5FU'=38Q86%,<$XF(WA!.WIQ;#)S:C(Y<VY.,6AJ
M959Z,C)607AX5FE0:S=Y<C5K=G159S@S*V,U,EA755=28D12-V554%HR85-6
M57-P569%-W@P1&9%4C0Q3DLF(WA!.TMP<C5Z.#AW*U@S=')#,7-R:E9.8S%(
M:W5N5T9T1U@U34YY,&HO6E)&5W)'<#9!-'%G4'DU.&QA;G!!;C$S>D)C4WHK
M84Y557!Q0VDF(WA!.S9M=4Q623!K2FA32DI$46-6,U!7:$Q"9FAX5E<X-2MD
M<G5Z;FLX=F58<DM8569.33A3=&)X8TA&=D-K:#0K=%!-3TE613)R43$K2F,F
M(WA!.U96=GDO=T1*2CAT5U4X.3%D6$8S<D]P*VY.<3 P,7I*8TE:,55J.3,V
M;$YG1'AR4W!!039!04MS<GA6,DMU>%9:3DE9;UI*06I31D8F(WA!.TQ#3DM&
M;6]+.%9Q44MN='9I<D-D13!'*SAY83=A*V(O041$8C-&;6QQ;$Y).'589G!U
M='1-2R\V6E911T5R2358:3,R9F5I:TMQ=FTF(WA!.U1Z9&98;7%3*U4O2VXW
M>EA39V$X=GE0,TYJ17I"6&M,34-J4W%'*T9.>E=M>$A+:7%0,%A39DPS:U11
M8FQR<E5M:718;FMV3#=53E(F(WA!.W5$47IZ='EC.'!7;V]*-DM0>$Y35E=.
M*VAQ;C5J6&1N92MQ8F)Y26IV3EIZ5U8S3$1092MM54U4>6]Q2WEH6FM*56-L
M230Y-FEH5D\F(WA!.U!-+VYX<F956#AT*UAB4U16=DTX:U1S<V-F=S(Y<U%%
M4$LU;DMU:V1&;$15;V8R45(X4S%#<6YL=GDW;VYK9E$U=%$Q2S1I*W5T2$@F
M(WA!.RMM9%E91TU3<W)(9T%P3#A2>6M)5E)U4V4W13%662]B>%0O;6AD,E=P
M6$YK.7(U1G0Q6C1R5SA1<%!Q16I%<GI+07$P55-C458S4$TF(WA!.V5X27=Q
M.4MH:&EG:%-'1D9J:&E52DA';V]Q<6]O04%/9T%W2W9X5C)+;U!6.4@P>E=.
M3VTP-U4W9&)M>6Y!17-,,4%.1%5B9V=J8V0F(WA!.W-65C=7,71B4S)I=&)7
M1DQE,F=54G=W4DM%:E)&1D965E5!2T%/9T=+='A7='1$2DY,1D-K8W1W=V5D
M,%5+,&I"46=:>4XR25913BLF(WA!.S)+=%0R;')C96XY66AJ;3E&>$Q$-FEH
M=45I+UID86<P661I35964T%243=G-'%P5W1R83)K0S(Y<D-K14-6-%)22T52
M86UP;W%G06(F(WA!.VY&5EA&6%EQ-T9867$W1EA9<3=&6%EQ:SEH-54P;7@X
M=S,K=G=I5G12,4-.27!M:VM:,59%3F5+2U0X24HO<W!I<6-9<6MN;#=Y9F\F
M(WA!.S)G,VUQ6'1J-GHS5W)Z3$YE5%A%>GI-94%+>&]V36UI;T-A9"]%;D95
M-WA6,DMU>%8R2W5X5C)+<&1O=FPS43E%:G5).4IS;W)*8G4F(WA!.UIR;35%
M4S U>75A<S=(=6-64FPS6C)L-6)V8C-C161X8GE#:VM-<7$V35!D5T)">%9F
M1D9&1D5K55-,2$9';U=/3E%&5E9554%!1W<F(WA!.T%'2W)%<S=33S5L=6\T
M23!U6G=Q>E1Q<6E2,6IR=T1-0E9G=DDP<C!X5C$Q83)T,V)Y5S$Q0VQX8GEJ
M:DQ$2V]D1U4Y;59G45)I<7$F(WA!.T%&04%&04YG0C!P:7)S5F1I<G-69&ER
M<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-64S=5
M5CAW+U=9,S F(WA!.S$W5#9S17!,1&-,24A,;5)0:5=21V]!275F=SA.,G!U
M0EA&5TM88VXU,7DR>E!A439(8E1.1T]%8VI816A2*U(K,5%C5#A.3SE09D8F
M(WA!.U5F<45V-7%R2$PY46<P6C509T50<E!C:G%Z0GE30BMY=D5J8F,K1TMR
M2350>EAA-#E'5U!2-%E:26TT,U-I95@P<&=Q;&554F5)=6@F(WA!.U!)8DU$
M,#(W-'%I*V8U:E)Y,CA*5%-R;$1',S%I-DAR=V=30TE5<$=42U%';$HO85!W
M:G)81E5.02\U<&EE5#%O.4IA34Q*-EA&<&<F(WA!.T,T95EX.'1Q:%-V;W%E
M=%!I4'1H5E)N;2]/3&Q#64QB46=V1E=N1%-85E,S1F53:F)B-&DQ1'9S4&99
M2W9J6#@R<FEY5&Q.;W5N,W,F(WA!.V)U<W9+0S5U-'!5;VAJ94UR4&)S:')Z
M-4)G93%017%P:$Q,-2LK=5-2>%%A6CE70T5X6$1V4%5U6FE&0E5#=CEY2W0O
M;$A9:UEQ:SDF(WA!.VLO-7I$5DEZ95(V261,.45#4E5A-#EF,2]Q-7%A+UHY
M4#9X43E+.&%J=T]+;VUA6#@R=G)%0W=W84HY6$Q0.$%72%HW;FU&1%54:70F
M(WA!.TM62V9%9"MU,W9I<61E5S503DPR,"\X06E/2S!I=5),4S,K<$Y)>4Y&
M=U4Q8U-B<3--<TM!;EE$1E@O+S)1/3T\+WAM<$=);6<Z:6UA9V4^"B @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @
M(" @(" @(#PO>&UP.E1H=6UB;F%I;',^"B @(" @(#PO<F1F.D1E<V-R:7!T
M:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @
M(" @(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B"B @(" @(" @
M(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M<U1Y<&4O4F5S;W5R8V5%=F5N=",B/@H@(" @(" @(" \>&UP34TZ26YS=&%N
M8V5)1#YX;7 N:6ED.C!!-#DW0C$W-$0X0T5!,3$X0T5$1C8R-#@Q,C P,3A$
M/"]X;7!-33I);G-T86YC94E$/@H@(" @(" @(" \>&UP34TZ1&]C=6UE;G1)
M1#YX;7 N9&ED.C!!-#DW0C$W-$0X0T5!,3$X0T5$1C8R-#@Q,C P,3A$/"]X
M;7!-33I$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U
M;65N=$E$/G5U:60Z-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@\
M+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.E)E
M;F1I=&EO;D-L87-S/F1E9F%U;'0\+WAM<$U-.E)E;F1I=&EO;D-L87-S/@H@
M(" @(" @(" \>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" \<W12968Z:6YS=&%N8V5)1#YU=6ED.C,S
M,#(V8V1B+6$P.68M-#@R.2TX8F4T+3AB,S$U-C5B-V-C,#PO<W12968Z:6YS
M=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M96YT240^>&UP+F1I
M9#I!03-"1#8Q1C0W.$-%03$Q.$-%1$8V,C0X,3(P,#$X1#PO<W12968Z9&]C
M=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)
M1#YU=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X/"]S=%)E
M9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIR96YD
M:71I;VY#;&%S<SYD969A=6QT/"]S=%)E9CIR96YD:71I;VY#;&%S<SX*(" @
M(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @(" @(" @/'AM<$U-.DAI
M<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D$Y,T)$
M-C%&-#<X0T5!,3$X0T5$1C8R-#@Q,C P,3A$/"]S=$5V=#II;G-T86YC94E$
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 U+3 R5#$S
M.C0U.C(Q*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#4S8@*%=I
M;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA
M8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HP030Y-T(Q-S1$.$-%03$Q.$-%
M1$8V,C0X,3(P,#$X1#PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @
M(" @(" @/'-T179T.G=H96X^,C R,"TP-2TP,E0Q-#HT-CHQ-2LP-3HS,#PO
M<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E
M06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO<W1%=G0Z
M<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG
M960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T
M;W)Y/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C
M<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z:6QL=7-T
M<F%T;W(](FAT=' Z+R]N<RYA9&]B92YC;VTO:6QL=7-T<F%T;W(O,2XP+R(^
M"B @(" @(" @(#QI;&QU<W1R871O<CI3=&%R='5P4')O9FEL93Y0<FEN=#PO
M:6QL=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4^"B @(" @(#PO<F1F.D1E<V-R
M:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@
M(" @(" @(" @("!X;6QN<SIX;7!44&<](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]T+W!G+R(*(" @(" @(" @(" @>&UL;G,Z<W1$:6T](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]$:6UE;G-I;VYS(R(*(" @
M(" @(" @(" @>&UL;G,Z<W1&;G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P
M+S$N,"]S5'EP92]&;VYT(R(*(" @(" @(" @(" @>&UL;G,Z>&UP1STB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O(CX*(" @(" @(" @/'AM<%10
M9SI(87-6:7-I8FQE3W9E<G!R:6YT/E1R=64\+WAM<%109SI(87-6:7-I8FQE
M3W9E<G!R:6YT/@H@(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A
M<F5N8WD^1F%L<V4\+WAM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y/@H@
M(" @(" @(" \>&UP5%!G.DY086=E<SXQ/"]X;7!44&<Z3E!A9V5S/@H@(" @
M(" @(" \>&UP5%!G.DUA>%!A9V53:7IE(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @/'-T1&EM.G<^-C$R+C P,# P,#PO<W1$:6TZ
M=SX*(" @(" @(" @(" @/'-T1&EM.F@^-SDR+C P,# P,#PO<W1$:6TZ:#X*
M(" @(" @(" @(" @/'-T1&EM.G5N:70^4&]I;G1S/"]S=$1I;3IU;FET/@H@
M(" @(" @(" \+WAM<%109SI-87A086=E4VEZ93X*(" @(" @(" @/'AM<%10
M9SI&;VYT<SX*(" @(" @(" @(" @/')D9CI"86<^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z9F]N=$YA;64^0V%L:6)R:3PO<W1&;G0Z9F]N=$YA
M;64^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%M:6QY/D-A;&EB
M<FD\+W-T1FYT.F9O;G1&86UI;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N
M=#IF;VYT1F%C93Y296=U;&%R/"]S=$9N=#IF;VYT1F%C93X*(" @(" @(" @
M(" @(" @(" @/'-T1FYT.F9O;G14>7!E/D]P96X@5'EP93PO<W1&;G0Z9F]N
M=%1Y<&4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IV97)S:6]N4W1R:6YG
M/E9E<G-I;VX@-BXR,3PO<W1&;G0Z=F5R<VEO;E-T<FEN9SX*(" @(" @(" @
M(" @(" @(" @/'-T1FYT.F-O;7!O<VET93Y&86QS93PO<W1&;G0Z8V]M<&]S
M:71E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9I;&5.86UE/F-A
M;&EB<FDN='1F/"]S=$9N=#IF;VYT1FEL94YA;64^"B @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1.
M86UE/D-A;&EB<FDM0F]L9#PO<W1&;G0Z9F]N=$YA;64^"B @(" @(" @(" @
M(" @(" @(#QS=$9N=#IF;VYT1F%M:6QY/D-A;&EB<FD\+W-T1FYT.F9O;G1&
M86UI;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%C93Y";VQD
M/"]S=$9N=#IF;VYT1F%C93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O
M;G14>7!E/D]P96X@5'EP93PO<W1&;G0Z9F]N=%1Y<&4^"B @(" @(" @(" @
M(" @(" @(#QS=$9N=#IV97)S:6]N4W1R:6YG/E9E<G-I;VX@-BXR,3PO<W1&
M;G0Z=F5R<VEO;E-T<FEN9SX*(" @(" @(" @(" @(" @(" @/'-T1FYT.F-O
M;7!O<VET93Y&86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@(" @(" @(" @(" @
M(" @(" \<W1&;G0Z9F]N=$9I;&5.86UE/F-A;&EB<FEB+G1T9CPO<W1&;G0Z
M9F]N=$9I;&5.86UE/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @
M(" @(" @/"]R9&8Z0F%G/@H@(" @(" @(" \+WAM<%109SI&;VYT<SX*(" @
M(" @(" @/'AM<%109SI0;&%T94YA;65S/@H@(" @(" @(" @(" \<F1F.E-E
M<3X*(" @(" @(" @(" @(" @/')D9CIL:3Y#>6%N/"]R9&8Z;&D^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D^36%G96YT83PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" \<F1F.FQI/EEE;&QO=SPO<F1F.FQI/@H@(" @(" @(" @(" @(" \
M<F1F.FQI/D)L86-K/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*
M(" @(" @(" @/"]X;7!44&<Z4&QA=&5.86UE<SX*(" @(" @(" @/'AM<%10
M9SI3=V%T8VA'<F]U<',^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!.86UE/D1E9F%U;'0@4W=A=&-H
M($=R;W5P/"]X;7!'.F=R;W5P3F%M93X*(" @(" @(" @(" @(" @(" @/'AM
M<$<Z9W)O=7!4>7!E/C \+WAM<$<Z9W)O=7!4>7!E/@H@(" @(" @(" @(" @
M(" @(" \>&UP1SI#;VQO<F%N=',^"B @(" @(" @(" @(" @(" @(" @(#QR
M9&8Z4V5Q/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z<W=A=&-H3F%M93Y7:&ET93PO>&UP1SIS=V%T8VA.86UE/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM
M<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP
M93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP
M1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY
M96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*
M(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE
M/D)L86-K/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P
M,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP
M1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L
M86-K/C$P,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#35E+(%)E9#PO>&UP1SIS
M=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM
M;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA
M;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ
M,# N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.GEE;&QO=SXQ,# N,# P,# P/"]X;7!'.GEE;&QO=SX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P
M,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z<W=A=&-H3F%M93Y#35E+(%EE;&QO=SPO>&UP1SIS=V%T8VA.86UE
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\
M+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO
M>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L
M86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @
M(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C
M:$YA;64^0TU92R!'<F5E;CPO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3
M/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F-Y86X^,3 P+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N
M=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ
M,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @
M(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#35E+
M($-Y86X\+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C$P,"XP
M,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM
M<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB
M;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D--64L@0FQU93PO>&UP1SIS
M=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM
M;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,3 P+C P,# P,#PO>&UP1SIC
M>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A
M/C$P,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P
M,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z<W=A=&-H3F%M93Y#35E+($UA9V5N=&$\+WAM<$<Z<W=A=&-H3F%M
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+
M/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 P+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB
M;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T
M8VA.86UE/D,],34@33TQ,# @63TY,"!+/3$P/"]X;7!'.G-W871C:$YA;64^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO
M>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT
M>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8WEA;CXQ-"XY.3DY.3@\+WAM<$<Z8WEA;CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,# N,# P,# P
M/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.GEE;&QO=SXY,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXQ,"XP,# P,#(\+WAM<$<Z
M8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A
M=&-H3F%M93Y#/3 @33TY,"!9/3@U($L],#PO>&UP1SIS=V%T8VA.86UE/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM
M<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP
M93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XY,"XP,# P,# \+WAM
M<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M>65L;&]W/C@U+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA
M;64^0STP($T].# @63TY-2!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO
M9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/
M0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^.# N,# P,# P/"]X;7!'.FUA
M9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO
M=SXY-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @
M(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]
M,"!-/34P(%D],3 P($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3
M/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6%G96YT83XU,"XP,# P,# \+WAM<$<Z;6%G96YT
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P
M,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @
M(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-
M/3,U(%D].#4@2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM
M<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA
M;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM86=E;G1A/C,U+C P,# P-#PO>&UP1SIM86=E;G1A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^.#4N,# P
M,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/34@33TP(%D]
M.3 @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXU+C P
M,# P,3PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXY,"XP,# P,# \+WAM
M<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB
M;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],C @33TP(%D],3 P($L]
M,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,3DN.3DY.3DX
M/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \+WAM<$<Z
M>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C
M:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-3 @33TP(%D],3 P($L],#PO
M>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^-3 N,# P,# P/"]X
M;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA
M9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \+WAM<$<Z>65L
M;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP
M+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-S4@33TP(%D],3 P($L],#PO>&UP
M1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^-S4N,# P,# P/"]X;7!'
M.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N
M=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \+WAM<$<Z>65L;&]W
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P
M,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIS=V%T8VA.86UE/D,].#4@33TQ,"!9/3$P,"!+/3$P/"]X;7!'
M.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXX-2XP,# P,# \+WAM<$<Z
M8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT
M83XQ,"XP,# P,#(\+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \+WAM<$<Z>65L;&]W
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXQ,"XP
M,# P,#(\+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3DP($T],S @63TY-2!+/3,P/"]X;7!'
M.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXY,"XP,# P,# \+WAM<$<Z
M8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT
M83XS,"XP,# P,#(\+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z>65L;&]W/CDU+C P,# P,#PO>&UP1SIY96QL;W<^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C,P+C P
M,# P,CPO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIS=V%T8VA.86UE/D,]-S4@33TP(%D]-S4@2STP/"]X;7!'.G-W
M871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO
M9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXW-2XP,# P,# \+WAM<$<Z8WEA
M;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP
M+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIY96QL;W<^-S4N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \
M+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z<W=A=&-H3F%M93Y#/3@P($T],3 @63TT-2!+/3 \+WAM<$<Z<W=A=&-H
M3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#
M35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIC>6%N/C@P+C P,# P,#PO>&UP1SIC>6%N/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P+C P
M,# P,CPO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIY96QL;W<^-#4N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM
M<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M<W=A=&-H3F%M93Y#/3<P($T],34@63TP($L],#PO>&UP1SIS=V%T8VA.86UE
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\
M+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F-Y86X^-S N,# P,# P/"]X;7!'.F-Y86X^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,30N.3DY.3DX
M/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L
M86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @
M(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C
M:$YA;64^0STX-2!-/34P(%D],"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'
M.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^
M4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIC>6%N/C@U+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C4P+C P,# P,#PO>&UP
M1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY
M96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*
M(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE
M/D,],3 P($T].34@63TU($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#
M15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F-Y86X^,3 P+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/CDU+C P,# P,#PO>&UP1SIM
M86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL
M;W<^-2XP,# P,#$\+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @
M(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]
M,3 P($T],3 P(%D],C4@2STR-3PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#
M15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F-Y86X^,3 P+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P,"XP,# P,# \+WAM<$<Z
M;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L
M;&]W/C(U+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F)L86-K/C(U+C P,# P,#PO>&UP1SIB;&%C:SX*
M(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE
M/D,]-S4@33TQ,# @63TP($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#
M15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F-Y86X^-S4N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 P+C P,# P,#PO>&UP1SIM
M86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL
M;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @
M(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]
M-3 @33TQ,# @63TP($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3
M/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F-Y86X^-3 N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 P+C P,# P,#PO>&UP1SIM86=E
M;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^
M,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @
M(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],S4@
M33TQ,# @63TS-2!+/3$P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\
M+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8WEA;CXS-2XP,# P,#0\+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,# N,# P,# P/"]X;7!'.FUA9V5N
M=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXS
M-2XP,# P,#0\+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIB;&%C:SXQ,"XP,# P,#(\+WAM<$<Z8FQA8VL^"B @(" @
M(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3$P
M($T],3 P(%D]-3 @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\
M+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8WEA;CXQ,"XP,# P,#(\+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6%G96YT83XQ,# N,# P,# P/"]X;7!'.FUA9V5N
M=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXU
M,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @
M(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-
M/3DU(%D],C @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM
M<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA
M;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM86=E;G1A/CDU+C P,# P,#PO>&UP1SIM86=E;G1A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,3DN.3DY
M.3DX/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3(U($T],C4@
M63TT,"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT
M>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C(U
M+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM86=E;G1A/C(U+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,SDN.3DY.3DV
M/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/30P($T]-#4@63TU
M,"!+/34\+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C,Y+CDY
M.3DY-CPO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/C0U+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^-3 N,# P,# P/"]X
M;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8FQA8VL^-2XP,# P,#$\+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/34P($T]-3 @63TV,"!+
M/3(U/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXU,"XP,# P
M,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6%G96YT83XU,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C8P+C P,# P-#PO>&UP
M1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L
M86-K/C(U+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-34@33TV,"!9/38U($L]
M-# \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C4U+C P,# P
M,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIM86=E;G1A/C8P+C P,# P-#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^-C4N,# P,# P/"]X;7!'
M.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA
M8VL^,SDN.3DY.3DV/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STR-2!-/30P(%D]-C4@2STP
M/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXR-2XP,# P,# \
M+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6%G96YT83XS.2XY.3DY.38\+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C8U+C P,# P,#PO>&UP1SIY
M96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K
M/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G-W871C:$YA;64^0STS,"!-/34P(%D]-S4@2STQ,#PO
M>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,S N,# P,# R/"]X
M;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA
M9V5N=&$^-3 N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXW-2XP,# P,# \+WAM<$<Z>65L
M;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXQ
M,"XP,# P,#(\+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3,U($T]-C @63TX,"!+/3(U/"]X
M;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXS-2XP,# P,#0\+WAM
M<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G
M96YT83XV,"XP,# P,#0\+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C@P+C P,# P,#PO>&UP1SIY96QL
M;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C(U
M+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-# @33TV-2!9/3DP($L],S4\+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C,Y+CDY.3DY-CPO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/C8U+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIY96QL;W<^.3 N,# P,# P/"]X;7!'.GEE;&QO
M=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,S4N
M,# P,# T/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G-W871C:$YA;64^0STT,"!-/3<P(%D],3 P($L]-3 \+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C,Y+CDY.3DY-CPO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/C<P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL
M;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C4P
M+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-3 @33TW,"!9/3@P($L]-S \+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C4P+C P,# P,#PO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/C<P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIY96QL;W<^.# N,# P,# P/"]X;7!'.GEE;&QO
M=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^-S N
M,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @
M(" @(" @(" @(" @(" \+WAM<$<Z0V]L;W)A;G1S/@H@(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P
M3F%M93Y'<F%Y<SPO>&UP1SIG<F]U<$YA;64^"B @(" @(" @(" @(" @(" @
M(#QX;7!'.F=R;W5P5'EP93XQ/"]X;7!'.F=R;W5P5'EP93X*(" @(" @(" @
M(" @(" @(" @/'AM<$<Z0V]L;W)A;G1S/@H@(" @(" @(" @(" @(" @(" @
M(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP($T],"!9/3 @2STQ,# \+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'
M.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N
M=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,3 P+C P
M,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @63TP($L].3 \+WAM<$<Z<W=A
M=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D
M93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP
M,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^.#DN.3DY-# U/"]X
M;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G-W871C:$YA;64^0STP($T],"!9/3 @2STX,#PO>&UP1SIS=V%T8VA.86UE
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\
M+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO
M>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXW.2XY.3@W.34\+WAM<$<Z8FQA
M8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H
M3F%M93Y#/3 @33TP(%D],"!+/3<P/"]X;7!'.G-W871C:$YA;64^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM
M;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!2
M3T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA
M9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO
M=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F)L86-K/C8Y+CDY.3<P,CPO>&UP1SIB;&%C:SX*(" @
M(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]
M,"!-/3 @63TP($L]-C \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO
M>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC
M>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P
M,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8FQA8VL^-3DN.3DY,3 T/"]X;7!'.F)L86-K/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP($T],"!9
M/3 @2STU,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y
M<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP
M,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM
M<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB
M;&%C:SXU,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TP(%D],"!+/30P
M/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO
M>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM
M86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL
M;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C,Y
M+CDY.30P,3PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @63TP($L],S \+WAM<$<Z
M<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y
M86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^
M,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,CDN.3DX.# R
M/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G-W871C:$YA;64^0STP($T],"!9/3 @2STR,#PO>&UP1SIS=V%T8VA.
M86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--
M64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXQ.2XY.3DW,#$\+WAM<$<Z
M8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A
M=&-H3F%M93Y#/3 @33TP(%D],"!+/3$P/"]X;7!'.G-W871C:$YA;64^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP
M1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E
M/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'
M.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE
M;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F)L86-K/CDN.3DY,3 S/"]X;7!'.F)L86-K/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^
M0STP($T],"!9/3 @2STU/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\
M+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P
M,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F)L86-K/C0N.3DX.# S/"]X;7!'.F)L86-K/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @
M/"]R9&8Z4V5Q/@H@(" @(" @(" @(" @(" @(" \+WAM<$<Z0V]L;W)A;G1S
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QX;7!'.F=R;W5P3F%M93Y"<FEG:'1S/"]X;7!'.F=R;W5P3F%M93X*
M(" @(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!4>7!E/C$\+WAM<$<Z9W)O
M=7!4>7!E/@H@(" @(" @(" @(" @(" @(" \>&UP1SI#;VQO<F%N=',^"B @
M(" @(" @(" @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @
M33TQ,# @63TQ,# @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\
M+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM86=E;G1A/C$P,"XP,# P,# \+WAM<$<Z;6%G96YT
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P
M,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @
M(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-
M/3<U(%D],3 P($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X
M;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y
M86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6%G96YT83XW-2XP,# P,# \+WAM<$<Z;6%G96YT83X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP
M,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3$P
M(%D].34@2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP
M+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM86=E;G1A/C$P+C P,# P,CPO>&UP1SIM86=E;G1A/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^.34N,# P,# P
M/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3@U($T],3 @63TQ
M,# @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXX-2XP
M,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z;6%G96YT83XQ,"XP,# P,#(\+WAM<$<Z;6%G96YT83X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \
M+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],3 P($T].3 @63TP
M($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,3 P+C P
M,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/CDP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM
M<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB
M;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-C @33TY,"!9/3 @2STP
M/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXV,"XP,# P,#0\
M+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6%G96YT83XY,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# S,#DY/"]X;7!'.GEE
M;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^
M,"XP,#,P.3D\+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" \+W)D9CI397$^"B @
M(" @(" @(" @(" @(" @(#PO>&UP1SI#;VQO<F%N=',^"B @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @
M(#PO>&UP5%!G.E-W871C:$=R;W5P<SX*(" @(" @/"]R9&8Z1&5S8W)I<'1I
M;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @
M(" @(" @('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS
M+R(^"B @(" @(" @(#QP9&8Z4')O9'5C97(^061O8F4@4$1&(&QI8G)A<GD@
M,3 N,#$\+W!D9CI0<F]D=6-E<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^
M"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,  0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( ,@"5@,!$0 "$0$#
M$0'_Q  ?  $  @,! 0$! 0$         " D&!PH%! ," 0O_Q !=$  !! ("
M  ,% @00" D)"0 % P0&!P$"  @)$1,2%!46(1=X&#$XMPHB)R@W.4%76'>7
MF+:XU-@C)"9'<8&5UQDS4556=';5UB4V86=YD9:SM3(T-519:*BTT__$ !T!
M 0$  04! 0             ! @0%!@<( PG_Q !M$0 " 0(#! 0' Q0+"0L-
M     0(#$00A,04205$&87&1$X&AL<'1\ <4(@@5%C(U0E)35%5S=)*4E;/2
MT]3A%R,T-E9UD[*TM?$E,S=%<G:6U=880T1B@H.$EZ*DPB9&5V-D96:%HZ7%
MXN7_V@ , P$  A$#$0 _ ._C@#@#@#@#@$!O$9.=J8_1<>?=2'AE&:ZVO$%+
M#'P1W4#:Z#=(L!\B*V4-H+2^@\@J5[;:;$>Q*B6$Q#/VKJ.C9/H-2T-_#%TA
ME&U\[>.]K\+VSMV%+3;QBI_7-W1:^S=QRFS_  Z@O4OK8^FZ,NJNNHC9:UGW
MO7G:23Q:UI#M#XL,>B91(K!ZU#:A*Q"/$OLU2D=G,EXN#RW3&.MADH7O&WP[
MNUGE96RY6LV[M\#&M_$7[[1[IQ.(%9U]BX1WCG?>X_1L4GK.EXC(&M%06&]:
MZ=[(V,%0KL%7QL=+!$+.29U2R,CDT4D<AW5L$(8*OO?&C=^.#=C=;JNMUNS>
MMI.*>JST;\>5LC>BG?>_>SV8!9-5=M%.J<%0\*-?N-*!BU<TC*(?CL%$K3D5
M=V!$['=6G!#LL;1*.2..FHB8%0Z7P@MHL'W7:$&K_97U9Q\2\M_4-U*Z:O\
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M <;6U6S2+3RVEWI0H\"#=HU54;^!X$Z2*2,GCQH0+")*3^A3:2XV;[7=+O\
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M33CKVY;D\/\ [D3CMI:W9"QW+@R K\WU%\/:\JYJXD2:FV%8F;SK2[9=-6#
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M[QN<F\MZ^7T-F[9YY/MZM#QIQXU,O@%41Z;FJ*KIS.HK,+CB]^U7'[&NF6G
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MRH7UDI=G(ZGC;J(5Z92@8++^-QIXY./G(ANONUWV>-E"$GDQ/&27OJJ9622
MHDIH_-$W+H+OF\SYZYZ$=+:APWQ5_6&EX'EI(X++T-XQ!@PE7$IK A)R==']
MUFK?158K!W<SD_RL]6W46"-2RS ?L@P2;-D <I/5M^-]7J5^9\5CT%TDKV$-
M4[*J&GQ$&*MSM",!Y:%LB(XDV[9V['59)6S(0@P?+/4KDN4M'")88W:*X(R9
M9N7<Y1]W5=H@F^#?/7DGYE<U?6%(>%T^CX.(5# >I1N,2.;69#PL>A#2!2 /
M()_(:10B5NAOAXM1^U+R.0T&*:LY[J[3<O#<#W;$#>[MD52>/!6Y<7+QWY^O
MRGR!:+\,H>>6ZRM:@I"-R$1;\#G+"MI- G$1?R"Z!T!F)."S>$*RT4)WL:4H
M5O7=@[(2J$OY+MO&HE,V1$ANT&G6^@7EF[O--/LT:?)9K7FK&0GNN?AHRBM(
M=<\EK+JF8IZFVTL/Q2SS+2 K5Q#!7S\2F,S<*RUVM\M:QY"S42LD-,R[Y<&S
MF:+LHNW1,)*+:B7DKK-7R:SSY>3+L=M&9/5)OP_K",5_8E,2;K5,CL@N2WI/
M6LG@<GA!PF6OB204FK=SV-.1!%PY=6._KG)5W/FK7&YM.*9</BK=(;_AN ]Y
M9.^BR=].'BY&#ZD?"VE'9VNK6UDO3,UVSL02"D%62?$NJMU;<\8KL3\,B\IA
MB'Q;8Q*B.XD-)HA')0*:OS& PDS'11' Y@\9(BVE9Y2MQR=N>?G[GR)% JRZ
MQEH82ZRQN*U62A%0F8*Y-4P)2"/!E>'6)L/<=>;F(FV44VCS_0XU!V%&M7[9
MLJLX28'&>JB>4ULB9ZYYWSY\'GV9,UY)^O/1VP[&N.K933M+2*S[5%5E=MT@
M'<-%_,TP:1LI)(C4]F21^DQ2<.2P M'I0)BLB2?:'1+AH1RV<-_>-E%PN\GG
MEIR7&WZC\+&Z_=%H$)JU.SJBI4*(%BY'ULJK,AB(UPDS#WP/(!)=6 951FY4
MT868/W+,I$T<;^B:2=E,DE]]B#W=P%WGF^;UX:-]GD-G1FL>M-J=:8G5T;@5
M83?JK*ZQBPF(0'6-B"U5F*LW$CG,09#XX\9J"U 20Q(6[$:;-,;M=T&CM'TG
M:":N@7:=[N]]>-^W6Y'0[TA\-,0^IN@I%UCZ\-W:ZEDR^GX02K44LD26%9B#
MZT5&[Q8:JU,*O458<^D8 ^0=[R4<%9.U!A0?$EE! ;TLW=YY-W?G[_+UDBRO
M5#K2<(&RAJBZP+OI*;G,DD*Q.("'^ILY9M;#:=L,B50=-E6[Y>:56(&5_),.
M4E$RL59(!W::C33T\A=\WEDL^&MN_,A#?G@W]/[BCT)CD-BPNB!T,/RB1JCH
M#7M32:/2TQ*X*WKI:0R^,6M YZ&,3.,1EJ@E IMLW2D41>:J.&CMQHILAP53
M:OQOUO+.^5FK7>;),0CH%U+A*\(-8IV+RV>PBL8M4^EJSEBVD=F2V.1&NTZI
M'$I_*%D$%)C+'$#PM'7\I+-E2Z@MX['-UVHU75GH(VW?/5MVX9YF]8)2%0U@
M11+UY7,2AI-O7, J)!]'P[4<Y2K"JM#*=<05-5#37;6-0M.1'-(\,QGT!VI1
MWJCKC"N<8$N^?7XWJ_&;3X X X X X X X X X X!&$KTGZ>'4JM0,]6NOQ5
M"D$=6U/($*B@CM"LFJ9-,VFSA"*X/=*.,4CB*!Q)D,T;M4C3=N731U(MT7.@
MMWGF\]<]>WGJ^\_J7]*NG\_-S&2SGJ]04OD%AR2*S&>&I)4\(,E)E*X.++@X
ME(Y,]?A5W!HR !GSP0<1(*.'2(8X8%>ILP)OFZX7?-Y9+-Y+D;#AE.TA3# J
M\@-:5K6 W,-B<2-N8M%8Y$F68#6 LHPA,>)K#63%',6@88J9:1P:ZV^&1X<0
M(HL$FK=RXUW$N^9&9A+_  [K1ZSLJRPCU_-=6-HMU_&(53(X@%$5R)C%XOXR
MMUN$/:RDP0:A&TYT6+1->N!1&/C7FY1T'7'-F[W5#?1[>HOPDWK=-YWSNM<^
M?,VUIT_ZAA(NO'4.L]!"X<UBDRBJP!G4D&:1]"%S8X#E\[CF [4%HQUCTID<
M5CLBD0=-M[B6+@!!%XW7=CFBB07?-][Z_6^]GUP&#=7;FB\-O6"5[5<QCMH%
MP?9>(3U.!"-7$GD\SJYK"PMOZ*E S4OK+S-0OVL0^8""#>18AR^(X[W28XW9
M:A=K*[7"V>E[M=^=N9\T$Z9=1JO%.@5<=8Z%@@9[.XC9[L7$JHA !BO8=?E4
MS<"F>[88$;)9D<&+I)D8:4QKAU%G>N%@6[#;SSP+OF^*U>CU7CXGRRKI)TYG
M+D>\F?5CK[*W0HM-#PY>0U%!"ZC0U8TE5F<\*H[/@:^<$)=,5UI9('>?-<G)
ME-CSG=0KGWO@7?-][X*R[EEV'G=@.EM%]AZ"L[K8?CJ,)K.Y9J/GUG,ZY$1,
M"]F,AQ9,?M"4OC&Q"-F1[DE8)^/Z(S.0[CLR=ZW(D'PXV+/^Y&68*3336JR6
MO*W/K/KF\GZF7T3F'4RR!U>6NHUD*4#F=-S:"9E<:TD(FNH9=3,.3&G8^[BN
MZXZ 3.%S,8ZPMLBUR18Z#W6AMDNU:!FLU=973TRO:_?D?DET5Z5M]JKW0ZF=
M<D-J.3RE3V4:9KY+[-$\GW$L]B&8T :X :XECMU+=<,,(^S*W+B2Z^1Q=5_N
M%V[W;=]<WGVGFQBFNDUWC[+5 TM2$T9ZR^]ZCM1$A4P%)PXEDCL9C(K]C,H9
M'HVS>OMIO9$<"S>3O'""XZ>$V4;GS9\;;+@SBX7:XO@]>2R?B6G(BUV*\&;I
MCV#UBC%"-;TG&(O%9]#ODFFH#03&(O1]FD(<1F,B&B; IBPLU]:1#>!QIFWN
M:J5X';# >SPW:3%/=)@NQ%4VG?5]=_0U==3NNK4F*MTJZB.Y++IJ1ZTTB7FE
M@Q$I!)_,3=:Q,S*IW$SP!&*R$/,Y"3%NBTH1DD:01 218V[?.I '23'&%WK3
M35+ EWEF\M,]+:6-UQNNH##C,GD43A45C)^:_+WS@: @1@DI*/E(&VC$6^/O
MF+9!R6Q'(XS: 0>'RB^!8AL@.9>BT2T2P(9EP!P!P!P#"Y78L'@SZ+#9=)Q,
M??38ZTC46;$7'HJ&3;]RU8,F+;&-=L:;.R9 6(;KN,HM531D(%T7V*FQ3-X!
M@83LI0LA.'(V+M:';G8P#D4ED@QZ3U$N8^ B4DVB,D+&\%M&.@MB'D&-&#Q=
M]NAKIJX9O=?:8/F;I<6SY,W$,)C30T>9#$&)8069-20LJ,=MWXTD.?(:.63\
M>^:J*M7C)XV52<-73951!P@IHJDINGOKMD0^[@#@#@$)+;KJ:N^]G32Y!8 B
M>@<7J?MU44O>M$]%FT).VEI0T\A\I):9WU4;#GZ-&2:&[D,)J:IEI*"'YV2^
M*9PJ,E;=:XW37BNFO+?Q%<>OAH=O:SJ6AFM)6+4^UQP+IO->I,K(O+1M6HV\
M1<G+2!VU&;9IVTX55\VE:+\;( 309.(.9@@<?9$:29!G<D (LMMW8KDFW>]F
MT^'!6=\R4=!=!KE@$W[.6-+^TMG1*=WJZH_<5*Z9D@ DDP<5WUGZWU'-9H:K
MRZ*KGE4N[ E,SIZ7:-31>%S#T*^DK/W=0-)=M,@A+_*Y7W5;/CFWPL^/,^OK
M;UNN:/\ 9B2V]*&B 2-QJ;=F8XVE!V>R8O-K8B-E2N('AZJU1)P:/5+730I)
M(PRF)6?P0QN>F'R]&@3T(RCR#-B"!M>;*W%*VNK]O'$ EX>?<R'H3DU I)"X
M%6<6MC6\ZSZP5M=]N64):RAE6?:AE/3%6&K!A59O*F(7!-[>KHBQH4=)%JNB
M!N/'9$,LL<X?-D-!4UQS;33;79:]GG:SSU\EHA=;O"VO6ZZ'.QR=UOK4!P='
M.PHMP4L:52R*MK"MFRNJ=)U[3M@Q^#1BH*R,Q0'3-I09Z>D:TFCQAX6M#627
M/#C<U+R1-RR>WM^OB'*SYKDM+;U[:\LK99.W#.4MC^%EW'LNS[OF!FRZ+:#K
M)IN5U>D]'2"2,W\V6)2CK1)8:4LP:SH]I(B!6&;5%8+920R>U[62<JS >M!8
MK5HYW)@ST-Y))6=TT[OJOEKE>ZO;EQ,M+^%+?)R3DIF2LR".90"GY>>U,8Q.
M+007A!<KXHMB=P52R*+:.I-4#/X-LVVJ/5UHB^W;&WI^'M5TX*0<GGX;RM:V
MJL].$%%>7/\ M(<]8.J7:9^M(6$_ZWV1&[#GW;[HI8,BN.0OFC9L#CM(=K9[
MV.L1L2#O(3'2;J4"XM%M!DCMMK/[J 6&YG580IE/RCB*;>\BMQYW24DE;BXI
M+-N]KODK6;M>YU<\'S' ' ' ' ' ' ' ' ' ' ' ' ' ' ' (/=YH%,YB$ZR
M'H?'B\M1JGNKULLJ91T$S5)$W,(:RQS#S9Q,<AKNL\:0%:9,+)+:HIJK-0\.
M?D$$E%F>FN15QSM=/UV\=K>//(AG57AX7K0O9>%6[09NOJQJ]U,Y6#G-7O)/
M()_M'*/$+T=#X0'BQBQH?.I"Y/SBJ*?5'2]E$I=4XZ'+#J$@S!Y,X31C/<Z+
M=-6??UYZY^OB]6;^[-^'ZPN&V:&GM>226UK@1V>+7Q?<IC=OV7'IZ42UZMW-
M1@%S63GWF0C8R<]_F<*!F6(1.'C'M?#'C!==W\*$"U 3LI+G&R^Z3]#\=B-C
M'PU>R(KHU7?7Y"]Q)Z557(*YG(BF97D(]Z^S>651V^$=E!GSO8B%3[7@OI/(
MZ!2A$G5<+G(X+>F71Q.#G%QK;+@7>6\VUDTUUYQMV9:GF*>&UV$M[LR*[.6O
M)XW1KZ7=DR=N3V%]<[FG>LB@T0!],276J&ZQ*U\5K GLIGLMDN[,K8RZD8AX
MIO#%$H^Q?2)49E8B)?*V=MVRX?/*3RN\OU/J/%ZF>$)-('+*J)]AK)^(0^HJ
M8Z6C!T!K&3-'0">WAU0N7L?; "36*0D]5LYNXCD-+6?"3<-1A\TB*4F.:RAK
M88 R)8 T%!7)6R7STGGP4DE99OD]>IK,W=<_5_N4[LGONXJ*,]>3$'[;8HPQ
M&Y1.KBL2-RF.NJM@%?P6514M7P"ECH=ZG*1T=D>@*0+6.Z#,';P/M*X-*@.Y
MN.NI;7K=_(EZ"7C9)WROHEQOQ;[,K<\R$D8\*+NP*D5&'"DPK%W)X*"KV'YM
M77L1<B<RIX%!/$)NSLTBO$ 0:I(U&K@1SUOFT=HD>!E2=>A1BI$T&&#QT%1=
M-"U+O*SRY\.<;<^>?'-)YLV+5'A?]O(\Z1?6';#.729AV3I:U34G-7<6DD<L
M,76U@W!*RL_;P!#KW$RT(M$F%GH 2MN7L>Q-B#4>A$]S[*.P6)/GX;RSLM4U
MI:S:76[Z=7.W Q+7PV.ZE6UI&[,;60XE=ZT]65,BFN8-=-OOC4C"UAX:TPH"
MV(A"PI-".QPA*[.[):PR7@GQ5,$]DJ 4))I#)0!X,-&MYZ_1Z\^'K.46W96N
MWG9+62:OV):<.!Y'A\T%?;26]0%)?2EJP@E7/:BZ[ILRR)9K/T8D9B6G1+2C
MV8F+"+2JZFY]"F1RQ;5$,W,9E4&2WE\X@]KV'$SLJC.6I5G?1_8&U\*W%9::
M[U\[.SR3S5[72>=SI;X,!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P#4'82!FK4H
M*\*PCC[47(;'J"RX&!)[JY1T'&I?"S4>%OMUM?TR6K1\10<;*Z_5/">=L?7'
M!5DT^3124$\,"U[AC VWBATS4TOE@[PI94(IXG9EHQ.-Q3/44K4LANB(W)6,
M717KZ7REHUB!P16+E\PEK)C(4AC](O&T/8+-WM[>VN9E>S>CSEP5LU9-<>ON
M-;Q[PQ^STW6L;!1^"E,)J+MD3KJD*?OV5V57\'GO2V!1_L:_KK!8U!Q,QD#@
MM!+8[0?'86_WCVC*=,>MU7+/GP774)(18-KOBKO*ZD[7MVI6ZMYWOQV+!_"&
MNB&TM\"?R:I)G9@.MO#TK,<%)SNU!%:SNN.K<.IP7V$I&4%&L.(/8975_P A
MJU#=\9!0"5/I '81UO.HN0&HNHUH#E>3>:3<GE:]WO6[KZ7/X@_A&=@-9U4;
MRR+#K1W3H2+6% [7I:-6%<+@2>B-K%^X3X*UCQ<E'QS9X\ZA1;L)#ZPZXK2*
M.XVDL8'2DQ(%J_? *M$Q@')<K/*SZTDO^TU=\;\7=WB3OX>?>^Z:JZ[L; "-
M)=>%Q5QW>^V><7'*;-K:,50>=P[JY075R?$6T)'3 RTLR.0"F@UU1."O1S,>
MI:",OV^.P\YG24L)GY'WY6R[Q>*>6BMJD\LVUGPSMQN3<GWA2W&_;RB1MB=0
MW?+Y;V0M2PYK%KGLFW(I#+1K.25 ?@=08EIJ/0N?N@LJI&>2<_:T=A@B&$8D
MO)CA8HQDX.5*LI6PI-[A=Z65EIFGK>_#6]^&AB<B\)3MBYC-JAAW8.%')%.:
M@G$#UGT@DEA"9'*)F<\+KKYTD$3Z:9'QHNJ@3<7%4DBL4NX;$CS\?&3(XFQ<
M$I,H]#-A=Y7B[62>G_*<K=SL?/:W@_7P8+O0M<V:%%4DC=ERSB)52*N:05\1
MA(BU*@ZIQP38$6G,PZW]E_EZV8':5/W;+@VX&+"SR.URO)/&;BAAXI+AA8-Y
M6S6=E=YOC)VM=9--<>&F9:9TUKF;0R2]V9A, 1*,LKI[JSZP8,&*Z:(NMX7&
MJII>CFTDPVTVVR@SG1^GY!.!.^<)?$ LB&EL(Z_$,[J#%N^[U*WE;\S[B;G!
M!P!P!P!P!P!P#7%@U)7MI[1]2=1[!E>*D?BT>=HE#05\*(:KLGB+EL_ DA;S
MVVA06&.L-5%]TQ\D 1R3,M&Y^.A"3 #$H1UJI&NI*\F,2@K=E)2 .11MZ6(&
MY+(EW(26S!S/I,P5TDAHNWSH<F#MP>(JX1PX<NU/9W6RWTT1U"_K]O;(QKI7
MKKIT[ZIZ::ZZ::=<:3UUUUQC77776MXWC7777'EC&N,8QC&,8QC&,>6/IP66
MK[7YR3/!!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P
M!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P#3U_VD_I.FK"M<9$'T
M]>0./KR'6("\2'8D<09K(Y>-6.D5B4YD"KI-ELX=(I#8J644W0QHOHU:[+OF
MHJ5VESR*RM/&,@CQTCD32TC)!R+)25A2J$ZBSC!&NXV8MR-V(=SH,;$V&),)
M/4U)-(#$QQ4JRM &2!'QLI"ME"R @7=UOPMY;6O>R6O/GD60(]AH.I?V.MSD
M180NP'$.D4Z#$S%?2@77\IC\2VK]*3*Q.P7@]*+R1V"<V;$F95B*?N7+)Z[=
M-7&B:S%SIH);*_MW:\#>W!!P!P!P#\U54D$E%UU$T444]U5EE=]4TDDD]<[J
M***;YQIHGIIC.V^^V<:ZZXSMMG&,9SP#7GVQU%^^I7'_ ,<1G_O3@&>L7S(F
MS:D1KQJ0'OFZ+MD^8N$G;-XU<)ZJH.6KI#=1!PW72VU4161WW343VUWTVVUS
MC.0/JX X X X X X X X X X X X X X X X!&?I;^1[U5^[G2GYN(WP66K[
M7YR3'!!P!P#S3."^1!7$?V&Z'LC7V FYG1TH(U+Y:J_#=BJ;)1)ZH-U>^CE]
MHT53=;-<*ZMU-%<Z;8 K<"VUX@17L/.NO^VG3E)] Z>J&XGTBU#W7EH1&6S.
M+KA30(T99DOK(/@ZU+$7SAVLKNW<I'622:6F[1?947@GUOR6]99KP0< _!=T
MU:^C[TY;MO>7";5OZZR:/KNEO:])LCZFVOJN%?9V]-'3VE-_9V]G7/EG@'[\
M < < < < < < < < < < < < < UA9UQU]3Z42WG10LU<SN5(0J'!XY$)E/9
M)))*N**G=V J+0(!)I&Z28A 9<R7):"OA002.=D3#UBS2V6X%KF"P/MEUWLA
M.QG$7L\/AC5!)B-G):3,#T$"#,%CQ^+!30XY.A,<$2>(GI-%9-'H].(J]-PZ
M0&H^9&!CKYX.=HI"V>77I;/S&Y(K,X?.ANYJ$2R-3(.F[58*%HJ=%R$:F^03
M1679;OQ#IXUU=HI.&ZJK;97"R::Z.^^F-5=,["&2\ < < < < < < < < <
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M9#A@UDD@S8,6;=--NU:-44F[=%/1)%/33777 Q/2X X X X X X X X X X
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M=UUE5ML944WVR#^=[/2RP7@@X X X X X X X X X X X X X X X X X X
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M(#82"X]L,9%4<,+ 9MURZ/F^0=BU%1>X.W):+GQ2?,L9X(. . . . . . .
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M9 +AQZM;/CZ*:P<A+(<3B-PPD9*(BZD\6>Y %\$XL)D36.R=4E''X<ML)-M
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M#@#@#@#@%?OB>C@I'IW/M3DX4KALRD5<$FDQ3M2*TQD,48SV/KC5_M F1J.
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M;3N20]9JKK.NRWNFH](%74YT?)JZY<9<;N5AVR&R:.J2;G"N^R/ NF4<(ZV
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MMI8DF9P\;Q"76&>APW6UYM*U9"1!"P3S,\&2S[1!Q@!'6@0FE(464>CX[?T
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M8QC'USG/TQSXXO\ <N(^PU/YK,9_*5/L=3^9(BO\Y1#_ *51O_;@O^U<\J>
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MY0A#N!&6*5N$YKFLQ4ALU&!-#TEBG7[-=Q=@ZL>02Q-K"9K<C5B?D*($H_\
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M9,BV@XB08:D&R";O5F^=ML*X1<K:;U-IW3:?--I\N'4WWB[6CL5:]C_#OZ"
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M>1B'RYL6&O;"67"GDG$5W;'I ,O@_!OX\NM]?BOR[B!\09^,425:$R,P)A"
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M;-+3"$/)'61BM92N+B%D/Y%H:;1Q\&K*+56Q([ CCX.L+B]61^*P=^JY!Q(
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M77%MM\SY/@%/?].27\ND\_\ 'G.4>\NBOU[Q7^FVW/\ 7AI?"8KZ13^\</\
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M?$*^_48_JL=5."O2/9Z63JX(. . . . . . . . . . . . . . . . . .
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M[MEC"#AP;=RZW;(:D6RS5-/"+=@Q%*HN/;5W<+)[:HZ@[<+^-W]") <$' '
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M8Y)\0L,X;E)$5MO7VZ_1V$NN"#@$%>F7[(OB%??J,?U6.JG!7I'L]+)U<$'
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M9F1;,W[-Z+-BR(L@S>M6[IH^9.&ZZ6BB>VN ::=F9CP0< < < < < < < <
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M*T7TX=3TI4[8VN>LK6/I2LX>TB;1PX:QQ4X19#QXF#Q.%1@.*^897+) W$C
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MV_9Y^+QMZ+5D\^"#@%9':GQ/J=ZWS\77H9:!6:=$-)J9ML9I<$<A1N!#(.W
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MEK8G+57A981^.W7Y/(2"X(1][']CZ[ZT0/:6SHV '$C&DA&P$-(Y"RB J63
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MT03QC1%!%-/7&-=<8X![/ ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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MQ#7+*,E@7MU]7$Q2XXUVYD!BZ",%96>*4?P*=BZYVC]@5V%%*IY@$8"0H(,
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..PB-# &;I$&.$-B< _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g729258g03g67.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g03g67.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2%,4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (3"^A)8X0DE-! 0      $D< 5H  QLE1QP"   "N^@< E  "')R-C X
M,#0R' (% "A-:6-R;W-O9G0@4&]W97)0;VEN=" M(%!I;FYA8VQE7TAI9VA?
M<F5S #A"24T$)0      $"TP?D8R$V.<EEG:Z-G>9Z@X0DE-!#H      .4
M   0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $
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M=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M    $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO
M;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG
M:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0
M$ .__C4  @ ! [_^-0 "  $X0DE-!"8       X             /X   #A"
M24T$#0      !    '@X0DE-!!D       0    >.$))30/S       )
M       ! #A"24TG$       "@ !          $X0DE- _4      $@ +V9F
M  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8
M      $ -0    $ +0    8       $X0DE- _@      '   /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H     /__________________
M__________\#Z   .$))300(       0     0   D    )      #A"24T$
M'@      !      X0DE-!!H      S4    &              *H   '9
M       !                          $             !V0   *H
M                  $                         $     $       !N
M=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   *H
M %)G:'1L;VYG   '9     9S;&EC97-6;$QS     4]B:F,    !       %
M<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M       &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R
M871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG   "J     !29VAT;&]N9P  !V0
M   #=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$58
M5     $       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,
M8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T
M   /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU
M;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP
M965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S
M971L;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T
M<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@
M  P    "/_         X0DE-!!$       $! #A"24T$%       !     @X
M0DE-! P     %L<    !    H    #H   '@  !LP   %JL &  !_]C_X@Q8
M24-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D="(%A96B 'S@ "  D
M!@ Q  !A8W-P35-&5     !)14,@<U)'0@               0  ]M8  0
M  #3+4A0("
M             !%C<')T   !4    #-D97-C   !A    &QW='!T   !\
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M0S8Q.38V+3(N,0
M                    6%E:(        /-1  $    !%LQ865H@
M             %A96B        !OH@  ./4   .06%E:(        &*9  "W
MA0  &-I865H@        )*    ^$  "VSV1E<V,         %DE%0R!H='1P
M.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O=W=W+FEE8RYC
M:
M  !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U
M<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M,BXQ($1E9F%U
M;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M    9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN
M($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6:65W:6YG($-O
M;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M     '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>     5A96B
M     $P)5@!0    5Q_G;65A<P         !
M H\    "<VEG(     !#4E0@8W5R=@        0     !0 *  \ %  9 !X
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M)K<FZ"<8)TDG>B>K)]PH#2@_*'$HHB@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M)%%Q(S(W"ADS.$)X@;?P)28V87>AL;C!_\0 ' $! 0 " P$!
M  $"!@,$!0<(_\0 0Q$!  $" P4&! 0#!04)      $"$0,$(04Q05'P!A)A
M<9'1@:&QP1,4(N$',O$5%B,D8B4S0D-2%S13<H*2HK+B_]H # ,!  (1 Q$
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M<*R1N']:$.=E-]<[,'NZ95ON X#@. X#@. X#@. X#@. X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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MC;&"I2X#@. X#@. X#@. X#@. X#@.!598E;.O:QK#=+,;XK1S6C^Q=X;F$
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MWVGIO^/'KRX:#H-RAP' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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M3TQC^6NFN,8_Y<#[. X#@. X#@.!7WK%_P"%CO\ _6#LA_\ V+M3@6"X#@.
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MW;N6OC]/AI//B)UI/O\ ;WIV?<R*>=W+)H>(_6ZG/7:G>MT=ZO;.:+G;&O;
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ML+4<:[ ;=F>L=ST#:-"55"KN4JHM(Z?FRUB5A8<_3JR.R>&S^&V"_K]FW$V
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MKF+QE%^]&);_ ,_7SOLH8EIC*B[Y)/7.V.OBYK!PJNY-4U8D[L+#IG$Q)_\
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M-===-<:ZZXUUUQC7777&,8QKC[,8QC'V8QC'\L8^S'.U9N>[<\\!P' <!P'
M<!P' <!P' <"*I!1=+2NSX;=<GJ>NI#<%>#WXF!V@9AP E/8>,*:.="#"-RM
MVP5-AVCK1Z^U508O4$\X?/<:ZX]<<^E"5> X'+6RNJ7<3LA;=0-NPUJ];D.N
ME!]DHIV3B#6I*RL,3<\]-U@4+E*KBTL)3&>R*)0L:+<D6#B:&(FB6(R_(E0>
M.0B@PT];H!$D:\-KL (TAW6TA=-2..@U==J-.TL8B[2 2M/L*40&701[$12A
MY#)%Y4I DX%&[;?-'RDS'!<2DW% ;"-*"QJKEX7VOMUZQU;02KV2Z$6#VHU[
M,R.Q9Q#&LSEL<#U3UA$^J')'7U9T^"ET)L25#YV*73!.C,B[(2N):1Z\51&F
M4&U4M8W @;LJF,-D)+.NNN8GGJ7U@D- 4#/:S/D(.W/V18=U66O'*T%/PU3U
MHXM\^4.:0.N1;_1%^G$8WL^PIERH/$;ES#LT83!AM".@QL%+K'\*DM8?0#HA
MU@,G*8EUH='!].$1C>V*^(6/UXM@]7E2&:EE,8GL+6>!#ZT,E B2%7X@JT52
M.QHZQ '$F+M5BJP6M]9G=OM;A?VW>5_"Q\@+PUKB@,)HZ;TNPZ,T#V.H+L',
M[IBT.IFC)K"^L<G!6+3SNDYA#IVQ9R[:>%Y0[CK]4PRL\>F*6:NA8,%F&[CV
MR[Y=>^^\Z<^M/#YCT)>&UV@0KV1R)>]*8+]GF/B+L?$*@LA5KN7":6(R#:HP
MM5&:QE<2:R9], T95#NYDP$E1,H/'&:"<8+/W10EL7;[(X^.GW^P^9#PTNT+
M@=/;2,WQ2ZW:S;OW%.^U8R ;7$P9THF=$=:XMUV.5--(<M+',O3B)**IS $T
MD(>6/9&@AM'):ME0KDH XOSW6MRYS]?H)VL#J]W;GDMZ@=@"5L]9U^Q/7>=W
M0ZD07%<62.I1Y6-Y15C#BL<C.B,W>SMY*X2.##"(F0&R#%C*BBQ'5^+C;'9H
MW0@C=SX<MZ1%S'[7IZV*N&7]5W>+M_VGK=*?1B4GZHDD [:+2H9)*NG[8&2
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M8US$.O4"KAHKCRZDKIMQ)Z52US]NNVT1JD#+VBN^,9QG9!2<L\^7&=<J:_\
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M;;ZXUTV^S^';.<^37;[<?9G.,_;C[/MX'G=1-/7S]]]--?+C'G;[:ZZ^7/\
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M5_JKQ*JO%+?DQ_RQSE>^<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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MNB079P],EVK+0?N.4"<.I'<:S>PM@2F)3JA#%5#F\7$S*/NWVTJV("FCF%U
M3> I=H;AX,,ON5E4^F ^!R4 86Q*&-;S1N2BL9?1A=4L'0G@. X#@. X#@.
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M?*LFV?-7,?9DA^(T_N%7WA]G:OZ83&O>W%AVEUDKCQ/(A"+#MQ]WEN255Y3
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M#C@6Q6,,6RF=LJ-V9-1#9ZV0WSOMG=)%?1/;.VV=M<YSGRAF> X#@. X#@.
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M57P5E?SWX#V'>_XF55\%97\]^ ]AWO\ B957P5E?SWX#V'>_XF55\%97\]^
M]AWO^)E5?!65_/?@8M.$6\B3(&4IQ3:98JW&M"9+2BY+J](-0ZCU42@\<8O3
MTKE(:J2?J,=%=M]6NSQQE'&F5=O*&E3LW*:I"(E9W;U'1*//".S35\^HF5HB
M\$'ZRI)79VJWNU1NS]9<HJ/7#U[E!OLYU],NOZ;;7;(O;XZ-#VMT$!;@)(AV
M(ZSMV$M;2%2.R8-39UX+.),2!/<XBPD >\'#!RL], BVJ#/5[ES(2XEZD,0(
MOVBNF@2A$\3B?#FDTAUL4/)QI%!'5G)!%*'GZ+QNDMJ22T1(HWKOZ9-!VOZU
MA/"F<-WV5-MM4W>BGFAL3*%7 ->%2 ^<TXR?''*#PR\;49)47)1TV:(L6Z[]
M9.]-5'2J#-NBV2W6VWRFBGKIIG&OV<#)^P[W_$RJO@K*_GOP'L.]_P 3*J^"
MLK^>_ >P[W_$RJO@K*_GOP'L.]_Q,JKX*ROY[\![#O?\3*J^"LK^>_ QKB%7
M"[)C33J=4ZX+AT2#<435HV3;OQS<KJVU)H,W6UZY6;H$,,F?KJ26^J;G+1KL
MMKOLW1SH&F3HO+(5F+,YW;M&C%)2?9 8BQ(T7*G3@O(&2#HLR9B625W.5U7(
MYLT>$M%4D<:#D6Z[S=5OHGLI@-"S9XG$=)S_ $OCKBK'(J>P#(R1I1<E=-PY
M=B-W(:*>G:W4JNBS;1_=8VD=0UR(3B^')],C@"FN^U#?(I*)39RQ5K$[OH:7
MK@%-$2[9E34C?+#<._6D&BKA%2],J)M"R"+E42]\WU,T.SE\,7>#UM'"@;>*
M@=M U22P69TN*5,NT7Y90=1$C9[D7K<>R$H.GF6]YIY<+HC!S!@DHIYVR;1H
MW0TSA-+37 9?V'>_XF55\%97\]^ ]AWO^)E5?!65_/?@2@.3()#V219TS?%$
MVJ&A%Z/8K#&+M[JGKARX9C7! LNP;++8W409K%"*K9/;5+=ZZVTRMN'V\!P'
M <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <".Y
M+9H.*D]A+\+8+]QJ@BXRXC=8V'+!F=%O/QKI@M&8R5&9<:YTSZ9MAWEPAY=,
MK)Z84T\X.<G8CJQUG[)3@W9$O0[5 ID::1YI@C%JMM%NS&:Q9)OD*X&!RU4E
MQK,D@\9MUUSB2&L@<#%CD2R6TA<KE<=-#KKR0H]\.GJ6[-@36I7N"GF--8;[
M($+TW(R<?0*P0#J !EE0A6A'HYQG=!)H](C5D-ACL@,%;ZM4&C%-GL2T>6_X
M7WVZX0V33H/U#;F(:<8I]NVKV%F8(29([5M9KD6Z8P<:T:Y"*B%ZBV&L6LI+
MM/I?)R 9L-..Y:[(E&)0>D_<M-Q;ZWX=?=NUE=3.N=MO;,4GA/MP9!V09EQ]
M*(9IJ2MXY""E@$(02G+F+:H4)H9?YDR]>QM)PG.S$S1%M$GS:/I"-"3W*Q>N
MK_)JCCHAT[5GF9LW ]E6#95T1(/(4SI"8IPIX0(6O,K9W74"9I39+1OA_/)!
M%EF*>^K9U$O9S)?38DV<E7PZZZ^S%"/#\Z?"XD^AZJ';0JS64E&HLL5J>>OI
M( 82=:M?3-!IUW2Z[Y1=H-JT""]K$%'I8L&?&F<@>%M7B&6@MU]_75/M"TG2
ME VO+KD K]E9'+9M&6D=,MC="2P1&FZB;.(,2)(!&8-2T1"QS)5O!(SZ<2'9
MM J*[5TX1886=8V1"Y_OQBWW8N#X%W'_ &-P'OQBWW8N#X%W'_8W >_&+?=B
MX/@7<?\ 8W >_&+?=BX/@7<?]C<![\8M]V+@^!=Q_P!C<![\8M]V+@^!=Q_V
M-P'OQBWW8N#X%W'_ &-P'OQBWW8N#X%W'_8W >_&+?=BX/@7<?\ 8W >_&+?
M=BX/@7<?]C<![\8M]V+@^!=Q_P!C<![\8M]V+@^!=Q_V-P'OQBWW8N#X%W'_
M &-P'OQBWW8N#X%W'_8W C"<EJOL%^,>GP78'9)B6B!5T';U7>V(X:^@LCUF
M,<:%(TYASD#C1M*VPLTZ)#AP\^3]CCPY$PZCVK@0X"$C5756?>1;0D5[)NHO
M#YK9,\#0MYUR)$ J!BSMY$Y.MMGA"@G1]40F]ELBW]E+&%6)4>0]@R%$N"3W
M'K#KAUUY)6H_>M:%C!2'11KV++QYY)"9\4PE-0W$7UB[4BFU3UC<?4]WR&[4
M RRURNW;KY<NMW;IZ[=.W#ARHID)F]^,6^[%P? NX_[&X#WXQ;[L7!\"[C_L
M;@/?C%ONQ<'P+N/^QN ]^,6^[%P? NX_[&X#WXQ;[L7!\"[C_L;@/?C%ONQ<
M'P+N/^QN ]^,6^[%P? NX_[&X%;KTB=07WL*6D;'L*&>C"0U\F\%T=8YG9NF
M.9FV&NT;9SBJY:-KV1;('WVZ=A5NQB%C-ETAVZ,LPD.:()#KKS1HI2-7XK.4
MU,SE_:MG$98*$11\VWZ]/R:K: Q8:-!0F$,]S/7\AIH.A8-BLV"FE4UI8Y(/
ME#!X^9>-F7JY+>,_+VZ]+2S6P*IZJL.7V'%6G8M%6;M5]#L65IFTT8BX*+D&
MKO$A]BC:R8);'F[-BT$H$U=E':S78F\)+$3)HH3<E6#]^,6^[%P? NX_[&X#
MWXQ;[L7!\"[C_L;@/?C%ONQ<'P+N/^QN!*PQ^B5',2;=)Z@@_:-WB2!%@]%$
M$4W*6JVB3X82;M2 ]WIKOC5PR?-F[MLKC9%PBFKIMI@/NX#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.!RVAL(
M\2"*5)*Y =G4?G]AN2XJ< ($1,1H>:8IPF9Y.D*U9F&T+2BKYG>,.])!WNY
M\&95:NU&R(.<+NC!5,(373=X_LC[VSXLT?)BQ68?#YD.AXP>?-GD7,&0S84F
MVJ$B7/QX<BO)8^KK%G-MR5W'0+!9M'B3 ?!8DJ\D&K B=?E"Z\>NOW\%H^N,
MV[OR>VYVW[$5?#H!4B8'#V *AEQ;P^L\7=!-QC0TN+FDF20-HMUY2VE#)+1V
M(TR.CJX4HGA1]N9'777HO/P' <!P' <!P' <!P' <!P' J):>G8%I?D*,0UG
M+"U6,@H%=Z.CKV$H@=UVBUAJ66PF(^0D!9PD6/BEZO:U@L'74:C9"/,K%'@0
M2L8W+!5]L"[]*/PB6SZ>M-MC3%N2?JE:M="&UBXDL"5EDPV8[/<.W/6]W"D;
M%9PZ);8S-&Q=\TW=QL<1UCQ4037Z?#Y[OCSUG1;#J$/OT=6Q=#L*Z+NI-]+G
M&(WO(MP"DE^BZ,:BK1TY.YC1,V)1<&)RVFI\</;F".@@"6$B&RZ;%@T:MRK5
M\!P' <!P' <"IW91E?[DS6BM+;2#+%%\\]MZ@'L29MF\AS*:[7!$9RG*%D%B
M5:HPAM:K"2C(]EV=<%"D;4%L-B:# H("L<_:=W"*]GO8N/MX>[(D7SN"MF1B
MG] 3%\].NWE8:#VF\J9OAH2,PG;0';VI=4TR=V-D&60CU@0QG)4" 63Z?LNP
M[&)3A'L7L:4D.TZ54C:AQU'73C<%F.1_1_EKO'"99KNPWE"9YPU<^>#9N]5\
MJA(7# >HX$W"W7 <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
6<!P' <!P' <!P' <!P' <!P' <#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g729258g03k41.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g03k41.jpg
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MQ#4X.8:')"4F0D5&1V-D969TM\4G*$.1M+AB\*'#QO_$ !T! 0 " P$! 0$
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MU)2])*^].EU++KTT[KJ5K9;6E<Q1=E)[E'_%Y?R%\9%\52AWX#=TWXV/\H_
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M-O[P/]06O\6@_JD_9%23?C9?ZQ_VC6%]3U'6P&TZ6QV [I]M,ZEY1$'$H7N
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M.1PW%TEQ^;' [YQ-XW=D&4.@+=N=53& *8F[8ETF3LMFC2^2VD[&BXKANPS
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MD%0RA03M;JJ0N>%%V_W9%CTL>C,W31 5EK:M,7TDE0.(63=^UPSM*RG@.59
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M5UZ]E>[B:>UN8$(#S6\T2EB0H:2-D4L0"0 2,D G'4#U5+ XBGAD8$K'+&[
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MM:]E2#=R3<T*P,V""R*G#&X!MK'9A>:E>Y5@H<!JTMU?JM32E;6;8_\ GO\
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M8G_KI?VVK!VK-0TTI32E-*4TI32E-*5M9MC_ .>_^K7_ +_KEZE_(_\ F?\
MXZN6G\I_N?\ W5_74[X$'@_C+IR7>P2=U>%7"Q)W5+)TK33JY?*7.EZII]+K
MR+*JJWULLXZ\FWBIQUXM>,77]4555;A0% 4#@PG  P.?#\ KOOIMF68F(DEB
M2>))UDDG\JK?R"_@]>X.?>%"5^-:S[8-5_.%\Q!]W6O:RS\4?.2>M3R"_@]>
MX.?>%"5^-:>V#5?SA?,0?=T[66?BCYR3UJ>07\'KW!S[PH2OQK3VP:K^<+YB
M#[NG:RS\4?.2>M3R"_@]>X.?>%"5^-:>V#5?SA?,0?=T[66?BCYR3UJ>07\'
MKW!S[PH2OQK3VP:K^<+YB#[NG:RS\4?.2>M3R"_@]>X.?>%"5^-:>V#5?SA?
M,0?=T[66?BCYR3UJ>07\'KW!S[PH2OQK3VP:K^<+YB#[NG:RS\4?.2>M3R"_
M@]>X.?>%"5^-:>V#5?SA?,0?=T[66?BCYR3UJ>07\'KW!S[PH2OQK3VP:K^<
M+YB#[NG:RS\4?.2>M4D&\"GL,&QR31UG"YXF)DR@-0PWKDF2*7.;@;IRZ&UL
M746N7;\PNY6NNH@HG1:EU+5>7;;;2FIUW4V9',ZEDW;3P8>6X -RV8.0._G'
M>K8:=:!641'#%2?=).M<X_*^,U&_(+^#U[@Y]X4)7XUK;VP:K^<+YB#[NM>U
MEGXH^<D]:GD%_!Z]P<^\*$K\:T]L&J_G"^8@^[IVLL_%'SDGK4\@OX/7N#GW
MA0E?C6GM@U7\X7S$'W=.UEGXH^<D]:GD%_!Z]P<^\*$K\:T]L&J_G"^8@^[I
MVLL_%'SDGK4\@OX/7N#GWA0E?C6GM@U7\X7S$'W=.UEGXH^<D]:GD%_!Z]P<
M^\*$K\:T]L&J_G"^8@^[IVLL_%'SDGK4\@OX/7N#GWA0E?C6GM@U7\X7S$'W
M=.UEGXH^<D]:GD%_!Z]P<^\*$K\:T]L&J_G"^8@^[IVLL_%'SDGK4\@OX/7N
M#GWA0E?C6GM@U7\X7S$'W=.UEGXH^<D]:ITWX$C8-D%B.-2>%3UV_&L[8<S4
M0R7)6=B8&"K+1".-JI-UK+%%6H,*P06<WTN7=K)WN7%]ZRM]U=4U[4XP0LR
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MIYF+U*=J;'Q;><D]:GD!_!R=P&0_"M+?&=/;#JOCT\S%ZE.U-CXMO.2>M3R
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M>@'=$FZ(MR0L1&*/4'KY@DYX/27V"NEG1[2;C5X[G3]8CM!Q+JUTX71NX[<
MF2Y2*:",31P@!I5C8RK&3($9$<K/:=(;*ZG2 K+ 7Y(\NP(7Y80E6;!;\DG
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M)K74FF>.^DB>YMTND%M B%VX<LW"<5O#J/%GCCX!6*=[B*";B*Q9[;=Q \0
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M+ORI5^NY)ER;EV3)NW;]VX<*_CS5-3O]9O[K5-4NI;R_O)6FN+B9LN[G
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MS%F&<?1O,).F9<I7OI!DYAN9V]9%G4@$2-2EYUJV=XDQC*XL$?#7 -9C>Y'
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M!^52C!&-VIWU4<5665\%TRN=-GZ07D&C<-M'TQ8-'TR6,1D75KI<*68OFDC
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M <T#!'ZP) RY.W)VXUY2KE-*4TI7YW_O09_I(YYZ187]^:U^H?8J_P"B%O\
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M*X^.O8XO+4K6/<CGZ-;7, SK/<P"GY%',=!A)$D$B]@U0\1H3,B(^U0'6ER
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M*7TMK=96E]M*VUI76H9264,"RX#*",KD9&1UC(YC/6.JMBK *Q5@KY*,00&
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MLWRW,UEH?0#2;F_[$A>ZN(X8%N'OYUMTQ+,;>*)YY88%DN'2-EMXII3'&_\
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M&J;XQ'&[R-9V>EWO9\<2/)#<1"VC26:6%)-&U*V0'<6#*9 R[>:M'+%#@DD
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MTERC\.1#2E332E-*5@?<3B>2YA@X$%#I6"ALHBV4L3Y0"&9-%W\Q WOL79
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M-_U@;PH0DS["F2&V6L;@IXU<M7-A=<ZV5L;B3(!<>\"2$J!(!# &04H8!R0
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MTNL@;#&JTHETZFLX//H@,EDEF[(<1)2\\:<OE4)'+CSI%\XOO>-V3EL%;+(
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M0)RU%HWO3;H&ZG[:'5GR*::K@U6\JXJJ_44<7.SKW=O[*G+FU-B7+DN;-HC
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MUB)4S*PH1:C,@?=&UXC745M:RQH+<SM) \K964J@6-T,9<$*1W0!Q@[#K\)
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MF##!'5S45=Y1PO",P/L4$)F@27<X9RN$S/"*CR"C"Q";Q^/2F,CER5B=E]"
MVP7,35JH]2MB:J][9:Z^E6]+;L:9K%[I*:I'9M&JZQI<VCWO$C$A:RGN+6YD
M6,DCAR&6SA(D&2%##'=4EA28Q%\YAE69,''=JKH,^$8=N7AQX*U]*; L E<N
M/<O*VS])P2RH&SP3QJC/Y$GA@MG..L&3$'EHKC=)TD+>2]A46)?7J<^D+?$Q
M;$D_&N7R%KC7>BZ=:[%I2:2#8LL>F3:''J#6%N=8BT2XD>2?2HM1*F5+23BR
MIC!D2.5XTD5&*U7.GVYF,QXG.59VBXK\!IU "S&+.W>-JG/($@$@D9K1K;IP
M5^2X6"EV)\TY<:E,#3;$\UQOD2%0":9%?V97,2:1L2H:<U!S-M:!PJYB0Q$B
M/&Q_'UYILO0LJBX*]#0JBY]MT@]D_3KR>TU71]*:/7;+5+/4=/O;^ST^,Z5%
M;6\D4UEQK-C-K*W4C1R23WXA9>""(BS96A;:5)&KPS2Y@DB>.6..25A*S.&6
M0+)W,!0 @+'N'=8+8&#O#G/@_L";@I,4E,V<9)&NI'CN*XNF(V&Y ,1@)-HA
M!)&\ET)92D<SI?:14C$C?NBC&Y)1JB\4OL;FD"K)%%LGXO1.GFNZ#;Q6UDNG
M2+;:A=:G9R7EA#<S65W?6Z6EZ]K(^.&+FW18G!#% -T)B<EC?N-/M[ER\G$!
M:-8G5)&171'+QAP#S*.2R^'J;(P*ERVS#""YAR=48R.K]WNI%[R%KJ2%Q1+W
M]8B(,X0R?6IT1XK8[:"8H6J ..J"CKEN*K<=W(I4'3#6EA6 /;\-.B\O1!?X
M.N>TTMV]ZZ9SSN#/(Q$_O@IV@<@:V-E 3N(;/98O???RZH(P>KWNT#N?#SS4
MYA.VS#\'Q[+\5HQ)A*H!.YY/,C2J+SUJQF88O(LC31[/I#1X,-LW ]R-MDKY
M1X,8.6JR3"B+6B=;E&]BNJ5[TBU:^U"TU1KI[6_LK&QT^VN;%GLYHK?3[-+&
MWV20NLBR=C1A))%93)ELX#$5(EM"D;Q; T<DDDCI( ZLTCF1LAL@C<<@$8&!
MX*Z[!^U7!.W(]E20X;@ &#O<PR8?*)<@"%"10])P*!L00X0"8BQ[%$-&V:+)
M4@W!-J58(&2QLHBG8Y*N[KY-:Z4:YTA@TNWU>_GO4TBVDM;1IY999"LL\D\D
ML[RR.TUPY<1M.W=M#%#$25B7&(+6WMFE:"-8S,P9PJA1E5"@*  %48)"CD&9
MB!EC6P^O/U8II2JZ?PA?T4?OKM*5JAD?-NTB(90MQ[E.08U$Y+*^^P)N497'
M$[ZT54DIQ/#;DY+'H54",>62]M(*8ZH:-M';>0U?W1ZU,@YOJKZ?3]&Z57>F
M]GZ9;ZC+IT?;.)#:W! (%M =76"U283R(;1K?MAP875H.&+C,:C%66>T27AR
MM&LIX3'>O5W;< LY7:IX@;A;F!#9V\S67BV'</%[AKDYBS&I.\"]D14.X+0B
M+O;@Q&6D%2TL)#57@Q6HY[)BBRQ.1/&MR*YD@JJ])*.7"EZM>3%JVK1<18-3
MU&(3I;Q3+%>W*<:.TC$5K'($D'$2VB41VZ-E88P$C"J *F:&%L;HHVVEBNZ-
M3M+DLY&1R+DDL1S8DDY-1)CC+;-);)W"A^.<'G$0<Z9&LE15M#(*00&Y*=@A
MDJ'F9D%L&*HH35Q'9$)/M2AAO0VH*,LB"3BK9ZDJI;DU+I);&QO9-0UJ SV3
MPZ==->7L;2Z<DTEK)#9S&0%K-;B"6!XHFX(EB>,KN0@:"*V?B1B.!@L@,J!(
MSB4JK@NN.4A1E8%ANVL#U$5+/?.X=4+R U[ZS&EYZ2*+*2DMUCQ:XN?5>N [
M]Q?('_4NKPJH[=1^/O%KB*J]R[@('<7UO4&LKT:O;?5Q%!#VTU(06P M8NS;
MKA0!%F11 G%V1!4N)T C"A5GF48$KAMN##EFX467SO/#7+Y*D[CC+9*J3G/-
M5/>%05B$VTB,KN\=C(%C0;E.3 TLVD6X_&XAH\.,@\V&I-9N1D;:/ICB!YA.
MKAA!BL[*JR)(ND@<:ITO;4>IW7FZ1RZ6NH27VI2:9;3'1HVDU&5DA::RD9K*
M.W:<R) ]B)$D"1"W,+&%SAMAT"VRS&,1Q"9UXY B +!9!W98+@L)-I&6W!L,
M!RS68(O+@4Q&J%@2S^]FF;D4>KU5"'(X[N*Q0V2CIM-(=(QPHBNT1*"7UC(F
MBU4%F6*:1<,\("';-\OR;FTGM)!%.$#F&WN/<IH;A!%=01W$),EO)+&K&*5"
M\982PN3#,D<R.BS(ZN-RYQN9>:LIRC%&Y, <;E.#C##FI(()D=M]E_'R+K;N
M3==9=R;J7<F^VO%=;7BK7BNMKY5UM?+I7RJTU7((ZP1D9&>^/#\E;5RUBE-*
M5^>![T%_Z26=^D:%??FM?J3V)_\ HE;_ -LOO\X5RKW\>?Z"?LBO%.SL5]'\
M5-?3*Y[]8^3[35=/Y/TOQZMIUGY/M%0OU#Y?L-7"?R?I?CU<7J'R#ZJBJZL^
M!I]/[M=6:5=:MIUGY/M%5'ZA\OV&JB?R?I?CU=3\G_=^RHJN;.Q7T?Q4U:3W
MP^?ZC4+=_P#I-]E7>K:=7S#ZVK6KJSX*GT_N5U?C[_S?;5>7\KYOLKW!X"C
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MMK5U+G+5B*0HLBU9J.K&K.U9XI??<NY<J\77M=NM?O1=7(X:1H(K>W5BZ01
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M.+&&*I)*K[A$Y546YCVJK$M*-L E8@*=QDVDDHM1%;D[&QDHI [M0S$PODL
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'V/+TI7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g729258g03w96.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g03w96.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[3]44&AO=&]S:&]P(#,N,  X0DE-! 0
M    /SB^%AA#A"24T$!       *AP!6@ #&R5'' (   (  1P"4  6071H=6
MMO<F%L86QA9V4@26YD=6YI;#A"24T$)0      $# B&$=48S>)-,D!?0X<T_
MTX0DE-!#H      .4    0     0      "W!R:6YT3W5T<'5T    !0
M!0<W138F]O; $     26YT965N=6T     26YT90    !#;')M    #W!R:6
MYT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585     $
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M!OX            $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M        !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M            !2<VQT56YT1B-0>&Q 9-M#H         IV96-T;W)$871A8F
M]O; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U
M)L=                %1O<"!5;G1&(U)L=                %-C;"!5;G
M1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F
M]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M  #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<
M   #A"24T#[0      $ "FVAT  0 " *;:'0 !  (X0DE-!"8       X
M          /X   #A"24T$#0      !    !XX0DE-!!D       0    >.$
M))30/S       )           ! #A"24TG$       "@ !          (X0D
ME- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8
M$ ,@    $ 6@    8       $ -0    $ +0    8       $X0DE- _@
M   '   /____________________________\#Z     #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z   .$))300(       0     0   D
M    )      #A"24T$'@      !      X0DE-!!H      S4    &
M        ))   "%0         !                          $
M       A4   ))                      $
M  $     $       !N=6QL     @    9B;W5N9'-/8FIC     0       %
M)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P          0G
M1O;6QO;F<   ))     %)G:'1L;VYG   "%0    9S;&EC97-6;$QS     4
M]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M=G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6
MX    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E
M   $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W
M @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   "20
M!29VAT;&]N9P   A4    #=7)L5$585     $       !N=6QL5$585
M$       !-<V=E5$585     $       9A;'1486=415A4     0      #F
M-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6
MAO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0
M )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=
M    MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F
M]N90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P
M     ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG
M     X0DE-!"@       P    "/_         X0DE-!!$       $! #A"24
MT$%       !     ,X0DE-! P     )"P    !    D@   *    &X  $3
M  )!  &  !_]C_X@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D
M="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M       0  ]M8  0    #3+4A0("
M                               !%C<')T   !4    #-D97-C   !A
M   &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:
M "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV=6
M5D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#    "
M1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $/
M  " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA<F
M0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M       !)S4D="($E%0S8Q.38V+3(N,0
M                                      6%E:(        /-1  $
M !%LQ865H@                     %A96B        !OH@  ./4   .06%
ME:(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M      %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H='
M1P.B\O=W=W+FEE8RYC:
M                    !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F
M%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@-C
M$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                      9&5S8P         L4F5F97)E;F-E(%9I97=I;F
M<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R96
MYC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                       '9I97<      !.D_@ 47RX $,\4  /MS  $$P
ML  UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                   H\    "<VEG(     !#4E0@8W5R=@        0
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M,  PL#%@,A RT#. -# T\#6@-F W(#?@.* Y8#H@.N [H#QP/3 ^ #[ /Y!
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M!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,#
MP,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@
MX4% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,#
MP,# P,#/_  !$( *  D@,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
M         #  $"! 4&!P@)"@L!  $% 0$! 0$!          $  @,$!08'"
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MJO3#/4 I9Z5<MKIL^G8ZM[:[:F>K1]JM]+W^FM'I[&5]?ZE6P!K&8^&UK1H
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M#CLG_VXO3HABS2) MQLQCC]8^INWG:&XS?3@1.QY]3='J;MOLV[O34^F
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MYZ[,]6\40UQ =HSLRS@76MF)2QI/DO-O[2]M%'Z*:5[U8F9A?H]J&OD;V.;
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M=636]K<K.'LH[?KG5 %2=DI?X5[Y2YS5Q5#47$VVMC2] 0'8"'HRC6%,QO8
MH$5:PT01B14"I"8B0*@B"HESV2B;LE  # $=RV1E,/=A*=X\PV/WT.PB/!@U
M$VXC?+B-R([9'[\M79'N$!QS# #C8-]%D3/@.X ==SK*9HHFB)HB:(FM&/XC
MP\ B\76X"-'U<4 R(TY/8#/48QUMGW<QWUCI0_LVD_\ Q[4<K.-?;JR>L- -
MXT_0Y%KM(@^7U*T<G<>\!\\$4!#^3'?,P9'+A4 WP'@/O'?.O)NN+.(Z=II8
MSTFVNNVC.L_)FO7[<^@UM"/1[4[L"-5Z$;MD_P!G@>^ZC;A-?.$>Z#F@.<]3
M8$/AT^G6U0643&3S-QRX+EL6DV$)(B,ZU-_62C\GN?ZP/GV]OSAUWP/EK+LX
MV^$[NI*>UZ/CWE/D]ST0[_V?\7/\N^-.SC_*4]KT?HE/D]Q_61QW=O\ +@/J
M'3LX_P I/6:OM6CXC^;-IX=9L^3G(@ >I'?8?G!X=,#GZM_#3LHRX8[Z<L.,
MD]JT<L'K*^2[:!AY->:B4D6RBJAY%N0B8"0HB(G  #YQPR(\@ ,X'?;6>A:/
M:^U0G:CF6E0L928FH(F> JOCUEIUA#J_28MK^Y'NDR!(F=HN#07,;I*X@:&J
MX [7R ]'.^"F1QOC.!!01QC//IUR.N7>PZ21*&K%YS!#N<[\B2+EUG#Z1:)"
M(A[AVG,1>\U;WJ5:<I;T"AZJP':@GP#U#M-\!U#FIG/N[^_3V'2+X6-[!IY3
MOR[I@0:_T$ #:%_XLRUQE2\H-$50&,03\?\ ;-N>W_VNX>?CMI[#;S]UVP'U
M67](-!_,'_B\MCS/>I/N*JG]X)'_ ,S[OV?G]N5AT'28G$$(-'!!&XU&;\%1
MK[5\<HK1J,T0F>,/EX3%HNJ@': D!'&P91_QOSZ'5NEQ2B@ $A?\S,G*9WNA
MUWJ\3@M'B&,0;N 7,6BJK-@0@'^>8 /J>8#MG*@;;9^V=6SU;I,%I!:"S?9C
M$3$RD:-*3YT5AU]H8,)BM+,@$$S)>'$,#=OW+[K%0$W#^D'X$59.-59)N;@U
MNBDHKV# 8X4D7(8(<PA@NX"([" [:[#]!-'TC1-*M7A!%IM11&(8ESLD1,,
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M>=U(;<!QTR ^8" _0 #K%O>>[9;OYK$^\"!TQ^BT<*$;F&X?$\<>7X4]YQ'
MCC 2K<.>!Z"&_=Y:\R^L:"+[8TP5VH;&(!Q(&RA -93AI<<ROTA_9NB,/HU9
MQ.-DVFED3#D"*':SX2#ASG4@S/.X"("(]H>SGGG(<M]L\^_XZZW$$1A)P:M6
M8COD.$Y,O0AT@#;C>(P]H X#D/,$AJ.9N3G.M-ZV;@6X'#"8NXCQ3V/ 1'J
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ML0?\6MKQV5A*[^[(G+Z-FOT+]0$4 ]&[ 1@?%I3F9_%#O?>?)U5SV(>SD P
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M)RB B9,HDZZZW+JT>,BKK:R]2T/$VQG+CV^M)?2VG#S-W>JBXC$E45E4-?\
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M*QG"Y@$F!75$ ,; _KAN>0P'N !\==>:4/O[5ZF.)Y_0>,B[L5[;U);$:LT
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M>P@^'-FI/WG/?49R9;=KF&&'5T<8B>*&&+W>!88T[P<5=B ;9R(CN'9$<AD
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M':]4SEK6+/VPC6-C?62DJP93;J29-$E0]D6<$%#2>7-^NY5A1R35R"+JO08
M TP62> GXFIH.'J.#>$D86?BV$U$OT<^J>QLHU2>LG:?: A@(X;+IJE Q2F
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MH0?JK+>-)N8D5PV&[(A_/E<.)<CL.]9$ !V#?.?AGEUY5Z*V>QI B#;6PVT
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M&<"/+QUB=%A#L:9&\9Q92O&)JI_22**79G'XAG3W7?=YJ V[+G)9$V W_6L
M/?CYP>[GWX[L/9Y^9$I[B>0F+E!Z0%W%FQ>^*<YC\/S?N6.[BLIDL%QH^C!6
M]I%<%[XW13P).R(8MP(E'81W 0SSZ[Z^VQL3 8=DR839I\WITX9;#KW6D6DV
M40BA-P-#,AJ@"@)JS87#-5K[UQ)0, "&X9W#ZPTZYU3KDM:#@<1[<)Q-FP 8
MXR^($NX#D/Y?1O9[\;B XWR.P]1#JGTFLP=96D3?X=B36?N5^M,5Z ]!+4_9
MVC[1,31VL(F& $<A("68QNFU[GJ,CN.^.X<#L/ES\<<NFX:XN8!""),;K^FE
M+D+NPHK2$1PTH:R.%0XEQ$S.BLFXX&XIP'#4IC !QG<-P&$<  9K(@!OMD!$
M-<M]'((.V!$+>X\P9#;A!)#SRPR7!?3J,'5.D &;Y%P;.T)#BD^X,Y6RR 8[
M&-@Y8SWE,(ACQ' _Q:[0%!N"\[49L3Q=SXS7)JJIHBL6](!;BQE36!JZN+T6
M\5KU"W$+*/(%M&SCZEYL'51^SP:\.C4T8L@]AX>=5<,VTXIZP6H,0.X72,#<
M-% 9RN>;WR^N["BQ=\&5'_>LXLZ.B[FVBI2,EH.5J6U5M:BHJ^5S:\7HA\%&
M0]3/X4]+UC(R3"2IF0B7+>/-4<2+)%NK'D%5N"*Z( 0GYX>3</!;%@     &
M     [@Z!HJHZ(FB+7YEK:<1;#BDN-=ZA*!JZ+J3BCK6^-FW]7JQ3L&MN:"H
M]A;>F:-KUX*J $:L/D2F*\F:3(H/JYF;?1'JS&0?JF*QSZJGE/?UG)4]M5PL
MUK 6O3A'MM+EA3% 62XE+R-J-20J"(-6MS+K5P_C;>TQ--$2(.IBH*;I>EVS
MQ&,>>M.V<2S1ZH0Q?5F$.NOFR+[;IVQK>P%(S4 U2NVZ<U+8WAHM%/5$RDZC
M=U?=*MJ^N2#NY"D(X6.=Q(U90%NX21.R&*#VV/:+>RI8!(1/.NO._&Y*]_=N
MZQ95H;5=-V'I:\MP;76 NG5-N:[N%:RE;*4?6-!5S4/R=5T' "6K+\U#2)XV
M1J^ I]B\;E.L8\.SD)N=BB*M 1+)ED4W0R\5)/6?S?@:%9#N$JD(&#M%-U<Q
ME*SJ2J+I3M05M<6K*]I67H6H*BK%9L2*>N0I";:,)"GX&.:QK:)IN-.V[*$,
MS:CZY=0ZBRM1Z_2C5GFXGX*W?T.HB/!@V$>8WTXCM]PS_-FJ[?'CSY[>_16C
M"DJ+*;HB:(FB)HB:(NGE@ T=)E'D#-WC_;H*=KX[8[M:=K_=1_PE:NC%M+T8
MBO;6;?SP_,X>2Q**&_DA<1$,^N6$ Y?LS[<Q\/AY:X5I /;6DC\1H#\KUZJU
M3%MZ!H9) ,>CV1+4#0C'G63(!\\S% 1$=AY_7Y\]:.R<#R6YQD/(BGS40, \
MC%^'_P!7VV[]&.!Y%8.,1S^JB YZ@.W0-_K'Z<:;)P/)9V>P2T409GD;Y;TR
M'V# ?$<!]MM-F*X'D<9K4BAL0"1'08YUI7IE#M!D=RX\_M]OH;,6!Y+#[N7O
MUI,?+Q7IJ','W:4M@2G+\ML@'!<]D/6%'(B [!SP..60'OU]&B$C2(2T)),G
M$I$$"1!NOE-;!Z3Q&WU3I8(@A[.RB,.R""?=(9MHO(_HLAA! "@.!S@.8CMM
MW=-^F^VVN6 D@.'>HV37B6;-\.'01LG).W#,GQ3'B;J( &,>>X#W;^6/(X-8
M7-_N\GKE1\5G#"  "82U2YH^_KA. AWY]X%Z_P"U';8! .N,[=*"* &M0&'0
MO67NC\E0TR6%+[]S9LF.>!,.X9V*&V._ ]^.OYFU^Z>(KB)')VO;<@8E_<RX
M[VRY-NCC8<"8<9Z%_%V_M>?P#0D2!!NJ SGSW.H=EG.QP?/<15F-YK<@"81V
M,<?<..O<&=MN[GJ%@"=D"K.U>GO>2P)@F1#"]Q),B,;[I+&GQE@ \9?HN $.
M=]+H9SX6S5/]90S[\;ZSLHS@#-IB= *XW[UMVG%[(EIR(E> *9&]9?-?0MH3
M1%K><!K?UM-<3)A+N;C/XA"CD.0EJ",P'3&1$>@[[9SG'6GI3"+/6$(AF+2"
MR<F; !@!+#%WXKN_T)MHX=7V%-GM+5CA[^+\GG@KZ08]DV.SM@1' #OY=^>F
M=N@],<2,/::1:V40.S!"""/B^%YDO@+@15UV%#;PVEK!#$1,,XNF'&#X5ES-
MBW'BB*-+\-@[A_/H\-@9'?\ %K(IASC'7 "&_,0UR?T6B,<<9.R-GW9 LVU"
M79W?"ERX-Z;6_P#9+6R&R1$?>>98V5H9$$3>5,=ZV0"AD""/,  ?B7&/+?/G
MKM"&@W#P70Y#'<3YB:GU431%36[,Q:N%H*ICWGEZ-AK;OXMW'U6O7DE&1=-K
M13M(4'2$BXEEV[,4%$E.R<AC@;YP"40-@=%&+ROKCE*_NNW*PKAWJ'T8S&\#
MBHK$UO952\$W'LZ:CED:O;+SSV)9-$V:+&E$II\45VZC-)%%16$(LHZ032(L
MJH0@8*GSG7KZ.ZR;^M4'<$P$!W 0[6X#N [%$-PYX$0#H(\]%&!F0#FPGXJP
MOB&XJ+A6_OW2-@K>0=LV$[4M J5S$U%>&JWM)P=<2))EW$EMM0:B#(49.KB%
M:I2,ME\=2+82,6O\FN2N3'(ZZZ\4G.\;J;\GY/A3VS;C0MO3+"C(N]2,E:VY
MLW P4M6E!DC9BM6]L5YUW\G-"UM5])QDC3=-Q;IZ4WR=*U ]BT7K0Q790*D5
M42%5]%5\<W#/1$_6\!45PE4'=MWL-%5V\84K5\O TU+5(M!MZ;AY.H(J"?0J
M<O.+5'$)Q,<G('=O1>%,DB8A%#D/\N?ZK%INQ=B-[7B;4!POHOD<<9EJ*@I^
M&F*%JB).X=W31MA*QM=Q-84;+0TPQ@7M:U&P>0$I3[6<82K6A(YY4T8,DT9,
M'\85)ZF[.W61%9UUU\T8SJ7!K-P];L6N#RP*I'<7C=X3ZJM_4UT8=PC<23L7
M;R5XB:!).4O5=.QTPA%QCV(:S]%3U00T?&38'5D3PB[N'</C-EY))/L^O43#
M15KGJ?%Y2<RRP58*)XS;:UQ;*J:WAF583=1V^@J7?5O;^$H:LDZI;2-4QC21
MC&L'#SD+&/)J.?F<&393[0JD.=NDN^5D$VB"JQ2;\?TW4O[J+TW#!?*7XD+!
MP]XINAG%N5:P^ZT\92LA)-Y.0;0$=,2<=!O'SIJ'LH.Y*-;(/W:#8ZZ+=9<4
MDEU2%[8D.9>YP#7%N$I2XJU/T.X"'!BV <9^_GQ&[ /:*'\V:KMBF_9 &V!#
M #S -.NG5+N)7"NX-E.OAGE+T1-$31$T1-$75R10!F^R.0%HN80[P[!@$HYS
ML(#SZ=VL+2<!'YI<UJ6 ?2;"HV;2 T_>%ZQ^K4W" =01CT1$5E $1SD1 Y\B
M.!WR(9$/'G@!UQFTL@+6-YL6=FI??UN7?>@:QMX=%T80Q$0BS@ &U1@V#;Y#
MQ"XON<A-LQZ(],Y-X].7V[]8=G#6;XR?FR^Z/6>D0Q2C+,X][+<09W_)0"GH
M3]C'H@([CDQO'8 SW]>7=G5[.'/N^2Q^U=)_,?YO_P!5'[GX;][D1Z#^-MWB
M @.^!Z"&<=-.SAS[KN'7!/M323^*(;HI^'=1/N>AL@ QZ..N!.(=<YR;RYAC
M?;EIV<.?=\EB=9Z20VW'_-W_  ^#)]SL( @'R<B&?[KG@>X,;#OG(;=.NH;,
M3,Z7^'.N(D5B-8Z2&]^(_P#<9]?JZ[ZEH*)3J2"539)$.G)MCD$ $!*83<^?
M3D'=@=\ZU-#L8>V@C<2,,B)GW@*OD]-U%\&MM8VT6KM*LXG/:P1!]JCPF=)S
M!.;L:*\@J*. _4^@=<!]6M^8_FEN#MF2_A-=111VKD".\W$W_P 2D,W((B(8
M*'0,9QMWYWWWY>&J'O+YT5%K$TR2<7(OPW9J'LX=1#^]#\^JKVIS_F/R3V8.
M\/[P/SZ)VIS_ )C\E$&Y0'? ^ % /SZ*&TB(:?-U.""8CRYC]OIW^V=0B5QP
M><UAM18E8Q.-1,B?&7Z+D0#M#]_>Z77'*V"^/?[_ ,NLH(0T)!ENW%B<2_5%
M\^E1DV<;S9I8O7]2_DLN&M=;<@\AVSUQY:(M97@#NQ:Q*H>)*S:U>4T2ZKGB
M]XB9YI0!Y-J%5.().99.B2Q8@5?:Q9&03.H984P(0A1, B ";77'I8&UA8Q2
M<BR#,Q_%C(YW5-*]Q^B=M#9:JL21/M+6;M6.35#AWXUDLGA6@B8QL '3L 40
M$!\P' B.V^^VPZXQV&QI%K&8B=J$0MLM<9AR6K1AC>".6V-N8K6$0DY&8&,P
MY!8Y;EC!](!=>UH3W#A9L*[IH+KI\6_#C4BMO_E) :I)!#5OM"4J$2!_:C,%
M&Y"+"[%,J14C]KM& H@/)_1C1#9&(=IM;;1?"Q ,4(IM%Z[V(*XEZ5QQ1V=H
M]&+M1Q9Q4P-9M5PS4V2Z@E7L- RDE'PKRH9!A'NG3*!8+-$'\PZ00,=O&LUW
MRK=DDN[5 J)%'2R:!1/DYA( B/8U-D/E?@?UO'%=-@DF.LB\YU.$I5:;TN5H
M?!3?F\%]X&\[N\U'0% 57;Z^-96[;4A 2!IQ.%AX/V12,:R4T4$T)66(@Y(,
MB[9HH,O:A53;D,BF0YJARF>KU>[HJ*!ZWJV?B0H:@Y*CY:Y-51EN%IVVD#+S
M5*5#=ILYDZ#I1RF7U[F8EHY)RW Q2IHE*8Z9O;#@F1% X&-V3%.[E/KSQIB6
MI"\5T>*>33M$BRX.9"2F8Y>;IN#N3PRW^MH6KX^,(156;H.3J^1I].?:QOK&
M[I1U3CE1R@U50=IF!,Q%!G7Z25SZZW_-9WZ:BUH>G8*)< B1>,B(Y@N1D+E1
MF19HT105(S.^57>&:D43,5N+I=9?U($!550X"8:BQ^\3'#3Q!7@>W5I%I)V4
MK^U%TF<<%/,[MP,NI4%C)A*&1B)"6HYS J(JRJ;E=$LZQ1%W%R#.9 QBRGL@
M@@4HX$J7"YZ45%'?HW*T)<&;6/6L16E&5\2TZ->516<M5QZS-#6XIN$IF9I=
M&"BI!M3-0-:J:0QW+9[+D,:'<RKY15-Z() 2 -P1^?$W#B:_HOINWPW78IF!
MM9;"@&$+/55=#C"F+\7!J&0@)!U1+.EJ-5DJUI*GZN79@55 J PU&4I#NE3#
M[.\;%>)(+$; B>R'A\A=2Y'RE+.K7B3#JCGMJFX"[OUPYK2LZAK^DFUP+C*W
M=JRHDXME)A3]/UU5]L*>L];P( %A]J68T70D=(%DGKC#F6EGRBR"35N?V=,C
MO3PZ=Q1N]>WN-P)35:OTF$;4=.Q5$1MM; VIA( 62_98TK0-RV5<W50!,A11
M*6OXJ)BH))$Q0*0"'5<[B B1_P!"PX5E-A?7E7JF>'ZKZ8E>*RJ8^HH8M37O
M=L&] K@V<>R473E/4!'4E 0[L"B!U"-I1"1FCE0'LD,_,D0?F8TQNP1WN+2X
MN_<V[=C56S5L&=EK'T#:MBHDZ0M_;Z*I,'20#V7(PL25FJY#M?.PX6(HJ';_
M %0>V/K!$XF$2A(>X[F?&7!Z8X.K'?0[;\%[00Y#?+B,$ P 8 ;RU=@,!MMH
MLCY;\.F^2RF:(FB)HB:(FB+KY$F6COJ)VZQ YB.13-MCKR'N[M81_#UFW>SM
M-EJ6$K>SBJT<!X @G<_)V-ZL<59O3&/AB[$ 5.;/LZ@@(=HPY 0#&X]0''/R
MUQ^U![6.1/O&DQS"[DT#2+(Z)HQ=GLX3-G >^<EQBQ?YV8O,@'5NK@-Q\-L_
MD'6FQP/(K[8](LHBXBE2HSS$LV 4OL+_ &PQ=!@1_J!\]X[@ [#N&WNSRU88
M#$[-)G)+5=J[EAV]E^9/8'P#_E)W@0W$$%<Y^ XY^/4!UEV44_AEFYOPW=33
MM[+\R>P/@Y,G>0Q_4%,#R[BCGZ<"(CX@[*/(;RWBG;V7YE'V!]L/L3L>OZR?
MI[@W\\<QSRP"*QC:*E,4[>R_,NVI]!VA.1*RK==%)%^W56553,0A")B(B(F$
M,  YZ[<M:FB0F&(&*0!AOQ+\@*W/N6WZRM(;71K2R@<Q10Q2N^$C&N$E<V6<
MB0* #(M,@  ("X1# XY#DX &MX>&Z.$\<*U8+K^+1-(<_=Q5-Q>N#.IOER(_
M?%I_A"0_2!Q#Z?IUB8X!(Q"Z_&?6%ZP]ETC_ "H^2?+<3^^#3_"$O\?5$4!I
M'#S^B>RZ1_E1\L$^6XG]\&G^$)?X^CP?G@YGY*^RZ1_E1=WS3Y<B?WP:?X0E
M_CZI,(_'#S/R3V32/\J(<O(E G8@! 1D&@;AS<) '3F/;^WPSCM0F0CAI=$'
MX9CR5.B:0Q^[*QE\:3YF\XR?1=>R.D51)?FYZAO5JD5$R?WM3E$N"B8 $PCV
M0'(>& UJ010O" 1N!X M2]N5*'X-,L+2"SBVH2"2*AA2LPY'SYY>=:RVU-$Z
MZZFM=#T>-"4@Y9\2M=*TK JUD3C+XB8PE5*1;0]0$8$G&2 L4Y0R0NB-!1,=
M+U *"0Q!,0  !UP#TH,)TZP$0F.SNH"2 7<-]6S7;'HQ#!%JNS,_NXK2(\8G
M!&):IS9EDK,W$#8 G: ,#@"AC @&P#W;@'>([=P#L&D0M:B&$-M38BC"0G*_
MY%@N4V5I! ;*,/L1")@6VI$#=7A.BQJ>D2H6D46/#C77W*T\6LS<8W#)%C59
M8II]T/R<6L02%B,J)/:_9A2_4_5"J)1)MV<@ EY'J(BSM-F(DG9%TOCA;.=P
MRW!<7](HS:65I%"?<,,0:L]@W<"936Q45,HE*/9R(@4<".W+W[!G/7EKG;N!
MA=QFNIF )QH37QHK<.'ZRDK9R8OS(2DPRER7;OC5MU(PK1%5$\5&U&A'IMXE
MV97!57+4S17*B0 F)#!S-N!0F4Y/W,'P(E]<E<IHJK(^-:L[.*6]G+*W1J:8
MIA2YM'U/*HSL+$*S TK$4.FVG'%53A"(KH)1#&3(P039N">LG'*@Q#5-9=<"
M@ZZ91IO?3A56#<--U[PWUXBK*)<5"IZ()0T?5,O8)BWL55-J4+P2:\,S9R$R
MYGZ@J^K$HX6,(#9^WHLJ=.R#A1VH=PT<-T"(('[T,O G !Z5?S6=(1#]J(^(
M  AX8T54PE*;&0 <<M%&$\ZUZWXWJ7U9,=GLX#P$0Y\PR @.!ZAR$=%5-V0P
M ;X#8-QVVQW]W+NZ:(K,N-6Y]=T)15NZ-ME+I4O6]\KO4C9Z(K-9!NZ-1K*>
M1D9>HJA9-W9%&BLPA3\+)MX$KTBK7Y<<,1625* )'=;E-U ]U_U>Z=\P2K3^
M(6.NEPF437K^QO$E.5=6M0T=25(QMM;PU(6L)UK<2X5P8"AZ9NE#OGOM3Z%8
M \F'K=U %C#4X\=%;BW*Q(U6[:^O#SQ1A@!-Y==<%Z>1XWKT0,(6H(BT=,5A
M1],7<HGAKJ&=7K@\;4-272=S431=<3]-P_R0JFO2])U8XD6SHBZB,B^:L'TF
MBBFS; <Y6_G+EX>:]EP/R]V;G!Q"WSNI,.U6E67.N%1]O*>9U5*2=+0E$VYF
MI"CVJD53Z[-G&L32KJ$<2X2R)#O)%-]EQV$_5=I/#J?TYJ%L'ENN+SNHS[G7
MF/0[  <&#4 #!?OY\1O9QR[/WYJNQ_ (]-%2[\/(-W=893-$31$T1-$31%\S
ML ,BH!MP]6<1#_:CCEOW^>L(I@@3^8+M3#.YJF>=F2(X2/S#Q"MY.4I3&+@
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M# #D0W[N?A]&@BM0Q$3L)!R>.9;-BG8Z.Q]V$AL!-\''@K"^(T _#4]&3M@
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M4=/ZL=*_?Y'YI_371O\ +@;#>V5S3X-11_3(;/\ ]BE>]?\ 2]CT_P!V^?\
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M6II(;G5#$4\F\H1"270FGC^19J0$82.>(1#9X0K-HM'[KNMWS"E3P-WGW\,
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MFO."^2VLK*TB[01#W!M!C)PQ:68NX&Y>WX7@ /2(\"HB(B!:ZK?("(<QI8@
M.1[A$,X -=5>M#1K*&RT2W:$$[4 P_%XN)Y36[ZO#69?!^9IDPG@_?NI:Z66
MX*!N0^0_5J14.X\)%%A']&$W*M;/B84$,#^'!Q(@ XS^+/QP9#N_&W#ISWSK
MC.L:FL@'Y'=3B-Q"YGJ>,0D S8-+-CW/EABLE7L8B.=A -P#LAW@._=CQ#'/
M;IKXMC;L3<0Q#UF3)JSJPD[.ZW(6O]H,Y.7GD2&%:T8NSLL;/I.VX(VQX;U-
MM^-[AC#  ']F8[;;;>'AD,Z^W5\&R88B 'B&1!<UJ68--[R&H?@UK'M01 4
M)X[-SN9K-H7D'E]6VN3KA*CHB:(I2D(4! I0 !$1'GS'.1^GIHC?*IZXU7S(
ML&;<YE&[9!N=0P&4,W2(@900$PAZPR92F4YCD#B("(B80SHHW5U )!Z2I-?7
MHJFB)HB^8S9L5<SH&Z .CD31.X!%+V@Z29SJ)HBJ( H8A%#G.F03"4ASG.4
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MXB\ 1>1C];U#M-TT=>J<I*):*%Z@![N,LJTOH*3(LX]#L(?@8M@+CLA?3B.
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MUA\?$?#R^K0M[<Q65IM11S@B!)BB<2(KM&FY8]E )M <GKPO4]F:4B8'T@O
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ME^: G "B8""81QDV R.P%UU[ZP8K**QT,6<;Q2B(VMKW6<5)I,9.,5N&CP$
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M"5(287JN;<)D7581A(P!1*60*H1U^G=X*#&3SH<+KJ4#\W=7!3'&+3OW9U7
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M 1%MVA=C2&(D%BU : YW-25W'HY>R'I)^#D!V'[I:N 0[//%/@(!R#( ;(@
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MMT;I-+ET/#TY3ZCVFUZFDFA%:QGE:-J1*2:P"L_*MV\V[8(+J-VTTH].Q(1
MZ?9 -UUWS4,0 QNXYF@KDLR+",CHMBTC(QBTCHYB@DU9,&*";1HT;($*1%LV
M;MRII(()$(4B:*9"IE*4H%*  &JJONT1-$31%9_Q.<8%KK H)T0:Y%IHZ_\
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JLNB7C<?&%1T531$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g729258g04r02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g04r02.jpg
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M 0$! 0$! 0$! 0'_P  1" %! ET# 1$  A$! Q$!_\0 'P !  (" @,! 0
M          <(!@D%"@(#! $+_\0 71   00# 0 ! @0" 0\%"P,5!0,$!@<!
M @@ "1$2$Q05%A<A,0H8&2(C)#9!45AQ=IBUUC=A>;:W&B4X.5EU>(&1U? R
M-$-24U>2E]$F,T)41%5T=Y25EK&XU-?_Q  9 0$! 0$! 0
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M,0ZK0@[J1G9W07-CB50^04W^?A@)]'UG%O@0I4;6[J5OQF(\V6,*-=I Q>E
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M6F4=PX6VDH?$VD]'&<I/R/&N_DOK^P+4CE4..?>I*_)VI6]@6ES<=LBO(K%
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M8*)%0(;8BX8"C!EZ_/'P8,2$#%"1(JV1;8PH(DZG"A6EMX2W9K6H3N)[+_D
M[4D5L(7GSK45 \+4=-+#J'H/38(/JB0!I_?IZ>3]J'C,EFE<&6Y>!-8X]6L"
MN3LD8R(0-8AUBJI2/N0PL::^&F(;=52E3>%3"ND]7:->A9"MOD^K^:S*D 4U
MYVZFH.$=.EV\>YRN:ZX/! =;6M(R8)])XQ&],1>S)?-Z]D,[CPU^7@0:U8;"
M'TG;-5&[9)(K]HW83ALVFG&4IE*8G$-3LWF<$H4WW&%OBUSD&K>@.A#%8@;*
ML^GG73FX:M$*/WLBGESPZ<A<(?Q1WN!N(9R*-E8>,F3ZJ&L1-2M)$8/,JH/6
M#YT(U"NU-G%YAW3Q&.<\B)7GRITZT>N93K3O0[OF-C;VM%O^T&L6@>W.K2P\
MSY.JUE,;*V2C;SROFEF*?L%W:X^IW=<I2711+21JBTU"N@O"]U,3&L1,[8O$
MS&$7?ON\ZUYHIVP+WM\YO':YK0 M()*319.B;W*.%T&(\8)%L4U7I8X=+O!X
M,"):)[N2ADBQ8(:Y5<:>$2;<++*EM?D:AD<K"V+<Z"YWZHY1AU41 !.%7=Z5
MQ&?OG B5F4HW&0T&5JJ>V>/?6$7DKX+'$ZO-O@,_0,R *W6C^J#I1R@+PRTD
MTYVE1K>4L+7',Y6G>_XY8MTQ/G^SN>>D>5K.LV(26=4X)Z%C5=CV%N1^&)CW
M4P:Q(U6-FV<+9S&)#"H\U)8%*W,<E@L.YU(;#%D$766X<-I332B8F5/)I>4H
MUH_'7\I2$5Y/YT;= P/K>;"I+=,UI"7]CRJ/(2.H@]ESCHR?QFMHY)IK+IVC
M9IP(BF0B<'4G4?A$CKV+%51D/=R=J\%DV(<:JIEN&IB52IG&D*)UB393</R"
MQNO+<G])5CSKTOU5.Z;CT:D]X->=XK7Q4=4;&8#%CT6#2$C9%F5HB?G,AC:.
M)((@$#Q+)6Y!KLWJHUO^?8)NAGALFVDG,3-XZ)QU<+)A<\^5WFV+P'E"P(3&
MKFO5IVP/F"G/,>IF"LC\KE<@A8T<^+0PH$/R*,+QJ1HN7SD42V,;-P<5> 9*
MYFIF-" CLG@.%RTX49EVOSP0^)^2R["?R$0WF%7B[HX77$LY7@ELO61*)U E
M8T-ETTLH!'7\TEA#3H?<(VJ"OA9MQ$IV@*'%YNUL$":VCP>1QU-@1(APKAF5
MF-=IV];>9;.F.XPU^6F9A5;T!T(6JX-8UGU&ITZJ%K1"CW%AT\Z/BYR(30Q:
M*EOMA#21QHM$1<P(U0RB9J4H)#!Y=5%ZP>NQ&H65,3%YAQ&D73FS=B\7A!X!
MX!X!X!X!X#\SG&,XQG.,9S_1C.?YY_T?Y? ?O@'@/!33533=/;.V-5--M-LZ
M;[I;XUWQG7.=%$]M%$]OIG^UW3WUWTS]-M-M=L8S@#J1T["^/>H>XN9*6X1B
M504?QI\:G2$BL>07H\F#1>R.D.DR+QV0Q3M,%9;("UF6%!4Y$636FTL-%S <
M^-T&!8UA $)@V) .KE4MU7JK226R47:C,)1XLV\WR.^<=:WIPIS+(?BZ:41N
M40S7#:[A?4:]JI!OTUEASK,U81KF*;DLEL$=D<A<_EOT_+/&_P#?&%O#"X(N
MJIUAI+S3*T? ;I:*8;Y04[O6@KBX]/E4Z-UM)>L$SJ5<K3[$3J[$K4@J<GQB
M1IQ+<W^<V :'<?J^HS+;!#^^L*^BY;OU<^9K\2/@BRX%$YR\F_WU.8\!1JL/
M_&*=C_\ HL<&_P#:'W=Z:OHO6HNBZOTI+R^I!X!X!X",ZA_P&:_ZQ3S_ *^R
M;VJ_F?;T1FCY5W]629[)H> > > > > > > > > > > > > > > > KI$N1.8
M8'>DUZ:AE$UG&;_L5BJ.FMLAXN.9S*0-7.[11_AV422QLFN748,53CQKHW>'
M56;54PN^402VT%;;23;A86B+%^$'@*%='\*[W[?->=%@.H^BZ L&LJTE%6QC
M6I,4@4!- DU/CC\N*MQ5QTQ:V@J3R38''1)@X"5%NW@&/"Q.^<-?SNCP:54)
MJ$YWGZ->95WXW^<>I^"N+)\-F@VU.AK;<6U;,GBW/KZ<\\AFS(1).@K!*LSL
M/G X;#8TQ(V-$96RM>=-9O-"J3(RFX!1@7$5LXBWA:FJJM$H2F'HDKJ6XFUM
M-V9#\5\2ZKJ0?>M<]!\JR"F \]Z)Z<Z4C\\>6[2L]%+:W9<KJ:@:Z6"5Y-)%
M(6\@&A)$Z6(&5V"<=V5!NT$WV%W@]-<*X<14G%*6&L*)NEZDZW[1-G3GO_X]
MKUC(!%_65#1'L\5:!_<R&9K1]];\'J@+ $4 SQ^@9,X,D8P:155"L'Z0O5IJ
MJ5W9I.&VZHB:5-2U;ICM,^I73@CXS:GJR073=U_<NTVMTB?[4ZJMZ VD=CD$
MG$Y:5].+IDTKJJ1"9.ADVK'26T9?LWC!%)P/DD?PMEF\2'/-5V^@55-PDW$4
MJ)<2J4G;&A)3#B]O,_DAZ;OZZ*3K>?T_-.;N9H%61Z>!(%.,XF<$DMTOI^Q8
M1XUH6-Q_9JPDT4W<$G P>Q,:N4$63M\H.=)M ;FFFG9U-]XCZEKNKV# 5Q[T
MH+%LF@T8-YKN-@.',&R+-@P8,ZOD;=HR9-&^B;=JT:MTTT&S9!--%!%/1)+3
M73777 R:0.;Z_P"S>N.6OB)IZ6<W ZJI>@7/$'3DFZ3TN&$2J-V! J$K@!+J
MHBL KUBNC:8J?3MYF*M9_K+8V#C4+_*2=J"D4Q:.A+]8;<)U.;N4EJI;3O$6
M729[&"]4\/\ >5\#.F81,*+M6Y+0E?4K:>U!T$3[9TBW-\;YH W5#IU J_AW
M,R-IC136<1Z"@E(P7"3.GFHM](MB4[6M<Z:; 6SH5.E0[0ECA^*8AWVFZO96
MC?:4ZK7H>L/E&E]\16D7-IT5T5SM1-/R6P0MA5_&G%)R.I+!M<R6)RR(2TV*
MDTI E8[8+-V)5@+"1$MRC)88]',4%-2.HS9TQ,--N(S*6O*-=USB@!_XV>A7
MW*="($ZM0FED<Y_(;U3TF0H9K=&M9O[;IBZ[5OU-$?$[;A4F'-(?/5X59<<F
M\:P6E4?8ZJLG\3EKL1N0>MTAI5*7>)HIIF)AI4]XE-6ZPX)(F7%4CL/BWY#X
MK4/!TXYONWH+GYO541;W!U%'+FL2W'(]C,%@P0J<6N:V(; (]&21U; 11W9*
M>I1>1DER3 ,D,15>@JHJI;JE)RX6,<E.G@7BMWGZU)5UQ\8]J XZ@\A'.##I
M5O;Q?8V#;*1I2Q* 8P6):MQSH@B3/8)R=!1@ID T)88Z:X>/_P LRSA?PRFD
MJEJTDNU2;]"KM"4ST?45-]N\S6=PT-Z KJ67WTM;$*6)7)33&!=(5WT+?"TQ
M_8R 0\4>'X=,@4&ETB?O6]B 8W%G$BBP\0PF39,ZC(@XLJ:6JH<4IN'9I)3C
ME_LFKXT:5Z IM]T2A.8A:%,\VG3]<?UK7-]UW>&Z"L>G6(:,DVMH_;.0<SLY
MD&@$I..(_M!:^Q9TQS%D01=RGD*D;T&:"5-.-[RTH3VM"ON]2"NF.,.B;$=?
M-RM$80T)Z=D\N4%6W//WRR),,S:902G[:BDF%.L$#;7]J:,CLH!LDR$MR$&O
M-7F7+1VLU;.ED154E^7_ -M3;Z32_HRS]I<\6S)>G/BNL<-'&[N(<RXO_6YB
M>3@)NI%_WUR^1K:,Y;,')%$A(,$)@NB,W_;S8GEFGO\ GWN&X_79UJ)/S<\>
M*^DF6]]T;9=YC.1&U9@43RU4]\\KWE.=%C 8/^DUI6<N?%9F>2V,OV&I)86Q
M7363#C<NS)#.<I#F#I7&=,")Q/--&*H<L2:6=W=EV!8\.9DN=NA.+Z&Y_P!'
M:Y<,OB4O@DCZ#TLR,.@2#Y4ZQ;(QJPPFNQ @-;#G^I;9$<Z=KLWR;86?A2U5
M53\53'HR@'('QK=2&:>Z\@'8Y 6$F!'C<A\6W,4X'GQ$H74YAC@*P1K"YWR
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M=!PEG=/;133"B2F^F=D]]-]<;?73;7;&,X U[5_\2?QL57.(C95=\;4K$)Y
MY$)ED.E(:/N&Y:/20$]1(AS U?9]OA)Z/?-T7+=3.FV-54]<YUSC'T\-NNMJ
M'4VF;$_#!I"^&3_#3Y@?^F%ZO_W17'HL=ZO5FZ\4?L7K4;O?4P/ 4:K#_P 8
MIV/_ .BQP;_VA]W>FKZ+UJ+HNK]*2\OJ0> > > C.H?\!FO^L4\_Z^R;VJ_F
M?;T1FCY5W]629[)H> > > > > > > > > > > > > > > > > > > > > >
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M-A<*CYHJR*R9\Y*/F(MNV#M'BJY1^Q'):[O7K9!45)N83<9A3'78F#P@\ \
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MOECD7I[G;F7LWA6S>3?DV )V>SKGH\M)99(8!U4^D8J6L)0KB3LI0M$I$^-
MC*[,2SRRET0UD8MED/* ,F=BHZL.GXDM-TU*JB596X=E$*$K+?S,M^(WA+F[
MY@J9Z%[Y^0:,G.@+ONGH*QHB%_5[#L $SI""1AF!=1Z&0%C%)*"U!*!ESZ^1
MNRVJZ0T*TC[(:S9ZY,*F@KJ=#5--DDL1\3:NWOW7D=BCKF^ ?QR<"69<[,87
MG@[F>F0HR*"I,:<.R\M+C40< @C:62/*6SQPH8D#X%B4'=4-WJB2Y$@DANYS
MJEL.5*XJDL2SK=3^P/D2LWN7X%+![H#<S-@]H6G,[6J9;GW2<C"T81G5=08R
M9KJR0LS)&6ZQ6.B7,6<#S<;*D&"SEX=&NGK_ &'LB+Q[^QU2I5/XG#-J8<QO
ME->GF]+-R/Y4/DRMVI>S>Z>583R*)XVXVM.QX*UKJW!UGEKMNJ+TUH)?6--4
MY%')&)C$5_& E-#$;%?D=%6JZ+X2]V-J#D'IL3@I3II;;=25U9)O"B'/6=L7
M.0Z&^:6\5K@Y-C%92CF;C*FNE^.ZYZ<A5W]G0JU)G I[8U@;-'.U#I3*OCL2
MC,#2B(]WMB62P^ZS^"JWU=:*#D2D?;FWOWL%0HJGBJ=-7#%,3"_RB&X.>[G^
M92TJHZ[)\?UK<?&/.3VK*%AUH67<O20>TYY#[!L^<!1$ACE4U.+K\F'=L8TX
M!F1YHA-CVS]WD<]WPT8-70Q-(\)31-/$U4TVTE2KPM79ZVCK?>)YM\[_ $#)
M>5OCDNR/1VG>6PG7!>Z8I?/1]SP"U[3H^DIK3I9S&A( 2!@A8:<12MHXP5>@
M'LF-/$(\&6<H.UR:8"1R80+^6N*I7?"DTE:IIQ>Z>)NL_7LC<X3B33V@:OGT
M\FM-6!))'#&!TY/N?B!,E2DKW7T45TD==O3+TD3WC1)GA%X@F\)$5&JJB[7#
M]YHAHY5'-Q-I[Y--KKY$.ZG/'I'Y2PD=YJVY 8KO[ 9<TO(E8^>A3'-0J=K1
M=Q.][PULA"!"[4?QUJO.V$'S4#V--1BB$?=R1P9_$=ZC?"N+@OQ8EM1,8B)B
M;3.-#EXF#Z%F'SF6;(LRCG$S AG$G/)UBB:IZ>D)>SHDW>]VEH^!BIQQ;F@R
M/VQ^[A+@U()TI'W46*#D(PV:U\+*!%B;X2WY:5YXJNF*>4Z[[F^[PP/ / /
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M1!D-&,&Z#1FU1TU20;I)IZ:XUUQCT7U?DV6MM\#;E\"N^M1<WY>/_%>][_\
MHLW!_P!42/J2CYZ?W4^J/Y#_ (>X> > _MK1#_!*+_ZNA/\ =C7P^><'8%H0
M6K6# G.SN +$F[V8,5\CBY+\=WHCLXV2_#$,""J?T1TVW^]5--//T^W&^=LX
MUS4F\$;2RR*OZ[WG;_[(FG_]+3;_ (;]>"K;S7W)QT[^3^Q@U<=2T.!BB TK
M/-&CW0U+7>R&8W+UOHW)RXX38J?B-P"R6?QV+QLO]N-\[I_B?AJZIK:;IZZJ
MI;;:7FMC--222;\GN2]$.CJ8GDB'Q2)S/4L?*_FOR _ "4,LN/R3)R1=?WR1
M"-&:7X3-HX6_NSA/[_P_PT_O5VTTVRZ6KM>:-*I-PGY,F[V30\!"G1?_ "*S
M[_S8S_WP.]JCYEW]&9K^5]O5$U^R:'@'@(@L&_*?JF<5%6]B3H5$YI?,@,Q2
MI I1(CKF9R, +T,DP[,@@R6%,'NK)5#5FF8?#L%7[IF)%;/2SQJR6%AW>V>Y
MED&L*&V2.,EH0;1/#X],YM7IERBV?M=6,RKF4E85- F^A!JT546!2<(4%+.4
M$U6#I1ILX'NG;-1%PH)[\3"#'0E5A;494JH5DQBQG* -T0#P^MK+G8N(-I,J
M^2C;FR)?"HA((;5C>0;#7Z@1:R)!%4BK=FNZ8[+MD]E<"PXG3WC<FKP@\!6T
M5U]S:;:V4\%6L$?)4]>$9YOLM-%B?_-Q&Z9G.8K6L6A1%AN(U?*;G)S-(Y'6
M!YDV=1=1X\=*9-ZM!!EP/%A[:3VB9\$37-YG&:XADNL.:E4@4-@<8/S.6G%T
M';E$-&8N*=G#Q59LP;NWSA(<*8NW:B#)JY=JZ(Y3;-UEMM$]A#$:BN>#7C''
M$L@"<ZU"-G^H_P#&GE36O4+YVKNP9$DW0L-;D*@YHP(6:/VVZ!T2/>A%ULKM
M$2&[MH[00"(_VGZ$J^ > > > > K7V+SJVZXY=O/FAW+%X(VNNO#D!6F#8,G
M(EXYH92U3_5$P:I,,F4V;9TQM^3V*L,+8SG7\TE_\KPM+X6GLY,;L+E)G/;L
MXIN3>;.A:W&[^U'S&/Z@4GB4_P#XGTF8II5)V2R6;;QS]&0+9D":B+$S^>5;
MX&[:--%?SJ8)PFMU'FG]"*;+XRMUOT=8'3?*?3 WGV979#X#$;UBLYI!A?%?
MS]>K$# VOYL+%8L2K)!#IV#CQU]&7)!I*"D=-!FP?0G%EG@M-XJ*FH2:E)RH
M</FL.4_%:/*.%M3AVZ)E9O.'0T+ZO:QKI.BZIL&G)#8DXH"+6+#[&B]GOHJ8
ME)1I6(F95TSKN7H%XD/5 G8W(W"3<5NL!D Z3CEG&C@$U#35FTU#B&IY.5#>
M2,$_BL=,>2,<[#>F)0I98'L9QV] N@SU;Q<H3$W(E>:]Y"'4NKD85C\7ES!(
MPZ=CCK(4\A8XQ^94>#AT>;ZHBD@XKS&B42U;AX;/IO/1EHX=RA*6/3=5=5V-
M<2,]L:!\FS3F63MQ==-82#F9&;V?7=F$+#8LD)6>S%$6CF ZAV<.UW/8PU)X
M<KR95=CMJ^"?A=,6XI\$U'F0?(_C/%R'C;J?D/:X"#5GTYT!<-\.IYK"6ZSJ
M'.+9OM&\E(RWCN90FD<1!+(ZQK0LH9%;DDLY+;#V._T'X!514JHPDHZ)+Z&8
MV'Q?<(_HVS>E>4>G!G/\HOJ.5^#OB(3RC1]\P2;E:M%/(Y!9Y'V/\1:L/0J<
M#(D]_:Y!TC(C4;."QH38C%U'HS1VJ)-H:F)B\1/C_O6+$BNN3CA^]^/>@YQ<
M;^7S?EFK;WKXTNM!P8/%LE[W&5:R,2UTB!?L!4)R'<5K^::@10<HU=)FORV7
MC7([\=^$V:C,=H9"%@?&?'+%ICY!J<*VR=8->[[J_CAF1"XNP3?U))!\0IP'
M&FC)F[+NVLS:!Y#38>2.]G>8_P#JS0DZ Y28_@ZEE1>*]+CY4EU4N?&2PXFG
M.H=P_/>DNZ[3(R>M+"+RJ["L0H>)P^/]"Q!X/D;$57:T9(RF8NJS8"-R@1[N
M> R0T4(NP.ZN^K;)%/(P)5_ARK7=GOSULR-/D8X&!_()4,#@:MI2BDI_3UR0
MR_*<M6+!Q<G<0VSH(@8: R1.)&EF@V4"-&YQZJJ)6(#-]GZ(]SJ_U1;N&CP*
M:N%MPG*::>J9#O)GQJ3^H>L)=W'U/UN>[ Z9.4\UH2-2;2FX50<)A58)'VTF
M<C!T"A9>1-WYIV7:_C?K;DNEA))^83RP5W?)+-!75-*I222<ZMMQ$MLX_P"6
M'XF8C\I4<I8>2N,_14JID]-U6$UC450E1$O![-CK6.6%!5&RLEB^6362M!8?
M5=]N\?MM6S5VP=!G[8DOC0**^";)SOI#E/LS"!7PIT^!^3.)?(<!L<J*!0X'
M'?TKFM")H9A6D^B5,8HR-3[61_N37"3H1$$![MLPUB6SG]?8)D]C><JJ(Y#C
M?#PQU<WAN6N[R?,M\5'0U37?T397#?R(RCDRONJ+,*7-;E1D>:JMOMFWM*29
MWWEDMKF3SHZ*WA*Q]=59PJQ6 GVJ&^S9'?5TS%AVHX.)-)54RTH3EJR=DXTO
M&_,SB_\ XQ;1EO2T2[+Y9[3E7+G3;>CA//UK34O2T#O:)73!PKQH49D)/7L@
M+PX6)EVQ5DS=K&A#_5KHF-%-6 I@FW>;$0522X6I4RKPTXC,.W(Y*SOC(EU]
M)\$ENA>JC5S3WC&[Y+=$MF,BIJ#!F]^;24GL\WA9&'14F%BT!C@T9HSC;%-D
MPE'X@-GHB00>NE5G6PG%\T*)LKNR33UNW97ZVVK 8^!L2IRU=?%T6ZJE$>YR
MFW4$1Z2I.$$*R:R5QSLB(D!*02FKP!EU8#%>51&1N7 [(K=TB"5C;QD1,.&T
MC+2(P[6&N.:E4U=)IN<V:E\[_0@OYR."G/;O<?Q@0V+5E:)=.1RB71GI>RHS
M$Y&M607F6,2:$6"\CECS=FPR %EW3\=+=Z]$$RJ&JYXDOE5JH_>Q[\07\.KA
MIK<K2%-YNI2Y)W9V,K7KUW8U2S^L(]-Y74CZ8P8_#@=A5PZ1#S&O'1<.Y%C9
M1#G64MD&!F-JJHD!&V$L)I+M4M<?9K]-M1S3AIV<.8>'UY&I:K/B9N8GT_0O
M3G<_R SOMLKRGO*'W.,,<T16M#1^&'I4S8,'TCEJT#*%W5@&DDA0=ZF_>:"'
MJY@('=OG3MBU6%NAIUJ&J:4D\ZOHF\*>_,CA#X5;AI6T+E/<#_))<'%E*] 3
M4G8-DT('IV!6R%82@]]-3SZK9++#@M:LU7*.$V8\@+!OSPY@S$CE#+]@$$-F
M8KK3255*J:4)RUXQ$^.^YM,N[D:$="<=2OC.TI1-Y5$)E4 VJ#E@&BR)2R2+
MH**&MA5BE#3QMNU*SI$^''3!V_?,E69*0HJ*O6:K9=9OL,)PTUHY-5M0?"A<
M$9M7BNT[Z^1RS^C5>$9"T2I"%EZ3A<#AHJLV,8S'$8<LU RP@8(3!SHRCF"E
MIR0S)39(5'& 983C7";U ;=:^**4E4KW;>=WWM:[UA(X:9?!5/-DNC:=I/Y"
M;0HSB#K"SS]HW3RR*I6NY<76)3-T/<S@'7UW'#"$A@<>D*0Q@*R.0BQ73]$8
MLQ9O]PHY(;$0_,PW2G52DDVWIAM:OG/62=>N/B=L;HBKP_+U:]D+4AQ4UJ:K
MZ@?\X$^:ZPN-P,!U8T;"11FM[4E)@-*X#)B ,>+9.RZS63K-'K/8P,PT>.E\
M9$IJA\34U3,S'BO'Q/GF_P 14OA=VPWH3@_LF6<>64(YTKCE^>[R&G(5TC%K
M0K:I P6/0(@<CDR-Q+4?.18>. F+J3M'R^'*(=GJV&C\.CV#8*I1%2XE+>8:
M;SO9VT)4O'ACLRVJ-@E2#ODB(L"^L'L"#7])[#Y$HRU(W?K6>&52:)=Q6J[R
M)@:\*P]BX6CT7TC[]^*T#:,]2XTJ^;;OG B:3GAFZ:NU$>O/R@M?Q-R;"N'>
M5Z?Y3@)P[*HK4@ F*;R*49;9,'R4ADAN8R4J[0:Z:M62!"22,PY8BD,JHB1R
MK47HX=:-,.%1&W4VWEN2@#7XDILUJ5?CC'8TAV^/%>6.2?\ 6W:TQ&$[0UKI
MW.=[$7HC'2&);L^_A2J>54&*::UGI.\PQ3>))3=)EG5;5'OWZ=L%547CXMYZ
MWC?O$K!L# <QL0'8\]ZY0EBNZ\WYPJ_GC%?: D6[(.SK2PK*GB$F1/Z$]MW.
MY7-AY$_HOZ*V2'IA]7>A%UE]^69B39+9MSU26.VY:7P@\ \ \ \ \ \ \ \!
MQQ@N+CXDH>.$&@D*$'/2Y<H_73:L1HL:V5>$"#URKMJDW:,VB*SERNIMJFDB
MGNIOMC77.? :'E/ZI-^,59R\U 2&_)>+;/'31M(XQSS8KX$5PU6W0V=C7#I@
MQ=;ME=M,[)_FF31QC7.,+-TM_KIB-I9:74Z?EU?]JY.I3W-];5RF\:MG:/W?
M@ND$7*7WZYTW_#73U5T^_3/\]-OMVQ]VN?YZY^N,_P \>IS/?X!X!X#2%\,G
M^&GS _\ 3"]7_P"Z*X]%CO5ZLW7BC]B]:BTOR\?^*][W_P#19N#_ *HD?4E'
MST_NI]4?R'_#W#P#P']M:(?X)1?_ %="?[L:^'SRD?R!_P" <$_UN=?[F=>W
M1E]/JCG^)IW^AJE]U.8\!97D#_PB:\_TRK_J3)/9K^5]O5&J/F7?T9O#]Q.P
M\!"G1?\ R*S[_P V,_\ ? [VJ/F7?T9FOY7V]437[)H> > UX=I\EF.I[*HI
MENF[%0R,0?H-J2L42_$H2&JK(.-ZL-TA8478OGB+YY)X=84':3&/N6+-XT'F
M(TRV+_@M7&FC@5.$^UMU>5Y_:Y6^FN-^MIGSC&A-P'X-2%U;W[UA:-A"14CZ
M$.1<LI<EVR":!B47)<S]8\U*Y#$&+C]:',)VXEA44.,LQ^XV)&F\A;$HE'BW
MXN2MJ7%U:)B;+64_+S.)#<H]35ET/(B$,1MA^\F]^\@6-F]XU>Q,1SZ.IVKZ
M>YWJ#HZN+,HJP+UE]B3:8SR-TK/VL$,R&*W(:8O+,AAI]<8L[&I.;7OOW/T_
MLLJ-,-1K,U--.(24J5*F,8-VOA@> T#V%P/TBW+M+!J^*BDY#8?R%#9#?T5>
M2N-,$)5RW%OD9CW7U67"V=_JFS%Y-*J8 I.D'BJSEM('41N6>#5A[B2B  /,
M5O%^;DVJDI_;'?@=/UO;1:%QI%QG.-I;=$SFDA;7-6<^CUW#2U"Q>0]5 )?-
M(S9L=E(92""S-F=[DN?@IAV//Y%HD]:IA$:'.OHYBN*RU2&$0%).-&HO;Z4S
MYON2/Q5!+CA#BY]9D#MZ TT1D,,3H.I[^M<)=EMP8:(A[8?/').>A+'N376)
M2.1:M5X=%R%LS0@#1'%'F^8^U--8\.$<=]6E"Y>X7U+U^$'@'@'@'@'@(@OJ
M]:VYJJB475;IAV!KV'*1Y(^69""9UTUWE$H"PX-A,4';/"+K#@](!;53+=LI
MANDMNY6^QNBJIH]^)4FW")?\(/ / 1!;MZUM1N]6)V.8=B-KEN"'T5 ,-1!,
MM^J63.VYAS&@[G(ULYP+:/$0)+94N0_+C&>4=-73E+*R6-@^A+_@'@'@'@'@
M*?W9\@'%7-\[Q65\=-5'4\]_1A<A5C$VE3,*1:@C;AXU%%WV''T0'CWRS!YJ
M@Z>K-TLZMU%-MM4L??D7A;NDW-E")_)VU586M5+F+V5 AE0)1MM,E+3?R^/M
M:ZUB+QLB\9RC]ZK$-(YF/O&CANY:&,$LCW*"Z"J#A315/.PD.8B^(UG8KQ1?
MR%<2=,3/:NJ)Z;J6QY[E@Z*LX<%DJ*$D-"&*>ZSTQ&PY30>^E =DAILX=E8Z
MB4'MF^/S"[E-'.-\BNFI9375-'U%>_>*P=WH\WE^FZ@'W:M(V4,Q ',N8:$D
M9L2TUW&P=X^^[(5C.".%$M&$,>DV\G>K+MT&PI5=PBFH'"\PXB<:;GVWSW7Q
MYR_* T)Z!Z+JVJ9<=&)'&,=E<D;M"R$>7?;#$)*99HX<*QR+KD=%6*,FD.HL
M"J[;ND$R&RK1SJD"I;PF_>.;OC)EMU=8\U\Z0J-6)==UU[7L-FKAJUA)HR?:
MJZ3=P]8ZE&J4+9C<OB,NV5%[:E/_ ,'69+&@S."*F=6?]W\"3;A)SMJ977]\
MTK:M4L[TKJU8#,*;?"21Q&S@DI$.H2D*"[N4CCQ](/S6HX9H!69/6YY,DNT6
M".F3QJ53:.&CA),1J+,^NG;HJCH*O@UKTE/XS9];2)R<: 9O#B2)B.&%XV>)
M1@Y@:3;_ %;O4QYX.3&JKM]E$%%VBNR"JJ6=%-A6FG#4/9^)QM:=!4A<TCLJ
M)5-:L&L>0TZ=81>T!L+D(^1;P>2$F[ETU!'W Q9PT:%OPV3W1RP_,;N6+IF[
M9/DV[QLN@F#342LW7,F#P@\ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \
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MYU3TVSC33;;./IKG.-4I\2L]=.3,55)II/R>Y+O]<SSG_P#9ZIS_ .Z5#O\
MWQ[,/9^#-<=._D_L9S#;*KNQ=2&\ G</F^@G9KJ5WB<D#R'4;L]PXRSU?;"7
MCO#39WAJZRVPOE/*V&Z^4\;82W^TTUE-=2IIX9FWH4> > > > > > > > >
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M;,&[59/"7XF4?IOLN]:[8W^Y/;/TUTVU^W.,_=]?KC'H/.9K_'F'?_J^2?\
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M*7_UI/\ ^TU_^][)H\\8QKC&-<8QC']&,8QC&/\ 1C'\O 42^3/_ ,!N^_\
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MS:ZK:LV;1!$<FV\[)=E@E+PAJ#J+Y=:SZ!^1M7A:FH(?DL.#599DO/\ 0)=
M[%H\3G57S!G#I-"Z\!FHXVWFH0"66>!SLW;%&@Q.1CGXH2W*M6OZHN-.EJGB
M>K22Y--I^6,Z[3M\\,FD+X9/\-/F!_Z87J__ '17'HL=ZO5FZ\4?L7K4;O?4
MP/ / / / / / / / / / / / / / / 1G)O^4FK_ /\ 9YW_ +I&^TOEJ_\
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M7QI):X&?%Y0QWGZ&=X(%RE-E9*6+&1UZ2"N@*OXD1*6^P&M*]&2-=XW<28-
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M W$1.?MU2!/6L=CLHR=VBN[1TW=;:C5/S4-_-PU<4YF*XFV8C.5'?:147/\
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MU R;+28NB"$L!"162'W>Y [("28]NWT?&S3]11Z6*NL*OR3M3=R\<++;[;Y
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MD]7QC7"SM]C3#IPKC77"BRN^^,8^OT\.!S'@'@'@-(7PR?X:?,#_ -,+U?\
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M*DM!9LUK2:#3J<A8V(^=MGKQ,9!64=T*EY<73:C":[P1'QQ FP3&$]GS1O\
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M+$OD?X:G,%M2RHKTO6I:$TBB#>6P;T?OVN(,)DSM%C')$;'/A[4LG%#[A;7
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M_B9.OH&YET5KV1]D20L86C;@W'H8>Q10?]D&B[[+-R,!$L2!NGO%GI!5LO\
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M4*)RTFXY+73)Q?\ 5!!=M6_,U<=A5AU),:5Z7YFF@8IS?%X5-&*0B]C5D3&
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M@'@'@'@'@'@'@'@*]57_ ,L_4/\ KK6W_8W"?5XIZ?5@L+Z > > > > > >
M> > > > > > > > > > > > > > > > > > > > > > > > > > > > > >
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M#O*V9>IB"6[!=*."/S4A:LE76^HI^+:%$]ME&6F/"UJ'4E2DD\Q]3LM^',>
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M-NBO[WZ/(-8M9U>#K;DCB8EJ_LT&OS/<1:?C8)("IAK#2L=FPY8K&,#!A!H
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M-^IC51Z_<8T_%=NM]<;KK[[J;8QG;./0')> > > > > > > > > > > > >
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M^+0O-316R+9F&]4U?V9"9/\ %CKR\>JFHAT*PG99V<=.-:IJHDYD5:&0HD:
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M);Z:BO\ #:RZ%UJ2,G_L\-$?YEWR?_[%4L_XB\)P/]5'\T/[/#1'^9=\G_\
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M!P/]5'\T/[/#1'^9=\G_ /L52S_B+P<#_51_-&\/PP/ / / / / / / / /
M/ / / / / / / / / / / / / / / / / / / / / / / / / / / / / /
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M?D,!:?".XTS27-C8WHU<:[R,CNB1,X=:ZN6B&K?7"@Y/I%O'G<L'X0> > >
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M<^I*HXJHQQ..DET_#(\ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \ \
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M5Q";2P=E_P"F,?7Z8QCZY^N?^?/TQCZY_P N?IC&/]&,8_Q>',> > > > >
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MBJI^"E]^V?P]/H*FUAM='!D;*KZS'9@FP^NX*PVJU)^WK+9E$0#7-=(%1*H
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M.8H)M6+!@Q:II-F;)FV22;M6K=)-!N@FFBBGHGIKK@0J/SQQQ":*@ECU*27
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M!)B1R%49EZIIL2>.-EG:PY-MV;;2PFY@L;X0> > > > > > > > > > > >
M> > > > > > > > > > > > > > > > > > > > > > > > > > > > > >
M> > > > > > > > > > > > > > > > > > > > > > > > > > > > > T.
M?,MRMT5-I-S5VK2T>0ZB!<5R9S84RX FZ&KJ!7 Q33>X?6-"F+!ILX*W=#13
MM=2*L)&WE;+&&+%W#P&YQN7BMD#I0TII?P\5N-95\9P]<<^6#_"'!ZQZ?K+L
MKNJ8$*CF<G^1>P&S*[N>82*3<5O2L7K43(X='J5F\9.#6+@U8#^.2D@9LXV:
M!,F,S5/-"XQJ]&O]SAT*VTU3=*B4IS?+Z3\O*#;_ ,C\CT_Q+4&E%T2E+V-:
MLYA,I>#!2Z9'9GB+9F9MP;7B\77..7&X.'!-U\,P0%EC1-+31<J56+28L>/%
MAAMU.7GWY[EG/"#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P
M#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P
M#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P#P$+59SG1=(2:VIE455PVO
M)/>TQ1G]NF8L(1&.YW+T&&H],V:RC_<\KX3R[>;MVB;9DJ9+2"0*MMSLC/$2
M(K;<2VX4*=$33X0> > > > > > > > > > > > > > > > > > > > > > >
M > > > > > > > > > > > P*U;'CE.5?9%NS'+_ !$:K@4PL>4Y%M</B>(Y
M!X\1DYS(YELJAJ\?X&"W7Y-KLNCAPX_#2RJGC?[]0R5,AWR-<V3[F"L>MHL0
MEQ&KK3M.NZ6%L=HYHTF\:LFQK=$4@QC$VC#LDBI'7T>GAENWE">[MSNS%)J%
MQNA9HNPV>BPY:U4OLE+\KE[=E$]=]$]E--5%?N_"TVWUQNI]F/NW^S7.<;;_
M &:_VVWVXS]N/YY^F/"$=LK;KPC;4CHQE(TE[5B5?Q&TI#$\#R^BPZ!SR03*
M+1,_L54'Z G*98]7\N8:L&91P59[!]G!!BT:/1R[P(M.EUX1/JB1,*)[;[IZ
M[Z;*)XURIIC;7.Z>-\9SIG?7&?NUQOC7.=<[8Q]V,9^GU^F? >?@*%T1WW%^
MC#XIK6O._4SF!F)G/H0SNPM7L/'5'^I5M*I1!Y0_6-XL=S($Q#>60\T#;N?V
MOEPN]21UV9I)JY4T&G2UEJ;6F]R^GADKUU/T,#Y8H*Q;]/@24L#URV"."$?"
M.V;0F^R;DX*,))-W#W.6J.Z"YU!VKA?_ .4@EOKKC[]]/"I2X+"^$/C?O41S
M-R\6SC.K=NX7PGC;77=;\N@HXV22^_.,;*;)I;YQC_)KG;/TUUSG $(<PWZ"
MZ>YRI3HX$%(10!==;Q*QQ4?.N6:Y0(REPML3:"R+IGMEDN\;8=:-U%&VV4E5
M<?5/^6V,>%:AM;-KP9/.ZFB>-<J;Z:8VWU3USOMC7&V^^<:Z::_7./KOOMG&
MNNN/Y[9SC&,9SX0P>S)\RJ^#2&=OX[-I<W -FZNL8KB)%YU-SKMZ^:C& R.Q
M<&@N_(O7;]ZV2W5W_+#1C;9<L;(# K$@1:@K_P!D#\W]@P;I"56Y7+.!6Y3]
MLT:K"M[)JB[(H*C,R#!;('%R<!E3):-2691(_&I4A'I"D/(@9214;/09)B5;
M#G:.B2HKI:AVAS#33F,^NIC]^]QU_1-@JU.QK"^+WLD176MO3:'<_0!C."E=
M5@X*% HJ83-4S)8F-;Z2$F D;6+Q@*^.3J2YCAM4'%7R#!17()2IE)3%]_ZE
M3U+'53:\ NVKX'<U92-G)ZWLN(@YQ#9*WU6;-RD;D0] F,>;MWJ;=XP7RV<:
M:/!Y!!L_'.]%V+]LW>-UD4Q&H;3RK,D+[]/O_#^_7\3[?O\ P_NQ]_V?7[?O
M^WZ_=]OW?R^[Z?3Z_P OK]? ,;Z9VVTQOKG?3&N=M,;8SMKC;Z_;G;7&?KKC
M;Z9^W.<8QGZ9^GU^F? 5%OGJG2G;CINFP\*VG!NP83>UNSA5N=P+5KJFZ)AC
M9^6F*C3442P4>2*R)76U= 1CQR":N%9,6+:E5,QQ8<[%2GR7=NR>UI?8ESGF
MX!G0M T=?P4.^CP>\:?K.X!( HNW<DP8RS(6$FC .1<M/[U</AC4VDR=KMO[
MW5<(**(_W/;7P-0VMFUX,E[7?3?&<Z;Z[XQMMIG.NV-L8WTSG7;7.<9S]-M=
ML9UVUS_/7.,XSC&<>$&V^FN=<;;:ZYWV^W3&VV,9WV^F=OMUQG./NV^W7;;Z
M8^N?IKG/T^F,^ _,J)Z[Z);*:844QMLFGG?7&^^NGT^_.FF<_=MC3[L?=G&,
MXU^N/K]/KCP%?*\Z'!6'?/1M#- )$67YRWIY,T>>NV>XV3;W##7LR%:"&Z><
M.F^PEJRV9/=7?\W#C?7=MC*>,^%:A)[SY,L&HHFEC&RJFB>NVVNFN5-]=,9W
MWVQKIIC.V<8SMOMG&NNN/Y[;9QC&,YSX0_=]]$]=M]]M=--<?7;;?;&NNN,?
MTYVVSG&,8Q_ESGZ> CJ*6W7DWG5IUK%I&D5F]*%(J%L\%H/+M5(L3F\1&3N+
MM57KX>U&$\E8H8'%]%0CTD@UT<X:/E6S])9JF+#L]'CGH2/X0A[H>XAG/%!7
M??IH._D0>D*BL>W"H 6NW;$S@VN(>8F#X0/<N_[U;OB38.JS:KN?[@DNLFHM
M_<]=O"I2TMVEXLS$!,&\B@HB<,1K]=(O$ALL0!M/RSDQE,H$0-MA22>RZ#94
MDHDX3;(Z*.$$%G&VF<K)I;?B8$/17,U4L"OX;/'D.F=;KR^/"#RL$LH<.!SV
M(K%VJ+G]NS 2++G1@V2#=UL,R;!B:*-T'NBB*+UQC7&^0(QA/0X*:]&7]SFW
M DAQJ@8;0TQ,21V[9["9 A?6+/\ T5@+;:9P[;N0F:P?:O\ =U_:.MRK/5IC
M.4EOJ+%D]VUX1]T2K84M6@4$F4W;1&83]Q$(P<DB,&KX<P+SN7JA1S@AI&H<
M**% @XE)C6S? \(P?&!;5V1<-T%W[5/?9;03R]\CG!1/!(.*+KL7X38HP'O=
MA1M-NU*C%2""*V!A1%!RZ;(DVBBV&;M!N[=):.]%$D7"^N-5-P.4\ \!7I7H
M8$AU2ERNJ!(Z'E.>W70F9;N[9Z TPC6QV=<;1_=KMG#W!/=\\U(X<_7#3#73
M*6?[MG'A8M/."1#D]<A;&@5?)P"P3;:<AYJ6<6&$$"G5=07>&Z1_= 1/#+DX
MS*B3$SR>WTA388"-(E-P1_#]R*U9(;.Q##^EKR#\U<]7CT(;#/I.'HVK)S:1
MB-AW+5J5,L8/&R$E<B63EW]6K5X0;L-D&RSK'X*>ZNBBF,Z8SC(J4M+=I>+)
M;!%T#P<68;ZY23)C1Y+#???3=9MJ19(/DT%_LSG7"NB3C3[OI_+;ZXVU^NNV
M,Y$,.=VW7C&VP%$NY&DC:\GKN5VN"B.1Y?=9_7\(DD.B,ID6I5,?N";IBI%/
MHB-V'NBB!9WL7U<,&#IFR(N&@1:=,>,QZ,P'FKH8%TK!)%.@0$C&6T>N2^:<
M4&%W;-R\=D:&N"8U 8.(;,\_AX'G"406,,4-L97:,W[9NZSE?3?;85J'V3\4
MG]2P>=],;:Z9VUQOOC;.FF=L8VVQI]/NSKKG/UVQK]VOW9QC/T^N/K]/KCPA
M^:*)J9WQIOIOE/?*:F--M=LZ;XQC.=-\8SG[=\8VQG.NWTSC&<9^GTSCP#51
M/?.^NF^F^R>V-%-==M=LI[YUUWQKOC&<YTVSIMKMC7;Z9^W;7;Z?3.,^ _=]
M]$]-E%-]=---<[;[[[8UTTUUQ]=MMMMLXQKKC'\\YSG&,8_GG/@/Q15-+3*B
MJFB:>OT^JBF^NFF/NSC&/KMMG&N/KG.,8^N?YYSC&/YYQX"/)3;=>0J>5=64
MGD:0N<W0]EHZLP.X\NY4E#V"QAU,Y6@D^9#W(P9D1&F3DGON:>C4G6J7Y9CN
MZ>[Z-MA8=WMGN>R$SYS,C%C"7$ L&%)U[--H<V,380*&![#0Q'0,@_>5=.1Q
MPNN9A>=SNX#!,JU!/_W"#/,LBL(,T7CH0D#1317351/?11/?&-M-]-L;Z;:Y
M_HVUVUSG7;&?\6<9SC/@(\M:V:]I"LIW<EHR1&+5K64:,S"<2?=B4+I 8['F
MRKPR14' &)4R^_(MT%=]V8P<]?J;:920:JJYQID$I<++LC/M'3=1!!SJMI^
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MW4=AP&P9Y:A",Q9S3LTZ/3EEN3U1K>M<6(WU8"2\^#C+7+$IS+6!=\08Z/\
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M?\N/\F?YY_\ ;X#]\ QC&/Z,8Q_/.?Y?Y<_TY_TY_P ?@(7ONB(3T; 6E<6
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M*-<,CC@6E@D#1:++,]BMY^;DDPTU9I1Y1YHRNNJ!ZHBL>G+22]150_EI6)H
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-#P#P#P#P#P#P#P'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g729258g06j64.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g06j64.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2UT4&AO=&]S:&]P(#,N,  X0DE-! 0
M    +5B^$6"#A"24T$!       1AP!6@ #&R5'' (   )G91P"4  (<G(S-3
MDP.3,< @4 )4UI8W)O<V]F="!7;W)D("T@4&QI86YT7T-L96%N7W9E<G-I;V
MXX0DE-!"4      !"FQWK(KQ'(Q1YUN4.I,!8(.$))300Z      #E    $
M    $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&
M5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M    MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V
M)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M    $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P
M X0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M  0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F
M)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
M !        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&
M]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4F
MQT                0FQD(%5N=$8C4FQT                4G-L=%5N=$
M8C4'AL0&<%RL         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M   %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W
M @56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !
M!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M        QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&
M]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      !  N"
MY6  $  @"X+E8  0 ".$))300F       .             #^    X0DE-!
MT       0   !X.$))3009       $    'CA"24T#\P      "0
M   0 X0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &
MQF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M ! #4    ! "T    &       !.$))30/X      !P  #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M    0     .$))300:      ,U    !@             "N0   QD
M   0                         !              ,9   "N0
M             !                         !     !        ;G5L;
M    (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&
M]N9P          3&5F=&QO;F<          $)T;VUL;VYG   "N0    !29V
MAT;&]N9P   QD    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6
M-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M  !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T96
M0     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T
M]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G
M1L;VYG          !"=&]M;&]N9P   KD     4F=H=&QO;F<   ,9     W
M5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;V
MP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T
M53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G
M5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&
M]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&
MQO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M   C_P        .$))3001       ! 0 X0DE-!!0       0    &.$))30
M0,     "+S     0   *    "-   !X  !"&   "+7 !@  ?_8_^(,6$E#0U
M]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M  86-S<$U31E0     245#('-21T(               $  /;6  $     TR
MU(4" @
M         18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48F
MMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D
M 49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]
M0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<F
MEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M      $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3
MDV-BTR+C$
M               %A96B        #S40 !     1;,6%E:(
M        !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !
MC:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W
M=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                          9&
M5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W
M!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%
M)'0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &
M1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14
M,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:7
M1I;VX@:6X@245#-C$Y-C8M,BXQ
M!V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M!,"58 4    %<?YVUE87,          0                        */
M   G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *
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ML)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W
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MD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8
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M@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,#
MP,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1#
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M "$0,@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M !<! 0$! 0                 ! @/_Q  N$0$  0(#!P4!  (# 0$
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M.6W!O2IHM(I@@W;D0:QT6T31303*1-NW8LD0(7D*4  @-D$2@0A0  Y0Y0
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M>R,Q6RZ99)-AP,$3UK^UV67N71=$:)V?%QZZR;"23,L<.66:.E6 E*8QC]H
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M(N42E7\#,'6-Q1L?Z/\ /^+]-DGAS,>6\F9EM*7N6PXC%<9&R[B7=QSEPW)
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MX2T+TC[DT9LX][>DV^/%'@KL2DK;3NA(+9,B\5=<XLU 2'VP2;$!4VY1Y!W
MC#Z7XZ6GZ#TIXCU=2.*<PDL7+V;)'!D1;K-O O[JC+A8(NE!E73-M)'1=LWB
MK4K-FV9*+.SN5TMT0*)A!=Q[+3/<N-@OB>6/J<S7=6BW)F%,]:4LQWACV=N*
MPHW)[1M!R-Y6:[9KLU9VUI2&?+K1TVQ;K>G@@8Z2[19+9%4JR7*!'Y^#EJ O
MO(6*\Y:>,P7+*7EE31GG"Z,)S=VS[MQ)3=RVD+Z1E,=S,Y)O55'4A.N+<*5*
M3=JG,94S=$QA$_/0O"X3'4"@4'SW"0*@L0#@4%2+)' 1Z@)R 0IB]^VP"(B'
MC\NX!JJ:5</7XOI*XU6ABVX165S=$YERD]M:UCJ$:R%Q065+;:R%F32)W1R%
M,WF56[Q-HL<P(F[(I>;;FV#U^1="VI^<TZ<#RRH_%#U>X=+=^XOF<[1GIT<!
M[%9PB$(627>[K;.NP5:+F,+/M0YTQ'F,)@W+KSV;\)V4KVK+MU+\-S47J,UD
M<5)RSMOW-8[U+Z9<967B?(<B];EA9J^[-9P+XD.Y(@HH[;,U92)]KW*JB1 (
M4QS@4Q!"AA2-<:^S'?2#H-SE/94TD67D_0;DFRE]-[V-G,C9FR_J-N>XL=,;
MKL=)$]MW#A*U6<B^:'&3D&: J1 M6S%NW5%N8X-DCF&;>'3'6Y3G7E?:==BP
M>?\ 0WQ',]6!J@Q]FG31F3-NI24RFO<]B9SELT)QF X3&3*>9OHN/QOCQK*-
M(QU<KI@V%GZ ZA5RI(.#*K+)ND3!5N\;U6*1IE.&=9QSY^VVLLLM:NB_)%_W
M#A"XL@</;(648V&TV8ZM2ULN:8<G^X74?8>0X*V(YJYMG(C1^\0@G4+$R171
M6T@W1=*%;"FDFX,9,42$O'7!\;(F@KB3RW"^T\P]\Q\IF//^ ]6L%J!@,6W#
M=3>;OQAB2'2=-(JQ'MTJ<K>=NB-!V9\X(*BZA$%3M4S'.D5()3M?"\*+A7=X
MWXXTKQFC(NRL0ZW-0O%#L_6;DW2U,X)QC])[>>)(J(F[IA)JY&<JY93IV2%S
M)1BATH^0E)664(T:)F/Z,Q!!5P<#G$M6[OPEW?L^CI X<>>'G!)R[HIR3;Y,
M4YIR"OEUQ%1TTY;K-TI:4GEY2U%9AS'"N3T&5%NT374**QDT%?WP@@7E$5G.
M,ZU[_N;$G1YH2SC(92T<6-D[0-DRSUM-TY!364\SY;U(7).XUC9BQRIDA[DP
M?:;*3?MUY&1.S3,E'%:-8YN58J'1DF90!A3ZSB;C#>NU:N@S5;'\/_B[XC=8
MEDT,CZB]2.7;SQ!;QG\:+F\[7N"YBOH64:K J"**;IMS+$(Y.FH7F$H@01I>
M-,=^'UP6=TX4C#?C6\>Z\>9-%6HZZI_@>*0^-9!9CI@:VRRSRLW>L$SX_(G9
M%NPDD#G98/2E$7+5R01: J3G2 P"8#%$Q+XHT X9VI;"XY[TT2>BS)NI,F4,
MU3]QXXRI;^H2X+)T]RN/KSE2N7R65;7CY%LDTDXIMN#A46#AV]<(F!4PHD;B
MI.O&_CW:C?3*8QC'+#9G7+2FR$NV/-$N9\=\6+31EN-QDC'8"Q1H<@<*KW3%
M2_MG"0-TP\$YC1MI@M)"28>LVXF2;L7[A JSAL"9UP*?GY;C??#[2N%-]:\M
MNN.W[8=2/#JU9S^F?C;X]2QJXCKGU+9J3OG!S)[(1J89 A&+A=\HJS6!4$VZ
MKI,.S32>@B/I!DR ('-S!.][<NW1-D1I%$[/#NN7+4[I#Q)'YEPM<>![]L2U
MX3&R]F72]:OI%RWLF"C8%G<YA:>]093:C51T@T.(JH(ARJ"(CO5&L#J<T2<1
M3/T%K6Q]F+31F/.^<KCOZZIS"V7WF:DH+3S;6*222BMMQMDV&RDH^/>WB2(4
M1:-V;^+<"J<%1>J)KI<YY/YA7%8IAQQUIQSQB9BD:,VI?3KK4TD:EM+&O#$N
MFZ9U M2:,L=Z<LTX7AY^,B;^L>X;0M=")0?Q8O ,VD&:STZBCI5KN0"HB"@E
M3.4PU'Z]5&FCB:ZRM(6/,UY8Q?C>$U%X)U2LL]XHTYVP9%FY>XKC5"%3M6[Y
MCTUY&R=^*,@%5)5 C0H+D,4Z(.#% "_''9R^MZU[3+&H3/W&^T4W/GW3T\TT
MFE]+69H.R[&G9^.G;Q49*IKMIR<N+VM#L620S:PIPS)3F6&.3*X6*F=7EJ7^
M4I/Z;.?Y[UX1SL@;2_Q*K*T#:V.&K;VC=[<"EZY(R1?D!FKW9P[>TKCLZ[[P
M0N(D?;K)0_ILE=CHJ+8C-B IMFY!<F?+)'2(0U3;NPY:]>B2.S]'6HV,U[<-
M;+4ACQ\AC["&@R7Q-DZX1?,CM[;O]:"0;(6^X3!7TE1=1P(IE4;E.W$0,;F,
M  :I%[.->>VG ?'T,<//.#?AKZW]+&7+;6Q7?>?<QY]EK46?.6ZXKQ=SS!Y*
MT)5TNQ.J)6#XS= J@G$%2-%E.@"4I LQ59W;O:ONCYTN\/#/ZTQI.P+E?0-D
M9"4P/?D!,95S-D34C<;K!B32T)9*2A;PQ#:<7*.FY)E4R*!B0K:/123,)40$
M"F<F)/K6^77,F:S,Q3&=/F.^V<8KFR9M_ .O_1=D3B.X!Q/I9/J"QUK=NF]+
M_P 5YH;WA%0L%:3B\K8=04G'9#1?$,Z17BD':BB#1N4RDD]0 K8 0<BH2IIC
M7KAUNM>,RJ<&7 F5],G#_P 18:S9;2EG9$M=[=@S,$LL@X.FFZF5G#-=([8Z
MB947*&RB9>83 0Q0,7F 0"1%+OV,V(6,-(6H:$U?\8S(LKCQ\VLO4GA?W-88
MF#OF9T[TG0MZY67H35(JW.V,+AZV3 794P*"H==A&KKVO#SS'F,)\.3-=Y<!
MP^A:]XA+%V<9*U;H4;Q$NN@=FUN=O>KFZ85K*+M3G;@UE^Q1156$QR(E<@N<
MI@3Y:7];5C"<<>^%*85[5VL;KGPWQ'==MA:--%67-(*>G.R--63L77CF;/,G
M=L5)6W.,,0\A(Y+&#&- CMRM<;9NJFH!2\K-TNV/VO8)**!-^G#;?ZEW?!D!
MB'11J/M::XX*TCC5\S::GU;J1P(X,^8*&OULZM69CXXR!P6[1 [EPX0*H+P$
M@*HL8V^P"-6_GVVM?ZT]-=]:=N?797)9B\] ^JQ_P_\ A X@C<2R*^0M.^?\
M47=F:W$W<:FM9UOPD\+R8DWBQ5>1<C-(HG,#4RJJ@B8!$P@-&;N]B='B.XQO
M;,^AG4]BO&D&M<=_7WB6Y[<M6WT54&Z\O,/&Q"(,T55SII)BJ8HEW4,4/,0Z
M (0ZYYT2:FKJT \('$]NXL>O\AZ<<H:=IW,5MI/(Y-:S8VSHINE<SITH94$7
M(,5DQ[<C85!5W$2@;?>A'SKRY^[+_*O!6P]EK)M\Y.EM4FN&VI"_[IE;MDH"
MT,]R$+:<*\FW9G:L= 19(M4L9$-E3@FP8D.?T5$A4Q$2   +V?NRZL/>(_IH
MUUX=TH8PT/</R%S?FC'MRR=Q2.;\K7ED=I)90=VJ_>BX<8_;7?()-7C1&=*N
MY26?(-2JL6)$&R G(HJ%2;OPL9W>#-SA(M\T8]QK)X'O30*VT48SQK%PRECJ
MH9#0O][D29E#KC<,E..RQC)V>7%1)%V\?O%5E5CN033*DBD0@5.=4?\ Q,;P
MRM8/&SX?EY84QNCE^_[>PAE=\WQPK,,X)S<L$6.N/W1-824>E!JE.IQ0NG$4
M1<P)NWR"#01("IA$++7+PR]8^O&U>)GJ#R/C9OIQR/JJ98XB\*88N6?0>2:C
M/%4K$SB1[V>QY1:QCJ?"%;Q[8RGOD'*ZSDX%0(F<Y;F\>M,WL=%>BS+]SZB-
M/4UD?0=D_%3/3Y9TJ>[\I9NU#W+>J33(S6"&-8?0/ML)-^R5M^5>$*99LY(W
M:%:* D82)M4P-,?V9KGCC73(GE7A2.T=<.J2K@JZ;,S:8<#9XM7-UEKV+<]X
M:K,OY A63I=FY<2MHW XC30DL!F9U"E(Y*@OV2:@@8.40 NQMJI/+E?59+C9
MXZN9O?FA74[C2YL9N<MZ<<T'G[2P[DV^HFP2YC9NCQZLE!VG+S!R1ZEQ- ;D
M$J!S%7%NH<[;M%2E()&#&)KOU"ZA.-'E2>RWB^TL=Y#N+AQW!%1.,[.O)A?B
M]KQ$D-QL;=C+MN>**$4%U2$NZ7,\1YBIL6KN-;@)A#>I>O"O7EW-F&,URRC;
MQ]J9<,N=,7#FS-<O WNG0MDB&'%6:;QM_(R2;*3=)*(,KB?3KJ5MKVZ<1YU"
M*,9+LFJ;LZ(J@D@H J (D,%5<*QRKGCK//EFQ6O'"_$FUI8,TJ\/?)VD!K@"
MU\%7CC!WES4-*W5%2=H/[8Q.LV+&N,<LF "\>2<TV8MS.2D.4I5EC%#E2,=0
MLQKEAC[4V\3#&F&D<?KCYI>E[A/7)I1XA&O&\,3Z6Y+4#CS6[8=NL,?WU$W;
M$6_ 61-0MD-;35)?SF4,*[-%$&ZKD_8HJ+/#G0(U!03J&(NOMWFEUN$QG$3$
MSG7'*F43ECW1?ZA=/.HG2KPP.'[BW(EC,[>SE$\1%&=B+4FWS56(D9%ZC(/(
M5-V\2$R:#"872[ JP@8S0JQ53  $V&F<^K;AA,UV4Z5\TC+!,5BW%.L;6#Q/
M\1ZQL^Z;W&E/%FD[%-T62S8W'=,9-SM_WE.K=J_<PKJ( R#NU6:@'<-Y)?L4
M56!  ?W\YB N_M+O?EDN'P7X)W>.0.)AJ6 @IV3GW6-+HV(N)3D3DF&*V4C9
MTI)MN4 35:.Y%0>P<HF,DN5,3E'<#;NZ7U3Y4"@4'$2$-_"*4=^_< Z^'7Y*
M"PT9@#$MOYTNK49#6NE%Y=O2S8FP[MN=FZ>M_=/;=ON%'4&VEH\JH1[UU#J+
MK)L7YD/3$6YO1BKBD/( Q]_M?<A $I3&* &Y0^;O#?S\!Z^-!RY2_P":'3NZ
M!T^"@J)2CW@'=M\GP?+0<13(.XB0H[[;]._;J'S#U^'K05Y2^0?L&WY.E!3L
MR (CRAN([B.W41Z!O\P!W>5 [,FPARAL(;"&W00WWZ_+05$A1'<2@(@ @ [=
M0 =MP#RWV#?;R#RH'(7I[T.G=04[)/??E#?IU^ =P_'U^&@KR%\@Z@(#ZP'P
M'S^6@ 0@=Q0#X V]7R]U Y"^7[?M\] Y"^7Y?[?4%!0R:9OX1"CMYAY_M^7S
M&@KR%Z] Z]^W3U^'KV'X0#R"@<A/\T._?Y?,?/Y:"G9)[B/(&X@ ".W78!W
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M0'O\/E^$*"@$* \P% #=>NW7KWAOY=.Z@Y4"@"&X" ]P]!H./(3_ #2].@=
M[O+^SR\*#EL&VVW3NV\-O*@X@4H=Q0\ [@\.[YJ#E0*!0*!0*#Y#M4Y"*F;B
M"BA2JBBF<Y@!18=^S2.8!'E3%7E$Q]A$I!Z%-L-! *SU/<0[$.M#3/C'.N0,
M+W8]U+Y#R!'S^EK'=NE=S6(<,6^A*.;>R:%\H/5GJHE;M&:LVK,-463E9=1F
MT$%@$"+N\!9S ?$JU$Y;UR3./KVU!VGAS%;G4E>&,\88XO+3S=\>CD^UK6?
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M H% H% H% H%!Q$I1W 0#KW] Z_#0.4O0>4-PVV'8-^G=U[^E!42E'O !^$
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M=U4*#6=S[_*3])G_ -EVZ/\ O"@V8J!0*#6@TI?RBW7E\0%D?SD30;+] H%
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M=])'(=,J@+."G S>'W2]J++*N.>)M:+%#)>?^*=I_P!.OIKT$8:V('%\;$V
MU=+"51&%4>W5-%D[D5:@;LG#D#)F<$**YTTR"!0'",-\XQVQ9[:.YK6[VCV)
MU.W#@+-%A.;>;35@:A,)KO+?"ZW"ZVP1DS9"SF29( #(?2&\U#R2K1<Y3D,D
M41#E:=[O/<)!D1$4DQ$-A$H#MUZ?_NZ_/0=E!QY@\_';]OA\//PH*[AZ^[?Y
M/^'C_;0>>NKK;EQ!XC;\N ?>*P_D 1^2D8S$:DX1,Z(E.!?TX?\ ;X>68\Z?
MTFS=!,2E]2)]R%!V4&O3[)8 1X=W_P"=V)@[_$;G9[?.&P?)UZ!1KT?UP_/=
M.3A7^)W%/JQQ9(?-;<;1E<V@_.J [''R#YMR' ?GZ;^?3RH(9."7TP)J9#;_
M -_SJ^_%E&2#;X0[A\O';I4C"([\=J;9X1VK<<$T=52@UG<^[C[)0TF=^PZ7
M+K[^X>49 !^'N&@V8J!0*#6@TI?RBW7E\0%D?SD30;+] H% H%!9C4)_$-F;
MXI,@_FG*T$+WL:3ZV';?QW9H_/%:IZ<HX1X:]?\ 4\O$-@BJR4$;G%N^MN:O
M_B>N;\J=!YC@O_6PM'_Q5Q_^O+U(RY^KS*^K.>,^4I55"@4"@4&LCQW0VU4<
M)$/^M*T_VI T6,O5P]X;-U$*!0*!0*!0*!0*#$#76TL*1TD:A([*619+$^/G
MN-[C;7;D*)C6,M)VS"JLC$>/(V,D4'#20D%4Q%LS:J)',NNL0B0D4$IBAJ[:
M(=26)@U :>,:V)Q'N*3D-D6_("Q[8QADC3I#VQC6X5&K$[EO:MS7*\;=O'Q)
MXM('2A2K&DDF"::I$Q2V4+,=>RSMK29UB;]IQ;76II=^SP??S^+S<STYNXB+
M++IYGDF4+(0]DGC7:+STF8C;@41C'D2Z!+T!\BLLF==!T=-L8CDR0U4:U&H'
M,MP:M8S%M_Y.O;%ES0^"I>ZK39ZM\&8Y1U.Z;';:^8^+:21\S8&F"-KRQ;="
M36.3D(^XO0IB(C.W<=@L+=0% %WPN&P9H+QIC;%&E#$=DXER>TS%8D=%O7<3
MD2.%D$5<*LO)O9&14B6<>LLTA8]L\=+,V<(D?EB4$P9&*11,0!& S7)MREV[
MM@  W =MNFVX=.E!C/F'5?IVP1=]H8^RUF.RL<WUDLY6>/;>N>1.WD;E>N7/
MM>U)&M2HG!V(R"A$ 3 Y1$Y^01#>AO\ :J#BVW&J'%_$7P'B:W=8V1M3>:KA
MNN^[]U?60R:-2Z>\6Z?GJ,DM9D6>)(S.:SKH:F-&,[>;J/C2LL[$RRZ)6JA3
M"N^YKELXWRV9XK8XYS)J@LK6U'7;K-O#7+A?%N5]7TYCG +<7&/OI>IEF\D#
MI8XQ_<EOE16O9DWN=)LZ.C,=IZ&J)>SWV]^,NG/,G=LSSK-8KPPG#WP24YMX
MKMG8ZNW)^+G6DW6G<[NT'EQVTXNFT\)2$M9\HLT;N&PR<)-%?))OHA0PF.B\
M*F!#H[J<H<H#5.G.8CS<OD<!>0)+\.BRI=-LZ9)RN4LS22;)^D+=\S(]R)+.
M"M7K<PF,@[0!3LW*(B(IK%.7<=MQ"9E+ZD3[D*#LH(L>+9H?R)Q =+#K V-;
MQM>Q;H&_+5NYI/W<WD'4.@E;D@D^Y54HT#.#KG%( 2 I!(!M@-THL3,5INIQ
MB8GY1LQ&@SV0#!Q,9"1G$LPFVC8>/91<>W+CY\<$&4>W3:M40.>(,<X)()$)
MS'$3F H"81'<1S7U?]>\(^A])![(/\.)GA7\'KP/^YAI6=OI[Q/P*ET/^R#N
M8!/Q,L*\@;"8 QT]/T 1W][[3]=QVW -MQV#<.HUKE3I[3*\_/Q>NV(^N'5I
M7XQM]XNS$_T[:Z,7XQMJ(U19YMZ\HB<L]Y(.)S)T3>KMM?EV-5R1S@J+"XIL
M%Y!HS$2"BFJ!!(4VX N[]TPPOMN[YI!/I(/9!P]0XF>%-AZAMCQYML/EO#[[
M>59KZO\ KW@/I'_9!_\ \9GA7\'CP?Q>T_7X*5]7_7O ^MI6X5_$(MGB"8PU
MMZR-5&+,X.\=61<UD)M;;MR:AILT9+-128M6I3M6L>FFW=*+.%SJ!S&[00 3
M;CMH;)A1$2@(AL(AOMN _C#IU[Z#E0*#6@TI?RBW7E\0%D?SD30;+] H% H%
M!9C4)_$-F;XI,@_FG*T$+WL:3ZV';?QW9H_/%:IZ<HX1X:]?]3R\0V"*K)01
MN<6[ZVYJ_P#B>N;\J=!YC@O_ %L+1_\ %7'_ .O+U(RY^KS*^K.>,^4I55"@
M4"@4&LCQW1$=5'"1$>_Z:5I_M2!HL9>KA[PV;J(4"@4"@4"@4"@4&(FN'&^.
MLOZ5,\XZRO>K;&MAW#8,RC<-_.UDDF=I-&:82",\\%4Q4SH1[IJBX40-N*Y$
MS(%W,<"B&L]CB\],N6M7>GN"QQQ2\379:,UDG"5_7SBZ%Q9<<=>V1\^8BLX;
M'CIBP[F+&H,K:A+WC4$?=#&F730=&36%4%!4+S"[O#&K8SXB=EVQD#1YF&VK
MSMS)USVZXC(61>QN'89"YLD-EX2Y(F98S%NV^Y.1M/C!O6+>5>0RP*)OV31R
MW,DJ"G9F")/1'K#X8VF(N4KKR+KTB[MRUE,(-I?K;+N.4\-3T'$VTQ58Q5L/
ML7P=M,8UH]:@NZ!\X%JL\>J+"DJ<Q2E*"[R7EEAACG.ZJ4S2+K T]Z@I6>L[
M3%8=Z%Q1:S->94RBVQM(61AV3EI.0%1:,M![*,XP\Y(O%SJOW1HR/]$2+S+J
M+=H?82)!4PV3*'J\ #QZ]WR_\-Z"U=[XHQWD&0:2]V63:=P7+!$.6U[BG+<B
M)F7MIR83+(OHAR_;+*LEVCH$G28)G3 54B'$=PWH(G],7")NK2[F"<RI:>N_
M4#,-;XR4]R7E6RI:"LE.,RA*/15YV%SRP,E)OT%-!4K9L1HZ2(@BD7L4B&WW
M4NLEW?%[>'X3T"&8;/NZ]=2.:<E8:QAF)SGO%NGF\'3.2MBS\FG65=QLF%U*
MF4N:6C(%ZY=.82'>K>BL_2%$P 2  4$K=S (6S< F#W_ +GY8PB(  \P,5NN
MP;[" B.WEZ^\0B8X%P!^Y_V^/B.8\Z;CY_\ .;-T$Q*7U(GW(4'904$I1VW
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MDQ.#;,)'VU!J.G#UVCSQL+&)HL8U R"1#)H-D2%* @(@ [T1GD4! A0'?<
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M8I)FLS.LU2 D  ( ;AL!>\!Z>OJ'@'G1&$VH[6;C73SD+'6*+UL7-=URN85
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M;M7S9_)J\@HG1.Y,NX*423/E=">%-<XSQIC?%NL%WY2[]^P;]!#\0]:J.0@
M]X /PT%-@[M@V\MJ"@[  E#8!VZ &P"&_3< ^'N\!'I0>'7N^U$KJ)8WNHA
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M7CP?;TT'_@RR'^NTI.L]O@/<+QX/MZ:#_P &60_UVE)UGM\![A>/!]O30?\
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MXOSB@^9QJ,JK*N<938S2$ H@JZ;%0;29A[!5V!SG;![\$%!#EH,V2CN4H^8
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M0[!\M&/IZPIN68,X^\8=H_0.V=2,,JX;$W*<AC)G*896)ROG?:1GH0=B%WV
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M+L5;QEU1?S=PN6+A<$I*27(FY$2;$O'E?$N[^$N!0Y2E#Q  #S^'K\-!RH%
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g729258g08e28.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g08e28.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2'04&AO=&]S:&]P(#,N,  X0DE-! 0
M    (;2^AB@X0DE-! 0      $D< 5H  QLE1QP"   "N^@< E  "')R-C X
M,#0R' (% "A-:6-R;W-O9G0@4&]W97)0;VEN=" M(%!I;FYA8VQE7TAI9VA?
M<F5S #A"24T$)0      $"TP?D8R$V.<EEG:Z-G>9Z@X0DE-!#H      .4
M   0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $
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M=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M    $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO
M;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG
M:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0
M$ .__C4  @ ! [_^-0 "  $X0DE-!"8       X             /X   #A"
M24T$#0      !    '@X0DE-!!D       0    >.$))30/S       )
M       ! #A"24TG$       "@ !          $X0DE- _4      $@ +V9F
M  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8
M      $ -0    $ +0    8       $X0DE- _@      '   /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H     /__________________
M__________\#Z   .$))300(       0     0   D    )      #A"24T$
M'@      !      X0DE-!!H      S4    &              *E   '8P
M       !                          $             !V,   *E
M                  $                         $     $       !N
M=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   *E
M %)G:'1L;VYG   '8P    9S;&EC97-6;$QS     4]B:F,    !       %
M<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M       &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R
M871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG   "I0    !29VAT;&]N9P  !V,
M   #=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$58
M5     $       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,
M8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T
M   /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU
M;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP
M965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S
M971L;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T
M<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@
M  P    "/_         X0DE-!!$       $! #A"24T$%       !     @X
M0DE-! P     %TP    !    H    #D   '@  !JX   %S  &  !_]C_X@Q8
M24-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D="(%A96B 'S@ "  D
M!@ Q  !A8W-P35-&5     !)14,@<U)'0@               0  ]M8  0
M  #3+4A0("
M             !%C<')T   !4    #-D97-C   !A    &QW='!T   !\
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M0S8Q.38V+3(N,0
M                    6%E:(        /-1  $    !%LQ865H@
M             %A96B        !OH@  ./4   .06%E:(        &*9  "W
MA0  &-I865H@        )*    ^$  "VSV1E<V,         %DE%0R!H='1P
M.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O=W=W+FEE8RYC
M:
M  !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U
M<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M,BXQ($1E9F%U
M;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M    9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN
M($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6:65W:6YG($-O
M;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M     '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>     5A96B
M     $P)5@!0    5Q_G;65A<P         !
M H\    "<VEG(     !#4E0@8W5R=@        0     !0 *  \ %  9 !X
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M BLV*VDKG2O1+ 4L.2QN+*(LURT,+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #9 ET# 1$  A$! Q$!_\0
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M*&E7;5%BZDXMA(.&3=VH^0:*O&J3@[=%ZJSCU'2:)E!3*X.Q:&5 OF+=(1\
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MBIYSJ_3FD81T_CG#UVY9DEZQ+R[!K(G*A/?)/OI[>JF,[],0(@/V;5D]'?\
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MP ))V1]P'<UP'M&]H&/]G.!BS>0L;[(^]7T>-L[6P6(O)>2V]S=1":25T6&
MI:2!G42R%BBQPR%NUL16A8YRRWDIL"J4:R7&^:MB)VWWZ2CU9*3E9R;"TO74
M>A!/8N,>5^ A0CF4/ ,&MC^:8L:S NW)CRQG"R$M*W(<"RHA_-KOP >Q.NQ8
M^6.M$D_*O+%>SW 2XV]FZCQ6,S6=ZF@=^I\I/8JLU])=".1K.!Y![U9X^P"P
MVV-@22.6VAM+:5G-XC3&1J=JRZ:0I\$\TV\;S];:P[9Y.:;EW+UG".SJHE<O
M'^M9J2>SK^ES2P&,NK7W[N2I\Y(F66].M/I![,&<UD/YWLQ["10 ?/\ I%&@
MP&_(TP']H +58NF;_HN$/T.!-AH%+3=&7]U,UL5&FDEZ>R5R\\V*O'TTC65R
MT^)O9V9BN.N)Y[YO9Q)Y"4CD#2;/*U!M-1:T#?KDC)P]C;LF<NV3L%CE+1%N
M3M6;^0*5NLQF"-3G.J4223&1:^)BMBJJQ+"T) 8@@C8*[UY(UL@=^V^VP000
M:]_9][1L%[1\=>Y#"Q7UK^3[YK&YL\G'!#>(WII+%.8H+BY40S(Y52SJZRQ3
MQ,H,9)F6JL"I7?8SL7TXX$LE#MT&CZQS\C%,D74!%2"Y(Z%?R;F(C?4=K*J^
M4>Q;'*4YD2&*@/IYY5W]21BE,4IBE,4IBE,4IBE,4IBE,4IBE,4J,+W?+54G
MK1K :?OFQV[AF9TO(U.3UVR:,5BJJ)@P<IW"[UA^HZ,0A5P,T9.6OI*D*#@5
M@42)O,5BK#(12/=]18K#.D@1(<A!F)9)5*@^JC8[&7T00$E-22H_)2>''3'G
M,UFLGC)HXK'I7-9]'A,KW&-N<#!#"X=E]"1<KF,?.9-*'W%#)'Q=0'+AD6"-
M3\E=L;!A32<WQ+V[6U"S[N),!92DMFZ31!1 H/5$+Y8-?SZ@H@L<KD6<"[8'
M4;J%92#I8%F[;JL]T5T_B;D0VWM Z>O%-K'..4&3=VD8-N,/B;3+VBABH*>K
M=QRA74R0HO%WXWIOV@=3YJT:XNO9EU/9,MY+;D+<XB%!&C*/4*9R^P=ZY4,0
MYBLY(&9&$<[N'CCM:1Y#;9B[%8H,6](E!C;U/-81U#04S)Q%AC6T]'QU9U0V
MF&]H(+7;LS%.WTE,*.(T4*Z,090*W*,7IG#+YU !(;4.0/5EX2E= !#+9J\T
M>R1Z,$5Q+*Y8[)MY5;TTBDD'U>0!1,5;7!"R!NYV(KIU1U"@AI9((XE&SWGC
M*\V=$-W7;E+-T>RW%D_U,]=U&FJR?S=H:V90'SMI%I,DEG;>"5JQ&9"GDY2/
M0("UC*B2,3EY59PF>/:Q\G0L0BN1W=+AU'G^H&38!SKX?4&+E&]-HSVP4/ZC
M<++&6)"D'4L47T),GN&RH\$)[_'WV-^E/OCP7E..FMC'VSKF OYXZ.B@GE)G
MTF45-.9]D5O&SLE$-G*<@^@JS( 9^W8)OU&$E 14I%'<FC)-BW?M'*1?1EXD
M ]]JK?(CX@#H$$@ZWHGL=@@@$$5Y [W]S$??V.NX^1_ D$:(8@@U=MLFY.NP
M+Z7AZI.7>1:_+@WK5<<5]K+R'K.44%!;.+1-5Z$3*U24.[7%W+-Q%!!0K<J[
M@4D%"@$Z+!1W[G9 T/N!/?\ "L#*7EQ86,UW:8N]S,\7#T\=CY+"*[N.<BHW
MI/D[W'V:B-6,K^K=1DQHPC$DA6-L3#\H=P$VJC00X>;D&(5JYIP9GZO0A<%=
ME<'2^7!\2RGUX#8"% HIJ[$2G?6. !!B04S*^WI1\.7KIO?C3>/PUSW_ -#6
MOG7R\^TCJL=2IA![)NKS:MCC>F\]ZP?J"42%1'ZPR+=/^GH:*MU"E]S8:L>/
M%GO&X['W&HWK,A6(2'UX\?P6PI:?I^V(EC)N(9A4H.2.PLLE<*)L.2@(V*=V
M9Y3&!XY-"4D%(N4DY #MS1CE!'&?X6D"R(P6!G4GDB^H3PC4LP\EW5RI508H
M9M2!BI'U#$7MSDK&"ZO,1D<)<27#1OCLA)CI[N.-)&V[MB[[(6?&6&)FB,=W
M(X:> 2Q(>:U3D]_7EE3-8R"5!:72PW(LPE,.FTJXJ%?;J16Q:CKAO*PID8^^
M?4(&:D+DPGX9\+Y,K^FLG5A1$5%$HL+N-.JJ" RP]Y.Q#R\$4. NU!D<&3L?
M2C#$>H5"OL0/S4DC$'TW((31Y*$FD)0EEV0L)5>P#2,H8H"6'NT7R9)NVXV*
MK(4T*N6M5"GV)^,C83KSJ<G:82%F58@]?4K\>06<867,T5F&LN\,#EJFG(Q<
M0J_:(G!0T;2 [7FJIVT2&,P/J#_1NOI \071A)I9"\<R1I 8Y/2;7,>J'XDE
M0T9C&T) ]1&YG3$(PX[9 KQL^5&5J*8I4&\E(12PZ.V7%+6NK4RON:?8B7>:
MN<9.2-<+030K].YMI!>LVBGV&"*M '>BG9H:;2D*^H0LFW:O3M_E5'?P "3V
M&V":)[ \V5E0@]^3HZ#])2/$C6QLD $'L"V]'>BH*LP/@A71OHP-8O<$=TZ^
MLX7G4D'8I&<MM35:V*1>RG(RV\A&TRQ>-HUB=Q6)7:SYGMB%81K<]?>3,#-5
M")A8E>UQ"["7G5YI9X=O8!]193\RK6#JNR0 'L.*.NU8!Y8XI6*L"@ %&0QG
MB8_3!\ B[!.@">2W9<HP!&XXY)%52I)VU;$\5%,4IBE?G7^-#LIEJA]QPL]#
MI-6NFUH;E[KRPQL+$ZFE8Z=F'ZVOMH0L1#6/8:,N<T^E*2;IL!V4;%E65:,S
M*@<AXXJ;C$O)S#!.R(7D2!W5=$J?T0" 0QV3X79(!^>MX5[/Z-O.50NZP-(!
MQ++O?%0P!Y'9^0!V ?P.=W'+AV;CCQ_IM6DK,%GM[[9&O+/:[L>P[%=+7*<L
MEN@GLO-OVQ+77Q;2"MOF9&QM4SC(-!%&*0DT9-1@BLGK%LI+2TA"2(9&N[0R
M2-Z\G,2SQ(QT)HBK!G+H3R (7DKZK;]'83&227=MEX+N\"XG,9&!K/(R6;)>
M8W%W63MY)2]O<B:'U;7A)"$C+(_,R\T!.1W*[;6N==T^$C[G>X^I/9.XTJ49
MH'E:<QD'#.MW& F7JX$N4C'QX,V_RZ!EC)J_-J")2(D%N#Q1&N?S6-Q$$7OU
MY!;/+/ 8TEGM869$GB,CCWJ:%"JCSIBQ)T%8<M=Y[//9GU3[1+R\BP.-R=Q;
MV-G>2SWEGCLE>QI=>Y74EA;-^3L=DI UQ<Q+RW $$2.IECE>$/;FWMX<8-HZ
MJ>QW[6=?V]A,K0;EA$UB\IO)MTZ(];2#<H1E3E/Q$0Z*"2R[A!1 A4/2.#M,
MAD_$,>\Z@Z>O+%C%E\=<B3TC&EO>132L2RN/S4$C2C2[+ J.(WO5;C#>R3VD
M6F?6TRW0_5>,BMQ=B]GO\9D<19+'%')$>63N5M+1HFG,2IQNBDY9#'S4@F5]
MUN:-:=$W-1_86_X3DJJJLWEHNWOZZFY*HV*YC"H6"#EHM\!'B@($%LG(%)(I
M*&:.4G""ZJ*FUR,UL^+N)C.BP-;ETF2<Q*05W&5F1T/Q'CK3?%O7?>JX_IOI
M^_N.K\7@KS$7DUPV3CM;[&26<\DYC2;T[R.: (90L:"03-H< &8L-;$V1_RG
MR#'Z>N#IC\HV^2= \4D <- 1(#=?Y]99PJ^]5'P4^;5<+J.?+UCK*&.)S;%2
MI52A#*5!5@W(%=#1#;/($:/+9WYV=URLJ2Q2R1S(\4T<CI+'(ACDCE1BLB/&
MP4HZ."K(5!5@5(!&JM#:'UO]G-X"N-XYU-&J\T1@A+.7#...HHP6(I\TY:MW
M3A,A$#*G)Z:"@G4*0@^)3"<OC=-(EM.T2J\BQ.55V**Q"DD%@KD=M_HG9T.V
M]CWL+./(7MK82W!M$O)X[4W(@]Y,)G81+)Z'K0&4*S#:B9#K9!.M'VZ_^J?@
M6F_6T63>8"K0(2:$:NLY8)/0BVH.$V;APBW76;%5\@245024.0 $R91$0RUL
MSM;P-(JJ[0QLRJQ958H"5#$*6 )UOB-^="JWEJEE=W-G',;A+2>6V6X,7H&8
M02-$)?1]28Q>IQY>F99"F^/-M;->EW31A%R+Z0(!V+%DZ>NR"F57MNT1.X5_
M=G$"'$")B)2F$ $0#L0^^>CLJ*S,0%52S$ZT% )).^V@!\^U>"1O*ZQ11O-)
M(RQQPQHTDDLCD*D<<:@L[NQ"HB@LS$  DBHFXY*ME=$:D!N@1L+6@5>,=HD%
MJ8"2,/$-(F1+ZK)9PT7 CUBNF5PW7627(0JB:AB&*.8]DZ26EL\;*Z&&,!D9
M75BJA6(9"58<E(V"0=>:K[C>XT)8Y&RNL=>VT<<=S97MO+:W4$@13PFMYE22
M-B"& 902I5AL$&I0EZY7I]$[:=@8::;J%,51O+Q;&21.4WL8ITGB"R9BF#]0
M&*(#_$,R&56^TJM^L ?X@U5D1^SHK#QIE#=OIW!K'&U\&^&EW]<UGXL:!DG+
M@1%21+JBE1\QYB/D*B4U&0S.605$?<5D'J:O_KYC/864GV[2W/;6_20-K[F4
M!A^PUBOC[&0:>SMS]XA16\[[,H##N/D:A2Q?# XN+P<M&Z[;[<TN^?,'S=J]
MU5R"WG46#5P[;*($55KC+8)JXZ;%,8OKLE(KT7"(&1,!2F[#';%6G%EB$T!(
M8 Q7$X +#SQ,A77W  $=JQVQ%F%<0K+ S*0&CGG !.]?"9"I&SW70!K'3C]P
M"W+5F5QD*1SGY!Z]<M[9:*NT(@?7^S&;L:Q<[0W7=32.R-?OW;\'*BX.$0"0
M(N5RN_66<'!=))#$M<9/&'9+^XC/-T&N$F^$LFRPD0[))V#WT2Q^>JPK/&3H
M)6BOYXCZKQC6I01'(ZDL)%T>^]>?))/>LH$]+_$)KC<A8'F[JV^*)C^G:O$^
M,;+*E#[%6D-9;2I:/8@  8Z<,0WN8WN/0!F^AD4WQOXI._836BC0^A:*1"?Q
MU^RL[W?)H/@R$4OT$UHJ_L)B=?WZ_978M)_$XK::(?A'A3M4$P-\PJQN6YM0
MO7'CUXBBT?U7:3)(ZGN(D/("0@B >H8/?)!RB^4L9!H[*O/$2?EV99 -_B=?
MM[ <NGE+";]5YXF/[&5U[_CV^^O&]Y'\X*L1,UG^'LZLZ1 *#EWI[DQK&T>_
MMZAVT9?(C6,BJ7]0D3\1,(= 8Q3#UE3=7Z:Y8WD.VS#=Q-K?^JZQMV_;YWNA
MNLBGV\9R'S,5W&Y_$*R(=>3^[Y]JQ9U_\1)XGN>ZOY?A3R29R\W%H1D]&473
M]7MMU:FJ4];V"#B7>U/9<TK,%(F5%A(*BS1*F[9 DW'Y9HV,ZPH<D3<RDV5S
MME"L(X%:3<;R+LZE);0T&.AW  [:+8$.4_X7,393\V4*RPV_.7\T\B@L0^VT
M-!MJ-,-#L!RR90^)/K,B@$GN//.*I@'ZU)SB%N!=),?Y&/7H6>[_ -) ,'^?
M,S\J1:VUK?H/JUG+_!0Q^[QY^[O6<,M%^E:Y"/\ 7M'[?L4L?W _NJOI?$GX
MK$(!IB3W+5A_RBVCC%R2AO3]NQ]51QJH4$P+U^83*@ ?Q'+?E6S'VC.OZUI=
M#^_T=?WU89:R[\FG37;XK6Y'\(CK]NJ[$OB;<%#F\'/(>LQ)^_$Q+! W>N&3
M,'L(*A/5>.](0'V,"GB)1^_62,I8-W%RH'^LLB_]I!4C+8\_^4 ?K1RK^_E&
M"-?/=7/&_$.X*RH!\KRXX^I"(]>$CM&J0ZH#_(R,M),52C_XB!UEUR5@V]7E
MOL>0954_N8@U893''6KVW!/R:55/[0Q&OVU?$=S(XC2W7TSE'QW?";](-MT:
MY5$P_P @ MC$1'_, =Y<7UD1OWNVU_Z^(?Q:O07]D?%W;'?_ )^/_P#E4A1&
M[-,SY?.!VYK&;)V >41?:K)%['V /)G++!V(^P!WGHMS;MW6>%A]5E0_P:O5
M;BW;[,\+?JRH?X,:O=I8(&0 !83<0] WZ1:23)R!N_MT**QP'OL/M_//0,K>
M&4_@0?X5Z!T/AU/X,#_ U$VV]H(T.8UG'$N%+K25FN"C&Q&M"0.5$ZLUJ5NL
M3E^Q$M@A"QIA=UI)A]4=E?LD"NE3F:J'0\1\+B;TF@'J1H'DT_J=_P V(Y')
M'QKKN@'([ V>QU6-<W A: >K%&))=/Z@W^;$<DA*_&G'[&N1Y ;\'6C-Q#E4
M*4Y#%.0Y2G(<H@8IBF !*8I@[ 2F 0$! 1 0'L,R:R_/BOK%*8I3%*8I3%*8
MI3%*8I3%*8I6E#XI;S36JKAJ6_67AX_V;*6]I;263?\ IJ;V?J'D!KY>O2>O
M8NN-JUMO152>W9TH9G:)RUR4!9[?4Z^%-H-FEFKR8?PR-9EE*REX8OISDMP*
MKL3L6=V"TD;A%;3UQ8;6\MQK9<)*+B[[<:6>8A[O:M74%[.L)&%8D1@INRZU
M8SJL.9L:94FYDCFQR:E?'_DR^.OU!G.?5ML%LT4TI"L%9DKR1M*P%PU^CIIA
M7ME12+6%1ADKR$'Q^U!7'[EQ%.:^^@ZA\JK7@5L-K<3JE29QUX+\>^+%B7L.
MG(*P0@)TMGK^OP<E:)6<@*=5DD:N6785AG)*+.6REJ>TNL3%F>2+V4=OI:*2
M<MEF1%WB+A2LHY%<P2\ VZ1\3.W2W8N.G F)$RA! K;T_P R0 8ODMZP>)Q*
M04Q[\L@_+\?Y&E:R=9SLAO,UWV?NRGO*I&T3>$%3-=U=561<14=)N]EQ!+Q8
MTG+0J2\K8_1;?A,\T@DFPCV;*6C8DR:\G-%6RI0L2B.-@W,!W;YD:!1?N7OR
MUY)()\#7QSH*^SG6^6RO4W56#;#CI[(7V Z<QCRBXM898+B:WS64$C=KK)>I
M$N*-XB+#;Q07=O9:-S?>I?5QY)W];8O):L4;0]DO<53M>HQC&U0\TR)$/Y&!
M++I2A5U';=!)?Y5Y8)9@I%5]U/V$CZM/&9XDJQGOTKZ/:="8$XOIN_R_65CA
M[G-3H;K'7-NQN;2RF,AMYQPE=HQ-&D4JW%_'96/I7"2K<LH036O_ &D=2#+]
M5XW!]!9'.VO3\$BV>5M+I3:WU_ (5NK=N<4:R-!*\L+VF-EO\B)[:2)K5&:0
MV^4?'O:R>S]>P:TM%FJ-]B8IBVN>OY SI&=J[H"'29*NV,BTCY$(Z99HI2<2
M^,S!JZ;./30<N%&ZY@Y3JCI_\@9&6*UN1D\/*Y.+S,/IO:9"$*I?TYH))H#-
M;NQAN(UE+HZ\F15=-]IT=U/_ $EQ<4UY:G$YV! N8P,_K1WN,F9G$?JP7,5O
M<"&YB59[>5HO3='*+([1N1:D-J UFA%;$E84:KL^$NNSTZUL2G098AXT9GV'
M9CJP5BAW<I*,KC5GC\'#M[79M4[']\DO'?39MFVG"<ZDA4%2 Z'RA\?B#Y5A
M_:71UV.P2#ZYOI:TR<D.0L9Y,'U!9HZV.<L(X_>(U=S(]K?6[!8,KBYY6+W.
M-O0\3.?>+=[6^2&[BBC6'):PPVT]P5'>NO937K2ORL2T-M5K%VAQK*;?L8MI
M&$>GDUH$S*HQD]'-4+%%JS4ZY9M6SH\<[E3ND$5GGJT*E5:)^9;OZ9*\P/P#
M;8@]CI02>X&MZX?#>TO)0YK,X3K;IN[Z=M\,XMUZL2VRC],Y296*FX%S)8>A
MB;6ZB N[=KO(7$,:%K>>[]=%]7.B)F(F?CFLO!2D=-1+Y(J[*3B7K:1CWB)O
MTK-7K-59LX2-_!1)4Y1_@.>!!!((((\@C1'X@U]8M;NUOK>*[LKFWO+6=!)!
M<VLT=Q;S(?#Q31,\<B'Y,C$'Y&K+O1WY9?6J3*7DXQ%_>18R24>LDD228$J5
MIF 9//506,9 7T.R.;T3(JBF55+U/36.48K(J1<4K@QBE*8QC 4I0$QC&$ *
M4H!V)C"/0    B(B/0![CBE?*:J:Q 424(JF;OQ.F<IR#T(E'HQ1$H]& 0'H
M?80$!]PQ2OO%*8I3%*8I3%*8I3%*8I3%*8I7E?,64FR>1LDS:R$=(-5V3]@^
M;I.V3UDZ2.@Z:.VJY%$'+9R@H=%=!8ATEDCG34(8AA 8(!!! ((T01L$?0@]
MB*D$@@@D$$$$'1!'<$$=P0>X(\5XH*OP57BFD%686)KL(P*H5C#P<<SB8MF5
M991PL5K'L$6[1N"KA95=4$DB HLJHJ;LYS&&Q)/DD]@.YWV T!^ '8#Y"J@
M;T -DDZ&MD^2?O/S-5?(J:8I3%*8I5O,*C5(N=E[1&5FOQUEGR()3MA8PT<T
MG)I-L4A&R<M+-VR;^1(@1),J)';A8J14R 0"@0O0=@5'8$\B!V!;O\1 [$_$
MW<]^Y^IH>Y#'N0.()[D+V[ ^0/A7MX^$?05<.*4Q2H@Y JM4M%;D%Y5EKT@;
M5NP"GHS5:50>W,H5.74/5F*D"T?SI7DXD12/;FA&+V7(=<%(YJN[(DF81L'S
MK7<J0"!\SR.PNOJ00/F#XIO1'@G8T".0+;[#B.[=_D.YK%'@E2F9J_*WRQ7"
MZ[!V"2PVAHK;+Y![KJEA=QT_ :R;N6CR%W97ZK,O$(IG2ZU'1\A"P3:#2(D[
M]0[BQOK"Z<""3S+(^^W*.2VE7P !RM;6U12 -E. )WR;>DX@0!P"LNNX#Q3Q
M/^ELZGN+EF!+$<N?$:TH'Q<MAN*4Q2F*5IR^)EKB2G=E<"Y:PSIIBN3G/?3M
M0)6(5G)UN31AY&D;956*XL;6X(-W9VX@^4(Z)$L)%%%XNDS=D[.DY\WC1^7(
M,>2&,Z9EVC'9'8@;^A\@$@'1(KQEB1PQ(8ED])@KLI*,1L=F4;&SIMAEV=$;
M(-3WH:5WMLIMQZU;<I U5IUN@YK;-O;V)U+EIL-9+)1H37]5J<P R2\-<7DX
MUDY<OR3I@]CJJPE46SMH68 Q_F6<,^=R:X#&WLBV]K=0W.9O$F,C6L-Q/:QV
M-I9S#U#;WLLZR3$HT<D5I%($9/7!/[7]G$5A[->D3[1>JL!;)D\M@;W%]$8*
M7&QV1S=WB,3G[SJ++9FR(MEO\%;XV6SL2;B*Y@NLQ<6<DT,YLB!E8]X@\>*-
M6&B[37L9*V4UFHGU"_6=[*V+8$NX5M,''OEGUWFY%]9C)239PZ*]CD91*,4*
ML<GR8)D3*3I1TG@;*!&CQT4USZUF)+ZY:6ZR$I-Q#&YDOIY)+IA(K-S3U?3;
MD=IK5?(8?;;[2\]E9TGZGNK+%#%]0^Z].8J"RQ?35E&F(R%U;1V^ L+6WQ(>
MUEBB,%T]F]XAC#>N6+%JAO\ XV\>)V@R+R:UAK2(=1RT>HQG$*926;U ZKI)
MB=M\R^@W#9=!=JY73^6=(KD*H"3I J3QJV<(^^6Z8PM_:NK8>P>5"KH\>.LY
M)!W"-V:WD#*49@0RL%)#+IU5A@^S[VM>T;"Y^V6WZSZFFMKE+B.>RNNHLXUK
M+J&2X1^$61ADCE2:%&$L,L;LOJ0R%X)IHI(PV_P'XSI:ZFY&E4%MK^;KD*]D
M(R7J<S;(?U!:PSYF*;]"$LL0+P%F[E145P<(N3NR(JN%G+4SQD\U.3Z$Z:%E
M*UICTQ\T$;M')9S7=L>T3IIQ;7,!;LQ.PRL' 8L1R5NSZ(_RC?:M)U/86V=Z
MDEZEQ^5OK>VN[/,V.&ON(FO8)P]M+?XJ]$!22)5$?IO$(6D6-(IA!/!=47PT
ML5'C&#+4_+#DA23QZ:1$64]8X#:%8 Q0\E?"O7Z EE$$5ENU!;MY9)-,IC)D
MZ[$X^T72%Q91(F*ZJZDLR@&EN+FWRMOVV2/1R5M<,JDG>DF4@=M^-:>[]N6,
MS]U<3]8^QOV6YX7+NTD^.Q62Z2RY!.DY9/IS)6:2/&FD$LED[,0&;9  I.R:
M]SFIU(LRT+M?3NUF01JB+I.:U5,T:VH1:HII2;YF]K=CM<$Y=MV!G2YT?P>X
M\B@<6C%9<B392E];];6EI<&'*8;*KZ9&I\7<8^Z5#H2.);:ZO(&94Y'B+%B?
MT49@%.9TMDO\GW.9_$I?]'=<='7!NE>)K'K"PZAPLEV@9[2WGM\IBL/D889;
MD0Q!_P N1Z)7UKB.,O*OQ1]Z<JJG4:N.P>),]<(\(M,3V34^QZ7.2RK IU2Q
M2KFCV=KKZ22>*1I69W"3<Q1.<QE3LV"QSQS:+/-]46MK;G(]*372"/O<8?)6
M5S(4&_38V=XN-EY-&%+*FVV?L*246V?]GOL>S.:RXZ9]L^.PES[VW'%=9]+9
M['627)53>)%U!B)>I;5X%NC.L3R@Z "">YC"W<MRN>=^H(*-?.]CT_>6I%VA
M3D^1V3IFZ0R+QP/9$FC2Q,V$I3C*.UNF[51U8VK550Y#"X(B(JAD'K?$Q1N^
M0M,WB2FQPR6&OH%=M\51+A(I;,L[$*N[E021L@;(U4/^3OUMDKFWAZ7S?L^Z
MSCG(/O'2W76!OW@B^T\\V,GN;/.!(8]RRK#BYID52!&SC@?5QZY7\<K+J_7\
M8VW)K2*G(RJ5N%?UR9O50CYIM(,H6/253^3&;4!8JHF*=,S9182G.=JY!"0;
MO&C>^"ZJZ=NL=8I'F<8DL=M;PO!)?V:S+(D,8*E!.=D[!TI)!)5M.K*OE[2_
M8W[4,5U;U+=R]#=57>/N\QE+^VR=AT]F[JPEMKB_NG5O7&/4H4TRL)40$*)H
MC);2P3RY;Q<_!3B0+0LU$RZ(^X*Q<BSD$A#^8*-%EB#_ /?.ICFAF :&6*53
MX:.17!_ J2*^+W>.R&/<QW]C>63CREW:SVSC\5F1#_=56SUK#IBE1#IR/<Q\
M3;R.'3QR5?9>P')/G'D<].1=6S2 R!D3QU;K1$6SB1^:=-VBZ,BX:I+%1-)N
M"D*!,.R=WCF+#6KJZ0#D'_JYWC)V(X]<F4L%(8J#KD=5M<MB;7#S6L-K=7-V
MMYC<?E96N8(8#%+E;6*^:WB$,LPDCA$X02N5=V#'@HT*E[,RM53%*8I415IX
M@OM_8S<D"HQ%G6J0V"6.XK)RR*I'EL>.3HM(Z9>6!JD?ZF@0%IJ)BR.UVKKY
M<S@K<%#8T<B&ZG0 <TCAY=TWHF0C8#%P#OL6502& WHU=K"]A5;^6SFBLKL>
ME:WCHHAN9+<DW$<3ABS-#ZL?J J"O-2>S*3+N9-4IBE>9=DS<AXN6C5P40Z$
M%VZ2H"'\NE"&#K((!\@'\1NH(!\@'\0#5NOJ)1Y,ADY*FU203/\ K(^KL0[(
M;_Q%79J%-_M <J8HSYC0[\[13_$51HHF^U%&WZR*?XBH\DN,W&^9$QICC]I&
M5,?]9I'5-$>F/W]_,7,"J)N^_P"(CGD;6U8::VMR/H88R/W%:\S9VA\VMN?Q
M@B/\5JQW_!KA7* 8'_$;C0X$_?:AM&ZS(M[_ ,ETZR18H_YRJ /78?81RAL+
M$@CW.UT?I;Q#^"5YG'V!\V5KW^8@B!_>%!JQ7OPUN!;XQCFXJ:?9&-_E0M:)
M7Q+U]O3^A+1WI]?P]/Q__K/,XO'G_P EB'ZH*C]RD#_!^M4.+Q[>;6(;_L\E
M^>_T6'SJ![[\.7C_ $O8>G[%IR$+JZ1E;5+U%R#24OT^R32?:MVHL9^WBGVP
M6T0*Q$!40%L^CGS0P@@H"1" [0?8DV+MHY8&@40F21HV[RN-&&<\@#*!OY=P
M1^S8.!/B+9)K=K8" O(\;C<KCXH+@\@#, #Y&B"#^'(-M1:H%:MF[8@B8K=!
M) IC=>1BHIE3 1ZZ#L0* CT'7?VS=#L /I6] T !\AK]U=^*FF*59=PV/K[7
MI6![Y>*E2R2AG!(PUJL43 %D#- 1%T5D,H[:@Z%L#A 5P1\Q2!9(5/'U"=^<
MDL46O4D2/EO7-@N]>=;(WK8WKQL?6O.2:*'7JRQQ\M\>;JO+6MZV1O6QO7C8
MWY%8WI<S-7F?)JJW#3:=84M1JV66)O"IJS(-QLQZPA,FKGR290:J+@G(J)A,
MCZ,4<SD%E3$](V)[_%R[M;B/U.'/WE"VO4],-PX@:)T2.?9=GOK58/Y2BY=V
MMQ'ZGI\_>D+Z]3TPWI\-:)T=<^RG>_E61U?V7KJV0TK8JO>Z?8X""!<9N;@[
M'$2L3$ V:@^<C)R#)VNT8@@R$':WS*J7IMA]8_2?YLRUFB=69)$=5WR96!"Z
M&SL@]NW?O\JSXI(Y_P"I=)>X7\VP?XCX'PD]SOQ6(L9SQI\Y(QJ,5KRZGB33
M9$K'+R7R4,>N4Z:W,VT=1KD>'D#)2KL+E97J%A;UY5O'R\12VDQ(RA4YUBTK
M4G[(CN%/$J"RH>6P4EDFN88XF4@,'+6LGJ#7YDE0_<G5G94Y?$&UR(XD$.L<
M5O-(Z,-JRJMS'P()]3N5[:W,=YY9:'UO99JI7"WR<9-5Y1TC-%0HM_EXR/6C
MZQ$7>517GH:KR$$"\-2YV.M\TB62,K$5@[F=D2-HU@^<M_-75BR@C:D\M]M!
M3&&8[U\"F:)6?["M*BE@6 JY1E"$CLXVNB"3OGQ  )/)A'(577)EC=E!"DU=
M=;W[JBW6>?J-?LZC^8K3"RRDBH,#9&L(XCZ9-(5JVNX2SO(AO6[(C6K&X+ 3
M@UZ5DQC)E)S&NP2=M'*24A@8GF!!C3B68$'082%#KR5<0R%& *L$/$FH((=8
MR#S?EQ&O)7TPPWX##U8]J2".7<=CJ '_ #)?L:[6; IIBPM"[0AJ99-,-Y6V
M5]J%PA+IM#4.K62EJ7CTI@U"E$'^ZJ;8C11D+(96N'D#_,I3,>^AFQB4/$C\
MX#'M-[(5Y$B<[ (/HO(BR?+DZ!&<$D%'(!@?@)90WU<1R2JH&_\ 2)%(R'^R
MC%@O8')'5FR@V1'V<KRMR=/L]%MSZBW.L2CF/D#Q5A914-/I'82T6NNQEX68
MKUB@9^%D2 U<K1DLV))QD3*I/HMG;0*JX)*OSUL%3N.1XF!!^CQMH@D$:(/>
MJ[^)E.N2%0P!##XXTE7N._=)%)! (.P1VK3E\4I2G;/V;K2L6ECL& '41;<@
MG'[ X(\N>5^A=JGV-$TA[&S=76XUVJKPY+?3%861@V[FQ3!9N/4D[&P;PZ<>
M\!^^BIK;YH&V(W73U!GFU3MM);&@6T6WK]WH4UJZ>00@?*#3>&U]97LA9:E%
M2I8\). A;&Z/.M(-W'EE2D>"J&*5,.*4Q2HFW&4PTN>4]61:@VKEL>)/&3\\
M=\J[8U.=>M%TW3-RVDT':+A!-9%5L<J8%(<JA_S 0T'Y>//S_ _X_#=/'FM:
MS20VJ;C/K"GZ2MAF>QMO;3>;$55G!;/Q@:C9;D>SDGE'[IF_/%-4[Q;*6FH_
M.W?/7SYZHG'E],7)4?HG15KTW'=9/,=8V<UU@L9!%;Q)$\J^OEY9H1:VJ)%)
M UPS6L%[,\32I"D<9>?:\5;\_P MWU7<=#=(8SH>^@LNI>K)<AU/<22QP/Z&
M%S$V0S=]>2RS174=JIOLO80).L+SR33*EKQ8.R9U,:VTK##8^OX6#DZY"U_3
MU88,I=DXBOE7*B2=Z5<N&BBLK*3BSU\[7=N'KZ;CP=/G99!V]<KN'*3EYQ62
MO[C)W]W?W4CRS74[RL[\00&/P(%0+'&D486..*)4BBC18XD2-54?<,3C;7#X
MRQQEG$D-O90)"B)S() !DD9I&>622:3G-+-+))--*[RS2/*[.;JDM3QEHK54
MDV<M+P6P:[ M2U?8T:LU1L[ ZK4BWT^34!F,?8:TY6,0LE6)N/?0CQ---<6:
M<BV:/V^;B<Y<8P26LL<5_B;IE]^Q5V&DM9P#KU8N+)):7L:[$%]:R0W,7=/4
M:%Y(GUN<Z=MLN8KR&6;&9RR1OR;F[$K'>VQ.V]";DKQ7V.E?7O6-O8Y[2<:?
MTUG2&:/'[BWNF[H0CVN\A!K$).S&PKDWJ5JK3A@ZH4V_=6)ZI*U@UACI64CX
MZT%LBTLM"P\NK&/9F <Q:L6G)+)NC%ZCJ? ].73>_>S^XN<ECK:U1LG9W!D.
M3M)%Y,]V+66"&:6Q](QBXN(%FAM[E9>;10- 6X[I#J;JFS7\F^TZVM,3E;R]
M=</?6RPKA[V)PJQV'OD-S<6\.1]996MK:Y>WGNK9XA$L\\=QK*"IQKE*];1<
MKS4F_:NI6"(2(=H0@1S/SJ\.?ML=I#M)-02D_< 5](O""EV)RF6_>Y\\KZF0
M"""-@]B#X(^AJ@RN@Z0>17GZ2O.:EM"ZBBZ\[K%^G7D)!TIV)W-AJ*S5_0K6
MN<W7DXL]5EW90[]!R@?HX>HE;L' D4?)QO7X,-.O_18;^>ZXZZZ'P[7#WV'>
M]Z6R4C-))>]-SKCTN)6.VEO\4\4^#RLA\&3*8N\E4;].2-M,,<]S7+D]JZ>T
MPS1I,%OV,<['\AGZJQ<TRS(I)UR<8K1LS7UY&4@0D%X63F)5I8&<G&PRB\(L
MW>0D0DLBH>Z+!)R)9H=#L"0XWH]P= D Z!71;1V&.C7(]09[VH=*S8:WM>G[
M+K^TO;\0W>1QD$V(R%I:*4Y+>6+7-U8)<21LSQ9-;FWQ[20O#-8V7JPO64-3
MW;KJW2*< A-*UZW'\NZ1=HY_2[GV0>E#-J]9&\<^E&Q#?E"1AB2,8J("*#U4
MOOGFT3J-ZY+YY(0R_M9=@'[CH_=7<8OK' 96X6P2\:PRS;_\2YFWGP^8[?:,
M>/R,=O<740/;WFS6XM7(/ISN.]2HJDDX2507236063.DLBJ0JB2J2A1(HDJF
M<#$434(82'(<!*8HB4P" B&>==/4;:6:-66H-7(,VS=HA^SZG+>BV1302]5Q
M7X]==7TTBD)ZBZZBBRQ^O)14YU#B8YC"*E2;BE,4IBE6U:;(-78-G_T.8G2N
M96)B/EX4\(1PBXFI%M%,%5OKDS"-Q;GD'C5L<47"RR8KE5,AZ!%E4U*N7%*8
MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*B?>+/6ZNJKM*[:@BV"AU&ORMWG
M&A&CIU(MFU18.9Q22@QCU6\HUGF*3-56*=Q+IG)(NO'Y5T@<WF#6R!R9.X^-
M&=&7OY#1$2#[^'<C8T=Z+>MGBK=OLLJ,K?<5D^ C];MOO\JB/BE&Z[>05AN-
M2TKL+4\L\D20+YSMRVP&P;[/1C-JTDF:B=NB=L;D=#6DU9!0C*'>VIF9L^1=
MKDA44E4';J2I4C<EQ)L>;@W7(?<JW0# ?>H /S[BJJP(T$@0 ^(/=^)[?I&W
M'$L/];9'R\FLM,BK4Q2F*5I3^+U9*?JLO"J^Q],1LEYC^=6J;"2(A61D)NQG
M94+:C5C'O)ELD LDY"76BVP&<N"K+(I.%FK=V5@Y(GJLSD5QN/O;E8);N:WM
M9+B*TA#<YW4JL4?,:6/U)F1 68$CFRAN# =MT#TK/U5U/@,:U_;8:PR.;LL7
M=YF[,+16$5PDT]U<+;2'U+HV]C;W$I6.-HTD-ND\D)N(6:<]/:Z>\=-;KR=\
M<SFPMEWW=VLD;Q/5*O@^9EFSSM-F$D5!;'!4(.+ R-0KKM0R+,C-K L6,:P5
M>.C.-'TITSD;6TN5Y+D\M/>0W^4G6:QM$XVWN]U<-&;NYMA-#9VZ>C#'$TDH
MM;>/TX !(Q^P^U+VB8;J_J*P2P6+I;H_$=(9^PZ8L,@,I=W#+?6V9Q-L'2QL
M;TVU[D[IQE,BTR(IO;N]>[R$Y2V1,SM_-8AU06A9J$AYUF78&K"D;3@1?R:+
MIUL:L1[94@RQ#M@<KJ/ C42D %U?GS(I^0*F3/W%NM^\G#'-*MQPDF8Q3/"Q
M@LT:]G^).Y BMF8+XY!2Q4 LOP+ W%C:W\DV0G,$!QV7M5<0-<$SY#%W>/MU
MX*00OK7:,[;^%%;B&8JI\_(^2J43J*Q/;J\@&$&F\K93N;(JP0C$W"EEB4FX
M'4DA*U(L<YQ31[$#F,?P)V)NAQRTRJPMS*)F1U00<_5;X2Q"B/XS\*DD#Y D
M]A6=T9!)<=1X](HVE*^\NP V%06DX+-\@H)4;/;9 \D5W\B?D0T;LH[N=<UM
MLG4I-5*682I(59%9-N)V:";XPE(0CM<$FID/LY36%L #ZO0UEG2&*21U@D0H
MR%;E5>)O5'#1#$ L>7P=]\M%>^JGHJVGN>K>GH8(9II?RM9N8X4=Y D4RR2L
M50%@L<:,\C:TB*S,0 2)C9@D5HU*@X.[1!L@"+I1;YD[E($B@FX.X['USK$Z
M4,MV/JB83]CY9Z%@Y+CCIR6'#073=QQ [!>_PZ[:UJN89&C9HW5D=&*.K@JZ
MLITRLI *LI!# @$$$$;JV-@NUV%$N+QNQ5DEFU9FU2,4%FK=9QXQSCR(FL]6
M;M2& OD;M99,H^/B!O(0 :2(LD<B-(L2M'(#(P=E3:-W(16<C]52?NK888$Y
MC$@ DG)V  'DDW45>JE.57E.JCM9JHQ6<UR$749K*H+*M3JQK8YD%%6JJS90
MZ0CX&.@JHD80$2',7H1(H1$17$BHBJ'4,%<*  P#A6 8#8#*&&^X!JF5W^5,
MEL:/O]YL?0^\2;'[*JDPPBY.+?,)ILT=Q3AN<KYN^*F=H= @>H8RWJ_D*5(2
M J541**)R%5(8AR%,!XEF4Q.@D5]*4(Y<MD:&OKO177<'1'<"O"TN[FQN8;N
MSGEMKF!Q)#/"Y22-@"-JP^1!*LIVKJ61@58@X[:KTQI2R:=UJ,KK'6]H0=4:
MKKN'$W4Z]9#O'2L(R%VLZ>RC)^N[7,N"A%CKKJJ 8GI&$ 3 A=%983%28VP2
MZQ5C,396K,+JS@F<E[>-BSF>-V8MO>V))!\ZKZ;U9U_US8=:]4R8[K#J;&F+
MJ+,Q1+C,YDL;'#%%DKE(XH8K&YMXH8T"@!(D10=G7(DGQR?"/B?)K"Z+HJBP
M;SR$Y7M.8N**]3./W42=TUU!.$C_ ,C)J%$/X9CR=&=+2,7&#L('/^DLXC8R
M ^/A>S:!E_Z)']YK*M/;[[9+2,0GVA=0Y"#04V^<N(NH;=E!WQ>#.PY&)U[=
MPRD&K6/P=UZQ5.I2]L\G=<%-^EO4.0>P5&:0=]B"3*V2%I:@4W0 )#I'( !X
ME*4/;,8]%V",6L\KU-CM^$M.H<DT:_/M'=S74>M_HE2O;7'7:MLOM_ZEN$5,
M[T;[)NJ"/,N;]FG3*SOVT"T^&M<1-L>>2NK$]R2:[$N..^JZHJ:D\U-L VZ$
M4(_95(UALA(! H@F1=^>NUR8.3RZ%0R4@BJ8 _5DCI[.6Y;W+K++<3]E,E98
MG(@:'@N+.UF(/SU(#YJK^U#V=9-$&?\ 8/T:9=CU+GI7J#J[I5R"VV,=LN4R
MEBK:V%#VTBCZ:\0]HZA<ZJVQLRC?;>F;"T+:K"T=,-@4J[NG$A/,+!-)3DHS
MDX78SSZ8TDG1DS%*5F0BH)@<82/6257D]7AK'K>V2<_E?#7,?O%POIWN/OB[
MS)<SB:42Q9.0(KMH@+&JG_D8R"7[?V@=1_Y/64GQ2R=%]=8V<XC&317'36>Z
M?ABM\=<XVP?'V<]K?],0^]S6L(926F9DY<?RA<HZ):S:E:.=$.8PRFH>.-U1
M(4P@%6W#>JD[6,'Z0(E9-83+9,QO_-4>>("/0J]!Y#M_>>MH?MXCIV]'_H^9
MO[1C]X6XQ,Z_L,@_6^9X%L1_D^7P M.M?:C@79ALYCHCI[-0Q@[WR?%=6V,K
M:[=T@V1^AOM5/_I"\DX=82VSA#?SM2!^=YKW;&J+OY&]NO192,Q3WRA/N(F,
M@F8 ZZ3,/?7G^7^HHB?>NB\@4 [O897$7F_KI);BS<CYCMOQL [ RO\ [-/9
M7?(#AO;]TV)6/PP=3=&=9=/Z'_G)[:QSENI[]M2,OGX@!NN4^:$<Q7%"W\<.
M6E, @ *KQ]I&4LL:4?81 CVA25L!4 []S)IB7V_T8'6$:-QN^G>J[/QMWPDM
MU$/_ ,S'R7@.NY.@>P^I J&]A5S<(),)[4?8QG>7V(+?K^TQ5V1W[M;]1VF%
M*;T-!G![CMK9JQ(7X@/'4=C69*;E[=563B#BF31Y9=<;$BEC.JW,61O()/(M
MS5"2#'U#R13-3*(J$ K=PD_,P>E*S-B1==]/>^SB:>[M5:)%5KG&Y.%BT$TZ
M.&B>S61-E]J=$:5@Y1M*>AOO\F[VG_T8Q3X^QPN8GBR%Y/-!B>J.F+Q!#E++
M%RVSP7<68:VN."VK"95=3N2-[;WJW)G67&/.;B._,)2;ZH;(P!V)9IZ[KQ@_
MCT)9UE'" ^_N40 0_B&;)>MNDSYSV/C^Z>4VY_=.L9_N[?.N,N/\GSVTVP!;
MV==13@^#8V\.2!^\''SW6Q]X['ZU<;7E[Q6>F K?D9I0YA^Q3[+J*)O?^95I
M5,0_V@&9"=6]+OKCU%A3L;[Y.S7M_P!*85JYO8I[8+<;E]F'7JCZKTKFI!^^
M.S<5=T=R"T-,'!.)W9J234-UXIL-CTYVH;O[=$0F5##_ + S,CSN$F_J<SBI
M=^/3R-H^_P#JS&M+=>S;VBV2EKSH'K2T0>7N>ELY @_Z4EBJ_P!]7BSOU%D.
MOD+I4WW?V^3L<.Y[_P!'HO#]_P"S,Q+VSD_J[NV?]2>)O^RYK1S].=0VV_><
M%F;?7GU\7?1:_'U(%U5P(2,>YZ^6?,W'?N'H.D%>P_F'IG-W_LSV61'^RZ-^
MJP;^!-:V2VN8=^K;SQ:\^I%(FOQY*-5[,O7A3%*@_<-:9V*P:.,[G+!"FBML
MDD&OT&=<0GSSE&@7M0K1^" A\^T7*D9JNR4[(NT=.VY@$C@^:W((7FQ@]>6$
M>_D$1NJ>J!9W;A&Y*VU+(-A=$C8WHFNGZ>M;2XLNJIKK&6^1DQ_3WOMD\YO0
M;&Z;-8?'F\C%G=6RLZ6M_<J%NA/;@L':%BH-3AFRKF*8I3%*X$I3?J*!NOMV
M #U_]\4T#Y&ZB=+3M>2E227UV[J-4[*I:R5]6V22E;++'G5+*40B1'TODT9I
M3YU%D)Q;IF(FD!!0(">> MU#;YRD<_4XF1N'+ES^SXT&^(+X!^58_NR<@W*7
M0?U GJ-PY<R_V?&N9WKQNI%F8.$L</*UVP0\7.P$Y'O(F;@YA@UDXB8BY!NH
MU?QLI&O4EF;]@]:JJMG;-TBJW<H*'163.F<Q1]B 1H@$?0]Q60/A\=OP[?PK
M'-KPWX]QM@C+)"49*MNX^P.;&YCZS(/Z] 6!VM:HJ\LV5H@(A9G$V")@[E P
MMDK\=(M%D8A_')HM/".=2+%Y*DKK1.@.P))&Q+-,C:WHM&]Q,8V()C]0\2"%
M*PP#;V!W/<@ $CTXXF7>MA72&,.H(#\ 6WL[NRX<<M5WIQ:7-BB)!RK<7=I>
MSID)J2: X<7+5<9IF>.B5!<@-@<4*(8QR)4? K9XF>31 KU0ZH^?I)MSH_G%
M='[GNLAA9P/ILV\1V.XXD#08@^AD8^GO7YHJR=O!02A=_70GD'?SL?,"H_U-
MQ?;ZRV]=MCDGT5:[,1MRA:C0&'XG-!5MAL&[-K]<7 MK#:I^*:N9FP,D'KAG
M6HB CCOW<V]625;/HR+@;Q@1Q/$ .+F+MKLJ0^\"-%!V>.KAAQ)( 554!0 *
MN2\B2<FVBOW+=V>00<W.M 'E"""!L\B6);9-(=\'-4+O$3-[7M]C!1M?BZW6
M*FEL62?05#CH'8-%V?7RZ]5F6\G/4KZ+;M<5%PU:04VUBG,7#QL#)QSZ(A:\
MTAQ ((.V_JM,3MQZ+\U^/[9V=!^1;F I;; -3??8T/ZS8'93ZB\6^$?"-#?#
M0''DVM ZK)2@:\K&M()6!J[=\"+R3>SDQ*3,M)V"PV*?DQ3&1GK%8)ET]EIJ
M6> B@B=V^=*B@S:LXYF5M',631O8GL  % WI5&@-L7;]K.S,Q.RS,S,2234?
M,L22S:V2=D\5"J/N"JJJH&@J@*   *U>_%2Y+;=XWK<?WU)W"ZTW0+B_V'$W
M6:K3SAVRO,E9F36HK42-BOZ9>PJ12', *#JV+V(M:1?3S59&'=.GL?&E51?Q
M2MJU.</W=1JSJ46?.)-S7(-Q(N),D&227?K1C51VM($K*[JMD?*N#*'=DK[E
MS!E7,H$2NLP!NH92KCQ2F*5BOS)M452]![!GIJNRUC8?AJ;AA91J"+PI75CB
M7\!'NUVJRX$21BI"2:S#J2%LH,:R8.72*GS":2*OI$ADD1 1W.SO>B "2.P)
M)/@#7G]]<9[0^H?Z*]%]0YP6]U=26E@\<$5G'ZDHN+UTL;:9@2H2WMY[F.>Z
ME)_-6\<L@5V4(VE_6ZGQ'['Q[=73CG6]2M95[M+4U3C+IM*89)3BU8I-C;QB
M51J=/;0"L''TJ%OB[)*:DI>5@;&HJSL*436I ZS.;+]ZR\OLM@FP.,R*9JVQ
M\.!7)3XVRAD"+E<M:VES%=WUP;IKA\C+:+" D:36BAH!)-%$LL3?,_8C:]13
M]+?T@R$UO<S9!;/&8EYX5@NK/ X)I[&''F!(DAMH([I;AXX(BQV3*\DDCKZ>
M0>P]!\G^+UZY0<S8+=$[R:O4AI6#)>M RD!+5FG6"+?@\8O$M7-X6RS85:2I
M@U@9.H-G==M+E[$/;+ N3+SEC-84N4ML_P!-]1V>(Z-O,7:]-8^&_9K7J))X
M9[NW,AET<HT\$(N8I_4*W3K<VJK*+>90L-MZ#_;F@GMWEO%D>X=DTUOHJK<0
M"1& 6XMO7':MVY [+;&P/AIRBAN1^I:@^F8-?5^X6E6CG>P-(V4TBQNE,$3J
M,F<D>,GXFOS$A69M%!%_#6-O$C%."NAC@>'D6+U%+D.I.GFP5],EK<IE<.9F
MCQ^;M?3DLKT* 659;>6XA2XB/))8#+ZBE>?$1NA.5!-ZR*60Q2\07A;?--_4
M$*2/H=:[Z\U,=%CHVYT2PPMJIX!#R-TV:RD*_9V]?E&LDU4V!9%#^NUCI&;C
MU4"G.+82.%2K%<-5#II"@#9RMHK6ZN;*XBNK.>:UN8'$D-Q;R/%-$X\,DB%6
M4_+8/<=CV.JK>6=ID+::RO[:"]M+A#'/;7423P31GRDD4JLCCQV(.B 1W -8
MNZOI&Z=:[:W4:E7E/9=1;242WB=8[!>W*+6BHH(YFZCT838<JTLR1I""CG",
M T3>(OD)YDW;N)!_'&03<D^@Y+J#I#J'&XNUO</)@LQ"KMD<]BK.Q>*]NF 5
MY+G'0FP$D5PX]XD,<D<EHY=+>*>,\#\OQ72_772V5S%YCLY#U)@KAT7%],YK
M(Y*.6PLT9FCBM<K<+DS!/:H?=HUEBEBOX@DEU/;RJKKDQ%[TJ0/T(*],IO4]
ME<*D;-XK8C5O$Q\DZ4]B(5^XM'<A2+&JJ;OT6L/8G,D)>O78-U/),O.3]+9#
MT7NL7):Y^R12[W&'D>XEAC'EKO'21PY.S &N3W%FD._L3.-,>KM^L\6)TLLS
M%>=,Y!V"1VV>B2U@N)#V"6.5BEGP]^S'[,=I?RW&OZR"-MJ*KL5.46G-1&C'
MT>U2#8XF=@\C5Y$SE :'=S"1JHA*QI6JAD"N$RK*$>D!19%84#E0,BXYH@@D
M$:([$'R#]#77 @C8T01V/\Q5W6JEU"\QPQ%RK$#:8P3 H5E/Q3*5026+[D70
M(\16^7<ICT9)R@*:Z)P Z2A#@!@D,RG:L5/U!(/]U:[)XC%9JW-IE\;8Y.V)
M#""_M8;J-7'=719D<)(I[I(G%T8!E8$ U"$_J;8M'@9AWH+8\TTD6L;(.(37
MFS7+C8E%?R*;54[&-;2\\_2O572<."I-D%&EQ<P$60X*A6UTTQ2-ZB1&($J#
M6QMT'!];[D@?"Q^?=0Q\<AY''7W3&?PUE=R]$=07D5Q%;SR6> ZCEDS^%GN%
MA8P6\=W?3KG,8LD@2.,PYB3'VBGD,9(J\#&_'JY<EXC3&M@O.F8*TB2J1(,G
ME'V% ,IQ:!!L0M>,^K=E0B(%N_\ H@1XN1:7AT1P?S7418N3J1Z,LL))X2%1
M]'1M;U\F7DW<^-H-?,_.M?T[F/:C;8>S/5?1UAD<EJ3WE\#G\;%=MN>01>IC
MKY;3%Q2+#Z9<VV=GCD ,@6%S[NLRJ;Y:19@);-5;OJ8]B!U5-<OKJS3Z$ $R
MC_5;N_,R)^X#ZBBQ"@'9A$"E.):^EL;62)NV_M\3X)\2!#\OEOY5O&ZWBMF"
MY3ICK/%D_I'I^?-1+K6RT_2\N>A11O[3R*- GPK:J#'D5HYZJFV4VA4H9\J)
M0)&6J2+39?S.)0*F:(MA863(J)C%+Z1VI5 ,8H"4!, ",,HW\#'7S4<A^]=B
MO:'K_HN9EC;J7$V<S$ 6V4NEQ%WR;0"FSRHL[I6)91Q:$-ME!&V ,M1\I&2[
M<CR)D6$FT4 !(ZCW;=ZW. ^X"1=LHJD8!#W 0,(#_#/,@CR"/Q[5U4%Q;W4:
MS6T\-Q$P!66"5)HV!&P5>-F4@CN-'Q5L7[_L)A_KKK7_ (BU7(KVJ]<4IBE,
M4IBE,4IBE4F;GH:MQZDK/RC*'C43I)*OI!PFU:IJ+J%21(=94Q2%,JJ8J:8"
M("8YBE#L1 ,4JJ$.10A%$S <BA2G(<H]E,0X 8I@'^(& 0$!_D.*5]8I3%*8
MI3%*8I3%*8I44[W,4FD=P'/)5B&(76-[,:6NT8A-TZ,*%7E!%_:H9RQE&\M7
MF@?OYB-7C))%['D<-E(]Z10S960-D#2MLZXN>*-OY,25TI\,>2Z&SL>:;UWV
M5U\U&V'WJ "2W]D '9UV/BL+OACP"M=U+LAH23AY&(=[5=R=8.RUY6M6S0UE
MY3ZE](=VRD5G26BF]>L4@DD=U)0DA6YV5K[PSFO/;0\/$A'18DG1*PCMH&!8
MT1@"=,%C9M _HE^+E..U T6@#1/Q2L>V_6>21E)&RH>0G8'S"$H&Y:.]@;)\
MBIIBE,4K4S\276E"?W_X>]@6JD,G/2_Q"]/0TM-LFA(V7E8I_0MK+/&$E)1_
MRSQ^V<'CF8'(Z65\4TA23$B:JQ5/*2"*7?J*3M&C.F==QN5+*W!EV#Q'G?;8
M&@S ["SRM]CN/NDJQ\+J"\CYP03^E=6ZR)#/%Z\4GIR(LSZ*<0S"-W#-#"4\
MW*KF/)Z(KB==4U@REMJW;DY!L]?:_P#Q]$,VLQ6M=.*)<YFW34[].\:Q""BP
MBX-/RC9-=.:L$:R00>K"*!OH?0G1SYBZR=S)<7%CBH,;=W%Q>RV<<C!\A:RX
MZ""V@M[R83N7$\P5Y;=_0MW=TB4@B.J,A;)'@H[6Z@R5PF+@MYE@%Y$(;A;N
M[N98YWOK2U8M&DT8>2!9X2[@1RR$&O-N;B#OCDI5("S\J^0+)2$_%FO7D;H+
M1\=8ZSIR.&6N5:8M7DY:0L,'L;8<Y&IOU7+"8?/ZY&LG7BZBJ\P<%3<%W&'Z
MLP?3MU/;=,8%Q-[I?I)G,W);W.7D]*SN7=(;7W>?'X^&0H%DA1+B1T^&6XD7
M:GGI+2:X"M=3_#R0B"#DD0VRZYN&664CR"2B@]PF]&J]NSX9/%LVIFR:-6D4
MYBLDB#OIIY9;=85+(N<S>)='DF=JLD\W026</#RZ2;04SM7R+44EQ30* ^&&
M]HW4WY58FZ0PW)E"0I;VD ME :5!$]M;P,2JH(B6V&0MR7;;JTF/M6C"F,;&
MMD[8G7G?(GR>_P!00"#L58V^OASR%$T9/LM!<C^3-6*RK;Q"WPEBY#VZ0I\]
M LZU(D?K(UZ?K-_9M963ET(H[EE%(P$<$:M+-V3B.$6I"YN#Z_COLU ^=Z>Z
M<NB]PC6D]O@+2.[AN'N8S$K7$%S8.T4432A7D,\AD6)I%DTQJDEAPC807-TG
MPD,&N7=2.)WH2"4*2=;XA>V_%9#5W5_Q**C$1RP<H^/NS99.. CZ!V3H>7C&
MOSY$A(4B5XUM;:BX=I'.4IC/U=?-% $QC&C5O'P/H+C)>SR[E=?Z-9[&Q&3:
M3X[.12,4)V2;+(VEVJ$#P@OW'R]0?+U$>00;]Y@E.C\,EN5[_+\Y%(HT/_5;
MJQMS[TYP:TU?;C[9XKZ'O,&[AW<(XL>MN1HQ461Y-$&+C5WU8VQKNN&39E>N
M45W!0LCDR2":B@G)Z?GF3C>GNA\S?0067467@+2*[666Z;6Y,D47YV5/6QM_
M=(Y**P4-:J&;0T=U>._RMA(ES"@AN(6#PW5E?26\T4F]*Z.4ADC<$C3)*".^
MF'FNK5OQ(Z!'Z\JRNP>.W*C6,1%03&*=V=KHZ;V%K$B\&D$/)JPEQU&M=X][
M"-I%DX;M7PM6A5DBIJ%1*4WM:^]G%VMY/!B\WTM>GU&,%BN8M\9?I%)J2&-[
M#*+8F*3TG0F)68)]G?8;A\L]P\ES>I?M-,[23W,R271EF=B999+B-IVE9W+,
M\C,69B2Q+$UD76>=/#C9352,KG(?3KJ5DF:R*=2N-MCZ5..#KHJD^GR58N*<
M78&WJ]&2=-UH158J0J"+54.B&T%YT5UAC0TLO3^5XQGDMQ;6\MU;<ETRLMY9
M+<0\=Z(D1V \C9&J](+W'RR1J]TBQLZB3B4,RQD@.5@EDAYN%V5C=XPY !=0
M2POSBC-U^=XY:5?5MQ6EXY76E.5(6J/V[^*3,M!LU#B51NU9 1TJH8ZK]([1
M)1-\=RF<53%,LIH+W'7^(N9<9D@_O=@[64KN)?SAM#[NLB&95?@Z1JR CX4*
MJ"0 3T/463LLUG\SF<=ZXLLMD[W)P+<I%'.BW]Q)=F.58)KB+E$TS1\DE82!
M1(0A8HN0F8M::F*4Q2H8TE,NIF&NBCE%BB+3:VRV*8,7#YP4Y$+=)@*BPOHV
M-,FJ8XG[21*X3*0"]KBH)R$\+>-(T=5]<<I[F4BX@,!(GGDFC:,%F]2)XW1H
MY1I7!VNQHGJ.JTXW>+(DAD!Z;Z=4F&>&<))#B+6":)VA=PDL4L;QRQ.1)&ZE
M74$:J9\]ZY>F*4Q2HP@X^KDVA=W#!G!%FQK-0^I*M$& 2@"[DK:JO\Z=$OS0
M"Z,BT56]80%<R3913S$B0AB1VRQWEQ.( AE@M]3>D%,FY+GEJ3B.6RHY=SLJ
M-]U&NFO<A?S=+X2TEOKN6VARN9]*VDN9G@B]*TPJQ<(6<QIZ2RRK'Q4<%DD"
M:#L#(2T;'."B5=@R6*;L#%6:H*%, _<! Z9@'O\ CV&9!C1O*(?Q4'^(K0)=
M7,9!CN)XR.X*32(0?J"K#56N^UKKJ3$PR5!I4@)_UB]JL$Z$W\/S"NP4$?;^
M>8TF.Q\IW+8V<I^LEK Y_>R&MO;]5=3V@ M>H\];!?LBWS&0A _#T[A=?LJT
M7G';C_(B(R&C=/OA-^H7>M*8Y$W?_G"M"G$?]O>8KX#!/]O"XE]^>>-LVW^^
M$UNH/:;[2;77NWM!ZXM]>/0ZLST0'W:2_7M]U6@]X<<3Y QC.N.&E1.;OLZ&
MN*LS/[]^X'9QB!BC[^PE$!#^ YA2=(=*RG;].80GZC&VBG]ZQ+W^_P UN[?V
MX^V2V 6'VH]>!1^C)U3F)U_:L]W(#^!!JWOZ"O$<JOKMM%4V/5[[ \0$M#"4
M?YD^E2;,"#_(2@'7\,\#T1TH?LX.SB_YN);;7X>[R1Z_96R_\(7VT%/3E]H6
M<N4(T5O?<KX$=NS>^6DY;Q\]UY'W!3C<\/ZK:M76$4_R1KFXMOP12"'V$B,=
M>4$"B'\/W64;HCIP@".VO;?7@VV9S-N1VUV]&_3_ !^)KVM_\H7VIPCC+EL%
MD%^8RG1'1&1)_%[KIZ20]NWVZI']!/5[<WE$[,Y-P/7N0L3R0VL4J?\ +P*^
ML#X/;[ !O(/\W>>8Z(QBG<.1ZF@^@BZES.AK[I+N05F_^$+U;("+WI3V3Y+?
MVC>^RWHUBWXFWQEO_=JHWNG#-.,O&HIAAO??5C3):I>%+$[/V+*[ BF)Y"CV
MQT66C$)(J*K9ZT+&F!,I5R'4<&:.".VXLQ(XPKCI$17V+G3.9ZX"W4T?HY+(
MRW\*%[&ZU+&LHY*Z<3KXP22"&7CINIP7MS>ZZ?ZUL;CV=^SG%L<-97QO>D^F
M+/IJ[N!;]08: V=W):%TEMYC=@L3&56)9HC!+Z_*+8V4OB4I?(QO$H%\C#V8
MW0 'D8?XF'KL1_B/>=Z!H =SH:V?)_'[Z_+Y.R3H#9)T.P&SO0'R \#[J^LF
MHIBE6M9HZVR!685:SQM;,D*XO32-9&Q@[*<$O0!(H3D+\H*(E5$XB+CUO4*'
M27I]GQYTN7X^[SQP:WS]2 S\MZXZU-%QUH[^UO?RUWV^*NL-;&<YC$W>4#B,
M0"URPQ?HE2_J%R<??^MS!0*-1<.)/Q\_AQS1UWNTMA07+:(EO+)W%]*N;L:G
M,U&SFO++.E4V!A#8AIEVT4BE6T(E67,,C%QSQ$'[=R)H]E)N=&+++>LI%S$)
M1=/(UV;12K0%F(C/_#O593%QA$!B$:./44_ KM]/?J?H$XV2,X>\DLVP=O9Q
M8$9N=)8LDD<*/<@?T86QBG6]27(/EHKY[RZ@D]WEA N;BSAG)PTN,53+:,R=
MMLV8"'F%HJ A8UM2E)PY(M;T*VFZD)]^R;.9AT7Y-*5=R#)JS%T11<R22)UL
MWD:7"QN)Y8[ESOCPB]W&N.N!!EE\G>VV- _9[=_E^2N<3<7$+XG&W6*@5 )4
MN<D,J[R<R?52065@$ 0@>EP;94MZ@Y:&L^*XX[V_%U?G&]0G8%G)RE5GH:';
M6.L0E-X^6IEO2@W.]C4:S'767'\*6/54$M6$)*$!U-6:9:W5K-5NL5_9#J/2
MS$**0&V[*T!64C0,:RWDEQ&4V2GJB:)$12Z<$C5Y%,7(Z9N3+\/P ^MRC[-\
M;16J6\@?2EO2,4KNQTQ>5F5#LBIZW'3N8TE;=@36KMA6>%AOJ%O+1:TQ+J4T
M(HPB]%U24HJJIK+77TVFK+;\9SD1-%=RR7K5UX];KI,HE=G)H8RF4-*64,-2
M-$"1W=7M!$AXD$(R>]EMZ)/';#2JWNWID1 ;'=!*1L$*5N/4(WL%@WNP70T!
MR^$[8BGZ,V#NNS[]V+2+9<',B$/5MN.)EG&/-:SVOJC/%VPQA-/I0(54%KI#
M/BZZ;//Q!!;&=,Y-]8V%C<-&!T&QW);QAVM9N143#T C@$CFPO1-Q(^%HU*6
M_%2#(J\?4 =VY5?BMQ%I6],B5BIT-H/=3%RW\0=@\NR-(VSP+*J\<?)/4VTD
M6^IZ"GH?83:?9Z^HQ]W3 RU?L]6WS::3R5XSVZW/I&T?BEU$S,NZI=5VY.Q+
MS<3BDS<_!7!W4X:/?K.;%#0)P7+% %C'N[>@>*L")T/('[#&% ZR!6+S^JLO
MQ^D=%(4 -W<M*/4V6^$PN"I'VE$KM&R$CC$(3& HD%;"^.U,LE,KEU2FH1W3
MH2P;)L%EH&NWTVWGG6NZ4^CH-HWKBCJ/?RL-'D?3\?8;<A7*_*2$#5F]G2KL
M4Z.VC"E+<;"1J3R8"3DW<]FFD>-22 28XF2,D[ X\5)15)IY>0CLI*<5T!KC
M%&CG0)&GE5Y!X)#<F56+*-/WQ:]HQ<9M&GU.1ONG-.7:%U;M92#L=CY@Z\TS
M:[AQ]O+"@LMM0DA3MF\1^1M=:'L5H@6$-4 CR,[U,+T^3E*-)/4FEP@8Z*FM
MW&F @RZ>U.6L-2,JT76E$"O,DW\C*IM(,*O%!$M4Y28CHB7DB-V'RZ17\I$Q
M<B\*0'#Z.9.5%6R2E25BE,4J'=ZN7K'6UO?M4FCLK.HW5=1B[47:D6*E2[$H
MN?YUNUD52"DT*X,D@2.7%RX!%(56Y#F5)Z0PO<3P6\2EI9Y4AC4=R9)6X( /
MF2Q  ^IKQN)HK:WGN)RJPP0RS3%M<1%$C/(6WVXA%).^VJQ=T#,PM&XD:XF;
MK-1-8)8K_3[6]=3D@UBVP2UYV;"["D&YEWIFI/F"!)2+I5,P%6*DV<JJD#TE
M1+TO6\T<W5N?]$\H+?(S6$#?(P8WCCX"-$C7I6J<=$C6M'6JYCH2WFM^C>FU
MN%*W,^)L[ZZ4@!ENLB@R%V& "CD)[F7EV'Q;K*.T(%>.MM(>NX0*MK&  %VB
MQD'! _YPC 9)8GYB"/77D'W*(A_'.6KKOD/Q/_[:MRWZ"HFU*;4"S82\=<JQ
M#-EJ-M. E7<-LRD22[1-3YR M\>HWE"-%%!3+*5]VJZK=A9)_3+#$2D<=1L?
M:8S,7F+:18626UN-+>8^Y19[&\C!^Q<6T@:,L!OTIU"W$#'U()8Y &'E)$L@
M[[##[+J>+J?N8=]?4?9/@@BL(^(E[Y*<9*U,U+GW?8B^Q=LVM=C4;D76F3-M
MKROO'-ID(A]1]F';5FI*T!>:M;*5GZK89F+7IK@;$C4S6J/ED(6#=]?U#:]-
M]12I=]"V$V/-K9HM]@;EV:^G>/D\E]C@US=B^1(V$=Q#%,MV!#[U[H8VFE3%
M@:X@'&\D60LYX3*-( ?"/V7B>VU8CB=ZY; WG_1KE7IG8^UZ]'.W*\K%R<$N
M]2/$R[9J1(E:A6ICH2;I@A&/ %80 H,GC@QR#ZQ ,C^\SYYX\UG5*,I$Q<XP
M<Q4U&L)>+>IF1>1LHS;OV#M$WL9)RS=IJMUTS?Q(JF8H_P 0SU@N)[65)[::
M6WGC(:.:"1XI8V'ADDC974CY%2#7A<VMM>P26UY;P75M,I26WN8HYX)4/E9(
MI59'4_,,I%8);ST7*P=ETE^Q?:=BTXS6V:GZE8;IV>V4H'J,!+/&CB,JP2Z4
M=!,2,V<E#OJ]'JQ%?E&DXJJX2;"R46/]!P_6V.$.2CZMZ=M.II[JS:WM+]H[
M.TR<+OR#M/?BTDFFE;:/'?2B:]MWCTKO'(RK\QSOL\RAN,5+T1U3?=(6UI?+
M<WN,26_O<1,B<3$MMC#>Q6]O"FG2;&PFWQ]TDO)T22%&?(D;QMRHB<MYU@G;
M(M$@":TZ@D@EG!BEZ [B0UY9#15A8]^XE8UF8OKL0$H%\Q$WCHAB^GL@ <7G
M#CYV.A8=10^@@)\)%F+(3V<OR'JWMMB8_.^(UOHSF>I\7L9GIT9.V0=\ETK/
M[TY&P"\^"R!MKZ$:VWHX^[S<O@+R)[7-7-LZTO9G$/$VQJE,&:K?/5F34D*A
M=H] R9BK*.JW,DA;7$G3*)A([%DV,D8H+(+@)2J!@7_3V9QJ":ZL)3:LP6.^
MMBE[CIF.M"'(6;SV<I.QI4G+=]$ ]JV6,ZJZ?R\A@L\G +Q%+2XV[$F/RL"K
MOD9\7?I;9"$#1VTENJZ&P2.]=&C$6:&F=6$8.5G;8:!4SE7<2CR84,HI!LCN
M"?//W3UR<B3@RJ2: N#),R$*T0311031)J)(I(7:*:-XI$.GCD1D=#]&1@&4
M_<0#6\BFBN(UF@ECFBD'))8G62-QLC:.I96&P1L$]QYJ5<I7I7@D(J+ET#-9
M6-82;4X"4[:09MWJ!RCV @9%RFJF8! 1[ 2B'N/\\D$CN"0?J"1_"O&>VM[J
M,Q7-O#<1-V,<\4<T9'T*2*RG]HJ*'W'?1[U91TGK"I0S]7OSE:K&$ITSV/79
MBS-3-#2A#]@40.1V4P&*4P#V4HA?U9-:YL1YTQY#]S;%<O-T#T9*[2KTWBK2
MX;>[O&6JXF\V='8O,9[I=*=@$$3 @JIW\(UC3R/XVQ[FF5]M6M_;=U6BGL&D
M&$TCLNZW&/<@XGFD<FFS3MEM4>LG<2H]3GF!V\H9JDO$D$\>HH*;IK=9]';Q
MQML:[(BG?G9(0@_?L=_&_E7)=4>RN3,65M:8'K?K'IIH;^WNW8Y_.9R*2.!7
M AC3)9?WB!PS))$Z79A1XPSVLK$,F0I*IR!A#?\ ).W*7;V:?7@SOVLE&DNN
M4/L52RT:V5Z-0.8/RF5+1W =CY@B(@)34Y1'RC+]2C]OQXLK$_AS%=,N,ZYL
MR?=>JL1E81KC%G.G&CNY /T6R.%RN.MHR?'J#"R >?3.B#R6Z[WAU/&P:2@[
M$V+T N]8[1C9)XJ'OVH,-L6 UJ@W'[&% E@>B7LQ2++"4HJ.,9\2$'_70@?O
M0N3_ -4=_E]'Y8ZUM'U?='6=_$-#U>F^I;>YG;N06:TZ@L.FXH^W$\%R$Y&V
M 9BHY_ \@ZU'* C<*3MZB*>P**SVL+1*Q" B B/KV>C-+?5$2E\3 90\X5(.
M@$3]*)B>?18_9:-_U74'N= <6*ML_A_.H_IWC[=Q'EL-U7A7T"S7O363N[2/
M>]^ID\)#EL4@&CMFO@HT#O3(6NVN[GU';%P:5O9M$F7PB #&LK3#*2A#")0\
M58P7A9!(_9R@)%6Q# )B@(=B 94QR+W9' ^I4@=OOUJMGC^L.E,JXBQW4F#O
M)C_Y/!E+-[D'L--;";UT;N/A>,'N.W<5)8" @ @(" @ @(#V @/N @(>P@(>
MX"'WRE='Y\5SBE1[M3_$.;_]I#_[]C,4J0L4IBE,4IBE,4IBE=2RZ+9,RSA9
M)!$G7FJLH1),OD8"E\CG$I2^1C 4.Q#LP@ >X@&*5V@("'8#V ^X"'V$/YXI
M6+O,J;FZ_P >KV_@MG:'U,L=LA'O[+R4BE);4#^&E%!CY6JV9!*RUA1 ;2T<
MJ0[)VFXE3HN7!0+7IL5 9'L@<DA(5N&T?S;O)&I&N[%X_B4*.^^P^I [BK<>
MW*5X1R'QQI'(_P!RJD@*DL>VM$_0&L>OA;(B3CU/+FJK:L'<;-L7J*,J9/5*
M.LAF\;!M?Q/!.;C?[S>K95I,J)0JUFN+6C2SJ#09M&](BHEG'N7QE*G1YD_,
MO[TS$^2?5N;F[]5>^ED@N)(2/LD-S D'8'CQL!?=U '@;CM[:U]-CK;)+"LH
M)^+8T:S_ +L:8)4+*I7YV.J\RE"2*T?8I:)"<CH1=%LHJ$D[B32<.1\DT(0R
MPH*R35$3%*9<QTBG24K4UJ;O?-#?-&K\-9/J=1=V*(U_4 GM:R%<;G-8%ISB
M/:MXSVZE'<=(LYF.I]=V5$Q]1<F8>A5RQT5:(4S@]DD8=S$JC_!_'^/??^/G
MGIH[9MTL=0NJL\F;9[NE;5L^OHJW4MC7H1O>H2&:Q;HEG28R-B8P* QTC(2%
M2EOI4LLW6F*^[7:M42J+-FBIK7_\2G=54CYO@PXLRSFAM:'S[U+;+5(2]AUN
MLO!PT!K?;\A)JOF$5;;(^9D*R[,LL]BDFY$%! KI!RJT$V1:VT][<V]G:Q--
M<W4T5O!"@+/)-,XCC10.Y+,P';ZT,B1 R.J.B*S,)"P70!VQ*.C;3[0TP')1
ML,-J;,X>-+;?E=F<S-\U=>I7?>VY-'-M:I6J6CDAH&JEMK4^>@=:UJ+=2)Y)
M@=]"'KEPLT@O&PCB?D7:9%X[Q@RN7'V'JUK6Q&-Z0PERMW98/#YMLB;6*0B^
MR@Q=W!/D;F5(_2D$<PN+2V199EMT4\9-SE5U-ESD]2]G4I)</&(PYUZ4',&.
M)03L%AQ=SQ7DQT1\(K</M+_%1#_7367_ !*J6?)L9_G3?\SR7_TZ[K:-X'ZR
M?]M:\>Y_^[2S?^&)_P!^QF7PW_&5M^,O_<R4?[)_9_$5QN[_ +H-E_ZE6'_=
MKC&%_P"-\;_SVV_[U:/]AOU6_@:E'-95JM2^?XCW/_52Q?[H>9DV7^>6G_.8
M/^]2JO\ 9;]4_P #7?3?\4*K_JW!_P"[&N1=_P"=W7_.)O\ O&J5\#\!_"K$
MVOH?5&Z*_(5_85&JL^@_(@0[Z3JM5FI% B#E)R)&ZMBA)EN0C@J9VKDJC54%
M&CARD $%3S+FXO-Y3#SI/87MU;E"3PBNKJ&-B5*CD+>:%CQV&73#3*I^6JI)
M#',I61$<'^TJM\]Z^($:^HU\S6"6D?AI\.I33.O9A[JTS:P6>G4^T2%CJEEL
M6M9M&3D:E"@N#)WJV1I)$6X+IJ/03416.J]=.W#I5P=8>NVS/M%ZNCR]_"F3
MY06UY>6R6]S;V^1A:..[FUS3)QWI+%=(2& "*JJ% K#CQ]H8T_,JI*JW)"8F
MV5 \Q%/Q_$DU('_D[J[#(BEKOE5S@UJ5/LS1I"\D+'9HAJ83 ;_L?8S"Z,UD
MQZZ,FJ @("/N B(CA?T_N)CO(=,=%Y$G[3S=/6]M,W;_ );'R6;@_>*GW!5_
MJ[J]C^@%RSC]TPE%5(G'+FA7$"H4SX@4O+HH&_P=OM_CGJN[*J(E*!4T7<O3
MW6LY-8X  "HZ.<ZRAO(YP$YA-GD>H.C[ABUYT)%$6^T<3U#D[( [V2D5VF2B
M4>0%"@ ?/L!5C!=C[%\3]/6MX7_#9C]$D_?^/;Z?3E'XEU2;J*)3?#+;K5FW
M%4QW=<W1J&<>>D4QU0].+F-MQPK'*7I(K5F43*& I&YAZ*:%;V=73 -#U?BF
M=M:2XP^5@39T#N6'%2 #?<LY  V6'FFL@OZ5G+^*SPG\.S3_ "^8\?0UCUQU
MY2<UUF=X;SO!=[;(]&^WBR+RM%VO%5E:.3L-LL#@]5:PVXZWKP;'-5Z09OVL
MHZ82S<PI+QJRT9'J.BH#OL_TST<KV30]:I:R-8V=NL5[BI;A9#;VMNHN6FQ%
MSD/=X;A'C:-7B;164++(%W7E#<7OQ![+D.;GE%,HT"QTNIUAV5T02"!X.AO5
M3F'Q!FT(=5#9/$#F_KI5K_UQZKH1W?Z^D!0$554)W5D[=4'39( [,N5 A1#]
M)1'VS3?T#:8!L?U9T7D WV$&=2QN"3V"M!DX+)E8_($^?G7I[\%WZEI>QZ\G
MW<R#]A@:4$#ZC^.MW# _$HX5S >$MNR,UT\ 2E4C=P5VWZA?)&,/0%,38T!6
MT3CW]_175 O^4)<QY_9WUC$?S6&DR"=]28FXM,LAULD@X^>X(\'[2C>NU2N0
MLR-M,L7W3JT!_=*J?W5D34N0N@[\1%2C[MU)<"N $R'X9V-4)LRH /0BF2-F
M')S=#[#T7[^V:"ZP.<L=^^X;*VG'S[SC[N #Y]S)"H%9"3PR?8FB?]21&_@3
M735DXO\ ;5M)5HC6@>GIVL%7SB,!N,XH1T\OWRAIHR295>EDFODU,JH<%6Z2
M I]E3]L*2"[6V@N9I'-M-)<6]M$WJ<4-IZ3R,O(^G\37A!5 "C*2Q)?0W$][
M:28K'X^*.875I=Y"[N97,7I.+^.QBCCC5=R#TEQX8M(?C,I"JH3;3-F-6LIB
ME,4IBE,4IBE,4J&=KRZL78=(D2<0S?ZCM<61QEWAF@G*?7.PCB5D!0'UW1BE
M,DBB/0'750*(@!A <:?T!+9&9V3C=,4X\.[FSNT4-S9>Q9U!X[/?0&R*ZSIJ
MWN+C'=:>A#+-Z?2R/)Z4;R<$7J?IIV9N"GBJHKN6;0"HS'L"1,V9-<G3%*8I
M4:;%VC%:U)%'DZMLNRA+F>%1+KK6MSV(=F+(&XG&5)4(>6-%%6^9*#,S\$ >
M"DX!N*@MUO#8X_&2Y$RB*YQUOZ00G\H9&SQX?GRUZ1NYHA*5XGF$Y<-KRUR&
MZ/((];5SO?V(WDUK7G@K:\]MZWWUXK&U'FQ J78T0;4F_@I[@BL'&3Y-![D4
ME7FP(\KF1E:R,.6DB0$$8-NY<I.".SNR/86<:O639-)@L\Z%NCIQ9>L,K@O>
MU(FD@.=Q B2PD*QQ7/K&]\F=E0J5XE)H&1V)D">'O2\M>G/Q\!O=YC\0\C0C
M.AKN"3Y# @:&\F*'L=EL:)E)2$K-]@#QK@S(K'9%$MVMWCQR+4CA)1JUM<,Q
M>N8XPJ$14D6;-V@DJ"J71UDC)9S>0Q\N.=(Y)["X9T+JUA?VM_&/B*\9)+26
M98WV-\&(;B0P!!%>Z.L@V Z@'1YQNA^1V X4D=_([;V-[!K"1OS/V0$A"QLI
M0:/'R$-*N2;'8L+#.S*;MDZY?2G%*-C=>/W$7 N'KV-4CE[K*3$Q"II/E"1-
M93@(<]G),P6)&G,D\AP#6L?T?G=-.JMQVP"(8"2"=ORTI!4[EVX ]B3_ ,(8
M:&QQME@8@G8/-Q../;B.#;WOM*FTN9U=U7:;C77^J=I6)C275@9R]HKOX &%
M,YJ6JZ[NFSI-F\U>H>=4&,UY80D4CC#E2D92/<PC)11ZLT]?P65&9U.U],.S
M$C8"1M;H[_#LZ5KF(:UR8%B 0I->K1L/3\$R\0HV0>3B8HI) '=8)"6WI?A!
M.SVO'7O)RH["MDW7H&G7!JQ;P^SK!#6MRC6AB[FTU%?&^L;G])CX^PO;.W=-
M[>==A&IV""B!E&C7YYH<Z*J11LKJ\#W"G:1B)^.CS*S+.T; :U\2V[G6^0V@
M(#;589"LR0G09S(O+]%6B,(=23HGB9U!(!78;1(XEH$D.5VW6M4U98 A]5@O
MR J>N[GKQ-BI8IQ&A,+KNOCSJU>.N)22T2>]G:Q._6<TG,P2M'9DFJZY@5&2
MR$@TE"RYX-Z9V7!C);6HRK2Q1.H[GXOSH:$\CZR+))PC$94PHYKS'9274 G;
M;$4DBLW8:7\T1)V'IL\<?)F<$98Z8V)/7QG?HZTL8%"Q:UV/,:XEY.J.G;JK
MV-Q&0M=GTIJ%*_ SV.$6=E;1<Y NG<HK7;1&3L$,Q+%CRR#B1HHCCMS]0<20
M2#%-+">X\AC&6'8$ \2-@DU[AW0[VGI]]$!A)#',- [\"0*=$@D$@]]#4/\
M&-AZJ_N''\LIOG6_'>S2%$W+^#K5L.^Q.BXFV3E>N6A99Q3I7?3FBWN0K,<[
MI*]\3CJX$8YCWMG?PEC6B)I6MD:D5-;I-8$?IZTUXG*6"-MLFG1JD21M4,[7
M?P]F?D@(\KNP13YTLX<O8V9< I),7;APNNX:N4EEEE5#F.92KYQ2F*5AYSLC
M]JR'&Z^IZ9;N)&] R*="(;V!A65I.OH HYN3-I,28%8M7KBHHS2*!'3EDB]
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M9E#(.D4W")CH0SQ=$YDE2G()T5DTUDC"7M-5,BA! Y2B"E7\  4 *4  H
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M;WM= -VWH]@ -CZ?,?6KGO%(BM@0R,%,O;"P9H2\3-D5K5AE:T_,]A'B<C'
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M;K&:J+I(+'0,HF8R1E44E!((>9"F[ (N'26XGDCY<))I'3F '"N[,H8*6 8
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M]QU3[BFW<6]'8+ GMT!/EMJQ=Z6(@'0#Z31VT$.OR*$ RGGDGJ9;@C\I=/\
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MCB0I2B<X@)SB4 #S.)0*43&Z[,(%* B(]  >V*5R8I3E$ARE,4P"!BF #%,
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MV^^G*X'F.)OO61E/[FC(_P#F_P!@^S<C;O"I>=YXG\BZ\5/OYA]6V6KMIQH
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M"SPMC:B40[]UH=Z\3*(?8Q3& Q1[ P ("&<G=V%]8/Z=]9W5G)XX75O+;O\
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M:]9;.>>%1\4LME;3S7L<"$/.]N(D/)Q77=!6^%N.K\"G4.2CQ.(CODN;N]E
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MNX=EBEF+-!T=5V=$/!0NNTIUR=4 .]NY12? !/SWO[)V"?EVK:@,>R(7)[:
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M=PH %PK:&MO#LGMY/"1/B^?T/C7SJN*/.:,,F/C7^,>Q3D WYB6O:6GS+]"
M%$J"M1W61N8Q0$PD,\7*!A GJ]%%0WB$Z4E(W/U!8@_6VQV4X_M%UB.7?ML(
MO;OQ[Z$[N1^C _;O\3Q[/W?#+K\#^^O,GM_DO%GZLG$*0E"% WJ*ZLWGK&T@
M80,  *">R#:744*8OD?I0J!P "E ACF$I;G%]/R#\QU0D1.M#(X?(6P T2>1
ML/RMH[T %Y [)) &R]28?:MR?KZ<J-^[GZ>Q^X_=78ORD+#FZN''?E+5  !%
M0Z&H5-EII@!@* ^6D)W:)E ,(B(>B502D*)U (3H1A>G?6U[KG.G;DGP&R?Y
M/WVV?^.(<<!K_6(V3I=G>GKZ&VAG7Z_F^>O_ (9?_=\]5RAS2XX!V$[>9:@B
M7R]3]JVN=G:D(D)#@F;U5METVJH$#S'P(8ROBH8# F8_B/4'I3.G^ILXKW>M
M?DV_QV3)V-]AC[NY)[=SH?".[:I[Q#\V*_+XT>/]_-5U^WS4@5OD=Q[N*I4*
MEO;3MG<&$Y0;P&S*7+N?),0*H46[":76 R9C%*<HD Q#"!3  CUF%/@LW:@F
MYP^5MP-;:?'W<2Z.]';PJ-'1T=Z.CJKB6)OLR1G\'4_SJO;5F(AGJ?8\N[E(
MYK%-J);%G,FY?-D(]ND$$^ 55WJJI6R28"8H"=14I?S![^X9KDAEDD6&.*22
M9V"I$B,TCL>P544%F8GL  2?I5R0!LD  ;))T /KOQJI!:NFSYLW>LG"#QF[
M02=-';59-PV=-ETRJH.&ZZ1CI+(+)'*HDJF<R:B9BG(8Q3 (T961F1U*LI*L
MK JRLIT58'1!!!!! ((T:D$$;!V#W!'@CZUBCS<@*=9^/MCA=@7#?='I[R6K
MH3DUQP924AL55JG*)*%BE&L55;BX6JLJL5)G:&ZT(JP>QBAX^14!D[716 L#
M\$CQL>P=(GE<;\\5CBF<$C?Q*FU\AE\U! /VD5P.Y5Y%C0_K,\D2D#^RS:)T
M.)\51N$S=.*U_9:S#+[V=4:L61A$T1;?FM8;4U@1A"U6!76C*Q3(/4^GV#*G
M1C]5PWCG"5<=D7>C(E3DSII%:-**RD:5P_'L2(/=QLDL=1^A;DG9)+%6Y$GX
MCK0L58'; @M\7>;USK0 //UI^VAV4,-#Y=ZS.RU14>V';&M*E85:I9KQ6X&Q
M-Z38-DNXJ4E&[-PQH-6<,VMAM\@*QRI1\!%.'[9)S(O5$&_D97TSG!LY%%2J
MK2;W4=C01+)2IQK/0YGCZ-4<MR.&ZS22C7!FLA&2+!ZBUD8N29+D%-U'R+1J
M\0$2&40*51,QE*U_?$8_QH^'-_\ ,>TE_P /=QXJ#X_:O\16R[%33%*8I3%*
M8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*
M8I3%*8I3%*8I3%*8I3%*ZE6Z"QDCK(I*F04]5 RJ9%#(J@4Q052,8HBFIXF,
M7S()3>)C!WT(ABE=N*4Q2F*5&6TH^0E:W(1D1'.Y*4EH>QP[!ND];-6RCF5K
M4TP2!4'KYJS*9(S@')UU""<C9%<B)S*G(W6@^1^/\C2I';*J+-VZRS=5FJJB
MDJJT6.@HLU44(4YVZQVRJ[8ZJ!A%)0[==9 QRB*2JB8E.::5W8I3%*8I3%*8
MI5EVR%F9:1I#N*+&&2KMJ^N2(2#QTT44:&@)R",DR*VCGQ57!2SAW92KG;)&
M%H5 5"@X%9NI5Z8I72X7(V07<J%6,FW147.5NW7=KF(D0RABH-6J:SERL)2B
M";=NBJNL<2IHIG4,4HJ5&FD'R$EIS5KINF\32-K^HI>#^.D(MQYMX%@W5,9G
M)M6CL$CJ)F,@N9 $72!DW+919NLDJ>       - #L !X 'R J2222222=DGN
M23Y)/S)JYYFBTFQ=_7ZA6)L1]_*5@8N0, _S [IJJ8H^X^X" ^X^_OFDR/3'
M3>7_ .->G\)DCYY7^*L;M@>_<-/!(P/Q-W!![GOW-;:QZ@SV,_XNS>6L-?*S
MR-Y;#7T*PS(".W@@BK64TU0B#Y13.;JY@_2%/MULJB!!^X"#&!FF,>8 '[%4
M:')[% 2B!2@&B;V==*J2UA;Y/"-\AT]U!G\#$I[D$6N*R5K9G1;8#6[+L#8(
M %;=>N>HCVO)\?E@?M'-X7#9F1A\]W&1L+BY&_F5F5NY.]DFN?V>V-D7J#VS
M?&@%]TF\RE4[0T#^15E96MC-K%^P>\X13H!_> <PG&?Z)9BV3CB^O>J;?C]B
M+)1X'.0 =]+(]_ACDY%WK9_*:R$ CU 6+4_I)BYSO(=&].S$_:EL7S.)F_%$
ML\J,>A\G_B]EV1\)50M1!N:-Y&,:S$EJMKU]8%!O%(!7YVHO*\^3'\3QGT@R
MSE2SSD<Y;?7_ */]0(VC6+KY45SME  ID3<?UC9^W.VQ]H.C,[T=E;S\I6OO
M)OL!-B+A; >IZQ>:;-Y.RFC+>D+A8+*UN_3+M:2"151NDZ:NO9+/>7!ZFP_4
M^.MO<9_1]US4>3@:\^#T^$46)Q]W$^N9A,UW<VX<*MRI0EA+A+EL2._+8-3O
MG9"^RCRC6J L+8 #KM4&EB/2I82C[CZ3=@[6+^D"J#T(]<O475UGL9?H.YG5
M=\[CI?.XK,0Z _K!!EVZ9R!!^<4-I<2J?A42ZY'G6P?3-UWQO6-O"Q/P0=08
M?)8R4[WI3-C%SUF&'8<Y;B",^24\#DFY:,B84YUQ.4U0H]'&[5:QU5D0?M[3
M,Q&-H)8O?MZC:463'_)..%]HW2\;&/*2Y3IV1?M_TEP69P5LNM>,CD+&'%RK
MW^W!?2QD^&-0W0_4#@-CX\?G%(VHP.7Q>8G(^^QL;N7(1G_5EM(W'S4&K[A[
M'7K"B#F GH:<;B ""\1)LI)'H0 0_>,UUB?80_C_ !#^>=3C\QB,O'ZN*RF.
MR<6M^KC[ZVO8]?7G;2RKK]M<]>XS)8R3TLCCK['R_P#)WMI<6DGG7V)XXV\]
MO'FJSFQK!IBE,4J,-R.G+37DVLUC74JKZ\(7Y5FJQ16\33L;Y*><B[9-_$G0
M>0>OYCV'B0WOTI4FD,8Q"&,0R9C%*8R9A*)DS" ")#"0QR"8HCXB)#&*(@(E
M,8.A%2OK%*8I3%*" " @(=@/L(#]A#^0XI4<VC3VH[N0Z=TU;KFW$5#I0EGI
M%9GBJ!YBI^<LK&.P-^<1.'??1Q\OU>^9UOE,G9Z]TR-]:Z\>[W=Q!KMKMZ4B
M_+M^';Q5&CC;[4:-^LJG^(K#WDE\/CB5L71NTZF&H:WK]"3J<H^/+:ICX^@2
MZ#J%,2R-5$_HK(D4Y*M(Q;8'B$G%2#=TW%1)1'R]-1/H<5UWU1B;^VR$>4GO
M9;5N219-Y+^!P8VBX.)G]4+P<@&&6)U\JZG9/A+9V\T;1L@4,.YC^!AW!V./
M;R!Y!'U%9AZBU=5M):NH&H:061+4=;5.$IM="7?J2DH,3 L46#,\@_4*073M
M1)$#KJ$201]0QBMV[= J:"?/9/(W.7R-[E+PH;J_N9KNX,2"./U9W+OP0=E4
M$Z4;)U]IF.R?>.-8HTC7?%%"KL[.@-#9^9JR>1NBVO(2@LZ,[GV]?296F$M)
M%I&G5;8,&_6A"O 1CIZF71E(5J>CC*.RO4D))FL5I*,HV3;@5TQ0.7 ;EK2B
M,[[%95=T9?F&6.6%CWT>S@;'<$=J]%(!!)D4CN&B9$=3]59XY5';8/P$Z)T0
M>]>GCQJ6SZ0UE!:UL6TI?;#>JLHR$K,Y.5NO5N1C*S#0\=$1<(NE7$4&TD+8
MK$ZXR3LHO53.3(G-Z*")2@7/>3TRWS:-9%Y?4MZLTY+$[V0R@]OAWLF"$'9.
M87Z.T;:^Y?3AA 4?(%2?];Y"<LFE8U\@^/*.]6CY,UD/77:NF]R:L8. CS2"
M+=SM5UKEXE,O&Q7K(7S&)5U^DD]B 7;&E6DDN@5^R\!.=2JSKG3;F#K]Q2N\
MTJ^LFP]D36SK*M1I>UTN-92LE'Q<$QB(=U%3;.=5C(Z @HELY.\>D)+R:;J6
M68-3+I-6RE:R^;L?(Q&^.!<61I=?H+/XANF4V#^P3UFG8Q<1H.T3@"#R?W;;
MS.7 B=7P64UO +E(54A7R"8"205!_FO\16Z_%33%*8I3%*8I3%*8I3%*8I3%
M*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%
M*8I3%*8I3%*8I3%*HLB"WU*!,"B0-P?N0.D*)Q6,J,/*"0Y5_6 A4RE X&2%
MN<QS&*8%2 42'@^1^/\ (TJM9-*8I3%*8I3%*8I3%*8I72X.LFW74;H@Y<)H
MJG0;BJ5 %UBD,9)$5C%,5$%3@4@JF*8J?EYB40#H5*LO6$5,P.NZ3 6%FW83
M-?J\) R#=H^+(M17A8YO&&7;O 0;>JBZ!J#E(#()*)D5*FH4%"&Q2KZQ2F*4
MQ2K*OW_83#_776O_ !%JN*5>N*5P( (" @ @(" @(=@(#[" @/L("'L(#]\@
M@$$$ @]B"-@CZ$'S0$@[!T1W!'D'ZU8LKK#7<VX%Y)4JMK2 ]_\ *:42T9RQ
M!$1$13EF2;>12-V(B!DG1# (B(" CG+W_1'2&3E-Q>=-862Z.]7J8^WM[]2=
MG:7]LD-Y&=LQVDZD$D@[)KH;/JWJ:PC$%KGLJEL-?\$>\FGLVUKL]G.\MJX[
M#8>%@=#8["J,35:,</E6;WLBM]?I1+:EK4R+]^B%97YO;6Z2?V#P;%;B!0 "
M&(( (:]>AH[,[PO5'6.&UV6,9V3.VP'?2BVZLAZ@BC0 Z"PB+0 T00",YNKW
MN>V5Z>Z7RF_+MATQ$Y/]HS].2X61W^?*4R;)/(&A8K<,481:6VEVQL4!\&M@
MJ\A79-7H/8%9V F'L>4P^WD9.HE+WV()@ @ %L?:'8D&#/\ 3>>A7Q#EL'=X
MB]D&^W/*8K(W-HK$=BR8#CL A%!(H;SHF\&IL+G<-*?M38W+VV3M$W\TQ^1L
M8+D@=]*^:)(T"V^]"W+8<<(A/ZG?.DR_K>4:U0%B;@4.^U/E;">DRI@ZZ'TF
MT>[6^Y2E4,  :!U%U;9[&5Z#NIT4_%<=,9W%9B(*#KU/0RYZ:OV[?$8H+2XD
M ^%1(0-C@^FKD;QW6-O$Q^S#U!A\EC)"3^CZN-7/68/RYRW,*$Z)*@G48;@W
MI08JA3(6 ;567)W$0BFTL=&N$0=PL688KG39NG,*6-?F*@W76$6#YR04TCG*
M80#L=/F_;%T3TS8R7_4<F?P*1R11&+*]*]1V<DDLKA%CMI9,9[G>,.[L;2ZG
M41JS\BHW6RQ?LRZJSEVEIA%PV8:1'D]7&]18.ZCCC1>1>X1+_P!YM0?A4"YM
MXF+LJ<>1U60%?N%4M31N^K=CA9QLY13<(J1DDT=B*2I 4()TT53*HG\3!YI+
M$(JF;LBA"'*8H=SB.HL#G[>&ZPN9QF4@GBCFC>QO;>X)CE4.A9(Y&DC;B?B2
M15=#M756! Y+)83,8>:6WRF+O\?+#(\<BW=K-" Z,58!G0(Z['9T9D8:96*D
M$W'FYK5TQ2F*4Q2F*5&>Y@A1U/L;\0%C3Q7X-L'K%EB-U&(K_37'R(J$=%,@
M*@/OEA;"8/(KH$3)B"@$$%*DHGAX$]/Q!/Q+X>'0$\.@\?$ ]@+UUX]>W777
MMBE?6*4Q2F*4Q2F*5ICYYQ<&AR%X)2+8*I]7<?$1TP5V+'4$A7[+X#K_ &AY
M?4-HJKF965+\B?FT11(98?ES (?3C]J@_P Q_$5N<Q4TQ2F*4Q2F*4Q2F*4Q
M2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q
M2F*4Q2F*4Q2F*4Q2F*4Q2J-(D,,C J>JH!0D'!!1#T_2,(P\J(*&$4Q5\R@
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M7RL2M C(F9.$C)O&[7YAT\3]1TV%5L/BW,MXK&^7,DOZ:I%*O H"!0 1$P@
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M>'J=CUY^/MBE5'%*CN0@7R^V*E9B,S'CHO7FPH)S(>HF!6[V=LFLW[)F*0J
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ML@]5;8KFW8RV25=1?-1I>R+[K&<9R)6P.$IJB6!U$'>HG9N';9>*L466+M<
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M0OU)%)AJ6IW5M<E8@M<)9FU+D;+)S$'';66O3BN2-F9KZS2U\C*-?Q;BG_\
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M9LU'"1';M)GZ/S:C5N8X+.$VOS#?YDZ1#E0]='U1+ZI/)]WSUO\ 8" 3^ )
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F8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g729258g08k75.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g08k75.jpg
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M 0$! 0$! 0$! 0$! ?_  !$( 2$"0@,!$0 "$0$#$0'_Q  >   !! (# 0
M            !08'" 0) @,* ?_$ &(0  $"!0,# @0#! 8%!0<.#P$" P0%
M!A$A  <Q"!)!46$)$R)Q%(&1%3*AL187(T+!\ HD4M'A&"4S-?$G-$-%55:4
M-SE$1U1B8V5R=7>"A)(F*#9&5V1F<W1XA9.5N,+_Q  = 0 !! ,! 0
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M^ R[,,TFC)IN$RJ3B)N8+PV<X.<K#*PDI4W$8:8D+'^]RTI;P 2M2BE"74H
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MXR7_ "W"(7A6Y!,S'"H_''P9<Y0P)*VFA FHEKF3#*DIG<TKQ"M"PEF>(\J
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M)#)0J4N;+\5,U*%H3,ES.4HF(4K$C-\%B,/B,3+6KDPP*IZ5((F( !()1KS
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M+#)+>+B<1.4E" 2#RI3S+(2M81X<N8M"F,QV'P*$KQ"E#Q%B7+0A)7,F+/\
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M=FEIU!1D=(ID^F&;AVG''/DQ;#<4XXXR_$<&\?YAG_$/#^7YWE6>YCGF*RW
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MGI5,E>.LM)*U32Y0QAUL,-Q2DI=/XY#)!" #^,FD*%*A)"5<H_,!RT=XLCT
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M-*Y;'4S'5-L1N3'P<.N63N'CH1$?*H%<Y8;HY+#T*C\-#;DSB(1WH^65<_\
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M" 0Q (-P:@^4<FF66$-M,M-LMM-H9:;:;2VAIIL!*&FT( 2AM"0 A"0$I
M &@DDDDDDDDDER2:DDFI)-23>,VM'+M3VE/:GM((*;#M(-[@BUB#<W%LW-]8
M@C&BY? 3!+2(^"A(U##R(AA$7#,Q*68AN_RWVDO(6&WF[GL=0 M-SVJ%];)6
MM#E"U(*@4J*5%+I-TEB'!U!H8P0#< ZU#UWBBO6?T,2WK#KGI*K:/W(CJ"<Z
M5M])'O7"RZ$IABH45LY)IM3DV--Q$2]/).J0(B7*<99_:S;$W4RB)=5^S7E(
M1>Y\)<93.%<'Q/@T9>C&CB7)IV4*F*Q*I!P8G2L1*_$)2),WQRD8@GPB93E(
M_P 0.8C\?EXQTS!S#-,O\)B$SP @*\3E4A7(3S)Y7Y6YF4SV,7LAH.#@P\(.
M%AH41+[D5$"&8:8#\4]8NQ+WRD)^:^Z0/F/+[G%V'<HV&J8I:U\O.I2N5(0G
MF45<J$_E2ER62-$B@T$2  #L '))8,Y-R>IU,=RFVUH6TMM"VW M+C:D)4AQ
M+EPXE:""E06%$+"@0JY[KW.L D$$$@AB"#4$6(.C:;1F.J&A(6"89AH.&AX2
M&AT?+8AX9EMAAALFY0RTTE#;:+Y[4)2F^;:RI2EDJ6I2E*+J4HE1)W))))ZF
M,,!8 -;I'> !>P N238 7)Y)]2?)/.M8S'6]#L1#+D,^PR_#NMEIV'>;0ZRX
MTH=JFW&EI4VMLIP4*24D8(MK(4I*@I*BE0+A0)"@=P14'J(P0"&(!%F(HVS1
MR;;;9;0TTVAIII"6VVFTI0VVV@!*$(0D!*$(2 E*4@)2    -!)))))))))+
MDDU))-22;F,QRL/0?H-8@BEG7[TC33KBZ<9YTYP>[LQV:DU75'2TQK"?RNE6
M:NBYY35-3$3PTHF!>J&FT0;<PGT%(IB[,?QD2$(E!@W)?$LQKI;MW!'%$O@[
M/Y.?JRN7FT["X?$R\)(F8DX5,G$8B7X/XDK$C$%91(7.EB7R)<S><3$E =AF
M6"5F&%5A1.,A*U(*U! F%2$'FY&*D,Z@DNY_*S$&+/[<4!36U>W="[7TA!)@
M:1V[HZFJ%IJ L@B%D%*2:#D4IAU]J4H4IN @6$.*" %K"E$74=5S'XW$9ECL
M9F.*7SXK'XO$8S$+K[T_$S5SIJ@Y) *UJ(#T%(=RI2),J7)0&1*EHEI&R4)"
M4CT AZZ:0I%"*LZ%I75?Q#-N>OI_<6+AX[;_ &(F.R"=K#2T-$RZ<,3"-KN*
M54+]5+G;;T,4-5U$L*DXIZ)0Z8!IPS%"7W&47;"\9S,-P+C^"4X!*D8[.I><
M',OQ*DS)2I:,$D2$X822%.<$E0F^.DCG(\,\H)CEY>E>9RLQ,T@RL.9'@\@(
M4"9GO%?,X_S#[O*;"L7PAX6&@X=J$A(=B%A64!IF&AV6V(=EL<-M,M)2VV@>
M$(2$CP-4I2E+45*45*47*E$E1.Y)<D]3$B !0!AL([K"W;8=MK=MA:UK6MQ:
MV+<6UB".#K++[3C#S3;S#K:FG674)<:<:6DI6VXVL%"VU))2I"DE*DD@@@VU
MD$@@@D$$$$%B"*@@BH(-01:"]XZX6$A(&':A(&&AX.%924LPT*RW#P[222HI
M:992AMM)42HA"0"23R3K*E*6HJ6I2U&I4HE2B=R223YF,  !@  + !@/(1W@
M!(L  ,FP  N2238>I))]22=:QF.+K33[;C+S;;S+J%-NM.H2XVXVL%*VW&U@
MI6A:24J2H%*@2""#K()!!!(((((+$$5!!%00;&"]XZ?P<(83\ 86&_ _)_#?
M@_D-?A/P_;V?(_#]OR?D]GT?*[.SM^GMMC6>=?-S\RN=^;GYCS<SOS<SN[U=
MW>L88,S!F9FHVS6:.4+"PL%#M0D%#,0D*PGL9AH5EN'AV47)[&F6DH;;3<D]
MJ$@7)-KG0I2EJ*UJ4M2BZE*)4HG<DDDGN8   P  %@* >4<8N#A(^'<A(^%A
MHV%="0[#1;#43#NA*@M(<9>2MM82M*5)[DFR@%#(!T)6M"@M"E(4'925%*@X
M8L000X)!8V+0$ AB 0;@AP?(QWH0AI"&VT);;;2E#;:$A"$(0 E"$)2 E*4I
M 2E*0 D    :P2222222Y)J23<DZDQF,>$@8* :+$!!PL$RIQQY3,)#M0S2G
MG5=SKI;90A!<<5]3BR.Y:LJ).LJ6M9=:E+(  *E%1 % '))8"@%AI&   P
MV 8?""%@8*!:^1!0<+!LAUQ\,PL.S#M!YY2E.O?+90A'S75*4IQRW>M2E%1)
M)T*6M9=:E*+ .I146% '))8   6&D  %  !L T9( !)  *K$D  D@6!)\V
M%_ MK6,P !(L  ,FP  N2238>I))]22=$$?=$$&B"#1!!H@@T00:((-$$&B"
M#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!
M!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@
M@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T0
M0:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:(
M(\__ %#]?F_NW^]FZ5"TU-Y(Q**5K2>R26-Q$NBW'6H*7Q:F6 XMN9M)6KL
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M-^5]NU--;1R>^+#U>8"*AI8>;B21_'H;3L6/&M?_ $7\*$%\/B"'%/&1U_\
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MQCJ:WQB4E2-UZN5;!M,U"WC_ &3Z8O>UM(XC(,ID!#99AB$ARHR$ES=K]/\
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MZ]7TZU.FT;, S-V'G?H^E'&@>'HU).UL#M2%=H(-B2+>OTY]>>>,'33\3S.
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MO4]H[.]MJ(_"NME%@E(7;CZ 2+$<@C_AJOS,5SB[$@4=M*.U@1JS]1"P9@P
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M%0O,L):2+"PSG) /H;X],V]>-4#$X)*II<5!-=R]A>[]][PX"F+DD&UQ2E6
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MS%R!AN9 < %AT.Y9M"]G9KTARE<R<>>;4DUTO8WL2W7>)9:AE%A*PD@VY)&
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M+738Z:7BBM35-&59,'(R,>=7"+=7\M!4HI(3<)N"2GD><$CS?5U09>"1X<L
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MO?05:)#)L!CYJ4+2@J0HBKT<"X#NU:[NX$6+I"E52VGF8-U"7(A\!UU2@"0
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M^Y96D\E95?N(SC[V]=0,['3)D]:G*@LL&MU<4J+7-*ZQZ2RG(\/@\*@)"$J
MH]R0!UU&NA+=\?\  35AA,5!+^6%V+K22DWN2+A-R+]H/ %[BYU$8_GF<Y#N
ME%$OLY(!H-;_ $<Q;< 9,ID*":%W(!#,!:IIK<W:E\F71JXE:V(ELA# )*GD
M6^I6+A2@38@$?O?E:VHW+L2N8M4F:"*?U4) (#>;C4_I(8V2@2Q,E) <FJ6%
M&>@[@:.>D)$5*X9Y44VVOY*BXI32DE03^]<6M<6() '%O35MPQ&'""A 8@%3
M /6I^))U9K13\=SX@*2HN!JX!%S0%NCT([0CM0\4AE;!05OMD]JC;M6W>]Q<
M@&XOVY)%O'&IN3/2%)5S,@MI4$W< 4JU+; W/+>)LIE3I*U<H<!BIC>P4"GX
M&S4[Y\M4B'B6W02VXBP44%22#>Y'TV)MZD$GUL!J6*O$0Q#@ZD48BCBW]FN\
M<4GRCA\0M#D *+,[TU%-];[1:6@ZM 0F'5%D*18 J62HX \DW&,\^OJ3S;BC
MAJ7BY:IDN6 ;N :N"*FFII6KMTB2D3RR0[:*U.GGJQ>T6ZHZJ#V-(<>*D]B;
M$YN. ;C%_6^;XQC7G_.\EF8>>HA))"BEG#^;&@I3N]@6E94UT@%B5 #E^9\[
MZMTH8D=^:I<BH= 6E39*3VWODY (YM?D>A\:AL/@E/[P(+C7:HML^VU*PH9A
M2+7!8%NM>E*FQ#:Q\FDR):LD E(QVBP /\#;.//)&K)@,+_B#E>I&U7]!6VC
M;UAL26K5SHX8CKJ'&XU9](EG<0Z^LFUB$*''[U[7P!:_TX_/75,AY)"&60DE
M*0]=SZ@%G[B&DXDN#=Z4U-]2+5>C=(9+*TL1"FUI #IOD6^J]^0.2+C^.K:1
MS(!!_+?KY_$?8AJ:MTMIW^;/</1H=L(VE1*+@!: + W.>+'CT/\ AYU7LS="
ME%W_ "FHHUS8Z7H*:W>%TGW0^M--*#X#O'"-@B!VY!&1<@7OQ;G/(]L<<Z1R
M_$M,J;N-7K9_07L'.P&%.:,^HMH:Z]KOV>$%3)A[GNS8E0!N2!<\W/\ F]N;
MZL@((L7[AO@]N]]ZPB2"R35Q;37H&MH]:O$>5)/HE"E0S:U) -@ <>H-^2<#
M[#@7R)##2$EEL'U-'>H_;M?8ZS"); 7;N1:@??3I2"FX>(?"8EP%1*NZYL38
M$D<\<#'/)MK&)*0Z6Z.WD'UH-6U8;0HA1Y'.KAJ4!!:QU?T!B6X1]:$INGZ;
M9P!Z7MZFUO/(YSJM8Z6GFY@SD:#6M& ?KYVHT*2^:V]10!^K^;5J;QV.K""%
M( SFXP<WQQ_G&;C31*#, 2I+Z%_1[[==](V+#\Q(VN[[4:G?S<QTOK4ZRXDG
MON+]BLFXN?[U\#^!%ASK&(PDHRRX#M6E>C,SV8P))#;] 0P(I]0X-#3K"' 1
MBVUK;7]"0H@BUB,^+<\VQZ#Q;5)S+ I0M3(T#5&SOKJ-=ZL!#E"RP8VW^6['
M^Y=X@O?K9R6[FR1^(A66D3V$AE_A(C+;J^PK=2V5'Z5 J4H *Q=1OJ(1(8LS
M;/5C>PMZ4[642H&KT[@B_KM9A0QJ-J"F9O3DQ?E\X8<AHAHJ2CN 2" JRE7!
MMR!YQX\ZG,(5H*$D,YVVWI\1TWA,BE0="-M?F'_39*@7FY8^S&-V,4RZEQ-\
M_2+]Z3<=I!/((Q;&<ZZED4D*EA;.P\JU:M#KT(ZM#&>I0+EMP=G'Z>@\X>-2
M/MU/^'G;$*EAXL--1"6V_EH6II(:6JP':5J[;W O<^N-3<W!I4_N7W<WO9CN
M-0+ PD%#E?4:/7:O[@5\H;+4*I#Z4PS9[G E*0M."K(-@N^;W\&_IC2F"P*D
MSDLBA*2YH"[^=M*1JI=F.A)>X8?'MT#0JMP\3 0L4M2%(=-LD!*DW*B0 2+\
M7-AZW.K7-P4I<A2>0:"H-:%VZU%M7O")6 :48,X%;V\GZ"@J!6%VDC+P(N,F
M##:A M'Y:U>7'/I]>;WO[DWY&N?8C(@<0I8EMRDU<@4+^;,]*B@I#A$X%)25
M'F(<O1WJ0W4%Z:B&!-$MO1T5&)5VIB(DJ2.["<WPDFX]/L<7OIW)PLM"""&)
MI6C&]#3^T84IR].YN=0[U;84K6@:%>G8)4RC6(9??$)==0A)LI2TBZ;"X^H)
MN3:^/?6B2F6I:0  "R35B[ _-]/*L;@@CR!/1_OO&143*X":"&BT*8[%J2I/
M;VE3? -AB^#SG&F&*Q2Y:DJ<V- HL!0L&.UP]K"-A*]X%F9A1G+WM2S'Z&D=
M\IFCDBF(CY6\XT&B%)(N%=MP"E0M<@C)O<8SJR</YJB<@R)ZJ&B0MVW.AM=W
MI2NR&(D@$E@U3N:U</6U YH^C-%TMJ=W)/4;T'*)S$MP\>3\I"G+MI>4E)*;
M$CM-P+6) OQXL]S-$J2%3)2T\AK=Z$]!YOJ+B$Y,LB]0; &K;$;O3STC8E2E
M/PBY6RZEM"TNI"@Y:X((%K&^4V(X.38VYUS7-<Z\&84H4S7(9[L]1=Q:M+]9
M!,L$5#$$L*NP#U ;L*![M2-M_P )V3H@-Z:[>0@ .4E"))''_3S"W&+^WL>+
M:YC[0\R5CLGPLM2G*<62-P A-/D[E^D.\&DI5,#$"A%&!N_5AY5\H<_QQ5%%
M%;,J!((J*;V/_P!@7_GW^]M._8J/][SL$4\"2SOK,T\OUA+-"R)-_P#,NU/R
MFGH\>=!F/BVT?2ZX+@D6)MP?%\>@_P!KQZZ] &4@D$I?7737RK$3XE"$E]A7
M=B&I]Z4KBE3L4^D.J4I9('U&U\WL+XM>^>23B^A1$N6HI#,YU.VC_?K"N'E>
M+/E()8+*4'N20;?8(B9Z9IG\1",N,M_VJUI"0#<DV!-Q<^O!'\]>5/;MQPG*
M<LQ&",[E7/E3: EPP(%K7U-]A2/H1_#OP')P\A&;3L.GD1X<P35@,2D%0J35
MFZ6!%7!O'*XN5R6A6(>-^2(H0Z$*20.XGL225&QN01;)\G&<?*C.96,S?-?'
MEJF+29JE4+T)+.'%*UU=K6CN^<X;&9IF?-(,Q4I$P)'*62$I+)+ AP0QKLVP
M.NS>UU$QB9F84)" HJ;"$6R%H%P !BU_M>_@Z])^R3AM$TR%8P*!2I)8K/Y7
M/O.%6JPJ'VI6W9KB<1D^02T)),TH2CWO>*@ Y -6H"QHYLYBJ\KD<SCHI(0E
M2C\TC-D@9%L&V#>^3G^7K6=+R_)L H29H"CAEL I1)5X:@E[N78$4J6:H?C$
MI>+S7&)"T#WIZ$_E2X"E@ TJ=WH0W9K-42Q#HDK<MB4]T6R^' E2.XV  Y _
M=NG@&XN+7'/DSCC,L3.QTT)FK )4U;N?GN& +6$>A,BD?A,JE)"4E2;J8$B@
M:XH*4O9V+@Q=+;NC6ZBEKD8ZV $0P2V !8W P.T< 9OX&/6_#.(\\5@UHE^(
M2MV427/,FAH7KO\ K%<XASU>&F)2%\BD,EQ3\H8T3?H>]2U.F5TZ*:K9E"V4
MA+CBE"X*KDI-E=I[K<_8@W]=06-SF;C,O_#E:^2:!4;-0?>L0N+SR;C<NF2D
MJ5SJ2$$A@""SNHC_ $W.YZ5LY,*W9B99"RDK;"(<I04A(21W*!)_=O:Q)))M
MSYU0<!DDV7BIV*2E:W7S!7,6(I1B0]-@Y&MXYQ@L@Q$C&3<:3,45J*F%:EZU
M[Z;/=X[!1$KJ* 3$O,-J0H*^NX"B<<$9MQ^?/@ZL\CB?&9#,EJD+FR9H*5#E
M<*'*0SD$EP]MB&:L6/\ VEQN3E*%*4I)8&2H!0Y>H*?@X[C76]NS($4M/4Q,
M"CMM$+:>[0+$!1R0<$%0[L?P-]?7?^'?CB=QQPIX&9K\69+E2P MN8CE8DL
M0JSDU(T$>6?XG.!\%EZ\OXFRJ0)/\P4I>(,IPE)6@3 5:"KV +N1L)PVW8_&
MR&&<6E'S'FD$V"02"D^@[<@@7-N+7-\V#B3#IP&,G(0Z1XBB@= 27ZE@6Z1Y
M0029:'5S%@2:U)9JGH7T#0ZX:G%-.Q2RT>]3A[<6(L.0>+WOD7YSSJO2,<ME
M,NQ+N#^Q8;CSZJ\IL$DM4_W!:FYWL!#UD4M6PHK6CZ&TWY.""3^8)YM?Q<C
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M-@!W=Q)&+WR, _?7%N*\W$R8H@NL\W*?/Y'6_36+'B<0G!X+P4'WZZZ@,Q8
M@Z]6%HN?MO3RY5!(2EU'R$-?*4D%(^KZ1D$Y/T]HOGT'!'GSB5<^=B1,))99
M4HFSDV+/IL&)KN_$N*9V)F3DK)('.Y-W9W+:F[^5'$)U9RI4%,FITXT5I96!
M<BV%?0FQ]@1G\@!C3C+L7A\1*1(4N6%IY4J#BO7IUZ^D.,JQ>'G2Y<OQ$)+
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M^;E*9! )(9RY-7 ->QFC9^ ?B)5+@V5=H8:[C:XPD #C'H/X\Z](<>SY8S
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M215<(5NG5RCZ ?M!PD_?&/Y\:]B\%S0GA'A\@AQEF%N[UE Z?$5;SB%EX?\
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MM?C/KC TRF)*IH4#1_>\S87\NQ!ZY#V[#O;ZZ5C%86 \>[Z0%' %C8<'%_\
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M]M:"2%N2DTJV_=_AU[1L$,QK0; OVZ^5[1B//OJ+:4'O%TW(X(YMGTMSR+6
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MTVAE5TI5VI[OIN,6&+F]N,$6U@X,J<LU_P#BZM35AUUWC;F2&8DU.XUU-RS
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M]M#)]]) ]/JWG2^P!,0N.S!>'0HI64J8DOV;MTZUU##HAH<0[@992H-A0"2
M2;>YY/@XY\G4S+0E* I0KR[M5FIY].S1S#,,?.Q<U8*R1S%@HT+%JW?4?$-%
M@:1[Q M('<+9)R 0;D@8Y&J]F?*RRL.]+/4I#$"U]>GE"" >:20+)(+ZEU4Z
MCO:'%&RP1*@JX4H@8)QC];?RYL?(K0D!:_= )<VJ7V/]^_5<@))%_C4_I]+
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M76'BC\=$PKL"\TI++CG<E'  [4B_)Y(Y'@>VM"):5!8(Y@&-WN2='9]7A,S
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M=VT+6M6D2K*HA3"&VFE)L#P$@\G-[><V_P")U$8J4)J5)+UUK0L[OT+&NT.
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MYXTY0I(<,*7I9R*;4+DM](P 2==A2@^M;_$4B9*'E*1#3'YW9\F)4&W0K!4
M@@VN;6(5;&/ -[Z8XQ21,EA+@W!TN-Q=PU3;RC8 UJX#4#V#OJ*:CTWAO.T]
M\Q^*_9Y'R$/?+-K*M<JMQ;FQQ^8]0Z1B $)YV!*7_P!.@)OW[W>-%@_T[M0.
M"_46\K;#3,F%.?L 0$PBEJ5?M6E)4$D+4GN L/JM_'\AK5&(,\S):0 :L=TA
MGO1V+$$?M@@) 4UW!TY;D=&J+7?4PX9"HS]Q]:B;LI-@#;Z4(!3@W\7-Q]O3
M2,]/@)2D 5:]=:V_<4KN$TJ"9W.'TZ MN;M9Q3?LIRIO\),DNXNAT)O>UK$6
MOG-[D<V]](35/+"3J'-#:H+/V^C4A98\516*,*,SWZ.;FM&ZTB^FVM;?@X)J
M#B'$]J4H[5J5@^J<FQ][>GD\4'/,H1C7>A<E-G!(J]'/GHUA#V1-*626#"I5
MKJQ)/D&_O/+LS8F4*/J2YWH!\'"A@7OP<6]O0ZIV'P$_ XIP5!"7":,"' K2
MI;JX+[0\)2I)- 7#,14OML^WF;1[!-E $[-[2@8 VRH, >PI65 :\XYQ7-\T
M_P"\<=_]3-A\D%A0V&AVB3=1T.(\2/7,T?\ E?=1Y )(W8JT_=0F+W'/H//N
M+8O[#X-7_P#=+( :?\EX4.-/\,#0>L0JI*CBR= LGH>EB;M2E+14"7/N$Q:W
M<'N<0A)\]JE)'@>!SIEQ!E<G&S4E0K1B&(M45_7RJ(]3>SC.UX/*I.'L4((:
MH8%3L^^K$,-VCNAUQ2&UP]K&+5V]N2E04>U(O<9L.<_GYKDC!C!3DJ38*!M9
MOV9VN]*-'1YV*_'H4[ K !<?=7.W;00U)V'H1YV'0$M-D?6% Y6;W-[@6MP"
M ;I/WU<<#/04\SDD,QT9@X8"M:Q0<]RC\46()HS ,H'=V+'U;M#3FD1!2>&9
MBSW.N/8*1:V+&_%P.;@WMXOXL&$G+Q)* >5M3]_+YQRW-.'SAUN0[6I9OB;?
M)X[9;N+#-)2AV&"D( 2GM/=])(&!88%K^Q%L\Z3QF6+FEPHUJ3L6WK\-'>L2
MO#^)1@P4I(YB" ' #D[AO0CU+1ESN8P%3L*2@62VVEP)18J2!961^HMX^^D,
M.E>#(!N24N: D4VI?[L7N*DS)TY6(-5$. S.6\ZL+M4[6AR4]M^9G!I6EY+*
M5)[0&T9(M^\H7'U9(Q>XS8ZC\=F!DK_*Y-22?@'/WZQ/9.J9/099!H.4&]>[
MVK;ZQVJH)R3+2ZAU;SJG>TBW">1<7/D#FW-KWQIS@<T3/6$D!( )'72ECYMZ
MQ5^,\KF?A%$.=;4%#JY>W:W2))D\6J7H2T4BQ"03>Q)M8'C'MZG[#4G-0)K*
M#FE.C;%Z]>A[QP$E4F;,02274"[AR^CNS:#0$7K#Y@9DCYB"@@$E)(/O8V_S
M]_0Z9KETU/D:;&_6,I4%T8!RUW=WZ4UM6[Z1(D)&I<AK]N>;BWI<^H)].+ >
MNHK$)F!8"6+DN>CL=/3N>T*A/("E^NE19JF]ZW8"CTC!=F: HI2HCML%*6L(
M0D#D@D&_IQSY&E/PW. I8<]+OV:P;IVK34 W% S5'P#ZW# /VB"MS>H.E:#<
M$,[%LQ<8A78MM#Z,=H4%'^\1;MMQ?((Q@NQ@U)DE2_=]PE(M0"_W2\:AG-C5
MBPV8M<$L1>@L1T2-N^I.0U[,695"_+8=7<-]SH5<_4?1%R;&P YL+X&J#/3,
M_$S@@T\1VTNF@UH6#_!J0]2D!([._1A0D.&(K7TBP3SSJUMNN *[>T#GM()X
MO^8O;_'3_"SI\N>A) #ABSTK0_L;:7A-8.I\^E:Z$VH>QL(1YK'/0Z"XW]*>
MTF]K$\#D$#U'Z_86^0D+ >YT?87+[T=Q\X050;L2=*BC&NE-]+Q$DQJ5UN,^
M4I:U+6HE"4\ W\Y)X/@'U]M2\O"!2' 9M=J:;M^T-E3@E3.1S-1GT8/M6L*#
M,^?=^6TZBY-N;_5G%\$WM]LCG21PX22H-W:K?+T_6-TS 6!9G%=?CVOHQH6C
MHG>W%-53#+7,97\YQU/U*0$]V1?^\A6<W]?XZ2_$+0>7F!2/Z=Z6-=[]>L*>
M&%$%M0';Z[5_>*Y5?T?2B<773\0] O?6HI>:0M)!M8#L+9 !3D_I;6)N(24C
MW0#T+.3>XU)&]M[Z*ELJ@(#Z[5K>H'SMTCR5])4YE#W;,(LO(2H*[FF"D]H(
MM>ZU@7 -QP+B^I++\<B0Y(<LP!(\R.@Z5W+,VJY94.4EPW6PL-KM3N]WBT=$
M[?0--P3,,U\WYJ&P%*( )4#<^?XY^P&-:8O&KGJ)+,X[-MT;2NN[OE$LH+ 7
M_-U+[;T ZWZ"=Z6ARPY]2E=M[\>!86YM?'\O&=0V*+I+$/3U^S6%7(#*<LY(
MMIY_>SP\IL&7&0$E))!O<^,<^^--)3I4&J'%*7J?H^IO>,@E7GL7%'UZ0Q4P
M*E/** E5O/L""?MQ[VN.1I]X@:JN]>E'[:^AM3)EFMJ#X786]; ]C#D2RIV!
M=AH@I^4ZT6RBU[I*>TB]^<6-O/\ %L5<JPI(+@N"[ FA^WVZ4U !5H]NH>WZ
MZ/%-MPH"%I>8Q,+*(115&%;SGE-G2I!^E";WLGR3:P],6[+IAQ$I*IJJ MM8
M#5^_S:&.*)2_*-'KL?O=M UXK7-9-,T1"WX%I]CY@[G"A"K%5R>T@6P0HVN?
M %M6)$V44@+4DL6#D'T+WIW\H;2EJ)W+.]:M1]6&FM6%(P(VG*BF$*@]B^P)
MNLGO!O;)*<GG)_[=:F=AQS)!8FC@%M6K8-U^)K#D ER[:Z@VNU_[TA>HMFGV
M&79-5C'R'G5.!J)44H[@"5(N%I'^SP%>MB#@LL1+FCEFX<I5J6<\PU+"[6+I
M-@=8V!2Y2LTT#AQ7[%^CZ%A[@R5F51;D1*(D/P 0%([2#8]RA97:I0P.T@W\
M^V-EA4V05+24S&((+L:4*79GJ*;- "Q(!=[&[5/U/UUB,"MRV7 %*))!3<JX
MQ^][?;U&-5#%R)H6SD@O8;4L2[?+SA="Z5N[U)UWH6.I[^O2Z0JQ4@*2,A5[
M#'Y&U[^N/-^ M@\'+402FY'T]1;K\8Q,F,D@&[7U;9O[%^SKDK=4I/RW$%30
M"TH!_NW[B/!N03>V!GTQJVRLOEF4D*#LBOKVMZ]H0\0[-6KEWT'WV$7(Z0*&
M;FE</3Q86XS+B%)[T_1\T)*P 3?A13?S;C5"XJF# I(0]$N*U;UZ$!^D.I(!
M)-2"UF_O376_EZEOA0PZF-Y*[!P/Z*0@P+##\?\ N^HS?G%_<ZX!Q_C)N)R[
M"\UAB%LY?WN5-]J-Y1+89(#L6_*6[N_P\S7:EA?BS-MNT?MFE8!(G4Q*;^#^
M"='^?R.;6U!<!39\K&8@RE<KHE\]Z@*=OFWU=H4Q/Y!W^_BWQCSN3R1I,8I2
M&KAQPE5@2!W*)N,>O ^VO1^#Q"C(EE98F6DN[BP!%=>IT<1%*EA0=1LHER&I
MT[]&VATTM(&(91<+1(/[W<!<63D7\9L3C%[>FH3.\R4A!E2U-,4EKV>@#.*^
M@-C&\M',X#<KLYJ==3Z@,]#5H=L?)X%\9;0.;#FY/K@>F"#_ #.J]E^:8J4X
M*UJ8T#']:@:[7UA4RDE@#;4=&I0T\W-]8P(6GH?N;#;2<+"C86^]P/.<8O[V
MP7V)SN?X:G(26H2[]M[;?#0$M(]US6O?Z:>@M#D>D[?8HAOL(2!<8Q8#/!.?
M.+WU!2\WGIFE06"26UHQ^3]:=1&WA) %P[LX<&G[-<L*0P9G3,/&._+=!42?
M[MC<<D6//)R;VP -6_!9W_@\TS\P!KJ0 2.K$T=RP:]H1,H D#4ZTN6<:-TU
MO2IBK'4;3LHE$KIUF%@&7*@G<T,-"Q!9:_&*@H-H?.90ZE(=4%149 H2A2BE
M/S%V *SKR[_%'B\FQN1</X>3E& G\59SG,K"83,CA)!S09;@I<Q4["2L;RC$
M>$O&XW I$E2_"'C32$A2W/TY_P#LU)W%$OC#C[&XGB?.L%[-N#N%)^:YMD9S
M/&)X<.?YQB)2,)F6)RPS58$3Y64Y/G4Y6*1)3B%?A9 5,5+E!(6Y;M2BAX5U
M$'%13[D8W!KC&G2E;*8J'96EYR'*4(6E#RW3=*RNP0CMMD:[Y[*O9MD7LTP.
M-PV48K,9YSB5E<[,)6,Q$F?A9>88+#39,_%8 )PTF=*EXQ4XF;*G39X2)4D2
MS+"5!7D;^(7^(GBS^(/-LIS#B3+\BP@X8Q'$6'R+%95@L5@\QG9'G&.P^*P6
M SGQ,=BL-B9F5(PH1AY^%P^#4M6)Q*L0)RU(6GBVIQ+I:=*DD&UR"+?D<8.;
MW_W:ZIB9$J;*+)"@7<.'[GJ7M'$<BSG'9?C9<Q,XRRE5#6H -ZA@W:G9X=5/
MPZW)@T5NJ6D* %P188'DG@'@_<>->=O:CE<G X:=F4C!)5,EIYS,%QRU!HAQ
M8F[4':/>_L9XE7G6'P^$Q.*!2M7(4@N22 P;F-#1^Y8U8V>H2+D$D;>=F:6G
M%H27$)4M"22!>Q"@H6P#S;)MFUO"'$^9\2<08B9@L),G*2N8I(E2TK4$O[K$
M@WOMV81ZMQ.7(P6'E)PJ96%*D<QQ*B?>V/\ 3N6 +BM6($5LJV:M5=5[:V V
MW#J?40&E=R3=Q-Q]AW7QQ^I/N[V!\#8C@7A'%8K'&;-QN*DH64*24J *%J*6
M8EW:IUTI'@#^*/C23FN/ROA[ 3$S)&%6M<Z<%/S*2E**@. 2ZC51;UBXFW++
M,HES*FC=2FV[CP/I'I>YO^?^+;-US\9/GKF<XYYTQ3*=PZR0'I0,Y/EK'EA+
M,.5K ;4U(IJWPO2)XDD>_$.MD7 [T@6OQW &_P"7/@&^JYB)00@C4#]?J^M8
M<) 5R7I3J=+_ -@=1$KP4:M 3WJ4+  $\$^;&_D_ER=192""1^9[=.S!FJPZ
MPH  IBS:%[7H:7&]+C:',8D1'8D"Y(R;^;6P=-U)U&[E[=]_3RC=*>5R:TN-
MGO\ 7UAOS6$?2A:FNY.?0VO@7L"/S_/&G$M?4A[:5>H-OK&K)8EWI4'S[/5J
M4^(A@Q#T1#J4IU:A:U^;$ VMSP?OYYN=.TAP".4*-@379][?45O&A/+VIY[$
MCXU^<1!7E5M!E;*5CN;2I1NKD@?3;. #W>Y\6Y-AR?+9LU:UK"F]T<Q2P(<D
M\N]"Y\B+B&TQ=B7H[%@X%'LU?4:%XH%OB[$Q^WM7*NHN1,,\XG!N0 H@9OBQ
M\>G.3?HV!P<J698+ A08=ZDL-KZ!G(TAHHNX8@L26M\&HW9GM:-.\B[6FB^L
MJ/RUE!!\*%T\VOX/@9S]^X<,8C#HD(E<R0KPP!46&EZ>FAB+Q"2I1T#FVOD*
M;CI1FH8F*FXJ(>9B$PK9'SV_EJ58DA*TD*(M;@$FU_7/!U9\0$^XI1# N!;5
M^O8-Y-$=,=)9(=[.*5H+&SFII$@RZ4MKAG&HY^Z/EFW=;!(-\$GUYO<_87TQ
M7-=0* Q!N YO;KI;UVV1S2W?6H HQO2G6PMWB+U)E[$:^RCM/RE%/<"GUYOP
M>#Q[>#J2_P 12$DZ@:.?.W?4?",A2J*5]V<@%F?RA!%-N32*=0PE:R\M:@ "
M<7)!'M^?CVTHN:$( 60 &>CW?[INS%XR%;@$GXA@X] YJ!>.Y%,Q4N?(4HMK
M:^DDH((N+6)[LG/Y^F=)I5*+*2Q)J!1]?LWC!G!)8 T%_77T)+](5W8R8P<O
M6W#=Z47/>M(/( N2![9SP.1K'ARU+!4RBU =&- +/W&V@I&4S'+V!87L+'XU
M+[=HP:8B76$1)BHG!6ET)4>TK4"KZ1GC/O;TMC6LY!)2R2IR0.@VU\JBQ[PH
M*@/T/[C[[QC3^H(N;Q*0NX8:/8VB_ 2.T$FPS87M;G/ MI23(3)!:JC=7T'0
M?>L9)+ "@^K&O?\ ;:'#2\>J7-NJ"Q:+;6D&_ (*2+WQP>,WQI/$($PI#%TE
MW<=*>?WI"$P<H<?N*?N#V>'E"/(4@DG*UW!O<X ^P_C_ (:93D$U&@9F.C]/
MA\!&<-."'"G_ # ASVL_EMK%@J+C3%2T)2Y9UGM23?!L#G!&+\"]Q;UU XD%
M$P$I'*0?,V._ZW>YB6Y9<U (7[SV+4.U]?D=:B)9D=53*7E*"L.-I 391/[H
MXL+D7^]\8N,ZC9^&E3G+$*:X:AVT8:#1ZM"7.I "5$E+M\:M9O3:D>Y/8V*2
M]LGL\\2;N[6[?.G'ERDI0H_SUXQSH-G.;#;,\>/3%31$\A9"$  ,$I^0B5]1
MD+QXG>N&Z.L'J.)'TKW9JT9OVF\R=N3_ #M:WH3KV%P:CFX2R!F/_)6%(8AW
M\,>CUK\GB#7B?#Q:W=A.9]J'X%JT]8IW,X5N$_UA*Q\MYW(X*"HD$)\#U-K"
MUQ]W\]!F%0(JE-SJPNQ^=W$=>X4S/PY<KD6H$C\H)8U?\MO( M2L+D+&RV';
MA4N]KCR!WAQ*4D(Y()4;'N%LXYSSG5<Q&'4M:R*"P%R304Z_W>.SX#'S/PZ5
M>\DDWJ]^AULV@Z&K!JA;LP4^XUVK38E*TW^HB^#BY ]S_>XXU'XB8O!^Z%*0
M6<L6>XT(&EBS&KN2]BPJ$8T<RD)+T90!:VX:Q8_,N8AV)B8N)#L+$PSB@@'Y
M?< I S; (N !G YU9,AS),U7(5$$BY=Z,*E]'JYTM%0XER92D+4E*4\I>H;1
M0H6>UN_KC2B6!R,;9=+3:'%)"ED J'>0+8%_(  Q@ \ :N.)GCP2L D@6MH#
M2U@'.V\<EPLB=+QOA#F#S"'#L0Y8CS#FS/:D3U+J=E,A[DH8,4_%,))4H=R?
MK0 +]YO8 W&"?8:Y_CLZ2F8?%6J6E!HW0[/I<U%VW?L679 O%X64.0**@+I!
MN;BY5L>CW80Y$"84^PW$,MJ;0^24("K)2+> ,"_Y^E]5G'<3X*9,3*!*UEKU
MW;7I7S?>+3E_!\S#2ES2@) () #4 &PZ%NGF(58&H8*+/RHM26WED66I(/><
MX[N2<\D"^?.I'+,0N:KG0D@4)2]B2*AK5TZ@Q \3Y/*G8!:2Q6'J14AB*DW)
M+W+4K5P.,Q0&8@K0"4<HM;((OW6_B+< WYUT+ S>>2GFU#$W-:WV8W)VK'D'
MB'!*PV/G(ECE"9J@R00".95#9SU^-HYP$>/G('<I*NY.;FQM;[7'CR.1;-M+
MS)5"?S5'U'EW?8#2(9$Q0/*0S$$G5WM\/WAX.5!$0D)9M8O>UDJ(\>W^!'D
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M.$N4NPHY(N"*U(-&CMW"BD!.'E3 D"SM5WL-!WVWA5F=8,1B1#O)0MIL!*0
M04\\  <_G]QQKSM,S3,I6:"<I2V2MA+*E%# NQ:@?4N17H\=RE8/ 3,!R<B'
M4AR>4/\ EN*,'KU;>T+,/*9"[!P\;\YI3B%)44A82H*MPJQ!^_@D6(Q?7>N%
M,UF8FZRZD@L#06# %F+Z_P!XXQQ7E<N7*492.</JQ>AZL]"U'N'C.F3\,\A*
MVE-J"4)3])RD@8 %[^+9&NL9=B"$A)4:U-;_ *:"_P X\I\4\/S%8F=/&'4
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MB%H^2D)2HI2 C  &23;!!N/MD>= XQ,V2"Z.=O>42;U((\FM0"[QD88T"N8
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MAM2^XIY[>Y5LV_R;8OKI7#F9_BI"7/O E)8:"U7(H[4%0!=WAE/ELX <N]2
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MI.^GET/T=(6#HQ\QZ?9Z/#J$U4^H 64% 7)L!G'-S8?K]]-"AK.68&C^F_\
M>L8*TLU2;7:C-6G[=*0L0,7\I8*[V&,>GCC_ #YP=(J23;2H=O30'33ZLIS
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M60E)^H@9N >#^=_R>)PIGRW0'#-4OY=/.SMO&%K!F%2:6;3YL]Q7^\.V&JV
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MGZYO?WUE*JMO\&<^FC?9V2Y</1B[Z4;[M8Q%E5,I$"^4C(0HBPM?SGD^GO\
MP D,,H^*@]6M<T/1G[0BMJD.&8]:N/I]"["*+U])77UK?^7];2U*N!<D<9Q<
M<&W\>+Z[9PKFJ,-)Y%6( \@;U'7YQ'30YM5RX-=7VNQ/I$8PS*%*2%GL*<X&
M2?T%B;Y%B!?G5^3BY*T@I6*C<=+&H.H-'[0@5!-@*UH;O;Z]!2L.%$6U"M"Z
MNWM -_/KW'P/S!Q^>D)F'&(#ZEFKI4 L-:C4^6FH47I:[ 6(%=:CTIZPG1L\
M96T2A=U7L,CG%[IY_CBU[:WP^!$I;LYLY% :U?4]#:E-\E)5^8L'/0LWPH-W
M%36(&W+K:%D<KB''(I!>6A:0DJ&#]/F_DGW_ (:LF78-4Z8D!!Y003>]::N:
M%_,PA.6$ @:T >FCGY12"43!NH9U%OQ#B6(-+BWHI2E=P<05E78DFPMW6)QB
MW!U<IZ1(D) JI@ 69B 0YN]V%0Y/6(U"2I6Y)K2YT%*%K7M$;U8U&3^JHK^C
MK:V(*" ;:4T+A2&6PE2B$@ A5C?T!YO?3?"35**3,7^555$T+J=B375OA9X7
M6FE-1WJ/*S7\S#?>,=",I6ITW1W!Q1N"JRR%((N1>_=?( N,:FB4,H]'#EA0
M;OKY_&$4AB 6H2=R7+6Z,[T^9AK3&9,N"'#$/^'*&275))/S%$X. ,\YR;G7
M/<ZS-4J<I"7 \W#TVUK8Q(2D<PH&84[!J CYZTK>$2 AG8I4:ZEU3"H=H+;*
MC^^HN)PD7%KW'K_NJ8FKGK4HD@GZEFKHUJ]J7<I0 UPUK4T'FWQA>EU0U%+D
M!B+6'84G^S2Z5* %_P"Z3;R,<X\ZF,'+6AB2UGM^;HUV.[?*&ZR=6.@:_6M1
M6KM<UWAS,Q#\Q6EQH(*%66XWDY!!-\^EO3%\6.K;ETR8?<-G 9C:FYUL]*P@
MJB3N7I]^;]C76)\@R/E0,,XE+L"N'!"%<M+P"<WP<7M;@\G4DH-XBPZ5\ST>
MVHNX?]>C-"5*6E 9B2!>][?I=SYY\"TVF/7"-F[:P0GSGN%QC&!>W@<"WEG-
MF*F!*Z@O6IL7'I9M[N(L>&PDO#X54Q8!6I(8EKFMR^CU?]8D2F-L)C54^@PV
MA;<##.H==<[#V*#:2JP.!:XL+FU_TTWQ.92\'AE!13S*2PJ'#WHQ<N_P=@(A
M$RO&G+F$, HANQ8-W=M>D6IB*08DS#"$*PTT@$V ![0 ;\>A-P<CFVJVC%JG
ME1)-2:=":?H1INUW:I;)<!F'[[>FQH3&W7X,C@.^6X38(-J-A/X1$PS^?\,:
MY9[70^28*M\6;7_*@_;BNE+O,M-9@U+="U6H:Z=-;TBZ7Q;&TKIG::Z>XBH)
MGGT_U%P$G\O?^%]4#V<S#+_G026*I,H.^RS3I:_;9B[Q8<2_^L='TC3C");2
MV@!("@D7-K?W>3YXOJ9QOB"8222DDN'&Y?NQ=K-VK":6!2= !U-4UKL#<C:.
MB8-N+!4A>.TV-KX]\^@(];9TXR^:CL>;4BO3ZUL^L:KN" 2"S@6</\W!;2QZ
M-Y$,L*NH7%\V^_D6]?''YVM/3,1S) %+L7 <4M;R8;1H@)=G).CTITJ[];_&
M,IQ2&TG !M8)X \Y^_VX^U]-T2US%442#J]=/NE[:QL$ZT-;D FE!71OGM:,
MR71+2%A1 )(X^_I_&WK<<'3/'869RFJKT>SMJ^FKT:S'78&I!!LP/6GT]:C1
MX[YE&I+9"<7O;Q;SQ?%O8^FF^7X%?B<RBX"@6%J';5[=0UX"0$G74@] >]+]
M^C5;27%ESO2K'G-_O?\ SZ#5F7+0F2Q%7^+;]* ,U[0@5$AF&^H;]*49OC&2
MY&J2I *K743_ (_EDW\_RTWE8+G05-H]MZL*BHO8T&[QEWH30#LQH*;T>Y%'
MA9A)B"VF_P!7TD7%B+ Y\\GU]_?4+B,N)G'WBQ!<?=O[^2DLW<.!J==G^&](
M:-6H5&0SP2/^D8< -N%%M0!X_P W\6!U:>&4*PZTI*B0%$W;33>@L_6II",\
MN2JQ#!^FH)V8L?H[BJLU@'H9]YI0-PHV-B.;@?F#@^_ZZZ9*6%)!9V II<?,
M#;RB/4D DBCU<5<7IWZ:[Q)%#P806K)RH)'%LDC/W\7MJE<73GD)3SD DD@4
M?W2SZ=.^[-#W#I 8^3#4ZL13;Y $1:25P+L) MK*B0L)Q8CM!_/./RO[:Y#.
M4#S $LY%2[UK?JY >G0P_)]T"K-4[-WZZ;1(%.MW6G%U8N;^_G_/OJ*Q@9!J
M'/6M"7]6'EZ0HAZ U-OCOVN;L3$F0)*2+GZ;)L!GSG&+W\:@5D@$![MMO4O;
MZ/>,@7Z _"',_=+2U9%@"#^8M^O^;Z0A95NS'T(,)O[50A(94GN)'^U8D>1;
MM./\\W&E$X8BM7'9MMXTY@[\MQZAVJ/O:$6-C&@AQ2 !^\; \8XXR 0,V_X.
M)2:@$FAU?6A![^MMB^H#$$I( KKI77T^+Q&LZCWUL.!"E8[\@W/K<V ]" <
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MP2 0==?KI<*(+.%!B:_M7[-;$PKU50#$A$*]#QL-&0$4VIP?+<"E(*>RR2D
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M-N-+I(!*E$,QJ2S;.[=*OI"Z$*+<U2:#JU;>0M\Z0OP$NJ&)8,*AET(/8;J
MMRD&YL;G!P?STS7/PZ5\SAQMMK4L#K4$W,.1APH"FFCW8::5[5>AA[RO;R:N
M*2\\S=1']Y0%KV\#W]>,W.FTS,)8H%:&@',:_ :G:NNN/ -$L;U%NS"AKU](
M<"]OGU )>82H#Q>X&#P2>";8&/TOI$8Y&BR/)OD'W^S&JY)T%1N0&_\ F'01
MMFZ=OA2HZC^ANIMW*1:,%OG+]QZF>H:!>B5-2>MJ(D,FD4'&4M$?.6F&@9Q$
MS]N?.2&;?V<.F.ATRR:.H@H\Q\HY;Q![31P]QIALJQ)\3)%Y?AACIB4@SL'C
M)\Z>M.*3RCF7)3(,@3Y3E1EJ,R4/$1R39"5EQGX-2Q2=SDHLRT)"?==VJ790
MUH7N-2$\VXGU.S6.E$SEL5+)C*XF(@9C+HUAR%CI?'P3RX>+@XR%?0A^&BH6
M(;<9B(=]MMYEY"VG$)4DC75)&82,3*1-E34S)4Q*5RUI6%(6A8"D*0H.%I4"
M"E0)"@00[Q'+D*EDNEFH:5#-<&H^R0\,N)E<?!/H=2VOM2H%SM'<2 1<=OD8
M/KX(SQF=,007(J/=V];@ZL0*4,6#(I/CS.1V+ZEG%M&T8&O4[A14IIUP1#*"
MFZ 5_1VD<<WL1Y_/T\1XG<IY20:T#WM5K'1K&GG%QGY!.,A2D(<D4(+G707#
M^==-+);/MHFS2$=R2II.23FP(2+>,7 P3CUTQS:8)2/$_IY78!SO9_F6U>\4
M#PU29RY4Q)"DS"FH;^IB3J[:T^H]W6RC26]FMI$6_<VRH)')_NTK*A_AKQ1G
M 2K-LT4!168XU0O96)FD:]8L"".5-1^4:C81)^F$;QXL^N^"<8ZL^H%X92_N
MI5CA)!  5,'"1?(-KC^=K7UZ_P"!U)/"V0#5.689(8W]Q-;TH+=7WBN8U)\:
M96ZBIM0[T/4#IZQ3):U-.&]OJ&!:W(S_ !!MXMZXU<?NL-$>\DT#BSAC?YT]
M7%J1U%:0;V)!-CG&>;X./O<>VB-R%*#$@?4]?V_MW):=*5.,H6OM22$-V+BR
M 5!*>XI3W' !4I*;FQ4!<A*<M,N6M9EKFE"%+$J7R^),*4D^'+YUHE\ZR.5'
M.M".8CG4D5"F%09DZ1*\>7AA-G2Y:\3.\7P)"5J2E4Z?X$N=/\*4#XDP294V
M:4)5R2IB^5!8+^^4=*G'86!D1<B8=:F 9PM;19=;5VJ0]!0]G2I*DE*D?C&U
M @@V-]?/;VM?Q 91G9Q_#V6\$YC(Q&'Q$W#3YW$DU&!Q>&Q,E2Y,V5,RG!^.
MM,Q,SF!2O,):DE+*EN2$_;K^'/\ @LX@X?RW*^)>*/:KDF9Y9F>!PN/P>%X%
MD3,TR_&X'%2I6)P^*PW$F9C"25RIDDI4A<G))\J8E7,B>I(!5?C;V(A9W3DI
ME-3I@T3R-ES#TR5"MEEEN*B6Q$.0C2%..?1#?,$,DJ<6ISY/S%**U&_ESC'@
MK/>'<0G%8_!S\'.,M$R<GPYJ4(FS$A2Y8"G/^&HE!=RX+U)97/)^1YAF>-S+
MA'&G%Y5+Q,V7@YOCHQ,R?A)*C)EXI:Y82E2L2F6,1[B$I1XO*A(2D (]4[$P
MLO:?G,#!.N)25/(4D**5C-SP4D9( S<B]\G4GP;[4)V33L-@_P 2H$+""DK
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M<"&Z]-%U!_;=ZFX6Y O]/?;ZL%5N;VP#?SI_+PX9S0/< U%*N.CWL]-(U$X
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MB4P<U/(F2 W(DD$FY=S1J7.NFE(T,]4535QN#O/N!4&Z4'(F*\AI],J=J?\
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M@S@'B'B?&R<+AL-B%H5RH)2A2J*50%G#EB3>HTJTUPWP;F683I.*Q2U2L'*
M,Y2CR"7*=R230N$THS@TH2-8.Y&X=1;ASQ^7PKMD*>6+H*E-LA)6"!8 &X/:
M/W;\VM8:^PWL(_A[R+@7*,OSS.I:IN8HPTF<$3DI ES%24*7U<$D!PUG,4#V
MN^VB1D,G$<%\$"7R)"\-C<T"RJ8I2%^&L(" P?E+DDZ-2%ZB:/;D,(TZXGYD
M6OO6^LBQ6XX5$D_O$)LH ?;WMKM'$/$'XQ:L-A_\/#I 3+ +IY4@#86 -NST
M,>0^5<U9GS5F9-F*5-GS%?FFKF'F)/91%?DU%J?31Y40S!H^IJ&*7%')'S"?
MWC;_ & E/YC-M4J7)"IC&H4:EAT(J6T.E19MMA1J, 3S4Z!C7Z>EG=\DJB'=
M!2XM*'T@&Q5<<Y.;<FW/MS<Z2FR5+/+R4)J'ZD;=NMW +&,<P>I.XL23HQ84
M8FC4KVA[RRI6GHA#14+*)%P;"X\6)).,<XXTRQ6 7*0_(0U03\7I^C>4*I4D
MBY(+?8\AZ/4-'&?4\S/'F8EA:&UI=0IX@7*D&U[?4/!L1GCCQJ.EH9RH$-V
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M#<4CKW#WMVRR:M$V7,4%  *2HI (+/\ U&GI9HFBB=PY[ -PK3"EW;0D*25
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M7$KYK&K$Z6;R<Z]7U$4PC)HY%1SK[[RU=RL"_ OQ8&UAZ?SQKN\N2F7*2A*
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M0:((-$$&L$/J1V+00:" 6.HU^G:"#68(+#FV?71! 0#@ZPP<'46@CX !P-
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ME7\&*LRY/_O1-1S7'))<$L*_[N1J*AA47AZ0OQPD12$K_JHA4A0O8KCCC_\
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M@U@A]2.Q:"#6.7J3T)<01\L/0?H-99]_4CY&"/NLP0:PPZUK<CZP,#</'P)
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ME7U):=\M7N \6_*<M&#4@KG)9)<LDDA@6&E/05<5$8:?@*=42E]RZGHI-S<
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MB"#1!%$=Q/B=_#_VCW0J'9G<_JOVAH'<BD9Q 2"JJ?JN?.R5JFIQ,X.!F$%
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M.@]IZ2FD1M9$[:T9+)+.:@F,VGU1P>VDQG\1(99()"Q&P"HF+C(X@#,5<HN
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MZB*KZ-*1W#ZG=Q]U]R=Q]Q:RW*J6633=^D*-H"H8;;2%K>=4QM3$P%%4C0-
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MI..E$"J95YM!%S.-IJ4U&9O(YX(NDXUV:Q"9W RT2F;Q*$,B!GDN4E:G#Z0
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MVW4#LYN]1]8U]MW7DIJ*D=OJNK^@JWG(9F4J:I6K]K9G%R?<"13R&G<#+8Z
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@@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@C_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g729258g10f17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g10f17.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1\V4&AO=&]S:&]P(#,N,  X0DE-! 0
M    'QJ^>6(X0DE-!"4      !                      .$))300Z
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M8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
M    3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K
M9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M  !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@            0G)D
M5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M4G-L=%5N=$8C4'AL0%==LD         *=F5C=&]R1&%T86)O;VP!     %!G
M4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M      !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M         !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T
M;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C
M=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M     ! #O_XU  (  0.__C4  @ !.$))300F       .             #^
M   X0DE-! T       0    >.$))3009       $    'CA"24T#\P
M"0           0 X0DE-)Q        H  0         !.$))30/U      !(
M "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H
M   &       ! #4    ! "T    &       !.$))30/X      !P  #_____
M________________________ ^@     ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@  #A"24T$"       $     $   )    "0      X
M0DE-!!X       0     .$))300:      ,U    !@             !!0
M 5@          0                         !              %8   !
M!0                     !                         !     !
M    ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !
M!0    !29VAT;&]N9P   5@    &<VQI8V5S5FQ,<P    %/8FIC     0
M    !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO
M;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'
M96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   04     4F=H=&QO;F<
M  %8     W5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G
M951%6%0    !       &86QT5&%G5$585     $       YC96QL5&5X=$ES
M2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE
M;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG
M;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO
M<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P
M3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O
M;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M       ,     C_P        .$))3001       ! 0 X0DE-!!0       0
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M!0$! 0$! 0         !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$
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MS_UWOMR\=V#AVVUW8Q]2QK'[*[9:=V'D1M<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0'_P  1" $, 6$# 1$  A$! Q$!_\0 '@ !  $$ P$!
M  @&!PD* 00% P+_Q !*$   !@(" 0,# @,%! 4("P ! @,$!08 !P@1$A,4
M(0D5,18B(S)!%R0S47$E)D)B"E)A@9$8-#8Y=7>QM"<U.$-$4V-SH;/%_\0
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M3"CFS>DM#L[W0]1DFN65KX&"4(RK\,ENQ=&.[@EF^=LX!0XQGFO)R.?8?O\
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MQEPJA0I&QW;*C+A&R+27CF,JP5!=C)-&[YHL " *MG21%D3]#\AY)G*(@/R
MCT/R&:YDC>)WC<%7C9D=3W#*2"/WBMFQ2)-&DL9W)(BNA]U8 @_N-=W/%>Z8
MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*UG/JP_4&UCHGGCQ6KDWK!U<GG'F3=7>[/%"L4O>QVRH"/81C*']
MTW6%TO"H')+"*@^F9P<[9($UB^KFQNE]"N+W1-4D6Z$(U!%@@4;CM-O(S.S@
M$8WD%0!D[1N/H*@>2/8<GV_@=\^GY\;(]9G65HK<!98XBJ<?886+FV)%B>FL
M1I*LD'S8BI/^!0J*Y"G+_P )@$/Z9KR2-HI)(FQNC=XVQVW(Q4X^F1Q4:]S/
M%*8I3%*8I3%*8I3%*C!R1XBZ=Y2M:ZELV*?*O:LNL>(EHB0=1DBBT=F3,^CE
M%VJJ1EF;H4DS"FH)@24 RB7B<QA&\:5KE]H[2FT==LH^>.15="P!"O@@X(SZ
M=\#/:L$ZT\.^G.NUL_TU#+YUB6$%Q;RM%*(G(:2%RI >-B,@,"4)8H06.;F0
MNE-605!BM8M*/7EJ3#QS2,:0;^-:OFQFS),$T1<>Y34.Y6Z#R.NL8ZIS"8QC
M"(CE))J-[)<O=FXE6>1V<NKLI!8\[<$!1]!C%7NVZ6Z?M=(@T--*LGTRWAC@
M2VF@CE1DC&%,A=6:1_4NY+$\DU5CJ)C(*HR,3",6<1&L8.009,H]%-DT9I$9
M+ 0B"3<$BHE)T'0I^ EZ[ 0$.PD!VEG5Y79V>12[L=S'+#)R<Y/XU=4@@L;,
MP6EM%%!!"XBMH8@L854)$:Q( ,'&-H'.<5J>_2.)>&7U%[*QG'C:QU]5KN%Y
M%V!=47TDU$[B5\HTLKTY4=H 8_1R.G0+HBF4GJJ  D/NOK6&)>DHY+2X+PLU
M@)87.QT8>7AS&I"L"WW6 [')],<\>'ESTIJW74E_9V%WTSU);C48]0T>WB:#
M3=2#13+\3-9S9>SG1"90T)VSL 6)Y)VL)'6.NI:WL+_*4BKR%VBVIF4=:GD(
MP<3K-H8IR"W0DE4#.2)^"JA *"G[2F$I>@^,TRE_>QVSV<=W<):R-O>W65UB
M9N#DH"%)R >W<9KH633=/ENDOI+.VDO(UV)<O"C3*IXPKE2P&#[U$#?OTV.*
M_(_:-<VWL.E+&M$&1B@_)"R+R&C+0TBU06CFUBCX]9NV?E;&[3,HHF91PV\6
MJYE$"%(&2Z/UQU!HEA/IUE=+Y$I8H94662W9P0[0NX++GN " K98#)K&-9Z!
MZ=UW4(M1O;4B9-@E6%C%'<+%C8)40A20!M+ ;G3",2H $[V;1M'M&S%FB1NT
M9MT6K9!,/%-%!!,J221"A\ 4B92E*'] #,1=F=F=B2SL68GN68DDGZDDFLR1
M%C140!410JJ.P50  /P KLYYKU3%*8I3%*8I3%*8I3%*I6]OY^+H]RDZFR+)
M6F.JEA?UJ.. &(_GVD0\<0S(Y1^#%=2*;9 P#\""@@.38%C::%93MB:6-9&'
M=8RX#G\E)-*TH.!W-/ZBMM^HU4ZS8KOM6W*V78DK$;6UI81E%*O!UI)9\#WU
MX5= &-:;PA4D/M[I%)K\ 3TCG!4>]PZYH^@1:!-)'!:PB*W1K6YCV^:\I V_
M./FD+\E@2?\ "'; SD_V\\_V_D/?%;Q.:9J-,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4IBE< 8IN^A >A$H]" ]&#\@/7X$.P[ ?G%0!!S@@X.#@YP?
M8_6K8PNZ]1V.T3E*@]C4^4M=;]89V!:3K!62BP;J@BX%VW!;R3!!4P)JB/?I
MG$ -UE;)IU_%#'<26EPD,V/*D:-@K[AD;3CG(Y'O5AM>JNF[V_N]+M-;TV?4
M+'=\7:1W<1F@V-M?S%W<;6X;O@]^*PU?4/B>'%UYP<#%=FJ:IEY5:U7LE^<2
MTC&&,M7(:O-7-02LBY5_248-;$548U-X?H7)!3* E+X9EW3RZU'H^MI:I=C]
M5";5$1L^8TA$YB4C.XQ'Y@HSC)QGFJ[]+:8T<\JZA:/%:,BW4D=Q$ZP%\;!*
M49MFXD 9X.3FLRDGMW4%1IREMDM@T>%I$.S0]2:/8(I*&8,B$*FW(*Z;@4DD
MRIE*1),.OV@!2E^ #,3CTW4KBY%M'97<EU(QQ"()/,9NYPI4$_4TFUC2H+9K
MR;4;..U0!GG:XC\M0>Q+!CW]/<\=ZJ.D7RF;)KC&WT&SPMOK$D!Q83L _;R4
M:Y],0!0$G+<YTQ,01 #D$0,7L.P#L,DW=G=6,[VUY;RVUPF-\4R%'7/8E3Z'
MT/8U/LKZSU&W2ZL;F&ZMY,[)H'62-L=P&4D9'J*JLIBG*!B&*8H]]&*(&*/0
MB ]" B ]" @/^0@(93$$=QC\:J001D$$>XY%?K%1IBE,4IBE,4IBE,4KQ[#X
M_8)SS_D^SR?E\=_M]DOY?']?COX_KDR(@2QD\@2(2/<;A4N7>8I!&<2&-_+.
M=N'VG8=W[/S8Y].]:CWT=HEJV^HA<Y*HVLLC4W:.WR24"*J1#,9@KR4[-]O6
M6(NS4%4J@]MD5"+)@90Q"$\E"[LZX:TEZ6A>.-K>X4V(:/&Z)T_5C<CXRIY#
M,&/?'J<5H+HS5-2DZ[CTSK'IV*'J."'4#I?4!4"6ZL3%*S(MW"!#J*>2&0%L
MO"-W'RYK;YS1]= TQ2F*4Q2F*4Q2F*4Q2F*4Q2F*5\7"WMVZ[@2'5!!%5;TT
MB^2BGI$,?P3*'R8Y_'Q(4/R80#(@9('N0.>W-*U3>!'U$)#8'U9=V5M72K*(
M9;_GWE9*Z;(&_4E)'6K'[.VD)/\ NI/!K-(QX.)CLZ8)N5BF[5$0$=GZ[H"0
M=+V<@O6<V$8DPQ'ES_$,&*K@GE"Q$??(_.O./FS[Y&/P]?ZL'ZFMKC-7UZIB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE4?L%O:7=&M[6CN$&EQ<5V71K
M+ESX^@A-J,EBQRJOG^P"$="F(B;]H==C\=Y46A@6YMS<@FW$T9F"]S&&&\#Z
MXS5KUN/49='U./2)$BU22QN4L)) "B7;1,(&8'C ?'>L'7#+1/U$G5QV"SON
MR]BZ:K;ENH6:L%M8Q]R=S,^5^D!2TMA./#-44EFYGJJDU'@>&(W(@B1-551L
M">P]>U'IA8+9[>TL[^8,OEQ0.80D>QLF=HE!R"$^1QO)[  -CEGPWZ3\8)M3
MUB+4=<UWIBR='%S>ZC FH//="=-JZ?!?NR.LB&8F[M3\,(T"EBS0BJ[T_P#2
M%"I[DE;9LO92=RUX4\NHQBX=>>@+39322@F(%J?,EF@M$0 YEWZ,=*/ ?.BI
M@8Q40'NEO^MQ/8)#:6A@NCLWO((Y(HMO),(.=QS]TM&F 2<9XJ[].?9W?3^H
MI;W7-:CU'14^(\J"U:YMKZ^$H*(M\P51$FUB\BPW$I+J%#%3NK&Y]<S0G'#5
MDOH2KUZI-==??H.R"A8&9)%PP.\;OR@@G,R[QT^=$=&4.)D73DYP#L ,8P>)
M0ROP^U>^NHM2DO\ =>PK-$6?"Q21-LX,+QJBH<#[IP&[#DUD75G2M_T9+97O
MAKINGJD5M)^ENGHIWN-0U.U$C%ITL;V>4:A#$"5D5 \ZG)3  J<<C])'4N]N
M&6J$M3._[,MHR%+J4R[L#J=N,E4;4[(R*HX&QU]PN#7R>',"J,FR@4'#<QO5
M205((":WVOB+?Z1U#>?'E]2TZ.:>*-#%:I=PQD_+Y<R 9VCAD>4@XY8$&KW<
M>']AU-TU97VG6HZ?U2^BAO9[=UO8+?SF&9(I[2XWS6Y#9*@1@H>RE<5TXOZ<
MO-;BUQ)O50X\\G'DM;Y9E+2LQJV JT6WB95\_:I-9!.BV^9=-9J%G%H] $VJ
MZC5))=X"/II-E2E7&?)UMTMU!U%:7.M:"L=O&\<<6H37$C2(B,63XNVC#0R1
M!SEAN.%SDD<53IT)U;T_TY>0:-U"\L\JO)-IEO;H(Y"P"R&VNY-MP)C$#MVI
M&S':JD,JM4@?H\4'F#0M5;/:\J$[Q'L']MB5]:P6R7J[ZX,4TF+XEL=K&?KN
M)9K#OW9H@(UO(*=&6;/W#0A$%O)6S>)5YTW=ZA8-T_\ ".Z6\@OI;%56U?+1
M_#J!&JQM*BB7S&3D!D5LD<7OPMLNIK/3]07J 7D<+S0&PAOS+\4C+YXNW*SD
MS+')FWV!\*2K,@Y<MF%S6M;3IBE,4IBE,4IBE,4KQ["8"P$X80 P%AY,PE$Y
M2 8 9+B("<RB12 (?'F95,I?R*A #R"9#GS8L=_,3'X[ACT/K]#^![5*G :"
M92XC!BD!D(R$!1@7(R,A1SC(SC&16H=]'YQ1I7ZE%LE(U-S6[6E';@:O:V^=
MB<TBV]U)_P"TH]VTESQ\XU$"%6$?.=.U\A4*)0*#]'>'7LDIZ8ACO+8I<@V)
M2<*8RT>$PLB%,-@<*RB/V8@_(=%^'\'5VE=1_ &]MNINCKEK^:WURQ6.6*PG
M"2O\+<1R2&ZTJ5Y!'&$^>*Y# KN#>8NX3FBZWS3%*8I3%*8I3%*8I3%*8I3%
M*8I7S662;HJN%CE31024654,/14TDBB=0YA_H4I"B81_R#(@$D <DG 'N32M
M97@QS@XMW+ZK_).)K-!-$RN\)-M7=970:W&-O5EJ-&IQUJ0,9$OW")+:GK%U
M)).111!^/_U@8B@@ [&UK1=2AZ7T]I)]Z62^9<P^8QPD[%HCSP_E!@F#G;CY
M,U#')/N !],?XULW9KBHTQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*
M4Q2F*5K _P#2$Y5G'63C^E/5 ]AJ[VNVA&4D6":XS,2;WX>"C0AXL\>_0\!,
M=Q'GE%')@#S)&E*)5U]Q^%QO%M]5>UVR*LD?G0-M=9%*#):#=O91VWH@93V9
ML871_BMI,>HZEHLNG]3MT_U-;02/I,-X@CT>_59BS137\86>QNV?Y8IBY@ P
M)%3=N;/AQ!3CDN+VATXDATXPNL:J#$BC(L<H5J,:D*0'8DBH0K4_B(>2013/
MH>Q\#B/JJ:QUQ@^KZBP4(#=S':I9E7YSD N\C$ ]MSD_AV&V]#&I#1]-&KD'
M4Q:0B^(N([H&XV_.PN(HXHY@QY#K&H(/J<DR.RU5=:8I3%*8I3%*8I3%*8I3
M%*\F?$Q8*;,00*<(B2$IA[Z P,UA*(]+M1Z >A^'+<?_ -='_$+,BYEC' _6
M)W[?>'?AN/R/X'M4FXV""<R9\L0R^9M;8VS8V_:^5V';G#;EVGG(QFM2/Z14
MY(/_ *D=O8VBJF96)"/V\HULL,1=*'E(LSR2]/[JS5D9E1F_$GI FX^\2C9\
M<H* ^76$BAMX=<K=P])6\;O'<6CO9&*5=LHB<!"R))M22+U4QLBCG"A1E1SS
MX;:3I$?5DFJ=)=3R3Z+,M^NH].ZQ<L^JV]R5E$;V5U;O);:O9^=B5FG8S6P!
M<M(VV0[>6:+KHRF*4Q2F*4Q2F*4Q2F*4Q2F*5UGKUG&LW4A(NVK!@Q;JNGKY
MZX2:LVC5 AE5W+IRN=-%NW13*91594Y$TR%,<YBE 1STJL[*B*S.Q"JJ@LS,
M3@*JC)))X  ))X%2YIHK>*2>>6.""%&DEFF=8XHHT!9Y))'*HB(H+,[$*H!)
M( KQZ]:JI<HG[U5+)7K5!J&61"6KTQ&SD2H=$1(X2]_&N'3,QDA Q5B>J(D$
M!*< 'L,]RP3V[^7/#+!( #LEC>)\'D':X5L$<@XY]*IK'4M.U.W%WIM_9:A:
M$LHNK&Z@N[<LAPX$T$DD9*D$,-V5(YQ6";AAQWXB0'U0N9MOIL%2"6:A/ZO^
M@2,[6#YM7IRX0+20OYX*$&56:DDEI==RF[\6ZQX@QCM&I&7[BCFVK7NL2]-:
M3'(;@PRK)\2Y@8;DB<K;B639PNP C)&_ 8[N*F_$VX>-&N( TP+0*98PTRC[
MQB!;,@4@Y*;@.WIQG,L^P*%25XIM<[O4:BXGG/LH-O9[+#0"\R\^/[I%)2KU
MHI(N?D/X#,JROR'[/D,PVWLKR[$C6MI<W*PKNE:W@EF$2_TI#&C!%^K8%>+G
M4+"R:);R]M+1IFVPK<W,,#3-_1B$KH9&^B9/TJKLIJJZ8I3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*8I3%*8I6L?_T@4]U8V;0DK66;68C&];LR4Y /VR"S
M.40-(>10,L1@$@W50 1%-9*3402$_D>.3$QG"NW_  PB$D6HE+H6]RL\1@#$
MKO.S+;9-^U7. ,,A# 8R> -!>,1Z.N-2T33NI8KBQN[FVE;3>H[&1X[S3G69
M@(C&R?#7=LS9>2VDE$A+%HU4D%L\G$14J_&'1*Q&2<<576=74!@DHFJFS\HY
M(1;D52*1,Y4A$2@8I2]]=B'?>:WUXR'6M3\[/F_&3;\]]V\Y)]\]\^M;BZ;@
MCM=!TFWBO!J$4-E"D=ZL/PXND"_+-Y'/E;QR5R<'/)J1F6BKW3%*8I3%*8I3
M%*8I3%*8I7AV*5C(B'E'<I)-HMLA&2+E5RN*)A1;M6BJSAP1NMY%<^V2(98R
M0IJ%.!?$Y!*(@,R)6:1 J%SO4!1GDEAA<CD9[9[^U>77>CIG&Y67) 8#<",E
M3P<9['@]CQ6K7]+'>?&"Z?44VTRB]DW2RVV8E+,;0\Y8*C6*]&W>,=0LRZV$
MS<(1;$#PZ[-9(SJJ),CL"R,.S6,Z#U7(LU-L=6G5/\W+>,6=O;6JQVXOX(9Y
MY#"\<B"WD.^0K(7P%E+*VUR-IXW5K'IWPLT7IKJ!.I+&]OEOI#>F]MT^'CTZ
M\>\5U#FU$)-N\/F,R_#21!V)WKLR@VL,U'6T*8I3%*8I3%*8I3%*8I3%*@O]
M0U]R$C^/#Y?CE^H"VS]21!+$M4BF-:T*>9)Z,BI >B(/ =^_"+(X%A_?18'=
ME1[[, Y'TNNF-JBC5?+\GRG,(FQY)GW)M$N[Y,>7YA&_Y0X4]\5J?QDEZPBZ
M09NC3>"]^.@%\VG%QJ"Z=Y<YD-KY0\[?\2+4/Y&)#"91RA<&$&O]$\]^3/$F
M0IFT]N#2H^5(_;155N]1!Y>;<PCI%M)Q 7*V&D$I>,C7$DW.W1049JR16#=
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M!S60],=+ZWUCK%OH6@6@O-1N5D=(VEBMXDBA0R3333SND444:*69F;L,*"2
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M>V[('0QBP(B/1W!.BB<+YU+X'^+_ (;=*R0=%=06^KZ9;SSW]ZNF6OPVM'S
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M>  *M$A!_'[J59EGPYTY"3J$]4$K11E2S+V7>QU.LCV"B)5)_.*V9Q"2$>T
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M P=^F<O?8_(W&)_,0,0 3E77C 8$JP(R>#R><<&K#<1>1(R!F8#8T;@%6*,
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MWPV\$?=(/=02,]R1Q6D-,\->C_$;I?I_6I=-FT.X^#BA*VCD;XH?DV.'QO#
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MP=CE[2_9(GGZBWKCJ=^Q*_;PE9 KP%VIT%FS2-*M))F\!4=L$1503./1<9
M()R3@8!_CGZ>GK41=HA4Y96) R,@AC]1CG^[/-6:+N/C3.70O]ESG8FJM@M[
M@E5GMQUM%.F,1#/'EAJ-7B9>VP8I+U-_7IB=OE;9IBJQ;/%".W G=M2MUU4O
M7F;OE8AAG&&[9_'N._;TQQV-5!U%95\FZ1+R%FV&.X0N1D@9688EC;YN#N8
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ML&9V17!-84_J!_3HK-K"_P#)#7MO94*:9PLG:+U 3$6^DZY/NHUF98\HP-%
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MV2-9V<9E>-&[JT[A(0PP5,@-:P&W+I.4/24WI"*)%EU;N38C&P7!Q*,D7$U
MW9@BXF&T[5)TQ2*UZ9MZ\<C$R+LAO3;MD 80*<<K*.2.=?\ V3>HYM0ZWU+I
M_5]45+>XTZZUG3XF,=I<W&KVTUK%-%#-$L>_S;.1YY+?!(%MOC^42XR;_*(]
M/?HGPBTSJC0=#:ZNK?6=,Z;U:X\F2_M+'IZ>WOI;>:XMI3+Y7D7\,-M'?'"@
MWODSEGEA(RJ_1 EIQ*A[LI1(=$])KELAY"&MQF8GDY.P3K-RYL,#*6$2^<^K
M!D2C5FHN%%7$4RDD(GS*W:-TD^N.O+:V@U2)H9Y)9980TT<DIE,1SA0&8D@,
M.=AQM.?QK@S[/FHZC>=,7L%W80VUK:WI6TNH;5+7XKS 6E#H@ =HCA?,.2RD
M8.T #.KF#5T!4+>8G"77O+V B"34H^IM\JH.OTG>HEJB^79I.R]N8J7BUU$$
MIB$=*%346:>Y9N4E" LT>(*AV-YT;7+W1+@SVI5E< 2POS'*H]#CD$>C#D?4
M<5A'7'06B]=Z<MEJ@>&> L]G?0 >?;2$8R,X#H>-T9(#8[@@$8MZC]%/8*UC
M33V%O.J-J:DX SA:D5V65M4BT*;L4$"SAT(J$<+D#T_=B>=(V$WJ%:N!(!3Y
MC<>(MP\)6VL(X9V4@R/(75"1C<BX&??#?AFM)Z;]FJRBOA)J?4$MS8)(K>1;
MVXBFG12"8Y)&.(MPX+)OQ[&K]<YEZGIC4FN.%&KX=""UW+51])7!@4#.';JJ
M,I= D?'+2"HF<&?VZSFE9N=F"BG(K+1+CT%DC/U#I<;_ &@.NK[3K2ST.VFS
M>Z_Y]YJ-PZK(ZV=M-"$C0.KJ&N+EASM^6.!U0@D ?3K[*WAII,]S<Z\UJ(M-
MZ1^%T_1+6)FCC&HW,4SR3RA&1G%O;*2021)/=J\@.T@X-N2UYG+NCK/3=N6C
MV-2TY33LM<RD:1.#M;RN2BRJ2\5+6)#TEI&)J_V])C&-2] W*)Y"3%P]>G<J
M[E^R;JZ]0=$ZA'J&HK+J.BWXTR.WAF^&FCTOX>*2TDGC0J'.'D@2X5-K>2P;
M]8KBN./\HOI=UTMXE: =*T3R=%Z@TI]:DU"YLS?P3:X;V>*^@M[B4,8N(X;A
M[(OO3XC<@\J2,5M#_3BLMFM?#O3\E:J\QKCQ&(<QD<WC8<D"SD8&,=JM(6<1
MBTR)HMPEV2:;LPHD*DJ8XJD#H^9?KL,%OJMY%;SFYB69MLK,7+$DD@L22Q!X
M)SS7CP^O+Z_Z/T2YU&RCL+J2T0/;Q1K#&%7Y4=8D 6,2* VT 8SVJ<66FLSK
M%5S(^F%5.1=K?;4US;D]9;-E4D"6-)_&*2]-N*K1(K=H]DVC5=M(0TRBW*5
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MFS1[NP:[<+&  !6%VG663NLK,E1'S1&RDJ$H0A@!U$-C@<I9FP-]QQ(#@ #
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MZA-'Y4U_IMC>2Q8QY<ES:Q3.F#R-K.5QZ8J[&4]7.F*5\'7_ )LX_P#V%O\
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M!1*/OFW0@8ICE$!]3Y 2D.8!_ E*(_@,S[RY/]6_K^RWIW]/3(S^-:GK@;#
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M+,SAIVV<%;NP!8'!%_$'!Q*(DQW0.I]2OEU?S+R=S;ZS?:>A>T$95+*&*Q
M,"9 D1I0^#RQR>"HR_J_3X=*?0(X(TB%YTUIFI2^5()@TNH)-<%V(=PC8=%:
M/Y2NP?(,\R/#B5H]--$ U_#_ ,,B!!']3R(=^@T>-1^1G"_)C/ -V ?\(CT
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M21,CZ@%(8G90+6^'.H7$O1'2]HTCF./IO1A$#& $9+=3N+! 6_G  26!P<9
M-:X^T V>I=?7G_STO>".,K<71'S<9Q\H(Y. <8)YSV,>)^DG*+)X>@Q/FX:L
MG*AALDDF<QC*_<A[3&:*8HB5<">(@7H?R ==CDPUW4 @7XF3(&/YA2,A1'D$
M1X[C.!Z>N*FQR-Y<>2<^6H/RG^BO/;OZCTY[8KLH\3=(D$#?V?1 @DHDH81L
M\@/^$#H!((A.?M$0=%_(AWX] (#\#$Z[J!X^)?)! _DZAN=OO'Z;3W&/QXKU
MYAYY/'NIX[>N/IZGL>1VKIJ\1-(*L5&XT&($PM%VOE^IW_7DO"-H0IA,$V8
M$JC<5A[^1 ?(2F W@'H:[?J^X7#XW @>0,G;*TN,>6",JP7WXQD&O7FG/[6
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M^:3G&X$#&2N<?*!]<\YSGT('MB/VSM%:YUIL[B:]JM4CXB14VS/,W#]O+.I
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MJ],M(S]/%"*51NJ22;844F[E:8ZJ@0JP))/[0;& IS@ 8R21@C]GOR<>CY>
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MS+(G&T-G)VYQC!J7(;6VYZA.[#Q Z Z(F_\ II5Z\2R"JI^OV_(BW$@"'0?
M!T B(D"F_1T'(%CU'P#_ /=;]R@ _8[Y!X/<G&1WJ\?I#3O_ ,9!R#_IX1QC
MG]O\O^7-5E$.>54]#I2T'7./L['"U.5.3AKW8I-FLHG7I5LIZ#MC'+-U#$D%
M68F J_95 * B!1,H6CG_ $+ [Q7$FKV[<EDEMHXY%7S4;E'(*@J&Q\IR,^H
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M @!3#-H.!_*=2/\ ^S![/C.&]R!CG& "><B&Z/@ M@?0=L']WIV_QK]MHOF
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MR9A#K]BA@$?$1R= ?UJC. V5/IW!']N*L/4L;/H]U(@R]JT%XGT^%GCF<_\
M\2O^5>415)=--= Y54%TTUD52"!B*)*D Y#E,'8"!BB @(?D![RJK%<@\J<C
MN#W!!Y!!]01VK]8I5*7NS-*72K9;'Y@*TKU>E91<3=="5NT5$I?GH!$QQ*4
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M0+$^"8[=%Q&C#&-Y!+2 <;B>_<R)I^H]7Z^"0"CT"I53[L!PDA@H*/CC/BG
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M/+IJ%G:WJ#55=M'J?J6!UQ1X:P^JKZZH3<768QE*E47 3>LH5\@N4ZWD/JF
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M:[)JLPAWFVI!W3D?1L5<O>O':<@T.Z=&C /(O4Z;%6J+([7(*<0XEFDT(.!
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MI9T?Z4]LAD#*VKDK.3+PRZR9FC6LH%CE8\BH*,2*JK/DW(K)B'DN0J0)'-\
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*Q2F*4Q2F*5__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g729258g14g69.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g14g69.jpg
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MZ08EOMCU[N$B/,EW*'>FTR+W;[284>;%N$*Z1Y[(:C-.E\2'*/.P%MSTH,9
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MK\Y;XB .<<@ T@O2!4>MM1.5JDG4GEJ!Z"!I5DM>UGN';+E +AK/V-BM55:
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MA=>1'9;:1@E+275EU^0\LA+;2"_*D.J2D=*X<GP-9VJ[J.UZU(3+N]\O<Q(
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M+;3:%...+4$H0A"2I:UJ) 2E*05*42  "2<"I2E2U)0D%2E$)2E()4I2C@
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MW5_;2& DP*&7VAU/INY[@[:6IBQR%?VIL?>(UJGX;KT!UAM]NBM=;2J>TIV
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MKW*U);X%E-LNX>R8_6$WX<UCU89/VH:BVD>9L1D?OFQ0,!L.2+)ES8YF5O\
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M7DZ@H3=]=J4K.<DNCP$2-::_&@NN^HEZ3GJA6)8_"\E*^%E33&V;>ZI&NZI
M )]K[=) XC&H&>W=)ZM35)2,'(*=#P]L.T\]?+I7<0%RN9@RBH.6UQMF,95E
MI95?F/FO--991AWV5M_$6>!F)-\?/X3F"JA&8>R&5Z XV3=7"@H_Y*L<P=TZ
M<<@DZ]HW1P. #I24G]Z4G^W&<9.>(Z@<9R,UDN-H1@?DFS5RZ5)S/GG&9.MF
M2H/HPGUX?7,5+-DAQ6%XPK",R!X3V'$.#.LM%M/#MSO@<04^4'&.O(R!SXD'
M3A4$$<1CUTX9&N#S[.-99!6NKVA+BZU9(&P)9]/O*A)>/E<,Y4TR^G#WP)#_
M +65,DCO8POTYRT^RYC'I=1E50(4,I((ZP0?3CA2N_Y-*<4IQ2G%*<4KIK'_
M /-Z>_\ 4TI_U%_FJOO[AWG^2KC_ $1ZLJ#^W8?\:C__ #(K@4?_ .9=0_\
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MJ.B0>Q(\F=2K7ABJMT$@JUQRX#T?7GYJG6,BXR% %BH:.!B8L%E X,;&"#@
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M&<9;3A*,J?#=1EI.6<1T+?).,8X%0&G#0$#3EY^NHW4]7RGZZKWVGU%JZE:
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M6+:Z\VRI#, E<D[E S;BTZL=Q_N2FW>R_?#Z;67"UW^N]J;B=*)9@=&7G E
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ML0&D9:_1<ILFX,4PRBP%-T]H^])V!&[&CP)6@RU!DJ?4YJ,N$9<(Z4CR8$N
M+.;,^)P-GVS&2!F=7#[DG<EFVM^\M+N#5OB*EHFOR[E)A&"Y <6U.:G-RFV7
M(CL1QI:7T/I04;N]J@I4;J[Y>&WDL%M@NKZ,MI0WTG2!T!3:FU(<4E86% I*
M20<XX@@0R?X^OBLQ1QL7)[LA(Z2C2R0)"/.TAJ,4T$X-Y8Y89@K]'0\,4*0V
MXP0P\A#K+J%MN)2M.<8VS?<'[G+J$.M,7)QMQ"7&W$75U2%H6 I"T*"2%)4D
MA25 D$$$'%63M)<P2"& 02""RH$$:$$%>00>(J9M:>+9XYVY:X?;M42=@V)6
MXVTPM(*EZAUNUE.B_/&Q+'1#5@;X"A/.'3AOQ8B\1@+9);#)@CY+3+!0[CFI
MN/<F[C]HD(BW28[ D.1GIB6I5\4RKO1@*+LA6^ $,HW%CI%E*5%"TI*BE0%Y
MJ^7IY)6TRVXD+2V2B.M0WU^Y0,+U4=-!DC(SC(K +?XX7C!T!%4<NVSQ*NB\
MU,.]5#,SHK486;#3Y"4EX4*Q1B7:3A3\63+0$U'M$8QC"BHPMKR]32N9T3N)
M]S"<90AB=),*4N%*Z&[NKZ"6VVT\N.YA/M7$M/LN%/XKB#P(JVO:&ZM[A6AE
M'2(#B-YE0WD%2DA0RO5)4E0!ZP:PW]L">*7^/BM?8OI[]"N9?Z@G<\\5NGQH
M]]FJ/"6Y?YO\$?MUF=,\;[QB]BS\'5:#L)VYV6SJE$5R!K'7C6,W+SRX0!^4
MF40X$=0""9)45&BDGR*1&WLA",.D$8;:0I6,.9W$^Y=;V'Y,Y4N)'C!LR'Y-
MZ4RTP'EI:9+JW-U+?2N*2AO>(WUJ"4Y)Q5:-H;LXI*6VVEJ5D)2AA:E**1DA
M(2LDX&IP#@:G2L,_; GBE_CXK7V+Z>_0KF9^H)W//%;I\:/?9JCPEN7^;_!'
M[=9G$>-]XQ=@C;5,P>PG9:)HM;!N%SDH_KSK$L*K523D8V)CK)/DLT!;45!G
MR4S%!!RABV0R2) 1MEY>7D>>&[W$^Y<PY&:>5+:=FR%Q(C;EZ4E<F4VVXZY'
M82<%UY#;3JUMH!6E*%$@8-5)VBNJ@M24,J"$A:REA9"$**4A2B%X2DE:0"<
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M[O-SENN2X,=EI*HD8HRRXZXP^XA) #;:4J:9#J2%M)W$$J]5V7VMOVT%_O\
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MML"N:IUK8J+7]KV\?KCU?,J$JNVPN9D:)/U'.W"EC1TV3&E97$%3M1D/@'C
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MT:_AY_D-]2_S?-5_HMQX8;6>^:__ !O/^\4[UC>+L? M_9I]&OX>?Y#?4O\
M-\U7^BW'AAM9[YK_ /&\_P"\4[UC>+L? M_9I]&OX>?Y#?4O\WS5?Z+<>&&U
MGOFO_P ;S_O%.]8WB['P+?V:?1K^'G^0WU+_ #?-5_HMQX8;6>^:_P#QO/\
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M2'S%JJG%*<4K%+'1*9<"H@VUU:"LA,#DQ4.N<C!)1$>J0P-@Q0[)C3S*5/\
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MSPEIU:E(0VXI:<[R4H4I2<'!WD@$C!T.1H=#0D 9) '62 *_9TG&Q@+LG)2
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M>85'[UV^1\+)!X94X;ELZV387NQV<>3BUMNX]#^,YPXM*L<!.,@+6.(&'%@
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M1,/'R*\FROW[,&D4&3:)^*14D1+,M%>RZ4Z_E0YY#/GQZ-/7T5T4!?._-EL
MI4C5AJ-%N6@JM(BWJ-&RP#<),7?JQ[UFF5.6%B11)TJI6'LP%&KBYMRJ23].
M$+^,N["ZW,V137/5QZM<XXZ\M1YL]AL'U[LO8>4GY:'W#44UVJQ>O=8D5B2R
M$M1\M=3JG#D;0B924)MUCD7QZI8G$"0<A)#1Y5@7(SS.791NJHFY=09Y^NI]
M>)/7UFV'%33BE.*4XI3BE.*4XI3BE.*5"^SM^:YU42U#3<@;-W(P/!T5KVG
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M:XSG&:90HY!P1@Y';CCPQKH1Y"=,U*<=:^P>JFLJ'EP=[4T$YU"X^WN@UO9
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M$? 'Q#D2PR$B6V!,&)4:,7+B VJ"*;(CY>2GT/!.!WVE+WMTG>3NDA1SO9!
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MRRQU*96UK&%+0Y'V=L#T+99N$NP[2W3DI7#@6>! ;8F8]LO(1[5&1[8D'/\
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M/7A5AN4U33BE.*4XI6,VVF52^0Q->N,!&V*'+0I+@<D.EW#:\X\DDB/IR@H
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M9(#K5L+@3JZK+3^7!)^6'#>:AHR*$8]#VWL-LB1;-?+&T&K7<XR$*;"U+")
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M7BPJ(:?&ZTF+1$LH596YUIB4K\$Y(V"-&"EHW-<9/HXXQG&O6>SRZ5!0<Z$
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M#A]&.LYXX_KQ7IZ?J&P:9UK#UWJV7<(V11M(QU!HEJF$1QQ)MR@M=LUB"GY
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M&UA91:TY6CUI':<]O"DJ<]",^KF1'BR):^CCM*<4-3@82D?C+6<)0D<2I1
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M -N(^2MNG%4TXI6N3=']TZZ*?X.W=S_*76GGH%G_ ,'&VW\O;&?[&T5:U_\
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M.8<7*+=BLLN%/I0,YZ1DX;95EUG"WD(;>7GI5%;;:#:7BZ4?KZEA&Z7,G :
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M"R8F&EGR"2#*24D@Y\HUUYCJY\/+V5(2H<OFYZ>?3K_MQQC2]^6\25(QBSY
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><KMJ()TZO7U]1<2"!KY?7T5:#E-54XI3BE.*5__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g729258g16d60.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g16d60.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1:L4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %I"^5W8X0DE-! 0      $0< 5H  QLE1QP"   "   < E  "')R-C X
M,#0R' (% "--:6-R;W-O9G0@4&]W97)0;VEN=" M($Y%5U]'4D%02$E#4SA"
M24T$)0      $!O0SGM=5459J3!V<46O.T\X0DE-!#H      .4    0
M 0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N
M=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP
M"W!R:6YT97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M    # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P
M 0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"
M24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M%P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#
M<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O
M;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M      !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B
M0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M              !";&0@56YT1B-2;'0               !2<VQT56YT1B-0
M>&Q <L            IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5
M;G1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R
M;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M    #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ .__C4
M @ ! [_^-0 "  $X0DE-!"8       X             /X   #A"24T$#0
M    !    '@X0DE-!!D       0    >.$))30/S       )           !
M #A"24TG$       "@ !          $X0DE- _4      $@ +V9F  $ ;&9F
M  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8       $
M-0    $ +0    8       $X0DE- _@      '   /__________________
M__________\#Z     #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z   .$))300(       0     0   D    )      #A"24T$'@
M!      X0DE-!!H      S4    &              )L   '9          !
M                          $             !V0   )L
M          $                         $     $       !N=6QL
M @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M          !,969T;&]N9P          0G1O;6QO;F<   )L     %)G:'1L
M;VYG   '9     9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4
M   2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &
M;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9
M  !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J
M8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO
M;F<          $)T;VUL;VYG   ";     !29VAT;&]N9P  !V0    #=7)L
M5$585     $       !N=6QL5$585     $       !-<V=E5$585     $
M      9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $
M   (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L
M:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%
M4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T
M   115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N
M9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "
M/_         X0DE-!!$       $! #A"24T$%       !     0X0DE-! P
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MQ $_   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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M %-JDDIJ=0S,/IV.,@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! ?_  !$( ,8"70,!$0 "$0$#$0'_Q  >  $  00# 0$
M" $&!PD"! 4* __$ '40   & 0(" P4,% <'#PH' 0$" P0%!@< $0@A"1(Q
M$Q0505$6&!DB.%9887&6E]47-C=455=V=X&1DY2AL;6WTM/4UR,R.7BVN/ F
M)RAT@I7!)"4S-4)&1TA266)UM-'6-%-D9X:'DK/A\4-S@X2CI++'_\0 '0$!
M 0 " P$! 0            $" P0'" 4&"?_$ $L1  $" P,)!@,%!08$!@,
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M-DT'9B$3*L4>Z:?L[P[73#[#=O\ 9QBMVE'$YQ+L;J&=[<[UDR>R[T?59O\
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M;;\9XGW7@6OA_P #$K%B.3"6(TSD@Y8Y#DQO3B'(<K!P)3%,$. E,40 0$!
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M=,DMK?-F316F46VA:&("L-E:1N7/R%]QJOWN9/MI^T#-&:QD68L[99DV3Y/
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M(-OFPT7Q;[:RT:Q, 0T[]3<>F6K2@>EP%-3%3AZQ/^3]L T ,1 =R9!RAB@
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MS<,61)7*_#UB'(=@ ?#MGI$4[F#=4A!<RK058Z0?]S -TROG+15V0@>E*"P
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MB)HB:(FB+AL!A >MY=@'R[B/VNSV]O)RUA8Z=B#!:?<C),YCCAQOI-8Z'?\
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MF5JMOW<6P_E*^2K/7J@^,OZG+%^<G'VO5/9W^&YD_P!3_9Y2O.6=OXAG+?\
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M*KY&I42J1S]:4M,V"0"H5B=V",:Q0;E5>.7ZZ:""1A4VUQ@ 8;<D.1:P 2F
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M:5)X?Q?(TV!?IRL'4WU!JKNM0TFD8ITI&*@EXI2+CWR1BE,F[:-45R&* E4
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M8.>WV1WY+891E>56-A9:),9T882!,F4R?6[<M-K;9!DF1Y7;6T<8BA&D\V#
MF3#@1K*A(CTF_""4I0/D%\4IS@0#G@)0I"@;K )A."0@!>8=<-@,)0 1W+L
M?LK+[/\ M+'''%9Y,"(X1$"P:0DV)E([*+\E8=M<R]T83:VA(B,))<R<XML
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MD(G(V_)T=<[.))6SQ4[)G8PTSFHT'(71W77(C-/(FL5R3>V%*%2$=F$<DU(
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M SIF2WS1;VN3Y19&"ULXB"0(C#%4N(]$ @MM H*+N/(,[V.7V<%O8Q:4%H'
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M6S;&5MG#/5HM*OVDS615;+IMB/7:?=&?? BYFYC)^7';PFBV^ZJ+B?D0X_\
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MY=DEE%:F&64 B'O(XCX8@SF&(@CPQ$N?NF)B5^:R#.><\@RB$V%I' (2?V>
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MO-%#&W 0Y[E[]#K  #N)0YB&X!S$-$7B-[3C()<)KS1T4)<60QPRHS, #\K
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M1O\ -0SX3)&/E>(_I!WL8_9R3-3.&+02=L'2#QJ<2\/N.0.!%VZBB1A*8-C
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M[([)9ORW-F9+.RC)TQ'&3"6T@\VT3(:W<D\IDAS /<#7Y(LY:CEMEW)?J Y
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M<7EU^=Z(F92R8\DL.84K$=C+(Z^,I!]/T-FU+,3R+%-^8T$R*T6>NFYFPJJ
MJ1$KA--%59=,J(%,*<ISODX):>&J^YL48X+(<M7^B&@YVOUJ3I'#4WF;2G6G
M$(V&J,%P?(7,$QJSU1=JR%LDA-G53;LU%5D2KK'[@8O=1VU6-S5EL;?RE?B"
MZ*L&QK=%9$YEJ&%X;!N![)+R[_(<?<)>/K4.G$X\-C> 1G)I:<>.D@140!(5
MT'!V+A8C-5HL5UW,"D :BO1O$=$ ZI3K(*5&X<#55E9&%26?A3F@+C8)1L:2
MCH]*-/'$?+*O8X#23,$&HH.H]-1P"AB)F,63;RU7SK?1G:4D5<,T#HX,J</"
MO$M*\->$:#C5H]LR+Z5L58A!;-6-;GW5=\('<HI"F*4HLV3,V;IG.Y.NZ;-R
MI"H8I1=;GG,7L9;-J+KG9=#\E4(J^J4?AP)7)J?F:JP<J4Q(7+FT03!.5E:[
MX)!D>62?LHE1-X=JJS%<&[A)4#*)J$$&-.KS3J].NNKUZXU3HC/"- B"4CAH
M7>Y/C(*7I!$:S&.DYB,M#Q6.K;D7*;7N#$MCD4U(^,(^6:+O'J!FS<07((DD
MWW\I<9WX/>B]:@8YZ*;*5\7QG0\9\.EEO#="Q+'@8^I-!<JGJ$FA"68C)15L
M1%P>!D%TV\F@BHLHV%RBHJ'54(8N< \0PG=61J]=M]:%2,EB<&\Z2H-BD1YP
MC@L]C%ASWF1?ZG6YA@. 6K2/1B_J7B6;@.X,4*W/KH<,N'DUD(6462.6G1A#
ME429+G()#@CN4P&*'5-RZH[#ORT88#@%1$7^I]2RCEP-\%7"5;>#KACL]GX=
ML4SUBG<'8TDYN;DJA&K2,O(/ZG&.GL@_<F2$[AXY=F,JZ,8=S+G,<1'?G!#>
M9N!7 L<3?/"<M61C;;ON+8"4N-RE3YPG@L]C#AOWFQGZK588#@%CIG5S]U3S
MA'!9[&'#GO,B_P!3HPP' *:1Z,7]2><(X+/8PX<]YD7Y-_\ S/DY^YHPP' )
MI'HQ?U(/ 1P6!V\,.' V[=Z9%\O_ .'1A@. 32/1B_J3SA'!9[&'#GD^4R+[
M0[0_V'Q:,,!P":1PYQ>Z><(X+?8PX<]YD7^IT88#@$TCT8OZD\X1P6>/AAPV
M/NTR+_5:QC :0%;AM64)).[$GS)51X"N"P"CMPP8;[ #E2XO< $Q0W#^"\0#
MN(]NP#MSUJ:*K2V'SH>7O29R(JS//"]Q74-JR3T96.Z+BS(''=3<<U:"IE4C
M\]4$["O5Q@E'1+,[C!6/EG"C=LB4I"BY5,990=MQ,(\QT6TEX8=3CR6:LV^J
MOX8_JCRC^9VQ:EYV#SB6*E7JHFB)L&^^P;^7QZKFCEL'48,S!L+DU%4T1-$3
M1$T<XHFJ"10D;"RA -0#MFFIUUP'!5A@F@D[2>K7[4O>_&^5.":(FB)HB:(F
MB)HB:(FX=F_/R:(L68_ WA_*1@_V/S<B7F/8<(>+$WN#S#<.6P#[8:*3?5UU
M^D\IZ*IHB:(FX<N?;S#VP\H?:'[6L+8^-GDPX^ZQA!8!IX;TW#GS#EV^U[NM
MMH_=AOEIL6,(.E%+'S"XE#RCN.V^V^_(/'M]KG_8:8S=+'V]\=E4, _F .HL
M<9];:TY<@\@=OX!V'[0CL/D$=NT=:HX=*9G%B?4S*W0'1D T. WT$A>N(% .
MP1#L'Q=GB'L\>_(?;#68A$1FQ&[7[)%:L)"=6>[$R02@/:(\O<Y=GM>YI%"(
M3(2/4TAM7#F%FK.6.&"H8 -S 0Y"(#S\?8(#Y!]*("'M#Y!UA#'W?A+3'&OO
M/T6%J#;>(&FXTNG5@1YT03!V\^0AXMOXW9ON'C >7,-];8( "8\9^8-WKY*@
MFT'=@29R;Q>)/-SR52E  W[?;]KG^#D/VA\G+!80PL[U$MEUQ8AQU=0Q0'R
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M"8\UH7*BI!L] KVS;ZJ_AC^J/*/YG;%J7G8/.)8*5>JB:I! <A@;SUJ4!!)
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M:'NWFYBJTW$5YW:JG% '9A-RVUIRV'@7G)H#VCHN\(9$QW5L29.R3F?)-8I
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MN8&;AB1P6)BTLGA$(_=Q$O5_$.1#-.3LL)SG0V<+MA+86<I9<N.XF4-<5*W
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M[L5OWH9-N< 4[N8A!AH=6ZC&OE=BBS3Y_GA:]?-N'_W*YV#\(XSVU!&Q!(
M+GQ TU*&AV%5\_SPL^OBW_ OG/\ =GK;WT&O@M6B>A%_2@\?/"UZ^+?\"^<Q
M_!\C/3OH#>>'O)6&$@CV/K"RX^?ZX6@$!\W%O]*(&YX4SJ(>E'?F'R,^8#MM
MIWD)EI'_ +2MJUW\3>5\!9CS*^E8R_VYG5,I<,]XP':Y]/"><%EJ:Z5FU[/
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MZF6P,9"TM13,H= I=<C.$ [V&RAC\  CT@7$P7WR F3A4KCY! #9QBU.BQB
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ML$3&E_Z16;;K%]L/]3CS\7+R_8$B[[1H@T(9-NW0;)";K FW2*D0/%N)2%*
MF'M$=@'Q;!MHB@=FWU5_#']4>4?S.V+4O.P><2*5>JBX"4HB.X[#[H:C U .
MY9"U,(8$!M?U5.J3_E?A#1A@."O?'\0XGW7Z!V!MY-58DZ1>4\.":*)HB:(F
MB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB+KNVY'C55JJ90I%2D'K("4#
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J$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g729258g16k85.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g16k85.jpg
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M P$! 0$!           '" 4&"00#"@(!_\0 1!   @(" P  !0("!@4*!04
M! 4#!@('  $("1$2$Q05%A<A(B,W=Y>V&"5!5]@D)C$R,U%66+C6&4)VE-<X
MD9BUU?_$ !P! 0 !!0$!               ! @,$!08'"/_$ %P1  $$ @ $
M P0'! $." H+  $  @,$!1$&$A,A,4%1!Q0B815Q@9&AL? C,L'1%@@D-#5"
M4E15='65M>'Q,S9B=I2ST]1#5G.2D[2VTM76%R4F-T1%4W*"PN3_V@ , P$
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MCDZL,4V+L9.WBF.:QT$K87R2PRR&.5I]ZY+%D[$=E\4<4$-NFUD<':)S[<;
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MHVS:F=7<JNYV8PV;93;NDG(*=J+WMK3\VB;C=00G$YZ29BSU?+^U9@B5^:W
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M9&RW*]\DEB.-CVQQS.DD>\R1M:[F<X@]RKX@@'A#'^X(R2QI)8 &AA)!):
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M&E,!A.\:LEEKPLF/:XL27]1'=WA,:%)W)UW%$$=]&77U98YZ7+8^GE9:%*[
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M'#G]4>$F>./6794+V\(M?MF0N%6LN9Q+H(+"ON<C#*UB=G8Q!<5Q/9!*#!9
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MW'361L:7/>X^36M!)/D 2JB; JNUK90-25/6NP,-4W2TWJ':]L8DUXBP3BJ
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MFC0 !   &EL<35DI8^M!.6FR6NGN.8=L??MR/MWY&=AIDER:=[&@ -:X-
M"C=V\EPLNP+F/#&9WK2L=TFKA29=Q=LKO:(5-E;KNOH^KLJ-KEEK!(JEQRQE
MA:9/@<<.LI,^\L^],:.)VUH=-8Y[88?"3I=2K0B!WMKY;#K+2T?OB2!P/AK.
MRUMV,PDT\;1)8D9)9BA<3J>9G/5QM8:[B2Q<?+"&@;?U8='>M:G?;Y;M0$Z&
MUMKRBG[*S9NTZ2]DCDK1":UKQ>NS6,[?-T6Q!Z(>DM9!VH*R/HHEX"FN&8L4
MDJZ>:'F+MVUBW86A1IOR!DFBANN:YC7UZ#(S'):(=(WFF=*6RLC',Z9D5KE!
M,9(X7,9?)<-2<(8+"XF;.F>W6JY>1DD$<E'"PP&"?)O$D\7/;DL%EF*!HDDM
MQ5<F8VN= ]S+*F%BKQ"CSB8 P0AYRS"R9<(!A11HLIB"2)I.\8X8((<,Y99<
M\L<(X\<L\N^L>N^^=&UKGN:QC2YSW!K6M!+G.<=-:T#N220 !W)[!=\UKG.:
MUH+G.(:UH!)<XG0  [DDG0 [DK0=:AE3J3[BU&G%<[ 8]V<@0N+.$M4FD&@"
MJ2$@>7K[H)2JL"K/UH#J20>.U%6(L?OKH[/OO+NN:)&UHW!T5-G0:YI!;)('
M.=8F#AV>V2=TG2?H.-=L+7=V+)MN >V!A!CJLZ(<T@M>\.+IY0X=G-?,Y_3?
MH$PB)I_="D;F$L5.$3A$X1<GO8OP\[OZ<W3MK;JC8B^H3D^/,-+:<#$+F5L^
M]LG5OV-574MZLH]4;OZWJ0P+T'06KA716$[*Z/:2M)LZB42B5P-Z50<!K8V-
M@D>6@0=?;KS_ (E1W-X7]B.?3-6]*P[*U?K4EI<Z!+M+6RZ];#VG3^ZQJ_1!
ME(U[9ZUDSU]K3!Q=*ILDVQL9D):BH)K53-C6&%U8HW-6K/4Y-C1![^A^T;^K
M8'S[_6O/LKPC[.N-\]6[ -VCI.]Q>FM%7_0Y5".;;;U6O3"JZEKM#HNZ9VI)
MAL4>.%-94.TKX_H2C7P&*LW=]RKA=YV0F'4R!$V.W8]COR)W]P^0\?+:R2[P
MKLG:%A9+=W4+5F,@GJWS-N)C?B6,UT:K=3ZE\H>?D;FB:,M9]-56 8JQ^C-(
MF5^YRMEVN)"]572WN1\)73H=3.38&M$^!'IW)/<_9H_6->6UJ6N_ /M.@U]9
M2:+NFL:1UTKV#9+3!7-:WV&*X-@7%I\>P?D['V)4?-6IA-LV6>AZ[]3AQV*T
M44>UPD7S60-EMEU-%9VBLE/,/'6SX=_#^Z^>QY:UX=_J,:JM)_$NL.Q=IZ%W
M(5?[]J*[Z\H&B)]GA[+$ZH^&MK&O\T*-Y7)@J:3UTMU<#J8-Z,7:_LR&O0[#
M'O;6S$['AGKS74Q:4GPZ!';N>W??R]?EO9^KS7UNWFSXCNC+1"@U<\/N>F;[
M['V;MW!!I._,*.VU]J.^[[V]M"36DX9:FLJQ7+5;L(-P3<F#-C4263*P4FUP
M"J=8:GLUI*=M=K>P0T#?CW  W^'8=_O/:3G7B_V=?,-)W@.QU.I&V#:R_P!3
M;QUW;=DO4/=:W%/ONJ[54(FP%#HUZ2;=RUQJ*MT_0M;EGN=;65?O6P#Q(TL$
M;XDJ$J=@$_5H$#?EHGN01OQ^TA:.Y\W_ !,1JG)0]K7Z';U,N6E?69FVM?T6
MWV*V5YQVJUXY4Z)TO6[;MF)1;I6>U+ONJPR66:S,&<&55TW54I]IC5P88XDV
MWYCN->._F3W_ "]?N[CZ\4OT% HR*UL_UNTI:?65-E<_7G+^KOUJ4(-RS^Y+
MUU))^>QA)*^N3KK//[OU9]=9=]]<*D^)UX>2W#A$X1.$3A%P[^'9J1L#Z<O>
MXDWGYU3Z8U2>FT5FW 7N[^(VG7EU9;ZUXHJJ;R;3X?0NSS:A2W5'U3+%ND>X
MZTUPV26O76NZC5@J_7DQ-.7E43VUOT[:T>P(^+L._H 2 -^?<]Q.%2G"*(//
M?]@>C_[H-:?Y+2\(I?X1.$3A$X1.$3A%3SWULJ_ZE\D[ANFL*;^_KI$I35Y;
M5NE3IUF>)=+.EISLB%;7I(FI$ZM&]8MH.X,NXH90L)R\) XYX\N;XOO7,=P[
MDK5"K[Y:$<4,=<1RRE[;4\5:5P9"1(XQPROD'+V!8'.!:"#[A_4X<*\-<:>V
MG@? \79W^C>!DNWLG:S!N4*#:TV!Q&0SM"-]K)L?3CCN9#'5:<@D'/(RPZ.%
MS9W1N$0>-?2N_P"_^:]7V*Z>2]DPV+I6R1%85]EK"J*\AJJ]:5A7-"AVAMBO
MW8*>=6H#F.R;* X2C9""U6,BB<&:37<,YO,7,)0GM</76S<DD3A"^C7CY:\T
MD$9$5_(0VFDQQM+^I&P.<2Z,&,L)[;VZ>RKV;\-^U7B[%X#VS<*R8SWNKD(7
M9.KQ;F+@FS&.IY>XQ^1X1X,R> L1QV[T[*XI79WPUVQ07"V['88V;?,[QO8;
M[ZV9O:<\H;.;>]3ZGK5B.J[)J%A%YE\_002SETZP6=#)B9%%B5#B*X(DCAFC
MP)P@)ZE@C]/R$LDV&X1?+6EJ2'"7>:"9T#Y&:XGXA )=6FGA/, '#ED) (#@
M'; ^8<ACZ6,R^7J8_-X_B*I':K&/*XNOEZM.P7XK'22-C@SF-Q.288'O,,AF
MHQ-=)&YT3I(BR1UM>:58Z<(G")PB<(G")PB<(G")PB<(G")PB<(OSU?&2U\-
MUMO5N\[!0AMATO6VB-F+;)%?/)GI?TMJBAJ"K17;4^O1C?1.W-3J=;MQ%E5Q
MP?'V4\R)A6A(S#L8!$89(\'U\QX=M_EW5;#X_9X%H/W.\?L&_5=_J]E'F@1Y
M0]0=0Y)UF470T,@XW4>04'>'0\$TY4T,'6/?7VH922)(X_IPSGFRQ[DRE4++
M\(M?MF8L56LLAICE<%'7W.9;"N1ERV$$7!<3D08AB7C&GRN1HNLYE<8099>9
MV$&(PT\W>$69%R"^"*6@.T7ZK,JMGVC=*X3\0#TE,EMF[ K(NVW85V8]"R&:
M[$!N"&K6D2UEQ]]2MX'U=2M(R>\\2UPTG7<?15O[$;U^Z/#P\_3LNSO"H3A$
MX1.$3A$X1.$3A$X15_C_ .<UBS'_ .TPM>R#3I^L_G^6)2M(S J\H,)._P"I
MR#GVBO#F_$^6?<ZJX,,NL/JRGDBT8_KB?E\19R#WNW^\RIAW,C(!\"QV1C8>
M7N3';>=?O$<:/Z_O%G[PR.;EF>'?\)%BN%'Q5RQKC\)B?Q!%$_I_$7ULG,0
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M*&FBP(LSPB<(G"+'MFRM"J9O7C(!,D2KS6SAPU+'7K%2M<-(8P9,CRY(A0@
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MPNZ=&LYGT9%D[$DEFDS"6!BV0NL,RB[2Z=U0FURHZG'KR6NM#Q!QL$:.*/\
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M:NBV);"DZ[:]._U[/\->OV'L+3\*$X155\O7[T3>I]_X^AM6DZNDK.]VR34
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M"/#'+//+K'KOOJ0"XAK07.<0&M ))).@ !W))[ #N2I +B&M!+B0  "223H
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M,E)=SM!Z1Q!K#/S])21; H.9D .@U&7F/4WU"'02CL,5SN-E&7'9'&!1-G]
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:H3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g729258g19w26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g19w26.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1J24&AO=&]S:&]P(#,N,  X0DE-! 0
M    &G:^9W0X0DE-! 0      $0< 5H  QLE1QP"   "   < E  "')R-C X
M,#0R' (% "--:6-R;W-O9G0@4&]W97)0;VEN=" M($Y%5U]'4D%02$E#4SA"
M24T$)0      $!O0SGM=5459J3!V<46O.T\X0DE-!#H      .4    0
M 0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N
M=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP
M"W!R:6YT97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M    # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P
M 0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"
M24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M%P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#
M<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O
M;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M      !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B
M0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M              !";&0@56YT1B-2;'0               !2<VQT56YT1B-0
M>&Q 8=)6          IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5
M;G1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R
M;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M    #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ .__C4
M @ ! [_^-0 "  $X0DE-!"8       X             /X   #A"24T$#0
M    !    '@X0DE-!!D       0    >.$))30/S       )           !
M #A"24TG$       "@ !          $X0DE- _0      !( -0    $ +0
M  8       $X0DE- _<      !P  /____________________________\#
MZ   .$))300(       0     0   D    )      #A"24T$'@      !
M   X0DE-!!H      S4    &              $J   #@P         !
M                      $              X,   $J
M      $                         $     $       !N=6QL     @
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M      !,969T;&]N9P          0G1O;6QO;F<   $J     %)G:'1L;VYG
M   #@P    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I
M9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4
M>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG   !*@    !29VAT;&]N9P   X,    #=7)L5$58
M5     $       !N=6QL5$585     $       !-<V=E5$585     $
M  9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (
M8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E
M2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI
M8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    1
M15-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M      IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M       +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M       X0DE-!!$       $! #A"24T$%       !     (X0DE-! P
M$)T    !    H    #4   '@  !C8   $($ &  !_]C_[0 ,061O8F5?0TT
M ?_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3
M$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+
M#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,
M# P,# P,# P,# P,# P,#/_  !$( #4 H ,!(@ "$0$#$0'_W0 $  K_Q $_
M   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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MM\?_V@ , P$  A$#$0 _ /2:^HXGJOQS^B-=PQ:P8A[_ $V9'Z+;N]OIV?\
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M3OW%MYQW,+F.J:]KV#=]"VT
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M_4;_ )@CC\_,4C;](IC9"AMF$JS9Q5<95^>9$J*K%W-2%B:/*N>(<(VY4ML
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MEM6V]B&,-!JHN[C,@9NDTVB..8QVLY2X]JY1'P)LUO8A^SP%7E!$1']7]?,
M^G9_D)=2/Z <T_LRPY,?[9/W&+Y$3%^! "F^OD0'Y\>/CQ\_/P'@?H/.@KI
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MCF,=K+YQW5Q_6&:7H/YO^;$I\A\#\A\^/Y^8!].WQ_@)]2/'T_<!S3QY\_\
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M"QY'I;&_SP:/5Z.&=100"A4IDT=8 %S9_MBJN#E8Q/AP3[H<IA]RZ7)+]49
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MQ3?I'3#G5Z=8^>B/48?'CS@&9CX'ZAYK# ? _P WTYJO?EEO\ NDG^<FP?\
M<Z#S0J']Y_47^[GZ3]Z']?\ M'FX'^1T?Y7_ &D_H*@/[9#SZ'X_("'[>?.N
MHBKI"U]LU&+0'SLG<CM"=NT%R5H"ZO[J$N )F<&(H5(!\B(B)# /CV^/GF(+
MQBSV^[%G6PR^:QIIK/F[M%LV_.F,,C)^%E'<2H\(6. HFC'SET\0^T X_:J"
M)C?HEYF+17LR]QO4SS<*G"N"Y[=RD;IR3>4 Y0K4I^F*Z"20 8?/@0]O@? ?
M <W4O2M$/^#;Z+AX^?\ !7Q4?/\ )^8T1\<JO_*;U7(]1,%CTGT@S:R_:&C1
MTF2.D'L:=ZP6C)H56BZS!PW6.W5$I1.F*GM-[0\AY !YJ>&R>D&\@9A)F*/G
MW$&S6<2&\^?=^B,S\ 81^G[WVB8H@(#\<3H^1T)&OD^[Q#MJ4\G.B8C2?L+4
MAA3G)% ASD;RJ1#J DDF0RHE]YP( F$1Y:5Z+$,VJWJPXC$P+J79QDOD&TKR
M;!6<FG[-XLQB(_[FJLVD'[E$QVXK*&3,)/@3>0\"'GF_<0H$+[2AX !'X_K'
MSX_8'[ #X /@.=?/6R$S$1*D<E*2D=&JS#\D5$IOWK9HI)RBC5T])'1Y'"B9
MGCX[-B]=E:-P47,V9NEP3%)!4Q.EE-PTD]E8Z.EHU_(03I)C-L6;YJY>0[U9
MDTD46DFV15.LP<JQ[YD^30=$25.T>-7)2BBND<_M..=E 1%(!$?=\G^GZ_!A
M#P " >/IX /I^P1#P/-333W%)VSU/\_[*:;E_:W#4Z7J_6&#1/EE1Z68K,5_
M1;I3\R)7\S[F;S']F;#L&F,E)*R0\0YRYC6F*;J =1%7J[6TLRQ4I+W<^I9V
M#Q[K!D-#V?;>M5F[%U6D:I"3L:>MR6&P8Y/:&$5,FAM$D9[>M7R&KQ34!5<5
MHAX^PO9)ZK/%CUHIQ&.GQT\-^E5O\CVRF>V_9>'P*-Q'&--T++6F,/3+XS*6
MZ_Q5*R>&K5PE;A9,+T_5J1/+PUR;R<7 JH6%-TQ@!9,W+1)PFL0EOG'(D=]_
M\BKM-_09HW]FW_/-ZO?Y&>"_Z-^<?[M8CGQO]Y_QZ[5_2QHG]KYGF)!_?_UE
M_NY]5C\FL_BBNOO_ *WOW]IU>5L=GG?W'U=^_P \^[.7@M,IZON?NK),5GK@
MJ%.LR@)-$@ ?>N<X 4A!\%'SY^O(29%>9@.VO8(Z_6RR5,)-E14G&F)('67L
M235FHWABN6AF35- A457S]\*3MRNW $@$BYCE$EM/HD" ^H'ZD@AX !I'7 0
M\_0 _"K"("/S]/YO_P ^3J]7WU(ZQT2I>8T.U8U?-H:]IV^F9^6+SVVMJ5.Q
M;"(@(\9=PWG14;/X]XZC[ H1@]C'*#MFLV*Y1725 #\UZL-]8W*^JU0RS(<#
M]/\ [$4_.:*^T"0AX2?V:/ODPV=W1D /#1,M;9"8=-T6CLRT@BR66,S34,<"
M( )S^9,>BWZF=4S_ &>C]%6F2]G1'LEIFCWJ)OV[7B@VE6O3PUJ9O%K0:DK,
M=%N#,)AU%*.3D.5P*+IY[D033$2\W$T5!.)@$1\E OD! OD!, B'D0^!$0\"
M'@ #Q]?GSR-7;CM9B73+&9?=>P#^7C<ZKLK!,GKJ#JTK<)%*2EI-!E$'0AH=
MJ[>&$CTZ:GWH$RD:^S[8RI!*41SA2;17KY5Z]?JS]HK#W&!AYZ+>.H]:-D',
M3),TY"-!ZT>(HOFJI&[SW&9O$R+-%%%4SIIJ>\.<KYT&43(9,ACD*=43%2(8
MQ0,H8I1.8$RB("<2D*8Y@* B!0$P^  1YTBX0*FLJ9=$$F_VGVZ@J$!-#[(O
MO5^V.)O:E]F7])3WB7V%^3> ^>=WCFK]ZRNATG4=PQ^M4'L?5NN=ZR9_88^2
MV^\S.U6.!H%PKTW7W[J&CNKD;B6AY=L=B0CIMM(M+?8)BFK1:3I-C!W1MX<)
M'N:[95/,]1Z":'4=ZCM6W#.+GCE=87H<#SR=L6M7E.13@#)VK.LWJT--3!IT
M\R9G;64*S@9)"(2;J&>QR\<Q=(C5MT!S_K T]0FNVWJ'Z?78WJG0X;JEJT!H
MFAZ]UFV/KG!V&VS>CY&ZK-?31TBMQT99I52+@YR0;&B7S=6.2(_+]P.BX]R.
MPG9;36:9#.K%;[#!U6 8BB#V<L<JQA8AH+A9-LW!S(R2[9F@*[A5)!$%%BBJ
MLHFDF!CG*4>)2FS9!!O[7%36J9U$2E$@&]JN\=)W6N,7]/K#H""UL5G:.I))
MQ PC@%$Q0E)1-JQ5^T3]BYO>3SY$1KF56"=A:Q Z709JR62KI7>NU^)M]?D9
MJ=IJYBD1MD/%M)!9[)5M4YRE3FV:"T:<Q@ KD1'GN+U_ NV!^L:U/  ?M'\)
M>?\ 8'U$?H ?(B <KZ]'[^+IZR?YC?\ XK(\^8!ZO/\ &C>H'_I;;E_O G.5
MVC_[/]O]_/H^?D@'\7ELW^E%9?\ =_0.8;]:G^-FR;_0[D_]XI>0[/\ O4__
M $?[^2H](/Y]7H?/_P!"F]_[T:+RRG\I+*(=,,,$?H/=C"?'S^R-OPC_ +0Y
M127Z%_F#F%M?#Q:>K@#\"';_  7^H1L:H?W\^BM[RD3]YA\%#]?R/U'P'@ \
MB(B/P   B/ZN>KG%"#"3'@P#XC'_ )#Y\_\ Q14WT\>?'M^?/T\?KYBGK<JG
M_@^XH/O#Q^Y50C^?/Q[1K,9X-Y^GC^7Z>>9L*<I_/M'SX^OU^!_9\A]?VA]0
M_7SJXXXYJ(>J_A\IFO=VU;CF'IJXCN<1:#]?7.A:9JF/=J]PF-(T"?-JQXAE
M1H/*;Q YQ%JP:U&A*C/ELD;*,4IRZT1];$X.M&1>O[I_5@IQ;[UAS>O-5\S4
MN+CL_P!9'6=9EL\+8IC(=JT)GI$2XKV*:1%U6%LTPE5+@H5PF[D"P,RPK[F.
M:3<NQ<Q4:\*.#/3KS[1JAW4[02VW9OUGZP:M.]>NO?LZM]5'<[,TA2C-+QM*
M49N5TM+S.\XK=BOEAG23E'3;UN*=O*[5ZM#H6.1<#+0K=E=WQS&6U '[CNL#
M^L,UO7CX ?'_ #8E/GY#^0/Y/Y.8 ].S_(2ZD?T YI^P/_DRP_9X#FJ[^66_
MP"Z2?YR;!_W.@\T*A_>?U%_NY^D_>A_7_M'FX'^1T?Y7_:3^@J _MD//H?\
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MT<V&/0&08F$%FYVHN(LL6PE49-W#M94\_N.=E WN((@/D/><"_3S[0,/CSX
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M[S^HO]W/TG[T/Z_]H\W _P CH_RO^TG]!4!_;(>?0_Y\[C-OX<=K/],OL_\
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MY$COO_D5=IOZ#-&_LV_YYO5X _P-,%'P'G_!OSCY_P#]:Q ?[/CGQO\ >?\
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M&C^H$ ?K[;;G_P!F@3@\KM'^7^3_ &_'_;SZ//Y(&<">GCLH^//GM%9O]W]
MYA[UJ?XV7)A_4/3N3_WB$'^_D.CCY @?L+_MY*CT@Q\>KWX\?7I3>_G^;4:+
MRRC\I,5 W2["OC_]MG"OD1^/F,OGSRBL@_!1\?J ?'^KXYAC7_T[7U<_5[NX
M&"?VD4YO?]QC>.IW8PGC_P"9;10\_P U7DA^G/FX8!_B8SC_ #99?_\ 2G.;
MWC^!MI_]02O_ ');F][Z-/\ %<])/Z#X#_ODCRS3CCCFJQ?O0^[:V/N#:NP(
M2W0K1Z-8]QUO49VM;5 ]I9J8U:-O>@Q=KS<NWPU7TN$H5YG>O%?8/:IB[12&
M3J]<83LJ:1BIIS]Q>,MJ-$@II)$$$RB1,A!*D E2*)2@ @F41$2I@(>" (B(
M%\ (\[G,92VU9!!:77L9FM.H<3K=MBUYNL9K(VJ%9WBP1#8'AEY&(K*[PDN_
M:$+'2!_MF[50AB1[XY!,5FX%/\@MJR&T:/:\?K>G42>U6B,&\I<\YB+3#2%T
MJT:[^Y @^G:XU>*RL8U.:2CBBNZ:I)D._9$4,0[M JG5M/\ B<UC^C6]?V8E
M.1_].S_(2ZD?T YG_9EAS5=_++?X!=)/\Y-@_P"YT'FA4/[S^HO]W/TG[T/Z
M_P#:/-P/\CH_RO\ M)_05 ?VR'GT/^?.XS;^'':S_3+[/_[T)?F5^8ZV#_%+
MJ/\ 1U=O[-2?-SCTK?XMSHO_ **V*_/_ /@\1_5RJW\IL^.J77,?V=KJ"(>?
MIY",FA#X_D$ $/V"'QS6&_F\!\>!\? B'D1^?V_(C]>?@  !X    $1
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M#*1?U67D(YN[D*X^D(E=:,?NH5VNM'.73!99BY6;G5;G41,0P\I  * %*
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M")A'P'R(B(C]1$1YU<<<<<<<<C_V.W^#P#,;];4F3"[Z-7LRT70,^Q5I:(.
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MGC5"K6;T*$,Y4C*Q58U&,C$%WJYW+UVH1,!5=OWK@YUGC]XJX>NE!]ZZZ@@
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M3>A7Z+AF-6KLKL.@!JEIH><0Z-;R?/)A2GU:G(5+.X1$A%G#1E%51@XL]VF
M_.73+HZL-]GD8]W/!#QLYN.........<7N])J.DT^T9]?ZW#7&CW6!E*O;:I
M8H]M*P5BKTVS6CY:'EHUVFJV>L'[)=9NY;K)F(HFH8!#Z#R&?57H96>L%XL]
MX4U?2]B?_F;#8]D9=.=14F[QOK_6;!+6ZKY'%3C9BA-W!" L,_)ILK?<GLG9
MCUEA5:^X=*G@7$I,3ID'J,:P>R+@%3-V#1R]7*@D==<R+5$ZZH(H)@91942)
MF!-),HG4/[2$ 3& .5KT;U7^K-LJ=OM<V]LU 2JS)*R,F-ECF<@:YT!1.G+N
M+O3)>H/[)7)]"MIW>);7ZKLIA2ZY]+-I2+ME>C56B:CCGO7WK/U>LUY3[F5.
MEY=>K-<96Q7;$]</G",=I-(IFCPL6E::NC:)PAK*W:.YU&P+IPI6==1KS.5<
MP)H@CHD@Y=SVY&3N/J6RXMUMU#3L!R[]V+4JE$,Y"!HP(/)%1TT-+,&U@FT:
M]&/XF8N*U4KR\G9TZ1!R\1.W$T2%<A9-G)R+58M$O5W'.Z/?K+L8T?2[WE%_
MZ^ZUK=FWY#4G,]>6W8#JG:*;HMG@W,5UA"5?V22A*=LU<C8T&^7ZO89Q;"V<
MY?\ +KU%Z%6185%ELH5&F5&@PB%:I%7KU0K[9=VZ1A:O"1=>B2.Y!RJ]D7A(
MR':,F!'4@]67>OETVY#NG:RKA83*J&,/MY1=\VC)%S&,2R<DW8NUX^-.Z(Q)
M(/DFZBC1B9ZJ11-H5VN5-N9THF<C<%!5.0Q2"4=77+]#]2+U!+MVT;2E3P-H
MO12U'K#N'1_L"AH\+CK2OWJ/M<W+2DE77-EMT^^TO'7,K"SL1V!SEO4\Y[39
M[*# 0$/5[%2(2=KVP?UGZX4[K7F-4I$*5&?M,75*]7+;IDFP9'O-]-7D7"<:
MK:[.*!K#94H8CQS'P+BTRT[.-XL$BRDU+RJLA*OLZSDY#5F$F+)8I1A!U^OQ
M<A.3LU*ND6,7#PT2T6?R<I)/7)TV[-A'LFZ[MXZ74(BW;HJ+*G*0AC!K<^IW
MW HW;?![_AF1;\3.ZSK%*^_]8>PV8R+7:<([/6*1K[N$NG6/2XRDUNSVVC:H
M#B4!_0ZL@R-:',HTA[M EF'54GZ8>T'J1U,O,')4;L-VCL$?<>Q4=5)YM$,8
M6EUG.(3.W&FLZRYT=6;K]!L,Y2;KK$PXKT;7+!J[+[D,M6H2.CXR)B4EY49&
MQGCCCCCCCCCCG;!%(JIURI)E64(FFHL!"@JHFD)Q2(=0 ]YR)BJH*93")2"H
M<2@ G-YX];KI3J!".;-?+96:36V9TDW=@MT]%UN$:J+G!- CF6F73)@@=900
M32*JX*90X@4@&,/CD8.\>2*[_P!9M!I58M%_@;DQBX[3*'+8W?)F@Z<$]0Y!
MM9XG\R+95WC68C7\Z+(]?:NFZQF#L9@&4BF[C73IHOC;J1T?_<@F4=?W71'W
M9[L(WA4*K4=VU+-<UK&RUW,@:(N&%+M<]0X:.2M=@C))[8 -9Y Z[]JQEWL1
M'*-F[Z;5F;#>0/[3]SI;K=J^+YTPQZR:0AIP/WCD:\:1-9Y1C&2+-E-Q.6PR
M$,\B;O>:G$NU;]8:9*V*J2CRAQ<I(U(++(L7T>QX14.R_7[NQK\)E,%'Z*VE
M,O\ S+["4ZSR-"1:5FVT^PYY!.6I3+VN,?+1R<@&E2%=D&;Z#CWB<S5+"QB)
M=G:JM)$A+%(6$AJW$1M?KL3&0,##,F\;#PD*P:Q<3%1S-(J#1A&QS%)!FQ9-
M42$2;M6R*2"*92D3(4I0 /9\H-N_I1V/0_41TW2-DD[%L_5W>,OTYU^<9[J\
M@M2QO39.1S!6E4U9R,RW04SW*S4QS<^KT[G5>B+OE.AS%I?S\S)HNVTBXN5P
MW$*%UYS6 R[.VTL$)"$77>3-FFY&TW.WV"17.]G[G>K=,K.9JVW.T2BSF7L=
MBEG*SV2D72RQS$3^S13R[S65[+^I1=MG["VSJY6.N-_LTU1=!U# ]<Z@:;6*
MQ><?[39+*R$/$M;2?0J>SL,IU[U-VS%A:L9/LB$#E.@U.=E6*$X_EE6\O6;'
M/3)]-').B>7Q;ICGT%7]>GVTDZL"K.9-:3TV-GI1S/(9XWM"497&5W5J"D@Z
M@R:;(U5A>+5&II)V27F3IF?.[3N............>AL]HKM*K\O:[9-1U>KD"
MQ7D9B9EG23-@P9-R"=5=PNJ8I2@ ![2$#W**J&(DD0ZIR$-1+W4G\$[:6O)+
M;UFO=)VG8;?ET9;X'#)+5+-FU7[-9E'5N_W//E*?.PSJ'FF.IYXE8M&MN:W.
MG.U5*?9G2T'HK9@SF(F5KUBO5CIS7,+L[[9@O^NVS0])S&B0&@HZ!+HIL9*Q
MQ<'7OQZWOZRV!R+&W6*<BG<_,(/)R>;PE@L=S-!+MB6:9.^G'QQR$?;SH=CO
M;Z4R*[6DJ]2UO"[_ $Z\YQJ4%&Q,A--&E7N,'<7]#L<5-MGD'<<_LS^!8N']
M8L;)\QCIYE#6Z&(QLD''/TIIMV;1H9R9HU;-3/')WCLS=!)$SIVH1--1TY%,
MI17<G3223.NK[E3$23*)A*0H!Y/'*X/55Z>S7='J%;L_H49!RFT4>:@=9PUM
M9I&2BZZ[TJEN3K-(2<>1<U773:/M,"[G:P$@G.1*\$^EV5C8RD9(P[.0;<@Z
M<>GED?4MTYORLU;]O[!3M6@:C9>QFVFK%FVR3J\)&,&K6J/KO$0$/(2L6V<M
M#*@_FUYJS/&A(N&E;+*PE:K#*(G_ ,<<<<<<<<<<<<K+[7^I;3.K^_4GKZIG
M5BNUELU<B)R:D(Y\W1+6C:$M<ZYD"Z=8CFT[?;36[1HU+7HEOL]2J4S'Y[(V
M.HGE2O'$Z@P)PSK'U,E9;8KGM.E9C/Y+%2LCKT;=^LM]5I=[RR4OFD)5=P^V
MK)5Z7,.*>R;VBKN;#0;F=U7F#R[LTTYNQUFO7M[>)*U6IPD)#5J(C:_7HJ.@
MX*'9H1\3#Q+-O'QD:P:D!)LS8L6J:39JU03*4B2""9$TR@!2E  Y[3CGI8&M
MUZJL#Q=8@H>NQBC^3E3QT'&LXIB>3FI!S+3$@9JQ100,]E91X[D9%T*?V[U\
MY<.W!U%UE#F]UQSTK6MUYC.RUG904.TLD\SBXZ<GVT:S0FIAA!F?&AF4I)I(
ME>OVL2:3D1CD'2RJ3(7SO[N5/[PK[O=<\.0CV,LP?14FT;OXV39N8^08NTB+
MM'K%ZB=L[:.4%2F36;N6ZBB*R2A3$43.8ARB4PARK?H7Z4N%=*96U75*)8W3
M5'=PMC6IZ.Y?6,DBPQA)U',,@H<U7U),M1>S67TF&AZI'VA.!-,* UD9DLG^
M+66QNI&U3CCCCCCCCCCCCE4??C2^I^ZX?:J$[[&T6MW&EZH\IE>D6]LKPQ\)
MM3#.7[^1I%UC9>081,[#R^7WJ21GZHH_9S$_"6 K:BR+._&K3UGP?J/TELDX
MGEVHZE9]SR"WX)K>@(U3'X/9+3?,Q&CIK5QO#5Z&O%T&1MVAY!+O863N]"7D
MGS!W$U?1IO.I%D5C%H,HZY3F%NQ6PI]?L0TO:5ZK8KHTS:LNK0_KM4C7LS/.
MXUBJC^).F43&MW<G(IQ#!1Q,OF<6S>RB\?'NDXYD[>B@W4J'S.Y=C/5"QS/_
M -UK"\J6PY>Q*U'4IVC:C9JO*'NE>D;-$AO_ %?MB4?-)7&AM"NZA=Z&\>S&
M>7BJSD-+P[E:S.Q=1J-UF<TIMG=$IE';//Q0E.JL#5B2YXJ$A%Y-.#CD& /E
M8JN1\5!1IWAT3.U&$/&L(MLJL=-DS;H 1,O->....8JK6*9M4-7TS;*Y74XK
M1MAA*# Z+--G3PJ-E:9DG9$*>Y>1@KC'!*1S*TR4<I*IMB/W<<E&LG*ZC>-:
M$3RKQQQQQQQQQQQQQS"_83#*GV1R&WXY=)*T0<-:T(Y1"R4B>=UBY56?@9=A
M8JO:ZK/,A^WC+!6K%%1DW%.1(L@#MBD1TW<-CJH*< ZS]/<8ZMYA YG2*^SE
MTX:VV;0E[/8(B!-.R-_N$U,3L_;4D8N+CH:O/G#F<?LF+.K1<+%Q$,9*&C&;
M:/2! 93\<<<<<<<<<<<<<<<<<<<<<<X3-YKG=EMM6OMAHM1G+O1R/TJ;;Y:O
M14A9:LE*D(223K\VZ:JR42F_*FF#M-BY0(N*9#* 8Q"B'-N.............
M.........=*A"*D.FH4#$4(8ARCY\&(<!*8H^/ ^! 1#X$!Y7%UD],'K[UIL
M6F6%!S8]8-HE5:YFG':J6#GX^#QZ)EW<M6LS=-&\4R:7=A54G+:N0=HO;:P7
M1"FP5:JKB?<Q4&S2"Q=HT:L&C5BQ;HM&3)NBT9M6Z946[9JV3*BW;H)$ I$D
M44B$323( %(0I2E    YY''.A---(A4TB$23( %(FF4I"$*'T*4A0 I0#]0
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MRV]W QQX1_;)%U)R<TYX'V/]#B(VK1NPFE5O4LRKDOV&V+2]&GF-NZ_HW-C
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M:I1H*F=H("/Z^?@TU7LZT2VR;G0^NLQ9IF2/<*]/.%%H2-3DI&K3;<&DED'
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M!;SA[?\ :3M]5ZOUAO/3_";1?(7L'-O\LGX"\XOHZ%UQFWW\L(?*M<UBJ"O
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M;PE'B86-:M<6.V1=TR<T,R%<SYU)2KTK$>$9GHGJ=J;=C,>=QWC#*EMPI"V
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B .J:C_LG><XXXY&1;_+)8?Z-$E_O0C.2;XXXXXXXXY__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g729258g20r95.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g20r95.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[21:4&AO=&]S:&]P(#,N,  X0DE-! 0
M     &$< 5H  QLE1QP!6@ #&R5'' (   (  !P"4  (<G(R-C<X.30< @4
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M=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U '
M  IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN4')O;V8
M   )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2<')I;G1/
M=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O;VP
M %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB;'-B
M;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L
M  !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M         $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M  !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M      !2<VQT56YT1B-0>&Q ;*JGX         IV96-T;W)$871A8F]O; $
M    4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M             %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R
M8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C
M=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R
M;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"
M24T#[0      $ /      0 ! \     !  $X0DE-!"8       X
M    /X   #A"24T#\@      "@  ________   X0DE-! T       0   !X
M.$))3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M      H  0         ".$))30/U      !( "]F9@ ! &QF9@ &       !
M "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4    ! "T
M   &       !.$))30/X      !P  #_____________________________
M ^@     _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@  #A"
M24T$"       $     $   )    "0      X0DE-!!X       0     .$))
M300:      ,U    !@             !"0   ?D          0
M               !              'Y   !"0                     !
M                         !     !        ;G5L;     (    &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG   !"0    !29VAT;&]N9P   ?D
M   &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S
M;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N
M=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N
M=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M    4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
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M;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M"W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M.$))3001       ! 0 X0DE-!!0       0    &.$))300,     !FT
M 0   *    !4   !X   G8   !F8 !@  ?_8_^(,6$E#0U]04D]&24Q%  $!
M   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0
M    245#('-21T(               $  /;6  $     TRU(4" @
M                                                       18W!R
M=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4
M<EA96@   A@    49UA96@   BP    48EA96@   D     49&UN9    E0
M  !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0
M _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U12
M0P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y
M.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@
M245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M
M %A96B        #S40 !     1;,6%E:(                     !865H@
M        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M             !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                            9&5S8P         N
M245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@
M<W!A8V4@+2!S4D="                             &1E<V,
M+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M             "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#
M-C$Y-C8M,BXQ                                  !V:65W       3
MI/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?
MYVUE87,          0                        */     G-I9R
M0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M #( -P [ $
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M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !4 * # 2(  A$! Q$!_]T
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MDE*22224I))))3__T?54DDDE*20,G-Q<1H=D6-K!X!Y/]5H]SE6_;W2?]/\
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M%\K))*?_V3A"24T$(0      50    $!    #P!! &0 ;P!B &4 ( !0 &@
M;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E "  4 !H &\ = !O ', : !O
M '  ( !# %, -@    $ .$))300B      %&34T *@    @ " $2  ,    !
M  $   $:  4    !    ;@$;  4    !    =@$H  ,    !  (   $Q  (
M   >    ?@$R  (    4    G $[  (    )    L(=I  0    !    O
M .@ (OY2   G$  B_E(  "<0061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W
M<RD ,C Q.3HP-3HP." Q-3HP-3HQ-@!R<C(V-S@Y-        Z !  ,    !
M__\  * "  0    !   !^: #  0    !   !"0         & 0,  P    $
M!@   1H !0    $   $V 1L !0    $   $^ 2@  P    $  @   @$ !
M  $   %& @( !     $              $@    !    2     $X0DE- _T
M      @          /_A 4A-30 J    "  ( 1(  P    $      1H !0
M  $   !N 1L !0    $   !V 2@  P    $  @   3$  @   !X   !^ 3(
M @   !0   "< 3L  @    D   "PAVD !     $   "\    Z    \     !
M   #P     %!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$Y.C U
M.C X(#$U.C U.C$V ')R,C8W.#DT       #H $  P    '__P  H ( !
M  $   'YH , !     $   $)          8! P #     0 &   !&@ %
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M<V#5FY5:'&(V*T;.I-P E:'50"W,K$0[<Z)FRK9!5(P[SZC^R'I#J,//B_\
MN_D7TW*R0&S=G4-^+CV9(QY?3>E>W/(,&#%2*P-GG[B'2S?CQ[(VY]_@Z\2?
M7_W ^"-"K('$[JR\/.6014)"7I/6FRY$$T?NRV>JTKLTX?'#M[2O3!US5RT&
M4, ^V0B9,\JJGV.M%-3"*9>>^J/LNZLZ7,LTUD<CCH]G[QQH>XA5!^]/"%]1
M;:'YFDC[2GP)6^:D]KD[2Z "R!'/\.0@-O7P#\'_  ._Y>:DQ 0$ $![@/U
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M-L0-RN6TO9D]MX_+C!Z=W^1D)3D4Q\DI_J^H>I<Y<[_H8M%U9Y%]BG?#.H$
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M2;.0.H)21[T6_P _T29W_P WZ;^=#^D+GR=Z '[!Y))50!Y+21*-F:(/;O\
M;KTU'LM@>K@%V3_1=IX #,2?Z2\*%21F)T%6*9CH0RE/;_V\M8AW\J#N(@E\
MO(IZE%$,3P!;S Y360#%,F9J\34*8 %-5B_2. *,794?0^R+/'1&7Z:(.M:R
M4YWOCQ(U8^0P>,J1^9986'B:,M0;[?.EU.FZ?ZR!&]@XBU!!'/D"/O'8*F*9
M6!_*T%PIT;>8)W^E<H([8@NOL?J'=$LDR5]!TZ/7*W&L$7'U$6QI"6M[%D+D
MA?$ZC8K@RZ9%$CJ)E(JF8V&RG04^%[?WGU'TO;-*O..,7U[/,Z;UW!#;8Z:7
MMD["N4",58*25(J08/[5+;J3NG"]']:WB0/VY9CC<;:VZ2?)B-Q>9>W@[H!#
M-$)#(BLI90&&_/8>PMOR40O#4O16PD5))!1L]F'L_K:.<LFJOY2Z<85"\O3I
MOETC'(E)'[EC $7J31^X12:*_<)A>FH+E+K*]6X5E@=9(K6*TSD\<LBGDIN"
MV)B#0J0"T \W'B)I849Y%^=2=1]9W5E+98/H'J*-[F-HI[VXR'3-M+#$X*NM
MH(\Y<%;B1242Z;Q:$]](+ET2)M8%:UO\1 $=$6$A"]C))?/-:)MDP)[ 46X-
M!MKE(&:1(F 9%9*"Y0"'KT/!K^\8M)X]XGZW_1FO=U=9DGPS>DS9D;8FYL9!
MCHV,K-=7DIE41OZJ\NKM#'+)9C$ZJ;%?:(#^'T%?A5\H@ONFTB]O9X1]DY61
M! BV.,@2!S+&+''V./E[T%OD6SW".:;R+53,F&A["H4R8HF!>W4$XG2.W<M#
ME55&U^Y5,JT?RZ#A87)'RXV:Y.P?)35G/-QERF3Z(#<CU=9J=\APQN7'%@R2
M JGH.VH66*V9$"&)!88R/M-:V"VEQ:-A_M-(X#H*_92"K=S,8(DJ4>$AW&2[
MLA>&>\620S">0Y/,R]]+[*M?VG +T/E0X7\F^CIPJHJBN#E:\Z[;*D7%P#T'
M8+(V!!(KM*2]&82410001EHR#=,VC1M7*;'5&N,M]GR+[NJK8C04HF)S#J4X
M=OME&M68QF#E;,&=V:WGN4DDDDO,E/D:8P?VK22;'1-TK<A)W),[@D82!Q+W
M R7<:"87'&Z5T1$6[MK.:&&"+'X>WQ.1*)QFW59'*7V];UK7L#XIE78-)1O:
M946Q6[1K\O1C6: U\K0(]HVA03<R;MJ,/'LXQW'R$4]ML=;L%E^MNE[.-ONB
M2^S-WLE9I+=[" .7DD[SS2MZLR=Z1[DE((W]1+)/'+%/%CY<?+L!]G_6U]+&
M<['C<#8@*&ABNDR=V$5(XQ EO"AL!&((X[34ES)&+:"&WDM[BVER<64D/JE6
MAZ7 ,*Y!I*IL&)5C"JZ7.[?OWKM=5Y(RLH]5[KOY:5?KN)"3?KB9=X^<KN%1
M$Z@YIR_OKC)74MY=,IEEXCBBB.**.-5CA@@B7VQ6\$2I#!$@"QQ(J#P*WYC<
M=;8JR@L;16$,(;W2,9)II9':2>XN)6]TUQ<3.\UQ,^WEE=W8[:NQ99U?4Q2F
M*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5KGR;W2TTSKQ5VA)(1UKM*KN#JSA9
MN9\6*,A'N92PVY>/3 RCYE2JXSDK$HQ*'E,/FD;7FXB_FF2:DJZ0P#9[*JCQ
M-+9682XO$5A'W^4BQ6MBLI\1R9"Z>*U$A\01O+=-^';R$1GJK-?<V+=XI5BO
M;KG!:.R]SL$(TEQ>M%Y,J6-LLER8@"9Y$BME]\Z Q*C-(&%8CCLW,F9XD\3D
M_%TV9F3-9&THA8I#OZTDVC#M;XRN<PB<59N)HG)BT-E0=[*AUB[T$;#B5]P/
M;,;1;1G!%H\+VD7Y87F#8V3'VY'&WGR/2%HXX8>=*T-/$K%PPT/Q%<3 .BG]
MK29;N7\TR1C[Q3(3!N=Q!9=77:,),Q PY9.5.=3Q,@]%=540,C,O_EKPSI9T
MLD9M/KM 3^5OQE9%>-M;YKZ7R6>5WU8F'H?=G5%(H$  ]\?%5&FMXN\@C5 >
M5JDG+O1=B%9K&-^7J+5.F+23E]\7XGL98>3>4D+%CM+F4Q.7DD92EU(G#L2-
M/,T-]+&5]-<R]4WD)4X?'-;_ &-Y1-04C) HY4,= 6A <#&2$@JX5@S1Z""*
M0D2@I>57EZ0W;E(0B58M.P81BF"33CW&H1M3B0&!U& &YGCWX855;KO,Q()N
MK>!8<DS\B6O;+%W,AY2=6SM-CGA!*LH,C;4QA6]//,S/:&%4":6SNIWFQ:1\
M0BV-_EK-%XQ=&6RP]\US7OO MU=JD*]9*J3*R':4BF)$FC>%;,8N2=V!HW6*
MHFS9MJVUA;%"L%/)-BSMVA(%=)1*M2J#NSR^1^Z,=>Y&YBD MU<=B>4M(]S)
M+/#':2.NC)))>27%I<RC32R6'5EVK WT#Q^\-@OOO*V&,M)(^5W(@]5;0@1P
MVD<=M<37T43AEBCBL8;>]LX6';A3(]$V3*R8RXCEF"@H*)K,/'P,$Q0C8F+;
M)M&+-N403113#_>8PF.JJH83*KN%3'7<+G4774464.<W.-W=W-_<S7EW*T]S
M<2&265SY9F_D-!54:5$4!$4!$ 4 #J^PL+/%V=OC["".VL[2)88(8QI41?U)
MVS.QV\DCEGDD9I)&9V9CRV6]7E,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4KQ.<B1#J*'*FFF4QU%#F I"$( F,<YC" %*4H")C"(   (B
M/;/H!)  )).@!Y))^ !]2:$Z\GP!Y)/TJM_R%Y1H;OW)8+;#SZK2AU7R@=?/
M$6GO!95^$75FW-V3CS_^>6E92M2.UD&A"F&5;4?C_ &((;#%N[Z<Z7Z8. PM
MO9RP*^0O/VC)(7X=RXG40+8F4;[:Q0W4>(+_ ,(W_4-P"/N_E'I+J')/ELG+
M<K(RVMNIALFX<NW%$W=:Y"'\Q>6$Y#C\N;3$P$?M)5NAL[6+=+L*AF'LP%,4
M72@OH6#)$%5;^SDE"F.:5@*L373AA..P%0;!1-";0?%.J.XTCN\P8>1^.X9/
M/)!V[BX,Q#<X@?ZFYNCDA+ O^K9#J'%(>/W&0L9>/B#XX<?&F]\4(B&N,GG<
ML-MZ$),=GO6.'R).SEMMRZ=A[#Z/L3"8QA:>QM$AV5$PG&%-%6UV4Q0$YUE0
MJ-\?B< %97EU/E.4I43C[$>_=W-  /W+2/P/'?$UDGGPJKZW&Q@'PG15OK>]
M8V:+R1VM_*<+J3R=_@F*[<'][EZ2_DV-][JVX\<QOE2V@%BD**:TG[P/Q@X4
M%M-S99(I3$:*E(;^S[+86FPD@<]O2^5[(Y(R0>1/NS/\N]+ 5V>2Q</(XCE;
MV_9(',$_UMK:OC!P'N$V)Z3A&B<O^-C)TY>"K2\_S%CPGN!(&]A\GM75TF3<
M.?;V<IU3,=K]U#M2Q\&Z,N2HR>W)@S5V^NQUH^LO6B'MV;NKLY%T[D[+'MQ(
M06S*\6U>5E(4A2D!/7\;KV,\"IQ"1"Z3^TG*J][!@;?FD6."S7D;OSD2]>%(
MH+25]D/)C;!88;@[.\I-E9N1:X8G<OV983L6=SG[@1O/DBT%G)&@1&L8YWEN
M+N)-#MQY/(---  !K%6^(@T%MD WOS6-;3K1GD)U+N!W%+8'W5<B>3VL]3;$
M"$C;(-2M+Z01EBP<P=TG&21DFD<[3*@],R=>CY*@<01,82 42B92L(I]<#I-
M*'(F7G5HX#*'*0HGEI=,@"80* G44ABIIE 1_$<YBD*'<QC 4!'%*D*U/N34
MV]Z9'[%TMLBD[5HDJ8Y&%LH-EB;3!+K)E(99K\QAW3MND];@HG[EDN=-VV,<
MI7"*9A[8I7#;XY!:6XPZWE-O;_V/6M5:UA7L5'25OM;L[2*;2$X^2C8EEY))
M+KK.G[U=-!!!!!50>YE#%*DFHH12N]4>[5/95,JFPZ%/QUJI%YKL/;*C98A;
MW$7/URP,$)2&EX];Q**C20CW2#I QBD,*:I?,A3=R@I7:<4K&NW]PZPT%KBT
M;=W+=8/7>M*4S1D+3<;&X,VAX5HX>-HYNJ[53354_/?/&K1$B22BBJZZ29"&
M,8 Q2O9J/;NL]\ZXJFWM.W2#V'K2\1ZDI4[E6W(NX6<8HO'4<NNS7,1,X^WD
M&3QBY25336;NVJ[=9,BJ1R I61L4K4GDMSPX>\.7U5B^3O(37.F)2[M9%]5(
MRXRRC>2FV$2LW;R+]HP9MGCH&+5P[0;G>+))-C+G%%-4ZB:A2*5LO5+56KU6
M*[=:;.Q=GJ-N@XNRU>R0;U"1AI^OS;)"2B)B*?MCJ-WL?),'+=VS=(G.DN@L
MFH0PE, XI7/XI6OFN>5W'#;FVMI:'UKN6BW/<>E%BH;4US"3";BT4M070,5/
MFT>8I#BFV?F38/EFAG*,>_519/CMW*R21U*V#Q2M=+!RXXU57D'4N*5BW/1X
MCD7>X0UCJ.HGDF)+A.PI6LR]!\S9@B9$"*,Z]-N44EG"3A="-<*(I'*!1,I7
M)<B.3_'_ (ET1MLWDAM:IZ?H;R?8U9G9;@\5:,'=BDVSYXQB&P((.7"[UPTC
M)!T5))$_BW9N%CB5-(Q@4K2'_3A])G_CJTA_S.:_Z)BE/].'TF?^.K2'_,YK
M_HF*5*# 3T-:H*%L]<DFDS7K'$QL]!3#!4J[&5AIAFC(1<DR7+^%9H^8N$'3
M94OX5$52'#Z#BE<MBE12]5WE8AI#3334E:DUD=D;S3?PGI1BGC-0^M41097*
M4CA*!A;S5E7D8S7=1.<"&-8;6F^0.!8=RHEM/[*^ESFLRV6N8E;'8,QS[E'X
M,N1;D]G')_:AMA')D+H#?X%J48'NJ&CO4EXT%D;:$D37@:-BOYDM_B4K_O2<
MA#']>4FQ^4ZKOP%](Q11.2:(T(V*5X$C"M ,DR(T,C,$EX9FJ*7NFK12 9VR
MIQADQ]Y%Z[XUUY0GC:%@==%RVAD+ PERWM,4S>7+AH>U*X#<6=;A[2Y?8X2Y
M#J*X!W;#CK&2$H/!T/G:J/81IPR*2OY7C66-->X6V/3]\@Y 9[ *55(I%B,
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M)N$@,8S209',HQE&"H@XCI)LZ8N2D<-U"%4JI[RP_P 69P@_D?$?MSR%_O\
M_C_]SY^O]_\ R^G^/_2GZ?Y^IJTMR,XM\?.7%#:ZQY)ZIJNX*$RL#&U,ZU;6
M[E=BTL48U?L6,NV,S<LW2#QNSE)!J51)P4#(/%TE"G(H(9]I50_XDWIL<%N(
MO NG;-XV<:=>:AOK_D12:H\L]51F"22]=D:=L-^^B3F?RSU'VKE[%QSA0 1
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M:V4UKP8X=:A(@&O.-.G*^X;>/HR9J/"S$Z D$1*8]@GFTI.*J (C^8K('/\
M^IOH'; 9#K+JO*;]=U!EIU;YB%Y-##Y^@@@:*$#^0C _E59+:WC_ "0QJ?UX
M@M_^QV?_ .UM*V:M62";9FV0:-DB@1)NV13002*   %322*1,A0    *4
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:Y\$_<-@>LE@07],GJI>*G@7R\04K*F*5_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g729258g21k52.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g21k52.jpg
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M$0 _ -N51_+)Z*C++U79%['US0OS. ] OZDJ']'H5&U/5;1U[XL[SN%L9].
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MRXW KNM[?<7V#LBN!\/KJ!78RMF#M*:C_GJ4)0>,:GL$?5PM:_) P D]D"W
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M=VYS;+(RQ2WN NTC&-S]3A^KQ77HW>TWB+.9"6GQ1+:L9C Y?'Y!^$MX>/\
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M6J9RUJRVR$,B3&-U<WG)B433<-!5K7,6E4H2K.!QPV8DA(?R,+VT482X1 @
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M_?4_6^T>W#Q-Q-#/3X&IS^JWUX;'$MB%^GTZ;QROCQT;VF._?C(<YP?2I/\
M2._GH^EL0(%1\4.!@QS(0&$,FPX6+'-DF; >P9I<(-6;-JAQPBW;-T>.$D44
MN.>...=<\ZUK6>&+-FQ<L36[<TMFS9E?/8L3O=+---*XODEED>2Y[WN)<YSB
M22225]1:=.ICJE:A0K04Z5."*M4J5HF0UZU>%@CA@@AC#61Q1L:UC&,:&M:
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M.]>5HQXSA7H2G8#8D >E&I%+R1ZCATY@KET8G<6K0^>CMFSJA)W, B\L:Z_
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MD<CXX^Y=GW:/V%>XM%NU>.DU2"J?7'YF3^PJU!-5>55>5GRS%BYT[M3[4Z/
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M+#8Y$H(3KM_&JF6I:"2^*RZ3.Y+7T)X%6"" _HM^F!24@M2*" [7L@)6DH.
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M*^8VQ8<]D$GC,$DI"*2"Q7L%'QF'QZ!PIU%I5.P[A@^5?-/N86R[YW'AO?\
MOF?Y<(X^SEI<<7P\S,CZ-6%RS8DEBKRNADLNKLB@CKP&*:>,M=S-U T_:V[Y
MY=C1L]VH9+@5]K$]_4X]^M[ P<4Y_.7LECL)D;&+O\0382OC<3C\'AY<;E,Y
M5D@F=-%R8>!P] KG_*;P>S'IC[OM8"5FZ06B(46!1EQZKY%$B-Q%A)$HP\D'
M6K:;OGXIO591 8K)@[]IJ*,4"A+_ '\Y<H%W8\7RD25IS9^W&^P&8^!\<1RW
M(YUU['/;AY VPYS!4<&&1CF]TT/?Z^P\M8 XX_+]M_$]&UF6T^",/:I8Z3M/
M%6S8XMM5;%F#LJNQ1YJ>>JSABRRL_)5)XABX([-C_+1(RW+!5#;#L=L;WU+'
M JS14<A 2/#]-;E@44EK.P>"-B!YS$_-!.^P<K<UVI$-,$HL@R03%KDNY*[Z
M0-Z2VHP48\;Z<T['$,KFV615V1M(NUXI19#K+)X<8[(,F-;N>40AHY"XRDA^
MO5+1MUAQ!VZ922KQ'6QV&I4*_=<78/%Y6+/"QQ!4S6+[.;/'-+*2</NQ(@9C
M&0L;5?8.1F++G(70NA'VSN&_MVT'S:61F&U/W(G,$@[T:4L(V^DS1DVGPGSR
MQN7F02)%C G<6:Q4F[=HQULR:RU:5/"+AJ2YCS8"[_%MYVYRVYLL4%/O75X"
MQUB1TH:+#,:V]WDH;7,0B>XB(-;,97.+7]VV-VQ=1]L_$L\65QV(X5=D'X/"
MS5[7$%R;(PPQ9VKP#!Q@+^09!@IL7%C+,LS,?%!%E79.:Q)%9%".A-WL??07
MVQ91D]3\(>T^PE!^0P2BI;99J$&Y63%B6=WG2X0:<C_?%>:"\CXTP$:D<O1E
M9^+\(N%R47BSJ3.P>R!"I!G+3Y*<!I-EDDKX^:T^"29S6"_(^-LD9]&[OEB:
MSO)A-)%HE\43I3$7.O\ "=LG$5R]PEA9N$H<G?R&#X)RW$=S"W,I9JU(>-+U
MNE6O42,!Z&*^.@J#(99F4OXP-DDL8S&2Y&6D;$^R?-F7HA,(F$3")A$PB_S*
M;\]W>WP]ZW4)$^Q_5 L4+MJQQPP8.]!VRR'CA[&8F6S)BQ9MI:DV:,VC9))N
MU:MTTT$$$^$DN.$^.>=?0W"<%\'RX;$2R\*<-R228RA))(_!XQ[WO?4B<][W
M.K%SG.<2YSB2222225RFSD+XL3@7;8 FE  LS  ![@  'Z  Z #P42_V?_N_
M]M;UI_\ ,9<'_G',G]9'!?X(\,_W%B_]U5'X1R'W]<_*9_\ &NS;>Y/D(>Z&
M[9^O_8[O1E^J*#[;7[=2^BQ-#;/2PX;M*5]_CGZ.R##2K-K]ZX3V^9Z[3UMR
MC]NF[@W@9O><W"W"K>Y8))>;"XD=U&[GU))NL.1A[M^GNTT\C]'U3J(OY$ZU
M=NGF/*-69^KAK8'K]3U'0=>H]H7)?^V/D3%M7#XGZU]H#F+0PYCSIX_O:[V;
M5L?9\;4=@W#AQ*4T43#5/GKMR,4[Y>H<<[Z50YYUO>2LX0X$E<UD?#'"<CW1
M-G:QF&Q#W.@>=,F:UM<DQ./1L@!8X] XJ)O9( DW+P <6DFQ8 #AXM)+^CAY
MCQ'L71_V?_N_]M;UI_\ ,9<'_G'*WUD<%_@CPS_<6+_W52_".0^_KGY3/_C7
M9A_<GR$2(B@(C_K_ -CG2SK[S\*+#W[=1,BY^Z3[65^X9,I6NY6^Z13454^[
M2Z^PGQVIU].>>MZIR\&\#01NEGX6X5AB;KFDEPN)CC;L@#F>^L&C9( V>I(
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M)A$PB81,(F$3")A$PB81,(F$3")A$PB@/T?>E3^>*^8S^W4"1 2\G$'@T2
M(D_G$KE5DSV0LXO!(M$(T,:.WA"2'#I%!HPWQRW1:\]+O'CUFR0<.$Y7-:X
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M2&MN-D:660&Q1-](;'+#Z3^I3QG:)8X[&0X3F-/AFN88^,K%V.23$6Z.R]E
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MS;.BCIOZ?/QZG_\ KT^(_'OKH5AN.T/<\G9^@F]8J^VE0\V]*7<WIU="C)E
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MPU@XM?(XQN#S&&]XP?=M:00,QRLLLF$3")A$PB\T_P#NH+_B9T3_ /$X(_\
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M)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81:&OF:__D- ?_\
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MB2XDDDDKH,445>**""*.&"&-D4,,3&QQ111M#(XHHV!K(XXV-#&,8 UK0&M
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M8I7'S\F//CT:X[T3ZHKCBTIG-56!"86;9QF33**&(H+DKY)PNC'.I$T4#NI
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M^TJNKTHNNHJNJHIUX?NW;>1MV+UZQ+;N6Y7SV;,[S)+-+(=N>]QZDD^ Z!H
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MS+C8]V* %" TI1Y^&]=-CIXC?YO=^?QK4VKST:O?;1XA#?4(F>H^H*3DL%L
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MB7H>V*BN2D+3F<P/SFR'Y.M+)$VR[5$7/)X ,>,EFU]5.R%0,Y'2H:-ILN5
M[110CO ?H!!'Q]/#?L^,[\%6"M:FL8U;-3#C55>AF'J]O[ O@KZPN>2!;5'T
MU-/)AQ_>C85'V]H$%4Z>GU;R6 FJAC]35'""!24UN>9!BC^)PPA%)$;X?3Z?
M3:'Y-:&OCT-^\==[\C\H5[/C5I-AYY\1PZ)F*W,04LJZLR1SJ($0IYR?=NW$
MTDZ#?MQ&WG#XJY<D8BP!)LA;-EWV3:_A-MF;A=Y]I<H..S\@]GLZ^'O5 N$)
MY/ZH]5N(K17HO\4#^3NA?:HR#ROSY;E<%+0H:L[?\N2R1HP=K8</B[*3S!N'
MK"7& ]=M''4K($8X-9IA^>RPSIP4PZ$=1]RX="#U(=X_.-_+I;$/(C"02^^_
M9GH[J$SZ!5W<\AHZ/UNPL^#RBL)I*6M25=H+)9\^KJ<"P4XBPXH</]Q(0C,0
M $\2;0;HKR+Y!.PCY^4I\AT\/([\3X?)^WVK3AY%0L C5/GZTZ&HKU!-;3CO
ME;U83]*O)J<M^'13T8S<UX3;T+6$6N0^<<164&Y58S:(]54]J\R1.4A%&$B9
MD4*^?N%0+TISK>CTZ@#PZ=>IUT_/T/O&B,GAE*7Q,(]?T(#P.X(Q4%C71\31
M88*KNE?37E :W'*>HB3/UZ2B,6M*Q)5:X)\ K<2$U;EBLG\'Z*AAC":] F+%
MRTE1]]/9Y_3X_B0D=/ GU][(/D.79  \=Z'7R\M!2-ZD\2P2.VW[M8P7S=9+
MTC/?C,@@GRA)Z[BUMR((.O*F0/LU,E'4)K&%'PF(SMHR.T.A"0DK*#G4J>+"
MVD-;E2B!='@H C3?#HXD[UX'E]OCX'?C[^BL]4L36'>PK!(^BJB]%RZSGTZI
MA[Y8LT#'K=)U1!Z08^=:N$24"]GD=?-*RKE<3=3*[2MIPVP"8P]8?4A#+M@4
MX'KA1X\H>0(UX$.ZC>R3Y'J1K7AT!&^AZK62TB\CW%:XJ>]ZD]=V#;POX4_*
M3"(0VOV%SEI#!/5#D[Z1!AC,U%0XNW<5_:?,@8MVP&X["8#@5>. I[4BG<0[
M(-DC13G7B.77>.]@]7U>@WY:/@/;\:LY9D:]3$_2E&+$ZDF+"V*NO#P0,E-N
M1:I[_G+RTJS<#*A:^EYZR]!B)^'\_5/5S$B?LB 3FCMP>4R22(1\Q:!04.&'
M^)8#?3Z?G4HT ?/8/B1T/76QX[\P1H;.O:%(E.^6)J+E_F*PC\%N#J6V3[=^
M1^&>F7TA.V6\;NO*TT1]WNZJ!RL02,JB(W4I,L&\^E:\X9L1(3@Z< FH]VF7
MFCUZ8*'31\/N1KH/';=]=;\-JKD;H\A6W@;RU&8Q0][<W!1'-G,IEYGD_FGT
M]**PO:\A</A@)=D=D<&Y#*UX4)<H!T:#]7<$RU%Q1]N:$E%R;AH^V/*;?K'P
MT==00"/E/C[QXGH/8MTGHT-9L@N'P*9C8"5\"0=W6F8M=$!V]?"8V$)^*_3
M03J8O1?T']!^;&,Q(*->$/H/<2IV Y9_0@NPULI1K3O>WI\?,W]6UJ(@_E_U
M35OFRAEZ$C5Z17T):?PN7J(O J=ED^4D3CV +COC]Q48F5%YV9>L87=09Q(;
M]CE6;(J!W,5:-"X1AIA&XCRT%%,2W;CT([P$>]OK;\/+P5M837<!*V=X8->:
M?/?HFL*Z@_IVQ9!9.K;KVZ8/L&Y*>#?2D'U)7T?M];\\')*RJ11:(GYX@+:1
MZ=3<JQ48R68D'6B?92G?79'A[O-P/E\ZI\!8>UY5Y\H"JJSK7U%"KW\^?$/Z
MZH2<3"91>80$.^]<=@/)D9A@N&V!*^F0N;S$@^KF=FZ[M42L4AKO@PB4 3-V
M]0ES,&43KF)Z:+P1_P##L^('4#6MC6U\))2LV=*^N9+X?H7T[34%D_FOPI%.
M$;+@-X1N32QG!_55B2;U5%H%!YW-X/9SX\K0YPL-D8"+22NRUGR4L8*0F3K'
M9LRL0J4?8':\7>!;KJ!H^KL>(\]^'4>*V>>%H,?@53WX1C;X_, \FF+T_7E2
M2/S7>'CV$Q0BSK2,BGT1K^MO2DRGE@ H5,Y .Y,%WZBX^'<3 Q+B(0+QIT3<
M.RD/EY=/:#\Y'TT%2KXRJILJOKJIYPXB_H F!&>0I5!;&#^@*>LZKHCXKE6I
MU7,E">:_)4BL)NS0G=.G%5# )\D*-7:Z0CM%U:\<WCT 'Q6)]E,XC1\!U!&B
M#OQZG7GX> 'GZN]ZYEY5S:9NZO0B?59>B2OK<QZNHL]X[N^. [2<4W!/. I&
MB%#+?FSPW?-.5U# / J[.+KJ^:/Q$JM-X4+\M8O/$Y/&-<DZ=.HUH[!]O7RZ
M$GPT1X=-D:.LK@WG.RH[:=<7FWB-R(6D[^5;TVA*9 _-V,]1:^1Y4Y]*(A6"
M\>(E7$<%T:656@4C#-T!#:+J2EX!E@_Z'GC8@J4"=].GW( \/'H3\OEOQT->
MY=+\MXB\)<5EX*HJ6FQ281SS5U,:)MV&U'Z#N22/KL;2R8.5(/7):K+!A5=^
M;)S"F *+RY6SK(;'W5DLY8.A0".2WN+.(P1@=ZZ>/T]X1NO;\8) &OB/C\0\
M/'WJ7H?60&2^K/2(+T?2U_3.TYS;TQ:T]:#<%<"]&,?+A^A0,?#1M&R8\2'U
M#%8PV<=S0#*ZO-D6TN,VF14G"<0,KN@TM:13R!!_;O>_#Q]G7SUK?DJ2^7?$
MKP_37C6JH_5UX^?9 2^._P!%>;?4<M(QBVJ[<Q+T0(@?E8%$Y1]](>1HPBX#
M39&?2"KIK%?Q47DZ@60NH>6*#FC[[LHDCF<X:/KAP]XZG]FQY>!&UWDFB_N&
M\:<&^C;8KZPZ[-S3T#YY@%]TD3K*R[95'>;J!I6Q 4O(=4%5<[KJPK.ALR]K
MSD_8CH% #;0O/J28P8P_"3"-CG,3*%'30= @].AV!U)V.I&AIO3V!V^JV%5)
M'+!JCX\;B1B@RP_1$C1C/HJ3U;5QFO[B\KR8FR-+RLK%J5AT5LR92>\JUC+-
MTX[CE<*F)3S+@4:6"-XSR*;CP+5L4O3F&^@V-G8=\9Z=#[?/96N" TC=\I'6
MO!QL)MT-2$S]7?'3(1(V!4OZ8\D@NX7U-'HSTR2C,"LJQI-;L,%MPP<8UM61
MZ,0W1=%OS+>P8YH6;R T4>G3PZ!WB6N\NF^GS;W[CX 2E(J3ET *(0.;U-?D
MH\.P/Y"[>>D*I@D>MVPE^JBDWE*+EJG(C(-"=&+#G5#@/2$@F2_0"+LC\=CL
MV7#E'0= +#G+@(4/FWRZZZ_TOS'0\>G3SZ];D>#4)+YK^/LT4D=,WHV)P>R_
M<-AB*5(!RTP] &HT9]:^@)]  "; @;-DYC.)A$#$=<C2;J3F.).Y,-32DE(M
M'^S"SZ?3:.ZN\O!HWX#HT _(NY^/LF0G#V][JL6(6M$+\NL]!Y598.=TC<52
M1"!QH-'G<8J^G:W,6O!81W9#:N0@THO-)B-:]N#DZE1^1*#HW'#\3C@LCO(>
M0V!U\>OB1LZW^CVZVJ85A7-J;NZJ%EZS]$"O8P3W'<DL]"WF;!VDSIF1^27D
MLN9:-AVEH$N^:8FU;&:F)5+%JRIJ+/BDJ@4R9AC!2&1DM%Y#)."B3TZ$$:'0
MZV#YZ'CO>^OF/'V+*_!_G.RJ9D/QY3%W$;D!R>:>/[J"^O"<U-V,;5=3UFOY
M_*U>)L]"7E230/(HXOS.Q%<L7" ]X C_ #(XR 3;!$G;#@CB"7:U]UTT .GK
M>SY-^WIM0=ZI#FI]Z>][Q2$0/T=+_1S$[Y+2\BS6!(6F3K&G[(>5[!B1"0E#
ML9*]5Y3R3'M%I(K'D5B-HR.G<";.HD/*2UQM_%M$&M-WX==^TC?A[_#WZWO0
M\\[LV!V2-8V%#Y/YYD4EA%E>\?5DR=2XY25_WR%C8=W%HOW6Q=.B:,F]:R*6
M-K,)?F@F)VJ=E(V"UF\$N2SXL/<E&3Q)]/I].BAT\?<.G3R ]N]:(\-$GV:7
M4>>(;9;0AY:=^Z*?]7V<8;>&O$T?IMU'H_<TE7K?TI&2<^UZ+6LTK!B;=*K;
M6)*KT^1-VC;9@&+-Q@$_")S3MRTDHHJ0ZZZU]T?9X>6OS^'AOHOE0=+7ZI=<
M@,VJ>LH)=@B;^R7=B-!OE#TDF-O"OYBQN,9549D?K8K<,C\TR^L6 XQ5\PJ:
M%1&!AY="G\2C$$;1F(K\3+3XHDC70="!KJ-@]-D@#8)T=_)XC2@6HZ3]$@J"
MBD>\FTWZMI.UHG\6DTK3TYQ8R%EP$C/?1_+;S^VJT#6$CL@QU')1:X$!'_0+
M:!6%7!=6,U@%DT7AKJ0QGM,/&8V'0!1)&R3HCFZ=-=.N_B'4'6NI\/-7-JJM
M+D<VK9)GP3%[.\UT([K>EQI<%Z'@]J5ZRDUQ"BUOJS<Q#JYNT7W,6IEG%B==
M#+"L)L#8Q^QB* 51A()@]CI0FB4-CS ))/GY=/9T]O3R]BW?.VR3QHZ:+_>;
M0=-UFRVDEEFRNTET^DE/NG#91)PW4^QUO["R"J2R77T[24X[YYZU*YH>US7;
MY7-+3HEIT1HZ<TAS3H]"T@CQ!!4897P2Q3Q\O>0R,ECYXXY6<\;@]O/%*U\4
MC>8#FCD8^-XVU[7-)!P%2HJPZA(&NN8)&$(/%%PCR+1IH*;,AD:?QEXD1CY(
M DTX0Z#%0Q!!)^.*#NVQ!H]YVZ1<\K]]J=61QF.-2&AZ'7%.LZ%]>NV-K(Z[
MZ[Q)!) &@&*2*1H?')&6O:_U@[9)6QMXTXL&>R7$YXARTF?S,>0@R^5GN2V+
M>5KY6!]7)5<D^=T@OT[U:1]>U4M-EK30$0OB,;6M$C9?K6$PB81,(N /%"Q"
M;E(4-8#$GC]\5=ICV;=DFZ*%'*CTF2<\-DTN5WY%XJJ[?/%==.';E51=PHHK
MWUWLBY^$3")A$PB81,(F$3")A$PB81,(F$3")A%\UD47"*K=PDFNW7341706
M3Y51615YWPJDJEWKKA1-3CKKA1/OG?/?.]\]:WK>]818Y$X3#($,["06(QB%
MAE':[]03$P J.#%'[G7&G+WM@':,VO3MQI-/2[GI+:RND^-*=]?9Y^A%D^$3
M")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(L:AT-BE>Q@+"H-'0T2B,<9<#
M0$;CX]L*"AV"?7?:;,</:)I-FC?COOOKE)%/GC77?6_I]=[PBR7")A$PBQI&
M&Q1O,"-@H1T.E."T:#0TG+4Q[;F0/XI'2ATV"CKLII/3M<.(+RB1$QX_M7;9
MJ]-DW"2?*KM;KHGT^GS!9+A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A$PB81,(F$6-"H;% 1^52H-'0XN2SE<0ZF)UB/;-BLG<1\4D#!K''J2?*Y)
@02'01&#^W7:FVK)+ANCOE+G7.$62X1,(F$3")A%__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g729258g21y89.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g21y89.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2M*4&AO=&]S:&]P(#,N,  X0DE-! 0
M    *RZ^$05#A"24T$!       1AP!6@ #&R5'' (   (  !P"4  (<G(U,#
M T.3,< @4 )4UI8W)O<V]F="!7;W)D("T@4&QI86YT7T-L96%N7W9E<G-I;V
MXX0DE-!"4      !#4Z%[[EQ*3W+9^:*TOU=7E.$))300Z      #E    $
M    $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&
M5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M    MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V
M)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M    $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P
M X0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M  0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F
M)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
M !        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&
M]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4F
MQT                0FQD(%5N=$8C4FQT                4G-L=%5N=$
M8C4'AL0'+            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M   %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W
M @56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !
M!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M        QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&
M]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !+
M    $  0$L     0 !.$))300F       .             #^    X0DE-!
MT       0   !X.$))3009       $    'CA"24T#\P      "0
M   0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &
MQF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M ! #4    ! "T    &       !.$))30/X      !P  #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M    0     .$))300:      ,U    !@             #5P  !+$
M   0                         !              2Q   #5P
M             !                         !     !        ;G5L;
M    (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&
M]N9P          3&5F=&QO;F<          $)T;VUL;VYG   #5P    !29V
MAT;&]N9P  !+$    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6
M-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M  !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T96
M0     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T
M]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G
M1L;VYG          !"=&]M;&]N9P   U<     4F=H=&QO;F<   2Q     W
M5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;V
MP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T
M53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G
M5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&
M]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&
MQO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M   C_P        .$))3001       ! 0 X0DE-!!0       0    $.$))30
M0,     "#*     0   *    !R   !X   U<   ""N !@  ?_8_^(,6$E#0U
M]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M  86-S<$U31E0     245#('-21T(               $  /;6  $     TR
MU(4" @
M         18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48F
MMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D
M 49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]
M0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<F
MEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M      $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3
MDV-BTR+C$
M               %A96B        #S40 !     1;,6%E:(
M        !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !
MC:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W
M=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                          9&
M5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W
M!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%
M)'0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &
M1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14
M,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:7
M1I;VX@:6X@245#-C$Y-C8M,BXQ
M!V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M!,"58 4    %<?YVUE87,          0                        */
M   G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *
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ML)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W
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MD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8
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M@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,#
MP,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M! ,! 0             (!@<)"@,$!0$"_\0 0A   00" @$# P(#!@0$ PD
M! (#!08!!P ($1(3% D5(18B%R,Q"A@D,D%1)29"83,T0W$U4H$9)U5B<X61
MLO#_Q  > 0$   <! 0$              0($!08'" ,)"O_$ % 1  (!! $#
M 04%! @#!00(!P$" P $!1$2!A,A,0<4(D%1%2,R87$D0E*!"!8S0Y&AL? E
M-%-$8H+!T28W8^$)%S4V152#HE5DDK*TPO'_V@ , P$  A$#$0 _ -_CBE.*
M4XI3BE.*4XI3BE.*4XI3BE.*4XI77+6IL4EQ&?2M [RT*_&?"DMJ4G/C.,XS
MXSC&?SC./]\<4K#CUU[X[[L.D>L%= U%CL'NJ[=':YVIOUSL&QZUJ2",88E6
M*Y. N(CZ3.IQ:)J0<0_ B15=&@'GEO,RIU;$80:] >0#]0*54E7^HC;YS<7Z
MWDJ? 0'3-WZ>E5[N.60ZR*<V3#UB;&G+ 1,FUD:K+'>E&FH_](/4T>T."LX"
MS;!I\I9N*^S'_*E>76/J_P"LY&'OA,W4*C)6."T[ [FI5/TIO[6F]I6QAVG8
MU*U)!ZWN9=9^U16L]L9V'LS7<%(PAIE@J+3=G4?$WF;9A)E(BE7 N7U#-BZM
M<W)6=F]6WP-G:CB>I4HQ4*7N>O6N&OF>W.]IK151$K5NEJE3D1[M<FX9XB97
M9X6$9(,04",M$0V'9I%\]?K_ ):_]:5^[=W2O&I+3N5ZXZRMMCO%7$Z*UES2
M5>V+19*F1%Q[2[5M>JQ&*'<I#7])EBB&)18!MHE+I).1$HQ&QC4$!44HDWI!
M2I3]=M_6/<$SNRB; UN-J[9NA;_"TBY0$1=6MAU>08M6OZGLJK6&M6W%<IYA
MH4C7K<(,<%)U>&/C)@"0%RT4)@0\I2H>.]N-BI[WI':M$<OJ4SL9GH\;7?@P
M_P MGLX70U;B:VMF:PWF=S7$2BH[K3B+]_$7_$.1SA0WRV\$84J^T;VWV1;K
MI:DZUZW3=[TU3MV2W7N9V4%? 1;3F_5^4;JMFLX&L6ZS(/%:@IM[<=J=PNB[
M:Q9(K$58;&'0)6N0^9 I2HV:D[>[\N5=Z]RNUZVFKVK8/?3M)H"#AM8WFMG5
MRVP^HXCMXN(K>PG;+JI4@-7X9W304&B1J+\'8K%.PT#>2I.+BCIRAD*5>ZM?
M4#A[M6*?.4O4=JLDQ+]5[5V7NU09LM6A9?7!5>M$90@]53TC:"H*M-6B4O8N
MR:^1+2\W7H.%:U+<I$YY26F1N*5%?8OU1+W8]%=B9K0]7T98=LZ"L'7Q5AE*
M%V'@-UZ@Q2MXW0BO1A\1>J[11$RER%/@)BK66D2=>@W:ZF0#MH4W-@X $DE*
MDI/]PIC6U[W1 S54MUNV4U;^J^K:%I@6WTURH/;6W=239E5?I]Q51JS+QE:B
MVX^=LE\MUT?LCN8:M'R]8KT<O(]4,4K@GN_=NJCV-?S_ %T-_O!B]AM<=?9'
M6,1M&$+J;S^W->678E!V97=FR5;AONVO#X^L2T?++DJ; 6N)D86RC(K$@3%Q
M@\^I4B>OF\)CL33]M1D_53=/;'U7LZYZ+OT9 V>+NXL#<(: K\\-8J-;#JU&
MB3\857;G7)Z'*GZ5&NL'//1TQ75?">;(4J(6DZ3O5[MUV'U]8^[79NXTCK_%
M=>[37ZY/QG6-@6W+V)"WF8LL+=S:WUOK\N3#//5@ 87%8DJK*BBO&83*J(<9
M('4JVW3#OQL*%Z^=2B^TU)DP8':O6:Y;(C=]&;$ N5HM<AI.@CWS8$M?:2'
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MVA8]PD1^^6W,C@3P[R<M=PB/>M_VAX?Q?#NJ#*RO!C,C/' +EX;&[E2V,+W
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M%LICDV7 #:Q6F"#FI=Z 1(D1@)D1B0.!,SMKV8&(KF4GM)YH.-J\ES"LNK8
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MX!IJW4C"F2K3L:*^ZA\YM8R'4YJ;-Q'>6LAD6$)<P.9G5W6(+*K&1EB(D94
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ME^-FOGNABC1GL$2BF*'K'J+%93'PV=GW)K@3I.S/!)";8*CAD/=56,C<PI5
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MWK8!KAGV8=5Y?IOJ[#&RN9VM;_(6MA?V =F@N[>[F2!N41)7NQEQ+#( '5T
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MKX944M"RGY,)0O'7DDZ\@D'E;V=7&1MNN.F),49/>VS%G$%CW]Y;S2K'=QN
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M:RCHG P]3]6]/=/W$S06^6RMI:7$J$!UMWD!F[1(($K1*ZQ;!'<9=@CQ6O\
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M3(8UE98FD"+(P0M62=(+T\W4N''5=Q=VG3_O8.2N+$2&YBB6-VB9#"KSJOO
MA$SP(TZ0F1H5,H2M>OKQ%[K%[$2C.K*X/*;,K$IEXN!L.-7+I=<;%*Q$V!ZM
M93(,!*CPE%K!L)6O39.5KK3ZX\#,:X^V"]R!T5:]8P];W7V+A^EVS=E<H<E
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M@Y#?C:]S?GQXK7OZO7^RU?LMKVVNRYITW>[M'5>\G/.YR_;VK_)LPIJYM?\
MF*P/,R05A$1G.$BG10:&,-C)6PKB'V8]5Y=?:3C[R>]GG;J"_>TR8=V9;D7Q
M8(74G0[%PT4L6@.V(PB@(2I^B?M?Z,PDOLFR^.MK"VMXNF,8N0PW;C56LCC
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M2#0Q:)5T=D4%\%T,#$0T Q#MQX#0"!&=8Y2YOKN^N)<DS->!S%,&55*-%\'
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MAB( .1)A14)F@S)D=RQS2_N D9&J>E&<SZRZ>R%RTN>58> AB]XM8BQFA1$
M[C.559BN]2%0O #8Y*I8:/\ 8E[1^G\5%:]!W#W@EFO[DV&5N#&ME<W%PXXV
MJ0\C)9)(4_9Q(\@EE<AS%)($K92YK&NK*<4IQ2G%*H3:-A-J.L]B6N-3A4C6
M:-;;!'IRGUXR;#0,A(BXRC/^;&7QV_*?^K'G'^O+?EKE[+%Y*\C&Y+3'WES&
M-;V\%O)*HU\]L@&OG5TP=G'D<WA\?,=0WV4Q]G*0=$1W5W#!(0?EI7)W\JU?
M(2D3>Q;'4:%#W(ZHRUWME=I[]H5%1]I2MBXS(D!,?J&OS>%QMJBI)F4?=G(>
M5SD:7QE6"E^K/KQQA[".L)^F/:YTWGIK)<P]W?SV=U#/=WEK(_VLDEO+=QW-
MI+'(EW;M-[S!)()429%E[?<2.1/HK[=>E[3.>R+J?%)-]G0XS&1Y&S,$%M(B
M'#%+B"T[4\3JL$R0^[.(3%(8G,8D$;.CR IT=VA^EU;):R7>+AK'I63(;JU5
MIE0W=3]=Z4N-JF8R>EV[ Z!NB1.D]7SH(E:DI.:B*MD:(EY>5 !@DN10) 97
MUAO)>G/:5;Q6]G-+!ED4W,]W<X&]R&;LK:"2&-H.]A0L.3MW:XCC@END[T,4
M;M,W>D1A\GHUR'3[L\J(]J3VTBCO8H+.65PS!^%V2]NZB-F=(SP=F 32*152
MS_UC=J'.+9KL'U7IA2RFFAHN8OVV=V2[S;F7OV--Z6UZ3'**REKSC#A[32%J
MPA7G.?QXV_LCQB*&N)NJ+Q I+2Q6&+PL0(UO?VS?I*%&_.HV8C?@$$":3JBY
M/A$QT1) "M-<W;_/Q^RQ<2?H.0]=GZ5L%11[4K%QLHQG.69( ,]G*FWF59:,
M';(;SEDA#;[6?0YCRV^VV\WG]KJ$+PI.-#2H8I)(V_%&[H?(;RC%3Y4E3Y'J
MI(/J"16:*P958>C*&'@CP1OT.B/T(V/G6JAV&J$_T%[]5:_-D1FT(IZU3^^Q
M &[+*U.V(@[M-W,!B"F9%RK6 %)STFY/A''"N'HGH.-)08-#O6#&(_;.)DGZ
MIZ9DQ$4$%K[HEO;-=2$O&SQ%9$,4**&61E0=QRVEYDJ'+$+QQU;:VGLH]J5M
MU9=7MWEQDY\AEXL9; 6]S'#>=^VECN[N5FBDA1Y7]WC2/<HA59#"%#/LE]=>
MP=![-ZOB=I:]>,;CC"28J9@Y5 [4[5;''I95)5Z<8%(*';.&;)$,8='(?%D(
MLZ.E0GG0SAW%:QR./N<7>365V@6:$Z.CM'4^4D1M#DCCRIT#\B 00.JNF>I,
M7U9AK3.8B4RVEVI^%P%FMYD/&6WN$#,$FB;X64,01IE9D96-\^4-7^K8[M(D
MQ--;:+A,NIF!M9WLB*4QG.'TR+-7E' U,Y3^[WDD);4UZ?W>O"?'Y\<M.>:=
M,'F7MM^\IBL@UOK>^\MI,8M:\[YA=:^=7SIA+>3J3IZ.[X^ZR9S$I<\M<?=W
MO[=9N6_''MEN6_ENM::B4F2V'<J/0:[9I6EGVRS0-9$M%>8#*DX./FBVHF8+
M%#.;=!-'_3Q<FQ( %(R*?%.FADYP.^[G'$/L4R;XCVJ]&9);*'(FWRX:2SN'
MG2*6)X)XYRSP21RJT43O,C!B%DC5G21 R-]'_;A9Q7WLGZXMIIVME?#,Z3(L
M3,LT-Q!-;J%F1T(DGCCB8 !^+GMLC\6%ZH;47:;Z:6Q"=HENPECT+')QB:"U
MOL6HZBUSL^9F7LPL7^OZ/M24?J^K+)F2D1)0J=U\V/ )#C!H".2T1)N.H^NL
M^6Z:]HEDF-7NV^9E\0'(8N[RV3QD<($TAL<ABE6XR=KVXGB$&05IP\KW$CE8
MPM?(Q+6_P,S7)XR6B_C$%Q%;6]PS?"O>AN#PMY>1#%X"$XJJ*-L2*IL'UD]E
MG-.?IZK=7* 0ZT.\&+:MLW[<\@I#^&O#:PM&4&1;R3A1#2,M9-:2E27,*7G\
M>/"W]D6.31N+GJ:^7;!FML5989!QY>>6<O8R%^$G? G1'@5._5%P=\(\= 3K
M0DN9KIO0$^+2%EWY\?$ /J:SI:DN)&PM6:XOA>!<&7*C56S&X !F(T%)TW!A
M2)J08^P#B3H0:2B'4BBS(H\HP/AML]ELI+J<:4RMHMAD\C8IR*6=[=6R%WAD
M<I!.\:<Y+=F@=^*CFT+-$S;,9*Z-9=:RF>V@F;7*6&.1M*RCDZ!CI7 <#9.@
MP# :Y '=:RG>RBA],.\-5NVAY.4A3W(5.\V8>Q P5AJH%HN=DOD"3&1(1$2R
M:BO JAY"29!(DB"PS)49,9(1P\2$UC9O3 GZFP5QCLC<LMI:M#:QK;JJ3NB(
MLB=Z1@X9$T@0*BEBIYLP&JX^]J8LO9C[0,=U%TW8*V5R,5WF)FR#/<6$4]S+
M-:SBTMT,+))*&F>4R2RK'WE[*1GS6>CI!VK&[;::3=RXD6O76M39%/O\&"MU
M46S/B@@2;$K!?)>?-Q SL7)!'AM&.O/QYF9*$<,DG(E<B7KS/8>7!Y&2RD?N
MIQ66"76NY"^^+,O[K JR./3DI()!!KI#V>]:6W7?3EOFH8A;7"R/:9"T#%A;
M7L(1I%1CY:*1)(Y8F(#<) K?$K5,7EFK.*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4
MKC=_\)W_ /37_P#USQ2M<_Z-[:$;=C%H<'7DCIR6\[AII:,Y<QVSVPQY3ZQV
ML-(PTRWA332D-J7G#OMJ=4XYCH+VN?\ V3+\+#_VO7\3;'_W5Q1_B;S^9'IX
MWKQ6#]+_ /,KZ><63X&M_P#$KK]/]*V-.<^UG%8SI3Z=D%3&KK==-W2VN[?D
MSZI(TN7M,OKJJLU=^K;)E=@"._JN"T1;)2Q3.,V>V1!5JVO6=P3D_$RRH^RN
MRB_1(CJ54VL>A8$'5ZJSL'9UVE+ 87"V'=,+72JNW2=M62N;LNO8"J8GW3J*
M/8F!ZE?[Y+M9D*.1K;%VB!A ;3!_9\,5\%2KGQ'2S4\-G7J@Y>]^=:U+5M-K
MZ\S<:VX[%:CML[<ZP^<^+!COJD2)6PFMRI8+H'O"-BI!;CR&E$N*5X- Z,T'
M79E9EXG8.QRI^J[BB=R@3+XVKHG!<U':YMNJ#8J6@*GK6N5.09M-*O-E#MUI
M<@$[&L,F:),F77)\/#. *5-KBE.*4XI3BE6BV7H'2>Y2 B]K:LH^P"HZ..AP
M2;57H^7('BI%UD@N/0\4RMS(:C!A9%EA2E-BR@@<J(EB1$'*:4J'GU,=>AGZ
M.?W2EU#<AH\:2ES!,HSE<U5)Y^)#FHP5W&<)9DV30X:3CW2/4,M(9H#N1\R"
M31--^VOI).HNEQD$F2"\Z?=[R)G#%)K><)%<VY*@E6)$4L;:(#1E" )"R[__
M *._6DG3/6?V/)"]Q8]5)'8R"-E#6]Y:]V>SN@&(#H%:X@E0%6XS+("3$$;W
M]+/Z[Z3=0GMH[3L;(<9*C#;/MQX++YBR9>U1D,%7ZM7 LMLER9_VX6"@@F?;
M8^X2V"Y%Q$>*2[@7.?8Y[/KO'83#]-XP+>Y/)L<C=2K]W!WKJ*-Y)&=QN.VM
M+:.-7D<;(B9PO)PE8/[:>O5ZJZQRV:N(WM+#&#[&L('(>9;:QFF0%@A*M/=7
M4D\W!20@E6+FPCYG&'0/U=]2#L_;(ZVUJQ:(AZ8Q*3N9'5M'UH;-TL8TFOY@
M:YM[8UE ECAMJSN88F0)A*_'M3E8>;>A)\17VXYBM=5WPM?9]T[;R6TT&:DN
MS# %RE_D4M[]T$S7%SB,9:R1HV*M^\L:W%TXCN?$UNW&2)[K0$!DSE^ZR(]H
ML0>0FVAMV>$,5"1W5Q*C$7+\&8I&I:/91QM66/)=0/IJZ8IDY5[+.;*['[.F
MJ?8(NT03FP-UV0F+$F88T.1CGDP-<36X=8PY@+#N0G@W17DX4P0V\PKVL:^O
MO:+F+R"ZMH<=T]C8;NWEM9Q88:W65X9D>.0&>X-S-R99& <.&4Z92&&ZOL.!
MM8GCD:>^G:)UD3O73E0R$%?@C$:Z! ^$C7Y:\58_0D21:>U]DL#<!-V >8N7
M>+6>X)5W6U]A!UP8^X_MU -LNY9AO]";&KL'6Z5!:WHFM:_G[M47Y"RRPYSH
MT=98V-P$$@@@Z(.P1Z@CR"#^57EU5U9& *NI5@?0JP((/Y$$BL+G<;IAM'IT
M3.3=F#/(T0-8H>$@MY!)Q(PT#%6B=&@:X=?AX[+TU6I&(=. ;GC7(K[42;C"
MX(HUXL8!.YK'K/'7V)>"Z#_:/NCPO:]LE;E^T5+1/Y0*X^)@[*R[8 $ $\/]
M1^Q?J/I[J=+S'&-NG!E(+FWRPF4/C;=KI'1+J'??[MOL(CQ(Z3%4/-&<JNXP
M"\T0$&0.6V>P^*.\R<RXVZR8TZRA;9;3K65-.-D(4EY#C:E-K2O"D9RG.,\T
MR?4^->?3Z?E7<*D%5(8," 0P\A@1X8$;!!]1HUVN0J-.*4XI71E(T*9C)&'D
MF$%1TL"7&R KGGT$A'#N"E,+\?GT/,.N-J\?GPK//.6))HI(95#QRQO%(I]&
M212KJ?R920?UKUAFDMYHKB%S'-!+'-$Z_B22)P\;C\U90P_,5@HZ]:)G(/M3
MN^HQ:1+K+]0!(.S0\48=F%:V=9+?5)&=U7&DR*@C$P"1O0/(620RP2@.P@!,
M L2,6020SS5[-O99:XSVIW_O^3'V9TS<VTT4D<#2SE<K'(;6:2+<:L;&V:26
M1$D'=N(XPAX%M=A>U;VP7&7]CV$:TQKPY#KFWNK>ZY3*L%NN%NHH\C'"PYN5
MO[E%BAYI\%I+*9-2A0: ZZ:-[(=LNV9V[=\#1IE9U_/OP>SQMA:_CYS7I,A"
M.R*&='Z,IEUCCT)@:NL[_FC;"TC2)4XLU< 7(-$$25@^BO4&9Z?Z7Z8CQ&#D
MF2>^MA-C!CKYX+X).(B<[G;VS='-Q<A-6F*5NRD 7WA%*QQVO 5C:7^1R375
MX%*02%+COPAX=H6'N=G#*"O!-_>W)^,OY0G9:38$@:G5:JQ\6L5FOUP;QC'Q
MX&&CH=CPG'A./9CQAV_"<?C&/3XQC\8_'-%SW5U=-RN;FXN&_BGFDF;_ !D9
MC_G69I%'&-1QI&/HB*H_P4 54'*>IZQ#?5 Z1WKL&FI[@T['HL.P:9!O5.P4
MQ1P4<;:JA@\R8B7Z^7)O"1GWRN2TE+K5&GG1[4M&31;C!N9*)CXN6S7H[J2'
M"3SP7G/W*[XL712YAF0$*Y0>61U/%^(+#2D @$5HWVT^S2]ZXLK#(X3MMFL2
MLL0MI9%B6^LIF#M"DK:1)X909(NX5C</(I925-6Z^BFI<?6NU-.ER"X6YT+=
M$54;EK69&(CK%5)B+JK&')N1C2$IRV)9%/.1,<<U[C!Z:<0XR^ZPAE7)>M\A
M:Y/)6UQ9[> 6:(L_$J)B))'VH.FTH<#X@K>?( U3V$8')].=/9G&Y?C#?#-R
M2R8_FKR6:^ZV\0,C(6C)G:)V!C=T(0?%O8&;[F&5O*N-UII]IQAYM#K+S:VG
M6G$X6VXTXG*'&UH5C*5(6G.4J2K&<*3G.,XSC/($ @@@$$$$$;!!\$$'P01X
M(/K402I#*2K*058$@@@[!!'D$'R"/(-8>.IFG*I!]V^U]?C0G30.LB]?XU-'
M&FK;0P3MRC2TN7]V.PR0\3F "436:^2IAU0\4>0;*,S$RT*>SHKH3H+I_$>T
M;JRZMXY@,,UB,;&[+)'9#-6\TMTT::1G:&,-;VX>3X8G<,6D*R+TU[3/:1U+
MF_9-T%:W<L&^IH\DV:FBC,<M]_5Z^AM[17/)DC6XE"7=WVT7G<1)VQ'#RB>*
ML%J?MMW1[B.3NVXX2K@:EG@P=B0EIJ@-NTQK6JJ(A[.'INBP-KBR(;:6Q[0(
MU$2EWOKC"(B,%(CI"%,=:9KN%][7&2Z6Z0Z42+%3R7#92WDDL)+2Z-KE\I=%
M9;9LOD+BVD6XQ>.M&,L=C8(RS2R+(EPOF<#BR.WR65R;-=((Q;.%G22,2VMO
M'M9!:P1R*T=Q/* K33,"@!!C) 2M@RN4:DTYK ]1I]6JK&$):PS7*_$P;6&T
M)2E#>&XP05&$(2E*4HPGTI2E.,8QC&,8T1<7MY=GE=W=S=-LG=Q/+,=D[)W(
M['9/DGU)K-$AAB\111QCZ)&J?_V@55/*:O2L?W>[HQ%=O8"O2L'.A4W:](:-
M%KE@D!'BH6;A)!QL@RJV= ?^/;!^8RV=$RPC9A4"8X<MF..&DY 0C(^G.HI^
MG[F21(^_;3A5N+<MQ+<=\)$;1"R)L@;!#*2IUX(UI[2_9O8^T/&V\+W/V?D\
M>\CX^_$?=51*%$UO<1@JTD$O!&^%U>-U5UV.2/$?Z0Z$ZKNG<GJWL41-?[ :
MIVA7CYR'8.=,A+)JJ1JX":%>JB27'Q1DA%RIA$T6>Z['LO1X\Q6QCD,$D881
M[=594YJYM<BD0B@:V$$:<N;J4DD=Q(PT.6W]    0"VBQM7LAZ87HJPS735Q
M<^\92+)^^W3A#'#+#-;016\MJC$OVN$0Y%B3MT)"EPHS<\Q:MP4XI3BE.*4X
MI3BE.*4XI3BE.*4XI7S.,9QG&<><9QG&<9_IG&?QG&?_ 'XI5J*#HC3.JSVY
M36^L:72)%JO9J;9M:@08HE%:5/2%H5!I=%:;5B-58I61F5"XS[69 Q\G.,N+
MSGETOLWE\FABR&2O+V,W NBES.\JFY$"6PG(8D=P6\4<(;U[:*OH!5-#9VML
M>4%O%"W#M[C0*>WS:3AX'X>;,^O3DQ/SJ['+7536&BJ]A^W%_P!C76FP\O=H
M.M35SU,-&V,S4 *+%JP:>WA;:7L2J9C)36P]4BY"%U\+79A<=8[+N22KBB K
M=,6AV'GA8!I2N".M79@S8YBKO;MHV-PB(ZA1<53I&AQ<=39=ZG_4)M^MMJ;*
MCXN(I@+D;9OX61-&N]N>CY@>+"CKRQ-+C&ZE'TQBM*5077O;?8BD:?U-K]BZ
M;&'HL9JW04;MV_3FC\"63JG)&.V"*L$!"CR]%^-<7'XV(K3,N==8.\NT$.8Q
MM"Q%O4J<A@1%*J>[;2[%;+1KFJW>;O\ 7!4W_JA-T>'A=)FAKW["QO>@R-LF
MS+:434I$Z@$0VG:'K+:LQ4(XREBTYJ[R#UQCSH&7AXB'4J<W3;8FZMF0NPC]
MQ$9P7KFT-Z%\MP$="@7.^:;29 ;:W)"?$';>;KVR+J40-!PN7LQT&!46T@BB
M/FR&7U*F=Q2G%*\N<E$P<++S2@9"33$19\HJ-B1OF2L@D 5TK(48)ZV_E2!6
M&O8#']Q'OD.-M^M/J]6)XT[DD<89$[CJG.0\47DP7D[:/%%WMCHZ )T:#R0/
MK4/T=U8=;"7\:&[&9PL5DM&,:[95[C;]4?MB<-*Q->ES/PF%-XRG/I5Y^1C/
ML)RKE^/3LH)!R6*!#%3NZ8:(G%N=[BV-.0-'Y_#ZZKU[1_B7_'_O<?\ ?Y[%
M1Q[B]AF=N]9MPZSBM0[KKDA<JJ9$!SEKH^8VO1CX[=8GE.S!K$B8\*RIB298
MQEL9]?OY;QE'H>0KF/\ 5/1ESF>G\IBX<Q@[>6]MU@2:YO)$MT:2Y[:L[K [
M:+1,HTI+/\(&QNLMZ$R<?3_5^"S,\%Q>0XZ\]XDMK%!+=S*(IEXP1NT:,_G9
M#2* JL2?'FY-9[.5&1U%7J/8]";ZL$4'182$DE!4/#@$DF#56*]F3A3V)L8I
M",''"3$-+C+#-"4.,>(\*<@9Q%XPF$N[2SQ,UOEL2)([.R,<T5WS1BUGS\;A
M*2Q2HCJ596CFC9E=6C+ V+.1"ZRN79T*+/D;Z0Q3 QRH)+F5^$BC9CEC/J%;
MDCJ2&!4&N+2&V-/]?Z/7]5:FZQ]@ZU6!"490VWKWYA\G*REI,K)LY/R9$XX?
M+S1Y\>H@LXMQYU;?QP&/::&8%8O69ARV>OILGE<UC+FZ==$FZXQQ11PK,D,$
M:Q!(8(XW^!$  !+G;,S&S6N/ALH1!;A(XUVQ\DLS$<F=V(VS'P2Q.]:]!H5<
MX;NC$$H#6G0W8U.#,Q>$XSKIG/IS*#S9#6/VS>?5Z$PA&,^/\_K]2/.&G/%L
M/3THY;R.*^'G_P!J/[AC5O[KQHRKO?IL?454F$C?Q)XW\]>FOR_/S]-CSYKH
M1G;VJ18;WVGKOON,'+<D+ 0/'ZQ!#:*D)>O$;!E)!U TLVV^?*K(().-6E3Q
MQY3LB0ZY[SCRG]7I0=?:.+_%Q/[4?7O^[^G;_C\?K\/K3M'^)?77J?7?'Z?7
M_/Q5![MWMK7>.H]DZAV+UV[&2E*V#4K35;")_#EA#^ \P\02X8(ZJ:5@.3CG
M9L*0BC$_S(^3CQS4Y2M+"N>D."GCEC=,GB@RM&5/O3>K/(@']ELAC$PU\QL>
MH(JFO,=%?VEQ97'%H;F)HI!OSQ<$!E.OQ*0&0^H90?!%1EZ!=I;KIG3N.JN[
M:AL79&U>M66J4N6HU;?E)(K6F)B(A]9$6Z&ERHN8@)]B%E1XM0SXY09<5"@'
ML2YY1[J4>UW@&E=;J*^QT<-SIQSN=#FT3S.%81E6&D)V#OR3K0-6KI^UNK.R
M7%WMW:7-UCPL8:"5F<VK+SMC,CJKI(L?P:(961%8.VR:G6UW*BG7@64Z'[%^
MH]T)IO&-=-*RWDVQ2E<1EU.)KSCP3%.NXPGU97AQ#*?YJ5X32'I^0!B<CBM(
M&)_:SZ+$DI_N_DKKOZ#SZ&K\8B 3R7P"?7Z#?T_V-'YUP,=T8A] SB=#=C4I
M)3&J3E6NF?'F2C9B3:2E6)K.',H:AGTJ].?W^K*T8REISDQZ>E'+_B6*VO/8
M]Z.QP>-#O[OQYD7>_38'JPH8B/WE^?S^A ^F]^?S\Z'S%?/[Z4/[&'LZ'[%>
M,B.%^G^'C&?#;=2;MV<*S][_ !G(3J6<9\>GU9]_.<,9]7']79=Z^T<5^(+_
M ,TWJ9S;_P#2_P"H-?K\(V:CV3_$OT]3]=?3Z^/U\?G7*5W.B14F*7H?L8K
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MB?'_ &Y6$.!+RX:T^]<O3LC?'U/]AQWO7R)\^ML^NS\COUUKB/3_ ,&M_/\
MGXKJ-_;,#9]O,EZ<% ?'_ ?N>KTRGP/3C&?'I]K[OZ\YQ_\ )_7'GDY[G+SV
M]Z??EOK%SWXWO?:U_/\ 2GG?GZ'?U]1O_,K]#ZU^D?9?<7[69#V\Q?\ *\_&
M]/Q,5EOT>G"L^?=_3'CQY_&7OS_3C[W0Y<-]SXM[WR]X.]^-Z]X]?G_CNH^=
MC>O!_EOG^7_?/RW\QZ4>S%8#&P_F0]K+YN"?P+ZLI^*'@_W/&<>&_B?:LXRG
M]V,__7D!W.3:[>])K\6OQ/PX_GR[FM^-;^6J#>_&O&M>/S.M$_GR/^OH*QU=
MPXV<TGNC5_;>@"&XB(:XYH?:( 1MMA,WJ6;<( 'M1[@Z75$XU_<R(PR/:4,L
MHV2=KP;I+$2(5C%PL^=Q +(F,!PLEJ26\2K!)\+?3G!R\#TT3^(UC.966QO,
M?F;=1VTD6VR:C?QV<D4BI*^CY,!8:.B2YA4D*#60V%D:],B4Z7@S7I$&5#BI
M*&D170R CQ3I$\J'-^0TI33XQ4D\0^R\PI3;S"VUH5E.<9Y;W#@3APHUS##X
MAK448<+X]>UP'GR->F]BLD5E=>:E61P'5E\JRLBGDA4Z*LA!!^GGYUV$9BOB
MD81]R]K#P'Q<?X7*\*^/)X"]O\YQX^%]V]SU?Z>G_MP>YR&^'H_(_'Z<H^9/
MS_'V_3QNIO/CR/F#Z[^1/U\["_R^?K3'V3UH\9D/;^V/>K_ROI^-^FD>O/XS
MY]W],>SZ<8_];QG\?GD?O?/A-]P:WR_'[QX_+_F.7U\'SYH>7GT/GY>///Y:
M^?/]?T^=?"/MF1D9>S(8Q@PWY&4X%ROQ[<<B0]?G/CV\)^S^/]?]\>//F"]S
MD=!/PQ\=<@/60QZ\;)_M?4_7SO6GG_37U/EM>GD>>7^]"H : R#_ '\_J*^[
MDG&<L]></Y9]K"\&?IQG+^$>K/I\JG,"H1_I[*G<J_=C&.:RZ8Y__6'[0-<?
M['I7COEKC]CW7'>_EV>6]_O:UXK;?5W_ +K/91K^/K'7Z?:L?U_[N_YUD$&S
M'Y77ECYD/DY=%]CS@3\YR?*9#^1CSGQC,E]S]7H\^,>/ZXQXYLYNY]^#V^.F
MY>6^21\N/H2>':]1Y_(FM2$'XM^  =_R"[_P''Y^?U]?F/M663O;S(>QY P)
M^!O7GP&:D3VOSX_^%?=/7ZL?[Y3^?'B7[S:;[>_O WXOXDWR^GWO:]-'TW0[
M\;UL\M^OU&_!\>O'T^5<*L0OI']?W'VOMY'R/P-X^/\ IIK#GJ\?GU8K7Q,_
ML\)]W^N<?NSR;[[DWX.7->.B^]BX.M?GW^?KYU\B2*>=GR/7QKT/Q#__ '_Q
M]#]*_3_VSV2/>^X^OY1WO>,#9SX]V*^Y>/SX]/N_8_'^N?\ 3\><<+W?@UPU
MQ37XA\I>WY]?G+_/>_3P&]^/D/Y[\Z]/7][U_GXJUN_M,T'L-J3:^D[ZP>]6
M]D566K<FXV@1;L=)%3["XZ;C?5G&,2,#?&@)F-6O.&TE LJ7C*,9QE$\D9A=
M>'P%6 ^+RJPDZ.@1HVX(\ _7UW5#D;"#)V%Q87 W%=1&,_-E/$-'(/HT9TZ?
M]Y1OT J$WTQ-T6&U:GE^NNXGRD]BNGUS%TE?TX?9><L5;CDR1.I;XSDC"27X
MNQP*SQ6SW?61)$P[\LZM.))G&:J\1U=W4H8IHVD'('8.D6;7CSX$1&]>"1KQ
M5BZ4OKB6TN,5?L/M+"2>XW0+;:6%-"UN03Y9)8550YWSX%V/QBLF./M/^/\
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M&!177&/WXSA6-2=)YE[?V@^TRX6RL'-W)TN[(\+&.+ACKKQ$ XX\RW)R2>3
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M$1;3"<JRK.4+]S.?6A..07J"10B_9V+T@4#]F;]V%X1_>?PN=?0?#Z&G>/\
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M1ED?LRLA64T=]E7OHEB>ULX.,HEYV\)C<D1+%Q)+MM>*@D:V2%\_#4K.6&M
M>=^/TU]?]^/IYD%RUU)3BE.*4XI3BE.*4XI5D^Q^GL=@-&[+TUF?S5\[!K;T
M$BP8CON^(IU1 Q3)2HWYD=\UM+HR$N,8.%4MM2O2\A6,9Y9^H,3]NX7(XCO^
M[>_V[0"?M]WM$LK!C'SCYC:@%>:G1.CNLBZ3SW]5^I,1U![K[[]EW:W)M>]V
M.^H1T9!-VY>V2KDAC$X! VI%7,J4 BJU6LU=LE1C=;K\- -F+;PRLM$/'#1R
M"5LI6XEI3Z1\.J;2M>$97E.%JQCSFXVL'NUM;6W+G[O!#!SUKEVHUCY:V=<N
M.];.MZV:L]]=&^O;R]9!&UW=7%T8P2P0W$SRE Q +!2_$$@$@;T*J#GO5+3B
ME.*4XI4 *W4J7>2.Q5,V+5Z_<#9/=-F=O]9N,+&V"/EHM+L1):K=D(:9&+$.
MB1Z %27();PSHK1L6\X+G!X9*D9Q?@M8X4IIK,X>W6V"^4$J&09!2!X[OVC[
MRT@/Q?$A/PE*Q52RW=Z6)687DA<^5;@0O8(.]\/=S&%(.O!'J&K%K10NPG77
M3O1V@:8U)?\ 7Y[^JNLLWNF)JNI',0MFN\I;-9U3<XVSFJ]HRZGMWN%UZ%83
M+1)W[8>H%B@/)/A92WVB.4S6+*"Z+$%4@:7E\/@[(!WH'SKU+%3YV"Q]+@1$
M[3%V4^6"_%Y4!205VP\<O0*K#QYTI.ZNT_2^TT.K4>OH9K:6GZO-2=?BK_:J
MSKJHMV,"N!:Z[LVQP0Z?N]!M; 8B=D!Z5']\X5U\ BPQ4/&O@8M[[<@42;5?
M*@D<B N]?>GU(/ST=^?I\Z.82&?X78;(!)T3]T/0$?+E^IV3O0U/G5,Q=['*
M=%I>Y!OQV[I2@+L6Y8UR-3"RT9 2>C"E[&#G(5+;3T-'-;I,UT,N,=999#L
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M4FYPIQA6NB:O,1%\/MU[D+N\DY74\UQ* .,DLKR$$?&$3D2$C(72J"-> $
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M1>WCLIA;3"V$A17GF,<P=9)">Q;&%R=B4,O-0U("57<)&6&C>]4C7C"["NJ
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MPR+/ 7WP,BJR%'(!(62.22,L 2O(-H\=''[NK<.OZ[<*!);3TCN9&UXF'O\
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M>55=4M;KW2:!&CS-ZM]9IL07*!P@LI:9R,@8\B8D/<^#%LF2A(H[D@7AIY3
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ME$*&0@$ \-;S?[<O8PIGCQ63AX]TM#WK"Z/  (ON<ZW4!E'_ 'KZ$L=\8TC
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MD@,HQ(:)-J0C5 ^XV\0X)EUOT3EY>T96M;998NX#+*Q*[175'5(SIR&TP!/
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M.6-?</OQS5RH:/C*I([;AANK+5GH+VVL<;&(@]05]V"*BH_!4A?<1=:FHU2
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%G%*__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g729258g22z44.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g22z44.jpg
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M$ $?\/WTTUXZR_ZQ?]X?\]-->.XG_KD_[1?^>N,CXC^(TUYZR#]CE'_^0?\
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MRJV* 6?U+<UR"RQJ_ T*J1Q>HR8*L)&9?))_<1<R#Z308J 0 Y$Z<2U*'D3
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MTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTUJ
M]9WU"W.PG;#W*$\;IY\S4ZE*5B45 06-646C-%:WY(49+E.D[+3V+^/;12*I
M%4#6J>KJCQL[C$9!N;*GA)T(O6W4>*U6-DM"QUETQD"H+.12V\.O*FK=)&D(
M((IH*@(RR&,ZL]ZN)M]+]6?](G)2'UVX WRX]=@( [^^R9!7(U_.>EI:4GY6
M2G)R2?S,W-2#R5EY>4=N)"3E921<*.W\C(OG2BKIZ^?.UE7+MVY547<N%5%E
ME#J',8=^(HHH(HX88TAAAC2***-5CCBBC4(D<:* J(B *JJ JJ   !K'!)8E
MF))))))R23R22>22>23WUVMMBGI+UW"NR*W[P]SV(:=D#*5[85,:5CG,$'*S
M5(PUB"UVZN05CRG=ZI'OX:1>V&*ILK,9 53)(L7M6KL0V4;NXV87D%&.K77?
MBG5W?JR#IGIJZU=!:Z%Z@5-?:YXX*R[7.GIIY8J*EJF61%IY*E(J&,%&6HGD
M9F62/R@9C;+/'#2&JK(4DED"%8YE+)!"S*"[ID9<(3(WJB@ $-NUKHR_M0&I
M8!W>4:H0!5(3'.]N\2M',B>1?3*N*,961IB28D6;Y?%#U*5@(QY=J\@J\5S5
M$N3O3,%%Z%*.)./EU9G:NKA4=1=+7&KG#3UG1-+3UK-L6%;M7037.%'1:] D
MTPI)/=6V.%#.!5QK&\:T4U 5HZV*-<+'<G>(<EO(C*PDC,?*KO')E!. =G(+
M;@L]>C5BC<CLLL\UMNQO1*1GC;Y;+Y4L<SF-XF7B8;<15L=J)QTS7[,O+S<R
MI;KB:PM;'5X?**CE$MILU:!\1I"5NP%C(7&W3WBU=[!U92KU#<ZZOLU[IJ.H
MN5/7RQRR6.HKLO%44H2*,4U,D+PU,E B_4TL_E$RU$ DDNE79:>HHW]EB2*>
MG9UA:-2OM"QC!1\D[W+!E$I^TZ[O=1B-=-Q\QD862>1LBT>14M$OG#%^Q>(K
M,I"-D6"YT'31TW6*FX:/&;E(Z*Z*I$UD%TS)G*4Y! -NXY(IXDEB=)H9HUDC
MD1@\<L<BAD=&&59'4@J02&!!'!U!R"I*L"""001@@C@@@\@@\$'MKOL^@=ZD
M$YN\PO-8"S%.*S.=\ 1489M8Y%P9>7R/BAPJ2+A[%)KJ"*SZQU%^+6LVB15Y
M5D4'U5EGJ[V8E9=QK2;QN\/X>E;O#>[3"(K+?)9=U/&H6*WW-1YDM/&!PE/5
M)NJ*:,<1E*F)52**(:GW3]R:LA:GF;=44X!#$Y:6'L&)[ED.%<GOE"223KL$
MZP9J0Z:::::::::::::::::::::::::::QNSKG9,/J "()-!ZG(@(!T(GX+W
M.1$/"9^D3?L03"'D-><A*J6'=>?\/\=>L05B4;LXQ_CW]/O&HX"X)F _2N!N
MD ,'[C^OG]>1\??]>>/MJF:I' <]SP/@<>H]/F?Q^>O<4N,E%].<DD8S\R?E
MZ?P&L=-D-(3G_,X^9@XZ^/L/'GXB'/\ MUVWCYZXV'Y?G_EK[4+\@<"B*H>1
MX'A3R/\ N //[Z["10?E]W?\CKS[L%PV?Q _'7.-;@V4\=8B8>./EU!^_GGD
M _3S]O[PUYR2D#*8!W?,<?#@<_<?GKOY3'L,^N"<X_CD^O.,ZYO\2(=(@*@
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M_H_IRDEW@L/+:JZJZ<I"Y((SNCFEC*MD,)&./=UMY>*H0W'I>FWA#67J=-N
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M@<Y],G;C'8<'X:]IXH[/:9:P_623H84W9RDC8QCY+N#<Y!P>=;XB% A"D*
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M+K,YN*LL:D5JY2>(G+16_I/HNT=.V[J2V=&]*TETZ?>W5D-QM/3-FIZMY>F
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M+4+=NP8(NFU/'%-CKUHS\U<-VBRT=7<I,ZR<V.93@R)6BN1AFZ+**$<,"2=
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M--?1,TT*Q+%,)EH%DC>)88EA$1C2&.-(H42)506:7P@\9):I:MNE*OS41XT
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M6]['.<X')]?0^F-4#0S0'ZO=*K$%\\$+CWNQ(X^'KCY\9!6\E% P,WG4BO\
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MGA3C&1Z\9/Y'[N-2NAL\,(#$;FX.YADG^)]WD>@U&;&#;-@(1,B9>.//QZO
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MQ0+VC0 GXMW=O_>8D_CK\^7B-UG7>(77'4W65P9S-?KK4U<,4AR:2@5O)ME
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M)). !\23VU!W\2+SDO\ J^%8)O'5M7P?,F1(N2;UE=(?(.,?44J\-9\B$5*
M"VGGSVDT1TT=M9NMVBZMTEXI2H\J.+F=B6_V$1&[[I9,,L7_  @22 @JZ1G!
MUY>8TGZH87_:N#M/_ F59_\ B)5,$%6?D#+:9B*MU26-;)%W+WO(B[55D[R-
M>'#65M ,G!DSN8N"3:,X^ I, Y.B@HYK=%A*U /'""<@_CGDJ9=^MTDF9QL
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M:Q0=7=!2]05<%9+54UUH+[5VFHDAE6(?H^MAA7RYH$>(LDP?S465T15]YGB
M^RZ/98IQWC6$NJJ3BHY:C<L6"Q2,-[A2S2S=LZ:/T48]"21+%$6;J,T6G+I]
MV4F107,X6647UCIOHRTE+X?]&]$6OJ=TFZ>\0Z'Q"O%YK;;YS7RXPP5%-511
M4<5;$MO26&2GBI\U%5Y4=*HE,\LCRZFH\=*F?K#J;JFOL2/%>>C:KHZVVRFK
MO+6U4<DL,]/))4O2NU8R2I/)-]3!YCU!\L11HL>I,9;?7%=SC9<K4RTI0%>R
M# N8_(E&-$'<M9R=%!T5G96#M.1;(Q[\CM5!VY%1BY4544FA!8#3:QFTWI?!
M^:R^*E\\0.F;]':+1UC:9J/K/I5K<T\%TNIBG%/>Z2H2L@CHZM:AXJB;=2S-
M(\ET(E#721H8I/XD1W/H"U]'WRT/<;ETW<8JGIF_BM6*:@MXDA,UJJ(6I97J
M:=H5DABVU$2HJT&8R*!!+&<?L^?,L$T7#9KXT4<4_*#+(BL^%>6*B^1:OY)T
M:*3CQF!.@H=.0 H.S.U2@=(0%OTGZBP>B^CA54OA1TKX;'JVG>;ISKREZSDN
MXL\@BJHZ>JK9S;THS<B\3LE6 *@U#J&0_4D-D2JI\:J>?Q!Z@ZW'3TRQ7OI.
M?II;<;DADIWFIJ6$5;5/L0615:FR81"A*O\ K 1SSFX/:-%YMOE*R''64E1G
M:\HP;3P_1QDT[)%1DDC)1R1P3D8[V[YD<KE CE4'0+H+MDSE(6/0*:Z^,/T=
MJ#Q0ZLZ8ZQHKXO3EVL[TL%V/Z--<EZM]#6Q5M$C!*VB\FJI7$\2S/YXEBEA1
M@BT<0:@\-O&>KZ#Z=OW353:C>K?<UJ);</;12M:ZRJI7I:EQNIJGS*>=3"[1
M)Y)CDCE92QJ9"+CZV3UA'3333333333333333334*;E#O4]NF?E([K^H$PIE
M0[#M?VGO2T6=,U[?D/GWP)T>0^7'D-5%)CVJFW?9]HAS]WF+G\M07Q0:=?#/
MQ$:FW>TKT+U<U/L^WYXL%P,6W^]YFW;\\:Z&Z""[I=%JV24<.7*J:#=!$AE%
M5EUC@FDDDF4!,=110Q2$(4!,8P@4 $1UD=F"J68X5068GL !DD_<.=?GXIJ:
M>LJ:>CI8GJ*JJGBIJ:")2TDT\\BQ0Q1J.6>21E1%')8@:[8E5P#8MG.T"F4F
MFN9J!LMJ );.5FH+6%;Y'E;))Q17'T2 O=J.QHF.8.%_K$4>_7-Z+>%C8WMU
M^.5L]D2=-L?U%4:RK>:3&"<1*Y;8D:G"@JFYFXY*I]IV)/&0?MITAX<OX/\
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M:M!64U9ZZL@I&%/,VVJD:!8H"#YA>>:.*!\$8"B5T?<Q"A1O)"9;5THJ.2K
ME&13JKLTP9%'N*Q"@LR_;=1&<=B2.#KK'IT?+6Z6Q35RM>4OPZUFY)T^=KJJ
MO4K=/JF4$IG\DY53ZT2J"40:-DRE8-FH$9A&G13;K%['Q$Z!Z%%13"P?VUZH
MAC>2NJ+YBHL\%3A&>EI(*;<[/#N52T2,C';L<E2!WAZ1ZKZCE0O?9.G+'(TD
M$:6-DBNDS,,(99Y3Y.P[22QD "N3W.=?/6=OB]8/<*E&9GJ;4SB623CY4C!P
M[E6BQ4Q3D3(MU)%!BK)NUNTV676Y;MWS1VZ%L)W0)(3*Z^(/0G47]G>K>JK1
M-8([?;2*^VU!-OIKB,8I::C-0$WLT(4PP@^<R,H"''O6>S=*]74377I'I.KB
MO]=4U@>EFID_2%93*A'M,]<]+O2 +*'$D\S1PAMS;BIY]TAL-M:;TRC/---(
MC+MTE)<JK4Q)OE\X)_G!Q++23YT^EC,$'ID4A73!(_M_B0ARF"0I]*+I^AL=
MSFH;#;Z*S6V,T-F]GKZ)9F9HX_+:+,X20JU1 S+@$#=GWE;'>I^CU+_:'IZ@
MN]]N%QOD];%<.K(_>6BI*99IEJH* [2U-43PTU3 LDI$1#A@PCDB9LWC]J$[
M1.TTQ]1J2\^2B@6:RN).3?F3,<Z97"# [?L.3@4!ZU5GR/7QP''QUIE=?$>K
MOM?+=;R+G<JN<G=<)*>&[1) 9&:.!887D,1CR29-H#YP"<'7U M?BGX<]#V6
M"Q],6.6VTULI8Z6W6#IVWT5GMJHD:DM57-I$JYWGDW2U+%';VII9$)#9,C16
MVS,,P=$LK9[Q\C=0-J<T@ZY&)E$.. !5J^<$2((^#>])R'@0$O)->,?5-K<A
M3-<MQ&[$=LGH4&[D 0M%M!^) ]_&2<YU![G](#J60NMJZ3Z/MT;<HUSN%RO]
M5DYW-(E5[/ 2YY*C<%SM4XUG0[-,D_E(,9+,S=94"?UI"UPBB BJ')55/J+5
MRF)2^3G[34X])1 B1A 2Z\I>HH48&FIK]7N.%#S4T4>3P WG2(54'X@8/;GM
M::?Q_P"LU.^NI>A90A!\M[ XC(4_984]7#+M/;,<J,!RK9',092V:7]VUD(G
M(E6:7@C=L=>&MT6BC7<@ULH%*)7R=FC6ZB+]1(1*95L]CW+!0"F$6!#"(IWW
MIKQ\\1/#FXQK;;/=+G;8V66>V>9!44T\#.-Z52QS,?+498>7D[L#A1JU=?R^
M%'C/;%I>J.D;?9[_ "QL(KY99B6IYA&0L]/530QW" DG_HLTLU,ZGRW;LVM<
M-HC;Y1I&0@+&1V[M-*AYP(.4=I"C^+Z4[331DD%CH\I?B&%03:ODSIG/^<D@
M E.@L<A=\K5U;TA]([PZNULH'_1]9/$AN%NF.)[/>J>-9:+RX2?,DHYY3LC,
M8;R]I$FT[=VB_3K]2?10\7[)UC[&;U:(EK(8AB-(+U8+J305T%9%$=D5RBIW
M-;3K 6@0P\ONE"G:K^.,/9*L=4OUDC:=+3ZL3!6%O+21(QZY>0;1M%3SMTX;
M3B2LJ4P.&*(5M9JYA46PNI)%F$:W;JJJ:%WA+O8KG76:N6OAJJ"IDH[A'4JD
M<<KQ2&)P[,0JK.R$QD.H=6)7 '/TBM=AL'4U!17FS4=+=:&Y45-66:NJ;=%)
M401UA*4%5$\1-0@C=@DLLD3-'/&%?=*=NHFR!E"1SM/PQG2*K2@0M@</*55X
MX7 35Z=$5.9&=E04_JK"'2(@FJR:H1[--,"(NW"#N2[2#7S@@FDB]L,-4Q0D
MTU'"!&TTO8 B0H'C*9.(\]P>>3K),M=TKX)6XW*]5L4_5]VI#YT3MN:S1R(=
MI6D4>?!(5 0S5 2-N45L'+R$YPEGF_-I!K58JFXY>3+%9,BJL$W>R ,WC<Z!
MG!7:@%<$=B13J2$I"]*@@<43?(H76P7>XV^]4-9?NDMMO@FIZEJ:DNE/;ZJ1
MZ:0NDK1S4\R,TA]PL9EW!-I1=FYM?NL/'[]+].7.R=*++-5U=#4VR2Z7RJO-
M10K'5"42M06^T5E+"M1&LH9:BM>H##:AI=B>_"==V0[P:>T=5>G/'C&O$=+O
M2LRN*@"*JXD;-EUT_K<2Z75(=)! "]PI^RD4A!,'28=;!]1^,G@=U;<DOW5O
M2?6)O#TWLM930U!>"G-(,(D;PW5(G0NI"R1D*<[RJ XUJKT%<OI!^&O3L?2?
M0_4_1--9HJRJJXKC56>WO?9GKW:1S53O9"&B7<#*'Q*5!4#=QKA7VT;=B@Z.
M]DH5J9XW#J1DWB=<0>M3=0&!=JO3#UR3(;H Q ,DHJ0>H0.B8PAJ+U75/T8+
MI%M_1/7MJE)W&6DIS6R1J RX999[A$B%G4F1(TD!55$BJS!LH6[QK^EA;XY8
M+M6>'/6UKFA>&:U7.V4D=)4;RN3(UNHK?6J0BNGNU"XWY/(4ZG_#3#(]644B
M<OIU.:8(J=!9:-]XVLT>82 )4Y5D[8QS>02( &_LB#) 3YG<R:AC!K%U\M5E
MJ9'FZ-NURK;<_P#T?]/"DHZM9,L1#&!4RQF)5*8#FGF#L^85&UFYK^J[-6T\
M$]VZ'3I&\S-F2BL%PJKCTZ0 K/4Q1U<25U(6?S%]G=ZQ%2-66J)=DCO1#UW%
M\M#F>-[S4U%"%+U(-5DEED1.')$W"*IFJ[9QX'K0<(I*DZ>.!^^H3/'46R18
M[I.M-+,3A7=3Y[#'F>04+K.4Y,@A9S&,EPO./&DN-+<0QM\:5*[ Y,'/DHP)
MC>53AZ>-P!Y;3!%?@#)/,3SE8B7CP4(ZT1IT2B;N&;QZ@]'(CP *$66 QN Y
M'@ #S\1'].L-ZH1Y@@AFFV95ITIJK;D\8'U0R#R<KD?/7J\4LBD,R1@$')DC
MW$@'&$W;L=^=N 1R>VN:QA;;MB2],5L7W:62G5TE"K-V;4KN(>)% 3&9R\0X
M(J@Z1.7YE440ZD#]*B*J2O2H2HH.HI:&K\Z!9:?*[0TL<B(6.3RLBC(([G&/
M0GX4=79H:ZF:.KVRKG/'+#\0<KZ]NP[^N=A^-O4(M$?/*U7*].CI$6B*#A],
M4M):/=QR2QRIHC(1,D]<M5UE@ RY2(/6 B@0QTTC_E]S(]OZPJ4I(:J[P+[/
M/+Y,=53<%G'+&1789P.2T:[." 2<#4)K.D(6,ZVV<^;3QK++3R<[58X4;B -
MS'@ ,Q&<L .=;-J-D2G9(AD9VG3;298*\ IV#&*Z9JB4#BVD6:A2.6#D"^10
M=)I'$/D0#$$##-Z&X4EQA$U),LJ9P<9!!^:L%<?B-0JKHZJAD\FK@>"0C(#
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MZM5FJ8+EH=1O61HQLL0@@H#%)E&8V9/6Q3\=L2=2*X<^':8AW I72YRY#VR
MN>\II45L_'=D(?7D@C/X:G=LN/T;NF4BJK-](WQ$H+1 @D3IZBZ[OLM'Y0.[
MR$MZ6F2Y1;@-OEPO%./V65CDTIWR[^&V>*]#X,PNTM=<P-5GA7KAY;K!,SEU
MR9+('%9M*VZ1F9*6EEF+-R=5VS82TO+.G3X&\H_627:1[..NEJM)IF]IJ=IG
M(.Q%"E8L]SE?=WD<>[[J@D G/&NOTB_I+4_B%;8?#_H%;I1]#4DR2U]QN556
M273J>6$^9 M2:R6>M6WP3DU&RNJ)JFLJ4@GG6'R$C-&L%XIFLXYAQSB6 36/
M(7NUQ4&=9$G<-'1:JX+3LTH7@?ZM!0B,A,.Q IA*U8K& IA "C=ZF=::"6=N
MT:%L?%NRKZ<LQ"CYG6L_0'2%=U[UITST=;E<U/4%WI* R(NXTU([^97US#!^
MJH*".IK9C@XB@<X.,'OJQ[!I%,&,7'H$;,(UFV8,FR?/;;M&:)&[9 G(B/0D
MBF1,O(B/!0Y'6-R2Q)/<DD_>>3K]"=-3PTE/!24\:Q4]-#%3P1+]F.&%%CBC
M7^ZB*JCY#7V:XU[::::::::::]+ANW>-UVCM!%TU=(JMW+9PD1=NX;KD,DL@
MNBJ4R:R*R9C)JI*%,10AC$.42B(:[([QNLD;,DB,KHZ,5='4AE964AE96 *L
M""" 0<ZZ21QS1O%*B2Q2HT<D<BJ\<D;J5='1@5='4E65@592000=:,MV?I'I
MSDC*7S; ZC8AP\46>R&)IMR#"(%RH(J*_@B<5ZF\6FLH/*5?FQ2BVQCJ>RFH
MYBFUC$MI/#_Z0C4D,%IZYCGJ4C"Q0]04J>;4! ,#])TJX>H*C[572AIW 'F4
MTTK/,=)O%7Z**UU357WPTEIJ229GFGZ5K9/(I3*V6;]"UK9CI5=N5H*TI2Q$
MMY-;3P+%3)I6R+@/-6)7:[/)&+;O41;G,07DK7Y L.OT"(&.QGD$5H211 0$
M <1\@Y0$0'A0>-;,V;JWIGJ"-);+?;7< X!$<%7%[2N>PEI'9:J%O[DT*/\
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M&S?A[^ N>H[-WM0A_JOXJ%AB_*F-PK/?^J1OT3N_Q+^L_6.U+='T7Z?]+/\
M4?>L6GQ^?^8/^&JXXR]/+%N*=JN6=O52:T&%O.9L=9DH=ZSO7L35VN6VSKY7
M6NJK>=MK>-D"S%L5JQ+>FD@TF+@J>0+%$Z'T8#DI6K7.>0?AC ^[5O\ $^+:
MKB"C5NDU:&K\8E"P$!$2#V KT=6R3SV$AV<2:9>LHXHE]T\*T[IN^X>*I ?L
MBZ6 O69K@G/]?D-23IIIIIIIIIIIH(\ (_MYTTUINWW[Y[)7;._P1@J8+'S+
M!%1OD:]LNE5W!.7"12A6*RY QB-YE%$YC3,H4@N(A91)DP.C*).EF-EN=R6F
M4K&0S#[0![>OH#Z'/]9U=K=0-4.&D4A.ZY&<_/T]?Q^&>1K0AD>/ED(U^^IU
MO4K2T]**(W9ZI(.3-+9*>_33=+30$]RZ;2+=03BZLK9 \BY-T$D0EF;1NT+
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MTTTTTTTTUZ$FK9 QSHMT$3J>3F2233,<?OR<Q"@)O/GR(Z[,[N &=F [!F)
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MD@^$H@Z?IL$:\S[+N79N-5W4,=PNUZH^DZ&EEJJV>ZTL%9"B>?/-<)IT>J,
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MRTJY @/9N>E7*CB4L$_)&3*K*3TT]D)F4<<N)!\Y7,908\\CR'<[%B!M'8
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MO&C*G1\L^20Z8AVG)RM0K]<@(Y G:!RV6GVIIM@=#E@+2.<RZ9E3(-TU]F?
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MQ<K:U1-7L=WG2>;64*QI&45(*/R@,,K#89M#@6,+AEO)HI D:SV6V2 B)2E
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M&NVDD;A-,T_2Y%8B933B&J#Q32C\1_#^S^*E'!&]UM'DV/K2"'AEVLL<)*
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MLAI9B<=FQL##ONSGOK;GLPN BXL]*74#YI)3K+[>#(&29OB\"(^3IKL1+P'
M B<1U;.@J\1UE?:F('FH*Z)>YW>[&XS\, 8'Q!([ZYZ[H&:EH+DN=L<C4,A^
M1!ECS\#G<,^N1WU?_65-8STTTTTTTTTTTTTTTTTTU'^1\7TK+$1!0=[B3S$9
M6[]CS)L.W)(2$=[:YXLN<+D"DR9U(UTT5<I15IKT4_6CG)UHV22;G8R35TR7
M7;J- <=OF/XC!_(ZKDGL'VXQS6K-JA%Y(QH:E(7F(J[[%.;<P8SDX>F9%M9;
MM9L;,Y*E7:%>(XT2LQ$Y*HT<BQ8''':3:XY:51F7V^FN<G^7P]./_/X^NLFN
MNS+ =\7LDE,P-J966RY'IF7CW>M9)R'5[Y!9+H.,F.&ZU<:I=(&S,+'6I5+&
M3$U-F"Q4@W9VF#E+ QM+690L4V1^TR?\/3XY_GKCT-B^UY.MQ]2>8V&=@FF/
MMP&,I!O:+9=+.\ME7W3357L>?U+W,SUAD)J\6/)L[3X24G;=:)&4LZ;I-T:.
MEF)7SHJC3)_E^7;^'PUQ-:V'X,IX79Y79G/D?;,AQ6,X.W9'-N;W OLFRL3A
MYU>W./(U2]R.1G=A3BX(F2+<T4B$WA8B8:R"03C"2<,FCA%ID_+^ _RU8?'M
M QY@C&5<Q]2F+6GXXQU7TXR);R$P^>I1</'D.LL[EK#8W[Z4D72IS.)"8GIZ
M4>24D]7=24J_<NW"[@_(!)  ))X  R2?@ .^N">Y) ^)X '^ 'Y#6&_Q\@;"
M/9Q)6[5F=4W@DQ26;1KCPI3? '?\4[0\@J#,-&Z_"<BVI<W;K$R %#!7ESD[
M1O?V9E_7.D']V0DR_''DH&D4GT,BHI_>UX^<&_5*TOS3B/[_ #&PA^80LP^&
MGX7SE<_E;K["8KB5/)JWB!HG8[&(!\#H/LI9!@@:.&+Q(3"HC 8GJ<Y'*" L
M+4<Y".--].GV(FF;]^<[5_"&)L@C^].ZGU33;,WVG6,?NQC<WXR.,$'UVQJ1
MZ-K*ZAAW'%'DCS\)6TG%L6;G:.;S9G\K<\@/&9Q 18N[Y;WTY;G$:40_(BU)
MD8UJ7\MHT03X('1YY9!M9_<'(C4!(P?B(T"H#\6VY/J3KLL2(=P7WL8+L2SD
M=\%V);'RSC4FZ\M>FFFFFFFO6"20%.0$TP(H)Q4(!"]*@J?SB<O'!A/R/6)@
M'J_7G3.NNU<$;5PV2PP,,6^T2.QW>N>_KH*20E(44TQ*F)3)E$A1*F8G@@D#
MC@@D#P42\"7].-,Z%5( *J0N"H(&%([$#TQZ8[>FO2[9,Y! S9^T:O6QA*8S
M=V@DY0,8H\E$R2Q#IB)1\E$2\@/D-<@D<@D'Y<:Z300U"&*HABGB)!,<T:2H
M2.02CAE)!Y''&O4=]&,7$?%J/&#-V_*N2*CCN&[=P]*Q1!5R2/:&.11P5FW$
MJJY6R9P;HB!U (3@=<:]%4* J@*J@*JJ  H P  .  . !P!KV-6#%CWO9,FC
M/W"HKK^U;HM^^L;^99;LD)W%3?JH?J./ZCKDDGN2<?$YUY14\$&_R((8?,8O
M)Y4:1[W/=WV*-S'U9LD_'7EPQ9.SMU731JY5:*=UJHX;I+';*^/S&YU"&,BI
MX#YIB4W@//C0$C."1GO@]_OUS)!!,T;2PQ2M$V^)I(T=HV_>C+ E&^:X/SU[
MS)D/QUD(?C[=10-QS]^.0'C7&O0@'N ?O .O I)" %%-,2EYZ0$A1 O/WX#C
M@.?UXTUQM7@;5P.PP.,_#7Z*4I X(4I0^_!0 H<_OP'&FN0 .P ^X8U^M-<Z
M::::::::::::K)B?:U0<79?W%9N(R@9_(.?\M,\EC:7=/A&UKI,6TP;AG"P4
M.*M8E=S+ZOG+B,]LZ#+L&I9"V2;,8TX-S/7S7).<?(8_,G_'56K;Z<DIFRP7
MBW;D\^+7ZX3.#'&!J1;\8XGKF%['5(@,H4#,\%D.RNR3]\97S*5-R3BNAV6F
M/S1U9Q_6UV-@0CL<)(6Z;(LTS@8'X\_(CY8!!.?CJYF%J1G6HEG5<W9WALSN
MWC>%8P"5;P_$XCAX-"*^IB^E';-"V7F6FK+91>LPFW8S\=64"P[(*Y4( SB4
M._:''H,?CG4Z::XTTTTTTTTTTTTTTTU&&:\LUG ^(\D9GN24FXJV,*;/76<:
MPK4CV7=L("/6?JLXQLJLV05?/.T#9K[ITT9D65(H\=M6I5G"?M!"]1-% A4/
M+(L:ECA06. 2<$X'<X!/P!/&O.6188WE;)6-2Q &3@#/']8^.JE>G]ZB.+/4
M$I-OLM&KL]1+#1)\D-8J5:'T2]DR-'K8CN)GXUU&+"1]$OTQ5:JJ':M%F4FT
M=-%4CH"R>/:RY6R:VR(DC+(LB[ED0,!D'#*01PP[]SE2#WR!3T=;'6*Y161D
M.&5B"<'LP(/(/;D#!!';!.P35MU6:::::::::::::::::::XF?E$H2#F9I<>
M$8B+?R:P\@'";!JJZ/Y'Q_*D.N#P"?EH.2!\2-=/K&_NK-+O[$^Y4?3\P_FW
MAS#\E7DL[5?.5!YY$3G67.8PB/DP^>1U KP[^8P3+EY"N.^23[J_><' SJ>V
MF'>D8"X \L#T'OL%&<?%F S\QGOG4/9=MWL\D9I=D64*JPJ=*PZR[/)E@@9Q
MHZO=[4;D#J,"IF,8XK_4F *).YMB("!CE#4BZGD%N\(.AK8#ANK+O?\ J.?C
M!%);D-M64]LPLK1!23WGX R3K*_T;NEDZM\?.H+K6 -:^@;59:8.1F".JJZC
MVAH)R?=5_;C35!0YW0T-1GW1Q%,O6?P5N/Q'3W3<$YEC6XM6V(I%Z@;6V;K5
MJLLJV6.'("+%O>HB$;J#_,RBV210 B:90F%D_P#4_P!'"LW82?J[K!HT/:0Q
MT;PND:$<LL4=CW*!@ .SC!8[KS:+V_B7]-6XWXR-/:NA>@KK/;@&WQTD7UMG
MBFD!/U?M5NO#U:MC<4;.KD8JN$HYPY4*M# (NX\UJBWCLP&*1D@PN%@9)=0E
MX%0X-T2 F0.DQ@ O(@4>1P'010Q!WF')=L9P<L6;/?DDC!.2>^?NJ?'??'XG
M]4PP%0));;.2!]H5%FMLJ-S@D,C Y.<@CT&-1>T@47>56Z[Y4[\\*P<+$!P/
M4#A^OU&(H8H"'!42(',5,OD#F3^0<<:CWBIU)5V;HPTEO!IWNU5'&9>5944[
M2@=?>"O@,5! 8\X.=8LZ2M$%RZ@>2H!E%OHY'/(,9)RP;:V1O4$+NQD 8R1K
M/$LLY"H.;U92@6 ]>?4]E'QW]611,RDS+LVLB^";9*D5:RB*CAV#8A7B1RH)
M-DO;]E43K:C/A]T[1P66CN4@WUE5**LSJHRDRC88)&(W$%'9@A.,<\8&<M5E
M+255(E/5*S0SAA[NX,@ ;;Y1& N,#)!&<X/ &MKV.]]LY:ZXNUO].0&09%[:
MDO5RKMVKCX%,<31TBY5*181^2ATWI4P 0,*21#$ZLKUE')41J(IDB8)R2< G
M [$_=GCOW[]\9'IM:69Y*69MH<D!R-R@YVDE0#\!^'?.H]OF5\67B.774@6S
ME\?J4[<M$,%G29!+\%3NVQG3,.L0*")3R')A*7D4QZ.8P;;=(9HU61I$=CO9
M6.U ?O/'?X?(^N;O2T]5#+YTF\M& RX)P_J!_>P#\/Q[9UD;E-NNW[,C&)D"
MQZU<=0A5B(6N#?GC)"09J+I"YCU6JD)/,WJ /%3K-$7+-FHR.H84GJ*3Q<5<
MIV+J:IZ:AE2A:.6.7:\M/4([QM,JA#*NQXG60@ $A\.%4,#M7%BZ@Z7;KNX0
M?I2.9:JGC%/33T)CBE6 N7$#^9')$T:NS. R%D=G*,-[Y@:N8JJ%$A2P$)&*
M.86-4.X[2Y%3K2<PL/29W*N"&,=Z1H5/@>3I,S+CVDVS9%NFWU';M=ZB^U\E
M;6'?,0B9V!8XHU)"1Q(2=J(22!G)8L[DLS,<RVI*;H?HZ/HZP?Z,E:\LM?.T
MN^65Y47SI99!@-42%$3.T;(D2.,(B(BT[W OV[5X\CD>&J"BR3@03;@F!$F:
MI.ZDV34!(B34A6QTP(AU(D.L04TN!,(V\*LI6F4D2U#>6'/*@< 8R/GZ9[]N
M^J2D:&E6 2JSPTLE)73;?VS2,7 D^(FR?M?: P<\8^K#B:5J;-7:PN ,];BD
MT,=8SA8I&)W'MFH=)@,Y439]LY@2,F8%BJ+-P2,0I#];W!31/46V-(0+0]"E
M0C$+Y@G2 2R@XX9'GHZ=CDX2#S0=TCZV@Z+K:ZJHJ3J6::JK8.H*:HJZ:)&6
MEDBA'$1!<FE6HHXA(E#*08JVCKHJ21 ]O+M,=QY@W, @]5 TOW0(19J@F*)F
MQB& JBR1DTR':J*& B:RI63C\Y0PH =0_76VNW4E52UC2P)0BEHY*A*[S&DV
MR1C<K4\+ QSM&BR2NC CRD=L<'%HZVHI;C-1$5QJ*VLKJ6DCH((/(J9$E/EI
M#7W2(>STT,D[0QRO&ID97:.-@S+J0ZM;JN<H1$VDS*]4:*HD]VS;*LW9I(KA
M$Z"@+H!U)O1;.6Y2KF JJ!R)E.43%XIZ]&CH*69V9HIZAJ>C\R0LTL1IH*J
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MR:UQ:VS#(1"4VUQ+(94<U1*@Q^0CM5T6"E>>3Z*K:TJ$HCE5&]&+6Q:8/?\
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M,69U'L!-LT421K\_8=E72;HJG8@JF=R[N/0,%=366&GK*>171BRK@<'XD>F
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M5#W/W.=,G5QT-5R%+VTB](E14$IDN0,X*(F(!?/'J5]WOZ]NWR_#/?MJXO\
MZ$@Q.JU+'(9<^HR ,YY]/3'.-0+=GIC%.5%+VR(I"F0A"%2*!"D%)(2CT  D
M XCT_P XB8W0;N\=6O-\8RBD;>3V' /S/;/\3]PUS!,[RHTLC2,2,;B3\S]W
MNCU(^/?6K'=3,-(8J[$JWNK%*E4608M3D,X;1O\ 5T'KY=,O*[9#VZ)DF@AV
MA=KBJ5 @@F<"U-BHIKI72>2I(I::NJT."<M;Z<5$B*,'WW4A5[#<1DX.JZ\7
MBEM=+![8I\BKJ*6BD"E%>-:AL+([-[I0'.>2>#@:S# DTS_#S--PHV:N#M^X
MD9 XIC'F.1LY2Z%%2B8SI 0-P#=(Z1U!(@AU_)%*W7F*:(37"552*OVQU)ED
M7S7FC20;44'.]9UIB,]O*([@:VXZ#K(JRTVFQ6XBI2R&7R*2&GG%%#22-4>S
M2F9E!:41)&\A)\DM(I7W=NIFEW*MC62= Y2746*W(Z,*9VXHK)G8KJ'()%Q%
M)RFNU(T3*7I9?VASMRKF*)[C9;K&:=E>6))H8R:*-P"DLM2!15"S@9+J**IJ
M2@ XE",0 #KVZJM57%.DZT4TL#3P+<EAD5:F*CBF6HBFI-VU2Z5D5+)(2RD0
M>80VT8U'&1E2M:Y(N.A7NK-62A" #A59))%GV3)B190ADSD=)** *0>W.U=M
MUP,=9,I$O*^V^;V2"U4P9(*9F6CED8.T];45-3)&R,IR!-0""EB)/#4,H;";
M,\]*7VBEJ*SJB693.R[+I3)"T!I(K;:K?;:Q5,L8,<M%=J:XUL$D)>"MM]X@
M#%MVY-CNR126G<0XWL\ZA)N)4T!/Q3^76[A4WK!HJJ^K!CB<47 .A9G;IBH(
MB<Z7845.FKU''PBACIHXP#O2-5591GWT7&V3G'#*H;) [_?K57J2[Q55SO-(
MK"GB:X5%124L8"Q49DE=JBG6-<HJ!MT:)'[J@!<D#5O9^HVF12!*-@SH H84
M& HJ-&C-50Q"+ +I=9R[!0HF A0$RQNX0Y1*@3J'K]7K*2-=TLJ[>PR2.2"1
MW_'/XZACR)&?U@4KR6';&.0,?D3\.^N;HVP.QY-<%<6NX1M;B@$J0H1K1:9F
MCH@!2])2]36-:+BF(E[YEWH=PPJ';F .V-$)HZ^0FF!,83!; ()&6R/7L0<G
M_+5)5=616U5$2M-.<;?W.^.0>3RN<#'&.=8IN$JNW;:A6FF$<6S<;(9-N4X9
MQ-HJR:4Y;'TH9H5(9ZYKL2@A$@W:-DF$-#E0C4")"(M693&=N5L/>)EIKJJ&
M.=%=X;8KS,22559%9E![X\L<%>,C@=\ZO'3%96726IK*F-O+??+[JA4]XEMJ
M XR,GODX& >.-9?1\II/\71H.DT&#FN-"UUP1 I46ZJD2S;D3=($$P]M-V@9
M!8Z0F'M+BH0/B!1->NA[A%?NGZ"2FC"K K4S\<EHMH)7;D8;N,\@@C/;5LO>
M*.KE9F&Z7=,H]1R<*2<9;)X([^IX.M4^XF:?6RY/GY5 2$&Y6+)181(5.-DS
M&:)J"/( *1)]M'N5S"( 1!!7D  .0RS6VGR[/25$*A2E0BROC["8!PP'KD _
M  @9&I[]&OJV)/$&[])7:;9:NK[144J(S !KE3B04J'/<S6^:\)&!^UW'.-2
M-3H"!S92FT;(=N.L;1N)8B640*JXCW!N2JQ\BD'E[%JJE.SE(XY_N7W+4[>0
M;-7*7C=8(:B!*RF(+NF[?Z;@,%6 '.2N.QP>1S@ZCW0_6?5/@KU;<;([RS4M
M'<:FBO%FG;=%<J%6*4U121S_ %-(9(71UJU422HP25=NY=?#AJU6'&>Y"*BL
MB-"@:P1*>+YM\\< Y.JZ[B3JEO9%PL(I2YUT$$X^#GU0*=W7" RDNB7C7@KS
M?IIY^I/#^]='"21J[I&O'4MB57(JUIJV%H[M149/O>73JQJX\8 D7<<$:]O'
M7I+IF@ZCZ=\7NBTC'2GB'%/9.JQ"H\BU=1HL+4$T\4?NP1Q0^?::I!^IKI8E
M7ZN92;\X\A"0MM2C6I ;,&\C:Z4B7IX*FU*HG>ZRFH(B7K,1A(/VB(CP(H()
M% O48>JQ7RK-XL4=2S9>:WVF\.03M\Z$5-OKVQZ3-[+3U%0<;=\I)(W:PS:A
M[)=Y8=GDJE16VM8P-IBA<03T._'!$<;R(0"<L#CCG5V<*LUD,M40!#J*G8HO
MKX*)0#^O(&#R(CY'@>/[Q^_Z:QW;)EFO5H<<,]=;IVC.-R>4AD:,^FX><%X.
M 4.I;<4,-GN3$946VNB!'[35)1%8<< &/+9/8CUUNHUL'K!>FFFFFFFFFFFF
MFFFFFFL!NF4<?8].Q;6^U1D5*RQ5#0=<3,M*6ZR&1$ 51JU.AT7]JM#H@C\F
M=?AY)UP CV> $0](X9)<[$) QN;LBY[;W;"(/FS :Z-(B8W, 3V'=FQWVJ,L
MWW*"=8+^/,M7+X8\QA^%(E;PG=LTNE('J;J_V$I"8N@#O[K+=O@?<P5]D<.2
M9>2\+!SKT\N%/UDN\_[. ;N?@TK8C'R:,3C73?(WV(]H_>E.WCXB-<N?FKF(
MZ?P26L_YV7\@VO)(*?-:J,UST#%Z8G\.&04FJ.4'UG@W)0*52%RI:LEM@X,)
M3AU" //V?J(TB^#GZR;Y'S'&$8>C0I$?X:>3N_6NTG]W.R/Y^XN-P/[LC2#4
MP0%>@*K$,H"KP</6X*-2[$="0$8RAXA@CR)NRRC8Y!NS:I=0B;MH(IDY$1XY
M$=>+,SL6=F9CR68EF/WDY)UZ@!0 H"@=@  !]P'&N8UUUSIIIIIIIIIIIIII
MIIIIIIIIIIK%JW1J33COU*C3JM55)10JTF>MUZ)@SR*I3',55^:,:-3/%"F5
M4,4[@5# 90X@/)S<M-?F*HE'@GK^2A*;5(>1E7$R[E)"*KT1'O9)U8E(Y:P.
M7[IHS17>.)U:'B%9E9PHHI)J1<<=Z9<S%L*337B H5&JC:.95:EU.M,XA>1<
MQ+2 KD/#MHMS+AQ+.(Y".9MDF2\H'B15;$24>AX<F5TTU\LIC3',XWK[6:H%
M)F&M3="^JS:4JL%(-ZT]$2F%W7T7;!9.&="8A3"XCBME1$I1Z^0#AIKEG,-5
M43"9Y%5](TE8&,R8SEC')F?VILFT1C94152 75@02C&*3%\/<D4DX]H1NJ4K
M1$$VFO>WKE>9C'F:04,U-$KR3J*%O%L4!C',P==27<QXI(%%DO*J.G*DDLV[
M:CX[A<SHRIEE!,TUQ];HU*IJLNO4*?5JJO8'HR<^M6Z_$P:LW(F,H89"74C&
MC4\D]$RRQA=O167$RJ@BIR<W+3.LITTUJERIZ6=9R=1ZM CER6K-SI^\O*NZ
MB*OT33VJB[NHYEW)NMP][P#.PJ]CZ)2GR[Y&I,E9LLFT<%MF/:5?DH9)6(_#
MBS78-WX[C'Y8!_K[M<M,^F!2IEG8KDME2^([CIC= 7=9'9F2L&2B5.'O</E:
M/MM+C#8"3RJGC&6AZUB2"KNWIPN_:C,SE C%73B2:R+LA6K3=_#&,?SYY/)Y
M^&=?G+_I\9$W#6#(U@S/G^B2$C,;9MS>V/&LYCS;J:@W"$JNY:OM*X_DLPV1
MUF6VDS"G1VT<RD*[5JW%8;JZ\Z+V;=QY9!6/5BF@;&!CC()Y^'PXX_,_/OF9
M<P[><@1UGKF>,%2D*OF/$NTC<'MXQC4YF'CV%;F[OFRP[>)^L7^TSR\H4L=7
MZ%,X&9.IV 1AYM[.0T_(C&K!)132*GVN >,>A(/\ ?\ /4NY3P<_RTTV_&GK
MDFSF<)YAHN8Y.09UTIFUSEZA5[17WL6DQ^L(!6VTTZLZTDFY*O,#&D:D9 U>
M K[E)KC^OZXU36-],*!9.]G2BN79-6.VS,E(;(T,VIC1K'[BJ]7\H5[.^)(F
MR%5LCPU4#$V<*C7;W!.$!LGOFREIKZR+5&S*/X]KMN[X]?\ F#_')US.._3B
MKF-LK72Y12FWJ6K%FR1GW*\-*6#:ZRD-RU/MNX5UD&<M245N/)E1NW5@XFR9
M-M:4&FIB9.R)4)XGCUQ:5H],\DJT+9&.>P'?CCY?=JU5)V_IT[:34=JX6L\B
ME5=ND!M_"\#"%:*/DX/&C3'06L:Y]5<E;'<E:_5_HGUQ<J)C^Q^JJ@7WAFN,
M\Y^>=50OGIRN;=55(*(SD[JLLEM\V08-BK&CCIA,*Q3[9;GN1SK%WE.+D+4#
M!XO>'KU*"-77I5F5;!J$FL^M"2QXD'S_ *]?\]<@X],_:_[PQK**;L:M"&6J
M?GW*&:8:Z9<B]T/](ZWO:?BESCZC3C**V<Y1V>5#&]5J<GDW(,S48Z$@LDJ7
MV2LDU=+W*3ME;2T>1M$P\O%H5AKC/ICTQ\^^>?Z'\\^@FQ.TA>7#!3-\6IMN
M6W8DWG%Q*.*50R83+J=U1RVG!CFS^)(PA\8)YG0)D,M?##)+<!2EJHW\8 !0
M,TS_ !QC/R[=ONX_YZQ.C>G1-U^P/['-Y?I;%-[G? &<BT'#F%);$^'FL_A.
MQWJRS\ZQQO*9HR0RALFYK=W5%'*-\K4C PLP6GU)Z:@*3#65DY=KG=\O0\GO
MSC\AC@>F3J<=K6U&?V]WC,]WF+[2)-++OX34''F'L4S&$\2PD[7I.\RM@R1^
M )+*^5XXV6LG.+FW)DRWUA>F1%J3J58<NJF66;/)1ZUP3G&,\?$Y_P !Q\!]
M^KJ::XTTTTTTTTTTTTU&5NPYC>[R99^;K*"%K20(T;WFM/I6EY :,T^1*Q:7
MZGOH*XM8XW(@M&H39&#DOY;ELLG\=>J3RQC:KG9W,; /$3\3&X9"?GMR/0Z\
MVB1SN*^]VWJ2KX_XU(;\,XUBOX2S=3OG3<BQ.2HM/Y%J^9(]**FC 'P191N4
M\?Q#<T8Q;I=(F7LV,,B3SY4G4ZF^M0ZNN^^G?[<31']^ [E^9,,C')/P26)1
MZ+Z:Z[95^RX<?NR#!^X2(.!_Q1N3\=/XZ-*Y^5END7#% I^%;'*,DK3C4Q$_
MBXD3Y%IRDS#U>$(IP5%]D]#'3Q<IB'^EI<B4KV<M^ID2;^Z#LE^0\I]K,WRB
M,H'QT\[;^L1X_P"\0&3YG>FX*/\ [P(?EJ8X2<A++%,IVN3$7/PDF@5S&S$)
M(-)6*D&Q^0*X92#%9=H[0-P/2J@LHF/ \&'C7@RLI*L"K#@JP((/P(/(_'7J
M"& *D$'D$'(/W$<'7*:XUSKYWB";EHY;+% R+A!5!4I@ 2F363,F<I@'P)3%
M,(& ? @(Z'GC3X?(@_B-=.5G9BXU9WQ1$Q'!J8XMY&PH'*9%<:\I()IF24()
MB'24]F4Z9RB)3%,42B("&H@+2;IU/:K=$&/M-VM\'?.1+61*X(]1L+?#GOG&
M#,HJ\4EDGK9,!8:2J<D< E*64K]V9 GRP<<:J?M@EST;'V5\I.W282=:H\\G
M&F5'\I]9+]:'<974E#FY-RO(5:#9D_U4WQ^KX$ VI;U);_[=>/+V:D&:9;K:
MK?(JG#)0]-);A< AY 9(;/59.""Q;W1NP,U]25TGAW]$/PGMU;B.KNEDO76-
M3CCS*J\07*[PM@$$0D]4TH1#N942-=Y*Y,\4RCFH^TC'9W*1DWUSRC2;@H93
MD%/:/YABG7E#]0=?>4J43"BH!^DP'66Z_F!M6KQVZBCO_B36)!(9:*T34=GH
MYQCRFEH9Z@W!8P,KE:FIQQD"-57'N@FW_0JL;6NOMYJ%\NMN5@ZHO-5N^W(E
M51TZ J2 =@>L8J#G "@D[<F2,<R7ML)M'1AX%:>R2Y#SSR!\B6PQ?\1$I2A_
MN_7C6-+;&7DE48VFLES]^X8]>.>_X\]]2KZ0;LWB9?OC!2VA%QQP;/0D;OGN
M(^'SU'->52D)AU"]TJ1WR@QR2XB')5S$* "'4/@RGYP (" ]PI0'[B.L*^/%
MMK+=?>G.J5@,E(T%!0MM!.*ZU7)KJ >0-K4NU7!/O 8  YU#O#FM26@N5O\
M=>>*<5K(PX]F7!E/?CD'!)QR.-31AZOY5PY:3*P;RTUJT'4"1;H0\K(QK*QL
MT5#$:G.9HJFA,L7B2BS4B:YE2-W"P H4BS86Q\Q=,7:BN4$-3!D&LI/-VY&
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MW;<8D=XYSE3F6,R.(W' 5F&",G5F\4.HNB.G;+5_H*LH:FLND<3M%%L=!3K
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M/!X'Q!R3C*_07@O_ &AI8;WU'/+06N0[X[="-U74IW)EP D41!!1ED9FR05
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M%(CB4217$"JJHM991TW3[@=TO;$J@@<!*6CG6*WU,-/2G]5%AI S-GL"F>V
MWPP>!SG(,CZ!@J^HNA[=+=BSUL$3Q2F7A4C5_J50'.T-&%;DD' ^[2,ITSD"
MQ+/'*(G*HW 2G5_,,G]S /)@'C]^.0\^1$ X#7K#3RU<IE.YB3MS\,8;'8G'
M(/P^\G.K_476FLE''2JJ@A_V 0"N, DC/.003V( XR<ZK[<:+)-,@?@Z)1!9
MX^=)1J2#83 11R]<$233,<A_/;,<3'ZO_)E-T@'Z=J"TRW:_4-J1&*O,6K=A
M"NM+%+]:ZD[@K"%6.65AN_9/8W6OZII[)T76]1L4,ZXI[=',-Q:LF3RZ9F4;
M&:-IVC.%*';R6]=6JLV$J+C*-K#9TVC&\O#%(\>_55TES'DQ/[QPLY074,1X
MBL?DYDETU4E2B?N ?DQ=90O=/'2543TR;6@6*-%CX&V-2 Q'Q;@MVY X'(UB
M.QU=QKK5444CR2PW6$Q5J 9+EA(PDR0<2%I A;!]TKCT.MJ6/K'BHE&@K'4*
MI6S&FX-C)-Q91J3*)8'=M$SJHD:H%13740<=:7!032*HGP)Q$! +F*BHDACD
M8.QDA!9I<LJ1Y(PH&W&#N/O$]SQK4N]VFKM]WKK561O#)054D7EMP4&[>F/D
M58-\#ECP"-4YW$RTE/QCV"KZ"11,=U-S -"-H] J33@AEE@3%)/I]PH4H$,
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M+IJ\M:\4Z)R!HHI1Z-1661::1O9*2&-CP9:C%5...P$BK3+C/NE*99%X^L.
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MW'<.^..<\?'TQ%^K^II[S<*R\594>="(J>-6RD48((C1<E54'LH &<' SKM
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M8QY:4\9(TAXUKL,QD6JL:_EU+.XN%A=G8QJ-<:R0JRT.,Q*D3(HU9U>4<.B
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M.<UCW.;J<=UE9ZB>P,SF2*L@=HFLET%7 BHG5\' $S.#&*"H#R0YN5 $#*&
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M8_L\'=:/8IFI6ZM2"$M7[)7Y!S%3,/(MC=2+QA(,U$G#=8O)BB*9P Z9CI*
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MM1+Y879$G$CMP/B=OIV[ ^I^[6"LL=E<61)S*H=THG]PBW4+^6)2G*=(54C
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MD#X?(?=Z_AJ'WBKQ%QPS,5&#[WS/X #GD>F-=E8I2D "E*!2@    '
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MG2FRTJ4D]&:$T9DJIJNGN<%<94VCSIJ83S1R3,I[1+N;N&9<XN5E[<#N&P/
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M8O\ MN/9M&1'3Y!NW*"[Q)R8B:<<H:N@%=3T%#/[)F4_I"Y5J^:WEXY"QMN
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M>8I#Q$_ 2(6C)^0;.N4EC<X#>]W*-E7 ^:, P^\C&I,UY:]->! # )3  E,
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MP(<C]A$?^_\ ;_EJU2C=[O;'^(U=TYP3QGOVX]/Y#XG42VX_;9*E-P'4!O\
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M)%V=,[ARL)$^LC5NT;-[M?.HKOU'/#47:I]HD@C\J%5CCBCC4X+[8XE5=TC
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MF5=3B#I6'<UQ5S*+,T3.!;)QC^.<H*ND$3%<*L3*'%!9-H55UWEFITT%>V<
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M^,/_ .\T_P#XNGGQ_P"\_P"QF_\ #UY'<1B\O\ZU\2^_E?#F8D \??D5J&F
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M96^K3DNV2K$J1P?757!8KW[/U!73T=EI+J;<DE'<+%2^R7*E\MXP(HJO=(Y
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M?AC4 +'#CX@Y[YP01V[?@-3GL>GH4<US#!\"7U%[2Y%."64YZ^\WD(U:103
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MS:F.,8VK(K>HXNI$I%0]HNME1JK.0DV\5$/)EEWD8Z.E)-1$556[!4"<&:Y
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MB.2//N#@A0=OKACQ\\&;(B&<8P=IU::3%W&.T#M4 64,N5$QP,F1$_<,H<$
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MGC:*1*0$4D&RJQTC/% .NY GE4B7"04E?!%"33X\V4Y.4/"R-W"[<]N>3@\
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M,#GQP2:<%,'D>#@(QQP P%Z2FZ@/W"@4!Z 3*&NG]EKEN=R:?<PQ^M..^?\
M9_>#\CKU;JJ@>D%,RU& ^[B-2.0?]YQJ/I'T_<])S:LK##1OSC!U@YL3@AA+
M\>?Y(?@>>/M^WWY\ 'C+TM>-T;Q>R[E;)S,RC'R^K[_@!J\4?6UH]B:DK?:]
MH!5/+@5_=P,$AI>#WS_CKW2VP[<9*M!:&&AH]TP)J*!970]M W '%,@0P<G
M!,)2B/'/'(Z\)^DKW4L#)[(.?]NQX]?]7^7YZYH.K>FZ&<RK[<PQE?\ 1U!+
M>@(\X8&?R^&I(J_IYOZXD0!CX)^L9,Y5#OYP[E,ACAY,5 (M)$QN?N82B(?Z
M EX#1.BJ\$[UI2,>[]<W!SG_ &?W_B>#\?.H\0WE9]DU0D8?ZI1%^QSC/UF
M>?X?=K(T=DEI8K^YCH6G(K\B8#_4U X,'\IB@,><@&^_!Q()B\CP'/G7=.BZ
MN.3S%BI<@#_7'/<_[KG\AJC?K<3+LFGJ'0]U,7'_ .4[XU[/Z(F71 Y2_A5
MI_ BG-KB($YY$@<QP?</B(B''2(AQSYU5_V7N60?]&'.<><>.>P^K_#OJW'J
M*W[F(%1@D\>4OJ?COR<?=K[&VTG*[7R4*J=3Y "AI=3J+R)1 X&&-'Y% !Z?
MCX'I$0$.0'E^F+FPP#3_ &@3]:>V/^#C\.==TZDMRMG_ $C _P!TO/X;_P"L
M:^L-J&51Y.?\,=\$^T"@3*_/'GD2_P";1Z0^0CTB!AYX\_8 I)>DKLPPOLO
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M78,\GGG^/?5GN_4EMKK-44$(G\^0Q["\0">[(&.6\PD< \[>QQZG6SC4Y48
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g729258g29q85.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g29q85.jpg
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M&3=%2'%R@9>A)B=HP>%99&=U=K&TU_#_Q  = 0$  04! 0$
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M<VQ!NJO<TZFZEL&R#)V^D=9ZQV")?.3F*K-@D!=!IS0--@G8R(;@5YO+T,H
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MRFI= %WDP/G3W*FH$JJ5:9M&80MM:YM<$]A(Z-MM]NO<MEM%M0^]4BG7<3/
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M;P.<"&W05KU>( RRSCA"X'Z_BWU\17ZI$"/6JT?**F^LNM>(5L*5%GJ5&FW
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M?ADNUMOLM_O<*W[%7<R6+1'K5JM9A-%=%4ZHNQ*[)R+M?RO,-1K+')?(BVT
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M1<\3VE<'*U^.?KE?9S_99^W_ .WA22;G,[3O/%52[JJ5GKX1QE6<X^=_JO\
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M4X\=5:0SGPQC&,8\<YSG/AC[.?'GQA\)A)TYT@N;_P"T4VW_ ,!2+K<- %%
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M(QNP&6JT@-9AF)U)+Y)<59!A)CIN;3NJ)(S$^#DRRJFD$,KJ"[7/C;K 4YG
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MV+KMP3(L3>MK;H"XN-32SMB)'9#*RFES+@6(9-'!HAV]R9<" /F02C]EE%N
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MCX"RU&, &"('/]+?:?F.Z5KH]W0_[AC]FY_M\]UUW<>X>"YW4;P[SXKTP^@
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MPK;D,(MKY"S;ZC9(C=SB[^^PRM( N !;.P./1R_I"Y$&KS#52'X)C1IXI)&
M5ZY&1BIW-9V?$BBK5,?V&1;9AQC;VMWJLV$A%(!+#I63:U"W1L=;F2Z+0!KZ
MED-7)R4LD$;99QB$KH8.=88]\M*QN'1ESW0#$6U)G?$^/5B;2\J)76H#L0M&
M7,%PUQ<&\D-9^I* UQY5UAK<D6ZH<""=:Q%U\R"_2$6'7I))$*'%60F".C6
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M=1O#O/BO2/Z I"6^KO8%"?'RX[C[$\/'/CGXZET9G/\ ]<\^0OA&STUQT_\
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MD"$HL)ASTVH]B:H1,@OR_;L9DO.YB0?9IL.%[BV>>7!%*02BU&O 0%9%@8"
MU7"L5T%%F-9)N0 L?(Y;8]$PFJ7-<94Z(%OO>OD.+D21T*2^IQ^*RXB;;N'W
M(NT37:^AN>R@$&0R4>5()M)&0DMD9"YCY!;\]&&,)F/+GRI,Y3LC#BU3)+\G
M*LO/.+41=(]KFA/5JSTWY&UN/5KI!)C;8!@!X(T;881H5@&59*QQ[,9,S,X/
MA(R0Z[XO*A-M1_68;:;2E8<$7PQJ_7'B4<>HM3FR3HEL#8)Y,"-*E+(';:B-
M>[[*6)1Y1*Q1W$0(69"3<J?F4N*P[)4ZZVE>%AP"+(HE=K\!;#L $'A.15I<
MC.1!D*,N.M R($0MA;+"%-+2&@01"5-Y3E(R'$@8SB)'9:01==*HU)G/C)4V
MGU:9)"P)PH/)E5\3(?$C"C"HI(:,>=B+<@0",92H\Z'%4U'EL*4S(;<;SE.2
M+\1:%18,>N185+J<.+3GWY-1C1:X'CQZM)DI<3)D5QEJ&AL&_(2\\E]T8F*X
MZEUS#BE86K&5AP1<RJU4!2:^,JU7'(% Q#+C,&&EZ3*6G+S[LN5(DS9S\F>0
MGSIDB1.(DB$J40)3Y,F=/DR)<AYY9%DC/]%:_P",1_UL<(ND-U*J$CY8P1K-
M>GEYPV?6)I6:%&RB4RM2I3KTJO2IS\9R5(!R77%NR!+KJX#SBUK<CJ4K.<P-
M@ZA[D7R%5BM@91F<#KP,--L4Y12P3!0F .E'2:L*PHB9D0X[+I.<K"U85+FK
M?D9PI6,N>&<^,HHBMO6+1%V?K#QW78QINH9)X"0*Z0.4P-ADT4J9HM$+@J<4
M!!K(/(DZ-4Y,P=8X!6"_[DC,.1U1G)++\$ [ME^_;V[U-SV_S'WE2<%HM.KP
M$+61%;$1@=>"_)T/ 7$;EIA!59A+>'X>FXD27F9CPV!)(*DO/.D9D./-GN29
M;:7L3L4+NX@D4/>D2( P?!D3/-[6_$AQHSTKS3R)17M#K+:%O^8F8+$5>M4K
MQGE",S/C(G27'2+L.$3A$X1.$3A$X13AS'1-L$/=.K-EE?7#XWNS7]R(>T%A
M7OT5']BKA*3ZXF$_],#VO5>>:*_](1DNQ/[=S'1:G_0R2(\_4M_?'7WK3:P"
MU4U H-U_L>K+*5"1Y#ES)Q2&P9&J]6:@B5U\L#)@Q8&FFJJV5!OUFQ3G/=KQ
MJ0$&$4@D^@MY%=;]@==*+\S^*L=[.6'LE7A-L>M4^L3&AO:.@[XI6J[J*4$)
M/EJW::X#LM=V$>?E%)T T\)(11%O8EDU,1;*WG;OZ]_'-%&VVNK]\T-ICH15
MB'8_8]F :@WIZ/;5A#64<#JZ%JRP%*ALS7=5?L[#\K7LS;D%3\V+[X@C\[27
M"BK:BQ'(SL%#L-T?O'O"+N?3?;!N-'ZI:O$4JPF:Q/VQVOT?IV>6!EYX:5'&
M7A=G:PZ^^-6U*DPXA2"+(2!Z'F,3,0TM*>;\?-SK-#,?HM&L<AQ2OPJ'&*=D
M,\)II3&#&^9H:VHBY6.6/E8P"T!S+%DC[.:ZQ&#B-))6TKH(JA],]SF.Y1@)
MN&FY:0'-.J>APS O<7!U5ZK9W!0*[/"F-VWRT2IAPD543D66TI?>;(H@X=1)
MQ,/SEJ==>A)DR,I=RAQW*5+PZZG+JO"_Z0F@&+?#)IE1:3Z-:65N@>'TVC5'
M@K]'Z:.5]&*JEJZFHDJ(CAU5AD?)5+*AC9.6IY)M>EB.L8^3C@]V^"+X3\ ^
M#G1J7 L;T'P_2RLDQF?$AC%0^E94F&:".)D,@K:'$'Z],8W<ER<L<6I/)Z#9
M ]\U]?1)7"^RR?I!*1=KT>MD6C6?79P3*LADN<@0%;%I%KM1%R-#,2",F'C#
M6!L0DAN7(;G^[6GLH2KQ2KV?$\5IZO!=#\(CI2:O1G1K#<$K\9J.1Y_C]51T
ME-3RXC6\A#&P232P23YF1^O42ESSDO&:MPJ<7QW$HXHZ.FQ;%Z[$J7#*?6YK
MA4%54RSQ4--KDGDJ=DC8F:K8V!L;0R-@  WW<T*I5,>F/]*]H?UYW8+_ +X$
M<(KG<(J">D<KFQ)/6;:EQU?MW:.N+M5M9WR/3PE(BZZ(5*VW8X(Q$IK.QQU]
MU]=L2*Y'L#<&',5$E!HC(XH143<=:]6]$Y?3/'<$T=T<Q+%-)*>6IP*.-M/B
M<<="[$F<VK'MI7&II&M?RE*3*UDVLQS U_IC5N1TNB&"8WI%I#AV%Z.31P8Y
M+*Z;#9'US<.>*FE8ZI:8*I[V".H:(G/AU7M>7,LPZU@;(Z"K$VMZ\&O3-G[4
MVLBS8BVB"=V^FHM6@? *"QV(P=J-3J71H$0:TEC,YF+-$O$FI,^4F1,4WZF-
M&W&$XA3XMAE!B=(R>.EQ"D@K*9E3"ZFG;3U$;9(>5@?Z<+S&YI,;P',O9P!!
M U&)T$^%XC78;5/@DJJ"KGI*E]-,RH@,]/*Z*;DIXR63,$C7-$C"6/MK,):0
M3)XE:52[#C#C2\MF\(5AMOR*:5D,'7ZM[/EQZUWRK2OUGBK\R6TCS?6>5.P6
M"N[\<8^SG&/_ /O_ -<?Y^$3A$X1.$6/EEI26JZ<N,HRLG/PA#C>5N.YP!*J
MRF.OPSAIQ*<*<6K.4^9E+J/'/F\N2+(.$3A$X1.$3A$X1.$3A$X1.$3A$X1:
MQ.UNLO1S%][U"O\ 9^J0)FVMX4?>*!)D@5V/"&IIP_05DHNU(Y@]73<(!2DF
MM(KMK =$MT3+,O50K9*PI=MI+1<450+K&U["U^W+O[U!,6H>C,O]YK$TAUNW
M"*-]DJSL2SC+I;*7O>C"3M'('-D;7V#;2)HP>#HK0":_V3M=K,D'VADB(*M%
M9!3VX*-=U<!3"7=V6&X]0[E*VN]H= ++?.GN^Z&*VC7IUYK-^Z\]?;-#9WW1
M-6UV#34[-L=WU9?**@N'UH#L;J]47LX<:V#47S4J1KZOE+&0;< 4*2P2Q (-
MLK$[+[K=._=QZU)G72[4B_=[>[!R@VZJW4&WI+I1 <+T\^(L8I!!@IVM=D0E
MD LN9#3,9:D1W7HRGL/-MOLK6A*74945*V'\(M;G2\*B?4-\OJD*:SCNUW<;
M\N&\*Q];V>V;GQ\<K3]GS?8\/T.7XZMT#=0,#LRZY)&W*V0Z%EP4PF9KEY;Z
M1%M6^RW2.*N%\F&_[\7^TI_C.5_E)_JF_6/@KW,1ZP_5'XE\,?#&,?:YG+7D
M6)' V5,N_B?/UJF)\?#S;SZ?I\?M>/<'1&/'_P"O+,YM'?@YI['!0K7?(IC^
M_P!W]H1_&<S>?'U8^L?PHHUVH[G7M;CG(Z?>:WB\8;F.]GV9"4OQ9TC+N'$8
M=SE2<Q<)PGRXQG"\Y\<>&,9V.%VQ"H= []$&Q.DUFG6)+7L;:Q VZ][]'2HO
MLZ3;N)^Y5Z^>Z;^I^+_I[OX-S?\ Y&C]>_ZK?%2J ;;F*V/VENDR2C O,?KG
MU\:PVPK,G"L-;3[9^"LJ<PUG'F]HSXX\,^'EQ\?CGE_ 6##\?JVM)D#L+C-W
M>C;6J1POLU!VJS*-:PV6)Z=P\5POF_C_ '2>_P!'1_&\[GGQ]6/K'\*L\GT]
MW\U?;T0T%(W77;6"ES+J8_=.ZIPXI.$Y5YM&=>G/'*<9SC'AE?A]G/V.>(:4
MR<KC^(OM;6DBRO>UJ>$;<N"R8\F <-8?O%=WZ0F=[NWMT#E8SY<IV9O='CC/
MAGZ_KY<,<LX!'RF(QM_X<IV7V,5,QLPG+:-MK=^2A+?MM4YHG=3?K%?7ZEV.
MCXJQX?74XRGX_P"?G;34A$,QN<HI#L.YAZ%BM<+C-NT;F\>I;2.K?YV7KI_D
M)U%^]_7N>7K/4[<(M<=YV^6K/8W J93-3D-A@79LRNA!?73L_?+TJFVQ(('*
MM#/8BD:C/5NMHL 8+68=MB#::?""9(2#4CEJFIKS4]@J@+[\NL;N@D<>/O6Q
MSA4K4UO3M!6]:;@(T2Q; 4#,&;2.%AAN Q&?'9?M]GE5:E0B9. &G#03]NL,
M2:#J;1^<.<LI,<3AA<3WQA!$;H(8Z?D8-=HUGQQ_/.;@ VY&3=8W O:Y!ML*
MM'6))!-@2-MMFW*^X;3NW[5"IWN26";_ *IH5QV0\1M#4=I)=14+&E1R4RI;
M!NC*8M==@^V$PD$3KR1$/FV9;.19NV4H=''DVRA68"N&.G$K8N3%W#YQOL>=
ME\P S,[BYHL<R%G:NMK'JSV7 S-\LSEQL>"RJ]=I#%$V#K#7,YXS+*[3=.MA
MB.)=,#!HJJ_)KS$V%F79BP5PS87F+%@R/JE;8,V(C7Z_:RL,<][D]GEU.AIV
MN8TQB[[V]*PRM?:\7.=["Y(#C;)0-8@G6.722>[8.DY7L%!5>])56[-4M-VD
M<SL5+NYB%HB#:U*$51FQ5*#50?O^4=N,?!M<*"))02-.=">[)Y8@2BW^J$FX
M"1CQ.6,M 4I;&[DC^DO89W;87NX:^0(+2-I(<TVL;BK4?<C6V6N=8VSW#??;
MNW%6RI^YK+=*E5KB.+$HP^V5P)98$:;''(F1X9T9%*16):6$/L)E-,2D-R$L
MOO-8=2O#;KB,86J^VG@<T.$8LX BY=>Q%\_25!+@2+G+I*R+YP;C]W)'[3#_
M  ;D\V@]6.UWBESQ/:4^<&X_=R1^TP_P;CFT'JQVN\4N>)[2GS@W'[N2/VF'
M^#<<V@]6.UWBESQ/:4^<&X_=R1^TP_P;CFT'JQVN\4N>)[2GS@W'[N2/VF'^
M#<<V@]6.UWBESQ/:5]XNP+@J3'3DY(SA3[.,X]3#^.,N)QG']+_HXY!IH+']
M&-AWN\4UCQ/:H;V)VO-5S=JM,A(MDM%K(!+A9&\C?D]#"#) A,F8"JY,J5D1
M?4G+3%ADWX#;#,MD5#@-3K$\*C&0#A2TV*"T;>2UG&,.-B0 =4$ DN N[.PW
M 7-@1>LAV9UK#6MM-]NT#@/^BP2G]TK99Y.LXTRHWH"WL[9FS-6#2S\JA$08
MVP:P#[!+$7I4H>;<(S1QWYL;;&K\X0(GPY'N],R9)A02 >03EL<!U+P$:[WL
M'I7 + XF]G7L=1UB 1EG8$7$$7]+8 ;>D#8V]F5QO6;Y[4D'-XQ=$Q)=@FGE
M4(_>25ACQ0ZJP'6")TR%FIS965XF*M<J!=Q%B4-8A.)' 90N>2>C(/A,3:N1
MI^4Y,1@G5+B;FPL6^B?2^59X-MP()VA19VJ77-@0-IOGOZLB+\0>!45W#TB=
M&J\.+.AVBTV:,B]5VG6!T;5I0AFLC3CU_;F[ F2+:-KT8Q0:PC5NPG;"?J[Q
MUN+FHG8T9J5.@/1<4%M(!?DR1K!IL'BP.MZ1UB+L&HZ[FZVP[;*0UYWD9$C.
M][6RR)L3K"U^(W9J4];]JI^T+?MBIU^786?FGLT6K3SDZ*&0'LDY2)T4J_75
M,./S7(H"RA[#42BB4,<[[[ $,PVI0_,6=(J9%3O<]HB_JR 22;'CJ^E?(@M-
MP,P;7&:I.L "2<Q>USEP[1FIB^<&X_=R1^TP_P &Y<YM!ZL=KO%1<\3VE/G!
MN/W<D?M,/\&XYM!ZL=KO%+GB>TI\X-Q^[DC]IA_@W'-H/5CM=XI<\3VE/G!N
M/W<D?M,/\&XYM!ZL=KO%+GB>TI\X-Q^[DC]IA_@W'-H/5CM=XI<\3VE/G!N/
MW<D?M,/\&XYM!ZL=KO%+GB>TJZ_O8C_?2_V+?^QS1\FSYH5]9GM-TDQK'8SX
M:;,&EV:';W11$=[)[P@$FZ^17!FP/;WXT'VR+*PT_%]MDQXGKVT>TOM,^=Q.
M$BTL^AGV2<V:_MHI1-P5W;&D1@75X\[(\_8J82@;>=J>2)F:%F=AMA7FTHFG
MX$R.2V''BJC4GWEFNKI#Y.5FVE9L>WH[/OSS1;XN2BI!WO\ ZA^O_P"O=Z8_
MZP5(Y!V>UOO"*COIY?SN?5/_ )Q7J=_WI;>5-VCK'O140Y?16N]$OGPVKZ3/
M.7<,XQ-ZWYR\IOUJ6L8TO8LY<RUG^B81X>;*/[+P\OZ/+#OENZF_>BM)VP]+
M/KOJKV%G];7NMW9S=EW$ZYJ&S2Y+3->UJ2K@L#=2MG#A8\N9<MG4R=[R5*J1
M13[#(YUE#66%(D.94M+=KE8A-'3F6)L\H<Z.)TC&R/:RQ>YC'.#G-8""]P!#
M007$7"NM@F?%),R&5T,3F-EF;&\Q1NDN(VOD +&.>0=1KB"ZQL"J Z%],[J#
M4L?<;AWK_P!B"8J^]@]I;,Q8@HK7K@&HQ;O+B3 =:N$@C?QLZ%97,PGX[L4.
M/.04/(SXS_)E*E>NU'P18U%B^#8/%B>$SSXQA]17B02RMBIF4C83.UUHY))F
M.,\;:>6)A$]I'%D;8W.'.-Q^E-/55+H:AC*69D!!:TN>YY(;JW< TC5)>UQ!
M:+;2X!>A33VS@FZM5:]VW6X14:!V/4 5Q$CSC#,8Q!@GA[)!B(29C2)<5,N.
MA[#3RHDN7#<6G+L25(CK:>7YKBN'3X1B5=A=4Z)U1A]5/23NA?RD+I()'1N=
M&^P)82VXUFM< ;/:UP+1N8963PQ3QWU)HV2,UA9VJ]H<-8;C8YBYSV$K0MW3
M].5T<MO5SMKKO5UXW6YM'.F-O52MSH/73>40<(O+E3L P#,D6IVBI!!XD<XR
MV^T?G3V!D=J.J>N4F,RIU.'C& 2OHI:+'<'G%!B4$U/+38G0RQT];3O8&S1%
ME3&QLS"QX#P+V#FDVN"LO#\1FHJR"NPVL=!6T,\=13U-+,!-35$3]>*1CXW7
M8]CVW:<LP=N:LIKGTVO5S:&Z=1:0UQ4]O$T[0L=5H8NYW'7=OU2*A6NP/2XS
M(E ?8M>KYLSF.Q#1+<D@XTZ&AJ2A+[\;U3RD=%ANC<59HYBV.C%:*D9@LD%.
M[#I&2\YG-2 VC;3A@U-69S96"]N3$$CW ,;=:Z:L<RL@IC#-(ZJ$DG+C5+&E
MEW2&0DZVMFT[#K%XWW6X05G&91_P<PYX&4XRG#?DRUGW.(SZM6?[9GPSASUG
MVG,(_L.<TLM5YW9I/K?MRTQ8NWGX+UK+TJ7KT>(5LH[429"J6&T!#[\* %#6
M4,Y)ED+#5A:8QB-$680B)+$P9[4.<3B2M558[@=#74^&5N,X528G6<ES3#JK
M$:2"NJN6E=#":>DEF943<M,U\49CC=RDC',;=S2!LZ;!,9K:*HQ*CPG$ZO#J
M3E.=5]-05<]%3<C&V67G%5%$Z"'DHGMDDY5[=2-S7NLT@JSC3:&6VVFTX2VT
MA#;:<?82A"<)2G'^+"<8Q_\ #FU6L6![/OJ]9TTA<44J][!R/F!HJJOK8"FS
M6^6@P9@!US( 7,R"J7%$IG9*EE-OY<BB8<V6EIW#&49)W*#9?:F1$CD'_P K
M7VDDJ@0]NRO41=71WGICFIB$6"U#@IQ8O+)E;+;E8GZM2A7J[9"8DN,N1UL+
M1B+]?O\ ==%8!HI@NBAELQ2 ;)C_ '0P(,PDQC$3,VLSYF1I*-AQ[ \E!PO*
M)[*7G,-2([L;UB\9\V93SY\]:S'A$X1.$3A$X1.$3A$X1.$3A$X1.$5)>S/5
MSJ);)EH[,]D <3.=;4NN&SM^-V [#@4G7VEYMTO,UMB- E)CP@!*!;;M!V!$
MCPWG;I5R\RO%TS8*(49@I%]@W]_G=PW*G<TYZ/&!4A6H;^:[:P1E<T)NB ';
MW/K'NV&.@]#WT%4M67<%#M-^UH.)1X\L>!I]$I(M!)5O,6LV*@59LU?[Q'<-
M%/I$WRVC@;D=&_;GNSS6:Z3U%T,_+"U2-J,'ONF;$#U^W;7&:H,:\[)4K6E+
MK&VY!.@6LC8:CL*B#Z)KV-M$MHFQ-HAG9( C>)(DQ-#H*"[&C),F=K96V;L[
M9[=IMW;%+/7.GT>D=[.[ ;7]7JE1!KTETHFN"J<$$ !*R#Y3M:W(EK@A(L2&
MJ8\RQ&;>D*:R^XVRPE:\I;;Q@J5L0X1:^NCJ,*I&^LYSG'^_?[O8^QX_^LYL
MK_'CCDM?/6M;+9?IXCBLN&JY%FIJ:WI$WUK;;96U3PXJZ7J\?IL_L<?[7'(?
MX_W?_<KO/_\ A?O_ /L76_)_/]]X_:,_QO-AR_\ @_>_]JU][Y\<^U4H](0*
MS!ZQ3Y67\.^JWIT]SY,-^3S>/</0^/#S>L5X?L<\MR2\HT,U;:SFB][VSX6'
MO16*^7J/N6K_ $S'X+S;_DT^N'U#^)%&^T5XV%7& :<>Z<L%HQ+,E7\W85AB
M--C^I]3CV3PRO,O"_6>MSY?5YQY,^;Q3L<,C_)]0Z<GE=:)T6J!J6UGL=>YU
MMFI:UM^W)1;9T&_<1]ZK_P#,TO\ 5$GZ)S^,>;W\K#U!^T'X%*I;;Z<H)VPO
MHK)#$G/Y6KKY-]?[+EG^B[9[8->K]5[0[_.^J\WG]9\?-X>7'AXYMX75\MCE
M5)R>K_\ #8V6UK[*B][ZHXVM;=M5MXW]/W#P67_)_/\ ?>/VC/\ &\ZOE_\
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MPQQ31FDDY-SI  UV;FW%B2#=A]$YV+3O(;<,MG_=>K?FSC?B3G_F:&_,A_\
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MV'.['')]MMFH[]I"R3B="KLZK2J!=>N(;1F(4:"J4UL##Z+)1M;;8,1Y^SR
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M=S#RH;(4PO)D QVF[%[PVK0HI%_&?::T?JVH2678[;LX%8,-1"D8BGSTR'8
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MIF6R^VT^PX^;>?%!Y'AEV9+(====-%SYNP54:YTNXSC=1(@R$L<B";/U^-L
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MN>R(F70ZD2GF(M?O]G&6BM,^\'Y@^;6VU3B)5X]8)$^+9W\V\V\VL6= NJD
M(37):NDYP1*+T"<]7?=2WQX(5JRY,WNDUK7[Y8T7(4X*W8$273L-<HY&D09G
MNJKQZ<+%@80F4/GI5M>$3A$X1.$3A$X1.$3A$X1.$3A$X1.$6G?TH>L.DEYO
M770QVTW\<T_8! 3;8O6-4CT^M7ZL[*PLKJ>^R'[%5++JK9:"Z-8[(UMJ'944
M1!? C;!)KS :]0K94'Y@AHBV<:0J]/H^EM0TO7A$F7H%0U?0*O1BQN0_+,E*
M> J@D362)>5*BP9,DG-"Q(4F?(D0H;[TIUUQV+'<4II!%*'")PB<(G")PB<(
MG")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")P
MB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G"+5]>W.EUROI.^6+:0052
MHVOK<F;4JN')59J0C5I[;%:V\?*V$,$BV!J#&(;>=AFX(0B)R4+PF9)59R*I
M$=)#?S[.ZW\E+0C06E E7?G#=S$A]9@* 2H4Z42UN.AUC+MO@;"'1W4(J@R)
M"P6V$+!V# PE$9\C@EFM#HL(*^0%22+L=?#M+ZODUR\U+<D6!7C[PZHEV24$
M)%8M[E?$K!>T6!4 0#?C63!LC6)4JW'XR\#A38BKBLB0AZ(AZ-GG;Y 3S_)=
MI:PV@]\UZ#0M<V36XZSDR0:[BY BNU^::37J5M77.P+H^R&F0$YR/L4I0'VM
M\A%<%EW+(*-/1R\*0VI]EL]@[+^Y/N4(KUMU IES158VUK"#N @W1--6H4^[
M@M.L9\C5!)H/62LXE4B$N-(M-5J(>6ABODA@ )!%/)JL*M/$BV9TIY\]2[JF
M0.MEV,M3ZGV$DF399-2WA FDX]=AQOD^(W%;;CDFP[,J@6(T(M&UB5@9)IS(
M;(MQ&&PP58N$E3K\>>_S<*?Y]X&[W'PRN,UL>G55^L4>X['KD^^RHH89+QYX
M8^:6,R5"!2"$@+"=DMUYD^<+BH@MB8ZS%=)G1 6!(E32$!F3*BQX+K9G8+2@
M^;)'3]E5:#,AD7A<QJ60Q&Q%D,%FJ^[(DNO(0RP)38WV:TDZZXD(Y97$5UL@
MHUGV'A%W]7VSK>Z$H@:K7((9,S1!4^P'BR<X+8# S3%<+$7QKR&IL2/".R&1
M;JI;#&<RU^K;2ORKRDBD/A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1:>_2[V/
M>>LZ+JO<U&W;7]-:8H1FRP=TF9X8DV=#)ML04,#743L.J=;.RVQM9P1]6:V)
M1#=RH .F%:]"V/DS,M*(D+#XDBV:Z1<+/:7U$\?M\;8)UW6%!<-7V&^B5$NY
M9=4$J)6^+);$5]N1&LLS+QIA]L"$0\U-2X@0-2K$)DBD_A$X1.$3A$X1.$3A
M$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.
M$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%UZA(M:5H4-'J0XW.96A4.
M,I*VBCV)!-I:<MYPILC(2E^<C.,IEO8P[(PXO&%<(JO,=.=4325I.6Y)>T&[
M'9K(=AD,3GJ\Y5X-@MVP[0L$!=KRX$WV1:-EV488=*SB:S466MIU$6 W#'0B
M>?!=E.ZG:[+C6A1TY=SD-U<KWZF>2!MKM;!.4&DFXAY8^N0<^SFVZK28,]0?
M B2U!I85H9('N2[(Z>)Y\^?N7- ]:@U0F@2U2O\ ?A)D' +BLD92J>766@GF
M]?#22BJ)E2\53VJWK&G5\5,@N041&!+4Z?%*SY15XD3W\?/;[E8?(^ IW+RH
M413RI")BG<QF<NJEML8BMRLN91Y\R$1<8C(?SGUJ6,892K#>/+PBBW:^GPVT
MZQ"J[D]^KQXQVOE5D00\0HE[&!FN34C(F24&;!CMR%.NH2X_!F-QLNN/-1LO
M9PM)%'S'4;4 N8-DU=FR5",-GX+I$ SKCX:28;LE4ND8LY L$<XW%G1[G1ZK
M:UK%*'-D2XI?OEHE *G().+>;GS[.OB4\^?/>ND+=+-0'GYSQR;=2B"D&0!)
MQGSD%EB=37+JQLB'27<P@T20T $WV/BS#945^/9FWW7Q,BPR:X\H-Q8>_OVJ
M;V]BDRF:+ TBS K5 M%Q)$0@.[!5M&'ZT_&-.; .UNP6(R8S"K$":HJY)J%:
MBP\#9@P5"@"6F&A?K)$YZ5/GSYW!1Y\^=YW*;>$3A$X1.$3A$X1.$3A$X1.$
M3A$X1.$3A%2KO7U>O':[552IFN]LJTY:Z/LT7M,39V@KA&3-)UNGW<0"",&8
M$\98J4V]9+(%*$[749L>S-!1),&/=:;.R76R*SFL*[9:?K37E2N=I<O-PJ]&
MJ5=M=U=9EQG;A90@ >,.VEV//(%IS#E@*1919;,TJ3EM*EY1)(37DKDN$6<\
M(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")
MPB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(
MG")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")P
MB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G
M")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB
M<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G"
M)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<
#(O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g729258g32m38.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g32m38.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( /T"3 ,!$0 "$0$#$0'_Q  ?  $
M 0,% 0$             !P4&" $" P0)"@O_Q !F$  !! ("  $$#08&"@X'
M!@<% P0&!P$"  @)$1,4%1(6%Q@9(5976)66U-53DY?2T]8B,5%4E-<:(SAA
M<7>!D9BV"C,V.4%R=':AL;*SM-$D,C0W=;?C)28G*%)X-4*"A[7!\/_$ !X!
M 0 !!0$! 0$            ! @,$!08'" D*_\0 9A$   4" @,("PH'"@P$
M!@,   $" P0%$08A!Q(Q$Q1!4516E=,5%A<B87&!D9.4T@@855>2H;'1U/ C
M,E*6P=76)#,T-393H[/A\24W0D9R<W1ULK2UXD-B=H4F1$6&HL5C@\;_V@ ,
M P$  A$#$0 _ /7:J?%;[(1",]E;-O WO(E*2;V8+I*IG82$Q@7V'!R;Q*K)
MZMXO<]-P\72=A8GU58CJ^K&1Q$!D21; M"]C6(\.NI]#BX@+AI+*W"1&9YY=
MX2C+QGF9>8M@RYCOBK79O+>O%:3#KC&!4Z[4'O:=2#H+/<R"*RHY7/9A:MNP
M1=X_!(F] 8R&]=GT?[""8^Z?+R-L[1ET"-:[J1S8^Z??Z+_2(U2SL9V+;E;;
MD1;./(_)LV%=UT]VKTK/M]8M%U+& -@2*97%UYIV%B[=G[F-UE"]ICU+[,7^
M:DPM.&5F6ES511U2C5J8%$24FUD*[Q+4:^AB6FZN $DK7/B,\MOXQ%PG;A\'
ME&(-K>+G:]U]2.Q<NK!&J^O9Z.="(->0C0Q;3K7L YL2XNM#^^&!6CXDI%$A
MLPAE=[I>UP@=>+,WCUP'F!O*(OVI[!BP3J$1V.YYJ+9E8KEGGE<_OGEDM-?%
MPD@N:S^JX'6=7S.VH9+>^<7Q7;ZXPD2.I:=53<#$5:3D/M@V9-HVC<B<R5=L
MO7BXMF^5'H#XX2>*/?/H!22=ESL1V*]LLR,_T6^<1.'\625E)@T/Q1>'EV]N
M1+I5#(T3L.6&:\ZX5?,K>L'O<"F\RDK$Q7K6QXUNR4ZT8AI) G*C0V435]"H
M_'GPT6EF4R8)U2+SJ^8DF1%Y]MMF=N 7+ ?%_N:P"=5%AW7ZL6E=%/>1-;7*
M*6G)W)]%SW*[86]U)"&J@00@. LRAS([6C>T AR0DXTH<@9=@U;M%7A5,B,!
MJ>$_\JV5OQ4DH[YG;([<.8MF:>(Q<M1NI;>D0C.]KC.W79.\J_ZSQR=V&]B]
M312F>F,!=0])V 2>N=!(N4]C;3C%B3(<>TW&:OH,5&2@F@?80<8&? (B.V>P
MKG8KYF9\1;"*Q'Q'EPBX; \9^8P2?]BX$\HZ#(+T;6 RR61LE:"^D:D#F:-.
MJS05"7$D% "P9,W1YCL:Z-=H2 5R:'P6OQ$)D@5,G[?7"46!J7L=\C.VS9F>
M=K\)%EQF1EE:YU )XC4[KCLQ-/=7GM)R>KI++^BE4$)#"K3U?]?:MVM,=W?4
MG5AQ*=&!PM/94J8IB% 9 .D+A)J+D6%X]ZV>.!*+PD$FGO2L1W[X\]IVU;%Y
M+^7RB#)_XS%C2ZB#9Q2'@:GUG_3<[=]72*N[#0.3D_,PC(B;E >-EE(;.@%;
MNXD 0$DVR-L0G1.5!S'KZ+O"64D!#@"47,B//OM4RL>5K[<R/BX<A+MG^,W.
MJ^+WJX8T[5<F"UZGW881B%,+5+XN*-D^ED]C\"?';SBVD35:PB&7,[*JDX.0
M8JNG(AH0B"2^)#O)-U1H02+V*^9V/9D9&5RL?&7#Y>+/)<EXAMHP;JIVPMZR
MZKK-A:_5WLX%ZQ%A$?L.1*T\\+S4_1(N/6*8FQR&"Y&!@$2&WZ%.6&\=1C#E
MJ*A\E(--6J+ELFS>3[\?W^<1JYD7 97\-L_"?%EP^ 09;GB!]@B ZY@@5G3&
ML2H[/1O:87%U_N9^>?RJ4=E>R45@"8NL%Y#54DBJ\+8BPTK8SM8[[,SE KO%
M@2R!)LM+6@222,RL>W6M<N(C/@/[_,(3;^+YV@KVN@C&65Q1-LW+)+_\0J'-
MF "P]X1'P,=Z<6PM%!=8REV>8"6L8L.;LS Q.&&32V$/<]!+V5(P[YRX("FP
M3JEGF9%9)[+GWQ7OEM(O)Q7$X3'Q&+BS*04VED7C534Q!^\=W=?]51-BDW9N
M4BZ,ZE=I+DF9:[!+>HYKJTA"*T$B/H@6KR165;'0[Z0-R1!@U81,X$:I9YW/
M5(]G&I)%;/P[3MQ#,'PY^[YKNQ%;N)2&+1@ 2IVV!$ 0*0PB8>1V8!)-4-9V
MX$/MF,A:-38)Z@TL3( D((Y5<Z.0V7J^HUR]7""@A22296.]RO\ .96^;] ]
M&.!2' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P <
M' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P
M < ' !P < ' !P L_:$0!XDHQWB$/=(-49$-59[  JZ3=O,EM"LL8*-\M-M$
M494X53)2)KMIKH<64T>$DW2F^JF0"PWG76FWDXIBP-80,&G.O;>P4:A: LK
M(U#5;0$-8_,7[&)AE&4<6)/@:#H4T?NQJ[D6R,R!(;NVR<);. FYY^';_?M^
MO+B(:A)[1<QN"PZV#/(D8N2I$(-)K!%^HL>OHQ[< !M&%$G!IT,3;.B"T7<%
MD==1A-X2! CK=(HF-82D;J4"+</'^@=&+:]?K +3<6 BD *O:C70I>0J*PX)
MJW%"R%>P.T-(@(>N!N&[V%J0RRX@06:"E58[JJ158JZ8=-'*283F7T_3_:*2
M)D_6B=6#.(4F,KI]8[DM+(M+A!J+!$9!+E(?'*Z5E_G/6(_#J6AA "T*_&DG
MN=WS'1$ZQ%[[;:I[HI@S\.7S"3LP*JBP'(;,+KXE&#(D1'<BLQR./ )8%'%'
MKP""RQ]#4'OA(%54BZ$#,I*LQ:BKU=F@AMNOMD(N>V^?&*#-%*=C UKF5B H
M\.68,V6QEE%WJHP*%K\!*)\"(G)/'Q:S2!Q^(CX](2D1DYXG'PX>1X:#HR40
MEAD,Q?@$:U>%ZJN(E'NK5?Q>#F*^IJNZF<P^"$Q*4JBP^$%A!UK6ST(^E."^
MLD>:"HB776+J/"AW7;38D8?*/"6[EP$F9W,SVG>_EVB_Q3VD9+(K"B2$?A^Y
M>O)'I$YBW)Q86T;)G;/A<;D[IBW<OF*;8MO+HL> IFLM-U\%?+J+(^?4:Y1T
M"!7EX/3C00YCKF'UFV ZMXZQ> EX_%D1&K0*_<[1)FY&*--6>&XDGZ9M'6ZJ
M'FF#_P!)R,T2<>=SP%SVWSXQV$Z[J9<@\V2@U=K%7,<2!O\ 9.,QI0@O$73I
M1T@'>9U8Y<JQQR]25<)#UO9#%G2:BVB.RNFVV "UB3JC6UK;5Z_CT,4LNUX-
M,)29UVB@IPZE,1K$O6$<.H3 UAAOH\R.?6[7Z L,?=*+O6Q7*PQLJW8NMD0G
M.W@+]/\ <)&=AX7LR,"WPN,;#I@Z?IGQSMB*RRE#U=AJR*:&&BR64#;I86/U
M:/\ 5ZFZ648,=4'&-F[;&F@0(2-V1UE@].!;7PC$WE02SW*A48(5[7A"P&\L
MS(I %#4\,C,3KB,20_)=E9 ="HQ!B&!/]ACAXBZ:),DTU5TPG.]N'/A\^WYQ
M9 .W^FML&!\0!B(O/'$QVTM4GA*C929C(8UYR6AM9%;$E7K]6)UA/='E=S"/
M;,K7+12<)%HN1CV[+0FVU8Y!F7T;>#B\.V^7C$DU)9U$7NU?$ZT%J&Q0QZSF
M;4Z9J&;0L#(%)HP-L&-@P(_.H5' ]A"I2(2-((6! 7TB#F0[S?V)MP/+-\NP
M&1EM^DCV"7XS#HC"F.XN&Q6.1(8HIHKN.C(,8!8[JIHIMM%=V@IJT;[*:-T4
M4--\IYVU1232QG&FFNN @7'P < ' !P < ' !P < ' !P < ' !P < ' !P
M< ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < '
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MV%FNE+8%(=J+#3AQT>[CQ&F)5")G'O7R3D+J\"2J'OW<*;;2J,21$[(&+.,
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M5L33]' =N [^2PF/@0' !P < ' !P < ' !P < ' !P < ' !P < ' !P <
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M !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P
M< ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < '
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ML/1F2F!S#&[9)/;T)KY?,)A2*EP < ' !P < ' !P < ' !P < ' !P < '
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MK%KINY8^F)(^EM]=EF_G$]<[8 *IP < ' !P < ' !P < ' !P < ' !P <
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MY&48.C&K]VQ*R$\4:KHD#))RZ!<_O]_OEQ";N! < ' !P < ' !P < ' !P
M< ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < '
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M0A*K>MG::.R&(/K!CLHF-8#K$MPH'JEG?A:$/X,XFL?ZO+5K/B+@#-S+10-
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M(S(R,K&1ED9&1YD9'M(=>.7D ' !P < ' !P < ' !P < ' !P < ' !P <
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M1L&GB%.,Z$CT,%$1 &%K2 $/M!^<TJ^&VC-[=A, 31D4G, =4H_*YT_T6E&
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M9 ><K@,39E<VKN^0<N"VVJJMVFF,BL]SIMJ1UW;NY.>&#B^SQMLBZ#D&39R
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MY_-;R7O](ES@0' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P
M< ' !P < ' !P < ' !P < ' !P < ' !P ^3SJGX*;F]N_?;KMMVYBRK:CV
M_<OLL?J.I#C;9):YE=;TG+L;,I@Q6UQNG4^F?-.0P=?77>R=L:.WFF(%A-.:
M_05=TL.4[ N&\(8<>-$U.'Z<S6*DVJRHI+B-FJ%%61Y2#2JTATLV+FTDR>UC
M:YYFC)<J4F=)(E(-]2F&CS(]6Q;HLN&QD>HG9_E'P6^KY!!!J@BV;(I-VS=)
M-!NW03T10001TPFDBBDGC5-)))/771-/3773337&NN,:XQCGS\9F9F9F9F9F
M9F9W,S/,S,SS,S/:8Z$<O( . #@ X . #@ X . #@ X . #@ X . #@ X .
M#@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X
M . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #
M@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X >"M3^->
MU+2.WG%K5"/6K:MR,_$NRW7^022V[#@LGCW=D%TPKJN;;@3B'QUB$GET$Y0)
MLZOP\>EIHN1@S$X]TCRFB#1=ROM\&T5FFUL]I$>>6U.L=CXBV<&WQB=ROBU5
ME7#.R7UK5W;BKN,3^XQ@V&5[6;DO-HC"*)HFB+PM-Q:K-[*\!QLA@4>N-5](
M'04LN!<HAEP8+<G(TV30Z#4/(LLRXRSN9D7G,LOT"Y)+XO76*(U18%P2&*W8
M$CM6S-*)3L1)(A%H7*P;)_5$9O"/S# 6<3N,^M LLJV8 )3%8Z&=$;.-ZO%
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M^6(NHXV"#(RS\-N'ZO!LV^ 9S\" X . #@ X . #@ X . #@ X . #@ X .
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M8UR3L>[K@L]M#HL5&@0QM,"(GTUD(@>1."HN"9%2;=CH[<IL5%==TW)(LN_
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M)B4S',285$CKM5JS9&XW'#AD4%= MM\%^*^7@N(FLGQ"GD ORS*1&4XQL8A
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MB-OU*:ZF%3U9**0ZRXA3\Q&4=M9-1U')-;D3WRC\?!1,$&B\7#"X[&XZ+8A
M  (Q;# X4.,;)LQPL6-9)HM& ]@T12;-&C9))!N@EHDEIKIKC7'V$M:W5K<<
M6IQQQ1K6M9FI:U*.ZE*4=S-1F9F9F=S,>-"K\H . #@ X . #@ X . #@ X
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MOX]M]MMMLYSG.>/OYM@#=P < ' !P < ' !P < ' !P < ' !P < ' !P <
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M&<+,D1^[A1TE_;$-5-/CYEJTY:9$-4]]>%J:EBK.,-4MY6$)Z6JD[*1ND9N
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MLH?PL(9U5E;*-:2MRX-*!29[2L1$9WL5[%XBO_;F9#T*X$!P < ' !P < '
M"*;W_P#<?<O^*FQ/]4#',N!_#H7^UQOZY I7^(K_ $5?08^7B&?[CXG_ ,V@
M7_\ BVO/RLQ#_']<_P!\5/\ YU\>&.?OCG^FK_B,7+S3B@. #@ X . #@ X
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M-2#)MM)$DGC2E):J2*Q$V1E91EM.Y%PCZ0*_K^&57#([7E>1T;$X9$QJ0H
M%);)M&+1/;=3?.=U-U7+MX[<JKOB9-\NY)%B3EV3)NW9!VY<J^T..*<4:UF5
M[)21)2E"$(0DD-MMMH)+;333:4MM--I2VTVE+;:4H2E)=PA"6TI0A))0DB2E
M*2L22+(B(BV$0O#E J#@ X . #@ X . #@ X . #@ X . #@ X . #@ X .
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M #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@
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M;W,SRSXMOTV^<9B<" X . #@ X . #@ X . #@ X . #@ X . #@ X . #@
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MV<%ZQI=OG\8Q$)VHQ0J\Q0<0]2PU1)X?&/T;.:=I#,['/H^\79E'=0U.;:K
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M,=8':/C3FABCH"K?9 ]T^M/G#@WVM ?B''9*G<OA>M,=8':/C3FABCH"K?9
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M7&,?':E*4HU*,U*49J4I1F:E*,[F9F>9F9YF9YF>9C[B'8Y !P < ' !P <
M' !P < ' !P < ' !P < ' #%.@>D_6WK#:'8ZXZ5K_,2L+MA.T+'O$WM(I(
M9TE,J0?20MJ[:#S94@.CS90W,I8:68 6H]JH0/O,[)^BH#FK$)-1F1$9W).1
M>#[V&5G @>;1;P[ YMA.&!*Q6CW29^^ TWV?5ZU>:L&M\]T'G<!XRRFO*-\/
M&P)==K UDL[-TSWJ]O*U4QN^J<?1";^#B^8K??S>$=:8] I?))H)*C^PST/
M4.Q0;L08KK$0EB+!Z=!=G(KV109-E(M<,0 DGC]>+I0U\2LF)66)'HK:RF)1
M:+R'<JL7 1D7 >RVWP'X..WDN7",>>JG1J]VH\(*NM!C"=Z_3J=V/DKK1.2R
M*1/H;7W8Z OZ[":B;RG<:UJ6(K7<O*H+)T8K2YPD2+2AB1IN.CW@A"-A)VX/
M#Q_I+;^@B'8[ ^'S98F-T\TIPH^EZ$1 TK7TI&1@((C9?VNT]UH[&T*L59,7
M=\T=HX96"QN],6>9C;9CI>(@Q^-1>DQ65;J@0$99^'CSX2/B//+Q?I]<ZP82
M$76M>#)<(CD?E@Z#1)A)P$/=OW\1!R%H 'MS0B+/BNB9-['!I)-RR".R*:;]
MP,1:K/--7&ZFN I\0OG@ X . #@ X . #@ X . #@ X . #^/^/@!P^CM_R"
M/YK3]7DW/C/SF >CM_R"/YK3]7BY\9^<P#T=O^01_-:?J\7/C/SF >CM_P @
MC^:T_5XN?&?G, ]';_D$?S6GZO%SXS\Y@'H[?\@C^:T_5XN?&?G, ]';_D$?
MS6GZO%SXS\Y@'H[?\@C^:T_5XN?&?G, ]';_ )!'\UI^KQ<^,_.8!Z.W_((_
MFM/U>+GQGYS /1V_Y!'\UI^KQ<^,_.8!Z.W_ ""/YK3]7BY\9^<P#T=O^01_
M-:?J\7/C/SF >CM_R"/YK3]7BY\9^<P#T=O^01_-:?J\7/C/SF >CM_R"/YK
M3]7BY\9^<P#T=O\ D$?S6GZO%SXS\Y@'H[?\@C^:T_5XN?&?G, ]';_D$?S6
MGZO%SXS\Y@'H[?\ ((_FM/U>+GQGYS /1V_Y!'\UI^KQ<^,_.8!Z.W_((_FM
M/U>+GQGYS /1V_Y!'\UI^KQ<^,_.8!Z.W_((_FM/U>+GQGYS /1V_P"01_-:
M?J\7/C/SF >CM_R"/YK3]7BY\9^<P#T=O^01_-:?J\7/C/SF >CM_P @C^:T
M_5XN?&?G, ]';_D$?S6GZO%SXS\Y@'H[?\@C^:T_5XN?&?G, ]';_D$?S6GZ
MO%SXS\Y@'H[?\@C^:T_5XN?&?G, ]';_ )!'\UI^KQ<^,_.8!Z.W_((_FM/U
M>+GQGYS /1V_Y!'\UI^KQ<^,_.8#YL.MWAN2'L5V<[)V9?4=*1GKL&[>=J'@
M>)DT%QA>^G.>Q=E/6R>R.?-.A]-HIJHY(O<>9=6,K[,0.RC$$R+R0_2%<TO+
MHV ,,81PV\::H>'::U5JB@\X"78C:CBQE%_\VI"RW5S_ , CU2_"7M\Y4S09
M!GZ6,4Z2<5(9FLN55A[#5(41.L$J-"AL=E*@DR-+CB'V5[RBGK(;-!2G=9PV
MD,_26Q8LA;)F-&LVHX<.:MV(\>Q;HM&3%DT1T;M6;-JWT30;-6R"::+=N@GH
MBBCIHFGIKIKKKCYO4I2U*6M1J4HS4I2C-2E*4=S4HSN9F9F9F9F9F9W,?1NS
M8.UR #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@!1I&
M25#1\Z703357%!BA)%)7V7FE%6+%=TFFK[#;7?S>^Z6-=_8;:[>QSGV.V,^3
M/+K""=>9:,S(G'6T&9;2):R29E>Y7(CRN(4=B,^(C/S$/,SHKXF]4=B^JU5W
M)>-CTI5=I3+6:YE,"8RQ(6U Y 6)+8N&PDPD1A\80]9QX(),[X>.E<J*$=UD
M/8-5$4]/3L3Z*L34ZN3H5 H&(:Q263C[TJ**<\^F3ND1AU^SL=A+*]RDK>8/
M4(M4VC2KOB48X*5I.P'2GW(%=Q?ANDU6/J[ZI\VK1(LF/NJ$O,[JP\\3B-UC
MN,OHUB[YMQ"T]ZHC&6WORNJ'TB:?^W8#[[S0]S?'W,[$?1,SJAC]U_1;\8.$
M>G:?UX>_*ZH?2)I_[=@/OO'<WQ]S.Q'T3,ZH.Z_HM^,'"/3M/Z\/?E=4/I$T
M_P#;L!]]X[F^/N9V(^B9G5!W7]%OQ@X1Z=I_7AGN7U/QC.??$T_\7Q_%.P&<
M_P";#SRY_P &/CX[F^/^9V(^B9A?2T'=?T6_&#A'IV ?T/#9[\[J=](BHOMN
M$^]<J[FND#F=B'HR3U8I[L.BSXP,)]-0NM#WYW4[Z1%1?;<)]ZX[FND#F=B'
MHR3U8=V'19\8&$^FH76A[\[J=](BHOMN$^]<=S72!S.Q#T9)ZL.[#HL^,#"?
M34+K0]^=U.^D147VW"?>N.YKI YG8AZ,D]6'=AT6?&!A/IJ%UHTSW/ZG8QY<
M]B*C^+^2;!,Y_P V'6<Y_P F..YKI YG8AZ,D^P(/3%HK(K]T#"?DK4(S\Q.
MF8V^_1ZF?2(J7[9A_O')[FFD#F?B#HV1[ CNQZ*_C PKTO$]L/?H]3/I$5+]
MLP_WCCN::0.9^(.C9'L!W8]%?Q@85Z7B>V(4[(^(A0-5=?[GLNM[AIZ:3^!5
MG,I;#(BZE;9VVDLE @GI$,$7:BW[4BX2)/FZ+3=%BY0=*:JYU05T4SKMC8T?
M19C*55:=&JF&:_ IS\V.U.FG =;*)$<=2E^0:W6U-H)ILU+UED:2M=1&5Q=8
MTLZ.)SS4*FXVPU.J$IQ$>%#8JD=UZ5*=42&&&FT+UUN.N&E"$IS4HR(LQW>O
MOB$]>[,H:E+'L"YJ?B$\G]35W-)K$VTL:-6\8EDHB(@W(H^@V)/W)!NB&+OG
M@Y)!\X7>):-M4W*RJVN^^U-5T6XSC52I1Z;ABOS:='GS&($PJ>ZLI<-J0XW&
MDDMMLFUD^RE#NL@B0K6NDB29$#VEK1M">=AU#&^&H<^(XN-.B/52,V]%EL*-
MJ3&=;6O60XP\E;2T*[Y*DFD\R$NY[I]3,8\N>P]3?Y)D)VS_ )L+YS_T<P.Y
MII YGX@Z-D>P+7=DT5?&!A7I>+[8V^_5ZE_2'JC[7B_VW'<TT@<S\0=&R/8$
M=V715\8&%NEHWMA[]7J7](>J/M>+_;<=S32!S/Q!T;(]@.[+HJ^,#"W2T;VP
M]^KU+^D/5'VO%_MN.YII YGX@Z-D>P'=ET5?&!A;I:-[8>_5ZE_2'JC[7B_V
MW'<TT@<S\0=&R/8#NRZ*OC PMTM&]L:9[K=2L?Q]AZI_R2X9G_J5SQW,](!_
MYGX@Z.D%]*0[LNBHO\_\+=+1C^A0T]^OU*^D-57VL'?M.3W,](/,^O\ 1S_L
MB.[-HIY_X7Z5C^T'OU^I7TAJJ^U@[]IQW,](/,^O]'/^R'=FT4\_\+]*Q_:#
MWZ_4KZ0U5?:P=^TX[F>D'F?7^CG_ &0[LVBGG_A?I6/[0>_7ZE?2&JK[6#OV
MG'<ST@\SZ_T<_P"R'=FT4\_\+]*Q_:&W;NUU)U\GE[#59GR__IE+#?\ S^QW
MSY/\O)+1EI!/9@^O>6 \7TD0@],^BDMN/\,>2IL']!F,-X;XI]5G>[=Q=?S,
M^IX;2$&J"$S>'6>F:>:$I',) \9('(XX>K$5 BS<6BX65319CF[S3*>,K.%-
M<;8ST$C1)B9&'($YBAUQVOO5"2Q.I.]2,XL)M*CCRMR)!/)W56JG66M2#OD1
M7(9*]*F FHC57?Q90FJ%*=<BPJJJ:@HLF8R5WXS;IGJ+<:22C6DBNDBS&8WO
MW.I'TA:N^TS/_P ^:#N8:0N9]=]1<&+W:-%'/_#/230>_<ZD?2%J[[3,_P#S
MX[F&D+F?7?47 [M&BCG_ (9Z2:#W[G4CZ0M7?:9G_P"?'<PTA<SZ[ZBX'=HT
M4<_\,])-#;GN]U'U_C["UA_DDC;;_LXSR>YAI"/_ #0KGJ2R^D1W:=%!?Y_X
M:Z1;/Z!I[^#J-](2L?M$W_\ +CN7Z0N:%<]36'=IT4<_L-=(M_4'OX.HWTA*
MQ^T3?_RX[E^D+FA7/4UAW:=%'/[#72+?U![^#J-](2L?M$W_ /+CN7Z0N:%<
M]36'=IT4<_L-=(M_4'OX.HWTA*Q^T3?_ ,N.Y?I"YH5SU-8=VG11S^PUTBW]
M0V;=X^HFN?)GL)6G\O\ !/I[8_SZIYQ_D\OEY/<NTAG_ )H5OU-1?28@]->B
M<LNW[#?DGI/YR29#3W\G43Z0=:_7NG[+CN7:0^:%;]45]8CNV:)^?V'/7B]D
M/?R=1/I!UK]>Z?LN.Y=I#YH5OU17UAW;-$_/[#GKQ>R,.Y)XJM4BN\===?!L
M\J-[14HH>1V+([3W*$]BH:?"Y(0%#8FB[3>Z!M&CT8V;O=T7 M9[MNMMLF[T
M3SKIC?LZ(L3JPW+G.T2MMXA:J;+$6D;W06[TY;2%.S-S-)NGN;IK;UDN$CO;
M&DS(S&6G2M@%R$Y66L5T1R@1WTP955*5>,Q4'$;HU$6[;5)UQHTK2C5,S2HC
MOF,Q/?R=1/I!UK]>Z?LN:#N7:0^:%;]45]8Q.[9HGY_8<]>+V1IGO-U#Q\7O
M@ZV_R&\9_P"G".<<GN6Z0^:%:]5/VA'=LT3<_L.^N_\ 8-/?S]0_I!UO]=?_
M $>.Y;I#YH5KU7_N#NVZ)N?V'?7/^P/?S]0_I!UO]=?_ $>.Y;I#YH5KU7_N
M#NVZ)N?V'?7/^P/?S]0_I!UO]=?_ $>.Y;I#YH5KU7_N#NVZ)N?V'?7/^P/?
MS]0_I!UO]=?_ $>.Y;I#YH5KU7_N#NVZ)N?V'?7/^P;<]ZNH.,^3WP5<_%_(
M7WSC_/AOG&?\F>3W+-(G-"L^KE[8CNW:)N?N'O6SZL:>_JZ@_2"KKZV4^[<=
MRS2)S0K/JY>V'=NT3<_</>MGU8>_JZ@_2"KKZV4^[<=RS2)S0K/JY>V'=NT3
M<_</>MGU8>_JZ@_2"KKZV4^[<=RS2)S0K/JY>V'=NT3<_</>MGU8>_JZ@_2"
MKKZV4^[<=RS2)S0K/JY>V'=NT3<_</>MGU8B.^_$AZW5S1ET6#7UPUI+9[!*
MGL:90B*O7Q%1G)I?%X>8-QJ/N]&>C-UNU,F6+(<OJU>-7&R3G?"#E!3.JNNP
MIFB3'#]2I[%2PU6(5.>G1&I\PFFB.)"<?;1*DW4I:2-AA3CMU(41:F:3*Y'<
MCZ9M&,^0Q!IV-:',J$QYJ)!B-/N*<E3)"TLQ8[9;F5UOOK0V@KE=2B*Y;1T.
MN?B5==K0H.F[&LJVZSAE@SFMH?*IK$F#TFFRC<G. V1 T$:IO</GFC<:_77:
MI:N7CI?&B6,*KJ[^7?-56T1XVCU.H,4K#=8G4UF9(;@33::,Y41#JDL2#-*D
M)/=6R2NZ4)([W))%D)DZ9-&=.D/P*GC.B0JC#=7&G0W7W$N1I3*C;?8<3N:K
M+:<2I"BN=C(\S$S^_OZ?_2!K[ZP<_<^:_N4Z1>:-7]"WU@L=W#1+S]H'K#G5
M![^_I_\ 2!K[ZP<_<^.Y3I%YHU?T+?6!W<-$O/V@>L.=4'O[^G_T@:^^L'/W
M/CN4Z1>:-7]"WU@=W#1+S]H'K#G5#;[_ !Z??2 @']->?<N.Y3I%YHU?T+?6
M"GNYZ(^?E"]*_P!0'O\ 'I]](" ?TUY]RX[E.D7FC5_0M]8'=ST1\_*%Z5_J
M ]_CT^^D! /Z:\^Y<=RG2+S1J_H6^L#NYZ(^?E"]*_U >_QZ??2 @']->?<N
M.Y3I%YHU?T+?6!W<]$?/RA>E?Z@/?Y=/OI 0#^FO,_\ 4RX[E.D7FC5_1-]:
M'=ST1\_*%Z5_J!L]_KT\^?\ @?\ 22'X?R>Y1I%YHU;T;76B.[IHCY^4/TDC
M[.'O]>GGS_P/^DD/P_CN4:1>:-6]&UUH=W31'S\H?I)'V<==YWZZ@H-'2R-^
M0)19%LNJDGER1\BBB:6VZ>F?(PQGR;[8QKGR9QGX_BSC/)3HHTBFHB/"56(C
M,B,]S:R*^9_OO 0DM.>B11DDL>4,S,R(BW21F9G8B_>.,6SX;7:B8=T^G%5=
MD)Y'8W%)3/7=@-R0*(X*8 ,]8C8\LAC+9E@R_)D<;.6$?;.G7GWJV/2UE_-8
M31\VEIJL=8>C85Q14:%#??DQX281MO2=SW9>^8$:6O7W)#:.]6^I*=5)=Z17
MN=S/TV&^J3&;>624J7KW)-[%JN*05KF9[$D9Y[1G1SD1E!P < ' !P < ,<>
MW%WONN/7"XKK%"6APK7-?RN5BA)#=9-@_) P;\DQ:/E&^VB^C-PY:I).=D=L
M*ZH[J93SC?&N>;6A4]%6K='I3CBVFZG5*?3UNMD1K:1,ELQE.(2KO5*0EPU)
M(\C417R%B4Z;$9]Y)$9LLNND1[#-MM2R(SX",TD1GQ'QV'R)_P!E#=G_ */5
M+_6TQ^^<^J?>VT+G)5O588X[MIE<G9^4L:Z_[*$[0;9QKKUYIC;;;.,:ZZE9
MEG.<Y^+&,8P\\N<YS\6,8^//!^YMH19GB6K$7&<6&';3*Y.S\I8T_LH;L_\
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MH\:73(\*E(B2S1,A..K=13JC&<-MDJBY!-923IC\)Q^+(4I27">>@MLJ;F;
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M&2MS6MF.9(-"-R0IQ;T@C0A)ZJC)!2&WR/5L1L*2:2U[CRXYZ2-8/U7>G/\
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M$<JY7RE['U[Y/-96SE;*?D]CE7.5/)[//EY'=OT9WOV<=O?6OV&K%]:VK?\
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MC6N-5<8\F%-?8G<>Q4QCXL;X\FWD^+R^3D'IPT9'MKSAW*QWH]7.Y<7\!V>
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M #*?ZO !Z(T_FS?\RG^KP >B-/YLW_,I_J\ 'HC3^;-_S*?ZO !Z(T_FS?\
M,I_J\ -VK9MIG&VC=#7;'\6VJ2>N<?X,XUQG' #FX . #@ X <.S9OOG.V[=
M';;/\>VR2>V<_P"'.=<YY-S+89EY1%BXB\PV^B-/YLW_ #*?ZO%SXS\YA8N(
MO,0>B-/YLW_,I_J\7/C/SF%BXB\Q!Z(T_FS?\RG^KQ<^,_.86+B+S$'HC3^;
M-_S*?ZO%SXS\YA8N(O,0>B-/YLW_ #*?ZO%SXS\YA8N(O,0>B-/YLW_,I_J\
M7/C/SF%BXB\Q#7#5KC/EPV;XSC^+.$4\9Q_E]CQ<^,_.86+B+S$.?^+^+D"1
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g729258g37k41.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g37k41.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[29"4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )B:^EV8X0DE-! 0      $D< 5H  QLE1QP"   "N^@< E  "')R-C X
M,#0R' (% "A-:6-R;W-O9G0@4&]W97)0;VEN=" M(%!I;FYA8VQE7TAI9VA?
M<F5S #A"24T$)0      $"TP?D8R$V.<EEG:Z-G>9Z@X0DE-!#H      .4
M   0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $
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M=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M    $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO
M;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG
M:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0
M$ .__C4  @ ! [_^-0 "  $X0DE-!"8       X             /X   #A"
M24T$#0      !    '@X0DE-!!D       0    >.$))30/S       )
M       ! #A"24TG$       "@ !          $X0DE- _4      $@ +V9F
M  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8
M      $ -0    $ +0    8       $X0DE- _@      '   /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H     /__________________
M__________\#Z   .$))300(       0     0   D    )      #A"24T$
M'@      !      X0DE-!!H      S4    &              ,L   &T@
M       !                          $             !M(   ,L
M                  $                         $     $       !N
M=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   ,L
M %)G:'1L;VYG   &T@    9S;&EC97-6;$QS     4]B:F,    !       %
M<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M       &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R
M871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG   #+     !29VAT;&]N9P  !M(
M   #=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$58
M5     $       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,
M8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T
M   /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU
M;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP
M965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S
M971L;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T
M<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@
M  P    "/_         X0DE-!!$       $! #A"24T$%       !     @X
M0DE-! P     &[T    !    H    $H   '@  "*P   &Z$ &  !_]C_X@Q8
M24-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D="(%A96B 'S@ "  D
M!@ Q  !A8W-P35-&5     !)14,@<U)'0@               0  ]M8  0
M  #3+4A0("
M             !%C<')T   !4    #-D97-C   !A    &QW='!T   !\
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M0S8Q.38V+3(N,0
M                    6%E:(        /-1  $    !%LQ865H@
M             %A96B        !OH@  ./4   .06%E:(        &*9  "W
MA0  &-I865H@        )*    ^$  "VSV1E<V,         %DE%0R!H='1P
M.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O=W=W+FEE8RYC
M:
M  !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U
M<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M,BXQ($1E9F%U
M;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M    9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN
M($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6:65W:6YG($-O
M;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M     '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>     5A96B
M     $P)5@!0    5Q_G;65A<P         !
M H\    "<VEG(     !#4E0@8W5R=@        0     !0 *  \ %  9 !X
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M?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M,S52<W6!E*&RL[71)%-4563!U.,E0T1RP]+A5F*3E=/5\2:#D@AC98*B_]H
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MXN/M6,\VVPQ.@SVSM$)?E)SH^;H(D22;\80<];@27L9-+.&+B?4!/G9O(>6
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M6FTFIEE,(VNK%H9%D2332DH")()$+L-D@D3<AZ<3J'ZB Y3+-GOOM3)2/2)
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M]QG8_8MZZ)"54ATGU#!P6(-3;C[H\@55(L&[-T*##23GF.Q]+;1ILN8QT*_
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M+TAYIZ5!KY<MZO)R,<F.BRS1PE9-5R^@U:0ZM-8D2H$<N0 6.TEBT7 X.TE
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M.R9*A)5R9I28H07XKKQV3;YE$DQW8Z%^YAB*7M;[ 9LOM&I=S\V %PS\J #
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MFHLFWZ',Z@,M1HTNRP;<,-EI%=**U(FU=\TVA*T+#OI1UU%+U"VYX=_#Q/\
M#=>C!4Z*X!\H&J\S &ZW6S"Q=5R"037)LWG+.IS)I?JA=*U$C321Z?JO0II"
MK".=DBU.FD?8[>*$D(4[6(<*]$JP%'0]K7%+/%\6:A6T6 -]YJ4J:T#).&#
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M$U6XT10VW8D,9TLZ,X,FX*55PRIPP(5O<2P?,_F'+4P#(:AHUN<>Q<CM*\[
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MLFG\*:+51NVE*S1>'/I71)(M1I_#92$<R2L75D\9'(",C*2>C#\<JZ.URIR
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MBF%&N#1 &V]U"R<[U'H-3JGD&FAG>5"K.L:.SQJ?+;A U(35L0%&ZFHY8BC
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M05W %1M"C@)XC%03RUT+X6^3>8F&+IT74UC75F31>,P;4,I4-""5"E/VT$J
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MCQNH>I! "DC=9-<'FZDH=P4,NYE##<-W&U10*D"P#8NB=K<V#!_8]9*]K\V
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MW_+VDJH"=T<$8[8FX;A^0I]X6WG'/6<6Y4E6 V[?*:)))"ABVTFQR/HI2>*
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M%(H,=S,OH";"\<"J4C-"Z]K9^H=8U&HX$!U$I0ZAB7$#.S1T>0QY+$K?)X)
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M(>Y.8O=,JL%*A7%,JMM)):@.P('?BU4BP.2,Y)%-/$DL4<FU9T7QBK*M@,%
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MIZQD!&1EMP@5H'3[O$;;9B+5*95)8"U1&:C*P+$6RTYH&B:!"@BP.38RW%R
M65%HH&T65:@7"@L*7?N9=P\JDU9LF!^79\# 4-^.ZBD#:* H9&K9B"QD)3;)
MP"(7D-6Q[EV)PVP#MCV 1B 6!&T  ^=2."11W59JK'NC;0))CR;[>6P6VA@;
MH;;KN=MD_$G:1VRD+OYF/<UUD#SPP&9!PYKHDCU?7NO B-1;$^[C;,F8T;Q5
MWS3P+)^3-88+X22"[TNB<]/UDC!VWLI251M:,@@HC$\G<290U %5:BVQB<A%
MM:&2+L[QJZ(U*941W1I84==\J1LRQR["PC,L9D*EX\G\8#E"#[H&RW) 09<=
M9<;D 'FC1@3).>UKR%MKUJRI..!X""A]T4Q\T)CDO>I"GDL2ZW08$E58O3 )
M1!4$;BQHD42%BVH=A.U265E%EP2U, !SNHA[)YM;(R8)(]?=/O"?D7RSK7BV
M"DZBMJV@BK0@AJV1-J_V<,5[(J&ZXVDT1V[WNE4&PEN=H!W6 /PB06VE@I/8
MT,H/N9@@YY)-G@"P0V[O0LD]R>#W-91F<M%(QJ:T$^P%XWXB#'@*^W,EP6K!
MMRV@=HP@'Z>L*=":4S;9^:?:;'P=1J0WE=%1E7[6MH;)9KH$]SO?;1(!KGD"
MCS0SG0VC7J$8ET\4D=2$EN%CE:!A!.ML7'A:@Q2N(QO,:L""MC*PPS3>'4'2
MO.ZA(EM);R[%GI[N0T*2 A4K$#'LA=QQ[$0KCL(3?VU)JVVIM=;S)#UG>6TV
M-,.-*EW+Y3]YDZ-IM5T-^H++NG 9R/*JDHP0H5#HH<JM^(2&<DL+,G-MU/VM
MZKK_ *HNG]A=3IXDZ3KT@@Z?U!HGU6J635Z4:].I'4IIYY&T*:EGBGT<4:Z?
M1::)X@$71QF&7UV4T-O!:L8$V.J21 '(IDK;Z*\RS*98DPI"?,1W7V'1<>;0
ME%TGVW$0_#V\T+4:64%U X44&!<^7:UM0M;Y7@,>0"2"=HN-5T[7Z+4MI]3$
MQV'>CK1AD'BF,E)$'F7Q%*K=$$$ <Y,3<=>8\F'$15 #[N=B17!7V^;8I'%3
M0 [?<-QT#(W5:\$;$CQ\K+"RA5%1D$LH (Y'O5V6R0"EE5"@^@%MM >F5@]E
M&#*0FX+1"\42:L*P%< ]@!#(^$:*:L-(VX?8O<VK@B2]U^J-L$A"O<$53]9M
M@YW$#;)TB<K>)&[#[8B@76VF:@0U!-H%;AV_"L$=C4 K2N!(Q(0@!7\HHD&C
MN(07N-<4S4."0#&@D>57>M)TEM#<:=G'!?<A+(5'&Y+,=Z,RV,:5%CN-"3<=
MYIP%<CA+%OW,M]I)8H9RRR(AC=8B05$B QRK+$2IW(S13*)$;D)(@VGUR9"=
M/J:;30S !A&FH2.6-.!;)(S[XW()N6-T<(SH6,;,INMI.,;^T-2(XY'9[;%P
MV0+BQFR]HIED!M6T1E5%ASL@L ((\(N 0@+(-IZKK0K(NMTL1:XFU6F<.JB-
MU82QLJN"VV1&.[:55:! IC9&&ZTX'2NO,Z.1]:M:D2LY,B-\CD#60H652;8N
M65E!._Q6Y?TR\ZWGE/'&,<8QQC,<.H+<]UJN%7P\:K(5O?Y#!GM5K*P[RYG5
M<]9M575=M*Q^F@%]ITCDZR&M<82ZJ[>==RZ6GH(5W-LG&(K&7.U5?7>3Z^QF
M^R.?C5I<V4)YZ988@\K^/RO&;*9CNPR65.1I_P"5;8&SBA-EM0K49L-F4^TP
M#IL9<'C&8>?$+;;>Z#>LUEYL'6G>E[>C;K3H"XVXV>M<D$VW -%$P,543 D4
M2%50D5%5.,9DYA>*8O@V)X_B.%X[28EBM!5Q:^BQO&ZN%245- :;16H574UK
M$:! B-J1*W'BL-,@JKX@G=>,93VY-F5.EM2;/W!?5]C:T>K-?Y?L.XJZ=(JV
MUC68;03\AG0:Q)LB)#6?*C5[K$1)<J-&]YM^Y]IOR,:D,3SS0P1[?$GECA3<
M2%WRNL:[B Q"[F&XA6(%D GC))'6.-Y&O;&C.U<FD4L:'J:'';GU&:65^/OI
M-%5%Z>-V_153_*NM/XO_ +W\[!]@SVT_S_0?Y_J__MV:)]D?V>_S75/YI#_Q
M>6YW!\<+3^R=3;/UW7:%W%66&>Z]S/#(-C866NS@0)F3X[8TD:;-&)E3\HHD
M5Z:#\E(S+SZL@:,M..>(*^P9[:?Y_H/\_P!7_P#;L?9']GO\UU3^72PC^GY7
ME?1?CY:4CQ8T<NGG=A$PPRR1#::T\25IL04D[Y>B]E4>Z=T1>WX\?8,]M/\
M/]!_G^K_ /MV/LC^SW^:ZI_-(?\ B\^R/C_:/BL/R7NGC=_JCLN/NJ%GK0S1
MMH%,U$?RP3R+Q%>R=T[KV3NGX\DE^HA[90Q22O/T+;%&\C;==JR=J*6- ]/
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M==FR9S1RF8SMD3+TSR<E2Y0O2OFFU+YX&V4?=,GFVFFS:CQ\=J-2]21QLZ*
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M0Z\TJR'SDN(V'9UF.,MY?.0,9MMLGT1YP5=^X-+5/-J FYGVH*"[A2J0-VT
M@U7.WW>*'<DQEE::21W"B1U4R%%1"?#78B.U%G\*Z3<250B- %(SOD(^X+1,
M-"VTXT2(B=NY-MNN(U^D%5;4D4?('^X(1"BB2D]V2P,;@.PVEJ\O<;N%-FB
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MR/G>X\VPS5.OH8USC"W%/4OW^58S6M,6$=AC&ZGSGR&64;L'G:<_3]3.3<Z
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M'JXK=[?8[CDO$:2UGH">R76XS.R3+YE+&-%% @R,FNG&U156<[Y(@L"_7O\
M-F.W7K^H_P!8/^K'O3_EGDW+WIO[I=._']%^DQ9;ZO[DU7XO-_9MGA#/]^7^
MD7]:\^B>>5\X\8QQC)=<?Y'M_P!F3O\ AG.6NN^XM9^*ZC^Q?*NG^Z=-_#Q?
MUAGZ,>*_P8QS]@T_]GQ^?.A>P^@?FSU8W<_2?SY/N1R&.,9\+\%_F7^KC&?G
M899_"G)/V];_ -H2.?1G2_<VG_@(?[-<\HO^V2?PDG]=LI_E?)<<8SZ/XI_.
MG]?&0;L?H/YL]_\ TR?JW=/W]">J_P"XU%SY^>U'WS>T7\>]7_O#49Z@Z/\
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ME\A[=_).XZ[1@T=5IP2+ ,T=D<\UNNN#S\QR Z)U@\CI?4"+JQI)^_P]SO\
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ME5/L_IA?>?5[JYJYC7 (H':"3R !R:[8N1W$<$?,$;0R\S7R=$2%PD;-2\4
MNR@;HD2"/=LB1YH_-T2L--P:+% U@DW0 4!B&[@$O1(- @@DC-DEVL*6CV*B
M@?PN!1%;K%$$\V"=I)RVNV</N,MJ:V-36CM;)BR@=D^B;(AM3X4@49L(LYV(
M*RG8KK!.A*@.(] LFT2/-:,"<$;V.==-N7<?MJ4Y5RS_ !IB*H[&6@UW0H$9
ML/LSU/1].U<SZ_3+/!+#)&M1)(4FC5GT[+'+]KM9PI6=3'+IF)EB<2*"+@QO
MF&X;8/ V+[; L>,5M&  V_NBJ-MJA"I"GF*+[#$4[(XYV15QADWL?,+8 !K
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M[DQV/1[6E,1&% GI+C35RX$9GZ('M?<#UBBCXJX?E]1+NO0.@JZ]%"L06K4
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M2-2=:;5WUB8M*3G;[S:D0>3IJTHH**!=X2QQ @V!O7RU9K\("_*!>TFR2;(
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MDV*)JU/8#DT1P2> M9-#>94&O<UW)Q17Q!%!0$?!XR7](H.M"K7XF)"ZG87
M<0C!*B!  -H8$VRL =E!0" 18H-?:Z-FB*-%XVMJ;:L:D*;H,2=I-B_,:7@4
M5V<\&\X.10CD3L4_4A,N*ZX*(TV:%[%:(P[F#G@ZH@H.D7F2*HJ""+:525[
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MN G?U.IZB49'A'4U%GR,VW$^Y[A11)%(6V3-3=,R1?,56U>1F6[![?"B H!
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M?4#, 1%(R5LB'N?BB"X1BHJI..DCID;7@J(H^!*O89UM6IJ%EK(  (*@*37
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M3^7%MY!0O4XZ#PJB'W>7MY.-H@_>%6O8C@+XFXGU!&))&;<2+#.0>.0?+R>
M-H%,'7;9)L?@TN/:!>X"]U%E"@\+R0;<$L5/E H;?5CR-V.HO&?K^KJJI"A(
MB$'=0-LE:#Q O'NH^?Z1344#ZKW@RJU'=N-U[@!;ER5.T&QR:]2 #>4MI&T
M42!1W&QN7OMW$[O4_@@FP:)&;6NGE%'I-NON"VOV1L=?!5 FQ[-68I]1[ H*
M@H1=D3MW5"%"14YM/3%,?27X%@:IJ '!)<A?@2.Q-439]<Y'[24?;" 62#-T
MP$F[/,0)HDD<_P OS9JRCFO9L'$57%$4\Q,"%"81 :;4/'[YB/<2=\/(T^\0
MH:IWPC26.""#5&J->OI5#L:[':+X-=;*HI! [<U6Z[XL63=FF]>".X85\:9;
M-U44VV3(E)/-.R$\) B^;YEW+P/Q^\:F7GZS($5%,)P%=P6) -T"-HL+ZFZ
ML'MV]1ZY2)94.P%J8$E#9ICR  I\WK\#[MB[R,)QM@7'/O$\#XB/@ J)@B=P
M\2< ?)D146B)Q2;[#V434E7DK*$4,!O(>QNL[E[&KOBP>*(LB[[9&/>YVD;
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M'SWV%<VWGW"["K:]R0!!Q423V1%$VT4P1P$'OYD2)Y(BEYHJ((+;L))&8#:
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M8:]@H2$2@X2KY"X@&1]O(D+R\T$P$C O% 1OQ0OT8D@<")/>8A2=K#S6%6N
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M(H=DSO%$,0453LN00212'Z(*HACV)%<^[W[**H7C5@\NIT]'GY1"&-T;\4
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M-MBV)^1@2KW$4]HBA=T5ON@().*V:F0=R[@%ON8!%M9"2>2>0GF 4^4*.+L
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M@61VX<[AP H8BNU7N:Q1JL^#(3R]!@X:,B"B;:^?J42>/R\B5LA%"[>3AH"
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MS]QM1 C(4_2*2J*HW3@ -M)?M7 W$>AI2*!Y4610:^\'C9A^"#^"23?H/,M
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MM=2IJP:-$T:X/.:SE_\ )[ZU555ZQ\U^JJO_ ,CF%_Q__>'G6_LW^VWPZ/\
MS"3_ (K-'^QU[._[?_._^5GS_%[ZW_/'S7_<YA?_ %#Q]F_VV^'1_P"82?\
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M^M_SQ\U_W.87_P!0\N_LW^VWPZ/_ #"3_BLH_8Z]G?\ ;_YW_P K'^+WUO\
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M-JZ5TS3='T46@TGB>!"9"GBN'>Y)&D:V"J#YF-<"A0],O)^9KK+_ ,];'?\
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MA*H Q6@ 2I">?BV7:".QUEMUL2;<[-.!X 2"R/K[JO8E0D%M>PJZZJ(JB'B
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M \RB-6\=<HL-,8;@>0;6@)$6L%:S+\=J9:$,0I4F-<>OS_[OR]OY/Y,9BO\
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M$=/S(D:;1MMTFT5>R"]ZU$$$V_ 412%/XA%DE-51/WW+159^6('#,H(ONI%
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MO%,VQN7>0)SLVX"35L9(<*^&;F6#Z9S;1\'J6C66,[TTQ4:=ZDKRUTRAY9G
M1V\RI,CS36,V#M&#2ZHR7*\)S:?CLQBZH-IT59855%D-3517F+6ON&,K#//A
MJT>:9UU)Y'&V]D&.XEU"X6Q@3&"P,>0F-:T&PBU'1]5RXM=M9)#DE9]1.O\
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-.,8XQCC&.,8XQG__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g729258g38a86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g38a86.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X7Z@:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ
M-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O
M9&,O96QE;65N=',O,2XQ+R(^"B @(" @(" @(#QD8SIF;W)M870^87!P;&EC
M871I;VXO<&]S='-C<FEP=#PO9&,Z9F]R;6%T/@H@(" @(" @(" \9&,Z=&ET
M;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F
M.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/C P,3PO<F1F.FQI/@H@(" @(" @
M(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^"B @(" @(" @
M(#QD8SID97-C<FEP=&EO;CX*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M<F5P86ER(CY&:6QE($YA
M;64Z(" @(" @(" @(" @(" @,# Q+F%I)B-X03M5<V5R;F%M93H@(" @(" @
M(" @(" @(')R,S(S.38R)B-X03M,;V-A;"!4:6UE.B @(" @(" @(" @(" P
M,BU-87DM,C R," Q-3HP-3HR-28C>$$[15-4(%1I;64Z(" @(" @(" @(" @
M(" P,BU-87DM,C R," P-3HS-3HR-28C>$$[4V-R:7!T(%9E<G-I;VXZ(" @
M(" @(" @,BXV)B-X03M);&QU<W1R871O<B!697)S:6]N.B @(" Q-BXP+C F
M(WA!.T=R87!H:6,@='EP93H@(" @(" @(" @07)T=V]R:R8C>$$[)B-X03LJ
M*BI4:&4@<')E9FQI9VAT(&-H96-K(&ES(&-O;7!L971E+B!0;&5A<V4@96YS
M=7)E(&UA;G5A;"!C:&5C:W,@87)E(&-O;7!L971E9"!P97(@<')O8V5S<RXJ
M*BHF(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!F;VYT<R!A<F4@<')E<V5N="!I
M;B!T:&4@9&]C=6UE;G0Z)B-X03L@(" @(" @(" @0V%L:6)R:4)O;&0F(WA!
M.R @(" @(" @("!#86QI8G)I271A;&EC)B-X03L@(" @(" @(" @0V%L:6)R
M:28C>$$[(" @(" @(" @($%R:6%L)B-X03L@(" @(" @(" @07)I86PM0F]L
M9$U4)B-X03LF(WA!.U1H92!F;VQL;W=I;F<@8V]L;W)S(&%R92!P<F5S96YT
M(&EN('1H92!D;V-U;65N=#HF(WA!.R @(" @(" @("!";&%C:R8C>$$[(" @
M(" @(" @($--64LF(WA!.R8C>$$[+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM)B-X03M&:6QE($YA;64Z(" @(" @
M(" @(" @(" @9S,X83@V+F%I)B-X03M5<V5R;F%M93H@(" @(" @(" @(" @
M(')R,S(S.38R)B-X03M,;V-A;"!4:6UE.B @(" @(" @(" @(" P,BU-87DM
M,C R," Q-3HT-#HQ-B8C>$$[15-4(%1I;64Z(" @(" @(" @(" @(" P,BU-
M87DM,C R," P-CHQ-#HQ-B8C>$$[4V-R:7!T(%9E<G-I;VXZ(" @(" @(" @
M,BXV)B-X03M);&QU<W1R871O<B!697)S:6]N.B @(" Q-BXP+C F(WA!.T=R
M87!H:6,@='EP93H@(" @(" @(" @07)T=V]R:R8C>$$[)B-X03LJ*BI4:&4@
M<')E9FQI9VAT(&-H96-K(&ES(&-O;7!L971E+B!0;&5A<V4@96YS=7)E(&UA
M;G5A;"!C:&5C:W,@87)E(&-O;7!L971E9"!P97(@<')O8V5S<RXJ*BHF(WA!
M.R8C>$$[5&AE(&9O;&QO=VEN9R!F;VYT<R!A<F4@<')E<V5N="!I;B!T:&4@
M9&]C=6UE;G0Z)B-X03L@(" @(" @(" @0V%L:6)R:4)O;&0F(WA!.R @(" @
M(" @("!#86QI8G)I271A;&EC)B-X03L@(" @(" @(" @0V%L:6)R:28C>$$[
M(" @(" @(" @($%R:6%L)B-X03L@(" @(" @(" @07)I86PM0F]L9$U4)B-X
M03LF(WA!.U1H92!F;VQL;W=I;F<@8V]L;W)S(&%R92!P<F5S96YT(&EN('1H
M92!D;V-U;65N=#HF(WA!.R @(" @(" @("!";&%C:R8C>$$[(" @(" @(" @
M($--64LF(WA!.R8C>$$[+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM)B-X03L\+W)D9CIL:3X*(" @(" @(" @(" @
M/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.F1E<V-R:7!T:6]N/@H@(" @(" \
M+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!'26UG/2)H
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(CX*(" @(" @(" @
M/'AM<#I-971A9&%T841A=&4^,C R,"TP-2TP,E0Q-3HT-#HR,2LP-3HS,#PO
M>&UP.DUE=&%D871A1&%T93X*(" @(" @(" @/'AM<#I-;V1I9GE$871E/C(P
M,C M,#4M,#)4,34Z-#0Z,C$K,#4Z,S \+WAM<#I-;V1I9GE$871E/@H@(" @
M(" @(" \>&UP.D-R96%T941A=&4^,C R,"TP-2TP,E0Q-3HT-#HR,"LP-3HS
M,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^
M061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO>&UP.D-R96%T;W)4
M;V]L/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^"B @(" @(" @(" @(#QR
M9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z=VED=&@^
M,C4V/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM
M9SIH96EG:'0^,30X/"]X;7!'26UG.FAE:6=H=#X*(" @(" @(" @(" @(" @
M(" @/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=);6<Z9F]R;6%T/@H@(" @
M(" @(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO.6HO-$%!45-K6DI29T%"
M06=%05-!0DE!040O-U%!<U5':'9D1SEZ84<Y=TE$375-04$T46ML3D$K,$%!
M04%!04)!05-!04%!045!)B-X03M!44))04%!04%104(O*S1!1&M&:V(R2FQ!
M1U1!04%!04%F+V)!25%!0F=114)!545"9U5&0F=K1T)164I#=V='0F=G3$1!
M;TM#=V]+)B-X03M$0D%-1$%W341!=U%$031014$X3T1"351&0E%417AW8D=X
M<V-(>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA54D92;V9(>#AF)B-X
M03M(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X
M9DAX.&9(>#AF2'@X9DAX.&8O.$%!15%G06Q!14%!=T52)B-X03M!04E205%-
M4D%F+T5!84E!04%!2$%114)!445!04%!04%!04%!05%&07=)1T%104A#06M+
M0W=%04%G241!445"05%%04%!04%!04%!)B-X03M!44%#07=11D)G8TE#46],
M14%!0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)4DEX459%1T4R16EC
M645537!':$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG=D5L47I25&MQ2WE9
M,U!#3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*4D92<5,P5G1.5DM"
M<GDT+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP86UT<V)7-799,U(Q
M9&YD-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K-5-6;'!E66U:)B-X
M03MQ8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)0T%1241"455%0E%9
M14-!341B445!06A%1$)#15--545&55).:$EG6GAG6D5Y)B-X03MO8DAW1DU(
M4C133D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!33F5*16=X9%5K=V=*
M0VAG6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z:$I3:W1-5%4U4%)L
M9%E75G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD-&58<#=F2#$K9C-/
M16A984AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U8VY:-F9K<4]K<&%A
M;G%+;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X03E.-GIQ=C9-<WID9E9:
M-W-,>7)()B-X03MB2TAC0E5:-C!*1S-W52M:1TMR9$LQ<4\O9T5P=')I,$Q4
M>5<V4C--6E)M359A<TMC:'A)56M'=4MP:&ER<U9D:7)S5F1I<G-69&ER)B-X
M03MS5F1I<G-69&ER<U9D:7)S5F1I<G-69&EQ4U=7;C9096%J<GAL,'%%4W9/
M;')E5'EO2D1D4B]624A(3&MV,D%(-&-.,7%P4%5N1E5P)B-X03MU269,65),
M1G1!<TAT8D]2>F)1;4-,:$=X4'A-:6-+2U=),W!L-'<K84Q60F1A3TPR82M'
M:C)G=G)H5$AC6%AP<#9S:4U!0W)V>#5-)B-X03M#04YI8U!G*V%,55-V;'<R
M23 X-D)91W=75#%L=$1$1C9);'!X.5%2.$]02VAP5VQC9D(X,7175S8P:&(V
M4%5&,&4P1B]#;VIH=7A')B-X03MG;5)!<%%+<VY(:T)X4$=G4%1(=V9.8E59
M,3AU4C)C=&Q(;T9G;&Q/>79.87)$14EN6F9S<WE"3TQ%9'%J2'=F3F)8*W)O
M6'$R<S,V)B-X03M%<R]6<U963$M4,&\K54MO87%):G=Q9T(V8V-F0C@Q='!(
M,$9"9$MM:#)3<F9F-S)G4E)G5#=L=C-T12M08S$K3$AW9DYB86M0;"M3)B-X
M03M',6AK,$MX94=X2DYL1S!-6E=%<U%Z96M#;$5Q44-E3U!G*V$R:G1-9S!/
M.#%'-F,V4&%*8UAS5'@S;'=);WDX,&(P1'!+,T=R<3(Q)B-X03M1,UA)5'@P
M3%-#:F1(,'E05'11=F)E>FIT-UA3*T5$5S%L8DEK66IK2FLY5FEI2W1/9G<W
M.39:56QC9DU#9G V1%-%<S=L>%!B;35&)B-X03LK27HY6%5":4]$3V%58S!R
M5$95,7A6,DMO938O=C=4+T%)>6XO:S%*:7%895HQ,#%R4TE8*W!P<&MF<69"
M2SAI4D)M;V9H<357=FIM)B-X03M4<'!M2DY2-&Y',5=$>%EG8U)I>#-Z5G R
M:5-E65I,;3@X.#-7:5,O5C-$859(<456=$=I*VU+>F5K-7%#;RM,:V1S>&Y*
M5R]O<E)2)B-X03LV-6LX.3-V0U%20F8Y>45#*VM43D]9:7!!-G5Z36TO,B]4
M0VUV2$-Q,&5852]3355P+TU056E6161,4#9Z63A8-$91,5(V4$DK;W=&)B-X
M03MA94I!<%555EIB-61T9G%U:U%X9G!/6%=!0S57+VUA3C-C335.3U595E-%
M*WE/*S(K0E5Y>%9$6'-E<$]%*V]Z=W=%5C5M849P<2M&)B-X03M/37-.4'AY
M55-/<7-/,7(X<F),5W)I-G5.4TYT3DQE>E)85GIX4R]J5C5O26QH:6-P2&9O
M=%5J54%52#1K-4LT9'@K9C=%2F50>5 X)B-X03MU07E%43(Q2E5I:FM8+V-K
M5EI91$=9-G(K:TM62&]P.%A5,#,W-#-$=5!Z+T%'2EID;RMI87)P3VXR5VU7
M9'I:>#9D67AX,CA%071P)B-X03MY5FAI05951'9D4TYS;W!6<30S1'50>B]!
M1TMN;59Q-T9867$W1EA9<3=&6%EQ9TY.*W-F6&17.5<U4V50-C!V,65*1S5.
M06XQ5T-S)B-X03M59V]/3$8K56Q00F=E*TMS9G5R1SEA-6U)=#5#0S=%14DQ
M0TLO3$UY36A83FEP9E5,+SA!-5IP9BM!8BMM2&I(96EK:SAX*U):3F1L)B-X
M03MT2EIP3E%S-4Q)5&5I.6U413%:,#E.:5-563%#.4ME2GDS1G%"0RM2=G92
M2TYO0T@X<C4T8EIB84A63F5J:6II5T=%3&-U4%1#:S!+)B-X03MJ:%-T1'@S
M0D%&2V1":WIQ=U1D4BM33T0S<DIF>7-G=DQ/+W,W,C8Q4R\X07)9:6IU2DHS
M5U-29E)K861&52MM074X=E-N4VU%87EI)B-X03M#3T56+UEJ=S%*9GEM-#)C
M96Y2-G1R>7=W3%%W<F-M:&EF6E5D4%0T.%!H24AW*U!8<V9Z;3DQ2#5,-&9M
M5U1A4F]6,UE74S)3=&0S)B-X03MN;TTS2V$U2FQM<3='5&EZ54@R431#+S5.
M37@U-4%497=:9TEZ-FAF+W=$3$Y,+W=$9C!Y4$=/.6%43%%B5S9I=FDP<TQO
M=D%J:WEK)B-X03M#=%(T:DMS<V=1:TDR>2MO+W=#23E5.4PQ9G)N;U=N,6YL
M>#E,:%=B,"M&4&ER.7)L6#)P;4]Y5$,Q+S-L:"\Q1B]535968U913W,V)B-X
M03MR*VDW2G)R-G)094)E5EER6D$W,%=.;G)X<4]V1&HX>4U643%J<7<Q3DQ7
M-$9P8U=O5S9L:3182T-.+S-C8V<U9U90=W0R3TMQ6&Y$)B-X03M49DQL-7!2
M:S$V,V$V=')5;5=+0TUY*W$X9U4P4TI)4W)Y4TU.;%%62E!43$UE5U5$8U-G
M9T9J,VU#.#AI4')%<S)Q*U8W<2MV,FE%)B-X03M:=6AP8VQY6&IL:5$K;5=6
M6%E#:FA32&]+9VIT:T5O4UA79GDY=&14=4Q.=DM&-DI*5E9:-6PP858T6$5J
M<V502E5)86AN3$5D=5AZ)B-X03MO<6QI,R\U5G)F1UIV>2MV63=Q,U-.,6Y/
M:$4P15%!5&A)1EE64F5.2TAW-VI:5E!.3C@O*U=.23!A2F1/.'1A=EHR261U
M5FY$<&MQ)B-X03MV0S!H85)M:VA8-#$U=%AE;35)4%%G-'%Z8E1R*TLO<S0W
M=4I*630U2S!394YO6D)X67%E4T]!=S-(8UE&4D]+=7A6,DMU>%8R2W5X)B-X
M03M6,DMU>%8R2W5X5C)+<%AO-U=2,4180F)O-GI,96],>&Y)26%8-FQB14UN
M9W9P1D(X=V-65%1&574Q,WDY<$]U,FDR97%1=%!B;S1K)B-X03M%87E3>&9%
M05%#5$5Y13=-9&IL;5!*2T)U2T-,650U<R],=GEZ87A78W1L-51K,39A4U@V
M<DM'=C=I4#!)3&E.8EHS3%!*27A667=O)B-X03M!02M%8C%8379$<7!M-VYW
M+T%E.6A+03=K<V)Y:D\S,4YP=GDV5U$R+T9)9W5S53E*3%)A,G163#!B-'!#
M1'5D=WI(=%=Z>'AV*S@O)B-X03LR4&9Z6&@X;#,K1'!,6C=M-G1F>2]*;&MJ
M=5E:8EEA=6=765AS=G!4;FMX2D99255B<79W<U9P6$AX-V](2C-F=SDS-U8T
M9DIB3"M8)B-X03ML<6(T6$5F:U%R3$4Q=4DW;CE-16QK="]1-'%68WE!2E)N
M5VY5:4TY3U,T:E5M<3A4=CA!-&4K+W@X5C1D*U1*3DTO3$1Y8E!A4UA&)B-X
M03LW-69&;&58:W-K.35".6%M;5EY3UI%2DUI>6(X,&Q*24<R+RM32UDX.5AK
M0F]3<T1Y4TE";7%)<4EQ2TM+;T%597<R>D5:=#1Q9V):)B-X03MB.&%X9DY,
M17$R4FEG*W)39TQY6G@V;G%H<4AL.%!W,'(T-UEQ:%E,1%=Z<3EP97)Q45A3
M571"2$QP9VE5.#5I86E8,4-E46]#0E%9)B-X03MQ;D=+=7A61#-8.2]A9CA!
M1U4O.&UP35981WET5&1I.%I/5G=Q.$5K66QU2SDK04IO=&4Y3W9F<&EQ4EAV
M;$LO=619=3<Y3F8Q0S)G)B-X03MU=E-(,4-&,45566E4:694<4-63#E74'DK
M;%94,$QY:G)';F%V3F8S;FU7+S%30C5*2&=S<F=2<D9%:F=G25!40VQU3F8R
M=D%D3C9Q)B-X03MS;GA6,DMU>%8R2W5X5C5T-30X+W=26#<V9G K=%1A5&17
M;D]+-%E7:5A+;5%V1U998WE0<W%R:C,U6FM1,#!P0W<Q4WI20G!F-5HO)B-X
M03M->7EM,5),4SDQ4C<T,W!T<F4Q:E=Y1G9W;5E#3C),0U(V<3=N;%-N=S1:
M85=91F]'84I.4%)S>&TU,DMU>%8R2W5X5C)+=7A6039D)B-X03LY92MT-G Y
M6C0K:CE:6#9L>#0Q.4@V=$18;'@S<C9V<69A,W!4=%1&561I<G-69&ER<U9D
M:7)S5F1I<G-69&EQ5U=A,F<X=S9M,&-Z)B-X03M09$=',3EE06=H555'6&=6
M4&9L.%9F;&EQ3G185#!)535$;5DQ25=U.4M$96U+<3)+<%1"-6AT=%(P3S4Q
M5%$Q8E5$17-Y,CA.1V=-)B-X03MS,$Y2-F1:5E-L6$A'=$M9<3%9,W5P,U-7
M<VUO5T)S2G9R57%,1#9I>3%J5T]123E6<#EO9'-65&9&6%EQ-T9867$W1EA9
M<3=&6%EQ)B-X03LK8F90+W=$>6UE<V8X>$Q:=6-(,$(Q,E@V:6AF2U X07EL
M;6DO=T1-9F$O.&YL>5=8-D0W:6I(.5$Y-S9C>E-/>61I<5$K671D=C1,)B-X
M03M'-6DP845V<39&4D%,<3!V;71395DU.'!,94=1;C1+,$LQ,WE9>&LY,WI#
M<U)0;5 X-$9&,%9T.4=K4')R.5-5,E=U4B]W0VIF=D]1)B-X03ML4&]39G90
M-W%H554K,3=(1#12.'9M4#%R864V4#5J.#!(5TQZ.4UW47)O,W@O;R\V;EIA
M;V)O;C%N.5 Q=E5G15DO8V-/6$@Y=79A)B-X03MM4&A(>2M9+U=T<VMS=%1T
M<G@R5TI*,4MI<#EA,VYG2#!'5D5"*VI)>6=2+V%&4F525DLY2%=Y1V]A-&)D
M,V%:<C%$94LT04-Y+U5R)B-X03M90E4X5CE)269M5&EQ85EQ-T9867$W1EA9
M<3=&6%EQ9V1),793.5ET-4QN5%HO<D5%57(R-WE"5U5E<$5A3T8U0F510B]A
M1S)%:6Q2)B-X03LR0E5U=%!6+U1M;V-R5EDT=E-T=48R1DEA52]V95-L=6@Y
M4&%N:'EX5E%T+TQM:W1Q=')R>E)S9%1H=%)B4GDX,F]):E9I3TYA9%=X)B-X
M03M616%T<F1P<&(R4UA!4#A!<#%W=')#,T]*04I(0DLQ37)X,7)464Q6:C)'
M2W!**U8X,&LS:S(R:VMK95=1>C-19#5'3&UQ,TUG3D=.)B-X03M34E5B5E!4
M17%Y3S8O=C=4+VI+9BM456U+;VI&6%EQ-T9867$W1EA9<7 S3GIB,C%V2F-8
M16EW=U%Q6&QL8VA65E9&4WI%.4%-5E%S)B-X03M/=F%(3WI,1'%&=$EY>6E"
M;%=:0U)+83!J24(K,&%'9WA6.#DK9CA!+VQ-.5DO-6E7>F,T4&]$<G-V,49#
M*U5F*U5S,%@O;5!T9CA!)B-X03MK.'53>2]19F-562]Q2'9F5&UA4C)4<U9D
M:7)S5F1I<G-69&EQ6%=C.#!5*W-3,U5#5SEV1&-";UIK56=Z4D,Q:%IP6'!8
M:W=F;6QF)B-X03M"44\R14,Q4VY89E!%1FIA>%1A6&%N5G!M;FEJ;G1L9C9U
M>7=-,4I*5F%646I'3F0K0DDU94EY>G=:9'E,67EN-7(K8F8P5$9D4RM3)B-X
M03LR1BLX>DI.<#9A;&)S56E!*T=14W-I27A,8F-E,VHR>#A'6&-T<'@U42]-
M3RLQ4T,U9GI&;W@X=7EX3T9T;VIC<F4K<6A&4SE914%3)B-X03MH,F]C9D)L
M,TQB34Q7-F=U-$9U3&1U8TPQ-'11:71#461I065O>7554T124W$T1E%/;V%X
M83)C:3(T5C=M*VM(2TMY9TA+5FAU3U)Q)B-X03M1<4I5535U479V6$953"MI
M8GI5=FDQ=#%.<V5M;%%K;40O;G4U06%B+U8R5'A6=75+<'5Q<6EH5D%65D9&
M56)!061!0FER94MP8F%))B-X03MO,3=56$8S-FAA1S)"<SDO,U905BM,8S O
M958W9GDT<6]7*W9+=7(R=6I#>75M36QO3&HV.$DO.4=7:$LX1V-M;UDX9'1S
M5EE4<DXW)B-X03MD465E16EE.74R9V)7<D-/2WA39'EI2SEV2WA9<395-$TO
M5D9Q3G5O,F]52C,U0W4U53AH4UAM;E$O6&)H6'98=#=F:$9B1U8T-6Y6)B-X
M03M%+V0Q:D9E055.:6Q08DLY,4LV5S)K=C=!,D5O=3554TEY3$I73EDU06MH
M2SE/43=91E1F1E5O.'DK8DY!.',R8V0U<F0Q.55T<%AA)B-X03M/3B]4;&QQ
M>5%V3W=P17)T=$A#-V1/,4]T3593>%!Z4CAI=DQB46Y5:DA.9#,S-DMG:FQT
M-VU*:F56<#9216MA;&%N64TQ1DHW-'%J)B-X03MV2R]N8GEV-7!J=4I.079H
M9E(R=G!E=7EP26=8,6]X3$@O94ML86\Q9'5N43<T<6YM2W5X5FE(-6LV-V1A
M6'!C36-554TX5C989W59)B-X03MR:$]A3D=5,U5I;S8Q>EED;C9A3U=2175J
M<64Q=&)05'=":%<U-G9.;#@P<7-H:UA2=$M%:E-P3U@K<4QY37-:2E(V,2LP
M=DDP3V)4)B-X03LK4W-8;39,*U@X+V1(-69T67)R.3E.9C9Z9%AS.5!7=4@Y
M4U1I2TQ69T-A1&9+:FI%4%-/460Q:'EN2D%44$UH5SAO+SAP6F]V+TUF)B-X
M03MA+SA!2C5C<GDO469C5R](.5$Y-S9C>E-/>61I<G-6475Q,S8V9G!D-69U
M:&M7,&=K;EI!849H16AC9T@S<&MO>'-G26MA1G9&8G(X)B-X03MW<DME3U9)
M-W)7-UIP6FYM.5-'-VI"5EAE4B]36&Q'-$-J,6%$=G-01$UZ.&ME.7@O=T%Y
M3S4V0BM8=FYQ,S$X3G!Q4EA":W-914PS)B-X03M6>3902DQU1G$S0E5(22],
M2V,R;DU"9'1M4$M*33!Z2&)5<S!H65)Q1W1M3S9--W1E;UIO:7)+24@K<%<T
M.4E%-TY647-L5C(K2VY5)B-X03M(1E5Z>%9X24%Q96U+=$MY=%AI46%%9S S
M,TA567%P,V0S83)D=3EX9%1*0D%N,C5:1T-Q2S=D5&EQ5V973E@Q5&$P5CE-
M<T0O=T%F)B-X03MC<40V,4E0*TMO6$)%42]Y<%)Y+WE/:EEQ:G10,'5X,"M.
M:W19*TIK4$MA5FE8:VMB<'EK:V-S-W1487)%-'%I<U9D:7)S5E-Y>FMH)B-X
M03M/=C9K:3)P:FQ71S%-;#-5:U-G;5AI=$-+1# V2' O3FEQ3W1F.3599CE2
M9C%$1EAL,G5&<F)Z-G(S8E<Y,4A*<D]N+T%&1S-3-&MM)B-X03MM:5IO2D%7
M:VEA64-(<CA0=S!06E1H47I(.'5O-W50>7!B0S=267)H<$QH;FE%2G1Y=DMD
M>49A3FQ1.&=/<$DS.%0Q=T9+93-8.2]A)B-X03MF.%I4+W=!;7!-5E9:;TE:
M-&YH;FI75T=18UAJ8T)L64AS461J:$)R:W%8+T%/1B],4#A!,6%,3"]P2&DO
M=T-A8VXT,"LX+TY&3R]W)B-X03MV-5HO-G1&;"]W0DDX6"].3U!J5#=Z.#%P
M,RM&+TQ0+T%&84Q,+W!(:2\U<'@X869E9FUT22LR=&)A,6=70S%H4T-"2SA)
M;VQ#24MM)B-X03MP;W$P07%46$E%:VUY;%5W2S@K+T](+VIM-F8O04U:;B]W
M0TDU=4]X+W%L-VYN=F%,*S=J+U<O43AS>F9V2DI49B\W,78Y2"]!0D5:)B-X
M03MQ<W8Q1C=(4B]W0GI(*W%%9#52+S53>E)F*UDK,2\U4$QL1U@V1#=I-650
M-F@W,S U;6MD:S=&6%EQ;%!M-R]L13EA+S5G3'(O:WDR)B-X03M7679R2'9$
M1$HY2CEZ-6IZ9'5T96UF:U@O=T%D;E5V*UE:9BM*:DU,5R]32$LP,TUV6G,Q
M<FQP9G!:<F9A=CA!-DEB86PR;C<T9VHV)B-X03MZ+V]K2#<T5D$V9C-7,SAN
M:FEQ65EQ;S-L<$)E5VLY<&-!=$)C4G1&2V]*56Q(0E9H>55G:EDY<U996F$K
M5B]+.6YR:C-N;#)X;'5D)B-X03M74V%74V4T*W14<EIX5%-616YQ;FU9,F)F
M94Y&6G5N24PQ=W%Y83 P4E)/=#5Q37AV-SE#5$A)-CA9;W$O=T,K26%S22]W
M1%=*3# R)B-X03M,2$%Q6C1Q<'HS5G1B9T=E6DE1,GEM4F=T9FQ80T%4>59I
M4&UF.#!D23!#-6UT+S!:<65Q=$9"2&-H.4UT>&-X=4I*5$59,&9M<2MO)B-X
M03ML3U1)9"M*<4LW,%!"3'560C-(-7EA3D4P:7)O971Z3VM.=D]O:G-Q:'AC
M3$4S0E=:,5@Q22]7<$EP231L5SA-4$),=59L5VLK6DY,)B-X03LQ3%1B4RM7
M5#9Q8G5+3U57;#!5:G5)>DEO8C U62M2-'5T84U02$)W4S=L5F):8F]A>F9-
M.7EK;'-9<F8P8E5.5C0R2'%C,EIA8D(Y)B-X03MQ8C<P>4MQ15 V9B]!16Q9
M;5 V=BMH9G%X*W-Q95AR*W1T=TMN-U!';EAB1E=",T5H9GHS94QB<E!).%=T
M,DAR96A%<TUA:')7:#E7)B-X03M:435K6&9C4%1W1T9$379,;6PS*V=E5C)T
M4F)24S-S06YL:G1B85-1>'5Z37IO:7E82DPO04)607%X=TI25FYE86ID0S)E
M*W-467EI)B-X03LW;%))+U574W-A4GE"2DMI;$]9-UEQ;3)+<UDQ3'HU1%E3
M26IA4'%L=T=L=4EM83)T5VPT+U8R0VAI069S>3$K02]F5$96;FUF>FI9)B-X
M03M73VE79'DY,4YP575O.$I,6C5B9&UK5E5:2&M2-&E0:$I1.&0O2$Q-94M5
M*U1#8WA(;7A,5"]Z1U-(5T=U8G9Z5CE:,'1P<$@O4B\V)B-X03M.2W-S8C$T
M4G)-1W(X1S(U1U<O;$HY>D1X-'949$PQ2S Q4%0T3"MZ679B6$,X-&U)2VMI
M=$]H,S=:4DM*:6%,8419=$9:1DQZ-S@T)B-X03MF*T]B<"\X07AM9B]!26IM
M-#=(*W%8=65E.6]V-W50.6(Y1'EZ3BLX:VQ.+R]V5R\P9CA!15)M<7DO55AS
M9$@O04A-9C9O4C-L2"]L)B-X03M,3D8O-6HW6"]K.'556F9O4'5,;#0O<4AV
M9E1M85(R5'-64S=69DU/:V%63F)W,S@O;W9D5CE!1E=A=$A24#)1869&2W98
M1E5I,41Z)B-X03MF-6(X=V569DU#-E!F>#-J5RMN,T)M0V-G5D1W=G@K,$(T
M6EII*W-E.$U-;C!N,U!N=DXR-C$V6BM29B]!0C)D4R\U:&PO-&U-=W1B)B-X
M03LY26-R5&-Y.6UZ5W57:VM/<E=.:F8V;W0Y<6-,3DID<6)7,#4X<%DQ1G!"
M5T99+W1&:3%:3TMG+V)(:FEQ=4Y8=G)I;C90,#)6,5!3)B-X03ME.% Q4U!B
M<CA,0C=G2'=R1%0S>%8U=BMC:F5B3&4S,#)6.5IE,G1:;6Q397=S03EU<C=!
M:C%*9S5K8T1P5#119D1->E-116EB84TX)B-X03MI0G,X.&<X>BM:8F5&24QF
M5G)Y1T-*47-C561X2W%+;S)!5E%W04%Z4#A+2&-0:S1N:5,W>2MG9DED>F,S
M6&Q$4S=I-6QE96532W-K)B-X03MS:D8S63AJ=5=A<$]A;D]!2FUN4'AN,&A0
M<W%:<6,Y<F)804%N:%-93'5O:U5.5#56=V=K8VQ59C!4<%@O3$9"+W=!:6LO
M<&@T-60V)B-X03MP4G)T,7!':W9B<"MH2'9$8T=G3G)B2DE%+V52>"](,' O
M93AV:T1H-#5D-G)F3'5P-DAR56MW:#!3-'-7="M,5G9R13(S3&Q8-T)9)B-X
M03MB,$DS>#0U9#9O*WEA>5!M3%4Q:E)X94Q"84<T8VMC1U%M8C!W;SA2.%9C
M9W%0=%=8-G9#=%)Y.4Y45'939WA6:E!M:GEE;6]8*VM8)B-X03M&:&$R.%%I
M,5-'*S%6=W%O.'%W;W="67%!6%E%:6Q4:7)+.%91.3$O9C)N+T%";% O2G%4
M1E905UI(:C!I*VMJ66\V5SAR239M:$)#)B-X03M%9V=J3$U)=6-F94=R3U--
M8VE/-'9#=CA4*UI0*W)T968Y2D5V+TY79%HK5GAF>EDO25!!9FYS+S@K9BMM
M2U4K64Y5,4\K:&DK=3-C)B-X03LQ,39B2# O5VME5&I58C U13!R5$UB55EO
M=W)H04AU9'8R5&YY6D],:FM:5EA-,S-P2FU/-V@Y2"]L,2]Y:$]K9CA99BM.
M:FUM,4@Q)B-X03ML,D],-E%Y4$M7>#4Y*V-0+TA.,"]W1#1Z4#A!.%)Z8V1J
M+U9,,U!093!8.3-(*W0K:#5:;2]E4U-M+R]!3C8S*VHO:4EZ5EIF<4PR)B-X
M03M/:B]U62\Q46IV2U O2U=A3"]Z2#)V.$%Y95A+378P2#-&>3AF,40S=G!Z
M3DDW2C)+=DHO4%!M>GI$665A<GDQ=$QX;V])9E0Y2D%Q)B-X03M(:GEI4FUO
M4W!/-T=U9$)O9$AI;FE%<$-Z=CA!93AL,FXR:FYX-FE567EQ27)U-V=X<2LX
M-F5:<')#-G0U3#5M:&YI94]63T59-4MY)B-X03MK14=I:GAZ2VQO8U514TDW
M:'AC2&%M;VQK:D5Y,DI(9"MP9U5L+V%2=5EZ2GIL6#=555E-:FHU<6=9:DU0
M:40P9%!2=GE3;C%E5%8Y)B-X03M31FYB>'A6=#%";'5N*WHX66]Y>'AC=69Y
M3'!M1G)$<TA*,"]-=EE";SDU4%$V:'%5.'9J1&%N-G!&6'-635HY9C9$35)M
M=6-T4CAU)B-X03LR5VM7=#5R365N,EET5VIU,%,U9B]F<B]!1E-"=S8Y-F-8
M05 K5GE056Y&539X5C5H*V5V+TA.,'(O:DY*+WA!6FYA3&U81S%025!()B-X
M03M-,DQH=F\O.'5V.$%L0V1)+W=#35 O1WAZ5&%J-GDW2$8Y25I(;$Q9-T98
M67$X12]-1'I,-6ET9D]/<#(Y<G%T-4)"2$EO:FEI=4I5)B-X03M24G=5-TMR
M041.<F=X>$U"641G-5IK4T\V0SAR96%F33 S;6)325IT6'9:65IB,C-34TXW
M:59L6E=L54970F%H0D=4>31O:4HR2$IJ)B-X03M#8W5)8G9E-V1T44]R6'%Y
M;&9Q06IG*W%G8V518RMP-G1A9D8O3%-V,%IP,UE+14]H85I*9C)E<U!%5'%&
M=F(K:$9.>6)A3CEY0TLP)B-X03M053!R:7%A67%O86A.8W=71GA.87=F5V)M
M2TXS:'0V.&959%9*5D]7.4]2,GA63#=+.#%/-E<R:W8W2#9H2TQU5D9I36=K
M<D=S8V=3)B-X03M11E%0=&5">%9&834O=T%C5%50*UEA8B]!2DYN3&-(.35(
M,VAP,4@Y,TPK<69U9E!'9&LK8F]052]W0S94+U<O:&U(<2MJ=D]X9C0O)B-X
M03MH*VQ,8W<S979O+SAU=CA!;$-D22]W0TU0+T=X>E1A:C9Y-TA&.4E:2&Q,
M63@K+T](+VIM-F8X03A:;B]!3TDU=4]X+W%L-VYN=F%,)B-X03LK-VHO049V
M,%!,33,W>5-5,R\X0797+S!F.%)'87),.5)E>#!F.7I(*W%%9#52+S53>E)F
M*UDK,2]W0U1Y-5)L*V<K-'58:BMO93DY)B-X03M-6$XQ8E=S3%1837E147(Y
M<5-29VEJ-6QQ1$Y)-TI,+T%014YR3'195SEX<4AG,79(4TEJ>%=E57A1<U Y
M5GII<GAB.'<R,6EB>FAQ)B-X03M"9$EB36XP87)5>G14,%5P+W9P46%F-G<K
M9610,F9F9WAR>BLX=D5D<CA),4UR<SAV.7E'3%AU:C(Y>%IZ4C-K<W0P<DMA
M<3=L1DY.)B-X03MX5DEV5%4W*TEZ2WE9+U-B,S)C5%,U4TUS84%(<4@S*V%"
M:FIJ:E%*1V]20C!644%".4%Z5U!84%1V>4PO=T-/>G%8+T%$1$PO=T%4)B-X
M03M'665T*VM/5'!U6F5Z6G)83%,V,VYV25@Q96$V;%=A,VEM-3)K86-E56-+
M,G-26D=O0CA2;#5T=C))-UE9:7E!>&Q+9U,X>G9V3U=K)B-X03LS5W-P<6%8
M=717=D-95&9624IO>$%W-%)O63)2:7=+2# V,#A38S(S.&M:3SA/:2\P431F
M-7-V<R]7>"]Z<#5H=&11,$A4<D-+83EU)B-X03MN<S5P1V4V=C)J859X24MG
M1F]W;U!';$]M5&AO<%E46DDS8F-8855.5%EI0TLW,D9:83)V;R\X04QR+VQ#
M9$DO-'<O.&)(3DYQ4'),)B-X03MS8U@P:&ME571I,F%A2T=&-7!N5T]+2E,X
M:VI%0E964E5K:SE!0FEQ1%18=$1E5EE6,4<R37)-63%J.5I/4F--5C1H83%R
M>55J1EAG)B-X03M0-6LO.'!X<3,O1U9F*U1A-75.4#E!9&9M*V]P9C52+S53
M>E)F*UDK,2\U4$QK.'8P2#-&:FHK;V4Y.4574S)1.'AA;3!B=6)X;TQ1)B-X
M03M80T5$9W%!>F5M5E!I9FER;6MD:W%75W)71#-A-E=K;&(R3S%J=5A103 Y
M2C)A34AL,"LP:#)X5DU-5F1I<4AU=C<K,"]W0TUP+S5.)B-X03M367%P834O
M>'A.42\U:'!V*U1:>3-"+V52.31A9%(O9'DO<6XW;GIX;EI0;39$,5 K-E0O
M049V-%IH-G9O-WIS6"M0-&9P4S--3C-R)B-X03LV4#A!>38O-5%N4U K35 O
M04)S8S R;RMS=7AX9E-'4C53,E!.+WIN=C='0W<P.4IR:4M*+U=C.%AD5DY/
M4&=4;3,W26M"2U8Y>F]0)B-X03MA0TI/3TY#+U8K:#54*VLW32]93'EJ*V%+
M3U-29BM#4E='8C-J1'EN:%,O0D-46$XY9#-&>$E9<DM32VIC9CA!4U-S9%%!
M0E5"9E5B)B-X03MF=%5$3EAK2DUJ<SEF<$DQ:6IV,$-9959,4S=M.# V37,Q
M,'E+8C8R1DQD4D=A1UIF,FTU=%@S56I+8V]0069C-550<40V6'1D03!I)B-X
M03LR;49W;'-*3'!F<S-5-TYC5&EN65-Z1C5+93-,3DLW1DU-5F5)9FU0+W=!
M<&YQ4"]!1'@O-4U2-3%06G8Y>$@T+V58:$\R9CAA;CA0)B-X03LY>4=,6$@Y
M>$HO<70K<DUV2CE*.7IH-E@K.6HO049H.393-7%N<VYP;C5&+SAD;E5V*UE:
M9BM*:DU,5R]32$LP,TUV6G,Q<FQP1$8Y)B-X03M2<#5O*W)E<C8S,6<O6&95
M-#AF5B]2.794,'%B.%!3-&9A,S5C=3%-;FDK;V4Y<GDO469C6&A/9&\K86]4
M52\Y-3$O,7@K;S5H-G9O)B-X03LW=G-8;DPT9G!3>DU.,WHV4"],<B]L0V1)
M+S1W+W=$1WAZ5&%J-GDW2$8Y25I(;$Q9>&8X>$YB=F1),$M/93 T1G!P>$)+
M<VEH,4UB)B-X03MX=5=&1"]Q-6YD;C9E3U=:17569G%D6#)T<34T35%L1&YX
M5CEH9590-6I:-VQ,<#E,,#%R;4YU8V-Z5V-29%<U;5-O66EO*TTQ>F-F)B-X
M03MY6&@X+VTX.2],,F\O;R]*:F9M1%5B;E5T675B-C5)33@W0G!#;V]+:%%/
M;C!:5$Q'24AH2$E/-C R85=81TIY-6Q6.&\O.$%+5V%,)B-X03LO=T%X.7(O
M>6582W-V,$@S1GEC9C%$,W9O,C)A-D]S,WEV8DI(8D-+,SE'-D,P95)J-FY.
M5V%U-%1A;3(Q8S!J<VM487%V,65*<41K)B-X03M9,4A,=E-N5$968D954'%0
M,3<V:&,O;R\P>F9E:R\Q5516.5 Q94HT8S9B.&586$951%EP-6EE,VEF56MT
M5&1X6$5J0EE':U904C1U)B-X03MS93=+-3558F9&5F952612=7)#-71L:6A6
M<#1N:D1'5G%!=7!7=CA!9"LK5'AY-%I!.7A96EEC551(=D1Z5"]L55!M1"]L
M<G10*T-K)B-X03LO=T-A33-N.'-2+VUL-68O045/>B]N:C5*2G%N-5DK63,Q
M3TQ48F4Y,'!N-#AN170P.&-G:U R53E)4D\O=T%3,5EB9'-O>F1P4FY7)B-X
M03MZ<TY$,E-C1C-+-W S+TMI=D]Z9&14,#%!96]66GE2.&U)+S0Q>D@O041O
M-VY99FQV3C92-60X<38U<&UI5VUM,T]O>51I,U1G>7A4)B-X03M*0V@S4#)7
M:G0P;$A8*V9-4$I0:6M3-4U9,$M43"]$,74S.2]:<&1Q3VE89#-C6%-J='-S
M-GE,*T=6<VMM.#%E4C4Y5G,W93,P-C-S)B-X03MT3T55:E-0=W%O8FM+9$5I
M6$TW4F%S65-34F1U=#=3,$(Q35)%1W%,1T@O2U!8555U.35:<7%G;&U,4T%!
M1'%394=B2"M722]Z4S9B)B-X03LO43=0*V50:VQG+TM(5CE1:V%A,#%45' T
M,D-S1$A+-VII9&=A<6@V.%1M2%!8>$I*<#-E1%)'14)'*U%2*VDO:S4U:C O
M5TQ#+V4W)B-X03MS,U,P=4EP,E%.2T-W:6-/44MX.39:6%!707A)<'5J<'E$
M9'96*V5O9C<U:2]W0U)R9CA!5E!-0GEN8SE1+S-Z1B]Y3F(O<6YI<D%V)B-X
M03M-+S5C-C5R3W583W!2>C(P2U0X2U)S.&A)-%)Q;E52+S5/8F93.7!2>#1X
M16DV968Q,UES<S)5>D5G3')P-55K5CDK5F5Q,CA(*VLV)B-X03ML65<V>6XP
M;S)L:V1!>G-$>%5&:T939D1,<&1R>$E)-%,P675W2E%M2F-9,DE02D)19FMR
M<C@X2U1186I94W=Y04Y(26IY37)!.4-#)B-X03M)-D5::"]N4C-/."],2'9:
M9"M8,VM$6%!+.3ED6$TX=')C<F-20TY6:F524T-'-58S:GEJ4'%"34%5,C1S
M6$-Z;FYQ2"LK678K4G)F)B-X03LY53AX5S5,;S0Y9&TO4SA-,7)B>%)Z4SAB
M3U%3148T,G1O;$QV>%%K:U,X,3-O84%B56]42T)O9W-:>'-%9#=Z-R]L55!M
M1"]!2F$W)B-X03M4+V=P4"MA33-V.$%,168U<&57+S!/>B]!2C0K4U@V:"M6
M,2M:57-8,69463=S<W9'0C5M16A,06A1131C=FDW6E1M-U1J3W1I-2MH)B-X
M03LW2FQG2G513G)F.$%L4C-M6"]L='-V.$%G<&8K<659+S4P9'IS9GEX-S-Q
M2&QJ4SE5,&918DQ42D9G;&4Q:C1.27-R9TAC;EE'4#-Z)B-X03M#>50T<$5U
M5$-.0VLP-39H+W9M3"]K83,O5E!+,E-196103#)R95ED3&ES;W919V%/9%II
M-U-/=TE62%=M,&8K6&U:;W1334UZ26DY)B-X03MQ9&8R;&]J<4U9:4161R]V
M65EF>6DQ-$%K,VQO04YY4S!N+TY'8E K5TDO>E,V5"]!14]Z+VYJ-4I5;C51
M-G1Q1'1.6C9R<#%X1W=$)B-X03M!>%-U-#1K;%%A<6@R2E)H.4)Z17EA*TUP
M6%1U9$YO5&IX:4XX:W<P6#AN4$UE;C9X65@W,V1M-E=L>$9/>4)P45=%5&AY
M0E=0=E1+)B-X03MP-G='2D9/4DA4:T<W96@R6G52-6@Q3FQE3U-9=S)O:W1#
M.&=%44)L-'-'369%*W!V,#95,WI!8W!',FDV=VPY=VU%03 Q8F%-2GA,)B-X
M03M'8C9W1UE0=5%&-&-/3DYQ,7A62#1Q-T9867$W1EA9<6LQ>#50.'4S1W)J
M5C5R44YQ26UJ;BMS8VU"-7=P=VIR43!O;S-P,')V:7%C)B-X03LT<6<Y4S%N
M4W1-44YF,V-6<T="2T-29T=93%%(:796<6-H5VU2;$E$;3)9.$TU+U-#5DLP
M.'@K6#=W:&)857)79'E62$)*:TQ69C=))B-X03M+9S%"4%E9:5E027!N9VY(
M;D5J-$IJ:VUP6F-14GIW4U%3:FQ&2W))-')3<7-+2&-E,DMO3%-T03!J4V58
M-D]T;'1G.&-53$ML86-))B-X03M!=VHR.%)Z3R]F1E5W>%8R2W5X5F),3$9$
M13@P>G)(1D=P95-2>4965E562DI/=T%'2U%#5%%9;G)/=B]!2F4V>$Y$66%N
M9%)Y;3)M)B-X03LY5TAM<W%2<DM%94U0-FY%4C=,265*-55R=4\R5BM.1RMB
M:VY26F%V:"](=51N>3E.-65J<TED3S!7-V=U3&4P:E99,&EM5UIL:C9+)B-X
M03M347I(9GA/5$5G95123$9+4$U%2G)H64]X5DLY2%<R1V]A-%E:,FQK83E1
M,T5B2U%)<%!Q5G-!:6LO84)12SEF1G%D<U92=#=F,E9J)B-X03M$-C$S3VM%
M5F%";DE&5%%N:71E<&]$<TU":T)Z6E%H2U)O0S)+<R\U8C9V<7$V:3EX03)O
M4GEW>G),23=W35AT<6U+;DUP>4,Q2G P)B-X03LW-45:66YQ,GDP=5-03TI:
M9$)C45A%2WI7.&E4479U:VMB0FQ08EEI;T]30G1P24E.1F9H43=&6%EQ:#<R
M-'-965-,,F%/1TM7<59L)B-X03MC24158F=%:UE$241M>6I!>35#,'4X=F57
M+TQE:RMP8V%,0VM3>GA1=U-.13=/:DIB:&A(=%5R56-Z56IR,W<S84-#3V%C
M-&]3-C!0)B-X03LK-7I50CE4359)<F(O5&%':S,Y-SA&4TMF=2]B*V)&57AX
M5C)+=7A6,DMU>%8R2W5X5C)+=FTW>B]R*W S6&UB5C1M;DQ#3S9L='A1)B-X
M03LP;VM,<VMA065#:CAA;G9M<WEM-4<S<DY&05)X4G)U66<K<T=%;4Y*0UI(
M54E1=&%%8V<S13 V,7!7;5(T5SAY,V929C56954Y53!$)B-X03M19E4Q3S9L
M:W5R.$I+8D)I9E-T5BM*9VEQ4E@Q1'HO94AX;T\Q5'--34]%4$YA+U52>50R
M1W<V.2]W0T]J3F-T8T8R2W5X5C)+=7A6)B-X03LU.2MC5W S5G!P9&A"1S-#
M0S1N67EK1VA:;W=$1W S,T94>39D44UX.5-F4S=0<W5)37E4,&5+,U8K+TEY
M>E-&:6%G.7DQ9G8V-6AG)B-X03M/.31K.3AL955T6#@P-C Q;DUS.6QP.6]X
M5%5P;5%O>6-F:#E&430R:TY+8FHT971$,'DV1TMY-%=O,5EX=W-C>GEF4D9N
M85<Y;%IW)B-X03M79'-V0S-T;S!H:%%K=%)),4-Q3U1%<V%!9%-C>E%+961L
M26LR95I6<TM%=C!V,69R=7(X-U9B9&9R82ML2T9)3G=V,5-$.39X4#)I)B-X
M03M'<DA59&MP,GA6-78K875O,VEA-&M(3&A&1F)J,%)8.6QY5$DS*WDT,% X
M07$U:&%K*W S9EIS4G=%.6)E6E@Q*W-2-7-X-4MW2VEP)B-X03LU06119'5M
M5E)I-T%N6C9.*U50;&DY=F)X4$Y&,4I*1&)18VMS;V=/4')S5DM/-4HV>'%'
M;TMD5RM61&M9361B=7(W43%)<F=$,2]-)B-X03MP,41S5F1I<C4Q,2]6<&(K
M95A58C9D6&UL5W%!:&EN5VY,:%9H44)Q2T=90VTS9F)14VU:1WDY8FEX:45E
M141:-3E&<CEY9DU3+U4O)B-X03MR1C%C,U5)161V1'EL:V52;5@P,5)"6&LO
M=T%48V1H5'(Q>69H1U%&8S=:4VU">C55*W!F>3DP2%A.2#AV<$AR=6]4,RMQ
M6$QE=F-E)B-X03MV2S!W9TQ+4#-#37I.5E4X4C%/+U1.>&EG66IC,CAX<7-S
M6GDY24%(:VUT<#9V-F,Q1&QD3$I&-E9T=W1!>$Q22#DW>5ER,$AQ8E4X)B-X
M03ME3U=/3VU/2W5X5C)+=7A6,DMU>%8R2W5X5C0S8F9K.68V,35W,3(Y.'=E
M<EHV5$ID5'I75%%342MP3TI:;5ID>#9H5E%N6&MO3S1P)B-X03LS>D9'0S5%
M;#-%=3!"1$A%43-L5R]W06YP,F=E5E!,=FPK,4YR;SEJ2&%X33-Q3U)6,UIT
M-D9P2$Q/,4MM;%1T;5)'24A*,6U43D]:)B-X03MU4G1.<VLQ3WA6,DMU>%8R
M2W5X5F@O-6UE5G17.'@V5EHR5VU&1FQ7-35Y=DLU4D94,#,S64)72BM+9S)&
M9C166EE'47!Z3DAN:FEK)B-X03M3935F-6,O2R]W07!A2V)E8U=I,VUP44M!
M8C8T<35,9VAU85)S5VIJ24DK2&E+:GAW>'A!36,R<WE4-C!'5S59-')S5F1I
M<5@V5TM8)B-X03LR<B\V5V)M=#)N-VMK;C9T+V]K2#=K5DHV+S-U,S@O:FER
M0U!0;FLS5W9-9FTK>FIT=S!/;4,R:E<X=G%,4E S:W)554U2>6%I:EE6)B-X
M03MP558R>DAY67I+6&LW2%1A;4]01V4K+S%-:#AU+VPQ-5<P2GI.8E<U=6)X
M;%I'=DQP=E9K2W97<6I92711,5!H559(6$Q9-'=(1WDV)B-X03MM8RM:6DU!
M04%!2T%B041*=4\W1EA9<3=&6&IN;#,X:TIB*S5&.35R;&QH:6I!4U!43%=2
M534X4V52;6QJ-4YW655O<4]0;S9:<CE.)B-X03MO-DAR-74U,5AA9E1(>3<S
M<4]G95<Y0SAV865U;C9,6E)73F]P3&5N14XR66=!=3='<D]X0VER35-D<WIX
M141K-FUE4U5Z8VIA6EE7)B-X03M#5C)45W@X>&%M<5%-;'=S1F]:<'EX2W5P
M33-"47918TXV*TYC5E141EA9<3=&6%EQ-T9867$W1EAM.35A9CA!3U%53W(V
M:$YP=#<U)B-X03MC=4Y-;75*1' Y=&9I-T11,G=9*VE#8F5/36U1<69J<7I$
M=WA63C=59FY#4S1U,CAV241D<#92:48V-5=Z<$QZ-4)I;DMA=F\X9'=V)B-X
M03LR+V)&56U44G9Z-%A8+U=B6'1+8E)0,&<X;C%9<"LY+U(U;41,2%57=R]E
M:45S=C)U;T<U,T]+<DQB5% K8VE,3#9W1C%F>3EQ=E P)B-X03MJ03$O1F-2
M8T12:DMT3%9)+W="<&=!>$IQ1G)283!X5FPO:SE04$-736<X,W9P.&PX5TQ2
M='!N<F5M1EIM4$4K<W%':6II1C<K2DHS)B-X03M+<699<3=&6%EQ-T98;6UP
M>"]N-T)Q,#%T<%5M:C-7;EAJ,U11,W0T>D)R3TU4<S%U<$558U):>D$T569U
M-4)Y5W).+TUQ<C)L="MF)B-X03LP1G9"13DS-6)U6D%7835N=49V0S4U4S%#
M;TE69U%"27E1=%9R<TLQ,V)&5FEA6BMF:T=U9E=5,6I1<G93<&UC>5=6>D1-
M:&=6<$MQ)B-X03MK3%%O:G9X:E556C,O84Y1,4%X5E1Z>6EN-7!,9$\S;34Y
M1V4R9%I31C!V-GIY4B\S46A#97-Q+T)14VPK4DIQ5F]A8D)6;&5+<$9P)B-X
M03LR<C922')/=E=P0S)T,T)-='AD8VY*37-9<S=F+U-/2BMW<7)X:C(R*T=V
M56Y&5TIA,35J."MX,VPU<5=H-C,U96)Y.6-436QI9%1.)B-X03MW>E)U;'1(
M>&E5,GE29F%M16I0>5IY1DEP-%EQ:&17=69Z:W8W;514<D1Z1#5F,'I6,$UR
M,FQR8G!.2C9S5&E.;VA0.5EI;4ML13E2)B-X03MU4T-H,C(S,E9C,VUF.#%*
M9$1M=30Y5CAP0V%%=TPY6E)R-%%#67EL<$5F:TA00F]G1D9+3E=P<4YS2W92
M0C5G,%@V>&$R>'99=G)&)B-X03LW1VMT<D9Y,VM34W9&;#A186)91E=R-6LP
M1F\W=5)B-D5X,D)#,VIC=&]I>D912#A.=U)I<E(X>F%!1G173B]#1G9J4S!0
M269V0T<T)B-X03LO1#0O1G1I<D9F3E=Q96-P=DU-3&55.6(P;4MY,'E/4CEB
M<TY1-6Y:95%D;3E/3G!0:"M(:5)+9T)"-4)Q-TMP26YM3#@R-$Y!9VUU)B-X
M03M.6#AQ<S=O16<Q37E887),8U)3:W5(45)C941X04)U2$5G,7 R;U9E;$17
M.4HO4T0V8V)Q4#8O179/4S(U9D=Q.%$Y4U Y53%W2VAT)B-X03M&,4TV;&98
M,7IA,V-D,7!)5T=/,4U253A:;$1'645G5C9.2#%/2W!V:7)S5F1I<GA(+VY*
M8GI$<BMJ+S1C+U)/<%A7;F5V.$%89E@K)B-X03MQ5'E18RM(;V-E9G!S=DQJ
M>4Y+*T]:,FEG1&1I*U1R3S!C:V\X3D5J;BMH-&HO>7-(>CDO,4UU<2]W1%-B
M8R\X,35N*T1$=4AY9&(T)B-X03LK5"MC9FTW+T%*5T0U*R\V;5A69BMK,C4O
M=T-A.&9":#-$-4PT*U0K8V9M-R]L65!N-R]Q6F16+S948FXO;79(=UED=RM3
M*U!K+VY()B-X03LU=2\U5T0U*R]W0W!L,5@O04M48FXO;79(=UED=RM3*U!K
M+VY(-74O-5=$-2LO-FU85F8K:S(U+S5R>#A'2&-0:W9J-5 U>"MB3E!,)B-X
M03ME=E1A<#5D4C<W>GAQ*VUA,CEW,$IE8E9M.4)9>%!A;TI$05%S;%!4=7!'
M+W9F.$%D5$AX-#!4:E5T;V=J,V4Y>7-5=4M/.'E*9C%V)B-X03MC<F%S9%AS
M3DMV3"M(.#%P<C)3,6MJ4DQ'2SEN.6561VY-3'-G13<Y3U!.859Q=3=C86EO
M:E).8T@R37!!9U@T="](.7%+;75O<EAZ)B-X03M*1$10*UHR<%A'9WIF6#-A
M93-V-41.16QS:&5#<$5J:'I)84Q1;VI-=U!!8U-R1TY82#9"93-2;'-*8C5$
M=S<Y5E!1<DAZ5')N,59D)B-X03M.+TUI+VUU2D%R,W1O3&EC>E%21S K=%-/
M0CE9-'5),EE1;7!597!58E5W>DU9.#1"1T]%<#AS:"]!.38V94154D1.3&(O
M;35.2UEP)B-X03LU64)#.3-,1DEW:61516=$6%A(9S59<T-'4'<P4#AW4D)(
M*W O:C5*-$0O<78R+W1B=E)C>'DS4F@O3F$X1G9A<71$.61E6C5I=&]K)B-X
M03LW*VUQ,TMB=DMZ26DW9T931V9L>$1O+W%F6BMX5$@O8F9T+V%O-E!C6&LR
M<V%H<&UP9FU89G=,0DI&1F)A:75O,&=+>5)U>EA!06YK)B-X03M%<4-2551G
M2%8V4'IB:GA:47E'=TEG4&MX:'I)3U$O4#EQ27142D5,1SAU+WI6=7)I>G5'
M:T9X87@V:$YB,T53+U58=5EY-34S9D4K)B-X03MQ<7A.>&IF8S!&5RM(065T
M42MZ>E-"5EAL,CDO;#A65R]W0T(P,C!V3% X04Y3*W0S93!T-4QQ,VTQ0G)L
M:&-Z<T9D1D5C,%5I<D9Y)B-X03M":S52,4,Q235%14)(3VI!9DIL2TER8DMF
M;7!#2SA2<FE/5#@Q8G U4'$P:SEU-C9G5D-34E-1:C!P04QQ4EA::VMK,E-3
M;%9Q<D]-)B-X03MB+V]F6BMX2$0O='8R+W17869C>3,K:S9C-2]-:E5.3C%+
M-U=!>D,U,5AM:V9*6E1/>GAP279P<4=73E5";$PW:W-O<G-32THY04DY)B-X
M03MY>$%-4BLX25 Y6E9I,#=8<F$P,#8W,68X>G)U,DXP9$]M;7-'=EIO<%1B
M6#!Q<DI*13=Z34-);S)Q4U4R26)K04%#=S1G8D%H,SE&)B-X03M/3U%O>7E(
M<#$W+VEO<75O6$8Y4$=V-7%Z5U5A+U<O4U=455IR:%%B6C9)=G)R2D%(17%S
M<DDT:DA,-'%,5F1Z=%@P9EEV1%HO=F$K)B-X03M0-U9#-FXQ:E1V32MN861C
M+VU*<4XW<&0O1DQ..69I=G!B6D96039)>E!*3$MO5G!O,C9":55O5D),0F-)
M;WA*14)F=5EK1TUG1&M.)B-X03M(>G(Y2W1D=V%R0G%/:U=S9C5U4$Y$<6%&
M<')T8C)F,#=C<D5826PO,&=L45<T<790:515-T-L0T%24B]D.'9*5$5G9V5,
M>C@O=T)Q)B-X03M&=716=6)"=%)J:R]-6%4Y44U&<$I06E,R,2]*1W)Z>#-$
M,G9O<W9Q>FLX:G=N57%A;4E(8F-%15)U=E%".$9*<3=Y13=D+SEQ4'4W)B-X
M03M054QE,FUM6#@S-4QH;S-73DE98GE1=35K.4U)=T184R]#1$ME6E R47!/
M*S1%45(O<68T*U1)=R]W0G0K,SER0DY5.#<K9#=053=U)B-X03LP="].=7 S
M8T9V3DI&1F1*93-!5U9%67%S9T%L8V9%0EA::C@X>4DT;T58=VHU3TA03DU%
M9U-**TM&+S571#4K+W=#<&PQ6"]!2U1B)B-X03MN+VUV2F5$1'5(>5DK4&LO
M;D@U=2]W0U9G*V9V*W!L,5@O<$YU9CA!;79(=UED=RM3*U!K+VY(-74O-5=$
M-2LO-FU85F8K:S(U+S5R)B-X03MX.$=(8U!K=FHU4#5X*V)V*U9G*V9V.$%Q
M6F16+W=#:S(U+S5R>#A'2&-0:W9J-5 U>"MB4'9Y8R].:GIN1#5O9S!I.6QV
M4$U&<'%B)B-X03MI3F]P6DAN;FA0.$%V,DXU0V%+;S-C13!P=FU.<6102&AS
M8E4U;6HQ52M,:$YY0F94,F%T,TQS5F1I<GDW.#<O05!L5R]W1'5&+WAP)B-X
M03LY8R\T*V9Q2#%,+VYJ-G90+VA+6FQA8FHS-$A$,69H8F5).'0O=T-S8B\X
M071C-6PO=CA!>6-0+T%!6'HK,3,O049J9B]W0G)N2#DO)B-X03LU3"]G=FXY
M<G8K<V(O=T1T8S0O=B]*9CA&."]T9"\Q:F8O,G5C9C,O04I,+T%)3#4O83<O
M04MX=B]W0S%Z:BLO.&PO=UAZ*S$S+U=.)B-X03LO=T0R=6-F,R]K=BM#*V8R
M=2\V>'8O-UA/4#<O04UL+W=8>BLQ,R]73B\X03)U8V8S+VMV*T,K9C)U+S9X
M=CA!*S%Z:BLO.$%*9CA!)B-X03M"9E W6&8X05=.+R]!1W5C9C,O:W8K0RMF
M,G4O-GAV+T%/,7IJ*R\X;"]W6'HK,3,O5TXO+V$U>"]F.$%K=CA!9W9N.7)V
M.$%R1R\O)B-X03M!3%A/4#<O>5@O0F90-UAF.5DS+T%0835X+V8K4R\T3#4O
M83<O<D<O+W1C-"]V.$%Y6"]"9E W6&8Y63,O=T1A-7@O9BM3+S1,-2]A)B-X
M03LW+W)'+W=$-UA/4#<O=T%L+W=!1C@O=&0O=T)9,R\X06$U>"]F*U,O-$PU
M+V$W+W)'+SA!-UA/4#<O>5@O0F90-UAF.5DS+SER;D@Y)B-X03LO=T-3+W=#
M0RMF,G4O=T-S8B\X071C-"]V+TIF.$8X+W1D+S%J9CA!.7)N2#DO-4PO9W9N
M.7)V*W-B+RLQ>FHK+W=$2F8X1C@O=&0O)B-X03LQ:F8O04YR;D@Y+S5,+V=V
M;CER=BMS8B]!4'1C-"]V+T%#6"]!05AZ*S$S+T%&:F8O=T)R;D@Y+S5,+V=V
M;CER=BMS8B]W1'1C-"]V)B-X03LO2F8X1C@O=&5N+VMT+WEQ8C%B+T%0=V0V
M=C92;U!R2#$S+V5N,&1V-W5V*S8K6#)U4&5L9C)C>&14-&TS1GEC>E,K1G9W
M4%9->$A-)B-X03MD:7(O05 O6CPO>&UP1TEM9SII;6%G93X*(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @
M(" @/"]X;7 Z5&AU;6)N86EL<SX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^
M"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @
M(" @('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M;6TO(@H@(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @(" @(" @
M>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP
M92]297-O=7)C945V96YT(R(^"B @(" @(" @(#QX;7!-33I);G-T86YC94E$
M/GAM<"YI:60Z-#<V0S<V-#,U.#A#14$Q,4)$-$9%.$8V.30T.3=%-C(\+WAM
M<$U-.DEN<W1A;F-E240^"B @(" @(" @(#QX;7!-33I$;V-U;65N=$E$/GAM
M<"YD:60Z-#<V0S<V-#,U.#A#14$Q,4)$-$9%.$8V.30T.3=%-C(\+WAM<$U-
M.D1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I/<FEG:6YA;$1O8W5M96YT
M240^=75I9#HU1#(P.#DR-#DS0D9$0C$Q.3$T03@U.3!$,S$U,#A#.#PO>&UP
M34TZ3W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ4F5N9&ET
M:6]N0VQA<W,^9&5F875L=#PO>&UP34TZ4F5N9&ET:6]N0VQA<W,^"B @(" @
M(" @(#QX;7!-33I$97)I=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(#QS=%)E9CII;G-T86YC94E$/GAM<"YI:60Z-#8V
M0S<V-#,U.#A#14$Q,4)$-$9%.$8V.30T.3=%-C(\+W-T4F5F.FEN<W1A;F-E
M240^"B @(" @(" @(" @(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD:60Z-#8V
M0S<V-#,U.#A#14$Q,4)$-$9%.$8V.30T.3=%-C(\+W-T4F5F.F1O8W5M96YT
M240^"B @(" @(" @(" @(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT240^=75I
M9#HU1#(P.#DR-#DS0D9$0C$Q.3$T03@U.3!$,S$U,#A#.#PO<W12968Z;W)I
M9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z<F5N9&ET:6]N
M0VQA<W,^9&5F875L=#PO<W12968Z<F5N9&ET:6]N0VQA<W,^"B @(" @(" @
M(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @(" @(" @(#QX;7!-33I(:7-T;W)Y
M/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @
M(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HR-CE&141$-S1!
M.$-%03$Q0D0T1D4X1C8Y-#0Y-T4V,CPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @
M(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,"TP-2TP,E0Q-3HP-3HQ
M.2LP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S
M*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T
M179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N
M/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#II;G-T86YC94E$/GAM<"YI:60Z-#<V0S<V-#,U.#A#14$Q,4)$-$9%.$8V
M.30T.3=%-C(\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IW:&5N/C(P,C M,#4M,#)4,34Z-#0Z,C$K,#4Z,S \+W-T179T
M.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT
M/D%D;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W
M87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\
M+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP34TZ2&ES=&]R>3X*
M(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I
M;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.FEL;'5S=')A=&]R
M/2)H='1P.B\O;G,N861O8F4N8V]M+VEL;'5S=')A=&]R+S$N,"\B/@H@(" @
M(" @(" \:6QL=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4^4')I;G0\+VEL;'5S
M=')A=&]R.E-T87)T=7!0<F]F:6QE/@H@(" @(" \+W)D9CI$97-C<FEP=&EO
M;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @
M(" @(" @>&UL;G,Z>&UP5%!G/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O="]P9R\B"B @(" @(" @(" @('AM;&YS.G-T1&EM/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O1&EM96YS:6]N<R,B"B @(" @(" @
M(" @('AM;&YS.G-T1FYT/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M<U1Y<&4O1F]N=",B"B @(" @(" @(" @('AM;&YS.GAM<$<](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"]G+R(^"B @(" @(" @(#QX;7!44&<Z2&%S
M5FES:6)L94]V97)P<FEN=#Y4<G5E/"]X;7!44&<Z2&%S5FES:6)L94]V97)P
M<FEN=#X*(" @(" @(" @/'AM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y
M/D9A;'-E/"]X;7!44&<Z2&%S5FES:6)L951R86YS<&%R96YC>3X*(" @(" @
M(" @/'AM<%109SI.4&%G97,^,3PO>&UP5%!G.DY086=E<SX*(" @(" @(" @
M/'AM<%109SI-87A086=E4VEZ92!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(#QS=$1I;3IW/C8Q,BXP,# P,# \+W-T1&EM.G<^"B @
M(" @(" @(" @(#QS=$1I;3IH/C<Y,BXP,# P,# \+W-T1&EM.F@^"B @(" @
M(" @(" @(#QS=$1I;3IU;FET/E!O:6YT<SPO<W1$:6TZ=6YI=#X*(" @(" @
M(" @/"]X;7!44&<Z36%X4&%G95-I>F4^"B @(" @(" @(#QX;7!44&<Z1F]N
M=',^"B @(" @(" @(" @(#QR9&8Z0F%G/@H@(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @/'-T1FYT.F9O;G1.86UE/D-A;&EB<FE)=&%L:6,\+W-T1FYT.F9O;G1.
M86UE/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9A;6EL>3Y#86QI
M8G)I/"]S=$9N=#IF;VYT1F%M:6QY/@H@(" @(" @(" @(" @(" @(" \<W1&
M;G0Z9F]N=$9A8V4^271A;&EC/"]S=$9N=#IF;VYT1F%C93X*(" @(" @(" @
M(" @(" @(" @/'-T1FYT.F9O;G14>7!E/E1Y<&4@,3PO<W1&;G0Z9F]N=%1Y
M<&4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IV97)S:6]N4W1R:6YG/C4N
M,# R/"]S=$9N=#IV97)S:6]N4W1R:6YG/@H@(" @(" @(" @(" @(" @(" \
M<W1&;G0Z8V]M<&]S:71E/D9A;'-E/"]S=$9N=#IC;VUP;W-I=&4^"B @(" @
M(" @(" @(" @(" @(#QS=$9N=#IF;VYT1FEL94YA;64^0V%L:6)R:4ET86QI
M8RY01D([($-A;&EB<FE)=&%L:6,N<&9M/"]S=$9N=#IF;VYT1FEL94YA;64^
M"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @/'-T1FYT.F9O;G1.86UE/D-A;&EB<FE";VQD/"]S=$9N=#IF;VYT3F%M
M93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&86UI;'D^0V%L:6)R
M:3PO<W1&;G0Z9F]N=$9A;6EL>3X*(" @(" @(" @(" @(" @(" @/'-T1FYT
M.F9O;G1&86-E/D)O;&0\+W-T1FYT.F9O;G1&86-E/@H@(" @(" @(" @(" @
M(" @(" \<W1&;G0Z9F]N=%1Y<&4^5'EP92 Q/"]S=$9N=#IF;VYT5'EP93X*
M(" @(" @(" @(" @(" @(" @/'-T1FYT.G9E<G-I;VY3=')I;F<^,# Q+C P
M,3PO<W1&;G0Z=F5R<VEO;E-T<FEN9SX*(" @(" @(" @(" @(" @(" @/'-T
M1FYT.F-O;7!O<VET93Y&86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@(" @(" @
M(" @(" @(" @(" \<W1&;G0Z9F]N=$9I;&5.86UE/D-A;&EB<FE";VQD+E!&
M0CL@0V%L:6)R:4)O;&0N<&9M/"]S=$9N=#IF;VYT1FEL94YA;64^"B @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T
M1FYT.F9O;G1.86UE/D%R:6%L/"]S=$9N=#IF;VYT3F%M93X*(" @(" @(" @
M(" @(" @(" @/'-T1FYT.F9O;G1&86UI;'D^07)I86P\+W-T1FYT.F9O;G1&
M86UI;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%C93Y296=U
M;&%R/"]S=$9N=#IF;VYT1F%C93X*(" @(" @(" @(" @(" @(" @/'-T1FYT
M.F9O;G14>7!E/D]P96X@5'EP93PO<W1&;G0Z9F]N=%1Y<&4^"B @(" @(" @
M(" @(" @(" @(#QS=$9N=#IV97)S:6]N4W1R:6YG/E9E<G-I;VX@,RXP,#PO
M<W1&;G0Z=F5R<VEO;E-T<FEN9SX*(" @(" @(" @(" @(" @(" @/'-T1FYT
M.F-O;7!O<VET93Y&86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z9F]N=$9I;&5.86UE/F%R:6%L7S N;W1F/"]S=$9N
M=#IF;VYT1FEL94YA;64^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1.86UE/D%R:6%L+4)O;&1-
M5#PO<W1&;G0Z9F]N=$YA;64^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF
M;VYT1F%M:6QY/D%R:6%L/"]S=$9N=#IF;VYT1F%M:6QY/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z9F]N=$9A8V4^0F]L9#PO<W1&;G0Z9F]N=$9A8V4^
M"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT5'EP93Y/<&5N(%1Y<&4\
M+W-T1FYT.F9O;G14>7!E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z=F5R
M<VEO;E-T<FEN9SY697)S:6]N(#8N.3 \+W-T1FYT.G9E<G-I;VY3=')I;F<^
M"B @(" @(" @(" @(" @(" @(#QS=$9N=#IC;VUP;W-I=&4^1F%L<V4\+W-T
M1FYT.F-O;7!O<VET93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&
M:6QE3F%M93YA<FEA;&)D7S(N='1F/"]S=$9N=#IF;VYT1FEL94YA;64^"B @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M/'-T1FYT.F9O;G1.86UE/D-A;&EB<FD\+W-T1FYT.F9O;G1.86UE/@H@(" @
M(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9A;6EL>3Y#86QI8G)I/"]S=$9N
M=#IF;VYT1F%M:6QY/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9A
M8V4^4F5G=6QA<CPO<W1&;G0Z9F]N=$9A8V4^"B @(" @(" @(" @(" @(" @
M(#QS=$9N=#IF;VYT5'EP93Y/<&5N(%1Y<&4\+W-T1FYT.F9O;G14>7!E/@H@
M(" @(" @(" @(" @(" @(" \<W1&;G0Z=F5R<VEO;E-T<FEN9SY697)S:6]N
M(#8N,C$\+W-T1FYT.G9E<G-I;VY3=')I;F<^"B @(" @(" @(" @(" @(" @
M(#QS=$9N=#IC;VUP;W-I=&4^1F%L<V4\+W-T1FYT.F-O;7!O<VET93X*(" @
M(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&:6QE3F%M93YC86QI8G)I+G1T
M9CPO<W1&;G0Z9F]N=$9I;&5.86UE/@H@(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @/"]R9&8Z0F%G/@H@(" @(" @(" \+WAM<%109SI&
M;VYT<SX*(" @(" @(" @/'AM<%109SI0;&%T94YA;65S/@H@(" @(" @(" @
M(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:3Y#>6%N/"]R9&8Z
M;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D^36%G96YT83PO<F1F.FQI/@H@
M(" @(" @(" @(" @(" \<F1F.FQI/EEE;&QO=SPO<F1F.FQI/@H@(" @(" @
M(" @(" @(" \<F1F.FQI/D)L86-K/"]R9&8Z;&D^"B @(" @(" @(" @(#PO
M<F1F.E-E<3X*(" @(" @(" @/"]X;7!44&<Z4&QA=&5.86UE<SX*(" @(" @
M(" @/'AM<%109SI3=V%T8VA'<F]U<',^"B @(" @(" @(" @(#QR9&8Z4V5Q
M/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!.86UE/D1E9F%U
M;'0@4W=A=&-H($=R;W5P/"]X;7!'.F=R;W5P3F%M93X*(" @(" @(" @(" @
M(" @(" @/'AM<$<Z9W)O=7!4>7!E/C \+WAM<$<Z9W)O=7!4>7!E/@H@(" @
M(" @(" @(" @(" @(" \>&UP1SI#;VQO<F%N=',^"B @(" @(" @(" @(" @
M(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y7:&ET93PO>&UP1SIS=V%T
M8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E
M/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P
M,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP
M1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS
M=V%T8VA.86UE/D)L86-K/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\
M+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P
M,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F)L86-K/C$P,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @
M(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @
M(" \+W)D9CI397$^"B @(" @(" @(" @(" @(" @(#PO>&UP1SI#;VQO<F%N
M=',^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'AM<$<Z9W)O=7!.86UE/D=R87ES/"]X;7!'.F=R;W5P3F%M93X*
M(" @(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!4>7!E/C$\+WAM<$<Z9W)O
M=7!4>7!E/@H@(" @(" @(" @(" @(" @(" \>&UP1SI#;VQO<F%N=',^"B @
M(" @(" @(" @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @
M33TP(%D],"!+/3$P,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X
M;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y
M86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P
M,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIB;&%C:SXQ,# N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @
M/"]R9&8Z4V5Q/@H@(" @(" @(" @(" @(" @(" \+WAM<$<Z0V]L;W)A;G1S
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z
M4V5Q/@H@(" @(" @(" \+WAM<%109SI3=V%T8VA'<F]U<',^"B @(" @(#PO
M<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B
M92YC;VTO<&1F+S$N,R\B/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/D%D;V)E
M(%!$1B!L:6)R87)Y(#$P+C Q/"]P9&8Z4')O9'5C97(^"B @(" @(#PO<F1F
M.D1E<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#  $!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1
M" %: ET# 1$  A$! Q$!_\0 'P !  (" P$! 0$           <(!@D$!0H#
M @L!_\0 61   00" @ # P4(# H'!P4!!0(#! 8!!P ("1$2$Q05%A<A=[8B
M-SA8=I?6UPH8&C$U-G1UE9:TM1DC05%55I&WTM4D,S17<Y2S)2<R0GBRTU)3
M87&8@?_$ !T! 0 !! ,!               !!08'" (#! G_Q !E$0 ! P,
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M_KA8/Z3D_P#'QZ&V_P#4Z;XEG\J:[_SG?VCXT^<F_?ZX6#^DY/\ Q\>AMO\
MU.F^)9_*FN_\YW]H^-/G)OW^N%@_I.3_ ,?'H;;_ -3IOB6?RIKO_.=_:/C3
MYR;]_KA8/Z3D_P#'QZ&V_P#4Z;XEG\J:[_SG?VCXT^<F_?ZX6#^DY/\ Q\>A
MMO\ U.F^)9_*FN_\YW]H^-/G)OW^N%@_I.3_ ,?'H;;_ -3IOB6?RIKO_.=_
M:/C3YR;]_KA8/Z3D_P#'QZ&V_P#4Z;XEG\J:[_SG?VCXT^<F_?ZX6#^DY/\
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M[-MV##60()$PG4+B!&B)!@.S!9G2VWB*2.$3A$X1.$3A%&9@%MB23F/A-BU
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MR)#Y_P"F_(ZZRBF=@XUNLFJQ#U4FUP1MG45=V76SYJ7-2Q-.GH,PQ*UN,<B
MI *5:JR"A9-'812Q@BTD;,8G58'98 JXRZH4?4HV<[KU4*7V4Q<=?WT%6J"5
MO,&+<H08D5!GXFM)6QXU[DLRYHL%!5,KK>N'I\P?7"%L;3%MM-@N3FK*0)UX
M.4D;NO\ 7WUVDOO%HZ!%G/D';8,EA7(*;(&+ 6PQJNM3P(^S,RI8\L1A+*L.
M@GCY09BKJ/OV>#0K_,I[%BBU::]DF#V?]\>%8\#[\Z@)5B#8)X2^Q'5!*T6,
MLC:W)-"!3Y741'=MFA,V''N$.?\ (*A!BY4YE;,$@5]R]RJ@L^5>0-P4>84K
MT_L]KJ\7.JT<&/N:RESKT>W@IKM;6H.Y3R\6TSZA:2$Z)*EJ#A;O!I-I?KSQ
M9B%(CR!; >S1JZ?.UL29)C'@5B^$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X
M1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X15>W=V2QIO<?5S4OR,^4?[92\
M7"F8/_*+X1\B_DG47+5\2R*^!%/E%[_[/W#W/XD"]U\_>O>I/E[OF0,@GFQW
MU!."!SY[RM#R%*P.]:\"[ 8',&)12*@8[(>8R,>B,J6J2AI#F'LRH4S"DXPT
MG*/1AO.,Y5ZLJQG&,>^@N,]O=(Z%D3C*&AW&M>X -)(U=1[,>F.<YY-RX/8'
MXR2,9W8Y<<X/,HY_:WTC_2UJ_P#.B/\ DG*E]LM=^BI/BYO+KAQ#.=WPCQ)^
MUOI'^EK5_P"=$?\ )./MEKOT5)\7-Y=.(9SN^$>)/VM](_TM:O\ SHC_ ))Q
M]LM=^BI/BYO+IQ#.=WPCQ+&#6HM.UTY4:T<NI<98+Z2)B*:'EE@S9"QD P(C
M9BT<9&^"9=?^&@A,\C-=]*6([32$..I>DQ6GO1%>KQ/#55$-'!)!11QRU<K8
M9S'3QRSQTT3I'<?AO&32LC8WTSB20"UKRW@YD+',8YY#I26QM)&7EK2]P QR
M-:23N&P;R >LIVNM'7ZO9M=3O)TK7,9%X^,*DPQ\+.3(0)8AN$NE*Y"]69 J
MQ!W<X3C/L)4M0R3[$G$F0X_;5W2]T,_0U514\=0>,^Y!DDC_ +E--3R;(JE_
MI9:>4?\ ,UO&-S&YCW1&()6Z['ES-G5;AU36O'IFC>US3UB<':"!E:=!ZU6M
M]M-G-J<BK6W)0DP 4N.MKS]HA].!&5,K;\L^M+F$Y1Y9]6,>6>>4Z0W(!I--
M3@. +28:C#@=Q:>/V@\A&]<^*C_..S?M;LQOY.1&M":T?=:89M!MYY]R:TPR
MT9 ..O.C7,,D6FFT",K<<@.YPU-0C"E17,X0_AM6?+@Z07, N--3@-#"XF&H
M  D&8R29L 2#:PG8X;6Y"<5'G&L<G( UFY)&\;N3EYN5?A.B-8K<>91:S"G8
MZ9*I#23=>4XPF$W%=F*>1@3E328C4V$[)RO"<,-RXJW<H3(:RN3I!<P 32P
M.U<$P5&#KEP9@\=MUBQX;CTQ8X#):<.*C_./+RMY-_)R<O,NOE:>TY!DA(<R
M^2HLRRS&1]=BR++6&9!Z?('2R\>$'9<&)<)2GQ4"<298AI><=@PY,M"5,,N+
M3V-O=X>V9[*&-S:9A?4.;351; QLC(G/F(FQ&ULLC(R7X >]K3U1 7$LA!:#
M( 7D!@+V@N)!< T8ZHD D 9V G<%CIRD: K4C$<YL8B.Q@).LDB:\3%J$#:^
M-8DR9QLR<: .!@8N/'A3'U3C$^#'4U$E+;<6F.]E'?#<K]4-UH;?#)]VCIVL
M$4O&R3RN:UD,4)J!--(YSV-U(F/<"]@(&LW/%W0[#ATF.I+R21@,:"2YSM75
M:  3EQ V'F6;HT#K=QG,ANRG5L80ES+Z"X%3.&UNK80YEQ(?*,(4^TZRE>5>
ME3K:V\9RM"L8\9TAN0.J:>F#LD8,,X.0 2,<?G(!!/6(.XA=G$QD9#CCGRW'
M-S<Z^"=%:N6VV\BVEEM.R&XC3J3E>4V[*>B)(-1FUX$Y2N0[ 6B<VRG.7%Q%
M)DI3EE6%YDW^Z D&D@!#2X@P5 (:'\67$<=D-$@+"3L#QJDZVQ1Q47YYWX],
MW?C.-V_&WL;5T$W6.E1HB*=(72P0ALV96(##DJ3"8D8DW(^,K%93('NUQ)"&
MT6.&!L)B5+BL16\2T2Y+S,)#LE'>R[WF25T+*.F?(QE2\AK)'-U:2"2IJ-5X
MJ3&]T4,,CW-:YSB6%C07X:>);"UH<7D-)8 3SR.#&9&KD!SG  D ;<D@;5V%
MFT[J.G5\Q:;-;SHD" @D2)8@^0%+1%BB84@B0]+,<$]*DR(\*))?]RB,/S74
MM*2Q'=<\D9ZZ>]W:KGBIJ>DIY9IGQQQ,;',"YTKVQLRYU0&M:Y[FC7<YK!D%
MS@-JY/CB8USWO+6M!+B2-@:"3N;DD $X )Y@N0SI+5CY"6+9M%A<F083)&6E
M$X7F.S$??E1T+5-^ ^Y9=2[#?P_&3(5*C(]B](9:9DQENP;]=&L;(::F#7O=
M&W,<VLY[0UQ 9T1KXPX8=JZKCD-)+7 !'$20'$D $[1@ D@;=7&<@[,Y'*-H
M7+;T+K-U;+;5I-..2),F%';;-5]:WYD+VWOD1E"1&5.R8GN\CWEA&%.L>P>]
MJA'LE^G@=(+F 2::G :UKW$PU #6/U=1Y^[;&NUFZKCL=K-P3D*>*C_..TD#
MJF[2-XW;QRC>%V'[6^D?Z6M7_G1'_).</MEKOT5)\7-Y=3Q#.=WPCQ)^UOI'
M^EK5_P"=$?\ )./MEKOT5)\7-Y=.(9SN^$>)/VM](_TM:O\ SHC_ ))Q]LM=
M^BI/BYO+IQ#.=WPCQ+)*EI>KTTY&/C"!Z1,BMR6VVITD>Y&4F4PY'<RM$<7&
M=SG"'%91Z7DXPO&,JPK&,ISYJN]U=; ^GECIVL>6DF-D@<-1P<,%TKQO SEI
MV<V]2V)K2' NR,[R,;1CF4O<HZ[5KY':SOS7BF6;<#E5+HUC+Z*5_7<:[*8Q
M@$]=XV]"-B?K*)/K]62C01ULFMCT>6(JTK]7T^7)Y!V3W\>(J.4]@=XGQA;!
MN0I4:Z8^\]JCZM:+]EQ7)=O/9/A4-W#L#P*2N0I3A$X1.$3A$X1.$6.V_P#B
ME:/R=-_W9*X18'U\^\)I#ZH=:_8P+PBE[A%0;:'AI=3=PW^S[,O50L<^VW A
M@H<F1+M8QL9^7B,Q$PMF##FMQHR?8QFD^S90E/FG*O+U*SG-]6SA&TJM%!36
MVBJZ>.DI(^*@8^BII'-9K.=@O>PN<<N.TDE>"6V4DTCY7L<7O.7$/<!GL [%
M=253JN1JJ*29!"C]4P,A!W@-A@13@N:/'ML(BQR$$FS)BSD-^[,.>4IEW&7F
MD.YQZTX5BR)9'2R22O(+Y7OD>0, N>XN<0!L R3L&Y>X -  W-  [ V!8]\S
MVH_4E7S6ZY]2'JS(0KY$5GU(D4J L537TY^&>:7JD+<<&UEW'DL# <7#%*B1
MU*;SP7+)YS\//O\ A7-D:OUI+ %*I*UW1I-6.%G3YJM2*D > &#K\IF<^:*!
MG!ZAQ L].CL3'2,N,],<E,,R%O9>;0M),GG*^BM:ZY6:39%4"E*L2$,MH/JJ
MH+)I"(YUJT,(25S S.2ABS,,6)E.'\8;.LM%T820;1(P49/.NXDU:L38K\"9
M7 ,N#)P;Q)AR1 ]^+(Q9?>?E'A^.['6R[@_[Y+^-X<0K!7WJ3[_[?V[OJ(L?
M?U5J^5$CCY.MZ%(@1&@L>+"?I]>=B1F*W\5^3K,>,X.4RRT!^.G/@K;:$H%_
M&2ON*6/B,SVQ%]VM::X8?F2F-?TEF20B1($^0U5 3;\Z# !2JO!A3'40,.28
MD*LS9E=B1GE+9C I<H0RA ^0['61?Z,UMKH*69/!Z#2A)R/*,S6#(RK H!9B
M;8E^UL$MDC%@-3&I1US.7#,A#R72B_NYJWU?3PBS7A$X1.$3A$X1.$3A$X1.
M$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$5;]Q=<1&X=
ML];=KD+,2"SNN%SM=R$"(<&+*B6:1:ZLY5WX1*0\ZAZ"S$8<S+:=BH=6X[CV
M:TX1]/)SL(Y\=Y1C:#S9[ZLAR%*<(G")PB<(JU;9ZT MM6N/>B-TN]?MH$;"
M$T4B +N18-)C>UG.6)\>"7E8@F1M[<Y,0Y.,Q9JO=0]=3 ;AOAT/OW#:](9[
M73&BCI*.>EFD?+6QSQ!SZQVJP0-DG&)HXZ4L+H61/8-:6HURX2D-\D](V=XD
M,DC7M $9:[ C SK8;Z5Q?G#BX'TK,8U=O6(ZFTB$$IH(28-QQU.V <NK(DLY
M\I*F6@&Y&PO*L$Z,8=?I[C (?L)Z)73;89!R#(JM,DS99.*#2.?[/MGK'S5<
MTL4+I*JAAHS+$.AZJ)\+: FICK80VK#IY* /J(3*87BIJVL;&Z8R-X]!1ZL;
M6N<!'*Z3!ZMC@[C>H=&[+#JB7#7ZNL"R,DN#<* 9_534FJ[#0463=98&;O%D
M'U*(\2$48=F_Q0\G7=L8K1V8H*TW.-64AJZ0BT6LD\_8;@6VG=Q$61#D6FO0
M@U;9I+=+E!6F"T130T5/)5.$<U;(*%TK*^E=40LXXED-/'<6FFIHP(*2*VT<
MKVO;3SOE\YHX871:]0YKI'A@RV,<8&\4\,<<;2YT)UWDZSW32-R"]H&44[1V
MCM#&ZQN8CL'Y31*F(&U$%Y-23@VN33\^^G LNIP A$HH7"8I6WBXMK,Z-8"4
M;6\,(M@]'"0Y>2/FJ[S>;U%46B.AZ'?4RR54PRV&2H9 RBAF95/FCC$CC5VJ
M*4B-T$;K@Z8&!TSVZG)E/3TSF3F77# (V[-9K"XR.:6!KCJ@1SN:,A[A%JX<
M&@YZ)'4;KB+C!,1=AU\183,BE?#29-FBQB=Q.0FJ4D;#L(R1&'R[;&O!6AWF
M9;JO)4AVW/[(V/">4TZU"6*[_MHO\KIM:@J)J>%M9QL43JUT=+"\UAD?!(UT
MC*5U%'6T3:6I:"*46^WN&6EXE@45(T-^ZL#W<7JN<(P9' 1@![2 7B0QR%[-
MA?QLHV'!'W<ZG]='*+"P.VD$C0[A:3;XC8B9>O7R)8\7TB?T.L?4#S,6,.CS
M@\@C8KD!#U]/PT!<99ED4"AQ$LQ1_$:37\5K^,MLSGTM-"):#5KVQQ017B"]
M"2J@<]SW,E9'!23RS_=)Z1L+I)G/+GR.@Z7B]DS0V1[L2YB+G.=3NIL1OQ@$
M9>]K6##7N<&M V#$_P!KYUEG1BP%S=]?])L1%,JGI;UZ-H1F=LBU=H(H;X,W
M#BPJL7:<C7';-&S4@\]V:BKU80V0>23BX,RO2+[I%&Z.86>?[C*Z+4)KI*V%
MEOIM''3<<7/=4Q.#J2V5O14S SHFIE,;3&XPMX=#4ARSCVX<T/S]R$;C*^KU
M=7 #3LDFCU&D]0QN<$9,AT6@=?"E2V"P1VYKRPC=@[/+[$DLPK+57P$#7^IM
M\G]GN42+$FHCL3:,)MS]SD7J7-ARHS<NY6Z T2176 #,'PUM;?(ZJA,=KKX)
M*&W14#7/IZEL\E==++!;A6O<PN<RLEI12-HF,<QQ924KS&9S.7]K(Z9T<H,\
M3A+,Z4]6TM$4-2Z4Q@$@&-LG&<82",R/&=75Q']=ZO\ 6=-:UJ?K>W!0*HB[
M3&@ ),^%KZ"(NU@U88TP(ER1>3(MB+/ED;-UI48EV$"AV38!=VNKPT@H,:'2
MX_NJ-(](347""HM<LU5+3NDG:Q]<^6D@N45VE:V412.<QD=-I!Q3()L-@DHZ
M021B6*1KNIE'2:D3F3M:P/ 82(@)'PN@:2W6;M)?2ZQ<W)<))"TZK@5W)CJ;
MUY"0_A3>Q*N[9!]'M0EP5:[%5!>+:(A:]J-1%,WB5$CJ.OU^EB->ZMEIFL,/
M*#-U2-.PWY$I;<CIBTFOLSN--!4BGDK*:42TT%5)T+*^NJJJ4T;7.$ GK):Z
MY-U21QIJ71ZWW-A;R-%3,V<:W6$;QJO<P:X$3&-UR!K%L8CA.<'!9D@ZR[63
MJCKW;X.HJ!-["URQE=>? K#8,RRVO3$K:AO;FPZWL3%HF1YR)H\98-I6?7!Z
M"(D5%#,N)4;=<:_46QL8D'FC^MMSOM*^Z5S+%44\==Q\$&K%71-ML-KH:B@Z
M&86%DDD%MIJ^%\@JB6NJJ2EGJC(Z.9C^1AIGB"-U4USHM5S\NB)F=-*R77(.
MP.F?$X-+ "&22-9JZP(SC'1G6B&*='C6&TB<54120$U\ D$'F6L-21UAD-1+
M!)8$K6^]8=@'\[,M4YK#<NP6" R/)N204PF.F^,Z97$NJW.@II>B9:R=C9^.
MF9335DD#2Z!KI<!L%#!Z'4S#ED$#W/C#9FQR,[/0^+[GASVZ@C:2T,:9&QM=
ML<=7^M([C7G>YPPXEI(7)UQTDUCKLC13,9U1 K1/DRJ#+6,CX=DR*S'L$5$Q
M4XD^9.191IA^A-GEL&?9S&-54P?&:A!XRQF.-?IA<:^.MB<.+BK>B ]@D=AK
M:AT#BS4C;%"YL3FUQA#HLM-SJWN+Y7"1(J"*)T;LY='J8.J,G4UQG)RX$YBU
MMNZ%C1AO4JYW+27O3A$X1.$3A%6B+V/B2NX!;J5BIR43A77@9V 5>,F&E1'X
MI'8<J@8J^ /P[#S<AEV-\4R6R56VMM?NF("5)]XS.-F>OCX/]PHSMQUL_#_L
M59?D*5!VF[/&5H>E%6V71R*]K.M)?>MC!&IB\K%TT;)<FNDR(]>6Z_Y8]3U@
MBQ)\-N.A^0RF3[!369<,$]D\H/+UE#=P[ ZW)Y[5&.MNS)6ZWD#2I]=KT1Z8
M8+ULJ\-L"I[^9\*1NY<0^':9CR(,RL/#M-->U>9)S,H)W2*/7-8DUZ7'*,;/
M/K>/'^Z9VXQS=_/BY,_!M5O^0I3A$X1.$4?;7 6*T:VNX*H%R8.UD*T6;K1(
M23R%F,'T0W70R?BJ$*=@QGR3<9F:^QEI[$-Q]+;S65>O ;QG=RHH";I6[&/G
M3:>D6N;$/VT#-%H8V"XB5*KPW<MVMUFBU*0]88[],19-,DZ=K@3&@RZQ[E9@
M\QU[(@>RS<B4][S^'Q<@4>>_F.?/X">529)"[%@]>L@U6 9 V-"UPS#G';3
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MQA[X]9Y:&O)?)U0URN(STEULSF(]FW["E$1H?7 P.7(_-T3)A9FJ[)&L=4L
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MOG-KJ(>&5R4R753F6G8C05%GD36%NPT8D08=4?AV^?-8]I$'TXF(MLUZ/7#
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M=;DP=JG;3FNC6LJS) G+J<O,A^0"E(*V J?,3FG8-#IU;-83,L9DX0PR:LX
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M>@U7^FM7R[8_\Q3HJ/: R8 @ _\ "U/)R_>1MY21C/+O.=JGSWTS_0NWO_\
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MN@TE6R)@<06U/)&&?3D3!)K9BPR#\A#2VXK,T-O?[PRH)QY\Y ^M141[8ZC
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M8S+TF2\U'CQVG'GWWW$-,L,M)RMUYYUS*4-M-H2I;CBU)0A.,J5G&,9SPBU
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MPG4EJ7QNRUSAAS"-N1M *JEEOMUJ[G24]15F2&5[P]G$T[=8"*1P&LR)KAM
M.QPW<R]-_,'+(Z<(G")PB<(G")PB<(G")PB<(G")PB<(J90>OMWC>(&>[2N3
M:YG71/J0&T5'')G$,VU-Q'[;FWI^8Z-R*P+37U!Y"&6YJ3:YRB&%,J&(8QB3
MF>0#KGOX\2CE/8'U^-7-Y"E1KIC[SVJ/JUHOV7%<EV\]D^%0W<.P/ I*Y"E=
M>5%#S8Z6**Q6Y@^:U[*3'<RM.%)PI*T+0XVI#S#[+J$/QI+#C4B+(;:D1W6G
MVFW$D4?NU(7KZJ7(G57">3>*Z6DLF;C=;!9YK;T =,DCV'K-L$K99 T-$EY5
M)S'=>4%A+=DS78*O:2,N$W*KG3*)7K4%V*8)2<$[(Q:8@@E!D; K]Z=;@X@*
MLS5ID(K>P-F1Z[-OUEM5OLTL,_=36("I"!0]_ H5!QR3LV;>P>3S[^SL*!W]
MW)R$[>?GV'=X;:C-9U,59W;@TFR$#JG"3L9ZQ7J\VL>(<+K]1!=< V>QEP-8
M4^WE4-.:Z,%^P&K<%1O8C7%Q51GSP%.//)6?<(JFO:WWAA[;^2MF'6F'=[Q1
MK!7XP\R=K>8%+KA^',L5$;CORY\82FQ4P:S3G'A+D"&6)3BEA->Q=*SG$3Y\
MA\]O+R=I1S\O6\SS<FP';G>I DU_8(?KU\FV[$%B["%ZX8'2C]C'F;\';(0A
M+:"B9C*+%3#MESF*U*@QR\D\*G2I:F#A%J0OWD=(A3Y^>Y=IU\^\)I#ZH=:_
M8P+PBE[A$X11SM:]S-;4@S<(5><M+H6'-(N!6)K\29+ABQLXN00/1"%&R$\C
MF".D)@#X(J2I^4II<]X6':)&1Q"H]MO8073[K$KLZN$9@$I J4>O6$=\3DO6
MRZ70LT."TRM)P"33I$K,>8,*2YI:_!5,#Y;\_$!P4,($V)QU^7K>//>[^Q03
MUL]CLX['?[2Q=KN1JE^.[*8%WUYJ*+%FR'IK+:%C0YVAGMI@R$U#Q-I2$%=:
MU@]<V8K.'B$:$/R&)0X-LDPJ])8['P^/SY=VU,]8][QY\^?8IEW%MFHZ,UM:
M-K7QP@S4JA&A2C+@J$HB02T0*P T?W:$EQI3ZLS2,;"TX<3Z6\K<\\X1Y9]E
MNM]1=*V"@I PU%2YS8A([482UCI#K.P<=2QV-F_ 715U45%3RU4^L(H@"_5&
ML[#G-8,#(SM<,[=RUH6+Q5.A-LF!)]A:V$3E5V8W/$.NTDBUB/(:GBRS6'FH
MQEEJ=&:, P9IJ$01*A-&@84PB.DD('2HUX=+?27]'1=UC^14'[;;/^?4?$'^
M98Z]XE'ASRG9[\T->R#I)AR-+<)4PP25F,^!.UJ4PQ[^>D8ALS@UGL<<BW#P
MP@E(.%24_$@G.D3''2WTF_,HNZQ_(GVV6?=K5'Q!_F7*C>)GX=<26_/C K>S
M,E'IEGD2$:\DX<=L$\Y4[+,++S\5^F9(/46H%''/+RS+KXY?IQAK*5.EOI-^
M91=UC^1/MML_YU1\0?YE<SK?WIT-VILYZHZGEVJ08K@'%C))/UQP+'2-R0B#
M/4R^N5(PZ][U-8Q[+"4Y]&5+]7W/EFC7K16[6""&HN#:=L<\O$L,,PE=KZCG
M[0&C U6G;S[%[[?>Z&YROBI3*7QQ\8[7C+!JZP;L))R<N&Q7&Y;:JZ<(G")P
MB<(O,OXHGX61_P#(VE?W6KF]/ )^3RC]\[I\^%\N/LK?ROW#WDL?T5RUW\S.
MM;DX1.$5;#O\.&?YU(_VM[FO]V]5;G[X5OTF5?3C0?\ $O1#]U]'_P"$TBZK
ME/5T)PB<(OZ"(K^"QO\ ((?]G;YJ"_T[OVG>$K.[=P[ \"Y_.*E.$3A$X1.$
M6)'[S6JN8K((W+F0Y]OG.#02D!#DT:]/1EE*(<XU!&R0P61+6^VT.:-SQRRC
MV'6AV)3D>0EHHR//S\\'F*Z&9N350TL>"%]@54(2K1(8&,M'C$0$Q&+F("28
M\8S.+N0H)">]!4EY<0=)EOQLJPU*0R]_B^%*YX[:FL"Y:&!$['H10Z1:AOCP
MHZX5Z:6GLD1?QP>]#'1B+LR4U/"XR8AN,,K1*%X^(,97$_QW"9&[.WF6E?QT
MOXB]>?RLOO\ <]=YEC@J_"[Q[GI/G)E9&FOWB@]MG_N1KSA\S0L?)PB<(O2E
MX&?WJ=Z?6%7/LVYS"?"IZH6KW'-\^%D/0K\&KO;XOFRMYW,5J]4X1.$4.[#U
M+J>_7S3EXOD!B5=M1V(]8-327;"2$NP#YL&L*:>8%PR4*)85NAEJ:5$)1";,
M5.?>6F&G<8=Q.3M'/O[2C R#S;NVL]M]TIVOJ^0ME]ME:I%5$M>W*V:WG1=:
MKXQG'GYO$#)F5"'0FL>6?\9)DMH^C/T_1R%*UYD/%5Z[VF?+K_5BI[N[SVB+
M(=@NM]4-9$KIKJ%.2O++2#/8*TR:7UX%Q5R$J0Z^K:<E]EM#CJ8;WDVVZ7+5
M/+@=DCP;7=Y</W_Q7][_ ',$'UFZ!TR9]PJ78YQ7N)V$893]U[5H( ?U=H:J
M$'DY2VGVMHV_!B+]HM3$Y*&\/$Z@<[CV@/AVGO#M;U]6/"ST_?7V2O;_ &YV
M&[R&?:HF/!^P.RY4'3#!#UX<><%];]20];:+1"4K&$-1+!1[,^TPEMIV?(4V
MEWA-8CTH#>QM([!.2.T0KK-:JU?K/45EH&N-;T+7]$CU8^PQ2J34*_5:FRPL
M1(:6RU700Z"(0VMI*6UH3#PE:$X2K&4XQCG?2DMJ:=S26N;/$6EI(((>W!!&
M"".LNF;;%+G;F-^<[<]2>=>#]*4H2E"$I0A"<)0A.,)2E*<8PE*4XQC"4IQC
M&,8QC&,8QC&,>7-N5@M?KA$X17I\-'\./0'\_P!D^P5KY:NF_P"*UW]IA^ET
MZK6COJU0>V2?,RKV;\UI67DX1.$3A$X1.$3A$X1.$3A% 4_=D^'(VN,;H\L@
M;UTU5Y D<-(3YR;7'N=CL56 J0[$KC\B,Y@G6IKI=(&#;V1<=S,#WB5:A=@K
M :<>?8[W:S]2@G'>[YP/]=G8RL)QW%UE$'.D#$"T,1QP/)<V4% R) ##=BUF
MMV0O!A.E(E?M$QT8JX58*IJ;4!))TN<9BK%QU"[+\"8[^[X<9YN_WDSS^,=C
ML];><A3+KW:P#8\D_ %CK ')5I[+)0=88,6))1EJQ6RGR7&%P9Y*)(9BVVB7
M&ON.-RLX?D 'B,'WL"1"%RD*?/S\^PI.X14K@[]O<CQ##_6%Q /YM1O4$+N^
M,XD>]BR?+6?MZ=2'T.%??<QU!O@L=O*(&!Z74S/4_F6I&?8XGD!ZY[V/&HY3
MV!WR?$KJ<A2HUTQ]Y[5'U:T7[+BN2[>>R?"H;N'8'@4E<A2G"+KC [!<24$Y
MF3AV"@Z:.R0&/XC$H.)L9V-F8/DJ;=3'G1L.^WB/J:<PU(0VYEM>$^G)%&NF
MM41]/5PS78I\@>8+V\]:V_?&L1889)M<;T@PD'$B5[B)AIBX>PS[P[E\C*(S
M\^RS,RPU).<=8 >?GN4 8^'X.PI;Y"E.$3A%CMO_ (I6C\G3?]V2N$6!]?/O
M":0^J'6OV,"\(I>X18K>[; H%(N-[*1Y<P92JK8;:1B0$LJGRH-<$RS$N/"3
M(>CQU2WH\-QN,E^0PSEY2,.O-H]2TU"TVZ6\76V6FG?''/=+A16Z&28N$4<M
M;4QTT;Y2QKWB-CY6N>6,>X-!U6N. :3?KO!H_8KU?ZJ.::EL=IN-WJ8:<,,\
ML%MHYJV:. 2/CC,SXX'-C$DC&%Y;K/:W+AJML/BI=8K<-6&MFF=@6<.XZV^X
M*L-;U\:&K>9SG++RX)*T28JG6LJ5EMQ365MY5G*<X\\\SK_1QTN]>M'/CKG_
M ):M6?Z9.@'L9TP^)LO^<+J_\)OU)^+X/_,%;/CN,(Q@W\C-9_%\8:.)L[>,
M$OE'[YC#=D2FPHQA[R0<2DLGRGXQ(X_HXZ7>O6CGQUS_ ,M3^F1H![&=,.?[
MQ9=_/ZL+_$>)MU';3(0WH&UH1+BQ(4I"*7K-*9,(> FU2!$D)Q8L8>BPJN3(
MUN)'<PIJ, (30[*$#I;\9Q_1QTN]>M'/CKG_ ):G],G0#V,Z8?$V7_.%"?<S
MQ)-1;NZS[4U;7*5L<6:MHP)&@SS<2L-BXZQ]K F'52UP++.EI2N..=:;]C%>
MSEY;>%82C*EI]EOX$=(]%:R"_P!==+)44MN>7RPTLE>ZH>)FNIFB,34,,9(?
M,USM:1O4AQ&3@&H6O[)S0[3JOI]%+;8M):2NO!?#3U%=%:VTL3H(GUCS,:>Y
MSS &.G>UNI$\Z[F@@-RX>=SEWJ]$X1.$6[+P.OO][>^J%/VSKG,8<*7J3;O?
M$_1IE>.AGX=5^Y/_ )HEZ;N8.61TX1.$3A$X1>9?Q1/PLC_Y&TK^ZU<WIX!/
MR>4?OG=/GPOEQ]E;^5^X>\EC^BN6N_F9UK<G")PBK8=_APS_ #J1_M;W-?[M
MZJW/WPK?I,J^G&@_XEZ(?NOH_P#PFD75<IZNA.$3A%_01%?P6-_D$/\ L[?-
M07^G=^T[PE9W;N'8'@7/YQ4IPB<(G"+%+M>:CKBN3K?>K .K%9&KB-SS15W+
M$&*Y/ELP(:77,)7E.9$R0Q';^YSYN.HQ]'GY\J%KM-RO=;%;;31SU]=.)'14
MM.W7ED$,;I92UN1D,C8][MNQK252+[?K-HS;)[S?[C36JUTSH6U%=5O,<$3J
MB9E/"'N )!DFDCC;LVN< JCW;L7T]OD^M3RO8JOP_DL29,CX@L[$;B.&(,J)
M/#E7DS0L]]B>&G0T.Q7QCXY4Z(^0!'<%ZX4)!Y5V=+#A!]B5X[G'\ZL'IX<$
MFS__ #[1[9_^:=Y-8#B]>'\@^7LC6Z #9(Z0:+$DN7H[-@.$T&Y%BD38@TDJ
M;"%.$34R80)-"68,:6_*=RMC&/1A#I8<(/L3O'<XY?\ [U'3PX)/9_H]V.BG
M8^:7,KVR>A58FAYXK=E81)!RX,V"MZS.NXP\/CUF+']KC,%.7$>QJ0=*TYSC
MUY0_GSQ[;R2Z6'"#[$[QW./YTZ=_!'G/V_:/=U.[7_I\G-NZV=JUL^,9O/46
MW:=HZ)K._P!>NDD)9;G)+,A)2I*X#$P6":BNR,*;;PA+[C#R&\^>?/+:O\W+
M\T%T4TCT<GN,E]L];:V54,#*=U7&(Q,^)\CI&LVG)8'M+N8."\%PT]T-TR;%
M#HOI%;;Y+0ETM8R@F,KJ>.8!D3Y 6MP)'1O#=^2TK0US)"IB<(G"+TI>!G]Z
MG>GUA5S[-N<PGPJ>J%J]QS?/A9#T*_!J[V^+YLK>=S%:O50WN?L3H3KG7<VS
M?>YM8Z;KN4.J8*[)N]=I[$Y36/-4<6DX0A/%IJLY2AF ,:ES9#JD,L1W'5H0
MH@!.X9["I/\ X2AW:O\ T7I;U'[-]L,2/H'[&?IO[6WKT]A/_6R<;B[$?(9^
MP#VLY\\3-:4C8N)*,95!:E^IC#Q<M7&\@=\_ ,X[9"I-V3U5XD>]NPG261N4
MQKCKZ)?V7L'%?G]/A%IV[>]$QY]">^*G[QN'<-,3K<@3+#DMU8*YC20D,*)R
MII&'/-RT#<1^0W.[7A\_/=Q.KK-P"<$Y)V#&-V =GP[>3"O]4/"OZ?#; /O.
MVZI;^V^S!KOO$78_<>_63L:9AR<>66Y *KWZ7,UA2W(ZL>J(FB4"KLQ,^GW9
MII+3.&^*G6/)L[&SX<;3V\K86/'#Q$&(+%088P8/CM1( X?&8A0841A&&V(T
M2)&0U'C1V6TI0TRRVAMM&,)0G"<8QPH7,X1.$6-W+^*%J_)LY_=<KG=3_A$'
MMT7]]JZYOO4OM;_[I7@#YMTL%IPB<(KT^&C^''H#^?[)]@K7RU=-_P 5KO[3
M#]+IU6M'?5J@]LD^9E7LWYK2LO)PB<(G")PB<(G")PB<(M?W;'Q$]4=0K\"U
MY?*9L.QE3]/B7.+,J,6MOCV1\PT<!MQI"C-B#R<3$R0,IU:6X[C'L'F,I>4Y
MEQMN[M']#;AI'235E)4T<,<-0ZF<VI=.'E[8XI2X"*"1NKJRM RX'(.S&":#
M=-(*6TSLIYX:B1[X1,#$(RT-<][ #KR-.MF,D[,8(VYR!2=WQ=NE3^3.7^MM
MW>S8Y3DVPY=HNIW,G9CV92GI9G*[2KXI*=S.FY<D3O;NKS,E94O.9#OKKW2N
MO?Z_:_[=7_A53?MSM_ZK6?V8/++Z9\7KI>J%\.5UQO>1_NB('N&:/JG,+W%N
M(*@-PO=<VKV'NB((()"1&]G[%,0.*C)1AD?$0RZ5U[_7[7_;J_\ "I]N=O\
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M=W[3O"5G=NX=@>!<_G%2G")PB<(J'^)7^!YLO^<J#]OJWS+? =^4JQ^T7?\
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MI:9*P+40;E/-2$28XD@S,#P(/6\^\/ I'7\^^?"I<X1.$3A$X1.$3A%CMO\
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M;92L-;<A2S\;20&.7,7$28;K'J7:W5#;@*H_[1WNQ^*WL#^N&D/UL\R-T_\
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MD;C7%'2RSMCSL!E>QICB!YY'-'75?8_B$],I$K,/._J;%=PKT^LBV;&1O/\
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M6.?;]'J;<3)8=0]ZO-+>,93RGT%9<J.0FEJYV:@V:KWAI):?3,=ECP<#'49
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M7PM:4X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1>?WQCS1&-LK2\%Z4MH/$IYTC
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M"91&B0XD=I*6F(T9AMMEEIM*4-MH2E.,8QC',O-:UC0UH#6M :UK0 &@#
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M/3I36(R6!=KI4T>QB&^V_'6[,G2?9(==84I*D)<91)5&5&<P9PPF1M1H^8\
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M8.C-Q(,.,TGZ$,QHS+;3:?I\DHQYYSGSSRZFM:QK6,:&L8T-:T# :UHP !R
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M%VKFN'H\V[5_$F%>[:4)!:W5249J>X^+,%BH4U"C12+<57M@Q?#N6TBYRHY
M"=P//\ SX%B=I[>:-J&Q[;J<F4OLV[4-BC2+G'K>E=TVJLUC&R28H52HQO8=
M<U^3UR/*'7C,*3%"2;8V:P,3-*N#T#QT^1&)CL?"/&NYUGVGZ_;;I 38-.VM
M2W:\?*P@$/!>PB 95BQDW7VQ=9)!BDV,1&60IB.M\8!FQV2I"+EN5$BO,.H6
MHH(QL*S)O=>G7XD>=%VKKJ=%F6:528#@ZZ5TADC=H367Y5+&-PB+[A&X,M)R
MI=7@H?._O8Q RI2<9(OIKG;^N-KBQ1*CVL85?*TZG7Q5=?=R,N@2L7\+&L-2
MG6NDD\1+547C J4W(8@V00,G)6EYAV.A^.\V@I((W\Y';"DKA0G")PB@C:/7
MFD[;V3H?:5E(V:)8>O%JLEOI$4+.&1@Y$G:*ZNLD&;/&FAR,R=":@.9=AM#)
MX9]N7C#CTE]GS8S.=A'/CO*,;0>;..VIWY"E8%M'9]%TOKVV[4V8?:K%#HP>
M0=LQUR$3*9@CH^4(S[N*"0B1HM.DONLPQP@,.(%BL^1&'C84N;)8CN%(!)P-
MY71!]ZZF+P@,IZZ#ZK,LH%5G%U;9,8GJG8& +93(1PD4UMLR#4[^!8:+XP,=
MP=K0UUJ:MJ.XVEQYE*R8.[M;-O?&0N[E[8U9 (N!YVRZ!"+M0K,3=%R[E78Y
M%L;2WI,>XD'(+Q)$E$*IOPIC%FEJ:PP!>B26BCD5;#J4%"Y(+9>N+0717ZUL
M"DV(\Z$Q96P@*U@BY=RN9G+&8/H&CY\B8L)DDVL?@JEG,',Y"XF'_>$Y;P15
M3QXBW55RI,WYFT[!32)4XE!@W OHO>%0JI7(BYTB@$2 2R7?7M:!GP+%HV#7
M1S=D!SR-?FJ^+J@$I6 )?$,IP?KY.;/@\]JLBYO#2K4%LH[M_5S8QVLJNK1%
MS8%31!=IJ)34)5M;EJ+8CKK*9K[$11Y+F16)3S4?,O#KB$**%PCV^M0U]X-$
M>O8$L2/S==QA@:JRTVXX]"VK:A%,HUD>#5KXH3B4LP=.#F5767%9JL&&ZX2G
M%X\".](03"SVKVVJ7<.S8:79J];P$A^7%8.5<T-/AWY(^2["GQV28F3+A.OP
MIC#T26TA]3D:2RZP\E#K:T8(LAX1.$3A$X1.$3A$X107LOLCJ'4EWHNMKD<L
M*[[L9F=/K%3IFN=E;.-X BRH0&5N%FAZTJ-N<HM!%&+("&%=@WCY.TD;-)QH
M\T^PYE:4%(!()Y!R[!U\;>79NWKZUCLEHNUURLV>'M"H"(EL!5VQ"Q=O,PZ3
M:61]J"Q;$";,U"V.A[, (S@TV-/2)-"H))$=U*W(J4_3PHW+J-==KNN^T=4U
MW=58V[16M=V5JO9B&[!9@U;R.(6D?&*@J]88IJ=#?K]H(0)D60S6RR8IA;;[
M2DPU)<1E1201O62F]_:>K]BC58A?J_DLHF?#F/<9K9(=2YU8J!.^&&]BEQ^9
M(O73<>K")Q)I^ZRP3,S"&V(BWY#[+2RCZE* <P(L(H:= %!QP&9@Q28@R'G1
MB8HJ-G,HDPB TC"=?ASH,R.XV_%EQ7G8\AE:'6G%H4E62+L>$3A%5"'V-*2>
M[QGJ;FL0$!A?6(5OY%QP0D9)O$B.SI=!57%"LQ\14P6HT;!%,[$K+ZGU98RQ
MAO&%\G&S/7(^#'C4<I'6'?SXE:_D*4X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1
M.$3A$X1.$6LW>?AG4O>>Y+=OPMN/:5?V2?.@L GA$YM55JNNQFDK?I EK=JH
M.O)%&89L-M/<IY=@)^HL..;,**@X1$@1F'2G)QCDY?A!^H;-VS.]0&#\%G7P
MN"U"<WM>(+Y!FY ;:>HE3K6M#YN@VCK[JOKBBA#V:@_#IT /(J6G*-9[>\<I
MMLD6'8HJ-<@'R))#P^1I3K'9UMW+_6+MI[)/-L645?P=]2A8-;R6OD\U8:\J
MO24V1RLNSI\HO7-W]<]QQ[$F5=[9>S8XZ18ZVU:EE7AQZ./4(+$7A8P4U&A#
M6R:QV]?P8(.['/YY4F%/#3K\GK=I3KT)VI(%M=?MB7>[:[LDO6=(.C7QMWHV
MW=7R:_=*"01\FK5+&43<MA;'V3.!L]%O& [2J/[!B:!G%&L<DG;D8/)S;L=C
MKCK+(J+X;.IM<]9MW=9*M93S 3=LL8LU>9HP'*O3, #3Z+2J_#*%FHL7Y4/"
M15%C*9G%4I7[<J2RRS&;<PCA3K$D$\A!QR*&*GX.VG:5;1=L [/OV'@VST7X
M9"(1 T]D97 ?9[IOV(UUJL2\M#;PVAZS#]+:#J6J#F?5EBMV&QG7O4>?RZ^3
M7.".?Q.&>WK9/7ZR[SK5X45&ZT[6T]LNO[<LED9T^"JL$<$-TFE-DC!JN]3*
M/U!DD)5WC1/E5#KI"C:WJ=FC4>),^ C+FNS%<>^I-Q&@I"XD$<_CSX2?A7 M
M7A :3L.JHFLAUS/UIU9'L$6LMK@U^OD2=N);^L\BQ3Y9H::1/"/*JC#R PF.
MN"] (06$_%8;_M'FUD#B-V-P'-N&!N(V]?GVKBC?"#UC##7AR7LB<0OUS^1!
MMFY*UO1(XNLW2E=SMA=WO>0%(1&6%B:\LVR;S$JMKU>A] L]0JW%@$2\@W/E
M'4$UCWB/A;J^!?&K>$-1ZH3%3!NZ[E"A-$=;V>TB1%=%"!E\NE [@4'N.R9L
M8-DD]4F!T&Z4XM3*&/ 5@,9I.O[D2K,JSVH0%K \.36W[/\ 08QCG[_P*[_4
M'K+#ZE:@;U +NI:YA(5C*EP#4Z+('AZ6!EQAT$10:4+G&;(2#4FM0AC+0$',
ML1>.%1(D"J_@+5(@"L R@G)W8\^7G/75H^%"<(G")PB<(G")PB<(G")PBH]V
MJZ3ANT]\TY<S5\E4G.GRJS(N76:=7/G!6ZY*;DD@87:3V&[16Z1>8\>* VM2
M&\$@&P:O%9%28PN2GXGPI!QGK^?GU\=O7'I;P=;A3]RFU['M6M+1HP:2T@6J
M$YR3:+3LHRGKY<^LUEIE;)T4U70FK:#6[E$T)*C[;^"RKJ6MY-ZF$XL\5\GB
M#!:!LV<VP+D7;-F_;GFV@YY2>79N&_9MV37!\&C4,.I9J:MFV>4PS1;10QTR
M15JPMX0/LW5JX=6\R!K>4Y1$6+!6MJV08[&6V$F 0N'Y)AM)6W)V@CG4:VTG
M R2">T<[.SR[]NU?+8W@_B+]J?9&DH_9"\5G7VQ-@[3O4M@/2*P/L^4;FQM@
ME= EFNH"97[/?8(NT[:*E:#"M1&97*R%$"JJ6K5J@)>DK>?PH'8(. <8V;<;
M,<^1MQM[)W;,9D4\)?5LBT.7@/>Y@FX?.[9=T)*R*%3R\>?;+!W.MW<%G%EA
M26VEV.,&>N9;5(YR7,:FM4[#,A$IM[VT-TFMR<F,<OYI;]>?"IIVAX>NJMI[
M'W?M8P8)1+QNB;UZ=6<8@1'9=/%: M=1ML4&%RXZEJ3"N4^GCVS;DUI3\1#B
MUP58RC"5% .,=;/?&%7'4O@X:CUQ=J9<CNR#5ZS12X*4$#/4.B5@>X+K5![;
MU,&HID# ;<*7<:?[B7ZW1-DS,.V9EVJ4 >A>) >>9*E.L=O7'UM)[74[N8X7
MQH'@^U"@/ZQ)C=Y6ABRZSL>IG8%IK](KM)+2=?Z9I],H=?H?NM3GBP#ORXJU
M-:$;E+V(+:(%]CD\RQM:J)JL4 O4 V(7;]F_/7&3RC.[')@[.4G)S9+IUT*!
M=.SL\C5]F6*Q!9FFM(ZE75'1N P,B0TOKJI:T8V@>'I,%1;VQ+)7*57Q1,M6
M!E18E!!HT=8XUIFAPYB"4$Y^$GDY=N-V?A[6%?[A0G")PBU;]\ME,:S[-^'"
M4.W]G7]&E;CVNW=B):U(JE3D#6=8.9A-VF7,GP [T%HB\QF*DLXJ.B:ZU['&
M'UH\^0]*[M>':N)],WM^!;%*+LG7>T1,D_K._4O8H*&1=#RS5%M(.W"8I9B-
M$FOBY)*OSR$-@BS#(0);L%UY,EN--B/K:2U)96OBN2K1O/=O5+8^N]BZ?.=G
M^L0619112GGH%WN.FKR'8PMW,,T"M^N[@?\ A)\9+;;EAK!7BS<5QV*_+CHD
M#YR694<BUXDO"!ZRZWK<BQ;;[&'Y&NLZB*ZS,'MKVMP,(JY>TTK<6K:W:]=G
M)5Y"TVB-5>N[V,5K7 4R"N$VKCAU>$52R#5ND72A<]<[-@&WF&W&#MY3N!//
M@DK$JQX;/3;;AH@ IG=2O[;NEKT+L&BW] B^U2XVH_>KS7NQ@F[=AA-9I.P!
M]>$6@T>[6;.L=BC&J=;1#4@RL>"E5AHW87C11K'X#D=X8[& .;KYP,6EK_6G
MI_U+[=F-Z'^P>L=<G+%71!,)J.^7@!1F*FZC5%!T,X<H8&5?@%;%U(_5=0"4
M2XN=>3R#UEC%51+>T+B0P PH)) !Y/&3M._E*CL1X6O5W:NBZ%5-0;I@E:U6
M1VT@Q'8M#:HNP!U[L5^VGIS9)DN?0J2>J<P@%E:;"5UP,IJ0-DCB4M)6"XM&
M&G2!W8/)\ ('>/\ LHCJO3GH37AUBB"N\FB)^TK):-26T;:IAWK]-BB-@:W[
M6;O[9OCQVOFSS8_.N;?LW>90._JF'+A0Q%?J]19$%D6 3%-M%.N3OVCOGJ0W
M?MY!L/7/.I,E>&%H#0$.M6.W]GEZVH ?YA8$^/<GJ=4*=>[UIO:VLMP!#MQ8
ML!J)19)^8[JB74:S"JU>JTH+KNR&:J4>N0:K4./3R%V>3&_K[]G9_P!=NS)S
M<SH>%T7J;5$'0.I.R]&W\NHR#I^)#K5^KUH?IU2(%6VQ%8!!HEQN]D#:_I\=
M\=7:U&/V0^H5$Q$$1"<<6T($#R@G)SR\O7YSX^_M5B+GV&T#KDX[6-A;RT]1
M+*Q'CRGZ]<]F4NKG&8LQOVL22Z)-FX,]N/*:_P 9'>7'2V^W]VTI2?IX4+-Z
M[>J3;ZLQ>:E<:K:*3*CD)<:XUVPB#=6DQ1,F7#*26+"-F21+T<;,@3HI!YN6
MIN')ARV)*FW8[R$$46BNUG5TZ4&@P?9+09DT9GPQ0@.*W#KPB4*E",AN&/&C
M1\.Q/2YT^=+>9BPX<5EV1)D.ML,-K=6E.2*1+WL[6VK1L,QL[85'UR((3<#(
M!6]VP#4!LXEEAZ5@?#G6 @/BR9N8L>1)Q$9=6_EAAY[#?LVEJ21=90=T:=VJ
M^2BZOVQK39$D,U&D%X]!O=6N#XIB8MUN(\29KQ4BY!:E.,/HC.2DM(?6RZEI
M2E-KQ@BZ"U=D^NE$/D*I=]^Z5IMI$JCH*UJU;3HU>/C%RXC$^*D@'+G89&$J
M3!E19L=,F,UEZ))8DMX4R\VM1%(,2\4J?4/G"@W"K3:#\%DV3Y<1+ )DU#Y.
MPH[LR8>^4K,M87X+$B1WY4DI[[[BQ'9=?=?0TVM22*A5JE]?]K]F]9;HTKWC
MU54=KL4N5I0U4ZK<=,;)QM37Q6YA;PQ6H $F6FE!%N@FQ,QL&? XEJ3"/F(Y
M$"8<0)?%E.=A!Y<?#M \/@VJ!*YX>O3WJC TQC;&[:&.72MDZ(O8 MN7&KJO
M)O*^L_4F+U8KM77*LDF+D@*C1I,;:3S$)R3FOW*6PY!:CMO-REL;^N?J_P!%
M)=OZX/+SG)\145T7PK^JNQJ=$"Z![25>R9INO:/J^PD:,*T[LX [&C:;W=I>
MQ62T5J!()!6MA7JI[AL!0;:""L3Q!VO1)'LK &D' TXFMMW;,D]?>#O[7GLQ
MQ+)T>Z1U,_?*A9^[FK@<)%LO4]K3-[O]*2 IY2Z:ZV)K^R_'*\4V:-MD.W6!
MS8LBT7HM6#6O%'+4%@6L:&J]X*VFW'RC.[K<O+_L.39LZZW :BB5'2/737,(
MYN5F[TNAZWK#,C>=\LX3W:V!(PJ&F+>#=O7,2&D1C3#L>:T:D$YGOS$EB3*+
ME93[I&44$@[>0[NWN7/JG9+KK?+ /J=&WYI:YVDMF3@56JIM.C6*P$\PH<@C
M,P/#!SLPC-S$'Q)<Z3B-&<RQ#BR)+OH89<6DB[Z_;HT[JI\;&VAMC6FMY)EJ
M2^'CWZ]U>GOE6(:VFY;PUJPE1SDYJ*Y(81)<BI=0PMYI+N4J<1A1%">NZ+HK
M9/8\]W$U?ML1LBPKTW ZYEHE&N5.M]#&B1UQ5L9M]]^O)GSHMK5*(M(=9DF\
M1OA+L=:1:7'$REN3'9[^/$HY>T/K_P!5;?A2G")PB<(G")PB<(G")PBU[>)%
MX@-<\.72U0W-9];F]GP;;M 5K%D&!/0*]+A2RM3N-J06=F$(!%EV.RS3WX:H
MR&4.+<FM.X=PEE:%W)HOHY+I/734,-5'2.AI'U9DDC=(US6300Z@:US2"3,'
M9SC#2,;59VFVE\.A=LIKG/12U[*BOCH!%%,R%S724]34"0N>QX+0*8M+< Y<
M#G *TK?NIW4?XHFQOSGUG]%^7UTHZWUYI>Y9?*K&/3[MWL=K>[X/()^ZG=1_
MBB;&_.?6?T7XZ4=;Z\TO<LOE4Z?=N]CM;W?!Y!/W4[J/\438WYSZS^B_'2CK
M?7FE[EE\JG3[MWL=K>[X/()^ZG=1_BB;&_.?6?T7XZ4=;Z\TO<LOE4Z?=N]C
MM;W?!Y!/W4[J/\438WYSZS^B_'2CK?7FE[EE\JG3[MWL=K>[X/()^ZG=1_BB
M;&_.?6?T7XZ4=;Z\TO<LOE4Z?=N]CM;W?!Y!/W4[J/\ %$V-^<^L_HOQTHZW
MUYI>Y9?*IT^[=[':WN^#R"?NIW4?XHFQOSGUG]%^.E'6^O-+W++Y5.GW;O8[
M6]WP>03]U.ZC_%$V-^<^L_HOQTHZWUYI>Y9?*IT^[=[':WN^#R"?NIW4?XHF
MQOSGUG]%^.E'6^O-+W++Y5.GW;O8[6]WP>03]U.ZC_%$V-^<^L_HOQTHZWUY
MI>Y9?*IT^[=[':WN^#R"?NIW4?XHFQOSGUG]%^.E'6^O-+W++Y5.GW;O8[6]
MWP>03]U.ZC_%$V-^<^L_HOQTHZWUYI>Y9?*IT^[=[':WN^#R"?NIW4?XHFQO
MSGUG]%^.E'6^O-+W++Y5.GW;O8[6]WP>03]U.ZC_ !1-C?G/K/Z+\=*.M]>:
M7N67RJ=/NW>QVM[O@\@G[J=U'^*)L;\Y]9_1?CI1UOKS2]RR^53I]V[V.UO=
M\'D$_=3NH_Q1-C?G/K/Z+\=*.M]>:7N67RJ=/NW>QVM[O@\@G[J=U'^*)L;\
MY]9_1?CI1UOKS2]RR^53I]V[V.UO=\'D$_=3NH_Q1-C?G/K/Z+\=*.M]>:7N
M67RJ=/NW>QVM[O@\@G[J=U'^*)L;\Y]9_1?CI1UOKS2]RR^53I]V[V.UO=\'
MD$_=3NH_Q1-C?G/K/Z+\=*.M]>:7N67RJ=/NW>QVM[O@\@G[J=U'^*)L;\Y]
M9_1?CI1UOKS2]RR^53I]V[V.UO=\'D$_=3NH_P 438WYSZS^B_'2CK?7FE[E
ME\JG3[MWL=K>[X/()^ZG=1_BB;&_.?6?T7XZ4=;Z\TO<LOE4Z?=N]CM;W?!Y
M!/W4[J/\438WYSZS^B_'2CK?7FE[EE\JG3[MWL=K>[X/()^ZG=1_BB;&_.?6
M?T7XZ4=;Z\TO<LOE4Z?=N]CM;W?!Y!/W4[J/\438WYSZS^B_'2CK?7FE[EE\
MJG3[MWL=K>[X/()^ZG=1_BB;&_.?6?T7XZ4=;Z\TO<LOE4Z?=N]CM;W?!Y!/
MW4[J/\438WYSZS^B_'2CK?7FE[EE\JG3[MWL=K>[X/()^ZG=1_BB;&_.?6?T
M7XZ4=;Z\TO<LOE4Z?=N]CM;W?!Y!/W4[J/\ %$V-^<^L_HOQTHZWUYI>Y9?*
MIT^[=[':WN^#R"?NIW4?XHFQOSGUG]%^.E'6^O-+W++Y5.GW;O8[6]WP>03]
MU.ZC_%$V-^<^L_HOQTHZWUYI>Y9?*IT^[=[':WN^#R"?NIW4?XHFQOSGUG]%
M^.E'6^O-+W++Y5.GW;O8[6]WP>03]U.ZC_%$V-^<^L_HOQTHZWUYI>Y9?*IT
M^[=[':WN^#R"?NIW4?XHFQOSGUG]%^.E'6^O-+W++Y5.GW;O8[6]WP>03]U.
MZC_%$V-^<^L_HOQTHZWUYI>Y9?*IT^[=[':WN^#R"?NIW4?XHFQOSGUG]%^.
ME'6^O-+W++Y5.GW;O8[6]WP>03]U.ZC_ !1-C?G/K/Z+\=*.M]>:7N67RJ=/
MNW>QVM[O@\@G[J=U'^*)L;\Y]9_1?CI1UOKS2]RR^53I]V[V.UO=\'D$_=3N
MH_Q1-C?G/K/Z+\=*.M]>:7N67RJ=/NW>QVM[O@\@L"V+^R2>JVWP3=7VOT G
M;,K34Y@FU7[]9=>V\*V2C(=;CSVQ9^DD(2)C#;[R&9*6,/-H=<2A>,+5C+I2
M5OKU2]RS>53I]V[V.UO=\'D%\M;?LD/JAIH'+K&HO#[E:NK<\J^>G ->V+7=
M-#3#<F'!'R#$H97J0.A2";\ 8-A/3W65RG8@^%'6ZIJ*RA#I25QWWJE/_2S>
M53I]V[V.UO=\'D%$!/QP/#7-$B!@QX26LRI8M-EDBA,B TA-($2,]]R5-GSI
MDC6;DB7,F2779$J2^XX\^^XMUU:EK4K,]*6N]>J;N6;RJ=/NW>QVM[O@\@IN
MNW[)7ZQ;+JDJB;%Z%F+Y29N8&9E0N-LH5EK$O(N2Q-&9D@C-+F"W\CYD6-*A
M>TBJ]UDQV'F/0XTA28Z4E;Z]4O<LWE4Z?=N]CM;W?!Y!1]KSQ_>B&H[#\K=5
M>&'6]:VGW&2+^4E"QJ2HGOALU3*Y@_XL U[ G^Y2E1V%2(OM_8/*9:RXA66T
M>4]*2N.^]4Q_Z6;RJ=/NW>QRM[N@\@OMLC]D"]%]QG8]HVWX90'9]EABXX.)
M8=@N:GN)N,%BRILV*)CE+#KXA-9&QYA$A+8@MOIC-29TQ]#279+RENE)7#=>
MJ8?]+-Y5.GW;O8[6]WP>06<:_P#V2GU?U/7&J?J[H25UQ4V)4J<Q6*+:Z#4Z
M^S-G+P[-EM!P5+@#VY,MS&')+Z(^'7UXPIU2E8\^1TI*WUZI>Y9O*IT^[=['
M:WN^#R"A%CQO/#3C3624;PCM81R,>4W.8GLU[1S4QF:T]B0U+:DHUDEYN2V^
ME+R'T+PZAU.'$JPO&,\GI2UWKU3=RS>53I]V[V.5O=T'D%-&Q?V27U7V^ 15
M-K] B&S*NT1C%VZY?K-KZW@VRL-J0Q$)(%'Z20@IGQ69DMF/+2QB0RU)D(;<
M2EYS"HZ4E<-UZI1_TLWE4Z?=N]CE;W=!Y!8GK7]D'='],EIQ_4/AHAM6G"@Y
M0@D9UY(U53"A 2J3'FJ&39]=U^.E2AZID2+*5#?=7'S(C,/9;]HRVI,]*2N.
M^]4Q_P"EF\JG3[MWL=K>[X/(+KK_ ./MT)VO8W[CM#POJOL:VR8T2%)L]Y;U
M%:[ _#@->QA17C!W7DX@[&AL_P"*BL+D*;8;^X:2E/T<=*2N&Z]4P_Z6;RJ=
M/NW>QVM[O@\@I%JO[)6ZPT6EQM;TGH47J&O8<4I!B46LVR@@JA%A&Y<V>9B1
MZV,I<4.S&+3B1&828;AI:FRI\Q^2EQV2\I<=*2M]>J7N6;RJ=/NW>QRM[N@\
M@H8">.1X;]:,B+%7?"8UP"L  G - C@<)I(:7#&!4IJ<,*BR,/6C,L>1'36&
M)D&;%>:DQ9++3[#B'6TJQ/2EKO7JF[EF\JG3[MWL=K>[X/(*5=E?LCWJ5N83
M  [>\/9[:0,61P7&!]AG]<W,6/*IC2(22<*!8J.1BQ9^(<J5%Q,8:1(Q'D/L
MX<]FZXE4=*2N&Z]4H_Z6;RJ=/NW>QVM[O@\@NGUE^R'.EFE9):9IWPW(&JI9
M]B)&.2M<S]74J09C0''G84<H]7*$-<GLPW9,AR,U*4ZAA;[RVDI4XO.9/!)7
M'?>J4]FEF\JG3[MWL=K>[X/(+&+KX\WA][)LY2[;#\+&F7NY'%15FK7<(>G+
M)8RZX,&,,A+)&S&N9A*<J(.A0X$94F2[EB'%CQFLI99;0ETI*[UZINY9O*IT
M^[=[':WN^#R"E*#^R5^L8RB?-:.Z&&(&L\U^74LZ]AVRA1J3FK$(K\&?6_DL
MS2T!/@4V%)DPY8GW'W"1&D/,.L+:=6E4=*2M]>J7N6;RJ=/NW;OM<K=O_P"?
M@Y?_ -!1%5_'7\.RD6$1;:9X4E"J=JK\YDF!LM;&:7"'@I&/G.6)XHN-UM&G
MCYC.<YRU)B2&GF\YSE"\<GI2UWKU3=RS>53I]V[V.5O=T'D%GNSOV17TZW6R
M'C[C\.AK:S%=<G/ &=CE]9W5H(\33%01=$MV.B$D#G)Z(,-$Q<3#*I*8D9+V
M5X8;PF.E)7#=>J4?]+-Y5.GW;O8Y6]W0>07ZUE^R+>GFE&"\73OAU-ZIC6!Z
M'(/1]<F-:4I@T^/1(;@/%6JY11J"#L)N7*1$<EI=7'1)?2UE&'7,*=*2N.^]
M4I_Z6;RJ=/NW>QVM[O@\@L M'CK^';=["7MUS\*6A6VU6":Z2/66RC-,'#QH
MB_G&7YY4N2UM)GD)CV<8R[)ER'7G,XQZEY\N3TI:[UZINY9O*IT^[=['*WNZ
M#R"EN=^R5>L!2A8U62Z%%B&LDU^#5$Z\FVN@RJ1BKC(T>&.KF*J_2U@\ H$2
M)%BPQ.(/N,:/&89980VTVE,=*2NW^C5+GGZ%F\JG3[MWL<K>[H/(*,*3X]'A
M^:TM N[:Z\+*FT.Y \RU!K93HFG:U9!*B$"4*GY&FPVN89*#F:,G31TO,:2U
MF1!ER8COK8?=;5/2DKO7JF[EF\JG3[MWL<K>[H/(+)]F_LAWI;NJ0(F;B\-V
M!M:6 9EQ@4G8T_5UUD!H\]QAV<P*>L=").#V9CD:,Y*:BJ:0^N.RIU*U-(RE
MTI*X;KU2C_I9O*IT^[=[':WN^#R"V,^%?XL71GL1=3W7W4^AZSTXN9V1BQ5:
MD0!])"5S:Y%J"E@KD5,J 6NCY%U&CH$961!&#DD3"Q_;B9,YL7/C0;<TDT!N
MFC]*VNXYEPI6G5J)((WL=2Y(#'RL<7'BGDZO&M.JQ^&O#=9I=>&A_"G9=+*Y
M]M-/+:JYPUJ2&JFCD96@ F1D,K&L G8!K<2YNL]F71EVJ\-W[<L-9/3A$X1.
M$3A$X1.$3A$X1>;C]E ?@,:8_P#JQJ'^Y_=O,H<$_J_7>\\WTV@6%.';\5+9
M^\--_#;JO"MS8!:I)PB<(G")PB<(G")PB<(G")PB<(G"+:;TRT-T@W%H3L/?
M=U"NU7R^ZUZUSM6U?-=LK4=?J%L!$MA5^E!PM?&6O3UN,B2T5JQQ99.:1.3H
M<IR)(]UCQ4O-M-6C?+A?Z*XVRGH'V?H:Z570<71E)6RSPR,II9WR2/AKH(WL
M)B+6-;&UPUADNP2;]T9M.BURM-YJKI'I!T79*$W"?H"MMT--40NK(:6.*&.H
MMM1+'(T3M<][Y7M=JNU6MR .S+^'>]M*)K0UI+-4U'4"'4:7VMN%IWYNYF?"
MQKIO?!O5?RC+$ ^JZY K1@3"<#OE:H.C'4$8PR=*KTV>>(CZQ*AFDK:0U3*[
MCJV=MZ%GABMU 6N-3Z'1U?%,:^LE=*Q[A(&3.,9:7M;(T1L=,.R30UU>VAEM
M?0]NIGZ.G2"IGN]T$C>@A=I;?Q\CXK? R"2-IB=)3L$P<UCW0O=*]D#L=VKX
M3'9/5E>NQE%RT%LHM1"VGXQ:BZJV<Y:[S)K6_CXJK:;V! #/UT3&34+_ &$X
M'&A4%"(RUHP4'$R%6A!9T0D]V4>F-KK)(&<1<:5E0RM+*BLI.)IQ+;HWS5U,
MZ02//'4T4<CY"QKH>H>QLSI&E@Z;AP>WNWPU4G15HKI*22VMDI+?7FHJG07>
M:.GMM8R)T,;>AJR::*.+C'QU XQDCX&Q/;(8E[0^'_NCJA4(=YNY_6UOKJ-F
M&]+VF7KHW9">:%MROB$G"5!L^+-4:DB81P.1/=B'::Y;*80<$%H\*SOOPU-J
M]EITCH;Q,ZGIXZJ"7H6.NA;51Q,Z)HY7F-M1%Q4\Q:W7U0Z.<0SMXQA=$ X%
M4Z_:(7/1^F;554U%4PBNEME0ZBEG?T)<88N.?1S\?3TVL_BP\MEIC44KS'(&
M3DMP; 7OPK;)&F=5Q&I]Z:?OI??_ %QSV%N."=@(5L3J:HAV;L6N5_L)64 5
M&1J"NA:FN+BTKSFQSK3%- XU3<]@,D$Z=3Z71$7=]9;ZVG9;KH+;!J1ME?63
MR&G9!31,;)DULLDVMQ(^Y-A,<AFVO#:O5Z SM=88[?=K;5R7>RF\5.O,^".W
M4T0JI*FLFD="1Z&PQ4Q:*C[\^H;+$VG.(W24V["]5[MUQ*:R^4-IU[L.D[CJ
M;5XUCM+4QXC8J%=*XD[/K11P5+.@JN?ADP)T7.%&PYZNB"0^8TA+L7+3S3BZ
MW;+M!=&U7%PU-+/13=#U=)61MBJ8)3&R5FNV.26-S)(WM?')'*]CVG8[((%M
M7FP55E?0\=/1UE+<J85=!7V^5\U'50B5\$G%NEA@E;)#+&Z.:*6&.2-P&6X(
M)W)]IO!IUC59]KIF@Y'8&@7D#VITKUEH!CM*0JJM9=AYVYH;^46'5A^HZTIA
M>/'HDM")-OS&%76*R)0\Y&?5-2Y&CV1:--ZN9L,]Q%MJ*>2SU]VJ8[2V85=L
M;0N'W.KCFJIV$U#3JP9? XR8U@&X+LEW[@TH*=T]-:77BCJXK_:K'1R7]].:
M&\ONC3B6WS4U#2R 4CL.J=6.J:(PXM)<"&T!&^%SMB68M<,GOCJ?6ZW4+[3]
M.S]D&=LF7]>3][W&(1FM:-"':_1CDDIL*O-"YBK8MD9BF!&4-SG+>\,=;FJN
M-VEE&(X7,M]XEEFIIJYM*RC8*EEOA<UIN$D<E1&&4TI>T0C6,\ART0!P+1:#
M- [@Z6H:^[:/0P4]736U];)<9#1ONU2U[Q:8I8:65SZV$1N-1A@I8@-8U)80
MY<BM>%%V*)Q[:FZW/2.G3M3(]A(?R3V;;K2S8+# ZLQ696\;%7OD31+L&=K]
M.;D-Y1,+&!$@^WZI==AE8"<R^1+I?;6.@XB"OKHYFVQW'4D,)BC==W%MOCDX
M^HIY.,G(.6QQR"/8)2QQU5,'!_>7MJ.BJFUVV6G?>6BGKJFH$T[+  ;K-!T+
M2541AIM8=5))$Z89="V1G5+X->%9OYXIK(&C877]9O9&GXW8.4$8V$9G&]::
M+D:[';&SM/9X4=3IA4!741"/R::@BH9^T$[7%5!"5XH-( BY8=+K<&U<AIKD
M(Z6M-M$AIF-CJK@*IU+T)22.G:R236;QI<]T<+(3K22L>R1C T NYDH8NC;/
MQM;;1>'1"LE=+0VHT3*WH^OB92NDA@#7\0&QLFGDJ&ED4,D;XI)/U(\*K?XN
M9LV58[WI2K:_UA0-2;-F[<,GM@KH%CI^\L6%.M2@%H/K,M>Q\8Q*J5F@%)EW
MI%.&U&<$EL7"<!]<14D-+K<]M((J>OFJ:NHK:5M%''3"IBGM_%=%LD,E4RG>
MY@GA<QM/43OF;(TP-DP[5@Z W=CJYTU7:X*.AH[=7NN,LM9T'/377CA0R0B.
MADJV-E=3SL>ZKI:9E.^)S:E\.6ZW)U1X==M9O72A6UBNOC0OMQ9-8RZOIP1?
M+;4-C%M>[)=(J"625<7-4V6@AA<ED<E!95>,72TUAPF*CG:L,E3T>P5>DL)I
M[]T(RH8^S0U8FK9*>&:F94TH;KQ" 5D52]X+B6<8R"&8,>8YGM:<\J#0RI%7
MHOZ(24<D>D4] ZGML=744U;)1UQ>8IW5)MT])'&X, E,$E5/3F2-LT$;GC'6
MUCPP]X[#"1+#6;%I^L&K\UN6P:.T9<-BSL;IV]4=+$;%%MY"BCH=.Q7R"(&:
MN?BC7[48HTJUJ DR ,2Y!0E?.4VE5OII'12QULL=-T#'7W"&E'0-%-7MB= V
MH<Z;C&E_'1.<V%E0(1(ULCP[*ZX-!KI6Q-G@FML$E8+E-:K54UKO1.Y4UL?,
MVH?2,;3"%^IQ$S6.J)*1U08GOBC+ NK.>&5O4%I"9NUR]Z((HA]>:+VK7JD5
ML29*W(O0MZ6"CQ]@9I[E:8AQ1E?('X@NPMD3L*4F<S)P#9.1?=9,KG'I5;Y*
M]M *>X-UKE46CHQ],!0^B-.)'&FX\2ESGR-B<^,MC<-4CC#&=8#A-H-=H;6Z
MZ&KM+]6S4FD'H?'6N=<_0BK,36UG0Q@#6QPOF8R8/E:X.SQ0E;AQBS6_3NSW
MWN#JGJ$W?==SSFRK7KD$Y?=?V8=L6E"1E["AK/-(Q"P:0S#,DJJ!*R&S 1F5
M&<:L0N< <E,NM9DX]=5>H::RU=Z-/4MCI8:J3H:IB?35#WT\DD36.9("YC9I
M&#BY""#$]LH!!PJ?1:-SUFD=OT<%71/EK:BBB-71SLK:6-E7%%.][9(B&ROI
MX9'"6(.:1-&^$N!!<K@ENH'3C=NN^TZNHYCL.$V;U-G569-?WD?UZ=IFZ*09
MV5"U<8/B(=-I58+ZU+C2I6 ?B"B)"YLR0JDC5O?$E/3(]$9>KW05-H]&F6U]
M+>&S-:+?%51ST%1'2NJV1R.GGF95,>QCHW/:VG+9.KQJ8:;DDT<T:NE%?SH[
M+>8J[1Y].YYNLM'+2W.DEKF4$D\3::F@EH9(Y)&S-C>^J#HL,SQA+A@6P_"+
M[144P%K(BQ:.VK;2/8L3U;-U35.R5V,W0]KV* 5-5B'>TDJ^!'@0Y^O!21YL
MDF?,6"AQ)$.WQ*X;BRQ,?TTVF=IJ&22OBN%'"RUON[)JREXJ.HHXGLCF=3ZD
MDCI)(Y9&1EFJWC'.#H#+&0\^2MX.K]22Q01SVJX5$EZCL,M/;JXSRTEPF9)+
M VK#X8F0QS0Q23!^NXQ-:YM2V"5KHQ7#L]TSV7U7&Z[L=JLNOK[2MHO78?4;
MQK0E:)M?E']<%!PF\5R5'NE0HUDADP,@R&?]Y< 9!FAY6$2KA@Q!6Y(;J=JO
M=+=W5,4,533ST@IW3T]4V%LC8ZICGT\H,$U1$YD@9(,"7C(WL<R5C'  T6_:
M,UU@91S5$]'5TM>:IE/54,D[X734,C(JN!S:JGI9VR0NDC.L8>*E9(V2"25A
M)&VS8'A5Z<HNY.JFLZWH[MW:Q.Z[5I@1,V]L':NOJ;H6]R]BZ8)[&.TFFV&N
MZ&(V6M6,47CO,QYDOY4H0-J]BA.P'Y<F,3@6;2Z7UM30WBKFN%FA?0PUTC:*
MEHZF>XTS::N92QSU$<MQ9%+$]A!(;Q)UIHG!P +'9#J] +;2W.P4$%KTCJ&7
M.>V1ON597T=+:*MU;;)*V6FIIH;1)/!-'(UP:YW1'44\[2QSBV1M<+KX8Z+O
MUZZZ;0T+9];C+]:.K^T=VWK4USV;,7M79#VL-B[$CV@CJ^K(K[P^3&KE#KXM
M;[,Z?5XYR3!)* ,DB,0O&B56'2KH>YW.DN,54^GANU)04]9!2 4=**NEI3"V
MKF,@<#+4RO +6RF,.;QI8PL<ZB56@PJK-9:^TST,=9/8J^Z5=NJ:Y_HA7&@K
M:UL[Z"GXDL<V&DA82'O@$I9)Q(>]LC6PROPK][M%-?!9&R^N<8G=].([$&X;
M^SYJ)&I-"YU\(V&[MK;T?%45(J=48AETU_V<5HS8)=DB/,#0<X/-"&BWM^VV
MWEM2\4MS+:>N-LC<*5N*VX]$OIA1T1X[$TQ<SC<N,<38G OD:]LD;*;]H-V$
ME'&ZNLK7U=M]&9&NKG@V^T=!1UIN-Q;T.74].&R<1L;)*ZH:6LB=&Z*63[-^
M%7O?,^R37MD:%:U57M-TO?#6_(MIO1[4]AUSL"T$:56B@+-8UJ<V+[=5H#&A
M1UDUKP,W4<B9<ZW/@Q;D*=+C[;K?J1 4MP-9+73VXVXQ4\=;'54T+:B6.02U
M4=-]Y>Q\9CJ9..UPV$2/#FMD: 78OG<:VTBWPVRFNPN[:BJFM\U%5SOI89(N
MAZ*:MSQ\4L<S9:.+H;BW/J3%&6/=W@GPX[5M:C:)-:WQ4:,P9ZS[&[!;5V-=
M-BV>WU:36J1O OJAVR0:I1-0E;F!:]]^$PHX*O#-B>W@+Q8R10/%;(>RX/TF
MAHZBX,JN.J#'=:6VTE-!2Q03":HM[*P1.FJ*UL$AU>,<9)'4N'#BVL>2U=L6
MA=1<*2TRT70U();'77BX5M56SU-.ZGI;K);^.;3TEMDJ80'<6P10LK=9GW=\
MD;0_$;]"^I^LNR/92\:7V/='"*:KK[99_7];UO>:?3"?8G9%-F0(-5U;K?86
MR1,NL!7KWB3.-"C9JO2UO!1$A*!D>1)P_#].D-XJK7:X*ZF@#.-J:2.IEJJ>
M>=ELI9PYTU754U*]LL@I\-C?''*W$CQU9 P[Q:):/T-[O=5;*VJ,G0]'734<
M%#5TU-)>JVE<UM/04596QNIXC5Y?+'++"[,4;L,:YV6RY<O#LJR-.=SMVL7$
MUUYE=9-BT*F#>O/9.6WG;^,V2DD+-/%6@O5Z>+"2S-H)07!NE9HD+ $W^+&G
M3BZJM&1#ESO'#I+-T;8J P1W(7:EJ)W7*UC_ (+[E4-B:^)DL[Y&QQ-=KUS7
MR.?3%S6LXXZP;4*G0VG]#=)KHVIELSK%6TE*RS7MP-RS-2/G?'/+3TT<3I:A
M["RV.CB9'5M:]TG0[=1SX_C>%UO>PB-2G=:[ T/MT3MK<(?144CKN\6"6.IV
MQ#=4,7B+"M96R4JLB9H1%6KEB*NVB@S[Q75I"3HD0E*GKA19?H.EEOC?61U5
M-<*)]'127 MJH(FNGI8YF4[G0LBGE>UYFEB8(:EM/+]T:XL#=9S?(W0.[31V
MZ6AK+3<H[C<HK2U]%53.935LM/)5-9423TL$;HA!#-(:BD?50GB7M:]S]1KN
MUSX5FY9$VL/ ]Q]=;11;%I<KV!F;5K]AVI*HU4U6/NS6MQQZQ1Y.GX=Z>FVJ
M]9FUJK5RL4FR6,E.#EWGA4.!"5,5P^VZA#91)0W.&HBKF6UM'+'1MJ)JQU/T
M4Z.)PK74P;#3ZLLTLU1%$QKV#7+G:J[#H#<R^ Q7*S3TDULDO#KA#-<'4E/0
M,JN@F2SAUM95E]15Z\$$$%+-.]\<A,;6-+EAVL>BYB'XANJ>C_8*9($8MFR]
M?U:S'];&(,K,ZHW\2*LP.T4@X9"38:V#E8-BRPI\Q75/Q4R\1BX6,0CRX#/?
M5W]CM&JR_P!M:'\325,T4=4QPU9J9[XI(:B..1KLQS1O8\1RX<6Y9(6EKCYJ
M'125FF5OT6O#C'T174=//-12,=K4U9''/%/2RRQ.;B6"6.2,RP9;K8DB#VN8
M),[-] 6JP7VZSI+7FT]>M=?-4M;@V'4M^[;UML6^W;7T_9S>LV;UK)C4.NJT
M$:!5\@XB5;1MGFLEH$%YN='4[CT1'_+:M(G2LHNCZFDJC<JPT-+-;:*JIJ:"
MI;2&J-/5FMJII#+*T$0NB:6.<"TC>1[;YHB()+B+71U]&+/;Q<JVGN]QH:RK
MJJ-]<*$5="VW44$0BA?U53'.\2,8==N=C7?H+X/?:0I;+)39]ETO6"X&_P!(
MT]!4?M5N]RM>[;SKJN[-CZ> 2@E -8BW"N [97QMO)6M%8H@*RDXP)RY/REI
MSE)IK:60PSMBKI62TU17.$<,.M#04]3+2&ME$E1'K02R02NA;"9JB2)ADX@-
M"F+@XOTE1-3/GMD$L592VUG'3U.K472JHH*\6V%T5'+JU,$-1"RI?4""DAGD
M;$:HN(SCU%\*;L!=PVE)CNQ.O-*M'86?<P^I]8WG9)(1LJS'M?V&^5.TA$5R
M%4BK,27 L=$<#-2Y)%L-.(V>LQ(121(6?; =E1I?;:>2O:*:Y5$5M;!)65=/
M2M?2Q1U,5/-%)QKIF%P=%4!Y:&F1K8I7.8!Q9DZ:3@_N]7%:WFMLU+/>7U45
MOH:NMDBKIYJ.:KIZB(0-II US)Z0Q!SGB-SYX&MD+C*(:LV[K/;M:!NN-FVD
M<KU*"=CXQ<Z&BR'"<BUTJE MB3M<3[?=ZX\.@_#1\TH&/SZ^Q$(SI!48%F/N
MX@*4RARKPW2&JDN<5)'+/);',CD<-00SSR4S:IL%/*'.UG-9)&V4N:T,?(T=
M5MQ0*FQU%#%99Z^6&EBO;9)HFN,CJBEI8JQ]$^IJX"QA8QTD4SX6M>YTC(G$
MZAP#LC[4>%NS7]ZZFT+U?U[NAQG8;URG5?L)MC9.L;EUZW%KBHU5FX3]LTNW
MZRIPR/3X <%#/G+)3R,ZY6&(&^!-0VY)F8U#)6O:-+#+;ZRX7:IH0ZF$#9;9
M1TM7!<Z*JGF,#:*>"KG>Z9[Y'11Q3M;!$Z3C"[5C87-O:_Z!B&[6^T6*CNA%
M8:I\%XN-;05-FN-#34XJ7W&FJ:"F8*9D43)I9Z=[ZF9L7$A@=*\,?5O8_AF=
MA->4R[[ 9,:VOU2I^OM8;4'$:&5N$N;?Z%M+8Y;4L$]2*]9:-6+,YFH[ %8
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M4ACV2:14L-Q%NGI:^"205G0\TL,+8*HT,3YYQ#BH=. 88WR1/F@ABF:W,;W
MC-/BT0KJBTF[TM=:JJ&(VX55-!43NJJ(7.HCI:4U&M2MIB1/+'%/'3U,\U.]
MX;-&PAP$PGO"8W95[)NFO6#=O5V"QUV@5][=ED@[!NUHK^MS-MM%FK%5J=I5
M3M8V(R*/&/DK..R7909NO5,)*@9O9ZJEW)0B)XH],*":*@DBH+LXW-THH(G4
MU/#)51PQ12S31<?5Q1NC9QS8P _C9I&NZ'CF8 ]U2FX/;I3SW.&:Z6%HLS(3
M=)F5E540T,M145$%/3U!IJ&:2.:7H=\SBZ,0TT3F=&34\A,;=6F<>6<X\\9\
MLYQYXSYXSY?Y<9_RX_S9Y=JL)?YPB<(G")PB<(G")PB<(G")PB<(NQ$%RM?+
M##P$F0"G I"&6#&1,R0.*B2HZ0W,'DAI"&XS+@SX,MEJ5#F176I$:0TV\RXA
MQ"58XO8R1CXY&-DCD:YCV/:',>QP+7,>UP+7-<TD.:0002"""N<<DD,D<T,C
MXI8GMDBEC<YDD<C'!S'L>TAS7M< YKFD%I (((7O(\%;QA$]S!,+K7V D8C=
MGJF D3 UJ:B>R%;IJP*,E4XR\B*TF('OH>(G$BRCL)CCSD?#E@")9\BHD5KW
MIWH5Z!O==;:,VJ:0-DA+LOH9I#U+!K'6DII';(G;71G$<F>H>_;'@PX2/MEC
M98[P[%]IX7.BJ W$=TIX6Y?(X-&K%61-&M.S#63-!FBQ]TCC]"_,:K,B<(G"
M)PB<(G")PB<(O-Q^R@/P&-,?_5C4/]S^[>90X)_5^N]YYOIM L*<.WXJ6S]X
M:;^&W5>%;FP"U23A$X1.$3A$X1.$3A$X1.$3A$X1.$5B=+=C+!I37W8_7H:O
MAC,#LCJT?JRP3R;TUN971H^[UR[(*!D176V7YSDJN-05-S4N,88E..X3[1M.
M%4VNMD5?4VRI?)(QUKJW5<36!I;*YU/+3EDF02&@2EP+2#D8W%5FUWJ:UTEZ
MI(X8Y67JWMM\SWEP="QM5!5<9&&G#GET 9AVS#B=X"GY'B&7Q&KL:LQ0:CD;
MCI6_TI^)YF&??OD@_N7&Y57/V?O'N_RD23Q@+B)Z?AGN'_2,M9D?1RFG1JF-
M7T7T1/K>CHOVIB/5X\4/0/$9U<\5J_=,^GUMF<*KC3&K%!T!T)3:GVL'1?C-
M:77Z&-S]$^B<:V./U_N6K][U>JQG8LH(^)[MMXGMD\&I=. 6#:&O^GM&:*QG
M2TM=3D=-;'KFTT2QBHTR0Y'FSSY76PQ9V(10[";:F26X:$>AM6>IFBE&&443
MYYY(Z2IO506.# )A?(JN&HB>6@%K8V5;^++>J):"X[2O0_3NXE]PFBI::&:O
MH]&Z02-,CNASHU/15%)-&UQP]\TE%'QK7]2 YP:-@6"]R>]1?N$AF48UV_1S
M,^Z$M@VMV-NK>E]J\^S%H\Q$Q-1U[L6^6*EZ[!8E$B,J$,KPG,L:U)2('%8H
M-KX:YZ+)H^RRY#*D5#&P,IH0:"WTTS8F%N#-4TM-%/4R$,8'.D>&O+==S'2'
M7'CTETJDTCPZ2B-+*^IDK*@MN=UJZ=\\H<'"FHZVKFIJ*+6>]S60QES [BV2
M-A'%F0Z7XF-CJ4/K]B5HG6-F,Z9T'=.J-L*F#.P&8^Y.M=U:N#$O65H"C+-!
M&@)$/Y;FIS%PK+<*Q.E&QSLB0X,C/")7FGT6BF-RU;A5Q,KKC!>(6L93$T-T
M@,!;5Q/?"Y\H/0\;3!*71!A> -=PD;[J73B:G99PZTT$\MLM%5H_4R22U@%S
ML=4*D.H*B*.=K(2WHJ5XJ8 V8R!A)XMIB=7/LIVEF[_=U"!":YJNH-4:#I3M
M$U)JZJ$K*>@ !9"S%+E8B9>RVXH6L-BL=FLIF9/+DY,F,PIM$./$@1O8.NR:
MG:[2VVBLD?4S5M9<*@5-;5S-BC=*]L3((F,BA8R.****-K6, <<EQ+CD!M$O
ME^?>#;H8J*GMUOM%*:2W4%.^>9D,;YY*F:26>HDDFFGGGE<^20N:W :UK&X)
M=)][\0C:NPN\U>[QV 1"E6&J[>J6W*_K&2?L<^BAIE4E@Y;=?$XFSGIPP22=
M!,*G9A*9=4X^ZZG&5)1C'DI]&Z.FL$M@C>X1344U%+5B.)M1(V9LC3*_5:&O
M>P2'5ULC  7NJ],*^LTJ@TIFC8Z:FN--<8:%TTSZ2)U,Z%PACUGE\<<AA;KE
MF"22<;EVFG^_[U"K]^I&R=!:VWIK^V=B(7:NNU2V';Y6$T3=PU@G CG!Q6E6
M -/-UV:&)8$'*H>5,@%8L*&M+T-]+[K_ !K='1424\]+<:JWU$-M=:)9H8Z:
M;HB@<6.,;V3Q/;'*U[->.:+5<QSG9#A@#LMNEQHX:NDK;1176CGO#;_!3U$M
M7!T)=&->QLK)*6:-TL+HG\7-3S!S)&M8<M().RZI>)?USV=U4.5#LU=[;BW[
M+,=L+SV%HFOVM[4&RW*];?.E3FNH6L"&L]@ -+&J9$RW5A]DB]AQ5NDPPXZ5
M7($.8$B0$2+6FT6N=)=XYK33P\32LL]/;:BI-OJ(8*>BC9'4FK;5TTM?'.[,
MSHG6Q\(<]PE<X2.=B^*?3BRUVC\M-?*JHZ)K9=(*N\TE&+M23U57<9I):)M"
M^AK(;9+3-^X,F;>(ZAS8XW0M:Z)K-;774O$SVC4-^5K>4&CU=?P_JM5.H-JI
MT<Y<04>VZMKE #4.1+8ME:-AKC3[=.2!%V0?8JN7@RP!^#$D0?:,-.,/7+/H
MK23VZ:@=43#7N\UZAG+()##62U+Z@-,,L;X)X&\8^)\4S'-EB<X.P2"+,I].
M*^GN\%U;2P'4L%/HY44S9:F$5%!#1Q4CG"H@EBJ::I?Q3)V34\C'0S,:YF0"
M#ENL?%"*ZDWM8-_532KDNW.UVN5ZG)MG9'LY;L!X8)BQ8FBKO*.;.DKVK3;-
M./M$SE$LS+%<;DA1N 4<*B0;P6Z:O1-E;;XK;-7 0"666?B;7:H.,,ABU7TX
MCI *.>%L99'41$RD2/XPR8CU/10:=R6Z[37>GMA=4&"&&F%1>[[4B)L39@]E
M49:X^B%-.^822TDX; '1,XIL8=*)6M?%1N6I*!HW7])TS3XPO4&Z=9;WGMF[
MUM&U"#]WUE%+L-.U"KV6T%*[IJ'=I9TF8OL/6T 5$,DG66A\8.$C-!L*O1*"
MMJ;A4U%=.7UU!5VYICIZ2%\=/5EA(GFBA9+7NIQ&QE,ZJ<\QL!+S)(3(IH=/
MJFW4EJHZ6V4S8[;=*&[/$M77SQS55"V0 TT$\\D-L95.EDEJV43(V22$!C8H
MFMB7QI?BFW.H5NBR7-&ZM/;MTQ7]SU#0N^")2^,6+5U6WC/MLZR0E5$?9(U+
MN1.NJO5I9HQ:R"W\ FY[*I4$J[%]H[,^B4$TM0.CZN.@KI*&:XVYC*;BZN:W
MM@;$[CW1&>!DO0T)J&1/;QI:<.8'%<:73VII8*0FU4$UTM<-SIK1=GR5;9J"
MGNKZA\[33LG;2U4D)JZ@4LDT9XH/&LR0MR8VE^(9?)<(S"50:BA!GP^ZMX>[
MJTS#.5,T2K&:J9C7YO&9'DJVRG:K'9?AJ_\ 8R6Y3RFX^%(;YZAHW3@QGHB;
M[GI'-I(.I9MJ)F3L-.=GWD"<D.]/EHR=Z\3M,:MS96FCIL2Z'T^AQ(=+LI*>
M2GD;5CJC_P 0XT[0YOWKJC@# 4%Q^R!&F]CJ7V1T=0J?H\]KPUKRRU"H53)H
MO4AM@H8<%!DS9#-C)D24^/<"0B89LT"1/]A)<.DX3.6XZTYQ[S:V3VR>UU]1
M/7QU,=3%/--Q;)GQU$DC@T&)C&-,#'MCB<UH($;'':%2FWI]->J6]VJDIK7+
M1RT4]-34YEDIV34D4+'.<)I'R/%2^-TL["_#C-(T8!5H;YXCS,^J[*KFD^KN
MF^NLS?5SJ-V[!6*D'-EV,IL9^G6]N_0*J$9N]N.0-:T.;<4?&RM9J$6/[ZIF
M$.S/0(B8@.4FGT8+9J66ONU=<VVZ":GML4\=)$RE$\'0SII#3P1NJJEL'W-D
MTQ.KES]4O=K"O5FFHDIZZ"V6&VV5UWJ:>JO$U++73R5IIJD5C*>(551*RAI'
M5(XV2"F:-;#6:_%MU#W<?Q8-U!MA;&V=5J/1 =IV#W*IG<U2W5&R0X5:J<#N
M->^0N(CD^.[.J)T7=",0L\J5%-893_T"?#><2^SP.A] ^FIJ2:>HDAI[%/8L
M?<V.?#-)!+T1D-(;/&^!KF#!CSZ9K@,'L;P@72*LK:^GI:2*HK-):;2;;QLC
M(ZBFBJH>A=4O:7TTL=4]LAUFR@#J'M)!%;NVG:W/:$I5I[5$+4.-6W;-,5!*
M;NW9N5$F?:9 I^7@;G;MSL\6JBH&!+3(\;6((QUYEW*#L\W[D)R.JEGM'H2R
M9IJ&5!EXH:S*"@H=5L0<&ZW04$)F>[7)<Z5SP#][;'K/UJ+I#I!Z.R4[Q224
MC8#.[4DNETN>L^H=&7:GHC53MIXV<6 QD#(R0<3/EU(]21U^(5?E]V=7]VU4
M2I_*_5T'5D ;2<337R8)(U9K0-K,>Y,DYDY)M.%1X=!*;[!Y.&9CZVV,>P3C
M&?+]K=.+#56 5$W$51K"Z<B/CF=&5<E6[5& PZCI"QN1M:,G:5[?MQK/MHH=
M*>A*?HFA90,92ZTO$2"@H8Z!A<[6XP&1D?&.P>I>X@;-ADFK>*-9*EJNETX=
MU]U*[LW6&A-F=?-8;WE%;^JYTVJ;A+W*9?B"*\S9F:28*NC+E.&UA\F"=76W
MU3YWM23!:2,1Y9M$XIZRHG=<JT4E7<:6Y5=N:VFXB>:B9 VF:93":AC ^!KY
M0R0"4:C<,+ \^V#3R:GM]+3,L]O-=06BNL]!=G25?1--3W*2J=6/$(G%+)(8
MZI[('/B)@.N[,C9'1K"Q7B.7B'NQK;)75U!L@$OU.KO3/8^L"DRS,5W8.G!.
MO .O2;,HT)*CK+7CY=FN"S[!<$1CN!S,5A<5MZ,AQA[ODT9IW4)HV5=3%(R\
M2WREJV"(RTU<^JEJF$1O8Z*6)AE?$8Y&$21D@X<01Y8M-*MET;<)*&DGADT>
M@T9K:"1T[8:VV144-'(UTL<C)X9I1!',)(G@QRM!:"T%IDVE>*N=H6X]?;4K
M6@:C7QFC=:T_5G7ZAU7:N\*F)UY5:C83UKDB[24"7F,1V^)OUAL,J=LL-L#!
M"#:688V RD1":F,S_+/HC'44-31RW&>1UPJIJNY5$U';YGU,TT4< ?"R2G+:
M)]-%$&TDE-JNA+GO/&.+2WWTNG\M)<Z.X06BGACM5#34%GI*>X76GCHZ>GFE
MJ#'42158?<HZN:8OKHJO6;4!C&-XIH<'X[2_$\M->N6B;P<T[6R9SK]3[E6Z
M5+I>Q-IZ?E,D;GN8]N2>4]XUO9@N,!5R[%/J$^DRV2%:)U-S,1R,Q+PU+9[)
M]%(I8+A3QULK([E/!+4-J*6DK@6P4,="UF*J)YU\1-G;.TME9,,ZQ&0>FETZ
MJ(:FTU4MMADEL]-4P4KJ6MK[:X/J;G+<GR:U%/%]R+IGTSZ5P?!)3G5+0[#A
M68+V1J93?6WMW;OZ\ZTW5&W,>N5J.4!XWL'6H.JV2X7)NZN%J 6UU:0IZON"
MIJ9 >%&G3#<-VO3Y\&:Q(ENM$6*K):YF6^BH+?<JJ@-#'!#'4B.FJI)8H(.(
M#*EE3"^.4/;A[BT1N$K6N:0T%AH45ZIY+O<;I=;-0W-MSFJJB6C,M90Q4\U3
M4BJ,E')1U$<L)C?F-C7NE:87O8\.<0\60V)XGMXW UVM@[3TUK.V!>S,33^1
M@=)*]BX^H#6@:N9I^I#=;EL69XE;E@!!EV0:'WZ8?@VLO'9DF&UCW9HJ52Z;
M12"B-G=25U5#):75NN_4IWFMCN,S)ZV.5IB#81(]F(W4S8W0L)##K!KVUNLT
MZJKD-(&5]MH:B*^-MW%Q:]5&VVRVBGEIK=+ X3E]1Q,4I,K*MTK*B1H=*"PO
MC==/7WC2Q=C;OT[*W_KJ#K[5]>["U[L/;#U3L&SMDR@EWJ.E]D:RK8^ETNX6
MXF,H>LFBUO"%/DQKJ,*,5*.-G$ZS,GG4B?<Z'4:#&EH*UMNJ75-7+;);9#'-
M%24K9*>:OI:N1U1/! U]15F.!\9EJB^.<N:V5K(R_6N>DX3FUMUMKKO1,HZ"
M&\P7FHEIYJZN=%54ULK:&%E+2U-2^.DH1)4Q2<11-CDIQ&Y\#GRB/5QW='B?
M:[HVTHMXTNLYN<QM;1)#4O:B6_LKM35Z@90,V W:M7.Z)N>S]H'.Q&NBE+@P
M6LEG7+$S5)TTN7C#ZPJ-/F2%=M%HI4U%(8*X1T+*.X-K+0!2VB:>/7IN)JQ<
M8*2DCME4R=SG:@$1F:UD9?+EH!Z+GIU1TM>*JV&6YR7"U/M]_<:Z_P!/32\7
M6"HH'6JJKZ^:\T4E*UHXPF<4[W22M9!JO<5K8 ]PS]5[E4_N( IL?)JCW>H7
M,'2+5>]C[#BN9IPL8*ACC%YOMFL6P#&)K0W$F7*FGEIBOR7(H:(+"QAXB'=$
MEECFLDUDEG=Q<]/-!)/#3TM,X<>][W.93TT,5-'JE^ UL>T#,CGR%TCK)ATD
MFI]):;22&F;QM)54U5%2U%76UK3T,R.-K)*JLGFK)-<,UG.=,0TN+8FQQ-9&
MV9=?>(57=-]D!W8+3?5#5-!B$ZALFE;:U8[>-NWFE;F"[-C/MF(]K5L"XV4@
M-8B350BL.!7G1PU<T;$5*AOMH]&/#4Z-R5UK=;:Z\5E0YL]+44=8(**GGH7T
MI!88>AH(FN);K,<Z4/=JO.J0=JJ=%IC#;+U'>+;H_;Z1KZ:MI;C0&JN-72W.
M*N:1(VHZ,J9WL#7:LC60EC"]C=9KAL6543Q6]K!Q6Y0.QJ6G8@C;_86V=G7?
M@&W-TZ4-U[9MVAM"['#:LFH;M5S!JA3Q<(1#33BDA3,!0F'+%3Q\I.7<=-1H
MA1O?0R4LYIGT5LAM(XRCH:^.2DIW%\3C%6T\T;*EKW//'M&7![FO:X;%Z*3A
M KXX[G#6TO1L=QO%3??N5QNEKEAKZIH9,T36ZJ@DEHWL;&WH9[@&<6UT<C'#
M*K\4[DWRVDNFJ4J$Z](]2"LYVG7Z*Y9#\_WT[NXMN9RU6!B5,(%23U?-&W$)
MCQ'Y! I!@8S(>E$93CBJBVR4T+;YL?4LO+&B>F<(HVZL= RA$,9#6L:)(XQM
M< UCG; &@*C2:25=0_1H9CHY-'9'FFK&F>9VO+=9;GT1,USGR/,,LN-5KG/D
M:S)+GN*D?Q'NWE1[1]X[5NRA!!9C3-2FU"J:EJ!P+/#5XCKNAI8?S (U^/(%
M%1H6[V1^T60B+;DC"D=FU2XZGH<Y*G4>;1BS36FP0T%2][*Z9L\U9-'(V25M
M34$C6;*0]CY*>(0Q-?AS"86G#F[#[M-=(Z>_:55%THXHY+93NIZ>W4\L3XH7
MT=)AQ;)"UT<C(JJ=U1.]FLR0"H<TEK]HE*I^++;-0KT_7NN_7W66E]2ZNN^Q
M]AD]6P[EM^YQ;S9=M4"3J^Z9FW&VWJ=<ZL*139DEBKCZ<6#+KYMWY1/2BQ-*
M7.>.;0Z&MZ.EN5RJJZMK*>EIF5A@HH'4\5'4BKI]6"&G;!,_CVM,SIV/XV,<
M4 QFQ>^GX0JBVFVPV:ST-LM]OJZVM?0-J;C5-JYKA1F@JM:IJ:M]33QFF<X0
M,II(^)E/'ETD@RNFU_XI=LU;V6A;_J.HQQ4'C4T_4=@U5M;;VY]U![8&FVA%
MV9(F+/LZWV(]%E#;2.K)(>-!?" #&:S#=^$J)SS!6?V5.B4-9:G6V:M<R3HQ
MM;%64=%0T#X9&Q& M9%2PQQN#H7RL<^37E/&N&OJ-8QO51Z>5%OOC+Q36YDD
M0M[[=-07"XW*Z1U$;I^B@^2>NJ)I6NCJ&0/8R'BX1Q#3Q9D?+(_BT#Q4-J ]
M>6B@;%J#FR$F-P[*WF%L(?<>\M+&Q=WVY(CD;U#/RM.7VHN76IDC41DY$#F'
M6B0LD\15!/-1YZX[?*IT1HY*F*II9^A=2BI;?)$^AM]=&^GH@6T[HQ74TX@F
M9&XQN>P%CV!FM$2S)XTFGU?%1ST=;3&NXRY5UUBGCN5UMDL=5<7!]6V9ULJZ
M;HJGDE:)FQ2%KXY"_4F#7ZHCX3XAU^%#ZH/10ZE(35>BFT.B+#[TTUEV;3-H
MRKO*)7J3G$GRQ:AJKO*3$BH_]E/>XL*D,YRZYY>A^C5,]TKNB)AQND-)I$0&
MQX;44@IPVG&S[R_H<9/IQK'!V!>./3&K9'!'T)3N$&B=?HF"72Y=35[ZI[ZM
MW5?A##5.#6C[F=09&TJ NMO8^P]:S.UC-=KX>Q/;8T#MWK^49,O3F&Q8/;U<
MS72AZ!F"ZTIPL(9],H>S(RN&Z[CT2&U)SC.*C=+9%=&4;)9'QBCN-%<F%@:2
M^2BEXUD;M8'#'GJ7$=4!N5)LEZFLDMPEAACF-PM%QL\@E+@(XKC!Q,DK-0C,
MD8ZI@=U)/IAA62UCXC=UHO6:L]9SM%<M(+7*MD?-=9 6Y-XZDG5YC:,UPU8!
MUM#ZIO=5"[(%0K*](L *+9(Z7QTB:1'KER@Y"4/<IE7HS!4766ZQU ADJNA>
MBXI*&WUK932-$<3H7UE--)2O=$!'(8R6O#6.U0]H<JU0Z:55+8H+'-2&HBHN
MC?0^>*YW6W.@%>\RSLJ(K?5T\5:QLY,T0G;K,<Y["YT3W,4FGO%LV2<Z_1="
M9U-484'YN^NNNB!B/=MG.!L#^M%\I=WI9*KZSDV=[7-)*65RG(C["EU^OL2K
M-/)/F$21RVO<G?)'H=2QW(W'HR9SNBKG5-88*0/U[K35%/4-FJA"*J=D0GS3
M-DE(A:P1D/SK#WS<(=;+9VVCT.IF,Z"LM$^1M57&+4L592U=+)3T+IS14LD_
M0H;6.AA#IWO,H='C4.(:K\32T:O[5[T[?QM0@"FT=PWPEL$:Q&V3MJI5RI32
MQ$^3)U4P#IUL"CMG:]-23$%9^IWJ+/;(*KHGW2<,:>*LD>^LT5AK+1;[*ZLD
M91T-.RF>32T<TLS8V1L9,R2>&1])4L#'<7-3EI;QK]9KR&%OFH-.)Z#2"ZZ2
M-MT,E?<JN2LC#:ZX4\%,^5\SY*>2*FJ(F5U'*Z1AFIZMKP\P1ZKV R"36@2G
M.E",\D^W&9?(S94YYJ'&9APVG9;[DAQN+$CI0Q%C(6XI+$9A"&6&L):;2E"4
MXQ=+6AK6M!)#6AH+B7.( P"YSB2X[-I)))VDDJQWO,CWO(:"]SGD-:&M!<22
M&M& UH)V-   V#8N%R5Q3A$X1.$3A$X1.$3A$X1.$3A%+NB=$[4[*;4J6F-,
M5(A=-@W0@F '$0$X2TRTG'M)Q<O.<],0.!#Q$ND#)D@ZS &P&7I,EY*$>6?'
M<+A26NDFKJZ9L%- W6>]V\G<UC&C:^1YPUC&@N<X@ *HVFU5][KZ:V6RG?55
ME4_4BC9N WODD>>ICBC:"^65Y#&,!<XX"_HH^&)X8FJ_#JU7[E"^'W3?5T'Q
M%;9VRJ)E+LUU.6Y.*;3<26TRP]"#RTI4PPI+,^R3V4'CR$O(%BPFM&E>E=7I
M-5Y.M!;H'.Z#H];8!M''SX.'U#QO.UL33Q<>S7?)N7H+H+0:&4&JW4JKO5,;
MZ(7#5VN.QW0U-K#6CI(W;AL?.\"649$<<6T+EI*_$X1.$3A$X1.$3A$X1>;C
M]E ?@,:8_P#JQJ'^Y_=O,H<$_J_7>\\WTV@6%.';\5+9^\--_#;JO"MS8!:I
M)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<
M(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")
MPB<(G")PB<(G")PB<(G")PB<(G")PB]B_P"Q8J\ <JW;FUN PZ[1%L&LJ_%L
MBQD)1^,!G#;,1FA&#"F,D61$P@/@3I0UN2F'(F0HDEYE;\9E:,*<+DL@DLL(
MD>(G,JY'1![N+=(UT+6R%F=4O:U[FM<1K!KG $ G.R7 )#"8-(J@Q1F=LU#"
KV<QMXYL3V3O=$),:XC<]C'N8':I<UKB"6@CUL\PTMADX1.$3A$X1.$7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g729258g38b11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g38b11.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2-.4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (S*^D! X0DE-! 0      $8< 5H  QLE1QP"   "   < E  %E-H87)O
M;B!#96YI8V5R;W,M365A9&4< @4 %U!O=V5R4&]I;G0@4')E<V5N=&%T:6]N
M.$))300E       01X,%<?47*=# 0.JC@I8("SA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!<+KA         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  $#O_XU  (  3A"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          3A"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              3@   &L
M  $                          0             !K    3@
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   3@     4F=H
M=&QO;F<   &L    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   $X     %)G:'1L;VYG   !K     -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ =0"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MQ]5[MGZ6N_(_TBED?4OI^3TW'Z;=DY+L?%M==3K7N:7"QAK#O1_FOTS]N_\
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M_P#7[DE-KJM].0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
M$0@!"@%M P$1  (1 0,1 ?_$ !X  0 !! ,! 0             )!0<("@(#
M!@0!_\0 4A    <  @$# @(&! @+!@0' 0(#! 4&!P ($0D2(1,Q%!46(D%1
M87$7,H&1&",D-3>QM<$*)3-"<G9W>*&ST1DH-CA2M"=5=:(T8I2FXO#Q_\0
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MZ1'WXR!XT]@>5M%2Q1S%=-!0T-]%X^_ %=LRN$K73[0CBM>CZ>U237E(. .
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M%(M&M58KPNGKD]="MJ:5JW+2X\.,NG#!,D$_]C?UY!I96:6@ZTW2M,KU(F)
M&B] 9)I.^GS:OM:2+-HRHC9@U3M:=>;*W!%!HFB9PY=*0*4*D*2"9I/U]4U\
MD\S[4[.?UR+K[WZ=4/M/;2E]PX+L/MF,Z)4LYK^5/8;.D<S=5JUTN!OKG01C
M)M*[4&U2B R<JN#5\XAY*-< Q1(1JJW5,HJ>ZUV)K7<CB[9^A"RL]%VBS]>=
MBTV2[ ;Y+PCO8Y72+56FD#JCW^G!OIY[I8#Q5*2-$6FA1"BE9HY*R6&C20$3
M&M)1G*R?UW[N.YQK70J>?#CBO93%'2EUV:&0>D-CF8ZOFV[3^P;9J^P4;8]:
MVFP72_2=.66TZP:QDAL2=1]TCH:HQ4>G'5RA(QK2)_1A&OJN9%B=[)"Y1<_@
MD$*9QS)/WKN6OSKT.<1R1_MBV;[5I]9B]9C+?%P\0-'P&;_0)M>YP+#96;>6
ML&32<Q;HA9Z!HYC$6IZ]:LJZX=1)Q<KJ(R+=''-=[NRI-YI6FKHP]/GG/"(%
M=]#G%:XEU4BVV][DO6>J]D;W>#@UDLU(ZLMQ;760OHR!;.A1DK-2(!_,R)V$
MM2*/*0U3D*VU:0@QB)!?.7R%=R]+O8DW\?WUFO!81%%1A]!O!XFM5.G47L%V
M(HE93QK_  =]A80\C07"N]8NE<9B\-:G<W#NDG+"/F\K+J,!GJ@WAG*T&"[$
M[<'3@LB@BD<("?#EWF^_UGB959QZ7."9;/5>;JMITY$E0[C7SNI"Q+N6K3F.
M2T*_YFURR1J*IAJI'RM!CH!FDZBF@O0LA)/W*O+*\:B#0$3?G/91Q$^T>LDE
M'*0< < < < < < < < < < < < < < < < < < < < < < < < < < < \S=
M5F#>G6M>4LBE-C4:Y-JR%N1=-F*U79DC7)G-A2>O"*-&BL,B!Y!-RY3.@B=N
M514AB%, @:4\QO.W6"@[C<^M7>33-FQZ6[P](:+UEB]Q[$+:%I\M(0FE-:SI
M6D3S2$?-+G2L&TFX/&L=&U9_&1L=.P[8ZS:/.V,S=R,PQO5<Y:4\N4<,S7&.
MMV<JY*7URK<3ALN_/;%KZ>?;+L+(T+-K#OO2[L1L65Z/#U5K/JTF[4?KYIT7
M'Z9;J['KN32\.L3,5IR?;(.G3XK-:$476%8JHHE2VN-5VIPI/IQH2%-<IOCB
MJPYIP53$!OZT78:T3N::?$P&34_IWK6_WNG4_5WL;(72Z%S2)M=0H6?SD_F\
M3:8NV,("]VAW8VZ6F1L5,5V)=*Q,?(,TCBFJ]-ZB^M85_6ZJ8BES=\Q<KJS$
M9_9)1ZF/:2$A/3;[+[#UX[ 1<9-Q\:ZHE.U'))N,MJT9HR5QCZM(56.L4"]=
MQ]:L OP?5E_..7K52E.7"DLNHV=,$1X<X!*NN45XTX7X&N5AG9[O%8-BZJU"
MC;C99_8J;V5[L0RM*W;5Y[:\YKE;B.L2%WC*[/ZW59QP??&#.!&0GZZ_=OET
M:]9G+-B@# K)8A626</LWCT*XI*BE;E\=\9E8$V6R^I]L%:Z =$.T]6A,EIU
MW[9:;CV>VL^C2;\N;T)'0H^REF9]:3*ZC%R,(I]!IO"&=.$2_A#J-U%"G$JP
M$Y4^_9<O4B5ZQ2]92UF8/0_K@=G+?G3%NT;]:,ZNM2I'<N\6+4[X[FD\BVP_
M5RX.(""J>'@>;CA?2VA-/PQR+(3<^I'K+-%&[)^F^2(#WO@KLUX<[JQ+I=/#
MA>5C1O5Z[@7-CL$#7X_/>M4]/]-9[>.O;25K#C3YV5FZYC,!JEW;OK'%S#^'
MIMTJ39]+ SI&D4J._$1Z4;+K'=*.6\.]36.OO^JDCUA3A+C'W6!F'>^_783*
M.C70^\_TA]>;IL':*]9_G%FWN8%PRP:CDG:]*V&3LEO_ "J61;-9)HA$?HW)
MMRR\4P"Y+*MT4F:8D9IT*N#Y*]ZON?R1*]2_58[,Y;U=CZE&7G)W%GA*!W.[
M02VJ=B;59+##:P&<;%,1D3BF02CV?9.).1E"*&-$ND)&7/&L5HU%O!KD<%'D
MG7"+UW7J::FM]\P^+JX5R48+"#,"]>N%V!SZ=V26N./UNM1C'KDIKV#9>WB9
M*WSMT>,Z)1IZTO+9?JW/NF5$6SZ7MBKJTTRZUFN2!:RBB]3E$5U$TU4\J>V?
M[JOC,?[*POH[WPIU1?S-?4;[.ZSZ:'J";S;J(RJNC81F=\<99=*:I&QH63\Q
MQ].TQMF)6(6WWQ]5)7/YB3.HH#R;4"7CXZ-GT"LDGJS=FK6[A1W?=^.18RE7
MWPZI3^JKY2C;;L^^MC[!99A/3?4>S<D_SGI5Z=E_@'\7V#8Q&'5"0O\ (A,[
M-H6ZT.[S;DVKM+]76EB(U8P<;,RB4J)%CE3;%:%&*?-:OA1RJOUZAN]2N<*L
M<;Z]9SO+CVOMQLMFZ&=[*!&=QK+6.S[7U+Y;+*%*QNLNVVMT#+YK7,JIK(]3
MAR6#],8G/8PTQ+HLF;$B<*FD=ZP34_67*.N?T'1TPF<<6JS.$%^?3[]1'LM:
M=U[,Q.^TS>M8TWK9D.'X9K6'97%L[ +3=ZQ?=*K=]TZL51Q.5^JDC;U#,:S;
MY&PQ#@45F,M',F2CR/:-3D:U^B<OJ.%?OY+GV?MM>\0]5#L,ZD=PTO8Z&CZ:
M=IV^J=2D92(6-3]9AM7J"$=F=;S2H.7QI+54JLTEU9%19O+W5:.?S(D56AFR
M?MCH\;GZ1'6_GT'"E,4N-\WX^U"*_ .X]\TG%_5*N_:/MIWJ@IW&7>-;1G,5
M2;AKG7F4CK[?\I=BYP*J)RM?C5(6MR.H6N,BJUG,>RCI&Q0,,TN45$.XUJ=Z
M,>*X*.=>V'.O$U$-4F'$NS?<XAXW^E8/B[G]J.\W4C'^EG7F[;GV\AKWE\'@
M.J;GL#-AKT\^V:_[=K$.O.9'.:Y&,'Z$C 9/1I"<K#BK2%B<*V^PJPS1FU=*
M-V4>6QA7._GWZX9DNJX=4J65#SK$7=7T-@7TS- FI?<?4RRT'UFD,_S+MA$3
M>;%LSZPNEJ]$ZUF-<O$W3V;6R*+2$.A$V!1[+J0RQT5XUQ8U6JS%B":2(TCG
M'EVCO?3AP@EVX(. . . . . . . . . . . . . . . . . . . . . . .
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MWJL?%9KC&I5/4JU0JS$0D74'3NHMI=HTK$A7$X\8<U5>MYIZD^BF[-%)0I@
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M X X X X X X X X!$5.>F5H$MI/;;2C]I?S9SVML%-FYJHW;!,OO-*@VV<
MZCJ)"'@[ BY0F&,%65F\+^)=%)(KN&+68!TB^(<QQ9_5]*SGG6O2#'N+] ;%
MX>M1&<M-OT<<JL3/+$][HZD+5A;ZT]Q>Z6._Y^I&.C,C_P!'L7'S]GD&Z\%
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M[$PB/B4?E*(@(?J@J'CQY,;X_=X$ _8 !XX&LRO\ < < < < < < HD.(&:
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M8OL_5DGI!]A3E#W%.'GX.LN/GY^X&*7QX\$+^USUZ(:UI5/0< < < < < <
M< \[%G*9(3 ;R'X^1)Y\*!X-^:N0]GRN("/D?W#^_P"WQQ72Q[^GJ7H]=,_H
MP=/^KZF+$QO@/\$F<^1_[1ZT'^L!X^"$@0&*;[" _P N <N . . . . . .
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ML=GUB?Q_NX*<RF X>0^WGQ__ +_?P#EP!P!P!P#J4'P8GZHF^_P E\CX,3[
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MH!Y\_P!80 QO)OG@$^7H[)D)0-?*0H%*%RA? %#P'G\I'Y'Q]S#[2@8P^3&
MI2F$0*4 B^7Z-@F<0$3)$$1\B(>1$?VB(CR@[> . . ?(Z$ ]HAX]X 8"^1
MOP)DP,/D0\!X^/GR ^1#Q^WQ'TYO2!0JG]#\"]%!RHY 9>0%0ZCQ5Z)%?>3W
MI$4667%(A0 HE0()$TQ,(E3+[A\W6M,'J. . . . . . . 0Z^JNFV2P.G"B
M8R@&T^52_P"55< "B:\@"YO<N94Q?<X*JH/M$OM$P@3VE  !K6N UZ_XNAK\
M\ V'O1[_ -!=^_[3)+_9D9P"3#5[X.7YQ<- + R5G&IPKB7" B *,G*B@8A?
MPC(I@,!ES^_W$)X$3^T2%#W&#GX/%-^_Z;X?O6_?PV]X_P"6V3VG\.S_ /J;
M2&EY;-'6LW7([G\>\(_Z_P"-^&>#?\WL-P_ZCO5C=O\ G-YE;#=_/+_DVK34
M6%$-RE9F71,M_P!9-O==@\GAM(>TZ7HSJ0<O6B\#-)&0>)*,EOI"X! YCG10
M<!X.B4ZJIQ)^L)_UO ?A_'?&+7CGANSWZWNUO=+=JW;L6ME;F^PX\UE.JLO!
M-OF=Q^=_BNS_  W\BWKP/9>)[KXOL]A8V6TL[YNEI6]E:6UL^;R>=)*W:L76
MFK-E>:5%#(+G>GCAP!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P"'_ -4?NKW/
MZJMJ]'=8NLS:^5Z=JD[-6?L%88B_:#4\WF(YO+?EU36RO+H9W;)B:GCMF2L9
M//YJ*J\:=7Z<R0[8YW+<51-=:Z/*IF9T:T:=UKJQD6C6C9(7>;);:\$O/:+7
MJ2RSR*=2[IRLI(UYO4F#MZA&'I[L5JLN)W*CEVO$*/'7L<+J$*5RP#Y1KYO,
MM."#@#@#@$97J2_YJZI#^P>WN5>!_?\ \7VCSX_?_'@EJY\G['CO5G_^7RM?
MQOD/Y_C_ )$?[\N#YKY&*Y/WLFNL/^X/]0#_ *_G^?(4GP]'C_X!V#_KC!_[
M&\_Z_G@$S+?_ )%/_H_[QX!W< < < ^5R8I?8(B)!'W 50">_P!H^XGP(>0#
MP;]OD?V?'V'D=*])Y_&95^^WZDHM73,FQ=^]1%43RK\_O1;G; /E0H>#E.<_
MO4 0'W*E'VG^  /@1&D^-=#TG ' ' ' ' ' ' (>/5:3!/ J9^JD;SJ,M\_A
MSMA QEI$QC%*"A@$XB(F$1#]<PB)A'R/)RCMKAV[#7VY0;#WH]_Z"[]_VF27
M^S(S@$N(@!@$I@ Q3 (&*( (" AX$! ?@0$/@0'X$.+[PFTY3AJJ:O3S.ELU
M;,D$FK-N@T:H% B+9LDF@@B0!$0(DBD4B:90$1$"D* >1'XYFS9LV+*L6+-F
MQ9LJ+-FRE9LI9))))<D;M[2WM;=K:;2W;VENTYM6[=IV[=IYVK5IMM\6V=PB
M  (C]@ 1'_7R\^/;#T,&($9WEZ^RR^SH-+%(G'!V[EW?C?E+@2LVS1\G&+J-
M_;Y,J))!0&WTSE24,4!<@46PE5'RVS_,O!-H_%59VNV_^3V;5O>W_"__ !L[
M2SL6[$-S_P!VTK*3\K:_LOZU/I6W_P"$_P"9[O8_%[>TW'8I?EUNQL_!U_S&
MS_[MO:;*UM["MS"LSL;/\C:\UE-JPWYT[*O/B>T4C?L^BM+SUVY>5J75=-T%
M7:'X=8CEDI]%VB8H'434^DKY)]5%11%00$4SF#YYV_A'BVZ>-[CL]_W)VWL-
MI:M6%_)9\MI6[#2M66I:<-Q-EM/!GE_RG\7\5_#_ !G>/ O&MG8V6_[M9V=N
MW9V=OSV78VMGS[.TG%EKS6:^6U95JS,-)EV \^1\_;X\?W?/_CSLSSE)>=SU
MUP/W@HX X X X X X X X X X X X X!K=^NA$]M;7>,2J/6&D]T0/+5>5+9
MM8ZX[K>Z53J@V+,.#J1[S(J9>Z,C?KV[0*!FLO-2C5I'1:C9(YG:2!VW(YP]
M;M3!5T^N54B5KTUX%Y6.EV*U^2DMOEY:(AY5E,2?8N<96'8'LLC/282+BVR,
M?,3S8%3NOJBP9!+O58^-_",UU151. 4-0^WMU^LB]W93LCFW5/+W&M:G^DZU
M<3LU/IC&-I=8D[C:YVU7VQQ]4JD# 5N(34?RLG+SDHS9-6K<OU%5% (F!U3)
MIG$5=7<S&2R^J9U,H\YG%<OTII5!E=!AZA.R*-SRFZ5]+)&.A3SRL4#^G)R]
MC2-\I<76>8/(ZN-K0HV5?'0%802:G37/)Y]G]&E9;F[O?R]N=#Q#7UD.D#]A
M8%XVS:5)S48]K"-6I#'(KTO?-;B+D[L;*L7#'*G^5%E-$I4PK4+.9O9H5(T<
MFA"/%W)T$OH&63SNF[XO_P!68\KI=7C/MU[/"I(%C^PYWO.4T3;,LL3>T9MI
M%6C;C4K"@FNW(^A)-N#A)1=JY32=,7;8?J-9!@[22=Q[YNY9NDDW""A"TRU!
M@AZCBZ+JO]2'+90JS=;MOE"R2Y/(I*)*1EJ43.13Q[3 <@@8O@?(^0  \B <
M"/ZVN*A55\H\IZM A_@^5C^-[AS!_$/P:@>?[_CEP?-?/V3%<G\?1KK#]_["
M_P"H.0IL%>CQ'H?T3:O)>5/KK:*T9&+Y#Z8)-:U&+I&*'CS[Q.[6 P^X0$ *
M'@! 1&PZ/.[H(QS)@R% A2D+Y\%#P'G[\@.7 'D/(!^_[?V< < ^9P3WF3#W
M>/ZWQX+\^1)\@;W%4((?O(/[?UO^;P"BUA 4&;PHJ.5/?+/U %TY=NC% 5"@
M!4SO%EE"(@!?)$B&*D41,)2 )C"(B<ZFIZ/@HX X X X X X!#SZK;4C; :6
M!E%A,.H28E_$NWCL1 RKX"^T7R[@P>1$/;[1 "B( 7V_L:UR!KZ\ V'?1\,
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M7PFR][=GP[=%_P \FM[_ .Q8C;JTTVK::B':2MM64D]HOY(\_P#8]%M/RO\
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M'@,#H%):4NW6B^PVF.;++ZL[M=$DXC1<WKM4-8J=39.F6N6FIUNZ?5MR[@F
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MJH:QY977<2[39;38VWL]JK/F:\UGRMM.RW"JTNK4\B[*!C&,<Q_'D?V%^P
M^ \>0 ?D  ?G^7,.,)CCZ^IQ)VFDK5E66FYXY'T\A1P!P!P!P!P!P!P!P!P!
MP!P!P!P"./U,>D-I[UY#FF>U&X9[4Y3.]JK^LF1U:C2NE9]9&\+4+O61@K#2
M8^S5IO+E%:VHR3-617<IL7,>5PU(@[^DX(*HQ]I^5[F0?3[#IOKAUYS['+&X
MS9W,U!K)HO7&1T-7-*"J=]+OI(IX2FKS,^K% )'9?Q@GE' NWOUW?A+ZWTB
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M]$O^_@I]' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' (RO4E$!B^J8
M/D?\+W*/@/O^M'6D0^/X@4PA^\ $0^P\$:<.F#/(>K04W^#Y6?U3?_'D./V'
M[?@E \_;]X"']@_NY<'S7M:&*Y/W1KJB ^?'@?/@H^/'SX$ \#XY"D]_H\?_
M  %L ?M_3&#'Q^WP,-X ?Y"/QP"42TE,,@7P41_R=L'P C\C[O ?S'D?RO=
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M#SRA*,<*PHEN_P#=/0E%S#U&>LFP72'H%)L%U=V6P.DV48A)YE>X)JHN8!$
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M[A$WO17)'M2J)*!\ <ATD43E$ $?DIP']PAP1SA'6?C7Q6@\@  /CR !Y\?
M>?'SX 1$?'[O(C_,>"G[P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P#B<
MY$RB=0Y4R%#R8YS 4I0^WD3&$  //Q\CP"#KU$/4LHC"#U+K;UQO4W;M8B(N
MR0.UN\96F6VKY9330Q6-PMN"S:T*-)TW8<E<3<),V7,*U9S7:+9*K()$BI]
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MYC<X3&+O"9QJ4A#J(TF[V.KEN<%7YHJR*J3N4K)GT:$JT5136:*)?C$S(?B
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MUN#CXF(BF+&-39QR"$=%1C4Y&@+I1S(%?PR0CU\]R^' ' 'D/CY^_P !_$?
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M,'#=?Z/N<$>(I&,9NNJC])84?<1PBKAUY%32F5--<N=^12^U.Q=N\LNN95W
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M2<I-C+1ZCF.?M/S!J"[)-VS<-%'!'*1T@%::O1YB9[;==&F=;AKD9=H:YU'
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M2LS673]G^'?W%PZ<3SJ'+87J$6X4A&J109(.W+Q=:D;P5TRO:N&J4+S-NBE
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M!#R @/P(" _ @(?<. ?A"$2(1-,A4TTRE(FF0H$(0A  I"$*4 *4I2@!2E*
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M)>39 DHB#.0DHEH]>M016_QR0-W*ZJ7TE?\ &)^SV'_6 >4P>HX X X X X
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M!(45"@/D! IQ#W% 0,8! ! !\C^\> ?A$44P "))D !$P 1,I0 PB81,
M B)SB(A\B)S#]S#Y X_AT/IJ)?01^DJ)S*I_3)]-0R@^5!4)[?:<3C\G$P")
MA^3>> <P33#X A #R!O %*'ZQ2@4IO@/N4I2E ?N!0  ^  . <"MVY"?3(@B
M1,5 5$A4B%(*H'*H"GM H!]0%"E.!_'N Y2F ?< #P#F"20? )I@ @<! "%#
JX4$!4#X#['$ $_\ ]0@ F\B < Y@  '@ \ 'P !]@#]W ' ' ' ' /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g729258g39k78.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g39k78.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1;J4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %LZ^6#@X0DE-! 0      %8< 5H  QLE1QP!6@ #&R5'' %:  ,;)4<<
M @   F=E' )0  AR<C,U.3 Y,QP"!0 E36EC<F]S;V9T(%=O<F0@+2!0;&EA
M;G1?0VQE86Y?=F5R<VEO;CA"24T$)0      $&MCCZ++%J)R'++CP=[N$;TX
M0DE-!#H      .4    0     0      "W!R:6YT3W5T<'5T    !0    !0
M<W138F]O; $     26YT965N=6T     26YT90    !#;')M    #W!R:6YT
M4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585     $       ]P
M<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U '
M      IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN4')O
M;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2<')I
M;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O;VP
M     %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB
M;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L
M      !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!O
MX            $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M      !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M          !2<VQT56YT1B-0>&Q 6>WSP         IV96-T;W)$871A8F]O
M; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L
M=                %1O<"!5;G1&(U)L=                %-C;"!5;G1&
M(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P
M4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M#6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<
M #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-!"8       X
M        /X   #A"24T#\@      "@  ________   X0DE-! T       0
M  !X.$))3009       $    'CA"24T#\P      "0           0 X0DE-
M)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M   ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4    !
M "T    &       !.$))30/X      !P  #_________________________
M____ ^@     _____________________________P/H     /__________
M__________________\#Z     #_____________________________ ^@
M #A"24T$"       $     $   )    "0      X0DE-!!X       0
M.$))300:      ,U    !@             !+P   HX          0
M                   !              *.   !+P
M   !                         !     !        ;G5L;     (    &
M8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M    3&5F=&QO;F<          $)T;VUL;VYG   !+P    !29VAT;&]N9P
M HX    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M  =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I
M;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP
M965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M      !"=&]M;&]N9P   2\     4F=H=&QO;F<   *.     W5R;%1%6%0
M   !        ;G5L;%1%6%0    !        37-G951%6%0    !       &
M86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E
M;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO
M<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E
M5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453
M;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M   *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M    "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M    .$))3001       ! 0 X0DE-!!0       0    4.$))300,      Q$
M     0   *    !*   !X   BL    PH !@  ?_8_^T #$%D;V)E7T--  +_
M[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5
M$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.
M#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,
M# P,# P,# P,# P,# S_P  1" !* * # 2(  A$! Q$!_]T !  *_\0!/P
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MZ?V=S2ZHDD[K7;'U^_:[V_U&?RUH))*<"OH'5JL&C KZD:JZ;&O-U;2+-L4
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! ?_  !$( 1D"70,!$0 "$0$#$0'_Q  ?  $  0,% 0$
M    "0,("@$"! 8'!0O_Q !L$   !00! @," PL1$PH#"0 ! @,$!0 &!Q$(
M$B$)$S$4014B4187&#(S87&1H;.W"B,T-C<Y4EAS='5X@9:7LM<U.$)355EB
M<G9WDIBQM+6VT=76&1HD)2A65\'2TR8G1T-$5(*$AY/"\/_$ !@! 0$! 0$
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MFP+U )A'6@V(@.A'N =R@( (@)M /;0CL-AOH% H% H% H% H% H% H% H%
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M7;U'OL.^M@ [ 0$-[H-W67Y?N#_LH'67Y?N#_LH-@K% 1#N(A\@>X!( CW]
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M'BUFD6J<OB3@FE&F=-0DEF&8<TK/$6/G)>TJ-$U\8II*/$FYCG23<*$14.9
MICE*(B4OALNZW[?#A?):TZ_9D?, "J>6'64O7TE/_1 7S"E4$@#L"B<I3"70
MB #VH.10*!0*!0*!0*!0*")3QH?YT6TOVT_%W\+MOT$LR'U!']23_B%H*M H
M% H% H% H% H% H% H% H% H% H% H%!155%,0   ?BB.Q'0;WV#>][-H?0I
MM:V/:@C8R5XB\QCJ_;JL9+@[S=OA.V)I[#DNVQ\.I3-I7 5F82A*6_*_#R/M
M\8Z#I.V<>2GUD'N4!#5">-7AT%XS-L71=]\8_MWA%SJF;XQH:WR7]:S##3!Q
M-6B>ZH_X7ML)Y@6YP<1_PW%%/(1OFD$7+0H+$V4W8;=:_;:O)XT<QGW(R?N*
M"><9N2N#2V_%LY(LOG#'Q;-AYDSQV=J#"(>%D7PN7R'2"RZ(IE J1RFZ@WW"
M]0H]12F].HH#KY-AOW;#[M!K0*!0*!0*!0*"DHKT"(:$=%Z@T&]ZWL!'8 7M
MH0$P@7UV(:H(D.6N /"CYAY!A+XY+9%P-<E^6/!&L>,7<Y\L^"?0T:VE9&25
MBE6C:Z$%$'24C)R0.!5*18HK'1/H"  !P^+?AC>&%8.0;;S?Q=MZSIJZ,=S"
M[N(N*QLI$O6*A95XR=,EB.PAYF1CRN%63UT4$'  H(& _J'50>0YJYLYXM3F
M_==IP<U&L,58IY#<0..[C&ZD,U6<W\QY*6W*SUQ7E\,+J(/D9*W%19I0R#0J
MC5-.*DBK"(BJ8@W_ +W_ +7]SXW*'GMF/%7*R>&(NN,B<*8=S+Q7QG=-E? [
M5^-^6OGA"XW5VW@$R(^U-G5LMXY%W"^PB9N08Y87("4YQ(UKNI]2_+??L]6G
M"+Q57&<L@\U+WOJ2)*XJQE!6+?N)\:XWAG%[9#86!*FDV"QG$%;X.Y:8NJ0]
MGC9B8AV[<RL(:1)'*#YK58QD\^!O\9W>D+MO#"RU;V;8CF7D^UXN[82!N_F[
M?;R-BK\M>4LJ[6I$,)8!9J)2]L3:2,G%N .U45\ERD!A0415 1 ]#?KGA??2
MFR4H5 H% H% H% H% H% H% H%!L.3K  WKN CVWV#OKOZ>@=_=0;2) 0! #
M#WT(ZT&S:UU#H #8E H>G]#]>@ZS>J8&M*Z3=1OBVU.AK?J Q;L1 ?K")"^[
M8:$ ]1H+!O"##?AJ<0!V(?\ RG9!H- ':6E0]   [ZV/UZLQ3E$\XJD7\Y\)
MF$CHH%$YCB8QNH #I-H0  *(  !KY1$P[WU#T@/8H!455*4"E H>[[OO$>WR
MCWH-U H% H%!2,H)=]@-V$W;L %UVZM^_?K];T"@^62;8'<HLROF!W;@JBR#
M4CI SA9NDH5)55)$%!4.FDJ<"** 7I(?13#H=T'U@$P]/8  0'J#W@/^S_:%
M!OH%!$IXT/\ .BVE^VGXN_A=M^@EF0^H(_J2?\0M!5H% H% H% H% H% H%
MH% H% H% H% H% H*2B)5! PB(&* @4P 791$IB[ 3%-H0 YM"'R]]AVH*1D
MBE$I0[ !1 .Q-ZZ@T7Z76BA\4.WTH=Q$=B(1&\,B%/XGWBZ@(  !(<+#!H
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M84)Q!K["A,A%L?A5%D(  LTI'R/;$VH@ ![.18$=  =&@"@BM\:  #B-:6@
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M)&,EY89!PH@#<Z+IX1P)Z:UKJ;=W.?JRCR+)@5,.Y>HH:#6P#0>@B4.G8^X
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MUDWV-;(GY,\BG(HSEU,XI9= [2*=,&(.&1)!ZT4>($-=<!Q,F^(-A?$V>HK
MUP0]\R$BYG[%LZX[X@H%"3LVR;TRBC*&QO:EPNB/DYH9&[%(EPC'KQL1),FZ
M[AFF_=,P=%,#P'WN-_-NQ>15ZW7CUGCW*V,;RM>VH:^T(#*UL-K:EINP;ADI
M"'A[J;1S:3?NHQ)X_BW1!AYY&+FVI/+5<QR)#")0^3PF.4EY<]$Q'9AYU7H&
M@] 'YPW'DPAU#HHB!0ZA HF'I$! !H+\Z!0*!0;#G FM@([^0.P 'J(B.@
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M-#_.BVE^VGXN_A=M^@EF0^H(_J2?\0M!5H% H% H% H% H% H% H% H% H%
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MTP'N Z,!0 0["/<-=_\ : @ <B@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4'
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MT*[>L)1TR]I;K,_9K.>&ZGL]8RQ\"(IC9I.%9FUNK,>UMF-G?<R'A* ^G;U
M=>@[^M\H>X1WKY*R-H)@ >H_2](CVV/]E_;![A]P=J#42#L! VOE#OH?W $
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M^WIO7\ _'B@OQH%!L.<"  B)0V.@ZA -]A[!L0V/UJ"F54QMZ*!NP#VWK0@
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M)0$2Z$!V/J [WZ]Q]0$1WLHF*.RF$! *28ZV0-    =P#1>P%$ ["4/<40$
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M3_B*@I+\V><"J"R1/"^S64RJ*J93'R3BGI*)TS% Q@2N,#& !'Z4=@/R".A
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M9M_A)Q)_Q%0/HW.;O]:\S;_"3B3_ (BH'T;G-W^M>YM[]@WDG$X  ^X1Z+C
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M.NKV@! -4$FU H+&?$T;7L[\/OF$WQR26/>:F \A? I((5@F#&)"+G?!' W
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M[XF/.5;YZ7C<_I4."W^,1D;_ ((H>_\ E\3YZ7C<_I4."W^,1D;_ ((H>_\
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M>@H>#:K* JLVAHYC&(*GZ1+YADFJ":8J 41*!O+*/?L8.XB'8" )2% =[ H
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M)W:\/)<Z0-%*'?L4H=QV/8 #N.S;'Y1V/?WCZT&Z@4&Q3Z0W<0[>H  CZAZ
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MW[>S%GV(LS3_ /.S6:1CG--LWUG/&)F+TLVO:BM*3AX1NCUVTE=@'H'V _\
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MZ>M>TKMA5Y,1:*E2%FNLBJ])'&.8QB@JX1-HY#%%,#;*4+BH.3+-Q$1+$!1
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;!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g729258g43h10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g43h10.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1FN4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &9*^948X0DE-! 0      $8< 5H  QLE1QP"   "   < E  %E-H87)O
M;B!#96YI8V5R;W,M365A9&4< @4 %U!O=V5R4&]I;G0@4')E<V5N=&%T:6]N
M.$))300E       01X,%<?47*=# 0.JC@I8("SA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!;%LC         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  $#O_XU  (  3A"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          3A"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              -    *>
M  $                          0             "G@   -
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   -      4F=H
M=&QO;F<   *>    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   #0     %)G:'1L;VYG   "G@    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !3A"24T$
M#      /(@    $   "@    ,@   >   %W    /!@ 8  '_V/_M  Q!9&]B
M95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ ,@"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M'$!KLN<]SBW<-KWNO_2;W?G;_>C])MKMKN=6:R'76._1EI_.+7,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0'_P  1" "X E(# 1$  A$! Q$!_\0 '@ !  (!!0$!
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M:4BZ8F*'DX%:X=^/Q=F34?C'G^C)W ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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MU5NK;K/9K.G:;2AUOSO_ )IT6E;IH5M;4VEM3133:*E2*YWYXL< < < < <
M< < < < < < < \@'QB-8L6+=^Y>[YFYV"@OG%#R&OZA;ZWV!98_6;F9E"WN
MYTVLQ,$:C3ZUKG_P.OVUA$1PR1I:Q6%=.L5Q@ZD7B392-P\4KI>.'?CNOXFE
MA>KK]WI_Q;RWW<D>O5BK\]DS6\+%^<U;J^EPFNBX+\Q(A_"Z3E!JY26#SX53
M<-FRY#^HJJ"*@&3+3)NN !\?G]O[> 0UPD _G,=XP\!X+?\ $O2'CV+_ /P-
M2?M^GW'[?J/)F^2]V7)<W\$R _HAX]OW?R^_V_+E(8$[(V:YTO"M3M= S!':
M;;7:=*24;DZSDC(E^*U1^8[K22ZK-^F+B28B\19IG9JH.'1BH*?NG_>FM77[
MNKS0CUPB_6KCF<%G[79\@S*P7:BM,RLTW3(.3E,[9/@D6]).ZCD%4:ZF\!NS
M(L:);"W9KD(T;_3*_P"3BBE\L2FO'IKMZ S)P!P!P!P!P!P!P!Y#]> . . .
M . . . . . . 55?&$F*6EU$EH:VYQ';0S+?<OL4[E[2_MJ#H+VEQ5[AD+!9
M<ZDAL]6>DL<.#Q!L@X1>K-F[:1>*/&3]N11FL-4XY\(WOME+Q6!TWX-,;/1^
M*:G^TV<9'09E318!!9;$YT)NAR3-AF-*9Q<!%G),3B ES:/2;YXO*LWZK"QO
MJ^]G&RCCZQ1TN(\LGFK[K[L6WQZHMF9VVK2%@EJFPLD$]M$"S8R$Y7&DLQ<3
MD.QDS+%CGDI%(KG?,&K\S9P5FNZ022<B@J")CBF?P(<54=*SN_N;&RHM[J%R
M>5"75@+6UJUCB)YQ6IU#R*T//(Q;QTI$R:7@?F,7Q4')/ ^I,/' .V/1 &CH
M!$ \MUP#R/CR/RCCP")O1E4@=9:)Y-[!/:R'J !$O_MEOX>H#@ E$@_D<!$@
MAY$#> $0 EN9=$GI]:A">LWH+ZQ]/J-Z1-Z2^KQZC"4IC  >1$I3"'L41 "%
MW9%C#S.]=,F$RPCY:,<:#K!G;.3:MGL>JFSQ*Z.P,Y:NR';J_3+IHK)'5(8K
M=8"G\IF$#"X:UPS&NYD&?[!8KG&W8]U@?S<=!Z+L%:O$WF]38-$&S%Q&T5FV
MDI1 WTP%;QAW<<:4>PS;Y!4GZ<#-^CPLU2(LUK5UP))D\^D//CSX_(?(!_8
M_GX^WGP'G] ^W /P95,OD#&]P ?(>#>P>0 1$?'@  1#R81  #R81 H"(/SC
M=AS!7W25.E)/B%:DM5ED3=WU\5K<=HL>%2NK9TRRF-E4G<7+FL#RMI4\Q9IQ
M*0#-==E85',NWAXE%!)8T:L4K6M/$93EO+!2JIG$ *;R(@(@ @(>0*/@?'D
M^P_]8>P#P#XJ #\OSX\ H4?MY\" #[A^@_VA[A[^.->HF,E5SB[BIS61U#1*
M%7-0I-ES^W-E'E;MD4YAIALDL9NJLS=$]*A4UB>#I'#V,4Y! P" " ASA[?L
M-AXEL>T;#M5+JL-ILZK*U5+=+=-6YK!G9^#>+[;X!XKL/C/AMI39;=X=M%GM
M6S6E5*KIIM;-S2W15=4MZ>)PV/Y+4,/S^"S6BMG#6MP!'!6:;MP=TX,HZ74=
M.555E/WC&574.<0_HE\^"@  '/EX5X7LO@^PV/A^QJJFPL/-Y?-5YJFZZG74
MV^-3;C(Y7\D_D7B7\J\9VOQSQ:NBTV[;:J7:U6="LZ$K.A6=%--"N2IHI5.]
MQ+O,F@/G]?N(>X"'V_C^7Z#]A_+G8G1&DNLDV16<+G*D@@DHLLJ8?!4TDB"=
M0YA_(I"%$PC^@#R55*FEU5.*:4ZFW@DE+;Y(U33575310G5774J::5C554TJ
M4N+;21&0O<_K&>EVO0B:Y6SU*DV0:E8Y8H/S%8V SEZU;1Y&X,_J79Y \<\4
MC%&:*Z,@W1%PT452,0QO/+^6?QY[+M&V+Q.P>S[+;K9K>T2M'Y;:IVGDH25$
MU?V*RKJLW2FJZ:6TSW;_ -+_ .>+Q3P_P5_QO;EXEXIL*\2V'9G_ $IVNQ_U
MV5I7;.MVO]=DK&FVLU;TVM=%5C75Y+2FFI-+MR/97#'-]J&9-='@'-VOE?-:
M*I"-U'"JLM"C^'&:NDG!&XM43224DFXBD'"R2\FW:R:S)-9.+?BAR:?Y#X-7
MMFR[!1M]C5M6V6*M]FLEYF[2SJ5#LVGY83M::U59JIIUTTUM?]6==5_!OY99
M^#^)>/6G@>V6?A7A&VKP_P 0VJTIHHIV;:__ 'JTLZJ*JU:5?T56%5&T5T45
M46%=IL]-K52]HL57G$?N'\?_ ,#SN3R9]X X X!21\5[;_A80:]9K'="]6A]
ML%!8R,I3Z'U_G=(/V!C(6YH1K*2:+M,D?-).NUFZ-QC$##>9& KL^5%(K=VN
M9N?T"KT5[G\7\+MY9OU48TB-ZWXFRS7,;;C%!0SFLA4,LOL86&NM'@3QR2D=
M!6N++)S)F4^V0.4THBM*/G(.U%3.G!W!E1X(2 X X X!#+L&(#V1Z.B @(?R
MB;![@/D/_8G:OS#@$RR_8?\ C'_^\W ,4:C<+I1XA&5I.0W'8Y%P_!JM7:9.
M9]7Y!FV,4YCR*[O2;C2HA5L0Q"D%!M)*NS&'PFC\D2CP"+&<]HK_ &NS7^&K
M'1S:(EY7=+;U'4952Z=8V:#"XK4ZB3JLC*G:;:L]L!F=+L=16</HMK*K*,$$
M(MM]0[CCL$&M<P^_+AJXGDAZQ]'K24(8?(^#%#]P##ZQ(8Y1.43)F$2B(&])
MQ\BD(D\" &^X)4I36L3165,GX])0,)O(  B(>3>/8/(%$ #V]Q'\OL CX*(J
MX^A%WK%W!R+MH76391^V)BXSJ-@R2W#;*5/T\3V2N+&;NW422;;(&>Q;A5)<
M&XG!O*-RI%&5BXTSAJ18:=,1>GOC+G[DIP'S[^_]X"'^H0 >#)]X X X X X
M X X X X X X X!03\0KXJ56ZP]K4>NUOP;)[Q$M\Q4T&*DM"E6IK=>]#95Z
M<F\[J^=UIQ!/R/7#N:(-2CI$%G3U.SSA63%)F59PYY&WDF^T:F[]&E@W,=8>
M7H7WM5S.6K9R9NX:&<-T5S-714R.FQE4RJ"W<D2462*X1$WRUBIJJIE4*8"*
M'* &&F2G?XH?>/:>I>F=3:GG$:HQI>HV"SNM%M",/7IN9EF\%.Y[7HG.J/'V
M0P,Y"V3![L[GE8E@ V&0A8-V:$,@#61=MHW'6Y<7ED:I2>,],<NE\]TMY;Y-
M2\9 1$E-S4@QB8B)9KR$E*2;I!C'1[)JF*SEV]>.3IMVK5!(IE%EUSD23(4Q
ME#%* CROE)DA)U=M]5O&_P#=VP4VRP-L@G&AXTBA,UR68S,6NLUPNDI.4DGT
M<NX;'4;J?N+IE4$R)_)%"E-[<F;Y+W9<ES?Q]$[0_HA_ /[?R_3\^4A#WL-<
M.SN?PUTO67H8<^I-1J3^PGC[TTO1[,_<Q$>L\D&Y',%,Q\65)<R)DF7J0 4P
M,!E3G /' .8Z]67LM<VE9MVL(XBTI=HHT;9(]EGS2[)V5K*3;.+DH]NZ<S\N
M^BUF2+)V^2=BBB"YG*2!DC$(*I1 E7P#X(@'W$ \^?'D0#SX^_\ F_/@$1NQ
M796>Q'3.ME A\"U;76F^Z#)4:6N6?Q[1W7\I;,85:6+-W!RNL3Z=-WZ%%6J:
MYF+4\1&V1^61%Q%IQS]KWQ&M:@EBW60,EY363.4IE"")52'\&3,('*)@$?)B
M" @?U># (>#@ ^0X!N0$!#R ^0'W 0^PA^O /AOL/C[^!_V?P'_8/\!X!6KK
MM&[,LNR"^EL[ _C,;A7F?V9I<0TLD+4,WS2HPRR^T5FWY1^%KK7:8MRC=^_A
M+"B]6!DC(-4U%87]G4QEFO;AKV:]^.O>36%]F\WWR3L$13F=WA)>NP=7M9XB
M_P!'L%(DIBC7E6P-Z7?:ZWG&C?\ %JC9754LK1B^1%-VU>0SMI*L8Y=1NDNT
M^=T:Y#2XDD> . . . . . . ;1^_91;%[)R3MLPCHYHY?R#YXLFW:,F3-$[A
MT[=.%3$20;-D$U%EUE#%322(8YS 4HB &*<7[!X;V-K;VX8+K6?[!5HZ36AG
M\_GEHB;3%,Y5  ,JP<O(ERY21<@02JE34,45$3$63]:1R',!7M\6'JU9NP]#
MR1W2+MU?S28AM6I$+:+/V8H+"WPM@ILK:H9TG0XET[<MC%5FIYFU]=7!5J2W
MJG2BRR\(I_EHM>VNBZ59W3=>HG]<\C(/PWL :=7:AIN33&N8=?\ 096Z):'/
M53"Z/!9C5*%#SL)&,8-BRHT=.3TFT:R:,>I*A*2CY3\06>J':@1 "@8-W;7&
M\P;!];^X.8?$"[A]ELKQ+KZ%#W^BX11(9_,;+8HF=F'5%M9B72\V: C<P?BV
MEW=-M$\$:R1FG!"2%3A$3KND915-L%UTO7:[UOQB;N"^$]\/?=>F=RU*>V)/
M+&+60S:@9'75<WFI.8>:(-$M5ZL#O7KLF^K=>3B;3;4;8U1?Q8J3KI!5DI\R
M;<H_)(G+]:Y>O -IX<9^)X[^?16V:O!7NPU86&=WM'.["#LK@; XK,;;$S1Z
M39T+N/"+E#D; =R845".O(G1^0)0 05$!NM:^"$>>A#&12ZJ9JWDY C^00D=
M-2?R"35-D5^]2UN^).WI6J/^*:E<K_-6(V3$4D!4 $_W2^DP:UJ_@=+[<="X
M#M/H^'Z+(ZUI><'R*S)3<O7J-8)2,A].B4ED?F5>WI-I%J",0HQ4EF2KJ*!A
M)&)+K>M^4A$RE/OS!0 OUQINZ=P]UP:R;M?ZA2(_9+I!5FQ03O4*O*Y+36G7
M^UR<R\IELOMPGZ]88--S$.8^6FP:("23)+N#A] =N4D4_A=,^%_-<B[N7?']
M="_/+/AJ=6*?'9;.O8"8TJ^YU$0B4!KUON=OD;A(*1OH6;30ND)\C!!1X _.
M608-D(]R*BAC-S)+J$/=:U>0L/3*)"%*(@(E  $0#QY\?GX_4?N/]O ,7;-2
MK5?\HT:F4>ZRF<72T5"?AJG?H(R99BG6!]'N$8>P,#+)*I&<1C\6SH2*)'35
M33.B8HE/YX!0;*T"[]29O0KYO.L=O]^TBA=7NK;C4IK"[K#,;Q8;!>=<V:IR
MKF-:ODX(CRFP$FC#G3CBN2*1K$\C-@@*'UA$%VM<?4KF+H2YW=IF^-7'H6I'
MS1JM6^H;3C-R-?B3KM;.[0?61LL,<W^8VGWC15RV<S+4ZAD919!=1NJ^^<HB
MJH7TB+6M;B':7'] H^KT^DX&_,1'P4P^D  !$1'\@* B(_;ASE'7]?7,C2>+
M:B^Y2Y7 P=O&Q1N,4A.>6A[%9['89IC2:#3:LP:2%BN-\GV[M:!@(M.5DH6$
M;G4*P>/GSV;FH>-8QS%XX</TBE(15=GK74=$UG/ZUP(6_#XV7<];:S%LU!>[
M,:?9JC5I&M,=41S:(M2FG-9JZ1^J1=.A:+89M\&;0+-K46T8[LB+5Z>5"=4;
M%.S0^J/%@W+ARY>7?(^MI515Y?)3Y82323O<N]WN7$2TDNTNSY-RF!/'J X@
M(@82" E+[CX]Q$ *7S^Z'D?O^8AY'A:OGCKID?,W"B::Z2B*I04263.FH0W]
M$Z:A1*<H^!^QBF$!\#]A^_#2J3I:E---/!IJ&GS1::G15352XJI:JI:Q33E/
MHU)@/^:W@05*R48,UKH5>W3Z]FGXH&Y@0D)Q=V[>@_4#U^?GH*OG)6I@]T$C
M@F3]TA/3TG_C?@G^-M&Q_P"!8_X^TV[VBVLX<56TUM5XW.G^RM4[DXR4>O\
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M76 ZOU1DVKTUCTR7Y@=KN_;4SGE96G_N9/\ B@(?8?8?</<!'S_'SR@_8CX
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MK.T?ELZW9U>2TJ3ATT51Y:G-T4MN;C4:NVCY!-TR<MWC58H'2<-5DW""I3
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M8ZQ8&1#IMY*+D42K-U"HK^APBL!3>A=NLF15LL4Z*Y4U"&*#6O<&13*E ON
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MY1]K961331/2F*SV+)G_ -"^0A7Z5D74^D<G<MUE*TTA)J8D1%L9FU6:UO\
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MN8>1<1K]NT?*K,URD:[S'LQK7<SDD?UD WD#>?/[P!X ?<?</S\?E[^_Z^_
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M%C*:BR9M6Z94T&S1IKU];MFZ*90 ")((D(FF0O@"D*  'MP-=B8? (H[;/\
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M1V._B #^@^/?Q]^ 2ZX X X X X X X X X X X X X X X!\,8"AY,/@/\
MJ]Q_U< ^_?@#@'G;^(O?,FU3LOHM0O78" Z8ZETURMM,8]?KM_)Y;(_>ZYV$
MH[Z0T&(CL[TZG/H9..@7U.@:PSN<%,2D[$6,TF'X.*8)(.(^D<;^>Y+/?)I7
M1C>UPAWYW[\(],;/?AF%KP= .HQZK"V*OU]QA])=QL3;)9M.V%NB\CBNCJ2D
MNR@ZRS?K.UEE'A'#2NP;8R#A($(IBF4K=.F2<(MVYE3+F01%<Z/TYEA2(*IF
M_J$_R#*"7UF1]8B;Y0B)/4(F]/D1'@'Y!HU*"0%;-R@BD9!$ 13 $D#@4#HI
M>"_XM(X$(!DR>"& I0$! H> -5---),B229$DDR@1--,A2)D(4/!2$(4 *4H
M![ 4   #V . 0U[!^D>R/1T2^!#^437Q\AX$/?$[6(#[>WO^\(?K[_V\ F44
MQ?'W#^D</N'Y','C^[[< _7D/U#_ #AP!Y#W]P]OO[A[>?MY_CP!Y#]0_P X
M< >0_4/\X< ^")?S$OM[AY$/;^W_ %_Z^ /W/M^[_J_A_L  _NX  2A[ )0#
M^SP'V#P'^8  /X!P#[Y+^I?]7 (#][NGLSV]J-&AZ_I;J@2] MCVR-F;YI.R
MU*M"<E$.X1=E:(BLVFDRRZS!)X+Z">(3Q2LWA7"+AJNB]%RTG[]^'ZYPQK3R
MUQ*\L ^'1KO63:<NJ%%L6X6:H4F]4V>6V:9T&F)TN6SE*IKN=1K4_6UEG.BD
MLMNU(%I)K$LUGD.A"ODF*TPLT9/@?/?&^=+CNZC6'?\ '?,] GDOZE_,?R^X
M_<?[_P ^4'1=0S^K:UFU^RN[M%Y&EZ73;-0+A'-7CJ/<2%6N<*^K=@8H/V*J
M+YBJZB9)V@D\9+(NFRARK(*D.0!XUO&MQ54?X2-4S&S5>X]1]>E<,L\2A;&,
M_(Z?59'M2%D9VAC6H[Z=-+5M!;HP3>-1K+(6@1YOGA]0[\'247,'(INY>O/'
MO^[.-V/*[=@N^_GA6'4^O7Q)?AT4V8C,JU#5-,S3K9*Z[:Z['VC/!+C=RS2&
MR>\7.*&2B*UOY)0Q)C1EXZ+-5H.EMY=%14'S.UB"1VCINS6><KLV_D;[OB+^
MG+<B]#ISV!O^T6/:X*UW[+M9KV?R5$;U32<FR>Z9'7IP+/7EY.=B',#==0UE
MR\?UUZDFV4D8^RI-A17*FO'%6)\PS=\^RPTLR:^R?*8E]!? ^/8/8P@)OOX\
MF\> \B/W\>PB/MYY0:G ' /RH<B1#J*& I$R&.<P^?!2$ 3&,/CR/@  1]@$
M> >*CXK.[4?LEV><V/*NU9G;*K/*EF%:S@T]IN=1E7?HM[I'7:P216N=2\=9
MF\-HS:CV!U"@];*6Z#3DH6/EX%QZ)5*-8W)W9_487OC?&!M1&*3O>/PGRR41
M?.#]H<#&,X:$BHJ/;Q[1DPCVK9NWB6)8R-3321('^0QQ%%BLFQC>3I-OG+"B
M4P$,LJ8!4-3!4E\2SXB6K],M+PNCYK2<^G&5W@IV\W!]I"5D +-$P>DY1GQ,
MSRUW7IV*(UU"9+HSN<9+S$?9&"#*(3 (![\]8R$>L^/LBI3,Y)O'=]MKU+9;
M388^IUN<L\L#L8R C'DM( P8NI-Z+-BB=PX!K'L4EWCU?Y1#?+:M45%UC>$T
MB&.8 Y2%8&1]JLTKFZ]K;5,1&JLX#0KEEDA49 ^0:*=.78P.0U>N22Z125X!
M33:3$<\:G]92F4.B)RCZ3AY DR'>3#O ?XO4!_M#&])\#_:'_H_P#82G?7 (
MB.?2DFOI+".CVJSQ\]=9#HZ#9JU0(*B[A=8\!Z$DDDRF.<YO8"@(C[< ^1_>
MW!)!LSDV*NEO&$@S1>,G;?(-)50<MG)"K(+IG) "10BR1RJ@8! HE.B8@"'D
M>3/IAKK^,VM:_'(?SY,._P"#U#_F;TG_ + Y0/Y\F'?\'J'_ #-Z3_V!P#B9
MOOSU[@8QY-33K1XN)C4#N7\@]R/1FS1HW3*8YW"RQJ^ )%2(!@$PCX'UE\_8
M!X!OVO>O"739!TW_ )35D'"*:Z"R6/:0HDLBJ0%$E4U KX =-1,Q3D-X#U%$
M!_/@&O\ SY,._P"#U#_F;TG_ + X _GR8=_P>H?\S>D_]@< XF<[_P#7>N1+
MV;GGVB0\1'IE6?23_(M%:LVB1E")%4776KXIIE%10B91. @)SE+X\B' -^EW
MDPU0 5(&H*$,!#)J%Q[2C$,11,#D$ _9\"CZ@$# H0 *8H@'@!'DF_\ $?G-
M=L@:_P#/DP[_ (/4/^9O2?\ L#E _GR8=_P>H?\ ,WI/_8' ."L/?_KK7(U>
M9GW^B1$8U.S27?R&4:*R9I*/WB,>S3465KHID,[?.F[1'P(G56633  \^1 Y
MI/O%B!2%*9/41, ?GCFE"/O[AY\U\/?P/@0^P?8!$/' /O\ /BPT?_A:A_S.
M:3_V!P#+F4;S0MB<R[6FEM9585!NX>_M'2K/5""FX4,FE],K8(YB1V?U%'UI
MMQ4.F'@QP ! > 9JX X X X X!Y]<B^*CI#[XA>KXQJUUR6&PB,F]GI+"KO8
M-6LW#*)K*[3F]/H,S8[8ZFE33?\ +A-WU9K%1TA#QS<1;Q'[/+&+]<H[:UIF
MHNE>E\NY][W=E&=[,@_"1[\=@NX=VUV(V:=S^RQC//*!JT0VI-.5JKC(YJ\6
MB\P<IAM@6">G!F92G,:O&NW3^9,UL1W<@Y!V@5J#4.3MQ6[7(C4)/?/I'S,Y
M;KBX'4[A*TBL#,P]!N&CO%'J; M=I",4O- 1RW<F&0%.8DXIG](U.B0BQ_JO
MFE.ND)$SE]91KUQUJXA _K-J&LY%C=:H=FZE]@CS45*WI\Z-&L**X9BG8] M
M-G8E35-=TSF.6/F6H+>1-Z7'SB!^Z4H Z3V^6@9[_G-WO^J3V/\ ]$T7_O[R
M2]S]/L'4)_NO)UFQ4NJS75OL8SG-!?R\94V1H2E'&4>P4(\L4FB50EZ,FB+>
M(8.W8F6,0IRHF*01-[<3P:UPD';@[.WLP>0ZD]C_ !_R31!_V7T>)X-]OEH'
MW^<W>_ZI/8__ $31?^_O$O<_3[ _G-WO^J1V/_T31?\ O[Q+W/T^P=.:=V9)
M[>I?-FW5SL8I<H*K5^YRD/\ @M)*HUKEHE+'#0<@94;V")BO9&J3K<B13BJ4
MS(QCD*4Y!-0=Q_G-WO\ JD]C_P#1-%_[^\DO<_3[ _G-WO\ JD]C_P#1-%_[
M^\2]S]/L'Y-V=O10\FZE=C@#R >\31 ]Q_3S???]?;\@$?L \3P?I]@ZG4NZ
MLK>/VD_9GJUV-D?V3M,S3)T2PE*2!E8H!8K>58>5;T7YHME3 054_4D<?Z!S
M '#Y-]OEH';OYS=[_JD]C_\ 1-%_[^\2]S]/L#^<W>_ZI/8__1-%_P"_O$O<
M_3[!M)#M3<HM@]DGO4WL>BSCFCE\[5_!Z,;Y39HB=PNIZ2WP3&]"29S>DH"8
M?'@ $>)>Y^GV#B:IW%G[K6X2VUOJKV.D(&PL4)*)?%A:0D#EFY3%1!8$U;V1
M4@')[@!R@/N "'OR@[#_ #F[W_5)['_Z)HO_ ']Y)>Y^GV#N] VBT7J>_!)?
M!==SIH#1P[_:"\L:RVA/FMR@*;03Q%GF'AG"XC_BBE;%)X*83*E\ !D\&NWV
M"0I1\E*/ZE ?]7*#[P#"FJ];>OVYR$#+;+BN8:E*5;U?LY(WRDU^T/H0IEOJ
M#)QKJ78.EVB0K_X_Y21RI?.$RGH]9C&$#+\?'L(EBTC(MDTC8V/;HLV+!BW2
M:,F31N0J2#9JU0(FBW013*5-)%(A$TR% I2@  ' -YP#'^JZA2<5SJX:MI$R
M2OT:B0CJP6:8416<@RC6GI YR-FQ%7#E=111-!NV;IJ+N%U4T4B&4.4HAB8K
MRGM-EV_X//[WB+Y_=:U#M[ZT&+=1$M6["E:L_&1:S=0EX&89-IF$G$9)A]&H
MR>LB." X;KE2.15,3 U&)%79=#UB>V_KO:X+JSN,]7L@M][EK!*132FF92S"
MRYE,U6.6@?K;>T<NTOQ250,)WC5B<K4%%_DAZ0$\Y9._.[IGJ 9T#M%?@#P/
M3WLL(^1$?$101#R(B(^!-?B#]Q^WI  ^Q?)0 1H/O\Z.^_U/.R_^AZ!_X@\
MZ;6^ZTQ;9&Z1D'U1[)OGV?VO]BK4D2&H9?PNS%K=;MQHXWS+N05#C!6Z"? J
MCY2]+XB?D 3\\FL/?2X [E_.COO]3SLO_H>@?^(/*!_.COO]3SLO_H>@?^(/
M --3M#?#!X-T_P"RZ8>_[WX1GP" _<# )KZI[@(![> #P(B(^P< ZI4>[,Q=
M1LX5OJ?V3DAJ-LEZ5/\ RX6BE!A98,&QY6.-\Z^)"<S<7B!A6( D5!4#%\
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M/X /;R( 4S:=MMO[H9#2NW?0'5X_5(NB5Z>A=AZ/W%)BPB=EJ]G%%E<LXO\
M'K%/8Z!KD0FQ<LZ-)/40AA<GD&KQK*1LC\PHU"4ISP:C'K'67S2>$L.E?1S*
MNJ:]ZN>=5RRYNGK*L/.)XF:[V&<H.-H+0T:M*U2L0"]BF*HWDUK,,U*3DW7F
MK)DX6?EC8Q$D:Q(X?(S^7[8$;E1S??=N7#2GQP0PKNG87)>MM;KERV:U-J34
MK->ZUG32RR2:H0L?9+<HZ0@2SC\I10AHUVZ:BT/+/C),6JZS<KE9(BOK "FG
ML)T\VW9-K6QK1MLD.Q.([^K?]>H+J4F]8JUMZO7F.0MRF>W',+9C[RF4$N65
M'Z_/(E*BW)[:;7/S2#VRQTV1NO(MUVM;],TH3S41P>2:]\YWYS=5B&7K8SEM
M/S9UH6B:J]K$85F^T'5;,\MUZL[TZAUW,A-33TQE5/*JAD634O\ BV3%)NV]
M:ZB:CE89?;D96X!&3MEV9ANIN6%UNST>_P!UJ+&QQ$;='.>01[')4&H/OJ/Q
MS3)N*1,#IQ5::DDD]G_H2.'Y&BOSF[98$E  %?<>=W,>K?:[NWK#RN[W=;EH
M^/?0K:-BW9NOZ/=7=-J5F96:LR]-V+![92;K7I1DQTZHE=L[5B]@?*?R?7.*
M<.*?)0< X;1\/.W"[\\M8:F)4-8RL[UG=D[YRG!WGJ,SVG)Y[1JG1T[)<+D6
MJP,="#;- L+NUW>R*,&Q$%9RU6)Z!5Y:<DU2G>2#OY3= SA4Y&C5HT(BV2ID
M[CP!P!P!P!P!P!P!P!P!P"LWXAW>C..N^)Z)&5S79.J;:-G@<KK 42I0>C6V
MI:9::1.:A6"2])L12QDA&25(J<Y+*-%%47TS'HKQM:=$LJS#Y0JXZX<.;N15
M1U4Z-;/\0"]1'8;O%96UOKT>X<I62-"FUFM1U]<,9!!^TI$&C7F!J_?L DFD
MP2W9]=94\;M^/WB E:R2R2;64D#MFM<M;RS=&*RRC"_%WX]]UR]-%2J=:HE9
M@J93H2.K=5K$6SA:_ Q+9-G&Q,4P1*@S8LFR0%31002(4A"E#\A$1$PB(C)V
M'@%&.L]K-9W3L#KL'B^IUR$S[IZRE:QMG4UQ5RN-LW)[8I*:J.AV(Y)!\FX6
MH%%S=TRN&6JU!FZ:V6^2(,+2[*$6W9("^DS^.5]TS^9,?#>Z&3?2:B7RL/\
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M!CI=-)Q,U7*EG;)2<B(*6GS/YTT>O*KL(@72,; LXYNB]6E!"9G ' ' ' '
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MS,P\!,!]"?U+YVJ*+9 J3-@U*WCX]LTCVC5JC2&6^ . . . . . . . . .
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M@#@#@#@#@'!V6RU^G0,M:;5,1]?KL$R7DIB:E723./CF+<HG6<NG*QBD33(
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MPSE6U_+==A+=#G>3#9VU4I1B&AW\>T"-G7,B+$/%9/'#7">!:OU-QBU9EF,
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M9&3<0-5CU081HOWSY7ZJ:E9B4D(E'=ON1N>2P6Y&=^4@X X X X X X X X
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MK,R@MW2Z9P.3X X X X X X X X X X X X X X X X X X X X X X X X
MX X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
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M*BD@J\(V2*4WS5""0P (8_#MCU8$S0@=ENOXFD*J2],"ALN="9[2%!,!+BT
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M  P>2.C^J<8((Q:B,9$*&@@!R!2/0I)?"_\ 'M'N7!<$' ' ' ' ' ' ' '
&' ' /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g729258g45l24.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g45l24.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1;B4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %L:^6# X0DE-!"4      !                      .$))300Z
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M8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
M    3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K
M9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M  !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@            0G)D
M5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M4G-L=%5N=$8C4'AL0&'_QJ         *=F5C=&]R1&%T86)O;VP!     %!G
M4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M      !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M         !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T
M;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C
M=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M     ! #O_XU  (  0.__C4  @ !.$))300F       .             #^
M   X0DE-! T       0    >.$))3009       $    'CA"24T#\P
M"0           0 X0DE-)Q        H  0         !.$))30/U      !(
M "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H
M   &       ! #4    ! "T    &       !.$))30/X      !P  #_____
M________________________ ^@     ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@  #A"24T$"       $     $   )    "0      X
M0DE-!!X       0     .$))300:      ,U    !@              ^P
M X0          0                         !              .$
M^P                     !                         !     !
M    ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M^P    !29VAT;&]N9P   X0    &<VQI8V5S5FQ,<P    %/8FIC     0
M    !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO
M;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'
M96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   /L     4F=H=&QO;F<
M  .$     W5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G
M951%6%0    !       &86QT5&%G5$585     $       YC96QL5&5X=$ES
M2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE
M;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG
M;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO
M<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P
M3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O
M;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M       ,     C_P        .$))3001       ! 0 X0DE-!!0       0
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M!0$! 0$! 0         !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$
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MT)]KM&F6I(9XF2S*Q:<IC2UE[&V-:Z-P#QO;NV%[>_[RI9?2,B_,?@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                        _^% @6AT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7
M-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX*/'@Z>&UP;65T82!X;6QN<SIX
M/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0($-O<F4@-2XS
M+6,P,3$@-C8N,30U-C8Q+" R,#$R+S R+S V+3$T.C4V.C(W(" @(" @(" B
M/@H@(" \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y
M.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/@H@(" @(" \<F1F.D1E<V-R:7!T
M:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7 ](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B/@H@(" @(" @(" \>&UP.D-R96%T
M;W)4;V]L/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]X;7 Z0W)E
M871O<E1O;VP^"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#(P+3 T+3 R
M5#$V.C(U.C0S+3 W.C P/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM
M<#I-;V1I9GE$871E/C(P,C M,#0M,#)4,38Z,C8Z-#<M,#<Z,# \+WAM<#I-
M;V1I9GE$871E/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T93XR,#(P+3 T
M+3 R5#$V.C(V.C0W+3 W.C P/"]X;7 Z365T861A=&%$871E/@H@(" @(" \
M+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R
M9R]D8R]E;&5M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.F9O<FUA=#YI;6%G
M92]E<'-F/"]D8SIF;W)M870^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@
M(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @
M("!X;6QN<SIP:&]T;W-H;W ](FAT=' Z+R]N<RYA9&]B92YC;VTO<&AO=&]S
M:&]P+S$N,"\B/@H@(" @(" @(" \<&AO=&]S:&]P.D-O;&]R36]D93XT/"]P
M:&]T;W-H;W Z0V]L;W)-;V1E/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*
M(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @
M(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M
M;2\B"B @(" @(" @(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B"B @(" @(" @(" @
M('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y
M<&4O4F5S;W5R8V52968C(CX*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E240^
M>&UP+FEI9#I$049%0CE$13,X-S5%03$Q0D)#.3E%.#%&-S-#,4$P0SPO>&UP
M34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-.D1O8W5M96YT240^>&UP
M+F1I9#I$-T9%0CE$13,X-S5%03$Q0D)#.3E%.#%&-S-#,4$P0SPO>&UP34TZ
M1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)
M1#YX;7 N9&ED.D0W1D5".41%,S@W-45!,3%"0D,Y.44X,48W,T,Q03!#/"]X
M;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I(:7-T
M;W)Y/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IA8W1I;VX^8W)E871E9#PO<W1%=G0Z86-T:6]N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D0W1D5"
M.41%,S@W-45!,3%"0D,Y.44X,48W,T,Q03!#/"]S=$5V=#II;G-T86YC94E$
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 T+3 R5#$V
M.C(U.C0S+3 W.C P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD
M;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F-O
M;G9E<G1E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z<&%R86UE=&5R<SYF<F]M(&EM86=E+W!N9R!T;R!A<'!L:6-A=&EO;B]V
M;F0N861O8F4N<&AO=&]S:&]P/"]S=$5V=#IP87)A;65T97)S/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I$.$9%0CE$13,X-S5%03$Q
M0D)#.3E%.#%&-S-#,4$P0SPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @
M(" @(" @(" @/'-T179T.G=H96X^,C R,"TP-"TP,E0Q-CHR-CHS."TP-SHP
M,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W
M87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T
M.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N
M9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO
M<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N
M8V5)1#YX;7 N:6ED.D0Y1D5".41%,S@W-45!,3%"0D,Y.44X,48W,T,Q03!#
M/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M=VAE;CXR,#(P+3 T+3 R5#$V.C(V.C0W+3 W.C P/"]S=$5V=#IW:&5N/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0
M:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*
M(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA
M;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z86-T:6]N/F-O;G9E<G1E9#PO<W1%=G0Z86-T:6]N
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYF<F]M(&%P
M<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO
M<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F1E<FEV960\+W-T
M179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M971E
M<G,^8V]N=F5R=&5D(&9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O
M<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I$049%0CE$13,X-S5%03$Q
M0D)#.3E%.#%&-S-#,4$P0SPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @
M(" @(" @(" @/'-T179T.G=H96X^,C R,"TP-"TP,E0Q-CHR-CHT-RTP-SHP
M,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W
M87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T
M.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N
M9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP34TZ2&ES
M=&]R>3X*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^
M>&UP+FEI9#I$.49%0CE$13,X-S5%03$Q0D)#.3E%.#%&-S-#,4$P0SPO<W12
M968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M96YT240^
M>&UP+F1I9#I$-T9%0CE$13,X-S5%03$Q0D)#.3E%.#%&-S-#,4$P0SPO<W12
M968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C
M=6UE;G1)1#YX;7 N9&ED.D0W1D5".41%,S@W-45!,3%"0D,Y.44X,48W,T,Q
M03!#/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#PO>&UP
M34TZ1&5R:79E9$9R;VT^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" \
M+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ IP)8 P$1
M  (1 0,1 ?_$ !X  0 " @,! 0$            '" 8)! 4* P$"_\0 ;1
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MR0,I:6'65*B2I^FST]I=%VOJ^"U@\WKC=.DM:]?+_33+7:CXV4UIJDO9\A5
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MA)IRTX<<RMU>?X$(?#JQA4,C)2R.RTG'RBA%Y5(9N[L3W8]V/7KL^0/0#0T
M*];F4W$GBO\ BX@ D$*G?APH-1QIOH H_*<C;N6D(9F8U0NR[(NDM9'Y>P$D
MO,1[KJ&$L!J:&&*0K/L&$0YA0V'FOLGYISXN6,86MG"B<YY] =SW)\^AUH#7
M3?UC7OZ^^L5G+   *H[*/+Z3U)/Q)/PJ?^M-M<V-L;9-G?6V\)7Z/K&JU_XR
MFU&L-'G7JQ3I3"495\./DEOP,?EU/A1$A63!W_+L=[6R,&V58,!TV#L$@D'Z
M]]#\01Y5Z30O!RQS1M'+H.RN"K!)%5HCHZZ.A$BG6F5E8'1JT0[/T.T*&83A
M,7:&BC<,I_1;$G@<-K*6TGSG&$S 3BB7D(PA"2HU\C.%/'/KS\ <DNA^3+MM
M>Z1>K?\ ^Z]?I0GS-9+-ZS9\[=9K(I'S=S):R[$88_\ Z>0!%)V2DRIT6-16
M8<]JP*BO=VT1=*ZINNT#(<JPMU")P<U! OH&+F32"QH^/C6"7&WFQUF'&#L?
M'6RZEE*U.J;7A&4Y](HS+(L8(7F.MGL  23]0%?+MR*S:WH=AY^6JP'J[V&Q
MV1UX_=GJ6=K^1#F'XLVL2$JS,DCM?+#&@&_/,!1Z%H/%)2YAKY9*F5H<;RM>
M4^[/K<VWJ[(.<2*Z<P8 K_I%2-$GL1WWUW7G#-XH?:\I1N4@G?<!@>P[@CZ]
MU9+F-7M3BE.*4XI3BE.*5Y\NS=#G)?U3=7WB ZQTRZLDS6B4B['Q!39^+? A
M'89M5RL6X([>]7@=7RVD &BRJA1)/3]U<V&2D$,,HEVS+3#QKKOY['7GT[GN
M/U4KT!&'@QS;;T@:("T\2*$RZ82R,VZ8:^@8(1M;ZT)<)+)=;'%83G+I#[B&
MFD+<6E.9I7Q7,1+4HQ".2D<W-%"/'C1"S1D2A (ZTMOF,1ZG<%O",N+0V\0V
MRIEM:TH6M*E8QE2NQXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3
MBE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*5HM[<7(;KQLJ6L/;
MOOWW:TS1)\GZO0=E:LH&N:EUFH:966)CH?7LABK4'8MNDIZ*9^EKDY?;J96%
MFBC5&!'QH;V8*,@]MDZUUZ?1KX[I6S/K!)1VS>ME7-?[%Q7;NNV^-M80V^H2
M&J-8;V!72YR<BFFS ->(#J3$] !I75)\NOQL P3-PQQ:J_ %N/10DTK&Y'HO
MH*3U_&ZM?8V0Q0(BEUK70-8C=O[,B8MNCUFAS&M&JTL:+LXC;T=-4R>D8RR)
M>2MZ:)R%-DO8GHJ+DPXT.GP[4JB'J1YZ_P!0WEZ>U2!UH'&;NM7>KJE-Q]YA
M]'V%UAVF5>9DZRJ)G-ZQE*>J42:.$!&1T73;#>@K!(1,>+F+ABHT-"VWF/GY
M\O?]'385NRY-*<4IQ2G%*<4IQ2H4OO8G3>L-CZSU)>KHQ [#W$5)A:VKCL3/
M%OVDJ&C3Y>49#,CXLN-86%'1IA3Z3C!<H;;1G/W>8PXI4U\4IQ2G%*<4IQ2G
M%*A/=^G8K;4""ES)0=DK9B92N2L<:Y&G-.X6RX2!DQO.$Y',R..\AHM! +<F
M''&%"DM"K8=4KXTW5=KJD:/$#[2LB(=H43+0>(>K9-$*2TE)C:22HV3$0*ZY
MC+J&!!V4LNY=4IXM3JG\NWO^OY/Z:@?I]WS^H>[RK*S*Q>16G'H#8II!C:,J
M'"MD' 2,2^XG&5)9*<A(ZORK3;JO"%/L'*<93GXB67LI^$I4U\8798>5,Q=[
M _-W9\MJ4N,G) -V)/RWCRZ]7+,A349-C83_  GPOYBF&&LX7(1 7G&,J5):
M%H<3A;:TN(5CRE:%84E6,_AG"DYSC.,_MQGBE?UQ2G%*_E:T-I4M:DH0G&5*
M6M6$I2G'XY4K.<8QC'Z\YSC&.*5#FQMJ:V@( Q^5N]9:Q%GP<B<.W+AF&-!Q
ML]&G&KR $X2:M30H[SGPFQUO+PC*6VUJ\)SY3$>&3W :-C] D0GK] /6LW'@
MM<A!^4\%W&OO+R6DZ(!\6=@!\2*IY8-I; _*F6M=<T/L!W0B0Y*8G=GGJ%KK
MPHRUY??EV]:V_,)LPV+992IPM05>)PT/\:0$:)!9:2K[/3??X_#>^NM=?CU^
MKJ=XJJ'[-[73E![-Y !O(ZZ $:/DP.A6/; EJ2;6(N2CYV*:BYUP-F$(8.'S
M'G"/+;+)*'?0]\)]#XN<I?(2HE;HSB\--D8>0R3A7]['9P\SNJL^TCV0/:/4
M'9UT (Z@$@D=&/0[+PIPW>\1Y(06]M-/!; 37AC1FY(E)TIY1L-(PY5!* Z;
M;H 6'[JN]1^HMLRT]#5'$A3=G0--K$M(QDHA),?*4\NSD068T&26"F1<F"KE
M-_-C,BAN++6-E!9+JL,8UZRR4EM<,!$9K2X/.2C O'*.C.H<@N9.G.I"]0&!
M)WOK_$G!EMF</ \E^ECG\4K6\8NH2D-Y8;YH;>XD@\9+?U/VQ!-S2;1S&\80
M1F.V4OV&UJ[.U9K&;VET22E22$9U-M5>4M,PLI'/>QQFFN,$)086.A3@[KK6
M?*'$.+;<;6O:2P=H&7>B6?J"#R^&PV0?<6 /TBN$K$]M'DHI"NU2* E"'1I/
M6HG4!UVNBD,C*21L ^?2NS5V=U4W))CB'+L#A>8U+9\GK:^Q03SDJ6['#-C9
MDJ\*66IN2^0CS%""/MA%SD$T4MK$H.K/O5=71;6LM0VA%0- &7+O(L=C;P4U
M(U6T1(K@\/"S=@2EPN7AP0L9P5%#+0VLC"W%I3AM"U?HYR;3K-\0IUT/<Z Z
M] ._??2O*;\D ]B?U$_/;XD5B/6>,'K&QMQU0%M+0 4/KDMEIO'AM+V";U&.
MKQ^K&5L !I_'.<I:Q^SGO=G<4)\Q+<+VZD?B7&_(=6;I\37E!TED'D8X6[^?
MXQ=Z^@ ?5\:N=ROK*IQ2G%*<4IQ2G%*\IFT=6U+5?J;?3;?L'3KV8+L/U'&U
M-0HSJ1U7%W"#0=DGR1 <3K2PV*R?G0FZEKF?AX"$OMYJ=,DY:-C+Q-V*"S%&
M4JRFP?SUWUT=GW#?Z?+OV-/U_/SVK?5W!ZM,]E$=?Y4)P(:U:*[&:@W)!G2L
MI.#1PT53[W79VYM,Q4:]F-DI^4K,09#0A,N"3B.5(F(%( 0>8ZY]4J#$]0-Q
MV7N;2>T-Q/UM&C1E@J%HF6H,^=DK%$,4'579;48-#K1!\&#AVM6\?=M>O$Z0
M3("-@S4-/QJ8:1^<CI9F/GS_ &_/PI6': -[*ZD]1N:ZR[0[=;0[.:VD^DV-
M[1S.T=?=?*C)U^\8WL-K_+L<?I/4.L'R0<P##R,B2ZY%KY@MY["<+0/EF??U
M_LI5,KQUD[]]!NNO:/;];[>Q%P8-%KLY(1LK#VF<LS$3&3\@.1)U2RV&<^6J
M4\P)9W'WX^/A9(:P9%8#R\,X&"E_H]OG^%\UD.$K*_X/%C%;6N)Q>1O,+<W=
MU/+,KLDS?@H8^ZDR%H92G-(\R9&.WN;RXDFFDM8$DVJZR\^4RM]*D]M?17N8
MXJS-A:<2+:X_'8K\)8^)\?:13V C\5S<V-K9!+R:UP]N([>:*"U6:^YZDI]5
MONM3.N&C2I.=2R;.V&=4[LYRL15AMUWK;%IL+!C9@MG67$$$1V6EPD0_%QD9
M_"PF!9$K"UI<)L,9:^C?+<;<:X.;(QX48*#(3VUGQ$UW@M06<<0?(0+/!8QR
MXJWD:1_6%O9YI[&-;Z2.)9RZYT-@+W%8[*8_AE^+LO<W/#&/S6'X0NVGBQ%W
ME?"2WB>SMX3?PW>>6+PH)HK:ZP29>\FL;"_N)[)[-=N#WJE5UCN-K/15@B)O
M6E$L5"EY2YN[.H$O5[!6K4]"NSD*T?*FSS0K4..W"R##TX!"2-?>3*,9^H/-
MI>D86BL> <IE.&LEQ)B\ABLK;6>5ALH;>P:6:ZFC@-S;9#EW*@25[FXQT]M%
M-;QSFT@N'2.5;NTE.KWTV$QK)B[N#++FI;.ZNH[H3P+B2/6['U,M V/-SI+.
M',176KT*+V2Q]N(6UQ!<6TT5VFHG9Z;[+T_66QQW'M67*-K\59(2,#>Q#0<K
M2()+4T*1+CFP<_XOD5L-(ACC)<>^""$K+;P:V''J7(XB[PR8&?(8;(6POK.2
MXEAR5O<VB74T64OX#"A'A2I_@4=C*\:,DJI<Q2CE\9=8DMN(UD:/)8F]!F6-
M1C,A:WTD :PL+L&X2%GY 7NY( S J;FUO+;?B6L@KH6-@;7>ZBZ4V:QLY:[S
M<2=!D6"QKJU1?8.8W)?:-69@!F+;C6HH1%?#NA689X9A)&7XH',HL[W&X)MF
ML,4G%>9QK8T>HV:YU;>W%U=JR-A[&]N87,K2M*QN'LU\8,Q4+*_A!-)RU8DF
M>SMI1+RR2"U+MR(=^.\:L I'*.42'E.O(;WUW.=@O]]A-YZOU@)$U20JEUI=
M\LTG83I.5%LPCNOB:6 >T+%"Q3D0[F2(O,4\/E9S*4-B2*5I:SD;"Z6WL+&;
M"9/)/+=1W=E>6-M';I%$ULXOUO'0M*\HF7PULI0VD;9>,@GVJRF=Q,D852C)
M(Q8L0P*%!H+RZ.RX_P!('0)T:X-&V3LZSW/?=5,J]&1^:J<B("K.!V:>;58S
M9REP-XC\SKQ%9>1"C8C[* "60 /+.,&C&.,BE,*9Y]WN.QMM9X*Z2YOC^%()
M9[H/;0$6Z07D]E)X"K<J9F\2V=T61H@R,H9D8&OE))&>92J#PR I#L>8L@8<
MWL#E'71US?MP +LY<4=:Z3V!DM-.2)=R>J*OR'IU]AY!V*CKO+1T' F$6"VQ
MM(%)=S*RT<(<(.#G(WS.'TNO#,D/-9S\-VAXCO,#'EQ&EF+L&^N[&:,2/912
M3SJMO:27KJ/"BD=&9_:Y>4@,54_(G?U=9C%LMR^PC@Z#-RCVG" Z)&^@^%2S
M8-IV6$V7K/7J-;&FC[#B9>4)L>+1!#L5?-=1'.SP9D8KXI<D\"W+ Y9<CG%L
M&J6ZEES&&?<NK@QEM-CLE?G(HC6$T426WJL[-=>L&00.DHTD2N8I-B0!DT-C
MKH>C2,LD:"/:N&)?F Y>76P5ZD[!Z:-<FN[*G;=<MF4(2BSU1,HC; PUSL;U
M3FJQ*'RPB#(1\:%KMT_*4@5\)YJ4<%.:@'%"H<"?.C9!2&T_-QC8;2SQM\][
M!=)?%F:SMQ=0W,4<3\DZM-<6?JRNK@Q!T,X#D.J2Q@DPLC.\L81D,8&G;D9&
M+ \I"K)SD>9!"'738-87&[3V/#Z18V58(>KWNP+DG4D1M79.UU&L1*IIR"84
MVF>G-@OD&,E-H>?7D\=M]DKVMCL*$RHO+DQF.FS+8Z":YL+<1CEDNBF1E,HA
M$S F""P54920H\-BI7JS<_L>"SS+:B=UCE?F.UC!A4+S<@_+>8D@]3[77?8:
MZY):MC;%@;]J*H@:\KA\7L/Y]NR3!E_* .J)4/&N2\LQ'Q+-+D&+.A@%I7RC
MZY:!P63X:4V,WGX^,>UQ]A/89:[>_N(Y<?X9MX5L5=+M9I!#$9)C>1M;%G(Y
MU$,_(O4%S[->[2.'B3PP1(#S'GUR%1L@#D//].UW60Q>XZ'+W*[41@V9$GM=
MQ[,M;W9JI6N KT5&$X(6.<FW34*!5CQ7VA#"&GHZ8+0L8,HG&?@#O.(\)<1?
M16=E?,D+P9"1H;00W=K/<2RH5#)ZI#-)=1LI=%(DA0AG1?RF /T)4+R)M@8P
M"Y9&50"-@AV 0].O1CY^ZOHC=FFG*R_=6]MZQ7319%,.3;47VJJK(TNM'Q$1
M;\\F5S%,R*F_X1(+A:25(_2PUE/WY!PN8%RMD<3DA>/&9EM#870N6B!T95@,
M7BF,'H7"%0>FZ^/6;8QF47$'A \ID\6/PPW\4OS<H/PWNNY<V1KMG\FOC7VE
MM?EFVV[3_B6F#1^5;3N6<-.5KW'8^NMNY(8PVN+^:2O+[.$YS\1'N\1CL@?6
M=6-X?4R1=ZMISZJ1O8N=)^((Y6V)>4CE.^QKUYT(4AU(?JAYAIQTZKU]KN.V
M^XK-.8=?5.*4XI76Q4S#SPF3X.5C9D'!!8F38HX61$P6 2Z&<+DD-UYGY@,M
MAX4MGW_$')9=8>2AUM:<>DL,L#^'-%)"_*K\DJ-&_(ZAT;E< \KHP96UIE(8
M$@@U ((V"".HV""-CH1T]Q[U#>]-[1NCF-;MOTVV7V?VMLB-U;3*S3W:N+('
M662@;%94**/N-CJT"!'L1-7E7GR2Y9M67$,LLM/.O(1GSJ:IG9/5<T;68FTS
MAFOML* UK09W8&X6'4ZRC9K5@53V5<-46R"EX.7V2 ?:[/ VVB6-"HG6Z+G]
M:C68Z1K;\PQ.0N3X)U^SS/T?II4[1G>?3DUV?VOU)B(^\R>U]2:U&V3)-!US
M"H:T)5#U2Q2E*II[QK*I>^5Z V!KR7FX!]D' 8=YK[F2U9<-P'-*ZA[OOJN+
MU?LG9EHJ>PJGG3.Z-<:*VW39,2IRMFH-RVA8=:P5=(DS*C;;+4)&%%9VS3IJ
MP&P%HEG8 !Z5&DQAYB%D8QB-]-D:^'?]%*AVF^K'U_V=('U[55.VGL"Y!;'W
MSKQ-.CP*; RYC/7:NUBU7R\BD7"YUZ(_(<N$N5;+K$L_),$3WU8% P*<F@Y*
MGY^?HI5T.MF]0>RNFJ/N^$I-MHU6V/ Q5KJ %T?JCDW)U>=CA)2'FG&*C9;0
M& V<,6GP ></*C.-.)+!8_@\K4J1[Q?J5K2N&V[8%I@Z=68[VX,F[!(CQL>R
MM>%9;:^,0M&''W,(7EL=K"WG,(7E#:L(5G"E8_C=6H%34]7D[.HF9JKPD39+
M%'8M,-\Q"P4ZF1<AY22_FSV"BR341)/B+=6G+PXCA"<99RAQ2E<&)WYI2>S0
M$PVTZ+)+VG&)F==MB6.,==M\6L=)*#H5K#_Q"F'&E8PTKVI^*]Y&;PHE*FL*
M5+G%*<4IQ2G%*\[7J(;-9ZS]Z,]A2_W-DBRWH"DP3+V_>L?9K:!>O7X:V7,U
MVT5+:FE-36R!J:)M,N.#,14K85FJS%1Q+8D9\1+IWR3H_'7NW]&]==;^D=NU
M*] =6A82#AVF(&'BH,61).L!8D-'IC WYFQF/3<Y)J%PRPY\Y+2QQDD>^2TD
MPDPE\@S*B7'59^OGW4K(N*5J&]3FXW\7:'IY48+4$U*:VE>_/5Z>F]VLVZD"
MP%6LX-LL T;1C*49-,[ E)"<$4N0'G(>!+KP33:AY \<E2&\Q[OGR/\ 9\]E
M;>>32G%*<4IQ2G%*<4K!+)J_7-QLE8N%KI%7L5KI*W'*=8YB&!/FJLX](1<H
M^Y7Y(EEPN(63(0D224L%UA1*XX1+^7$,H3A2L[XI3BE.*4XI3BE.*4XI3BE.
M*56/;H4T?L>GQ]BC9NQ:FEX25C3ZW77+%EUZPM)?/^K3#%=$0\0.RVQ'1<<
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M&F3D>8\&"Z:ZZ4X,PM#2GW%NY3E:LYXI4%_O1WI>?[']U'^_G_I$Z]_7^/\
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M.2$C  +L== #7E/,EM")Y@ZQM+'""J[;Q)7*JFB1HJ$=VZ\P12='H#+=7V%
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MPK0JLUTBPQNVMY0^J)KZ?&SLW-1$;*TN\6;,O"0=<!D9.8D&BZJ(+D-L1UM
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M_P#[K?/_ /,:RNZQ469LO4)A<: 46.=;L,%$!CODLX9K)3[6&GW6U.M_"?\
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M-..M(<6UC!#(Q'AM2LIQ\<=A[[?PK+2_<A,TKE<4K4#ZG5 @SMJ^G?LEZ^;
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M>3DFOE7&VXB(+M-=DK(^DYP.6W$S@<VB5=M@Z!W/T68&;.<9XX)&C0V ?(W
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MI=4TAS+Z?>XM7..-+V&[S=M;7$DCK91:G+;5I9[K=R[-W0%T]75RB;ZMH>R
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M]._PUV[].@._T:[/M_>\?L\?\6,_?\?&?O\ CC&?MY\J=/JU[M?H!Z]]'KW
M/3>WZ\_C]\9^_P"'XX\_?&//V_'S_%X_OJ>9[]0>O;N-]0-].^_AKZ]=WJ<Z
M(UEMWJ1N&:MU9$,M% ID[<*-9QEK!G*S98X#+0\F$8RI"'\_*9>#=$DVSH]T
M5YUIP7/G&4YV/):Z@B;VHY'".I+:*L>O0,H+=^4GJ-D @,=YEGE;S%-)<64B
MQR%""&CCD70.U&I$8KIM."C*0X5@05%5C]&[K?\ FLUG;[<]?Y2UL)V'M.IQ
MT/(0<*%D(\2QQP$C87I< =@PXD^$KM:AQ@5MLB1C8,F^WDAV87\MGY2ZY((L
M?%&(X%9;H^TQ=Y)((TV^R![(!"@#2AB%Y02#Y7N3NLS=?A&],?C>#ZNB0H8X
M88UDDD*Q)S, '=R7.^9R-N6.FK=;Y_7]_P#!^/[<?L_#[^,?X,_:BKPWY]?N
M[^\>[MUT/N/3OZU_HEGQ]_YG=\^/P_GD?X/P_5C[\W'@?\]-_(I_]N&L:Z_Q
M?O\ :'P'G\]A6?\ .OU74XI3BE.*4XI3BE.*5YD^SE;/HOJB:FK&D%]>JY6
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M"G04K/4^VTQ4S&'@BR4?+Q<?<86"DCH:0!-&) EQA'(XUM>?EB7<MN80WO\
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MV@16</0$;5Z]1ZK$LU0ZZ'C3BJY6&6(J1V-9G+N8UL&_?+@%W$: J+)$6%B
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MO>[U8-WF:X@%[LN=DV+/:WL5DN3VPK#-VJ;JNQ\$:NK<%$6FGOP\)#4MM%5
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,XI3BE.*4XI3BE?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g729258g50q98.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g50q98.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[13H4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %,R^4R0X0DE-! 0      $8< 5H  QLE1QP"   "  ,< E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0ZEZPJ5\QR](\0ZR,"!]+/3A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!83=,         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              )0   )E
M  $                          0             "90   )0
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   )0     4F=H
M=&QO;F<   )E    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   "4     %)G:'1L;VYG   "90    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ )P"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M         0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#(3$2!$%187$B
M$P4R@9$4H;%"(\%2
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M5Z'!T? D)3-#IM7A&#4V8G)UDK6VTO$F*#=35'>"@RDT.$559':3E+*T_\0
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MA+]IBS"KD6V-[\SI#<%;3ZHV195' DE94A12JW)XXY('Q!/?Y3BY3BG, /Q
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M'>U.38 7.$TD2/O,4.GDN;P_X;\3Q*M>.4U! !(U OYS!I85FF87\)WV97*
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M\[4/3;0RL'"YG$EY+JTF3YS/ZD=*V^3^LH#GCOP/V]OV\:LD3>OQ68X!K1
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MU*7^LHG7E'M'B<^=<V7#EQ7M-2 (<X4&E#3H%],_PYP\/"X UXB7!KB1 -6
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M);(D09];+;<7%GUDY!;76V$10C264/)2F.ZS(9:N.Y' LPR/>!;-Z$1O2)K
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MF2X$:RBQ+!EM95!E.093$U,=T)68\IEP A0.@COV/Z%00=#$=CZU51J]4?\
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M&I^$-.-*;CR1E<94RFG3EA*I$2$B-S(D(:4AQ#GDQ6U-.O(=%_'Q\++8'X@
M<(, @'FEIH8I6U8'4&%8X=P]^?S^%D'8APB7LPW.KRMG$#9O3E)N= 9B%CAX
M$?:*7'BEW(N=M,OP*OQN\C44K(JNQQMR:Y6>Z5<J%%G0["/.D3'6U=<QHQIR
M9"&@LF$IMQU:7$XN4XGA9O$&'^&6N!$4/;X1,VBUZ;7VA]F3P3#P\08WXX>0
M"X1!ZT)I),=-JSMNUMUR2XK6EM"UK4E"$)4M2UJ"4H2D$J4I2B$I2D E2E$
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MY)=E^>XR\A.N:QL#-,S;>4..&'@N@_VZS?I,Z>(7IG!\Q[,X'"L;#QGM.<.
M\8()$_B$4H8-3-=1\=Y%Y#RNNVNV6KMP)[-ANDQ/Q=FZF1"DO27XL)?Y3O\
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M78]_AHH(!!!L00>RHR]8KD^[6DVR50RZUY:X%W'L1438#[H*%MQ[!IULE$H
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MHR_QP^+/($N=;4C?K<V,POJ)#D.GRJ?3Q%=N>0MFO1R/3C@:\>XOB$Y]W_\
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MD?W;(,=F6OOP?<NK:KR";;I6_'*E*AF%475)6A/"4%EA*^.5<FO%KAV[UF2
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MAL.+'6H\@=OCQW[ZH<YC:.(&M?+UO97&,+@3!H":;P3?:B[R%MK0AQ!2ZA2
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MX^_B;K'_ )[*_P#5'D57_AV<_P"B[R=]D_W4_AT/;\]&W'/I_P ,*7U]./\
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M!C>4F!(Y6F3)K2IIWNL7*E%A9OM1H$67-E'ZB&(D=V0^[SS^JVTE2N.X[]/
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MA^&B)TI//(!YXY[#OQZ<_=P./EQHBCHBZO00DE:^ 00.YY].Q']FK4%\F=8
M]3'Q4@Q'0@Z?.)7S@^(GV3V_&Z^X^ZF1T&08JS69KE&37%6Y,L"B4B->V4NQ
M:]Z;2GE#\=$E*.GX)2$@\< :+.<.Q\8DM>X S'O.! MN-[7,G=>@<"]KLOPO
M";AORK'Q>6-=:)DEI-3J-8.A6&F)>P%\4F,.27G-P,"LC(>?6&Y-C**4!?('
M3U)5QQSVXXX(!''?6M_R_B_[W&;0\^-S6+[;S1;T>WO"+_X6R1RUY&1 TB!%
M?$TF%2[_ /!W_%&\\^\-W<<:\]YUSRD63@2P'75+"$$IX('8#MV'/'R$_P"7
ML6X>^;D?B.[B/>H?A&^D'V[X,*CA;29)JUM1UC?MTHO23_!]O$TB@<Q[\[&,
MB8[;MVJ9QM%>>B.F*J*8R1TE107%=1([<_:>=9.'P3&/YGNB-<0GQ!G786&M
M86O=[;<-.;;B_P"&#D ,@M;2A!D #>OA2\572>PH\2<*.S!8W P6V?KZSZ&F
M";:+=4RXI]<M,DAL?HY"@L#H5P?+^WC5.)P3&D /=$BSR2!($WWW\+2HPO;7
MAK78[_\ #6R[F#: Q),0"#$2-J+E4>PO\2;><HSIO<#!I,*/$C15P6;=9;0[
M7M(9>ZW>[02"VKJ2>"CD]9 !U6W@^*PM)Q'P")ESCYCF@S:=A*@>VF5((.4P
MQ((GD9KX';?]?H6\"WA^RGPT[(M[>9?/BV=VK)+FY6JN>]Y@LL3WDJ83'7V2
MHJ;X<=X_CK<)[CG709;!_"9RN@FEZG:YWT&D+B.*YO#SN8.-ACD:ZPB!0[#0
M"!J+Q0K%_P 77M>-C?";NXYLY=T.19/DM2W#<RQ=.RA,:@:L(L>6TVI;Q!EO
M)COM.EMCJ//"3QWU8Q\X,'$+(U@]]*=ZR;QK0+*RGL]Q#.Y;^:R[0YC6.> 2
M)AH+AK M423T6Q':+='#/$)L[B6YF$RGYF(;CX[])U[RDN1Y"&I0DQ)L=U"@
M%L/P)+#L9\I^JF6VI*24\:RFEN/A@P(<*]9O7M\ALM/B8.)E\9V%CM+7,/O
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MU+O<HL8;T.'7*1$<@5DMYI:$M,1JAIYV2U'0I4B2^?*Z$\IU:X?D3E):23-
M32LZW%R9W@0KW'>-YCB[QB8[ UV'4" 38%U@-K2:DQ4K+&;C"!C]94U'D,/X
M^:Y5$N:V)$))KT+@IA3FB%>="L:A4VCLD!*B[5SY*$ K5K9.;S L=4$%I!J(
M(CR@^2U&5>"X.!Y*S.K2# ,C:9\ME83;;PS>$':3<D;OXEX9X>/;K,ONS8<J
M W&F5=;92W@XF34.+>]WAKZPIY3S:.8Q<'1TK3K"'"\%V(,9C&M<QW-(@&0>
M:#O\M(%UG8W$,<,?A.S+W->PMY"]SB0X$0 38VCK-HG)5A5O:W5WE>1):;N;
MQ%?'->PX'&JJHJ3.%76!Y/*)*V7+2SF/21P'7)12V"TRDJRBX88 -026[T/P
MO'C&BUI/-7<@TIZH==UC?NEX=]J=SC7Q-U<0LKZOJ'IJL7R/&I"(U[7P[.>_
M83*6Q9<4/?((L'Y4F$0?\%3(4A024IZL;&R#<S/,"1%;>5J1KWGHMKD.+9KA
M],!QEYB)(K4@T/TJ8F5=7#L+Q3%,,H]L-M,7D8;MO26 O)PG.-NVV0VK:T*"
M9205%3+KB$+E.NJ!4AI#+2?0ZNY?+-RK0UH M8;>,>40L#B&/F<]B%^.X\Q-
M22=-*;3]#HK->)?P[8YO=5B'DK]I%KQ)C62;"G2T[,I[6##=A,R/=7%H3)KW
M(4AUE]M"O/0[PM*5#D&SG,G_ #C7LI+Q$1K]:;]EG\(XWQ'@^-A8F78'-PW
MF0'4@B30R:3KIJJ'\*OAVVQ\-=[>9?@V07F>[D6M-(QVL$V%]$U-!&GJ:<<D
MSR\4=:U+CM+6AM*BM+26VN%+Y-C(\/&2+K$0:D _?:LBNRS.-^T/$N,-!Q&
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M\^V1AE->0<3H,8H6W7;/,\IF5K=Q+;/E=T5U?'?;;=:*VPXL.K4KNV#C9OB
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MUO%\KI+:7$KEJ<=35V5/)I>3#4X5.HBV$:W;6&CUAIV&^YR1)"1O'N#\)K3
MJ)  F# TBM?EM3GBS$Q,0X3?[1S W',PG30$_OJJ,M\IVYP+;#<3Q%[RR%#
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2$31$T1-$31$T1-$31$T1?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g729258g51g23.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g51g23.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2284&AO=&]S:&]P(#,N,  X0DE-! 0
M    )'R^DT X0DE-! 0      $D< 5H  QLE1QP"   "   < E  "')R-C X
M,#0R' (% "A-:6-R;W-O9G0@4&]W97)0;VEN=" M(%!I;FYA8VQE7TAI9VA?
M<F5S #A"24T$)0      $&M5X1R];X+PYXHZEH.]_5(X0DE-!#H      .4
M   0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $
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M=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M    $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO
M;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG
M:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0
M$ .__C4  @ ! [_^-0 "  $X0DE-!"8       X             /X   #A"
M24T$#0      !    '@X0DE-!!D       0    >.$))30/S       )
M       ! #A"24TG$       "@ !          $X0DE- _4      $@ +V9F
M  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8
M      $ -0    $ +0    8       $X0DE- _@      '   /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H     /__________________
M__________\#Z   .$))300(       0     0   D    )      #A"24T$
M'@      !      X0DE-!!H      S4    &              +@   #I0
M       !                          $              Z4   +@
M                  $                         $     $       !N
M=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   +@
M %)G:'1L;VYG   #I0    9S;&EC97-6;$QS     4]B:F,    !       %
M<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M       &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R
M871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG   "X     !29VAT;&]N9P   Z4
M   #=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$58
M5     $       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,
M8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T
M   /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU
M;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP
M965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S
M971L;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T
M<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@
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M_/.=[/\ KGJ(^.;WNJ;Z5ILK)+KK"!3/\V^2UUMK?_"S$*ZVM'9B\W$7=-Q
M',J#&$C:UU L&^I\;O?[=VS_  G]3T_TA<UI:=N2UM>.X^GCLK>6-.X_0O\
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MZ;??O]7_  B5[&O#'TUL'Z0485;1 :7G?=E,+?2_3[F?Z7T]G\W_
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(S$)%D$D,E%A%Q@S0I$*&B4U<8&Q0T=9=,'_Q  ; 0 " P$! 0
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M[0L).U2 "; )-,!R3UIO]OM"Q2YB^5[1G4T;.@+KUN!2""?^#3 PJ)0M0)J
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M\XDIC_'I,Q[H(5QZ3\?J< 4$,%/M_P S^@'D@8SC'O5GY%G.;'<F^J'TMM#
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MZ;?B*;2?)F0A]5:AE6H,-6I8Q8&<Y[Y<!KC^"_>PU$ED@Q3@(97 2$D?P_\
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MX<?/:(8:Z281%.[X<TDBS2RL[.TBK;DLP2.&**.,%B3LCC1(XU!VHB!% 55
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MKZ=4.KU!YE8D<$U8_;OW!ZZ_[8R(_P 5O2/^(AMF(CTGUCTB+'I'[_XCT_\
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M@&,5'M3_  $"GVR;/:)P7UC&;6 FY:(NR%  ^U$  ?'N;XZ\HWCFJ8VLH 8
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M4:Z4H^X[SGU#U5['E#C.!9;I(V<K%X?(GN=ZSS;*[/9KZ6CT^2BCGS=>2&4
MLY>>D:TD5A[/42"D6ITX:AHY-:H)#RSZAM @8#"PI&JEZ%>:6EEV2EH\;<VD
MU^J6+SH4U31[MC&5H&LKFT\G<1N!R&-51 ODNSR!]X?+C=;A^:>=\G:6;0=;
MCGNPX+ Q*^DP"K/"@K5Y-^)<KV3H_FO1>]EE#/8E+J*9^1ZPZC6:8IYATS:-
M22 8-2^L-*Q!+*][;H]N".>233^-B62.":)XCG<X-6:L<CY K'TZ='A_[U]#
MR!<?P/D7.[7PMY.'AJ786Z_3GS:.?(+(I&TKE=.ZZ3OV*UN+JIH:%:6UD5'%
M9?'L%IBTDX8"5I8]1 VH>)7#EU"@X!6""-V/8$/C!.,!S5PZR)6?2:U]6M'<
M(51VA8$4K!@<M1 SWH$$7T/*WW?MY;)W*^5Y=Q4=0'$Z2<#EZ"<7I^RN=S9<
MVASDT\#,^;^L0V\^D-BLM]>G$&I]E]>N%I9M:7502S(6A1X(IY&U<EZB"%-+
M&*93)-3>=9!C53;"P1= ((?^('0,(Y(TF9$CEG1$VR62R@ *K(5PS$^FK!)(
M!0/ML\K?<[2\5X+//W0:^QY.TJUO1TAJA@A5JWCGY*F-^!BY:YRHCU.I8^1=
MVM6LUC65V'M77C)AEU&IU.HD@F)T?GNNF:2-$8:8L=A<5EPF;(N[NST3QCQ1
M(=0R:"<^7'IXBX!\W=/5/L9@20S7M -?R%F*?E3MQ4K4;JZ1UG_ 3Z)T*96J
ML,#V&$+.$$N$'(.?$?-8_B2P2R3$08BF8/)&\\1V60[^A31 V@XMCDY[71]L
M@^+>(!4D\YRC?F4(A87WR   !D<@G@D]3UXNZ'7WK6P6I>;:FNBI\:3!:P01
MLL"9# 1'J1PL/69F?XQ$1 SZQ]%@E>0L&V>FJV'<,][YOXX'U)ZW?!]5/J6G
M\^1I"JQ[055=ME[_ "C)- Y]_IU,GTSUN=#ZG4ZB_OMNSD7\E:+I5YNHM)16
M%RTE=M 0M$%>\Q)C%UUV&R 1,_&!E)![?W8;:8MV%W9''[<U=W^EWJ^&0QRF
M7S(1+M (NZ']/UZ;5S3V:S!:K3O LVBI86;3"5,&$ +V&L?19.^$C2N#((L/
M"MZ^]@D(F=0N[!H9^;.<$X']KZTDTNE"GSH(RQLC:* R,8R0 ><71[='%6]P
M$#)Z5ES)D"F?R;"Q])((-D1[FG$BN2,5?)(D<0$^D3[QHLJD9(^W'VNO_'5'
M@TA( @5:-$UR?8$BJ)'/MQD]$KN]I4S!1:EKY6F"E^^W[5"^S+/PQ>,@39&P
MU<UU2! 3&^BXF#F/2^Y:L&ZR!=? /;!'L*YP3T+\/I[Q''CL0,_-D\?8V+YZ
M,3M:7H,!?U ?"B/XU_\ 4!)P"Y)9RXQ4#"(YA"RMC)Q$G[X@9D1+J(B:8"NY
M/T-=B?C^==<:",#&GB;X  //%BOOP/K==)6EL;598ML=,%:DKVM8:GZ1WR41
MI4(_AU:]A[#AQ,@OQ@>I:1^5S $3(2>8KBXZ-<B[([?O?0J@3$FD!L\C&!S7
M(^;^/CKP^[TPN.LG?8W3?7FS3H5]BF=YU8&0$6:^?9M5G.1/I,-9[0]2B06<
M%Z3'/X@-XKF@!]3[&^>+^YZH9-+9'D1@9H%;(^IHY^^/<5T;J-\A-]Y"3H21
M,A-FS?2(FOW% '(1;M )1Z1[/28)@3$^@E$3'5)). !S8&>??C^?!ZKNTIYA
M4?3GFNWMS\]NE5%'M&^C+&X:!F9D10VPV&001ZP:[(K-4P?KZ?$PE^D_PF)G
M^V3H,CZ96H1@8)[$G)]OBK_7I*,NG%T+;MZHB+6-6EP7Z16AAS(7!,4RU(A!
M0K_E*Y64?(#P+ZG'/'?J7"5)$:Y&.+OL./KCOTGJZ7H2?6IV-"VNU;=*T5PF
MT/H,*)YPUY*2%0T+#UM!9.849K6MS6.2#)N7X_\ R%?RNKQS?SUQ1'G<BWV&
MT#L>?;C/-8%W?0K;75+9 MU-)@)K*?+9GY#"&Q8,H?52G]E"E1 DPC%S89*@
M5(_&(S(@)S[>W^>WVKYZC1QL;"T,<&O]CGO6>>.FST7::^.I%P^KOC7<$.KU
MX)(ML"E066"E;"38L-<AAD-&O8F[8!+!JH^5<^HUG)(!2A>38Q@D?R^_QT18
M4L#R2/8L201\BZS??C'L.B?!=%V6AY+R*FML:19C6:)1G3HW6+)(YU^:TW:S
MX8F"AJ0>J4V7!,&F2]A1,,OY@+*%.#=\'VKWY./\Q::!4AD8H PVU@?ZB;KZ
M?T/)SU;WZ+UF=1YY5.%\#TC"CU!=&&,& )A$"["#,0 ((B(@@H$8$O4Y&/8<
M?QGC55$@7@$D*+.!;$@#/N0.LSQDD>&:P@$U%9"\UO6^Q[7V/5"LW3-^6J^&
M.^$6*):&:-=U)EJS6=7"Q5%E*S8IVZ]UJC'Y:V@JM"3F%E:)8RP4M1HD0W+J
M%.]]KK'<BQ[R 3OBWHX -VC,.Q%BNOG<$Q?U&+82N^-]\?\ $&T'*7N4C@EU
M%J+!*X'2O?;8KL.6Q%L5U"17T$+KJ:]HV&0->VEUBLS\P0]P0JRYU=<@3%?+
M[E@M-"D3(B$NJL"LM462C9*FFY(HD \"L],0L[V[<A1Z6 H'-E<D#@"^39L>
MR1>#H<?"T-"E5/8VJ51MO*R/RY=<VKRD%:52+1?:0NIZR=BDBU)'^- KT6E*
M5G7+FY9'**P1-P\R1]SHB$46.E9422J'K+[C84* M]'A7<\1E.P22!11W>D[
M3NM<@"C[^D"J&13#P)]RO;]#T7>\SY9\2ZW"W.?U,]M_2X_3N^2^8N(T+B<F
MBG1UL?-=O5=!#%E.F>@F%!70<O\ P:L1$,K!)+)6EU<>NBCC<K^)1=$$2%3;
MZ>&0H(D4 LC$F,*!4FVCUN^)>$0:,1;-2 \L0E",')E#*"/4 P ;==,0<\<]
M25V_GWBN-RAVLWE>AWK^CK4N*8BG;_HES7O:=]",UBU[NIS&KIY7S7-"LW3C
M+LQE%!W@J_BQ^293!J7W02-IW*1^>%9)=405&Y!%-HTFCWNU+ZY% !LGD=9T
M'A)F)9G&G0*3(UE@1W%1DL2;:MRX!&+ZL'S,9MK'_$%E"I4"O4(W9]T[46ZD
M)2^B):9TT(M+!4IKK]"N5'U?54$"Q,OK*_$2O(LTRM%(C,SI(0&!8Y798;8.
M%!4 YK/0&A4EH58[5)4'()"T0;.:^"![$=^G@NCSEY5NZNO6NYNEF"!@#JT9
M#:P#/L<GW5K"!1[)(60@U5FJ,I*6DL9 [.7100<FV*G:3>5'&0&-UP.QH=3R
MMK-:D';0!)6C7-$&A5X6@;KZ)]CCN(M+^9W-X5U%*<VB%R<15R5J6Q+LQ#;!
M)<%E=9M@_@D997K2V9] ()D;JFJ5@I:38L4PA198E $FW>1YC@ MM%!?423?
M;KJN55T5BJ[D+BG"XNN!MY)L#&:Z@>UV7D3<+K\/L<.KXFJ<YT",O&Z*O91L
MY/04;>A9;B2NYDNK-H6-G-%-+8S-*I6)$6P*C=?/OK$!D@B(72>;JF\D2LK
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M^<Q1/<S.9"$LEPU%17%:TDR8$B-@C^1ZR)#[6Q(-8'H4N1F(,%BC\M4B1?\
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M >@@<^\6PE->'FP0_N-DA4H9][)"%[L@[2#59);CG-@#[_SZ$\3S+5 U1L\
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M!K.ULWGM^W\L#C'4U'_08C_N7(XYS_GV[]5#VOO)^\3@?-^OQNS]G_W ^2^
MYCR_YE3J=%XTX#AM"MT7B%U05>#G\?<T_)&#9?HIT@>WJ;NKG4@LT1@:S'V
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M^+(XLU]OMC.DCEC=HY*EV]S54R[O])[;LU_,GJ41:ME2(/+1-AI)@[31@'F
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M)#!"#'I9-OJ6.73&.8.MT#O+J /5'( 5/@'GT<QE1]&JNQ #I*QI;&[! (!
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M5FMO/VV9NK378=4FE-IL0D??<K6A(4E7([45'O"Q5^%C$2EAS<SVD0 MJ[1
M3+&K"A=DAOAJ[?0_'67+&^GGEBL%48H*S8'-V.#_ "Z6?]L<[T;XU]*AEZ++
ME%(?E/I(8UBU6*UNM$M8LGA-=R(8:1,0!Y$)K*1%DTEA&[<  ?D<<?6L#%?;
M'-EU,T,0C21@(S2\4+P1]<C.+'8=1WW7.OYE-3RGS-',R^AYJI>C8RQ8T,O7
MPQ&1MYM@ZM*L5EJ?ADJ5F:X0##D_>U0![UV+Q4Z#*FB.Q7N!8 ODCZ].Z*9=
M;NT6K9F68EHWJRDB D$DDX)-D"^*JBO2P?397+4:G8:KOR+?9%BIYGG+"*:W
MY]R_5IH;0N;@K_)?4"R++/YMP9BHDW2I+Y):P)/JH4BCD*V68!5 4M9-6V<4
M2"3G X[=*P:/5ZN273I:00!B\K6!48)8K0-M0.T"NWJ&.CU?+\FSH7-#/M\)
M@%9/^ZBKD;FTP 7"P%)6'7\NM D(H.R*J=>6F'R@02/L^NK+Y@W*"K@@V0**
M]Q@DWQ^I^G49]*5$+_B9A$-JM(51>_Y2&9K ( !QDG!Z);.+Y.WKZ*#_ "$K
M!YO0BU6N)Y[G*M#8)@((_P ?.T+][5*JQABYIVH!S(0/P#620':99VD9AM-"
MJ-YLB_VKZCMU59-'  8M/NE!P)&W)GN20OQZ0M=[%GI?P>/S>*I!6YS--26V
M"=H6VM'1V=P45 !#K6FUHO\ D:0P2V$YYI376E%4%M@D<J_S LP(VD'XX['Z
M9OXKH,NHDU#7(52@-JI>T 6*HXH77:S]P3^[H+=28V6S25*[*(ELU32^VN'@
M^$IL.65@*@5K-RVH)6V*HE)2V/DIMLRU61\@=B?TR#?S9OV!!576?;GCY[$'
MOR#7WZ9FK9=H>\WY";-LL6BB]>2874C_ %&+8,SZV:X&%#*8V0&ZQ]6LE]6S
M4:"&C[J(5VW5 9[YNKQ0'V[@UC'9A I7U&B<5[5\D_%'VSS?1S3'\,8N:2,J
MC2&ID@ZE<M"B; !64X9L+^"P9OIWEL6@&6#=_:*)$DS#SXP"1!%*D"]P%VWL
M.,F\GC]>1(+:A5 GO]:[GWQCWK-VG\-.\[O*=VX]::3+ERH.<%8;("JI0T0&
MQ&J4T6MBQ/X;DS-%HK.+%>987HY0XR!,GYK(>MO!JL-GW)Q7-WQTQJ,Z9_<%
M?YD_TZM#]:'65U /W0\"_P H>!_)/ UM8L.QT^!_3TZHDT)I&.A1M0SW(F'#
M[_QY47Q2)R)S D,^A0*8.8GV#<U<#)(!LU\UQ[<]5?4IHU.J=$D6&GV/E'-@
M!6&+!OCK 3FNDZ'[(_*&+QO3<+L)\>=+SJ[^QUR-C=Z*CT'753M#_N"EH:UZ
MVQ6I-.O6JV<9C:U5<6!KTUB$%8A)]5J=3I8]/+*Y@B94@CEVD0+NP+558A6-
MG<Q)[=9^JT&A\7TC:W12(NK,P9=/@,JM3%6VV2;)"E3Q0XOK4[GNBY;L<*IL
MY6M6T,S6!5FN07X;7:MZC?\ (F#(35#9GW-JL^.4 M<RI4*]($[6I!A,>P&/
M?1"RF\.F.#7TKOUXJ72RP3212JZOOLH2:% FQP*)/&/]-#'03DW9Z!EBBRTC
M,%JIIR-@3H"L:GXKLT,LX +5>PFPQBFUV3"WUI,26P(AC*2 11@F-3M_.0=^
M36#Q5V:*\W1SU0 ;[$8 R"6%C)X"BB;OF\Y[]*-;#^8S:3/BA-O1**JJ*1$Z
M(W?52?;82\Q6V $@8GX88!' S,P,!6>3TQVD<R%5"22 VDE89?+:,6" 1N#=
ML'KJ B0D.R^MV*@$"@W%$$@=OD$@9Z2<3X<_1.UD*M7,R[=<.O;N.F2@ZM/2
M.QH,K0 UEVSLUJ%8VBI-EH3Z,09+2P6O),B$2RA9?+5HPF 18Y!+$\]S[ 9%
M >]4<A%+ L=U@U>T_85SQ9%]ZZ,**8P6WPM4LNHZU8<I-U!5J@!%VVA;+.>H
MGI)QDQ=X!M-;^8Z5G8BK(KKHL2L<\:$O.&1 U46) !(XK!Q5<=\7U>R$W.P5
MB;KA:LA;&22>>>:XZC+NO'.)Y4\=[_CWR+FMWZFDN;MG67=0 U;^93=-/2SH
MO-^'\JK?JC[817BA8!ZK+98#&P2>NTD.K$BL%TQE4JX(,S2+[;D*J&KC!I@.
M1CK2\(\4G\+U8U$)P"=Z[O114J<<G[$_]W.!@V7^G-]PG.=AJ<9R'&L]EV@K
M-Y#R3Q_<_P!*S[-;G+&>E'4;V?<Z M>H$$A6KKYN8LE%MO2[-LC1KJI_6;%I
MX],T[))J94,KS'2M$[S1R2N[NT2DQ((F/>4VJJM>9ZNOI,_CGAGB&C6>;4;'
MBLA$V@R,X]0:U8D+M %=B<FP>IIZ_P G>2?M0U;RTWC\E=!X)Z/EZ??[WD7"
MN5>KZ_@/),U;>OU?'2=Z\X^DQ[^7I8%Z_E7&CH<K3R-(,R:573*B_+% \1E7
M5:A&U'A\LDF@B*R12:R+4/# LQCB1&5H4C+H 61W9/,8)1SM/#%J%2-D6*#7
MZI&&J',>R/8%E8[EVL5L+7>['!WJXKN*7<\QRG7X9U]'GNQQL[?S="HY;5'D
M:E%%[/NR#A1/S,KN#\E:''-=H_&7O*2]B\$CF*,%6B>%?+F5@+&I_P#4 L$!
M0+H9(_[B.?%ZB P:B9&8%E:A7=00+Q_JJ\B@:]S737\O<ETO:>.^PY[G]/'J
M=+M<]K4,*QMYBM2A4O65$DY^$R6[XW ,!68/R%4M$-DQL@'X\M+(^Z)P3&5:
M4^:@"V4@D<*]*;5F ##!()IE.>II'AAU,3SJS1@J7 (S9 - V#WX&:X)SU^7
M+H?/OG3QK;X)7W(=/V';<1G]+TN-DY?.]!U^/Y PMCBMN_QFA6YWHHM5L)6[
M2+,.]9BQ7MYPUK-275)*X*I$NK>&75P/I=+%% (RTVHT'AT^G:%Z\V7RSIH]
M3,@C+,%_%+*0-OGJQ\P>_E\.T,R!O#B7FU,0E$1*_P"M2VQO10JPIOW).,=6
M[ZOA.Q^Y35YSIO#WD[R?Y>LOYOF&\AR=Z0\>,\8Y>L-?0J:OGKR9RSZ'^YK6
M)+GGFY?*/=NWK>>+YJTQ59L7=QM3I-%IM/JW,?@^B#M^(TFC?\9J?%:C8&/P
MM)UFU&DA#O%+)Y\:Q->V 2[#(/.Z?420S/I]3H8H&CD/F2Z@%X?+7E(T!4"9
MFHHWF,H57WQ@L*_0=]B?'^5.$X8^;\N=I4[?IZ.)@+?IU:>A!DY06D6W6M>\
M8?UAKC6N(=^%1L "8*T%NPQMZQE:&9)P\BQ2Q,682&4@B5MQ99(U"KL3RV1"
MI+?Q$D-T0 ?2'3-/J7TX4;F%JE;*LT0.022<DT:XNR;Y?3_6AT/J=3J/.OJ4
M;6MD_DN$K 5+LUJ DHFVX]RI:45W%"W F($BGTB0+V3[H]?2;JQ"LN*:K/M\
M_O\ O\]:.B>1(YRJJ4JG9@;4'NIL $U60>>_'3'VN>K]0E5+J<A:*U&U6MT]
M.L[^VBV@"]UM,BU5BF)0P5Q,"7P&N3?)K6'JFT*DUD\&L5SW K Y![&NGH-2
MVC#20R+)8HQ.-P()';TFQ9/MS[],XN-N@N,UF]V%K!*E MG;Z=7XS42#FM6Q
M=-;[39 015;,MBHY;V3[C()$Z&!R0=[$#A; 7Z4.Q[YOIR+7HTJR-H=,)5)8
M/'$5>Q=$G<!CG%=*3:]S+3EKSJN):H+0Y(9NIMOSS94MC0J7 R/6DVR:W(.^
MFF#&(1-A-,8E46AL5"[F4!:  .<=N21DC)L@GCVZS7*322.2X9RS50/J))%X
M[$U62/?-AP4+F7ALASM&+B;-TS77KIE#\)5NM8LD6M6LWGV9(OC8V]<.):3)
M*S-=*V/;)) 7R*J^^1?'8BZKO^YX5"2$%6I6K[$<X%YP*%D>_(P[7IH[>-81
M+:-]=ZH55_H8V*$RQ<I,!&"9Z)<7N4T8F6'$C_\ U!^@LN"K5G..1=BK/UJ_
MI55UR-GAE20 J8SN!JK(!R:HD9SG'?W-;.L\$1<FG?Y&Y0TG?"VM=S>JNOMU
M(KDMP%-:RZK;LQ^&QT)LUB%Q2 @DR0Y:R^LR?1@NLH9V"BPECRZOFB,UGO7
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M5^'$$C:H+Y"J6EWBUVBB=P(-BP.QS7SU^=KE/NO[;[>NKL?:_P";L7R7YNZ
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M;[8B37,0R%S(R)'0';(T9SM HA?>S><Y&?CGKA\*UY.=/N'<F0 FN,;J_P#
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M081L5#BF'8C.#[C/3>/A,XWS9B]JK=[[)#Z6_>M<6H7#(!#@8B)$DK8LR6;
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-U.IT/J=3H?4ZG7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g729258g55f69.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g55f69.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X=RX:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ
M-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O
M9&,O96QE;65N=',O,2XQ+R(^"B @(" @(" @(#QD8SIF;W)M870^87!P;&EC
M871I;VXO<&]S='-C<FEP=#PO9&,Z9F]R;6%T/@H@(" @(" @(" \9&,Z=&ET
M;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F
M.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/E!R:6YT/"]R9&8Z;&D^"B @(" @
M(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]D8SIT:71L93X*(" @(" @
M(" @/&1C.F1E<V-R:7!T:6]N/@H@(" @(" @(" @(" \<F1F.D%L=#X*(" @
M(" @(" @(" @(" @/')D9CIL:2!X;6PZ;&%N9STB>"UR97!A:7(B/D9I;&4@
M3F%M93H@(" @(" @(" @(" @("!T>" Q,#8N86DF(WA!.U5S97)N86UE.B @
M(" @(" @(" @(" @<G(R.38S-#<F(WA!.TQO8V%L(%1I;64Z(" @(" @(" @
M(" @(# R+4UA>2TR,#(P(#$Q.C,Y.C(P)B-X03M%4U0@5&EM93H@(" @(" @
M(" @(" @(# R+4UA>2TR,#(P(# R.C Y.C(P)B-X03M38W)I<'0@5F5R<VEO
M;CH@(" @(" @(" R+C8F(WA!.TEL;'5S=')A=&]R(%9E<G-I;VXZ(" @(#$V
M+C N,"8C>$$[1W)A<&AI8R!T>7!E.B @(" @(" @("!!<G1W;W)K)B-X03LF
M(WA!.^* HB S(')A<W1E<B!I;6%G97,@:&%V92!A(')E<V]L=71I;VX@8F5L
M;W<@,C8U+B8C>$$[)B-X03OB@*(@,C(@0TU92R!B;&%C:R!O8FIE8W1S(&-H
M86YG960@=&\@9W)A>7-C86QE+B8C>$$[)B-X03M4:&4@9F]L;&]W:6YG(&9O
M;G1S(&%R92!P<F5S96YT(&EN('1H92!D;V-U;65N=#HF(WA!.R @(" @(" @
M("!#86QI8G)I+4)O;&0F(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!C;VQO<G,@
M87)E('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C>$$[(" @(" @(" @($--
M64LF(WA!.R @(" @(" @("!";&%C:R8C>$$[)B-X03M4:&4@9F]L;&]W:6YG
M(&ET96US(&AA=F4@8F5E;B!F;&%G9V5D(&9O<B!#4SHF(WA!.R8C>$$[16UB
M961D960@:6UA9V4@:7,@;&]W(')E<R8C>$$[+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM)B-X03L\+W)D9CIL:3X*
M(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.F1E<V-R:7!T
M:6]N/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C
M<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN
M<SIX;7!'26UG/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O
M(CX*(" @(" @(" @/'AM<#I-971A9&%T841A=&4^,C R,"TP-2TP,E0Q,3HS
M.3HR-"LP-3HS,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @(" @/'AM<#I-
M;V1I9GE$871E/C(P,C M,#4M,#)4,3$Z,SDZ,C0K,#4Z,S \+WAM<#I-;V1I
M9GE$871E/@H@(" @(" @(" \>&UP.D-R96%T941A=&4^,C R,"TP-2TP,E0Q
M,3HS.3HR,RLP-3HS,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z
M0W)E871O<E1O;VP^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO
M>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^"B @
M(" @(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM
M<$=);6<Z=VED=&@^,C4V/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @(" @
M(" @(" \>&UP1TEM9SIH96EG:'0^,3 P/"]X;7!'26UG.FAE:6=H=#X*(" @
M(" @(" @(" @(" @(" @/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=);6<Z
M9F]R;6%T/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO.6HO
M-$%!45-K6DI29T%"06=%05-!0DE!040O-U%!<U5':'9D1SEZ84<Y=TE$375-
M04$T46ML3D$K,$%!04%!04)!05-!04%!045!)B-X03M!44))04%!04%104(O
M*S1!1&M&:V(R2FQ!1U1!04%!04%F+V)!25%!0F=114)!545"9U5&0F=K1T)1
M64I#=V='0F=G3$1!;TM#=V]+)B-X03M$0D%-1$%W341!=U%$031014$X3T1"
M351&0E%417AW8D=X<V-(>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA5
M4D92;V9(>#AF)B-X03M(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X
M9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&8O.$%!15%G05I!14%!=T52
M)B-X03M!04E205%-4D%F+T5!84E!04%!2$%114)!445!04%!04%!04%!05%&
M07=)1T%104A#06M+0W=%04%G241!445"05%%04%!04%!04%!)B-X03M!44%#
M07=11D)G8TE#46],14%!0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)
M4DEX459%1T4R16EC645537!':$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG
M=D5L47I25&MQ2WE9,U!#3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*
M4D92<5,P5G1.5DM"<GDT+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP
M86UT<V)7-799,U(Q9&YD-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K
M-5-6;'!E66U:)B-X03MQ8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)
M0T%1241"455%0E%914-!341B445!06A%1$)#15--545&55).:$EG6GAG6D5Y
M)B-X03MO8DAW1DU(4C133D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!3
M3F5*16=X9%5K=V=*0VAG6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z
M:$I3:W1-5%4U4%)L9%E75G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD
M-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U
M8VY:-F9K<4]K<&%A;G%+;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X03E+
M95ET9%A38DY42$@Y63%#-F(P)B-X03MD4'-W84=756EU-2]:4D%/5'0R565.
M0FQM3TA%9DEC,$5S97103%=N.$=M,4]'2%5D4W5'.5<X=DIO;&1N:TE!;W9)
M2&EI9T)56'-O)B-X03M'4VQM3C=B0F%6+SA/*U@O05!Q,E=N+TEI4#A!-7!Y
M4&EZ-WHX,7 S*TAF3"]W1#%B3%0O04I%4B]W1$Y/4&EZ-WHX,7 S*TAF3"\O
M)B-X03M!1F),5"]K4D@O>E1J-',K."].860O:#-Y+SA!.5=Y,"]W0U)%9CA!
M>E1J-',K."].860O:#-Y+R]W0E=Y,"\U15(O.# T*TQ0=E!Z)B-X03M7;F8T
M9#AV+T%05G-T4#A!:U)(+T%-,#0K3%!V4'I7;F8T9#AV+SA!5G-T4"M2168O
M3D]0:7HW>C@Q<#,K2&9,+W=$,6),5"]!2D52)B-X03LO=T1.3U!I>C=Z.#%P
M,RM(9DPO+T%&8DQ4+VM22"]Z5&HT<RLX+TYA9"]H,WDO.$$Y5WDP+W=#4D5F
M.$%Z5&HT<RLX+TYA65(U>3%A)B-X03LR,%176',W4%%B0V$S:'-O<G5A5C=:
M4U%:6C-H04I8:GA(=VIS9#AZ9%!!>FI::V5D8R]*:51U>&%0.$%-6EA7;SAU
M8553:WIR25)#)B-X03M#;VE15DI,07-%<%$X:65G,TMJ=FQ(4V8P<$UE3D=8
M2&YU,&IG85EA1'!(03A*1TA&1$IB2S!K:4=#84TX0S@O-W-(9VAR4W T;6U1
M)B-X03M';4XQ>%,O6#4K-65.3F9++VU#,#$S5C=J5% P3'!517!G=5AS>4E6
M;"]E451'365S12M+3F%5,EE#=E94,GER3FE-23A81DQM16E6)B-X03ML3&)B
M>F]N;U=S."]L-U,S865/,VU7>FIG-%A&=W1Z23AD3%932$1E:C9D6% V=3EH
M,"LU06Q,<C=H6&8W,&-33CAV96)D2'9T6C O)B-X03M4-S-3=$A30SAP5SAH
M4E!4.5-305-*8G%802]F22]W<U!C8D$U1$QG;$=*24UT=C$X+V-K4T-&:S@V
M5UDQ=E5D3$]I85)B<&)8>E=C)B-X03M6+V-2<7--4TDX>6PW:FE$5&PV2V=6
M2S=T,$DS>5DP-3123&EL=4QR-6-K8V4V82M1=&4P-WI.<59X83-/:&%F84I&
M06LX9D=%1FY,)B-X03MH0WEJ:W10,U)F:2]U4C S1U9A<D5C8U%226YF.&9.
M351B3V8X3RM8+W=$<3)7;B]!0TEJ+W=#86-W9D9N,VXU<S9D+V@S>2\O=T)7
M)B-X03MY,"\U15(O.# T*TQ0=E!Z5VYF-&0X=B]!4%9S=% X06M22"]!33 T
M*TQ0=E!Z5VYF-&0X=B\X059S=% K4D5F+TY/4&EZ-WHX,7 S)B-X03LK2&9,
M+W=$,6),5"]!2D52+W=$3D]0:7HW>C@Q<#,K2&9,+R]!1F),5"]K4D@O>E1J
M-',K."].860O:#-Y+SA!.5=Y,"]W0U)%9CA!)B-X03MZ5&HT<RLX+TYA9"]H
M,WDO+W="5WDP+S5%4B\X,#0K3%!V4'I7;F8T9#AV+T%05G-T4#A!:U)(+T%-
M,#0K3%!V4'I7;F8T9#AV+SA!)B-X03M6<W10*U)%9B].3U!I>C=Z.#%P474O
M3%=N.$9M,'E'2%1T4W0R.5=Z=DE9;%)K:T%);S-%1&MJ06Q86'5P3U-J;4XW
M-VAA6D0U9#$Q)B-X03MD5W,R36MF,6953%9V4C%#>DIQ67!12S=(.7!(0C5)
M,V14-#%'4GE1-%0U2&MO3$=,665:-4Y4=4Y7,4QY+V536'-N2T<R:FIL<T1(
M)B-X03MB,G=A<6]H8395;&YO1VMA;34R-DM-=6U),$EI47(T-VXU25(O=T)C
M,3,O<5AB+R]!2D<V9B\R5C58-&-F-7<O,E@V:S(W-C5R=CA!)B-X03LQ3'0O
M+W=!:F10.$$K>79(=S0O>F@O<W8Q3&)V<FUU+SE3-V8O=T1),U0O*WEV2'<T
M+WIH+W-V,4QB=G)M=2\Y4S=F+T%023-4+SA!)B-X03MS<G@X3U X04](*WDO
M571U*W5A-R]W0E,W9CA!+TDS5"]W1'-R>#A/4#@T9C=,.5,R-S8U<G8X03%,
M="\O=T%J9% X02MY=DAW-"]Z)B-X03MH+W-V,4QB=G)M=2\Y4S=F+W=$23-4
M+RMY=DAW-"]Z:"]S=C%,8G9R;74O.5,W9B]!4$DS5"\X07-R>#A/4#A!3T@K
M>2]5='4K=6$W)B-X03LO=T)3-V8X02]),U0O=T1S<G@X3U X-&8W3#E3,C<V
M-7)V.$$Q3'0O+W=!:F10.$$K>79(=S0O>F@O<W8Q3&)V<FUU+SE3-V8O=T1)
M)B-X03LS5"\K>79(=S0O>F@O<W8Q3&)2=71B3F$K5S<T,38Q:S O="\P9%DK
M1U U=R]W0FPK<&)7*W1Q.4MF-%IV86(W8SE/-SEF.$%J-C<T)B-X03LX02]N
M1"]:9G%7+TIV-GAR4"]5=%@S6&PO96%D.7)X+S-Q-C0X02]N1"]:9G%7+TIS
M6$]T06MJ>3-F070Q26LP*W O-F5S9D1(.#1F)B-X03LW3#E3,S5/*W,V,55(
M+T1D.59D;%!Q869S4&(O045R2'=X+T](*WDO570K4S,Q=%E.0V9,3C=S95$K
M4%1V=&50*SE86$AG2#@T9C=,)B-X03LY4S,U3BMV<D9'2"M'<C)J+V(O96%D
M=C@O=T13<V5!9GIH+W-V,4QF:S,Y83%U=&8X3C,Q4E=H.514*RLU+S0K<V9$
M2#@T9C=,.5,R)B-X03LS.6,Q,R]Q6&(O.$$U1S9F+W=";&50:'@O;D0O04=8
M-FQT,S%Z6&8K<&1V+T%0:V)P+SA!,E8T*TA(*V-0.6PK<&)D.6,Q,R]!2VPR
M)B-X03LO=T0K4G5N+T%06EAJ-&-F-7<O,E@V;'0S,7I89BMP9'8O.$%K8G O
M+UI8:C1C9C5W+S)8-FQT,S%Z6&8K<&1V+W=$:V)P+R]!1U8T)B-X03LK2$@K
M8U X05IF<5<S9EA.9"\V;#(O.$$K4G5N+W=$6EAJ-&-F-7<O,E@V;'0S,7I8
M9CA!<5AB+T%0-4<V9CA!.6QE4&AX+VY$+UIF)B-X03MQ5S-F6$YD+S9L,B\O
M=T-2=6XO.6QE4&AX+VY$+UIF<5<S9EA.9"\V;#(O+T%/4G5N+SA!6EAJ-&-F
M-7<O=T)L*W!B9#EC,3,O<5AB)B-X03LO=T0U1S9F+T%.;&50:'@O;D0O6F9Q
M5S-F6$YD+W=#<&1V.$$O:V)P+W=$,E8T*TA(*V-0.6PK<&)11GE033AE<#(K
M<F%B-69V23<R)B-X03M0:D1C>'E3,D%J=4Q9=%9K8W)D35%Y5DQ2=%19-V1'
M3U=116%-5$E6.&1J.&M-.'I&6D]X5C4O*V%0-6I495A7='1',&UJ83=F<4="
M)B-X03M:45)$1$IY:E-18VE&-6U29F=Q0W9W;FPR<E)Q37=X>'1X<RMP.$UX
M1F-5<$=G3U@R,%AK8S)O959T5TQ83W123&9A=$1(-F%Y6')8)B-X03LQ,$E'
M:F0V>$9:<&UD,4)&4T-A5DHT;DY6;#=3>E)).$U#434O:CEL3S9L,F1J14DU
M36]-3U!P-&TQ.3-49C1)<GDQ*V,S;6)2=&-S)B-X03MP3E)A3656<G!L1GIB
M3UI:2DE9-4)'=G%X;&I,2W9O279W;VEH2E!I;V]:=5$R<TY:2$HP;RM4;W,K
M;VIH>BM'1'A1-D@X964S9'1T)B-X03MS*VHT2C1,:4-/-'0U1FUG;59:25IO
M,D1)-DU+<7ES2V=G9S%"1UAU679X5C)+=7A6,DMS5"]-5'IT2#5:,'A&9V5.
M9%=V035S5FYJ)B-X03MK;&AP0GAA5G!"1U5A9T1"4E$Q<7=.3TE9:5526EI2
M:5IC;GHY<EAL8GI*-7(P*U1Z1&8V.&MS4BM+1V4O:V-G;#DR5TI%5U%);V(Y
M)B-X03ML5E9F041P;#AS;4]!<6QW-F)*;%!P4U X=69Z5#@V*U5,=312.5%%
M*VXV8V%8=FPK-6LY6DAI:6PT4R]5,G%W:&M8:W@K16A'<%5H)B-X03MT9UEZ
M15-/3&MI1T]::UDY>C=",#-58E!5=$]T9%)S6E!7<W(R1T\T=%IG0W9/2U91
M-DY29T=&5EE(8UI1:$59<3=&6%EQ-T9867$X)B-X03M!+T]4.#-T5B]39'@U
M93!(54)P3FQB;&\W;E5">FIU<#=I0FES<TYU>6-N5TY8*T5V>%=R2W<U8V9T
M8FI1-DM"2$A0-$)W3E)Q2F-8)B-X03M"06(Y6&U$:GI41G)C,3AP=6)E-%-&
M,F95>DTX9#!*23 U=DU4-F]+>7E(:VI$<E-T5C5'<'%X.7 V2U=8:$A"4F]$
M8G(X=5A,9FPU)B-X03MU9E!S:E9$04HK<FDS2D8Y3G$O4SE:+TIN.#-D5'5T
M5FDX=&$Y<45E<7=Z.%ET3S%4:T9M:FU73V]T-2M9:F54;44K1U%G<U@R<2])
M)B-X03MC6F$W4E)G3T](,#E2,V9J.&571'!T5$EN9VU05C X,W5U87!Z;EEQ
M-T9867$W1E5O=4QO86YF,T]K5S%X-E-79U0Y2GE24T):=UI2)B-X03MZ4T9/
M3&,T*U-B=$I11V@O9&YL5FM6461Z-6(O04,K95-1,W5N-EIC6$5+13--,3-(
M1%!0>&A20WIZ4WI"-4=+;S9&;6,Q;U%39#A6)B-X03M85#-C5VMI6%9,4S<K
M=#9+<$UM<5%T35IJ8FAX-GAU25AD;31O<V)H;FAR>#E/:E)G16-:5E=1-'$W
M1EA9<3=&6'IJ*V-U;C9I+VYQ)B-X03LO=3<R9#1)03EU=6U.3$I$2$5,9C9S
M:%IK6C5&9F$U.5192C%Q83538T)Y5'%R1F-G0U0Y,T18=FM08S9J=$A!6E-%
M;WEQ42]&.#<U)B-X03LK6'A93&$V:G!E;3-P;$UK13 X:V)2=$A&>6XU.&PT
M:W,V<'=R4G$P,SA->#@O6E5J17@K:6E$8W!2034W96U0169,;C5U6FEY>FQ+
M)B-X03M01F51045D+S%#<CE895)F>$E3=517-U)K271R9#53<$E.>&5-1%0Y
M:6YP<%)4="]-5&TW,'9:=TUH17E%9DM',TMV-'!84&9Y-&1N)B-X03M#,4=#
M66MC:V]B>DXR9"\R93A6<RMV.$%Y1U%F23-L,&EG0C!Y>DE#9TMV*S@V9$%.
M9TUX8V=!:U)(;&5Z=&-:4$-,-3!X4#@P9$PQ)B-X03M3-S%I=VMT3$-A.&E3
M,V1784M*<%96:31/+T5':'!M6G!:9U).;70Q:W<W+T%!+W(S+U9J=78X07!&
M:R\U<'I*.%-0.#1F3D<V3C!4)B-X03M1=D]+879A='!T:%!P.3!(<4QY84HT
M;U519F(Y5V]8;7!(-TA5.7%F845*-4EC2G,R1F]V8F,Q5%DK968K8VM,5%94
M-7(P>3E#5&I4)B-X03MB87I2=E@S*W)O3V1W='E!2S Y4F<X1F%$<#%.0FU4
M<')V>5E:3UAM=U,Q=C5D56TP-WDV,',Y>$9-6&%Y36IR8D9L8C%*<$9M2$=1
M)B-X03MO:U4S24QX6#1L4$9E4$A+8RMN0E!&2W<W3%-A>5=/4&AW<5)/+W4X
M;4XV+S50.$%.;6DS=6\V.69*0EIV2C8S<'=313-%6E-4+V93)B-X03M%4VMX
M27)B8S9G54%/6'=X:7)(2C$R4V-U23-Z-G9Q6#AG<F$U="]Y:#AU4C-#36IM
M2V%2431:4UDU3&U6-&XK24$P94YL6E0S0G)M)B-X03M.3&UK4%%-0UAH;#=O
M3W9'.75$*VAR;#9Y3V5F,5IZ6#1J=EAJ=EA.=4UK82MO9DYR,U50.% V.2]W
M0E=/-B\V4EI0*V%C4&E2+VY$)B-X03LU<G5Z,SAR-TAZ3F%I-T8W13EP<$HR
M=#=3-%5R2C8Q9FEE3E11<$=2,4(K,#(T03-,665Q;$$Q5SAM56):-VU'>69&
M5VPV6F9F-#,Q)B-X03MK86<X:C9L<&-D6C=O<TAE4%55=6\R24UN2G%S.'%U
M;DE.6&5U8G)507HP>$%0.$%K-B\R3&HV2V-96F\X634U4#!O<C8S<E5A3DDX
M)B-X03M34G)A17I81"MP17!#1VY9=4A9<E1O;T]C44Y*:FME1TUR371H<V8Q
M5G4K:S5C=D)%>6Q%:4Y*<&].:F(R9C5Z,D9V85<W0T,O=4Q/)B-X03ME,&AG
M4W155%55;%IM0R]S4G)%>'(R541S33=F1DTO;%%C;C%E1TPY.58Y-S5J<4%*
M6F92>3A4-TMF5RMA5GI702]M;G R;UAJ-E4Q)B-X03MP6E,S9VI&=TI"1D<P
M=DAL-EA'=D5';&5*>DTP:V=,<S%Y67E92"]H+UAV*W)(9&8Y27-N+TY/6FYI
M4B]N1#5S9#!4<&YL+WID*VMB)B-X03M9-F9P,7I9,V]C1T<X94IO56I09&YD
M;'!W<%AK<$(U1&%H<E1)>7E1<F-G:&%,,BM-4T-.4DEW85%!8S)51E9,53-)
M56QQ1#)Q8S%*)B-X03MB2'A2*V-V;51Z:EEF;6IR9'1C6%5S5%<Q.38Q;VIS
M2D9%9$A.<31"-4M+450P2&=/=2M+44=,5&5A9DXP3B].3D9Q='EH-5A54$I*
M)B-X03M*0E91:V%Y259Q,W='3T=*95 R94MQ3V=X5E$P:GI$-6AG:'9283-B
M>5-3,EET:5=(<75S3&8V24EL-6AU23E/67%T3VTQ2TA&6#,Q)B-X03MO0S9M
M;6<V86UR2&QQ:3)S278R<7!R8T-.9E9.52M(-V1E;3)+169I<G-69&ER>E X
M-G9Y<69Z;' P5V\V5458>D1P,&)R0D<S1E9U)B-X03M9:CA8;W1)84975G%M
M36LX86QG86-U4S,T33AS4G-.5UA#2C%:<#@U;GE0-38P=E5I3')28GDR=5EN
M94M&:F)Y3D<X9T)J4'!S07E3)B-X03M#=$XQ<40X:FUY>41&<4EY12M':C4P
M82MW=$5P5'<Q-%A%92]B>B](5FY0-6(O:VAR;7(V<D)C-C=P.#%J;VM%=DLV
M:75W.79*3'A!)B-X03M0<'AX:TQ*46LP-6)!0W9&=5%W86I666]K*T=">&M6
M>&9T*T%707I:04)-*V=D4'0K,W$K;EDT-#0T,6IJ54I'9T-O:6=!04%504%(
M)B-X03M11$Y/-6DW1EA9<3=&6%EQ=S,X,"]W075R5'IZ-6-.9U=32%5B8W1*
M65A,<4M",E5Q63)C075Q4'-4>"]A5E=)64QX36]Y3653,"MA)B-X03M,9GE8
M*V$O;'5E-C!Q8E$Y4DYZ1T%93E4P*T-E-E%/2%HK4U-X2S8X6$1H;C1G<V%C
M4W13=WDT-4-A,U=(0T%B1R]2;% U5F9L>"M:)B-X03LK<V%X8S-'<GA8=FPO
M4G)K;TPK.'5I5G8W:%EJ>3E-3$U$3BLY1')Y66=*.%!1:V-C<7I(:G)Y8F-'
M6'=W9&=39G-F5&QT8E<Y<F)2)B-X03M7,71'<TYV06EX=W=O07%O:41I<7%"
M,$%!;TUG,4MM2W5X5C)+=7A6,DMV3"]W07<O=T%P<$Y1,4,O.$%-4&QT63$Q
M93ET,T8U87E.)B-X03MW17,X541,8E1235%Y<DER8U9+=%)7,F%Q:TYZ>F1.
M<2M#2FA)6$%U2'%D2UIZ:D]*<55$.$AJ3C,K5"]!3UHQ-W$Q>$@O:"M7279!
M)B-X03LX9U5Y,B]P075J27%E<TI&5FE$,6\R*S%6;V$U:S9--EA"04%'-4%D
M,U@X969X9&HR;#)N<714+T%%63A824AP9C9N="]W0UA0-5-1)B-X03LK6#<V
M,C$W5TA3-C$K0S K<%%H4#-K34-$-%,P8D]Q=GI:1D%*;TM!;&1X=6%.8G)F
M1S)!<4ED8F\Y26-)3FUY5"M!.4AZ06,Q,DMU)B-X03MX5C)+=7A6-'0K978U
M15A0;E153%AZ1#5F:VEH,71"1F)8:T4Q231P;V<Q1FU,<7!03TE..%9A.&M!
M03-50FQ.=DXY2B])9GI29FUY)B-X03M7-W19<E58<6%R27$S56E7.'E8171T
M3$AB<UEY9E=A275S0G!W-4$K<%912T9I:&PS-5AF:TQD,C)T3G%E=5%78C95
M.%-R2D$P17%T)B-X03M,3DAD3&,O=31B:4]&-#1W,%-Q5$MM-FAG<3A75CA#
M=F]01EA9<6\S,&IX,E9X26AO-E)U>6YW255K6DM),T-V;$1Y>BMA=C5K87AQ
M)B-X03MO<V)N>F-D3E(T<&UJ=5HT-V-2*W%K8DY':D5O3TED=T9R,C8U,&U8
M4C1O>'-1=C5U2DA*26YM>6QV35!N=')Q2T-$.'DW2C%U5F1O)B-X03M,:&IB
M<$=V<$IY4'$Q47-O9F]M,50T6FIE1FIQ+T-0,G1M+S@U6D(U9R]-5C=Y0S!F
M.'@Y4%4S4W59<G(Q3%@P14U28FM*5'<U3'E#)B-X03MG<'1V>4AU34IX-'%V
M=WIT-S$S+T%*>7EW.#$K96(P,SES;C5J5SA.-5E46$5B4U1I,6IT<&MT=E1(
M2T-3;DHO56%4-%!H;U%$=FAL)B-X03MH>&EJ-&5X<G9V9G910U0Q5CE6,6(X
M>CE-<VID6%@U9S)Q<V)96%5.<55H5V526'1N=5DK2T]I5D0X3T9A+V%0,WAH
M1$1),$U:-2]P)B-X03MP5'A$<6I0>48O35AZ<#5J.#(S1FQR5W!V93)Q,G)/
M<V)P1V]$0FAV.$-Q8V@R;'!S94]!35)7-C1::VYD-R]M;&-H,DMV:B]!1D0X
M)B-X03LU=GI15%4W;4-(6%IU2WI/:V%#3T4W0GE!0BLW>G%9-DA$45!#-%IY
M>71%=BM:2#4U>'I447E8.39K,$%*;6IA,VE6;$%4;6%G>"]Y)B-X03LW-4@X
M<G!U-$HT<&]E5#@Q+W=!-6]W<&968G-";#5,*S1I-F50.3,W-%)O.5 S0DA(
M3D8S9C5H9FYX6C-*=')Q-W8T2GA%.7=9-4QA)B-X03M.5#95874W=G9&.6Q6
M:6-K+W=#4V9$27@P,FU)<T%F3DIL3D%39FTY*V-%865P2G$Y,&E6235.0D5"
M5E12:%5X.7%B-4UA3$(S0DAI)B-X03M46F0K54@U<"MF9&$X.%=M;C9P<3AL
M,5IY9S@T6%-)02]%;S9Q:6YV;4@R:'!C8TUD>$9',F5+6DHS9E-U84IY6%EQ
M=V(X-F1F,691)B-X03MF>2MV=%0P:35A,'9O<$E&:FY52WA!95968EIG=S-"
M>DTP1T]-.&]%:%EA.&A):EEF4&MF-6\O;EA*67)F>#9L95!:3U=63&A926EH
M)B-X03M+1E%W0D5F-TID82]03C1D2G W<6AB:CAC-G124#5U+VY%1%$V=&0Q
M<%=N;U)D2V=F-S<X4TU0-4Q",T)F16UJ3#,X>&9Z,7-:4D9D)B-X03M8="]%
M-U8T,71O>4=P,31K4FM(-D\R*U)J<&1-95%(>E-:5%5R6#AZ+W=!-W)U-5,Q
M='11=G!B:51L=VA3,FI,2&=V2G%$,'5W1E1I)B-X03MD2G!W3$E(>E)X>E@S
M2#5K+VYN8C)R6&1X9E@X5G%I2DLX>C(P86]%;$Y),DQ'2VQ'4%1%85A413!!
M3#DV;6,S=%@U0BMA+TU(;51Y)B-X03MV9#-7=#-J6'1X2&-L16QD555H95!4
M-$%O>E0Y;S1O-#AL4D9#;DEX4TI'-S W34)S465S>GEW85!F5'A.=VQI=#58
M:EED;59#460O)B-X03MF2C1X8V=03EAY178U,2]M;WI"5C$V67-444%2445K
M;B]N;FY59FM-4#@Q=W9&;#-P<$PK668U.'A813EV2F1A:7,Y<VI3,T5:=$5R
M)B-X03M(1VDX,F1V,U=Y:&1Y8W%';3 Q6%$K8DQJ;6AF*U9R+T%*>CAE6#94
M=F502EDK6#%A3VY.>59682ML,4I"04=3+THV9G5(>E)X>F1C)B-X03MF;70K
M8SET8U,R."MQ6&%445 V8W%'0TMQ='E+,% W=GA5:D5A4%1K5T%&-#5O850X
M-F9Z6&ED;S5.9&Y34E12:V%+145(,T)J>5$P)B-X03M'02]W;SA75#!Z.&<O
M=T%X4$]F;5!Z4F0R970V;3DW8DIB;#!J9$DQ;S%E=G=+<'I89'!A8DAJ:41%
M5G4S65IK.#-U=6]+>E=&>7%I)B-X03MR1TIW04\U2VY.4DAM1SDX568X04MT
M+U S+U5V6"\X03!J>68P>G)F>E=,*V-(0CA/6&-M;FPS.'8O34U&-TTK=&56
M.5-U8E4R.'EX)B-X03M2>'=306ED:TEI8G%U=V)+<W5P9U(V6GAU,E5C6C9H
M;"MO95$O2GIX=4Q,>6PU;E=31TE,8F,T1C1Y4T=36GE:<4=V,EAJ56-33VYS
M)B-X03ME5TQ(535/<S1F:6UW=VHS1E(Q;GE*-5EM5S5F5'9+2&U/0UIO;5,R
M:CE%:4I:0D=&5GIY85)Z5FA7;DQR>3=C44I1,4UX5GIG9W=()B-X03MC5T)F
M.'$S."]F.$%5=E@O05 P:GEF,'I.+TY9=C5W879$;#-0568K8V5V2VYM8E(O
M3U4Y>'%U;#-.:D)*875I4U1X3D=P86]0149H)B-X03LQ;TTQ;F%M844T05))
M3S=D:&E19#,P8FUJ8V@R2W9I,B]W1'DO=T10-#%E-'5B9E%R+V$T95-+4EE(
M+VY,2W<R>G))-FY&=V='435/)B-X03M%65-T:TLS;C4U<#E515=K,U535TQ4
M3F)2>&%D2$=I;34O=G%Q<UE"1#<X<2M*>6IH,#(K-#,X*S5N8S%'-E U,S-/
M;EA7;E-A6&9#)B-X03MZ=EI7;75),'-L4W)S.&-H;U9J0D$U44IS3G1Q9$-C
M22],06<R3$AM9SAA3W5D9"\U>4-U3&EA-&MS<C<Q<#10<7-J0WA3=G!F2#A)
M)B-X03LO9"\X5W0K2&=-9TUE;$%Q>#@P,VM5+TU&+SA!;EIR,FIR<$XO;U8Q
M.5A%9G!/,&1R2VI/;VPY5E-26&=#4'-G<6\K2&)$:FIP-%,T)B-X03MH269.
M6D=:1E5Q+VLU-4\X,394-3AS8G95.4IU<D\Q0D-M86%*,%1K>G)15DDW-5@R
M;&YH3$954T-B5&AG460S,5)N4'53-T97069N)B-X03MP<&5O-FXK6$8Y6F%D
M8E-89#-*3&)L24E63'51<WES84M..6=->F5Z-6E/545M:'4Q-5)C6'HY;T9H
M*V-M9U)2>&%6<$XY0DA%.#!I)B-X03M+8DU39D9C3$5K=C(P879*8F1"5#(Y
M>FTW>5,P."]Q22MF-#<S2&E*:FMN4V$O.$%N-DQR-GDR;#-,>4=+4T-13G P
M641X>6Q#=V9J)B-X03M'=DDQ:EAF<CDK5F5(<&%Q>#@R6$9.4C!8569Z=C!L
M66\T9$5U6G)E3&-7.&QK=U9P4'%Z5V=L9&]H1S=/25<T,4QB,%=T85EC:V1.
M)B-X03M,*TEF4'IV-S%";4]I;'%.-RMF5V]8:'9,;7DQ2#9Y83!L:G-X159*
M:65'<3A%6&EE16A&4FAJ2%121D%J-7%43DQ,-U-0>F)V.4XO)B-X03M2=#-O
M5C%,869#5E$R0V=Q-F=$,4994CAH27EQ1F1W87-!2S%Y>4TX1519:TPY-T5I
M6D95.70O-7@R,&)6=$DX<C,Q<G%L<$Q:6$IU)B-X03M"24E:,$M.=TE)1%5B
M='-C,#-A95--<VQX3C=/4FE"160S<2MA.7-15W52=DIO;6]2>'%79#=A6E55
M8FMK>&M!1$HT>C9H-S%,-'=J)B-X03LO3'(X=UDS5C X=C,T6D-'52]6,S9J
M8V1S-G,V<D8O3TAZ8TAW-61Z354Q;B]N24I!;$Q454,P9G)C2&%Y5FU(,6@Q
M:V9D;WEE<41J)B-X03LO2TYH=&U,=V%8=DAZ8DQY2T=P6&XU.&%I1T8Q66%G
M=V%:<FEI,EE3:VIH5EEJ:6=O0W$P<# V*TIW>$=M:GE)*V%K>EA.9F9N<S9O
M)B-X03MS;6TS:V=J5E54;EE),4%L86)M4')V5W9I064R3F%B=DAZ5S5S93%R
M>6@K6BMT87)C-G)Q3V@S,#$Y9'8V:SAG=%=133%+5C1O<7%/)B-X03MN65IF
M:GHT65)%4DE54$YG65-*=6YO+R]!1&IZ-58X>6%.-71U6G17,'DU<UE:8F-P
M2$I01S!96G$Q;T-W1SE";74W57I1;D%C2D(S)B-X03MB8TU33'0Y170Y:R],
M3DDU1'A0>F)D4G@K8F]O669.8F%(8W9B2S!L<$IY949K1$]R379Q3C9#4T=Q
M+W,X<4-U8EA!4#-D.$A&=CA!)B-X03MJ>F%$>C5P2%HS=71X2F-N569Z1W-5
M=793:VA32E!36EEP0S102W!%6$DP5VXR9'$W6F9+351667I42#1U1W$V=SDS
M<49P2BM9159V)B-X03M*8GE'1TM2-UI%6&Y'5D5G2F1653 Y44PX3$=V,G9B
M0G=2;TAW+W18-'1X-G1C5$Q,-F8U:7A'-&<T>5-Y<D%#=F\X3TI#<#EH:C9L
M)B-X03M454-O>$U!4#AM;2].=31U-W$O84LU="]Z2'0T+U1T;&UJ55)O;$-S
M2W)*23!F3F$X;58R2W-0:'(P,GA%4DA9-&IZ4CA8<&XU93-%)B-X03ML>G K
M;GI386E.5FM-:S1A+U904T1L5VU79U%D3T9/2#!:<G152VQY-&9,-$YS1V0U
M:71J<U9E965C:6\P4SE,-F=U;&]R27I8<G4P)B-X03MA<4)-<$MS-DY'-FE4
M-T9664AF8F9->D(Y43)T<&LX-W5,<4]/=U!Q9FU&0V(W,5556$-586A%=UIE
M55%K24-H12M+=3(R+V9-.%(S)B-X03LO=3EM3C=C,4=3-3%7*VIU3%)F>DQT
M=U4U>%A(1S-J:DY(65)$9W=+;C=2;T=5+U1H06I(9G=J.#!B.39R<5!M3S=L
M,6UE,V<X*T=Y)B-X03M.>&13<&)7<VUM>4M)4GEK5#!M9#!59G4R1D-Z161#
M5&=H:4%J6G@S="]/56YZ6F(K6'1Z<4XW6EA6.61A,DY::&54,$EI269316)1
M)B-X03M--G91.%4U8W=6+UHW6FDV;T%%05(T5U575D@O04AQ<W8K66U(+VE9
M>D1N>6))<WAY<&TW1E5&<D@K.$5N>E@Y67E53V%*8VYK2&YA)B-X03LK;'0O
M34UA1'I39$%2-V%.:$A*0DLX6$I';2M0,5=P8FIM2&]68F8T5CES,F5N:F-0
M;S1T+W="6'AA4VQ5:S$T:T-Z:CAX23)V5G1')B-X03ME<4EK:4UQ8W!8;49U
M:%!):44Y:#)R5$Q!0F8Y,W1F-#,Y-B]&43 W5V)X<%)*2BM:15!P;S5$450R
M<U5-;C=T:50X36Y"<6-6;V1V)B-X03MX,GE5<UDO,5 W55@U<'I:95)V3V-5
M:EA&<#5Z;F5'945C1$EH;BM)+T='57EU-#0Q4&)T=&Q-=%)J3WAG;6EM,F<K
M6&9/3FYQ:U8Q)B-X03MQ9FU--FAA:$-S,7(V0WAH:45O<$)",F]X3$5G8CDX
M<GE:8UIJ55DP56=&-D(U9B]!3"LU+W=#36-8+T5P37=:.#)Y4$I/8V=Y5WDO
M)B-X03LS5"\V<"]6:7)Y,WI,-58X>&%L<4IV3DPX=WIA541"2&)I,U%"-'1P
M2&575&=703E2;%I65FAU2V4K,G=X6F]21E-J8E-1;&1P-4HO)B-X03M-1T5X
M3$HU>&571T]C4W-H9U%S.%E:5SE-=5<U8FM5-CE-<VQQ35(O9U)2-S!03#5'
M+TUM1D5G<W9.>&5",U@Q>D]$-FEO,TUY1DA*)B-X03ML8VUR1&E/4SE/;WE1
M,4=%-VU#,%5Y,&)Y,34Q<TY1<VXQ1'I0.65T<70Y86=:23!-:&]Z55-O62]A
M<#!);V\K-G9*;'AY0G%.2D%,)B-X03M-94(Y=G9'66E55'!I:V%N8C%P,69U
M1"MW8VA.;$9K:$914C0U5WI99'%0-6(V3G%6-#$U9C)D<F0S1%)I17E425@K
M0E-704%A;T<W)B-X03MD4G8P.$)M4DA5>FE+0G!G64)2;"]+=GDQ3$PV<VUL
M864X=&$X>D%P3F5V5VU%879)3W!8=W=Q>69L<&]5:VYQ4V%F671*5FTU1T5%
M)B-X03LX;DE,2' S;TU!,54K.')W0EEN-5AE6%59<W5M,DE9>"MI5SE%5CE-
M2T8T.4]L0F@O3C5/.')W0E1(-50K5G@P,')4>#A":D)%249%)B-X03M934-O
M,C9(;6-0-7I*,VQ(:&A/.4(X<G<V3W--3G%S8U9P07IU:TMC=7-N270Q.%=K
M2GEN2FM->EI:0TY*.6QB2C)+=D]04$5.-4YO)B-X03M&-TAA861&<3AX94DO
M;S9F:G=L451O6D%E4D%Q17%197A(9DTS5&M#67,X4&XX1VU404IR1%=69V$W
M=5!Y.'-:;FER13%U9VDU36=4)B-X03MK6D9)-6LQ-F-+135N0U5B;UI#>%!U
M9#E3=G)Z4TQA-6@O3'5&6F)H,F%E251F53553G5Y3D=7<7-5;GAY8WE"-T%N
M<FIX05-).%0Y)B-X03M03DAW4D,R+VY,.4E7*W)F-$]S4')!16IY3%-,,7<X
M,3 O2E),>G!5>$]Z33-(8VY),VIO>#1Z*T%N9G52;6YA;#4S,&TQ9W,Y33AM
M)B-X03M25SES<GET3D=L>7!R*S96;%!);7!:<$=O4V$W0VYV:UI1>'E.>6XY
M:3)E-39#9CDV<DPO04II668K2FI.8E!K,GA::FQ43C)+<48Y)B-X03MB4&,R
M<GA)=U9M<%)I2VI9,7=G,&=H:E=P95%R2%5Y1'%-1G!D:T%!971$>C)&4T)U
M9F,U8D102U!),&IG46MF-5=E6#0R1'!P.6=R)B-X03M#37=H:&)I=G!T2#92
M6'(S46-C;618:S=Y:F=#;3,U4BM6,C8V5G S46=5=&Q&07=)24902&MC4#5Z
M3"]!1&EV:&A022],;'I(1W-C)B-X03MC<U-2;T%Q27%%04%B04%!-T%:4V-H
M5'=R=C!"968W+T%)+RM!8BMU1&I8:%(R;#9D3&%.2S!K:75:06EJ:4-+8U-X
M-VLO>C5%;3!G)B-X03M5:CA#5G-V.3 O.$%Q;CE72W9-3F,X:C(K<F$U1G$O
M-E9V8DM72TM/17<R:W!I:F-24U!):D]!=%-16D-0;&UF:C%":DAH;T9P<$I$
M)B-X03LK5DUO:75Y,VUA*T5Z>')(83-83G<X4W!$-E9*1'HK358K23AE2#9Q
M6&9N3UAP0T]&6&PO2VUY=4Q/.'1R<E=R-E9D470T64QL9E4O)B-X03MD.#14
M0S-Q;VIH-DU48CEY5%)J=F='<TE)26E.:BMV.6$X2W!B+VQ4;T9R3' P;&QD
M6$9U9$YV1W999W)"=5)926]2=5-(-%%K4W(T)B-X03LP<FM4<DI'-T$S1DHT
M5G5I+VQ,;T=J6#EP95=6,4Y7,3E-:4]54GEQ>E)H<78X8UI+<WAA=%9P5&5L
M2S1C;71L345%8S!#3DTO=T)-)B-X03M!1W R*S1/-SE++WE(34-B6D9K;59S
M,UEQ-T9867$W1EA9<3=&6%EQ-T952RML86,W;#-T,%IM3E=*2%4T<70O42ML
M+SAS,&8S67$W)B-X03LY1#98+W=!<S!F,UEQ-SE$-E@O>7I2+V1I<G8P4'!F
M+T%#>E(O9&EQ-4Y*,#%(5C%T;W<V14UP<#!),T)X5D99<3=&6%EQ-T9867$W
M)B-X03M&6%EQ-T9867$W1E=N6&MJ3#1G:D98;'9M4#A!2T]45W1C9E='=4QY
M>G4R9T9S<'1P66MO1C5B9SEF,G9(33=&<E1#4$1126%Z:E%K)B-X03LS-4Q8
M:WI397!R3W-01DMP5U-"-WA'4F=X<3%19DA*:E@Q+T1(-4DX3G,O:W1-.6ID
M5V,K;V%H9%(S4'!C4F-4>%-Q9VE:5S)J649#)B-X03M4=T<U1T0X*V)"15%%
M*T<P9GE8=D$Y6618,6%#2W%%47A84TEO-$QX;T%/;DQQ8V9Z+SA!4FEV:&]N
M4W9Y;C%45'13:796,6)5-VQ5)B-X03MM5U8T3&TV1&]Y2W)5:C):9&DO1FI5
M1W9';4-E=#1H6$1&4FI:>' R;E@P9#E&3$Q&=U)/5E1Y53E623=%*T]957!7
M>4%P:6YL8GET)B-X03LU6FXX<V%23DYP1FQ,3DQ:5S=Y4U!B>$UZ33!3:W-X
M2S%*2GI)>EIP:6-G2DAM97%G0VMZ+W=!2655+RMR3%EF.4ES4"].3U8K4&LO
M)B-X03MN2#5P-%$W+T%!:#54+S9S=&@O,&EW+S@P-"M0:R]N2#5R=VA3=E!+
M9FQT3%-D-V91.5!A-%=.:D-R5W-2575&4$5%0F$P<C19634U)B-X03LS=DM8
M>EAH1'IC*V(Y3',Y3DYZ<79K0T-#4TY&85=1,GEW=S%F,"M+9WE1;F8Y.30Y
M:6,R4&=337%J:RLS.7)8>$1U5&$P,5A42C0W)B-X03LK6G9Y.5=/2WIJ3'AG
M,G%&-6EK>7AU27@V3D122#4Y83=%53<U5DM%:%$X5&XU+W149FML53-M2FI*
M8W1"*UA-85)7,S=V9SEH>EIP)B-X03M4-F<U0FQI56-&2W)88798,GDP6756
M-65F;6DO2E9(;4LS36M!4#5D4G!'2DIO-VQM<SDO,TUF27-Q:40T5C5&9'E4
M,T9$9SA)+S9R)B-X03LY=C=6=GE48E1D5#AU,TU.-DQR>4U,2SET-UDS5G!:
M4%I)6DQK24<U<6XW<%%'47%!9CA!5TAF8DM:=VU+<DI9=7)V;#EQ45(S2F):
M)B-X03LV-6)Q<4QE+VPR2DI(34(U,CEG1E)234%$6&Y(,54K-'(P.%1L<W-:
M-EIF=%)F:VE.3S$S4C=T-U9:4'DV940V,5!&1'I.;D=64EI()B-X03MK4G!'
M2FE79U0P>#%P,3=D-'IX4T8O=F58;BLQ45(S2TXS<G1I<W%X,B\U9&)O<VMT
M=UAS5DE+>$Y)<%--:4PW5&-&25!V4VYF1$A%)B-X03ME=5@W9C)R9FLQ4')L
M<5I,6G)F.'9),6=D6&MN16QN5U%#3TI:3T9&9S1G='HR4$DY3VQD<U)J3SDU
M9G0O870K4TMB5TY(4W=U-W O)B-X03MY.$EE,E<R84]%5V%&<%!R1E%W1EE1
M45DV94@S6DAW-5="-'9/*W9D.%4R3S5R5#E3<V)Z5DDW5G9Y*U<Q9U9*<$HU
M2DQ*1'HY3T5Y)B-X03MO<U)-4TQY63!8-'9(8D=50TDS-&PO2'I52'E10V5A
M=$QG,'@W-U50>3E32D5E8T9X84MQ:%EI<DM7-7=F0T-K9S-056<U6C1%:DMH
M)B-X03ML-W5V-U5C43=K5F4V-7!-4#%393(X:%)8='!065(S<G9B,G-C9S5Z
M=$=&:E-2675*-$LW8W4Y4C1B;45C8VI93U-J9&,Q2CAL3S0Q)B-X03LR,48T
M8F5,.'51<7AC;FQK97I6;%I)=W=D54MX9F$U<E)4=4-.*RM%67I6*TPY=C=6
M=GE7:GI2;SAH:T9V*UA1;CE%;VMP5S%1:%I()B-X03M#,5)Q44=J25A(261V
M=W<K1$QR;"LS.7$R3S55=69-1VY).'E1+VQU5SE+4U=-4$IA26EK4G!Z1$AJ
M035O45 Q94]!66HO<78R+W17)B-X03LO2E5U.5AS8DLV=EE*4'DK4S9%1C%,
M1$)00EI!4GE2<4A:0T-95W%A2G8R,S(X345C6DE".%-T=2]W1&%M+TI5<TY4
M,#(K,6EZ<T(K)B-X03M8-'1)<' S:G5,:31S54-R1VM0345F=6QO>%EJ-UAB
M,T]W;$-566LK2F4S970W.&Q&9%ET2C=7-F%(.'4Q9VUJ=&UU3&-Z5V%S:G-J
M)B-X03MO<&I+<D-R03!9+U-$,4<K4SA-9VHY-S$W+S)R9FMO=G)K2VAV*U%D
M0FTU47E);W-"6#!P6%%-;$1(475Q<S(Y971.<59)4&@O=T,R)B-X03LO86DO
M2E-T=DYM:3-L-CA&=#5$:% Q5U-/3SEJ*W%O.&DK<T1X96EW.&M153562VMK
M9&=C37-%9TQ/5&XU+W154TAC:C=85DQ#4WIK)B-X03MV6E!Y+U52;65#0T,Q
M5WE15$%34$MK:VI&;V=+3#93.78R9T-C<FQ!,UAI9$0Q.7EB.&M&*VYG2F54
M+VQU:5%&-6%2;7E";#E/1S,U)B-X03MK16E,:GEA6#12-V1J;&YH9C=B.79M
M:2]*15(K64Y,6EA:=GDS9$%)5$UP3FUL1%)725-V;S=.5F9U.3EJ131P9C9R
M.78W53,U33,P)B-X03LW>3,U5W4Y4'1R="],.6YB4&-22DLQ=DIA=V@T>39H
M:6IJ:CEP83!/654X,'=33TEN-'-G0C-):B]#2&Q0+W%Y,D@O4TQ$+WI4:V9(
M)B-X03MY9GIJ.# X260O:$1Y;B\Q6F)$+T%+4EEF*V%C9DAY9GIJ.#$T46QN
M;6YY=#5:9SAS879.1'!&;$9.1EI81'AY2F)X2WES<U1%37!#)B-X03LQ0D)Y
M>D1M;5IX0FME639O249*;C51+S524%)0*UE#,2]W0U1+-5AN+W9*93AP:GE4
M9DMK=7A6,DMT37%S2TU!4C1(9G!I<F5+=7A6)B-X03LR2W5X5C)+<U8X-U=(
M;GDY3G9(-6%V3&4P9T%*=5=K3$Q)5T1!<49922LQ0C=E.5)T;51P-5EH.5E*
M67EV;VM6,W!0-3%-6E9I,5=X)B-X03M);VMK8F992'%+,&)&5C1W9SA.;D9'
M2G%/=5AX;G!U-"]J-'-32DEJ.4=F;D)*36M5*W!72#%56$9S-WE28VML34UB
M;'!H55)J-V1")B-X03M552LT5G)(:C Y8D$S4E15;34Y2"].:40V+SA!;R]6
M8E8O5W9*<&)4-C!E6E-!<WAJ52]U:E0T841I3F=F87156DU"<7=E6%0K,6%K
M)B-X03LQ8S9(*V$Q>&%W2RMR,G-D,41E8R]7:4Q)1W0V4C=-<7AQ<E5+=G-2
M,WA'5$%$.4IQ=G17<$Q:.4HO3T,T=$QP2DY4<T5M-5%Y,EIJ)B-X03M$2T%2
M>4UK5"]U-DUM-%4X:'5".#A);G!W4G-6<5,Y8D0X-'9R;DPY26%C='%S+W=X
M8V5S23A326$W,#AE:'=C5VYR;$LO>#5R-FTW)B-X03M04R]Z86PP-B]H,4Q5
M-U):-3=/84\P93-O:E(S2EIF4V9K26A11D]12C9J86TK37 V8T5'25!0-U!M
M=%-1.6YO9C5V5VEZ26UR5W-S)B-X03MF1D=J37I'4U)N0TMR:FLX2G P2D@K
M5G5D='-L3$IP>B]#9G@X5G%33#!N4V9Z5&@Q3U8Y4C%3,FYT2FEO67@W1DM*
M3%5X;S!814%-)B-X03LV-TAC,$97;TUH3V5!>#)"=CAE86=&0E=U:B]N4F(R
M>5)R<71J2DE63%103U,U.54X*V@Y2#=0,F1H+UA*>7EA66YK9G@X559*:UAL
M)B-X03MI1'HY2&9Z=#5I=6)387EA2F9Q.&1U1'I76&MA,5!&3G50.$%$,WI(
M>DA&6&]"=&M,-G-L>DA:3WA6;TMO2DE!0F(W4CAC5F)X5C)+)B-X03MU>%8R
M2W5X5C)+<%(U=CA!*U54,78O;4%U=CA!:WDR5S10-WE0=D-*8VM*1B]W07%:
M.4Y04RMO*VQX2$1J>C0X86)5<'13;5AN>"].)B-X03M'>3<O04I!.2]W0758
M+T0T+W8X07I86C,O24AV*UA,+T%)9D@Y+S5R<S<O:T0S+TQL+W<K4#<O>EA:
M,R]!0T(W+VQY+S1F2#DO=T-A)B-X03LW3R\U03DO>35F.$%$-"]V+TYD;F8X
M9V4O=T-83"]H.&8S+VUU>G8K45!F.'58+T0T+W8O04186C,O24AV*UA,+V@X
M9C,O;75Z=CA!)B-X03MK1#,O04,U9CA0:BLO=T1.9&YF.&=E+S5C=CA!:#AF
M,R]M=7IV*U%09CAU6"]$-"]V+TYD;F8X04E(=BM83"]H.&8S+T%*<G,W+VM$
M)B-X03LS+TQL+W=!4&HK+S@Q,F0O>4(W+T%*8W8K2'@O9BMA-T\O-4$Y+WDU
M9CA0:BLO.$%.9&YF.&=E+S5C=BM(>"]F*V$W3R]W0U%09CA!)B-X03M,;"]W
M*U W+T%-,3)D+WE"-R]L>2]W0TAX+V8K83=/+S5!.2]Y-68X4&HK+S@Q,F0O
M=T%G92\U8W8K2'@O9CA!;75Z=BM14&8X=5@O)B-X03M!02M0-R]Z6%HS+TE(
M=CA!;'DO-&9(.2\U<G,W+VM$,R],;"]W*U W+W=!,3)D+WE"-R]L>2\T9D@Y
M+S5R<S<O04I!.2]W0758+T0T)B-X03LO=CA!>EA:,R])2'8K6$PO04EF2#DO
M-7)S-R]K1#,O3&PO=RM0-R]Z6%HS+T%#0C<O;'DO-&9(.2]W0V$W3R\U03DO
M>35F.$%$-"]V)B-X03LO3F1N9CAG92]W0UA,+V@X9C,O;75Y,E@O;%10<'8V
M=C%(,'5*-3AU9DAJ5&5T9'%5>$AJ*V$W4"\Y:ST\+WAM<$=);6<Z:6UA9V4^
M"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!
M;'0^"B @(" @(" @(#PO>&UP.E1H=6UB;F%I;',^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB
M(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B"B @
M(" @(" @(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B/@H@(" @(" @(" \>&UP34TZ
M26YS=&%N8V5)1#YX;7 N:6ED.C W03,V,4,P,T$X0T5!,3$X0T5$1C8R-#@Q
M,C P,3A$/"]X;7!-33I);G-T86YC94E$/@H@(" @(" @(" \>&UP34TZ1&]C
M=6UE;G1)1#YX;7 N9&ED.C W03,V,4,P,T$X0T5!,3$X0T5$1C8R-#@Q,C P
M,3A$/"]X;7!-33I$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ3W)I9VEN
M86Q$;V-U;65N=$E$/G5U:60Z-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q
M-3 X0S@\+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/'AM
M<$U-.E)E;F1I=&EO;D-L87-S/F1E9F%U;'0\+WAM<$U-.E)E;F1I=&EO;D-L
M87-S/@H@(" @(" @(" \>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W12968Z:6YS=&%N8V5)1#YX
M;7 N:6ED.C V03,V,4,P,T$X0T5!,3$X0T5$1C8R-#@Q,C P,3A$/"]S=%)E
M9CII;G-T86YC94E$/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YX
M;7 N9&ED.C V03,V,4,P,T$X0T5!,3$X0T5$1C8R-#@Q,C P,3A$/"]S=%)E
M9CID;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U
M;65N=$E$/G5U:60Z-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@\
M+W-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F
M.G)E;F1I=&EO;D-L87-S/F1E9F%U;'0\+W-T4F5F.G)E;F1I=&EO;D-L87-S
M/@H@(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" @(" \>&UP
M34TZ2&ES=&]R>3X*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z
M,#5!,S8Q0S S03A#14$Q,3A#141&-C(T.#$R,# Q.$0\+W-T179T.FEN<W1A
M;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C M,#4M
M,#)4,3$Z,S4Z,3,K,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E($EL;'5S=')A=&]R($-3
M-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T
M179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C W03,V,4,P,T$X0T5!
M,3$X0T5$1C8R-#@Q,C P,3A$/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 U+3 R5#$Q.C,Y.C(T*S U
M.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F
M='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I/"]S
M=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<$U-
M.DAI<W1O<GD^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F
M.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SII
M;&QU<W1R871O<CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]I;&QU<W1R871O<B\Q
M+C O(CX*(" @(" @(" @/&EL;'5S=')A=&]R.E-T87)T=7!0<F]F:6QE/E!R
M:6YT/"]I;&QU<W1R871O<CI3=&%R='5P4')O9FEL93X*(" @(" @/"]R9&8Z
M1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T
M/2(B"B @(" @(" @(" @('AM;&YS.GAM<%109STB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+W0O<&<O(@H@(" @(" @(" @("!X;6QN<SIS=$1I;3TB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+T1I;65N<VEO;G,C
M(@H@(" @(" @(" @("!X;6QN<SIS=$9N=#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+W-4>7!E+T9O;G0C(@H@(" @(" @(" @("!X;6QN<SIX;7!'
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R\B/@H@(" @(" @(" \
M>&UP5%!G.DAA<U9I<VEB;&5/=F5R<')I;G0^1F%L<V4\+WAM<%109SI(87-6
M:7-I8FQE3W9E<G!R:6YT/@H@(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&54
M<F%N<W!A<F5N8WD^1F%L<V4\+WAM<%109SI(87-6:7-I8FQE5')A;G-P87)E
M;F-Y/@H@(" @(" @(" \>&UP5%!G.DY086=E<SXQ/"]X;7!44&<Z3E!A9V5S
M/@H@(" @(" @(" \>&UP5%!G.DUA>%!A9V53:7IE(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T1&EM.G<^-C$R+C P,# P,#PO
M<W1$:6TZ=SX*(" @(" @(" @(" @/'-T1&EM.F@^-SDR+C P,# P,#PO<W1$
M:6TZ:#X*(" @(" @(" @(" @/'-T1&EM.G5N:70^4&]I;G1S/"]S=$1I;3IU
M;FET/@H@(" @(" @(" \+WAM<%109SI-87A086=E4VEZ93X*(" @(" @(" @
M/'AM<%109SI&;VYT<SX*(" @(" @(" @(" @/')D9CI"86<^"B @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$YA;64^0V%L:6)R:2U";VQD/"]S
M=$9N=#IF;VYT3F%M93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&
M86UI;'D^0V%L:6)R:3PO<W1&;G0Z9F]N=$9A;6EL>3X*(" @(" @(" @(" @
M(" @(" @/'-T1FYT.F9O;G1&86-E/D)O;&0\+W-T1FYT.F9O;G1&86-E/@H@
M(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=%1Y<&4^3W!E;B!4>7!E/"]S
M=$9N=#IF;VYT5'EP93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.G9E<G-I
M;VY3=')I;F<^5F5R<VEO;B V+C(Q/"]S=$9N=#IV97)S:6]N4W1R:6YG/@H@
M(" @(" @(" @(" @(" @(" \<W1&;G0Z8V]M<&]S:71E/D9A;'-E/"]S=$9N
M=#IC;VUP;W-I=&4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1FEL
M94YA;64^8V%L:6)R:6(N='1F/"]S=$9N=#IF;VYT1FEL94YA;64^"B @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI"86<^"B @
M(" @(" @(#PO>&UP5%!G.D9O;G1S/@H@(" @(" @(" \>&UP5%!G.E!L871E
M3F%M97,^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \
M<F1F.FQI/D-Y86X\+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:3Y-
M86=E;G1A/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D^665L;&]W
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D^0FQA8VL\+W)D9CIL
M:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<%109SI0
M;&%T94YA;65S/@H@(" @(" @(" \>&UP5%!G.E-W871C:$=R;W5P<SX*(" @
M(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \>&UP
M1SIG<F]U<$YA;64^1&5F875L="!3=V%T8V@@1W)O=7 \+WAM<$<Z9W)O=7!.
M86UE/@H@(" @(" @(" @(" @(" @(" \>&UP1SIG<F]U<%1Y<&4^,#PO>&UP
M1SIG<F]U<%1Y<&4^"B @(" @(" @(" @(" @(" @(#QX;7!'.D-O;&]R86YT
M<SX*(" @(" @(" @(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE
M/E=H:71E/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P
M,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP
M1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L
M86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0FQA8VL\+WAM<$<Z<W=A=&-H
M3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#
M35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P
M,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,3 P+C P,# P,#PO>&UP
M1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS
M=V%T8VA.86UE/D--64L@4F5D/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%
M4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P,"XP,# P,# \+WAM<$<Z;6%G
M96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W
M/C$P,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @
M(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D--
M64L@665L;&]W/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP
M+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXQ,# N,# P,# P
M/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#35E+($=R965N/"]X
M;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXQ,# N,# P,# P/"]X
M;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA
M9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C$P,"XP,# P,# \+WAM<$<Z>65L
M;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP
M+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIS=V%T8VA.86UE/D--64L@0WEA;CPO>&UP1SIS=V%T8VA.
M86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--
M64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F-Y86X^,3 P+C P,# P,#PO>&UP1SIC>6%N/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P
M,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'
M.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W
M871C:$YA;64^0TU92R!";'5E/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%
M4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8WEA;CXQ,# N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 P+C P,# P,#PO>&UP1SIM
M86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL
M;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @
M(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D--
M64L@36%G96YT83PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'
M.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^
M,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6%G96YT83XQ,# N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P
M,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STQ-2!-/3$P,"!9
M/3DP($L],3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT
M>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C$T
M+CDY.3DY.#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM86=E;G1A/C$P,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/CDP+C P,# P
M,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F)L86-K/C$P+C P,# P,CPO>&UP1SIB;&%C:SX*(" @(" @(" @(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3DP(%D]
M.#4@2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P
M,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIM86=E;G1A/CDP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^.#4N,# P,# P/"]X
M;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TX,"!9/3DU($L]
M,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \
M+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6%G96YT83XX,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/CDU+C P,# P,#PO>&UP1SIY
M96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K
M/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP($T]-3 @63TQ,# @2STP/"]X
M;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/C4P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL
M;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N
M,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G-W871C:$YA;64^0STP($T],S4@63TX-2!+/3 \+WAM<$<Z
M<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y
M86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^
M,S4N,# P,# T/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.GEE;&QO=SXX-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P
M,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIS=V%T8VA.86UE/D,]-2!-/3 @63TY,"!+/3 \+WAM<$<Z<W=A=&-H
M3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#
M35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIC>6%N/C4N,# P,# Q/"]X;7!'.F-Y86X^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P
M,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z>65L;&]W/CDP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'
M.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W
M871C:$YA;64^0STR,"!-/3 @63TQ,# @2STP/"]X;7!'.G-W871C:$YA;64^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO
M>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT
M>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z8WEA;CXQ.2XY.3DY.3@\+WAM<$<Z8WEA;CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO
M>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L
M86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @
M(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C
M:$YA;64^0STU,"!-/3 @63TQ,# @2STP/"]X;7!'.G-W871C:$YA;64^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP
M1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E
M/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8WEA;CXU,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP
M1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY
M96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA
M;64^0STW-2!-/3 @63TQ,# @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM
M;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!2
M3T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z8WEA;CXW-2XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM
M86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL
M;W<^,3 P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^
M0STX-2!-/3$P(%D],3 P($L],3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO
M9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/
M0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIC>6%N/C@U+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P+C P,# P,CPO>&UP1SIM
M86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL
M;W<^,3 P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F)L86-K/C$P+C P,# P,CPO>&UP1SIB;&%C:SX*
M(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE
M/D,].3 @33TS,"!9/3DU($L],S \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO
M9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/
M0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIC>6%N/CDP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C,P+C P,# P,CPO>&UP1SIM
M86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL
M;W<^.34N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z8FQA8VL^,S N,# P,# R/"]X;7!'.F)L86-K/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^
M0STW-2!-/3 @63TW-2!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T53
M4SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIC>6%N/C<U+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N
M=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXW
M-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @
M(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,].# @
M33TQ,"!9/30U($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X
M;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y
M86X^.# N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.FUA9V5N=&$^,3 N,# P,# R/"]X;7!'.FUA9V5N=&$^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXT-2XP
M,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIB;&%C:SXP+C P,# P,#PO>&UP1SIB;&%C:SX*(" @(" @(" @
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-S @33TQ
M-2!9/3 @2STP/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXW
M,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6%G96YT83XQ-"XY.3DY.3@\+WAM<$<Z;6%G96YT83X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P
M/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @
M(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3@U($T]-3 @63TP
M($L],#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^.#4N,# P
M,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUA9V5N=&$^-3 N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP
M1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L
M86-K/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STQ,# @33TY-2!9/34@2STP
M/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXQ,# N,# P,# P
M/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUA9V5N=&$^.34N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXU+C P,# P,3PO>&UP1SIY
M96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K
M/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G-W871C:$YA;64^0STQ,# @33TQ,# @63TR-2!+/3(U
M/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXQ,# N,# P,# P
M/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUA9V5N=&$^,3 P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,C4N,# P,# P/"]X;7!'
M.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA
M8VL^,C4N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^0STW-2!-/3$P,"!9/3 @2STP
M/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXW-2XP,# P,# \
M+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6%G96YT83XQ,# N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY
M96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K
M/C N,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G-W871C:$YA;64^0STU,"!-/3$P,"!9/3 @2STP/"]X
M;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXU,"XP,# P,# \+WAM
M<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G
M96YT83XQ,# N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL
M;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N
M,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G-W871C:$YA;64^0STS-2!-/3$P,"!9/3,U($L],3 \+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C,U+C P,# P-#PO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/C$P,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C,U+C P,# P-#PO>&UP1SIY96QL
M;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C$P
M+C P,# P,CPO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIS=V%T8VA.86UE/D,],3 @33TQ,# @63TU,"!+/3 \+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C$P+C P,# P,CPO>&UP
M1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E
M;G1A/C$P,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C4P+C P,# P,#PO>&UP1SIY96QL
M;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N
M,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G-W871C:$YA;64^0STP($T].34@63TR,"!+/3 \+WAM<$<Z
M<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y
M86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^
M.34N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.GEE;&QO=SXQ.2XY.3DY.3@\+WAM<$<Z>65L;&]W/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P
M,#PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIS=V%T8VA.86UE/D,],C4@33TR-2!9/30P($L],#PO>&UP1SIS=V%T
M8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E
M/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F-Y86X^,C4N,# P,# P/"]X;7!'.F-Y86X^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,C4N
M,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.GEE;&QO=SXS.2XY.3DY.38\+WAM<$<Z>65L;&]W/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO
M>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIS=V%T8VA.86UE/D,]-# @33TT-2!9/34P($L]-3PO>&UP1SIS=V%T8VA.
M86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--
M64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.F-Y86X^,SDN.3DY.3DV/"]X;7!'.F-Y86X^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-#4N,# P
M,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.GEE;&QO=SXU,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXU+C P,# P,3PO>&UP
M1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS
M=V%T8VA.86UE/D,]-3 @33TU,"!9/38P($L],C4\+WAM<$<Z<W=A=&-H3F%M
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+
M/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIC>6%N/C4P+C P,# P,#PO>&UP1SIC>6%N/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C4P+C P,# P
M,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIY96QL;W<^-C N,# P,# T/"]X;7!'.GEE;&QO=SX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,C4N,# P,# P/"]X;7!'
M.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W
M871C:$YA;64^0STU-2!-/38P(%D]-C4@2STT,#PO>&UP1SIS=V%T8VA.86UE
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\
M+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F-Y86X^-34N,# P,# P/"]X;7!'.F-Y86X^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-C N,# P,# T
M/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.GEE;&QO=SXV-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXS.2XY.3DY.38\+WAM<$<Z
M8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A
M=&-H3F%M93Y#/3(U($T]-# @63TV-2!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X
M;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y
M<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIC>6%N/C(U+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C,Y+CDY.3DY-CPO
M>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIY96QL;W<^-C4N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,"XP,# P,# \+WAM<$<Z8FQA
M8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H
M3F%M93Y#/3,P($T]-3 @63TW-2!+/3$P/"]X;7!'.G-W871C:$YA;64^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP
M1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E
M/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z8WEA;CXS,"XP,# P,#(\+WAM<$<Z8WEA;CX*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XU,"XP,# P,# \+WAM
M<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M>65L;&]W/C<U+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.F)L86-K/C$P+C P,# P,CPO>&UP1SIB;&%C
M:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.
M86UE/D,],S4@33TV,"!9/3@P($L],C4\+WAM<$<Z<W=A=&-H3F%M93X*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'
M.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^
M4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIC>6%N/C,U+C P,# P-#PO>&UP1SIC>6%N/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C8P+C P,# P-#PO>&UP
M1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY
M96QL;W<^.# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,C4N,# P,# P/"]X;7!'.F)L86-K
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA
M;64^0STT,"!-/38U(%D].3 @2STS-3PO>&UP1SIS=V%T8VA.86UE/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z
M;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y0
M4D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F-Y86X^,SDN.3DY.3DV/"]X;7!'.F-Y86X^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-C4N,# P,# P/"]X;7!'
M.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE
M;&QO=SXY,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIB;&%C:SXS-2XP,# P,#0\+WAM<$<Z8FQA8VL^
M"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M
M93Y#/30P($T]-S @63TQ,# @2STU,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z
M;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y0
M4D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F-Y86X^,SDN.3DY.3DV/"]X;7!'.F-Y86X^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-S N,# P,# P/"]X;7!'
M.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE
M;&QO=SXQ,# N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8FQA8VL^-3 N,# P,# P/"]X;7!'.F)L86-K
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA
M;64^0STU,"!-/3<P(%D].# @2STW,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z
M;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y0
M4D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F-Y86X^-3 N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^-S N,# P,# P/"]X;7!'
M.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE
M;&QO=SXX,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIB;&%C:SXW,"XP,# P,# \+WAM<$<Z8FQA8VL^
M"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(" @(" @(" @(#PO>&UP
M1SI#;VQO<F%N=',^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!.86UE/D=R87ES/"]X;7!'.F=R
M;W5P3F%M93X*(" @(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!4>7!E/C$\
M+WAM<$<Z9W)O=7!4>7!E/@H@(" @(" @(" @(" @(" @(" \>&UP1SI#;VQO
M<F%N=',^"B @(" @(" @(" @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @
M(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H
M3F%M93Y#/3 @33TP(%D],"!+/3$P,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z
M;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y0
M4D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM
M86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL
M;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIB;&%C:SXQ,# N,# P,# P/"]X;7!'.F)L86-K/@H@
M(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA;64^
M0STP($T],"!9/3 @2STY,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#15-3
M/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E;G1A
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^,"XP
M,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIB;&%C:SXX.2XY.3DT,#4\+WAM<$<Z8FQA8VL^"B @(" @(" @
M(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @
M(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TP
M(%D],"!+/3@P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z
M='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP
M+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO
M>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.F)L86-K/C<Y+CDY.#<Y-3PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @63TP($L]
M-S \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P
M/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE
M;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^
M-CDN.3DY-S R/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G-W871C:$YA;64^0STP($T],"!9/3 @2STV,#PO>&UP
M1SIS=V%T8VA.86UE/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIM;V1E/D--64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z
M8WEA;CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6%G96YT
M83XP+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIY96QL;W<^,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXU.2XY.3DQ
M,#0\+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @(" @(" @(" @
M/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TP(%D],"!+/34P/"]X;7!'.G-W871C
M:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^
M0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \
M>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C N,# P
M,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C4P+C P,# P,#PO>&UP
M1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIS
M=V%T8VA.86UE/D,],"!-/3 @63TP($L]-# \+WAM<$<Z<W=A=&-H3F%M93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X
M;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y
M<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM
M<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z
M>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z8FQA8VL^,SDN.3DY-# Q/"]X;7!'.F)L86-K
M/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W871C:$YA
M;64^0STP($T],"!9/3 @2STS,#PO>&UP1SIS=V%T8VA.86UE/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--64L\+WAM<$<Z;6]D
M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z='EP93Y04D]#
M15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F-Y86X^,"XP,# P,# \+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XP+C P,# P,#PO>&UP1SIM86=E
M;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIY96QL;W<^
M,"XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIB;&%C:SXR.2XY.3@X,#(\+WAM<$<Z8FQA8VL^"B @(" @
M(" @(" @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @
M33TP(%D],"!+/3(P/"]X;7!'.G-W871C:$YA;64^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM
M<$<Z='EP93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA
M;CXP+C P,# P,#PO>&UP1SIC>6%N/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIM86=E;G1A/C N,# P,# P/"]X;7!'.FUA9V5N=&$^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.GEE;&QO=SXP+C P,# P
M,#PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.F)L86-K/C$Y+CDY.3<P,3PO>&UP1SIB;&%C:SX*(" @(" @(" @(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3 @63TP
M($L],3 \+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E
M/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P
M,# P/"]X;7!'.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.FUA9V5N=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'
M.GEE;&QO=SX*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA
M8VL^.2XY.3DQ,#,\+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z<W=A=&-H3F%M93Y#/3 @33TP(%D],"!+/34\+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'
M.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N
M=&$^,"XP,# P,# \+WAM<$<Z;6%G96YT83X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z>65L;&]W/C N,# P,# P/"]X;7!'.GEE;&QO=SX*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z8FQA8VL^-"XY.3@X
M,#,\+WAM<$<Z8FQA8VL^"B @(" @(" @(" @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @
M(" @(" @(" @(#PO>&UP1SI#;VQO<F%N=',^"B @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!.86UE
M/D)R:6=H=',\+WAM<$<Z9W)O=7!.86UE/@H@(" @(" @(" @(" @(" @(" \
M>&UP1SIG<F]U<%1Y<&4^,3PO>&UP1SIG<F]U<%1Y<&4^"B @(" @(" @(" @
M(" @(" @(#QX;7!'.D-O;&]R86YT<SX*(" @(" @(" @(" @(" @(" @(" @
M/')D9CI397$^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIS=V%T8VA.86UE/D,],"!-/3$P,"!9/3$P,"!+/3 \+WAM
M<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z;6]D93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'
M.F-Y86X^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N
M=&$^,3 P+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL
M;W<^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N
M,# P,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.G-W871C:$YA;64^0STP($T]-S4@63TQ,# @2STP/"]X;7!'
M.G-W871C:$YA;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.FUO9&4^0TU92SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @
M(" @(" @(" @(" @(" @(" @/'AM<$<Z8WEA;CXP+C P,# P,#PO>&UP1SIC
M>6%N/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A
M/C<U+C P,# P,#PO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL;W<^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P
M,# P/"]X;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G-W871C:$YA;64^0STP($T],3 @63TY-2!+/3 \+WAM<$<Z<W=A
M=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D
M93Y#35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIC>6%N/C N,# P,# P/"]X;7!'.F-Y86X^
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^,3 N
M,# P,# R/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(#QX;7!'.GEE;&QO=SXY-2XP,# P,# \+WAM<$<Z>65L;&]W/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,# P,#PO
M>&UP1SIB;&%C:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIS=V%T8VA.86UE/D,].#4@33TQ,"!9/3$P,"!+/3 \+WAM<$<Z<W=A=&-H
M3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#
M35E+/"]X;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX
M;7!'.G1Y<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIC>6%N/C@U+C P,# P,#PO>&UP1SIC>6%N/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/C$P+C P
M,# P,CPO>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" \>&UP1SIY96QL;W<^,3 P+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X
M;7!'.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'
M.G-W871C:$YA;64^0STQ,# @33TY,"!9/3 @2STP/"]X;7!'.G-W871C:$YA
M;64^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUO9&4^0TU9
M2SPO>&UP1SIM;V1E/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIT>7!E/E!23T-%4U,\+WAM<$<Z='EP93X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @/'AM<$<Z8WEA;CXQ,# N,# P,# P/"]X;7!'.F-Y86X^"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.FUA9V5N=&$^.3 N,# P
M,# P/"]X;7!'.FUA9V5N=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(#QX;7!'.GEE;&QO=SXP+C P,# P,#PO>&UP1SIY96QL;W<^"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(#QX;7!'.F)L86-K/C N,# P,# P/"]X;7!'
M.F)L86-K/@H@(" @(" @(" @(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G-W
M871C:$YA;64^0STV,"!-/3DP(%D],"!+/3 \+WAM<$<Z<W=A=&-H3F%M93X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z;6]D93Y#35E+/"]X
M;7!'.FUO9&4^"B @(" @(" @(" @(" @(" @(" @(" @(" @(#QX;7!'.G1Y
M<&4^4%)/0T534SPO>&UP1SIT>7!E/@H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" \>&UP1SIC>6%N/C8P+C P,# P-#PO>&UP1SIC>6%N/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" \>&UP1SIM86=E;G1A/CDP+C P,# P,#PO
M>&UP1SIM86=E;G1A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP
M1SIY96QL;W<^,"XP,#,P.3D\+WAM<$<Z>65L;&]W/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" \>&UP1SIB;&%C:SXP+C P,S Y.3PO>&UP1SIB;&%C
M:SX*(" @(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @(" @(" @(" @/"]X
M;7!'.D-O;&]R86YT<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!44&<Z4W=A=&-H1W)O
M=7!S/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C
M<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H
M='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0
M<F]D=6-E<CY!9&]B92!01$8@;&EB<F%R>2 Q,"XP,3PO<&1F.E!R;V1U8V5R
M/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z
M>&UP;65T83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD
M/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$!_\  $0@ Y@)= P$1  (1 0,1 ?_$ !\  0 !! ,! 0$
M       (!@<)"@,$!0L! O_$ %X0  $$ @(   @* P80#0,$ P0" P4& 0<
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M5[D]=_A[CQ_XY^6'$WUYDOQ.G@W'^8U/1XO4T] ?H_ZH/6KW)Z[_  ]QX_\
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M2K[5\(Y6JQN.\25:T_X.^G;!U6=(DM(,BKBYKEP[&P6!\QP38EHF2<IEY%_
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MNQW5H;.VZRSU,!KT7! ]6]EZT9)$4B%MLB959<6>GK0WE(LY(R\U%#P$C(&
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MI2]8_6,T1[WM?_B'CQ5XG^3F>^I\A^'T[]I^=UOIXO7T]*7K'ZQFB/>]K_\
M$/'BKQ/\G,]]3Y#\/IW[3\[K?3Q>OIZ4O6/UC-$>][7_ .(>/%7B?Y.9[ZGR
M'X?3OVGYW6^GB]?3TI>L?K&:(][VO_Q#QXJ\3_)S/?4^0_#Z=^T_.ZWT\7KZ
M>E+UC]8S1'O>U_\ B'CQ5XG^3F>^I\A^'T[]I^=UOIXO7T]*7K'ZQFB/>]K_
M /$/'BKQ/\G,]]3Y#\/IW[3\[K?3Q>OIZ4O6/UC-$>][7_XAX\5>)_DYGOJ?
M(?A]._:?G=;Z>+U]/2EZQ^L9HCWO:_\ Q#QXJ\3_ "<SWU/D/P^G?M/SNM]/
M%Z^GI2]8_6,T1[WM?_B'CQ5XG^3F>^I\A^'T[]I^=UOIXO7T]*7K'ZQFB/>]
MK_\ $/'BKQ/\G,]]3Y#\/IW[3\[K?3Q>OIZ4O6/UC-$>][7_ .(>/%7B?Y.9
M[ZGR'X?3OVGYW6^GB]?3TI>L?K&:(][VO_Q#QXJ\3_)S/?4^0_#Z=^T_.ZWT
M\7KZ>E+UC]8S1'O>U_\ B'CQ5XG^3F>^I\A^'T[]I^=UOIXO7T]*7K'ZQFB/
M>]K_ /$/'BKQ/\G,]]3Y#\/IW[3\[K?3Q>OIZ4O6/UC-$>][7_XAX\5>)_DY
MGOJ?(?A]._:?G=;Z>+U]/2EZQ^L9HCWO:_\ Q#QXJ\3_ "<SWU/D/P^G?M/S
MNM]/%Z^GI2]8_6,T1[WM?_B'CQ5XG^3F>^I\A^'T[]I^=UOIXO7T]*7K'ZQF
MB/>]K_\ $/'BKQ/\G,]]3Y#\/IW[3\[K?3Q>OIZ4O6/UC-$>][7_ .(>/%7B
M?Y.9[ZGR'X?3OVGYW6^GB]?3TI>L?K&:(][VO_Q#QXJ\3_)S/?4^0_#Z=^T_
M.ZWT\7KZ>E+UC]8S1'O>U_\ B'CQ5XG^3F>^I\A^'T[]I^=UOIXO7T]*7K'Z
MQFB/>]K_ /$/'BKQ/\G,]]3Y#\/IW[3\[K?3Q>OIZ4O6/UC-$>][7_XAX\5>
M)_DYGOJ?(?A]._:?G=;Z>+U]/2EZQ^L9HCWO:_\ Q#QXJ\3_ "<SWU/D/P^G
M?M/SNM]/%Z^GI2]8_6,T1[WM?_B'CQ5XG^3F>^I\A^'T[]I^=UOIXO7T]*7K
M'ZQFB/>]K_\ $/'BKQ/\G,]]3Y#\/IW[3\[K?3Q>OIZ4O6/UC-$>][7_ .(>
M/%7B?Y.9[ZGR'X?3OVGYW6^GB]?3TI>L?K&:(][VO_Q#QXJ\3_)S/?4^0_#Z
M=^T_.ZWT\7KZ>E+UC]8S1'O>U_\ B'CQ5XG^3F>^I\A^'T[]I^=UOIXO7T]*
M7K'ZQFB/>]K_ /$/'BKQ/\G,]]3Y#\/IW[3\[K?3Q>OIZ4O6/UC-$>][7_XA
MX\5>)_DYGOJ?(?A]._:?G=;Z>+U]/2EZQ^L9HCWO:_\ Q#QXJ\3_ "<SWU/D
M/P^G?M/SNM]/%Z^GI2]8_6,T1[WM?_B'CQ5XG^3F>^I\A^'T[]I^=UOIXO7T
M]*7K'ZQFB/>]K_\ $/'BKQ/\G,]]3Y#\/IW[3\[K?3Q>OIZ4O6/UC-$>][7_
M .(>/%7B?Y.9[ZGR'X?3OVGYW6^GB]?3TI>L?K&:(][VO_Q#QXJ\3_)S/?4^
M0_#Z=^T_.ZWT\7KZ>E+UC]8S1'O>U_\ B'CQ5XG^3F>^I\A^'T[]I^=UOIXO
M7T]*7K'ZQFB/>]K_ /$/'BKQ/\G,]]3Y#\/IW[3\[K?3Q>OIZ4O6/UC-$>][
M7_XAX\5>)_DYGOJ?(?A]._:?G=;Z>+U]/2EZQ^L9HCWO:_\ Q#QXJ\3_ "<S
MWU/D/P^G?M/SNM]/%Z^GI2]8_6,T1[WM?_B'CQ5XG^3F>^I\A^'T[]I^=UOI
MXO7T]*7K'ZQFB/>]K_\ $/'BKQ/\G,]]3Y#\/IW[3\[K?3Q>OIZ4O6/UC-$>
M][7_ .(>/%7B?Y.9[ZGR'X?3OVGYW6^GB]?3TI>L?K&:(][VO_Q#QXJ\3_)S
M/?4^0_#Z=^T_.ZWT\7KZ>E+UC]8S1'O>U_\ B'CQ5XG^3F>^I\A^'T[]I^=U
MOIXO7T]*7K'ZQFB/>]K_ /$/'BKQ/\G,]]3Y#\/IW[3\[K?3Q>OIZ4O6/UC-
M$>][7_XAX\5>)_DYGOJ?(?A]._:?G=;Z>+U]/2EZQ^L9HCWO:_\ Q#QXJ\3_
M "<SWU/D/P^G?M/SNM]/%Z^GI2]8_6,T1[WM?_B'CQ5XG^3F>^I\A^'T[]I^
M=UOIXO7T]*7K'ZQFB/>]K_\ $/'BKQ/\G,]]3Y#\/IW[3\[K?3Q>OIZ4O6/U
MC-$>][7_ .(>/%7B?Y.9[ZGR'X?3OVGYW6^GB]?5M-M;3ZC;?IA52FNRVFH<
MMDZ-L-2M\!N77H-KH%XKY2)*IWNH2>9YS,;9*Q+-,'@/90Z*4A)$7*#'0\A(
M@%2F'QG&&%O1W:W#6:E'))!:JSX;(O5OTK"F.W1MQ][CM*UJ(M'(-PZ$K+$T
M<T<<B89YJ%B,QO;KCJ&1UGB#Q2+U22,\QY70]0=B#U5@5)!D+U [RZ]W-5[/
M3]B;1U&G=&FY&,K&R)"L72LKH]W8DQ2":EM.B&,S!0::YL"-!+.?KF32)2CV
M8&Q4Z3R1B&#EI;)Q+PA?QLU6[0Q>67$9>*2S0BM4K*W:3QN$MXRZC0HYL4)7
M5%L<BQ7:SU[<7+VS114IW8YE>.2:$SP$)*T;H8Y 02DT9#$<L@!)3<M&X9#^
M:"9@YU#J96<J5J_7:E*SG*E9I5:SG.<Y\><YSF,\><YS^G.<_ISGG,>%<F/)
MD;_IEC[S6WV$/P,7T:?9K\^9_4OV7:Z]B:U^S./"N4^,K_IEC[S3L(/@8OHT
M^S3YG]2_9=KKV)K7[,X\*Y3XRO\ IEC[S3L(/@8OHT^S3YG]2_9=KKV)K7[,
MX\*Y3XRO^F6/O-.P@^!B^C3[-/F?U+]EVNO8FM?LSCPKE/C*_P"F6/O-.P@^
M!B^C3[-/F?U+]EVNO8FM?LSCPKE/C*_Z98^\T["#X&+Z-/LT^9_4OV7:Z]B:
MU^S./"N4^,K_ *98^\T["#X&+Z-/LU8C=VP.CO6V+;E]\2W7;5@Q#*GP1K='
MTB.F99M.5I5F#KWP)R?G5X4VYC+</&'.>-M>/(_>J\3PKE/C*_Z98^\U:T=9
M%9WC@15!+,R1JJ@#<EB0  !U))V ZZ@D=X4WP6+33YT'4[-<X(9.7'K-4>EV
MVY.N8:2I:%OMRA&J06B!TJ0K'P@9+S"L8RIMQ:<9SB22/BJ15:->('5U+(RC
M(E64;;LK#HPZCJI/EU"2\0\*0%A/FL!$4_.$F0QZ<H]]N:4<H]\ML =7$U5X
M1/P2>WY@6N0&R-&U6R&D-!BP&WM8E:1D2CG_ "?,  YVY2Z8%*'/Y4E+ T48
M:Z^M26V4N+4E.=&3(9B)BDM[)Q.#L5DLVD8'WBK."#^L:WJ5["Y-2^-MXO((
M.I>C8J6U ]\M \@ WZ;D^7IK(VSJ;3Y++1 ^L]:D#OMH>8?9IE7=9>9=3A;;
MK3K<:I#C;B%)6AQ"E)6G.%)SG&<9YC\*Y3XRO^F6/O-;_80? Q?1I]FN7YG]
M2_9=KKV)K7[,X\*Y3XRO^F6/O-.P@^!B^C3[-/F?U+]EVNO8FM?LSCPKE/C*
M_P"F6/O-.P@^!B^C3[-/F?U+]EVNO8FM?LSCPKE/C*_Z98^\T["#X&+Z-/LT
M^9_4OV7:Z]B:U^S./"N4^,K_ *98^\T["#X&+Z-/LT^9_4OV7:Z]B:U^S./"
MN4^,K_IEC[S3L(/@8OHT^S3YG]2_9=KKV)K7[,X\*Y3XRO\ IEC[S3L(/@8O
MHT^S3YG]2_9=KKV)K7[,X\*Y3XRO^F6/O-.P@^!B^C3[-/F?U+]EVNO8FM?L
MSCPKE/C*_P"F6/O-.P@^!B^C3[-/F?U+]EVNO8FM?LSCPKE/C*_Z98^\T["#
MX&+Z-/LT^9_4OV7:Z]B:U^S./"N4^,K_ *98^\T["#X&+Z-/LT^9_4OV7:Z]
MB:U^S./"N4^,K_IEC[S3L(/@8OHT^S3YG]2_9=KKV)K7[,X\*Y3XRO\ IEC[
MS3L(/@8OHT^S3YG]2_9=KKV)K7[,X\*Y3XRO^F6/O-.P@^!B^C3[-/F?U+]E
MVNO8FM?LSCPKE/C*_P"F6/O-.P@^!B^C3[-/F?U+]EVNO8FM?LSCPKE/C*_Z
M98^\T["#X&+Z-/LUYLQKC1M>BSIN?H>J(.%C!W"Y*7F*O4(R+CQ&L>-TDX\T
M%@00=O'Z7'B'6VT8_2I6,<>%<I\97_3+'WFG80? Q?1I]FL<6RO"3>"%U7(O
M1-@V?HV</'4M+J-<ZLD-IA(4C.,*QF:UU1[- ^/&<^+R?C3RLYPK&,9\E7BR
MQWLW+_)6\K+M\%/;D_W'.K6CJI^>E=/TNL:C^=@!JB:OX6;P,EIDQ8E.R]5U
MHDQ[# Q%ZT+<:1$+=SXL>)ZP676D= !IQE6,96=)C(PK.$Y5X\XQFZ6WG81S
M36<M$O\ =2S7(QUZ#J[ =3TU:BU).L:UI![Z")_]W?63"@1'6':]:#N6KHG1
M.QZC(>/ -GHL=0;9 %J3A*EH8EX)@\!QQO"D^<:2_EQO.<8<2G/Z.8/"N3^,
MK_IEC[S63L(/@8OHT^S5:_,_J7[+M=>Q-:_9G'A7*?&5_P!,L?>:=A!\#%]&
MGV:?,_J7[+M=>Q-:_9G'A7*?&5_TRQ]YIV$'P,7T:?9I\S^I?LNUU[$UK]F<
M>%<I\97_ $RQ]YIV$'P,7T:?9I\S^I?LNUU[$UK]F<>%<I\97_3+'WFG80?
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M\^CYYT43@0\9J]:20XP3E7D8:QYZ0;2\K*OWN,L*=3G.<8QG/CQRGA;)=/\
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M %C[,P+*HARPB8PALTAQJ7CX]\61DB/)20C"G@<O)3CG7X/)=V?C^O6QO ?
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M_@]/T^YK00E*S*6[L/L;?$M7C8'7ECB:]+Q1)C>4(9C8?$(''1CZ\HRT1+'
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M,]R7N(V^#^%.$ZV?M3W+G 4^2LU9<E+W_DEK9#'7:5>@]UG>S(*45E51Y'<
M*:\3.L8U^*/\)GNN<,9/CB[E.$T6' Y""&*@4ED2L8J0@[XO1H[M!RV958*
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MP-\90(U?E!O+4EPXTJ??;1G I;G*^4 ^]T/ZCMMO^K8C66%@'*^3F'3]8/\
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M9.G3QMF.@9Z_)V:Y.SBXZ->:.S %G$R)M 536F:Q)%:M;SB9S8C,FZP1][-
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M*TEYL;)+=CK.RO-=JP\HD@1HY*5):/>XKN5[WDR,);MCR3&,0,>:3LG.T8E
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MG":EAY!MY-AMK]XU73C343=Y_P#6X'_T^)_^2EN3.._D'_QK?[B:B[W\JO\
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M%$3LVVRCG6*1=B6V(!VMAL'M%W?U["W:P3D,1BIU7K'-[!<V"'H^XQ-41OR
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M>2*?8@ELM) )58*T;<^T3H%96EV:0O&![=5CY K(W,WMHN5@5R;K_P"6K?\
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M"/VQ+/(Q((KVG:@[!T?K)M"M0%+N+%WNW8R>NT?!2&WEE[(#UE:;C!'$FF;
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MXV%6<5 L,]=EY:[A'9Y269^8)$%42#<_E6,JEMP.T['E42'RMU##JPX#-/\
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ML&'M6Z,IW!\GN'5K9'J-J65D69,W6\TMYBV6:^(%9L&P0X==UMTC*2\U;"8
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MD]%[5=:MF<6;$4%6A6[:17>2,2/6@BD:&*21WAK%^]H68F*)#JX5V#!NSD+
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ML=^VFN--!'V$5E>]C+)*B")"=]7QM**C2,7+M$64@\[!F3HP7E0*%8\Q7KL
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MF0IO8:N,<J7(U=N:3?=58K++()";2-SJB$-#&L'.CB,Q'E;8'VH;5<=;*MV
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ML1K<<T:XETGR5*6IU:$X0C*U+SE6<I1C"<>/.?$E*4X_0G&.-4V_23^O;_Z
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MNS+MOMMMUW W]_WO>'^G5D?D)LW[*E>\T+\O>;'A"7X./YW_ %UA[TA^$?\
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MTXTTXTTXTTXTTXTTXTTXTTXTTXTTXTTXTTXTTXTTXTTXTTXTU$S>7_6\+_R
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M>GKZBUU>Y[:F*RC7]7U_':LE3L2<O*:A'"L6Q)R,VS7YBJU>GXG*%8(%MV<
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M?EJSG-K<1VV>K(V1R324EY*<C6;!>HFVW)5<R\U==@!RQ%!MTVU7P>X# +$
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M5WA)SA_:<P4H#S'8*Q4G8;;;DJ.OEV&WD)WN-\;U_P#CUG]36S\/<C^_Z_\
MY_F_]=7=Y3>^GSCZNN1DH"3D:L#%&JDC/EQ6#<CCQ4^QE @:I#X20MT^)#'2
MAKS[7CQE[R\Y5CR4Y\6<XU+EF.=$5.;=6).XVZ;;>_K9K0/"S%^78KMT)/DZ
M^\-9'T_P8_[L?Y.1^ML>0?J&H:&^$.Z21QQ\89V5U@R=%R!T5(#_ !RZXH61
MC"W@) -U30JT>>$,'?&?2E:O(>:6C.?&G/.K7@;BYT21<!D"DB)*A,:KS1R(
M'C8!G!V=&5AN!N"#K2.2H@D&S'N"0>I.Q!V(Z#;H01KK?2,]'/69UA^MB?N?
M+O$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0
M\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/
MUL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3
M[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9
MZ.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B
M"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]
M73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<
M^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0
M\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/
MUL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3
M[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9
MZ.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B
M"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]
M73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<
M^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0
M\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/
MUL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3
M[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9
MZ.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B
M"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]
M73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<
M^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0
M\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/
MUL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3
M[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9
MZ.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B
M"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]
M73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<
M^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0
M\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/
MUL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3
M[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9
MZ.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B
M"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]
M73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<
M^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0
M\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/
MUL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3
M[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5T^D9
MZ.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]73Z1GHYZS.L/UL3]SX\1.+_B
M"_\ ,3[S3PE0\YC_ &O5T^D9Z.>LSK#];$_<^/$3B_X@O_,3[S3PE0\YC_:]
M73Z1GHYZS.L/UL3]SX\1.+_B"_\ ,3[S3PE0\YC_ &O5UP.^$0Z)OYPI_LCJ
MEY6,>+&79!US.,?V,96#G.,<>(G%_P 07_F)]YJAR- ]>^8]Q[N[#^@:XOI"
M>AGK%ZD_EBOV?QXB<7_$%_YB?>:>$:'G2?.?[-/I">AGK%ZD_EBOV?QXB<7_
M !!?^8GWFGA&AYTGSG^S3Z0GH9ZQ>I/Y8K]G\>(G%_Q!?^8GWFGA&AYTGSG^
MS3Z0GH9ZQ>I/Y8K]G\>(G%_Q!?\ F)]YIX1H>=)\Y_LT^D)Z&>L7J3^6*_9_
M'B)Q?\07_F)]YIX1H>=)\Y_LT^D)Z&>L7J3^6*_9_'B)Q?\ $%_YB?>:>$:'
MG2?.?[-/I">AGK%ZD_EBOV?QXB<7_$%_YB?>:>$:'G2?.?[-/I">AGK%ZD_E
MBOV?QXB<7_$%_P"8GWFGA&AYTGSG^S3Z0GH9ZQ>I/Y8K]G\>(G%_Q!?^8GWF
MGA&AYTGSG^S3Z0GH9ZQ>I/Y8K]G\>(G%_P 07_F)]YIX1H>=)\Y_LT^D)Z&>
ML7J3^6*_9_'B)Q?\07_F)]YIX1H>=)\Y_LT^D)Z&>L7J3^6*_9_'B)Q?\07_
M )B?>:>$:'G2?.?[-?TGPA?0]"L+1V-U,A:<^-*DG+2I.?[.%8 QG&?_ +XS
MQXB<8?$%_P"8GWFGA&AYS'_I+G^D:K:J=X>H]X<D6JGV UO-NQ" G))H6;PE
MP-N24:D!QY#[3*L(*5'')95C&4J4*]CQ^-&<<U['!W%%01FQA+\0E+B,F($,
M8^0N 59ANHD0D'^Z'OZO7(4WWY;$;;;;[$]-]]O<]W8_S'40NG']3W4__4VV
M?]<%]YFXW_LFR'^*QO\ \51U3'?U'%^N7_C2:D]SE-;NG&FG&FG&FG&FG&FG
M&FG&FH=6SN_J:F[D'T1*TWL 1L,]\S$0)#=?=KS43/1D:7& R]G@)R.K+\;-
MU"%*F(UJ9M,:^3!Q>2FLFFLX6GQ]E4X&R]W"MGX;O#ZXZ-4,SS<0XF":O+(D
MLD-6Q!):66"Y.L$I@JRJL\O(>1&V.M!\A!'.*S1VC*2>4+5G96 (#.K!"&C4
ML.9P2J[]2-2F#M=6D!GS ++ '!BR"(DHH.9CB1AI5UUIAN,??9)6TS(./O,L
MH"<4DE;KK3:6\K<1C/*O4M1LJ25K$;O&9D1X9%9H@"QE564%HPJLQ< J I).
MP.MT.C#<,I&_+N&!'-N!R[@[;[D#;R[D#W=<6+E4%/Q@J;56\DS0PQL,/B<B
M\ORP9KF&0RXQG!7G#QBW5):&?%2ZT^YG"&EK5G&.5[RN<LK]Z6>2!G2=NPEY
M87C!+I*W)M&R $NKD%0"2 -.=-P.==V *CF&[ ^0CKU!]PCH?<U3%ZW'J[6E
M0NU]NUY@(6IZX%67>I7X7\99K#3><8RB4 B4'R;1:\YPED% 2S7U?O&!W%?H
MYM4,-E<G<HX^C1L3V\DX2A%R=EWT3UWBDF,<10#JTA<(HZLP&L<D\,,<DLDB
MK'$-Y&WWY/UA=SN?(!MN3T )U6HL_!FB11XDQ&/ASN6\0I+9HRF993K#A*&X
MY?G/$8ZH=EY_S3'EN8:9=7E.$M+RG2:O.CRQO#*KP;]NI1N:(!@I,@V]H S*
MN[;#=@-^HUD#*0I# AOS3N-FW&XV]_H">GN ZZSUKJPQ 8A%E@&"I&1(B(\9
MZ8CFB#I81W#!<8&RLE+A4B,_G#) 3"5DLNYPVXTE>?%RY:EME=UK6&2.-9I&
M6&0JD+CF25V"D+&R^V5V(5AU!(T+H" 64$DJ 6&Y8>4#KU(]T#J-6$K':JBW
M"^3NOH.J[(+E*UO2Q]?YR4;K81%?B[?6=;1.SS9J0D@ILI<?3RH6:"BHZ6/%
M%.)L65QZHEH;+)ST]:X5O4Z$&0GMXU(K."K<001&RZV):=G)S8I(8XG@427$
MG@>62&-F1:^T@E9N:-=9+D<DC1*DI*67K,W("JND*S%B0QVC*L%#$ E^G*!L
MQJIKL)KDC=R="B&D&6Q.JK%MXN9#=AR*A&UVK7*%H\S&24LU+J,#L@LO.B/.
M1SL7@9F/;)>*/'?;;&=U3P]DEP9S[HJ5/"M;$)"XF6Y+8MTY[T$L4)AY'K/#
M7=1()>9I"JI&RDL+^^HC8%8$F3L7GYARE D<BQL"P;<.&<=-MMM]R#TU[5JW
MGJ"E,T0JS;#K$:'LVW-4.B'8D$'1]CM;P$K)IBA#X[!8;/D!0LDX0<8^-'"N
M#I&),:*)%9?PU,%F+K7UJXZU(^+J&_?C[,QR5J@DBB[5XY.1SN\T86-%:5PQ
M94*J[+<]B",1%Y4 F<1Q'?<.Y#'8$;CR*VY) &VQ.Y&ZG[CJ%MK\]:'?C&G0
M4%=['1?C*^,AU@2:,KLFN+Q.5\HH]P65J\^XC)58F&WT8F05((:8;\?D87,-
M<J6*]5>SNSV*-:_V5 O:>!+,0E["PBQAXK5<'EM0E3V,@*LQVT2='5W.\:K(
M\>\@"!BC<O,A)V9&/5&_MAU U7IMBK\:\R/(SL, ^2Y'LCL&R@0KS[LLZ0Q%
MM,MOOMK=<DGA"F8]"$J48Z,0V/AQ;+F$QZ5[$BEHX)I%42,S)$[*JPA6E8E5
M( B5T,A)V0,I;8,-\A90=BR@[@;$@'=B0HZ^ZQ! ]\@@>37L\PZNU%Z^=MM9
M46\V/7:8RY7>RUC2]FWB<-KR*BK5@BN5.YPM%EJ['M#SK!Q%W1,SHCB(-030
MZ06R729(=]#8SO4T.$<G?HULB9:5&M:S57!1MD9I:G+9MTI[T-B0M T:T3#
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M^MU@!)3PA:&)&' 9FQ5O7(L;;:MC9:D-Y^R96K2WNT[U1XFVF)E$3GVD;!%
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M[$>4';R'J.AZ]=6!UEVCUOMK2Y^[:>-9"HB/AMBSJZ4L.(>V40#K2SVRHRV
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MJJL+I'<LQU8+$D<BUFFED$8';!&4\K'=PG,P 8\I(VU>TB('W8$HA=E!!?E
MWWY=P>ON;[#?;KKPM9;;J6TM04+=T0X5!4G85#K6Q(MRV9CX@Z+@+1#!SH*9
M_P S('1@!@P9K2#TLRA@;)"7$M&D-82\O8R>(N8K,7\',%GO8Z_:QLHJ=I,D
MMBI.]>3O?>-)9$9XR8RT2.RD$HIW460SI-!%8&Z1RQ)*.TY5*JZAAS[,5! /
M79B-_(3Y=5PS/P1"$NL342^VN+1.(<9D0W$*A7/*\B82M#RDJBU^0OR)#&<B
M*\E7B>SY.?%HM7L*=F@F4B4P$-$X(G&V\.Q7^5&XWC_/&XW7KK+S*?(P/3F\
MH_-/D;]7Z?)JA*[MRKV S8##K,O6H[7ECC*T;9;8*+!5>Q/R\%"SX,I4)M\Y
M8LY"/,SP8"9'&1L.2J" VFG/(;==WK.(M5TQ[!H;,F1K2V4K5':Q:K+#//!)
M%<@5 \$ZFN\AC/-M%RN2/;!<23(QEZ,@B<(7<<J-S(CAD8G9EV<#FZ>VW'O$
M^#J'L'KK<VMX;:4$836ZW/6V[4J+:NSD1!29<]1+W9=>2@S+#4O("/9/G*K)
M$0S3!SI9D:X*^\**2MX,?8S'#V1PN2FQ<Z+9LUZ=&]*U$33Q)7OT*N1B=F,,
M;KV<%N)9BT:HDH=0SJ%=K8+,5B)9E)1'>2->TY5):.5XB.C$>V:,E0#N5VW
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MEC*JL"]B1F0NR^V#$B3\YTT^6NU.I6S"^@&@*A2ZC+;BI^W=,9,T_/"0]7V
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MD7K9>6<.*7*1<K36)+"=^024U2".0,&UG?'V&L,>QB8O;JV%O&1>U@AA6(/
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M:S'2W>$7>D7RPZ*HO8NC"=I.\^Q2=#VBXU *,FH;L))5U[5>RL(M8QU0)E(
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MU6/\GC_XD^I?]./ZGNI_^IML_P"N"^\X/C?^R;(?XK&__%4=2>._J.+]<O\
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MZ7EOW-IXT8_X&Y]'!^(T^L6=-OLF[->RVK/S?X]CEQI\;<+^EY;]S:>-&/\
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MZ7EOW-IXT8_X&Y]'!^(T^L6=-OLF[->RVK/S?X]CEQI\;<+^EY;]S:>-&/\
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MZ7EOW-IXT8_X&Y]'!^(T^L6=-OLF[->RVK/S?X]CEQI\;<+^EY;]S:>-&/\
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MZ7EOW-IXT8_X&Y]'!^(T^L6=-OLF[->RVK/S?X]CEQI\;<+^EY;]S:>-&/\
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MZ7EOW-IXT8_X&Y]'!^(T^L6=-OLF[->RVK/S?X]CEQI\;<+^EY;]S:>-&/\
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MZ7EOW-IXT8_X&Y]'!^(T^L6=-OLF[->RVK/S?X]CEQI\;<+^EY;]S:>-&/\
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MZ7EOW-IXT8_X&Y]'!^(T^L6=-OLF[->RVK/S?X]CEQI\;<+^EY;]S:>-&/\
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7%CBC1A*J*2>>9MQR22 C8^Z0=_<U_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>g729258g56w36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g56w36.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #: ET# 1$  A$! Q$!_\0
M'@ !  (" @,!              @)!@<$!0(#"@'_Q !4$  !! (" 0(# @8.
M!@<$"P % P0&!P$"  @)$142$Q06(1<9(C&5TQ@C,CA24U57=Y*4F+C7)#9!
M45C5,S1X>9&WU"5"0V$*-3=$8W&!@[&VP?_$ !T! 0 " @,! 0
M   ! @8' P0%" G_Q !7$0 ! P," P0%!@H'!00)!0$!  (#! 41!B$2$S$'
M%$%1%2)A<8&1H;'1TO (%B,R4E.2D\'30E1C<H*4HQ<D8N'Q,S0U=C9#='>B
MI+6VMR4F-T6#M/_:  P# 0 "$0,1 #\ ^_CA$X1.$3A$X1.$3A$X1.$7RS=0
M[J\B5S=DX^?@,U[DSF-!?(=V.KJ]U+' ]?$>C0CJ77UD6=%]Q$$-ZA!EVYN
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M-\RC3%O%;X]X2YD3N*=6J\"*RR*SN$2+1FK)?I2T4LX"7C$^!N6*IY1E]%*
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M80^0EZ,]U&S@=I*&THG2UNJ.)N&(!FHC2P]U!8@U[)J0/%!?ZQ(\WX_Q9W^
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M2C+ V5PGAT20!C<.U%=FVFV"<3AT)&-AN>GE\Y6S*AZH=;J"?""5+TO JU(
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MHW*-&:*>B3=)/3377!,G;<[=-^F.F%RYU%XS":!F\0AD=!1&)1FI94$C<7C
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MZ]LYY6]KZ[7=$H>_(PJBZ<N#L68C\H. "1(MHD!J&$3"7:0EJ^!E&[&9%P;
M3G1R!:/W;8J<',W)1P^L0"-B1DD '!QXG'PRJ3ZT\A<>J Q-B0N^9O6<9G/=
MWN#+YO39:@$F-GLHD]L>PRD<.O ]P 8J<B9V42,:*A!6+2=Y'WT91;NB+UD.
M=_-WVUSJ[54=BNEOA-Z?2L>SF5MOAH*>IFY 94NBGCFJ&M8#43QLI7,,[&QM
M!D]4Y)^UOP<?P?ZKM9T#K.YM[,*74%72U+:/2^K[CJ^\66UBZNJ+#!<;366^
MRS5%2^.RVJLJ[[%41VNHEK*B2.A_+,:(VS][.>3RNRO2,MV!I>96K79PC/7-
M;P%:.LZ#DLFVGVU=E9:!3G4>.&;)$BJZ4<J"])<BDD/L@?G1OHS&L47B*[[K
MWW7=$_2TEXME37T<KZMU%2&%MHGG[V:*2HA%7#++6QQT1<8^\@!E<S #6,#@
M7^UV2_@DZGI.WZB[-=>6+1^IK?2Z<BU3J-ETG[2+3:1IL:GH[+<G:=N=OH=*
MUM;JAL3*QUE>]]3I:I!E=/55$D#XZ>P'I7<@R_\ K+65LAS]A2EC*$).GJ?M
M47! T\). $TD<:>JG!M9L1L(;82>AW#85@(Q;85#(CER&F2JK[?;+]+W..\6
M*@N,<U9.RH;/^6N$=)'5O=%4S0O,K*%K*5H#HRV/E,;F(,+QS"\GYL[>="UG
M9KVL:LT976W3-HJ+1):7FVZ.K-15^G*6*Y6&UW6G9;ZO5E15Z@E+Z>NBEK/2
M%1*65[ZJ.F<*-E.T9;9'9>G:EG$6KF=G)(-F$V205BPT76EGRQL9^>H2T^0V
M-Q&&G0.CULF'(O2#!P31?"Q3;)@DW:BE$7BG9K;Y;;=54]%5RSLJ:H T[(Z&
MOJ&RY+QALM-32PAS1&][V&0/CC;S'M;&0X^+I;LIUQK33]XU1IVWVJJLE@?(
MR\559JO25FFH>6RD=S);?>KY;KBZ"5U=24]+4Q4DE/65DPH:66:L:^!N^>>L
MM=)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB@!V=_?E^-#^E7LG_ (3[
M2X5A^:[_  _2I_\ "JG")PB<(G")PB<(G")PB<(G")PB<(G")PB<(HK=F>U(
M3K02H825KZP9LO?-Y5K20\K%@JV\3@KBQ)U%8(A*)]+7*> H-FV)2\9J& 97
M5DLO<8>I@1JHT+)3 $I SG?& 3[_ &??;XX!A,EY=H:3EURP>-TT5/2>OK[$
M=;Z\C^MH5\-DEN6&=OPEU['%6T<(.4C$.K?,I!GR[B?EFKX3J#$*:M$GQA\+
M%O2GAZ;]1D['88SGV_\ 1;)EGDJZ;F^J<>L6Q;WJF@B5_4+)IA#:XNNS8%!Y
MWOEP,-QPF(1%$I"GJ:<A9:P)Q=P^ JD1CPHP5PP=+I[I[;$X7$D $X.,@$CZ
M/I7SETGX\7-O1* X@E,7]-Y"YZ2]2[-0PM/^OT:B*<QM:OCVJ)UVN2EHX[FM
MWS:'_!$A:?R)R@9#FMI8U:B'83W+0%^T8;EJ>_\ =+9>*J9T4-<,UEG@IA4W
M">OQ*XOJ&3=Q>*;%/&"VK$D<IJ&MC=%Q_L1V3?A.1:)["NR,ZBUWV;Z?ML5Q
MN6DI.#37:5=;TZQZ-M.CR^WP1TMEJK=^--/+?.*]5CN9IZ2AKK>++--6PU_=
M9E=WK0M+Q^A^O=5P4A;4-K(RP)S.)U=BWB$:F-8AV\@1S-*JD$VK0T5!V"#*
M/G*16)R)TN_D4-T)&1:9HPT49ZLIU37U^CHK-;Z1]QI:"5DE33T N3X*FAB;
M,.]6^:JH99(JR*1[A)33N+IZ4/DCYLK2WAZ_X/\ I'2/X2M=VF:PU#3:+OFK
M*"II+%>M7_B32W:QZMK9;9(+!K&V6#5E!1W#3-QHZ>)]'>K7#'36N^NI*&L=
M04,S9S4?315IY655E7,H63416DD$B!Y5)9VL0525,1\>0435?N,8</5--W&=
M=W:^,+.=L965Q\>^W-YT$IGH:*<@@S4E/*07%Y!DA8\@O=N\^MNX[NZG<K\G
M]7VYEGU9JBT,<U[+7J*]VYCV0,IF/90W*IIFN931?DZ=KA$"V"/U(@1&SU6A
M9WSMK'4X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X15]>17_43K%_W@O1/
M_$?!^%9O]+^Z?X+T]G_W[GC(_I%[1_X69YP@_-=_A^E6%\*J<(G")PB<(G")
MPB<(JPO*.*K C!>L3F?PN;VW)0_;>#$*AH6#U[7%I+7[.%*TMT;**LD40MY^
M)K="+DZ4?VR<)3>2F@OX-5@#.>!R"AP .%%"LW.^,#;<G.PR-]M\YP-L]>BT
MMXGJR@-<65W&;1J/=BZ=DNJU"1XIU8[(9AA\UUZ@H,-9):M U9V3 YM/04ZI
M8PVE4D'5\V5/O"L%:Q)["W#C=@*%H-".\.AZ[C._3KD#<>.PSL?')MSFM>0J
MQ48VWF\<'R-"'S.,V'&4R&JNVH>:PU_@I%Y&T^4JEG! *0UPZ9[*9W2PKCU4
M24U^[A5SCZ%&U?Q^=,G#6Q6:G7N!ZHVJ8&GIENW1*-72A</,R%C"WD9?-22+
MV [,;!+E9RV2@3B,H)R\H1DF$O>'KEXJ5N)PQN=OJQ]"D_"X9%*YB$7@$$CP
MF)0F$Q\1%8E%@+)$<$CL; ,$!84*)8-]=$&8\:/:MVC1NEKC1)!+33&/NX55
M\C=J=+ZRNNY)C+I39$U@92R>\7D%@Q8D$A;NRF0*/U+,9Q8+(D-@4:9)R^0E
M")4QJ*?-F!/?";)1-T@UTV;+[*Z?[0M,4%TO5HJ:BNJJ22M@JJ61\5*ZN;%#
M;J>>L;(RD@8*F9[Y)1&]K)-FD.#=B3^E'X&O;QJS0/9AVDV2SZ6L.HZ32MTT
M]J"BI*^^PZ5J+A<M9WBU::J*6KU'=9W62V4=+1T)K*>6II&EU0U\,DSA+&&;
MTK7ISU6K;Q;7;.;J;B"UIEADUD$0,V774II:<P.ZT*965AM31TE(70LY.V[4
M[\XJ.18Y5ATK,O%$=PC]\#SEOXE#IK3]#H&Z5=T$4M?)'534TM=13VNJI+H+
M8336Z!\SHY:MK9LR,#,TM1*X@Q/?%ZNT]5]N7;%JK\+W0.GM RUM%H^BK+!;
M+W0:4U1:->:>U'H&37;&7W6ETI+9#66_3LL]MX*2JDJ R^6:@@9(VOIJ>X#F
MV^T_U?K:-UK$YUT$M;>JQ!!@J\9,!IXS<- 6(X1?.42F)3#9))7JVKO!=N]&
M.)37THATI9Y;?1.B))B/0$Z['MMAH8*&FJ](W V^-["YK(YI;E9ZUP<X2=XI
M9IW'BYK7,=44<]-4-X>%SWL8(U\2ZW[6]5W755XT]^$AHYNL*ZFJ605%15VZ
MAT/VDZ8C?3POI#9[Y:[5!&8#1205<5GU+9[Y9Y^;WB&EI:BJDK3 KMMY&YK1
M?:;K1 [KZ^M&<XJ\R2F)!Y";0:F8A,QMEPN<U./*Q99_$V9L4P3>$U3&["2C
MVQ=#9@Z$[H*HY9GGV(ZBUK4VF_V.DNEG:VJH))*E[J6O;+353*ZFJK>R2 OI
MV2QL#GF4LG8V1O Z,@CAF=]&=BWX+EA[0^Q_M7U'H+M+FGT_JVAI;'307_2,
MU#>[%5Z4ONGM95-'=XZ:\SV^MJ7P4C*%M3:JF6BD;4PUK9&2<^VT_P!!W-Q+
M\TDX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X10 [._OR_&A_2KV3_ ,)]
MI<*P_-=_A^E2CL"^J=JR9U374_L*.QJ>WC)W4.J:'/'*BTDG!Y@%)2 BB'#L
MD73[V\8)%.ERAYVBV C5E![%\3;ORPIJ]*,'<^ Z^SP4=5_)3TB;QR<2K\/
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MB6I%]\IT*)_2N';5KLZV*,')&-QY*DGK2A9=B]L(N?IZ1U,4BT:[<>5&T@I
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MOS4JX<M2+]M%H>4CA07L.2URS)A=4B"3O"X]VYU;N<)<EBO,UV-8)1:7"F,
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MVM*^D*;SE_R\_P#+4/+N9$JMG.G:>I1!<T1:#& +L%6P88\R[MBKQ6RFS23
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MM,9W4WSZ:Z:8SMMG&,9SR#%(.L;QDX&6.&2>@Z=3Y*[*FG/%B>$X8XG$K#@
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MTQ:J[H(ZIMGWRLID47::BNF]W4L#G/<YA+GR4\KCQR;OI7M? ['%@<#F-):
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M\[+9JAU:^[-?7,K.SC2]8ZUU@H;K1L%##//+4Q.HF4=P,U7.)JZ6'D006CK
MB"KEVXTELC03<GA1E)FBG&LMF3(<R8-',9:Y6CJSK($TLS6(%-W3IT?T>DGV
M!1T6RPQ9,LJ,$A<]PK*EH=413A@;2\,<<<<;'4K"ZE+^[SNC,LI>]]0))9!#
M411\$;-0LN-,R*&,V6UR/BMU90OG>^["6HJ*JHJ9HKM,&75D(N- R=E+1MAA
MAMKJ>DIC6VZLJ.\5%0:@2#==FJI+Y(\T:DI(_5;NDHSA%^W.O';H>)>9:QML
MO@=$DG*3".;,UVA)1FR:YDI&1.\NG;DR"1KF$UE2\,EJ9"UXI>&1L[WOCA?P
M4K7<JC:\1TQC='*61L[U+4OXWOF:XTTL<[&V2U0.FI;73,EA?=S)32VZ"&&I
MK8!-=9HS57I\3ZFZ">.>D9/43BTTMJ@$$$/7?90Q[5D=^$2:?4YAZ47]Z^1"
M/=<%4TMD]Y[C7,,R*^UZ^VV%E4O:_L=A777Y4123]4\\?=)N3RO2-;Q]S%+S
M^&@YW-#<>D,=QY/?"?6+>5W+B Q1 9![/IFA[X*K\6+#RA?'W?T?S-0]S-&]
MX>--EWI[OOH.,#EL?WST[P./'>WOP\=BY!$%W#U=.72-HF[+@2:+1LG&LMQ[
M4-NRW>@F67,<<.<B)-AHJF>W>N7A?30@]]@+ M\,]VG(Z"1SGD5E2P/FIY0Q
MK:7AC9"8S)3L+Z9SC#5<!%07N?.!+)W>:G/ 6=6*XTT<4$;K+:YW0T5QI'S2
MONPEJ9JYM0VGN,XANL40K;29F.MS8(H*%SJ:G])45Q;SVSD 1!%RS7WETC=)
MM39HLJT72C.&S]F53?)LXZ\V;QQ!U@+'MGB*P7=FY:&]U!S'!LR92R]3>&P2
M!S'&LJ7!D\\Q8YM*&R,E$@93/+:9K^13%X= 6/9.3%'SYYQQAZ2XTTD4\;;)
M:H734%!1,GC?=C+33T;J=T]T@$MUDA-?<Q ]E>V>*>WM;55'H^@H'=W=!%+N
M/4X"3]6;=S.7Q*>Z0"D+(D()*4-8UNG]NX[!C[@'8J_L\>#[HRX9C+M!KN+W
M' =$B#S;(++C+==OB.M;135>DKT*]\EP%NL-TJ:<5<=*1Z0IK?4.I[D[DTT)
M;61>N&&$Q4X$LA[OQ<+F[E["]9W*T=L.B/Q>IZ739U+V@Z5MEQ?:)KL'?B[<
M]16V.X:7C[_=*X262K(ADF;6"KN3GTL ](B/FQR^,:Z<0&),VLDH^0RBA9.[
M# MVZM?;"$HFJLV:JKKZRF#/1JH.=MRCEWE1^O*OKSS))))K%C\:;ZYTRIM%
MVZCC946&HJM/53H8"TVWDMHRYK"YW>[>^(T]P;*YY,CJOF5+&M:RDJ:1H.;7
M7MSU)>IYK5V@VRT=H]HAK[@)6:F%:^],9+,V.,V?45/5LN.G9*.*$-IH[/W:
MVSO>^:\6V[2GB7DG9=M5$[;:]BV<B>19A(B!G>XZF%,9!7CL4[%OQS<#8<&3
MCK^Q:UCXM=XW-HD&#J6L6I,<T5/69@+]:(=R+I>+,YHU*RH?21U$DYO5GA94
M6U\+XI(VT]RH!327.UT\+GMG;+&^MC9)$PU%U$',@?#M)Z*UO#*>RZ>UP7BH
MME-0-T+K2LJ;9J>&LAK*>JEN6F-0NNE/I;5=RK(H)+?)3545EJ)J2JG9;=)&
MO[M70R%C.&,PC0DY$[;+RH$1BQD8.E()[ BS,NN87:*,YBB_&Q=46X/1[5HL
MU#:M$M(YE-Z]P<CYASJU6:9'2\%92PST=XFJZ>2EGBBJX'VZ9DSIG,+*T214
MAA?44P8YD' !2D/D[Q33OX7,UC=C462[5MOO.BJ*SW&EO%#5U5GN,&I:*>AC
MHHYVSV.2FJ[PRLBMUT,\<U>9WNNH=3TYMUSH83-'/HZ'S&[I/>MH5<<;A0$5
MA(FO"WVI!3YL8/["BY>8.8TZ8QDE2 T<D8FS.+.F%F-'LE?#P351FG!%]'F7
M!/G@T=;?:N_W6U3LIZ:CH(;=,*NGN+)ZDQ33UKZ5S*26P11":OCI'1W2.2KD
MBIV%@M[A(72K85\L6@+1V=:0UA;Y:^Y7G4%;J>B]#W'3<U#;1645%8X;M#47
M:D[0:JJ=0Z?J+Q%4Z2GI[33U-QF9.[44;X.52*3. )##O1S]KI)E+62*'LLL
MIQKZ3<?N%5$ZQ'?.(YAU]FTG:FL@34T=:R7WI%/521J!OFAU,HY$G&'=\J2!
M4F?E\-+P&,P&$49Q3!_=@\BI#@\57/: :DP9@.IC<:8PNB]"6H/-J9;A4!]V
MYS:EM>RM-[:/2IA]*OA:;8]CH76GN$CRVU-K^"N9QT8V42T:Z;3F6+Y;C)(P
M5452B/S'K@\]:.QYAU\J*))ZDXBBV5'QS5HFU%J,GSO,E&R)YAH\:U%-* W-
M=5N+8ZF,DMH\O=42,?',X-I&@24;6F*F# R(QR/[U%4R<#V<C[K2/=,1I^S1
MB6KM52QK'WOA@BMU//!4T,/'>7N-)>GS,JKJZ9TU8VHIH!::NUTYGIY_%2-%
M%$G*>LZEJ.S@/'1::Z:,0RJS=@WCUT_/ML*Q-5')B5I.TF$AT=).0R;0>RS'
M1$?=Y>NW@TTI#@*ZL'%#31 @4>6/@?(]]0W-&09JL/;'4AX= &1,[M#3/,CW
MRVZT;7Q/.G;*\1UUSK'1N??.">&X0T\5/;9>"]->*&S/A?46QT+X:]TU54"Z
M5US@%/#!RM@)#9VJYQ+I)JDI)&YW1CJE&?I$!Z 9L*4B*6=HYL[S'';M!0^X
M56=+27!EVYU;2-N'PV$-K&"3C+N^5(!J6SB/AI>!L;8&PFC&:8O[L][34N<7
MFJ$[W!M2V#@@;PBXTPA9$;+:R]EKEMQJ"^[<Z2IDKY:QMZ>!=1#Z4AAD;;(F
M,A9:3001&6URUYFKI8QW+V'A]*&P,!;26R;AO(ZRE+R(T%6HZ%R"R)8V/E,+
MC#DA;8!BPM?0F$>OM(JP)L8AL-;#M%DY,5EI["6%X;3RMX":VJ>&]ZX@YM'^
M4[Q+S(^,-I6D=R;^2I>#@!C_ .]]ZD_*+EDN--*V?AL-H@$OHG@?&^\_[MZ,
MI>[U0@,MWEXO3LG^]W83"<MJMK1Z)IO]V6GDNI=O]DQ#9WW8LA]]F?;AB07K
M/6),:M73!=CC55$W=\H<Q<<W["35=75%P7"/8A&J+;/D]DF%8&,(-3:DFGD-
M-R.]U(DY,<7>P*;O'$P8-1AU,:;GR'UGXIQ#G\R%@P!5MSIH[EWYMEM;Z?OM
M15^B7FZ"W<J=W$RW![+FVZBAIA^3IR;HZNX!F>MF>7.=/%I$?;$M&0>0%PH=
MJ4!NQ( 2QB;,,"!A!8X7K"Q#1.,YW;19_P"W[O7:6ZRQILZ?O$0QL4,T8#V(
MP2%SG"KJ6M=413AC12\,<<<<<;J5A-,Y_=YG1F64O>^H$DL@AJ(H^7''5EQI
MFQ0QNLMKD?%;:N@?4/?=N=45%34U,\5WF#+JR$7*ACG924C888;8ZFI*8UEM
MJZDU%34<MJ!(MUF2JDPDKS1J0DCU9NZ2C&$2"!YXZ=#Q;S+6-MEL#XBDX381
MS9FJT(*,V;7,E?R-YET[<F4\C7,)K*IX;)4R%KA2<,C:B1[XX7\-*UW+HVN$
M=*8W1REC&=ZDJG\;WIKE2RQU#&6.TP.FIK53LEA?=S)326Z"&&IK*?G7::,U
M-[?$^INHJ(YZ5D\\PM--:H!#!#U_V4+^UY'_ (0YI]3F((1CWGY,(]SP513W
M3WGF-?L9[7]KW.VV%5TO;/L=A333Y$213^)/;C[I-RN7Z1K>+N;:7G\-!S>:
MUI!N '<>5WUV>)PY7<N(#AHF@8/9],T/?!5?BQ8>4+W)=NX<S4/<S1O>US=.
M$^GN^>A(@TLC?WOT[P.=S+W([#A$?NZP<-H[2#Q4P2?(D>\/3%5L-=ZC,,0F
MC:Z(8U5;BMF@UJ_V1?*I;/W?NSXHMJ\<+89JM&?RFB799&YLDSS-*]LKF.9$
M\1<N -8UA9"61,D+9"TR/YTDS@]SN!S&<+&^<^IBEIZ6!E#24\E+!4LEJX35
MFHN!EFDF9)6":JFIA)3L>*:'N5/1L,$;#.R:?CG?@O;.U:PZZ=B^B5DWI;L>
M@5?#;0['JDIY:1^,Q2.@,R>C9@U! -S.[8$,09(O7[,"!P0V<%76,M$7I$F_
M4W<K<1C='$\.FEF+II) Z41 L;)(Y[86\J*(&*$$1Q%X?+P-;S99'Y>>RVHC
MJZB%T-#2T(BHZ:G?'1FK<VHDIJ=L,E;+WRJJWBJK7L-35"!\-()Y']UI:6#@
MA9*.Y^X#.L)[U$BT8K4]9T0[8V4(@H^X09X$/K6&#I!!)=.HZ8V);[D2DO+R
M=A%%EH\! "M1BX;!$T7E83+<*/D? NV!D..?S0#CQ.2!\V=_A\*^!?F>*21$
M6(C'5YN]G]JD:X*]:XT5O'44$LRKK*W[8.1<QL&4MZD++U))!X3IU:!4C"!\
M=LQMA4U!![>7K*ECBT:*Q;CQZ#?ID'U?#.X]8;[9WVV5O-!V^!["473-]15F
M^&QFZZJKZV8^-*?*]S'!K$B8F7#1Y+Y&VR/N#)F71:O?D[;)?4I*_+VVT^'.
M2J1@D'P)'R+-IE%ATXB$JA1C=TF(F$;.18HHQ5U0>ICI ,="7V[-?9-75%UJ
MV=J[-U=DE-4U<:;Y3WQK\.>"IIV5=-44LO$(ZF"6GD+3AP9-&Z-_"<'#N%QP
M<'!P<%>I8KO5:?O=GOU"V%U;9+K;[O1MJ&&2!U5;:N&MIVSQAS#)"986"5@>
MTN87-#FDY%*5>5@;H:Z8\"F4SD\^AM>7(;L4,"KNL>N\G?FI$G"R\(;.WPFO
MYJTOT233"O%"SN.AJQ+#6CU)5FEC9@@S:(ZPHJ":T72&*IJ9ZNEH[G+6Q145
MOLT[Y)NZR4K7/925;;O')RW&1\,5!*QK@6CU UH^]=3ZNH.T;0=SN%BL5ITY
M?=3Z&M^EZ^X:GU;VG6FFH+6;]1:@EAIZW4MAF[-ZRD?7P-HH+I7:MHJJ:"1D
M[\5,D\S[#.ZQ6O-*&*?; A7D;+G-%&M9RVX:QWGT*ADY="7JXT_)A)2%R]C'
M&S,=J03>%)$':LVFJJC%VLFJXPW4S+5$E'Z)D[R^C@DE!;0U-RH#5TM+5NC<
M8YIXY*6I9 UC.,.?/&UK02QQ!=@_,O8+1ZF=VBT9LE+J:Z45 YDVJ[+HC5C=
M-W^^Z>BK:>.KMMIK:2_62INDT]2:9T%':ZZ:>9S&5$+',B,K,TH62==B!FQ8
MOU]C,##,8UB#$9 ;K6/0\5#98E,8\J>C1(.7A^<,Y(BB,V62W>*IZZMEMU$&
MVZR>V^_.S:9K,^6M@L\%)$R#NKYI:&&FCIJ@5,)F@?')3>K.!&2"\C#22&DC
M)7A=HMJ[3J:@TQ=^TJ[:BKJBZG4%+;*#55RO=9?+,^QW-ENNM)745\'/M;WU
M88]L#'$RL:V25K' -5*G?)[+:)[3=@;<3[KW!#I;%NG^+H6CZ$!\?XL3FE@%
ML2S$9I*N'EZ5@]/S^3 7.MK2QJ\).GK]ANH%CQF3?7V''D,>VM7C< <+3DX&
M[\YV\ X 9V^38'"GIY'Y);:M)=<D*R9]LB<#G5WQ1KV$(=/XV\_9)MJ43IVU
M98W5C*@A-D6@>QJV0M4A)4>!.0A@0%+%!@M\P</=,<*&XR<XR!MQ=,Y'R[9/
MDL6\8AJR-YCV?B145W684N VI8O32O?=H:<WHD\D8J>MK("-9?*WA:8RJ C2
MT>!DHY]HSAE<.1/GV;)RDS53:HOO]_\ FCO#H3OT^&,_.K<>%5.$3A%0QXP5
MV++L'Y9B#\@Q:Y3[S6GC?5R\;H;M@P:6SEZN_7U54UR@/1<F77S':F-6^FV%
M/B4QG7;T\:S>M?M3OS^:;-![A'0R3X^6J)^/O6V>T?,79!V$TV,<]O:9=NAW
M-5JBBM?%Y$D6,-SY, \%;NI.(4D*:G59A%T@;YSLR9&5) )T%/'FF5L;M&I'
M9WAFX<Z9;KXV016W5URBMC.F/E[_  Y2M#X.<8.?+!S\B[',@ :F-([L<$8D
M"C?ZO0%DDRP8W:XUVWRYT&97^MV;XUTWV^=A#*?PZ[9^+TUSG!,'&<''GC;Y
M5UZ<VABHY^82ET84$"G&C4H43/BMQPUUONFEHV?OM7>6S-QNHLDGHBX534VW
M53TQKG;?7&28.0,')Z#!R?<%R%)9%DE J2LECZ:LCT34CR:AD=HH>36^5E%0
M+ILYQL4T5PNAE/9CA?7?YR7PYS\S3U)@G. 3CKL=O?Y+]TE485<EV:<C J.P
M"*C@\UT,#]W(1NCKMNJN70U<95&HI:Z[;**O-4=--==L[;8QC.>$P=C@X/0X
M._N\U&+N% X]V0ZN6'5HJSH1%&]F(!@P>;%RK%U&TWP:5ASZZ&B[9\EH^7W3
M NVN&[5SLLFK\6V^OPHJXQX&J+-)J"PW"SQ3LII*UD+&S2-<]D?*J89R7-:0
MXY$1:,$;D'HMO=@W:12=D':WH[M&N%KJ[S2:8JKC43VRCFBIJJJ;762Y6IK8
MIIVOBC,;Z]DSB]I!9&YHW(*KL\:?7B[*8H  ZK;LI53,O;WT%P-ZEF->:2@=
MNP.Q<"VTR\7%3*'3T:4U;BODKDF+XJ 3;MVRZ(+=Q];NYP+L_P!-WVTZ?AJ:
M"]436W0LN0HJJV.J*8">G@: Z:*JI:J.;$8:Y[9)(0&M+8"[C+OKC\,#MI[*
M.T'M@N=EU?V8ZHFET+%4Z(DU/8-;0V6]<=LO-TJ'RTUOKK%?[!66[CK'2QT]
M1145R=))/')=&PBG;#/73LC<,.&ORUBTK%YQ%PCC1H;GO7&XH=,AP]53=-)/
M8O$;+5JTX*<;*K(I;B1!.8/\;J::MLO=M],;9QZ3O])M7V#O;&]:BQ5\-5D?
MI.H[B+;4-Z[QP/K'#!+2Y?+7XA]D6HB#I#M?=IZKE_[*R]K&D[E8</\ U$.I
MM'2:UL\^<>I5W2FT[ [(YK8-\9;&^[/6<\0& REE,ZWDQAIH]&1:Y!1NGSI)
MNI\OX%0J%BCXZUDC=3YR.4'L9>&1[K55-1H[734TVS>'5-CDD;!/6&VU+MA2
MW>">TSN<3CA8VX1T[9CGH8'2M/5I(71N'8%VJTM)-=+5IH:ULL XY+YV<W2T
M]H5KBBWQ-53:/K;Q+;6;$.9=8*&:(@MFBC<.%:@==V&R';9'K_K-NM/V24&^
M[;EU;/*ZSE+;1-DGO%E FH38#K,5]W2AMH/R9^BWBK=0FJ]37URVYY9U6#JA
MEA;4V)T+V!X>+C(:XN(8!2BG$!B-8\OYL<0E+74XX^,.]5; ;^#Z6]@U3VLU
M%B[6HKK35,M++3NT?0,TJV&-U5(^_/NTES;<&:=IHZ86^LK74#9HKT\4@@=%
M^6$XU)Q"TA30ZK+XNF$?N=F;$PI(!.@IZ\TRKKNU:$-G>&CESIL@OKL@BMNK
MKE%7&=,93W^'-5\N8.<8.?+!S\B[',A 8,:QW)P/B0;-_J]062;+!C9K\.=_
MJ=1GS_K<M_@UVV^=A#*?PZYV^+TQG/"8.,X.//&WRKKTYM#%1K\RE+HPH(%N
M-&A,JF?%;C1SI3=-/1L_?:N\M6;C=19%/1%PJFIMNJGKC7.V^N,DX7 @%I!/
M08.3[@N1O*XLFH&14DH!-:1IIJQY+<R.U4/)+82RBH&TV<XV*)JX61RGNQPO
MKOA5+.N<X4U]28.YP<#J<';W^2_=)5&%7!=HE(P*CJ/HJ.#S;0P/W<!$$==M
MU5RZ.KC*@U%+73?911[JCIIKIMG;;&-<YP3!V.#@]#@[^[S7%4G$+2%LSBLO
MBZ80@YW9L#"D@$Z"WSS3977=JS(;.\-'+G39NOKN@BMNKKLBKC.F,I[_  DX
M79(P<C<C!R!YD+L<R !@SB.Y.",2#9O]7J"R298,Y:_#G?ZG SY_UN6_P8SM
M\["'R_AQG;XO3&<\)@XS@X\\;?*NO3FT,5&OC*4NC"@<6XT:$RR9\5N-'.E-
MTD]&SY]J[RU:.-U%D4]$7"J:FVZR6F-<[*:8R3A<#@@Y/08.3\%R-Y7%DU0R
M"DE )K2---:/([F1VBIU);">R*H9/9SC<HFKA9+*>['"^JF%4\ZYSC?7U)@[
MG!P.IP=O?Y+]TE4857,-4I&!4=1Y)1P?;:&!^ZX-!'7?=98PCJXRH,22U3WV
M44>ZH:::Z;YVVQC7.<$P=C@X/0X._N\U"B[2XD[W%\9Q,(3'&!KBU.RF$" I
MZV(,5LH]5K416PD[:*K(*9263W24QHIMG133?3;TVUSC'%-^8?>%W*,$.D!&
M#AFQ_OA6(RB"0V:NX>^EL:$2%Y7\L;3N%.2K--TK&)DS#'(ZUDH;=3&<LRZ
M.2GQ23Q/T4U9%WR.,_"OOZ]1>FHZO.AG3%_&Y_$'766G-XW:4O8SV?"=(4)0
M;R.8#'19Z-/.=D$$EFSP>ZD,D78ZCU6B#3>3R?Y"*>)(<P_*<GS.VRE,($"H
M^)& 00Q@%!A!S(0&#BF;<>+$BAK9)F.&#6#1-)JQ8,&B*+5FS;))-VS=)-%%
M/1/377!0HE=Z)2(A]"O3)LPR!L=95&VN7S^_; ZV-\+.%W&J2.;-K0(?E#;=
M7.N<:!4AVS(OG'RG:J6J6F<XUJN>.FM#Y)960M[Q WC?>*RQM!)=@=^H8IJ@
M$XP(@PMDZ.( 6\/P>[/6WSM&IZ&WT-1<*@V>ZS=WINS?37:K)RXHXR^3\4M6
M7"VVB5K 075[ZH3T0/' QY>[&J_&].ZW+U9)87%[+@<ZEX^;RV=R@?#[+E]P
M$00Z>2(@\CZ4KLJ<!8_(IH;PV:*,5#SX2R45;L6S+;5UNRW(/.AHFKHI+?/2
MT]?1U=2RJJ*NH935U1<GPLK)GOA%1754<,U5+AI89GQL+@P-/$6E[\Q_"ET[
MJFBUA:;]=]*:CT[9:G3]ET[::F^:3LFAZ:XU6G+92P7)]GTII^NN5KL- 99F
M5#;=3UL[62U$LX,3:AM-!!FS[ILS:WYG5C3M>*K^10JV+D*!IZA<$M>Q"7'9
MU,XVTKBGI5'E:M>UU70VJ8T,TBAL.8E9#1O)DC"[+&"\N,/&F*UUTKO2530-
MU#'1STMPN<D56VY5#Z:IEJZF%M%;:B$T#Z*B9;X(^[R1R5#PVH$I;^5J)7M^
M@](Z#TF-$V+6$W8U6:EM=_T;H:DK].2:'LM/?++;M/6&ZSZIUQ9KFS6$&J-4
M56L;K5.O-OKZ&S4KI;0^ABG/<;)0P37_ /-O+\VTX1.$3A$X1.$3A%1WY-YQ
MV8(6S6T!CM=]A@'7<1&[4)2Z6TOVFZ24$5N,KB# )-C=AOV!GR$O<16H(F&M
M+>PX[O%P@\F.+8F#HXH!B6&Y2,^PGY/XD*[<==LY&-B<?)XG;'UG;='9TC%D
M_&/7>\JAMJV 5/->G0.J8ZTO"&C+>=7S+K=IX'UX,*=C*WR>KYE( =P%8-(S
M5J0Y*1PY5H.(F1 N2AG"(DE*@?G''D[P\,'.Q]F=EK'IW7;B(>1:X99=W6B#
M]>>T=K=<W,Z=$:"O<Y;%#6G#%[,B8B:R0Q%Y36-9%(3=0Z2"H(WD1H4)W%6"
M*?X+$W+TZ.<.<$<<@8)(&0,@ CYR<?0KJN%5.$6N;A_^R.TOZ.9O_P#UDGPB
MK<\0POV?QM=3&&=?ASK73MQG'^W_ $Z721[C.?\ YYU<8SZ\\;1F3I^!Y_\
M6W"_3^_O%_N<^?CS,_5T6?=NGJ]I-P@QCN>G.SVWX_1]'=G>E:$M^!IR,>'F
M59#S*5J%.$3A$X1.$4<>W+E_GK;<X$/&9=+3DWK2>P0 &AD9+RHHN=E<-/"Q
M.SAB&;.G+09]:JBD\*+IZLV7SDLN%-,;Z^N,ZQ?)^+%\IX:6LK*BOM5QM]/!
M0TLU7,ZHK*&HAAXHX&/<R+F.:'RN 9'D%Q&0MI]B<5-_M5T%<:Z[62R6[3^K
M--ZBN5??KM16:CCMUFOMNK*T1U-?+#%-5]W8]\%'&XSU' \1,<6G&V:Y/:2:
M#QHRF(D8'#D:FAL)EH G%Y"S5'**#5M2 (P@U(L?FK--UVOU"&GU3)5L\1^)
M!PEOM[%MJ!54%+.(:FG#X@WDUE/+25+#&3$X24\[62QY+"YG$T<3"U[<M<"<
M+U3;76G4-VH'5UJN1BJW2"MLERI+Q;)V536U<9I;C0R34M1P,G;'-RI'<FH9
M+ _$D3VC->=Y> HW23K: 3-D)M3LB+438))?9X4+0ANT6ATM>Y_.K8%9/L?9
M&5*K8^+5<TBV"S+&FV<-)6SSZ;8QFJTS3B>2NLM3-8+C*XOEFH&L=15DG3BN
M-JD_W*L)&0Z<,@KL'U*R-;4M7:K<G4%-8-<VNB[1=,TL8@I*+4$L\=]LL .0
MS36KJ<^G+,QAP8Z!\U?8N(#GV:<$@U(4%VS[0LN[=ACK%KPS,0)IP6A,MS6E
M7$$'1)A4.)ZC%"L9;FCNF$V6'9EX_?)8*E"3\=E%%IH]=IZX<:=T]J_5K-=W
M**YVN>LIIG34-8ZUVB9CI8[-Z0;1S4K:BHP(R^=\CVB:662+A#!(\>M]K=I/
M8OV0U'X/^F*G2^IZ&Q7&WQ4=_LHU9J^FEAI:G6YTY)>:.[RV^VN+YS#004]/
M)W*CI::J$CYW4\#B8K;6?;F@LND1TGFJU7EUM\(ZB;FC4IIYY]1G\S=%6QPT
M;'OE-L_<GL->O45O7'R%5<;8SG<3-8:>XQ%55QM4Q(')O=+5V5_$>C6FYP4L
M<A/]'E/D:[^B3E?%<_8GVD\F2JM%@9J^BC:7FMT)=K/KF#E#K*]FE:^[5-.P
M?TA5T]/)'@\QC,*0(@T'/L42@$L,-C'&/B;D1#]J28KZ_G^)%VS56;JX],X^
M_13;'W\R*&:&HC;+!+%/$[\V2&1LD;O[KV%S3\"M:5M!76VHDH[C15=!5Q'$
MM+6TTU+41GIB2"=D<K#D$8<T=%T$_L."U5$34^LJ7QV"PJ.-<O3<HE)9F%"C
M6^-L::9</GRJ*.%5U=M&[1MIMLY>.E$FK5)9PJFEOR+J@$G !)]BA9^$3LAV
MS_T6CV1WK%U_>_DN;_G\8T1O.Q1*OYUJ-J*5,MT:]$$&^,Y8V;<HE0ML@X3>
MQ^J':&S.0ZOFZ'IO[L$>/G[<X\[8:W\[UC^B#L-O%PZG?HWQ&Y\%)BD^O-4]
M?0Q,97$>4;E)(\U+SF<R D0E5D6/(,:9T5D=ASX^X?2>7&5/BW^6N6(K-QR&
M_P! ':CAJ2#))]_?UZ_*?=T&RJYQ=U/3H.@ ]@Z!;LX4)PB<(G"*$G>C_4_K
MU_VV^G?_ )Z1+A79U=_<?]!7.N[77;N1X]L;8QMC[;=CONSC&<?O<9E_LS]W
M.*;\P^\+L4?_ &OP/T%3'L:H(-:K^K2<R'NWKNG+.&6]!-VI%V/T'S@1&)9$
M&+]VFT43T)-$P<UD#?8:\PHS45<(N-TLK-4-M.HO6R1GVC!]V0?I 4*?Q3_3
M=(+*1 Z-V(&7D$FC,D!R$1;UB,I36&D.=VH\C,7J,]J>V>U["A.UYW*V;Q8'
MLF+V'V7)AZR2K/88B-)Q'W^P@>.,Y]^!OUV4^(#!8G5\%A=:0,*VCD&KR)QV
M#0R/,]UU&@&*1,.S 1T,UW=*KN=VXL0/9LD=W"ZR^R:&NRRJBF=M]B@G))/4
M[E99PBIZ>U](2G>V"2(37AY5D O&5GCLG8=*PM8(M JL!GHS8L^[2.B3U6?A
MU21$:U<M]!C9Y,E'35XT7;/1[?X];OHYI-64DT=%,6Q76HFEG9IB*@#(NYU<
M?,??W2.-9&7OC:YO+#JDN:YI:]C<_;T&I;92?@[ZBM=9J:W,J+CV?66W6ZTU
M/;S7ZM?/7LU+INK%'3]D,-) S3=:RDI:N:&9U7+!8FPRP31RT]5*6SO[*VM-
MZA'UM)(]'39:%+V&BSMTM&:[E%K2..P1&-2,DDJ)A,.7T/*[G90QC\:=2)!H
M7:QAF66).Q#A/X7+/++Y<*JVLH9X899*4U@;<I(*.>X3PT@@G>#'2TSA,3+4
M,A@=,ULK8&R%[HR/6;\[=E>CK!K:IU5:KG<[?17Z/3$D^BJ.[:GM&CK7<]0O
MNMKI7LK;_?8W6UC;=:*BYW6*UR34,MWGHHZ2"NB=F*?0?0(;8R#:UC]H4A :
MDE,XVK&:D#%>0&0UR+G;V10Y0D_4,1XM*96*3EL7<.,B92J">-L[FEG?O3-$
MK\_37R-(,K0VX35]KI+=459H:I\E'2344=6Z:FXW&2&2HJ(^\0$\NH,+FYE+
MN:P29"V1^$C5:7DET=;=(]H&I-:6?3XU;8*:AU/J2V:IK-/4]KOC:6G;0W.B
ML]FK'66[Q1]]L[+A!*!01P]PGDHN6373Y!K8)=@YLO3T9 4N^G77BUR\P'7Q
M&()&KY?5M!PR96.DT9,"G?6F]IS5LB@MC$:^<6-*:4K2W86S7BN0EFV71FD@
MPR;9G]Q]_E'N7S*W;/7IN-Q[? C((SMD$YV!4Y_(L4GZO46"*PSR"TWTOD1J
M2P;!.[+%D,0K*&7</5B)T@7K.,V$?(JOJH?3_*&)@*F$ 0DDS B(T]0#L';%
M<B\;E4=>F?EV]NW_ "49?!FG"Q4'[.QQLE5<JM9&Z2,ML.[JL[7P/N2RM.*3
MF2S\M3HLO<@F6FK5*/:OAZ#B&I8N:+04\1T24/BQ3GW@QLU*S^H.^,="WAP>
MAV&V_78^.^ZO;X5% 'R15E+[5H2(@H_7I>X8F%[$=?)I==. T@[\E:M&1&S0
MAFQX=I'Y 3# Y@U4&MT#9*%E"*3:6# KP'AN17>HC'A6;L>N-C@^W!Q[M_'P
M6.=:Z7[=QGH%U8JEE:P:B[ZA4$A[*<DK$KU+L$H,!,PI9!K7#YFVLV&-EI!'
M&[N+BW<I:RTXSPI%W[)JD3;E$BK8A(XB2,@GIT^O[^'@JE?%GHV&]PO)71O9
MM*MK!F]M7M? Z)S%]1X.+B;WC$9E[YEV'AR#\G(YAL^&CGTKATAD%&OEWXT1
M&)</D"!&4H/9#F/="S]S=67Z2G$AG-QAAKC)C@,\-KMY8(-O^S%+-3<0.3S3
M*>G3.>T/\9H-*]D=)>30BTLT9=;II1M$7"J99[GK[6,50^[ G'?7WZW7CD/8
M&L]'-H6X+PXF\-YU.ZL$8$$JLAUIZ_OZPC1IU)(Y7#RFZZ=0(!(GV'6KT^$A
MZ\<WCPHT\U?/L.BK$<@^<8>.L*K[X<+?'[W"W&.$8'08&/D6I^;('%PD>'$8
M+N-W$1Y$YR1L-L^"S/:DZ:WLIK<^]25CM<+(9[*RM?:!17:RF@?Z!87[2UG6
M1690W&>V.' [Z!(KHU^@76:?*^G5W3V8&<X&?/&_RJ.-_#P<3N G);Q'ASY\
M.<9^"Q!CU3ZNC(9*JX&];:#'UY.B;$U-X$QIVO&D,F)D6Y0>C"TJBZ$=3!R$
MF.>-6KMB_+L7CIHY;(+MU4U44]]7"W<8&#U&!O[_ #4\V3(=S'\0& [C=D ]
M0#G('L"[5UUPZ\O7=:/WM#4P[?4P@.:T\]=5=!W#NIVP==FZ$-ZT<J@]UH(@
M+<CV#@<C%]Q2;%=BS6;:I*-D=M&!ML-NFPV]WE\$YDGK>N_U_P _UG>MGKQ;
M^MGVY7M;]=^O[,Q8LA:493K4_< PH$MHXWK*%(&+1#',*8-B+%)I!-7LV&&,
M*JX*,)*N3:D,**8=I+?'MZL#?8;]=AO[_-.8_#1QOPP@L'$<-(Z%HSZI'@1A
M87*NFG4R:58RI&0];J4<U&**.C@.O6-;Q4'%XX=?;N-WQZ+C00P:E&#SW+MY
MJ\-1_P!M*.DWKU%=VHD\<Z*\%3205E/)2U#"^"5O"]C7R1$C(/JR0NCD8<CJ
MQ[3U&<$KUK'J"[:;N]'?;15-I[I02F:EGGI:.X1M>8WQ9EH[C3U=%4MX'N C
MJ:>:,$AP;Q-:1Y5;TYZMTO(&4PK:B:YCTW&-U&0J?K1]N?L,0,5$I@MP@>?R
M7)B8B(_@0G[>G'AIMJ$1;+.]$F&GUSS*_7MMJH+13]UM\'=Z<.+VQ\V:8-)8
MQF&.GDE>Q@;&T"-KA&W!(:"YQ/LZWU_J[M&O!O\ K*[>F+NZG;325HH+9;G3
M1MJ*BJ#JB*TT5#!4U#IZJ=\E7/%)52<3623.9'$UG;L>J75P9"Y36XWK900^
MNYR38FYK F-.UVTA<P,C'#=V-+RF+(1U,'("8]VT:NF+\LQ=NVCALW7;JIJH
MI[:]_A;C'",'J,#'R+$.;)D.YC^(# =QNR >H!SD#V!<XMUEZW'](*F=Z^4@
M:TJX.E'JST+51 R.E= &^J&B ."ZO "V(B'1T;-M$AD?P/9)ZMT-=$-<))XU
MXYH(*B,Q3PQ31.&'1S1LDC(\BQX<TCV$87=MUVNMHJXZ^TW.X6NNB=QQ5MNK
M:FBJXW_IQU--)%,QW_$UX/M5.4W\45/RWOD222DN\5KZ55\7MA[6\0A<?"@6
MH[)D77Y6"L$$EE!*04TV)O7Q#94$NS<ZNG0UV'=LW2_QZ=F[/* ZZ$]-6S6^
M%U*Z\QT]O@BI!3NCGBI#!3OC<&Q!Q>9N8V+9Q+3&X.)7Z2T'X96JQ^"G+:;Y
MI>WZQN45]B[-:R\ZQNU;J!UYAKK3<=0"[7FEKH'R5\D+*>.WBDEKLNB8R9M9
M')&QHF8]\=PP+ P56Q G0\WJ:(F7<DB-/=C.H=&6' (^=?\ U>7Y(&UK8)3/
MLY=]E^^PXD.S$J85^L<Y>+/LKK84V%Z*OM, *+41J&-W;#>[92U@_N\^W&T3
MCQ]>0S/&=^+Q^/?]H/9->W$ZH[%VV:IE'#-<^R[7=_TW)GPF]$ZSB[1+6XC
M+J:E%M@=N(S!D%N9[16UHG9:%S2WI#UTM"UF0WV="[:3D4.&W+@'ABJ,W%(*
M7##(65'L\C%5F.@I"XB#/9BONQ^+".V^NSONI:4@U-BHKBT=9K1<VQS$>/\
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M35EJ[Q5OT92:*=<[90\F[7:#6E16U>FI;75S S05\M\C;-$.,QQ;-,G_ ")
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MJC['B<^:YQC[OJL 9WK4LI^5M^ZV:CQ9AVEC\G35QG'Q9>F-04IQ<-+RSL&
MZ>PW.CN+/:_N]P%FJ\$[\$4,[P-AQ8R7XE=F]WWTWVM4=!*_>*@[0M+7K3<V
M3ORC<=.'6MGXQT$U364,+SNXQ#80$[R]UJ&%H5"%F-4V:]/#[)ALX=L)K4+J
M,OQ<:A<PCQ>4A4,V*@"2*YDPU#Z1',9<F(^^W0U;F"35+*&=]>:^UUIZ!MF@
MK;3=7U++I15[XZVS/I9(:6@KJ6>K@:;F*83=[B!8WNCIZ:0M#9I6-+<_2/X/
M78'VCU<FM[A8]9:2@MM3I2_:>@J;#K>&[4U9=K]8KI16>OD&EY+B^C%HJY>=
M)Z6BH;G3"1TE#23/$@;**92(7+NR7C$E@1DJ-"R=Y=LB$#G"+=NNP%FNK4G)
M#V2S=HHLT05:M'*2"B+595NENGMHBINGKKMG;E-4Q5EMHJR!CHH*JEI:F&-S
M6M='%/"R6-CFL+F-<QCPTM8YS01AI(P5\:W:V5EDU+?;-<)V55?:+O=+9754
M4DLL=364%944M3/'+.R.:1DTT3Y&231LE>UP=(QKR6BS[A43A$X1.$7Y\.OQ
M?'\.OQ_#\/Q>F/B^'U]?A^+\_P /KG.?3U]/7[_S\*<G&,G&<XSMGIG'3./%
M5[>1(*8E5;P($&A3N5H)6.V(2$]':WGMNS*N&FL+FWLAL!"*LF,&GFN98=1:
MP$F?&R!NR%@9$:R3079JK*M<.UG%)445)#'2OJ *YKYIH**KN-31-%+5<J6&
MEH*FDJ\U,H;1OFCF:V.&>7F!S22WZ6_!CKZ&SZIU'<:Z_06>1^EI::VVVZ:J
MTYHFQ:IG-^L'?[?<M0:PL>H=..%EMTDNI*2V5=LEJ*RY6N@[I)'4,C9-Q_'R
MC82 2SM+$HZ,4H5U>5PVP-C]?$ZYVPJ'K\;'%82FP+S.:KRJ,U@T"#HO$[#%
MNA$;F;3+P@(!M%TR:[J-'BL$5<*RU06M_%1#@AHWT7K1T;(74H9)4U1J(*!L
M4=/3UL;HH*IO$^*)KN87<WX2S],R7#2;M,=H-WU[1F'5,IJKGJ6DU0"RNU+5
MW1E_?4T5BL,=GNVK9Z^JN]YTQ60UMUL,W(I:VX31NI(X;$N9DOF)5G>5.D&U
MH]<V=EK70SH=?JN=EO8!"?%*G<7>.%M6U*VO6!TBSK9E(HN1+3J.1ZS"LMJD
MH)*;%0%G (F19L"/P*LUGW^_FI:=\8SG;&<>((W]X'P\C@C0'B+@]>PB5=EA
M49C=G56?CL*ZG5D/HVUZ'VHR7PVBJK@<ZBM)SJ2X1E$O&67,[2>Z68[F-ALB
M0U9P3C*<:?1H(K&]-712XYQ\23G.YZX\L>6_GG!"MFMRPB=6P4I- ]765<C\
M:N-12K^HV<1?SHMJ0(MF"K@6UG,Q@<;W0%IN-B1++V3,E-![5SNT2>.L)-%B
MJOFLD'>#L2(M"^HG).U[U&&%>R,*8SRTZXG%9D(7T;Z\27NP:J8A";&C\ZZQ
M0TO0-RL*\: P:THM&:6U&B(?,SL,-[*.'1\\Z+DX0<8&_EON<>'K'._D!MCV
MJTNK[.[6W;XP:3EC*LF-T7G>=)M@4SVD,O"4K\P-,85)![:WG":\8>B5'IQ'
M$:/K1 4) M'&90NL,W%#V&C//4KZ=U70UM*QS6OJ:2IIV.?GA:Z:%\;7.P">
M$%P)P"<9P"5[^D;O3:>U;IF_U4<TM+8M166\5$-.&.GE@MERIJV:*$2.CC,S
MXX',CYCV,XRWB>UN7")WA7Z9691NE^32R20!@Z*R1>I'<9 $MBI,-*JGDAYA
M)=GK[<5D,[&+N7Z>HMT,>K[KZI*[KI(XRGC;6W9AIRLT]+?)ZB:DG;)4.MH;
M$9B1-;:B>.63UF1#ER%X,9R78!XF-*^Y?P\.V_37:_0=E5HLMLO]KFH[-#KA
MTMQ9;6Q/MVM[-:JJWT@[O55KN^4C*=S:P<#8 ]S>3-,,D2Y[5P@AU4M)OW\K
MQ Z1A.@</"N]$&!M$G3V44B$W<:QOL('%L1ZFQ&P.M.SY\1.:I,G)254<^F(
M-/=P4B<(9I;;YYXN+@CW&"/7P<'8GU\Y&X&^,'<' Q^=?<FF,1&:8X=Q,<>3
MQ-R-V B'AX7G!(+20X @M!=FQ4,T R,.)D,?D>QL"=&L3(0T)>"" LN(*-4G
MPTH-?M6:K5Z/?LUT7;-VV540<MU4UD5-T]]=LSWAWZN/_4_F+C]',_K%1_H?
MR%V7V;0_E C_ .+#_P!!QWAWZN/_ %/YB>CF?UBH_P!#^0GV;0_E C_XL/\
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ML$YLWQYRZ.S6Q PYEV8BH.]:MJ3ZAY6A<29IVVGYZ23V0HQII,R4%C,F$A1
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MPB<(G")PB<(G")PB<(G"*)/<?_4>H?\ M;=0_P#$17G,=U+_ -TMW_F+3?\
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M#OWJ+9%2R:MB%5]?+DIBR%*UEKB2B'S&: [11*S>UW;D868AY1J$K1DWB\7
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M]Z[/C-,]3;FLR86A/Z=CD3 C'Q2=52'$GK-;H*R8(SUC< ''1Y,5B6SU1SI
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M)PB<(G")PB<(G")PB<(G"*.*O;?KPBB]74LAIJD.['#.I#S?(&69PAV',O1
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M&)XC[/#X@'(!^0?(%[:K\7M)5?/X3::UEWU9%@0:P:\LAA);&E4(>N21JK*
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E$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>g729258g61n50.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g61n50.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2"V4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ()J^@T8X0DE-! 0      $8< 5H  QLE1QP"   "   < E  "')R-3 P
M-#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0U.A>^Y<2D]RV?FBM+]75Y3A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!RP           "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  $#O_XU  (  3A"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          3A"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8             !%D   0-
M  $                          0             $#0  !%D
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P  !%D     4F=H
M=&QO;F<   0-    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   19     %)G:'1L;VYG   $#0    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ H "5 P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MS06;O\]9/U9=]978=I^L;:F9)M)J;2  *W 7!KG,MM:[T76?9O\ T'_G<O\
MI5J4["2222E))))*?__2Z3H9P[OK)9?1UW'OBVUK.GMLR#>6!FWT;:<O/MK_
M $#OTEEC<#Z=7\Y37^@JT;/J9TV_J'4,O*MOOJZFU@R,9UA:W=4
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! ?_  !$( 60!3 ,!$0 "$0$#$0'_Q  ?  $  @,! 0$! 0$
M        " D&!PH%! ," 0O_Q !-$   !@,  0 $!1 (!00!!0 " P0%!@<
M 0@)"A(3%!$5%EB7%QHA-SE65W9XE9:TM=37V!@9(C$X57?5(R19F-(RLK:W
M=24F,T'6_\0 ' $!  (# 0$!              4& P0' 0((_\0 3A$!  $#
M @(""0X+!P0#      $" P0%$082!R$3,3914U:3E+(4%18B055T=9'1TM/4
M\!<U-U1A<7-VL<'5,E)7E:&SQ8&2M/$C-.'_V@ , P$  A$#$0 _ ._C 8#
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MX!Z.4T/%#O2!QXQLZWGSIM*.0PTP52-4BFS6Z,JUS&3*C2WD"] 0:I 7&3)
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MQD);0U.0!$A<+S7TOY8NB+RKZ*SKA-KY Y@B%02!MZ">KDD;!,9].+9*CZM
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M.]PDZ![U3]31667!8S6(9>C@DR%AKQG?@1-4,@92DI#*UC(M4)3R%29.<G-
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MS1-0HHHB:JJZZ*Z:::8[<U5568B(CW9F8B'\Q_S'6++&9ND<6\<W4,ECSPF
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ML2J4S>-E>R%AP=$> P.:/TL#[E"K_*.IO]6F.!T5UW]K^"_B=&/V(AP,QP&
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M^-3_  '<N?Z5M'ZRMS)TC]W7$_QI>]&A\Z)^*<#X/1_-.+*2E# 8# 8# 8#
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MWH*:O2P/N4*O\HZF_P!6F.!T5UW]K^"_B=&/V(AP,QP& P& P& P& P& P&
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M>O9H:GPIJFE8E>;E58DV;=5%-46KU5=>]RN**=J9MTQ,;S&_7U1UK#,J"LF
MP& P&!2#YI^?K#M=LX\M9HYD<NX*;YJOA_L6^N/F=Q0%.UJ1QYKA_BL7E35'
MG46V^=N582)>!Y(@AB9>9)R714VC1&-ASH84&#>)BHY ?TITOU'!.'I?XU^9
MK%J^K:RC?,LTCK57;_8=IPR12Y\D5[N-2,!*1GKS1,:?V:!H224NC)"%(L=1
M'FCT?\ 7[X# YH_2P/N4*O\ *.IO]6F.!T5UW]K^"_B=&/V(AP,QP& P&!2O
MVEY[>#."[]D7-U\F70&R(NSQE\=-0NM025@TAEK*E?FGW=V%(6_9QWN"PG:D
MOW4'L#O6*]8?J^ML(I?76_BHU_>=TG]"Q?\ _K\#^0^E<^*8>O6 ?TB,._[A
M!I@H6OL?W_9U+]Z^Q@9/"_2B_%]/)C$X.PF]%;?)G)6**,VEM.EID>W61.B5
MH;O>U/RL,]W3>^+"?;G^S'[(KUS/4%ZOJ[#HPP& P& P.=KO!%T*O\N_/R7E
MQVA;)<H^3![CSC8!>S8N2@!)[\'( K0!;'?>SC672TI'OW WX%0BM^L5\'M
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MT_K,.A_^F5U/^99Q_"/'L+T?QVT'RV+_ % ]BFE^-NC>5Q_MJ+W8_5'275%
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M1_4* SH>H_DWT#XYR/3U9=\[N$T;XUO^EJ*X+.>*08# 8# 8%07%/W0SR/\
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M<=R+$O(T]J?I?'VAR)+46A(32##4+@XIU18#BA!-*&,K03"Q!&#8@[UO O\
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MJ2EDKU$;&LM @F(7=T=C5#6H>$*L#*:S*Q-H"512I3[O$]J=QWS8# 8# 8#
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M3LZJRD+<@2%:!\)JE8L/)3D%Z^R,TP =?WX%E& P& P& P& P& P& P& P&
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M#00@,U&PZC Y)I"I5J/C(4?"[O\ IJV;[UZGNFGEQT#U/6]X%ZWP:"5& P&
MP& P& P&! #R<\+E>1WCNP>33K,,J(N=O<">=SHJ)!G VO<'FC++])]1P<CB
M@5FG+;/\7[-^.TWNFE'O6BU/LO8&!,&J(-JL*MK6M N>WH->0"'08+QM)IOV
M[:B4=;F#3GM!I2LTBVOTW^];2:5JM)MF^Q]Y/]3VH@S[ 8# 8# 8# 8# 8#
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MRM(H$2M0G"2/+4[M;>$W<!@,!@1.[SFDJK?A[L2PH*^+XQ-8+R_?,OB$D:S
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M9U:RA!$VL*+\TA_;DK[XZ_\ $XAZZN9L<-$\U1UY[RYF@53<LQ8D\XY&WUU
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M=8\(L2\K OR60=V8D[P]VPQR-JKYC@&C%"IJ;DDA:V)4%0[-RP]Q);6YP5*
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M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'-SZ,UTQ:-Z\&6O+NC+TF%JSAN[
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M_@/K3[Q9?YCU'],K1_#_  'UI]XLO\QZC^F5H_A_@/K3[Q9?YCU'],K1_#_
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MPIOVVM2Z6.Z!J;'-^4$;--]=P6M[&T)#SO6UZQ+>F#ZNO4^'8;SP& P& P&
MP& P& P& P& P& P-%-',M L-_2CJ9FJB(-W0\UB*:!2RW4S?L$S?H:C#'@I
M8XX./M=Z.;" Q2.:+(]D'X-,Z+^U_P +[(;UP& P& P& P& P& P& P& P&
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MDQLR-,G/4JE,@C[Z)'+4,7E5<.@8Z8=,4: D]V_TC>?O\GWZWMP'R*UI.7>
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* P& P& P&!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>g729258g65k14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g65k14.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1P:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &_Z^<68X0DE-! 0      $8< 5H  QLE1QP"   "   < E  "')R-3 P
M-#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0U.A>^Y<2D]RV?FBM+]75Y3A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!RP           "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  $#O_XU  (  3A"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          3A"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              O    4
M  $                          0             %     O
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   O      4F=H
M=&QO;F<   4     !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   +P     %)G:'1L;VYG   %      -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 7@"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M1_\ ,7NMI?\ X2O^<6OTB_(LZQU=EES[*ZK*@RIY$5RSBIGIUO:RQNRSW?\
MJ6P?UMOHM^J_6JJ[&OL9A9!>QK@7 ;+&^YH^C[F/24[B2222E*GD9>15GTT!
MM?V9];[+;7O(<T5[=VUFQS/\*SZ5C%+'RKK<O(QW5-8S'+0VP/W%VX;_ *&Q
MNS_/6!UKJ3C]9<'$J-K9JM L8-[6DGZ?V8,>ZVQGH?HM_P"C]7TK_P":J_2$
M1/%PBK()^G#Q<20!UV2?69^=U&AN-@6_9O2R*#;:\& 7
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L
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MPEIMS".M5H:6UU.,['8XV-G)IN^E(YDZ0(H4?I ( 'H\]XO  '_J\J/X!_\
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M%$!33$(.[BSR&^V[NZQ@4*0VI!:K PA#5E!FB!F"1Y;;%(+;;,9-'&SDVQ;
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MIUVLM,1K>&L*T=&PSV/C6K**3:!&-"+'_4IW31^M?1_?]IR, 3T.G5R#+79
M8Z+EA@%+)<ZU4Y&TDCIU1& =+5.(G7]D0)8E4ZZ"T4F>?.6'(]$"*CG3/4:[
M25NJWR(J^Y7N'MO6K->VU\GB7RH]?Y:?UG7\/WG"Z?6<-F+-4Z<2A7RD)4O4
M3QR]BR6%SJYSTA8(@7:L!/0+QH](OC^D ]]M2+U.[J]2S=!^V1Z.ZI^?1RW;
M9&HIFZ\-2OY;-KPM(*63V>_Y&/DUS4ATI[OZMF;JM@'P !PB](_6S]G3 OW*
MY9_ T%PBW5PB<(G")PB<(G")PB<(G")PB^:IQ3244 HG$A#& H"4!-[0\^T!
M.8A $?P 3F*4!'R8P!Y'G$RXB1,SOQ%RV;9G?9G?9G)Q%G?T\DS?6[-Y7(6Y
M$([LW(F;=V=V;=]MW86<G9O79F=_J9W\+S85[U#Y!UZD.A2\=^KYDG.YG"8L
MC$V.S,HV&A1IEQM\ZLZE+L5P6%4>08RC^6F3-WOR"S-9>.:KBNS*X2A,V3^D
M'=Z6Z<S6-Z39(VRO5/4M6OA;=>1Y:.E+F"TO2T_J*_+4*2TU.;+ULR9VV@:G
M8KN+0FU:;'6YMUOI3HS4S&5P^0ZC5QGQ>BL'EILE4,']NSX9#.S9?!4Z=@0!
MK(8Z;%1!6(_;*\_XVQ'S&W6CFNZTWL!VB=.*]U_G96]5HZRC26VA1G,XUUKA
M0*8R+HE2<1[A37=Z=-Q*JF!:S8ZW35ERHBXL::*ID^2$.D&4<!L]9.H^5 39
MI1T!T^$--32B7EH,ID:UBWF*<$@NS'[9F(YY!<ML6S^&A'X>X/'OPT'HG&QR
MC\+:DU>3:FM"[;;35:4\%;"#*),[@T.+G$'^%[SDV[R*P3T_,>R.>0TJZ?$V
MK;?HJ?2+S',1:P3@1*<2Y]2T 4KM'0(<H"1ZS2>VA<15/)65^==8322E+BL!
MC)<!HG3^+T5I^8F*S0PD;C=RI#R9I]0YN7EEL]9=B?E)D+,@,W%@B!A%FB^5
MR^;U!9CNZCS.0SMN)G: KTSO6I"_AX\;0CXTL=#MZ1U((_'@G)1MVWL1!LN_
M76V05R#>':M'S[LU73MF>.V!W(V19VOF[=*9I+8I?CV6 9A&NU74RP#Y=HU?
MLEC>"2!/,^P^(F/0VI0;(XD!M9#3,NY9&(0A81RKO':=W9H)2<QXQF[D3@3;
M;@^PL217L;$][%L]JE?F$RNQ]N!@+&FX69-G:"4N3"$9;D1,0^.+NK<XE^65
MC(^3*T>,"R+)J^*RD6JC&1:%=H)N ;2#)7_*M'J * DZ;*?Y1!<ITC_UB#S6
MQCP,PY 7 R#E&[$!<2<=P)O!"^VXDW@FV=O#JTD#MF8.0DX&0.0%R N+NW("
M;P0OMN)-ZL[.NQYQ7!.$3A$X1.$736*.B9> FXJ>)\2$DHF183"?Q5T/B1;Q
MFLWD""NU.FY1 [118HJMU$UT_/N24(H!3 ]I:G^G',8VJ.UEY"%C&-H'[O,A
M)B$F#AR=G$F=FV<7;P_.()))(PA8GE,P")@=Q-Y")F!@)G9Q)R=N+L[.S[/N
MWJJ:,BZ9>FE"[6]E*S E3F:G;LYE\R4_6ALCL4K(V3:2C<X-WEN6;R@DL"30
MWRTRDZ:''_-CI&;&.D-[8^DA5RN/QE%M:8B<=1>V8V"*/#XZ,KKRS#1>&(AQ
M('"9'+VF("A-C)C8F<>;3B[TSUC0H#D),/J"+L5[5K*329:]+&,-8C)CGC+(
MF!QA6!W(.)B0,[$+[[/=ARR4$7GZQ;_23.YG^[@QG^8=-X5']1^W^IUZ!>%5
M.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%0UZX98)PCTQ9V
MYE0GM+4U_1W5F+L%#WW6,?(@WR6>1C/OIFG7E!.WR[XTR\8A5;"[EV$=694#
M@JUD2RZHM'W^_P#(BL ].!&I-^GV6)49OEK2L%4N7V<AB^?:MEV<D$UXL9G7
MV#2-L7<Z3#F,[%8TF:P+'!_*"\D(SQ%.F0 132FX2&LL/*5ZQ1,;/0,VP=Q4
MS"3+%K*1$M%OT3MGT;)QKY)=F_8/&RBC=VS=(JMW""ATEDSIG,42+4R76OKL
MA"4FM(X/CB5<S29/8\Y@4\RI1(:A6%5S\ZK/4V,+" RK,RJ\_P [4DX9!D]4
M=?YP=<5@ X$5<'Z0#]/1Y[Q^/I_ZO*C^'T__ #9S[A%9#UL_9TP+]RN6?P-!
M<(MU<(G")PB<(G")PB<(L(TJ?M%5H-OL=*JI;Q;86ORDE7*>:04B@LLPT:*K
M,(7[328R:C$9!P0C8'1(YZ9(5/<#=40]H\#L5JHO9NC>*I SRV1QE/WCD2A!
MG*1J-'NP>UVG%G[-?O1/*>P,8N[.N^K6.Y9@JQS5*YV)0A">_8]EI1%(3"TE
MJSPE[$ N^\LW;/MAN7 MME73@'=[M+L&T2&767IHC0X6G6^.J6H6X-3?S1J2
MYE:BPN3%4T6?.(LCXZT3,0YRHK2+ /\ /RF^+X* 'R>0LZ7K8_35JL^O))M6
M4+=_%QW=#O1JT@IY2[BCBU!;]]3>Z)))<?-- Q0V'DKRU9-F[VPW[X*X#YIS
MR^D)!P5B&O,-343V+&0>>G4N">&@]WQ^WQQC;"*4WDAX3Q6(]G[.Y6BNW;5@
MV</7KA!HS:HJ.'+IRJ1!NW01(*BJRZRIBII))$*8ZBBABD(0IC&$"@(ABIIH
M:T,MBQ+'!!!&<LTTQC%%%%&+E))+(;B 1@+.1F1,(BSN[[,L;%%+/+'!!')-
M-,8110Q 4DLLDA,(1QQ@SD9F3L(B+.1$[,S.[J!VZZ_%V;-[E<)^TO\ -^M\
M)'O&;ZVLP=M+EL<J[(=C&UC/VB!0ER0<O)J(1S-U&I'G;H[.$; (I1JRT@XU
MMAX-0=:<Q5QFG@MT>G[6A:UD!<ZE_6T<$C%9@IRGP/%Z0 !/WCES**?*0C)#
M4>*D9V)=G2AB.EM9[>7:MD=>%&Q5\>8QW,?HSNLS1V<A$SE'D=3MR8J>+V.O
MC)7"6YW;@A6B\J^(>F+VIMW8ZK95/TB/JLC&UZC;+:R6JQ0)#1F:SM@4:MW#
MYF@M,.#SKMS%RD4K7EH]=XUD6JI)9L@R'Y@_TES/4S2M'35C(4[96(RENX6E
M'3K3#&>0JUPWCB/C#&-:()H9 G$Q HB'LN1[ WFBIIZ_/E ]K<HX>[%:L697
M&69X99928BC:0B.Q*\,K$!&[-(S\Y./Q/[EV3)I'M&S%BU;,F;-!)LU:-$$F
MS9JW1(":2#=!$I$D44B% B:292D(0 *4H  !SQ21$9$<A$9D[D9F[D1$3[D1
M$_DG)_+N_EW\NMBLS,VS-LS>&9O1F^I<KE$5.^T-^YSGO+U]GXNE=:SR,'2.
MR+3-V;[2=*193-2=N,^0D']T<(9BNM"V!!B>&59QT,C,QZSI:326D4DFK51Y
MM3$RZ-CT?F:<US4C-:MX"7('%C<:3PVH ON,=1BR@M- 1G*Q23=J1A&-VC=R
M)AZGHY>:*SD8 QSU*!M7VELV1L2-?.-XRX!4.-G#V-^;-)XYMQ<MG5N\.:6/
M$QAYY"/;3AX]D:8;Q+AP[BT)4S9(9%&-=.V[1TY8)/!6(S<.6C5=9N5-19NB
MH8R9=7RM$TLC0N90M(;0E*(A*47)^V\@B1B)N&SF(F0L6[,1,S._8V^S;[;[
M>=O3?Y[>GC^)=CSK54X1.$3A$X1<*2>%CF#U^9!RZ*R:N'1FK-$7#QR5NB=8
M4&C<#%%=RL!/AH(@8!55,0@" F\\J(\R8=Q'D[#R-]@;=]MR?Y"V^Y/\FW=<
M@%S, 8A%S(18B?81<G9N1/YV%M]W?9]FW=529+ZF75^Y;C.5.O*7][8--LM'
MK-4C1H,@FX/+-V/V*Y(_3,M[HU%H\4,H[<+A[&S1%=RK[4TCB$WOZ'S57%Q6
M)HJ(PT8;-B8VLQ.P@1=QGCV;XR(69A8=G(G9F\NS*<7M)YB'&PR2G5:.E#;E
MG+VK<>VY=UN+\=CW!G9F\,Y.S,[[JVCD'4%7F,L[K:V/KL^HL_ZYMH1_M\?Z
M7F1R&<15BB6LU#3=A8Z/2':5?>LGUTSQFF6?;HN(=*3=7"(0A%WJ4RJ$@1@,
M8](I)6!EZYD3U<P!M!36'V#LG!Z#)([DB-,KZ<5,Y]GSN#7AW[&RN]JAX^RR
MFHH5&P)F8MJSGA;(CJL<RE5NORM+6E'I%>37DIE" A$+&]9R5A1B(Y*>D8Z/
M/$Q[^939HDE'K&*4D9=2,9NGP+KMH\\M*&9('(V-(O12%RJ1=QPB<(G")PB<
M(G")PB<(G")PB<(G")PB<(G")PB<(G")PBAON75S1M&O Z5D7<#L+UOM2\+'
MP,G#TU3/-!RN9:QJSM5L_=Y7L%(O%>BK )'AT7,]4E*S(22*+).74DB,T *^
M_P!_]R+*>OO72R8T_LUFOG9'>>QMXMK2-8R,UK,W56%:A6<8L[<)-*3F6;5.
MBYW4RKKO5C/I)K77-CDDDV;64G7S=BU32(I/\(G"*G3](!_L>.\?[O*C_-G/
MN$5D/6S]G3 OW*Y9_ T%PBW5PB<(G")PB<(G")PB<H7H_P!C_P"I% C )^&J
M^Y>HE/V"29P\-%[EG#M_)/UTV[-HW2ZT8\)E%EE#%*4!$0*0H>3*',5-,ICG
M*49-K7)4,/H_1N4RENO0Q]+3V6GMV[,@Q001!J3+NY&9>GEV$1;<C(F !(R8
M7Z\)C[V5S%S'8VI/>OW+]:"K4K1E+/-*="IQ",!9W?QY=_ B+.1.PL[MWUZM
MD7;:K-ZWMLF?-.LM.:#.A SH+1DMH2#,Y3-9FZ,@*#]"NO70HHUK/DD5I6TO
M5&9Y1N<SIG#'T'B<%J#K-DZ8VZ%ZCHB:>-\-I>0)*^3UC*!N463U)&_ J.GQ
M9N]6PDQ"]J,&O9?A7&.LMKV\EBNEU:>OB[=3(ZY>(PR>HH3"QCM)C(W&7'Z?
ME9SCN9O9^W:S<6X4B(JF+Y3-):6'Y'G-P[!W*$[+[M6EJG4:D)GO6+KW-I%:
MI4-@+<R#36]-C0(+,^K3C(QA@8<Z*K7+Z^X(U:BI9G4D\:^B\G;H:8QDVEM,
MR033G$T.>S-5FCBMG&S,.$Q1@+O#AJI" S21CRR$HN_%JT<49Z>B&;(6AR%]
MY7<I"."&1WED%Y"?G;G8RWDN2<B<6)]XF+]5W#(FTI4=!O)_4:OTJLUQTCIW
MU6RB(?%0U5TM%$BPUO0E2KQDF-.2&0G@%5?XL&=JU3(D#57[2$7 D3B4LO4?
M]"W %+IG3@Y%^H&7"_5#4.5*"OAO<V%<;L$[Z::6:Z\G?$JDE>& 0CC)KA%(
M013HL;HULSDH(\MJPZX8+'V*DIZ7I!8ER'M68$J]BNVH3&"DS=EVNA+-(1G*
M/LC-&)R6Y@(" #Y#\ ^OD/Q\<Z%$UJ>][QBN8@<-"U;/Z<L3_P#!V"V0D;(J
M&\&$"-XQP])(.53>TP$2;ME53F#VD(8W@.7U3&9*]^PZ%RRV[MRAKRR VWJ[
MF(N(LWS<G9F;R_A7U;%Y&[M[+1M3L_ABC@D(/5F\R<>#>7;RY,R\V>^=L.VT
MIW0A6^(WZ:OS,CFTQN!3#'&(DLD[HU\+#/[2PBH:<I<2I;0A KJ<8:<50=IN
M$H!9^UDTDGCI0VY,3I_3X:9E+)U(JA\8#RT9Y(^ VJKR#7.26*S*U=Y>_P V
MC9QV*9@<'<19;9QN$PL>!-LA4BJ<A@DRD97Y. V:W-HBDECLR=ES:3N=MB%V
M[H@X.XLS7KQ79'4U(M@UB>I'92RNVS%NW=3%E;XS03R;Q!!-)=^NQE-09?)F
M>KE.X.@TCR(H_$,5! B9"IAJX\/18S*74&%@%R=QC@]YV^ N^["Q1T3Y,+.P
MLY%N_P"Z??RM<R8>B)D1Y[$0B1DXQ0O>ML D[N(,85"Y, ["Q$6[_NG=_*Y?
MZZ.U[T0^S.FWR13B'L4M78'.XP"%'Z>YPC7XZV+$$!_X14?CB >? F$  W%L
M=@1_5ZCY.V^[08BX?I\A>62OOX^O;=W;Y>E&QV"%]I-0\F9O/8Q5L]W^IGD.
M)OXWV^KP_I^A;^\\J8I66*]<JH A]5+%N5ZL(@/G\11@,=9 'T\?0' AY_XW
MU#CL:9#;ED\Q/Y?=H<75A]/EO-DC^>_GC_O=C3(;N61R\_U-#CJT7U?.6Z7A
M_+_6W\R_LT?WSD0-[K/U/JH&$0 C:GZS=5$RB'_"*X<V^E)G4 ?J '9 0?\
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MTT;%0H.$;RQ#98I(S>%VE%I991(3<R?SK@I<QG<Z$1/<RLMVQ)<N1N\M@IY
M B>S,+;\G F$MS9QY"#.S["S>M8=FV/L&)HKK+ ?<+-U1^7<=C=.KKHC1XW
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MZ"Y%$C#[B#R'F/ S#D!\"(>0$Q@7%W;D!-X(7VW$F\.VSLH@8\#,.0EP(AY
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MN^[OY=W]7?ZW7Q>_,?)NOE//S7RZWRW@""/Q_AF^%X!003$?B>WZ'$"?_J$
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M#A%$*#,7^G5I(^0\?T7,D#S_ *_UGZYR*P?MUR/^3.)_Z3RZW3D/_)[TK_\
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M06&V2&?R57T^WU?+I?(\Y^^%1I^>4ZM#&9K6+!/.JLTAXR*74GI5:3G7<O\
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M)+.DUR+7+WTF,'E$]FJDKJ?9)]A>T)[*XD^M1=6^S<2JMBWJ<^]>AVZK0D1
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M]&8Y';>XFC]JKB7/SU.3N3ZCMXQ"Y#C81ZUN)+1ZSIQ6R$%XA$'0DC&^"J
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M,,_.S1;NA/+1Q%=CZ>7S)>Q/JO)1GC[C%[S0JD1\ # P"\..J_7I;5@8 /T
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M_)1,<14XAW>VV3VOL%V-LJ79N ZR][\S[MXKDLS>7:S?KG&/\XS204ZDSV&
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63A$X1.$3A$X1.$3A$X1.$3A$X1?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>g729258g65l95.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g65l95.jpg
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M)3,U0D-2=9&ALK7_Q  = 0$  @,! 0$!             0(#! 8%!P@)_\0
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ML4K#"^"1P(W8[%MLOJTMN/$U#UUEET#&NK<KXVR"1@<V-["U^6/=R\K@>8.
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MPB%HJMM1.,8E>ZX'@/C#B'\M<"*1_*,<LOM; 9^93UYUK!T.FNC,6M%)'5M
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M:CQR.K[\[C"&6 \A\DHARP1<A$N(WM:7,(<YKBYN9RGY0UHU,#;-O0"THJN
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M$DK8C"U\LD( #FDRGFB>\$!@,8:X'F<&+0-5_*3<*5%T%9-[4'"XVO=EMW/
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MN8(]MTC)Z>W81M&,6L1C?0YTL\DXT8/L.IZS@H$BN0>S5U@<U&1JMV$.;N3
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MN9?']R ,B0Z"B:8&!HL)*72;&BPDHG8;+,KT+%#4&MYZB_%REH2U5E<1D)0
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M$+*!_'G(T]E^_03")(SPI8023F0TH_A2L67P145<,96&2B5UO&EIR2KB*.;
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M$;-0U-FE]@XPLU$VV1B,<C",9PO9HL%A\#PUD\P?"8RZR6@7,<[8ADQ0F?F
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M@TUIB2EW$AC< I*SS\2E$>(1N0C(/T)7(RSJP/:INM51A5B6 D5Q[]P!*%D
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M>(H0W_Q)&.B+?)6-+YD28QR0\7=)<822%C!"&';^,=)':U*'9<RE"Q'?4<1
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M1/$3Q$\1/$5/G"U."+"Z'[%Z+F,^OD]/:O[OZ%K>$@WO0]W;U((A3*%1(6/
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MU;'@TD:(RRDIN=MRG'(2:*OG0+?1M!8C@.U2<?I=RP=Z(;LBL<XW Q^R!^(
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M '6OW[A$K-;S9WP "2?+Y*\KC^].U+C?3Q#K3A%MQHR -8ZK!GS?J*L>BLV
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M"R*R:+MB_9KMB P@W:D1SIJ^:MW"1 <'(ZC<*(,?^+?@Z-4S95!L*!&O:XN
MU&I%9&DCF]FRZ<2@]"L-=8,7<VS*IJ9M=F0@FC-!.#.1<U8J0U/[_2-[#-7;
MS"Y6YG;;]!@=,8\,=-^_Q4E.?N=*8Y9K0=4-#0=G H"-)&3>HM$D</D21Z1$
M%2A^12.3RDH<E4JD1E^MNX)'Y(:*EW?V44EGFR#=NDD4$DG)ZJNGYEO[U7%'
M]*3P+_7*U\4MZG]E_P# Y7 ^*JK7[6^6OAWX^)Y$ZVZDLJ00F73:(XG$=8"*
MXG<S0=QS)DD!_%JOHH!+,VJOYF(?(_A'*R3G["6JWW7W2B>VQ6:QSL\HSCS
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M !*T>M?XJ@OI<+\<'Y536**8=,:6!IMF[,HS/-S.*3TM%9Q.]*WV%?H?4_\
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M2#V"-9S!3IFV\3'0%*ZR!QVNB4:WD>I%6,:PH9D TC^XUFU)G5$%SA$JNZ_
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M<X@!:'*8ZIK.8]OS@J&*I-0"0TZ:;ER%CXLANK,VQ+:LL&'*Q;\D<K%.V''
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MWLD7Z1OQ_A*L[]"_]IOYK$O;BU4\1>F^,7.-?GV'9VSC7&.%YA]<YSC&,?\
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M#)XV7V;;,P^)C)=6_P!P@BLIH56T<JKZ(M=4"Q_/S]P7'#\QT1K*A/E7^.B
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M5U7=*L-Q9-5(HAUW"_&>K<+/FB@[&_I%WV-3T+46"QI>H1. :\20/#FQ3%H
M98B D!:T2"6(&)WF:CI-;40Q[^:&U#O7N0'DL0.&2.5XP7,R23&XEIR2.5QY
ME$Z&=D71R)* E*_(XR8?ILL_2!5AVY$!F[6IYXIO]=!XNWAK=/.E5SE=/3.S
MMRJFC&W6^KQSKAN'&.)*_P"IN<'Z-Q96GUGT>/D]8BC=/J?!=R4.U:B!@R2Z
M3(XYU2B"?9:";#!RM/-+(VM'YL.J6],D94UT-Y'.#*^K1-Q6G)Z-LM&U:;Q)
M C."=FM[1UL[)ZR)LVA$<[:D![]L@]8OV3A)VS>LW26J[9VT=(;J(.6SA'?1
M9!='?=)9+?51/?;3;&<_*GL?&]\<C'1R1N<R2-[2Q['L):YCVN <US7 AS2
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M /?6[1NG]Q^*_#I_8^VFEIOMOMMKR ->6CH,?B ?YK-SN?"'..3VF,X VP?
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M_P"(;@8<[.Q&"N=X@_OWZ3IP_P#;=2B=*W[5:H#/./\ _,YZ#&ZM4_\ \?\
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M^/JUG]?WX64PG_THY_9]1_\ 4_HD^S8XPXIV[NUTK0(/O/9ZH_W#/<>O._\
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MWRSCV^(^+.(.++%>SK^HR7Y*L1AK Q5Z\4+'%ID[."K%#"'RN:TRR<G:2<K
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M79."0D&H48Z&"8YG]C\6_'C-E\/7K)K]YI^(=-D%4$/MZ?>J:_:Q]2+["9"
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M>DTWB'=<0DF3ZU'S)*6IQ!1NK50' Q&2;)?@%#NBQ!03KG\3H')9Q^'R4MY
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M'YC_ /%44=_G#8I_J.\3#/M._=']:T9>7R5_*#SMI42EG?%S4([6[[SKOG6
M9&=[ "^7UGVDN1;Q <_PSHO;\L&.E13S#LPZ^RS8XTTV7VQA37S^:D-:<^T[
M8$_5'=_XUO/^-#\Q_P#BJ*._SAL4_P!1WBC#/M._=']:?QH?F/\ \511W^<-
MBG^H[Q,,^T[]T?UI_&A^8_\ Q5%'?YPV*?ZCO$PS[3OW1_6K3:W+38]7T(-V
M5$&%?V(7B<?)3F"BI*C,AD.EST4U<R&,#Y<W'BD).R!E5'0UL?1&#TBR+;1\
MFR;:KX1T*ON^?S6:>(GB)XB>(GB)XB>(GB)XB>(GB)XB>(GB+G5Z1YQNN1_*
M<-G0ND9O(R!OHOX^+)J?HAA%,$8?5_/5'1BY&74$!)6=]<IUZI(G1\DU<5^L
M[8.+(6L44Y8CC>C-ZH,*X(Y<9[G9'F<8/^N^PWQL5)/K2J/E.Z$<08  JS@@
M/$:GZCI^_P"'ER_3'0.DBDPRC+-8SJ,A)(&9\EO1H!]*F8IHS.[##1U $X<N
M/P"YA-!-1<@Y!U+NA&S1U(Q]K<#W#/DMW_K'Y??YO7QR_P"5WTG_ +%OBC#/
MM._=']:LB;9<;-T,N]$4W>44LNDVZFZS?1QG37*VB"JB2*BJ.JGVM4E%$4M]
M],:[;I)[9SI@JJC/C&Q_EF-4<L^CM:<MV3'=;OZJ'QV8]*].=$1:Y",?$=2W
M()",Y( 8<RV.Q&" (MDTC\$093(NTVK\7%E6VHU!1,0P*[@S/4]!T:,=!T]H
M?E]_52J_6/R^_P WKXY?\KOI/_8M\489]IW[H_K3]8_+[_-Z^.7_ "N^D_\
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M^GT^F/I_U?3]G[?W_L\1?.,8QCZ8Q],8_9C&/W8Q_P!7B)XB>(GB+ [3A/\
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MSU&,]VW4=>\@!0:X1X84Z+@%$QV^N8^;M^3X/7DJG!JSH1: .YL]L],3#:M
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MC2<6MDM:9&-GKBO'H:Z+KL*019X3)BG(^33-^(IV.M2)H.#+*H5]04?JNO\
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MWQOGKCPP=_ G\\8TU^1:-9'-&IJA;JC5C3 =29VG*H,*5?M*K:C_ $$;/ 8
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M$;]=\>]2R\4)XBU+=UZU-SC7A2U;JF;""P40\$C'!=VT*E73PP?)-PX($"
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MM(6G+C9TH'3>L,U.B:/JO7)D20T)OGSS[NO\]^GOSC"W-6\UYKN:;&Q4*K\
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B\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q$\1/$3Q%__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>g729258g69b59.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g69b59.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[18"4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %>:^5@8X0DE-! 0      $8< 5H  QLE1QP"   "V# < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       02'V >+KXRIY:]UWQK  (.CA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!9Q6!         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]       $@ U     0 M
M    !@       3A"24T#]P      '   ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))300>       $
M     #A"24T$&@     #-0    8              0<   **          $
M                         0             "B@   0<
M         0                         0     0       &YU;&P    "
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P   0<     4F=H=&QO
M;F<   **    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90
M !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O
M<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M     0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N
M9P          0G1O;6QO;F<   $'     %)G:'1L;VYG   "B@    -U<FQ4
M15A4     0       &YU;&Q415A4     0       $US9V5415A4     0
M    !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0
M  AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI
M8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53
M;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0
M !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M        "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_
M\        #A"24T$$0       0$ .$))3004       $     SA"24T$#
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M 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M**;JSB%@-ME9;59ZC?5W8MWT
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! ?_   L( /4"70$!$0#_Q  ?  $   4% 0
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M ^$+=<6EC&SN-0HP%OK34O/'9$?W1BA^Y*>3G'C^1<F,Z65-WKN5#%*8R11
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MQBY<;=0RR*:AB]IC@(B'@=>1#QH1\" ;#ZZ$-@ [ .:E*4I2E=:=XJF!C&*
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M!=3QYT[N!\TH"H0\>9REEW(UKNC]R8.%2E;S"RKQN0#'1%S;\."2YB*?F(
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M,(#H1[?<N_L/Z^PA432N!S^Z']2_XUBH\(?\I>ZC0?\ \;VOZ>9K$O\ #QX
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MJ5-1$%!+V*")#&"K)S3E%SMNJY^GOR[Y7XGX13&/,F91MFSL:7C%3#VY\B6
MGE9HX<(O8>#(A\.D^>MHGX=T[;_$+0+Q5%,YT!6.8V8BP,4S8HE*!0[C (;
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M<YCG5$ZR(@5=4QOB3EV!M#NJG:4K01$ $0#8@ B ![B(![!OQY]JZD[Y7?\
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M/   >*Y%FR2W[8&V.MB4YB[  UHP /:(:]P$/.@W6P&+4 * I%-V"4Q1-L3
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MF696X:)A8R1B91P"#1X"SHC<ZBK!R5OGFQY@,V*(%*78F$0*&@V/G8AL0 1
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M6W+N3"V3/)7(R:NDID[<YN\48@5V:2R!ROI!J CJFW%W15YE<]+S@<\]8CD
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M!)4RT_=#@%95VV$Z0+&8F= P!41.1J01W5<B;=L<J:H)E-W%*8IA$QAT8 $
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M.2GSV428/(JU6]JKPB2L>U5(*LDL"Y$0,D0Y3AY,(F#R%XB-5$Q"$$H$$B8
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M0 0\!\QAWVZ 0\?L@ !$_#H]A4P3*4A1 Q2$#L* @ E]B=OT$0$!\"'N%<H
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M@P^Y@^H#]A#R'T$*Y  "@!0#0    ![  !H #] K6E0!EP+WG]4Q@[@*(#V
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M*Q3R)M3*D%;_ !^C<3V%:-RW+:<VE#VNTEXZ3?S]^E7?+%(:>N0XF4762*V
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MUV-R9NF<M1&UHK.-_7_BABWQVTAE6+]VG?SI:X/B;ACIIQIQ_P!+E7.BV6;
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M]G9V@-W:EDMD5&%L,7:J7IMOARMQ 2E2'/=8'%1JF(E[=;+V@42Z O@ T/\
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M2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E*Z)Z=8CHP$$X]Y=$ =@!3=AO/;Y
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MS5GYV ^ T\$=[T&_?^(^]:>A^*P_T?PF_P!;-O\ ?*>A^*P_T?PF_P!;-O\
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M8XS&A7UH6)TY(^W^0"UE-$T8V(OA1JHT;1]YJLTTT/S\]P).E?2D1%\!U$A
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M5H3/O0^X@\A<G9 R;<ERYXM5;+!T39-L^Q<G+PEDWLFD8AC-YB&<1<@L1LX
MG8NA'O621RF, %#?BZ19.)<?8]L6SL;6O;,8SLZP8")MFU(A5LB[2B(:$9(L
M(YHW,X(H8H(-6Z*0&WW"! $1WO?O2L6154ERM&I5T$Q116!!(%44A#0I)* 3
MO33$/ D*8"B'C5;D&;1J4Y&K5NV(H<RJA4$$D2G4/^VH<J92@8YO\XY@$QOJ
M(T0:-6I3E;-F[8JBAE5"H(IHE.J?7>H<$RE RANTO<<P"8W:&Q'05$4I2E*4
;I2E*4I2E*4I2E*4I2E*4I2E*4I2E*4I2E?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>g729258g69t17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g69t17.jpg
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M 0$! 0$!_\  $0@!!0)B P$1  (1 0,1 ?_$ !\  0 ! P4! 0
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M,M;7-6:DX>4D,S0V-T)B97)S='6%LK.TM?$E0V/D"4:&HB8X1$>$MK?"_]H
M# ,!  (1 Q$ /P#NVZX]\)\4[27GUJ[$S6U8I5\I\33LE1M']A_EUDWCJ1:H
M6=2R.N.F")MHY2<PQ_-A!N6D&DEEC!Z8L(<J]A$0.:3)N/.Q:+_;8NWJ_P"_
M>%9EJ(R^*1F7=W_;9W!*$QXJ-C:U!=_8B,]8\%Z3HR?3<+,#KFR124L$PNE>
MRLEH>^RK^!CQY&5:RF P80([#(!%1;$([A95]%'LE8'!X<I*)]O;V[XC-(CM
M?:5RL6VY$9;;;3.W:L)"]L>PTPA5%];+'8;G .]J]R^I,"U^8,I&@GCRNK?[
M!1N,@5##J3P*8Z+#9%$2P1Y8,,:C1))=H0.Q,+.P[C1O)\@(KF9<!*/AV$9[
MQ]JW!KWQ!]IXVQ40PMPW8'7\"' 5_6MXS<$1!6@2*>O.*4[SCND3U29:/J]&
M)Q.-$C<A#6(4,#UI,I%HH./Y70*N$D-=%_3WA.9KM?>(^^G.MK/NEO><:KX\
M0?L/UQ["SF536-1XO'H=TJ@,W)T9&K(1,5\1E\J\0;3K>-LT+.T8DN48/2]8
MF@LN6CRHQ9$0IOO$2>ZQ)DXDNX,TC+5KU[;?X-[6OPZAF6*^*J>/3.K !6CT
MP,.L3ME?W4EU:C21&)9"XY/*L[$LZ(K5&2XC\86,1/>\4DI(9AA$X.Q$,S 0
M,K=S*D5#RDL#!!IM?7O).W=3?S7(CW[:[6([1ZZK>+H<(5UUO GZUG<S5D8K
MJ,/G<TG<Z%2"PRA7N7V,N*AH80!JQBLH''YDTKTC6.3,O?MXS%\/Q)!00P9I
M%HZY>G!;"^_;]8G,V["UJU?Y!$9[3,[\!:_J+6,CTUXJ5D=D!<N@:-41^J)O
M.J+>R*EY1'Y\^G&S&=2'N99_1:.YD(DM!8RDV;CIU% ED*[LG!=!M&5"K=]G
M;9CLOP(--K:]\[[QZB(^$]>NW=W^#(2_B5VT\J;L_:E7=9-9M#^M!6YXTSR?
MML$+ETS,]:[M=5#9T/=1[5F_E25DGHNT;6G7@G0 NPD>Y<+ "9<5(9"#)D 9
MI7(C.U[;VS.*Y?:5^"^^+ZC?B$%KAG\1JVJXM CR,FZR4WV?DDPS:"\9QO4?
M8(C:$<"2*HTW$>76F92N2D.BJ,L:JKAMGI:=C0XIRQ)C]M'8#*Q:SUW,K6UZ
MK;=>K;V]AB"G53Q=;5855TU@MGPIG:4YLZN?#*WE=JF9EJ -R0KWHM:PZ?/G
M5(Z.A^XS)*!/(#O*4VK)T@TDJ!!89OB/98_*"X5&C6JVPC65N DV[>O;]7;&
M0I)XK,C*RFGWTBK6RJR)P/LQ:\)M:G8W(6R,D+ HOU+[ W=$=RZ)FMC@&VX!
M/XQ"A<IK0S5DW!C)83>1B2I2EHB()1!X%.;ML=[$1EV[J(ME]1Z]A][61BYF
MOC"3DH&@+8/UZC"TVG5H=2X)H@0LTRRA X9V]Z>2WMC&"&DF:5Z4?DC5>:Q%
M]!9.&1!H(GFKL%-&9  F<^;(P&;8C.^PC^LR42;;>W?OZA)M7Q&/6>FW2'LP
MRKL8+D_>&0T' XE%I)+5FL+@,XO.)%I,Q2ELT;@MG2P!B[!O(T*?) F+@_("
MD;'[HB,E5%6@,W6HOBWO8K[#M>WG[1"/-]>(!V.5@'B! !M-Q2OTNH'5*-VK
M9\ZB'8;/[H@0Y:75R96TV"TPX4H>:PDT?ADVC^T5;SN2ZMP&PY5A.&44/*ZN
M(>F$DDKIU_K'8M6K]8BUZR/9KU:][5M%)'>*#;T7L"UH>?@$7E3=/LSU6ZFT
M<PQ),"R:LJNWJ<"[&JR:R#KD*+&O'!A4DYBS/Y+1!#W,L?1./L!X])Z\-/0&
M@[:KG9)J/N$HTZNX1$9ZS'R]O$4[$EJE[^Z!J.'U0QZF]8X79EAR@7V"%M[F
MC)JX.KJ]T#XY6V1=-VO5S^7063Y6ASV:NS9>(YT093./C)6@MN"0CA]N#V^H
M"25TZ[YRK%J.VVW"1Z]N\?<$B*8\1W]T?N, ZC[P82LW)QFX-]9X,GK.3$6,
M@I2(]<922:21H*C[$(F2D3>^UFS\&S>-2T,?Q%/!=BHI*,CHS(C-/--7;(N_
M?7VM96[8[5.!2' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P
M< ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < '
M!P < ' !P < ' !P < ' !P < ' ##KWKOU_)#R0@C1E.OQ1F7YL$N,>UE"G
M0\K/=DU$=IN29+A%&SZ7[(K*I9DKI)4SE-533+WS=]L9!<^$6U->L%52QI)&
MH40WJ]2PI$S-7 0JZ.P2-%+O%HAC4>(PNW7[N(%W$QBIX*>?L">KC9O(D-/0
M+ Y"'<HX6R$W^O5;6+RG#JF#LI@E36.A 3LJD.IFQ*Z@TQ&!C#L@K5+N-_*T
MLC LPU=)8)P=W,(VMJ18Z:$A.Q=!TTW3TU752"/;OBPUX#U8C<^$5AM4U3BY
MO9]>V@HQ#M:B"IHRFN&)^,N+8$D3+2+9!*!2,CGT<(2.,&":>TF(&]BNPLIL
MB1=-PG7MN>TM_?UV%--P7J!%CX6H3U54J%>R6EIP@+CCVI(VVB[BAZT.Q):;
MQMV2VB^(>.@D</3Z*DG<,)D6C!1P8^66@9PFT(O&H-?;VEW]=OKVC)8RA:,"
M[C% U+U.)4"$R1H,H,KJ'L-Q)DPY1>%RPS9J'2V8$RKMNW=$G[7*3I\Y017=
M*JJI:;:A%SX>U]7 .0)I"EP"L46!5#5X5:!I.6\&6$P"*#588@]7>NGB,449
MB4=XZD[<DB+ARF'RST77?O55==U'2^R@!B+1IU%JT;&+&1K.NJ\43,P>$QQ^
MA1V8K- +^U+7VA<''[@$80QFT2$RJVI4X3:$B(H2!R9-D)$\>H-73XKD)UG[
M<'_;S"Y;' =9::!S^XI_7M:QH::,Q8_9<T0JX>6+2(^-*M!\//2Q6/1DF?D1
M0,6>LTPI<BB_<AEUM%6SEIC&5, UGV[?<,.-)AT$'385!4(74P6:4Z8F=7Q
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M #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@
MX . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X .
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M@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X
M. #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . $;.M7:2 ]IAUL$X#
M&[-C:%.W9.Z(DB=FP0G!7)265]L.U+F(L@2W4W,Q)YDDA@67_P!*NE%$W+=^
M-'.D-D.!)E:VS61'J.^WAMOB2? @=?D-ONYIUV,[*4PR-QT.RJ6]XW7$/=ZT
M+8DC%*1$YU5IR^7CZ:6.VG@J%,9*RD5CFA(P>ELR?$1P^.M%8\GDJYDB029:
MB/A])[VW>&(VW?"Q(WU?E%T3L/%G]@]5*E[)3+N= 8L +-4M)]UX;GX]B%01
M1])R3N""K3E@$A-*VDDGVFJ).IA:I)9)50DV-M FUSL5]9D17[?#;4=M_8?:
MWA/JOF5X).XR_L&75R>$D(2^<RT=%H@8!KC[ <N8NL(UAY1U+3B;B"MAOSN;
MNVYQJ\D#M_N#(HFDF>SH4B%/M[>86W";T='+$<U68CK(L=8[E4W\PJLUF?UZ
M 6%)[[ZA[$(^HB2E8S4GHBLNSB!IB4:[:^C;,I46<^?KJ$VU7^W5WN&WW[!&
M9]WB<RKL=85*4B[JNSGL7H:ZCT2A J<Q7-BS&]:JF,2BSB,/$"$P##XQ&D2)
M@T#41D&0Y)VXCIZ2:OD8NF&($@6/;O:M>\5]9>;6*! ^T790D+J.3'(R/+Q5
M,S,H_?Y!S4)6L9!#95%)L8BTG@SN'-KCN=M'9%#FC(>K&70*<V:&O<N18H5J
M_48&@RKD!D7"7?OO7X"W]7"6^6HQ*Z/]DJ];U)9UKS::QEJ-IH-.)E;:8-14
MBE6\;B24A,DF;[+/9\H?5C(6/%11.0@LO LDDD=DGS=SA)ML.9!&_8AA&R^W
MAI[*(?3E=1"9P^SY+=T9I^7?.@5 212NQDSHJQ;LBT\'C])^XBLJ'%F\!>B-
M&Z!]PHAN'F+)XU9F6 9N4"?-P=L^ 7S-.XD7JRR$*BF4)LL\8$/NO,:F=EQ6
M.P]I6@B1=F)29K:HG#EF4LM69L1TVM( XA*:+$+)<10J6!K2<DVC;K:48!8]
MO=\UC/S'Z-8MR"]^H%8 >!F@M-]B<M[ "U',A[9O X[)R02L[O?,!,!M24CX
M'.):Y"09T8S*V!EPKHJ=CS:N9U)3(!G#F B1FP6UF5RU7\W=]CV;=0QHS[QO
M9-8[QV':G1=%R:#^'E+ZIDVD.C!0S)F?<'LG9-4,Y(Y2WLA-PA!YL*"0%BS6
M("@LX@+61/Y&\AAATUR*1";=_P"%?M6*_!_-VQEUUW6!.\T@0BE564<AM\S&
MO \&L1YI#@T,.PRQH%:UC")^"?N9;NZ>LT(U5+I^4C91H"EP=C*HJ_)@V_RH
MW:K!%CU[UMM^[8<!KWGADN")ZP>OKF3DDRCVIRG=9+73<,)LX.1K.166PFL/
M)2"61J.G(R'$ -M90.>2F/24._)1L83&#-I?&79(%CU]KZ_JU7MVKV&?^MT]
M.VIUVH2SY3ZEB36/2U6SV18&M]F@[Y=F$&!2$OZ@TW57W:LOE BX]5;[+K;(
M(>C2V54SKG?8!ZC,N S&:>! < ' !P < ' !P < ' !P < ' !P < ' !P <
M ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !
MP < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' #"T+BU+5_9MJ
M;Q,H+86C<\D%6-98-S8)8V</'Q,&C4"%2!&'G9(3TCC=""0B,!=$HR'"BEQH
M!FLLW561W<;!.OO:OM/TBLLJ4J=@_N FA 8TH[O]TT=W/EX.2((6/NR@XFMF
MZ$H9OO669!AK!P8Z/*#-D-1Z[+1SLNV4</WZSD(N>K7LV=K?U?7K%*A5:5A1
M(44U$E#0<$.3!P>-_/ZT9K+&8= V6$@(U$@#JQ)4<]2W+&E08 (.:+X?$7B@
M8"S]8QH,8IA)G?:+;@[6*12>-J]']CW9PV#'.'6M'KK]?!BK$.J@KJW7S%83
M6,7FK 8/RKJZ9K-G[1OE1%+US=VWV716!?M?7K]-NZ*S8]5TR]>$+(F^?F:5
M0AQ&!NK$$V!)JK*"(M))/&SSYBWET5DL7<AG!22QZ/;9+-G[4NMZ/8/H^R/*
MD&#T!&>SZ[;?;4*H2CU1U^$B+&0$0T7 C)NB4 ?.N6JMT#E@G7A+=BL4(R4M
MNZF4F(G3+DP/3-/"Q%S*M1YYOHH=&#'C4(%"C'62D(D$L^-#(*P<1VXV18/8
M8(TZ('1)Z-&E).L_B&S$NZ>(,XALK-9?NA&V>B IIK)"J#9LDV7T02!?V]O8
MAP!G56D!3B(/T(Y(7!>"S0%8,>D!.R;-*R3651BORE61YX:D1&8.34J8B8 <
M-1UJ"E+XR!RD7*D5ABIDD^). 7]O;9]0L)GU]A4ZN^?=C#\B#36OI["NNZD,
M'!Y0=Q&FS^AI!9,[C<]?["3:<0E'HSU@,)%$WZK5QB,E8@'DC%ZN2P.7!A-]
M5NV?=UVW]N]PCE0/J[U8=LJ<DU8M73L/2\2TJVNR\(NNS'H5Y!8J:\C:O9N[
M#6 N/M^,1.1"EM6$:M)2:L(X51*-FK5DH[+(.07/7V^$BW_L^H4D%TGZDPE\
M#BPJ.E1;K8=6.\0B+F[;=4391KK/:25NU:*AL7?6*H@.A5/V-)&)(+'@+!"+
MQ]F3$Q9<?I&%F 3:+>W<._MWM@7,_/O%O[16H-U2ZO#1B 2"C'[L37]JHRX,
M+&W+9QQE5\_C>D@QI&HFUVGSY*MX^*93J1CW%2QW4'!T0DE=A741^1G*++60
MN??*VPM9??LVC9#]%.M$?C\5C(6*30:*@1_8]7V6UUW=J3KU':/'8E\T( <V
ML38U":P3BTE.1YM4T8?BZS:"7^6C6*(ZMF66P+GK[>W47M?M[1(ZOX)%ZN@D
M-K6$#UQ,,K^+@89$A3@H7-K"XU&1C8,#&[ES[XF:(^HC&;9KJ[*$7KY;1+7=
MRY64SMOD(%W\ ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P
M< ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < '
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MH7P4'"3)<&(**RT&H [;Q<&_KO8K[^PSV:OL'9)P(#@ X . #@ X . #@ X
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M[#1>VXO+[[CY6MDS3PP]6 T3?\TH0I,0I5['XVB>%O2<:"%S* QFNM#%9K'
MI_?18D)>%@&1EPVU:[<)7MWA?:?9.CUMVZ*5@C-W+O>5(,F6K$U\H/WT(MH?
M0\M#CQ_R9ZZ_/@;D+"*V(1YFW7.)2TN)%8'[+DV.%P6/V[E_L'"CUD==]K &
M.8Z]AC&Q[K'@T&QQM&\AS]@["(0YL&.Q4M)U0[-0G*@];NW\X%0 V3S+14'4
M(R5N ; =7KW4&NV_8O-<[7[E]5^$9^X$!P < ' !P < ' !P < ' !P < '
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M-AG?F PVW'AOE\+)WAC05LP("=AP#M8[=K@VZ[E?5<NX1[VL=K? I#@ X .
M#@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@!
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M '3D&[["Y>5-Y$$7]MFJ]]G=]MEIN<" X . #@ X . #@ X . #@ X . #@
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M-M:8SKMC^IMKG.N<??QG./O\N]8_)SV(D\J5$OMD"GJFJOQV? I'SVZWBO\
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M ZIJK\=GP*0]NMXK_O=$/J3ZT_!CCK'Y.>Q$GE6H\X#JFJOQV? I#VZWBO\
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MG_J2H_\ $B#G\3?P4Y_GF?\ >,>$KGVV/-PX . #@ X . #@ X . #@ X .
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MI$>2;>ET2]'Z=JV37T\OE\[?7'H\[J%ANG4]$M,1&C5,C+C.*T,5-D+(RO\
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M#6=S,[JUF9ZQ@O.$Z\ZZ2<TG'%N$GXI+4:B3O;+VV$+!YFBV' !P < ' !P
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M\$LX/"5VLICNCLDU256BTO$*,9S (L:9A)';N&6O7WC^KZ]_A%5KSJC*HK=
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MIZ5,I[#[@LCMK:D6JE:JB\1>@5RD11[!C8S")I"%H9-03I&8L-G,GA,LS!T
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M@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X
M. #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@
M X . #@ X . #@ X . #@ X . #@ X . #@ X . %AU]6%?U2,."*ZB0:(CY
M--)C8LC1$-<(;GIS/S[V3S&5&'&V=W)$R=-$'#ET\=K*[IHX;#VWH!S%BT;Y
M$F7)F+;7*><?4TPQ%:-Q5]''C-I:8906Q#;;:22E*2(KW4=U*4HZ4I2FY)(B
MNI2CMOJ49FHS[9F=Q?G,<5!P < ' !P < ' !P < ' !P < ' !P < ' !P
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MB"FS5JOOKOYC%3G9Y1I^"J[)RT5:&_2I%*.AY*2P3(IK+$:,>,8T7"E,K$6
MRRRP;*"H4?&ASX[;349UR'$D.H6ING.#4X?9J\)&#HKK<IN24S$YUEJ0I:W"
MI#CE3DQ'9"E*7GF<URD:!Q2E.))UYM*BSI"1'CGRX/3 X . #@ X . #@ X
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MANB,5=A</^#J/K /9S]D?>2I#[.,\_:4X][9R*\<LJ/*.$_V3#=$8J["X?\
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M:0L>N8Q,"4Z?Q:6#]%PNJ1J1B4"Z03JMV[%O[]S+9VRU]KZQVB<"D. #@ X
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M[2?!CCJGPAQYP!Y>X.]=AT\H_9&)X9/I#VFO3?\ 'FR_LQ]I/@QQU3X0X\X
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MU_M!SSC+)_<DQ_\ ZNH'_P#>,*#F<7?P*]_GH_\ Q2'51S\YAY*' !P < '
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M]XN[0&IB6\R>1>&5Q%Y!,&NS=T@3DH*OX@B<:Z#WI4:[D>YHV6 ?M[&9B2_
M@. #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #
M@ X . #@ X . #@ X . #@ X . '4;U2\/LP$MVQ[Q[&-A+]5EV)OR?T36#1
MTD5"AF<LNZ>S.+6Y.5-,99EIRN*.,7L'CF/6!E>([IR!WN\GZ['$#UC>&,.T
MO$];Q= 2J9B'$46EL2ZI(:)"J7#C42G4Q^D4E!FI32)"HBSJ50/,D34KZ!:2
MS 0_TPTL2C,,5"74G")R3(>6ILU$1DRWJ(LW;\-1%<U;2([%;6.W+FS&Z#@
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MHDFINW6V1V5;[[Z8VV15V;JK(;*);9RGOL@LLCG;7.4U5-,Z[Y"!N\ ' !P
M< ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < '
M!P < ' !P < ' !P < +/A5@0FQQI,Q!)0&E8T+*97"##L*]2>:"I?!C[^+R
M^-$M4\^D9&8\?&/A9-@YT2<-W"&<YTRDHDIO??C/Q5H1(:6RMQEF0A+B32:V
M)#27F'4[RD.M+2M"BN1D?#<B@E$J]C([&:3MO&D[&1]LC*QB\.6!(< ' !P
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M,:LF02"61]RZ66=AB!\ZF.7;,C)-JZ!<SU=N_P!WV$7>(<9_TWZT$RZIUY5
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M<>3*F%<85PIY/)Y^%,84QMY?/QC;R\"D;G !P < ' !P < ' !P Z6O'$_\
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MU2MRRAPBI,V/I3;<=N\\Y&T:"0TE:KF2%'>UB))W.]B/R?+9A*LXXR=5C#=
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MC=$$,#,-4$'203<_L\Q6].RVL[\%KZO;I[3_ &0DPB16P@:.(A(Q((DP"-%
M0I! /+XQ.(=-&[23L0"5C"6TTC<Z="Y<)"3<8!D3<!%L%!#G(C;+H!&9;/:W
MF\PM&0]'X;/8C'XC:MOWS:^@"-6=$LR*82F&LY45"6C"V4#?IO2\)K^(88$H
MT%'M'<8D$:; )!B1Z*RB2%)(?=O"#@%]9F5BOZ2/[A<(OJ:V'S*#6,YOSL$9
ML&,1UY"Y?+B)ZMVSZXX.N9'GA\1L46#JX-&10\ 0'85!EJD!5=*VV2<C5<R)
MVYE4E7+ OO6*WUZNWMV]V_>%O0_HW (')!IZ*V;= MAH%?Q&61!*00W>*V1
M<V'.[.BT#FC=2 [&, H#*+-G>L;(Q,U%9>4!R8K'9[)YH&=K,]P7,]MO8K>?
M^?:+PZ^=4(EUT*."<:G]H3'&:?J.AQ3*P24-)H :RHLM9A.L C!W'H/&#!!Y
M'T+7DX=<_)2AX^>&I"5I"2*F6BQ9V S,]7;,_K.U_L%EQGH;4<6#5H':2:QW
M^*D94-'H01*$8<L1'0+K<5.&:NKI;=M"&C-W&F+Z0/MSA%9EF;R71(?J9E[K
MY.9Y2!>]]1:[^?VWQQH]T#IR,BZW$#9'9&6=/H4Z#K#+LK%';F%U[1$W4GM<
MU:-=*PO+AY#!I5(*P?N#2A2:E@T7CS-_,%5FCEV\ 9F9F9[YW/NGO]WVV:AP
MFOA^UFPQ%LC;+N9@M$60E@-42*5RX1>-P]NR"YT4SHM_63P(?07D\F*,EV)8
M8Z&I#-1KQ@R92L,)DS(%S[7HU6U;^RW=MKW[TX3X<-'CJF=4F]DUE2:O7L>Z
MK1-T%E+BNS*3J,=/S $Q58$@BI7";$L,);1H2-G;<NS?XDXI)=IC(_+QTJJ$
MFHS._=\][GYQ?T)Z< :]E$+E48N[L$V>1. QFK2K5_+H>8;6+7E>R65RJJ8S
M8#PM 'ATCBKR4VDS<#( 1B.RZ4ARKL):DAL,6X<-5@@SOO%P]SAMW?\ M8;<
M9Z15/&FW6AG\M34XEU-BT,B=/.#>T(V,B64'"$HRQ=+2@5!A4J:.#T;?-0$X
M91PW'P$Y$! S&5!2J"#O5Z#./7V]OV]SZ]O;$QN! < ' !P < ' !P < ' !
MP < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P < ' !P <
M' !P < ' #I8Z@^&4O'>P%P=E^R3$45)J]D;YGU"5DFN@6"Q\9);HF\LBMLS
M3;3&[,I-G8TLQ(P>/8RN/@*&Z$B?9<SY9@G O6\3Y3YU0PI0,&TA;D6F0*/
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M?_,#VM'3[^&YY^8S_P#SCCK 91/FM*Y49_ &ZHR2_/:YR(_^8/F?%HZ?8_\
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M[6SJ#_"E@_F0Y_S[C<_Y0_D*1RHC\H-U7DF^<5_D5?YX>ULZ@_PI8/YD.?\
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MBNJ8G9ITFH-M4M=#D0)TQWH4RG)9J!N-FW%:5IFY$=*"=;?(LU9IT:BNKT/
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ML"^1V'?5P]+'@:6H)[O59;ASL-3'7.326)6.B$!O@W7VIHLBV!J1<(1]65:
MXJT;N%?7W+M7UE;39;S5-$_/\S377'SMEDDUK!U;I4.A8IQ?'CRJ7T2\E[%-
M<DJ4]T7(:SDK>G+4DLQM)9I&17UVN9CJJ!@/ -0CO.2L X'6M#V8DTX1P^BR
M20A5K)IY:[J,[COE^C-UO]WZD?JI@?Z!YXYU;8SXW8GY?JO.QT/6UR=<0<%>
M2M"Y@'T9NM_N_4C]5,#_ $#QU;8SXW8GY?JO.PZVN3KB#@KR5H7, ^C-UO\
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M)L"?1O@;R;H_, ]OX._L;G3?\W&OZL\=:6L?2CCKE.5SP.DV!/HWP-Y-T?F
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M4]"Q*,FI$O2=2J)B1SM]E/-=0_&N_JR&ZV-=LX#9SC&V=/)G.,>7R>7R??\
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M3M3\PY-^C>.KS!/&[#?+5/YP'2VH?,9?B[OX!V'>%)15U1OQ >N$BD-36*#
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M?X.. #T"/[WI_@XX /0(_O>G^#C@!N:ZZZX\FN,:X_J8QC'_ .' #[P < '
M#$5[IJ+51-DDM-U%%(^4T33TUSMOOOLR7UUUUUUQG.VVVV<8QC&,YSG.,8^_
MR\P9$\T9F1$3B3,SU$1$>LS/>(A0Y^HKN#\N!;K7V&;J[HKT?:Z*R6V=%$E8
M#)]%--]<^3;7?389C;7;&?O9QG&,XSS]%NKS!/&[#?+5/YP/)^EM0^8R_%W?
MP#;^CCV _(G:GYAR;]&\=7F">-V&^6J?S@.EM0^8R_%W?P"OLZ<[4#V"8IA6
MUXLA:29]%,:UC,T;L$TI6Q8C).EHT2::-]4Y$.&#6)O3">-2K0>R;OL+I-4-
M4["\9X 6LW5XFPJMPS8,W%56EJ69QEK<C&:S>-1FPXXXMD[_ *);BU(S34HS
MJ*!4R*Q0YI%\+43#Q%\,B2O42;?"21$KXQ$1'<B(7X'&]\H\C%6X)MVC#-X*
M*, H6@+Q9C%&*!)#JYT.AX\DVRGH'%F-'CO0D/8:H-'FKE?5PBIA53&V$[B'
M)@^<E3U9P4ZJ8ZT_+4Y-HRSDO,&DV77S4X9NN-&A!MK7G*0:4YIE8A<3%K"<
MS-8J*=&E26\U$@LQ*OUDHL7P4JN><2;$=]8MTW .Y4F!-XO(XIV*/QIHH.6:
MQXT,L(H$;*AV[UH)50%/DUV**HQH2(M1ZB:&N[-N_>HM]DTW2^JF0SBO)S'>
M5)CX@P>Q(43A*?9J-);>43RD+=)3J'269.*;;4LC59:D(-5S25J%0JJI)(5%
MG*25C)*FGS21I(R(R(TF16(S(M6HC,BVF*W'0O>R(/4B439]I(P10C8V&HOX
M]FSPSU*(AW6KT3%DW0[=LOI'1;S31V/"Z[X&LG.FB[=LFKKKOBR_B/)C*0;<
MJM8*DMG(<EFV_-HSR#E.IS'9)I<<4DWW$&:7'3+/6D\U2C+4*DQ*N@[HCU!!
MYI(NEN0D\Q)W2BY$1YI'K).PCUD0Q:IUT["*[[JJTM:ZBBF^RBBBD%D^^ZF^
M^<[;[[[[#L[;;[;9SMMMMG.=LYSG.<YSS9%CS!!$1%BW#1$16(BK5.(B(MA$
M71&HB%KI;4/F,OQ=W\ ^8ZW]@=LXUUI*U<[9SC&,8@4FSG.<_@QC'R;]_.>.
MKS!/&[#?+5/YP'2VH?,9?B[OX!^BWX2X W%^A?72/2002 G1%:QIB5#EV;@>
M3'/$66NJS5ZR=)I.&KA+;[RB*R>BFF?O;:XSSX2Q]*C3<9XEEPWV94616)ST
M>1'<0ZR\TM]:D.-.H-2%H41W2I)F1EK(QZ72D+;I\1"TJ0M##:5(41I4E1((
MC)23L9&1[2,KCLDYR V < ' #RB_S2O6U@V$+Z\ZP.$2N9;")!+URN(P!)G,
MC478@.DU5?8&MG'JNCA1%5-#9;S,*[I[ZZ9VSKG&/H'(%6Z/1*CB)RL56GTM
M#\*$AA=0EL1$NK0^ZI:6U/K02U)29*423,TD9&=B'*XHCOR&HI,,NO&EQ9J)
MIM3AI(TD1&9((S(C/?/4/)S]''L!^1.U/S#DWZ-Y]-]7F">-V&^6J?S@<=TM
MJ'S&7XN[^ <X90G9((2'F0U1W"*+B'S0F**#89+&1$:28.$W3%^P>MF";AH]
M9NDDG#5TW436;KIIJI;Z;Z:[8H<QQ@5YMQIW%>&'6G4*;=;<K%-6VXVM)I6A
M:%/FE2%I,TJ2HC)23,C(R,25.J*3)284PE$9&1DP\1D9'<C(R3<C(]9&6LC%
MT1^N^XD3-QN21>'=@X]((<Q(BXH;"AIZ-*1L67<&W9<8#?-$$G(P:6<R:1K%
M&#-1%H04/F]GB*V2K[T^._BS)U)9D1Y&(<(OL2UMN2F7JE27&I#C264M./(6
MZ:7'&DQXY-K61J;)AG,,M$C-J3"JJ%)4B+.2I!&E"DLOD:$JSLY*3)-TDK/5
M<BL1YRKE\([U[Y$[U_)+4%ZAV@^16*\M<LQ>=;,RP:KSYH9'SE5!KG/HD]IB
MQDDD:2?S=<8.MY'($2>'.ALIJ[L=4F3+2J>Z=8*TJRBI6YT;1L]28*V7(9*5
MI+F41<>.N/<_T*H[!MYILMYM70M7S23T/4,TL\R3HY%BTA*)RQ6M\,E*)?QB
M4J]\X[T!>NNXKF5&YTYA_89Q-I,U.L9',%Q-@*RB0,I0*=@I,T-'U$MBI1M(
M@C]\'.H/G2Z1<6]=CR&KAHY62WOEBW)TF,S"3B'""8<=3*X\4JE22C,+C.I>
MCJ98)W1-*8>0AUDT)2;3B$K1FJ21E2<*JFM3AQ9YN*)1*7HG\]1+2:5DI6;=
M1*29I41F9*(S([D8I9"GNU)8.-CY2MKP(@@VB:8D,^C$S=#!J:&7>R";%BNT
MW;-M&^2#_+?1%/35#UYYZ'&GK2_I+B,9X :=<?;Q/A5MYTS-UU%6IB7'#/-S
MC6LGR4HU9B,XS,\[,1>^:5H.!4S223AS32G8DV'C(K7M8C38K7.W!<[;3%O?
M1Q[ ?D3M3\PY-^C>7^KS!/&[#?+5/YP*>EM0^8R_%W?P#M0\&&D+DB?B$TO)
M915=@QZ/#6TXU(&S41.C!3'9["CC-IJ[?O&*+9OET[61;(854U]*NJFEIYV^
MVNN?,,L.*\,57 =4A4S$-%J$QR13E-Q8=2B27UI;GL+<-#3+RUJ)""-:[$>:
MDC4=B*XV]"A3&:DRMV+(:02'2-;C+B$$:FU$1&I2221F9D1%?68_0M3_ /-I
M_P"\U_R<<^,AZ(-? !P 9QC.,XS]_&<>3./ZN,\ +,?U]#R;C=T^ CW+A3/E
MW55;Z;;[9_M[9QY?^3DW/A/OB+%P%WAPOW+8'^+0O^*Z?^'%SX3[YA8N N\0
M?N6P/\6A?\5T_P##BY\)]\PL7 7>(/W+8'^+0O\ BNG_ (<7/A/OF%BX"[Q!
M^Y; _P 6A?\ %=/_  XN?"??,+%P%WB#]RV!_BT+_BNG_AQ<^$^^86+@+O$'
M[EL#_%H7_%=/_#BY\)]\PL7 7>(/W+8'^+0O^*Z?^'%SX3[YA8N N\0N,-&@
M8#7;00.;,==O]=ANGJGC/]W&N,?_ /?O_AX,S/:=[ 1$5[;XKO($AP < ' #
M'4[K"(V&@FA*!B)!)+/ETT6TUWQC/]7R;>7_ */)_4S_ $O))*-.P["#21[?
M;V[?I&*/HG4K^*8_^+)\KTJ^'SGZ13F%PGYO0'T3J5_%,?\ Q9/C2KX?.?I#
M,+A/S>@/HG4K^*8_^+)\:5?#YS](9A<)^;T!]$ZE?Q3'_P 63XTJ^'SGZ0S"
MX3\WH#Z)U*_BF/\ XLGQI5\/G/TAF%PGYO0'T3J5_%,?_%D^-*OA\Y^D,PN$
M_-Z ^B=2OXIC_P"+)\:5?#YS](9A<)^;T"X(UURJR*E$"P:.LVCU#;SDUDD=
M--M<X^_^''W_ .E_5Y!K4>T^U[7N))!%KUC/6NN--==<?@UQC&/[F.4"H:N
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DFM2MN_\ =[>822"+A\W>V#.>,8QC&,?@QC&,?W,?>Y2*A__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>g729258g69y11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g69y11.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2<\4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )R"^$ %CA"24T$!       21P!6@ #&R5'' (   *[Z!P"4  (<G(V,#
M@P-#(< @4 *$UI8W)O<V]F="!0;W=E<E!O:6YT("T@4&EN;F%C;&5?2&EG:%
M]R97, .$))300E       0+3!^1C(38YR66=KHV=YGJ#A"24T$.@      Y0
M   !     !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0
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MYU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M  5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
M     08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&
M]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6
M=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M
M 0 2P    !  $!+     $  3A"24T$)@      #@             _@   .$
M))300-       $    >#A"24T$&0      !    !XX0DE- _,       D
M        $ .$))32<0       *  $          3A"24T#]0      2  O9F
M8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M       0 U     0 M    !@       3A"24T#^       <   __________
M___________________P/H     /____________________________\#Z
M    #_____________________________ ^@     __________________
M___________P/H   X0DE-! @      !     !   "0    D      .$))30
M0>       $     #A"24T$&@     #-0    8              Q(   9
M        $                          0             &0    Q(
M                   0                         0     0       &
MYU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&
M]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   Q(
M  4F=H=&QO;F<   9     !G-L:6-E<U9L3',    !3V)J8P    $
M5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M        9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97
M)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W
M5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M!,969T;&]N9P          0G1O;6QO;F<   ,2     %)G:'1L;VYG   &0
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M1S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*
M  #     (_\        #A"24T$$0       0$ .$))3004       $    !C
MA"24T$#      <MP    $   "@    3P   >   )0@   <FP 8  '_V/_B#%
MA)0T-?4%)/1DE,10 ! 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.  ( "0
M & #$  &%C<W!-4T94     $E%0R!S4D="               !  #VU@ !
M   -,M2% @(
M              $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P
M  %&)K<'0   ($    %')865H   (8    %&=865H   (L    %&)865H
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M5#-C$Y-C8M,BXQ
M                    !865H@        \U$  0    $6S%A96B
M              6%E:(        &^B   X]0   Y!865H@        8ID  +
M>%   8VEA96B         DH   #X0  +;/9&5S8P         6245#(&AT='
M Z+R]W=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N:65C+F
M-H
M   &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W
M5R('-P86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@1&5F87
M5L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M    !D97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6
MX@245#-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I;F<@0V
M]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M      =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(
M      3 E6 %    !7'^=M96%S          $
M "CP    )S:6<@     $-25"!C=7)V        !      %  H #P 4 !D '@
M C "@ +0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )
M  E0": )\ I "I *X L@"W +P P0#& ,L T #5 -L X #E .L \ #V /L! 0
M$' 0T!$P$9 1\!)0$K 3(!. $^ 44!3 %2 5D!8 %G 6X!=0%\ 8,!BP&2 9
MH!H0&I ;$!N0'! <D!T0'9 >$!Z0'R ?H" P(, A0"'0(F B\". )! DL"5
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MG\FFB:U9M"FZ^<')R)G/>=9)
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( /P"  ,!$0 "$0$#$0'_Q  ?  $
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MBO7%YV,[ 45<E8 U+X["U")#M,ULXV5%T/,"\=?G5#<UL: !21U9N.U9OH(
M=%)J[F;:01J#QZ:LPF#S^#\E+'@VU"W'?&7*C;CEAC'90>'+*!@FX.^Y!@]*
MP5\>IVJ><_E.3ZX&&3G)($QJ2[MO;JLCNM'P8$(I!^N4/H2;5I(DLE4"4Y"7
M70>ESH.)&R>9T^'9;;KMF31%HDW7U9JY]\T]ZUSZ+-U==S$9>FV^LKZ$TUUO
MW&<Y-A7CX<9FU16?3J"=MU==A;C(ZEME?;OP$#<^I(/:1(H'S@4E)NMPFWNR
M$$L:D)>PZG59VHD0UQ%&ZD1GD6LJ3"JX9+4>_P 2DD4/CW%JEF,(#_/9O#G3
MU0@..Z[*Q9Q\X<;9=A(!SAZJPIP&+7*S)G) "ML<Y)\H4;R"1G !.<=OQ3N_
MA I/FS@D[@"I(&<D@#D@3;\8\QW66?1FO"5;0:]+-FMDVE:%*A:@KV,0&6V"
MSLZHX,QLJ51HD^$V:O62B"L&*#I&'E 6QC,-?CW>F^\B;;).=$)@\8!(*/9D
M X"UNJ/G.#D,R@  YR",AE)G8$G  >NOD@9:U7=,'MC"-DYX(.>S8XJ1^;3I
M?&L]:7;S-F*1[M&QACN$27<#$@[4"[FUAD*K; Y+')-.P4_*'HW.11(-.1M:
M0ZP]X7HS4)R#=B)4;O5BJ6<(N"6V%"",,+4#H1SV8'N< $A20<@#Y59B" A<
M,#W4UG#@C_4#GR_F(&0,8)T]"O-*$)OQ,CMJM'W7ZK6%S=\(!-"D[9OS9C6'
M=+H62E1.2 7$8=NFNA_; =XC+XX]&NL,BNV8S%WD@<()&G\7!K%N3SICJ"@Y
M()U-6G51V!!-BJ/XC8<8P9HH=[H""5N2H-G \U-EA)SV(Z9/P"8)Y.!9]0G:
M$3>4-E,U)U#>U"CXFBQ).FO8&",H2N5C)*/)2=C+8Z2"2.71DV#V$J[9))LS
M^QV-/D%Q4K"@B>FK3<^*U9G(4(6#Y[KL +$_+G@C()! )P9D>8@+SN"E2.0V
MXD  _'C.#@@$$]Y&2/\ E7HLU39R_7U4=GHI5>XVNBU2RF34XHBR[(-K>ES>
M#5<THK81(C&IV0SJ1OQ" 6'3'>#3%(8;%24L &1ASN82N&!1"I%EC(B5' <L
MZEU&.W" L^"=@4D]AEW#$$%$5V9P<HJHP1B3Z L0%R!N) 7)XFC[D\N;0!FN
M6-95:<$3%Q:G8"HKPJV\QGS6L:HI94742P^T,<9/F42D,DC1%"8,(W%%F)L%
M)I%'R46D:SH63V)-E$VO-F(5G&"HT^LN4Y[OI-H:L_#S'S<$@%2.^9T2O<5!
M."U^EKQP?)J68!QSR %./0D$'M.6IKS.4#*Y9U/INTPDJA-S=EJAIN<Z.6:$
M1S7(R66E1PZZU0;!J0GNMMN(PR'.'@M&>XK9Y D2R*0(A,4C65FVG>U%KLO3
M<-M)NR[8&5I!9VXSC"@GG&[!VYXSR7<4K;:3U"@  R<NY10!ZDG&0,E<^;!R
M!S GS6]1G($C,I-&[ZKF XZ_3GM'#I]/:T9BXQ:-'0F70V#)3*O-QDI-&".\
MSDL\CC&%QXV'C\G?IOFSXN&!L209P3Y'(!R,,%J;8?S?CLJU#X><NO.=HR22
M )L+DC:0P+6IN!RN:0QLY_\ $*<X!.1P.1/OB?F8ZMSR+18M!XA=DSF<LO1[
MUQ'U#$(]7LJL-"UD:N)7",$.74>L\E6RHB00@:H\%RD98A*-M'6ZC:0DP7PL
M\J(WM/EQYMRVOD9P!3CJ Y Y4%6QSE6!&<S/HQ) "FH') _S]PK(^3%67T(8
M8($GKUD[%5]VRHJO.PE6:GTH-9(Q\0$,Y4)U!R48X$FB<;-ACPK1T_19%PI\
M,4$OTFK]\SV<LU%63YXT40<JPC&.0<JC@@Y!5U#H0?FI!_I'JP((*LR,",$,
MI*L#]"")O?DB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(G7;\DW0KLSW
M-[K6+$JP$UW%JAN/QPQ[KQ8EUVG%9(;8Q1N2[/%YC)FM5NP.?D%[=#@68TX(
MCYK<:(>).69-V>$JBVGO:/O[^_[3TWUX>;YO.U>W<R&S/KE1@J^^M_9"@]B=
M0#[;8G.PN]LB6\?J>5]L(B4)K0-23TZ(;)N'TR@[8M*)W(]W!5=R!%*Z1Q!$
M]CKP<2).XK:L<;=P-2.&;ZZW6S1D%)!"NPNG0D>[)53VC[;!F&$-\IY(7E:-
M9-#('=EHDR%;8:H$<:Z;N5,(F4U?X=+DK>UJD[-;]LC<DOW-R=F9_P!B(Z8&
M@=*+DD6[9#).SM %6 L1!1%EC2#-TUI]T"UG4[DH%/-9LM&HP*W3&-6*)Q]%
M>*?ME#J]ZZ1JXK<ZPS_7I+U5LSKGUKKH37MH,8'-B-M0T'7,VEW824.)@E*7
MK,K7@A[$FH" APS<4X.N)1E4FX8-PJX'!S\.>0"/U!X/T/$TK%&5EQN5@PR
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MX*K=UZU<Q&8I:-XU!VX!UD<XS%Q<-2@BX1N]#ZQ77XJ26=T'GGL*;*@%./\
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MEEB<K*'RN_OV*X#AE< ARS/QR[. KEL8[J ,# [X )8G*^4J5XV !,<;0"2
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MN8J?.SYNDV' &\;9PHX^9,XL " PNI+?<^X:N3CLB0>LD$,, A+*\X'Y;O\
M,X[9(X& ,>F)#RK(?RLU3$? TY-8![X!))R223DDR0W77K]7/5NG8E1=3-"C
M& PI22* FQHJN;)I[2J5G)F7RY)NL:KN<*')"251QOC_ *!ONDWT]=$=<\>B
MC_0B5C_XUH$4$^N%4<GD]X/+.Q.2[O8Q^+.Q9C^I)..P[#B;MXB.(CB(XB.(
MCB(XB.(CB)#WO-:$UJ.B4)-"#FT/6*6[0\&EE@Z)@]]JUKFP;BA<-L*?:J29
MD2CC/>-Q,T4=)E#PY\(#J;:%B#55LR4QA(>QQ\)5W;OD3[ B>A_7&;01XH0N
MZ2':9=7U/Q-?/9"R@\!(V)"6BC@H #B2 J/3"\XK(P2L1;OF#46H!/2*21]!
M+8>#;JI?O[^_K+;XOV<"R7L9)NMCBJ;QB9\%$3$U#6+,H$@#J&Q L><P)D?_
M ).IADXY=2)X%>6/'&I)#<&PU:KY?)[J^TWTPNB27XB.(CB(XB.(CB(XB.(C
MB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB)'7
MME;V]#==[3MQ.>5;6.8/'TBV\^NE"0O:UBZ&Y1@Q<%)$)B;AG)9#NF@[43!Q
M8$^'DY5(E!,<:D6"A3#Q#+$C!],J#P2<%E!VC!!8@D*#C+8R<9Q5&3VSPQQG
M'(!(R><*",L1SMSCF4$J>:[LL-C\9DR41Z^6,]<UN6EXBJX(@4>6/? QW&NZ
M<L V%7F8S;MA#(:+AX[K37XRWJ_31MA_#99.I=%"<Y$FHZ,:O:P*JQ/E95<-
MD[A64TJW]1FQYJC8YI## WHVTMC#:"@LH!)#.JA@.6#:A:<!205<*>K@DG:5
M!5<DC+H[YA^P3R=Q:%Y<=:9P,;VE'8>/G4,CTL;@NW#*27!U5KDC'.M"&UMG
MT1$QK87V#EA&7+X+6^W<%*UV25#1X>Z-+A.@0;T4DC=8*V V[L'4:JDW9]*D
M33I:P/9;3YPJJ[<_X78<[4+C/ R**;17SC+LUI5?RG*A0C-N"W-TIV_B]S6]
M.Z.6JF\*EL2 PL%8CP3<4,#QA(_"9))Y-$1$DC#H/*I+H08.3<2,MO9>:CG6
MNB*:ON^==]L:8EDM^(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(
MCB(XB.(CB(XB>EPW;NT%FKM!%TV<)[HKMW"6BR"Z2F,Z[I+(J:[)J)[ZYSKO
MIOKMKMC.<9QG&>(GS[#!NVBR>P]CLFXRWV<)[-&^=%]FGR?NFRVN4_95RU^2
M2]WSOC;*/R:?R?L^QKZ(D>);^5[0WV>.U/[Q.H7$22O$1Q$<1'$1Q$<1'$1Q
M$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1/
M@)BA9MDN,,C6!<<YQIAR/)LV[]DXPFIHLGA=HZ3505PFJFFKIA1/;V5---]?
M3;77.&!\(G'CXK&!66.1<=!C?AB#IJ.]P$CV?N#9\KAP^;LO=FZ7NB#QQKA=
MVDA\FFX6QA5;7??&-N0@']1C[^..XSV/,3V(1J.MM!J38$';I!EE7 =)$8Q2
M3%.'&%=5UQNFB&NK%9?5=?591MA+=759;&^VV%-_5C[]<'TSW X';'81\OU_
M7X\]SZY/K(%@?K8+3_5[41]XWL/RQ+#^(CB(XB.(CB(XB.(CB(XB.(CB(XB.
M(CB(XB.(CB(XB.(CB(XB/7U_]_Z?_P#>,\X]>\1Q$<1'$1Q$C5+?RO:&^SQV
MI_>)U"XB25XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(X
MB.(CB(XB.(CB(XB.(CB(XB.(CB)AEA,YH0A<D95Y(AD2FCD4Y2CTE,1G>9#P
MK_;7TU?JQ=,Y',FE4$_E-FC-0RT;[//=U'6'3;19DYPY8*Q7N!GMD\<G [9(
M! [\D$C P:N-PW=LX/IW]?CP>3\1D<9R.MP2[0^8UN%ZUDXI$;:D<N.=&8#+
M9W"SO742-'RGLL;Z]=C)"?5DKA&J!@:)*B+@!4F-E<?)6M3C^-.WS2.1RJ9V
MVF+E^"Z/@-<%/ 4=/!W'_P#7J<MG.&S:;$&"QZGX;5H@ZIJ8S6&/!L8,W8%>
MNR 8[@"L!R< =,]0.S?AC. '8WRB*SP(-'?S@Y%7&MF1D=3\GEG5L+'#5XB'
MEL]6Q-A"NP3;2EHW_)%%HE7\I['O8O)D U)+EF4/;&\G9*J';I'-#9N0'L7
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M>B^5"J@>*:(-J6_[;\$87[>DC7^T831[:PA&FV^T =P[#JM[V^JQ82$VU8J
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MXB.(CB)5#Y$^P?84;B0]7.L$<D0^Y+ HF76%$K#C$JB :QAZ@4@NQR_I*&6
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M$'(;+F4;WDS^$,KRL%<S:DC@,7A8P](GR@K=TZ[,0"P4EEZC,KD;68'R@LH
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MB7L3W&N_N=:,;H?K"E:M61,(8:IS=N,7(U/V"-SX.@6UG$"'20F^W@D)E],
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M!_%3B(_! ^/#] ;_ /;5V _BIQ$?@@?'A^@-_P#MJ[ ?Q4XB/P0/CP_0&_\
MVU=@/XJ<1'X('QX?H#?_ +:NP'\5.(C\$#X\/T!O_P!M78#^*G$1^"!\>'Z
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M6WN&Y 4H!65"]V#9+[B1C!3&2&G?;IETNEM*:AKFU>J74>>I:'TU=>A:A*2
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MPIM5%L6S:*[04 M5;$M8!NHE8<6CBM=UJIM5E16<-L!E15E.=>BNU*W?44?
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M6BL<54UVW"#=FS[_ )]X#,IRI*G#+D$@[64JPR/1E)5AV*D@\$SW&NNO7V2
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M>"".3P0, _4#@?*.K;Y?Q+/*RLOG;RLBA49>>&1555(P54 #  $YYO5U:,Y
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M,F81D"E\K'&<Y'' X))///;@\XP,>@!Y.2>,< Z@(.FA*,S,Q-F;5.W%;XL
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M-L2=RE:T(FU+L4Q)5C%9-+BR^J3H7[B60<!XF;A\C8O6 HRMD':<E5;CC.2
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MR::E2G=>K]%@[W$TYI_"K.I=KA6F"-]H-C-:U@]<T\.V9,%C;<;;$.%FL1^
M:VADA5Q K&[@L<2T[#/IS9\]$CY['R4F+DIS?"<MB(N0FRS.-M(8Q )+ZN'
M:113:VE7#8R%W[5)!*A@0 "RMPO!&1Z$C!.9Z]-XH^GU5=_3ZE5'O(T]#LEA
MH2^MJUKKMU%.H.VKR% R-MVL:^E98UDN;A$5902%Q&$#79)^.AL7 15@^,OW
M94P\91X4T$-794H_6<OB1)P@S36?/WKA=V\=;JN'*RJRF^^W*?*F3\1'$1Q$
M<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$3 ]ZNKI2RD+D4A4;WM9M#5J\;V%L
M*:YEB,&7+Z'UHFF:RG[YJ!5-IZ%-QV%?=]GVNKC.GRF/7B)GG$1Q$<1'$1Q$
M<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$
M1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<
%1'$3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>g729258g74z56.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g74z56.jpg
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M)T?1]AZXJNNR&KV-J;;^#9&W8"5!+#;6+#>X4"6)(W24 "#8(&OAD<5!.?\
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M-G!RY%5N+EAJ:D@D*9.,=M\;=,_?R[]=ZR-,Z4:3HARK&0?Z\<CT/L!?^RU
MK9:^6 O5J+LW:-9W/6+VY50LZ0ZR+K1]KL!M(N_6DK<&QS9Z-*A-QHP8/#A*
M9/Y@ ^H&,?P'3R^>=8:]/'K##K>[:V'K%DKZ-\[T"]D;8: W2Q#;&!W#6;T-
MVE5K/0"[4W+U,CUO9P]_8(JO"D)KB;0=M$N8*EQK(8B2U,G;T&/ITP?IMYX^
M0KRB= -$0 H4? )[>B'@&_RG9P=L5O;MT=V4C<-CUY,U3;SSURE$9!%\9<*
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M,F6HSJE(;D."QTF<AAQ:<94A#JF,-K4G&5)2K.<8SG&.34#<BNC$/ZO^QZ4
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M:K@S=*A(ZFR7+18[HL,W]0P:5U&I+!P7"B8A3HY6=]DCU*2U(DDU*X.RO1E
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MQ$DWQ?O77.&D^-OC(+?$V^YKK,<9D$QC0RJC1B4JID",0S('QS!&959E!P2
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MM&T1OK8$6HF9K-3E":I(-TC6E@!$KO8(5WKL^LT<(2)VVR#Y,V>##3X@<P]
M4P=NF_J/Z^E8:7W]ZL0*76[Q-O%MBP[;M,_HX#5G=+;P_BI+W+6*Z9MIC5SV
MFD:Y5MD?>&ZV (F(%?)4R).-0?M[X5LB@R'S/4Y3Y=L]L8.-\],;_3O7'']V
M],V(IK2QU[95!C:?N&G^SFU; =N<78M)N5?@]8K7K2I[)?(@['21PNE1=7E[
MB6"[>!;1*TB]5DZT+A#*N62.N2ZZI@_J!^><?GC;SKF0N^_6&96K1956R]"\
MU&;K: 2J%BT3OJK;4(O;D+S .I7:EIVR:S%;5O4#9)H:6%TPG2Z<>''" .Q0
MXDI4BN'FQRG*?3OW!Z=<[[?6K1U&TBKO60EM",G8XD_ 9(P8]GJUGI%BCL/X
MSX8-U"Z" %LK9-E6%-S ]B""RT%Y*V)D)AY*D85'WY_PK8^*4XI3BE.*4XI3
MBE0!>(Q,_N+6P&&32,<!5K8%RS-;A-2W6GGG 54&_"U(=RPEQ$,\60MYQAS/
MG_,RC"UIY>V+10:/J<[QF3Q[O3;/EYR@9.6YNY5+*"V/$MH&*@C.V>U45XLL
M^KZ="DHC,-KJ%V2$5^0EK>VB8JQQS%9I5!Q_KX/7.F;;UN7#42]7(CN+;LMX
M%5#Q6&*&66!61+T^(,DO0V7VP(@?,7&<EH9:<:402C+"UX<]ZO"\9VD:E#+?
MZ?9KHVCA)[RWA>66UEN9ECEE1)&!FG="RH68%HVPP! &,5AZMIT\5A?WC:SJ
M_B0VD\JI#/%!$7CB9D411PC9G ! ;G;. V<5SJEU@K 6JUT;'O6XH,X8#$0F
MIT'9UE85$7!AQ&DIAP')+XEF.A49G&(:X#L5U#*$2FI/N>R[UW7$]U/=7$SV
M.C2"6>5R'TJT;G#NY^-A&')(=B6Y@P+'!  QVVO#EM#;6\:W>K1%(8D(CU2\
M5051 0%,C!0"B@!0!A0.F<QXYJK9(_>.(U%W;9I$NIZM^M1_%(=#V#!4J[6A
MR.Y'PJ([62$'+B*.Q[G69?ORWES#2,XRYCF>-3TV30^:]T.T5+K5N20Z9+-8
M2D6=H'1UYVN8FY#?,.0QA<A>;<*PP#IFH1ZR$L]:O";;3.=1J$<5_&AN[D*4
M+<L,QYQ9Y+&3Q  <,%8@\>I=@M^3=>W*SDM>:]MTNA3KW7[?FLW&74G01ZAO
M$(Y:),%6&$9RMQ;,6,5AYC$U-RAA"&][H[[KD9G6.&[GAGB>-/ OK[3+N+49
M](OK.YMEOUBU&TNS:7$4=Q:F%PC,%EA,EN"T4L;-CJVV<46/$?"LS+/96>HV
M4^EVVM:?>P7+6;W&F7UDMY;3M;W"2('0,\,Z1W+*LT$J*S$"MHU5<-SUG6])
MKD'KX8FY$UD4RLC.V)3X4<D]F#B0]+8RE<Z9A4R2YAWVSF&'&\2,_.\MYI[/
M-@U:TT>YU._N9.(H(Q)=3GPTTV]=T42%$10%2(JB@*"' PNR@%<ZSI=WJ]MI
MMA;KH$S<EK O.VHV8YCX0+22%B6#,QYFV<Y8Y)(-<B"5W#;]YTEFT5BGTF)6
M:9:[/&$?>9=K+X<+3PM;;?ESH2!HIA_Z5PEAMB,Q*PC&'4I(+;>5C'%XM'M-
M"OFM;F^O9+F^L[5I3;QV<7+%%<W+*$<W$C#Q5B+$LF<(>4]!R635KG6[);FW
MLK-;>QO+D(L\MXX,LMM "S".WC5BAD5" W23H#BK?8\^,>[QG/C'G./QC.?'
MY\8_IY_;FI5M=?O%*<4IQ2G%*<4JOFR/&N=@5;<+/L8KY9(W6>U,^_*&VPA$
MF[F@6U]&$YPXNI7 J\%DN9RAN-7[T;*3'<1PK>$[%IG_ &GIUWHIRUS"9=5T
M<8R6GBB'[1LE/4"]LH5G0#)>YT^")%YKALT6H?\ 9]_;:LNT$HCTW5-\ 022
M'W&[8#J;2[E,+$[);7L\KD+"*L%C/G&,_P!<8S_QYKM7M?O%*<4IQ2G%*@34
M6,VZU;-VZ\ASZ>P'/X>TW+B\J1^AM7SRP?[A'1YRC#5CO,V[&XTQG.$$J^]6
MWL_(AEES.PZS_F=II.BC'-;6_P"T[[ &?VAJT<,WA,>O-:Z<EA \;;Q7(NUV
M)8"CTK_.[K4M5;)6><V%GDG LM-DFB+J.F+B]:\F5U_TEN;9B2 IKQW#-EW
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MTK;]1V\]?J<2<H&]NTVYBH>MC+G]"Y'[%TL;7!]7#D;I9[58Y6:=*AN?5'+
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M+G7I'VPND0KZCFO)R>^<'D';?&YV%?F^X_U>I[5"5C.69V T"7C&,9SF!-L
MJ*0QCSA6,9S"=D8PI2<I3Y]RO&,9SAH+!=6M&R04,S@@[JRVTS(VQ!'*P##<
M';((.#4ZXO/I=T@P2_@)@]#S7,*X.Q&-\'((QL1C-2\CQA.,8_PQ_P#7Q_\
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M_P#Y%1[L;5?7VDQQY$AU?JMH!O+D),DZ?J>IV&56V64M*9FSZ^/B?JHI#?\
M<ZC/Z8#'I<;+'R28;4=6'DUVIZ)PU9K'++PE8W<#%Q/+9Z-973VR@ J\END?
MO4B-D@FUAG9.4ET53S5L?#6H\6Z]+<6EO[0I-(OT6(V%KK?$NHZ5%JDCLX>W
MM]4N'&D6<\?*A'[7O].@E\0)%.T@\,\"E:/ZJVYQJ[Z8%5FM'!ZEQ\6?4Q.1
M430Y_*DJ?$GH8"5 SG&'&T8(5RT#G6TNM(Q+'HD,-J;:9H7"$K?M#0;6PM9T
M!0W.D$6<T9)WAN8[<QG9AE[:ZB(#J"\8=01PXCU7VBZ4?V/QC)K,D4G+-'9\
M11O>VUP@!Y+NPGNUFCFC92?!O].G9)(V)CG:-SFU@R*_#@QXTF6[->:;2A<E
M[.,K=RG&$^_.?RK/N\>[^=;J_.<X4XO/\V=M0%5 9N8CN>_WZ_K7GKL&8L%"
M G\(Z?3^X >0KG\Y5QIQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ
M2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*
M<4IQ2G%*<4IQ2G%*<4J+3 (E,O27XIF2*7.I\J"J;#C1ER$-13K4A+32I"'4
M-*^(AA/RX;RORSA><^[QXLH9XTL2LD*S!+Q'57=U&7@93GDP2"8QE<CJ #WJ
MLFAD>_5DF>$O9NC,B(Q(2<,HR_,!RB1O[/4@^8J*=C]?XYVNGI)C9.W3:4P<
MOI#JO$P2(5B*ZF6XC$.N1PSKF7,-K2C,B4\IK"L)0O&,<MM,U]H+NW$6F:-%
MF3D\7W".64"1?#/QW#2@X![H<]P:K-1T)9[:X:34M7D8Q\W+[\\<68V#KB*%
M8U !&V,'."3E01G4=8]:_!A<:=L*+.5G#C9=K95W4395GQE.67WS3J$(3[6U
M8C*:5$6M&%NQW%J<4O'_ ,9-2S\4>G,HV*-I>GE",C8@6X)Z=<YQWZ5D?XNZ
M=@%6U!#UYEU._#9(_$?\X(+9P<]SN<[YU6+I6\UNXEUZ^W9=ACK]?!+5B^LQ
M-D0)J(LXTC$9S!)0XHQF+AQMN.^V5\-L2I25QI+N6GH^6^LV5S9PC4-#L) +
MFY!.GF7394+Q6YYX_#:6$9.24:$HS*" H+<V(FCWEO=S>XZU?Q?N+8@78@OT
M8*\X\-_%C68J!T/C"0!F^,Y4KTL[7*V-G;FR2A C"*V<5LBWX>("X[@H>2G@
M[,0B-J8C+D35Q8DS$)MIUK,A].6G7$XSEM7LQ\!\3<0#1_:UJ?$.F+)&ND\5
M"YMXY7$CE=/N(XY(9'01AQ*L,D3X50RN01@G/Z3<)<,_MOV,:1PQJQCD.L\'
M"TN)$C*(KZG:O+',D;F1D,33QR("S,KH&!R!7=W6=J;TL@ &7#Z'%9'%A TI
M!(SMM VHTN$0@LS(TJ,S#KTR3E#K;R%(;DLPW,XSX<0QGSX^[(;?ANYABNXN
M(9I(+B))X@FCS^(T4JB2,CGN5C^)&!R7^AZ'\ZKB7B*SGFLI] C2XM99;:4'
M58.5)8':*0/^X#C#J00B/C&-^W/J<?=,_8KYNWQZ'56YU7CQ&@X;)6RSD01A
M5U["9AJ2H1#1,6X6RXXS#&NQT?$EM$J0GP]SONFT6/3A#9MJ%VR7;/XLZPVL
M8:6%0P$*&=V7]RH5C(K;DE!L!CVRZNVHM-=BQM@]JJ>' TUPQ5)25#2.L*JP
M,C X1ATP3FK(8\^,>?SGQCSG'XQG/^/XYKM;!7[Q2G%*<4IQ2G%*<4JE/9_8
M)S0%NUWN6J:[LEY;LDV)JC9#0)M*!<"LE".)55M-CG-XER8*JE8YLMH;(R*D
MP7!MFLL27,@27ABU;SPGIL'$=IJ>A7>J6NG&UC?6=,:X),TEW%$4N[2UC;E2
M07EK&K2IXT;B:UM71)%$V-.XEU"?0;JPUBUTZZOQ<NFEZBMN!X4=M))S6MU<
MN"SI[I<R.$81.GA7-R'=&\/-U%K0VA3CBDH0A.5+6K.$I2G&/.5*5GQC"<8_
M.<YSC&,?G/XYHW7I6X].M5X-]JM(BB,D**M!#8!R$\J/.#:FJ5NVS/'R49RE
M<8HG78.R1Q,A"DJ0MDK(A+;5CPO"?SXN8N']5DC65X([.%AE9=1NK73D=3C#
M1^^S0-(-QO&&'KG -)+Q%I,<CQ1W#WLL9Q)'IMM<ZD\; XY9!8Q7 B;.V)"A
M'>L:OM72(>$NFM?]@J_"SG'DD4Z];?7!:3G_ /,DNC*B2<B,XQ_,MV4TREM.
M,J<RC&//.S_%^[;:&\T:=^R1ZUI@8GR'B7,8)/0!22>V:X'B&T7>6SUJ%=_C
M?1-4*X\R8[5RO;/,%Q]*R@&QZ[WG=J3=*5L>L6T%K=BSRW*V&GM2"<*YG844
M&.*'A^76YX>0%KLBTCV1Q0?&E_-87'U);5%1A4R+>:/87]C=6$]O/J;6B>\R
MKRQM8V\CW$L$+<I247%TEI*TD<A4+:A<$.37**6RU>\L[RUOX+F'3Q=,;>)P
MTBWDR+!'+,G-SQ&&W:ZC$<D:MFXYMN7!YMU&DMC[+KU'D#YC>O:/@1L"Y29<
M20R.MEC3-?<H-4A2%HPP2A R8MZZ6=MI2D1YH^F0GLO,$B$=OE8RQ:9IEU?K
M+&=2O_&TVQ2.16ELK5HU&I7LBCXHGN(9A86A)!:.2^D4!HXF,WD<FH:A;V;1
MN+"R\*_NW96$=U<!R;&U1B )$ADC-Y<XSRO':(<B1P)+NUZK&O CAZT$4P8>
M'F8D2.TR_-*%R4G.400X(1":D$C9H@]C#$ 4,C29TIW/M:95A*LXJ[&PNM1G
M%M:1&1^4N[,0D,$2[O/<3R%8H((Q\4DTSHB#=FZ58W=Y;V,)GN9 B A5 #/)
M+(VR10Q(&DFF<[)%&K.QV"FH?8I=KW0^R8VS!>K6O$K1("Z8Q(9>DFD)7ER.
M1V[/A..1"B\^UEYG7@UY^MCG$J_4!&U2%,QQ-T;ZST-6AT:076ID%)]=Y65(
M.S1Z)&X5X1^)6U.95NY5Q[M%9*&::J6TNM6(EU1#;V(8-#I',&:8 Y63574E
M)3T9;",FWC.?>)+EN58;#QXL:(CXXK#4=O"4)PVRVEM&$M-H9;3A*,83A+;3
M;;2,>/"&T(;3X0A.,:TS,QRS,QWW8DG<EB22>I8DD^9)ZDU?!0HPH"C;8  ;
M# V \@!\@!7M6VVYC&'$)7A*T.)PM.%8PMM6%H7C&<9QA2%XPI*OW2K&%8SC
M.,9Y'W^72I^_SZUY\4IQ2G%*?OQ2HDN6DJ#<B'ZA5 F5>ZH;2W&OU)(2:I<V
M4(SC+;,@V*4RX9@(5CW9#6%HN#?S_+*&/HSE.:B]T/3[V7WDQR6M\!A=0L96
ML[Y0.@:>'!G08'[FY$T!P.:(XK<=#X[XBT*U_9B7$&K:"S%I.&]?MHM9T%V;
M9WCT^\#K8W+ D"^TQ[+4(\DPW<9WK4,R-^ZWSXE1A^^JHPK.?JAB!-(VQ!A-
MIQX^H'27HE!N\O\ "LO/PIFN7/9C&(XF?)5A"\/FX@TS\:Q\06B_VXA#8ZNB
M#NT3%-/OG'<QOIQ(_#$['%7(B]G7$X'@S7/LZUAU'[F[-YK_  9<3$G(BNHD
MGXEX?AQ@1QW$'%"\Q/BWMM$.9=XI&Y:!?I;X@286.M,)'R$J19X,ZKW88G&?
M"G)E6.QX)?Z3"O*6B<:-)%2\8^2%/DLY2XK.L-:T[47:&&8QW:#,MA=QO:7\
M/F9+2X6.;ESTE16B<;I(RD$T.O\ !'$?#L,=]>V2W.CW#<MIQ!I%S;ZQP_>$
M[A8-8TZ2XLA-C!>TFEAO(<\L]O$X*B4N6M:G3BE.*4XI3BE.*4XI3BE.*4XI
M3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.
M*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*5Q%Q$+FQYOX^1AB1'QY_P#)(6PX
MKQ__ "CHS_N_'.0<A&3LS*Q^:\P!_)F'UKB5!97[J&7Z-@D?FH->4R,B;$E0
MW/RW*CO1U^?_ "O-J;5__A7",4='&Q1@P([$'/WG:CJ'5D.X92I!Z$$$;_G7
MN:1\;;://GV(2GS^_GVIQCSY_']/]O\ 7D$Y)/F2?SJ0, #R 'Y5B"CD44T2
ML,E6&V8 B2[+7^WB+!2Y-6OS_1"$N^<9_K^W[^>,LPBMY&<XCB#S,?(*A+'T
M^%1^7I7**!IKB)$&9)62!!YM)( H_P#R/T^IKY?I4^26DS"LU2ES"TJ23F+7
MG.5KED7ES)3CF<_G*UOO.+7G/YRK.>?G7J%T]]?WM[(27N[NXN7)W):>9Y22
M>^[5^I6FV::?IUA81CECLK*UM$ [);01PJ/H$%=_/3$^Y8>MNM77G,N/B(1>
MLK2I>5N-,5JP%0HUMQ6<YSY^T0Q[B<9_/L<3X\I\9Y]M>S2_;4>!^'IV8L\=
MH]FQ)R?\QN)K-03Y\D"GSP0>]?GU[6]-72_:+Q1;1KRQRWR7Z8& ?VE:P7[X
M&3TDN''S%675$0J<S._'R-1GXW[?G*'G&',_G_4IA/\ ]/\ 'F^AB$9.Q=7^
MJAE_@WZ5YN5!=7[A67Z,5/\ %?OMR^<:Y4XI3BE.*4XI3BE.*5JEXN%7H%3/
M7&YDHHFLU\>]/+SI2<NH;CHQA*66HS:7)$Z7,>6W#@#HC+\TC.D1X,*/(E2&
M65Y%K;3WES#;6L;2W$SA(E78\QW+%C@(B@%GD8JB(I=V"@D8]W=6]E;375U(
ML=O#&SRNV2.4?V0H!9V<D*D:JSR.RHBLS &M8O75S[$X;M.]&2]4UE,RF35N
MOD6?)&.$!:O<N&5WC/&OLR#Y4BSEJ0]K)B0FHUY*LC[!BV$D+>A7;WMMHI\#
M23'<7Z96XUED#B.3^U'I*2 K%$A!4:@5]YF_'#[LFS4*6-UK@%QK"RVU@Q#6
MVB+(R%X]RLFL/&5,\CCE9M.#&U@_!/[S("R\C:G9/2/6@AK?48H9'(76Z62M
MU&G:>UB,&N'X8XO/CP7CSM>'?3QP=:"0W')TF9+1#8<CQG6XGR>QU;,Z=H&K
MZ_'J&J.YCLK.WN+J[U74'D$#R1(66W6=^9I[J9\(D:<[!F!;E'7IU;B;1>&Y
M],TA(_&U"_N;:TL]&TN.-[J.&:14>\DMT*"VL;5"TLL\G(G*I5.9R%JTI0N)
M!#)ADV1'AQ(^,Y,($B<N/ @0HK*,K=DRYDIQJ/'8:1YRXZ\XAM&/.5*QCFO1
MQO,Z1Q(\LDC!8XXU+N[$_"J(H+,Q/0 $D]*VB26.&-Y9I$BBC4O)+(RI&B*,
ML[NQ"JH&Y)( %=/D[LQI+MKVMU[KK5 X(.%1V+K&D]F(YK^'6R"1\$*DR1@'
M1D]F3"-W>#!*QFW[3%,BSE,)BD28\T5(BY:<(>GCAS5N&>&KZ_U)YGF+697A
M_P 'W^PA@GD59)];7E>&RDDB;EM?"EAO(Y"I616R$\C7BW1N+.*M/TW2$MUM
MBE^/\9&N!IVH75Q;1%D@X<^-+G4H(G0O>R/#-821 IRR+N;ZT_8^P*=9\:<V
M[]H)7,I )R=1[*99R!J^WVQ<-V7)$&8L1F<W3]AA8R$2[ $B-2!YL2F7:*=&
M7$A&J_7=+N;*RN8?VGIQECM$DB74[$_OKG3/%95$L+,8Q=64C$K!(S*\4O);
M73!GBGF] MK^]M;C]EZGX<EW(DC:7? >#;ZH(D+-%,JJXM;Z( -/$BM'+%S7
M-JO(DT%OO5+U6_$-M[ V.79O&RE,NM1)^(RXU7I$.4E6'PNO 4AV3]FC.-K^
M D>DO2;/8L(3DL2^B;A"X'"^U=9+?]G:9 ;#2PP9X^</=W[K@K<:E<JJ>.X(
MYHK=%2TM<D0Q<YDFDRK33"DPOM0E%YJ/*0L@4I;6:-UAL("S"%<'EDG8M<W
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MX4IC^?Z??TK5H/<+J>3LMFI@[LMHB?;*6 M]IM]<B;7H\@S5Z[KYZ0Q?31^
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M4C5V"AUSF?[3^C/]./\ EJX?]/\ ->_QHT+_ &\?\/=_\BMW_P DOM!_\O\
M_NNB?_)4_M/Z,_TX_P"6KA_T_P ?XT:%_MX_X>[_ .13_)+[0?\ R_\ ^ZZ)
M_P#)4_M/Z,_TX_Y:N'_3_'^-&A?[>/\ A[O_ )%/\DOM!_\ +_\ [KHG_P E
M3^T_HS_3C_EJX?\ 3_'^-&A?[>/^'N_^13_)+[0?_+__ +KHG_R5/[3^C/\
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MM)BJ*ETD!_9K4VHNF1P!;&H([$F'&B03EKV&4BK3)#CGM>5>S%"D",,>("U
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M/Z474_T][9:[=LDN&D:NO.K:CO:JWZWQ13&LS[MZULSC;$ UD3"+5L[82E9
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MVCW9^C8]SBL)^8A'0I6,NIQGXKCDY+25@"2O. H*\Q+!0H',5&2<C=E&Q)(
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MT$;D-R3"UMR% /DX,^P/H:F1FHM?)&HA"0.GJ#3B<1CZI2E:'O+LSKC16:I
M.$81NU6S:.B=9QJ.'.@<6^$G?6Y:9I0!<9@&808)8J@:Q76#-+3VXR\+B19,
M>%\\Y3+"U2!D_0G\@3_*MH#;QHLJM%K5;9\758T1:=C5E[&RK)10JI#.M+Y-
MUZ6L\>6,MIL2W6R9:/!F"W)I*&9B03P2): M<L,I\%%5!V_3]1FMGLVT-9TI
ML,]<MB46I-6-#KE>=LUN  6SS;#+4AYP,LJ0B)*(9COLONK@Y?2VR\TZO.$.
M(5E2M6VEV"TQI23K2)M38E=I3FX+E^@M=N&92FHMALV*R=MZXR9C3;L0:/:
MUPE)?.EGH */(4-&ODFR1H/$G*D G.!G'W]_W5O&;Y1\6[&O\W*J8OBAWW=-
M)S8A'ZN4)QC.<E,5OZS[SD=C&,Y^MQ"^F\8SGY?'%14=E]ZUL'OP+H,C!F12
MA?2%ZWHY:Y,F!&K8RMT&Z4.F%()!Q^0W(9F.R;Y#)(DJ;Q 8@#IJI$AMS+25
M*=L_+]<_TK'7'M5URH0"B6NS;FH$6K[,OH_65(LD"PPC@ [=2?U6&!+1@&X1
M'16X^8;^"92?)BB V<-X+3X67F?D4QGZ;U*V+U2%6>-24W&JYN<T3]^AU'%A
M$9L\L'YSC[S& 8F?=7Q/G&<?<6HBX?G&?[[\9XI6 F[DU*/CV:3)V71?93:S
M(N=J9CVD+,F *I&2ZIVPE($.:_.BB?+#K;4UR/AA]]&8["W'O#>5.M:O7^P%
M&V#HX7O_ $PR9WI3+%5 EPJ0W638=ZTVD8?A#28^&/%W U3X@LXD:4C2R *U
M$ZZ3%>U^&2CQ2+68653C?!VQM]XS^E5:J'J5:KL=#NFS;!ISL;K6DT^[V'4T
M8I<Z33")"];MK>V9&CINDM=537&QK_<;;LJ5M"$2K T9#K[8><X,GDFSF ['
MUZE25/38G /T(SG) '3'>MZ.=WPU)U7LW:NT>NW9W5,+62:&M^L72E41T_<\
M;(MT6CU9FB%ZALVUZ[,$G;%.@Q3 ,A>PYZML3H,RP"QL6?"=D*C&XP0<_/;
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M1. R:Q,A(]XE4@J^FPL,VRG*WDH]X*^[QV[32U<AFK*OJDR O#%7":A#T]T
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MKL/[A5;<!GJ]J:JS]1TCL19G+?J.#O:*9UB W(-"BH0:6NZ[/J&G+-8Z4#V
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M*DYSC./SC.<<N001D'(.X(Z$>=8@(8!E(((R""""#T((V(/F*]O%33BE.*5
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MN6FHT&&UA,02*BP \!MF! BLM]MA9)8P>$':::1VFNKF0#Q;JYDP99Y,; G
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MW2Q1F/84LC-0@RAM9:*2,YSE]H)!G38X]OPE#")4C.,>YU:E*5'F^-^5/K^
MJ1>Q@[G;B^P+Z'UC0*1KT+&/7"YW8T+.GV P:&0)A1+68E;J]EL1&:8-"Q\0
M2"GNJE*D?31I"I )Z?7T&<9/IO4VMK^1MMSV+;^1"%_&XGVN(]R<*]CB?.?:
MM/GVK3YSX5C./.?'%17GQ2HPW%MRH:,H,_9-Z4216AQVD5V2H1"^XSL$=@7F
MMZ]K_LB?,Q[V,V&TBL37?DQF-"S(E80YEGXEJD#)P*]4O=&O&8Y*0,*D+?\
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M+N(=6^L&SZ8C?^WKQ4I4408M79<OMFWT#L(<7=HL8[I E1 <<Q7P9J<"'P*
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MN WJ7OESKGVBJ>^@#/5?9-="=B+[;(K\@ 2OG94[M>W:V[ N-7,>'M6DETT
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MTMUK]2D1K43?".Z*W9HVB3M9J,31<#81*V3Q>QJW"FVC-R<TPSLV>,MH^C2
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MU+GV;;T#6<DFQZE9&_5^:?)'PVNG=;3M?3^NP5B-F<0?FM=PH,?< ;7R!,R
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M,O*#9G7XX##+L)@B/8S,,,O-/S(<A[*)JW$O1WW]CA9)(^3X'"@*P#F92I!
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M 'BA9)#,>38Q,R'G*&9<6,ZS G*6.FR<-,2OA;5F4QE6>3.%4%\A@R+(8^8
M$X++N,'< [$[=Z\I]LRZ:G!%S>:C?VVE-9:AIDMEJMQH5MQ";&ZDNT@YX[&Y
MBEPTD4DJO<1 30QAFCYV_=R?2OI^X-YKSXN\:FK>@:_6<"ZU2JP<N%&*SGH
MR"M<I&(==DRA(<>-=9Q'%QL$9$R4U'E37XL%"6L.]EWK?#EF!^UM0T/3\/[N
MBZAJ&G1-SQ*\C1?OI5PT0C=_#R64([LJA21\%\2Z-(]\EQH^OZCQO>Z@)]1U
M;4;+1]9@B2:YF B)EO8H[FZFG5^>XD]W2&-I(X4EF8MRP3WFCZ'LNG[ &GR:
MIF^R61$RIR0+0"1:65_>$/-O8?0G,O["]G,S)-K#R$2&5OK:_P J^-S'S?\
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M37U;PM[;N"N);"RNS+?:3=7VM6G#\5A>6<\\K:K?*7M8HYK%+F$PS -RSRM
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GOR,2&FWV5^Q:7$>]IU*D*]CB$K3[DY]JTI5CPK&,X4KW<4IQ2O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>g729258g78b78.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g78b78.jpg
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MUY;2&"(U(394=':T(R0QL[4X=7BW)3)!_\0 '0$! 0 # 0$! 0$
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MF*:J+9PZ\RG\=8.5_)J\>55Y<D+/9ZG?.[*52I4KU+)9VW?:'T&V1UJLUDM
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M\3D[X\GIL^T$@4FKDJ6=:!^GE!<7*G:<MKELW)N\;?3OWE9<7*"RWO0JV(6
M6&S5;K=: X/M+;2;6RI92PV9E D,-6NYS:5)IJX6:T63#=]=]JITW6>Q6FRO
MHN;4-3:O;6##DPL%,A\XR[7"V"YQP]&US?,0Z^4IX=-BVUVP#0:CXSX=]B)V
M-U >8G*I;L8ZFX^RHA#M!  4">0>8[+2)5JU<9DY=FZA> *+M-%(3*"9!O\
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MV 7BH?A[!_K727\@<?3CW-?MRO\ =%[_ +)/F_>WDP]O9_U4^P"\5#\/8/\
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MH\XSK!$]BY;]W2_P2W]O&WH\XSK!%O5H?*<QH<C@ 5RKH=,J[)^AK>7JFHP
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M3UVE5G]?H=X@/>6PY?3H6%#YNLN L=<^SZ_7"TJA??*4ZB\947((C60L<6+
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M3C*HXH8ZFXG=45%XK4ZL\)7$>JB-S)1GUML?J^2CYIW7L 6:[).X&5OF2"Y
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MJ=1W8B>N@?OX#^=BOF^-C5YJIU'=B)ZZ!^_@/YV*^;XV-7FJG4=V(GKH'[^
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M5.H[L1/70/W\!_.Q7S?&QJ\U4ZCNQ$]= _?P'\[%?-\;&KS53J.[$3UT#]_
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MVW#30HVY)ZN,)MDRC;46U:$=G"*;9B+VV7?%%%<X9);[);ZY@J$-+JP;2 (
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M>]=>P@5[U-K(Q20) )UH[6V=:\CO?>=0ISB<1.:,;XPQ-Q6.H++S70O)7-E
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M.K;O,%(I5<6*V3&IE$@I*;9DIV4/76T:('W(&N## &L.W<O'Z$!.0!(EU3,
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MB2XU@12(.>!R)JN^CYD4=9-2IL"Z>!R+,FU;'(R8?1V2!EW#)9=)$K'Y ,)
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M&0N#BZG!5$%I^6U&%!DV[T%_A^)24M#TV5TT9#8]%B$9>6C#(>"( JS>.",
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MSHMIH'JWK= )BG/_ %7(8X$>LQKWLE:T-I((SE3($W(LEM9@]=LE5%XPV*@
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M6)U^JK,4)[5@YPM5YP7&X'>9&=E=&1-M5MF1].-Q*8R)9NR<%8Z>.[<,SO\
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M^_91I6$B,6[2*LYK6%V95";,?1=@!*T,UC:8>MV1Y+V>&]B$Y8 G0\Q6(DD
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M18*DB4DOHY'VL> 3(U\0T;RQL3%ZXUG?,^:.C\%TY,>IR9F]* LN/K5FR@5
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B)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G"+_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>g729258g78q60.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g78q60.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1DR4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &1:^9"(X0DE-! 0      $8< 5H  QLE1QP"   "V# < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       02'V >+KXRIY:]UWQK  (.CA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!8,%(         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]       $@ U     0 M
M    !@       3A"24T#]P      '   ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))300>       $
M     #A"24T$&@     #-0    8              2H   )6          $
M                         0             "5@   2H
M         0                         0     0       &YU;&P    "
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P   2H     4F=H=&QO
M;F<   )6    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90
M !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O
M<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M     0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N
M9P          0G1O;6QO;F<   $J     %)G:'1L;VYG   "5@    -U<FQ4
M15A4     0       &YU;&Q415A4     0       $US9V5415A4     0
M    !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0
M  AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI
M8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53
M;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0
M !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M        "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_
M\        #A"24T$$0       0$ .$))3004       $     CA"24T$#
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M 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MJ8W^9_I/Z1,.G?6&BK$9CY3+;*<7
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M1SJB)1$P@&U?S3: &\*PU\B8.;FT6XV$PG#<3"2S-,@$$VX;[D I0+N(B7E
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MEV3('*'*78A0Y2B(&$"[!T 3  [!L&X /> 4[-,   (0 +[4.4NP>;H&VP=
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ML)A'J)AZB/7>M0(0#"<"% PAL)@* &$-]]A$ WVWZ[;[;]:U$ 'H( (=^P@
M]?3UK02$$-A*40VVV$H"&WHZAW4Y"<PFY"\P@!1-RAS"4!W !';<0 >H ([
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M.4P<A>I=N78>G4.7R=AZ;=.Z@(HAN ))@ @ " $*&X    #L'4  I0 ![@
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M2E*4I2E>7YJL1AE#%-_8YDSR:;&][6F;9<&AKBE[2E0)*L%VP"PN>!$)>!<
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M;A\]?Y3[ G[6\%]CY#U^S6GL8O#Y'?\ E/L"AM_:W@OL?(>OV?K4]C%X?/\
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M-->/>(J$)XD<R1Q+RF.)  *GLI2E*4I2E*Z[L3@V6%,Q"G ODF4 1(4=PZF
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M:G=O'21E3"1'Y&F0W<F0NVP% *^-7X<>A8"%VTEX.*7F#FVL"" ! 1_^L$$
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M,"B8E*41!0@@!@I2\4% N(^+]FW)N:=5V6=&6.\C</9V_P %94QR_8Q)L@9
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M84Y!.<H 8H894[AYPYMA#O 1 -ZG5]5$O]O:_P#*D_\ F5SH/T%!,!EVP;
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M]+/([B#:J(N0EED7DR^91<.T>S+I,AD$W4H[:W*@L_62(4R3=:0-XT"(B!2
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MX\ ?K>HDGM^/^BK;M*4I2E==V.S=4=MP NXE 0*)@ 0W*!A51 HF#H!C*D*
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MPEQG>[_4\C^'=B]_NU;@I2E*5L'VY/>/_DU4G\&^_/5\7/O_ #RK_P"_D_\
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M%11%=LX3,51NLDH=)8ABG3.<H@(P8914(;P@G2L)3D, Z*LY!N4Q1#?QZ,,
M;@(]1*(&V\X" ]VU3O4I593PK\Y?8J'7EE$1U'XB$ Y@VV*TO@!Z[_T(CL(
M&P;AN/6I_=.@@& <&]0Z8FQV&^X=X6I&@(>_[E>W5MYR?HB_K@_?K3M$]]NT
M)OL [<Q=]C"8"CW]QA*8 'N$2F .X=M]*54H\+'.0=/.B  , _RZ=N]P@.V]
MDWJ4-]N[<P"4N_>)1 -Q :MKTI2JCO -$ XGG&+W$ #XIB0>CKZZ''I\_P"\
M.W2K<5*5MYR#OL8H\NW-Y0=-^H;]>FX=0W[Z<Q1[C%^N'[];JV*?*U/H#?<C
M523P3W8,?\1L!'J.L 0V'OW]1)0=@]W;<=O, ;U;>I6AC%* F,(%* ;B8P@
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M!,QV&X.]&-[GF31:I+:&-=S<8S;%:HR8H^JH+G 5F(G(7F5 0"7.E*4I7 Y
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M;[AM7.4Y#[<ARFW*4P<I@-N4V_*8-A'<IMAY1[AV'8:W4I2E:"(!L B "([
M CMN/?L'I';KTK\Y[,Q$:4IY&5C8\ASF3(9Z^:M2G4(7G.0IEU4P,<A/*,4!
M$Q2^4( '6N%5ZT?-F[ABY:/D5AYD5FRZ*Y%"\H_)&ZZ:O9"8@ )BF ^P[;<P
M;[UAQIMTS82Q!G[5CG#&]YN;COS4M=MJW)EJ(/<D1,1MMSMG0);:CVD9'QS9
M!W#@NR2%5ZWF%GCLSHIA17[(#A68+VZK8C'T=&25QP,?)2YQ3B8][,1[1]*'
M*(@8D<T7<)KO3E$! 2MDU1 0$!#I7[A3D/N!3E,)=MP*8!VW[M]A';?8=M_1
M6ZE*4I2E*4I2E*4J$KCRYDS=@SAV9!OW3_?UP8RRB-_8TMR NZUI$\-)M!N"
MX4F0LRR"1!.#=RHH!5')1 A2[E,;;<*BTQOQ5<X:@+DX3EE2-Z77B?/+/4YD
MO &N3$+1X,(I/7)9^,XMRQ5N6WTD"D=V[<BJH7+#D4![',%UWK!)0[MDX(3.
M2X./3:$4O>^7H31YG"YM!&-LO?$<OW7#$W!8I+;B+E2FT;77N6/Q8J<;YF\<
MLYQTVC%[M9.BIHH.4&BK).;<-X%7TV7XNTO(ZJ,XZ8L/:.LEYDB--IK-N3,V
M;("_K*@K#L>P+RL92^H^^G*$LV+,2CIT+*5;,K=AU5)69(RE90'[)FU4,EC9
M9_A",A=\=IBNUMP]-01[&UE/[PLW3=<L?DG$LC(9&S;9SKUO.K%2MIY+Q#BV
M[4-<ZR$2MDN[7UL(@P1D)<EJJV\T=KIY-8XXO<KE#33EW+UJZ*\TS&<,':EI
M72GD73%!W+9\L^MG)]OK$%[-7#EI/Q2QH3%L&B=09O(S]%*%@GC)X55LI#FA
MI]6.'5[QDKYSOH,U$S>&H6]M*6H/3+JNTSXJR<QMC*UGY)9-V&1;^23!.V,H
M8V=J6W<$-)Q\9.QDRVBD.1JH5%!54>8Q MS4I2E*5X]J&FY6VL 9RN."D'$1
M.0&'LF3<-*M%3H.XR5BK+FWT=(-5TP,HBX9.T$7**J8"=-1(IR@)@ *I%73K
MUSY*Z>>$0]S9Q ,\Z:[(SK*:@VVH?4!:%TO@NY2.MAV_"V'TJJA'3SB4<,G[
M6/B&G;0\@)V+XPD[%0HF+W'G$(U>1^A'BTS&'-9.9-0>%=/=R:?6>E?6M/6^
MXLB_Y>0O*\X]CD^VFET^I4.]EC0;<(MDL8S%!<6LTLZ.LT8O&,8C+%PCLD8O
MR_GMLYL3B@:_=5=PV[CAQ,73B#4):-P6WBY$D@>&05DT7=PXNMQN^DX234%O
M&MXV:34405.[!-=-)1P-FBE*4I2E*4I2E*4I2E*AWX^!55.%#JU117.V4<66
MT;E73YNT2[>88I"<@$.D8QB@;<I052$P].T)OS!5_B]4>8&+?AM\/S4^]?\
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).7U*E*4I2O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>g729258g78r97.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g78r97.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@!&@)> P$1  (1 0,1 ?_$ !\
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M,&,-.%1):F5 7D=(BR 11HK/)*[I&H4Y8$J"\;#U27),87N^R:C3M%PS?[5
M AVVZ%;-8]JU^*YHU<*D J_%AU3?)!-4#OM1ED"XCD"G57U=2GP(06BL;YM]
M>T%D*Q>.Q-&QBL1UY"9HT*B&-G,DD_%D2$"0CB21IQ;M:G<&':+?RP>(/8FF
MJQ'QRP/*6BBCEG\DB-XT:(NBDNQ64E"&2#3UAW/\@8NTA[J/5" H4XD)H;8F
MYT83D>T@X-1JNR+M;VQX0KC1;@R21$Q&EB,[0R"Z*B+:>=?X:WE!+_L3R20.
MZ310E9GC,?+R$A">2)P.9$#)VI#88:V3NM6.-9;2S48SG,EM%CB0!PBF6='D
M@B\F04#RYQ@$YZ$=2Q"0"B S![Q21;[1B!R:;*+Z+Z;)5VTW4VQA95;7.$H3
MKG&,X2C*,HXSC.,06",Y&,='\#]CJ14JRAE8,I *LO:L#V"#WT1V.]6WC5=>
MN;^!\?W:GM!_1=C_ %L:#XTUT*O&FCQIH\::/&FCQIIC?9[^YJ]AO^PWK7_@
M'8/&FN+#XTT>--'C31XTU^XQ\<XQ\?A\?\/\_C32[YYK=&S[<B4%RG!?:= E
MK.N683@F75S8NK:YQA;*-M2H0NRO,:K,_4C'$:YYS\N=[;:AO7JU;Z@DDF97
M49*5XD>:PX!]6CAC=P/?CC6*=S'#(X[8 *H_Y[GBF??'(@''WSD8U*3>M1"Z
M*#]X)*H-Q*MC#5ZY1&A*<*2+2*M9,,O('MB&.%F_\;80/G["4!Z\E7"E%_C^
MSN;=7W:J#725)U^;^0G:,$6S!Q9ZB-''&/%XRXC\BEX[196D(E'' I,*JP(9
M0(DF SR4LKYE*$M@DK@G(&,'U S"P@>RBVP>Z$J[:I2A979&5<Z[(9SB4)0E
MC$HSC+&8RCG&,XEC,<X^.,X\\_(()# JRDJRD8(92001[$$$$:W/7TU99Q\,
MYQ_BS\/*::/&FNQ[^FU_>Z_0?^A9ZL_U&Z+XTU-/QIH\::/&FCQIH\::/&FC
MQIH\::/&FCQIH\::/&FCQIH\::/&FCQIH\::/&FCQIH\::/&FCQIH\::/&FC
MQIH\::/&FCQIH\::/&FCQIH\::XOGN)_=<>TW](WM_\ 69L_C34<O&FCQIH\
M::J1QC&/C_/G'^#^;./\&?\ \/A_@\::=W0]? %_^$SJRF6!\_.A4DCPOJ9,
M:IQ^D2SHG?7B"4>S$L_&[XTLRZ9 QC=14PQ5,T::1QB_8*$*0U*M*H*VY4.6
M,P9D5:Z<6PK'E:9&AA!8.%Q.6=O$G(#($LBD (I]5#>[D?8?2"&[R 7YXQLJ
M:G=#Z-E V=^K<@&?<@)R5*M@W(E2?1?0[:DYKF#K<0#C#7A,2J?DA74300'#
M&28;E"Y8GOMY7G<3R1S6?ETB$DT*EA/%SEL0)!'+"[1>1BT<0;+X7.L%N-T@
M)@:*)HD(1F1W"*<$.(DR\C*.\+Z^^D9TG2&J5.]UQW4/2WTMN<;@*ANM9P$%
M(,$3L!:"%!189DK94A%U3&(LQ6L5YOE575?#$<$\3_*25IH6CF@D:]$.09A6
ME81RPX0L.*XBF&&/%8Y&Q]>=7121R&*='YQRHL1(4@<E5GC;#888)8<2.L@>
MNHNYSB.?AC'\K.?W_'X_NS_Y_P#T_P"#R!UM:['OZ</[OT\?0S^ACZN_U'Z-
MXTU,[QIH\::/&FCQIH\::\_W\)S_ +S]W?\ Z^\(_K=U/QIKEX>--'C36:UW
M7VVU.EVO(5Y35RW*J!6K@J\VE%EWSQ7335#&,_',I2Q\V<_",(8E9.480E+&
M:O!+9FBKPH9)9G6.-%Z+.Y"J,GH#)&2<*HR6*J"19))'%&\LK!(XU+NS$ *!
MZD_?\AV?;4[-*XWI?&J!-FZ4L%W[> #LREHK 4DWG:C[<>ZVNK8RT3E>TVHL
MCYA"AJP"EVN!3&E6SNV0 RX:GU+:OA/;-FA>_O\ .)[5:6*1(($6UMT2F!)U
M\Y(*7S*'5<(&J0G@)C,LJZA+4FX7U:*M+)MU5E*_,P\/UDY. >"V(9(:F!R.
M&6:SXV24+7..3M6]%UWL%.4_3>2<RHUY'(ITI.Y]S=!SQVGQ5)6PBN^?3*$!
M#I$?6)2F)P^R:7E&:<4N-'8A@LO+);GP_N4Q@N;77K5XY4:!XX/'/)9B2+A5
M9DL*Z4IWF6)SD*JJ91B0L^M2ML$FVL9]OW#<Q)*(4L_/;I<OQRQ(CH\BQ7)+
M"16 LAF#0J@:2-5*E&9&:1SL[<H^V"V4$26VFLP!.K!M4:X#;]NO%,N$&&(H
M$&J/F%4+$'^W65V8'KCCZT(9Q!6][EGB6O%&M&NZ1S1UX$$")([N)HU"!&^6
M<  1R<BK9;/(NSST%2*NJJ.4S1KP$UC]M+(H9F5I'DRSN Q!8D ECUIGF-IL
MKK""2+BCH7YG=\;CH%2G]V37/-D,?"VN,LSA&6:<0GB$XYAB-^+)XBVM2\EG
MDG2:W&S<0S2LS%I)'?E]0P<N3Q4*,\2!D:V.*8 X@#[ 8 Q_E]AW_GJA&RT0
MV3"!%]I 9M4:IY(^CB$Z_AB=!M=,XQ&A=&4*ZH472G55&RJ5MEL82EF7<;%:
M5)1)/.ZO&<2SL_*-$B9XY>^0Y\S&X#%L KW]1U:T2LK(?W6&,84C!!!&&!!&
M/;'V]=9ITT"Z?F(O0+<Q<W#3H1;E]&NAQ7?'%\!_VI+(G83L"VPC&*2)'6%O
M!8SI(6&0I'M4L9&94W]8HK?R=>V(0*=J.)*H$(FYDW%BPLB<&98N>9C,ZCR.
MC&-=5*HI\GIADC+<I:O)GB8 8Q"N>%9R<?5$(XF./*COQD6,^S:ML.G."4.S
MI6J!L+$>RU<Y *6FQH,'J,!)R*951=@<X*^@T.[Z?TB1"*":)V475V3X>1&B
MDDB<%9(9)(9%/126)RDB,/4,CJ593@JP((!&MR.2.9!)%(DB-Z/&P=#CHX8=
M'!Z/N#T0#KUC_P #X_NU/:#^B['^MC0?+-7ZZ%7C31XTT>--'C31XTTQOL]_
M<U>PW_8;UK_P#L'C37%A\::/&FCQIH\::K5Q^/P^&/WRSC'_ *<_N_\ 3^[_
M .KQIJ4_,=:%UK2RMJ80^#O:_N04.;:JYS5:Z+>%4S:U566TXN*>&711U#_<
MB6P6ULK,YL$9PMK[/:* I[:-S>1TM[A))7HQ* '6CD0SVP6PA:S/(E2%%99"
MJ6 #Q<,-.1O+/P*L8J^7E_LJ\N/HC+=$</I<X!&>/8P1I9+]4VT[*JP2T["N
MZQF6D))M@N'&AF_Y#C Z2K"H5_3/6P"MK"LE\YPMHV;HVT75RE]OVK<;)JPQ
M7)#%#+=M1-*162%GE6*Q8,/[1TA:Y6\3$'B\I@*J1(^3R(3+]*,S!4D*$MS.
M.D+ #DP&,Y]O? R&&[;KQ:/=<D7YE?7L*=7L5+"-'T1V<CZ95,& THYE5?22
MW&8S^O1G--L_GG7\(9QC'-_%FW6=OW8FR@!NU:M]9(T*0SM8A43RP^H,;64G
MXE3@XSUG62M)&\96-LB)WB(SDJ4/0;['B0<?8C3-SQ\,_P#3^_\ [_.9UL:^
M?&FNQ[^FU_>Z_0?^A9ZL_P!1NB^--33\::/&FCQIH\::/&FF">=*ZF5T7:M#
MYMSG0=CHTU)J+-RYW?J^PZ';87MWYZP4)8K0\=Z1 H<09)\Y!Q3,"R=Y7T:P
M,UT_<6M/;/Y_W8_UU]_M%[/_ .1[@_\ K'] _P!UCQIH_:+V?_R/<'_UC^@?
M[K'C31^T7L__ )'N#_ZQ_0/]UCQIH_:+V?\ \CW!_P#6/Z!_NL>--'[1>S_^
M1[@_^L?T#_=8\::/VB]G_P#(]P?_ %C^@?[K'C31^T7L_P#Y'N#_ .L?T#_=
M8\::/VB]G_\ (]P?_6/Z!_NL>--'[1>S_P#D>X/_ *Q_0/\ =8\::/VB]G_\
MCW!_]8_H'^ZQXTT?M%[/_P"1[@_^L?T#_=8\::/VB]G_ /(]P?\ UC^@?[K'
MC31^T7L__D>X/_K'] _W6/&FC]HO9_\ R/<'_P!8_H'^ZQXTT?M%[/\ ^1[@
M_P#K'] _W6/&FC]HO9__ "/<'_UC^@?[K'C31^T7L_\ Y'N#_P"L?T#_ '6/
M&FC]HO9__(]P?_6/Z!_NL>--'[1>S_\ D>X/_K'] _W6/&FC]HO9_P#R/<'_
M -8_H'^ZQXTT?M%[/_Y'N#_ZQ_0/]UCQIH_:+V?_ ,CW!_\ 6/Z!_NL>--,'
M[%^UO:/6325>^[]POF+9.WVD+41AM1]@=J8,H,CU+QS3??2Y]=$ L08BH#*[
M;:S+;XD6#0B-.N=MM+50"3@:GMXU31XTT>--<7SW$_NN/:;^D;V_^LS9_&FH
MY>--'C37W'$L?RHY^&?AG&/A_AQ+&8RQ_P!&<9SC/Q_GQGX?X?&FG%T[6:"A
MS-@<_&M*OE5373B-D;'3&=M&/Q8UL:Y8JC33=@M@7G,("#8KKS9$DT.%DGMU
M>$EK5V.4T8L@^/Z?//@&*N'[*AVQY'4$J@(Q]8(PROAEA0YE<!C@$^./W8X_
MM-V(U/3$$9P#A4L<&XOE3?;\TAI!VQC3F58\90^WKHHHC1'[>$:ZKOD'GB.8
M51KA7#Z?S9S+-<:Q\XYM%5L+) 'BC"^*%80ICCB,1\(18P%"I]8.2QR1K(H7
MA]&0&! )]>7H6(Z[S[??O)U(CV!0:JCZ#<VU;8UC1<T((.JIUB*PG-:6R_-Z
MID4,@^;6A;3UME<;0<D@,8'ALK3DJP8H&1F:>*+R12;C8"RR28MK54O+)&QC
MEALQL2$D2U&P*%II) %82%6P#IU)K$T2EZLD3"./)8A4#MGR18;$X>-@?WHU
M5@RLA;+!6R4BV_=!&F+C\ZZQ^L(6QNE9="^@VF\9G3@NR%6##,0MMNI%&S]Q
M/&"YUD?-"S$ZQ",78I#\RM&65H6>4EV6&=&BE:2:- Q=XVD4D@GBQQDC)V95
M9HW4%6D50X4=GDK*PQG /[I!]L-G[:C0V7WJ&)JXJ.8D &%!D1ECX9A>-=*J
MV./WY^/PG'./_/\ #_O\@Y8WAEDB<$/'(\; C!Y(Q4_X9_#/\=9%(95=3E64
M,I^X*AO\_P"/K^&NQ;^G#_>\O0W^ACZN_P!1^C>8]5U,[QIH\::/&FCQIH\:
M:\_W\)S_ +S]W?\ Z^\(_K=U/QIKEX>--'C34Q_2N'V'1-NV:R%L*$G*-^'D
M= ?%_P!A/9UD=1S?"'PQ9DF8KTN@/%$Z[K"[*:X3EB>:K.[_ $>48;>^3SV/
M+X]KVRYN:>*1X2;%=,UD:5 657FX# !+C(P1G$/O+2>&K%$8^4UVN&20!B\,
M3>64(&!!8! 2?[*Y;((&I"$I:"%4R*J[RRY"%G&QIB#FZTZ4\SLOLIJ%A:-F
MNRO V0XUCWQJG9\/J8GG&>\,%V:DSU"TQL&U8L2UI=OE9RM6"!)D\-AE5B(0
MW-ZLS8E8A_J7.4NBNY<A.+CCD-Q0,>E.,#)R "V3[9],8&L'%:ZNV<%T1V(@
MRUE]O2%"T7-K'(OQNIN*JKA;*L&1X@P6<5%1#JA]O&4B9W\D^S/%8K"PU<I/
M'EX(+2PR1RM*8525YQ$LAP'+1QN%8J6'2%=;AL+XV;&&&",D8() R1GD!WC\
MR!G[M38P'6L2OO Z[:!ZS<14V7C"VW2^I?=5;?"FR94XUVVU1B+'-DOCB\.=
MM5%\_J\X=O93+)R1S664?+S21UIP5EL=1P"2R956563*2ME2!]7'D]X=2P&#
MDC(/MCV[Z[[QZ=CW.DNTJ5G%A#U54U_?4C1A.=Q$<T72)MC\EUF:K*J851Q
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M3E39:TP>_P LC^8]_MJ0H7O-ZJL.0,>Z4=; ASM3ODN5,;C=9W=;N8O5,&"
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M2[R2.8<94I%(6*L NMJ)$DBFDEGA#130)\L7*S3Q.SNS1$AAB/PKYAD%1(I
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MQ.^N.<QC;BJ=6+)8S\]'D/*:Z\XX9;%I)HR%^F2(),1%-(&*'$B\O(0 J.J
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M^><_AGLX]LX_'1P/T^]JE6N_I\^O?5=0X]JG*_T[]N4;0/V?2NB--@V3NO\
M%QQ?I/$.:THN=$:$DLYY?M:OH>-NZW>]VIKD5FJ-UO7L[,&_LV%<U4D?4?\
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MW=#B-\!7;ECE@DCTZU:0Y?=I^R7405. P6?-!]LKQLJTC#I?%XA7;%D6%-0
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MTVO[W7Z#_P!"SU9_J-T7QIJ:?C31XTT>--'C31XTTPFC_P!T!WO_ *M<5_\
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MH\::/&FCQIH\::\_W\)S_O/W=_\ K[PC^MW4_&FN7I3',[(QQC.?Y_YOY_\
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MT,BUF>.0PS6/-*1#%9A9^$\-J.".;QV7&Q-MX@6S.EJ*Q##'8FCGCKV%6S%
M\23!9)(D6(A2DW[4+^Q"&0PRR10RL.<D7TIWM![*IHPD*I.4UT8A9\]V+*1S
MP[JJ@[842G"9#"$?N0<URE5*<[Y0E"SO:%6GN$6Z"Q'.]R.&":DZ-)X!,"BR
M5GPKQFPU5?*KEU=)8Y0 !^Y"R/*CU5B_W4A/ERJAT1E+1L"67'(G)/!@%XX[
M;6)7[8U(16:LRF%0J8V+WBP60@8]Q;I.'/7%9.&9(-A=E2U*&0'531,82RRV
MZ=HAII4R,0ZP/$E62P(X!>JQLA43-SDKJ1$ZDM(SS+C#&(?4 J%&)ZS>,<RX
M8LP,C#L>LQ)<$= Y]%)R5]1@]EA^NU@9IUZY??"VNC#95/%-4Z:!H!6!%R'I
MJNQ&^&/N6A=^*+,YJ'^M$4>4J:(3G&?$*4RE"2G*7C MUSD%"OADC8)P?ZU#
M%W< ]<F8+TN1='RRX88P%/KG.2P/8ZR,?G[Z8R?_ #<_]W_V<><SK+KL;_IM
M?WNOT'_H6>K/]1NB^--33\::/&FCQIH\::/&FF$T?^Z [W_U:XK_ .Q;[XU7
MV'YG_!=/WXU31XTUI/ZC:NTW]434]G4K[/8':-]W'E>B,-!=:/W)!T3U81T<
MT9WL>K<=Z<*)=Q_9."L CJ6O6]9+$5AV[NQ>K[=\=;<,-SY:U=[?;U_C_H1[
M8^_L,DQA]5?7=MQ[5_TRNP:!J?1=?[3O_M?[3Z)VELX;=')'-Y3L/-_=K946
MK;UK;%A>E1\V WG3.4NM77_AUB=3L40'":-;[93C6S5<Y##KI5QT/7*#^>,C
M^>L5ZK:RNV-M^G^!J>M]W']Y+-KV$7]41MNZ;LRJ;#3S^(]77=\6=QV#9AAM
M#=I7/=2]"SZ_"*S38T#PUUERC[33EC8BAHV,MZ$8^GT..\CT].L@_;\\:9 /
MH?NYP>"3L8NI]SWF?Z:^N[/^G?\ L/\ L_LS:?L*RVZKO^OZ3V$0>8LY;B&S
M8:K^G:YNW.51(@ ^R=/DY.IL"(OJ:KT1@\<O]7+KK[C\/[0Q[G&/?4LA^4B>
MJWLYZ@ZC26R]IN@:YJOJ/P+8>>[EJO?*ND<N-66,*-^]J>'=@"'(YBUTUF1M
M;CH/L@@V &H-T-JQB9AT 5E4#H4G_5_UZMR""/09)'X^G1&?Y>H'V]3J57Z@
M@^D7^S?JA_9/)]_>>FN.:^Q\70>I)>I[#J\?9R9_%\\8MZ JY,&>]O-_B^CV
MVOE=A0ME-.[V3RJS#:IZ[+QH/0^F<@ ''8.<XS^.-:X>":UJ^K<I]%=?]PM)
M[4%Z6@ZQ^H=@[6MYUKL;<9?[%G>Y!1_'[?9!*D%9[42])XX1THC0F/1:C%I.
MWF.3<%7[<9KY4Z#T_B?\3C53_:((SE>Q@=8(./0 9QG']PSJWVX'<-*]?O7#
MH_0EW0>L[!SB7M@1P/TK[]H_LL=NG8>%;5[)'L_6&&H]#U4(QGSKW"U+C6M:
M+JVBV]*6;9LR#5=MD'M:_1;9N]KJKJH/9P0 >.3T #Q[ZQZ9SZ8SCK.G#W[2
M>G;I[F]SIZEUL3B/9O[+7D[GUJVAOZ_^S?1^G"\+5 \@9:F@X7N_.>FKN.U<
MSVR\7=]+[1K>=.9K:GC;HS+KN"UY"TT6G>?P_+_ _P#4??\ A3K ./8Y[ [[
M&2#DDC(_F,8U.SWX4^U=/!=TLZ#M.L;9PLGOGKS9T%!ZW<RZ[JG8UOJACONK
MV]T#?MUG5-]?;?5_%/FT?>,\VUG4VI>IT;M>"% 4R"X6I_K&?\N]4&,C P<'
MU(()P<8&!COTR3[?QU?['J!"]1[],_335NKZEZW[/W+].J]X<?H'L.<K:^NJ
MDIR%WLKG6G5,]3[+L'$P+XDXW/7>5-$D3^=RW?&G?)K#42\QJ[/[N2"<-[@]
MXZR3D?Q^_P#/2@WU/K//O7K6FD>S/MX]>=Z_4J]:JSM#]9>2^S_(-:YUIA7/
MS4W5]+Y K9[GN73]@U/=1QL[1M:#D;>U4$\9;>+KZNG9#V04']_Y?]NJ9.1Z
M#KW([SD]GH9.??\ #.K7=$F[_L!TB?KT'N6N_IRL/U%^6E4A;ESKONVZ-3PZ
MCU6M&ZFQ%YDD?:5V%GZL&^X->I6[$O1-%6E3:U;>]O$.YAC:!SW]?]O]?QU4
M8]S]7#/J/7/0S@_5QSCWSC&#IX]%X!G<[O1_FIW2-C[5Z[[I[R>R^QLU'-=+
M]@^'<JTKEN?3?I3E3QL*C==T?;<WXG_&TG(/#K)VTGG;N6W$\P7"6H%]J*QJ
M@(^H@8PH]<$D\E[]/724AK%&GK.%<Y]B4?6R/0[F7O?^HMHC_7B0>M;2@3H4
MVT;/CT\4;U5KE3;='7&DU).WK.?W.<L].$V&OF8TR/B#K6:FJY'9!'+B#[>N
M>_PS^'K_ 'Z9-)IN[)N,^O2PE1M&D^GY7NO^IL^WX+V8Y+['])41_:+LKYKZ
MKL/8G1T6XZ5UHQ6RU@W>B:'G6'!J,;HI.IF;N.1N-B P6GY?WY_K^NNM.LM[
MGBH]1]@&P?3KTZ_LY]LZF#SGUGKZ/OOZ<?*NI[MOOL9P\3AOZD[ANVDC[OR;
M1':4[NGK2?Q;G>Z:SNVU';D]U#GFLG%:SRVCIS]YG:TNAI=U66MZ1A6DJZIR
M]2  ?I^Q/IV?X^_7OC3-<0Y3J8G4?TC.I^R&C]!;&:_SKW2X.)O>X)^J[*W5
M[WIOLIR$?U%UO<&@=+ \$_&I:[NENK.=P^@"]!7FE.F1]=(]D&F25;TR2"?0
M==@_;W(Z'W./4Z]-_C5FCQIK5E^KI_<W:3_VWZW_ . ^E>-7IZG\O\QK:;XU
M9H\::/&FN+][A1E+VY]I<1QG.<^QW;_W8QG.?_E,V?\ P8_?_-^__NSXP3Z#
M32+U55^# _: Q?@@QA&$->K/'LF/3&)>:+WT:90^F3$8BJ0(59%=P=Y62L2A
M.\6NO,S36.G +CJDEJ5BM%'4/'"(V ENRQMTW#EQJJRO&\@E9D/A4-B;]JW!
M&^B,@S $9.02L8;HCD"&8@AA]./WLC-Z_ !KL:6G8[2Z4I3L"MZS79NL827$
MG1P>1\QLL@S)H!MNG3B4!_JV?+DFZ,,YQ7@4"6PIG>3C-.BRS>21G8/( Y9F
M)R0I+?4<GO/OBYR$C8A<E%9E4#MBJ$@ #+$G &(XY)&R0L;G"E^=@Y!NNMDT
M/P]5O$T1XIZ"6MVVBPLG4W"P07;5*YN _87D2 6%8&^K6.SOK('F1BLO-MDZ
M<>:V^UU2*"&(P,WZPVZ23A9AF(0;Q3CC>0Q3/P!4(>PJY)(&#KK?@"P)MVW"
M09 7X5_2%$P9&4I./T>_$;F'#JC$HK9.5!'0Z;(&(M<\ZLU;5U^I*'*S=5V1
MX; ZNN+$A"[[*RFZU=FID:.Q%*+E4= HL'7CU7UXJ*EQL!_O;=MHT>L',@69
M9!!XHU(XUPBN;$D@SF21W:-P/I01K@=D#EPW;+P4)TZS,Y\F",-$4'[,HO'*
ML SDL58X TK->H:I[Z)(]B>+GU%XTU3A 1L )HU8Q8Q-!0IE!-+.G-%LI3S6
M,&39.0U>1YV3S'Z,LL9'.D;5^S=C:/Y6O7@>S5G\<?FCB(F(GB$;9/%-ND3F
M$"G)/+$A)Q(L2(&#AV/^\ D5HY IC9!B2-BC%@_1/0UB%VH.]RZR8+LMS>":
ML%;M.S%@PK(V=CK@>M7-=@>Z^I-MHGL10 :AN19,:6:)$UUT3LP20+$CG]L:
M>\;+RLTD[W-UM3D$QO+,+UR1N?% !+/(I#N(R>9^F%F/'76?'[)5WN-8@J ;
M#\%Q1!N1C ;X3V%41NP<*I 4+VP'W&LMT34[(,R3=7EAFB7KPKZW"9*Z3U+T
MC>-1VKSVF+(!34+L9:8I56XMMC,8MG5;&J=]\IW8E;GFN>.9*8A2-%2;C&L;
M#"*(I9E+\9+4L/B^9D!YRNJR.BLV6Y,%8\JS]L2RD^CDYSC)^D#[L??K&#ID
M]I C?I#NO,B8U LT[.J-L2!X2'KO8*L2B+;F8M6,X8T3CBN^Z5><8&CBK%-V
M;;'"';+T0:1G@LU[ :4&)O&)):H0P%G"GE,K9#$D<L=*1JQL>>$Y #+,@_$L
M@E_ =^+W_ADD8ZU?Z</][R]#?Z&/J[_4?HWD'K-J9WC31XTT>--'C31XTUY_
MOX3G_>?N[_\ 7WA'];NI^--<S'EJB+C>4=-L:Y#!6WNBHW44DU6C(A;G-H\Z
M";*1[ONX!?:PINMKKMG?&N<L1EGR9V"M\UN]),*5CE^9D#X"-'5!L.C%OI^M
M8BB\NBS '.<'#88K"^ 2S (H4X.7(7.<'TSGT]N^M27N9+V][WZ6"9/,DA06
M15"WQ$+SCZT&EDP9L#;"S1[S!<4R!A9*5$RC(XSD24;>[W"=+C7%E4WK$4E)
MXGKO+'1BFK@3W#\L)I QCED"):CDC(A9U>7$C$X$5XPO%\*%Q]97D0/I4<E3
M!'0/[O9[&!I5,3:EE!*%L$9K1&O%9^Y /&(OP0U6PH2LQ&ZZH\V8;.18Y@Y(
MD:<0 O\ J1LJ#@3?B&U4N?#\\$-.2>U0&WQQSK(#'9@MRU4KU3Y)(Y[<D?DY
M2QO%&KUW0%7QF5-6<)\ER!(90Z\B 'BC9N6%<(C>H&.8)[.,]'2^Y_O1+)B5
M2S8L0AJ-5O. &'"'G58PHO"'7"*X8::\ON)8'4+UH=%EX0PAAN9U%B5#2C97
M>/B^4;GL'S!6>*"Q-9JTS *JB9OAC?H8Q&T4,?@'*6')DC5:O[Z+''&P/4_#
MM7A\/_I&,,?.1_@_;XV.,_0WZ1?@)7SE)6(169VRI#A>+8!)#[QU^6T?=[QJ
M&M=1VYFV^@[W+6T&0& FN"E J$J'6E8(,OH7$KOPV?F6(*7&*9 @WWUE IV2
MU3#R;@]6]/N7Q%86--XO5+52G!:I1S3,H><44::2&%FIU5VU46-&DKS)%%\N
M)8D#<I%7+(T.WP2N8*^+,YIS20Q^2;Y<6)FK?-RP127+,=>.Q<DBCEMV(U#+
M-83G%=>+5O/0)*3J+:Y-&-H=LVR["Z<ZQJ66:I7B"?6O^J+4/3>Q%NC]U]UF
M%>)1HMKCGL$*?$^^,GB\LMFY6$:V$@@,L,:6!Q*GZ9?EX@UFQ#*_DDG)A$:A
MXY!C9C2J,^!],3<E4EB7."@#-Z*S' )]<XSITRM:T'<FB-3N-D4.A_M9MT;-
MXUJ_9;6&M;($[*E:Z!H+"*FGS:6' ![:%7#7RL7JBQ*[F2F)>>*BV^/=O@GX
M<&TT=OFO10I6^8%J:F?FH:M64UI(YC(E0O!YK$DHY[>9GC\4D#M8&NT^.9H4
M_2;^D/YN6XT<7Q?\2EXHT2294EW:_)%X1],,Q9N 57=)%5_K.,XS/5NNZ]KU
M2#5]#*+*+0*X&;5M2*^O6Z>A;+%W5D!I("E@ZJ56?BQ0Z+)*:\#VN+&'V2E(
ML)MH'[C:]WW/X5H/M5V=+<U2Q;LUYZ%ROC<8'&VFK#YQ"DWT206ZY\*SSM,L
M4,CL))B>"-"&U-+;X@)9@B40V:B++2<B59E=HY29#)])8&2)5S]#S+&FD<WV
MY%I^EHMXU:X<K:WU]X,:C1; :%EU&&L7306IC:W$F4RI*_'.20B_QS%;?D:0
MV)6V"#3V\?J>ILFW?$NVQPR[O9W"-$6[$J0)+7EM/;DB226Q79Y&98YS%8DC
M<$>.*"01K%KP16)K,U.=&6K& Q*.L@D0B,1KS54\87QAE4QA\<>3D \XG75_
M?%4WCYR5839=>/3F#'ZQ&+[YU%6B5U2^&*(Y^6JFN^=-D\TR(JJIG.R,?.)*
M[/8CLQ/);:S(S()$MAS&UADMNAB=D6N$95C2U(C%6>0%.4@,X"O%Q@((P.AQ
M !(SCOWR#DXSD??K7K>_@N3*P;V_Z[J,XTQ)#]1S]K<9KE7]:+39>RZ$(,*5
M&DDB'S4HD*DZK%T:BJY-2(W0Q*6?C!?&ER66U2HR((VI5FDF08!^9N.)&\BB
M215E2JE.&0*1AXF!'+D32JHS++RR&8(N#E>,>22!@=EW<$]_N@ ]'7N9\XO6
MYH\::/&FCQIH\::8WV>_N:O8;_L-ZU_X!V#QIKBQ8CG/_1_C\::N8QS+,<8Q
M_P Z6(X_Q?'.<8^'_P!?E0"<8]S@?GIJ02I;#3D<DL_A6\<_:G/B+)?'"ZN%
M,+U:&4:XYMA.G)&3'.+8YA@Z0P=H\;DUMDI\*^UQ&JQEKV[*,;N3Q,<(\315
M'C*\U=O(&G)"E5=%/'L'63,TAL'(BC#QP*2<N^>,DO6%( '",$=G)&01K)O-
M4/U@]?<["H(7$P'MOP(;3*Z>,U572$G;]:S%!=@-X]^8PE\/ELC/-F;<?NVI
M*4FUWXH[]86*C"&>6O'.D)EKS('5?.V3&SJ<J.2MQ(=6[#:O63RH60X92RYQ
MGBPR,XSDX[Z]2>L=:<[15&PK;WCQ&4O J^[3*EQ2O9%7WRIPVS6QUZ69TD%9
MHGF\2OY&!D844.!J?FO$:5#6U9]TA%::TZKML%2TRQB"&Y\PL4"^&=!++7\\
M?,1A1*9 V9 Y*' U171UX3(W[I+F2,*K$Y5>V !.1EE]DP< D'4I>*=0(TEP
M!JNS5ZYHFOVIWNK[V>+1DDJ*YEN>X,F6JTV9/+OCK+#8I,+G"36@6HC*%UH1
M2D]-$8.',U-L,MK?;,UPCY2P*%.$Q[1>I1\J5*V)P]_;+DM><.DC_K&,I8JF
M5HX3%'*R-Z1:N;#M?P[\&PR?!6Q;O/NVS6MZO;A>N_%\-VQ<7XG^*]J@#0;1
M\5[/MKU8:FW[?%'2%2..0Q-8F:2R5G5CM^V;1!R9"*M17 &P%%L8T$4M!J1[
MIUW'D7 ? RNZ@.)C2 H4YS@7@2 XY U$5H\,3%Z*\KXBWS=(7,*"6-:&R1Q@
M+$D^68;5 O23*BR%%S&Z$@ A-1%;XFV?Q(LGZ._@MCDKS^>_2 25#$ G_P"W
MC\6P,\.;<,X/[N-+?G:C@S*+9[OSW7=;PK0$AP30HV5F:8P/1VR75T9UX[88
MT+12BXR967@+&<RUQ800K&DRLG.K:@E3<Z2)NT]N.:%XWBW%]IJP5C%3AE>Q
M$-MV][#S!1(L-=*ACFDC"3R(KO/#NR6MFW?X9^(;,7P=M.QW=JDVB:K>V6;X
MELR.;DUR!ZL\'Q#\87:HKR-%$TMA(?F*Z@/ MA^562%G1 [)(2B)UU6?!X!.
M%]'U;(SF6O:8G;39;F=L:BI QS*N_.+IYHJM^-F)9^GO[M$T=-Q*X=VN03H_
M-9'D66O:AD8OR:1BLE,)() '0E5=5_9YX-&Y,O?]DY[![ !]0<'L@=9SW]M,
M%G'\^,_]_G+ZRZ[&WZ;?[OT[/0C'_P#9;ZM?U&Z+XTU-+QIH\::/&FCQIH\:
M:831_P"Z [W_ -6N*_\ L6^^-5]A^9_P73]^-4T>--87&R:[+8IZ?%^ESMM2
M6K9+-7PU!SL5>NWG7*Z'\TF+_P G!+<S'(75-9"X!L.HN$A?DBJ=<6FLUXTT
M>--6@QX!EQPXAHA5ZPF(3*@8FF^Y>9,48Z AU=4Y3$)F"8&9&@B-=LA2AB,0
MS3?5.;35WXTT>--6@)X+,:)BTT1@'.R^J!0)-)8T[12+12:XWT3LJE8.51<-
M?#$LRI(IMILQ&RN<<--76<XQC.<YQC&,9SG.<_#&,8_?G.<Y_=C&,?SY\:::
MK6N[\/W366^ZZ=V7E.V:;KX^S%OMMUKHFH/=92":5]']LBF[Y6X*5+1]2^XH
M_::XTNFM#]:G\K(3ZD/F::<T,P-B&*P7E#'@'C4& G!WU%!F!E51O&*%)HG.
MD@8BF<+J+Z9SJNJG&RN<H2QG+35SXTTW/1>3:#UC]A?V]1R=_P 6O1]7ZSIG
MRM&ZS\1OVFY-SKCR7X@\'\A%?EB9\5;/[Q07]7_CH!'TZ_D::783 !E5.]<:
M(?1448#;<$32556:N*N!8!SLHG9"!0)H]X9@\I8M&*HN'OA"ZN<(M-7?C31X
MTTFV^Y:AK[->E?;5K:1RV4[ ^5*6[Q8M9LT>I076;4Y7@&%4E&*=9K<*+-@8
MC56!IH-%TF5PT3ALVM-9%*Z3;(F4[%KK98_U]^L =(GJ4\5JF=)FHM1RQLI9
M@VWA,5C(*^@P \.^X4P6ZH@>VRFR$Y--9/QIH\::/&FM67ZNG]S=I/\ VWZW
M_P" ^E>-7IZG\O\ ,:VF^-6:/&FCQIKC<^QJ&!WM][8N&0\[$R?V.[)(B,LY
MKB<63U':<!K(3^'SYR1]*T@G-/\ ;*P!2[(9C9BKYI/;JRMYKEB-WJ5/&9%4
MA3--(6->L&/H)6C9Y".Q#%*0>7%7QN22L2MP:0,0Q!(1%&6<X]ATH]<LPZ(#
M:9<LDLTX@LJ=<YGVVXG;\\90@+17\N88#K_=$*CYZXCC3A9"$:XX%Q'%$L8I
M9M26[$T]J0M*[CF^ JJN %58\ 1QC($<:@!1@ #UU?&J1J%48 &,'!)]R6./
MJ)))Y')R/MC2HYV]3:WMBYZ[0I]H !BZE^%?XLRB*87)C*%=[0<*VLTE>O96
M!'%"UVQB7"N0DK8XS*,K8)(XYRTJ!XW610KL2@D*8C)4$-Q+8SQ.1[9/1LG6
M1T(CD:)BP)8!6+("#+$.0XJ95/'ECZ?7H]A;WK-M;.%C+67JAYG54FY)5Z=$
M.,I:H+K43VRF@-??=>R<*6+HHLJ@J%YV8G&&6,1%ES+%1,?N[3/#7>+BQBW'
M:440H 5;]:TF^W)T9CD%B02V!Z@:ZOX%"Q[UN/*-T$GPC^D)V=VY!S_W/_B4
M$LRDA651@DX! &"0,"7>[\2T6_H'&W6DU:2I$ZXT2JRN?A;ZHV-<J8%#Z]6Y
M(-V4.>;]2B42_(6R5%SNN4-%!)01I:PA==3)[7696K&]%8ORK;>K/QI2T[-E
MA+93A2AI"TT[AH<*U0SK)!+5F!66S\M'S>XR5XY)WAGAC@^46PO^UQ7/E5>K
M#+QFED\3JQ,A"QSQH8YHIXB2(U=D9NRZO4[;];<Z_KNEFI#CQWBO\T,=A25F
M*Z[[0MLP9%V#.*!+!B;<%S3S%')I$O52MNE>PW;5F+PU5BHP5#%R!F0OYQ,I
MXRB:61_,)^0!/84Q\2HSR)Q1(RCC),)6X1._:%6$R"1"&C/ X5@'"_NN&4]C
MCJ,W4&]1_0)R1URBJ%UI0$6T#G],9M?8*"PG=(BN48&#3A@6$<?&R-DJ(?2G
M9"(^<<UM,DHJ@(S*3-N1+AN#9.X6B0TAQZX&<G.3D:[/X["'XA7*JP78/@XK
MD9 9?A'8R",Y_NZ.>SWK**G;E944*,=D@.^L4FV\&V%D\0KF-*DJOY\9*HMJ
M)N#N^ZCFLJNX6JZHJ-HN;:YYOG*3R106/.GC@LM-68R!&XQNSF5T2:)U*)Y&
MC:$@!>;$!>/&<48 LH''*X/H!@_20<#T#'!]!R.,#6(:1",UG? K_N[3[TE1
M81LLQMG,D9LB=%5%2(N(OS16!29BV^JZ=A!GT+[;;J,?"&VBF6#=E9A*YHI9
M1^)#-BQ3D<,&)8F,>0N220%8MG&=8I<@P%<8$^&R0!]221]=?O!F P,'U'X:
MZROZ</\ >\O0W^ACZN_U(:-YS>L^IG>--'C31XTT>--'C37G^_A.?]Y^[O\
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M#, &*1B-8X\]<W5%9\+DGCJ[]2_!RAW_ .64PP!EF^&;@.!DX9S=!(&?I!.
M/3U.,Z=J@:_:R@MCC%:,.L+4+<2LG"-KM7KXH HK2[%1=RP.!^!9EDXKS9$
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MMG;]/Y_H0M)O^-DB/KS^ZF1?.9%F[6NR3R3^8AB=JN5D( 4!5K.4)X@ LS
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M$D9C)'%52:[/!7CD,<CZQM(P+,5*8(7Q\5>23B6&$*LJY8D 9+$>OWT[W!]
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M\CTUCQ30(:MP1D$VXPC4I*=?!YH6"')?7'4:T&5DE(!(,Y!M55$L*W0V?HN
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M=992M5(:@5/-<M2V6BKTZ,0DB:6U;>.O7/C=YDY#+3,N=Q7K4ES8A@-&*_Z
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MM6P[K<EW/>=MW3;VIV_T4P?I-^(K<]/9=N7<?A*39TE7;MGVG?&NWOBN*?\
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M<V_"R^ZLC.<2EG'FBK!9 Y#2\7#OR8 /CW[4X]QD\@<CKKO, !@+A3UQSTH
MSCWQQZ'H?X_96GES-,*/4@B R8,"9#J5>3?I"U%WRMA .-Y!I--%<8558S,F
MV=N<Y)^I.B0^*[Y&%F4E(^!>7"0Q GMN/$)T>;,>@!DY]!WJQ0R*H9B_%.Y#
M@9X\W/(@ *54$G(&%_+3#](=7';9=(<WZD$DZE0,Q\SIK&_&?+BRT''\BRFN
M]A]TPKGC&+9W$67SEFR<LYS[R4DM/7RLD-6-:*IQ'B*0+XY<(1@I/*99FSGF
MTSDY).E266NT5F%W@L)*MJ.:&1XY8IPXE26.16#QR1,%,;H5*<4*D%<ZZX?Z
M;+QHL]&O15'LQ."Z=C]0/6YCJ+R5 XL2;;N(Z<S/U$RL2H<.MFGIP44BS331
M-IK MF)U$L->=,C8"$FLZU9"S1L#\I*Q+$A06-:1CVTL2@F-F/.:!26+R0S2
M/U&XQ1;U4FWZG''%<A*'XAH0(D<4<DTBQ1[W3@C"K#0O3R1Q78(E%;;MTF1(
M!7I;CMU*ML#\W=<QH\::/&FCQIH\::\\'\)@VTVO]+/NR]$,(33KN\<+NV-H
M5&VVI<T.Z?J=B1,OA5957)[546-L95A$[JU2^*?%Z\C]H@R0]*8_,R-57_=(
M!\VX]PRAEJ@^G*52KS]Y2NRJ &L)+'U.V8V&I%\03*#N5CR#X;KN 1&\4CPS
M?$,JGMHJ$\<M?:EP([&\123M(T>SV:=SG\Z%IRO;-9T?9=E)FIU!O8J0/3P)
MB'-AA%9P*I@=(2X;%M^!Z%YK*T/)$<6TX"HC5?&W-V?2A32YMVQ6IL05;,<E
M!IUCY1)-3$-6$SLH+*4 A<@LI XN@9@-<;)-*3:$2&:PG*;#OCR/(&D"L[9.
M78'+G/J?<$ZS_2%"_2MY!4\L>M-G3A3- 'DZMC,PAVL9F:OAW0+D.JP)5LX"
ML%YJPDLVQ&4LUJ\\DHD:R1DM3&[03U.,T-NQ7AFKRU'FE>%16F^3CMJTX\PJ
M"!1#1E9EA1<>0&,R(VC&!/7<W(%A$G!G&.(12BRM$V">3(W)'(_?('''6&%V
MC>UVHEEU(;1V^Y60&@2]^I24#K956<W$5*K*X1%9-*")8HB=5B2L+%$[ I,+
M[ZB5\+O.]4Z\DJ4L7MPE0K8W*9(P*LQD9W2F(@D4CQLQC2PL:QJHS"O[A3;B
M1Y0K',<./I3OFX.,%^7:+C!P?J;.&QQP8Y63E;9.R>?FG.692E\?CG,L_OSG
M.?\ #G.?WYS_ /7G^?SAR2223DGLD^I/W/W)]S[GLZW ,=#7QY331XTT>--'
MC31XTU5HON%OI)'MG20/;"ZFZN68V56U2Q.NR$L?OQ*$HXE'/^#./+719$:-
MU#(ZE'5AD,K AE(]P02#K/5LV*5FO<J325[56:.Q7GB8K)#/"XDBE1AV'1U5
ME/L1KUZ_P0ZU=;[J^RYPUH@EK#U@G7<IQ;55;0=3U70;;Y #9EBRY;?7_P 9
MHS5'/V,OK W8^0<8HW6@=HW^5F8LZJ6@E8Y,\*X!Y$_^/A)"R^O,%)@<R/'%
M.[M5KWJH^(=MAC@KRS)7W;;X0%3:=TD5W4UT'0VG<UCEL;=TIJ2);VN166E6
MN;AT%O-O7-Z/&FCQIH\::/&FF-]GO[FKV&_[#>M?^ =@\::XM(@Y!9%0PE-A
M!%TOEKIJCF<Y_#&92^&,?S8C&,ISEGX1A",IRS&,<YQ9)(D2-)(ZHBC+,QP!
MW@=_<D@ #LD@ $D#6S3IVMPLQ4Z5>6U:G8K%!"ADD<A2[$*HZ5$5GD<X2.-6
MD=E168.%J>X'\QV!3LVIGU9W%&?2<(VAB!*U413G^72-5+.:&\[(9F*61?&Q
M7.BPFH.HV%@S.%E2S<6Q':C:2I%&6XQ@M'/:1U*2)9*E7AK31LR25E9998V*
M6&C5I:S3LQVW8X9*]=JV[;VZE)KZ\+&U;.^.QM)^J+<MT@;Z5WA@^W4Y0\VS
MI=E7;]\A=]WMT>@,+MTO4@UG/KB2W4$U-*\:&R64CS=3%%C*VL.N\@C+8:BN
MB(8M1,Z1L8KIM'JZBXZW11N0UXHD>,Q3PTX1 J6(4'F3LNH1D*31\B%C5R %
M1<+RD;3YD^8L2VIC([M8LRO8L3AFY&:>:1O)+(Y+&220LTCY=F9B2<?574#5
MB^NZ_#CZM&*%M5,Y79&G.RZZXNR4KX5QQBL6N5=./CGYX?#^UPOA5FKQ0&K+
M*%E:W&D9ABB1I'\2R22/8LN1Q!53&O*/Z @7+8)U<6(=1D<2"22?3HX /HHS
MDD_]A=7]A)P 2L64ETQ7+"R8Q<&2L;&)A@)?R(]5<3JYS(H)@139*_ N+;;X
M$49G][&.).M6@#UGLQM"MGR&"R)4\DKI%&8TQ&&#NL]68N>2E))5D=2#Q./R
M*[O$I/.+B9$9>'!6.%;)SD$Y"D>N#IW1%.H[;I>Y"DN!]-Z("2+L( QH0J]2
M3J8R2(C)(O*C-Q76_BU.;0"LS:C%RMQ4J*SC$_J*=2W!N/@*F&,56@0*$20;
MBLUQ@T;*)79)*4<26S9="74S*54HK8N!JKGDTS2ED"*H!A1%#E^8 YF5V:(1
M]A$6-RP;F"B?T%G<8!=J;=ILM>JCL*),X+I!'4RM& NF&UM *9+ B\8OJ<5_
M=6DYLH^K7:)@FVKZ)N6E/6LV8JL\DT<7C:.5@0(W1?&#(5>2)6)=0A97D<CZ
M%C9L XYU<*SP1QO-QQ&6 [!+%E,G%B@7]Y0 .1; (P2&DV8NABR=WP$C>-\]
M5*R[$OB#90-&8E,_[29F5--M A40Q:\UC53^,,0IKLE.4?:E2%;*V%BDE<1B
MO(B2 RDCB[2,LO!&1!XU!0*> 4@X).8#T(!4Y.5Y9&0Q'J!V" ""!@C5BN(#
M7K[YUCTP=J4#<@!Q [-TP2QU+)H)G%=D9"YD.137B==$HVURQ.V.;[J[?K[6
MV2PH)I)0KV$JWFAE*,\L,L=&W-7"KD+P6> >20C]DK,S<L8UCFY!00<*7C0@
M^A5Y C>_9^M<#[D#&3C42K;)669LE+.9RSF69?-G.<R^;.?FS*6<RSG.?W_'
M.<Y_\_\ -YR![))))/9).23[DY]SZG\<ZV 2"".B,$$'!!'H1]CUG_#77P_3
MI:,M.]!?1,UV>8TT_8/4#UA,L<,2;3#=/=-.+Z1??6S,(E9=?J#0V^<Q#"+)
M3U,V[["VS.K7@QU;0!^1(4_]Y,0$/_D;$X$9_P#]1B0(SZ5C]!_V<H*_6.!\
M5(\Z_P#A1$C264'K\2Q("TEJ,>_Q#$H+VT'>^QJUL#]=)9;>-B?F_KDM'C31
MXTT>--'C31XTT>--'C31XTT>--'C31XTU!3H7K+O^V=Z8=*4M$2]&6[UY^*>
M5O6Z3N#_ !/*]IYLV3D<EQKM^@,S'8NRE4";Y<_'V;6P2KYKA[Y#P#*[>A\2
M4*NQ)MLL4\DRP3P,BT:8#&7=*NXQ3+NOS"WXDA:LI>BL#5K,BJ)64'FL/-M\
MTEQIU9 C.CAC+*2O&M)7936X&%BXD(68N)(P3Q!Q@H,[U2[_ &ZT9HZK?=30
M*/Q-]RW:%>T;95L(KDCU5U/@_P"#I2SU*2X%$/MFMF[/6]J<$FR >9(IUP-P
MMEAGO)\4["+*WI:-N>;S*)*LM:H:[0K\46M\\S3?-^1YVJV$K& PJ@D@XFP\
M,G[+$=NN>,PK-$B\25D623F'.W1T^ 7Q<502(9.88MA\A R_4]:SURV&[@3#
MDF=M9<[:L]FOV"MAJFUL&@VNTV.*&<U.M&:#KGKKE2E*S3;/*1*B0K@[SSL3
MBSKNMS;R>^[C'N=\V8LLH@AA\KP25YIC$O'R6!-N.ZRRS8PAFEO2O(B)D+CB
M).E :\/!@ 2[OQ#JZ+R_LH5KUU5/<(L*A23C/KK&;UZKN=Q2^J.LD='V>8G
M^IN-YVK;%^X[SJ^][$N-X=V[F@M2?8QW;[8_R$GW3$E[&EMM.:2=>!;4R/NL
M^T7$0VML'&?Q_+[@_E_=IC7OHWT9_N;/=&&WZN8V6=!9;SS<XIWMTRM,)/\
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MZ\9=BD,:*S,P+'G;\HW$PWFC?0*,_<3$.+:5*ITVW4G#LH+ZYV8S3?3.F8I
MD8W6RB13.HJ%,Q;,RS\>WVEA?V5Z!8L=MLSVA60/RGBNQQJ6 C=2WBF@5'<D
M^/YB(\7QQ,2WT3<R0/*JQ@D9XLI(&,=G*L1CWQ^6L?M;5MH>G&XHB*&\VIF;
MK^#:HD3,%0+0@BV\0K[K?A36\P[452)C5 _%(9P=GVT;KXD[&Y36=CVV2FDH
MCM[DYBF:)N0.VQPQ-])=1Q^<:6,220K%)*:TJS(F2K8<+/8","4K(LA4D\&D
MD+<,KZ$Q@%P#Z,5;&0,1BE+,I9EG^>6<YS_W_P#3\?W?XO.%UO:_/&FCQIH\
M::/&FCQIH\::/&FO6+_!'M?JV+W#]GA\$V+F0/K-2S0NAZXV%HW0W5=&@*Q&
MC+,8VQ^E>0$P"G.(S908Q3'XM7L2Z;,,\(F3CR*.K!XI0,M%*H(5U],]$JZD
M\9(V>)\H[ R6U;D^V63*8ELU9XFJ;A1D8K#N%"5D::K*0"5/*..>M.H,M.[!
M5O5REJK#(G0BU;8+70Q0C,:M=LJ2^ &QJJYRLJ',S7BR@Y==9&,S$3@?Y6"4
M[,866"V2#/I"<@-5H-()C*K*ZA)HCPFC!R%;&0Z$_O12+AXGP"5/%PDJ21IE
MW?;4HRQ35)6M;5?C-G;+C*JO+ &XR5[4:DB#<:4F:U^ODJLRB>L]BA8IV["I
M\SZB-'C31XTT>--1O]MMD6)?7/N@!$B"FCCBG6J5BA=3]VT+A7HKF!AL1L3K
MC0L6X(HFR:F6BK0?KC5$EUWF"57X)ITAXKAI)9,^*&, R2%<9(!(547(#RR,
MD2<E#N"R@RNV;18W+S2^2&G0J>,WMSN%TI4Q+S\:NT:22SV9A'*:U&I%/=M"
M*9J]>189FCXS)+*FFBP!/"T<2V/TRS+L1BQ:1Q+$L1)S7.R(H>9QQ;%6/;93
MB<:I&$,;AAR*\<<#NZS6BKRJ>4<2DF"N2",Q\@IDEP>)L.H;'(1) KNC;MS=
MZ]>M+M>P1S5:$RB.]?G")NV]*K!@MPQ/*E+;S(JS)LM6>6N)%A>_:W6Q4J6H
M<-C.<9^./_\ GFWKG=+73MKSK1LIW@#N%16,U,U!=MU-)=4HYA&==]$XV"FC
M?/*T,N.+,56X^6^@H6P@6[?HWWI,ZF-;%68!;%60L(Y0IRC@KVDT9),<@SQY
M,&#(S(UDB%U(5C&_]EP 2#UZ@G!7[CK/W'J)%A!SDDLW;4OOC]0M+BJ^^E*0
M-^NO[5[!@.H8?;2B/2YJ"6%WP*'D0.P575DPQ1=B^@;HZS 0B:A)8:HTCL8H
MY!\S!/6A62-Y(,E6>,-P6P4$4O.08(7Z-1)07^6GX)8$9D95+%6A4\3(A(_<
M/N">2'(8=9*L6O0LI8T9I O9B43)8%GBPM^G<*02+-C3.4,2P1.F\2-U=.*:
MLD5PL*Q=*>:2M^H+#PF5;5>>2&:6U/Y@8? '8)(6C\7B:0+* Q0\0[A7!ZSL
MN4Z4C)?@ 5(R0N67)&3U[9/H>^L:1EE^9WPO7&&QA;F6+846YBP,(A,(R5=L
MJ!YSG1*K,K*Z8PKC_+IQ]6['W.:K*GS<E6"5KZBNXDC,>!);$J1Q.ZYX.4@@
MCPX4A87#21E06D;5'$8(7Q@L "6QC/KU_P"MZG.>@>_7.KHMC,:9$Z,LK@KL
M"#DQ+9_4GGYJ*IPJMMC&,K?I_1_E?*/9&N6+OC9\8QQ4>9P)E*2/'((Z\ZR6
M(WAQ'B93 \43NK!HRP50L88/R(QD4  (RH R",=L#U@')_F3Z9.-9@>Z$(SJ
MIA]8+Y9?0A]6NV[ Y<8YE0??7FF8MN,POM,IG'-?TITQE7;.G WFI%&(S(C1
M%T:,2JH5;$I61B@5L*61,(78 CIP0?0'*6'MDXR<#.<CV.!_/['HC2+Z8S%U
M)0,O$OJRZVY!<655@:,(+E)MMPF"(XEB=?WSJ A$*)48SBA43,F-TI,:OMJ[
MF8=IJ)XY5.Y;S0,EB*-3XJ5:S("\B,23YMP6",)&I"P4VE9FE^;C$.L&%B5U
M"DQ59^.6&"\R!<CB<X$+G.<Y,BX(!3!B_P"<7K;UV,?TXJ:2?TY_0T<BFH@<
MCTH]7J;Z+JX6TW4V\+T:NVFZJS$H6560E*%E<XRA.$LQEC.,YQY0@,"K %2"
M"" 001@@@]$$=$'HC5\<CQ2)+$[QRQNLD<D;%)(W0AD='4AE=6 964@J0"""
M-2,#ONY\6(F86VW:0>30#KC<BR=MFKG%61I"U=T19F4\J2[IUB:JWOGG%9%E
M&LL+(EV)+FVDI--EC<DU78+#(QR8&8@+7D)_\6QPM>0GIB('/(Q&3IYXT^)8
M9KU9$CW^M%)8W2E$JHN[5X4,D^[T8E  N0QJTV\4HURT:R;M60P+N"4W+\WM
M<KH\::/&FCQIH\::/&FCQIH\::/&FCQIH\::/&FCQIH\::/&FCQIH\::/&FC
MQIH\::/&FCQIH\::/&FCQIH\::/&FCQIJU.."5A&,F18P"]>->:<<9=6.(&(
M-5*X@DDBV4*J:**83MMMLE&%=<92E+$<9SY:[K&K.[*B(I9W8A555&69F.
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M%-(HE>+CF!QE]0:Y6N'E.O!+%F?>.  /FRO%Q9%5<K*XRS..*:5((VD?) P
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M^^M=7_0(W/4E>](.=>CIVJ.S+@4S8GU*UI9!K?1*VN^:X1OQX(\P2NRBZJ;
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M] PEF1.#8K*)*E& PXT\U_+?>1.48T559E9=*48UQEG.,9M+*HY,P5<2-DD
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MZS/T!J^VC7(CZIOKK7]"-UE554KOFMQ]*-MM]-=>9_+B=EU4(YS*R&,VL"I
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MPLL,LD,H!!Q-'(RRAB"PYB0D,,Y5OI/>!J5:02LTBE6#D,.!!&" %"@$GB
M /0?AJ,LZKX_+FRNR.)8^:&9PS'$H_NSG.,RQC&<8QG&99_?C&/Y_+'(R!G'
MKG\,_P!?RU0_8Y_O_H:V4UZ9=V7@O"FKU>SIV!33N&GW.S+1]72&ZLO8JI*'
MNW[!>OJ8; D2"8## 7JY%V_C$I$<M0IK91LZVHFU2;)6DW%9#/6O[@L$4+1H
M?DC5@G>:50XF=(+EAI1# OFE3R&,N  NB/*MJ9(PXCE2-QWRQ.<JRQ+@C+J
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M7I;>L<\J 1R/9OO Z2PHJ88&!YHD5I@JQCQ-'Y5+R<\,[R-&? H=BR@\FPJ
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MA7AVSSI%3F%E6:Y%(T[K.!,.8?R+%,8^**Y650H(4$U.><<C.[KECQ!5DE!
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M3C[0Z[ZX,(),I4D229Q,!IQKI8N5)*EJ">>U\M(:$T4F"I%R%"#6"OSD9BY
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M6>O-.YE8>2K25X*\8L1I$ANP1&.&2V426-\>60.,,;LHDB<9!;*D9Q^"LQ)
M9L'CT,XQC.F7?:EO4FKQZ/K)\J%[29("L=.WH=9JHR*7<Y6WTAQU4;)0M62R
MK,D[ T HS83.&<0B?#F]QVJW4EFN[IMX$,CM)(*ZR/4GD:3GF.>,1Q0592X7
M+2/+&OT!4^@#95@R@*Q P, D<N/MD8[Q]P #_/6XO^#J MJ_U7N!Y) :54Y5
M]_:1+:L2;F)@$..;\M$.,3S/)K75YN,D+]_*N4#"LYJ")NIC;B'+3_M7GE7
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MLL3C\<:$@Q^Z>,RQ/'^*6)2Q+'[\9SC/Q\C",$C[$CHY'\^\_GDZ:Y3WM0#
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M#R++-/(8YU>50"Z9Z"G Q9;<J*U6=8Y8Q C/QX(LJ%R8R4BE5P5"QET!XMQ
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M0FN8HJ,$,(Q'^-J^T P>>7XF1MQVS8;%:J(ZLBRPP3",Q3TS7A@,=3=$AC>
MA:\WGK6><?F@F6:5BM5XULK_ +.2<.$#*1R.0PES]/F&<!6;T:(\F'%<DA@
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M:M,R/AB 6LN6F#*,')BV9=M1LH3*,GC@2/B)9@IDL,KJT8=3'X>V=3%D!Q(
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M+_[MH&<AOID(C7Q$&1UZ#MR(C1U C?NFP+0(ZU$[C\:ZP8GG;T $YG^!BP$
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M< >N>\>X]/PZUTL/(C5VCQIH\::A/ZR^[.M^S73^U<N5\JZ7SEKQ>.L%EF]
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M:2+EQ_5_'EP9>6,G&<XR<>IU'S^*WF7^3K1/_5'7_P#[G^>Z_J?:?_->W?\
ML5;_ .%KR/\ 6>Y?^<;W_M=C_P")K9C^A D3(/:O]1Q>B4+$H&.=>C]V E(
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MNS3)B>F^PJ%<Z5)M>*0[^'K:1/LPJ]8'LAD*#!&!Z!BY0T6C7T%37&N+MKC
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M?72'@4BK\A2/YM<FB;<-UGG:"/:DN+&E&\CN'-CG*Y>2G3LRUKS& /:DK"*
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M:,2>BXDCHD'L<C[9.?; _P P-?*LZC)A&*41K*N0VP?D;A:"+;:6)WQP\8X
M$O66 AW(/KAAJBI744M*B+ RK:(7C9U#*K+">'$IY'E;R2,)'8YR69B$Z"C$
M83DP)<L, 7!<%F!/?ICLJ .L^OY=^OOZ9.=.;M7=Z,DZ:IC<?(XT7)2-&&SS
MEAL-IA*DI9')%,$51%)YPMQ]XU-<+2:HF#_5B-'=M20V73P3#D8@LN:<%4(5
M*JB((E8%(TC15E8\RHXLW6!9'E<@@  = $'D"3VW0P3C! QC6">@*1"%['68
M8KQ9',/LY[2&U)I5V7L V9S&6KC47AC$9S&VFVDJ(@"[,AKOO+RXYQI&1HV
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MV2JAC;V]KE0O;K6&JSQ/%)%Q+"624,41&574I'DLV6RO-$RIXDBUN+=,.0;
M8'!'0.?4'&?0_P#5C65O<?1 IO%14XS3A;T!JBL.A)3L&SI*&/[6Y*IQ]O\
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M?;'QG\=1V9TCFG")/*J8V:D<*LC!<,:))P .R23ZYTF>PK.?Z7Q+J+G1>_\
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MMS$ZNJR1O@*X8:W5#RLK,T:B/! 4JS(W JP=N\],>E_,Y(!U@'?4-NV^Y%K
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M/D[,\]6TDLRK+7@C6&;G$PG2*XU>*%[$LXXDV9))I69B#+S4KK!'&J-*BAT
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MI^IU<K!I9J;39/S=BND,D0->PN1P1A&6+DL0(RV3Y",)@Y;@0%PFN\LVC1^
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MEH+=-V!1((EDR*V13"C(0PX]?V(_F'PV+2K8DM0,T*ES TTC32I&R/Y&,<;
M-(9PB-+*CGB57 0 79'8P3]SUQ'6""#V>A[?]6K7\D2.I$555R@R#8D7!QOJ
MN^N:2Q+%+B"?12M('V V,XCBTGM[Q_I?*2%-=FF%4\UK[G*"*\<4<,BBQ'$6
M1<3QO.)T@L\*X>U*TZH(Y;4LD:KB,I'&&R9<@DEN^)Z)!P,X(_(9.1W[9]-9
M>)DT-RQ:]8'JH5&YL>0U_/Q:IOJV5U&)6XA8HQUQL#+2IE45$VKEMU-@PHU9
M]9E->!+3))/%)$ZV?FI&E,@)E1\-#-$X=9'X%N19"H8,.8))#:J1@#+8!'OT
M3^.<@@G_ ".1IV"U>=UXP;LJD*,.JE;%\T"M$9MW#3;%,Z&(3:S8P:65LT@E
MBL4\RV3<6L\F\3&8XQ%J15YCP\D]EC8>2S)%SC\+>1IF9\3>1RZ.%,()8,A;
MI>7?0'*J&/$+G!+$\CC..L$'./3U]M;ROX,?MW6;/=#GH6R.F#;FCVKHR76A
M6[%B=>%L.N\BW1F40HKLOLI"3TK+< 7QNA 8HNX>"[$KEIWTM"6 !(Y'C*G!
M:!_'CDH9TDXR$#*<I#S$9*E^!89&=94E=$E1&XB90DH& 70/'+P8XR5\D43\
M20.4:'!XC71$\U]8]'C31XTT>---3V'N'+.!:TKV_K>VCZB@>;?K&A)B;%SI
MR4UVW<6,%B%,O4Z\M;.#+K[<W&GD#@6!HT0#?9'A*W7DS9F&U4 GTU%7OV^Z
M,]]L?0;4TFZ:FXVI#[!=DD\UE5L:=AL":(_IW['"D2;)A#+F*Z-!5](UV3!J
M<57W54SS&RR$<T/JOY_Y'0>A_+_,:V >5U34#O8;]3+TK]5-T9\_[WUEUH>S
MIA]?)958XUW3:4HU>U?:1U^'[6:7S38M3N):7'A"#AT.[2\'%4+[:*S;(CY:
MJ%)]!_AI]O7GV;XM[4ZBWWOANS.-JU='LA&I,SW6@=%YV30^%6*G%XE:?I>I
MZ>Z,H@O=+;HL@EQ"NRR^P6LV98IE%#0@CUT_?C5-'C31XTT>--'C31XTT>--
M'C36FKV8]=OU0NQ>P7%NH:=L'H2JT_UB[GT+J7&%VRU>PN=DV!+M'..C\B3+
MNGY5U7J\M!M.Z#<S9YU2T$3.S!59$NFJ^<>UJ\%0"/J^H 'T]B#U_+6T[D?\
M;O\ %UK/\?&><9ZU]N;^V6>1XV>/.LE_E#OQ_P"S.-RE+9<#_A?QOWOY66;/
MRGWWT/\ BGV^/&K#CV]/QTX_C36J#]6GNT4'JI[->MB'A_M-UCHW>_4WN.HZ
M%?P[UKZYV+3:]DWK0]QTC7DVS[GH.LNT6KL;W1 ]A ;<H<D562.TMJP)=79)
MJ]!]0.0 &!.2![^V3[:D'Z.^QR;N',U6J@\D]D^6-^3:%S%%L-?L%Z\]2X50
MV8E:^2NMJTPGI&NH:MP@K*ULR+JQ%DN*B!J:P[Z,7 /UFK2,>X/Y$'^>-3<\
M:IH\::/&FCQIKD/>E6Q K=[]@]<F:.(^V?G3>6G5DL4RVMSM2#>]>;@ZY7<^
M^*V=[<.H^,1[ZB\%UCW _8%X+^6"]ML&[59*=J".Q Z%3%-'-)&KE?V5DK6(
ML$U90LX$1_:1I)"W 2B:*?\ AG?;?PYO%;=*4]NM+") TU":."WXRA9X87FB
MFC#6> KAN&8_)Y/VBJ\$TC]K]F%7.M'$V14!0_9).DI-/WO5CLLYA-*J%[PK
M;]?'<-5BTZF_-LOG%:9UX3[ J@*\>+/[4F-<A\'?#_\ R5J6_B"";:;]:>6?
M:*W'YE;5BO+/"ZQB%P(8(7VNC3E%A(A:9+<K"6%YY*E/I/TB?'B_&T$-!X9J
MEQ&IW+(\,1C2>*D SQ3L?F)+$%]Y3.K/%6:$58XJT(@,][)+GFN]MYN$_P":
M4,7E"IVV_;)9M6L+PK_S[A#F(EZ^^MP^7KVVOFR(V(#8?MB190HK M7EA$7H
MS-&C3V7X+^32/=)9-I^(;&Y2M72I8DW+9I=L3;VKBU*19BNUW:QCYR*."2..
M-I)!&)II(Y7<-PWW]*]5K1H58=U^&J^UT#SOQ15-RK7[+K9L5EG6&/;K(DC5
MVAC^:+QLJ-+8DC1GAOLG!V^IN6=CS%4PP<U5ZS?<P3T-]A( C15 P1@P&IS-
M*6UL&0 [%;D@&]_.RA3]]5FS[?HY=J=(8[4<Q:O-)PC=D ;/CAE@!"-)$ODC
ML5XVQ(5^89D!9$=U\G</$[Q3QM#/$S1RPLLB.LB.T<B@2QQN0KHR@E!VK #(
M(UB<:@GV"*JI5%NA=F@D(5I5%J@S5[V3%66":O<R6&$127G!%ITB5Y]6O!V,
M56FIE]5T")ZK335H/ED63S1FU&[1SDHPG58W\,0 0-)"JQY5QSC 3T"C5..3
MR&"IP5&.U R<$_?T(Z'VZ]=(EV%7JHHQ!IVOD.FLA9A4&)"!5>!8P9)[8X%J
M%^Z;'4E7UG?>;-7D*[(%V+I'DXN#KPF-HEDBG58RC)Q< K)AHRQ&"$;CAP&(
MY+R&,Y756;/9]AC[#[_ECVS_  ]?697J!M(K3LR[3L&GG\U?)MJT98$:3?;A
M;4\U9HU:[+&D3&O0G^16I]ROQ1,&5R]J>:730&-;(FOI]AWQ*,&X4;H>;:]S
MIVHK,$3#E\P8%2G:A3FA:W\P8HG)4,(9[+F7@&&H^]5,_@:,HLD5F!P9"5#
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M]KTR%AJ=BJ5+S;YH]C%#%"N&@$U=@;'=9FF'W'Y-.=DC%ET04QDLKLP 17#
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M3K22Y4FAVZ<3H/U9%7B$TLS>(&H6L"!+?RQKNKI+*R2BSXV*J!*!83EE8<U
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M9B<*.3RQLK!G4@9 ]&$X>I(]"W#1NI)+M<EM^UBYAT:B_:2IPC036TI7BZV
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M+-6@DC-J4AX[#P2R"H5\A>6]42.*,AY)F:O!!XWCDD"H(U5XY!D4R*&8X0
M)R!#AB<(DF<Y7&/JY9'WZT\W*--Y%L7-=JSIAKY$<ZAL"^AMO1(3:]:R&!%&
MK3)]7UZD@\@8\9[?C+^I-<;(<5G]*L6X><:9/;*^UKM]V2OND,$%GSUS#?IB
MQ>+QA8XUJUH['C#,D\DZRF'(,0C60,2-8I7L&:*-83)EX1E'"HW(,79G. H7
M RI)^^#G2JU+E>J:3TC*C67J/8=Y7-J%1\TX+ 83"ZW")F6? 2AA5=D/"=FV
MHI(!K63D8*OOFI7E"BCL)+X>V+:=QH[U5JRE-P.VI8HV)H)4=J[F*26-X%NX
M2:*(2.(EB\O.2NW!9(TBGNN--5LQI.%41S%'*2QR1F0?1B-U^F1<E3R!(*L2
M?I5F7K*/?A^$<_''QQ^*8?'&,9SG./M+OCCX8SC.?W?X,9QG/\WQQYY",9&?
M3(S^6M_7(1T\(J^[<FZ^TX+5U ;\L[336%ZYFRO(L:;.C,#)@,P86.UJP:S8
M@#5ZF=TA-5)+)%5B53-GTXVZP;(AH+:$T*-/@HT,\*PQS6FD*(S2.RUHQ+RC
MC!"<U,8X,[V-,H[9@O(X4$]'+(@/(= !W09]_7T5L8%OSN.Q=*4:YJ>S;;:I
M$"( UZI*&6U>641?,*0K(MI?@E-(+LBLIQ66:QH^C.TB<Z;2;)674AJS&>N*
ML]Z*Q9B BK ,+$EB?_=11SH\:RK9D#&)6X2. 0(S@:NQT[%>4<1)D8@D(H]6
M8'L*#ZDCH$=?9^+/7_=]IW_F^T/P!TMP+I,%L@NZLEC-M9I59MU9%[<"]I4\
MV(E>KF*N,LIKF[/L950"E:,&"=;61C06?=KNX5ZDFW7UVHH;,-F5;GR]N2:D
MK,\D9G)6-#$7++):9F3,<F)*KLVXW9*]>KMMEQ/2&XJJP/&!MJRA6O\ (H2M
M8M(H68PM&V04+CB-(WJ_J#V7CK=WLVE"H'7.V*.+]IA-L*V129'?=(J]3(+8
M"5VV607UPNKH;K@\R*6U7X(+Q94U'JQ^."26O-M\E:>AN* I!-+%6'E$K1RT
M0T]AF6Q'*C/##YOG6K/7FDB02A3I_*WE>W'+3L1O1GECL!5\X2*,(XLEH593
M4XR(IN M6,A:+R*ZE%9A6UMJ8*B\J1EHVPDMB96HG \%)QZ/7Q&%Y-T!_P D
MM*<B9(!M&HBGE2N8'6?;+;#K+Z+-G;Z-^(P/2GA2:^ER*.8RHXB2M +%XE%+
M.ZK!_N@$,CNI6'FQ4-J.Z$LK$Y4*3T0 7+*HR!@Y(.0#A>.6P-)OZZ$R%%HS
M;#&@W8#(W1H6D;#>%:QK'EBV"=OJBX%=6'<;6!32'>&.W-)^;^UT#1B-"RLQ
M>PS65=FE<@K&X\SLK!V(D,31AE<DAD PQ)!(P,Z]JO6,9Z_>R<?89&!U[GV/
M9&LC+2FE3L<C90X@('L79XYE-P8IA ]1!M(-F%AY 9-;%HV B(L"K!'&Q+[^
M"]654.12+CA4N8$!1!,_#ME"X9N*N[MTL?/D6/?$!B  <&I'J2",=D]=>OH#
MC^?0]0!I$[/EH1N[U&G@VT4,Q2-EVF:7/!:A0U6OP8EU'"0"_*%K:*X%7+L$
MKRB; K*+[?J2MMMSMR\OFI8X4.W_ +%HYD\DA'!(LO\ 4$YLLJAB%XN&#8[&
ML?+*@YY@D=@8]P 0!@8'Y^F>LX!7JH#9!>=JM=JUJ#D \XB9)I(3$LG$9LON
MKDB_$HCXK7T17B,QF(Q=2_%[QO7@G[XJF8V2*NTGRGRE5[LD8;RDQ2RPEK/D
M'RRCQQNJ+&HY.K"1)&DDCE3*/JA(P^6\>/[0(R.AVO9SC'V[P.M6&[MGVD-
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M+<K4E=*LD,,\\EF(H-HIQ4$2!:XJCE*(X@BW1*\5R@*D?[.[-+ZML6W0;/\
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M:M;V=YA5:S=CK;B(70L%A$#Q06'>5DA9&>1:I9RA86(I6CD18[5'F+QSB-B
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M./C\?A\?/G '!S]N^NC_ #]M=5KE^;![:<FT(S7]7]=]$T!['HSHT*NJLX\
M[3#=@E$:H1D/>O+$A:5>R,&M.D3?4,,.;&:F]?&L.^9-[XC:2YLJ;S)%0>=
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M]T>.B+"&I+SJ+[:# <47# Z+KFM8D3DVTC%Q+TW?]HLKB/B6;:\!+<?<_7*
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M_/E]2/\ 6'Y/_M7XTX/_ ,+?]$_Z:/\ A)/T]/\ /E]2/]8?D_\ M7XTX/\
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M)VRQS[@X+X:E[-,7NZ;-K/0M-3#T[MFY=<SUO6F@%Z?+E4352<\MOL!6J@(
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ME4/N6P0#G&KB>/?IZ'L=9_(]'OKOH]ZVJ^JS^?47@>ZE+50*XSC@V@*(ULZ
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M(A;Z5*_P[7CK6)'%VT+O%R[*K(@A:H62,P-/ K*[/Y%)3LB-B(%*6:0LRD<
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M0;M2S< N!52P9KHK4C&5#ENV2M,?]?KT<X_K_LR\W1-D]IESS>:.8<OY-LR
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MYI7[5=@YAJ_/MI/O]?DA,2-?T$36'[ RC7Q4T*-=1Z<A<_D=?,/$;KJM&4;
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FA55&=DL5PQAIK,>--'C31XTT>--'C31XTT>--'C31XTT>--?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>g729258g79j79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g79j79.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[27B4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )<:^EG X0DE-! 0      $8< 5H  QLE1QP"   "   < E  %E-H87)O
M;B!#96YI8V5R;W,M365A9&4< @4 %U!O=V5R4&]I;G0@4')E<V5N=&%T:6]N
M.$))300E       01X,%<?47*=# 0.JC@I8("SA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!DC1:         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  $#O_XU  (  3A"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          3A"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              ;\   04
M  $                          0             $%    ;\
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   ;\     4F=H
M=&QO;F<   04    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   &_     %)G:'1L;VYG   $%     -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $    !3A"24T$
M#      ;50    $   "@    10   >   (%@   ;.0 8  '_V/_B#%A)0T-?
M4%)/1DE,10 ! 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.  ( "0 & #$
M &%C<W!-4T94     $E%0R!S4D="               !  #VU@ !     -,M
M2% @(
M        $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K
M<'0   ($    %')865H   (8    %&=865H   (L    %&)865H   )
M%&1M;F0   )4    <&1M9&0   +$    B'9U960   -,    AG9I97<   /4
M    )&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P    #')44D,
M  0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0     0V]P>7)I
M9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C
M     !)S4D="($E%0S8Q.38V+3(N,0              $G-21T(@245#-C$Y
M-C8M,BXQ
M              !865H@        \U$  0    $6S%A96B
M        6%E:(        &^B   X]0   Y!865H@        8ID  +>%   8
MVEA96B         DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W
M=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                                         &1E
M<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P
M86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!2
M1T(@8V]L;W5R('-P86-E("T@<U)'0@                            !D
M97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#
M-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET
M:6]N(&EN($E%0S8Q.38V+3(N,0
M=FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(
M3 E6 %    !7'^=M96%S          $                        "CP
M  )S:6<@     $-25"!C=7)V        !      %  H #P 4 !D '@ C "@
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M5G>S>!%X;GC,>2IYB7GG>D9ZI7L$>V-[P@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MN7+=FW7=NUT6K1JBJY<N7*I$&[9N@0RJRZZRIBIHHHIE,HJJH8I$R%,<Y@*
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MFT[FPUI-T6SKK]:KZB< 6IN9N;"@JL'Z*2D;!%5*NL0?<"@)!Y5,FH!RF.0
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MW7M,SAG-]<[:>J*9#=9L$ 2^0')*&'@1'_\ 5N-_;_M^O(X(^9]Y9W,4I#&
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M/)O:80]P@ ?](H /[?J'UX'-X#@. X#@.!_!$  1$0   1$1'P  'S$1$?D
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MOY#8;!3\HM]&T;,(>_26@0%ZD;2_=5Z.>5QWG-@BU"MI!R@[< V4;N1(L4O
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MZ#Y#]G UY_1YZS]?]$]+6Q7>\X_GUJMJ2>P')89RLQ<A+E.S;R!FQP?.&YW
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MZH!F]0FJCJ!<=_@WLAKX=K]M+$EG:D<HI?;BL?@%71E5DAD2'-\92-%4'94
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M?ZM#'LF:W6M7NN).5&"LO59=E-QI))%,JB[(7C%19'[2B4Z8J)>[WE*=,P@
M'+YJ:UZLF<!P' <!P' <!P' <!P' <!P/BDV;H'641;HHJ.3@HX42233.NH
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MUT6Z"2SH2&<K)(IIJN#)@)4S+J$*!U1(!C 05!,)0$0+X 1X'WX#@. X#@.
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M![0MW6/3AL[E+XCT^MIWH'B?WP%8_.$Z9@$?MXN#.P>D^R@!U!5^SF\*)_"
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MJ_FQYR"B9*26!]^<CS[*BF$8@)3FX&?*+D?J&;1VXZ'[AV-QS#<<HW4RN[E
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M51I1="J7J*5GLU+%+9C&A"9C%=SG6YNU6TF$;[EIX*(L4Z<0#8GOEO,=]J
M^.)8W\X^8GX82TWTN+6S[%=L+%,='L?[FT;LOL,OK]2OEI[47_"GN?$NE>@8
M^U9_I-$B&C^.M<!&SL5(2<)*UE@[DY&*EAC)8H'01.@19CCO5>[9QWIU7=$8
M:J0&/6+IUUYP2EPT'+KN74/8,JL=\>R<.E&N&B2R-=C8B>AVD-(K+F6=D2.5
M5LB=(1,$ ,SZ+=R>N&9>DK:J1G>;ZWJW1JG=D,YU7,7&L(T6)EHSL'&,HQO8
M:Q?'U7F&;D*HXA8Y](LUX@KA\R=.T&"*KM-/P69OY1Z19L)D$XD(*A0(<2E$
MY2F]Q2G$ $Q0-X#W 4?( ;P'D \^ \^.$?K@. X#@0+]03#.C&FY$&D]\ZC&
M6#+\00FYIK+/YC1XU>#&X)1];E&4:QS&8C+'8WUK'[L@&M<;-9AU-.UVL:PC
MEW+H$E"Q,[O:_HQ7Z;59]-FO1]ND.@E;)5'=XHV7W:]14@?82V4U.D%;G%9P
MK),]=D)!VP;M'<+<XLL9$*D&*>L7C*5;MEP:D,2]_P"(CV6D<!P' ^*Z@I$]
MX%]W@?F'GP/CP(_+Y#Y'Y?3Y?+R/X>!"GKUMUQ4Z8-/T0#W[7CH?7SX\W..'
M]7S^G#43G'*9\J:ORF5VF#_Q*-G-_P"7@-H'Q^KQ45 \>?Q^OZ@X95]?D^7\
MFCEW]*KW^_#\#HORB7^3:O7]-:5^\3\+&?:KVE:QU7_BS]?_ .JBA?W;C>&8
MR[U>\J#_ $Z@N*GJ/>J>%"^X"6<;S&E;'L*;D\4+8K\_Q3+ U526,J4OO* )
MG)Y4$HG$Q $ALQE'"*8FWS^.CDJZVO-7'*_?K/YM>U*#R_L+G%.VLULE\ODJ
M[;F^@VJ<-$Q\JE*ME9**> FV9?%43;F(G[!\G6*J/X@ "8>6_*6)PSY3TPNA
M1^3F" ] Y<0'SYVO0#?S?*(+X^H_^3Y_#Z^/PY8_/OKX6K.>NM9\<4=_43@(
M"U>M_P"GO!6:&BIZ$>TV:2DHB:9HR,6Y2%60 OVMFN@NDX)\O>!#I?(X%'W
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MM.@J_9[526LHU6LM?KUK6E&]:FI:)(H+ME'3J\)+I1CI=(B3M2.=E1,843^
M\CI/8;"\=LV>TO5-;S_/[=K$TG7<TK-LL\5"SEYG%7L?&I1E9C'CE)W+.E)&
M5C&)4VJ2GN=OVC<!^*NF0P9CX#@<9X\:1[1R_D'39BQ9(*NGCUXNDV:-&K=,
MRJ[ERY6,1%!!%(IE%5E3D333*8YS%* B >8GYF@.JBM.6F5ISFAJH,Y)Q,3[
MZ%6J*C9)R@[CWZTA(JFACH)O$FKEFZ.L*9'*:"R"@*D3, =U!3\%:(MK.5J;
MB+%"OB"HQF(*29RT6\3 1**C608+.&C@@& 2B9%8Y0$!#SY#@=)7="HUNGKM
M5ZO;(&?L6;S#"OWZ%BI)L\DJ?.2D*QL<=%6%HB<RL8^>P,G'R[9NY*FHJP>-
MW)"BFJ4PA['@.!TL-6Z[7!EAKT#"P0STT^LDZ,-%L8L9JQ28(EDIZ6^PH(?>
M,U(%;MP?2CSXSYV""(+KJ D3VAW7 <#@-HN,9O)&09QS!H_EU&ZLL^;,VZ#R
M35:-RM&BLBY23(L]4:M2$;-SN3JF1;D*BF)4R@4 \P_#.?S^KXR84G^% ("<
M"JB_""_/X*L9S'#90KXN/^^$( SLD2,X$;_W.%R6.%__ (TK;P'[O.BT3,HJ
M/G-"MT!3(>6L=>J$9)6.2;1;-_:+9)H0M9@&J[HZ::TK.RSIO'1C(@BL[=K)
MHHE,<P!P/9\#I#V:MIV)*H'L$(2VKQ"E@0JYY9@6Q+0*3L&"LVE""X"24B$W
MP@R4DB-A9D=B#<RP+"!.!W? \;1]$HNF1<C-Y];8"Y1$19K+3)22KDFVE6;"
MV4V9=UZUUYVNT4431EZ].,7D5+,CB"S-\V6;K%*<@AP.BN.V8_GT3<9R[:?1
M*Q$YX:$)?'LQ:89HG3#61=NVKQ;04[OXL$:<7=MDXDLFFV&0%=,6H*E, \#(
MJ[YDU9+23EVV;1S=JH^</W"Z2#-!DDB+A5VNY5,5%%LD@4RRBZARI)I%,H<P
M$ 1 .+"3D+98B-L%<EXNP0,RS;R,1-PD@TE8B5CW2956K^-DF"R[)\S<I&*J
MW=-5E4%DS%.F<Q1 >!VG <!P' <!P' <!P(7^H55&-SZ?;/#OH*M3Y4(6)GF
MC>T[4'7-G&2E8L</8XFRQ>WG@K*AFUJJLC%MK'3[,]A7T:SL\9%%DTPCU')@
M+$VF_P"RJ[T!K#UGL%8[$H8XQ[!RFF5&>J%.U.^;5JE%W>IR+!@I;).MU3$]
M@S$&E"L]'K\I*VN2>EAX6'=GFY]S*222RL@F5N1;=WTG]+JO2;MG9<95F4-7
M@>O&NRV=N*Z5P>?;6YA1YIS!N84&B:KH)5N^3268&;)F<$=)I'0#XI2CP1G'
MSEW4N^E;V0PO.=5W=:I[V\L'4JXT_P!.K.Z!9[3I-]U"NN^ZVN4J_-M(H]9L
M%CD+*+*ZV9=*E.=(BQ>LV\+85(G[W3BUEW":;CK66L%W8<,?/AWC5W(],W0*
MU5O4)U+(*Q>Z#VJ>:+2>P6NV'L)D?8;9M):Y5&2W8EW,UO'MCRVV24QF&?6U
MI&R456*T>K%KDX@PICMH[AOL\@N[>$]_36:_;;S:L7+[9_ @:JEU46'BEC=R
MNS5;[V%0G@)DK'_*Q;"W!</" &.*GL#VB CX#6C]1Q3U11P&%+VE_P &8,G'
M7<H&8#,$K46VF=DND4=B+(95NFS%$%P '(' 3?#']$IA\D-,<.U[?S&&>?[3
M8M$SGC$VO;A/*]_XRG"^WM"/GI/L_P!?'\ EL\ ;Z@'YIJ> ']$O@0#P'CVE
M_P#-#Z B+1$>R*__ ,GR_DT<N_I5>_WX?E'1?E$O\FU>OZ:TK]XGX6,^U7M*
MUCJO_%GZ_P#]5%"_NW&\,QEWJ]Y4?>EH0IO4\]4 ! /G>&WX?_QRH_[? <D9
M1TCV<E6[K5[K]->2\93HWCQ\Z1:A^?G_ .!GG\_X_P"WR/X\K"E/\G,\!T(D
MBA\O;MF@@/CY (^V(,'\_P C!]?Q\\D?,^^"U3$S,QO8%]0<4D/7%]/]PX%P
M#3\PK.5P#,JIW?P$TY8SC[.1$BBHJ_!]WP_AD.<1^12^>)M>V^U]][=N=L-_
M!8_XU=O>51#KTK[$IWV=6XVF7=/%E=!/I!K^WS;5W%L*)K"H]1JY0;UD2C,"
MN0""K\7[$#$"."NE0/\ #,F+S^T=,/F\3AD?=/XQG=EOW>=]ZX+T\5D5O6[]
M1$Z!CF0/1JXHB97W N9%5VV.0S@JA2*D<&\B99-9--4AQ$JA0, \;YUKNFZG
MCCNZ?B>*<?K5]D-JZP=2$M!P>Y&HMW>WVMUU&9*P927PVLJZ(U73,@^163,4
M3&3-Y(!#@!3"!@\^TU(M?'#6OV5IWOK_ .LE/5G#K19^\M%D4+C=*H_JZ1JD
MQ1/#R\K%*.XQ^Y*:!( F:(K&2%(GQ05'R<1'P')5-%%ONKHO5;CA>+VG#=>T
MQ$YWMFF-_P#A7;C-K3CNM.%^&<$UJ7JE]2N\72C&>P?;"!U6G=@]"/#S$1!5
M6+9 YB8YS&HOFZ[A2(;*IF4^\_B$!J=,Q0)X,IX]I>6UIB/NBO\ ]U,3;=AC
M$3RRW<C.)FU5%MTVF>T8\+[\XMFV..SA!'KIM@_+W!F5S]P"/@/E O@\!X ?
MEY*;Y?(/!OG]1 "Q5-,Q,1$S>)QFV'*;3K>HN]'6ATV^^D'-L[C7(BQLF3C7
M)1FWEV#9[]ADV#9Z9!\T.X(I\)=-5(JB2A2E43, ^TP?(><&U\-L-M3]FUV=
M-=-[VJB^.[O''N[;Z9]:^I?1O&U^,^F^,V_A:]I_C,[.J:9FB?\ E$Q%6.-,
M3&,8Q&,6A\_5(I-2IGHB.OS6KL-!!,1&3RDL,5&M(\9.0=K)+N'[X&J1#.'9
MUE#G^(H<X^XPB(F\^.8V7A=AX>T;#8[.B+XVC[9B,,8M&.6_\L?5/JOC?J_B
MJ_%>.\7M_&;2J)M7XB;U1>(PB/NKMC?_ &[KM>G'\57K\'ZLIIXC^K]**1'_
M %_KYY7PZM2GZ9PE'U>?4[]OR\FKOR\>/\Q^@4WT_68P#^WZ\SE--^$QWPGX
MEJ<8B8PM%IZQ:_O#8"U0!#-+Z _7\T)__;%N.:94=_DWP"/2&^#Y\^>RVI^?
M/X@5*#^7^T/ <#82X#@. X#@.!UDVM*-X:77@VJ#V:0C'ZT0R=*BBV=RB;14
M\>U<+ ("D@X=E1255 0%-,YC (>.!2CZ-&\>JMMB?9O_ )2S'5\R;U?0F#''
M'DIG[?-W[YNL:8"RP,%'MT6P6ZC02:$(>OWI1-Z>6._=I_G!._#,+ +P>!5O
MZU_\E5W<_J;=?WA@.!B;2]H[O7KN!+=0^M.J8QBM4J/2C+.P#O0;_D<GK=F;
MV&4METJBE?AZZC=J7$.6-A&*A"R$I*R)QKC&,>&C8B6?S)5XMK7JO;6M2PUF
MOJ)]J>UV>^GAE.32>78?V#[>47L%=]6UZ8H<IIM.H$)U@EV%,MKK/\U>6:KI
M3,MHMMEHYS!,Y^WF:U*'+(%D$I=;[$LH1,:G;KVBI/=?K9U)VBVY;>?SRZM[
M[JFA6VA4&5I;>R6F@:G2:W1I>'AY>U6AS547-0L@GLE>++S;0)XZYF$F9DBV
M 1K6O)6AV"WSL/V4H?3RP0[[-X_7J?ZZVIX?FDI8(&6+2(J!RV*[0T>H2=IA
M8:23E9YU$UUD5[(-F4G$&L<BU(V.]ADWBCUL-8:E,FC]J^T.46;OGUX[-;QU
MW4N/6?)<BW+/.VL]F4EG>8HT/8E+I%J!JN316B2;A"1H]AI,FSC64!>T%+<U
M=Q22CAB\7 SD(*W+NQVBU3'_ %)^O<+VEA;X]H_I\6WL_GG8HO3W1>N=FCXJ
M.)=X32\Z8T&T7B*5D$[%7HMD.:;)7ILCFDRDVM*NHRVO:\DR<EY]>.L+Q;UY
MY6LG<+M3U(ZM^GCEEUWB$O.G=P(I258;_!]4+O>9/%\<H>"TBYKP9<-INAW:
MP[1I*TM)LXC\_I"?@(A1.:?6:P5<J$$=I)"U^T7UJ///OZQZCW;NP8BPH49%
ML2[CH7?#.NEF+=E]-Z\:)CM#N%3T3/)W6E=R>X'<9.*G%)FEUBG7&HRM0C[4
MA!RMRCXR1;2+*)D?NX@]L\=1TN]YT0@=XK'JS]_(#L3H5'U:_1?53IJW;Z+0
MZ,[S1A:ZR:S;PM#2$S1'%AM;6MV1(57;"5:Q%BDX=T#-O)LQ9?;E8UD7_7R_
M\GG]<J&XMO6X<:"XVS.29SGOI^K:R6ES775&US+3):YMT8A;,WB+8MJ#,\==
M;!:XIY;&&LLJ[]JAHQPTJ TF7(P)-.#.NO5TT'W8[[UOKSUP]1K0[_ADUUY[
M Z1BT7/]3X'()F,LN:9-OM^BJ/4+#7=W&_R$I<-$K2<] 3=DBY/.V5>EQ=2\
M9%(1IF+-ZY&N"4W579N[/8_M;VB^\=)QVF=9.K/:G0\/1H3++)&=TK6HIC48
M&28?>-Y7N49'T#\SGDS'/&SZ/KMG<W!1[*-)!"#;,&!W 8<]6#L-D=YN=>]/
M.\;+1\BI]MS>4WOL_/6W0H6A+2V/5QS(H4/#H!>4DHI:5E]YOT&I%V9E'O".
MV>:5VT$5;KA8&(<+$3NB_KZ*XB6ND7_TR/19;YNPSSMM><[M=)8)]%EEF=MK
M_8^=@L:L$5<Z/<$6J$_6:=+XG#65OJR4SI4(YJE5E(B)4GV[8[]@<X\\OX[+
M._1=3KS*-[KLBTMOU[T1[VGE+1H'2=A!&KL1U-2G*I"LJ?785LW195V>C=(A
M()30PN])B(BE6I[*/5(!B1-BN(DYZUQ12F;#W.SO>?6WV_K9J^-9Q4.OU_JF
MSV:M7_*)C3IW89;/NG&=VQ[GIY-O=J<SS:KOJ]!?92VF-:VFQ+2\M[DV48SB
M1-*C6M=DR [4=L>WFUTO"^KMXS;K(TCNF6#]M=4TJ\9@MNTNM.=@UIL*5E-1
MJ*USSN*;P\<SK$Q(6:Z/Y!X^6*9K%QD.P7.,B4OKK7;A.7EL4]0WL%>[%TNS
M^[1E B[W9N[7<7IEV>6K4/('K%BG>K5-U)PE:\R&2E'$A7(NT2U1KTZ9H_7E
MG$>F[D8$RZP( \.1YWL9ZBO9#+LP]5RVTYO07\_TZWW!\YQ5E,02Y(]S!Z'7
M<>DYQG;5T7YE)!RZ>W2:2;2B22)HU!9N<K1R9H4IQG:'1=@.QWJ!]8YO&JWV
M$[.Y/E^:WZ#N5]MG<&#Z86F]8]1+HX?U9M2>M]XAVFL#^8]3CVCJR2I]PL\Y
M%.;FV(QC2L:@[CY%\LUK7RN'+UQRYYSORCABLZ[EZGL&9])=BW# ']/LNHYU
MDYM9KB[F*6GJA<X^H-F-PL[&-9,I$RJC:W5&/G&5==H2+G[$XDHY\"[DJ G.
M16RKZPBK?NDE$*LZ\?HW(=2)#0H[1DR%^]0WN&Q9GVM?UAU8!7^PDCENOT@D
MLT9)MU%S3C5V82"4H> \I0ML[-:WI?1$F@QV&T?LMOGIT]J=?)K[C$6UEM.0
MRDS9L^G*)7ZZDYL\%-%K<95++ L[I64+-$)6^;ABR3AY'B8J)"]N&MV$H QS
M?MN^]%WJW>KWO=1VN6N/;KJ6XQ6#M>=3=5>TJP1?;*7CSI:3I1=$O,[I47.3
M24:Y.[1KM9?UZ';&BV2<D()+E$_$>L1/IZ[U['5+8>U4'W%WCIWV@TC,]O<U
M/#<G[$T34,]RMWC*S"-T2XZ#2Y[/IJGJW;0&L@V@Y*G(.Z[8DYU.1<1SA1.8
M1<.SE40(QMV9W*8S'U!+DVKM%RI>Q4STI-SVJ T:7HC!_IC2;IFD.3Q-2"[
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M^?F!!* C]0'C6M?+4[NGEC,?#T7Y02D >F7KPB/@/SCHYO:3VE*(EF/)0$Q
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M',WO]L\9O_\ S+4[_P#MI_\ %L ZF7W9M?"^?'FH3_S^OTBG _L_5S3*C/\
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MKC/O'[W^[F/WL+8&0RGV1O\ >(LP.*@-/MOP_M/V8%!%0$/B_" XB;V>X?/
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MU\^^/CR(?F)3/K^L6:X_LY-_:?C\3J!LD*JE2*)C#\_P#]?*..F[!0OD #W
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MV@-NB$^P^"PT=0M)O.-3OQ<O2:JO!B%'$:ZDFJB3=P(*.2J'.B;] Q/<(F*
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MF6=RF6X?V8QB-JLM:YN[.DIVA&FW1IZ?!$'RA%W+4WPT!%J@*:91 J8@80*
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MSY\_4?E]/I\N$?L2@(^1 !$/(>1#\!^0A_,/XAP/Z > \!] ^0<!P' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
M<!P' <!P' <!P' <!P(I=S^V]"Z1X3,;UH59N]SA8NQTZL-JEFT(G8;M.R=O
ML3&$22@H=5RS(^/%,G#ZPOT?M*:IHJ'?_92KN_@-U9:.$>4#7VWG">S/8HA^
MX^9]W'NC]5=3W3*;+ADYG%NN4U<:.GM&E5K"8>PP&=24,TK^/V+ Z1JFET6=
M_,6R(+7=!^QDKW68*Z5^4FEVN?KVS:B9C#E,6SB>._UC\KU/3^ZSZIU1PMSF
M&M:JWU.;4NLW8XE2+<7=[7*?!R3*(;%K-9=:19;A=0B7$JPE;6:-E+$]80,A
M97T%7DVL#'1Z7*S,WQE. PD* F.)2@'U,;P !^ >1'Y?7P'^S@5'][NS'<CK
M#JA]/98P:]^G;6,I81F_S^<R*!NQ%2G;A+6AM-Z_GD2U<FD'M?QN$C:VYLT6
M9L@\.RLSNPPYI 8%V,6$-_3%ZK7!UV:VOMAUQ[V]BM"Z5:5/YS.UI[H/YL7L
M>R+^JUVRY[?X*XRFFY^QT! *7*5>J$JFMU@S%S;Z>^0BD)Z668KRC=KXW_"Z
MUY\<XQW-CKP ?0 #A%.WJ4]TK1GN49S.]<NPM,RF@/NS!\%[)]K(2H5?>6?5
MMTWA)Y",2M=%DG2M?8I2FJ)4Z@W67L13_F1$6):1!B+]=@X;C7\:^52N0=?^
M[?;ON:PT!EVZUG.NQ75V\7G,.PFHYC;L[T_ (VF;%DM3TK&]9Z[T'18*8B4\
MZVB)K=40T7%_\K)#SIX^;*,41H"JI?+AJ^77R;<D6U=,8R.9/I-S-/6;!HU>
M3#U!BV>2SINW32<23IM&-6,:W<OE2'=+H1[)FQ255,FT:MT"II$(COV4[===
M.ID' RF][!GF5N+J\>0M!:WRPMH$EJL#=!,Y6+510JAD&2*[EBG*S+@B45#I
MO$%I)XV353$P:K$[V3[8]WLOJE>V3M4X4S/L-L]@ZQ:1F>%1M?Q;7>F79*\L
M;K6\SSK08(C>Q?X1W5B[Q8I-Y.6F2NY.73DF=KCWHHQ8MVY?CSUKBV'O2WZ]
M]F^N757-Z9VBW&\:C="Y_G#5*A7:.S1PKA+F%JC>/G\]B;[G\4R>:-%HRH&*
MPG+1)33UI&,(V/:O%12>OI :O[:WWQ6+NW+1DV<OGR[9HS9H+.G;QVJD@V:M
M6Z9E7#ERX6,1)!!!(AU5EE3E323(8YS%*41 C3Y[T=G.ZO9"_=A^GTK7>JO8
MGKCV692<IT5FLZM\=77EKF\\<,I6%2R7:W;Z5H$_V S:WPS69NN1:,I5E[$@
ME*-:787,*Z0C'<G6N>[^(F^\>>H79^DOUKTSK]@<;)VIS>LWJ>KU&A7IET\O
M#1DZ0ZJ:>^CGY]AJ] GR24A),LTM-C5:SU2SEZ)$,_;"LP;)-%G;M@UJ3RPU
MK6"UL2E-_G% ?YP ?]_ U\O5+[U]L.NVWUE; [)U:MW5VAL8N@]OJGH366L4
MKF%WU)N1[0W.\K50[ZW99E5SK,G$,*Y?(:OSL;&3<P96\12L \9.4'08M]%W
MH_M64W*T:Y(TBW]/XNN:!>:C)YA%62GZAC?:_K]9&*MLP6?83L!*#%.+3B!9
MM*H0.S041%R=UH;*-AYEJ9Z>93:2-9==W59]-VI[-E\2E'Z@ _S@ _[^5%?O
MJ4:W?<OZTR\%ANZYMU[[*Z_.1F:]<K?J$2TD:W-:@\^-.H4ILM+QLK58BQVN
MO0<[#U>7N#%U76D^ZCBNFKI=9L@>3$;XCOZ#6NQG&>WGJ;=D<XN&^TJFS3ZC
M5RS=;^U>N9S(L\#[2=7M6HIWMXQ32[=F+YVBA"ZOG-U2FDZ-H6+2D[1=-SJ_
MS,6YA(R.3?1;-%_7OEOQS^%]8W>_\YY]VY92(*7J]-JE;L%LE;Y.P%=AH:8N
MTZTBV$U;I.-CV[-]9)9E!LX^':2,TY14D7C>+8M&"+APH1JW21*0@5'J. X#
M@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#
M@. X#@. X#@. X#@. X#@. X&#.SNL6#".N>Z;75*,^TRS9-DU^T2!SZ-64;
MO;E*U"LR4ZRKR"Z+=XX2&378D;'.U9O7@)G/]C9NW7PFZH5%]=_4Q[!RZM8I
M>W93D_8J<[ XK:]_Z/Z)U7F%XC.NPK_/:\E9[O@<BSTQ^_4SC8Z"3_*#/I>9
M<1DDQ3<+':1$K&KQZS6MW5;>7'65]W[2EWTP]._,^M>P[GV?CVCZ%OG8R;=V
MEGES!O\ FUGN!0-O85*3M5$J]*AK-/T]:WSMHKC68TO0XDK+\\9MDV-'Q\3%
M-BMW1+ZUQ66<#4V[R]WYWOU.]7\PSWK]I1<-T?8M%89HTU#8E>O6.=Y30<7;
M<[80\5M6<RDS.Y??,[O#0=$H^<W^(26OQ(UNJDV1G6L+$OVO;7GF+$/2BB=0
MW#IEM/6SMO92=E,SH=_L77ZI[(\/:D6.[9DVIU74M\<WL,NJSLMV@<]OTI=,
M@C])4=$6O<;34Y0XD4,N4Q9ZWZZGFNAKU>@:E PU6JT-%UVM5V+8PD! 0C%M
M%P\+#Q;9)E&Q45&LDD6C"/8-$4FS1HV220;H)$22(4A0 "*NNR7JX8KUAVJS
M9W>,UU23RO*9[+:AV'[)0#6N.,PP*W;2G\?.HN[1[J<;7)W&OFBT:\G;'!P+
MZ'@4I>/0.N]D#.&3<(KZSZ8EKS_7\WNOIIS,)0:+VE&\P/=I'2V<1M_7N_YM
M;&T[>$-:LF<V^>.K>MA>S-B/"4=^T;2$+-1+PD=<WC*M-ERRPUK]ES>#==,/
MZQ45/.,#RJ@Y'3AD'4T\@<^J\758N0G9#V?>$R]:1B*0.7SKX:20+.3KG;,D
M&D<W.FQ9M4$@RC8Y%[#UZ=EXV*<3LC%PTI(L(-F8"NYEZQ8KN6L4U,(& KB1
M723:(&$I@!58HB A\N!JFZ_V'U??-*R&7WG.<;ZV^H;B5>D,\F>F'9B:8H=>
M^_'6OM5,5*(/3,MO4ZPDC1EY">90<*=$(N=7J=_CG45:D3UUP\6CWONY+K.-
MW[QAVS68>F?Z8&>]>Z96M+W3KQD$3V,K5]TZ7R!S\>+U>[==L;M$^]=9WBK7
M9W<+&/;JZSB!>/8:*M!69%(2(DU*K7W@0;),SDFM:\UG783;*IUMPO7NP%Z;
MRSRG8SG=MTFRLX%H5]-/(>H0KR:>M(IJ=5!)5^Z1:&0; NN@V*JH4[EP@W*H
MJ0*B)3L</JA9AL_I]:G7-A]/?L+K^)DT3,7L;>("]PFHXS/(L5$+=0M"IQXR
MNZ54G)7I*WL.;H*LG)Z[)2<0:36:N5Y%D&0NAGII5S,"I:EMN.9QG6A2)8-&
MZ]>L\/7+5U6>;%CT_P#<^?=P\OHK^LH$RG5K=48I!XLC7SLW<8WGW:4TH\GT
MU':(7*F,!2F,;SX* F'P F'P >1\ 4!,(^ ^0  B/T !'@5%XKZNW4?L;*3-
M!FM+K^"FU+2[7B76I2TZ-$P>N;2M#F"GS=WA:']WA,9,8N@*256S]M>7"<W9
M96)3=H1K)XNC#B%:L1T4[(3'J28QCW:2=T"R4:HY/HOW-W>S6.G65O[KXU%3
M=3DH/JQW<>,F<G3' 4QJ$C'SSVY$=_PL0*C1HQ59O95Z@(;0U=KL!4*_!U.J
M0D36JO6(>-K];KD#'-(B#@(&&9HQT1"PT4P208QD5%L&S=E'Q[-!%JS:()-V
MZ2:29" $!NXOJ.9MTFU?$Z5K-!T!;-=-:R[[0MY@XQ5]GF 1I9VOU.ISNG+)
M-53L:W9K7/HP[N:!RW1KA$TW[Q)T@X\(A!#U;>J_8W4:-K.S=4;&AV(HNK9;
M#9OOW4BVHN]:K<C ((HR%-WGK+72V2/:5?>LW:R[6Y04-"/8AM?!2C95)U]]
MILQDV?,6U=2^O5'ZV8G3:#37&@3:H0S%_/W+8)R1M>PVJ3>E5DCKZ):9MR_F
MI&4C#R*\:QC'<@Z:5B.10K\0",:P03 )+\!P' <!P' <!P' <!P' <!P' <!
MP' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!
MP,#;!V#S_*W["A*6>KO-SO%2O4]CN-.9QJUN.GR%+K[V9790D445'WV [ENU
MC'$RHW)'-WKYHS%P+YTV;+!KF8KW$[#0%6Z9]UX/O0Z[-3G:7>,NP?M3T+M,
M92HIMD]TU:=2A[/3>OM&AF$?I=!N'7&35>-YF(NCZS*7"J1#NV6%\BT,BY.7
M5^O;TQWKR\=].+IK@6Z63L7DN,Q5.TVR+6-Y]H82]@5JU:D[H5JG>9BC49U*
M+U"CR]W28,$+5(UB&C',NV9H-%C@U%5%0B</ T_O5(]0:6[BY=?I?J'K=ISR
M*ZA2.XQ&W9%,:-<>MNT2=E93L32,?[,41&MQLS.Z[E>9V2#ODE-45M]UH%=(
M**70K4\8BU;L^:Y:RG]M^I91].CH_9^WS2^ZC;]A<U+K>R[H5G8E<RPF--(=
M8^R^E9 XHVC1'8+ 9_2X)#2,MK]FT<CJ'T]*H&/7;S-5R?)4Y.%C'2K1B^<2
M<_/??COU?/>VL.$4$^IAZCC61KVU]/NLS_3XK=4U'5-0UB#2;T?/).^4IA7]
M-U+K93MKDWB;:K[I.XPK*IU^6;QSAE"3TFPCDY)"P"1%L%7O5'J[C'=#L/M5
M:R2:LFQ%=]:XJ3HW8KMKG>AWC<.E%LG[)+9W<NLVZP$W/T>IZOH-7ITM;9S
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ML,NQKM4IM-KK+_*YVTVJQRD9!PD:@)17>O4S*J(MR++)AK4:;M&_]G+7K?J
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M9K&PT)&Q<)%-&T='-D2A+C@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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MJ'N^4YA*QK#&]1J5(G]/L_73:Z):I";>ZO@-FBJM.5F?F)AC%7[-;QYM[9C
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?. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>g729258g83b31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g83b31.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[21*4&AO=&]S:&]P(#,N,  X0DE-! 0
M     %D< 5H  QLE1QP"   "   < E  "')R,C8W.#DT' (% #A-:6-R;W-O
M9G0@5V]R9" M(%!L:6%N=" M($9O<FT@4RTQ("T@4')I;G1E<B!697)S:6]N
M+F1O8P X0DE-!"4      !"T5G/JZND_!/4!<A#"^EZ&.$))300Z      #E
M    $     $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!
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M;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
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M;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M  !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M     !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL
M;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I
M9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M ! #P     $  @/      0 ".$))300F       .             #^    X
M0DE-! T       0   !X.$))3009       $    'CA"24T#\P      "0
M         0 X0DE-)Q        H  0         ".$))30/U      !( "]F
M9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M       ! #4    ! "T    &       !.$))30/X      !P  #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z     #_________________
M____________ ^@  #A"24T$"       $     $   )    "0      X0DE-
M!!X       0     .$))300:      ,U    !@             !"0   ?D
M         0                         !              'Y   !"0
M                   !                         !     !
M;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4
M;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !"0
M  !29VAT;&]N9P   ?D    &<VQI8V5S5FQ,<P    %/8FIC     0
M!7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M        !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE
M<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
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M='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M   ,     C_P        .$))3001       ! 0 X0DE-!!0       0    &
M.$))300,     !G"     0   *    !4   !X   G8   !FF !@  ?_8_^(,
M6$E#0U]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )
M  8 ,0  86-S<$U31E0     245#('-21T(               $  /;6  $
M    TRU(4" @
M               18W!R=    5     S9&5S8P   80   !L=W1P=    ?
M   48FMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@
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M14,V,3DV-BTR+C$
M                     %A96B        #S40 !     1;,6%E:(
M              !865H@        ;Z(  #CU   #D%A96B        !BF0
MMX4  !C:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T
M<#HO+W=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N
M8V@
M    9&5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO
M=7(@<W!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A
M=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M     &1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I
M;B!)14,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#
M;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M      !V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M      !,"58 4    %<?YVUE87,          0
M  */     G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 >
M ", *  M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L
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M76G_ (P_K S*ZBSI%#P:<([KP"#NO</:S3_N/4__ +<M_P""6%C=)ZYEP<;
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M]2J=@];JK$ZO;Z>+F[=6[FOV,_,_T?\ VKL6C_BK!'U(P0>0Z\?^#6I*:O\
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M )M']N?:OL?KU_T+9ZN_W;/Z1^BV?O+J&QM$<1HOE9))3__9.$))300A
M  !5     0$    / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P
M$P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ $, 4P V     0 X
M0DE-!"(      49-30 J    "  ( 1(  P    $  0   1H !0    $   !N
M 1L !0    $   !V 2@  P    $  @   3$  @   !X   !^ 3(  @   !0
M  "< 3L  @    D   "PAVD !     $   "\    Z  :/L   "<0 !H^P
M)Q!!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$Y.C U.C X(#$S
M.C P.C T ')R,C8W.#DT       #H $  P    '__P  H ( !     $   'Y
MH , !     $   $)          8! P #     0 &   !&@ %     0   38!
M&P %     0   3X!*  #     0 "   " 0 $     0   48" @ $     0
M            2     $   !(     3A"24T#_0      "           _^$!
M2$U- "H    (  @!$@ #     0     !&@ %     0   &X!&P %     0
M '8!*  #     0 "   !,0 "    '@   'X!,@ "    %    )P!.P "
M"0   +"':0 $     0   +P   #H   #P     $   /      4%D;V)E(%!H
M;W1O<VAO<"!#4S8@*%=I;F1O=W,I #(P,3DZ,#4Z,#@@,3,Z,# Z,#0 <G(R
M-C<X.30       .@ 0 #     ?__  "@ @ $     0   ?F@ P $     0
M 0D         !@$#  ,    !  8   $:  4    !   !-@$;  4    !   !
M/@$H  ,    !  (   (!  0    !   !1@("  0    !              /
M     0   \     !_^% %&AT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\
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M(S$X=WBV%QHD,C11<Y'P-CI!5UEQ=':7L;*U&!DS0E188=5B@866F,'6_\0
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MHE[SCU.H<3*'$3F,(^/+ENQ?M6;MJ1TMFW-)8GD<=E\LKR]Y\^PV3H>P&@/
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MAJ4:\MF>1W[,<32XZ_%SM<6-'ESB&@$D!0[V-S8[7;)*SR1"I7J>M,7-&92
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M+V<7$E?(3T[=,&/W/+5M=ZGVB3PJ7,42=@J@N8G5O'IF\8JAYO& @4%Q]P
MN *9,[Z:.I]?9T,!$>0=R&.+CL-+ ?BF(V&GB#HD-^#[NPIH_P#P\=&-<3+D
M^IYVEO#@_)Q-;KN"4CX*C3HR#F6D\3)]H07_ !+MBF<../E)<HOVE)-/R"(F
M,5Y<IJ9MG<HH83JJF933YU%^14_0ZA@8@)U"D4-U.4#!KN4^DOK'*1OADRGH
MX'Z!BQM:MC_A TUHEK1,L!K1X:.]X!(^96W8;Z(.@<+(R>/"^OL1ESA-E[5K
M)[<X[<\P6I7U>3CY+NQLD ^X!&SB222"::**::**1"II))$*FFFF0 *1-,A
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M--5:[+/<A=M&<"(O+]+P1)@P*IMD<G>W7<=9F,X#;KK<]?3768N]%!G+M4
MMDSF5]+TI@@S7;Q4%DU_A+W*Q[9U$VM V \J3:D%CXQ5E$,LV!HVRXZ?#@<7
MZOJ[.N?XFRT]46?C:UH^MC*I*(M1A2'>D53K):Y#RXF.M(I2THLMI>OSPK=A
MSN;M+DE.3VU#+""BT(VC&LEV1Y2)C,Z,AS_4$1:==-NQ7UQA=# UO45NKQY
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MUJ$6CVF;E?\ .6=YYS2'YGD\G6R=-#6[T N^LU]91,(F$7G8^E]_?/\ M/\
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MW'@V/5<X *BAG'54"D+U$H &:_D.N.C,3_OO4&+B<S7P16!:D&AQ'V5432>
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H($JQ)4D$T;JS[YV#%HP&;E%"IMB$,JH\.9=14") F1;_ &$3"+__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>g729258g87v56.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g87v56.jpg
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M1DA2561HAH>6IM'4\0I3A95B9H*2EZ/5_\0 %P$! 0$!
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M\;..,DY+16Q0L#XSXI4Q7E[VILPQ9*YI1@]FRDV(1O6-'&/2/9W>M'8L-G)
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M=0\N >0UZZ[VV'H ]_0=B'?J/0!V(_.'Y7T#T < \B "(#V/H(CZ"( /?T@
M]"'T /8!\V >?Z_U_K^YW@# & , 8 P!@# ,9D$UAL251U#*I;&8RME[T1&H
MDCD#\U,RJ42-47N:F8(ZG<5:8Y[>E!11AA#4VZ*5QI9>^Y9&VNFP@!DV >!'
MKKW>H@'K]_Z/OX!YP!@# ']?H_>P#AY ^P]=_P C#H/R3?U].OL_LOR0>O7O
M?S#WZ^_UP#D(=AUZ^\!]!$!]![]X>O7IZA\X=@/H.  U  Z 1]XCZ["(]CW]
M(CZ!WZ /H'IT'H& /*'IZCZ#W^6'U^;U]>Q#U]PB(?2'H& >-=?*'7FVV#YO
M,/8@'0!UYNNQ]W?>P[;"(CWL/IT!Y'7OKUV#H>PZ$0]>NO4 ]-@#OW#V'?J(
M#T& .O0 ['TZ]?<(]?3T !Z_.'77WL X 7T/Y<P0]X:CMV #V(B/8AYQ[[_*
M[;#H   !J'6 <@UZ#H!V]W7KL(C[Q$?4>Q['OWAZ@'70AT& >=0\H  "(@ =
M .PCL/[.PB(B/WQ$1P#S@# /'7IUV/X?01_#Z@/[OI][ /&VGF]^VX!]&NPZ
M^O8#WV'6WS===^40$>]1P#R >_L1'L>_7KT^\'0!Z!]_L?I$< \#H CWWM^6
M#;TWV .P  ZZ >AU].QUZ\HCV/78B(@>1#OYQZZ$.@'KW]>O8>H"'S="'O'[
MW0'G & , 8 P!@# & , 8 P!@# & , C!S:A5GV1PXY5U[2AIY-O3GCM<L2K
M/9(XE,ZS><2&OI TQE.B>#STI+.N5.RM*F1.YJI,6UJC2E^Z@C5.)N@VF$TW
MA-3TFY^;Z+\<^3")KIERLGAA.[9XB4Y8%B-D?I0[CI04!N1Y<9]P>)K1ME<R
MI&O]XU#9'&*[N U^KB$6 ]HC9PAC[T,H=%[JR(4<F->_WR]RYNWQ0W=N7_NQ
M/2*N41:Z7;XV<#N65<6=QLA%HT+*WNX(I=7AHVMIRB++BKS$:YHCCAPZBU:7
MI4*FS=7PU\;W%-.V.=0DJ#MB<]//#)]I+R2UC8N<W%,%52;;5E%5KRYJE=+-
M/R:Y'ZU<',TM>,^L&N(F,EKVK5-M+DII@ND?2S%BA!B)I+2*E"EXU=9 0>C4
M[I=R"2=&\K7X0<*@=M?33UU)-PW&UI,;:PI\X.Q1UIZW/4]?6HE:3F0B>QIO
MDNK&L5IU"EHT7Z!N"$Q21KJ4I,('< W.UUUTW#V8:@'FZ U#:S#C$>P3G[][
M:FX<PT8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# *(_
M$-XD<SK?YD<7[[KV'U#:-94Q=_&8^O69WG\MCDMJ5 UV$JEU]3]UCH0!UCBY
M),M6R!M+M)6R5*Y*RQ6"MK6P1%29(91NN??+4M.E4PVT[X2ARH4N9M?3+Y%[
MF"#&)FYO[-%WIUBL8,F<B;T!ZIGBY3L@8C'M<5H.Q+?J\.@"@;14#]@"M5KL
M42(^;;78 \HZH;NX6^8]#'.GI:_J:9X\7E(;F2V CE]:+*LE];3A1")'&54I
M9YAH6KT96A_)4IWQ@(+;#M#$3XBT]EKMY_/J=MV(:"&:U"33E/R]F8G+::AK
MS]R1N24, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8!A]A?G"FOZDY#_)*O-IRNJ[F/#Z,T!P9U >(7'D1U 1^
MIDP@ B =]#IN/7?T"( /X0 ?F#%67U8IPNB)7YAHP!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 ]_OP"(?&D0&SN8_N].0R<._\
MV3UQZ?M_-_GS7BG>'W<?)%/BJZKY)>9A8P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@&'V!Z02:B/N^24A^CW
M_%*S]GT[S5E=48\/HS07!GOZT+CUWZ?W,F /VBC,VKQ,RGPK[J2MR2A@# &
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M'E#<-M1 30V#778!\FWY( &!L'F$1VZZ'KSZFCWN,E'?P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , P^POSA37]2<A
M_DE7FTY75=S'A]&:"X,_:A<>O7O^YFP>OT_D9F;5XGU%.%T^^N25N2::?N6
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M;DB<[413Z;#Y#22=-] [V$.M=@^Q^Q_*^F8VY:EV;R_()*$X6$_NIE0 &H
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M/^];D-Z^OI_I#%/Z^N4O#5_Q[DOQ4_\ +X)[9)0P!@'55&&%Z#MH/76NP^H
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M7Y@ /<&95E]7W-6%T7/WU,JS#32O)#4!X^W;]B ]53/QU[ !Z$(NZ" AW[A
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M^Y@# & , 8 P!@# & , 8 P!@# & , \" #UV #T/8=AWT/TA] _?P"(G&D
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M\F*I/#]G^"'?'GQ"N$L:OOFG(G_D/6K8QSJTJ\=X>X*7$T$SXV-=215D7JT
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MN1_;K!H_<_K].75BCI\(BGQ5>>V^OWX+6\@L8!4M7X?ZLMR#'OT#B%5 =?\
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M\D< KK\+D0'C"O$/4!O2_A#]FT9"/SY=>5T^611A]7\%BPB ==CZB/0!\XB
M"/0?2/0"/7T .060UO+G_P 4^.,]+K*W;).CDX-8D,DU84D0F<B4:LKB>H3H
MUVYL=8'1-H6<<E.T !.\VNVO6P:CZ!2I;4V2YO[T)=23B&^B^_4R-ME>*WP:
M?J[G;(U6R\*G)XA\C;&Y.%6VJ4*A:X,ZQ,E(\QL,TT*$P\S0OLX2]==M@[$
M[$-5#G1I.]T];F.I-.)5GRTG['RC7/%KQ/\ A=7G'*E(-+K.?&J3Q.N(LQ/S
M;M5]H*-D+HWMA*=6E$]+#S4QHDFZ;:#N0:87MUWKOL @(ZZ6V[J]\WZ_GF%5
M"2BIZ2E/I>\?!,&H?$;X@WK8S'4U9V>I>Y])$SBK96!9"9U'S%Z9I2[+'$PE
M7((ZV(1^")M!--T%2!G70:Z#L/62Z6IU2S#^LU5)QE3NON2<624, 8 P!@#
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M:[X>LSOFQZN-L*P>4-&\QJ3F;5''KCW?=856]4Y/96V_"I,@FZ6W80+RZ0M
M],CBA96I'K%$,56I7=++&R41)B<$"=)J)JC1-/5-SZ65OLLL#P2, 8 P##["
M_.%-?U)R'^25>;3E=5W,JP^C[&@N#0=<0N/0?\6;!_!F9M7B?W-S*?"ON+$>
MO&%^YX7S^GJ>_IRK;-H\2Z5?VLRO'G^2PF#?G)A_ZEH__)*3^O[^35E]7W*6
M%T^X,IS#32_(_P"U]N_\4]@?S6=,VG*ZKN95A]'V(V>%F/?AZ\3A_P"*=K_<
M7N(9M?B?EV06/-]V3[R32J/@IZ\R_%!_'G7']&#1^'^OT9=6*.GPB*<M=>OB
M?YG&WG:YD%C *F*_^[*<@_3_ ,$.J/P?GE5_U'\(9;\%/7\D?OSJ_P"VG[Y%
ML^0650^*)^;7 3]?-4_\4><JG]W]+^"*\+K\,M>R2Q@%5?C%=?6CLG?_  C.
M.W7X?JEM/7?WLZ?Z>7_3\HFK'K_:RT9K_,UN_2*3^+EYS*.]@'S7AH:I U.#
M$^M3<^LCPB4MKNSO"-,XM3HVK"=TZQ XMZTH](N1*R#-R%*12280>3ON6;IM
MIL.H@==LC<>9%;JX,S RM"]\W0&/2UL:T*!6\;M+<G:&K=U4I4Y1R_=M:4B5
MK0;*]SA1-R9.B3"6F)+*U ^U@# & , 8 P"L'FHLY>3-^>*GA_AO<:.9''Q<
MSM2DQRO3D3%XDG='E2G.!V;U=92BE+ 1$ZM1FP$HG470XQ5J8)Y6B38!T 4H
MUJJ3Y)/WXEV-3>$O5]/-2.Y9G654V]Q)EE>6),^-UY\,SN0\BN7CC7MJQ@(7
M.3I;538YJE4<2"\Q*3Q=8T/L,00YKV9I$XLJN+:J$92DL;7,J6JI4IPDW-KZ
MS*B[<:%R^"!@$ .8W)J[^/=E<7&&MH55%AL-YW7!:B<H0ZR>7([O>RI(][?+
MJ65TP-,?5QHN,4U7Z=?94WD$E==V[5H0*F];K'M]FUP=1J2<SHF_\]7;[:?^
M##&9E*$,*B[Y+')*ZKD$?;SW-4B8FQ6]/"LI-J.PD-K2AT,6."S<>@)2IBS#
MC=NM2]-MN@S4I<&-Q<ACPFGK99,BY73%F;9"U-CYR!]LD12EC71Q](U35G D
M6X.#*YEDKD.VYB38PD#BP]H3N7N'Y;H-J41T^9^?LF4N74]XUV[?R;JY??:H
M\E?Q#VS_ #%?<RG*ZKN:\/HS5GAL_:'<5?Q/1C^"-S:_$_+LC*/"O/NR;N24
M<#?4HP/ITW_R1P"NKPN0ZXPN ?\ 'K?OK]/]U&0AW^R&77E=/ED48?7\%B9Q
M?M-?+V =" ^H#MV'0AL !KMH(".H[!J(;?8[="(;  ZC!94<C:&UV\8^;)W5
MO0N1)?#J%F:%+D9"HO4P)B^CYM2U&INN@]>G6@:_[+OS=AUTEJA<W$^;?WJ<
MXFM\E/LOR6F_(B(= 'R6C?8 .H[ PM>NPZB #W]BE#0-QWUUV'8-/+Z>4- #
MKJ)>[]67"V7H<]87#]===0BD;$-0Z]6)K]?I$?\ 0O78^HC^$<2]WZL0MEZ%
M6'(%D:&CQ3O#_P!6EL;FS0RN^0(FZ($29&!HEL.@:#O\'*+\XZ (Z!Y_-UH/
ME#+3?!4W?2_."6OU))1=.W+B[ENN<RQ@'';;77H!$ '8>M0$0 =A^?RA[Q$
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MHV](E0)"?/[)*C3E)4Q7M#-C3/9D$::%:><W?<S?RZAYC-]M]N]MA$0.U@#
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M5'B6O+R)J\+\NZ)(^33L1\H=C[QZ]1^</7W^@^[Z/FZR2FIR<L 8 P!@# &
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M;+%X_E-?3O3H- [^;S"'OQ5E^79"G"\^6KT^P3Q,U'?4=0'KOY^NQ#KU 0[
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M(4X\WW9/+,-*H>"8?WY/B;CW_MS5V'_P, _]675BCI\(BGQ/G+]*FBU[(+&
M56TYK_JM7,G;L/7C]Q[_  ]?!%X?OAZ?LY;\%/7YJ(7CJZ?@M2R"Q@# & ,
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M)'[O-_VTEM&0650^*)^;7 3]?-4_\4><JG]W]+^"*\+K]^\RU[)+& 55^,2
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MM."(^+1S)^]0/'L _!\"7#^^(^[_ *LZ/P4_=:OQ[$+QOI^"U+.98P!@# &
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M0P!@# & , 8 P!@# & , 8 P!@# (E27G)QFB'(1JXOO\]<DEN.SY%HD"4J
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M=Y,/9^@3223:E))W1C5C3F%:U_.>Y?&/6(270 U?FO81VW9ENNH &JH1'L1
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MSE\I&(&\SA[#TI:X79!JDW4:2Y[WV( \5 %"=KIMKN)7F]H&FP;#KY1 1O\
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M6:=]^O\ .>Y8)!IQ"OD5$0^5\7\VD8C^N^HO[4&VNP-",1UV 5?>NP (=ZB
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M$#/(X_BQ.ZG8Y-^1%D$E#4VE"Q?1:J'?*E6<9)<X,/AR:-LDP876,25J1/;
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MF4_#&=];$#RU+/8GI_A3:Z)"EJ%3\'5%$*B/;I3RC?8J2"5!7G\AQ19FNV@
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M19XY!<<4,QV:-F2++[.BC:2YLFCPS"[)2LI*\73UIJ6STJ5]'F%>]PFXD!Q
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M=H_$VUY@T:L,8A%),\Q8];$6E>M.<T20'9T2@XZMS>4)*(@9RT^WC<D5@P8
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MHHTQ.2U.V*),G<G91HG;FA&M6*="M1J3;A?XZP?F+=)=*^8G)ZL-IL[3.[8
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M$+].7A@84,99%,@<4Y!:E?JTLR I,A(-W$DD]0Y./D%R=W56L$2]S9V , 8
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M+)<G.L;6OB(_%Y?,TRS1SE1C48:=LE:C$;,@$MSR2PM%-W'*2<>#!@# & ,
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M6>VQY>J@\'?I05"V2123V6^K2WO4I-0.GQ$U'*@#9:X:-JTTM.4<"=.:<.@
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M$E@\*,*T/*:I._P&,O[17JVRU#2DD<N8X=&DZ_?1N9FM(G$OE]_SMH2(P8,
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M,+W>'UY7+ALNRT6.6IM?!@P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P"GN->)]8#^Y55:AG&YA2\,;MY='\-*ZN$FZ5"NY54X.M.3T?&[)?
M*.WJQ+'6JK95;<6615")-QKIL@;53?*G"+EHU&[>2*X<J?U)2U$J(G,Y2S:)
MU-GQ3Q>>#TOC4KER"<6"VL49@T6L1 JDM)6[&3+"C4RL=-3;$=4R9[AR)19J
ME3;RYNK(2(>6Z!\KW%(A+,,3;F+"PX*K6RXRGI-[VM=S@W(E\0+BVJX_S/DB
M,]5I(%73?92^=LCA&WU#9T5&G7)W:K21.E7*46DW%;!E3 ]'/>B-F5IP;&X]
M[0J%C-N0O.&<+E*+N(Q><7Q<^.C\2#B0[3.0U['+!=YC-8S;4LI1RC$&@DVF
MSZ?.8/2CS?\ )4[(S15A=W61MB&O8^["G=(^C<D[I*4VD-:?ATE4I6TX.%YB
MT3IAN._M?%SX4;\3WB*_*MFUQE<S@3RDDMJPY]8[,K">0)VBDGIRG&[D%,&:
M4II"QI 9EAM+N6EAQP%!@E25C0O.K08I<61V0HQO"^N+K%W"][=3Y?+WQ!$W
M'WBI6G(NH*C?>0,JO,J-+J2IDUU5UA*)PUNE;2"[I I6[NT9D+O&E<6IR&S"
M6+FQ?&#EFKHU)(VNU;%3B"E."4N&X2R\Q>--):OYF@[3\8NO:WOJJ*X35@KD
M-.W9Q A?): <@-9H2W,9LTMALNE_I>G9!' C"_XF"T6>CY(C89OI(EVNLO<F
M2*_)<\]P(6F9-XY)SUG\&JAN;W3AKDLO-XG&VIB[CXM-K/E=6O=-0\3H[.*H
MXN4!2E[<IULAOXZ&S%F"UZ'CG)"00BC8\13\D:;.=:PJB3MC\].TUDM2-\A7
MFA'F4K1>!QI&CAQ+NVU390X<7<J+\F;A;/$^2O;B_0MIJ #[5^O6I3BY H*?
M.C4P32M;U@<;O&(\AS7(868J9F5/QZ43ZQ'2)%,[P:E>:T?HB,C_ "75[3#.
M&-=&_-2HSO;SF&9YQ8\0ULY+\H.0G'D*Q5PIDK8A^>Z/LPZ5$OK=R*AM;VQ+
MZ"NJ4LC.4Q-NL:2UQ<\2^2X%:O,EU?FI_89 6H;R%Q"8T&H2<W>5MAJ\WE/R
MAK0[;YXK/!^-"\$O]L*6AR8(5R4GCRQKX?+"'YN:.)L[<:XN5 J9]VD%Q<D;
MI6T.B.-QP2?C>8ID"A?&TK@D LW<9PN)BUE/7'W34VA&.0TOGW-25T)#VMD&
MJ:@XZ1"Q+??G-K=BY>BMRZ)6K"HH"W';NB- T UUS!9U+9RV+V-S<Q^5->"2
ML9RQ5$N01:=6[=%GNHZ/RC,N\:?@@W%NBM7(KMU:&AE=Y6KD17&2_P!3&-H-
M$YNJKJP[$321-7AS*HKVL)DFUC]@S0M:,>8'96B:A7J753HAQ.GW^3>"K$7Z
MKJEG+T6NAMVV_$5HJ#Q&R38L]*'^PXK).2]61F-N$<DJ1H>[HXS4').04TBB
MYV+0Z$I64B&QXU3K(=5&C<X[[B@:EBAPVT*P8DWTM?JX[GS>%?B"L?+F932L
M JZQ89-*TJJAK"E<@<8?*4E:NRRYJPBM@&MD9E+DT)V[79N.DP)F%(M<SG"6
MLB);)F0M6T(5BHD:Z8ARKSJILVL9T-\61R[I>K;EC%"R)7-'"QI#%D4]<D<0
MK>=S1CKROG20K8DT3^UI1&6%SCU;0ITDK8[-*61RQQ;6XL65]<EIJ1D8W=S1
M#$FU.F.KV6[Y?P1L;_%NX5+HH\S(R4VBULS<UT_*&,IZH.Z&M]L:O[\L FKZ
MALNIXPJA&DCLN"3>;'E,S4\0]J=3_:G(]U*$C1S:Q7#>&K;=95H4N;VA;\]C
MH,7B_P#"5[;I@ZG22V8LC@E<7;94C-G= 7-!M"47&UU0LU^1)M.E,+:TS]8=
M2+W9H)FT+8CW%V:MW-,6)9IQ:PI*'!5M,M)77[IC6R<6;@E+Q^Y<TQR8264?
M6:N;$.%1/S>PSZ+3ZLK K.;L>[[%FV<11U,A$[CC#*C6.90YX;9)%'$IIVT>
M6]5Y"--5Q"I&0,::\]G*]5MJ:DY"<]X125$T;?[)7]DV1$KVG]91B/MC?"9K
M'I:UQF<D*I"]2AXASQ% EK4Y1J#-$@?R(F^L3*X.SDW$L:A6S"JW<$P)2VI2
MB<M1;GA_8D^_7_-J$NG%;CQR:M>'6/6FE]5_"9;\A([6%P7*]1)[E<4(DRI@
M6$UI6CP_FM3>&RDENESK%H^TOR71$N3%IQ<TB38(NTG,:V4^_P F46[S.I&E
M8)3]@R_:S%K9?DD10ZI(]%*9M:3V++Y6YP65V*UQTFL&N(FV T.Z^-PU\,^!
MO\<:C6Y626F>@;.S3"02;F(LI=TK3&6XR_,P6'>(OQ;L_6HB*?E$GN-\N1IB
M,H:(O6D$E,BD,$@LM=3FG6?W6E%N1I:1B3$>A>A=U=HK8LXJSH^]-$8;)%(D
MFC,<'"U,VCG;>)PWT-+\(/$>?^6UC1^)26D&ZKHY<'''?EKQWD+99A\Z=992
MA5G[U@879D?4P"&D5Y8'MET2E.L?8'NPF,&:6:(-Y/JZLBXH\:Z8F\PX?)_4
M]L$=)%XRLMC[7+9O]:ZV.5:R:#<RY=Q<>$5S.)DIM=3PBN./TU93?9D5(I]7
MI4R25KWW>50I>PNUIJ!CK8<6\-B1Q4Z)R1O!A3#_ $S:RXE*O*Z.8O93DLXX
M>\ASN3]*-MK*C:4W6*Y!(V%8GH2Z%U[P9O4L#ALA,;SYLZUK4KJGDJ?H/CV-
MN<(;5C&?N608:KT,T/V$M0[3YJ'Z2^YH _Q#6PCQ#4G"':L5?R-5M"B*:\@O
ME42#3IR83UN1>P\?MX?\1>BW>@E)%B:2896!NRHP(\$9\W3GL-X?T\4^6L3$
M])L0OH'QVH);4/@TCGE%.M3/*QYN==:T1.GQ<J=8#4E<\6K'Y702W8R9I"V
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M!D1K5\8C<CE26KXI;:.*LM@&,+XUJP,B<YBJAU=F1ND)+(I<_@"Q,+@G/2:
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=!&(\PM1$=1:M#>F2*M4" ;Q-4TQ:74WKLM>A_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>g729258g88s66.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g88s66.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1R24&AO=&]S:&]P(#,N,  X0DE-! 0
M    '':^<H8X0DE-!"4      !                      .$))300Z
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M8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
M    3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K
M9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M  !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@            0G)D
M5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M4G-L=%5N=$8C4'AL0&'_QJ         *=F5C=&]R1&%T86)O;VP!     %!G
M4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M      !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M         !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T
M;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C
M=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M     ! #O_XU  (  0.__C4  @ !.$))300F       .             #^
M   X0DE-! T       0    >.$))3009       $    'CA"24T#\P
M"0           0 X0DE-)Q        H  0         !.$))30/U      !(
M "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H
M   &       ! #4    ! "T    &       !.$))30/X      !P  #_____
M________________________ ^@     ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@  #A"24T$"       $     $   )    "0      X
M0DE-!!X       0     .$))300:      ,U    !@             !C
M G<          0                         !              )W   !
MC                      !                         !     !
M    ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !
MC     !29VAT;&]N9P   G<    &<VQI8V5S5FQ,<P    %/8FIC     0
M    !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO
M;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'
M96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   8P     4F=H=&QO;F<
M  )W     W5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G
M951%6%0    !       &86QT5&%G5$585     $       YC96QL5&5X=$ES
M2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE
M;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG
M;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO
M<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P
M3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O
M;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M       ,     C_P        .$))3001       ! 0 X0DE-!!0       0
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M!0$! 0$! 0         !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$
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M/Y$J
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M /_A0(%H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B
M96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^"CQX
M.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D
M;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T-38V,2P@,C Q,B\P,B\P-BTQ
M-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P
M.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX*(" @
M(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @
M>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(CX*(" @
M(" @(" @/'AM<#I#<F5A=&]R5&]O;#Y!9&]B92!0:&]T;W-H;W @0U,V("A7
M:6YD;W=S*3PO>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP.D-R96%T
M941A=&4^,C R,"TP-"TP,E0Q-CHP-#HQ,BTP-SHP,#PO>&UP.D-R96%T941A
M=&4^"B @(" @(" @(#QX;7 Z36]D:69Y1&%T93XR,#(P+3 T+3 R5#$V.C U
M.C(U+3 W.C P/"]X;7 Z36]D:69Y1&%T93X*(" @(" @(" @/'AM<#I-971A
M9&%T841A=&4^,C R,"TP-"TP,E0Q-CHP-3HR-2TP-SHP,#PO>&UP.DUE=&%D
M871A1&%T93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C
M/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^"B @(" @(" @
M(#QD8SIF;W)M870^:6UA9V4O97!S9CPO9&,Z9F]R;6%T/@H@(" @(" \+W)D
M9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N
M861O8F4N8V]M+W!H;W1O<VAO<"\Q+C O(CX*(" @(" @(" @/'!H;W1O<VAO
M<#I#;VQO<DUO9&4^-#PO<&AO=&]S:&]P.D-O;&]R36]D93X*(" @(" @/"]R
M9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @(" @(" @("!X;6QN<SIS=$5V=#TB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E179E
M;G0C(@H@(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(^"B @(" @(" @(#QX
M;7!-33I);G-T86YC94E$/GAM<"YI:60Z,$,Y,$5!-D$S-C<U14$Q,4)"0SDY
M13@Q1C<S0S%!,$,\+WAM<$U-.DEN<W1A;F-E240^"B @(" @(" @(#QX;7!-
M33I$;V-U;65N=$E$/GAM<"YD:60Z0S8Q0C0Y03 Q-3<U14$Q,4)"0SDY13@Q
M1C<S0S%!,$,\+WAM<$U-.D1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I/
M<FEG:6YA;$1O8W5M96YT240^>&UP+F1I9#I#-C%"-#E!,#$U-S5%03$Q0D)#
M.3E%.#%&-S-#,4$P0SPO>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/@H@(" @
M(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @(" @(" @/')D9CI397$^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F-R96%T960\+W-T
M179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E
M240^>&UP+FEI9#I#-C%"-#E!,#$U-S5%03$Q0D)#.3E%.#%&-S-#,4$P0SPO
M<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H
M96X^,C R,"TP-"TP,E0Q-CHP-#HQ,BTP-SHP,#PO<W1%=G0Z=VAE;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.F%C=&EO;CYC;VYV97)T960\+W-T179T.F%C=&EO;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.G!A<F%M971E<G,^9G)O;2!I;6%G92]P;F<@
M=&\@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<#PO<W1%=G0Z<&%R
M86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z
M,$$Y,$5!-D$S-C<U14$Q,4)"0SDY13@Q1C<S0S%!,$,\+W-T179T.FEN<W1A
M;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C M,#0M
M,#)4,38Z,#4Z,3<M,#<Z,# \+W-T179T.G=H96X^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@
M*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HP0CDP14$V03,V-S5%03$Q
M0D)#.3E%.#%&-S-#,4$P0SPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @
M(" @(" @(" @/'-T179T.G=H96X^,C R,"TP-"TP,E0Q-CHP-3HR-2TP-SHP
M,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W
M87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T
M.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N
M9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYC;VYV97)T
M960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G!A
M<F%M971E<G,^9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P
M('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C
M=&EO;CYD97)I=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IP87)A;65T97)S/F-O;G9E<G1E9"!F<F]M(&%P<&QI8V%T:6]N
M+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO<W1%=G0Z<&%R
M86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z
M,$,Y,$5!-D$S-C<U14$Q,4)"0SDY13@Q1C<S0S%!,$,\+W-T179T.FEN<W1A
M;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C M,#0M
M,#)4,38Z,#4Z,C4M,#<Z,# \+W-T179T.G=H96X^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@
M*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @
M(" @(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(" @(#QX;7!-33I$97)I=F5D
M1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(#QS
M=%)E9CII;G-T86YC94E$/GAM<"YI:60Z,$(Y,$5!-D$S-C<U14$Q,4)"0SDY
M13@Q1C<S0S%!,$,\+W-T4F5F.FEN<W1A;F-E240^"B @(" @(" @(" @(#QS
M=%)E9CID;V-U;65N=$E$/GAM<"YD:60Z0S8Q0C0Y03 Q-3<U14$Q,4)"0SDY
M13@Q1C<S0S%!,$,\+W-T4F5F.F1O8W5M96YT240^"B @(" @(" @(" @(#QS
M=%)E9CIO<FEG:6YA;$1O8W5M96YT240^>&UP+F1I9#I#-C%"-#E!,#$U-S5%
M03$Q0D)#.3E%.#%&-S-#,4$P0SPO<W12968Z;W)I9VEN86Q$;V-U;65N=$E$
M/@H@(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" \+W)D9CI$
M97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_
M/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! ?_  !$( 0@!I0,!$0 "$0$#$0'_Q  >  $  @(" P$
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M!&2_]EU-"#*\R#1C5XQK'J;%(D$\"5T$H1#$>V*57.F@G;Y,2$!2=)U-,B;
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M^?ZO[+H.NZ"L8KNVTEYUGU]JKRSW[.R83KKM;3(M3HQ'E_*9*R*MZB!C1E3
M9.,)(>AQ+X5;%.1)!"-#!*DH(PM QF4A@ &)F 60F@ =R*J57103;%F-I"9"
MX:MC!%V   ",>'GWB=VYB2>K'R S#'^&W1&5T%,/35U73P6MK;NK0^WYB!22
M[0-*Y'$);^'ZTF<E: R :M='-%/$R!KB)BI9RWD+\ 0@,@B:':?-'<N_(H@L
M20:( 5BH !R@4+N(4*S2K-N%DJZ*%4#<6&U:!4;;M06)(6K_ *&'M+.4E1GZ
MW#=?-KJ2M"J@6S]K:>>9! !XQ1TEFDZD5\LB11-];W?S3O-41$\D27<R.SM6
MYB6-"A9]!Y >6$0(JHO10 +Y-#].99+3M_\ /B.N$_\ I0TO]C_K1K_97^YR
MN6^?GY^[+"%<4\8=YT, YCH8W%0"D2%C0D*Q%EC@*E%"E(A8_P!38YI Q7R-
M1'N@B558C&<CC&.,8XQCC&.,8XQCC&.,9X5%5%1%5%5%1%3R547]5/-%3S3[
M_JBI^JB\8RJ;, ZM((98=VVU0Z$(FXE%,%ZS&46I@D],YTB&93WVUPCG)%(;
M,Y8HU\DFF]?U6+')L4M;C?3<:6_2SP+ZG@8VWP+LV!1/-<FAZ@437V]<B9&E
MHQ6V+Y_$<2V*H$KK"QD;!UE+$*%;^CY84^6+(2,? :DD;H)(WO:YDD;E5&/8
MJVHBR00 VPDB@&-\&ZKW6N^!M:_=-5++=;A94O6[\D4">M<;E^-L/49'L'F^
MOB;&W!Z^[D@L[.^L;+:7*4M=UA;E65B^W,$/NR2DR);I9(K=A@S7)-Z198Y(
M1V11M5J2H;9X0>[C(Z72M(+LG^,XHDGQ$$$FB+,07MB"[KM'(!*QB@H KPH.
M@Z#GSO,T?X<,Q:_&?,K5#OCR+$HU"<+U7*A1%M'+%9S3>K"K[DI\<TC"GN\W
M3(Y4>J\K9VA0:512@= +L >E'I73RK+>9;S+;B?,M06R>MT +^ ]!DDS?4,N
M/&)$RVXN:$8PA"BXJO+];"-)(;%' V8A8L4U9I4ABCB1\BN<C&-:B^2<DL6Z
MDGDGGU)L_>3E0JCH*- $CBZ%"ZKYOUR1_@AK?UU];_X#Z\_]3/\ /^UR,FOB
M?O/Z?T<Y+Z<$VN!C%L+DV^):^1SK*P'JQ296O=YM8Z&G K06MC3\EBQBL<J?
M5[GN^O&3F4XQCC&.,8XQCC&.,8XQCC&.,96/;/:E+U#F(M-<UES=?%6<%174
MU!'7R6MB=,,8?)&.MK855=&T:NKCSIGE6 [5B%?%#[I,D$$KJP4 FP[$^2I$
MC22.WG2HI-*"S&@JDG+!202".-@ )HLTDB1(H^+.ZV30"VQ-#,$%W[U_9;WK
M_KFMGLCM!V+BK'?5*P!>8-=0 C5A<*WA+Y6_ G6D-DDE:$UD\TS S99$ABCC
MDEN8V$NHA(\6F0O(?R>)88BJG\I@9XV(H;48$U8&9;QW4$M';J)5B3CD,T4\
MP+@>ZI&GD4&R"X(%@$BQ]-L<GBQ!S]=I*3,A%DH&*7>V8=6.26L4DZ#02F2Q
M,EG]F&6;VF*Y_M122>GTL<J4R^0IW?'2R(OI[6Z^5WDOI1VMIFHKOS(KD*<K
M45?)%5&N5//S1JK]%8S73M+N.^V.6)SV+[4\/F$LB[*N<[30=WVA1X]6*8P@
MR 8<7 5DL!1T$2#)*RQ],"2/];28O5%('OQL>55]SKTW@*P"WR!XBK$D,/#1
M5@2,L" K@J"S+2$D@*Q8'<:()\((H%3XK#*0#E<WUW<6,+5K^^^I1RUVE9KI
M9[KQ":&\%B;7BM'=3U@$.(J(JP">5B%?##R+7LG?,KZV;UIZ;JX5XVV*5221
M]IHDAW5@A:KVJ%[L7N\#,!M+$YDZ%PPWLNY47PDA?"I7<1=EK.\$,#O5"V\
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M,_%B_P#;(_\ PT7_ )7,<WL#J:Q\6)_VR/\ \-'_ .5QC'Q8G_;(_P#PT?\
MY7&18]1CXL3_ +9'_P"&C_\ *XR;'K\_(/W9]F/9(U',<U[5^YS'(YJ^2^2^
M2HJHODOT^_[^,9[<8QQC'&,<8QQC-;^Q?$"SK[MO&=;DYT<FLT8]3/::*>\<
M"56-O#+T(*2MIOE1++@>O?0$DW\K[2N=7!$#$1QE*KV)>).\,ML%6.-F_C,6
M6#4:BBO!"LFG9%8;B9&50OGA[5$8 L7<+70 &6"&PW-L&U"MMH#8K'=9 S&=
M0>*?(]J93M;;RU5IF\YUAV);8:1\H=O;W-L,$/2S5UNW.UU,ZZ'+N770[!J
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M%T*NG>]Z./HUA1I)6;GG:J$;5LEJ 'F(3Z1-Z$,"(]GEO,LB11J+'!9I%Y-
M"R?C\0N[:>QV> R86>OR!NQLJNKH]$QU0H,03:UUG(T^M2S6^%A@A^&&(LWU
M?RJ*RL*ZO0R0DI&LL8F6341,0KZ<$MS8:G5/"1=66.S=MW[) H)0Y0.#'%*
M2LIVCCD&B>;JZ MMI;:"I:@PS,;?^CSIO]L^H_@!IO[7,O3Z_P!!R^6666*
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M:]39)YJ2(B&]^3O: COF]Y4R>ELJ5SA8QX9A9VNL&GSC>@57R@7Z3<2. 4H
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MUA$#G*Q$;-&JH](86"+J_/K^;T/0Y(^WSZ4"/B"018ZBP>?+*>T7A;[&O1*
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M;+%&)&BOE9Y;ZK]US(HX[R=R=VX+'$KRNUGEB$0T!9+$ <<YS:=2T*'@$+$
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M@N)?[$+'RR^F)?;C:Y[O)J*O+2Z'601":;2ZB&%F"K++"\<;,18 =E"DD D
M'H">@PL\+L426-W4641U9@. 254DT"1?'%Y*_P <W6_^^&3_ ,!Z+_)/.7-+
M^O[C^K()>>+?PVYG35>*T7<&1HMA>"O.ILO;D%UV@M0HUE:\NOJ"Q(CS!V.@
MF1\T$$D;5BD1SD]#O+>/2ZF:.26'3S2Q15WLD<;O''NK:'=054FQ0)!RK21H
M55G56:]JL0"U=:!Y-?#,=G?&=X6-?I9L;E.\L'I-<.*0:1F*.RDM+^$,1\49
M14M2$/,<P<>2>&.>5T",B?+&U[FN>U%O-H=9IXUEGTNHAB<TDLL3I&YHM2NR
MA6- F@2:YR%FB<E4D1V LJK!B!=60+/7C,L_>975]S]9B4%HXX@;)]G3SQNK
MK0/T0K/@6(Y'GA#1N7UJB>ECW/\ S^GR\UYR]+^[+]?L^SR_OS8;C)QQC,!J
MFW[\QH6Y646#3NI+1,],<K4"BNU"G2KD+5\4[$&8;[+IU?#*U(D<KHWIYM6K
ME@I*@%AR 30-=1?E8\_+)6K&[IYUY?'XUUKSS6+#:[>;G+=F=9>(/*Y$/3!9
M,ZZ(!SQXF^K+3(7"VP=7,54R45=5DG1359#9:N5\[#YV-:Z"""1GJUU,<;Z9
MY8U954LC*P5PL@WS1%22+*H$H'C>A)<6,K 9$F17*MNHJRDKN4;(Y0P%D6S-
MTYVM0!(.4#]EB%7 =+[R"J0%@*=J:'VHZG+56;K&.2 1DBQOJCK"*P/D>Q7V
MWN3I\N.62OA8D$$;WZR&]+H> /H;&URXHA#X2>2I))W?E,6'Y  . NJG "CB
M/W2+)IK,BC]JD/G#2A5VM5N3FYW;/=]+U+:8^LLZ6UMWZLF3W9JZ0...FJH+
MS,9PBU(0N:)Q?M6NPI(T!#1Y4@[RR&(J#>W+E$C32]VOD(]S$B@97,<0J[.]
MP02.% +'BKE_!$9#TM@!YGNXVFD-]!MC0D \L2 M\U\L/WI1;KLK:=; TML$
M7D$/5EP6X10;GY/;-H[E!8(9GEB?!6;V0Q*9$Q#854B%4:U6\+&S0B:@%)!
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MEHJ:*QTTI$J-&!M!)/7 J-6;&--_?>(?10O($'ODK#/*M@T LCPKITJR9ID
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MA]-I8!._)]ST^VJ/7T='V3VAVA!J]3I-/WL&A57U3]Y$G=*^[:=LCJS7M-!
MQOCS&82ZF&!HTE?:TI(C&UCN(J_=4@58LDCKD:Z^^TQ\/7:?<$W0F$I^U;WM
M@>MN+>;)MQHM>]E=02C0VQ/SBTO0:%R"2F#,6)MHZ:;W44>.9K7JW75]A]JZ
M#21:[5Z4Q:69Q''*9H'W.RE@-D<KR"U4GE0!7-6+I'K-/-*T,4F^1 2RA7%
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M93GV9]I?\YHJ].2?U#/"[3K\-T/K4GW5FKWV7'^VP[W]CJ3LS^$.-YZ_MO\
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MQ**>U AN289R\#[$P]9).TV:*;X$WVI(X',D^#*]"K\/+Z&,O7C&.,946^L
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MUUK 9%*^&4)S%<YM&0O)  ;?OAW:;0Y=RCBMK @@1F1F)!V*#):[-PT0D+(
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MJ 0I8+O+!E!O"Z*.0T8DL\%;VU:\^%K.PD@L%+; I5CD^A_TF>L_S?Z3:3_
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M?+S\D1$]7VR%>RO8W)/_ "H<DEC?X.Q-EB2>OK^:LYNROW?JO\EN    )"
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MTW[^P_Y4G^R;K^CITSNLY^-Y]KGYQ?M1/]L]\ GZGX/.\_N\E3\,[/S1?/\
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M3)Q1(W+'$[R>42..U?RIIXHT<]M78(K.02%!-"K->0L@6>@LBSEE4NRJ.K$
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M''%4!P/JKY&6OQDXXQE >)R]N:CIS35V9I:S0ZG:J)U_EZ:Y+<#6F7VRF2E
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M />*5CG92PZ$22110(HY+SH=UTATDM57:.3*J$DC8UR:=:4@\$)+)*6/ $+
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M&P"_"#Z=5->,BQF;Q8G98NUZN?VQ:"66J+K.WRD@!%K(!ZFM>3@F 5C9JJ&
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M1J)I"$BAB0%G=CZ*H9V53&NUVG[.T[:G4LRQJR(JHC22222,%CBBC4%GD=B
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MJ 9*7!8!5H,BJ#![\L$<[9.WV>]JO9GV:[0?4]FQ>U44%0,\?X=V=M[2[O\
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MOX/$D2YV*O(/H)R YVED)+/ZS]B=H1]DQ=M,B#02S&%&[U>\WAG2S'=[69&
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MSB+BI:K!J?/)BF9^D2:KMW$RD-<8Z,4SYD2GQC/HNT6[(/8_90TG9VJT^O\
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M\ZH/LQ_%/U[V7H/%%48+PZ[+H6YHM'\'#J?]4WMD!H[K2U0#,7%5-1.'RAU
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M_1+!/&V6&5OFB+Z9(WM>WS1%\E3S1.2RE696%,I*L/0@T1]A&55@RAE-JP#
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M(4<XI(B6*@0LDD@:J8]Z$W!JI224W%MH+,S$]<H5!E,O0M&D94=*1G*D$VP
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6GXGKG*Y7+8XQCC&.,8XQCC&.,9__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>g729258g90l67.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g90l67.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1IF4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &DJ^9S X0DE-! 0      $8< 5H  QLE1QP"   "V# < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       02'V >+KXRIY:]UWQK  (.CA"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!8/XU         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              10   )*
M  $                          0             "2@   10
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   10     4F=H
M=&QO;F<   )*    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   $4     %)G:'1L;VYG   "2@    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 2P"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M         0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#(3$2!$%187$B
M$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D
M154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=7
M9W>'EZ>WQ__:  P# 0 "$0,1 #\ ]520LK(KQ<>S(L!+*FESMHDP%FW.R+ W
MJV/E6UT%C-N(]@#9+MN]VYOJ?GI*3]3=U=ME7[/:UU8!-H.V2=]/M_2%O_:?
M[5L_[L_9_4_0^HJ>+D=2=U1^6ZF\8=I;6VM\C;O;BNJ>VG_@_P!:^T[F_H7_
M .$_G%N)DE/-6GZW8HR[JF>N/6RK&A^U\TAI=TZO%KKL:[?ZFQE['LK_ $7J
M_P"'].RPK'?7/]$YPH#38&V L:YPK#7'U7M;?6QUC]VR]E5WZ.QGZ#U*O46O
ME97ZK:<2RHY.QWH>H?9ZD?HO4VN9^CW_ $_>J6!U#JC[VCJ%5-51I;O-5C7;
M;]UGJCZ9?90ZKT?3]C-C_P#P%*:,_7-S6/=6QKV,9N#7,)ES*VY'IU[V477,
ML;;;3Z[ZJ/TGH_X'U\G2Z2>O>K?^U_1VD--(H&C7;K6VLESG/>STVX]K'/V?
MSJOMOI>[:UX<X\ '5$24I))))2DDDDE*57J%F<RIIPJQ987@/![,UW%NYS&_
M2V-^G_+5DD $G@:Z"3]P68RT]8J;D861;BUM]2MPV@;BX;6V?]9^G7L=_.?S
MB2FF_/ZL_(Q[35:S[-7NS*@T-K<YLMR=CBY^YON8_&_GO5_X+])<I]2N^LC<
MRR[I=7K4?9*SC4V&MM3L@V/]<9#W.9E,_5O2]/9^C6K@6OMQ0^P[G;GMF(T:
M]S&\?R6JPDIYL9_UQM9>^K#J#*W6BH6,V/?LL%%;16<H_P""WY7JO]/U]GH?
MHZO1S+IOR/K<X^F<6OZ?\Y66L$ XUC3N?=:YK'?KE%GZ+U/\(Q:O4
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*KEZ(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HBXBRJA3])#<<]/GT^0_6-W
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MDQ& U;**E\=8S5Z@F)450("BA0$J0<%-%7'&H):QX9G@ZJ$X  34#CGJ;^\
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M1-$31$T1-$31$T1-$31$T1-$31$T1-$6TO\ V(_F' <\AP(AP(#R #V$0XY
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M%%7>0J3!PR\%@1SXG+SSSBHQN6T/'H3G0/D0U00N\WN;.]V>2<58YV^H;5\
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MX[]^WRX'MQ\>...>_GWT1:?"3Y$>D!$W(&YY'D!YY >1[E[B %\@#@
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M<&#D.2CQ]I3 8OE\A !X\A\AY#1%H!%,/(OQ$1]XP\B(B(]7(^]R(CSU<]N
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M+W*MIEJ,Q(3<S,%8)3YHL\Z>%:2+URTASSQX=@I+ Q21];.AU !$U%B'$O=
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M@CMA)QSQI9%FSQHY2_%+(*IG*)#I"8GF'(F W 7Z'V*$N 1K#[A7!2>0_?\
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M^R\>N7KZ*0V'(>R:*IHBI/C^N2T&\OKB8(0#3]UF9B.5(N145HIPH46/B=
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MMGP%!LX.Q5EG$8?QW'-:];A(-IA6[2JQ:*,98A2_%>VF:9"H28) "97A%BD
M   U%D':M_/.%E7W1508WV_VN[>/WU>)/\Q9M47Z1>Q4-NL/N%.0GD/W_P!
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M10_U0#(C*AX447]K;5J>-RN=1 BAR9RRJ0@F(4QDR%M3\@$*)@$0*4O8"AP
M (@' =M<#8,F48]H;TN7$V.Q @WH821#OTAA<%@ &8-RJO<_&TZ:/]']V9'
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M^<*B_M7$?9^60Y[?AUROV_\ Y5(:X&P/YMI__?S_ /S*]U\;6^'?_P #A/\
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M36M+<NR+.U2#G<;Y.JA[=/,ZO%24[7RM(WVQ(H.E6;=PY(\6%,3E:KF*84S
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M9Z+SME*4(.6#I+[K!V'8 ^")PY_+_P!&OABV^4:L\,50<_V6S@8HAC)5369
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M5G<+76)AVZK0CQ\JM'G(W*^=-V*:JA"*"<Y/'<I\\%#MR/?N [LW&Q2X@\!
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MG5YQ-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$6VJ(@F<0#D0*/ >7(_
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M,V#'50F)-\?Q7LA(P3!RZ<J@' JJN%D3F4Y+P4!,(B !Y\=M9C$3)8W1-BA
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MR\$=FPX_$XF;+BFS(X(8((!$!N1&%R36T+TLY)X<^;BYT.(BDRY(C$(A.\2
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MK/.R%LH&X+&"6WR'VUV/;N6?B ]M;HE\%U[/,:U1>MS1RF/6="?.K1+S!B=
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M]N=V-;6=WLA3Y'<7B&M9/=T0DTE45YU-=16!^D9H4)DS,45DS$,]+ Q)E>D
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ML[PMVK5VZO1?#X)W*@'3^K#NA@[_ /B\Q: B/S[U8O/8>.W_ &_/^+V02_\
MAT4)-X89T6Z-*,6<"[]C>108I@3&YU N1_\ +*@H[<<J?[<JM=:ENQW(1-XR
M%)9-F1Q5M^=C8)2'@H9T5FM*9=31CRM8"/C8[PVATA,94Z"SKAVF(< (#KI;
M6G82;L/9,6'D'#@8C&#=?>!)F@4)#N^0,(U)+*R#B1'$)CF &'ZC=V)<6MU[
MT5PHH 9(#&#I$0X,4W)@$1\P*(]Q*(]73U<#T\=0%$1*'DR0*$N"8N3$V+Z
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MC!?,#8XJ3!NX@</V>ZKN%A24;P5G,@HS*0@""RPS=C8(&3,("0"H&*< X#H
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M1?1"!#%*C#B$&$WAS(>IIHSK=Q\K!.\DEV!<F@>K.2_&^5:%XKFI #JY4X
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M P"!SE$1 P]8G$3'$>0'W2<Z[ (H(J16YC71\N/4KQT?S=\N!$&)>@8MT#$
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MX\=A#Y_#[AUE" (0(8=T!V%LWL^O)0@$F(ER6)T#!N5N:* (@!_[[GGI#GN
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M'#%)@$,4P3 0(15B+L]B<PSZNNU-^/?B6."9)F[3BBDQPF&(&3 00QHP8W)
MLSD79I/,&R3=%)L@F1NV0;D(F@0.0223(F4B*9@Z4_#(02%( =Q "]^PAKKR
MH),N$0RX0&H&-&9@*<6_-5XZ='-FQF:9F]O$DQ_+W#$23]3DO7ZBVN86\L)
M)U\\%Y$ *41$P\E,'!?>(41 0ZO>Y+T@8!#GRIB B$-7)8=LO9?%P&BBB>SF
MA< \.O%GYJ)F3\>9G-F"'R9B5U0SJ-:;)U9^WNQ)XQ3%?2D/*^.T]B)(@ E4
MB2$'J64(8%# ).K@0Y>-PF-F8F";AXH9;!CO Z!PP J7# FB\YB=GXJ';(VG
MA(Y,<!P46&,$S?=XILN;O PPG*  5H!8$T\C89?>?#1<G.NTL%&:Q;1PZ6*D
MC>05.DV(954B(&<E3%4Z93 EUJ)E$XEY$!'C6M,F[9D1$1&3' (7A#&ASNSQ
M,!XY6OB9OQ#!*GXD# 0PRH8B/JGO$!4O2%OI>U 1?);-,LF\:[U>OV2.#!R#
M2Q1$=--"/4+N+ANC(M$G:2*Y&T@=,RJ*:H%/_5!.5"FY( \@&SAIVT)T!CC@
ME@1#Z:&CTJP!\'!Y@Y^W\5AY$Z(X$"=")D,(BGQ4B#@$BCUK4EW>@*]=CG'^
M;U<O!D+*[F@BW9U9W5X].F%GR&5,YD&STRSE.7%5,@<-Q* )N5%.H0YX+SSG
MA9.)@Q$4R?N"$P;@$.N\_4,XOR!7VPF!VF=JQ8[&1R/EB2</!!)WW??AC,41
MC!_M8L::9J8;8W5U<B/4 !U%-Y@/P^SR#MQ_+WUTUZA;Y1Y4-Q_>A_/HH"X]
M"-"MS15-$31$T1-$31$T1>"R1C^GY4IUEQ[?Z_&VNFVZ&>0=CKTPD9Q&RD6^
M2.BY:.4>D0Z5DS"3J2.FY+SXB*R1D^K1.'GE*:&RM7.?1(1;!XHQQQOF](/B
M['!C@F7%58W)33NL1[$  @1D)*V>.G[-'1X)E*@V:(67P6R12HMC(BB0 *-]
MR:>?=3RV[;7<2;7*K(UC%T/,HJV!^66MEIMMGG+Y>KK-))@DE+W"Z6^3E+)8
M9(J0G(W%RX!%JF(H-6Z*!"$$@IY^@4E&W=+GCCDQA$.HQB@(CR(%$W?I#RX\
M@-U &BJA!OM_M=V\?OJ\2?YBS:HOTB]BH;=8?<*<A/(?O_H#456O1$T1-$31
M$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-
M$31$T1-$31$T1-$31$T1<"4;M7D<]:/FJ+UDZ;+-G;-RB5PV=MER"DNV<H'
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M,W!%FCDI5#$*LB8"F,3I.>B_0^Q6,5830Y4SOP5R8DG&@ \R#$.__G:'V?\
MXFHLEK]IQO[8L?X6W_2:(GM.-_;!C\O_ *6AY_+^R:(GM.-_;%C_  MO^DT1
M/:<;^V+'^%M_TFB)[3C?VQ8_PMO^DT1/:<;^V+'^%M_TFB)[3C?VP8_PMO\
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M2KTJ&]=709&=O960>R$F[<2,M+S,Q*.'DM/3DJ]<JN7\I(NUW3ERNJJH?DW
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M4E3QSB4<F?O(""77*+AM68MRH=M",5%5?5F";=,IBD*5-.*CS1\V]ZZJ: B
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MFS[;!*WC8)!7>9P5EK,M8R>$#DN->LI-K#2UWKM88(I.B05=EW*0+ Y=I*N
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MJ]7>C6;\CV>WJSX^]*WLA6:[C,2Q8,[#*VW'F2*>*Q7T:PNM)F'$',2]-G
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M0A"\$ IGT'N:MEWKQ97&ZKLHVTTO<#:=T59Q/68?-5RC&\7/7-LQ3!THFAU
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M2IKJ&Q<TX4;WJ? ,_3[)?1WX_P R8SPSDNN9^S))[-C9&;[B,;[4YULR8TJ
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MHB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB+8<E,9$X%,8ANP@8H"(@)3 /(
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MV$J!!DWPM6B9G"#5R_,X=MVAW*A405 @#P' EDI-Z(FB)HB:(O@B  (B(
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M:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(MEP4#)& 2B;R'@.0'L(#SV
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5(FB)HB:(FB)HB:(FB)HB:(FB+__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>g729258g91e38.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g91e38.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1F>4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &8*^93 X0DE-! 0      $8< 5H  QLE1QP"   "@  < E  "')R,S4Y
M,#DS' (% "5-:6-R;W-O9G0@5V]R9" M(%!L:6%N=%]#;&5A;E]V97)S:6]N
M.$))300E       0?*D#_A)/=0K%,M[*_D93I#A"24T$.@      Y0   !
M   !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E
M96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M   +<')I;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!8.6B         "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  (#O_XU  (  CA"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          CA"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              +P   %H
M  $                          0             !:    +P
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   +P     4F=H
M=&QO;F<   %H    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   "\     %)G:'1L;VYG   !:     -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 5 "@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M9=6=2,<7759+7;A5CAU.0WVN&ZRBYS++*?=^;^C2
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M             /_A/_9H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_
M>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK
M8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z
M>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T-38V,2P@,C Q
M,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI21$8@>&UL;G,Z
M<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M
M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @
M(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C O(CX*(" @(" @(" @/'AM<#I#<F5A=&]R5&]O;#Y04V-R:7!T-2YD;&P@
M5F5R<VEO;B U+C(N,CPO>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP
M.DUO9&EF>41A=&4^,C R,"TP,RTQ,U0Q.#HP,BLP-3HS,#PO>&UP.DUO9&EF
M>41A=&4^"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#(P+3 S+3$S5#$V
M.C,R.C4R*S U.C,P/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I-
M971A9&%T841A=&4^,C R,"TP,RTQ,U0Q.#HP,BLP-3HS,#PO>&UP.DUE=&%D
M871A1&%T93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.G!D
M9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(^"B @(" @(" @(#QP
M9&8Z4')O9'5C97(^06-R;V)A="!$:7-T:6QL97(@,3 N,2XQ-B H5VEN9&]W
M<RD\+W!D9CI0<F]D=6-E<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @
M(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @
M('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^
M"B @(" @(" @(#QD8SIT:71L93X*(" @(" @(" @(" @/')D9CI!;'0^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^36EC
M<F]S;V9T(%=O<F0@+2!0;&EA;G1?0VQE86Y?=F5R<VEO;CPO<F1F.FQI/@H@
M(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^"B @
M(" @(" @(#QD8SIC<F5A=&]R/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @
M(" @(" @(" @(" @/')D9CIL:3YR<C,U.3 Y,SPO<F1F.FQI/@H@(" @(" @
M(" @(" \+W)D9CI397$^"B @(" @(" @(#PO9&,Z8W)E871O<CX*(" @(" @
M(" @/&1C.F9O<FUA=#YI;6%G92]E<'-F/"]D8SIF;W)M870^"B @(" @(#PO
M<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIP:&]T;W-H;W ](FAT=' Z+R]N
M<RYA9&]B92YC;VTO<&AO=&]S:&]P+S$N,"\B/@H@(" @(" @(" \<&AO=&]S
M:&]P.D-O;&]R36]D93XT/"]P:&]T;W-H;W Z0V]L;W)-;V1E/@H@(" @(" \
M+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T179T
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V5%
M=F5N=",B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(CX*(" @(" @(" @
M/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#I#.4)!-# Y1C(V-C5%03$Q.#4P
M,SDQ03!!03-&-T0T0CPO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM
M<$U-.D1O8W5M96YT240^>&UP+F1I9#I#-T)!-# Y1C(V-C5%03$Q.#4P,SDQ
M03!!03-&-T0T0CPO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-
M.D]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.D,W0D$T,#E&,C8V-45!,3$X
M-3 S.3%!,$%!,T8W1#1"/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @
M(" @(" @(#QX;7!-33I(:7-T;W)Y/@H@(" @(" @(" @(" \<F1F.E-E<3X*
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T
M179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E
M240^>&UP+FEI9#I#-T)!-# Y1C(V-C5%03$Q.#4P,SDQ03!!03-&-T0T0CPO
M<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H
M96X^,C R,"TP,RTQ,U0Q.#HP,3HU-"LP-3HS,#PO<W1%=G0Z=VAE;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG
M960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D,X0D$T
M,#E&,C8V-45!,3$X-3 S.3%!,$%!,T8W1#1"/"]S=$5V=#II;G-T86YC94E$
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 S+3$S5#$X
M.C R*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S
M*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T
M179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N
M/F-O;G9E<G1E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z<&%R86UE=&5R<SYF<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP
M:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z86-T:6]N/F1E<FEV960\+W-T179T.F%C=&EO;CX*(" @(" @(" @
M(" @(" @(" @/'-T179T.G!A<F%M971E<G,^8V]N=F5R=&5D(&9R;VT@87!P
M;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S
M=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T
M.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^
M>&UP+FEI9#I#.4)!-# Y1C(V-C5%03$Q.#4P,SDQ03!!03-&-T0T0CPO<W1%
M=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^
M,C R,"TP,RTQ,U0Q.#HP,BLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @
M(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P
M($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^
M"B @(" @(" @(#PO>&UP34TZ2&ES=&]R>3X*(" @(" @(" @/'AM<$U-.D1E
M<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @/'-T4F5F.FEN<W1A;F-E240^>&UP+FEI9#I#.$)!-# Y1C(V-C5%03$Q
M.#4P,SDQ03!!03-&-T0T0CPO<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @
M(" @/'-T4F5F.F1O8W5M96YT240^>&UP+F1I9#I#-T)!-# Y1C(V-C5%03$Q
M.#4P,SDQ03!!03-&-T0T0CPO<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @
M(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.D,W0D$T,#E&
M,C8V-45!,3$X-3 S.3%!,$%!,T8W1#1"/"]S=%)E9CIO<FEG:6YA;$1O8W5M
M96YT240^"B @(" @(" @(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @(" @(#PO
M<F1F.D1E<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD
M/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$!_\  $0@ N@%E P$1  (1 0,1 ?_$ !\  0  !@,! 0
M       ! @8'" D$!0H#"__$ %T0  $# P($ @8&! 8)$ L!  $" P0%!A$
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MOAV1Q/1-!N =12L,@7J; A?4>C)L? _V9,;M_@:&?U_3?7YZ?LSB/_P.J_\
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M]*V5E+B"-=GV5[0MX$]SBTN+B#G,#H?Y^&5YYV[[)5>TNF92I.:R!!YI&=[
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MUGJ<-I)D%I:08OOX?65L#8GQ*R*14.-+9(DU.FVSQ5V2QD&;2A#VYWABPTG
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MUPTZ=19NWUTWTVS%J%!DU LU&Y4/NKCU%AZ48DB6M4EI 90 2YX02LN<C9:
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M%OSI\AP/NJ4I06I(;:&/6>=22YTM).(($;1-X&T$>2CZ_%7>" /B=4A@WO\
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M#!/Q&,DWD3;K,8SX-OYX_P!1'AY@GORX H)&/B?(#YYQT'?YCXZEQ(+0 8D
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M@FH^C1:7/(<0PP&@EIATR1$ @P/B6^X=K2X-95J-$@R"X VG8G:!,&#FY7L
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MYKJ>P4B-5JE"D.(]RTH/,.H/7774.%\1U;.;2Z+5UF3RA]*A4>TD9'.&P3W
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M3'!##4JO&IRRVVE:)3!5R:Y;5<6>ZF\,<#!B 9N"01&(QXSDX/V3V7[(=C>
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M6?'CE)".5;7*"3H^V?:CCVEX[Q/AU#5UJ=!E:HSE8Z!REH#FX@R"3 BQZ7'
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MXEG5)^#==A7O:\UM2PN/6[<J]-7D*(409<)D+2"#A220>XSY[&EJJ#P/B;<
MW!(GIL;XR"GV<_XKQ&!X9,^@)(@WLJ8M.=<U9G-Q:30J]4I+JTH:C0*5.FR'
M%$@!+;,>.XZM1)'1"%8\\==14U-%LD.%MA.+WPK)I/DP"8D6N/$P8LMI_#CP
M2<6>\3D$TG;ZJV'0'RGQKLW BR+?C1(RCE4B'3)C:*U4%@>TEF/%9C.#J9:
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MRXBF5-R+)G4Y4ACE;CU%<-#N$K6T!S$I(!!YBGQOBG9PU*?#Z[VTW/ J-8\
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3B:(FB)HB:(FB)HB:(FB)HB__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>g729258g95c69.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g95c69.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X55*:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ
M-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z>&UP1TEM9STB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O:6UG+R(^"B @(" @(" @(#QX
M;7 Z0W)E871O<E1O;VP^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S
M*3PO>&UP.D-R96%T;W)4;V]L/@H@(" @(" @(" \>&UP.DUO9&EF>41A=&4^
M,C R,"TP,RTQ-%0Q-SHR.#HS,RLP-3HS,#PO>&UP.DUO9&EF>41A=&4^"B @
M(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#(P+3 S+3$T5#$W.C(X.C,S*S U
M.C,P/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I-971A9&%T841A
M=&4^,C R,"TP,RTQ-%0Q-SHR.#HS,RLP-3HS,#PO>&UP.DUE=&%D871A1&%T
M93X*(" @(" @(" @/'AM<#I4:'5M8FYA:6QS/@H@(" @(" @(" @(" \<F1F
M.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.G=I9'1H/C(U
M-CPO>&UP1TEM9SIW:61T:#X*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z
M:&5I9VAT/C$U,CPO>&UP1TEM9SIH96EG:'0^"B @(" @(" @(" @(" @(" @
M(#QX;7!'26UG.F9O<FUA=#Y*4$5'/"]X;7!'26UG.F9O<FUA=#X*(" @(" @
M(" @(" @(" @(" @/'AM<$=);6<Z:6UA9V4^+SEJ+S1!05%3:UI*4F=!0D%G
M14%304))04%$+S=107-51VAV9$<Y>F%'.7=)1$UU34%!-%%K;$Y!*S!!04%!
M04%"04%304%!04%%028C>$$[05%"24%!04%!44%"+RLT041K1FMB,DIL04=4
M04%!04%!9B]B04E104)G445"055%0F=51D)G:T="45E*0W=G1T)G9TQ$06]+
M0W=O2R8C>$$[1$)!341!=TU$07=11$$T4$5!.$]$0DU41D)15$5X=V)'>'-C
M2'@X9DAX.&9(>#AF2'=%2$)W8TY$03!914)!64=H55)&4F]F2'@X9B8C>$$[
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(
M>#AF2'@X9DAX.&9(>#AF+SA!04519T%M045!07=%4B8C>$$[04%)4D%135)!
M9B]%06%)04%!04A!445"05%%04%!04%!04%!04%11D%W24=!44%(0T%K2T-W
M14%!9TE$05%%0D%114%!04%!04%!028C>$$[05%!0T%W449"9V-)0U%O3$5!
M04-!44U$06=10T)G8T1"04E'06Y-0D%G35)"04%&25))>%%614=%,D5I8UE%
M54UP1VA">%=X46E00B8C>$$[571(:$UX6FDX0U)Y9W9%;%%Z4E1K<4MY63-0
M0TY546YK-D]Z3FAD55I(5$0P=4E)2F]-2D-H9UIH2E)&4G%3,%9T3E9+0G)Y
M-"]0128C>$$[,4]4,%I85T9L85<Q>&18;#E76C)H<&%M='-B5S5V63-2,61N
M9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;RM#:S535FQP95EM6B8C>$$[
M<6)N2C)E;C5+:G!+5VUP-FEP<7%U<W)A-G9O4D%!24-!44E$0E%514)1645#
M04U$8E%%04%H141"0T53355%1E523FA)9UIX9UI%>28C>$$[;V)(=T9-2%(T
M4TY#1E9*:6-V17I*1%)$9VAA4U5Y5VE9-TQ#0C-04TYE2D5G>&15:W=G2D-H
M9UI*:EI&1VED:V1&53,X<4]Z=WEG<"8C>$$[,"M0>FA*4VMT3515-5!2;&19
M5U9P8EA&,658,5)L6FUD;V%7<')B1S%U8C)2,61N9#1E6' W9D@Q*V8S3T5H
M66%(:4EM2VDT>4YJ;R8C>$$[*T1L2E=7;#5I6FUP=6-N6C9F:W%/:W!A86YQ
M2VUQ<39Y=')Q*W8O84%!=T1!44%#15%-4D%$.$$Y531Q-T9867$W1EAI+VTR
M+W=$>B8C>$$[3'-V>D(Q<34P0S,Q83=I*W!Y<EIW=6MO<TEI='%J3$I'2U17
M<SE:1E!%1&I.>DI"5FMW<7!W834K9$4R;E0S<W)8.$)S<E%45SA%9"8C>$$[
M:D9),3,O=51E26U14U=C57!K*W!R>45A4E)-9&TT0W1-5E4T9&4O3UA58G5E
M94MB5F)#>DXS-F1T13)L=V\S,6%A8E5U3'-*<EIN1"8C>$$[4G@R.7%.+S5H
M>7%7,U9:1')&,S5N=DY+.'!89712879$6C-/:W9.<F-7:7!D4EAQ87$X1412
M2SAD=%-61D1'6#172$%.5#%.<T-P1"8C>$$[<FUT+VY46C9F2F,V54Y3=5AE
M+VUG=')7-71,9C%)-%E927IB3$HV1G).>D4X<G8V<VY)2CA)0WE2:7)%<6QE
M<F%R*V)'<S8Q1W1Z8B8C>$$[-G9"<'1R<6-C.%-X5U1*-EI!=EEU04M7>7,P
M6#EX.%A/4V=B,4]A;BLW5E)Q83,K9'1T<&I4,B\V46YD961R2%I4,E,Q4T]/
M=W1*4B8C>$$[8RMQ64I*;FLY5C5L2$QN>5EC94Q%57A63CE5=79Z9#%(>40U
M66QS>$QA96%P=%=K4V52,&Q24F%#1SA71U<X:E-+0VEK96MX1'A)=B8C>$$[
M4&IY4F9S9TML8T8U*UHS3S)H,&AT9# V,VUT,49W.3E!,3=-:S%V65AC:F=T
M9%)Z2BLX=DDP6&MT03%60S=&4FA61'(U>"]/<31..28C>$$[4S(Q3S%5>%)L
M6&)44T)#-EA-4U V449N3WA$>$]7<4)/,U5I3F%&47%Y4'E*-6@O3G$Y.#17
M;'8U9W-P;TY*97AJ939%:TAP4G$O,28C>$$[4T)U65E1545R6$Q32WEF5T=O
M3G945V=:9W(Q8D9867$W1EA9<3=&6%EQ.&XX=S94-71S9&(X=S-/:%A'<WAY
M1V)2,# R5#$W=3EG4B8C>$$[8GDU2V%G.%9V8W108DYW:DY45TUI361/3TMP
M1')F;D0X,71-=3-I=6)V56)E,DXK;&YD5"]O,D)X16HV;$9B,C,Q1B]12S-5
M;'A:<R8C>$$[-W5&1#!E9TA(-T]&5F(O12]W0V18,4AM66(O-BM,9&I:=T14
M:TUC.$AP6$).>F-0-E W<395<$-69RM'<DAJ-F)6,E953"]5=GIO5"8C>$$[
M5F)71DIT56M-379O+U@P<U9#1TLV8E-79&YI5T@V=3-O*W)D2VI-:$MG4'95
M36-66D)Q5W5E93 X;F575&-V8W@V,6-A>&17='I)628C>$$[:$).2W1S3# R
M9D]*4D%L2GIB=VUN=W$Y9D)S5EET<$=V9FYH3'%M;%AL>DAQ8VQV1TIO=%%9
M,FI28S1';7,K1$-"-V5"4%4Y4C-5<R8C>$$[649C4D-1<E=N37%Q<U!M3#@Y
M2G1*4SAM<S<S.4DR.&MN1E)!-F)T84%Z0F]H87A+-G=Y12MJ5TM7<F)+,'5X
M2W%N86%P*V)C36PY<28C>$$[,3%&<38V=&8R3FY"8D=+>#E61FIJ=F)S0FTO
M,$YH12]P*VM8<F(X=C-J35EH465M<6YN-6-A,S4T;3@P85DS;49R-D,U,5IB
M=#=R5"8C>$$[-W1:;S1X2$9P,FU/6EEO6D%&:E9,=#56*T5!5EIH9U8W2&ER
M<U9D:7)'=%(O36IY4G Q,V17=#=Q<V--,6I):U8R0VMH5TXS575/5"8C>$$[
M:%-L07%N:V$P6#EQ;4MQ8T@U;R]L.4U46%AB84)64FY:-W!J86]!:V=I6E=E
M8U)Q2%8R04M%.&A58F(T<7E7,75R83=T;W)Q,6Q3-"8C>$$[=&)H1FQG;FE9
M4$<X8FIK<F]Y,41+=TY14FEQ<&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I
M<G-69&EQ5C8U-6\P1%%J8FI6<GA,5B8C>$$[<G(Q9G$V<T=9=C9%6FQK-&A1
M>"M&1B]G3GE-5E5V3"]!2GDX<RM96&Y44G(U3'0W64DP>7%R<59$;&=$.&%R
M6#1K6E14;W=)3S1P:28C>$$[<6,T<3=&6%EQ;S-6;%I887AP9#(X9'=S56E4
M>$Q+:75&;&E94$A);UE':DEW<7)D46-65G-69&EQ;&-7;')C:$9U65DU:$9)
M<W-1:R8C>$$[54]&:VI02DA7;TY'53=G.7-65F-69&ER<U95=G%L<6)O6&9O
M<#EB0T=)6$A%96])>5%X5&Y4;'@U0W1-5E9C5F1I<G-6671Q9C59928C>$$[
M4TY4=7)U-G9T3SEA5RML4V$W0FQM0T]Y2WDW;W)H94Q">GE7;$<W,7A66#!$
M.'8O04-L;T8Y.64P=7DY1S<Y3C1V5F%75U$P;6-34R8C>$$[="LX6FAY9&Q(
M2G5U,VAI<7HX<W8O2F)E52\X071J868O=T)1<V5+<VQX5C)+=7A6,DMU>%8R
M2W5X5C)+=7A6,DMU>%8R2W5X5DDY9B8C>$$[.&QE5V9-1GI"8S9T6D,T=4Q:
M6DDT6E$W;WER2VIX<T%56F8R6D0X:G8Q1TMS83AX9FQJ-40P>GEF<C<R,FDR
M-W-,1V%61W5&3GE5:R8C>$$[9VAL84]34#%J2G=C3DDW8VQO4WI%:S%X5FY'
M;68X8S(P+S1W>"\X0452:7%*>%8R2W5X5C)+<EI*230P3'E-15)E<DU105!P
M3TMQ2"8C>$$[-E0P,R]L<F@O=T-2:2\Q>%9%2WEU;UI31U9H5E='-$E046<T
M<3-I<G-69&ER<U9D:7)S5F1I<G-663$K5U@O:W1V2V8O8D<P+W=$-B8C>$$[
M:%DX5EI,:7)S5F1I<G-653=M2U-71F\T-6YT,V%L2F]W:%IA1W4S<4LV-SE.
M,7A62F]R6%4R,64U=$1R1C,V54YV0DMP-%=L955R>B8C>$$[2S%F,TAH14U6
M5'A15E5!<U=)1D-X<%4K-6]!359B>%8R2W5X5C)+=7A6,DMU>%9*9D\S+T%#
M:&UV+SA!8D]U+RM41#1Q;4]M9CAC,B8C>$$[,"\T=W@O.$%%4FEQ2GA6,DMU
M>%8R2W%D>&(R.7A#,$YX16LP3#=02$EO6E11,3-"<41I<D=B6'DY-690;D15
M-'IP;&]56%0Y4%I6.28C>$$[0T]G3%0S;TI!-#DK27A6;$5556-585)224DT
M;W=&4D9!0W%O1D%!0C!!>%9D:7)S5F1I<G-69&ER<U9D:7)S5EDQ*U=8+VMT
M=DMF+R8C>$$[04=X=% O-FA9.%9:3&ER<U9D:7)S5F1I<5A19CAP2&9F.'=D
M<"]Y9'5C5E1(1EA9<3=&6%EQ-T9867$W1EA9<6MV;F(O;$1.9B\W6B8C>$$[
M,3,O>5EF1E5X,'HO04DU=' O>&AJ+S1I35923TMU>%8R2W5X5C)+<$QA9CAP
M;G%N+V)/,#<O:R]F67%N5TMU>%8R2W5X5C)+=7A6,B8C>$$[2V]+-C%V4G)3
M57<S5B]B5SAW6D9-8W-Y23-+6&PV66]X0G$O0G50:E$P-EEQ-G@Q>E)B*U%2
M,D]O5S$S25DO5T-15%)Y35DK6$AN4B8C>$$[4V9H-6)6-E9X5DHO>7DO.&QT
M-50O=T,R3G O+T%&0W@T<7E81EA9<3=&6%EQ-T95=6<O-5-/*R\U9S=4+VLW
M8S1Q;4]+=7A6,DMU>"8C>$$[5C)+=7A6,DMS43@Y95$U+TTY>EEZ4EAY,E Q
M3TLU:DQ#2FYK8C9X0S!82&M*27@V9GA69&%F1E1Q3599;69Y<G8O3%!L2'I.
M26YM5R8C>$$[-V(Q.5!K3')"1D-O9%E9<#)A3U0V=W0Q.$(Y6&=V1&EY;W%Q
M1W=Q.5,P>B]!235T<"]X:&HO-&E-0V]N1EA9<3=&6%EQ-T95;'10*R8C>$$[
M57HQ5"]T;F%D+WEF=G-65')&6%EQ-T9867$W1EA9<3=&5T)E669Y6CAR-CEQ
M5V]8.3=C,W9Q86]9=G)I3$MV1FMI5U)05$):1UI66B8C>$$[6F%B1V]O2T59
M<3=2=GE9.'(V6F1.8W!D-FI*2WE42WI*9'9A='IU2E9L;&M%;&XY6&Q"67AQ
M3TEB:E1T:7%C9FQL+S5,8GEN+W="<R8C>$$[8E0O*V]74$974S1Q-T9867$W
M1EA9<6PP2"]+4C,S+TU(868X;F)N1E5X>%8R2W5X5C)+=7A6,DMU>%8R2W!,
M-3(O-5%Z6"\K,F1D+R8C>$$[.&U(>%9-9$TO=T-/8F%F.%E9+RM):D955&ER
M<U9D:7)S5F1I<5,R;B]+6C9P+S)Z=$\O-5 S,DMP,6ER<U9D:7%685HU;# S
M5718,28C>$$[6%-B65-I-S!D;VMV4%5I9$5R36AD3T1S04<R0C9F4&]14W%M
M=4MU>%9*2G9/3V=P<E=N-E!$8W!D6'5O>51227-%:V-N<$Y"13AZ928C>$$[
M<4$S2F1O>4)T,7A63SA69&ER1W9Y>2\X;'0U5"]W0S).<"\O049#>#1Q>5A&
M6%EQ-T9867$K4%!06#4K+VTQ<&9N9GI$<&QJ<G9O,B8C>$$[5FIQ9#5B5W-8
M,5-Z8FA&1&-/:4QY849M3D950W!.8U4P>#EF*V-H=GIH5S5E-4=V,&UK4DDS
M9C9P6F)R1U=:4E0P2V)'4G-5,#E(+R8C>$$[04-(+T%$:B]!1$DX,69M2F$V
M4G)U<V97.4]E0V52-%!Q,7)&5FMJ2E@T;V]K9EDW-TA&0F94;4M(67$W1EA9
M<3=&5TQE8V9.5W9A1B8C>$$[8S(V,E=K2G%.<F-)5#9O3W!027-I2#1L84]W
M,#-547$P6F5,3S8X=#9$-&$T<7EN1E5L.#=F.$%+1V$O+W="<S8W+S5-4&EQ
M639:+R8C>$$[>'IB5"]J1$@O=T%21TMO;D9867$W1EA9<3@S,68O;DE4.')D
M23%7.#!Q+S%'84LY<TIP3&$U:D9R3W=74TII:D%-16]25612:7%1,B8C>$$[
M+W=$>FM:*U9#95IB*RMB535V<3 Y;EIW4G0Y5G5+;#1:8G!N1D]&9&A-=4LP
M>69Y>BME=C5B*UIT8W1D1#!E+VQN,4<X3&E#23(P-B8C>$$[02MM:E-.5FU5
M05560V-66B]I<G-69&ER<U9D:7)Y1'ER-E9T*UIK8V1K,$YX1F-3,VXQ;$Q:
M2C--2$9(8FY.3&1X37DX;BM':V-O1B8C>$$[5"],=&A1.69W2F1I<D=V>7DO
M.$%*8F55+W=$=&IA9B]!3E%S94MS;'A6,DMU>%8R2W9Z."]-,R]!36U4-7,O
M-V)/;V8Y4E5M3$IJ3R8C>$$[2W97=BMC6'8O2G179B]-3&1F.$%*=D9"9EHK
M2TA9<3=&6%EQ-T98:C,U.6%D9E!C-F9Q-E=#87AA-E9986A03'!O1VU,2D9!
M:&AK=28C>$$[<G1M,4Y,-%-+9VII5E5H=$]1<6%Y1&MQ37!$2U!.1W)E9'(R
M,3!E*SAO4E-T0F4R:VQZ3'AA>&QJ2'%1:&]636AE5E=F:W=+=$<U:B8C>$$[
M3D]R06I&1$A48R]N15!+4&UB+T56;F%44DA4-4%N<GIX,C521$90-G)2+U99
M<FHQ2%=0,'53=GA"9FQX64QH5C9L<&XO2$YT4"M-328C>$$[9B]%4F=6131Q
M-T9867$W1EAW1BMB2"]K>G9.6"]B5G4O=T1K.#),24U4>%8V6"]Z:F@O-4]F
M>3DO=T)(;B]51%!I<&9B,DQ&,DMU>"8C>$$[5C)+=7A6,DMU>%8R2W-A+TQ,
M+WE7,VQ0+W1J868O,4-X-'%Y6$9867$W1EA9<2]0>CAZ9B]*:RMB4#A!=',V
M:"]W0E)5;4Q*:D]+=B8C>$$[5W8X06Y&-R]!36TQ6B\X04U,9&8X;3A51CEN
M-&]5-3=I,W0T5VUU2E5H:%0W8VMJ0E9&5%1C;6<V-'%S:#%#=VUK155.>D9*
M2V95;R8C>$$[:4]R3691:SE+6%E'=C=U5#1'.$<R3RM+<2M+=7A6:5 U9V56
M8G9Z1"MI,%-W:#%+,W-*:F1R0E!Q5GIP9G S4V-F<3EX2$QA5S%X3R8C>$$[
M6&I":T,P:U)2>7%1>#1L1E=65W1R8E=L=$9A,G-35SER8F]S545%4VA),&I1
M8U921E=G5E9!;T%-5E-N>G0O>6AM=B]!4&)/=2\X028C>$$[:W<K2W!J<&XO
M2$YT4"M-368O15)I<4IX5C)+=7A6,DMV9TPX,E X07E:,VUR+W1Q,V8X07EE
M8D9K1THT<3E,+T%/8V-0+TIZ*UAV*R8C>$$[:GHO<4)N>%5V=#=&:6@W.#9I
M3&-N5#%H831Q2T-D;59+9#DP1$=V,%EQ:TYP<79N1S5V<C8P5S$P-5=S5VI2
M,DTP.4<Y4TU30VXW=B8C>$$[+TMW<7EB07)S5F1I<GI8>EHU4B]-,U5D6#%#
M8E$Y64=M5W,P<TIT1TXS8TYW0U)S1VLY2&=51DAB94EF0S%"56LT5F$X<RM5
M4'I:<R8C>$$[3#1Z,V9M2S-A4#!*55-/-BMS-FI'1$I/<GA)66DY;U=-55E9
M97(V;DDQ;V%G67%Y8CAS=B]*8F55+SA!=&IA9B]W0E%S94)74S1Q-R8C>$$[
M1EA9<3=&6#4K9FUB+W=#5$HX,F8Y=&Y54"MO<51&:WAN1EAR6"]/3#,O:S)R
M4#A!-6AB<B]K,VEG=G,O1D-!,3-19$DQ-U,U=$LQ928C>$$[,E<X,"LT-"MT
M035)1&-71$1D4T0Q2%DT<6QE:69L,35*,%!523E2,&Y326)/.&E34T]+5U!L
M.$M414TV<4-3;T)O2V)B1%EB67%Y4"8C>$$[1EA9<3=&6%EQ:W9N8B]L1$YF
M.$$K,F1D+W=$2F@X5E1(5% K3V)A9CA962\K26I&551I<G-69&ER<U9F05@U
M<V8K5$\X,68Y=%<W+R8C>$$[04]4>EES9WA01EAP9B]/3T@O:S4O3#,O045E
M9CE132M+;#EV67-72E$O;6(U9FYJ.5=#,3%+84EK:%I%,"LV6E1X2E4P251F
M8UDP<28C>$$[03 W>G9P,$=R871C>5='<4-+.&MH845J5#=O:VA)5E)Q:FAT
M.%%W<6YM:RME3D<Q4%4T.4UI:79)3'573U-A2F)Q,6YT,5I):6]E:B8C>$$[
M4TMO3D]9,G=+>41&6%EQ-T9867%X<CAS=B]*8F55+RLR3G O+U5,2&ER2F-6
M9&ER<U9D:7(X+U!Z3B\X;50U<R]W0S)Z<4@O049&4R8C>$$[67-M331Q.6$O
M=T-C6'8X07EB5FXO=T%W=#$O>6)X45@R9FEH479,1T<W5E9L8591<'%04FUL
M:% P;4IK2BMN1E5Q,%!425I)5&-35"8C>$$[6%1Y>%A6>7%C<G4U6F5-3GI)
M:4%Q6D],04MG1S0S-S1Q;FU+=7A6,DMS5S@Y965V.$M#>%HY4&MV27(P,T-M
M6EI%:E-.;TQE4S1!828C>$$[=DIV:452<5%T1D94-$%Q<T]F.$%.-GDX>"M5
M=DUS8VUL6&1P-F5N>4I',$U5.39#,7A&3V=-;F]22#!K+V-L;&0O:$M&5TI&
M85E6928C>$$[;S9:+WAZ8E0O:D1(+W=!4D="551I<G-69&ER<U9F05@U<V8K
M5$\X,68Y=%<W+S503FEY1$4X5F5L+SA!3T](+T%*3V9Y.2\P968X028C>$$[
M5410:7!F8C),1C4Q-4LO-5)Q,"MC,R]*-3A+13AX5DPT9CA!;%!D12]W0UE0
M55 Q,C)+<S5W2F1I<G-69&ER1W9Y>2\X;'0U5"\W628C>$$[,FXO.5%S94MS
M;'A6,DMU>%8R2W9Z."]-,R]Y6E!M>B]!3&)/;V8X05562FEY67II<C%R+T%*
M>&4O=T1*=%=F+T%$0S-8+TIV1D)F628C>$$[5W5833%T;W5O6$U$8TIO3&%A
M4THV03!:27EY;6AQ3V]X47=45$QF>EID86)A6%5N;D160DI01$A+-%=$4V%!
M=6]9,')92&)F0W1Q="8C>$$[=F]V;4LS:DUC4&TO5E92;F51:C!D2E!X4W5:
M2$\Y:#-::6-64B]K>38Q,69.3W,V6'%'<UA/<3(Q=%DV9F,R+S%Q3S!2:VMU
M6G)X2B8C>$$[3C=70S)Q2U=Y57)8=F=6;6U+=7A6;W%R57%!861++TMM2W!,
M-3%65CAM82]1058P-C=R5"]M2%E9<6U7;68X04A.=% K34UF+T52:28C>$$[
M<4IX5C)+=7A6,DMV9TPX,E O2FYE878K,G)D+SAN;7A:0FEE2W93+RMC8U O
M2GHK6'8X06\X+S9G6CA63#=E>%EV3W9*6"]+3E=N>B8C>$$[;2\U4%!H46YM
M2W!F1"]Y;G5I9CAW96]F<G1S5EIZ9U,W1EA9<3=&5TYF;&PO=T-3,CAP+SES
M8E0O=T1Q1FIX5FMJ37%+5UEH5E566B8C>$$[:G-!0C%*3TMP9CA!-&PX=68Y
M6%=Z+S93278X06UR1E5B8EA.=&-W<E!B4W!00SEE17-B0C%.1%$P6F%J<4U6
M5DU69FXU*UIV+VMY9B8C>$$[3FXO8EHQ1"]!2VEP35=41V-6971F.#1V9BM4
M87,O.$%M1G5V*U1E2T,K=G9-=CA!>6IM<2]W1$U(8V8X;6UX47AJ45 K3T9P
M,R]-3"8C>$$[1"]Y8EA#:$@T<6A02S,O2V8K65 K,E9P2"]55'%70DQ.359D
M:7)S5E-8>G0O=T%O6G(O+T%'>G)V+VMW*TMP:G!N+TA.=% K34UF+R8C>$$[
M04)%67%I8U9D:7)S5F1I<C1#+TYJ+WE:,VUR+T%,870S+WEE8D9K1THT<3E,
M+S5X=R\X04IZ*UAV*VIZ+W%";GA5=G0W1FDX-CAL9B8C>$$[.&\Q869/8B]!
M2E!0:%%N;4MP9D0O=T%P-V]N+T%$0C9H*W4R>%9N3T),<U9D:7)$<'9.;FUY
M1'IH<5=M<C5E=4PW4TQ71EAT6G)54B8C>$$[<$Q)>D-%,3E7-FUT-V1G5VML
M6&E'1$0P*R],6E9#950Y53AZ-DPU4S!44C=R>61Q>C-7;3)&<EIZ=D9.<$)J
M36M%2WAS54Q8-FMQ4R8C>$$[=3%13593+U=F34@U>'IA<$LR:V582C=85$]+
M0T-/-$=L>E1&<69'5TDQ3D9!<C!P:7%3,TAM2#@U:S%Q>6EL,&U29%%L9W5"
M87@K:"8C>$$[<#%':E9O:DUA:E9/26]E2%4T5E1#2%AF>C!3-71N;#!"-7)D
M6C149%)#4%19,F$S.5)F6$-.*VLS;R]P8W5&4E1L4W4R0E=9+W=#3"8C>$$[
M3F4O-FMZ5V8K4C)J+W=$95%X5CAU*V-0>4DO3C=7=DYU=#9X82M7,U,Q,4LO
M=7)Y0DIB=7=%9VIN;6%24317-%E"9T<S;U1I;3)0>"8C>$$[9FM$*V)C,2]C
M5T5E:&-R=3!32U,T:BMT,E$T<DYY.4TQ33-%,3E.=6AX5&(P2#AM=GEP+TY(
M>50U-&<Q-U9F3$4X.6Y&1$Y%,&1R9"8C>$$[86,X=DM63TEO2DQQ3F%E4'A9
M;TPS8E8O35!M2S@P;3ES-'9*=7)I5S5G;&A1=$YO-%5--D925VUO2&)F1D-4
M-EIC96),6%1B4S%K."8C>$$[;C9O6DE)631N2WHV5%%L1D-M;&(X8F)95G Q
M:C5J,7DO4U=3,3AP87)):TTP='9+9E8P<&%3=W59-48K2RM(,E=5:7941E8R
M:3-F;28C>$$[=7@X>C9P<7-V:R]61W0W,GES8E=*16XP:W5(=$IB=5)Y=TXK
M0E%I-EAJ42M05'5&6E!:*UID6G5,<4M'6'EP<71P2$EW5C=M85A3>B8C>$$[
M2$=$*S T:79P6DM$+TI1;C)X5E X5F1I<D9033-M3%)D4CAU96).3W,W<%IR
M,U1T4'5L=DE11T)1=$1+;S-904U/4TUT5G)U0T]U2R8C>$$[<VDP>B]J;3)N
M+T='4"]I27A615-32D=J4U--15)!5V0R3D%!3GE35&EQ6"]!3TIF3&XO5C%S
M+RMK:4PO04IQ>%9',CEX8C-%2WI7."8C>$$[<511=G5K:V)";$Y$5%EI;T]+
M<6U+=F=,.#)0+T%#6C-M<B]T<3-F+T%#96)&:T=*-'$Y3"]W0V-C4#A!>6,O
M;#<O;S@O=T-O1V9&4R8C>$$[*S-S5TQZ<GE6+WEJ5G X-78K5'HT54HU:7%8
M=R]W1$ME-DHO>D(V:"MU,GA6;D]"3'-69&ER<U9D:7)%4'I':C@Q4&%A85!,
M-'9#4B8C>$$[8W8X05A"<#=W2DYX*W)3:44Q=4=63T%U1$=82&AI<D-'=%!Z
M>F95=%=G5DI#8G!$1&)8<GDR.&1V07I3>$XV:T)R3$M!659L569U.28C>$$[
M:59Q1W=Q>D1Y52]N<518-S4O3556>D)B9E9,64MJ;3)E,4XQ=TAR1S--5&5O
M<7$Q4CA1*TQR=%%$1E=B649E85A%=C5R5W-';U-7;"8C>$$[=&0S3W!T8VQ8
M37)736QL-E!Q4VU.<D-)>5%Y8DHV4W8V>G)S5TY#=W=Q9S-U+WHQ935%<'-O
M26%T33-#2F)C<4LO5VMI4C)A8FMY228C>$$[<V-49S=%;#9(,E94<E%*9GI3
M;#AY>$IR8TM2-E!B>E1,2DQ%255%:6Q*4D=11FQL9#0Y;U=$1E9B;7I!<4%"
M:7)08T-S2B]-<4@X=R8C>$$[;D]M=C5/2C5Q6C!V5DQX<71*;%='3GIZ27%9
M=E5A554O;'A6:&UM5T@U-G!*<#1K:W56:#EA>&4O5U8W27-80V8V5CA32"LV
M+VUB:28C>$$[5'DR-'-A=5-R,FY!<G-69&ER<U99-TPK6&9K:64W=DQQ.#!7
M,79P<BM26G)J-C5'3'!E86QY0VE48S%4959Z.$E(,FII<7HO04I6;"8C>$$[
M*U<S+T%&2V5J9CA!8U!T9BMQ94MS9#@S-D0K5W9L>&)1+S1&,'4K835%-W-S
M5FQ9;U5I=%EJ3DLO=T,X4E%A27!O2S<T<F)#<FI84"8C>$$[>5E&>F8V>DHU
M4'-O661&:FUT24Q-,FQK:TXV6C=X2696-'-I9U!%8EDX4V9S<3=E3T=L=&TS
M;#=24'ES,7I68C)Y=&9*5VQR0F%X428C>$$[5'<S>'-,2F]P;S=H95-%8U9*
M47-V>$M',TMK3C-W3&))9CA!;%=8-6)F.$%5<#9.+W="=RLQ+S9P-'%X0F\O
M>6QI4S1U<FIY3%E2-B8C>$$[8VLX;'!:6%-A9%I3=F-Z=U1.0DMI5SAA=$UV
M1C0R;U=7:%56,C)'2S)K>C9J*U%-1W S1W!X*U@W5S9T8FE'2T52<G!50G1K
M4S)J=28C>$$[-W!R;497:E=P9$9):TDS*T901$=L=$XW3V8X04I'.3%7=S!Y
M,#AO-F4Q>F982G1616UK=U%H5U=+5U-1,65)0G9394%X3T(P8D=L="8C>$$[
M;5 X07ER3#AT=CA!<54Y1R]W0S1F82\Y53A663<U,C!J.&\O2T9L63,R<&55
M3DIA,79,>$Q*-44P*S O9&,T-4I$2W<Y4#=+<D5A,"8C>$$[>%9G;&XU:R]+
M0S-3*S%'8GE(0WAV5FEU3%-Z97ES2E9!5E)&2VM)5E1W0V-/8VTS53%.059*
M3DQB,6TR+TQN.',W:3-I=4DO2VUJ928C>$$[;DUI>4HO;T9O9&U&4G5Q169C
M8T-Q;B]+<W9Y,B]W0W!4,&(O04QH.7(O,51X5FMU2W5X5C)+=7A6,DMU>%8R
M2W5X5F=V:R]Y+W=$;28C>$$[1F%E571%=$QJ5W)E,75,97=T67!R85=W.5=3
M3C!H5E=J95%8241S<$9#,V9R:7%B+V]N>C$O,4U.<"\S1%0O,E4T<3<Y12ME
M=BMP:"8C>$$[=% X075';B]!3$MC5F0K:6906"]!1DU.<"\S1%0O,E4T<3<Y
M12ME=BMP:'10*S1A9BMY;D989F]N>C$O,4U.<"]W0G<P+SA!6E1I<28C>$$[
M538O;U!N;6%84FUK,4](54QE,S%3>FYU64E,5#9S=VEJ:W$W;'I02G-O-FIJ
M=FA6;D]"6%EQ-T9867$W1E5"<2]L+U$Y6E=&9%<P*R8C>$$[,W8Q=&XY5T)B
M;4Y:46IJ.7!E44Y-5E%T=C5-.&\R,3=*9E%A3EI2,VMS<'5*3&A927A)6E=$
M0757<%=P16IF96-65F1).')E5SE';B8C>$$[;6XP;E,W5W=M=4%Q>E-7,$M2
M1FQ4-TE0141967%M;4MV2CE&.#4O;%AR;6EP<75Q95AY;#ER8TU5,G%2<F]L
M.61)-S=/05HP=$=7628C>$$[2S(T64AF<FEQ6E0K62]Y:6Y1<$YO,'-I3EAK
M1SAV-FEA.&=W4"](;C-$=#DK2W%S6&TS.'$T8CET46DP=31J=C)K5UIR<$Y!
M,4I:5"8C>$$[26E.1W)L>&%6-4)*1U5(=TIX5DTO=T1L879K+W@Q4"]!3&<K
M<F8X05I,:7%$,5!Z-2M83W%W3&(V;F%8;#=!<$Q,1F-A2'%K:6AM4B8C>$$[
M;WE11W1#2VQ*1U@U131Q9UI.9B]!0V5K.6-0;VMJ0S5#:31".'9A:E-14G8V
M:3AV.40S;RLK2V]J>D8K8W9L:E,Y078W*WEG=G W:28C>$$[>F=E5T,S;#!Z
M53=A2C)286A7;6MT9VMA+W=#53)W>%8V0FER<U9D:7)S5F1I<G-69&ER<U9D
M:7)S5EEX-3-L.#AP2%EJ>7!(17IT2R8C>$$[9G)R4W%J:%DV0VQ!-WAE+U1&
M5TA386@K93=Z<F-R<#92>7!P-$%T471S8EDS5&DQ3#AI8FA:0WDO=C9D04-!
M2VM(;&A61%@P2#5Z=28C>$$[,F]Y44QE>#-5,$YZ2EI+2F)0-G1(2$E,;WAX
M34$U8C9W:&%!258R,DY45$966%)V*U8Q;RML>5A6=DXY4G1$34QX6EIR63-5
M>5AC:B8C>$$[26@Y4&LX8DYA9TQ)3U5O<5 U=6=66GHK6'<X>$1Y>D0O:4%8
M0S9I6DI3579$0S!Y>&U1*VUR4$%3:C!8.7)9;G='0E=2-'$W1EA9<28C>$$[
M-T9867$W1EA9<3=&6%EQ-T954' R;E=/;3)&=G Y:$-T=EI7<4Q&8G=*<W%)
M;V]Q:C)'2W!B-7(X,S9,-5<P*TLO,60U171P6F925B8C>$$[;V\R;$E94E!-
M>$MR53A6:FA9;C59<7@K5#@U9DIY4W@P831.<G=,,V0Q-D5G4S-:94):2D%2
M6&MI>7%Z:&$P1RM';%$P;C5Y-F%M<28C>$$[,VQR*VER<C9N62]6:%!E:WAQ
M43$U5EEL.4EN;B]F2UDR+VQ/+U1';%5,3#@Y9DQK,6Q96$8Q8E-7570Y9G@R
M06=L9$%Y2DI&2$HY628C>$$[,TE,4G(V>4MA0W1A.6AJ4W-W.'$K6C X=U<Q
M-4]L;DY:+U9,<#=5<DU54$EO<7-3<&I:,3(U.%A&9FAC379B07%:86IP,6IQ
M5FAC828C>$$[9F9W<F-75C!J4EA%1#=Q-DU+37 Y:FEQ27A6,DMS1R]-5'E8
M-6XQ>E8Y1C%F>3EQ34]N86AO<U8T3&%39FU5.6$W83-3<F]Q;FUO9R8C>$$[
M4UED9G1&9F9&5T4R=C53+VUV<$9V3G R:C8U8DA3;S%N5%1O-7(O5DE(5T]7
M.&5:56PK<F5M0U%J.&I+;D=4;#A"67@W1E9M9FQ,>28C>$$[:C4W<TY3;G4Y
M83$Q<#%U<DE7.'=H;FUM161W='1:>'!.0D9C23!#15126%1N-%!I-7)Y0C-!
M5F$X<"M5+T]D;&5*9&%R<5EU<C)W:"8C>$$[='10:'9,,49U>DQB14Q09DY%
M,$IT1U%Y>6Q);&551G8S25IL8713<7AV>D0K55=U,R]M=696661.,%<U,#)7
M.&QU<')/+VQA4U,T828C>$$[4S-U249K95IB2#%5.4UZ<31I6C5&0E@T1VIP
M=7%Y<GI4-4XX,#9H-54P<E-.33%Q5T,O<TE(4S0Q15A.>&%35'I,<#@P145J
M=&)(:R8C>$$[,RML=$9+-FY99TA9.4-Q9W15.&IE93=R5$QA2SDQ<3,X=S,Y
M=').;G%D<E!C>$145G193%=:6FUJ45<P9'=*;EE)54)C1%II9EEQ<R8C>$$[
M3FPO3')Z,6]0;'4O5TE+6G1.:&AU3DPO045C.#AG:W9:67)A>'5:-E%*2&1R
M25EB5V%757A,>2\P;'5,3S1,67%M3VAE4V9Z3'9T2"8C>$$[<S<O.4U8;'9C
M>6U!1T,Y,41566YI5T,Q:&@K<T=*;$I:;75)-7!V46M64DES:2MO458T:%91
M;CAM9FY/,VU84V)78E93.6I&<$IT5"8C>$$[95%A;'%#4FDT=$IO=CE/=457
M2E9E959:2VE",DMT>%E&-D1D5C=::7)S5F1I<G-69&ER<U9D:7)S5F1I<G-6
M9&ER<U9D:7)S5E%M<"8C>$$[-E!P5W%W3&(V;EIW,W-#:W-S539,26],23!:
M241!:7!34FPK4D]+;T)V2E!K-7)G,T1A2EEM8V=+6D1B4F-Q3$HV;T9E4#A!
M4#A8>B8C>$$[>%9B2#5'.&U2,TU.>6UH,DLS1G5J4G=3+U8T*U-)-5ES;TY/
M:#5T.35X5C%P-4<X;5=D=DIB5W5H,DU-17E34GEX<&)X04]K=D532R8C>$$[
M,W<W:'5#,2M1>%9'-E!O1VEA3$)*0G!&:D)947I31V%73S-263%A46=!<U%O
M1SE!3592*TMU>%8O.6L]/"]X;7!'26UG.FEM86=E/@H@(" @(" @(" @(" @
M(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \
M+WAM<#I4:'5M8FYA:6QS/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @
M(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @
M>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(CX*
M(" @(" @(" @/&1C.F9O<FUA=#YA<'!L:6-A=&EO;B]P;W-T<V-R:7!T/"]D
M8SIF;W)M870^"B @(" @(" @(#QD8SIT:71L93X*(" @(" @(" @(" @/')D
M9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F
M875L="(^9SDU8S8Y/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*
M(" @(" @(" @/"]D8SIT:71L93X*(" @(" @(" @/&1C.F1E<V-R:7!T:6]N
M/@H@(" @(" @(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL
M:2!X;6PZ;&%N9STB>"UR97!A:7(B/D9I;&4@3F%M93H@(" @(" @(" @(" @
M("!3=&%M<"!P86=E(#0U,RYA:28C>$$[57-E<FYA;64Z(" @(" @(" @(" @
M("!R<C,U.#8U,R8C>$$[3&]C86P@5&EM93H@(" @(" @(" @(" @,30M36%R
M8V@M,C R," P,#HR,SHU-B8C>$$[15-4(%1I;64Z(" @(" @(" @(" @(" Q
M,RU-87)C:"TR,#(P(#$T.C4S.C4V)B-X03M38W)I<'0@5F5R<VEO;CH@(" @
M(" @(" R+C8F(WA!.TEL;'5S=')A=&]R(%9E<G-I;VXZ(" @(#$V+C N,"8C
M>$$[1W)A<&AI8R!T>7!E.B @(" @(" @("!"87(@0VAA<G0F(WA!.R8C>$$[
MXH"B(#(X($--64L@8FQA8VL@8VAA<F%C=&5R<R!C:&%N9V5D('1O(&=R87ES
M8V%L92XF(WA!.R8C>$$[XH"B(#$T-2!B;&%C:R!T97AT(&-H87)A8W1E<G,@
M8VAA;F=E9"!T;R!O=F5R<')I;G0N)B-X03LF(WA!.R @(" @("#B@*(@,S@@
M<&%T:"!O8FIE8W1S(&AA=F4@=&]T86P@:6YK(&-O=F5R86=E(&]V97(@,C@P
M+B8C>$$[*BHJ1DE8($%.1"!215)53B!04D5&3$E'2%0@4T-225!4*BHJ)B-X
M03LF(WA!.U1H92!F;VQL;W=I;F<@9F]N=',@87)E('!R97-E;G0@:6X@=&AE
M(&1O8W5M96YT.B8C>$$[(" @(" @(" @($%R:6%L+4)O;&1-5"8C>$$[(" @
M(" @(" @($-A;&EB<FE296=U;&%R)B-X03LF(WA!.U1H92!F;VQL;W=I;F<@
M8V]L;W)S(&%R92!P<F5S96YT(&EN('1H92!D;V-U;65N=#HF(WA!.R @(" @
M(" @("!";&%C:R8C>$$[(" @(" @(" @($--64LF(WA!.R8C>$$[+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM)B-X
M03M&:6QE($YA;64Z(" @(" @(" @(" @(" @9SDU8S8Y+F%I)B-X03M5<V5R
M;F%M93H@(" @(" @(" @(" @(')R,3$Q-3 T)B-X03M,;V-A;"!4:6UE.B @
M(" @(" @(" @(" Q-"U-87)C:"TR,#(P(#$W.C(X.C(Y)B-X03M%4U0@5&EM
M93H@(" @(" @(" @(" @(#$T+4UA<F-H+3(P,C @,#<Z-3@Z,CDF(WA!.U-C
M<FEP="!697)S:6]N.B @(" @(" @(#(N-B8C>$$[26QL=7-T<F%T;W(@5F5R
M<VEO;CH@(" @,38N,"XP)B-X03M'<F%P:&EC('1Y<&4Z(" @(" @(" @($)A
M<B!#:&%R="8C>$$[)B-X03OB@*(@,S @8FQA8VL@<G5L97,@8VAA;F=E9"!T
M;R!O=F5R<')I;G0N)B-X03LF(WA!.U1H92!F;VQL;W=I;F<@9F]N=',@87)E
M('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C>$$[(" @(" @(" @($%R:6%L
M+4)O;&1-5"8C>$$[(" @(" @(" @($-A;&EB<FE296=U;&%R)B-X03LF(WA!
M.U1H92!F;VQL;W=I;F<@8V]L;W)S(&%R92!P<F5S96YT(&EN('1H92!D;V-U
M;65N=#HF(WA!.R @(" @(" @("!";&%C:R8C>$$[)B-X03LM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TF(WA!.SPO
M<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z
M9&5S8W)I<'1I;VX^"B @(" @(" @(#QD8SIC<F5A=&]R/@H@(" @(" @(" @
M(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:3YR<C4P,#0Y,SPO
M<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO9&,Z
M8W)E871O<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.G!D
M9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(^"B @(" @(" @(#QP
M9&8Z4')O9'5C97(^061O8F4@4$1&(&QI8G)A<GD@,3 N,#$\+W!D9CI0<F]D
M=6-E<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S
M8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<$U-
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @(" @(" @
M("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4
M>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0](FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT
M(R(^"B @(" @(" @(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z0T,T-T-#
M,C!%0C8U14$Q,4(T1C=!0C<T0S%#,S%"-S,\+WAM<$U-.D1O8W5M96YT240^
M"B @(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z0T,T-T-#,C!%
M0C8U14$Q,4(T1C=!0C<T0S%#,S%"-S,\+WAM<$U-.DEN<W1A;F-E240^"B @
M(" @(" @(#QX;7!-33I/<FEG:6YA;$1O8W5M96YT240^=75I9#IA-&$Q-3<W
M-"TP,#DQ+30Q830M.3(S,BTQ8S-B-S!D.3(W,3@\+WAM<$U-.D]R:6=I;F%L
M1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.E)E;F1I=&EO;D-L87-S/F1E
M9F%U;'0\+WAM<$U-.E)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \>&UP34TZ
M1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" \<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED.D,S-3-$,# W03@V-45!
M,3%"-$8W04(W-$,Q0S,Q0C<S/"]S=%)E9CII;G-T86YC94E$/@H@(" @(" @
M(" @(" \<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED.D,S-3-$,# W03@V-45!
M,3%"-$8W04(W-$,Q0S,Q0C<S/"]S=%)E9CID;V-U;65N=$E$/@H@(" @(" @
M(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z831A,34W-S0M
M,# Y,2TT,6$T+3DR,S(M,6,S8C<P9#DR-S$X/"]S=%)E9CIO<FEG:6YA;$1O
M8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIR96YD:71I;VY#;&%S<SYD
M969A=6QT/"]S=%)E9CIR96YD:71I;VY#;&%S<SX*(" @(" @(" @/"]X;7!-
M33I$97)I=F5D1G)O;3X*(" @(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @
M(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D)!14,S,C=#-3 V-45!,3%"
M13 P1C$T,3$V-#E&-39!/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3 S+3$T5# P.C(R.C(P*S U.C,P
M/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A
M<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I/"]S=$5V
M=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA
M;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\
M+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A
M;F-E240^>&UP+FEI9#I#0S0W0T,R,$5"-C5%03$Q0C1&-T%"-S1#,4,S,4(W
M,SPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T
M.G=H96X^,C R,"TP,RTQ-%0Q-SHR.#HS,RLP-3HS,#PO<W1%=G0Z=VAE;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@
M26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N
M=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z
M8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" \
M+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP5%!G/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O="]P9R\B"B @(" @(" @(" @('AM;&YS.G-T
M1&EM/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O1&EM96YS
M:6]N<R,B"B @(" @(" @(" @('AM;&YS.G-T1FYT/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O<U1Y<&4O1F]N=",B"B @(" @(" @(" @('AM;&YS
M.GAM<$<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]G+R(^"B @(" @
M(" @(#QX;7!44&<Z3E!A9V5S/C$\+WAM<%109SI.4&%G97,^"B @(" @(" @
M(#QX;7!44&<Z2&%S5FES:6)L951R86YS<&%R96YC>3Y&86QS93PO>&UP5%!G
M.DAA<U9I<VEB;&54<F%N<W!A<F5N8WD^"B @(" @(" @(#QX;7!44&<Z2&%S
M5FES:6)L94]V97)P<FEN=#Y4<G5E/"]X;7!44&<Z2&%S5FES:6)L94]V97)P
M<FEN=#X*(" @(" @(" @/'AM<%109SI-87A086=E4VEZ92!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(#QS=$1I;3IW/C8Q,BXP,# P
M,# \+W-T1&EM.G<^"B @(" @(" @(" @(#QS=$1I;3IH/C<Y,BXP,# P,# \
M+W-T1&EM.F@^"B @(" @(" @(" @(#QS=$1I;3IU;FET/E!O:6YT<SPO<W1$
M:6TZ=6YI=#X*(" @(" @(" @/"]X;7!44&<Z36%X4&%G95-I>F4^"B @(" @
M(" @(#QX;7!44&<Z1F]N=',^"B @(" @(" @(" @(#QR9&8Z0F%G/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1.86UE/D%R:6%L+4)O;&1-
M5#PO<W1&;G0Z9F]N=$YA;64^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF
M;VYT1F%M:6QY/D%R:6%L/"]S=$9N=#IF;VYT1F%M:6QY/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z9F]N=$9A8V4^0F]L9#PO<W1&;G0Z9F]N=$9A8V4^
M"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT5'EP93Y/<&5N(%1Y<&4\
M+W-T1FYT.F9O;G14>7!E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z=F5R
M<VEO;E-T<FEN9SY697)S:6]N(#<N,# \+W-T1FYT.G9E<G-I;VY3=')I;F<^
M"B @(" @(" @(" @(" @(" @(#QS=$9N=#IC;VUP;W-I=&4^1F%L<V4\+W-T
M1FYT.F-O;7!O<VET93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&
M:6QE3F%M93YA<FEA;&)D+G1T9CPO<W1&;G0Z9F]N=$9I;&5.86UE/@H@(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS
M=$9N=#IF;VYT3F%M93Y#86QI8G)I4F5G=6QA<CPO<W1&;G0Z9F]N=$YA;64^
M"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%M:6QY/D-A;&EB<FD\
M+W-T1FYT.F9O;G1&86UI;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF
M;VYT1F%C93Y296=U;&%R/"]S=$9N=#IF;VYT1F%C93X*(" @(" @(" @(" @
M(" @(" @/'-T1FYT.F9O;G14>7!E/E1Y<&4@,3PO<W1&;G0Z9F]N=%1Y<&4^
M"B @(" @(" @(" @(" @(" @(#QS=$9N=#IV97)S:6]N4W1R:6YG/C4N,# R
M/"]S=$9N=#IV97)S:6]N4W1R:6YG/@H@(" @(" @(" @(" @(" @(" \<W1&
M;G0Z8V]M<&]S:71E/D9A;'-E/"]S=$9N=#IC;VUP;W-I=&4^"B @(" @(" @
M(" @(" @(" @(#QS=$9N=#IF;VYT1FEL94YA;64^0V%L:6)R:5)E9W5L87(N
M4$9".R!#86QI8G)I4F5G=6QA<BYP9FT\+W-T1FYT.F9O;G1&:6QE3F%M93X*
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D)A
M9SX*(" @(" @(" @/"]X;7!44&<Z1F]N=',^"B @(" @(" @(#QX;7!44&<Z
M4&QA=&5.86UE<SX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D^0FQA8VL\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z
M4V5Q/@H@(" @(" @(" \+WAM<%109SI0;&%T94YA;65S/@H@(" @(" @(" \
M>&UP5%!G.E-W871C:$=R;W5P<SX*(" @(" @(" @(" @/')D9CI397$^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \>&UP1SIG<F]U<$YA;64^1&5F875L="!3
M=V%T8V@@1W)O=7 \+WAM<$<Z9W)O=7!.86UE/@H@(" @(" @(" @(" @(" @
M(" \>&UP1SIG<F]U<%1Y<&4^,#PO>&UP1SIG<F]U<%1Y<&4^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @
M(" @(#PO>&UP5%!G.E-W871C:$=R;W5P<SX*(" @(" @/"]R9&8Z1&5S8W)I
M<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,  0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( -0!:0,!
M$0 "$0$#$0'_Q  ?  $  @(# 0$! 0          " D&!P4*"P0" 0/_Q !0
M$  !! (" 0 ""@T)!0<%   % P0&!P " 0@)$Q4*$1(4%C<X=GFX%Q@9,SE8
M675XM+:WUR%WDI:7F;76V!HD-5>8(B,E)C96<S$T5=35_\0 &0$! 0$! 0$
M              $"! ,%_\0 .!$  @$" @4)" (# 0$!      $1 B$Q01)1
M88&1 U)Q<J&QLL'1$R(R,T*"TO!BDL+A\5.#H__:  P# 0 "$0,1 #\ [_&
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M2+1)M<U7=8+(N4FPJM[6E1=J+8CL4-A*&F*@*TRLP(F09*:QR%2Z<PN)2BL
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MWUIKB-CHQI:#PO<+:ZY/;A^=25_8"5=IPJJX- (\8.J@S9!UPNLX9Q':=O#
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MB]N6F!+PEQJG;/??I-H/:EK(E/2%H$8'%G]A%Z\VJ4K+WH9FZ.$JRW,NY#O
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MA%A>A7"LSD@3X8N(Q84:>-G.[U-179PMIRWTU2U45&6HC!RI4=+7>F2DP08
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MK-JBDW;I:<<:II)Z::\<<:\8+3]7599_@R, 8 P!@# & , 8 P!@# & , 8
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M.L&JL*.J_'463X,C & , 8 P!@# (;=0_P#C7<'],FR?V!JK )DX P!@# &
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MZP:JPHZK\=19/@R, 8 P!@# & , AMU#_P"-=P?TR;)_8&JL F3@# & , 8
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MSE$O>OBTG;RS99Y+)T_KVP:J>2'R!/'*]?VH-!B)_&MF_3_J*PU:R0=&I%+
M;5TYT::D&V@^0DT]Q[QHHHJDONJW1"I0J+I^[EUJBV?!@8 P!@# & , 8!#;
MJ'_QKN#^F39/[ U5@$R< 8 P!@# & , 8 P!@# & 5H^2?[YX_\ Z2[J]^J6
M'@U3]75?D678,C & , 8 P!@# (;>0;Y&E]_-)G^T83 )DX P!@# & , 8 P
M!@# & ?A5)-9-1%9/15%73=)5)7351-5-37G7=-33;CG7?3?7GG7?3;CG7;7
MGGCGCGCGGC ,77@<'=:$4W,,BCA,P#:1@LFO'1"VA2-,.%=6$>(ZJ,]M7H-E
MJNOPT$N>%6#;A97A%OIPIO[8')-8['V)-0TR!!F9E48S"*EFHMDW)JAARBJH
M\0H_10T=;C&*JZRC-ALKRU;*+*[H):;*;\\@5X]"/CL\J'TA>_U+^G6#56%'
M5?CJ+)\&1@# & , 8 P!@$-NH?\ QKN#^F39/[ U5@$R< 8 P!@# & , 8 P
M!@# & 5H^2?[YX__ *2[J]^J6'@U3]75?D678,C & , 8 P!@# (;>0;Y&E]
M_-)G^T83 )DX P!@# & 1FK.P^QLAOV](18M(1V$4?"M(Q]AVV6,Z5-%K15*
M,M71CA:+\@VOJE,1MMNW);.W;#D:0228#-9:S=KFQ@MH5[YK5^_NV3."# &
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MA\\1YY1T6&$F\".ASR8=+H_K.MGULD7/-?%F@4NF$JZW)&L;>N'DR'OMJ]0
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M*:DYC!593KI6LH._V=?S)_B9$?[;^M7\9,'K[7D^=V5>AKBO/!GY4+67L)M
M.JCZ0+U58YVI)]II;E!CO@_8<:'!2QN.[[%[4'Z$=V(^1!G')(1L0#+\/>$F
MI%=9!RFB'M:.=C?!^AL?_9U_,G^)D1_MOZU?QDP/:\GSNRKT.^G1_9CN15U*
MU!69?Q2]K"!:NZN@$%*/QMS]%N1SXC$8F) /7C#EUVG;N>63ER/56:\N$$5^
M4-T_2I)J>ZTU'+HKGT\*_P 36?=6X>['9GJ)V5Z\Q/Q8=H $GNND[&K( ;D5
MT='=0(HM,HP1!L7YCD;VB?D.!S5P\36=\LF3ISPCIOZ%!7?VM.1:52JDW73"
M:=E5DYYJ/R)N'NTP%C6"OBO[/[J,A[-HING=71[W&^[9NFCOMI[KM!KM[C;;
M3GG7W6O'/M<\>WQQS_)GI[39V_Z/+V2_]*>%?XF#RKN/V4A,[JVLY/XS^SPN
M<720E@JL@6UK]-7>\G?P:*O9M*F^C]CV0="A7(J+CGA390X^&(N]4>6C!1T_
MW2:[O:;,=O\ H>Q7_I3;97^)L?[-G=?\E;VA_MIZ._ZH<>TV=O\ H>R7_I3P
MK_$UKUOFW>6F.PO;>X#WBY[+% G8-2A]XR,$73TBV*A>*I@AB*&>#O#WLZT:
M<<D7A%)R,]7N7GMMM%/?7O=7W*>V&Y;>L]%2E333ITVG*O-SS2;7VZ7;?\DU
MVY_MGZ(?ZK<@T5SZ>%?XDR:1L.=V?!DI38M&SOKS)%"A%CO75BR&LY/)$63/
M9+AJ94*5+-[!B&S(IPIOLT03D6Y!'A'?W\S:[;)\;B.SQ3VJ8[4GV&WL$& 8
M9/['KRJ(N]F]I3R&5K"QBS)N2E\_E .'1<>N2>(CQR#T_(GPX4T6?OW+=BR3
M7=I[NGBZ+9#5197338$F\%/00 \D*R3CCQ]KH*IKH+^2KJVLBLCOJHDLDHRL
M+=-5)33G;11-33;C?3?3;G7?7GC;7GGCGCG!JGZNJ_(LRP9& , 8 P!@# /%
M\[1?*9[%?SZVY^W\@P=]."Z%W&BL%& 7K^QL/PQ_5G\S7_\ 5UM3!Y\K\NK=
MXD>I#@XRI#O_ /+.\7?SY[9_5L,YJCXEO[F*OEU_;XC?^>QSC & :T\-_P"#
MKHWYS]B?K.W+G.=+QW4]R+.\$& , 8 P#\<)I\*;*\::<*[Z:)[J<:Z\*;Z)
M\[[)Z;;^U[K;1/953;37GGGC7E3?G7CCG?;VP/W@# (0]I.S-PU#:E#4W1]*
MP*X9O=D<O*5Z)6)=)JE@H<92 F#%7S%F6"TY<2A,W)>)JFT%HOQP$2S79>D(
METFZ^RK<5*4VV[1@IQWKS*R2'EWK_L;)8#4Q[J[#YCUVNY7I S-+65.YDVD"
M;;N",@4MCCDG%]>OQZB^$JP.24;H7'S+L3"R\L=!N-*^'R(^0 @B8TZ(F^&E
ME;W7&N;O9:9=IB6]9^3YE=<_[EUE556QTW*>MZ#LM4[B079&8I%[VB,5L.54
MU:TX,2-R ?HU)%JIM2#R-I)'1!I+7K^"KQ2;1]@4^%@L)R(Z82>3B=DWWV[9
M61,[J1?)'LWU\@%WE(4E 7$VYE?+<(R//)2!(BX[-9'% DVALG(QF&$I)7UD
MA@3"PZ[/D8C&GYF#R@ 1=A6"SG=#41J''[_U8/;K)'X(0?[$]G[9@=PQ*@.O
M=+0^Y+5,T[8=_'FEBW XI2*"ZZKR20Z(>JA$D:5Q9JA6>3&2S)H. ,"8J/Q,
M2U'D2\IEPI#5@V("I6EN%*6$OA;#IZ,XQ*8^3CK)6[VP1UAKV!%U:MCUBOIF
M7X@1TU#$YI3M0)7K;-21N<!T'<:EUD0*LN7DC)B@3YR-?)"#C(,6(%09A@Q#
M1;B+RX7&$]B;M+-#<>3?J%2LNE0\#4-G0L ;W[973V)E6M5&(N_ALSZ[0BD9
M9/3,ZBBS'4Z;D<U@=I5H3&$D-=E]VC^+"W^NA<GH-9"Z+[4E=9SG.M>IM.RO
M*91$"!6/OK%;63F$"A\P<^HYM7DL@L:^S!'>OQWLR(Z^2J<N@Q47#;2D50AD
MYEH*>-'W T03'MW/I)*Z:1MR"I;C;W3$QC"98/ I/S-H-#)GRRX&\RZ)QV3\
MCN''OS@?R?#LRO++AWR@UY=<->7?H.''O9OZ?T?I?0)>Z]'J,NS:U&68!!OR
M%=RUNB/7S[/2=9.;90:SZ&Q8K%F4DYC#]  ><NU)%(A[K6/27<F_CH,<0*,X
M[HP05/N4$QB1%BJXT6X&J5I.)BTE>9SRA-+"B=X]HXYTZAUC1GHGV1GM?1FR
MC-O\LR"U7/HB@(>WC7[MA4$GXCREG@CF[$<U-O M<C8$[6FME7'"(@D]>H'M
MR&C#2G%3@\9P?">Q)NQ-GJ_Y 1O9GLE>M&C8*PBX*J3EM1Z)RE](YAO);$=4
M3:;6G;.+,XX8JJ-P9Q&ADS>-4FI*NK:M)T*8D([M8(V"%)8 $NP:A)SCT6F^
MN>R-I8O@R, 8 P!@$.^[76F3=H*LCL3A<OCT.EL.G[&> GDPC[^3Q(BMQ$9G
M!"(R0B!9<(07;< YV4*C5&S[7E&0"PZBR>[;5;W(J</][)3[B/LM\3-!6,SK
MK6PK:[>EGE9AZF0C+>,=M;\KZ&@933T""0",SV&UY%)XRB4%EN[$-N6<F(PP
M8D=CQ@X7V>J$"S]TX%534PJ;SEDSF?N6]1?C*^1O^\8[?_Q8P-+^-/ ?<MZB
M_&5\C?\ >,=O_P"+&!I?QIX&'RKPZ]9)ULQVFUO=[9AL,X<ZC=I1WU[3G]A^
MKSE#EWJRY*V8[Y:\.N6S;EQPARGPMRW1Y4]UZ+3W(JK:P5/ BI"?!M4_VP]]
M?#:5]JOM>/@;1OV!N&O=.]_77$R]S9WV<O6_O2P/7GO7G;[&/JGUSSRU_P#O
M_5'M?^(8+[1ZE.?NJ-D?[)>QSQ'=?(>-U#1*\^_\7$:K*N=14>\@7; *.U<+
M\Z\KKZLAMH-FW"RW.NO*JO"7NU.==?=[<^UQ@CK;NZ:>!SWW+>HOQE?(W_>,
M=O\ ^+&":7\:> ^Y;U%^,KY&_P"\8[?_ ,6,#2_C3P(:E/8S_B<-DR)HU5-J
MES!=\[*%BQ._;5?DB9)^X4=OB!!\ZD2KIZ^>NE57+MVY547<N%5%EE-U-]MN
M1OVU>S@1S[2>QB^@_P!@.Q_M7*9E_%^>K!WV..9!>4T]3^M/7PGUC[^^$)[D
M-Z/U#ZV]Q[^X]'Z;T?H_^_\ 18*N6KF\1L2DW]_LQGB)_P"3-C_VYV=__>P3
MVU>S@9S6_L=OQITY,!=AU%&[_JR?@]'Z86<5SV>NR$2\0F5'.A!1,7)8S+1A
MEAH2$OGHQ_JT>I:O![QTR<<*-G"J>XCY6IJ'#3R@D_\ <MZB_&5\C?\ >,=O
M_P"+&#.E_&G@8F?\//6B5F8Q(Y1</>^22&$KEG,,.GN^W:@P9B+D\-W#''$9
M)D+,</0*YD0HH**JBUVNY$=ONR=[+-MN4N0TK-:-,/%1O/O^Y']?/^>??[^\
M![7_ ,4,LO6^+)*YE']4:!K[Q')?9X[#_9!O/O+]@?WO4'VO'#+R ]EO6_#C
MX+%_LO\ KKWE9_KCVN93ZH]6>N^>=?>_I/5G^[^EQ+UOBQ*YE']3?WW(_KY_
MSS[_ ']X#VO_ (H8EZWQ8E<RC^J/FAWB"ZX5W'6,0@%T=]H/$QBI%8;&(AW[
M[5QJ/#UBY-X:++,0H:SF0YHJ3,D2!8@H@V3W>DWSQ^YY4=.5E=X5U3]-/ R;
M[EO47XROD;_O&.W_ /%C TOXT\!]RWJ+\97R-_WC';_^+&!I?QIX%EN#(P!@
M# & , C??G4NBNS3^$E;@CDJ*EJ[;3!A$2L/MFWJE*#QE@-0S&;!G9&HYW!G
MIP')V4?$-# ,^N4$NV[/A'=GZ-9QJL*FU,9[$\,,35[[QP]-GTN'S+FIR0]R
M,XJ#5"* ;7N:-5.XXH%D"'TMZVI&/6&+IPYS6C6,1[B);&H(0V%+AASQ'GWX
MU27U#2<1.MSG?&^-\U,,X4]XN^ADA@8BMG77@"+BPBN9!4G_ )1E=B022G:Z
MECR)$91&)O.H3,(_.;":R,A!HP_..YW(Y&2*O1RKM\]77)EE'PJJ:<IWF9A8
MKI)=5;6,3IN" JW@_,I^"T;T?)B=9G8$^M"1)I$";PLND]F]GR:838NDDZ?K
MICTC$A?IB1NC0,+U9B![!BV$;ES;<DEP4(V!@A7_ &%7W5#O-<-NTY9M=38I
M-NJ*4>A4BDPV;3:JO7$8[#P(%.R\(82FHK%C$JE];R@(P!M+%@$V32AQXF(8
MZ/H^<08M'V@J;IP>-]>#:P=I63RR,AD/CAZ72@E."!FE6RK:Q(A+H3)8PQG-
MF!J^3$3VMV5/30C%ZT#3,?7T#FDGJT<S@)FQH+&8Y8+V+(\B59-RV56T4!5-
M1?"&MUUTQJ=CD;"\?'42TBDG,S>JG1,A-75LN9>JPLFV(XE)^+RK:O:EM-@=
M:1F<AV9,+*X-4]:L%0#M!4&*,PJ/S $/%S)@F?P$VMT9+)RN_P L#D[ Z']5
M+2L&76=/*O5/RF>#B[*7);SVRQ\1./SE6D:0(S%U70J9,*]TLS:GRK^M&EKM
MXNC9@R%K\ !DL9CT4$4@EVV=&N>^\$I@009&@@>.!&O#$, %#P@AEPJNOPS&
M"FB+%@UX7=*KN5N&[1!)+A5PLLNIQI[M9513;;?D0Y7 -6VW2M87M'1L2MF)
MM9E'!$F"S%B(>OBS%KI(H_NON)?+\"" ]1ZDVY<K\*#GJC@8\T5V3?,W*?M:
M<!,=Q%3GQ>=&-(&UK)E22P:#-FH$:J!CUI7+&TBP*/U:!I1&*R-Z!L,<2E,,
M-U=&0D2F\+DCTK%;#:,O?L\#R0LY=D%QK2JF9OKSQF5J<X-761O"N>I77RI;
M8F=W5[7VL=L:>HR!N=)IR>9D C1*7F0DCFW$0A!:1/X+7N\\D<;CTBGRL!C<
M:5G4@!B3<MW,%&#9VF)+B,L<NA2\7&4X9&0=@[YB/6ZN4;-G V1E0*UB4Y6>
MK.*M!CTOP=NZW813$5=[(%RX1GP)'RB>B'\@7X?\O&H%L2<CF)4@BV&.P2G@
MWP3;[C=N"# & , 8 P!@# .GJ#Z8=L^>HR,/K/K'>]3RQATQ8U]VA'R5X'72
M[%]@>>R/7&50XU$(.WM1;:7&8-7T4O)U(9H_TA?)8%+F\0X,._6*B8H>NDIU
MJ95\%#E3#B6UT1A!MM'J-WWL'KK874&NZEDT)KJZ.UQZUMYC8,T)=2 T:J&#
M415_JJ,QV,UL_P"U\BH_1_V5:!I/%@@K>3[6-M!;&-2$?#&$SU>:3]S7K!)4
MIMX*+0W,O&83M:5A*=W)+&O@?8RV^X726QKFZLWW5=@0"MXR][$WV()KG8E)
M[5 PNRZX(4]&Q^UBM(]7W7PJ7D!2W)J<%1 H1LHJYJ\3N":N 3^2M*1Q%4-1
M,)8.)33=I;RV7+_L&!@'72K.H^TU41.V"U>=3[AU\@X2O>T"LV[;R.QH_O7-
MOR:36F@8KGF(QXO8SV,7<4.PI1,M4$=LF,@(G12L=;0PRC'6Q%<4Z&W%KVM9
M+5C.IZXQ=]IRTB+^7XI$YF[KV4W^,#1*O>W<TI)].JRZLMKCML]#B'5%7K1"
MK[C[2NEHM'W\K-E>T0IL.@P:NBIZMP4;)21V(DRNCY5^QK+[EK*?=3NX^J6F
M^BG9=P<S&(1Y08]9]WA8!8%\)"6<X\E%LQ3BS!%$%8!8DT1,T*^Z+5IQ+S4#
M>R$13DG$&+%0)LXV5C140B*-@>#\80"AVP\2:8NE]*M,Q?2>,:4I8VAJQEW7
MD#WOG-_]9);=0Z\#M5UM<<\(M)9>,;IV!VHT%R;I<> S/2<Q>D&<<A:L%:7\
M5<@*Q>*1[@^XT4<*.')B/M8Y)" CT<HNL%+2<VN[S&/K*+T,&1@'7N\F'5_N
M+:W=2*3KKT!F+JOYUUWK_J!:QH5)/4H4/4U^SZ_ E\2UFGJ3;J\2JK1;NIYP
MB\:LMB>@S51,0ZX?>YU3EYV0O.?(VFHBTSI*5-U$<;J,^!&ESU5[KZU;U5"4
MY2U[U]VEB'C@+5!9%IG)^V%Q!S*BG0B60F'M&TY5M@KM&Y37G8I.-1WBKFT"
M##RLY.<W\_/[;0] Z[I9ITJIATZ4I?=@E;&F;SE#Q1<%XM*_LBLNNLDBE@5N
M<K$>WMV3/:X#RIBO'Y84@Q",0ERZ.22$?#VPQ<$?*6%O/1#,& ,,AI<('$SE
MR*T.RXR1)#-43;?=N_2\2R7!D8 P!@# & , 8 P!@# & , 8!5<;\6=%6_VN
M[3=ANR=>0FTF%P.Z7UK!#U].AYZ*":]JP9"I,S/MQ#R/"]=RIX?ZP&;-'9K;
M9A[C9PLQ7YW:<#6DTDD\,;+69?\ <A_')^*_%_ZV65_G7 TZM?8O0?<A_')^
M*_%_ZV65_G7 TZM?8O0?<A_')^*_%_ZV65_G7 TZM?8O0?<A_')^*_%_ZV65
M_G7 TZM?8O0?<A_')^*_%_ZV65_G7 TZM?8O0?<A_')^*_%_ZV65_G7 TZM?
M8O0?<A_')^*_%_ZV65_G7 TZM?8O0?<A_')^*_%_ZV65_G7 TZM?8O0TU>GA
MMZJF8C&%^N5/0*L;;B5V==+*!S(Q)[(7:, E5WY6]CSI@DBH6DR*I,_ XM)8
M^&3<B%6NQ<HQX=.QC?TA1F*JWFY45++-->9</@P, 8 P!@# & , 8 P!@# (
MB^0"?S"J>B?<ZT*\.NXO/:ZZK7_.83)6&C91['Y9%*KE1V/&V:;Q!RTW="RS
M%H]0T=-EV^RJ&O"R*J?.VFPU2IJI3P=27:19K_R$7V]@<)>/_&!Y I"^=Q&-
MN7A]IIT^X:G':X9DJX,-N%^V#)?AN36WW>H\+,VBO":^O"C5#?VTM T5SZ>%
M?XF7?;_WC^2I\A7]'IS_ *N<#17/IX5_B/M_[Q_)4^0K^CTY_P!7.!HKGT\*
M_P 1]O\ WC^2I\A7]'IS_JYP-%<^GA7^(^W_ +Q_)4^0K^CTY_U<X&BN?3PK
M_$?;_P!X_DJ?(5_1Z<_ZN<#17/IX5_B/M_[Q_)4^0K^CTY_U<X&BN?3PK_$?
M;_WC^2I\A7]'IS_JYP-%<^GA7^(^W_O'\E3Y"OZ/3G_5S@:*Y]/"O\35@#NE
M>UG]]NHE4%^N/9CJK7TIKCM6;E@.\4J-Y%6J3B0:IUXKN&4JNV+6(:.8(L5*
MN'7!+>.H;\29KZ#8MSJOHP%T5HU.4VHPTK7VI%PN# P!@# & , 8 P!@# &
M, 8 P!@%97D2[N6KT]2BZU85?"[(]\TIV4O&4(S"1R*/<IA.NB52OW$; +
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( & , 8!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>g729258g95m24.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g95m24.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[28\4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )B"^EV X0DE-! 0      $D< 5H  QLE1QP"   "'_T< E  "')R-3 Y
M,# X' (% "A-:6-R;W-O9G0@4&]W97)0;VEN=" M($Y%5U]'4D%02$E#4RYP
M<'1X #A"24T$)0      $/UB_DT^WP)^X,L3;*+^8:8X0DE-!#H      .4
M   0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $
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M=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M    $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO
M;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG
M:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0
M$ .__C4  @ " [_^-0 "  (X0DE-!"8       X             /X   #A"
M24T$#0      !    !XX0DE-!!D       0    >.$))30/S       )
M       ! #A"24TG$       "@ !          (X0DE- _4      $@ +V9F
M  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8
M      $ -0    $ +0    8       $X0DE- _@      '   /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H     /__________________
M__________\#Z   .$))300(       0     0   D    )      #A"24T$
M'@      !      X0DE-!!H      S4    &              $W   "6@
M       !                          $              EH   $W
M                  $                         $     $       !N
M=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   $W
M %)G:'1L;VYG   "6@    9S;&EC97-6;$QS     4]B:F,    !       %
M<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M       &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R
M871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG   !-P    !29VAT;&]N9P   EH
M   #=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$58
M5     $       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,
M8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T
M   /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU
M;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP
M965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S
M971L;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T
M<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@
M  P    "/_         X0DE-!!$       $! #A"24T$%       !     0X
M0DE-! P     &[<    !    H    %,   '@  ";H   &YL &  !_]C_X@Q8
M24-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D="(%A96B 'S@ "  D
M!@ Q  !A8W-P35-&5     !)14,@<U)'0@               0  ]M8  0
M  #3+4A0("
M             !%C<')T   !4    #-D97-C   !A    &QW='!T   !\
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M0S8Q.38V+3(N,0
M                    6%E:(        /-1  $    !%LQ865H@
M             %A96B        !OH@  ./4   .06%E:(        &*9  "W
MA0  &-I865H@        )*    ^$  "VSV1E<V,         %DE%0R!H='1P
M.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O=W=W+FEE8RYC
M:
M  !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U
M<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M,BXQ($1E9F%U
M;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M    9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN
M($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6:65W:6YG($-O
M;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M     '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>     5A96B
M     $P)5@!0    5Q_G;65A<P         !
M H\    "<VEG(     !#4E0@8W5R=@        0     !0 *  \ %  9 !X
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M?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! ?_  !$( 0@!_P,!$0 "$0$#$0'_Q  ?    !@,! 0$
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MBK)#'3 #MUQ"60[\>@N>"_'T:_'DZZQI[2B;5O3=-M(44M"$;E\E*7)=F.:
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MP8&&J:Z;\=7BGH5KF,U'XGO$UF*.1K]<%BCS]YF4\OA<BAWALTY9=3216(I
M!%:JVDDA>%I#&L4_1+Q?I[YM6[ENY;0L+4$I64)Z@Y,!3/&[%L-P:EN[!Q C
M!=IR9 X[YKZN/R7GGMS'YK<S_$SC]<<Y>=/-.'%\OM%7:L/-/6^H-55<5<L9
MJ>.T<-6SFH\ZM5NI7KR6HUJSV(HU\Q -U6[Q.[I[2-+:1;Z5*#E?2D$L@N"0
M 6!! !)#@M3 WDAG<DLQC\<?X^0[QMY.]>\97BKEMV'FGB\2//&.*1MMU2#F
M=J6.,#ML=HQY9W&Y'?U[G 5%1ZCFIRQ[ /\ MM,>7J!7E^61YG+R'J8C;?\
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MR(J, ,""XD,S'#A]_P \G&S7$4,#+N&,1\P^@+^@ W_6'IOON?4@C;BQ5BZ
MY0H))8$@XV./VH$2-\$@[?3[F-BU%4ZOS#2ON/(AB:660N HA$B ].^QD;J(
MW5-VZ=SML#Q)-HI(ZB VV20QG_- WX([;D>0CF "V,48&A-E69MH%4A21L/3
MZ21MOL?3TV[=MNYXC\H4S9,[CM'KL1WBAPWKMNS,[$1[D$&9-&QUEFAE\FO,
M\T8>=I5W9$@0[EV4>L:#NS']0$<6KM'X?4F03LP@,\9C'T:F""[RX!=H_8QB
M#/%-ZJS%I%/3T]_0]@>P.W8['U'[N,Y)( .&CT</1F1Y  =WY$N7/3 \J+(=
M^IB/;U[ ?<[[D;^Y/X\1@$ X)#P<'GS_ 'H8DS#=VP03,G!)>G;&U:,\-LW[
M,E=A!(U7Z"P>94+*C$ GID(Z 3L 6W<[ \;K2;!0ID%2B/E2EG)'GWDEIJ)4
M4@["(AY+'(<GG;R%6'DL;=P6E=+F2NABU!C;>:94BE6Q)%7R>1Q<1N/.[HXZ
M*33P>0L41AE1@Q&Q/;U-K^UT>G*=&I0NV^JY.%298;IQ';=J@ME=(2"_UP_E
M_P"(=@9J%W;4$^)IUHL=7BGAEG>:TC=4TW5L DB@]@#V!7<;;G<;$#G:G5V-
M7I+:-/IA94@%)ZLDONXV;N ?:K ,06,F"?0;M]9EZL/0&ML?HW3^<2C@:F6U
M5F9*E:.UG,)B,WB,!2HW*EVO9QU:_%<+92\R9"M:GL5HT@@BI_+/(?F>BK3V
MEITZD71T@B")W)#X;L<%O4UK2Y<3]/-AA^_8-787FBUK,_ <Y4V[EZ#(7<I\
M1/F3=%BI6$"6;=WE?IIRE>O%'$D?Z:3R4B$"1B3?R^F,*.,G]LJS<27*@0%
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MCH&Z70@E2O5]6P(4MV5C[G8D[[[]NP!';AVD*LWOB+<\9Q,-(X_>F\,'9O\
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M;REY%BYFB_IVUIM4K77;FDN)MV2D?$5;0E2@52"I,DN&  [<G;>U!N%"$&"
M6$$?,6<?5XV>*\]93(8F+)3P7]-8U*LL^56"UIN>U6JV6G=TJR4;%]Y5DQU6
M?I>(F!':J'$Q238<>2\2OH"KML:*R0M1:ZE2TVVP"AH;R'2^S.^I(N)^7( $
MD0=\%TP8^U7%H+3KSZ$>*UE])1^??+IBM7PP7L?<6WY: 8F?#"SJS'YSSXF\
MR&GCWBD@DKNS,9#&G:T_A&GU?@Z K66TW KK*"I!4PDH?+-O]7#55J+UZVP
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M?Y_3A4Y8=B3[ ?G;.,<-AL0H4;OO[[$?AV/;W]^W;OP.</'%'Y/K^9;E]@X
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M_P#KTY'8'M/TDX)!@>6<'<<!O($OM28,21MW.^_??8'U[ '8 >WO_5Q$0 .
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M_5_U#J-8#93IC9NV+=T7%*!2X+=+*F?E),CU>LFETE]20+UQ-U"U$@ . V0
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M2W?OZ;[[#OMP *)*6((_']L^V:D V&) ).T88O\ A'$5O7G#K%3EDZ:QE5W
MC4L Q 8AO5F []).Q/KV/9J24EC2)#.((SN&GT,"=BYI8^6D2M4I05:T#TY;
MK_/)$1:LK9,/2MIG8HR0+&W0(T4J7[EN(=2B0D D'SCT;:(V#FD&?(G:<9Y!
M,P!SOBE^ -.N]B_)8EK7L?&+>+5%4--D(G051YCK(BM'*1/&CPRQSF/R&"=?
MF+ML6P028+8Y((;D#U:F[$-!,0S3@/,GD[L*9LE9GO69+MF66>S:FEL3RO\
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MWX72&).\GL<QY>OU-)Y<R?7]N*W%BO%7EA6/S"SK^E4LI"CL8F7JZ90Q)8J
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MYM]#[$J-^K^4EG?VWW/2"3Z<54BSQC;\^]?+]XS05\8/BNWV_P#*5Y[?C_\
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M-.$UNE7IH*LSR6K/F?-1O7"?*!6Z:Z13I8D>=[";RSL8HQ'TA".^XT*NI2Q
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MS)H)$NSLS,7B.6'G]):BSU*.DC;?OW^W]QPC&Q\MZ6(P^7XRWY.!$N97V\^
M'L#+'W.^P!=03O\ L)_:-^QXFB%$'89V=V$EL_G%#,_^1OF1C:>:?9('N263
M)9K0+!&[ .65Y@CA4CA$8(:5M^H)VZ@K$'MQ>IBGY=G$^P?/ILT=JD_#;  $
M^CDL^_<0S4CK1(UB!/)>P$F1F@4/U,J.KR;[,I(:,2=>QW .VX [1TZ6NR"[
M._EZLW,;\T;&&&PRV"9/,>\<$[4%W\YY:YD$JP5(9G AK0*J1UX(U"01!5V
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MO4;;Y!)"JVJD">2*W#U/C6NUWA*=,+:M0>I1U5Q2>I12&-H=IZO^QWR8$_\
MBTNN%LI(0L.A)4X20_41\N2X !8<S!H7E[IW-ZCU=I_"XS&/;GS%Z''Q^?C9
MKP!LDI\PD,;*TCUT)G$D +Q'RY$0;]/'/\"TVMUFOMC^S*[-M1ZR;8"4IZ9#
M[L[G!). *V7[EH(O*MW 5IMDA,.&V;&[N YX.:]A^+3PWZPT'/B=?PZ4:G4R
M&G\+E]19>OGL+D:MS,7Y*]634,5"N%NTZN3MVHIG:Q'.3-(?._2&PJV^(Z6X
M-1>M(TEY*D7;J4%-LD*"5J"5@@!@<R2 -S5&EU-NYIBLW4J6#(=@",I.78N
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M\;\\3O#G(X['7VEH4K<N*F@:M'E))9&K'(LT#BGC)B*MJ6Q&RR/NCSA:\<S
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M;[#AM@8&^)+_ &B<>3)0SLAC#,4'?HW^Q!W^PV]]_P!FVW$"LLP R,0TC_=
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M3UH9)J%*!&:*O4@L-*(44F0!NF0EU9SH_JT7--XI=LV[WQK24(5T@DI2HI$
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M'-600PN>MX=X[JM?=.AU]DI^!:5U)<NR02.D& P @#,F:QZRV=.NVFP62O\
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M8"52-MJM+KKVF5J@DJ^-<BS<2"I(!EL%]N?I$%H"T$-&YXQWWG.=AD5ZOO\
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M57(3@VJ64K)<LVU22=)X9U<.JEMG3BW_ !O5?WR+5G_\?162_P "ZI)5UH(
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M9^I]6R[;KW9B1MMOZL23WW)W';TYWQ+TI'2E)4X91=I9R[CR)'T:I.P <CL
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M_P"U_!0Y.2]9'P,_A-@@CP3<K@1ML?SEKWV]/_2_VV'#<\F,=J*N7G5\+?P
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MQ)))WR.NB"20=R/Y7;;@@$';=?8C<\5J/4KJ5*N3FAAQ6B_ U^$ZNY7P4<L
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M"""#[C@HK;@HKSSRX\5OAZYL9?F3@=#\TM,Y'+<I.<68Y ZZIWK,F"DQG-[
MM#'E-#TSG(\<F:S%>>7Y9(L,UY+%B.6.L\O2&8H8\4^<MO$/R?YNZ^YS\L.7
MNLJFHM<>'W5&)T9S<P4%/(UYM(ZCSF#K:CQF-LSW*E>K<>SB+<-KS,?/:ACZ
MC')(L@Z>"BKJX**'!10X**'!10X**'!10X**'!10X**'!10X**'!10X**\N<
MVO&YX0N0VN*?+3G3XD>3O*W7M^G0R%72FN=<X/3F8DH921X<?=:MD[5<PU+D
MD<BP6)VCB?H9NOI4G@HKTQ0OT<I2J9+&7:F1QU^M#<HWZ%B&W2NU+,:RU[52
MU7>2"S6GB=)89X9'BEC971F5@244KX**9<WJ33NF8:EC4F?PNGX,A?K8JA/F
M\K1Q4-[*77\NGC:DM^>NEF_;?Z*U.%GL3O\ 3%&Y[<%%/7!10X**;LOF,3@,
M9=S6>RF.PF'QL#VLCELO=K8W&4*L>WF6;M^Y+#5JP)N.N:>6.-=QU,."BE%*
M[3R5.ID<=;K7\??K07:-ZE/%:IW:=J))ZMNI:@>2"S6LP2)-!/"[Q31.DD;L
MC DHI3P44."BAP44RX/4FG=3UK-W36>PNH:=/(7,3;MX/*4<M6JY7'R"*_C+
M,]">Q%!D*,I$5RG*ZV:TA"31HW;@HIZX**'!10X**'!10X**'!10X**'!10X
M**'!10X**IW2WB$Y':WY<:JYOZ1YK:%U#RNT.VK4UEKW%ZAQ]K2^EVT'#-9U
MHN=RZ3?*XPZ7K5Y[&;%MXOS?!$TUCHC'5P45/-&ZSTIS$TK@-<Z&U!BM5Z/U
M5C*N:TYJ3"6XK^(S6)NH):F0QUR$M%9J6(R'BFC)5U.X/!15=\HO$/R?Y[Y;
MF[@^56L:NJ\GR)YHYWDQS3K5J>2J'2W,?34%2?-Z<G>_4JQW)J N11R6J#V:
M;2K*D<[]&Y**6:%Y]\GN9O,#FMRKT'K[":FYA<CLKA<'S9TKCC;.2T/EM0XP
M9G"T<QY]6&OYV0QC"Y *D]E1$?TC(_T\%'Y^>](]:>(?D_R]YP<HN0VK]95<
M/S6Y[TM<9#E7I.6GD9K.JJ?+FIB;VL9Z]JM4FH5%P]?.8II/G[54SM<C6L)6
M60(45=7!10X**'!10X**'!10X**'!10X**'!10X**'!10X**'!10X**'!10X
M**'!15>\W/\ Q4\SO_V>ZT__ ,;R7!17P'U-.^.N/X)OAISV=YD<@K/@Q?Q/
M\C5Q.@<?HG4T'.Z#(/XGJ46,DN:OER;Z>FKPZBZK5I(\>C2XTB!"LHZN"F?V
M'VCZ-ZU[<\7/BZ^(!J_QV>-'0_*KG=<Y,YGPQ:OY-XCD'IO4GBAY3<A.4B:1
ML8#36H\WJ;F+RMYDXELGSLQ6O:U_)4_SCC,W1JX9[%*M5*V*X+(G\<1YR(SS
MBF X,@8R"3AX(26WX]1--GB^^(=STP7BSCUERHY]^(O3^<Y<^-CP[^'GF3H/
M47.7E#A>2<M_5<NFZG,CE_H7PX5:T_,O5>DZT>2NRU>:&<\M)9"SQVF>OTU#
M<9W_ -?Q!Q06EF]I,Y=CMG'ESXOY_P"BQE><W.;5F4YWZSY+Z5QWY1OS/TUG
M=1X'+XG"8C2":@UGC&CYG39/+4YZN-U#HN.I-/@\C<E7'U?/LO:@F'24= _3
MS\TCD1_CW\JN[FM'STY6ZM^-%XLO#]XR>;VC;'AL\0?A9SN$JZ/R."DTWSZL
M9/EMRQQL^IN:%^*D\NIJ.>T].9X*5">MAYK&3N7VKSB: 0HQ[CZEOWI#<;L>
M-@^^\&O5?C#\;?CPY*>(;FGX+]*<U>8%[7?Q'=-^$'F%X']<Q?+.W)B3767J
M8CQ#833MV.NM;#8O2DM3-9N&K<AO3U-.)C7_ $UB^O6?O1QC[8VF# !\S7V%
MX+&/A<)A\/)D<AEY,3BL?C'RV6G6SE<F]"I#5;(Y.RJ1+8R%UHC9NSK'&LMF
M660(@8*'2IUX**'!10X**'!10X**'!10X**'!10X**'!10X**^0;QY\C>=GB
M1^,=XM>2?([DIX>.<&>YC_#EY<:1S&1\1N0>GIGE5AL]K5L<W,C 05]-ZDR.
M0U'A;,\*U:V*KUL@$E:6"9@C(2I#!VQ^\8+@]V&*EF)Y%>+/E)XW/"3\-'1?
MC.YT:3Y<^'/X47+?G'J;$\L9J-3^=SFER_Y\\V<2*(DRM.UD*&'U7%@L%I;(
MPI,;%K2]"#%D(99F8I8/(?W^]>6_AP>+_P")ISNYM<A.=>"YHKS1U!KO77B!
MQ_._P_<RO%SR8H836%#3M#7%C36@N5WARM8S$:[Y1:HT/'IJ*\^0N9'(?/8J
MO+G\TIP[6)53S@S#PW//GM^U, $.2(S!<.8PEO<F':<>@_C+YGQ2<ZO"AX4.
M8_BYT5G? 5G-%^/_ ):Z5ETQHWG+R^YBX"[HW5"Z7EQG.7-ZKT^<KB,)F=#9
M:GJ&KINK=MQ?F^5K^0R$,U;(TU4.WXT&?V]:!NTP,/,B&(^DR/2HYJ/FMXR+
M//7XJ^N^4/CDYW<Q>77PX_#[R<YH<@-"XJYI[46F.=6:R/@JT=JF35&N;6+Q
MH?5&G<YD\AD>8V1QF*=*>5SEAK\!2$01H_M^;TMS#9CC/V_&IQ^%]XGO&,^>
MR/-KF5XB<US!\.V<\"?,'G)S>I:@\47)KQ&\W,'S)T[7PN1BYG<H.5^E,7A<
M_P N\3CK6;BTQD-"ZAK7L)B,M=QM#*V(;9B+IYQ[D?23VX]\LA@[@X9@7&\N
M ,=R<-%<DN>WBIY^\[M)<U.6^#\3GB?S/)/GSX#.;/B'R>F.:_/7D_SAU3EY
M-#9K%933DM_3_+7'V:?)G':HH7[*9_EQ8FKY6E5@6K.E67'O' #\>>=GB<'=
MHV-#AN<X#$><3#O)C)>NN575'-X\FO@,>'#PY^/SF[7TKXII^8^C^;/,_1^H
M](:BU+A,?C?#/H;43<L<=<AQD^,HMROL3Y##Z3AM0')Z8MS5[EEIKU*$ATL'
MLQ;9X@SWFO)W+CQ$>/S0/*ODEXDY_'!S_P":>4T)\4:YX&<?REU-9P=C2/,/
ME=4U!:J23Z\6IC(LKJS7.;GL1TX\W>MO)0J04H,>D,RS33(;R8+?0>_+Y_=[
M>CE@'_4T<1^2:G'P^?%Y\1OGOS:Y-<Z'Y\/??7G,KQ%8CQ#\K>8/BEY23X:/
M1^GH=>?FS3W*GPK#%8WF5R[U?RKQ6FUU!7<W\I;S]#''+Y&)\99D<#SCMD-S
MR[MV^DT,&DC!+,7R6GI9O,GW9E?@TYV>.2VGP<>=.NO'5SYYA?TA.6YU<EN:
M>A=16<#_ "0TSAL/AGK::U/I*A3QE<)K?#RO)D_Y19'YJU/D4KDE::/4D-QG
M!WB.V-_I2VVR-N7WSMM7OS\FWTYB]-:"\7V+F\16K->:PQ'BTY^8#.\EM1ZA
MP-H:4@Q&NDAAYI6-.4ZE;,XW/\P)FEBS&2ME<=D)*"+1@A\IEX=-63YF?4^@
M\O7<5]-O!4:'!10X**'!10X**'!10X**'!10X**'!10X**^&OQ8?RZ\,_B&^
M()\(+E[%D<95^*?XF/#YKCP[0T4:/%830?B,ULLWBC%9J5AJ>&P6#&'U'A\U
M0L0PL-)7(9/E)*H#<([^C,3_ !'\<4Q/;.S[!_HY[;9I1F/$#X[Z_BEY_P#*
M;D/S?DY13>#SQ \I^0/(KECK#Q0<H^2W*''\D-'T-+X>&AK'D-K;$0ZCYKV^
M9>'M7(:.M,3FZRQYA8:F+C^:HR(P3].X 'G+_0TP'>0/0D\PP/U([U5FL,YX
MFO#_ %/BD^-7D_XGN9W*S+\H/C-ZAP%_DCI6;%IRKU_9U/K/$0:N?7M>2I)D
M=05[E*:MB*E-KB4ZU*"Q+%&+=E;,1QY_L:&A\AS'(=/L2\D5Z.\5_C(\0V@O
M%/XX>5F)Y\:@Y \I-=_%+\)?(+F+S\TU0PV(RO(WDUK#D1'G=36J&IX\1Y>)
MN9B]3##4.=EN7:M:E9K4;,"L#$'S;]]I_'[TA[R !Y\/&VX(FIOXQN9-GD[S
MS^&9K_PZ>(K/>.'4/)[P]?%GR.A^<6ILQB-=Z@U-J;2>GN7E^KA\OE],5JU+
M4DV@Y5BPAG2-[>2J8.)[\]FS/-/(#S?\Q_N:#GC.?]>F/:K&^"ESV\<W-WGO
MR)UAJ[GS_.ER;YN^&G,ZYYYZ9YC>*[E%SBU:G,B1<3DZ>M.6G*326+PNLN3N
M%Q.<S%71VH-#92*_6TXMV.GDYDR,$3$>68Y,N-N))SM#4R SN," "\\_*!SN
M?7-?6IPZC0X**'!10X**'!10X**'!10X**'!10X**'!10X**'!10X**'!10X
M**(M5J]VM8IVX8[-2W!+6M5YD$D,]>>-HIH98V!5XY8W9)$8$,K$$$'@HJJC
MR#Y*-R_QO*AN5>A#RTP^3HYK%:$.F\8=+8_+8S*#-X_(U,+\O\C!<I9A5R=:
M=(1)%= L(PD'5P45&^8GA3\-/-O6. YA<SN1/*O7FN-+K F!U5JG16"S&<QR
M57\RM'%?N4Y9Y(ZS_77CG:5(&W,2IN>"BBL[X2O#%JCF!DN:VH^07*;.<R<P
M^(ER>M\IH; 7=27I\!>HY/#6;&4GI/9>WCK^,Q]JM;ZQ926I ?-(0#@HIQU-
MX8O#OK+3NL](ZKY*<M-0:9YBZJFUUKK"932.&MX_56L[$J33ZJS=>6J5O9^:
M5%DERLN]V1MR\QZFW* 6D4M?PZ<AI,+K'3C\H.7;8#F$V%?7.'_DKB!C=6-I
MRG3Q^ ;/TQ5$&3.'HX^C4QQM))\I7J5XH>A(D **\Z\R? 7HCFCXU/#3XQ-1
MZMR2MX5.7NN-'<K.5%/!XNOINEG=>114,GK*QG(Y%R[VJ>%J4<5C<*L0QM:.
MO)."SV)$!Z_GYY45[QX**'!10X**'!10X**'!10X**'!10X**'!10X**'!14
M.K<O-"T]<Y'F;5TEI^OS#R^!JZ6RFM8<75CU+D-.4K(N4\';RZQBY/BZUM5L
M0TY)6@CF D5 PWX**R_+_0\FNXN9\FD]/OS%@TR-%PZW;%U#J>/22Y&QEUTV
MF9,7SRX9<I;M9!<>)OEA;L3SB,22NQ**K+3OA6\-FD>:M_GCI?D7RMT]S?R;
M7)+W,?#Z+P>/U;/-D:<V/R,YR]6G'9CLY"E8LU;]F)DGNPV;*6I)18FZRBK!
MYE<KN7/./2.2T#S6T1ICF%HO,>3^<],:NP]+.8:XU>59Z\DU&]%-"98)D26&
M5566)U#(ZGOP44WZ/Y,<I>7\^;LZ(Y;Z+TI/J3$X+ Z@DP6G<9C6S>%TQA*V
MF].XK*?+5T%ZAA=/TZF%QU6P)(:N,K0THD6O&B HJ&<M/"GX:>36<U7J7E3R
M)Y5\O<_KBI<Q^KLMI/16"PUW4&.R%B*W?QF2EITXS/C+EJ""Q:QI HSRP0/)
M S0QE2BF[1O@\\*G+R>[9T/X=^3NEK.2AU/5R$^%T!INE-=J:TBJP:KI6I(J
M :>CGX*56')4I"U2Q%"L;0]'4I**?](>&;P]Z Q^@L5HKDSRYTOC^5N8S>H.
M7-3#:5Q-*+1.<U)6-//Y;38BK*V*R&9J'Y;(VJC1RVX L4S,B*H**7+X>N1:
M8VMADY2<OTQ-/7G\Z53&II?%+2K<Q_/%G^6\%=:PBCU/\P!-^>$47?-'7YO5
MWX**8,1X3_#-@.:&4YU83D-RIQ'-G-+>7*<PL=HG T]4W3E*,V-RDDN5@I)8
M\_)T+-FID;",L]^"S92W),+$W645)<;R!Y(X:IR\H8GE3H+'4N4EVYDN6%2E
MIG%UZ^@;^0!6]<TG%%75,)8M@D3RT!"\@[,2."BE>C.2')[EUK#7','0?+/1
M6C];<R[,%WF!JC3FGL=B<UK"W6+O#9S]VE!%+D9UDDDE:6<L\D\DD\A>9V<E
M%6EP44."BAP44."BAP44."BAP44."BAP44."BAP4576:Y0\K-1Z^TQS4SW+S
M1V8YDZ*K7*FD==9'3^-MZJTW6R$,U>[!A\W-7>_0CL06;$4BUYD!2>51L)&W
M**@VL_"KX:^8G,7"\W-=<BN5FK.9VG36.%UWG=%X/(ZFH/2E,].2/*V*;V7E
MIRGS*DTSR2UF"^2Z="=)0^>^:?,GX>N1F9Q&K\!E>4G+_(837^K_ .7^M\5;
MTOBIJ&J];^9%,=5YZL]8Q9//&6"&4Y.TLEHR1HYD+#?@HHK4WATY#:SQ_,+%
M:LY/\N]18[FS<H9#F93R^E,/>@USD,55BI8O(:F2>J_YUO8ZI##7HW+1>S5B
MBC6"5 B[%%&Z>\/7(K2<'+^MIGE%R\P,'*K&YS#\MXL5I3#TDT3B]3)"FHZ.
MG%AJ(,97SRUX#F4K]'YR>))+AF<=7!13/RS\+7APY,ZOU'K[E-R/Y8<N=::N
M%M=2:GT=H["X#,9:*_;COW:]FYCZD$HJVKL,-J>I$8ZTDT,,C1%HHRI15]<%
M%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@H
MH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%
M#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH
M<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#
M@HH<%%#@HH<%%>:M4^,GPH:(RN7P6K_$3R>TWFM/WGQF;Q.8UYI^CD<5D(R
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MI5Q0/Q O!"IV;Q5\BE/IL>8NG0?X&[^'<^@X"" Y! [T@DD.!]JU'Q!? ^2
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M2I&]+((:ZBW,E1_-D+(JURDT@L'<EHRRN"">-WAZ!9NH4I05\R3/F#YN\!R
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M]5K7/1.I#,H(8;*W<!QWW.P!( [, -_7;8[<<<*%M^B9(!Y#X Q)[^VUJE
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M]A8K212()XPS>7-TRJLL9D W_2;G<[$@GC'=95U0:']P"^-GXJ6"9&[^9 W
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M+;L>.>W/:F=^.&VV<]N[SAP33U7S=V#%W\+%9$=/)/4L6(0KCS;%)9!5$A!
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MMB3V =N!4I)8S S!9X+!VW#[#-$O42:>..FP>28 ]/7W1C]3*Y8(K>6@8LX
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MR#[8YBHJ+ 3#\P?9MN7W=I9JOU;:L9W1O*ZPJ/V*?HXXU8!MQL=]^H>NS+V
MVWCJ+%PIZ2@E!_[N0$],;CYB7!?9N3,G!@LEQ ;]N3$@$@;YI=C\]^;\=F*0
M 8YFK6J2/WZA!#=KW'4>G:1J\;]NV\('<D;7:37IT=I=A#720?G(D%3'IQD"
M,]V=V"&RV/(O$ "7G)'G2-,S--'#4N3M8J5^L1I(2>A79VZ8SWZ%:0 N!Z
MCN!P[>M-QD70& 8$0/J7'HYAY:C :&$ECB,;B"\R'.SFG#(9Z-\M7OZ>K/A:
MU&'#RUZT%R6PT63HXZC%<R:RSJICGNY*O9R2J!M7%H55+K &:F[J2A:?[< $
MJ \B3!<.<N^?-G-"A\JADE)9@Y@$D GSAM^,5.])V;5W6U75>I)I[>-:W#>U
M+;;(]-F[C;4L<&02*S*)E;(202R-%6CAD7J8JZ!$B*]KPFWK=9K[/QU)&EMR
MI202$EHZ1(!=B^T'#5GU-PHL )'S!@V=Y9F>(F>"U6#KHZ3PFD,YI73L&:36
M-;433ZBU#D9X +.*G:W5QNG*;5T\X)!0>GD<C8-B0W;MN["(X:\-=3O\:T.C
M3?U:]-=N*MJ2@+"@9E, R\A\2(@57I+@NVV+]:%$])!&[8(GEAYDG%>=<;&M
M^W!5LVXJ,3RD-/8<QPQ=0.[.45F"'J^J-4+-T*O4-V(\S94J]J;>DU%TV_#T
M_I!QU<L2S8F.]:U!TM()]-H8C8PYSO6BP5WR ABD8Q&50)0ZHRQ@AF9I&#*"
M%W#%BW;IV![[1%A2+]U!NFY:2H]!ZLI.-]O)JBEPACWY$SZCS'J\5]$WQ\S6
M;0?PG5@\XP-\/;E2U8E]F\@X?3C*[A5.\[I_PA';OV'??BI"+J5GH+D. >2
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MCL#+'YG2ZJ0H<1RH7[[=0/?C,"^K^(A70;2NI*A ? /VX>3L!4D#K$PX+C$
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M#8QKD9#1SO4C>S]+C9 >D[_3QOT*+J =7JK(7I! "AG<$!W);Z@,7I**4P%
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MQ01>1%#'$IW9/-ZYV9^E)YF9]R[!H@2#^M])4G;?5?U -M(2_2,* +-+.X?
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M6%_1NVX5PIW!9=]UW[A@#WVXS6KZM,L74))4EV;(<%);T- $R6@EP0.<$/\
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MU)9,N[B#MNQW\BY'9B?S&U!D-6ZNU%JO)%'MZES=S4+]-KYE4.3MS6A!\QU
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MI0J/Y18>7U(/\<*#U$$C[]SQ3<">HA ]1/F .U$L6 (YW;'8MZ-FDRP]43R
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M8/-\L[.T'4O1^/'HM%X%_=6%W E:;J+1N(ZF^926 !>02[C=IJ%Q2D,4ASU
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ME3EI:#G.S1S4;2<& !S/9O)R'.6'>H_3>:*Q6GCV25)4:.1@.F-U8M'(5Z2
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MP,?2LB+(+#R.K)U=F0[=2IN2S/U!OIW9@NVQZ>W'+*+A!*+[]1FVCYE D_\
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M$2":<R2QQ0TX9ECDM3*Q58@_<;@C'I=(LKZ2ZE$1NT1)&([137="0Y#0&()
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M@GML!OT[>WWYRK]RVX?!DY)V?(S[]\4%"2PR7G(SY9:2XY/-%K+(XD=W9V4
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M9 H)O&-M$@ $0Y<@H/T:1D^7^=Q#U;1J PC5MO\ &[ #)JM3<OK*TDI=BQ/
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MAP44."BAP44."BAP44."BAP44."BAP44."BAP44."BAP44."BAP45XVY5?$
M\(O/#Q"\P/"YRDYRX#7_ #FY7X)]1:WT_INOD\CB\+CX;L.-MJVJH:1TS:O8
M_(3I1R..IY6>[1MK+!9ACDAE5"BJLY'_ !9? 7XB^>$'AZY2\[X=0\R,I+JB
MOI9+6D-:8'2.OK.BW9-3U>7&OL]@,=HO7]K#B.66U7TGG,M,L$4LRHT:,0G#
MD??]O8^U&*Z.<.BAP44."BAP44."BAP44."BAP44."BAP44."BAP44."BAP4
M4."BAP44."BAP44V9J7%PX?+39L0MA8L9?ERXLQ&Q7.+CJRO?%B!4D::$U!*
M)8ECD,B=2!&+=)**^,/P>^*CP#8?XBOQB8WUU3T?X?>=W)?EW@>5LNAM&ZVT
MC7SN)Y<Z)U>==P:$%+2V-& S&G.H/C9KB8@2Y9JAQ\EJ5UZBI %F8Y!D'9W_
M #/%6Y^3YZZY]93Q%9G2?C)U-SEM<PJG@]Y=YCP>XGF!9R46*RWA,RFK<GDJ
M.I<[5BGDI9'FE(+VFZ>=OYTRYZK@HL11D93$[2(?F_YQZ4$-Y?[@\%LBOKSX
M=1H<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<%%#@HH<
M%%#@HH<%%#@HKXP/C,^(/ \RO$[RBY;\K?$)GN?_ #%Y3^-CDMGX?A>9'PV9
M/2M?)YW")+B\MS-GYPZ3Q.G]8ZGHU#D8KM"WFL_E,$GYUD*QFK5$4Q3_ ,'#
M[^6SEY8D-4&T?S2U[_2[8M[NK^?%+X8^KO'M/C<2+.:SL^F(?&UC^5] Y+0E
M3,5IURTW)6IS'RD%3%T4$6EK^7IX2!$DJUK F*9'8;G=XSG;]W [_;QP5&AP
M44."BAP44."BAP44."BAP44."BAP44."BAP44."BAP44."BAP44."BAP45\8
MNDN??A:R7QO/%KISP]:OP&D</SC\#,OACY-V])Z&UCI;!7O$GDKV?@M:;HM2
MTG17&YF'45LY&]J&TE3%M.)+WYXD;]+PMHXBI,7<@Y<Q[UXSY :QY3\W>4WP
M;/"[5P>K\!S3\ ><\46NO'GCDTSJ_2^;Y"<N<+%D[FK9]79N;$4JM>_K"LD=
M;!O#DY[4F7@IXZ"-Y[L,;#@?F&_88I >_+^;-R\,W'$U[P^ YKWG/?\ &2FD
MO%AJSG?;J-X4%SWP[L=S%NYA,?J3PX9?FIS"OY34>L8XYVKYGFFF&7$4X[6I
MC)F*>D:M:M+'&U?&2,#U^X;L?P^C42V,9AL1/N('F9>OL6X=*AP44."BAP44
2."BAP44."BAP44."BAP45__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>g729258g99j21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g729258g99j21.jpg
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M/#@/>RFQ7/AF+7J5F<X0"0QUDS5(DZ1(!^;W\/\ X\/RV.+C_$CO)]9Z_?\
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M:C^(G\/_ (\/RV.+C_$CO)]9Z?H/R+^:')?^P9)^Z)\991^7TWZU'\1/X?\
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MR+^:')?^P9)^Z)\991^7TWZU'\1/X?\ QX?EL<7'^)'>3ZST_0?D7\T.2_\
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MHI,%_FOF+&9EJ%%B0VY1I,40XKH3GLIL4!KF071W5P8GD 0V1'>5;Y#A??\
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M1& $5U4PI/)<UU8M: XBC2JI]J#.5L52 /'5Q-B-[=QFMYA-VH6X/%[?:S'
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MWEAVK/;5[?$-QY57H]BK9/;*NNN%1(Y#AE,D^DX@CD[/4Y^(.6/@-=5><J4
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M3:'EYK(#,S+LW<QT)SN:+P(<7GVM)YT!S1$)-H+I&K6JR"_.V_"C]N-M"$M
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M@46$_P#<O^$0J-"K0;G.!<3:0O/\7Y=^1N_=7T3_ ,/_  O>Y[A_R2K3>9.
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M2/*/DS0:#D7+4"GTJ%EVC4J)!AP:7#<VCLR?E."^*3&H\)A#8D>$R0<73>"
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MY%KD-^*XX?++7&>5;ZM&4\PI4O*F751I#\=3C>4KRP^\UG.6W5I5RB0( ?
M@P@#%<"!#8)CF(QD?)M$P#(Z0#> J";;3=B<0JQY_7OKK;?>,Q\9KKF]'U$'
MLF=U29Q.TIY_7OKK;?>,Q\9IF]'U$'LF=U)G$[2GG]>^NMM]XS'QFF;T?40>
MR9W4F<3M*A++NIN(!KYHU#/W<]*%#)D]@-"MDJ'*).16%O)BM2B96)!CY=RC
MD4])?0AM'A*QAQ>$M+AH]' )S>"9"<A"AV[1)4$D@5C;TE:RP^/ XU+&2[7.
MW J%1,[<TR] SD\YN&1)VB;<1P,BFM4L2)JTH1;YP-)R/&-1PMJ?L<5]M<CS
M64,PL@WRJT86NH\)K2UK@3"::Q=*QH#).E.V1K?^LK5HM(G)Q)#B")R E.TD
MFR[2 .E>A_[0ZB18S#\K<G=N')E$Q8F*)G@MRAQB3*+3[6&9S''$(<5Y]E@_
M1+D D.M>%CG6NS6H^)##XZ1-2H<IF#"%H%L  VD@6%F+7#U@C":J_&X3/E"S
M??:-OKEM;Y_7OKK;?>,Q\9KMF]'U$'LF=U8F<3M*>?U[ZZVWWC,?&:9O1]1!
M[)G=29Q.TIY_7OKK;?>,Q\9IF]'U$'LF=U)G$[2N<7Z]\N/_ +UMOW\?^8S'
MX_\ _LTS>CZB#V3.ZDSB=I5ENMWND6XVR+%M]HC1HUF/,1X[!\LRPPPR4E-M
M,LM-RTMM---I2AMM"4H0A.$I3A.,8UR@0(!@028,(DPH9),-A))8TDDELR2;
M23>J29FTWG2<56?/Z]]=;;[QF/C-=<WH^H@]DSNJ3.)VE//Z]]=;;[QF/C-,
MWH^H@]DSNI,XG:4\_KWUUMOO&8^,TS>CZB#V3.ZDSB=I3S^O?76V^\9CXS3-
MZ/J(/9,[J3.)VE//Z]]=;;[QF/C-,WH^H@]DSNI,XG:4\_KWUUMOO&8^,TS>
MCZB#V3.ZDSB=I3S^O?76V^\9CXS3-Z/J(/9,[J3.)VE//Z]]=;;[QF/C-,WH
M^H@]DSNI,XG:4\_KWUUMOO&8^,TS>CZB#V3.ZDSB=I3S^O?76V^\9CXS3-Z/
MJ(/9,[J3.)VE//Z]]=;;[QF/C-,WH^H@]DSNI,XG:4\_KWUUMOO&8^,TS>CZ
MB#V3.ZDSB=I3S^O?76V^\9CXS3-Z/J(/9,[J3.)VE//Z]]=;;[QF/C-,WH^H
M@]DSNI,XG:4\_KWUUMOO&8^,TS>CZB#V3.ZDSB=I3S^O?76V^\9CXS3-Z/J(
M/9,[J3.)VE//Z]]=;;[QF/C-,WH^H@]DSNI,XG:4\_KWUUMOO&8^,TS>CZB#
MV3.ZDSB=I4,<WB-5B-'FV3=,I7H<N=%%Q)9R[RQ,:43G*4F$.COSR<=IZ=+4
MA28L1M:I$A258:;7E.<8A@487P8 ME;#ABTW"UMZ N-Q<?5,KO#[L6.PC(9H
M!N4;.!B+7CQY8/<IY,9.8\)2/'0Y\(D_%E->&A:/&,.K1X25)\+E3G& H]&(
MF(, @W$0X9!]H:A+A820<"2I+S^O?76V^\9CXS5S>CZB#V3.ZDSB=I3S^O?7
M6V^\9CXS3-Z/J(/9,[J3.)VE//Z]]=;;[QF/C-,WH^H@]DSNI,XG:4\_KWUU
MMOO&8^,TS>CZB#V3.ZDSB=I3S^O?76V^\9CXS3-Z/J(/9,[J3.)VE//Z]]=;
M;[QF/C-,WH^H@]DSNI,XG:4\_KWUUMOO&8^,TS>CZB#V3.ZDSB=I3S^O?76V
M^\9CXS3-Z/J(/9,[J3.)VE//Z]]=;;[QF/C-,WH^H@]DSNI,XG:4\_KWUUMO
MO&8^,TS>CZB#V3.ZDSB=I3S^O?76V^\9CXS3-Z/J(/9,[J3.)VE//Z]]=;;[
MQF/C-,WH^H@]DSNI,XG:4\_KWUUMOO&8^,TS>CZB#V3.ZDSB=I3S^O?76V^\
M9CXS3-Z/J(/9,[J3.)VE//Z]]=;;[QF/C-,WH^H@]DSNI,XG:4\_KWUUMOO&
M8^,TS>CZB#V3.ZDSB=I3S^O?76V^\9CXS3-Z/J(/9,[J3.)VE//Z]]=;;[QF
M/C-,WH^H@]DSNI,XG:59JI=[I((ST2+?:'T(K-O?0AX^5=2E^-5R\B.\E*Y:
ML)=COM-OLN8QA;3K:'&U)6E.<<XM'@!K2(,('G8(LAL%AC,!%@N()!%Q!5!,
M[S<=)P*K/G]>^NMM]XS'QFNF;T?40>R9W5)G$[2GG]>^NMM]XS'QFF;T?40>
MR9W4F<3M*>?U[ZZVWWC,?&:9O1]1![)G=29Q.TIY_7OKK;?>,Q\9IF]'U$'L
MF=U)G$[2JQ8M]9%05$1;-XWJNN>P2E046+<)814V*'8;DEY,1)(O&S)8%1GF
M9!)YG"VX+#K;LI33:TJS#!HK?.@P!.<IPX8G*^\:-*H+C<7&X63O-P]NA6)G
M<6ZR66I$>]6B1'D--O,/LV<LZR\RZC#C3S3K<Y2'&G$*2MMQ"E(6A6%)SG&<
M9U<WH^H@]DSNJ3=B=I7;Y_7OKK;?>,Q\9IF]'U$'LF=U)G$[2GG]>^NMM]XS
M'QFF;T?40>R9W4F<3M*>?U[ZZVWWC,?&:9O1]1![)G=29Q.TJSUF[W21YP>/
MM]H>\36"TAGQI\JYXI]OQ'BWVO#EJ\6\WX6? <1R+3RY\%6.7.N46! '-R@P
MA.*P&4-@F#.8/DV@X*@FVTV#$XA5CS^O?76V^\9CXS77-Z/J(/9,[JDSB=I3
MS^O?76V^\9CXS3-Z/J(/9,[J3.)VE//Z]]=;;[QF/C-,WH^H@]DSNI,XG:4\
M_KWUUMOO&8^,TS>CZB#V3.ZDSB=I54L>_:J<MINW;T*JKC\5Z:PW8]QL@UO0
MX[\:+(EM()F(JG(K$F9$CO2$84TT_*C,K6EQ]I*H8-%;YT*CCUPX8]X5%8W5
MCZIF^Y6OS_O?76V^\ACXW5S>CZB#V3.ZI,XG:4\_KWUUMOO&8^,TS>CZB#V3
M.ZDSB=I3S^O?76V^\9CXS3-Z/J(/9,[J3.)VE//Z]]=;;[QF/C-,WH^H@]DS
MNI,XG:5FS8:U6<O;R48M8SQ2,BMS'T1R)@A-80^DH';2\EJ3(=;2ZEMUQ"7,
M)PO"'%IQG"5JQGY^4H4*' 860X;"8K02QC6DBI$,I@ RF 9= 6V$DF9)LQZ0
ML)7W^?5T_2RQ_P"\3-?0H_[O _HPO]&K#KSZS[U4]=E$T1-$31%>::-(%H%W
M@#(4DA->JT3+,2&RY(D.X:N53=<\!II*EJ\!IM;BN3&?!0A2L_<QG.O/'<UC
MJ.Y[@UHC&;G$ "<".!,FRTD#UJC3ZOM"\_1Y>^I]C[(G=SJYU1]?"Z[>*2.!
MV%.CR]]3['V1.[G3.J/KX77;Q21P.PIT>7OJ?8^R)W<Z9U1]?"Z[>*2.!V%1
MIG::W'Q)$*2I]NR/*PWX,U,%D\(EJC26\M/)CDQ+D$G"<4A2DXD0ID>0CESE
MMU.?NZAI-&((,>%(V61 -X((]B .%LCL_!8NB\'P"*@*SG:>TSXM;$C@E=@F
MYEYL X# $N#W(',HXZ6(P1<YI H;$65@QV"LD=!C"Y4UX:TB+C'.T,2'.PB
M  #%F !*4@7$"X6BV0E<K-]MAMG.30)S]0__ #0J;?\ @0#7R> +-T_<2CF*
M](D/Q3-#8R'+NIDE+,=RUDE/"EY@YV.;N5I+P2@!X.<'$#DZ1!*Q\J;PW'1*
M(X@\_#:1I9$8#>3?;*USC,2())!G)4%PG9.>(.B6VX7S"V5Z/+WU/L?9$[N=
M=<ZH^OA==O%9D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\O?4^Q]D3NYTS
MJCZ^%UV\4D<#L*YQM[>L9Q_]H6/[^/\ PB=W.F=4?7PNNWBDC@=A5DNE$NDN
MXVR5%JI^1&DV4[(COLBICC3[#Q24XT\TM+64K;<;4E:%ISE*DJQG&<XSC7*!
M2(#8$%IC0P1"A@@O:""&-!!$["#852#,V&\Z#BJUT>7OJ?8^R)W<ZZYU1]?"
MZ[>*DC@=A3H\O?4^Q]D3NYTSJCZ^%UV\4D<#L*='E[ZGV/LB=W.F=4?7PNNW
MBDC@=A3H\O?4^Q]D3NYTSJCZ^%UV\4D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC
M@=A3H\O?4^Q]D3NYTSJCZ^%UV\4D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A
M3H\O?4^Q]D3NYTSJCZ^%UV\4D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\
MO?4^Q]D3NYTSJCZ^%UV\4D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\O?4
M^Q]D3NYTSJCZ^%UV\4D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\O?4^Q]
MD3NYTSJCZ^%UV\4D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\O?4^Q]D3N
MYTSJCZ^%UV\4D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\O?4^Q]D3NYTS
MJCZ^%UV\4D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\O?4^Q]D3NYTSJCZ
M^%UV\4D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\O?4^Q]D3NYTSJCZ^%U
MV\4D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\O?4^Q]D3NYTSJCZ^%UV\4
MD<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\O?4^Q]D3NYTSJCZ^%UV\4D<#
ML*='E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\O?4^Q]D3NYTSJCZ^%UV\4D<#L*=
M'E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\O?4^Q]D3NYTSJCZ^%UV\4D<#L*='E[
MZGV/LB=W.F=4?7PNNWBDC@=A3H\O?4^Q]D3NYTSJCZ^%UV\4D<#L*='E[ZGV
M/LB=W.F=4?7PNNWBDC@=A3H\O?4^Q]D3NYTSJCZ^%UV\4D<#L*='E[ZGV/LB
M=W.F=4?7PNNWBDC@=A3H\O?4^Q]D3NYTSJCZ^%UV\4D<#L*='E[ZGV/LB=W.
MF=4?7PNNWBDC@=A3H\O?4^Q]D3NYTSJCZ^%UV\4D<#L*LM5HETC$)SDBJGV$
M+K5NCH6Z+F(2I^55R\>,RG*FL8RX^^ZVRTC'\I;BTH3C*E8QKG%I-'+0!&AD
M\Y!-CVFQL5CB;[@ 23@%0#.XW'0<"JUT>7OJ?8^R)W<ZZ9U1]?"Z[>*DC@=A
M3H\O?4^Q]D3NYTSJCZ^%UV\4D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\
MO?4^Q]D3NYTSJCZ^%UV\4D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\O?4
M^Q]D3NYTSJCZ^%UV\4D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A3H\O?4^Q]
MD3NYTSJCZ^%UV\4D<#L*='E[ZGV/LB=W.F=4?7PNNWBDC@=A5FK-$ND?S@\?
M53[/CZR5CL^,%S$>-?<\1XMEOPFL>$XOP<^"C'*I7)GDQ]S7*+28!YN4:&91
M6$R>TR G,FVP#%4 VV&[#I"K/1Y>^I]C[(G=SKKG5'U\+KMXJ2.!V%.CR]]3
M['V1.[G3.J/KX77;Q21P.PIT>7OJ?8^R)W<Z9U1]?"Z[>*2.!V%.CR]]3['V
M1.[G3.J/KX77;Q21P.PIT>7OJ?8^R)W<Z9U1]?"Z[>*2.!V%.CR]]3['V1.[
MG3.J/KX77;Q21P.PIT>7OJ?8^R)W<Z9U1]?"Z[>*2.!V%.CR]]3['V1.[G3.
MJ/KX77;Q21P.PIT>7OJ?8^R)W<Z9U1]?"Z[>*2.!V%9KV(J5G#V\C*+5\N-C
MN5N8PA^:/DQFEOJ)AW$M)6ZVE.7%-M.+PC&?"REM><8Y$YY/!E&-"B0&-AQ&
M/(BM)#7 F51XG(&Z9 ]JVP$$S!%F'2%@^^_SZNGZ66/_ 'B9KZ%'_=X']&%_
MHU8=>?6?>JGKLHFB)HB:(LO;/?A*T_HK_P#)JUKPT_\ XX7]8?\ 5%6V7GU?
M:%F+7S5U31$T1-$31$T1-$31$T1<I^_C^W'^>B*3.?AHQ^="'^K>UEGF-^BW
MW!%%ZTB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HBPF_O[0X9BYQ"62HFL4
M(HU6K%N258'P*"W=7EUYINC0",@F@P4LKLBU!!T; \%(#3K!)?J0\Q*MP\@!
MBR?YT>K\_8967YZ+?=)?E'$KP^NNS&(^\^VTM^"'"6"2S!MX6<ZD-9<4Q5=G
MM-Q);ZY+)W&XVWV1&(V'G"'GS4/)4.^<@?RQ,&X@W:<;MMFT8A)' _F? ["J
M[%XN.'J62+#D[FUJ-@$1M 4Q+)DH8AJ&?J=RCT$@":AE9$,P4GR[0_S:(="B
MR0TF^EIF-/5()!V"28Q&G3I!D=_YN21_/JG[E*V'BBX?:N@<X6W8I^$%Y-2C
MC5#B23*9R+TRU)JL^+D.B=B0'+1I$62V:9RL4Q'FP7I4QA$Z'E\2!I"DCA^1
M?L0;Q0;!3Q,0L_NM1!/E%5JMPDCR5NK2IHT1<V:<Z \K<&EB(Q^1+7N%0V$)
M%D2+#SMUJ#D61(BVJO2":8E.8EZQIEQ&T8JR.!_,^!V%7.%NWMZ3*T 2(LL$
MTYN@ F6BC3@J\E1)X%#'L%L$HQ2!A^&F'-&OJF#I;KJ(LYN.^AA]3_B6G:I+
M=9^=BR1HB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)HBE0__ #,C\U&O]IFZ
MRZX?29_NU%%:TB:(FB*MW.Q(I]/M=M<B*GMU>MG;$N"A[$=<Q 07*)JB(D*;
M>2PJ0F+EE+V6G<-97A>6UX3X.2+1NI<?H&W6';*MQ]OI(Z;;Z8'*7A^=9E.P
MMNMPY^_FVNP!+:OQPRM3UV4V&L5W*%7BJ6@<)T4/J$]QF*%OK)P!FM=9>+9F
MXS (L!F1,]%V@S&JIM_"T2)G?@/S)9$V)XN!V^5AVTKXNE%Q:;ILD2W0-GWG
MT/5T59A0K8 N2H8&7EIJ8?<%1M]X#90W+@ XB98O,,6T5D)-H  Z9 EHG[C+
M>/S.4(E/H,O?P6XFM*)HB:(I07_XC^:Y?_IZR[^'Z0^U%%ZTB:(FB)HBT5L_
M'34*-NM<=L+I3C 7-8W%S4!9UH@@BBY (^P!W><K8JR)9&MRYYH&?"PMNC-/
M8=>>@/W.@V)XUANU10S.:ULI:98SLG=+1<?8=,E963GHGO ^V<_8ML]O;Z)W
M'K?G&)AEA>&#=GK)4,=CQHQD)8Z;8RE4LH8BB!,)#77AIP//C(G"B1,.2CH9
M)""1 9+BS'M SW[K#^=BAL5WT1-$31%?-O/PU*_-;_\ JX6N,?S!](>XHM+[
M[_/JZ?I98_\ >)FOT%'_ '>!_1A?Z-7!UY]9]ZJ>NRB:(FB)HBR]L]^$K3^B
MO_R:M:\-/_XX7]8?]45;9>?5]H68M?-75-$31$T1-$31$T1-$31%RG[^/[<?
MYZ(IPU$>49+*QXKD43GYQRR8^,\F93N<<N,NXSC/X\9QC./O9QC.LLG4;8[S
M6_PNP'0BC/(W_P"I]JC=]K5OHNZKN")Y&_\ U/M4;OM+?1=U7<$3R-_^I]JC
M=]I;Z+NJ[@B>1O\ ]3[5&[[2WT7=5W!$\C?_ *GVJ-WVEOHNZKN")Y&__4^U
M1N^TM]%W5=P1/(W_ .I]JC=]I;Z+NJ[@B>1O_P!3[5&[[2WT7=5W!$\C?_J?
M:HW?:6^B[JNX(GD;_P#4^U1N^TM]%W5=P1/(W_ZGVJ-WVEOHNZKN")Y&_P#U
M/M4;OM+?1=U7<$3R-_\ J?:HW?:6^B[JNX(GD;_]3[5&[[2WT7=5W!$\C?\
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M@W$K!!!D=(!!&D&XX[1-776E$T1-$6>^';^>Q3]%IO\ NP37S<J?N[/ZS?\
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M :;#S<OCD)C8R:31#>]AOO8XWBJ;VZ6^2<19<K5?T[>F>.-OK4V V.,U01$
M5>D!:V"'X>Q "@55D.)A8DR'I<C$0</EQX<?RB7(?E/^)91XV0^\^YX3KBU*
MHI5%: &Q&@"X!K@!Z@&R4+7&TB9Q)'%3'1A>?4B>U0OS'5SRC:T=5_=2H[#>
M.*=&%Y]2)[5"_,=,\HVM'5?W4J.PWCBG1A>?4B>U0OS'3/*-K1U7]U*CL-XX
MK,VQM*LP*VD9A4:F+'<KLN,ASRX<_P"$\LF(=2CP(TMYS'*VRXKPLIPC'@\F
M584I.,^#*$>%%@M;#>'$16N(DX6!CQ.T#20M-:0;1HZ.A8'OO\^KI^EEC_WB
M9KZ5'_=X']&%_HU8=>?6?>M2.(L'?C4#;=6WC,APP*N]GGYD---R(HR=)V*W
ME"4DL3CO,2HRX W<\Q1)67Y<61#&3&X9>6AN./<D,6*'&I5O#B<9'FX@:3HD
M'EM]@,B;IK3" 3.Z0]HK-)'5!]=RK86C<1<25XHON/./5D6;)+>%D7J*T:NE
M;F!P\O(^?-A[;)Q#D<^OV,7"<&%JGF(,2.PIW&&D2]0-B@VO):";#4FYLA?)
MF,Q86R$DFS0+9"5]A&DVR,[";"L*T_9N] G=MX5LVM)2:E5[ENS<I9L=)I;]
MH#U&RJ.I&;83:6"M3P<: +)L9*780^V.+0.+BJ_50/,4DB9)O@>;6.%6LPD!
MSW3%28:2Z3"T&4C6,PRM,!HD9FK2X6R-ID!H!EIG*9(T5I6F<UN9LH,LP79K
M:0-=/*?/$3ME0AEL\LD>52_.:!5144]Y5*\-SRF3SHU*\?(\8OQSOA.>&KPN
M7/>&"&,#O.#&AT[YR$Y^U8<07.(N))'JFMJ]GOPE:?T5_P#DU:UY*?\ \<+^
ML/\ JBK3+SZOM"S%KYJZIHB:(FB)HB:(FB)HB:(N4_?Q_;C_ #T129S\-&/S
MH0_U;VLL\QOT6^X(HO6D31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31%\W
M*S]H4Q+%U":>V0W;FDKCM+L=?0]7H=.GV:S%S&YM3WNNME; BLR6'"M6"!=G
M7FZ\387S@=)%41W8$2(S*(0\UN@W V"=\[)7V2WJRM/093-@O ^VW *=W%X_
M*P $[NP*5M_<3]WV[K6X%A%((8J4.G& U*"6>2J\LGI-U&,&J8@[6WQ<J'79
M<RWS?^,D.#E/1".!XNOL,QB+--M]UGKP5#;M$_MT>N1G]MZOX+C.IMLO!/;F
MK4:^D[- (&?%ON8ID*N3*@#=&0YVXXT_/N4,<=J;9 O"BLQ@#Y.S%,8EO!P4
M]B!-=CVL)RMG^;1B/5;?985)=(N_(]>[I5+VLX[!MWA[2!#&SN[K>XU]9K+5
ME#5:KC+.&J//%4X?K//MQ$A7[18&X%%A1.(^BD),Z5+>G!A$2S.F&6I >&V:
M@=.4P9GHGAA.0M&])=(XW\"M^]:431$T1-$31$T1-$31$T1-$31$T1-$31$T
M1-$31%*A_P#F9'YJ-?[3-UEUP^DS_=J**UI$T1-$55O5B=J%(N-L9BMS7JO5
M;#8FH;KBF6I;H01,)-Q7'4)6MIN0N-AI;B4*4A*\J2E6<8QDB^>]*X_2ENM.
MVE7>H, 6X3KX$3NM.B3I)INH[VSN(+9390KMN#C/*!9FBX [=)F^><1.1$GY
MI=LVTM,*NEXYA\3(P'3LE+'3(S (T8SGA(RM6JMD]G2)$SW2TVS$Q)9-X=N+
MPEOK:-K*WFE.!V+1L.8W%M5C6\*:%/WP,$X9CA"OTT<FT$+0V!&,[^/1IDRS
M@(*I<D? 6*GS(.<32M#ID#HF;K_),KYZ=(4(E.VXR]]^Q;RZTHFB)HBE!?\
MXC^:Y?\ Z>LN_A^D/M11>M(FB)HB:(OG;>>/#&V.\%OVXNU!4T)$;DDJ[43
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M<UF>LI9-S*5(<22#QBF8ZF+7M-;&(N9L*,/>!O #!4F"E$I887HT@"0J&L2
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M44G[0E^/4&;@C;A1M&:,(LTZNK+LULR#=%UKB^N-\P>D/(-9@GV G"D5'CJ
MZ%CS UI.CQ=@M"(DDE/K,K63D;IR-A%CB9WVV2EC?T )_GU2]XMG=OOG$IQ=
M6'9W<294*^#BRZX%VS/S[7;IU5N),37MR;/4[X=V='3+<+;320<9PMMRW6K%
M5+)-BV:QDMX]IY-8>APV2^"=<X@W:#;(RG(RMNT2(OF0DK)].(]UYGNDHP!Q
MX1R@ZR2950J4>/1@X&5:;@SN5,-;>S"=NGU 13X-0.4W;ZV%[1@J9NX<$;='
MUS+=9LT&S5]*C3P1B255NB[2#,6W2LF9Z;+#.])2OG=.ZV_V8$JO(^T9K<T"
M%M<:I8ABIE8I-^6'66P5/$J;>.%G<SB$B379B(HFL4^(/*T1ZJ22A$T>),($
M'2E@J%6 D:[8YD+Q*8NE6P)%4GV72MX%6J??M!E9C?T;I+*=$XQTW6_5RDHV
M^C-Q)YIBL6"VAKU$L-?BGB-GXAJH'=IK[5>@9NU9F$N'2QJE'7LUB7 9/!VE
M!'R$0W!&T.F0)>V?KNQ\TX7CIE)2$_S<#]OXK=O6E$T1-$31$T1-$31$T1-$
M31$T1-$31$T12H?_ )F1^:C7^TS=9=</I,_W:BBM:1-$31%4-P;#+J5"N]K@
M,QY$ZLU"RV&%'F)=5$?EA0TTE&9E)9=9>5'=>C(0^EIYIW+2E8;=;5R*P1?-
MVD<=VY5FMVV=7)T^IC$<T5NG[Q3HPH^]F/OM.XA.'K:HP$ID:=98*Q=-SM_O
M**W.$/F<V$G(K^Y6W!%,N4X".AK'BL9RLLL)_P#:;18)W2,[<1TK4A;N]4B=
MMDCTV>K(_#%Q@V7?6^;94HB,J4#G'AVG;@794,TVJSOWV+7.%FQ9DM4Q6%3:
MA29#.^AENO2)Y W(LS<)N:E0F'#A.GZ"3(=!-]LQ5T#1;[K$(E.^^7LMX="^
MA6M+*:(FB*4%_P#B/YKE_P#IZR[^'Z0^U%%ZTB:(FB)HB^9VX_'1;]I=X+K2
M;=2@,FGC-R[$(I9L;@E%EFZ31^%HGN]?HAPC+)/AZ_8JK?WJ(N7:"#42O.[<
MWB1ED"X1I5@L"L%Q!,QILZ15F=^G ]!5E.[0-I)E9MZ;?6MW]G-RVMVJ,S<6
MQ\,:M-CN]5E,BC;=F!2"%#NA^D$2-;LK4$6@_72<ZOR)P4HH6,DOP)#*9PP=
M/;E0H^@9B:A$EE+51-$31%?-O/PU*_-;_P#JX6N,?S!](>XHM=KAM?89]MM$
MYF8"2S-L1N6TEXGAMU+4DG*>;2ZWXG/@.80O&%HY<^"K&4\N>37UH-,@M@PF
MD1)MA0VF3)B8: 9&=UBYEA))LM)QX*N]$EE]-KW:V.XUTSZ#A$ZAXJ5#B-_!
M.B2R^FU[M;'<:9]!PB=0\4J'$;^"=$EE]-KW:V.XTSZ#A$ZAXI4.(W\$Z)++
MZ;7NUL=QIGT'")U#Q2H<1OX*^46FS:@JRE#A,%&@+K[<3,A!+QJ6G7;$ <;R
M[R,XRAM>6<MX7R9_XJVT<G\OEQYZ3';2!#APFQ'/YVM*K*8$.).5M]L_4"M-
M:6DDD2EP5EYZK/6NN^W+[C7GYF-J8G5'%:F,1M"<]5GK77?;E]QIS,;4Q.J.
M*3&(VA.>JSUKKOMR^XTYF-J8G5'%)C$;0ORX6JSJ%M.VBM.-N(4VXVY-RM#B
M%XRE:%H5'RE2%)SE*DJQG"L9SC.,XSIS,;4Q.J.*3&(VA=&9M-4^Y*58:HJ2
MZTTR[(R^G+[C+#BGF&7'LQ?&+:9=6MUIM2LH;<4I:,84K.<N9C:F)U1Q28Q&
MT*BWB@[+[D(@M71ZIFFX#9&,VC)@F/3*&&F\,G0!; MV#@Y5[ TE#5AJIKR^
MN'VVVD&!<U+3>$C C'_PQ-GXW=%R5AB-H60^>JSUKKOMR^XTYF-J8G5'%)C$
M;0G/59ZUUWVY?<:<S&U,3JCBDQB-H3GJL]:Z[[<ON-.9C:F)U1Q28Q&T+G!J
ML\N/_NNN_?Q_^^7W&G,QM3$ZHXI,8C:%*GB]>;.FFWK,!8>;+$4.L/35I=9=
M1,>2XTZGQ.?!<;5C*%IY<\BL9QRYY-9APHQ8PB%$(+&D$"P@@2(MN*3&(VA1
M//59ZUUWVY?<:US,;4Q.J.*3&(VA.>JSUKKOMR^XTYF-J8G5'%)C$;0G/59Z
MUUWVY?<:<S&U,3JCBDQB-H3GJL]:Z[[<ON-.9C:F)U1Q28Q&T)SU6>M==]N7
MW&G,QM3$ZHXI,8C:$YZK/6NN^W+[C3F8VIB=4<4F,1M"<]5GK77?;E]QIS,;
M4Q.J.*3&(VA.>JSUKKOMR^XTYF-J8G5'%)C$;0G/59ZUUWVY?<:<S&U,3JCB
MDQB-H3GJL]:Z[[<ON-.9C:F)U1Q28Q&T)SU6>M==]N7W&G,QM3$ZHXI,8C:$
MYZK/6NN^W+[C3F8VIB=4<4F,1M"<]5GK77?;E]QIS,;4Q.J.*3&(VA.>JSUK
MKOMR^XTYF-J8G5'%)C$;0O%Y12.3DY\J')Y6[/Y/&-<GESZ'&WYG)Y)R>5O-
MO/(=D?\ ^9Q#KB5KRE:L9<S&U,3JCBDQB-H40!$;85<(,K8";21@,+B+S6-C
MN8S'A+A(0U$>:P['<7Y1';:;0U)6M4A"6T8P[_)QR.9C:F)U1Q28Q&T*>P1J
M*<ISBR5?&4^!X.<2L8RGQ:EJ;\'DC?<\!3CBD<G)X*EKRGDRI6<N9C:F)U1Q
M28Q&T+S)=HR$1VT&J<EN(I*XJ$K:2B,M"'FT*CIQ$PEE2&Y$A"5-X3E*'WDX
MSA+J\*<S&U,3JCBDQB-H7:N93'%1U.6"IK5$0XW$4M]"E16WFO$.HCY5%SEE
M#K'_  7$M^"E;7_#5C*/N:<S&U,3JCBDQB-H3,VFYRO.;!4\Y<^XYG+Z,Y7C
MQ;K/(O/DO\K_ (3SS7\KE_X;KJ/_ ,7%XRYF-J8G5'%)C$;0NQPC474N(=LE
M6<0\M#CR').%I=6WXOQ:W$JC9PM;?BFO 4K&<I\6WX.<> GD<S&U,3JCBDQB
M-H73Y32?$.1>?:CY,\AUMV/XUOQ#K;[CCSS;C7DGBUH>>====2I.4N...+7C
M*EJSES,;4Q.J.*3&(VA<HE4MM:W&SU2;<<\7XQ:'D)6YXF.J*UX:DQ<*5XJ*
MM49OPLY\".I3*>1O.4Y<S&U,3JCBDQB-H7Z9FTV.AEMBP51AN.VTU'0R^EI#
M#4=+B&&F4HBI2TVRAUU+2$82EM+CB483A:L9<S&U,3JCBDQB-H7IYZK/6NN^
MW+[C3F8VIB=4<4F,1M"<]5GK77?;E]QIS,;4Q.J.*3&(VA.>JSUKKOMR^XTY
MF-J8G5'%)C$;0G/59ZUUWVY?<:<S&U,3JCBDQB-H3GJL]:Z[[<ON-.9C:F)U
M1Q28Q&T)SU6>M==]N7W&G,QM3$ZHXI,8C:$YZK/6NN^W+[C3F8VIB=4<4F,1
MM"<]5GK77?;E]QIS,;4Q.J.*3&(VA.>JSUKKOMR^XTYF-J8G5'%)C$;0G/59
MZUUWVY?<:<S&U,3JCBDQB-H3GJL]:Z[[<ON-.9C:F)U1Q28Q&T)SU6>M==]N
M7W&G,QM3$ZHXI,8C:$YZK/6NN^W+[C3F8VIB=4<4F,1M"<]5GK77?;E]QIS,
M;4Q.J.*3&(VA2X4O75RI.&K,!>5@0<6I+4U2E);;#SEO.JQEG'(VRTE;SJN7
ME2VA2L8SG')G+X48 3A1!Y3!:-)>T 7Z20!TE)C$;0HCGJL]:Z[[<ON-:YF-
MJ8G5'%)C$;0G/59ZUUWVY?<:<S&U,3JCBDQB-H3GJL]:Z[[<ON-.9C:F)U1Q
M28Q&T+A1BKJ2I*K57%)5C*5)5.5E*DYQR92K&8^<9QG&<XSC..3./N9TYF-J
M8G5'%)C$;0NGG"G^%A7G'5O"QE*L*\IQX6%)RQE*L9\FY>5.8L;*<\O+C,9C
MDY/$M^"YF-J8G5'%)C$;0ORU-IK#N7V;#5&7E--L*>:?2VZIAK&$M,Y<1%PO
M+3>$IPVWG/@(QC&$XQC&-.9C:F)U1Q28Q&T+T\]5GK77?;E]QIS,;4Q.J.*3
M&(VA.>JSUKKOMR^XTYF-J8G5'%)C$;0G/59ZUUWVY?<:<S&U,3JCBDQB-H4L
M*+UY?.7BK,!=\ 3,6YXN8M7BVD^+\-US_@8\%M'+CPE?=Y.7'W-9=!C"K.$\
M>4 )B\VV"V\I,8C:%$\]5GK77?;E]QK7,QM3$ZHXI,8C:$YZK/6NN^W+[C3F
M8VIB=4<4F,1M"<]5GK77?;E]QIS,;4Q.J.*3&(VA.>JSUKKOMR^XTYF-J8G5
M'%)C$;0NE1*I*SG*K+5U94I2U95*Y<J6MKQ"UYSF-GE4IC_@J5G[JFO^'G.4
M?<TYF-J8G5'%)C$;0N6"=3C,M1HUFK$>.PVAEAAB7XIEEIM.$-M---QDH;;;
M1C"4(0G"4IQA*<8QC&-.9C:F)U1Q28Q&T+MYZK/6NN^W+[C3F8VIB=4<4F,1
MM"<]5GK77?;E]QIS,;4Q.J.*3&(VA.>JSUKKOMR^XTYF-J8G5'%)C$;0L@[;
MD0TDY+;@G1!!W E]:F84I3KJ6\3(*<NJ3EI&,-I4I",JY?N*6C')]W[G"D0X
MC6 OAO8*X$W"0G)UE]]AV),&X@^U0)W\.&?SJ1_U;VJSS&_1;[@JL"\0=;N]
MPV;O=8VXF2QUU-C(L '.@E9@63$==+#_ "R0@D./U8C'0V.3,4_@=9 <^0QA
MV-")PY+S3R:9R,KY&7K18$VJV[WXI6[^[#I#,DI7935*B4"T6$U:B=&<!C=N
M]FP]I@B0Q3B'NMD!S)EL"7LD.'FMM9!)J:L@6);L&F3N!LR $$WRQG9<,7'I
MT8VVVVRSU6^N9^R2QG5-E.(RB5;;LR8/[L[AV\AO'MI9K+4Z_N5+@":15@Y<
MKYZOV:3?-\Y<*\\_A"F&30.O/(ILAX2$E@-L11V-/.$@!$IS)Z#["3,V_F0F
MK,3Z #+IOEH]]N)7TLUI94%;_P"8]O\ S<*_ZIK^NU&_>8/TG_\ 3%67^:?9
M[PM7-?:7%-$31%$GC@FL!#%D/3F1@, ,GF3!&1X>6((P9%=F3I;N&TK<4B/&
M9==4EM"W%83X+:%KSA.82 "38 "2>@7H!,R%YL"P,&XK]DS#-?GN6237P5D#
MA"<2TVT5-JU6@$+!18>YPVIG#QQ$* $N"]OI\:V/ 23L=^.+<QAYQ,S*8N>8
MC0S(S(! ,W AHFT/ +C8'5#6E.Y:+'"\6C1>93E.S1.SUJWM<0FP;PWGIG>[
M:-T/Y? %<ZHW'IZAV"96/)E#!V9N#&8V)Q"-"F2(47+OCY3,.6XRVM,9_*-<
M[#E/G&2G*==LIF<A.=]AV%*KIRJNG?*1G+&Y9@UM931$T1<I^_C^W'^>B*U7
MS^?%S_2NQ?[O,UQH_P"[P/Z,+_1JKKSZS[U5-=E$T1-$31$T1-$31$T1-$31
M$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-
M$31$T16NG?A,A^BEU_Z1-:Y1O,;_ %8'_?#5%_L=[BJIKJHFB)HB:(FB)HB:
M(FB)HBME4_\ ,OZ)F?\ VVN,;_Q?UF?:J+G>K[0JGKLHFB)HB:(FB)HB:(FB
M)HBSWP[?SV*?HM-_W8)KYN5/W=G]9O\ I$6V7GU?:%EH[^'#/YU(_P"K>U\]
MGF-^BWW!=5@C?"UG:?4ZY/K\SFV66W>V+J,PEY/&E)BA+IO)1ZJ>8RQ+8DM>
M,-""\RNQI&&_&P9AB-/8<:>BH<329;0-I 0;;_=]EZP]M3O[N5N!3B!*\;=)
MVJ?E4P#<6[HW,BF*=MZ(MFUXJ]0GKS#N$R@V"86!$II "4'UD4:A,SAJ<&)@
M.,X[(0!Q$OLL!TR]7L5,@<?SHO6LY#BBW(F[75*U!=SD1;XSP.'=Z=Q:Z1J]
M9B5Z%?A>UQ$[ 77FI(#!^?>%;@ K FT5F*1)5>J4VN%1U@  [&>IY CF9D#.
MVK,V2T7ROOT:!TR5 $Y7VROM/V2V7WV%?5AM2EMMK6A32EH2I3:LIRIM2DXS
ME"LISE.5(SG*<Y3G*<YQRXSG')G6UE0MO_F/;_S<*_ZIK^NU&_>8/TG_ /3%
M67^:?9[PM7-?:7%-$31%6[=40-Z 3*Q9HLF6'G/C93S4(J7!S42@Y2$:%RHA
M<#.&%Q\J"5'0IL>3 GQGT/1T?\3P,J2J.:'"1G(RN)!L,P000000#,%4$@S%
MA_(6M(G@MVG##J\!B&=PWZU69E5.C*^4M#!F-YZ5"J":"+O4HL5$S+1)L"J"
M&B4Q^$X?\TVPF7,CZS!))8(L<A 8 !-U452 3/RF@-#ID5IU0&RG5E<T&U:K
MN)F93,Q/H)G*SIMG?TRL58W*X+1]F,5H_0K\1I!4-,<>GJ*A1]P'DV,6K<BZ
M0V7A$Q< ;*C1K!NI:798XG&GQ"L% >$XJ)Y!*?)9?1YEI:\M(OF Z?E.=<9"
M]Y!Q$L+0>1.=H/3;<!?H,@!/1;?8MX=>A831$T1<I^_C^W'^>B*U7S^?%S_2
MNQ?[O,UQH_[O _HPO]&JNO/K/O54UV431$T1-$31$T1-$31$T1-$31$T1-$3
M1$T1-$31$T10QRN5^S1H\*QA!)Z)$G12D6*8'Q"4>,2A*4J&089F-/-M38JE
MK5'DMI2\SE2LMK3G.=0@&\ VSM$[1<;=*3(N,EWAPPBO#(84"+'A0X]KQ$ 6
M*AQX ^$SX2E^)BPXK;4>.UX:UJ\!IM"?"4K/)RYSH  )   7 "0'L"*2U431
M$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T16NG?A,A^BEU_Z1-:Y1O,;_
M %8'_?#5%_L=[BJIKJHFB)HB:(JQ8J53K>J(NUU6NV5<!@C&@J/!AY94.,89
M;C%F(N9T=_+#)..RTQ/;:\%$MEIMM_#B$)QB%K77M!E.4P#*=]^.G%)D7$A6
M)AAF,RS&CM-L1X[3;###*$MM,LM(PVTTTVC&$-MMH2E"$)QA*4XPE.,8QC&J
MB[=$31$T16RJ?^9?T3,_^VUQC?\ B_K,^U47.]7VA5/791-$31$T152QT.D7
M%;3ELJ%9LSC$9Z$PL^#&EULPY#\>2_%:5/C/Y1'>DPXDAUE.<-N/1H[JDY6R
MVI,+6N\YH=ZP#[_4-BLR+B1[5:]51-$31$T19[X=OY[%/T6F_P"[!-?-RI^[
ML_K-_P!(BVR\^K[0I:U;I"A]HLD!RK39#D(\8B+?39&6$OKC$)#*GDLYKKV6
M4N*1E>&LO.Y;PK",NN<GAYYPJ$Y\*&\1FBM#8Z7-$RK-!E/G1.4Y3D)X!4OD
M2)7&5_X*K3MSJR3C^2$J&X0B^/B2O)IU@A2X_E,"6Q/@R/$OU5QOQ\*=&C38
MCW@^,C2X[$EE2'FFUIZ9@_7M[$^,G.=&_P#!>OI=$=4)_O2Q],:9@_7M[$^,
MG.=&_P#!>2?N=62L.0/)T-PC E(\5*@S[!"F0Y+?+A7BY$:157&7D>$E*O <
M0I/+C&>3EQC3,'Z]O8GQDYSHW_@O7TNB.J$_WI8^F-,P?KV]B?&3G.C?^"LU
M?LX&_P 2S )0 H.BY!QYC[S%BC/ON)C6,!XMEK+E=0VSG+RVG%NJ0]C+;:VL
M-I4[AYKE$@Q*(8481&/(B%H!A. \J%$F3**2;)V66D&=DC0:\Q*5D[^D="\O
M1M1/1[3[P"_I?5SVD?R>S?XR5!B=W!.C:B>CVGW@%_2^F>TC^3V;_&2H,3NX
M)T;43T>T^\ OZ7TSVD?R>S?XR5!B=W!.C:B>CVGW@%_2^F>TC^3V;_&2H,3N
MX)T;43T>T^\ OZ7TSVD?R>S?XR5!B=W!.C:B>CVGW@%_2^F>TC^3V;_&2H,3
MNX)T;43T>T^\ OZ7TSVD?R>S?XR5!B=W!.C:B>CVGW@%_2^F>TC^3V;_ !DJ
M#$[N"=&U$]'M/O +^E],]I'\GLW^,E08G=P7.-MJ)RX_^GM/W\?^8!?X_P!%
M],]I'\GLW^*E08G=P4S9-OZ7,L1^7*8LF9,HT5DR,L'1K3.7WYS[KN66EUMY
M;;67%*RVVMYU2$<B5.N9QE><0J7';#AM'-2:QC1-CR9!H F1% )D+2 /4$+
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M^E],]I'\GLW^,E08G=P3HVHGH]I]X!?TOIGM(_D]F_QDJ#$[N"=&U$]'M/O
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MTSJ/K/\ %G=2HW#>>*>8]'ZO+[8*=_IG4?6?XL[J5&X;SQ3S'H_5Y?;!3O\
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M,-IG9C*VY::XDR,KN"G#OX<,_G4C_JWM>=GF-^BWW!;45K2)HB:(FB*"M_\
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M"5S@-_%.ENR^A5[LG'?Z9C!QB=<\$KG ;^*=+=E]"KW9.._TS&#C$ZYX)7.
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M?SJ1_P!6]KY[/,;]%ON"ZJ*UI$T1-$31%!6_^8]O_-PK_JFOZ[4;]Y@_2?\
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MG&<OBQ2!.)$/E,-KW7A[2#?H-HZ4D,!L"B>:P/5JM=A#NXUKGHNMB==W%)#
M; G-8'JU6NPAW<:<]%UL3KNXI(8#8$YK ]6JUV$.[C3GHNMB==W%)# ; O"3
M34@PT@8*A*I!&"H,LD1FR @Y#$.!!8<E3)3Z_)\^"S'CM./.*Y,^"A"L\GW-
M.>BZV)UW<4D,!L"QB,WEV!-R*+#"&=O3<S<REP=Q:)##!HY:79*&2.5*MQ+=
M!BCX$E]-?6:O-7ANDY+;$6+@DN5*<9ACBDB$YZ+9^UB6B8_:.M&(MNM&U6J/
M1&%POP4[6[]M';ETMJN8IY1W<.AO;FTYEFN(:>,45C%2RY8<-21S+D"/R7JJ
MY1&)IA$'>=D>*B+\DG^2N>BV?M8EHF/+==MZ5*HP%EEP5_YK ]6JUV$.[C3G
MHNMB==W%)# ; G-8'JU6NPAW<:<]%UL3KNXI(8#8$YK ]6JUV$.[C3GHNMB=
M=W%)# ; I84."HYR\77J\WX0F8A?BPT!'C&U>+\)MSP6<>&VODQX2%<J5<F.
M7&>367Q8IJSB1#)X(F]UAMMOO20P&P*)YK ]6JUV$.[C6N>BZV)UW<4D,!L"
M<U@>K5:["'=QIST76Q.N[BDA@-@3FL#U:K780[N-.>BZV)UW<4D,!L"<U@>K
M5:["'=QIST76Q.N[BDA@-@6.(>Y6R9"SE:5");<R;8#N;&WIBO-0!:BHVZ2M
MOGMUHM?F1/)\.,S9.W<:5;(^5XQ'>%1)BVGE/1)#+3GHMW.Q)X<X[UXX6I5&
M QN&,O>LA,0JU*9:DQ@%5D1WVT/,2& PMYEYIQ.%-NM.MLJ;<;6G.%(6A2DJ
M3G&4YSC/+IST76Q.N[BDA@-@7;S6!ZM5KL(=W&G/1=;$Z[N*2& V!.:P/5JM
M=A#NXTYZ+K8G7=Q20P&P)S6!ZM5KL(=W&G/1=;$Z[N*2& V!7_;B"+8.2EQ
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M9D^R1QNZ4(%OK-FFZSITVZ+,9+Z::TLJ"M_\Q[?^;A7_ %37]=J-^\P?I/\
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M92AJ/&C,-MLL,-(2VTTA#:$I2G&,$4;;_P"8]O\ S<*_ZIK^NU&_>8/TG_\
M3%67^:?9[PM7-?:7%-$31$T1-$31$T1-$31%RG[^/[<?YZ(MUC>6.>B_*/#K
MSSI/Y5NA!#KB\^5N\JG'7(2W'%JS]U;CBE+6K.5+4I6<YS^>875&^4\>2VP/
M<!<-$UWD,!L"B^6/ZM"=@A?@-:K.]-_7=Q20P&P)RQ_5H3L$+\!I6=Z;^N[B
MDA@-@3EC^K0G8(7X#2L[TW]=W%)# ; G+']6A.P0OP&E9WIOZ[N*2& V!.6/
MZM"=@A?@-*SO3?UW<4D,!L"<L?U:$[!"_ :5G>F_KNXI(8#8$Y8_JT)V"%^
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M!TNY(QEE1-;L),:EZ.C,X>",3(OC8XV8XRS:BSJ\VRM99,SM!(LG.T D8@'
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MQ+$@!90@>&,&9@PK8[*[7!QBSF7F,R3!EADE+6_/:\K5J%"YL6N+W6^4;+"
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M- P"*-YT(^FR?[U?[]:D,!L")SH1]-D_WJ_WZ2& V!$YT(^FR?[U?[])# ;
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M="/ILG^]7^_20P&P(I,22GKD/X5,D*Q@885C&759Y%(%RUH5]_[Z5)PK&?\
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MU-&%8,P=.8CS(K[#=DW ; HK#SH1]-D_WJ_WZ2& V!$YT(^FR?[U?[])# ;
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M=G$*D#.*C9LQ'ILH?NP/?9O]SO.W]3RI\Q'62MFVD>S2[T->9DQ67A3%<BU
MY(FES#8\*MEL:Y%(R$GP&2<\FRP6D@6"TB<_<K([I^PRXA91F[A QLEV&1O
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D31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31%__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
